Citrus Sinensis ID: 017362
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 373 | 2.2.26 [Sep-21-2011] | |||||||
| Q9NBK5 | 463 | Serine/threonine-protein | yes | no | 0.852 | 0.686 | 0.545 | 1e-98 | |
| Q54Y26 | 530 | Probable serine/threonine | yes | no | 0.919 | 0.647 | 0.511 | 1e-98 | |
| Q2LZZ7 | 458 | Serine/threonine-protein | yes | no | 0.900 | 0.733 | 0.539 | 5e-98 | |
| Q5R8M1 | 465 | Serine/threonine-protein | yes | no | 0.871 | 0.698 | 0.519 | 5e-97 | |
| Q15208 | 465 | Serine/threonine-protein | yes | no | 0.871 | 0.698 | 0.519 | 5e-97 | |
| Q9Y2H1 | 464 | Serine/threonine-protein | no | no | 0.860 | 0.691 | 0.528 | 6e-97 | |
| Q91VJ4 | 465 | Serine/threonine-protein | yes | no | 0.871 | 0.698 | 0.519 | 6e-97 | |
| A2VDV2 | 465 | Serine/threonine-protein | no | no | 0.871 | 0.698 | 0.516 | 2e-96 | |
| Q7TSE6 | 464 | Serine/threonine-protein | no | no | 0.876 | 0.704 | 0.513 | 2e-96 | |
| Q5AP53 | 732 | Serine/threonine-protein | N/A | no | 0.871 | 0.443 | 0.498 | 5e-95 |
| >sp|Q9NBK5|TRC_DROME Serine/threonine-protein kinase tricorner OS=Drosophila melanogaster GN=trc PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 360 bits (924), Expect = 1e-98, Method: Compositional matrix adjust.
Identities = 186/341 (54%), Positives = 236/341 (69%), Gaps = 23/341 (6%)
Query: 41 LSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEK 100
S+ T K AK +EN+Y + ER++R LE +L D +SE + +
Sbjct: 16 FSDHTLDKATKAKVTLENYYSNLVTQYGERKQRLAKLEAQLKDESLSEAQRQEKRLQHAQ 75
Query: 101 KETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQV 160
KETEY+RL+R ++G +DFE L +IG+GAFGEVR+ ++K TGHVYAMK L+K++ML + QV
Sbjct: 76 KETEYLRLKRLRLGVEDFEALKVIGRGAFGEVRLVQKKDTGHVYAMKVLRKADMLEKEQV 135
Query: 161 EHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARF 220
HVRAER++L E D +VK+Y SFQD LYLIME+LPGGDMMTLLM+KDTL+E+ +F
Sbjct: 136 AHVRAERDVLVEADHQWVVKMYYSFQDPVNLYLIMEFLPGGDMMTLLMKKDTLSEEGTQF 195
Query: 221 YVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL----------DCST 270
Y++ET LAI+SIHK +IHRDIKPDNLLLD GHL+LSDFGLC L D S
Sbjct: 196 YISETALAIDSIHKLGFIHRDIKPDNLLLDARGHLKLSDFGLCTGLKKSHRTDFYRDLSQ 255
Query: 271 LQEQDFTIGN--NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEV 328
+ DF IG +L+ S +++R A + W++NRR LAYSTVGTPDYIAPEV
Sbjct: 256 AKPSDF-IGTCASLSCSPMDSKRRA----------ESWKRNRRALAYSTVGTPDYIAPEV 304
Query: 329 LLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369
L+ GYG CDWWSLG IMYEML+GYPPF SD+P T RKV
Sbjct: 305 FLQTGYGPACDWWSLGVIMYEMLMGYPPFCSDNPQDTYRKV 345
|
Has an important role, with fry, in controlling cell structure and proliferation of a variety of polarized outgrowths including epidermal hairs, bristles, arista laterals, and dendrites. Affects cellular morphogenesis by regulating the expression of target genes that encode cytoskeleton-interacting proteins and not via the direct modification of the cytoskeleton. Maintains the integrity of epidermal hairs and is an essential component of the signaling pathway regulating dendritic branching of sensory neurons. Drosophila melanogaster (taxid: 7227) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q54Y26|NDRA_DICDI Probable serine/threonine-protein kinase ndrA OS=Dictyostelium discoideum GN=ndrA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 360 bits (923), Expect = 1e-98, Method: Compositional matrix adjust.
Identities = 183/358 (51%), Positives = 246/358 (68%), Gaps = 15/358 (4%)
Query: 19 GSGKKKEAGGNGSNEEST----DEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERR 74
GS ++E N +EE T + LS T + AAK YIE +Y ++++ER +RR
Sbjct: 12 GSDDERE---NFEDEEDTTTVYSSDPLSRPTMDRSLAAKMYIEQYYINAQQSVKERGQRR 68
Query: 75 NILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRV 134
LE KL + +S ++ N+L K L+KKE++YMR++R K+ DFE++ +IG+GAFGEV +
Sbjct: 69 KDLELKLENMKLSSKESNDLRKELDKKESDYMRIKRLKLKRSDFEVIRIIGRGAFGEVSL 128
Query: 135 CREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194
R + + +YAMK+LKKSEML++ Q HVRAER++LA ++N +VKLY SFQDD +LYLI
Sbjct: 129 VRHRESNDLYAMKRLKKSEMLKKEQAAHVRAERDVLASANTNWVVKLYYSFQDDNYLYLI 188
Query: 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH 254
MEYLPGGDMM+LL++ D TE++ARFY+AET+LAIES+H YIHRDIKPDNLLLD GH
Sbjct: 189 MEYLPGGDMMSLLIKYDIFTENQARFYIAETILAIESVHTLGYIHRDIKPDNLLLDSKGH 248
Query: 255 LRLSDFGLCKPLDCSTLQEQDF---TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRR 311
++L D GLC L +F +G+ + + E A TQ E++ W+K RR
Sbjct: 249 VKLCDLGLCTGF--HRLHSSEFYQMLVGDAMTIKMKLIE---ATPLTQTERIASWKKARR 303
Query: 312 MLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369
LAYS VGTPDY APEV L+ GY E DWWSLG I+YEM+VG+PPF SD+ TC K+
Sbjct: 304 ALAYSAVGTPDYTAPEVFLQIGYNKEVDWWSLGVILYEMVVGHPPFLSDNTTETCLKI 361
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2LZZ7|TRC_DROPS Serine/threonine-protein kinase tricorner OS=Drosophila pseudoobscura pseudoobscura GN=trc PE=3 SV=1 | Back alignment and function description |
|---|
Score = 358 bits (918), Expect = 5e-98, Method: Compositional matrix adjust.
Identities = 184/341 (53%), Positives = 238/341 (69%), Gaps = 5/341 (1%)
Query: 31 SNEESTDEEAL--SNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSE 88
S+ TD ++ S+ T K AK +EN+Y + ER++R LE +L D ++E
Sbjct: 3 SSRTDTDGSSIRFSDHTLDKATKAKVTLENYYSNLVTQYGERKQRLAKLEAQLKDESLTE 62
Query: 89 EDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKK 148
+ +KETEY+RL+R ++G +DFE L +IG+GAFGEVR+ ++K TGHVYAMK
Sbjct: 63 SQRQEKRLQHAQKETEYLRLKRLRLGVEDFEALKVIGRGAFGEVRLVQKKDTGHVYAMKV 122
Query: 149 LKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM 208
L+K++ML + QV HVRAER++L E D +VK+Y SFQD LYLIME+LPGGDMMTLLM
Sbjct: 123 LRKADMLEKEQVAHVRAERDVLVEADHQWVVKMYYSFQDQVNLYLIMEFLPGGDMMTLLM 182
Query: 209 RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268
+KDTL+E+ +FY++ET LAI+SIHK +IHRDIKPDNLLLD GHL+LSDFGLC L
Sbjct: 183 KKDTLSEEGTQFYISETALAIDSIHKLGFIHRDIKPDNLLLDARGHLKLSDFGLCTGLKK 242
Query: 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEV 328
S DF + S A+P +++ + + W++NRR LAYSTVGTPDYIAPEV
Sbjct: 243 S--HRTDFYRDLSQAKPSDFIGTCASPMDSKR-RAESWKRNRRALAYSTVGTPDYIAPEV 299
Query: 329 LLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369
L+ GYG CDWWSLG IMYEML+GYPPF SD+P T RKV
Sbjct: 300 FLQTGYGPACDWWSLGVIMYEMLMGYPPFCSDNPQDTYRKV 340
|
Has an important role, with fry, in controlling cell structure and proliferation of a variety of polarized outgrowths including epidermal hairs, bristles, arista laterals, and dendrites. Affects cellular morphogenesis by regulating the expression of target genes that encode cytoskeleton-interacting proteins and not via the direct modification of the cytoskeleton. Maintains the integrity of epidermal hairs and is an essential component of the signaling pathway regulating dendritic branching of sensory neurons. Drosophila pseudoobscura pseudoobscura (taxid: 46245) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5R8M1|STK38_PONAB Serine/threonine-protein kinase 38 OS=Pongo abelii GN=STK38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 354 bits (909), Expect = 5e-97, Method: Compositional matrix adjust.
Identities = 176/339 (51%), Positives = 240/339 (70%), Gaps = 14/339 (4%)
Query: 35 STDEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNL 94
ST ++SN TK++V K +EN Y + +ER R+ LEK + + + +E++
Sbjct: 6 STPCSSMSNHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLR 65
Query: 95 LKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM 154
+KETE++RL+R ++G +DFE L +IG+GAFGEVR+ ++K TGHVYAMK L+K++M
Sbjct: 66 RSAHARKETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM 125
Query: 155 LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLT 214
L + QV H+RAER++L E DS +VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLT
Sbjct: 126 LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLT 185
Query: 215 EDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE- 273
E+E +FY+AETVLAI+SIH+ +IHRDIKPDNLLLD GH++LSDFGLC L + E
Sbjct: 186 EEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 245
Query: 274 ---QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL 330
+ ++ ++ + N++R A + W++NRR LA+STVGTPDYIAPEV +
Sbjct: 246 YRNLNHSLPSDFTFQNMNSKRKA----------ETWKRNRRQLAFSTVGTPDYIAPEVFM 295
Query: 331 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369
+ GY CDWWSLG IMYEML+GYPPF S+ P T +KV
Sbjct: 296 QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKV 334
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q15208|STK38_HUMAN Serine/threonine-protein kinase 38 OS=Homo sapiens GN=STK38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 354 bits (909), Expect = 5e-97, Method: Compositional matrix adjust.
Identities = 176/339 (51%), Positives = 240/339 (70%), Gaps = 14/339 (4%)
Query: 35 STDEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNL 94
ST ++SN TK++V K +EN Y + +ER R+ LEK + + + +E++
Sbjct: 6 STPCSSMSNHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLR 65
Query: 95 LKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM 154
+KETE++RL+R ++G +DFE L +IG+GAFGEVR+ ++K TGHVYAMK L+K++M
Sbjct: 66 RSAHARKETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM 125
Query: 155 LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLT 214
L + QV H+RAER++L E DS +VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLT
Sbjct: 126 LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLT 185
Query: 215 EDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE- 273
E+E +FY+AETVLAI+SIH+ +IHRDIKPDNLLLD GH++LSDFGLC L + E
Sbjct: 186 EEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 245
Query: 274 ---QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL 330
+ ++ ++ + N++R A + W++NRR LA+STVGTPDYIAPEV +
Sbjct: 246 YRNLNHSLPSDFTFQNMNSKRKA----------ETWKRNRRQLAFSTVGTPDYIAPEVFM 295
Query: 331 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369
+ GY CDWWSLG IMYEML+GYPPF S+ P T +KV
Sbjct: 296 QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKV 334
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Y2H1|ST38L_HUMAN Serine/threonine-protein kinase 38-like OS=Homo sapiens GN=STK38L PE=1 SV=3 | Back alignment and function description |
|---|
Score = 354 bits (909), Expect = 6e-97, Method: Compositional matrix adjust.
Identities = 175/331 (52%), Positives = 235/331 (70%), Gaps = 10/331 (3%)
Query: 41 LSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEK 100
+SN T+++V AK +EN Y + +ER R+ LE + + +++E++ +
Sbjct: 13 MSNHTRERVTVAKLTLENFYSNLILQHEERETRQKKLEVAMEEEGLADEEKKLRRSQHAR 72
Query: 101 KETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQV 160
KETE++RL+R ++G DDFE L +IG+GAFGEVR+ ++K TGH+YAMK L+KS+ML + QV
Sbjct: 73 KETEFLRLKRTRLGLDDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKSDMLEKEQV 132
Query: 161 EHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARF 220
H+RAER++L E D +VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLTE+E +F
Sbjct: 133 AHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLTEEETQF 192
Query: 221 YVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE--QDFTI 278
Y++ETVLAI++IH+ +IHRDIKPDNLLLD GH++LSDFGLC L + E ++ T
Sbjct: 193 YISETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTH 252
Query: 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC 338
+ S QN + + + W+KNRR LAYSTVGTPDYIAPEV ++ GY C
Sbjct: 253 NPPSDFSFQN--------MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLC 304
Query: 339 DWWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369
DWWSLG IMYEML+GYPPF S+ P T RKV
Sbjct: 305 DWWSLGVIMYEMLIGYPPFCSETPQETYRKV 335
|
Involved in the regulation of structural processes in differentiating and mature neuronal cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q91VJ4|STK38_MOUSE Serine/threonine-protein kinase 38 OS=Mus musculus GN=Stk38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 354 bits (908), Expect = 6e-97, Method: Compositional matrix adjust.
Identities = 176/339 (51%), Positives = 240/339 (70%), Gaps = 14/339 (4%)
Query: 35 STDEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNL 94
ST ++SN TK++V K +EN Y + +ER R+ LEK + + + +E++
Sbjct: 6 STPCSSMSNHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLR 65
Query: 95 LKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM 154
+KETE++RL+R ++G +DFE L +IG+GAFGEVR+ ++K TGHVYAMK L+K++M
Sbjct: 66 RSAHARKETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM 125
Query: 155 LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLT 214
L + QV H+RAER++L E DS +VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLT
Sbjct: 126 LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLT 185
Query: 215 EDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE- 273
E+E +FY+AETVLAI+SIH+ +IHRDIKPDNLLLD GH++LSDFGLC L + E
Sbjct: 186 EEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 245
Query: 274 ---QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL 330
+ ++ ++ + N++R A + W++NRR LA+STVGTPDYIAPEV +
Sbjct: 246 YRNLNHSLPSDFTFQNMNSKRKA----------ETWKRNRRQLAFSTVGTPDYIAPEVFM 295
Query: 331 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369
+ GY CDWWSLG IMYEML+GYPPF S+ P T +KV
Sbjct: 296 QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKV 334
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2VDV2|STK38_BOVIN Serine/threonine-protein kinase 38 OS=Bos taurus GN=STK38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 352 bits (904), Expect = 2e-96, Method: Compositional matrix adjust.
Identities = 175/339 (51%), Positives = 240/339 (70%), Gaps = 14/339 (4%)
Query: 35 STDEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNL 94
ST ++S+ TK++V K +EN Y + +ER R+ LEK + + + +E++
Sbjct: 6 STPCSSMSSHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLR 65
Query: 95 LKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM 154
+KETE++RL+R ++G +DFE L +IG+GAFGEVR+ ++K TGHVYAMK L+K++M
Sbjct: 66 RSAHARKETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM 125
Query: 155 LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLT 214
L + QV H+RAER++L E DS +VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLT
Sbjct: 126 LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLT 185
Query: 215 EDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE- 273
E+E +FY+AETVLAI+SIH+ +IHRDIKPDNLLLD GH++LSDFGLC L + E
Sbjct: 186 EEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 245
Query: 274 ---QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL 330
+ ++ ++ + N++R A + W++NRR LA+STVGTPDYIAPEV +
Sbjct: 246 YRNLNHSLPSDFTFQNMNSKRKA----------ETWKRNRRQLAFSTVGTPDYIAPEVFM 295
Query: 331 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369
+ GY CDWWSLG IMYEML+GYPPF S+ P T +KV
Sbjct: 296 QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKV 334
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7TSE6|ST38L_MOUSE Serine/threonine-protein kinase 38-like OS=Mus musculus GN=Stk38l PE=1 SV=2 | Back alignment and function description |
|---|
Score = 352 bits (903), Expect = 2e-96, Method: Compositional matrix adjust.
Identities = 173/337 (51%), Positives = 237/337 (70%), Gaps = 10/337 (2%)
Query: 35 STDEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNL 94
+T +SN T+++V AK +EN Y + +ER R+ LE + + +++E++
Sbjct: 7 ATTTFPMSNHTRERVTVAKLTLENFYSNLILQHEERETRQKKLEVAMEEEGLADEEKKLR 66
Query: 95 LKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM 154
+KETE++RL+R ++G DDFE L +IG+GAFGEVR+ ++K TGH+YAMK L+K++M
Sbjct: 67 RSQHARKETEFLRLKRTRLGLDDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM 126
Query: 155 LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLT 214
L + QV H+RAER++L E D +VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLT
Sbjct: 127 LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLT 186
Query: 215 EDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE- 273
E+E +FY++ETVLAI++IH+ +IHRD+KPDNLLLD GH++LSDFGLC L + E
Sbjct: 187 EEETQFYISETVLAIDAIHQLGFIHRDVKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF 246
Query: 274 -QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332
++ T + S QN + + + W+KNRR LAYSTVGTPDYIAPEV ++
Sbjct: 247 YRNLTHNPPSDFSFQN--------MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT 298
Query: 333 GYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369
GY CDWWSLG IMYEML+G+PPF S+ P T RKV
Sbjct: 299 GYNKLCDWWSLGVIMYEMLIGFPPFCSETPQETYRKV 335
|
Involved in the regulation of structural processes in differentiating and mature neuronal cells. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5AP53|CBK1_CANAL Serine/threonine-protein kinase CBK1 OS=Candida albicans (strain SC5314 / ATCC MYA-2876) GN=CBK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 348 bits (892), Expect = 5e-95, Method: Compositional matrix adjust.
Identities = 173/347 (49%), Positives = 237/347 (68%), Gaps = 22/347 (6%)
Query: 41 LSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADV--SEEDQNNLLKFL 98
LS T+ K A+ K +EN+Y + + ER +RR LE K+A+ D+ SEE +N L+ L
Sbjct: 256 LSKTTQDKAASIKLTLENYYTSSVSHAIERNQRRLELENKIANEDIGSSEERKNRQLQNL 315
Query: 99 EKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRG 158
KKE++++RL+R K+ +DF + +IGKGAFGEVR+ ++K TG +YAMK L KSEM +
Sbjct: 316 GKKESQFLRLKRTKLALEDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFNKD 375
Query: 159 QVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEA 218
Q+ HV+AER++LA DS IV LY SFQD ++LYLIME+LPGGD+MT+L+R + TED
Sbjct: 376 QLAHVKAERDVLAGSDSPWIVALYYSFQDSQYLYLIMEFLPGGDLMTMLIRWEVFTEDIT 435
Query: 219 RFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278
RFY+AE VLAIE+IHK +IHRDIKPDN+L+D GH++LSDFGL + D
Sbjct: 436 RFYIAECVLAIEAIHKLGFIHRDIKPDNILIDNRGHVKLSDFGLSTGFH----KTHDSNY 491
Query: 279 GNNL------NGSSQNNERPAAPKR----------TQQEQLQHWQKNRRMLAYSTVGTPD 322
N L N Q N+ + + ++ +Q W+K+RR++AYSTVGTPD
Sbjct: 492 YNKLLEKEPSNTHLQPNQLTSGRNSVMVDAIHLTMSNRQTMQTWRKSRRLMAYSTVGTPD 551
Query: 323 YIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369
YIAPE+ + +GYG ECDWWSLGAIM+E L+G+PPF S++P T RK+
Sbjct: 552 YIAPEIFIHQGYGQECDWWSLGAIMFECLIGWPPFCSENPHDTYRKI 598
|
Serine/threonine-protein kinase required for wild-type hyphal growth and transcriptional regulation of cell-wall-associated genes. Involved in the biofilm formation through phosphorylation of the master regulator of biofilm formation BCR1. Candida albicans (strain SC5314 / ATCC MYA-2876) (taxid: 237561) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 373 | ||||||
| 255577946 | 575 | serine/threonine-protein kinase, putativ | 0.989 | 0.641 | 0.890 | 0.0 | |
| 224082842 | 561 | predicted protein [Populus trichocarpa] | 0.986 | 0.655 | 0.892 | 0.0 | |
| 356503620 | 542 | PREDICTED: serine/threonine-protein kina | 0.983 | 0.677 | 0.881 | 0.0 | |
| 7339534 | 564 | protein kinase MK6 [Mesembryanthemum cry | 0.986 | 0.652 | 0.873 | 0.0 | |
| 356545884 | 575 | PREDICTED: serine/threonine-protein kina | 0.978 | 0.634 | 0.865 | 0.0 | |
| 224066229 | 561 | predicted protein [Populus trichocarpa] | 0.986 | 0.655 | 0.863 | 0.0 | |
| 449462463 | 557 | PREDICTED: serine/threonine-protein kina | 0.978 | 0.655 | 0.882 | 0.0 | |
| 356537081 | 554 | PREDICTED: serine/threonine-protein kina | 0.978 | 0.658 | 0.862 | 0.0 | |
| 356570656 | 542 | PREDICTED: serine/threonine-protein kina | 0.983 | 0.677 | 0.868 | 0.0 | |
| 147815455 | 550 | hypothetical protein VITISV_001730 [Viti | 0.983 | 0.667 | 0.854 | 0.0 |
| >gi|255577946|ref|XP_002529845.1| serine/threonine-protein kinase, putative [Ricinus communis] gi|223530673|gb|EEF32546.1| serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 705 bits (1820), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 333/374 (89%), Positives = 352/374 (94%), Gaps = 5/374 (1%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNGSNEE----STDEEALSNVTKQKVAAAKQYI 56
MDSARSW QK QPR+K+R + +KK+A SN E S D+E+LSN TKQKVAAAKQYI
Sbjct: 1 MDSARSWFQKFQPREKLRSTTRKKDASDESSNNEPKSPSEDDESLSNTTKQKVAAAKQYI 60
Query: 57 ENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGAD 116
ENHYKEQMKNLQER+ERR ILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMG D
Sbjct: 61 ENHYKEQMKNLQERKERRTILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGVD 120
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
DFELLTMIGKGAFGEVRVCRE TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN
Sbjct: 121 DFELLTMIGKGAFGEVRVCRENTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 180
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH 236
CIVKLYCSFQD+EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH+
Sbjct: 181 CIVKLYCSFQDEEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHN 240
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN-LNGSSQNNERPAAP 295
YIHRDIKPDNLLLD+YGHLRLSDFGLCKPLDCST+QE DF++ NN +NG++QN ERPAAP
Sbjct: 241 YIHRDIKPDNLLLDRYGHLRLSDFGLCKPLDCSTIQEGDFSVVNNSVNGTAQNEERPAAP 300
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
KRTQQEQL+HWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP
Sbjct: 301 KRTQQEQLKHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 360
Query: 356 PFYSDDPMSTCRKV 369
PFYSDDPMSTCRK+
Sbjct: 361 PFYSDDPMSTCRKI 374
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224082842|ref|XP_002306862.1| predicted protein [Populus trichocarpa] gi|222856311|gb|EEE93858.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 697 bits (1799), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 333/373 (89%), Positives = 351/373 (94%), Gaps = 5/373 (1%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNGSNEES---TDEEALSNVTKQKVAAAKQYIE 57
MDSARSW QK QPR+K R S ++KE GG+ NE+S DEEALSNVTKQKVAAAKQYIE
Sbjct: 1 MDSARSWFQKFQPREKFRSSSRRKE-GGDEDNEDSKLEMDEEALSNVTKQKVAAAKQYIE 59
Query: 58 NHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADD 117
NHYKEQMKNLQER+ERR LEKKLADADVSEEDQ+NLLKFLEKKETEYMRLQRHKMG DD
Sbjct: 60 NHYKEQMKNLQERKERRTTLEKKLADADVSEEDQSNLLKFLEKKETEYMRLQRHKMGVDD 119
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHV+AERNLLAEVDSNC
Sbjct: 120 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 179
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYV ET+LAIESIHKH+Y
Sbjct: 180 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVGETILAIESIHKHNY 239
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT-IGNNLNGSSQNNERPAAPK 296
IHRDIKPDNLLLD++GHLRLSDFGLCKPLDCST+QE DF+ + NN N ++QN ERPAAPK
Sbjct: 240 IHRDIKPDNLLLDRHGHLRLSDFGLCKPLDCSTIQEGDFSVVNNNGNETTQNGERPAAPK 299
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP
Sbjct: 300 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 359
Query: 357 FYSDDPMSTCRKV 369
FYSDDPMSTCRK+
Sbjct: 360 FYSDDPMSTCRKI 372
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356503620|ref|XP_003520605.1| PREDICTED: serine/threonine-protein kinase CBK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 686 bits (1771), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 328/372 (88%), Positives = 344/372 (92%), Gaps = 5/372 (1%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNGSNEEST---DEEALSNVTKQKVAAAKQYIE 57
MDSARSWLQK QPRDK+R S + K+ NG+NE D+ +LSNVTKQKV AAKQYIE
Sbjct: 1 MDSARSWLQKFQPRDKLRASTRNKD-DTNGTNEIPNVPMDDTSLSNVTKQKVTAAKQYIE 59
Query: 58 NHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADD 117
NHYKEQMK+LQER+ERR ILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMG DD
Sbjct: 60 NHYKEQMKSLQERKERRTILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGVDD 119
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
FELLTMIGKGAFGEVRVC+EK T HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC
Sbjct: 120 FELLTMIGKGAFGEVRVCKEKATDHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 179
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
IVKLYCSFQDDE+LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYV ET+LAIESIHKH+Y
Sbjct: 180 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVGETILAIESIHKHNY 239
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL+E DFT G N NGS+QNNE APKR
Sbjct: 240 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLEETDFTTGQNANGSTQNNEH-VAPKR 298
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
TQQE+LQHWQKNRR LAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF
Sbjct: 299 TQQEKLQHWQKNRRTLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 358
Query: 358 YSDDPMSTCRKV 369
YSDDPMSTCRK+
Sbjct: 359 YSDDPMSTCRKI 370
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|7339534|emb|CAB82852.1| protein kinase MK6 [Mesembryanthemum crystallinum] | Back alignment and taxonomy information |
|---|
Score = 682 bits (1760), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 324/371 (87%), Positives = 347/371 (93%), Gaps = 3/371 (0%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEA--GGNGSNEESTDEEALSNVTKQKVAAAKQYIEN 58
MDSARSWL K QPRDK+R S KKK++ GG + ++DEE SNVTKQ+VAAAKQYIE
Sbjct: 6 MDSARSWLHKYQPRDKLRSSTKKKDSMMGGRDDSAPTSDEETPSNVTKQRVAAAKQYIEK 65
Query: 59 HYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDF 118
HYKEQMK+LQER+ERR+ILE+KL DADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDF
Sbjct: 66 HYKEQMKSLQERKERRSILERKLHDADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDF 125
Query: 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCI 178
ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHV+AERNLLAEVDSNCI
Sbjct: 126 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCI 185
Query: 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYI 238
VKLYCSFQD+E+LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAET+LAIESIHKH+YI
Sbjct: 186 VKLYCSFQDEEYLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETILAIESIHKHNYI 245
Query: 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRT 298
HRDIKPDNLLLDK+GHLRLSDFGLCKPLDCSTL+E+DF + NN NG S +NE P+RT
Sbjct: 246 HRDIKPDNLLLDKFGHLRLSDFGLCKPLDCSTLEEKDFEV-NNGNGGSPSNEGSTKPRRT 304
Query: 299 QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358
QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY
Sbjct: 305 QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 364
Query: 359 SDDPMSTCRKV 369
SDDPMSTCRK+
Sbjct: 365 SDDPMSTCRKI 375
|
Source: Mesembryanthemum crystallinum Species: Mesembryanthemum crystallinum Genus: Mesembryanthemum Family: Aizoaceae Order: Caryophyllales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356545884|ref|XP_003541363.1| PREDICTED: serine/threonine-protein kinase CBK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 681 bits (1758), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 322/372 (86%), Positives = 344/372 (92%), Gaps = 7/372 (1%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNGSNEES---TDEEALSNVTKQKVAAAKQYIE 57
MDSARSWLQK QPRDK R +GKKKE GNG N++S DE LS+VTKQKVAA KQYIE
Sbjct: 1 MDSARSWLQKFQPRDKTRAAGKKKEEDGNGGNQDSNEPVDEALLSSVTKQKVAATKQYIE 60
Query: 58 NHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADD 117
NHYKEQMKNLQER+ERR ILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMG DD
Sbjct: 61 NHYKEQMKNLQERKERRTILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGVDD 120
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
FELLTMIGKGAFGEVRVCREKT+ HVYAMKKLKKSEMLRRGQVEHV+AERNLLAEVD NC
Sbjct: 121 FELLTMIGKGAFGEVRVCREKTSDHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDRNC 180
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
IVKLYCSFQDDE+LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYV ET+LAIESIHKH+Y
Sbjct: 181 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVGETILAIESIHKHNY 240
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRDIKPDNLLLD+YGHL+LSDFGLCKPLDCS L+E+DF++G N+NGS+Q+ + PKR
Sbjct: 241 IHRDIKPDNLLLDRYGHLKLSDFGLCKPLDCSALEEKDFSVGQNVNGSTQS----STPKR 296
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
+QQEQLQHWQ NRR LAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF
Sbjct: 297 SQQEQLQHWQMNRRTLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 356
Query: 358 YSDDPMSTCRKV 369
YSDDPM TCRK+
Sbjct: 357 YSDDPMLTCRKI 368
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224066229|ref|XP_002302036.1| predicted protein [Populus trichocarpa] gi|222843762|gb|EEE81309.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 681 bits (1756), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 322/373 (86%), Positives = 347/373 (93%), Gaps = 5/373 (1%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNGSNEEST---DEEALSNVTKQKVAAAKQYIE 57
MDSARSW QK QPR+K R ++KE GG+ NE++ DEEA SNVTKQKVAAAK+YIE
Sbjct: 1 MDSARSWFQKFQPREKFRSPSRRKE-GGDEDNEDTISEMDEEAHSNVTKQKVAAAKRYIE 59
Query: 58 NHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADD 117
NHYKEQMKNLQER+ERR LEKKLADADVSEEDQ+NLLKFLEKKETEYMRLQRHKMG DD
Sbjct: 60 NHYKEQMKNLQERKERRTTLEKKLADADVSEEDQSNLLKFLEKKETEYMRLQRHKMGVDD 119
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
FELLTMIGKGAFGEVR+CREKTTG VYAMKKLKKSEMLRRGQVEHV+AERNLL EVDSNC
Sbjct: 120 FELLTMIGKGAFGEVRICREKTTGQVYAMKKLKKSEMLRRGQVEHVKAERNLLTEVDSNC 179
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
IVKLYCSFQDD FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYV ETVLAIESIHKH+Y
Sbjct: 180 IVKLYCSFQDDGFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVGETVLAIESIHKHNY 239
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT-IGNNLNGSSQNNERPAAPK 296
IHRDIKPDNLLLD+YGHLRLSDFGLCKPLDCST+QE DF+ + NN NG++QN ERPAAP+
Sbjct: 240 IHRDIKPDNLLLDRYGHLRLSDFGLCKPLDCSTIQEGDFSVVNNNSNGTTQNEERPAAPR 299
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
RTQQEQL+HWQKNRRMLA+STVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP
Sbjct: 300 RTQQEQLEHWQKNRRMLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 359
Query: 357 FYSDDPMSTCRKV 369
FYSD+P+STC+K+
Sbjct: 360 FYSDEPLSTCKKI 372
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449462463|ref|XP_004148960.1| PREDICTED: serine/threonine-protein kinase 38-like [Cucumis sativus] gi|449502113|ref|XP_004161547.1| PREDICTED: serine/threonine-protein kinase 38-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 680 bits (1755), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 330/374 (88%), Positives = 346/374 (92%), Gaps = 9/374 (2%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNGSNEEST-----DEEALSNVTKQKVAAAKQY 55
MDSARSW Q RD++RGS KKK+ G NE+ST DEEALSN+TKQKVAAAKQY
Sbjct: 1 MDSARSWFN--QRRDRLRGSTKKKD-NSMGENEDSTATDQMDEEALSNITKQKVAAAKQY 57
Query: 56 IENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGA 115
IENHYKEQMKNLQER+ERRN+LEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMG
Sbjct: 58 IENHYKEQMKNLQERKERRNVLEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGV 117
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DDF+LLT+IGKGAFGEVRVCREKTTG VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS
Sbjct: 118 DDFDLLTIIGKGAFGEVRVCREKTTGQVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 177
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYV E VLAIESIHKH
Sbjct: 178 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVGEIVLAIESIHKH 237
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+YIHRDIKPDNLLLDK+GHLRLSDFGLCKPLDCS L+EQDF IG+ NG+ QN+ER A P
Sbjct: 238 NYIHRDIKPDNLLLDKFGHLRLSDFGLCKPLDCSILREQDFDIGSTRNGAGQNDERNATP 297
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP
Sbjct: 298 -RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356
Query: 356 PFYSDDPMSTCRKV 369
PFYSDDPMSTCRK+
Sbjct: 357 PFYSDDPMSTCRKI 370
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356537081|ref|XP_003537059.1| PREDICTED: serine/threonine-protein kinase tricorner-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 675 bits (1741), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 321/372 (86%), Positives = 340/372 (91%), Gaps = 7/372 (1%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNGSNE---ESTDEEALSNVTKQKVAAAKQYIE 57
MDSARSWLQK QPRDK R +GKKKE GNG N+ E+ DE LS+VTKQKVAAAKQYIE
Sbjct: 1 MDSARSWLQKFQPRDKTRAAGKKKEEDGNGGNQDSNEAIDEALLSSVTKQKVAAAKQYIE 60
Query: 58 NHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADD 117
NHYKEQMKNLQ R ILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMG +D
Sbjct: 61 NHYKEQMKNLQVAYNSRTILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGVED 120
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
FELLTMIGKGAFGEVRVCREKT+GHVYAMKKLKKSEMLRRGQVEHV+AERNLLAEVDSNC
Sbjct: 121 FELLTMIGKGAFGEVRVCREKTSGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 180
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
IVKLYCSFQDDE LYLIMEYLPGGDMMTLLMRKD LTEDEARFYV ETVLAIESIHKH+Y
Sbjct: 181 IVKLYCSFQDDEHLYLIMEYLPGGDMMTLLMRKDILTEDEARFYVGETVLAIESIHKHNY 240
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRDIKPDNLLLD+YGHL+LSDFGLCKPLDCSTL+E DF++G N+NGS+Q+ + PKR
Sbjct: 241 IHRDIKPDNLLLDRYGHLKLSDFGLCKPLDCSTLEENDFSVGQNVNGSTQS----STPKR 296
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
+QQEQLQHWQ NRR LAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF
Sbjct: 297 SQQEQLQHWQINRRTLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 356
Query: 358 YSDDPMSTCRKV 369
YSDDPM TCRK+
Sbjct: 357 YSDDPMLTCRKI 368
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356570656|ref|XP_003553501.1| PREDICTED: serine/threonine-protein kinase 38-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 674 bits (1739), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 323/372 (86%), Positives = 342/372 (91%), Gaps = 5/372 (1%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNGSNE---ESTDEEALSNVTKQKVAAAKQYIE 57
MDSARSWLQK QPRDK+R S +K + NG +E S DE LSN+TKQKVAAAKQYIE
Sbjct: 1 MDSARSWLQKFQPRDKLRASTRKND-DTNGEDEIPNMSMDEATLSNITKQKVAAAKQYIE 59
Query: 58 NHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADD 117
NHYKEQMK+LQER+ERR ILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMG DD
Sbjct: 60 NHYKEQMKSLQERKERRTILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGVDD 119
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
FELLTMIGKGAFGEVRVCREKTT HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD+NC
Sbjct: 120 FELLTMIGKGAFGEVRVCREKTTDHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDNNC 179
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
IVKLYCSFQDDE+LYLIMEYLPGGDMMTLLMRKD LTEDE RFYV ETVLAIESIHKH+Y
Sbjct: 180 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDILTEDETRFYVGETVLAIESIHKHNY 239
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRDIKPDNLLLD+YGHLRLSDFGLCKPLDCSTL+E DF+ N NGS++N+E A PKR
Sbjct: 240 IHRDIKPDNLLLDRYGHLRLSDFGLCKPLDCSTLEEADFSTSQNANGSTRNDEH-ATPKR 298
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
TQQEQLQ+WQKNRR LAYSTVGTPDYIAPEVL+KKGYGMECDWWSLGAIMYEMLVGYPPF
Sbjct: 299 TQQEQLQNWQKNRRTLAYSTVGTPDYIAPEVLMKKGYGMECDWWSLGAIMYEMLVGYPPF 358
Query: 358 YSDDPMSTCRKV 369
YSDDPMSTCRK+
Sbjct: 359 YSDDPMSTCRKI 370
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147815455|emb|CAN61876.1| hypothetical protein VITISV_001730 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 666 bits (1718), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 317/371 (85%), Positives = 343/371 (92%), Gaps = 4/371 (1%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNG--SNEESTDEEALSNVTKQKVAAAKQYIEN 58
M S W KL+ RDK + S KKEA NG ++ T EEA SNVTKQKVAAAKQYIEN
Sbjct: 1 MKSIGCWFNKLKSRDKAKSS--KKEATNNGKEGSKAVTSEEAPSNVTKQKVAAAKQYIEN 58
Query: 59 HYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDF 118
HYKEQMKNLQER+ERRNILEKKLADA+VSEE+QNNLLK LEKKETEYMRLQRHKMGADDF
Sbjct: 59 HYKEQMKNLQERKERRNILEKKLADAEVSEEEQNNLLKHLEKKETEYMRLQRHKMGADDF 118
Query: 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCI 178
E LTMIGKGAFGEVRVCREK TGHVYAMKKLKKSEMLRRGQVEHV+AERNLLAEVDSNCI
Sbjct: 119 EPLTMIGKGAFGEVRVCREKKTGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCI 178
Query: 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYI 238
VKLYCSFQD+EFLYL+MEYLPGGDMMTLLMRKDTLTEDEARFYV ETVLAIESIHKH+YI
Sbjct: 179 VKLYCSFQDEEFLYLVMEYLPGGDMMTLLMRKDTLTEDEARFYVGETVLAIESIHKHNYI 238
Query: 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRT 298
HRDIKPDNLLLD+YGH++LSDFGLCKPLDCS L E+DF++GNNL+G+ Q++ RPAAP+RT
Sbjct: 239 HRDIKPDNLLLDRYGHMKLSDFGLCKPLDCSNLHEKDFSLGNNLSGALQSDGRPAAPRRT 298
Query: 299 QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358
QQEQLQHWQ+NRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY
Sbjct: 299 QQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358
Query: 359 SDDPMSTCRKV 369
SD+PM+TCRK+
Sbjct: 359 SDEPMTTCRKI 369
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 373 | ||||||
| TAIR|locus:2054784 | 569 | AT2G20470 [Arabidopsis thalian | 0.983 | 0.644 | 0.826 | 5.4e-166 | |
| TAIR|locus:2129650 | 551 | AT4G14350 [Arabidopsis thalian | 0.986 | 0.667 | 0.803 | 1.7e-162 | |
| TAIR|locus:2090925 | 568 | AT3G23310 [Arabidopsis thalian | 0.989 | 0.649 | 0.790 | 1.9e-161 | |
| TAIR|locus:2024167 | 569 | AT1G03920 [Arabidopsis thalian | 0.890 | 0.583 | 0.861 | 1.1e-156 | |
| TAIR|locus:2204574 | 562 | AT1G30640 [Arabidopsis thalian | 0.981 | 0.651 | 0.689 | 3.3e-134 | |
| TAIR|locus:2125894 | 519 | AT4G33080 [Arabidopsis thalian | 0.900 | 0.647 | 0.717 | 1.3e-130 | |
| TAIR|locus:2047590 | 527 | AT2G19400 [Arabidopsis thalian | 0.903 | 0.639 | 0.690 | 2.8e-128 | |
| TAIR|locus:2178208 | 516 | AT5G09890 [Arabidopsis thalian | 0.943 | 0.682 | 0.647 | 7.4e-121 | |
| UNIPROTKB|Q2LZZ7 | 458 | trc "Serine/threonine-protein | 0.898 | 0.731 | 0.543 | 5.7e-91 | |
| DICTYBASE|DDB_G0278457 | 530 | ndrA "NDR family protein kinas | 0.919 | 0.647 | 0.513 | 9.3e-91 |
| TAIR|locus:2054784 AT2G20470 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1615 (573.6 bits), Expect = 5.4e-166, P = 5.4e-166
Identities = 310/375 (82%), Positives = 334/375 (89%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNGSN---EE---STDEEALSNVTKQKVAAAKQ 54
MDSA+ W QK Q R R G AGG GSN +E TDEEA+SN TKQKVAAAKQ
Sbjct: 1 MDSAKGWFQKRQMRGGSRYKGASGGAGGGGSNGSADEHNVETDEEAVSNTTKQKVAAAKQ 60
Query: 55 YIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMG 114
YIENHYKEQMK LQER+ERR++LE+KLADADVSEEDQNNLLKFLEKKETEYMRLQRHK+G
Sbjct: 61 YIENHYKEQMKILQERKERRSMLEQKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKLG 120
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
DF+LLTMIGKGAFGEVRVCREKTTG VYAMKKLKK+EMLRRGQVEHVRAERNLLAEVD
Sbjct: 121 VADFDLLTMIGKGAFGEVRVCREKTTGQVYAMKKLKKAEMLRRGQVEHVRAERNLLAEVD 180
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
SN IVKLYCSFQDD+ LYL+MEYLPGGDMMTLLMRKDTLTE+EA+FYVAETVLAIESIH+
Sbjct: 181 SNYIVKLYCSFQDDDHLYLVMEYLPGGDMMTLLMRKDTLTEEEAKFYVAETVLAIESIHR 240
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
H+YIHRDIKPDNLLLD+YGHLRLSDFGLCKPLDCS + E DF+ NN NGS++ A
Sbjct: 241 HNYIHRDIKPDNLLLDRYGHLRLSDFGLCKPLDCSAIGENDFS--NNSNGSTEQEAGSTA 298
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354
PKRTQQEQL+HWQ+NRR LAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY
Sbjct: 299 PKRTQQEQLEHWQRNRRTLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 358
Query: 355 PPFYSDDPMSTCRKV 369
PPFYSDDPMSTCRK+
Sbjct: 359 PPFYSDDPMSTCRKI 373
|
|
| TAIR|locus:2129650 AT4G14350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1582 (562.0 bits), Expect = 1.7e-162, P = 1.7e-162
Identities = 298/371 (80%), Positives = 336/371 (90%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNGSNEEST--DEEALSNVTKQKVAAAKQYIEN 58
M++A++WL KL+ +DK++ S KKKEA N T EEALSN+TK+K AAAK YIEN
Sbjct: 1 METAKAWLSKLKSKDKVKSS-KKKEATSNVKEGPKTAGGEEALSNITKEKAAAAKLYIEN 59
Query: 59 HYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDF 118
HYK QM++LQER+ERR +LEKKLA A+VSEE+QNNLLK LE KETEYMR QRHKMGADDF
Sbjct: 60 HYKMQMQSLQERKERRKMLEKKLAAAEVSEEEQNNLLKDLEMKETEYMRRQRHKMGADDF 119
Query: 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCI 178
E LTMIGKGAFGEVR+CREK TG+VYAMKKLKKSEMLRRGQVEHV+AERNLLAEVDSNCI
Sbjct: 120 EPLTMIGKGAFGEVRICREKGTGNVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCI 179
Query: 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYI 238
VKLYCSFQD+E+LYLIMEYLPGGDMMTLLMRKDTLTEDEARFY+ ETVLAIESIHKH+YI
Sbjct: 180 VKLYCSFQDEEYLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYIGETVLAIESIHKHNYI 239
Query: 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRT 298
HRDIKPDNLLLDK GH++LSDFGLCKPLDCS LQE+DFT+ N++G+ Q++ RP A +RT
Sbjct: 240 HRDIKPDNLLLDKDGHMKLSDFGLCKPLDCSNLQEKDFTVARNVSGALQSDGRPVATRRT 299
Query: 299 QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358
QQEQL +WQ+NRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG+PPFY
Sbjct: 300 QQEQLLNWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGFPPFY 359
Query: 359 SDDPMSTCRKV 369
SDDPM+TCRK+
Sbjct: 360 SDDPMTTCRKI 370
|
|
| TAIR|locus:2090925 AT3G23310 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1572 (558.4 bits), Expect = 1.9e-161, P = 1.9e-161
Identities = 295/373 (79%), Positives = 337/373 (90%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNGSNEEST--DEEALSNVTKQKVAAAKQYIEN 58
MD+AR+WL+KL+ + K + S KK+ + GN T EEA+SNVTKQK AAAKQYIEN
Sbjct: 1 MDTARAWLKKLKSKGKEKSSNKKETSRGNVKEGSKTAGGEEAVSNVTKQKAAAAKQYIEN 60
Query: 59 HYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDF 118
HYK+Q+++ Q+R+ERR++LE KLA A+VSEE+Q NLLK LEKKETEYMR QRHKMG DDF
Sbjct: 61 HYKKQVQSQQQRKERRDMLENKLAAAEVSEEEQKNLLKDLEKKETEYMRRQRHKMGTDDF 120
Query: 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCI 178
E LTMIGKGAFGEVR+CREKTTG+VYAMKKLKKSEMLRRGQVEHV+AERNLLAEVDSNCI
Sbjct: 121 EPLTMIGKGAFGEVRICREKTTGNVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCI 180
Query: 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYI 238
VKLYCSFQD+E+LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYV ETVLAIESIHKH+YI
Sbjct: 181 VKLYCSFQDEEYLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVGETVLAIESIHKHNYI 240
Query: 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRT 298
HRDIKPDNLLLD+ GH++LSDFGLCKPLDCS LQE+DF + +NL+G+ Q++ RP AP+RT
Sbjct: 241 HRDIKPDNLLLDRSGHMKLSDFGLCKPLDCSILQEKDFVVAHNLSGALQSDGRPVAPRRT 300
Query: 299 --QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
Q EQLQ+WQ+NRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG+PP
Sbjct: 301 RSQMEQLQNWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGFPP 360
Query: 357 FYSDDPMSTCRKV 369
FYSD+PM+TCRK+
Sbjct: 361 FYSDEPMTTCRKI 373
|
|
| TAIR|locus:2024167 AT1G03920 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1527 (542.6 bits), Expect = 1.1e-156, P = 1.1e-156
Identities = 287/333 (86%), Positives = 307/333 (92%)
Query: 37 DEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLK 96
D EALSN TKQKVAAAKQYIENHYKEQMKNL ER+ERR LEKKLADADV EEDQ NL+K
Sbjct: 56 DGEALSNSTKQKVAAAKQYIENHYKEQMKNLNERKERRTTLEKKLADADVCEEDQTNLMK 115
Query: 97 FLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR 156
FLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRV RE TGHV+AMKKLKKSEMLR
Sbjct: 116 FLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVVREINTGHVFAMKKLKKSEMLR 175
Query: 157 RGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTED 216
RGQVEHVRAERNLLAEVDSNCIVKLYCSFQD+E+LYLIMEYLPGGDMMTLLMRKDTL+ED
Sbjct: 176 RGQVEHVRAERNLLAEVDSNCIVKLYCSFQDNEYLYLIMEYLPGGDMMTLLMRKDTLSED 235
Query: 217 EARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276
EA+FY+AE+VLAIESIH +YIHRDIKPDNLLLD+YGHLRLSDFGLCKPLDCS + +DF
Sbjct: 236 EAKFYIAESVLAIESIHNRNYIHRDIKPDNLLLDRYGHLRLSDFGLCKPLDCSVIDGEDF 295
Query: 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM 336
T+GN +G + PKR+QQEQL+HWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM
Sbjct: 296 TVGNAGSGGGSESVS-TTPKRSQQEQLEHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM 354
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369
ECDWWSLGAIMYEMLVGYPPFY+DDPMSTCRK+
Sbjct: 355 ECDWWSLGAIMYEMLVGYPPFYADDPMSTCRKI 387
|
|
| TAIR|locus:2204574 AT1G30640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1315 (468.0 bits), Expect = 3.3e-134, P = 3.3e-134
Identities = 258/374 (68%), Positives = 303/374 (81%)
Query: 2 DSARSWLQ-KLQPRDKMRGSGKKKEAGGNGSN-EESTDEEALSNVTKQKVAAAKQYIENH 59
+ RSW Q + Q DK S KK GN N +A SN TKQKVAAAKQYIENH
Sbjct: 4 EPTRSWFQIRQQKPDK--SSPTKKGQEGNVKNLGRPPMNDAPSNATKQKVAAAKQYIENH 61
Query: 60 YKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFE 119
YK Q K+LQER+ERR+ILE+ LADADV+ ED+ ++LK EKKE EYMRLQR KMG DDFE
Sbjct: 62 YKIQKKSLQERKERRSILEQNLADADVTVEDKMDILKNFEKKEMEYMRLQRQKMGVDDFE 121
Query: 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIV 179
LL++IG+GAFGEVR+C+EK+TG VYAMKKLKKSEMLRRGQVEHV+AERN+LAEVDS IV
Sbjct: 122 LLSIIGRGAFGEVRICKEKSTGSVYAMKKLKKSEMLRRGQVEHVKAERNVLAEVDSPFIV 181
Query: 180 KLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIH 239
KL SFQDDE LYLIMEYLPGGDMMTLLMRKDTL EDE RFYVA+T+LAIESIHKH+Y+H
Sbjct: 182 KLCYSFQDDEHLYLIMEYLPGGDMMTLLMRKDTLREDETRFYVAQTILAIESIHKHNYVH 241
Query: 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER----PAAP 295
RDIKPDNLL+ + GH++LSDFGL K L+ + + + + ++R P+AP
Sbjct: 242 RDIKPDNLLITRNGHIKLSDFGLSKSLESKNFPDFKAELVDRSTKPAAEHDRLSKPPSAP 301
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
+RTQQEQL HWQ+NRR LA+STVGTPDYIAPEVLLKKGYGMECDWWSLGAIM+EMLVG+P
Sbjct: 302 RRTQQEQLLHWQQNRRTLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMFEMLVGFP 361
Query: 356 PFYSDDPMSTCRKV 369
PFYS++P++TCRK+
Sbjct: 362 PFYSEEPLATCRKI 375
|
|
| TAIR|locus:2125894 AT4G33080 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1281 (456.0 bits), Expect = 1.3e-130, P = 1.3e-130
Identities = 249/347 (71%), Positives = 294/347 (84%)
Query: 33 EESTDEEAL-SNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQ 91
E TDEE L S++T +KVAAAKQYIENHYK Q KN+QER+ERR ILE+KLA + V +E+Q
Sbjct: 8 ENGTDEEVLGSSLTMEKVAAAKQYIENHYKAQNKNIQERKERRWILERKLASSGVPKEEQ 67
Query: 92 NNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK 151
N++K LE+KETE+MRL+R+K+ DDFELLT+IG+GAFGEVR+CRE+ +G++YAMKKLKK
Sbjct: 68 INMIKDLERKETEFMRLKRNKISVDDFELLTIIGRGAFGEVRLCRERKSGNIYAMKKLKK 127
Query: 152 SEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD 211
SEM+ RGQVEHVRAERNLLAEV+S+ IVKLY SFQD E+LYLIMEYLPGGDMMTLLMR+D
Sbjct: 128 SEMVMRGQVEHVRAERNLLAEVESHYIVKLYYSFQDPEYLYLIMEYLPGGDMMTLLMRED 187
Query: 212 TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271
TL ED ARFY+A++VLAIESIH+++YIHRDIKPDNLLLDK GH++LSDFGLCKPLDC L
Sbjct: 188 TLREDVARFYIAQSVLAIESIHRYNYIHRDIKPDNLLLDKDGHMKLSDFGLCKPLDCRNL 247
Query: 272 ---QEQDFTIGNNLNGSSQNNER--PAAPK----RTQQEQLQHWQKNRRMLAYSTVGTPD 322
QE T ++ + +R P R+ QEQLQHWQ NRR LA+STVGTPD
Sbjct: 248 PSIQENRATDDETMS-EPMDVDRCFPDTDNKRSWRSPQEQLQHWQMNRRKLAFSTVGTPD 306
Query: 323 YIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369
YIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY+DDP+STCRK+
Sbjct: 307 YIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPISTCRKI 353
|
|
| TAIR|locus:2047590 AT2G19400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1259 (448.2 bits), Expect = 2.8e-128, P = 2.8e-128
Identities = 239/346 (69%), Positives = 293/346 (84%)
Query: 33 EESTDEEAL-SNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQ 91
E++ ++E L SN T +KVAAAK+YIENHY +M+++Q+R+ERR +LE+K+A DVSE++Q
Sbjct: 19 EDNFEDEGLVSNSTLEKVAAAKKYIENHYNRRMRHIQQRKERRWVLEQKIASLDVSEKEQ 78
Query: 92 NNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK 151
LL+ L++KETEY RL R+++ DDF+LL++IG+GAFGEVR+CREK TG++YAMKKLKK
Sbjct: 79 LELLEDLQRKETEYTRLMRNRLCVDDFDLLSIIGRGAFGEVRLCREKKTGNIYAMKKLKK 138
Query: 152 SEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD 211
SEML RGQVEHVRAERNLLAEV S+CIVKLY SFQD E+LYLIMEYL GGD+MTLLMR++
Sbjct: 139 SEMLSRGQVEHVRAERNLLAEVASDCIVKLYYSFQDPEYLYLIMEYLSGGDVMTLLMREE 198
Query: 212 TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC--- 268
TLTE ARFY+A++VLAIESIHKH+Y+HRDIKPDNLLLDKYGH++LSDFGLCKPLDC
Sbjct: 199 TLTETVARFYIAQSVLAIESIHKHNYVHRDIKPDNLLLDKYGHMKLSDFGLCKPLDCRNI 258
Query: 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ-----EQLQHWQKNRRMLAYSTVGTPDY 323
S + + N+N S +E + +R ++ EQLQHWQ NRR LAYSTVGTPDY
Sbjct: 259 SAMNVNEPLNDENINESIDGDENCSIGRRGRRWKSPLEQLQHWQINRRKLAYSTVGTPDY 318
Query: 324 IAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369
IAPEVLLKKGYG+ECDWWSLGAIMYEMLVGYPPFYSDDP++TCRK+
Sbjct: 319 IAPEVLLKKGYGVECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKI 364
|
|
| TAIR|locus:2178208 AT5G09890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1189 (423.6 bits), Expect = 7.4e-121, P = 7.4e-121
Identities = 231/357 (64%), Positives = 279/357 (78%)
Query: 17 MRGS-GKKKEAGGNGSNEESTDEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRN 75
M G+ G + G G E TD S VT+QK AAAKQ+IENHYK ++ L ER ERR
Sbjct: 1 MDGADGTVRVKPGRGFETE-TDVAVSSPVTRQKAAAAKQFIENHYKNYLQGLHERMERRR 59
Query: 76 ILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVC 135
++K+ +A + E+Q+ +++ L ++ETEYMRLQR K+G DDFELLT+IGKGAFGEVR+C
Sbjct: 60 EFQRKVQEAQLPVEEQDEMMRNLARRETEYMRLQRRKIGIDDFELLTVIGKGAFGEVRLC 119
Query: 136 REKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195
R ++T VYAMKKLKK+EML RGQVEHVR+ERNLLAEVDS IVKL+ SFQD E LYLIM
Sbjct: 120 RLRSTSEVYAMKKLKKTEMLSRGQVEHVRSERNLLAEVDSRYIVKLFYSFQDSECLYLIM 179
Query: 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHL 255
EYLPGGD+MTLLMR+D L+ED ARFY+AE++LAI SIH+H+Y+HRDIKPDNL+LDK GHL
Sbjct: 180 EYLPGGDIMTLLMREDILSEDVARFYIAESILAIHSIHQHNYVHRDIKPDNLILDKSGHL 239
Query: 256 RLSDFGLCKPLD---CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRM 312
+LSDFGLCKPLD S L E D + + S ++ AP + +EQL W++NRR
Sbjct: 240 KLSDFGLCKPLDDKYSSLLLEDDEMLSQDSENQSGKSDADKAPWQMPKEQLLQWKRNRRA 299
Query: 313 LAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369
LAYSTVGT DY+APEVLLKKGYGMECDWWSLGAI+YEMLVGYPPF SDDP TCRK+
Sbjct: 300 LAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAILYEMLVGYPPFCSDDPRITCRKI 356
|
|
| UNIPROTKB|Q2LZZ7 trc "Serine/threonine-protein kinase tricorner" [Drosophila pseudoobscura pseudoobscura (taxid:46245)] | Back alignment and assigned GO terms |
|---|
Score = 907 (324.3 bits), Expect = 5.7e-91, P = 5.7e-91
Identities = 186/342 (54%), Positives = 240/342 (70%)
Query: 31 SNEESTDEEAL--SNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSE 88
S+ TD ++ S+ T K AK +EN+Y + ER++R LE +L D ++E
Sbjct: 3 SSRTDTDGSSIRFSDHTLDKATKAKVTLENYYSNLVTQYGERKQRLAKLEAQLKDESLTE 62
Query: 89 ED-QNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMK 147
Q L+ +K ETEY+RL+R ++G +DFE L +IG+GAFGEVR+ ++K TGHVYAMK
Sbjct: 63 SQRQEKRLQHAQK-ETEYLRLKRLRLGVEDFEALKVIGRGAFGEVRLVQKKDTGHVYAMK 121
Query: 148 KLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL 207
L+K++ML + QV HVRAER++L E D +VK+Y SFQD LYLIME+LPGGDMMTLL
Sbjct: 122 VLRKADMLEKEQVAHVRAERDVLVEADHQWVVKMYYSFQDQVNLYLIMEFLPGGDMMTLL 181
Query: 208 MRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
M+KDTL+E+ +FY++ET LAI+SIHK +IHRDIKPDNLLLD GHL+LSDFGLC L
Sbjct: 182 MKKDTLSEEGTQFYISETALAIDSIHKLGFIHRDIKPDNLLLDARGHLKLSDFGLCTGLK 241
Query: 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPE 327
S DF + S A+P +++ + + W++NRR LAYSTVGTPDYIAPE
Sbjct: 242 KS--HRTDFYRDLSQAKPSDFIGTCASPMDSKR-RAESWKRNRRALAYSTVGTPDYIAPE 298
Query: 328 VLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369
V L+ GYG CDWWSLG IMYEML+GYPPF SD+P T RKV
Sbjct: 299 VFLQTGYGPACDWWSLGVIMYEMLMGYPPFCSDNPQDTYRKV 340
|
|
| DICTYBASE|DDB_G0278457 ndrA "NDR family protein kinase A" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 905 (323.6 bits), Expect = 9.3e-91, P = 9.3e-91
Identities = 184/358 (51%), Positives = 247/358 (68%)
Query: 19 GSGKKKEAGGNGSNEEST----DEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERR 74
GS ++E N +EE T + LS T + AAK YIE +Y ++++ER +RR
Sbjct: 12 GSDDERE---NFEDEEDTTTVYSSDPLSRPTMDRSLAAKMYIEQYYINAQQSVKERGQRR 68
Query: 75 NILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRV 134
LE KL + +S ++ N+L K L+KKE++YMR++R K+ DFE++ +IG+GAFGEV +
Sbjct: 69 KDLELKLENMKLSSKESNDLRKELDKKESDYMRIKRLKLKRSDFEVIRIIGRGAFGEVSL 128
Query: 135 CREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194
R + + +YAMK+LKKSEML++ Q HVRAER++LA ++N +VKLY SFQDD +LYLI
Sbjct: 129 VRHRESNDLYAMKRLKKSEMLKKEQAAHVRAERDVLASANTNWVVKLYYSFQDDNYLYLI 188
Query: 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH 254
MEYLPGGDMM+LL++ D TE++ARFY+AET+LAIES+H YIHRDIKPDNLLLD GH
Sbjct: 189 MEYLPGGDMMSLLIKYDIFTENQARFYIAETILAIESVHTLGYIHRDIKPDNLLLDSKGH 248
Query: 255 LRLSDFGLCKPLDCSTLQEQDF---TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRR 311
++L D GLC L +F +G+ + + E A P TQ E++ W+K RR
Sbjct: 249 VKLCDLGLCTGFH--RLHSSEFYQMLVGDAMTIKMKLIE--ATPL-TQTERIASWKKARR 303
Query: 312 MLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369
LAYS VGTPDY APEV L+ GY E DWWSLG I+YEM+VG+PPF SD+ TC K+
Sbjct: 304 ALAYSAVGTPDYTAPEVFLQIGYNKEVDWWSLGVILYEMVVGHPPFLSDNTTETCLKI 361
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q5R8M1 | STK38_PONAB | 2, ., 7, ., 1, 1, ., 1 | 0.5191 | 0.8713 | 0.6989 | yes | no |
| Q54Y26 | NDRA_DICDI | 2, ., 7, ., 1, 1, ., 1 | 0.5111 | 0.9195 | 0.6471 | yes | no |
| Q2LZZ7 | TRC_DROPS | 2, ., 7, ., 1, 1, ., 1 | 0.5395 | 0.9008 | 0.7336 | yes | no |
| Q91VJ4 | STK38_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.5191 | 0.8713 | 0.6989 | yes | no |
| Q9NBK5 | TRC_DROME | 2, ., 7, ., 1, 1, ., 1 | 0.5454 | 0.8525 | 0.6868 | yes | no |
| Q15208 | STK38_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.5191 | 0.8713 | 0.6989 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 373 | |||
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-165 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-134 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-114 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-106 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-104 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-99 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-99 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-92 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-88 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-87 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-85 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-84 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-84 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-83 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-79 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-74 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-73 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-72 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-70 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-70 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-70 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-69 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-69 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-68 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-67 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-67 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-67 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-67 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-66 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-59 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-58 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-56 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-55 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-55 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-55 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-54 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-53 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-53 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-52 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-52 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-52 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-52 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-52 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-51 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-50 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-50 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-50 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-48 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-48 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-46 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-46 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-46 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-45 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-44 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-44 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-43 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-43 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-43 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-43 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-43 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-43 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-41 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-41 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-41 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-41 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-40 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-40 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-40 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-38 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-37 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-36 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-36 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-36 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-36 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-35 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-34 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-34 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-33 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-33 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-32 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-32 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-32 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-32 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-31 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-31 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-31 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-31 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-30 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-30 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-30 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-30 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-30 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-29 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-29 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-28 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-28 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-28 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-28 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-27 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-27 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-26 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-26 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-26 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-25 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-25 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-25 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-25 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-25 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-25 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-24 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-24 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-24 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-24 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-24 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-24 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-24 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-23 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-23 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-23 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-23 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-23 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-23 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-22 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-22 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-21 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-21 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-21 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-21 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-21 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-21 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-21 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-21 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-20 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-20 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-20 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-20 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-19 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-19 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-19 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-19 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-19 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-19 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-19 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-19 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-18 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-18 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-18 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-18 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-18 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-17 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-17 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-16 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-16 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-15 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-14 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-13 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-12 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-11 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-11 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-09 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-08 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-07 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-07 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-07 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-07 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-07 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-06 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-06 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-06 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-06 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-06 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 6e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-06 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-06 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-06 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-05 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-05 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-04 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-04 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-04 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-04 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-04 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-04 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 0.001 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 0.002 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 466 bits (1202), Expect = e-165
Identities = 163/255 (63%), Positives = 197/255 (77%), Gaps = 5/255 (1%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DDFE + +IG+GAFGEVR+ ++K TGH+YAMKKL+KSEML + QV HVRAER++LAE D+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+VKLY SFQD+ +LYLIMEYLPGGDMMTLLM+KDT TE+E RFY+AET+LAI+SIHK
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
YIHRDIKPDNLLLD GH++LSDFGLC L S E L+ + +N
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYR----ILSHALPSNFLDFIS 176
Query: 296 K-RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354
K + + + + W++NRR LAYSTVGTPDYIAPEV L+ GY ECDWWSLG IMYEMLVGY
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236
Query: 355 PPFYSDDPMSTCRKV 369
PPF SD+P T RK+
Sbjct: 237 PPFCSDNPQETYRKI 251
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 386 bits (993), Expect = e-134
Identities = 141/254 (55%), Positives = 182/254 (71%), Gaps = 12/254 (4%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DDFE++ +IG+GAFGEV + R+K TG VYAMK L+KS+M++R Q+ HVRAER++LA+ DS
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IVKLY SFQD+E LYL+MEY+PGGD+M LL+RKD E+ ARFY+AE VLA++S+HK
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+IHRDIKPDN+L+D GH++L+DFGLCK ++ + +E N+
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY------------LNDSHNLL 168
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
R + K RR+ A STVGTPDYIAPEVL YG+ECDWWSLG I+YEML G+P
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228
Query: 356 PFYSDDPMSTCRKV 369
PFYSD T K+
Sbjct: 229 PFYSDTLQETYNKI 242
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 337 bits (867), Expect = e-114
Identities = 140/260 (53%), Positives = 190/260 (73%), Gaps = 6/260 (2%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+DF + +IGKGAFGEVR+ ++K TG +YAMK L KSEM ++ Q+ HV+AER++LAE DS
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+V LY SFQD ++LYLIME+LPGGD+MT+L++ DT +ED RFY+AE VLAIE++HK
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCK---PLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+IHRDIKPDN+L+D+ GH++LSDFGL S ++ +N N N
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180
Query: 293 AAP---KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349
+ ++Q+ W+KNRR++AYSTVGTPDYIAPE+ L++GYG ECDWWSLGAIM+E
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240
Query: 350 MLVGYPPFYSDDPMSTCRKV 369
L+G+PPF S++ T RK+
Sbjct: 241 CLIGWPPFCSENSHETYRKI 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 317 bits (813), Expect = e-106
Identities = 150/256 (58%), Positives = 190/256 (74%), Gaps = 10/256 (3%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DDFE L +IG+GAFGEVR+ ++K TGH+YAMK L+K++ML + QV H+RAER++L E D
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+VK++ SFQD LYLIME+LPGGDMMTLLM+KDTL+E+ +FY+AETVLAI++IH+
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE--QDFTIGNNLNGSSQNNERPA 293
+IHRDIKPDNLLLD GH++LSDFGLC L + E ++ T + S QN
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN----- 175
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
+ + + W+KNRR LAYSTVGTPDYIAPEV ++ GY CDWWSLG IMYEML+G
Sbjct: 176 ---MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
Query: 354 YPPFYSDDPMSTCRKV 369
YPPF S+ P T RKV
Sbjct: 233 YPPFCSETPQETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 310 bits (796), Expect = e-104
Identities = 154/264 (58%), Positives = 192/264 (72%), Gaps = 26/264 (9%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+DFE L +IG+GAFGEVR+ ++K TGHVYAMK L+K++ML + QV H+RAER++L E DS
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLTE+E +FY+AETVLAI+SIH+
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE----------QDFTIGNNLNGS 285
+IHRDIKPDNLLLD GH++LSDFGLC L + E DFT N
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN----- 175
Query: 286 SQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345
N++R A + W++NRR LA+STVGTPDYIAPEV ++ GY CDWWSLG
Sbjct: 176 -MNSKRKA----------ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGV 224
Query: 346 IMYEMLVGYPPFYSDDPMSTCRKV 369
IMYEML+GYPPF S+ P T +KV
Sbjct: 225 IMYEMLIGYPPFCSETPQETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 299 bits (768), Expect = 1e-99
Identities = 129/258 (50%), Positives = 176/258 (68%), Gaps = 10/258 (3%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F + IG GAFGEV + R+ T +YAMK L+K+++L R Q HV+AER++LAE D+
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
+VKLY SFQD + LY +M+Y+PGGDMM+LL+R ED ARFY+AE AIES+HK +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPL----DCSTLQEQDFTIGNNLNGSSQNNERPA 293
IHRDIKPDN+L+D+ GH++L+DFGLC D Q+ D ++ S + +E +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGD----HHRQDSMEPSEEWS 178
Query: 294 APKRTQQEQLQ--HWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
R + + L+ ++++R LA+S VGTP+YIAPEVLL+ GY CDWWS+G I+YEML
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
Query: 352 VGYPPFYSDDPMSTCRKV 369
VG PPF +D P T KV
Sbjct: 239 VGQPPFLADTPAETQLKV 256
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 294 bits (756), Expect = 2e-99
Identities = 103/249 (41%), Positives = 148/249 (59%), Gaps = 41/249 (16%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
+GKG+FG+V + R+K TG +YAMK LKK ++++R +VEH ERN+L+ ++ IVKL+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK 243
+FQ +E LYL++EY PGG++ + L ++ +E+ ARFY AE VLA+E +H I+RD+K
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
P+N+LLD GH++L+DFGL K L
Sbjct: 121 PENILLDADGHIKLTDFGLAKEL------------------------------------- 143
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
+ + GTP+Y+APEVLL KGYG DWWSLG ++YEML G PPFY++D
Sbjct: 144 ----SSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK 199
Query: 364 STCRKVRKK 372
K+ K
Sbjct: 200 EIYEKILKD 208
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 277 bits (710), Expect = 5e-92
Identities = 99/256 (38%), Positives = 146/256 (57%), Gaps = 44/256 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DDFE + +G G+FG V + R K +G YA+K L K+++++ QVEHV E+ +L +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+V LY SFQDD LYL+MEY+PGG++ + L + E ARFY A+ VLA+E +H
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
++RD+KP+NLLLD G+++++DFG K +
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKRVK---------------------------- 152
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
RT Y+ GTP+Y+APE++L KGYG DWW+LG ++YEML GYP
Sbjct: 153 GRT----------------YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYP 196
Query: 356 PFYSDDPMSTCRKVRK 371
PF+ D+P+ K+ +
Sbjct: 197 PFFDDNPIQIYEKILE 212
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 267 bits (685), Expect = 1e-88
Identities = 93/248 (37%), Positives = 141/248 (56%), Gaps = 44/248 (17%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+E+L +G+G+FG+V + R+K TG + A+K +KK ++ + E + E +L ++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKLKHPN 58
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
IV+LY F+D++ LYL+MEY GGD+ LL ++ L+EDEARFY+ + + A+E +H
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
+HRD+KP+N+LLD+ GH++L+DFGL +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR--------------------------------- 145
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
Q + + VGTP+Y+APEVLL KGYG D WSLG I+YE+L G PPF
Sbjct: 146 ---------QLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPF 196
Query: 358 YSDDPMST 365
DD +
Sbjct: 197 PGDDQLLE 204
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 265 bits (679), Expect = 1e-87
Identities = 107/249 (42%), Positives = 149/249 (59%), Gaps = 33/249 (13%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
I KGA+G V + ++K+TG +YA+K +KK++M+R+ QV+ V ER++L++ S +VKLY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK 243
SFQ + LYL+MEYLPGGD+ +LL +L ED AR Y+AE VLA+E +H + IHRD+K
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
PDN+L+D GHL+L+DFGL K +G L N +
Sbjct: 121 PDNILIDSNGHLKLTDFGLSK-------------VG--LVRRQINLNDDEKEDKR----- 160
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
VGTPDYIAPEV+L +G+ DWWSLG I+YE LVG PPF+ + P
Sbjct: 161 -------------IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE 207
Query: 364 STCRKVRKK 372
+ +
Sbjct: 208 EIFQNILNG 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 262 bits (670), Expect = 5e-85
Identities = 117/281 (41%), Positives = 170/281 (60%), Gaps = 45/281 (16%)
Query: 93 NLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKS 152
N+ FL + E ++ + +M A+DF+++ +IG+GAFGEV++ R K++ VYAMK L K
Sbjct: 20 NIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF 79
Query: 153 EMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT 212
EM++R ER+++A +S IV+L+ +FQDD++LY++MEY+PGGD++ L+ D
Sbjct: 80 EMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD- 138
Query: 213 LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272
+ E ARFY AE VLA+++IH +IHRD+KPDN+LLDK GHL+L+DFG C +D + +
Sbjct: 139 IPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198
Query: 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332
D + VGTPDYI+PEVL +
Sbjct: 199 RCD----------------------------------------TAVGTPDYISPEVLKSQ 218
Query: 333 G----YGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369
G YG ECDWWS+G +YEMLVG PFY+D + T K+
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 260 bits (665), Expect = 5e-84
Identities = 124/258 (48%), Positives = 175/258 (67%), Gaps = 6/258 (2%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F + +G GAFGEV + R+ T +YAMK L+K ++L R QV HV+AER++LAE D+
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
+V+LY SFQD + LY +M+Y+PGGDMM+LL+R ED ARFY+AE A+ES+HK +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPL----DCSTLQEQDFTIGNNLNGSSQ--NNER 291
IHRDIKPDN+L+D+ GH++L+DFGLC D Q D ++++ S++ +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
R + + + ++++R LA+S VGTP+YIAPEVLL+ GY CDWWS+G I+YEML
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 352 VGYPPFYSDDPMSTCRKV 369
VG PPF + P+ T KV
Sbjct: 243 VGQPPFLAQTPLETQMKV 260
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 257 bits (659), Expect = 8e-84
Identities = 122/260 (46%), Positives = 156/260 (60%), Gaps = 46/260 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DDFE+L +IG+GAFGEV V + K TG VYAMK L K EML+R + R ER++L D
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHK 234
I L+ +FQD+ LYL+M+Y GGD++TLL + +D L ED ARFY+AE VLAI+S+H+
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
Y+HRDIKPDN+LLDK GH+RL+DFG C L +G+ Q+N
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRL--------------LADGTVQSN----- 161
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYE 349
VGTPDYI+PE+L K YG ECDWWSLG MYE
Sbjct: 162 ---------------------VAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYE 200
Query: 350 MLVGYPPFYSDDPMSTCRKV 369
ML G PFY++ + T K+
Sbjct: 201 MLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 258 bits (661), Expect = 1e-83
Identities = 126/261 (48%), Positives = 175/261 (67%), Gaps = 12/261 (4%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F + +G GAFGEV + + T +YAMK L+K ++L R QV HV+AER++LAE D+
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
+VKLY SFQD + LY +M+Y+PGGDMM+LL+R + E ARFY+AE LAIES+HK +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ---------N 288
IHRDIKPDN+L+D GH++L+DFGLC T + + G+++ S +
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRW-THNSKYYQKGSHIRQDSMEPSDLWDDVS 181
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
N R +T +++ ++++R LA+S VGTP+YIAPEVLL+KGY CDWWS+G I++
Sbjct: 182 NCRCGDRLKTLEQRAT--KQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239
Query: 349 EMLVGYPPFYSDDPMSTCRKV 369
EMLVG PPF + P T KV
Sbjct: 240 EMLVGQPPFLAPTPTETQLKV 260
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 245 bits (626), Expect = 7e-79
Identities = 102/255 (40%), Positives = 146/255 (57%), Gaps = 44/255 (17%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
DF++LT +G+G +G+V + ++K TG + A+K++KKS + + +V HV ER++L S
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH 236
+VKL +FQDDE+LYL MEY+PGGD TLL L+ED ARFY+AE A++++H+
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
YIHRD+KP+N L+D GH++L+DFGL K +
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK---------------GIVT------------- 153
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
A S VG+PDY+APEVL KGY D+WSLG ++YE L G+PP
Sbjct: 154 ----------------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197
Query: 357 FYSDDPMSTCRKVRK 371
F P T ++
Sbjct: 198 FSGSTPNETWENLKY 212
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 232 bits (594), Expect = 5e-74
Identities = 108/261 (41%), Positives = 150/261 (57%), Gaps = 47/261 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DF++ +++G+G FGEV+V REK TG +YAMK +KKS +L + V ER++L+ +S
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHK 234
I +L +FQD + LYL+MEY PGGD+++LL R +D ED A+FY+AE VLAI S+H+
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
Y+HRDIKP+N+L+D+ GH++L+DFG L
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLT--------------------------- 153
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL------KKGYGMECDWWSLGAIMY 348
N+ + + VGTPDYIAPEVL K YG+ECDWWSLG I Y
Sbjct: 154 -------------ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAY 200
Query: 349 EMLVGYPPFYSDDPMSTCRKV 369
EM+ G PF+ T +
Sbjct: 201 EMIYGRSPFHEGTSAKTYNNI 221
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 230 bits (587), Expect = 5e-73
Identities = 120/260 (46%), Positives = 159/260 (61%), Gaps = 46/260 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DDFE++ +IG+GAFGEV V + K T +YAMK L K EML+R + R ERN+L D
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHK 234
I L+ +FQD+ +LYL+M+Y GGD++TLL + +D L ED ARFY+AE VLAI SIH+
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
HY+HRDIKPDN+LLD GH+RL+DFG C ++ QD T+ +++
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN------QDGTVQSSV------------ 162
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL--LKKG---YGMECDWWSLGAIMYE 349
VGTPDYI+PE+L ++ G YG ECDWWSLG MYE
Sbjct: 163 ----------------------AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYE 200
Query: 350 MLVGYPPFYSDDPMSTCRKV 369
ML G PFY++ + T K+
Sbjct: 201 MLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 228 bits (583), Expect = 5e-72
Identities = 114/281 (40%), Positives = 172/281 (61%), Gaps = 45/281 (16%)
Query: 93 NLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKS 152
N+ FL + E ++++ +M A+D++++ +IG+GAFGEV++ R K++ VYAMK L K
Sbjct: 20 NIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKF 79
Query: 153 EMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT 212
EM++R ER+++A +S +V+L+C+FQDD++LY++MEY+PGGD++ L+ D
Sbjct: 80 EMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD- 138
Query: 213 LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272
+ E A+FY AE VLA+++IH IHRD+KPDN+LLDK+GHL+L+DFG C +D + +
Sbjct: 139 VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198
Query: 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332
D + VGTPDYI+PEVL +
Sbjct: 199 RCD----------------------------------------TAVGTPDYISPEVLKSQ 218
Query: 333 G----YGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369
G YG ECDWWS+G ++EMLVG PFY+D + T K+
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 224 bits (573), Expect = 2e-70
Identities = 115/281 (40%), Positives = 168/281 (59%), Gaps = 45/281 (16%)
Query: 93 NLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKS 152
N+ FL + + +++ +M A+D+E++ +IG+GAFGEV++ R K+T VYAMK L K
Sbjct: 20 NIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF 79
Query: 153 EMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT 212
EM++R ER+++A +S +V+L+ +FQDD +LY++MEY+PGGD++ L+ D
Sbjct: 80 EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD- 138
Query: 213 LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272
+ E ARFY AE VLA+++IH +IHRD+KPDN+LLDK GHL+L+DFG C ++ +
Sbjct: 139 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198
Query: 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332
D + VGTPDYI+PEVL +
Sbjct: 199 RCD----------------------------------------TAVGTPDYISPEVLKSQ 218
Query: 333 G----YGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369
G YG ECDWWS+G +YEMLVG PFY+D + T K+
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 220 bits (562), Expect = 4e-70
Identities = 89/248 (35%), Positives = 135/248 (54%), Gaps = 44/248 (17%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
+G G FG V + + K+ +A+K +KK ++ GQ EH+ +E+ +L E + IVKLY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK 243
+F+D +++Y++MEY GG++ T+L + E ARFY+A VLA E +H I+RD+K
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
P+NLLLD G+++L DFG K +L
Sbjct: 121 PENLLLDSNGYVKLVDFGFAK-------------------------------------KL 143
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD--D 361
+ QK ++ GTP+Y+APE++L KGY D+WSLG ++YE+L G PPF D D
Sbjct: 144 KSGQK-----TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED 198
Query: 362 PMSTCRKV 369
PM +
Sbjct: 199 PMEIYNDI 206
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 220 bits (562), Expect = 8e-70
Identities = 88/254 (34%), Positives = 135/254 (53%), Gaps = 44/254 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DD E + +G G FG V + R++ + H YA+K + E++R Q +HV E+ +L EV
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I++L+ + D FLY++MEY+PGG++ + L + FY +E V A+E +H
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
++RD+KP+N+LLDK GH++L+DFG K L T
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT------------------------- 155
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
++ GTP+Y+APEV+ KG+ DWW+LG ++YEMLVGYP
Sbjct: 156 -------------------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYP 196
Query: 356 PFYSDDPMSTCRKV 369
PF+ D+P K+
Sbjct: 197 PFFDDNPFGIYEKI 210
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 221 bits (565), Expect = 1e-69
Identities = 98/272 (36%), Positives = 146/272 (53%), Gaps = 51/272 (18%)
Query: 98 LEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR 157
K +T +L DFE+ +G G+FG VR+ + K TG YA+K LKK E+L+
Sbjct: 7 FTKPDTSSWKLS-------DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKM 59
Query: 158 GQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDE 217
QV+HV E+++L E+ IV + CSFQD+ +Y ++E++ GG++ T L + D
Sbjct: 60 KQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDV 119
Query: 218 ARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT 277
A+FY AE VLA E +H I+RD+KP+NLLLD GH++++DFG K +
Sbjct: 120 AKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV----------- 168
Query: 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME 337
P RT ++ GTP+Y+APEV+ KG+G
Sbjct: 169 -----------------PDRT----------------FTLCGTPEYLAPEVIQSKGHGKA 195
Query: 338 CDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369
DWW++G ++YE + GYPPF+ D P K+
Sbjct: 196 VDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI 227
|
Length = 329 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 218 bits (558), Expect = 3e-69
Identities = 96/257 (37%), Positives = 150/257 (58%), Gaps = 22/257 (8%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DDF+ +IG+G+F V + +EK T YA+K L K ++++ +V++V+ E+ +L ++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 176 N-CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
+ I+KLY +FQD+E LY ++EY P G+++ + + +L E RFY AE +LA+E +H
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
IHRD+KP+N+LLDK H++++DFG K LD N P +
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLD--------------------PNSSPES 160
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354
K +KNRR A S VGT +Y++PE+L +K G D W+LG I+Y+ML G
Sbjct: 161 NKGDATNIDSQIEKNRRRFA-SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
Query: 355 PPFYSDDPMSTCRKVRK 371
PPF + T +K+ K
Sbjct: 220 PPFRGSNEYLTFQKILK 236
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 214 bits (546), Expect = 8e-68
Identities = 86/256 (33%), Positives = 131/256 (51%), Gaps = 43/256 (16%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+ELL +G G+FG V + K TG + A+K LKK + R E +L +
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR-EIRILRRLSHPN 59
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
IV+L +F+D + LYL+MEY GGD+ L R L+EDEA+ + + +E +H +
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRD+KP+N+LLD+ G ++++DFGL K
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAK--------------------------------- 146
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPP 356
+ + + + + VGTP Y+APEVLL GYG + D WSLG I+YE+L G PP
Sbjct: 147 ------KLLKSSSSL--TTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP 198
Query: 357 FYSDDPMSTCRKVRKK 372
F ++ + + +R+
Sbjct: 199 FSGENILDQLQLIRRI 214
|
Length = 260 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 215 bits (550), Expect = 1e-67
Identities = 96/259 (37%), Positives = 143/259 (55%), Gaps = 14/259 (5%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
F+ + ++GKG G V + R K TG ++A+K L K EM++R +V+ V E+ +LA +D
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT--LTEDEARFYVAETVLAIESIH 233
+ LY SFQ + +L L+M+Y PGG++ LL R+ L+E+ ARFY AE +LA+E +H
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
++RD+KP+N+LL + GH+ LSDF L K D + + R +
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSK---------ALRKGSRRS 171
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
+ E R S VGT +YIAPEV+ G+G DWW+LG ++YEML G
Sbjct: 172 SVNSIPSETFSEEPSFRSN---SFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
Query: 354 YPPFYSDDPMSTCRKVRKK 372
PF + T + KK
Sbjct: 229 TTPFKGSNRDETFSNILKK 247
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 214 bits (546), Expect = 4e-67
Identities = 99/247 (40%), Positives = 142/247 (57%), Gaps = 26/247 (10%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+DFE + +I GA+G V + R K T +AMKK+ K ++ R Q++ V ER++L ++
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+V ++CSF+ L ++MEY+ GGD TLL L D AR Y AETVLA+E +H +
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+HRD+KPDNLL+ GH++L+DFGL K IG L + N
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSK-------------IG--LMSLTTNLYEGHIE 165
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
K T++ + GTP+YIAPEV+L++GYG DWW++G I+YE LVG
Sbjct: 166 KDTREFLDKQ-----------VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCV 214
Query: 356 PFYSDDP 362
PF+ D P
Sbjct: 215 PFFGDTP 221
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 212 bits (541), Expect = 4e-67
Identities = 90/241 (37%), Positives = 134/241 (55%), Gaps = 42/241 (17%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
FELL +IGKGAFG+V + +++ T ++AMK + K + + +G V +V ER +L E++
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
+V L+ SFQD+E +YL+++ L GGD+ L +K +E++ +F++ E VLA+E +H
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRDIKPDN+LLD+ GH+ ++DF + A K
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNI-------------------------------ATKV 150
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
T ST GTP Y+APEVL ++GY + DWWSLG YE L G P+
Sbjct: 151 TPDTLTT-----------STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY 199
Query: 358 Y 358
Sbjct: 200 R 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 214 bits (546), Expect = 7e-67
Identities = 115/260 (44%), Positives = 156/260 (60%), Gaps = 46/260 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+DFE+L +IG+GAFGEV V + K V+AMK L K EML+R + R ER++L D+
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHK 234
I L+ +FQD+ LYL+M+Y GGD++TLL + +D L ED ARFY+AE V+AI+S+H+
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
HY+HRDIKPDN+L+D GH+RL+DFG C L +D T+ +++
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKL------MEDGTVQSSV------------ 162
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYE 349
VGTPDYI+PE+L K YG ECDWWSLG MYE
Sbjct: 163 ----------------------AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYE 200
Query: 350 MLVGYPPFYSDDPMSTCRKV 369
ML G PFY++ + T K+
Sbjct: 201 MLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 209 bits (534), Expect = 5e-66
Identities = 99/243 (40%), Positives = 143/243 (58%), Gaps = 46/243 (18%)
Query: 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER-NLLAEVDSNCIV 179
L I KGAFG V + ++++TG +A+K LKKS+M+ + QV +V+AER ++ + +S +
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 180 KLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIH 239
KLY SFQ ++LYL+MEYL GGD +L+ L ED A+ Y+AE VL +E +H+ IH
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120
Query: 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQ 299
RDIKP+NLL+D+ GHL+L+DFGL S+N
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGL-----------------------SRNGL--------- 148
Query: 300 QEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 359
+N++ VGTPDY+APE +L G DWWSLG +++E L GYPPF++
Sbjct: 149 --------ENKKF-----VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA 195
Query: 360 DDP 362
+ P
Sbjct: 196 ETP 198
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 195 bits (496), Expect = 1e-59
Identities = 96/255 (37%), Positives = 141/255 (55%), Gaps = 45/255 (17%)
Query: 121 LTMIGKGAFGEV---RVCREKTTGHVYAMKKLKKSEMLRRGQ-VEHVRAERNLLAEVDSN 176
L ++GKG +G+V R TG ++AMK LKK+ ++R + H +AERN+L V
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH 236
IV L +FQ LYLI+EYL GG++ L R+ ED A FY++E LA+E +H+
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
I+RD+KP+N+LLD GH++L+DFGLCK ++ E T
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVT------------------- 157
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
++ GT +Y+APE+L++ G+G DWWSLGA+MY+ML G PP
Sbjct: 158 ------------------HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
Query: 357 FYSDDPMSTCRKVRK 371
F +++ T K+ K
Sbjct: 200 FTAENRKKTIDKILK 214
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 3e-58
Identities = 95/242 (39%), Positives = 133/242 (54%), Gaps = 44/242 (18%)
Query: 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN-LLAEVDSNCIVK 180
+IGKG+FG+V + + K G YA+K L+K +L++ + +H+ AERN LL V +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
L+ SFQ + LY +++Y+ GG++ L R+ + E ARFY AE A+ +H + I+R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
D+KP+N+LLD GH+ L+DFGLCK E K T
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK-------------------------EGIEHSKTT-- 153
Query: 301 EQLQHWQKNRRMLAYST-VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 359
ST GTP+Y+APEVL K+ Y DWW LGA++YEML G PPFYS
Sbjct: 154 ---------------STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198
Query: 360 DD 361
D
Sbjct: 199 RD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 2e-56
Identities = 93/246 (37%), Positives = 137/246 (55%), Gaps = 41/246 (16%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IGKG+FG+V R++ T +YA+K ++K+ ++ R +V H AER +LA+V+ IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK 243
SFQ E LYL++ ++ GG++ L R+ ARFY AE + A+E++HK + I+RD+K
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
P+N+LLD GH+ L DFGLCK N+ + N
Sbjct: 121 PENILLDYQGHIALCDFGLCKL---------------NMKDDDKTN-------------- 151
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
+ GTP+Y+APE+LL GY DWW+LG ++YEML G PPFY ++
Sbjct: 152 ------------TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN 199
Query: 364 STCRKV 369
RK+
Sbjct: 200 EMYRKI 205
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 1e-55
Identities = 86/240 (35%), Positives = 127/240 (52%), Gaps = 42/240 (17%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKL 181
++GKG+FG+V + K T +YA+K LKK +L+ VE E+ +LA + + +L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
+ FQ + L+ +MEY+ GGD+M + R E ARFY AE VL ++ +H+ I+RD
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+K DN+LLD GH++++DFG+CK L G + +
Sbjct: 122 LKLDNVLLDSEGHIKIADFGMCKE--------------GILGGVTTS------------- 154
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361
+ GTPDYIAPE+L + YG DWW+LG ++YEML G PF DD
Sbjct: 155 --------------TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 2e-55
Identities = 94/242 (38%), Positives = 134/242 (55%), Gaps = 45/242 (18%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL---AEVDSNCIVK 180
IGKG FG+V R+K T +YAMK L K E++ + +V H ERN+L +S IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
L SFQ D LYL+ +Y+ GG++ L ++ +ED A+FY+AE VLA+E +HK+ ++R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
D+KP+N+LLD GH+ L DFGL K NL + N
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKA---------------NLTDNKTTN----------- 154
Query: 301 EQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPFYS 359
+ GT +Y+APEVLL +KGY D+WSLG +++EM G+ PFY+
Sbjct: 155 ---------------TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199
Query: 360 DD 361
+D
Sbjct: 200 ED 201
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 3e-55
Identities = 84/248 (33%), Positives = 129/248 (52%), Gaps = 47/248 (18%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN- 176
F L ++G+G FG+V + K TG +YA+K LKK +++ R +VE + E+ + +S
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 177 --CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
+V L+ FQ ++ + +MEY GGD+M + + D +E A FY A VL ++ +H+
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLM-MHIHTDVFSEPRAVFYAACVVLGLQYLHE 119
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+ ++RD+K DNLLLD G ++++DFGLCK
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCK------------------------------ 149
Query: 295 PKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
E + + ST GTP+++APEVL + Y DWW LG ++YEMLVG
Sbjct: 150 ------EGMGFGDRT------STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
Query: 354 YPPFYSDD 361
PF DD
Sbjct: 198 ESPFPGDD 205
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 5e-54
Identities = 87/239 (36%), Positives = 123/239 (51%), Gaps = 41/239 (17%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLY 182
++GKG FG+V + REK TG YAMK LKK ++ + +V H E +L + L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDI 242
SFQ + L +MEY GG++ L R+ +ED ARFY AE V A+ +H ++RD+
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDL 121
Query: 243 KPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQ 302
K +NL+LDK GH++++DFGLCK + + G +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCK---------EGISDGATMK------------------- 153
Query: 303 LQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361
+ GTP+Y+APEVL YG DWW LG +MYEM+ G PFY+ D
Sbjct: 154 -------------TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 1e-53
Identities = 95/254 (37%), Positives = 145/254 (57%), Gaps = 45/254 (17%)
Query: 121 LTMIGKGAFGEVRVCREKT---TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
L ++G+G+FG+V + R+ T G +YAMK LKK+ + R +V + ER++LAEV+
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVR-TKMERDILAEVNHPF 59
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
IVKL+ +FQ + LYLI+++L GGD+ T L ++ TE++ +FY+AE LA++ +H
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
I+RD+KP+N+LLD+ GH++L+DFGL K
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSK--------------------------------- 146
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
E + H +K AYS GT +Y+APEV+ ++G+ DWWS G +M+EML G PF
Sbjct: 147 ---ESIDHEKK-----AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF 198
Query: 358 YSDDPMSTCRKVRK 371
D T + K
Sbjct: 199 QGKDRKETMTMILK 212
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 1e-53
Identities = 93/264 (35%), Positives = 144/264 (54%), Gaps = 49/264 (18%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGH----VYAMKKLKKSEMLRRGQV-EHVRAERNLLA 171
+FELL ++G GA+G+V + R K GH +YAMK LKK+ ++++ + EH R ER +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVR-KVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLE 59
Query: 172 EVDSN-CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
V +V L+ +FQ D L+LI++Y+ GG++ T L +++ TE E R Y+AE VLA++
Sbjct: 60 AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD 119
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+H+ I+RDIK +N+LLD GH+ L+DFGL K ++ E
Sbjct: 120 HLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF------------------LAEEEE 161
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK--GYGMECDWWSLGAIMY 348
R AYS GT +Y+APEV+ G+ DWWSLG + +
Sbjct: 162 R----------------------AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTF 199
Query: 349 EMLVGYPPFYSDDPMSTCRKVRKK 372
E+L G PF D ++ ++ ++
Sbjct: 200 ELLTGASPFTVDGEQNSQSEISRR 223
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 3e-53
Identities = 79/230 (34%), Positives = 117/230 (50%), Gaps = 46/230 (20%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
+G+G FG V + R+K TG A+K +KK + +E + E +L +++ IVKLY
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSL--LEELLREIEILKKLNHPNIVKLYG 58
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDI 242
F+D+ LYL+MEY GG + LL + L+EDE + + + +E +H + IHRD+
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 243 KPDNLLLDK-YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
KP+N+LLD G ++L+DFGL K L
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLT---------------------------------- 144
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEM 350
+ + L + VGTP Y+APEVLL K Y + D WSLG I+YE+
Sbjct: 145 -------SDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 1e-52
Identities = 89/262 (33%), Positives = 143/262 (54%), Gaps = 45/262 (17%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHV-YAMKKLKKSEMLRRGQVEHVRAER 167
+++KM +DF + +G G+FG V + K A+K+ +KS+++++ QV+HV +ER
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER 82
Query: 168 NLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
+L ++ V LY SF+D+ +LYL++E++ GG+ T L R D FY A+ VL
Sbjct: 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL 142
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
E + + ++RD+KP+NLLLDK G ++++DFG K +D T
Sbjct: 143 IFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT----------------- 185
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347
Y+ GTP+YIAPE+LL G+G DWW+LG +
Sbjct: 186 ---------------------------YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFI 218
Query: 348 YEMLVGYPPFYSDDPMSTCRKV 369
YE+LVG PPFY+++P+ +K+
Sbjct: 219 YEILVGCPPFYANEPLLIYQKI 240
|
Length = 340 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 177 bits (449), Expect = 1e-52
Identities = 94/241 (39%), Positives = 134/241 (55%), Gaps = 44/241 (18%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN-LLAEVDSNCIVKL 181
+IGKG+FG+V + + K+ G YA+K L+K +L++ + H+ AERN LL + +V L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
+ SFQ E LY +++Y+ GG++ L R+ E ARFY AE AI +H + I+RD
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+KP+N+LLD GH+ L+DFGLCK ++ ++ T
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK----EGVEPEETT------------------------ 153
Query: 302 QLQHWQKNRRMLAYST-VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360
ST GTP+Y+APEVL K+ Y DWW LGA++YEML G PPFYS
Sbjct: 154 --------------STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199
Query: 361 D 361
D
Sbjct: 200 D 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 176 bits (447), Expect = 2e-52
Identities = 89/240 (37%), Positives = 127/240 (52%), Gaps = 42/240 (17%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA-EVDSNCIVKL 181
++GKG+FG+V + K T VYA+K LKK +L+ V+ E+ +LA + L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
+C FQ + L+ +MEY+ GGD+M + R E +RFY AE LA+ +H+H I+RD
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+K DN+LLD GH +L+DFG+CK LNG
Sbjct: 122 LKLDNILLDAEGHCKLADFGMCKE--------------GILNG----------------- 150
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361
+ + GTPDYIAPE+L + YG DWW+LG +MYEM+ G PPF +D+
Sbjct: 151 ----------VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 4e-52
Identities = 73/261 (27%), Positives = 121/261 (46%), Gaps = 46/261 (17%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
+E++ IGKG+FG+V + R K+ G +Y +K++ S M + E E +L +++
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHP 59
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL----MRKDTLTEDEARFYVAETVLAIESI 232
I+K Y SF++ L ++MEY GGD+ + E++ + + LA++ +
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H +HRDIKP N+ L G ++L DFG+ K L ST+
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVD-------------------- 158
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
LA + VGTP Y++PE+ K Y + D WSLG ++YE+
Sbjct: 159 --------------------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCT 198
Query: 353 GYPPFYSDDPMSTCRKVRKKS 373
PF ++ + K+ K
Sbjct: 199 LKHPFEGENLLELALKILKGQ 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 8e-52
Identities = 88/240 (36%), Positives = 127/240 (52%), Gaps = 42/240 (17%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKL 181
++GKG+FG+V + K T +A+K LKK +L VE ER +LA + + L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
+C+FQ E L+ +MEYL GGD+M + E ARFY AE + ++ +HK I+RD
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+K DN+LLDK GH++++DFG+CK N+NG +
Sbjct: 122 LKLDNVLLDKDGHIKIADFGMCK---------------ENMNGEGK-------------- 152
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361
A + GTPDYIAPE+L + Y DWWS G ++YEML+G PF+ +D
Sbjct: 153 ------------ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 1e-51
Identities = 99/262 (37%), Positives = 152/262 (58%), Gaps = 46/262 (17%)
Query: 117 DFELLTMIGKGAFGEVRVCREKT---TGHVYAMKKLKKSEMLRRGQ-VEHVRAERNLLAE 172
+FELL ++G GA+G+V + R+ T TG +YAMK L+K+ ++++ + VEH R ERN+L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 173 V-DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIES 231
V S +V L+ +FQ + L+LI++Y+ GG+M T L ++D +EDE RFY E +LA+E
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+HK ++RDIK +N+LLD GH+ L+DFGL K L E+
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF----LSEEK---------------- 160
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEM 350
+RT YS GT +Y+APE++ K G+G DWWSLG +++E+
Sbjct: 161 ----ERT----------------YSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFEL 200
Query: 351 LVGYPPFYSDDPMSTCRKVRKK 372
L G PF + +T +V ++
Sbjct: 201 LTGASPFTLEGERNTQSEVSRR 222
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 1e-50
Identities = 77/259 (29%), Positives = 112/259 (43%), Gaps = 50/259 (19%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
FE+L IGKG FGEV R K TG A+K +K ++ E + E +L +
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKK---EKIINEIQILKKCKHP 57
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGG---DMMTLLMRKDTLTEDEARFYVAETVLAIESIH 233
IVK Y S+ + L+++ME+ GG D++ + TLTE + + E + +E +H
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQ--TLTESQIAYVCKELLKGLEYLH 115
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
+ IHRDIK N+LL G ++L DFGL
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLSA----------------------------- 146
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
Q + + VGTP ++APEV+ K Y + D WSLG E+ G
Sbjct: 147 -------------QLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEG 193
Query: 354 YPPFYSDDPMSTCRKVRKK 372
PP+ PM K+
Sbjct: 194 KPPYSELPPMKALFKIATN 212
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 4e-50
Identities = 70/245 (28%), Positives = 114/245 (46%), Gaps = 43/245 (17%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLY 182
++G+G+FG V + +K TG + A+K ++ S ++E + E +L+ + IV+ Y
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEE-ELEALEREIRILSSLQHPNIVRYY 65
Query: 183 CSFQDDE--FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
S +D+E L + +EY+ GG + +LL + L E R Y + + + +H + +HR
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHR 125
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
DIK N+L+D G ++L+DFG K L E
Sbjct: 126 DIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT------------------------- 160
Query: 301 EQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY-S 359
S GTP ++APEV+ + YG D WSLG + EM G PP+
Sbjct: 161 --------------GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL 206
Query: 360 DDPMS 364
+PM+
Sbjct: 207 GNPMA 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 170 bits (431), Expect = 6e-50
Identities = 90/240 (37%), Positives = 132/240 (55%), Gaps = 42/240 (17%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN-LLAEVDSNCIVKL 181
+IGKG+FG+V + + K G YA+K L+K +L R + +H+ AERN LL V +V L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
+ SFQ E LY +++++ GG++ L R+ + E ARFY AE A+ +H + ++RD
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+KP+N+LLD GH+ L+DFGLCK G +Q++
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK------------------EGIAQSDT----------- 152
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361
+ GTP+Y+APEV+ K+ Y DWW LGA++YEML G PPFY D
Sbjct: 153 ------------TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 2e-48
Identities = 84/246 (34%), Positives = 127/246 (51%), Gaps = 42/246 (17%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS- 175
DF L ++GKG+FG+V + K T +YA+K LKK +++ VE E+ +LA
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+ +L+ FQ + LY +MEY+ GGD+M + + E A FY AE + + +H
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
I+RD+K DN++LD GH++++DFG+CK N+ G
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCK---------------ENIFG----------G 155
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
K T+ + GTPDYIAPE++ + YG DWW+ G ++YEML G P
Sbjct: 156 KTTR----------------TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQP 199
Query: 356 PFYSDD 361
PF +D
Sbjct: 200 PFDGED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 3e-48
Identities = 89/238 (37%), Positives = 127/238 (53%), Gaps = 42/238 (17%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN-LLAEVDSNCIVKL 181
+IGKG+FG+V + R K YA+K L+K +L++ + +H+ +ERN LL V +V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
+ SFQ + LY +++Y+ GG++ L R+ E ARFY AE A+ +H + ++RD
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+KP+N+LLD GH+ L+DFGLCK N T
Sbjct: 122 LKPENILLDSQGHIVLTDFGLCK-----------------------ENIEHNGTTST--- 155
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 359
GTP+Y+APEVL K+ Y DWW LGA++YEML G PPFYS
Sbjct: 156 ---------------FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 1e-46
Identities = 82/240 (34%), Positives = 126/240 (52%), Gaps = 42/240 (17%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKL 181
++GKG+FG+V + R K +G +YA+K LKK +L+ VE E+ +L+ ++ + +L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
YC FQ + L+ +ME++ GGD+M + + E ARFY AE A+ +H I+RD
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+K DN+LLD GH +L+DFG+CK + F
Sbjct: 122 LKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF------------------------- 156
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361
GTPDYIAPE+L + YG DWW++G ++YEML G+ PF +++
Sbjct: 157 ----------------CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 1e-46
Identities = 87/239 (36%), Positives = 124/239 (51%), Gaps = 41/239 (17%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLY 182
++GKG FG+V + REK TG YAMK L+K ++ + +V H E +L + L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDI 242
+FQ + L +MEY GG++ L R+ TE+ ARFY AE V A+E +H ++RDI
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 121
Query: 243 KPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQ 302
K +NL+LDK GH++++DFGLCK + + G +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCK---------EGISDGATMK------------------- 153
Query: 303 LQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361
+ GTP+Y+APEVL YG DWW LG +MYEM+ G PFY+ D
Sbjct: 154 -------------TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 4e-46
Identities = 83/249 (33%), Positives = 125/249 (50%), Gaps = 42/249 (16%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKL 181
M+GKG+FG+V + K T +A+K LKK +L VE E+ +L+ + + L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
YC+FQ E L+ +MEYL GGD+M + A FY AE + ++ +H ++RD
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+K DN+LLD GH++++DFG+CK N+ G ++
Sbjct: 122 LKLDNILLDTDGHIKIADFGMCK---------------ENMLGDAKTC------------ 154
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361
+ GTPDYIAPE+LL + Y DWWS G ++YEML+G PF+ D
Sbjct: 155 --------------TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200
Query: 362 PMSTCRKVR 370
+ +R
Sbjct: 201 EEELFQSIR 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 6e-45
Identities = 85/240 (35%), Positives = 124/240 (51%), Gaps = 42/240 (17%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKL 181
++GKG+FG+V + K G +A+K LKK +L VE E+ +LA N + L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
YC+FQ E L+ +ME+L GGD+M + K A FY AE V ++ +H I+RD
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+K DN++LD+ GH++++DFG+CK N+ G ++
Sbjct: 122 LKLDNVMLDRDGHIKIADFGMCK---------------ENVFGDNR-------------- 152
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361
A + GTPDYIAPE+L Y DWWS G ++YEML+G PF+ DD
Sbjct: 153 ------------ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 155 bits (392), Expect = 3e-44
Identities = 86/241 (35%), Positives = 125/241 (51%), Gaps = 45/241 (18%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLY 182
++GKG FG+V + REK +G YAMK LKK ++ + +V H E +L + L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDI 242
SFQ + L +MEY+ GG++ L R+ +ED RFY AE V A++ +H ++RD+
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121
Query: 243 KPDNLLLDKYGHLRLSDFGLCKP--LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
K +NL+LDK GH++++DFGLCK D +T++
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGITDAATMK---------------------------- 153
Query: 301 EQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360
+ GTP+Y+APEVL YG DWW LG +MYEM+ G PFY+
Sbjct: 154 ---------------TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198
Query: 361 D 361
D
Sbjct: 199 D 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 4e-44
Identities = 89/251 (35%), Positives = 136/251 (54%), Gaps = 47/251 (18%)
Query: 117 DFELLTMIGKGAFGEVRVCREKT---TGHVYAMKKLKKSEMLRRGQV-EHVRAERNLLAE 172
+FELL ++G GA+G+V + R+ + +G +YAMK LKK+ ++++ + EH R ER +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 173 V-DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIES 231
+ S +V L+ +FQ D L+LI++Y+ GG++ T L +++ E E + Y E VLA+E
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+HK I+RDIK +N+LLD GH+ L+DFGL K ER
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF------------------HEDEVER 162
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL--KKGYGMECDWWSLGAIMYE 349
AYS GT +Y+AP+++ G+ DWWS+G +MYE
Sbjct: 163 ----------------------AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYE 200
Query: 350 MLVGYPPFYSD 360
+L G PF D
Sbjct: 201 LLTGASPFTVD 211
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 1e-43
Identities = 73/247 (29%), Positives = 116/247 (46%), Gaps = 46/247 (18%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
++ L IG+GA GEV ++ TG A+KK++ LR+ E + E ++ +
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCKHPN 76
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHH 236
IV Y S+ + L+++MEY+ GG + ++ + + E + + E + +E +H +
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN 136
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
IHRDIK DN+LL K G ++L+DFG L K
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLT------------------------KEKSK 172
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
R S VGTP ++APEV+ +K YG + D WSLG + EM G PP
Sbjct: 173 RN-----------------SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
Query: 357 FYSDDPM 363
+ + P+
Sbjct: 216 YLREPPL 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 1e-43
Identities = 82/246 (33%), Positives = 129/246 (52%), Gaps = 42/246 (17%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
DF L ++GKG+FG+V + K T +YA+K LKK +++ VE E+ +LA D
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 177 -CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+ +L+ FQ + LY +MEY+ GGD+M + + E +A FY AE + + +H+
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
I+RD+K DN++LD GH++++DFG+CK + ++G
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--------------HMVDG----------- 155
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
+ + GTPDYIAPE++ + YG DWW+ G ++YEML G P
Sbjct: 156 ----------------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQP 199
Query: 356 PFYSDD 361
PF +D
Sbjct: 200 PFDGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 155 bits (391), Expect = 1e-43
Identities = 91/264 (34%), Positives = 128/264 (48%), Gaps = 46/264 (17%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS- 175
+ +L +G+G+FGEV + R++ + A+K L K + +VE E +LA ++
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL---MRKDTLTEDEARFYVAETVLAIESI 232
IVKLY FQD+ LYL+MEY+ GG + LL RK L+E EA F +A+ + A+E +
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 233 HKHHYIHRDIKPDNLLLDKYGH-LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
H IHRDIKP+N+LLD+ G ++L DFGL K L
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSI---------------- 161
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG---YGMECDWWSLGAIMY 348
L ++VGTP Y+APEVLL D WSLG +Y
Sbjct: 162 -------------------PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLY 202
Query: 349 EMLVGYPPFYSDDPMSTCRKVRKK 372
E+L G PPF + S + K
Sbjct: 203 ELLTGLPPFEGEKNSSATSQTLKI 226
|
Length = 384 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 2e-43
Identities = 87/242 (35%), Positives = 127/242 (52%), Gaps = 46/242 (19%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLY 182
++GKG FG+V + +EK TG YAMK LKK ++ + +V H E +L + L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH-KHHYIHRD 241
SFQ + L +MEY GG++ L R+ +ED ARFY AE V A++ +H + + ++RD
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKP--LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQ 299
+K +NL+LDK GH++++DFGLCK D +T++
Sbjct: 122 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMK--------------------------- 154
Query: 300 QEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 359
+ GTP+Y+APEVL YG DWW LG +MYEM+ G PFY+
Sbjct: 155 ----------------TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 198
Query: 360 DD 361
D
Sbjct: 199 QD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 2e-43
Identities = 78/238 (32%), Positives = 127/238 (53%), Gaps = 44/238 (18%)
Query: 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVK 180
+IG+G++ +V + K T +YAMK +KK + ++ V+ E+++ ++ +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
L+ FQ + L+ ++E++ GGD+M + R+ L E+ ARFY AE LA+ +H+ I+R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
D+K DN+LLD GH++L+D+G+CK ++ D T
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCK----EGIRPGDTT----------------------- 153
Query: 301 EQLQHWQKNRRMLAYST-VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
ST GTP+YIAPE+L + YG DWW+LG +M+EM+ G PF
Sbjct: 154 ---------------STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 6e-43
Identities = 83/258 (32%), Positives = 127/258 (49%), Gaps = 46/258 (17%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
DFE+L IGKG+FG V K VYAMK++ S+M RR + E + E +LA++DS+
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-EARVLAKLDSS 59
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEA-RFYVAETVLAIESIH 233
I++ Y SF D L ++MEY GD+ LL R L ED+ RF++ + +L + +H
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QILLGLAHLH 118
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
+HRDIK NL LD Y ++++ D G+ K L +T
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN---------------------- 156
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
A + VGTP Y++PE+ K Y + D W+LG ++YE G
Sbjct: 157 -------------------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTG 197
Query: 354 YPPFYSDDPMSTCRKVRK 371
PF +++ + K+ +
Sbjct: 198 KHPFDANNQGALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 1e-41
Identities = 69/249 (27%), Positives = 114/249 (45%), Gaps = 42/249 (16%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
+++L +IG+GAFG V TG A+K++ + ++ ++ + E +LL +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK-IKEEALKSIMQEIDLLKNLKHP 59
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH 236
IVK S + + LY+I+EY G + ++ + E YV + + + +H+
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
IHRDIK N+L K G ++L+DFG+ LN S+++
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA----------------TKLNDVSKDDA------ 157
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
S VGTP ++APEV+ G D WSLG + E+L G PP
Sbjct: 158 -------------------SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
Query: 357 FYSDDPMST 365
+Y +PM+
Sbjct: 199 YYDLNPMAA 207
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 1e-41
Identities = 65/149 (43%), Positives = 99/149 (66%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
++F ++ I +GAFG+V + R+K +YA+K +KK++M+ + V V+AER+ LA S
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV LY S Q +YL+MEYL GGD+ +LL E+ A Y++E LA++ +H+H
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH 123
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
IHRD+KPDN+L+ GH++L+DFGL K
Sbjct: 124 GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-41
Identities = 81/243 (33%), Positives = 128/243 (52%), Gaps = 44/243 (18%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKL 181
+IG+G++ +V + R K +YAMK +KK + ++ V+ E+++ + SN +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
+ FQ L+L++EY+ GGD+M + R+ L E+ ARFY AE +A+ +H+ I+RD
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+K DN+LLD GH++L+D+G+CK P T
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCK-----------------------EGLGPGDTTST--- 155
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF--YS 359
GTP+YIAPE+L + YG DWW+LG +M+EM+ G PF +
Sbjct: 156 ---------------FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIIT 200
Query: 360 DDP 362
D+P
Sbjct: 201 DNP 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 4e-41
Identities = 81/246 (32%), Positives = 124/246 (50%), Gaps = 42/246 (17%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA-EVDS 175
DF L ++GKG+FG+V + K T +YA+K LKK +++ VE E+ +LA
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+ +L+ FQ + LY +MEY+ GGD+M + + E A FY AE + + +H
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
I+RD+K DN++LD GH++++DFG+CK N +G +
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--------------NMWDGVTTK------- 159
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
+ GTPDYIAPE++ + YG DWW+ G ++YEML G
Sbjct: 160 --------------------TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 199
Query: 356 PFYSDD 361
PF +D
Sbjct: 200 PFEGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-40
Identities = 74/251 (29%), Positives = 118/251 (47%), Gaps = 51/251 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ F++L +G+G++G V K TG V A+K + + ++ + E ++L + DS
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV---PV--EEDLQEIIKEISILKQCDS 57
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGG---DMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
IVK Y S+ + L+++MEY G D+M + TLTE+E + +T+ +E +
Sbjct: 58 PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMK--ITNKTLTEEEIAAILYQTLKGLEYL 115
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H + IHRDIK N+LL++ G +L+DFG+
Sbjct: 116 HSNKKIHRDIKAGNILLNEEGQAKLADFGV------------------------------ 145
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
QL R + +GTP ++APEV+ + GY + D WSLG EM
Sbjct: 146 -------SGQLTDTMAKRN----TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAE 194
Query: 353 GYPPFYSDDPM 363
G PP+ PM
Sbjct: 195 GKPPYSDIHPM 205
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-40
Identities = 75/236 (31%), Positives = 113/236 (47%), Gaps = 44/236 (18%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
+GKG FGEV C+ K TG +YA KKL K + +R + E+ +L +V S IV L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDT--LTEDEARFYVAETVLAIESIHKHHYIHRD 241
+F+ + L L+M + GGD+ + E A FY A+ + +E +H+ ++RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+KP+N+LLD +G++R+SD GL + G + G
Sbjct: 121 LKPENVLLDDHGNVRISDLGLA----------VELKGGKKIKGR---------------- 154
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
GTP Y+APEVL + Y DW++LG +YEM+ G PF
Sbjct: 155 ----------------AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 144 bits (363), Expect = 6e-40
Identities = 82/245 (33%), Positives = 132/245 (53%), Gaps = 46/245 (18%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKL 181
+IG+G++ +V + R K T +YAMK +KK + ++ V+ E+++ + ++ +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
+ FQ + L+ ++EY+ GGD+M + R+ L E+ ARFY AE LA+ +H+ I+RD
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+K DN+LLD GH++L+D+G+CK L+ D T
Sbjct: 122 LKLDNVLLDSEGHIKLTDYGMCK----EGLRPGDTT------------------------ 153
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF---- 357
+ GTP+YIAPE+L + YG DWW+LG +M+EM+ G PF
Sbjct: 154 -------------STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 200
Query: 358 YSDDP 362
SD+P
Sbjct: 201 SSDNP 205
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 2e-38
Identities = 84/251 (33%), Positives = 119/251 (47%), Gaps = 50/251 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKK--LKKSEMLRRGQVEHVRAERNLLAEV 173
+ F LL IGKG+FGEV +K T V A+K L+++E ++E ++ E L++
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE----DEIEDIQQEIQFLSQC 56
Query: 174 DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH 233
S I K Y SF L++IMEY GG + LL + L E F + E +L +E +H
Sbjct: 57 RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLH 115
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
+ IHRDIK N+LL + G ++L+DFG+ S
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGV------SG----------------------- 146
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
QL R + VGTP ++APEV+ + GY + D WSLG E+ G
Sbjct: 147 --------QLTSTMSKRN----TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194
Query: 354 YPPFYSD-DPM 363
PP SD PM
Sbjct: 195 EPP-LSDLHPM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 3e-37
Identities = 68/251 (27%), Positives = 111/251 (44%), Gaps = 46/251 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEMLRRGQVEHVRAERNLLAEVD 174
D E + ++G+G+ G V R K TG +YA+KK+ + R Q+ E L +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQL---LRELKTLRSCE 57
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH- 233
S +VK Y +F + + +++EY+ GG + LL + + E + + + ++ +H
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
K H IHRDIKP NLL++ G ++++DFG+ K L+ + Q F
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF----------------- 160
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
VGT Y++PE + + Y D WSLG + E +G
Sbjct: 161 ------------------------VGTVTYMSPERIQGESYSYAADIWSLGLTLLECALG 196
Query: 354 YPPFYSDDPMS 364
PF S
Sbjct: 197 KFPFLPPGQPS 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-36
Identities = 75/252 (29%), Positives = 117/252 (46%), Gaps = 40/252 (15%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLK--KSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
++G+GAFG V +C + TG A+K++ + +V + E LL + IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
Y +DDE L + MEY+PGG + L LTE R Y + + +E +H + +HR
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHR 128
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
DIK N+L D G+++L DFG K L TI ++ G
Sbjct: 129 DIKGANILRDSAGNVKLGDFGASKRLQ---------TICSSGTGMK-------------- 165
Query: 301 EQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360
S GTP +++PEV+ +GYG + D WS+G + EML PP+
Sbjct: 166 ---------------SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210
Query: 361 DPMSTCRKVRKK 372
+ M+ K+ +
Sbjct: 211 EAMAAIFKIATQ 222
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-36
Identities = 76/238 (31%), Positives = 113/238 (47%), Gaps = 45/238 (18%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
+GKG FGEV C+ + TG +YA KKL K + +R E E+ +LA+V S IV L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDT----LTEDEARFYVAETVLAIESIHKHHYIH 239
+FQ L L+M + GGD+ + D E A FY A+ + +E +H+ I+
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQ 299
RD+KP+N+LLD G++R+SD GL L Q+ + A
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELK-----------------DGQSKTKGYA----- 158
Query: 300 QEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
GTP ++APE+L + Y D+++LG +YEM+ PF
Sbjct: 159 -------------------GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 2e-36
Identities = 72/253 (28%), Positives = 116/253 (45%), Gaps = 53/253 (20%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
D+E+L IGKG+FG VR R K+ G + K++ M + + + + +E N+L E+
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEK-EKQQLVSEVNILRELKHP 59
Query: 177 CIVKLYCSFQD--DEFLYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIE 230
IV+ Y D ++ LY++MEY GGD+ L+ + + + E+ + + +LA+
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 231 SIH-----KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285
H + +HRD+KP N+ LD +++L DFGL K L
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG------------------ 161
Query: 286 SQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345
+ A + VGTP Y++PE L Y + D WSLG
Sbjct: 162 -----------------------HDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGC 198
Query: 346 IMYEMLVGYPPFY 358
++YE+ PPF
Sbjct: 199 LIYELCALSPPFT 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 4e-36
Identities = 76/242 (31%), Positives = 117/242 (48%), Gaps = 44/242 (18%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F ++GKG FGEV C+ + TG +YA KKL+K + +R E+ +L +V+S
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIESIHKH 235
+V L +++ + L L++ + GGD+ + M E+ A FY AE +E +H+
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
++RD+KP+N+LLD YGH+R+SD GL + E
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEI--------------------PEGET---- 157
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
+ R VGT Y+APEV+ + Y DWW LG ++YEM+ G
Sbjct: 158 -----------IRGR-------VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKS 199
Query: 356 PF 357
PF
Sbjct: 200 PF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 5e-35
Identities = 81/239 (33%), Positives = 123/239 (51%), Gaps = 47/239 (19%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS-NC--IV 179
+IG+G FGEV CR+ TG +YAMK L K + + ER +L+ V + +C IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 180 KLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIH 239
+ +F + L I++ + GGD+ L + +E E RFY AE +L +E +H ++
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQ 299
RD+KP N+LLD++GH+R+SD GL C DF+ ++P A
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLA----C------DFS-----------KKKPHA----- 154
Query: 300 QEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGYPPF 357
+VGT Y+APEVL K Y DW+SLG +++++L G+ PF
Sbjct: 155 -----------------SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 4e-34
Identities = 76/242 (31%), Positives = 122/242 (50%), Gaps = 44/242 (18%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F ++GKG FGEV C+ + TG +YA K+L+K + +R E+ +L +V+S
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIESIHKH 235
+V L +++ + L L++ + GGD+ + M E+ A FY AE + +E +H+
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+ ++RD+KP+N+LLD YGH+R+SD GL A
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGL-------------------------------AV 150
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
K + E ++ VGT Y+APEVL + Y + D+W LG ++YEM+ G
Sbjct: 151 KIPEGESIR-----------GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQS 199
Query: 356 PF 357
PF
Sbjct: 200 PF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 5e-34
Identities = 68/256 (26%), Positives = 107/256 (41%), Gaps = 51/256 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DD+EL+ +IG GA V A+K++ + + V+ +R E +++ +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCNH 58
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGG---DMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
+VK Y SF + L+L+M YL GG D+M + L E + E + +E +
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFG----LCKPLDCSTLQEQDFTIGNNLNGSSQN 288
H + IHRDIK N+LL + G ++++DFG L D + + F
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF------------ 166
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL-LKKGYGMECDWWSLGAIM 347
VGTP ++APEV+ GY + D WS G
Sbjct: 167 -----------------------------VGTPCWMAPEVMEQVHGYDFKADIWSFGITA 197
Query: 348 YEMLVGYPPFYSDDPM 363
E+ G P+ PM
Sbjct: 198 IELATGAAPYSKYPPM 213
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 4e-33
Identities = 68/237 (28%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IG G FG+V TG + A+K+++ + ++ + E +L + +VK Y
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQD-NDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK 243
E +Y+ MEY GG + LL L E R Y + + + +H H +HRDIK
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIK 126
Query: 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
P N+ LD G ++L DFG L T E++
Sbjct: 127 PANIFLDHNGVIKLGDFGCAVKL--------------------------KNNTTTMGEEV 160
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGAIMYEMLVGYPPF 357
Q GTP Y+APEV+ KG+G D WSLG ++ EM G P+
Sbjct: 161 QSL-----------AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 6e-33
Identities = 77/242 (31%), Positives = 120/242 (49%), Gaps = 44/242 (18%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F ++GKG FGEV C+ + TG +YA KKL+K + +R E+ +L +V+S
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIESIHKH 235
+V L +++ + L L++ + GGD+ + M + E A FY AE +E +H+
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
++RD+KP+N+LLD +GH+R+SD GL + + TI
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHV------PEGQTI----------------- 158
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
K R VGT Y+APEV+ + Y DWW+LG ++YEM+ G
Sbjct: 159 ------------KGR-------VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 199
Query: 356 PF 357
PF
Sbjct: 200 PF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 1e-32
Identities = 80/240 (33%), Positives = 128/240 (53%), Gaps = 49/240 (20%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM-LRRGQVEHVRAERNLLAEVDS-NC--I 178
+IG+G FGEV CR+ TG +YAMK L K + +++G+ + ER +L+ V + +C I
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALN-ERIMLSLVSTGDCPFI 59
Query: 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYI 238
V + +F + L I++ + GGD+ L + +E E RFY E +L +E +H +
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRT 298
+RD+KP N+LLD++GH+R+SD GL C DF+ ++P
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLA----C------DFS-----------KKKP------ 152
Query: 299 QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPPF 357
+++VGT Y+APEVL K Y DW+SLG +++++L G+ PF
Sbjct: 153 ----------------HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (310), Expect = 1e-32
Identities = 75/247 (30%), Positives = 111/247 (44%), Gaps = 49/247 (19%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRG-QVEHVRAERNLLAEVDSN 176
+E L +G+G +G V R+K TG + A+KK++ + G +R E +LL E+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRL-DNEEEGIPSTALR-EISLLKELKHP 58
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIESIHKH 235
IVKL + LYL+ EY D+ L R L+ + + + + + + H H
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+HRD+KP N+L+++ G L+L+DFGL + F I P
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARA----------FGI----------------P 151
Query: 296 KRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 353
RT Y+ V T Y APE+LL K Y D WS+G I EM+ G
Sbjct: 152 LRT----------------YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITG 195
Query: 354 YPPFYSD 360
P F D
Sbjct: 196 KPLFPGD 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-32
Identities = 74/242 (30%), Positives = 114/242 (47%), Gaps = 44/242 (18%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F ++GKG FGEV C+ + TG +YA KKL+K + +R E+ +L +V+S
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIESIHKH 235
+V L +++ + L L++ + GGD+ + M E A FY AE +E + +
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
++RD+KP+N+LLD GH+R+SD GL
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAV------------------------------- 150
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
Q+ + R VGT Y+APEV+ + Y DWW LG ++YEM+ G
Sbjct: 151 ------QIPEGETVR-----GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQS 199
Query: 356 PF 357
PF
Sbjct: 200 PF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 6e-32
Identities = 65/252 (25%), Positives = 102/252 (40%), Gaps = 48/252 (19%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR--GQVEHVRA-ERNLLAEV 173
+++L IG+GA G V +++ TG A+KK+ LRR G + + E L
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKV----ALRRLEGGIPNQALREIKALQAC 56
Query: 174 DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH 233
+VKL F L+MEY+P L + L E + + Y+ + + +H
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
+ +HRD+KP NLL+ G L+++DFGL + E P
Sbjct: 117 ANGIMHRDLKPANLLISADGVLKIADFGLARLFS---------------------EEEPR 155
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLV 352
V T Y APE+L + Y D W++G I E+L
Sbjct: 156 LY-------------------SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLN 196
Query: 353 GYPPFYSDDPMS 364
G P F ++ +
Sbjct: 197 GSPLFPGENDIE 208
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 75/255 (29%), Positives = 127/255 (49%), Gaps = 47/255 (18%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
+ IG+G+ G V + +K+TG A+KK+ + RR E + E ++ +
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHP 76
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL-AIESIHKH 235
IV++Y S+ + L+++ME+L GG +T ++ + E++ V VL A+ +H
Sbjct: 77 NIVEMYSSYLVGDELWVVMEFLEGG-ALTDIVTHTRMNEEQIA-TVCLAVLKALSFLHAQ 134
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
IHRDIK D++LL G ++LSDFG C +Q ++ P
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFC----------------------AQVSKE--VP 170
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
+R S VGTP ++APEV+ + YG E D WSLG ++ EM+ G P
Sbjct: 171 RRK-----------------SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEP 213
Query: 356 PFYSDDPMSTCRKVR 370
P++++ P+ +++R
Sbjct: 214 PYFNEPPLQAMKRIR 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 3e-31
Identities = 71/252 (28%), Positives = 115/252 (45%), Gaps = 48/252 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+D+EL+ IG G +G+V R+ TG + A+K +K E ++ E ++L E
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRH 59
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDM-MTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
IV + S+ + L+++MEY GG + + + L+E + + ET+ + +H+
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE 119
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
IHRDIK N+LL + G ++L+DFG+ L +T+
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLT-ATIA---------------------- 156
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL---LKKGYGMECDWWSLGAIMYEML 351
KR S +GTP ++APEV K GY +CD W+LG E+
Sbjct: 157 -KRK-----------------SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELA 198
Query: 352 VGYPPFYSDDPM 363
PP + PM
Sbjct: 199 ELQPPMFDLHPM 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 4e-31
Identities = 66/238 (27%), Positives = 111/238 (46%), Gaps = 45/238 (18%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMK--KLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
++G G+FG V G +A+K L + V+ + E LL+++ IV+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
+ ++++ LY+ +E +PGG + LL + + E R Y + +L +E +H + +HR
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHR 126
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
DIK N+L+D G ++L+DFG+ K + E F
Sbjct: 127 DIKGANILVDTNGVVKLADFGMAK-----QVVEFSF------------------------ 157
Query: 301 EQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVGYPPF 357
A S G+P ++APEV+ ++G YG+ D WSLG + EM G PP+
Sbjct: 158 -------------AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW 202
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 4e-31
Identities = 70/243 (28%), Positives = 105/243 (43%), Gaps = 47/243 (19%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN--LLAEVDS 175
++ L IG+G +G V R+K TG + A+KK+K + A R LL E++
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRF---ESEGIPKTALREIKLLKELNH 57
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I+KL F+ LYL+ E++ + R+ L E + Y+ + + + H H
Sbjct: 58 PNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+HRD+KP+NLL++ G L+L+DFGL + +P
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFG--------------------------SP 151
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGY 354
R V T Y APE+LL KGY D WS+G I E+L
Sbjct: 152 VRPYTHY---------------VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
Query: 355 PPF 357
P F
Sbjct: 197 PLF 199
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 69/251 (27%), Positives = 109/251 (43%), Gaps = 63/251 (25%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK-----SEMLRRGQVEHVRAERNLLAE 172
++++ +G G FG V + R K TG + A+KK+KK E + + V++ R L
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN---LREVKSLRKLNEH 57
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL--LMRKDT---LTEDEARFYVAETVL 227
IVKL F++++ LY + EY+ G L LM+ +E R + + +
Sbjct: 58 P---NIVKLKEVFRENDELYFVFEYMEG----NLYQLMKDRKGKPFSESVIRSIIYQILQ 110
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+ IHKH + HRD+KP+NLL+ ++++DFGL + + +T
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR----PPYT---------- 156
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAI 346
Y V T Y APE+LL+ Y D W+LG I
Sbjct: 157 --------------------------DY--VSTRWYRAPEILLRSTSYSSPVDIWALGCI 188
Query: 347 MYEMLVGYPPF 357
M E+ P F
Sbjct: 189 MAELYTLRPLF 199
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 4e-30
Identities = 62/245 (25%), Positives = 111/245 (45%), Gaps = 48/245 (19%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
DF++L +GKG++G V + + YA+K++ M ++ + + V R +LA V+
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIR-ILASVNHP 59
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL----MRKDTLTEDEARFYVAETVLAIESI 232
I+ +F D L ++MEY P GD+ + ++ + E E + + ++++
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H+ +HRD+K N+LL +++ D G+ K L
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKVL-------------------------- 153
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
++ +A + +GTP Y+APEV + Y + D WSLG ++YEM
Sbjct: 154 -----------------KKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMAT 196
Query: 353 GYPPF 357
PPF
Sbjct: 197 FAPPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-30
Identities = 77/244 (31%), Positives = 111/244 (45%), Gaps = 48/244 (19%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKS---EMLRRGQVEHVRAERNLLAEVD 174
+E+L ++G+GA+G V CR K TG + A+KK K+S E +++ + V+ R L E
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE-- 60
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
N IV L +F+ LYL+ EY+ + L L D R Y+ + + AI H
Sbjct: 61 -N-IVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
H+ IHRDIKP+N+L+ + G L+L DFG + L T
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARP--ASPLT----------------- 159
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVG 353
V T Y APE+L+ YG D W++G IM E+L G
Sbjct: 160 ---------------------DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDG 198
Query: 354 YPPF 357
P F
Sbjct: 199 EPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 5e-30
Identities = 71/262 (27%), Positives = 114/262 (43%), Gaps = 47/262 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+F++ IGKG F V G V A+KK++ EM+ + E +LL ++D
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM----RKDTLTEDEARFYVAETVLAIES 231
++K SF ++ L +++E GD+ ++ +K + E Y + A+E
Sbjct: 62 PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+H +HRDIKP N+ + G ++L D GL + T
Sbjct: 122 MHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--------------------- 160
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
A+S VGTP Y++PE + + GY + D WSLG ++YEM
Sbjct: 161 --------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200
Query: 352 VGYPPFYSD--DPMSTCRKVRK 371
PFY D + S C+K+ K
Sbjct: 201 ALQSPFYGDKMNLYSLCKKIEK 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 7e-30
Identities = 68/244 (27%), Positives = 111/244 (45%), Gaps = 46/244 (18%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+E + IG+G +G+V R K TG + A+KK++ + +R E LL ++
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-EIKLLQKLRHPN 59
Query: 178 IVKLYCSFQDDE--FLYLIMEYLPGGDMMTLLMRKDT-LTEDEARFYVAETVLAIESIHK 234
IV+L +Y++ EY+ D+ LL + TE + + Y+ + + ++ +H
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS 118
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+ +HRDIK N+L++ G L+L+DFGL +P + D+T
Sbjct: 119 NGILHRDIKGSNILINNDGVLKLADFGLARPY--TKRNSADYT----------------- 159
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVG 353
NR V T Y PE+LL YG E D WS+G I+ E+ +G
Sbjct: 160 --------------NR-------VITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG 198
Query: 354 YPPF 357
P F
Sbjct: 199 KPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-29
Identities = 73/250 (29%), Positives = 114/250 (45%), Gaps = 48/250 (19%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV---D 174
++ L +IG+GA+G V + TG V A+K + V ++ E LL+++
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQ 60
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
I K Y S+ L++IMEY GG + TL M+ + E + E ++A++ IHK
Sbjct: 61 PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTL-MKAGPIAEKYISVIIREVLVALKYIHK 119
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
IHRDIK N+L+ G+++L DFG+ L+ ++ + F
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF------------------ 161
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 353
VGTP ++APEV+ + K Y + D WSLG +YEM G
Sbjct: 162 -----------------------VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG 198
Query: 354 YPPFYSDDPM 363
PP+ D
Sbjct: 199 NPPYSDVDAF 208
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-29
Identities = 79/248 (31%), Positives = 125/248 (50%), Gaps = 47/248 (18%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IG+G+ G V + REK +G A+K + + RR E + E ++ + +V++Y
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQHQNVVEMYK 85
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL-AIESIHKHHYIHRDI 242
S+ E L+++ME+L GG +T ++ + L E++ V E+VL A+ +H IHRDI
Sbjct: 86 SYLVGEELWVLMEFLQGG-ALTDIVSQTRLNEEQIA-TVCESVLQALCYLHSQGVIHRDI 143
Query: 243 KPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQ 302
K D++LL G ++LSDFG C + PKR
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQIS------------------------KDVPKRK---- 175
Query: 303 LQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDP 362
S VGTP ++APEV+ + YG E D WSLG ++ EM+ G PP++SD P
Sbjct: 176 -------------SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP 222
Query: 363 MSTCRKVR 370
+ +++R
Sbjct: 223 VQAMKRLR 230
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 70/236 (29%), Positives = 106/236 (44%), Gaps = 44/236 (18%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
+GKG FGEV + K TG +YA KKL K + ++ + E+ +L +V+S IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEAR--FYVAETVLAIESIHKHHYIHRD 241
+F+ L L+M + GGD+ + + R Y A+ I +H ++RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+KP+N+LLD G+ RLSD GL E TQ+
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAV-------------------------ELKDGKTITQR- 154
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
GT Y+APE+L ++ Y DW+++G +YEM+ G PF
Sbjct: 155 ----------------AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-28
Identities = 75/267 (28%), Positives = 117/267 (43%), Gaps = 65/267 (24%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
FEL+ +IG+G +G+V R K TG + A+K + + + E ++ E N+L +
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYS 60
Query: 175 S--NCIVKLYCSF-------QDDEFLYLIMEYLPGG---DMM-TLLMRKDTLTEDEARFY 221
+ N I Y +F DD+ L+L+ME GG D++ L + L E+ +
Sbjct: 61 NHPN-IATFYGAFIKKNPPGNDDQ-LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYI 118
Query: 222 VAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ ET+ + +H++ IHRDIK N+LL K ++L DFG+ LD STL ++
Sbjct: 119 LRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD-STLGRRN------ 171
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL-----LKKGYGM 336
+ +GTP ++APEV+ Y
Sbjct: 172 ----------------------------------TFIGTPYWMAPEVIACDEQPDASYDA 197
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDPM 363
D WSLG E+ G PP PM
Sbjct: 198 RSDVWSLGITAIELADGKPPLCDMHPM 224
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 8e-28
Identities = 68/247 (27%), Positives = 121/247 (48%), Gaps = 45/247 (18%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+E++ IG+G+FG++ + + K+ +K++ ++M + + E + E LLA++
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-EKEASKKEVILLAKMKHPN 60
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKH 235
IV + SFQ++ L+++MEY GGD+M + R+ +ED+ + + L ++ IH
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 236 HYIHRDIKPDNLLLDKYGHL-RLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+HRDIK N+ L K G + +L DFG+ + L+ S
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM------------------------ 156
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354
LAY+ VGTP Y++PE+ + Y + D WSLG ++YE+
Sbjct: 157 -----------------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199
Query: 355 PPFYSDD 361
PF ++
Sbjct: 200 HPFEGNN 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 8e-28
Identities = 73/247 (29%), Positives = 119/247 (48%), Gaps = 45/247 (18%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IG+G+ G V + EK TG A+KK+ + RR E + E ++ + +V +Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRR---ELLFNEVVIMRDYHHENVVDMYN 86
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK 243
S+ + L+++ME+L GG +T ++ + E++ + A+ +H IHRDIK
Sbjct: 87 SYLVGDELWVVMEFLEGG-ALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145
Query: 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
D++LL G ++LSDFG C + PKR
Sbjct: 146 SDSILLTSDGRIKLSDFGFCAQVS------------------------KEVPKRK----- 176
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
S VGTP ++APEV+ + YG E D WSLG ++ EM+ G PP++++ P+
Sbjct: 177 ------------SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL 224
Query: 364 STCRKVR 370
R++R
Sbjct: 225 QAMRRIR 231
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-27
Identities = 65/237 (27%), Positives = 113/237 (47%), Gaps = 46/237 (19%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+E + ++G+GAFG V +CR K + +K++ +M + + + E +L +
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKD-ERLAAQNECQVLKLLSHPN 60
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM--RKDTLTEDEARFYVAETVLAIESIHKH 235
I++ Y +F +D+ L ++MEY PGG + + L ED + + +LA+ +H
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 236 HYIHRDIKPDNLLLDKYGH-LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+HRD+K N+LLDK+ +++ DFG+ K L SS++
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKIL------------------SSKSK----- 157
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
AY+ VGTP YI+PE+ K Y + D W+LG ++YE+
Sbjct: 158 -------------------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELA 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 70/240 (29%), Positives = 115/240 (47%), Gaps = 45/240 (18%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IG+GA G V + TG A+K++ + ++ E + E ++ E IV
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKHPNIVNYLD 83
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK 243
S+ + L+++MEYL GG + T ++ + + E + E + A+E +H + IHRDIK
Sbjct: 84 SYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 142
Query: 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
DN+LL G ++L+DFG C + P KR+
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQIT------------------------PEQSKRS----- 173
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
+ VGTP ++APEV+ +K YG + D WSLG + EM+ G PP+ +++P+
Sbjct: 174 ------------TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 74/245 (30%), Positives = 107/245 (43%), Gaps = 49/245 (20%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMK--KLKKSEMLRRGQVEHVRAERNLLAEVD 174
+ +L ++G+G+FG + + + YAMK +L KS VE R E LLA++
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS----SAVEDSRKEAVLLAKMK 56
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL--LMRKDTLTEDEARFYVAETVLAIESI 232
IV SF+ D LY++MEY GGD+M L R ED + + L ++ I
Sbjct: 57 HPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI 116
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H+ +HRDIK N+ L + G ++L DFG + L P
Sbjct: 117 HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL-----------------------TSP 153
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
A A + VGTP Y+ PE+ Y + D WSLG I+YE+
Sbjct: 154 GA------------------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCT 195
Query: 353 GYPPF 357
PF
Sbjct: 196 LKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-26
Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 41/241 (17%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLK------KSEMLRRGQVEHVRAERNLLAEVDSN 176
+IG G+FG V + ++G + A+K+++ S+ +R ++ + E LL E+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH 236
IV+ S D + L + +EY+PGG + LL E R +V + + + +H
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
IHRDIK N+L+D G +++SDFG+ K L+ N+L+ + N RP+
Sbjct: 127 IIHRDIKGANILVDNKGGIKISDFGISKKLE-----------ANSLSTKT-NGARPS--- 171
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
LQ G+ ++APEV+ + Y + D WSLG ++ EML G P
Sbjct: 172 ------LQ--------------GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
Query: 357 F 357
F
Sbjct: 212 F 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-26
Identities = 69/249 (27%), Positives = 115/249 (46%), Gaps = 51/249 (20%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLK-------KSEMLRRGQVEHVRAERNLLAEVDS 175
+IGKG +G V + TTG + A+K+++ + + ++ V+ +R+E L ++D
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 176 NCIVKLYCSFQDDEFLYLI-MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
IV+ Y F+ E I +EY+PGG + + L E RF+ + + + +H
Sbjct: 68 LNIVQ-YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS 126
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+HRD+K DNLL+D G ++SDFG+ K D ++ + QN
Sbjct: 127 KGILHRDLKADNLLVDADGICKISDFGISKKSD-------------DIYDNDQNM----- 168
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEV--LLKKGYGMECDWWSLGAIMYEMLV 352
S G+ ++APEV +GY + D WSLG ++ EM
Sbjct: 169 ---------------------SMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFA 207
Query: 353 GYPPFYSDD 361
G P +SD+
Sbjct: 208 GRRP-WSDE 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-26
Identities = 65/242 (26%), Positives = 106/242 (43%), Gaps = 41/242 (16%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ---VEHVRAERNLLAEVDSNCIV 179
+G GAF R+ TG + A+K++ Q VE +R E L+A ++ I+
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 180 KLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIH 239
++ + +D L +E++ GG + LL + E Y + + + +H++ IH
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIH 126
Query: 240 RDIKPDNLLLDKYGH-LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRT 298
RD+K NLL+D G LR++DFG L +F
Sbjct: 127 RDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEF---------------------- 164
Query: 299 QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358
Q QL +GT ++APEVL + YG CD WS+G ++ EM PP+
Sbjct: 165 -QGQL--------------LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209
Query: 359 SD 360
++
Sbjct: 210 AE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 73/246 (29%), Positives = 110/246 (44%), Gaps = 44/246 (17%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F L IGKG+FGEV + T V A+K + E ++E ++ E +L++ DS
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
+ K Y S+ L++IMEYL GG + LL R E + + E + ++ +H
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLL-RAGPFDEFQIATMLKEILKGLDYLHSEKK 122
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRDIK N+LL + G ++L+DFG+ L + ++ F
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF--------------------- 161
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
VGTP ++APEV+ + Y + D WSLG E+ G PP
Sbjct: 162 --------------------VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPN 201
Query: 358 YSDDPM 363
PM
Sbjct: 202 SDMHPM 207
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-25
Identities = 64/236 (27%), Positives = 114/236 (48%), Gaps = 44/236 (18%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+ + IG+G+FG+ + + K G Y +K++ S+M + + E R E +L+ +
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNMKHPN 60
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIESIHKH 235
IV+ SF+++ LY++M+Y GGD+ + R ED+ + + LA++ +H
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+HRDIK N+ L K G ++L DFG+ + L+ ST++
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVLN-STVE----------------------- 156
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
LA + +GTP Y++PE+ + Y + D W+LG ++YEM
Sbjct: 157 -----------------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMC 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-25
Identities = 72/245 (29%), Positives = 117/245 (47%), Gaps = 39/245 (15%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKK--LKKSEMLR-RGQVEHVRAERNLLAEVDSNCIV 179
++GKGA+G V C G + A+K+ L S +L + E ++ E +LL + IV
Sbjct: 7 VLGKGAYGTV-YCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 180 KLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIH 239
+ + DD + + ME++PGG + ++L R L E Y + + + +H + +H
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVH 125
Query: 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQ 299
RDIK +N++L G ++L DFG + L L+G+ N
Sbjct: 126 RDIKGNNVMLMPNGIIKLIDFGCARRLAWV-----------GLHGTHSN----------- 163
Query: 300 QEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 359
ML S GTP ++APEV+ + GYG + D WS+G ++EM G PP S
Sbjct: 164 ------------MLK-SMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210
Query: 360 DDPMS 364
D ++
Sbjct: 211 MDRLA 215
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-25
Identities = 74/246 (30%), Positives = 112/246 (45%), Gaps = 44/246 (17%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F L IGKG+FGEV + T V A+K + E ++E ++ E +L++ DS
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
+ K Y S+ D L++IMEYL GG + LL L E + + E + ++ +H
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEKK 122
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRDIK N+LL ++G ++L+DFG+ L + ++ F
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF--------------------- 161
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
VGTP ++APEV+ + Y + D WSLG E+ G PP
Sbjct: 162 --------------------VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPH 201
Query: 358 YSDDPM 363
PM
Sbjct: 202 SELHPM 207
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 69/247 (27%), Positives = 123/247 (49%), Gaps = 45/247 (18%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IG+G+ G V + K++G + A+KK+ + RR E + E ++ + +V++Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHENVVEMYN 84
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK 243
S+ + L+++ME+L GG +T ++ + E++ + A+ +H IHRDIK
Sbjct: 85 SYLVGDELWVVMEFLEGG-ALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143
Query: 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
D++LL G ++LSDFG C +Q ++ P+R
Sbjct: 144 SDSILLTHDGRVKLSDFGFC----------------------AQVSKE--VPRRK----- 174
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
S VGTP ++APE++ + YG E D WSLG ++ EM+ G PP++++ P+
Sbjct: 175 ------------SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL 222
Query: 364 STCRKVR 370
+ +R
Sbjct: 223 KAMKMIR 229
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-25
Identities = 70/250 (28%), Positives = 110/250 (44%), Gaps = 46/250 (18%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER--NLLAEVDS 175
+E +G+G + V R+K TG + A+KK+K E + A R LL E+
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHK 234
I+ L F + L+ E++ D+ ++ K LT + + Y+ T+ +E +H
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS 120
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+ +HRD+KP+NLL+ G L+L+DFGL + F GS
Sbjct: 121 NWILHRDLKPNNLLIASDGVLKLADFGLAR----------SF-------GSP-------- 155
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVG 353
NR+M V T Y APE+L + YG+ D WS+G I E+L+
Sbjct: 156 --------------NRKMT--HQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLR 199
Query: 354 YPPFYSDDPM 363
P D +
Sbjct: 200 VPFLPGDSDI 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 7e-25
Identities = 75/256 (29%), Positives = 113/256 (44%), Gaps = 44/256 (17%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F L IGKG+FGEV + T V A+K + E ++E ++ E +L++ DS
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
I + Y S+ L++IMEYL GG + LL + L E + E + ++ +H
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREILKGLDYLHSERK 122
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRDIK N+LL + G ++L+DFG+ L + ++ F
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF--------------------- 161
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
VGTP ++APEV+ + Y + D WSLG E+ G PP
Sbjct: 162 --------------------VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPN 201
Query: 358 YSDDPMSTCRKVRKKS 373
PM + K S
Sbjct: 202 SDLHPMRVLFLIPKNS 217
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 64/251 (25%), Positives = 101/251 (40%), Gaps = 70/251 (27%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSE--------MLRRGQVEHVRAERNL 169
+E L IG+GA+G V R+ TG A+KK++ LR E L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR---------EIAL 51
Query: 170 LAEVDS-NC--IVKLY--CSFQDDE---FLYLIMEYLPGGDMMTLLMR--KDTLTEDEAR 219
L +++S IV+L C + L L+ E++ D+ T L + K L + +
Sbjct: 52 LKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIK 110
Query: 220 FYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279
+ + + ++ +H H +HRD+KP N+L+ G ++++DFGL +
Sbjct: 111 DLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS------------ 158
Query: 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECD 339
M S V T Y APEVLL+ Y D
Sbjct: 159 ------------------------------FEMALTSVVVTLWYRAPEVLLQSSYATPVD 188
Query: 340 WWSLGAIMYEM 350
WS+G I E+
Sbjct: 189 MWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 69/260 (26%), Positives = 105/260 (40%), Gaps = 63/260 (24%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN-LLAEVD 174
DD E L +G G G V + TG + A+K + ++E A + +L E+D
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTI---------RLEINEAIQKQILRELD 51
Query: 175 ----SNC--IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
N IV Y +F ++ + + MEY+ GG + +L + +A VL
Sbjct: 52 ILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLK 111
Query: 229 --IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
KH IHRD+KP N+L++ G ++L DFG+ L S
Sbjct: 112 GLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS----------------- 154
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346
LA + VGT Y+APE + Y ++ D WSLG
Sbjct: 155 --------------------------LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLS 188
Query: 347 MYEMLVG-YP-PFYSDDPMS 364
+ E+ G +P P +D P
Sbjct: 189 LIELATGRFPYPPENDPPDG 208
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 75/245 (30%), Positives = 119/245 (48%), Gaps = 55/245 (22%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IG+GA G V + TG A+K++ + ++ + E + E ++ E+ + IV
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTE---DEARFYVA--ETVLAIESIHKHHYI 238
SF + L+++MEYL GG + D +TE DEA+ E + A+E +H + I
Sbjct: 84 SFLVGDELFVVMEYLAGGSLT------DVVTETCMDEAQIAAVCRECLQALEFLHANQVI 137
Query: 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRT 298
HRDIK DN+LL G ++L+DFG C + P KR+
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQIT------------------------PEQSKRS 173
Query: 299 QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358
+ VGTP ++APEV+ +K YG + D WSLG + EM+ G PP+
Sbjct: 174 -----------------TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216
Query: 359 SDDPM 363
+++P+
Sbjct: 217 NENPL 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-24
Identities = 71/251 (28%), Positives = 112/251 (44%), Gaps = 42/251 (16%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLK--KSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
++G+GAFG V +C + TG A K+++ +V + E LL + IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 181 LYCSFQD--DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYI 238
Y +D ++ L + MEY+PGG + L LTE R Y + + + +H + +
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIV 128
Query: 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRT 298
HRDIK N+L D G+++L DFG K L + G +
Sbjct: 129 HRDIKGANILRDSAGNVKLGDFGASKRLQTICMS------GTGIR--------------- 167
Query: 299 QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358
S GTP +++PEV+ +GYG + D WSLG + EML PP+
Sbjct: 168 -----------------SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWA 210
Query: 359 SDDPMSTCRKV 369
+ M+ K+
Sbjct: 211 EYEAMAAIFKI 221
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 4e-24
Identities = 69/240 (28%), Positives = 115/240 (47%), Gaps = 45/240 (18%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IG+GA G V + TG A++++ + ++ E + E ++ E + IV
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNPNIVNYLD 84
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK 243
S+ + L+++MEYL GG + T ++ + + E + E + A+E +H + IHRDIK
Sbjct: 85 SYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
DN+LL G ++L+DFG C + P KR+
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQIT------------------------PEQSKRSTM--- 176
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
VGTP ++APEV+ +K YG + D WSLG + EM+ G PP+ +++P+
Sbjct: 177 --------------VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 5e-24
Identities = 71/257 (27%), Positives = 116/257 (45%), Gaps = 42/257 (16%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK--KSEMLRRGQVEHVRAERNLLAEVD 174
++ L ++G+GAFG V +C + TG A+K+++ +V + E LL +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 175 SNCIVKLYCSFQD--DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
IV+ Y +D + L + ME++PGG + L LTE+ R Y + + + +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H + +HRDIK N+L D G+++L DFG K L L G +
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLS------GTGMK--------- 167
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
S GTP +++PEV+ +GYG + D WS+G + EML
Sbjct: 168 -----------------------SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLT 204
Query: 353 GYPPFYSDDPMSTCRKV 369
PP+ + M+ K+
Sbjct: 205 EKPPWAEFEAMAAIFKI 221
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 7e-24
Identities = 67/254 (26%), Positives = 112/254 (44%), Gaps = 44/254 (17%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+ + ++GKGAFGE + R + K++ + + + + E +L+ +
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKER-RDALNEIVILSLLQHPN 60
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDE-ARFYVAETVLAIESIHKH 235
I+ Y F DD L + MEY GG + ++R K L E+E +Y+ + V A+ IHK
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+HRDIK N+ L K G ++L DFG+ K L
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS------------------------ 156
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
+A + VGTP Y++PE+ Y + D W+LG ++YE+L
Sbjct: 157 -----------------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR 199
Query: 356 PFYSDDPMSTCRKV 369
F + +P++ K+
Sbjct: 200 TFDATNPLNLVVKI 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 8e-24
Identities = 69/240 (28%), Positives = 116/240 (48%), Gaps = 45/240 (18%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IG+GA G V + TG A+K++ + ++ E + E ++ E + IV
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKNPNIVNYLD 83
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK 243
S+ + L+++MEYL GG + T ++ + + E + E + A++ +H + IHRDIK
Sbjct: 84 SYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIK 142
Query: 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
DN+LL G ++L+DFG C + P KR+
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQIT------------------------PEQSKRS----- 173
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
+ VGTP ++APEV+ +K YG + D WSLG + EM+ G PP+ +++P+
Sbjct: 174 ------------TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 9e-24
Identities = 63/238 (26%), Positives = 105/238 (44%), Gaps = 57/238 (23%)
Query: 127 GAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV--DSNCIVKLYCS 184
G FG+V V + K T ++ K +K ++ A ++ ++ D+ +KLY S
Sbjct: 27 GKFGKVSVLKHKPTQKLFVQKIIKA---------KNFNAIEPMVHQLMKDNPNFIKLYYS 77
Query: 185 FQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKP 244
+ LIM+Y+ GD+ LL ++ L+E E + + + V A+ +HKH+ IH DIK
Sbjct: 78 VTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKL 137
Query: 245 DNLLLDKY-GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
+N+L D+ + L D+GLCK + + +
Sbjct: 138 ENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------------------------------ 167
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361
GT DY +PE + Y + DWW++G + YE+L G PF D+
Sbjct: 168 ---------------GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210
|
Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-23
Identities = 68/261 (26%), Positives = 113/261 (43%), Gaps = 47/261 (18%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
+F++ IG+G F EV A+KK++ EM+ + E +LL +++
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM----RKDTLTEDEARFYVAETVLAIESI 232
++K SF +D L +++E GD+ ++ +K + E Y + A+E +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H +HRDIKP N+ + G ++L D GL + T
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA-------------------- 162
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
A+S VGTP Y++PE + + GY + D WSLG ++YEM
Sbjct: 163 ---------------------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 201
Query: 353 GYPPFYSD--DPMSTCRKVRK 371
PFY D + S C+K+ +
Sbjct: 202 LQSPFYGDKMNLFSLCQKIEQ 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 2e-23
Identities = 77/257 (29%), Positives = 119/257 (46%), Gaps = 44/257 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ FE+L ++G+GA+G V CR K T + A+KK K SE + +R E +L +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQ 59
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV+L +F+ LYL+ EY+ + L + + ++ R Y+ + + AI HK+
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN 119
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+HRDIKP+NLL+ L+L DFG + L + G+N N +
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNL----------SEGSNANYTEY-------- 161
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
V T Y +PE+LL YG D WS+G I+ E+ G P
Sbjct: 162 ----------------------VATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQP 199
Query: 356 PFYSD---DPMSTCRKV 369
F + D + T +KV
Sbjct: 200 LFPGESEIDQLFTIQKV 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 3e-23
Identities = 69/267 (25%), Positives = 119/267 (44%), Gaps = 58/267 (21%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVY-AMKKLK-KSEMLRRGQVEHVRAERNLLAEVD- 174
+ +L +G GAFG V R+K G A+K++ + + + E ++ ++++EV
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 175 -------SNCIVKLYCSFQDDEFLYLIMEYLPGGDM----MTLLMRKDTLTEDEARFYVA 223
N IV+ Y +F +++ LY++M+ + G + +L +K TE+
Sbjct: 62 IKEQLRHPN-IVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 224 ETVLAIESIHKHHYI-HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+ VLA+ +HK I HRD+ P+N++L + + ++DFGL K
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK------------------ 162
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342
QK S VGT Y PE++ + YG + D W+
Sbjct: 163 ------------------------QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWA 198
Query: 343 LGAIMYEMLVGYPPFYSDDPMSTCRKV 369
G I+Y+M PPFYS + +S K+
Sbjct: 199 FGCILYQMCTLQPPFYSTNMLSLATKI 225
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 3e-23
Identities = 72/265 (27%), Positives = 126/265 (47%), Gaps = 54/265 (20%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMK--KLKKSEMLRRGQVEHVRAERNLLAE 172
D +E++ +G GAFG+V + K TG A K +++ E ++E E ++L+E
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEE-----ELEDFMVEIDILSE 58
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT-LTEDEARFYVAETVLAIES 231
IV LY ++ + L++++E+ GG + ++++ + LTE + R+ + + A+
Sbjct: 59 CKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNF 118
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+H H IHRD+K N+LL G ++L+DFG+ S++N
Sbjct: 119 LHSHKVIHRDLKAGNILLTLDGDVKLADFGV----------------------SAKN--- 153
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAI 346
K T Q +R + +GTP ++APEV+ Y + D WSLG
Sbjct: 154 ----KSTLQ---------KR---DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGIT 197
Query: 347 MYEMLVGYPPFYSDDPMSTCRKVRK 371
+ E+ PP + +PM K+ K
Sbjct: 198 LIELAQMEPPHHELNPMRVLLKILK 222
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 4e-23
Identities = 72/257 (28%), Positives = 117/257 (45%), Gaps = 42/257 (16%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKL--KKSEMLRRGQVEHVRAERNLLAEVD 174
++ L ++G+GAFGEV +C + TG A+K++ +V + E LL +
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 175 SNCIVKLYCSFQDDE--FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
+ IV+ Y +D E L + +EY+PGG + L LTE+ R Y + + + +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYL 122
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H + +HRDIK N+L D G+++L DFG K + TI + G
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ---------TICMSGTGIK------ 167
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
S GTP +++PEV+ +GYG + D WS+ + EML
Sbjct: 168 -----------------------SVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
Query: 353 GYPPFYSDDPMSTCRKV 369
PP+ + M+ K+
Sbjct: 205 EKPPWAEYEAMAAIFKI 221
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 4e-23
Identities = 77/274 (28%), Positives = 128/274 (46%), Gaps = 52/274 (18%)
Query: 105 YMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEMLRRGQVEHV 163
Y ++R + +E++ +G GAFG+V + K TG + A K ++ KSE ++E
Sbjct: 1 YEHVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE----EELEDY 56
Query: 164 RAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT-LTEDEARFYV 222
E +LA + IVKL +F D L++++E+ PGG + +++ D LTE + +
Sbjct: 57 MVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVIC 116
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+ + A++ +H IHRD+K N+LL G ++L+DFG+ + TLQ +D
Sbjct: 117 RQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK-NVKTLQRRD------- 168
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGME 337
S +GTP ++APEV++ Y +
Sbjct: 169 ---------------------------------SFIGTPYWMAPEVVMCETMKDTPYDYK 195
Query: 338 CDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRK 371
D WSLG + EM PP + +PM K+ K
Sbjct: 196 ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK 229
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-22
Identities = 68/261 (26%), Positives = 113/261 (43%), Gaps = 47/261 (18%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
+F + IG+G F EV G A+KK++ +++ E +LL +++
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM----RKDTLTEDEARFYVAETVLAIESI 232
++K Y SF +D L +++E GD+ ++ +K + E Y + A+E +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H +HRDIKP N+ + G ++L D GL + T
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA-------------------- 162
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
A+S VGTP Y++PE + + GY + D WSLG ++YEM
Sbjct: 163 ---------------------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 201
Query: 353 GYPPFYSD--DPMSTCRKVRK 371
PFY D + S C+K+ +
Sbjct: 202 LQSPFYGDKMNLYSLCKKIEQ 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-22
Identities = 70/242 (28%), Positives = 106/242 (43%), Gaps = 50/242 (20%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLY 182
++GKG +G V R+ +T A+K++ + + R Q H E L + + IV+
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-RYVQPLH--EEIALHSYLKHRNIVQYL 71
Query: 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRK---DTLTEDEARFYVAETVLAIESIHKHHYIH 239
S ++ F + ME +PGG + LL K E FY + + ++ +H + +H
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131
Query: 240 RDIKPDNLLLDKY-GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRT 298
RDIK DN+L++ Y G +++SDFG K L + FT
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT--------------------- 170
Query: 299 QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYPP 356
GT Y+APEV+ K +GYG D WSLG + EM G PP
Sbjct: 171 --------------------GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
Query: 357 FY 358
F
Sbjct: 211 FI 212
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 6e-22
Identities = 72/257 (28%), Positives = 109/257 (42%), Gaps = 68/257 (26%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK--------KSEMLRRGQVEHVRAERNL 169
++ + IG+G +G V R+K TG + A+KK++ S +R E +L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR---------EISL 51
Query: 170 LAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM-MTLLMR---KDTLTEDEARFYVAET 225
L E++ IV+L + LYL+ E+L D+ + M L + Y+ +
Sbjct: 52 LKELNHPNIVRLLDVVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQL 108
Query: 226 VLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285
+ I H H +HRD+KP NLL+D+ G L+L+DFGL + F +
Sbjct: 109 LQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARA----------FGV------- 151
Query: 286 SQNNERPAAPKRT-QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSL 343
P RT E + W Y APE+LL + Y D WS+
Sbjct: 152 ---------PVRTYTHEVVTLW----------------YRAPEILLGSRQYSTPVDIWSI 186
Query: 344 GAIMYEMLVGYPPFYSD 360
G I EM+ P F D
Sbjct: 187 GCIFAEMVNRRPLFPGD 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 1e-21
Identities = 72/248 (29%), Positives = 116/248 (46%), Gaps = 51/248 (20%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSE---MLRRGQVEHVRAERNLLAEVD 174
+E L ++G+G++G V C+ K TG + A+KK +SE M+++ + +R +L ++
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIR----MLKQLR 58
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
+V L F+ + LYL+ E++ + L + L E R Y+ + + IE H
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
H+ IHRDIKP+N+L+ + G ++L DFG + L AA
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTL--------------------------AA 152
Query: 295 PKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLV 352
P Y+ V T Y APE+L+ YG D W++G ++ EML
Sbjct: 153 PGE----------------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196
Query: 353 GYPPFYSD 360
G P F D
Sbjct: 197 GEPLFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-21
Identities = 66/252 (26%), Positives = 110/252 (43%), Gaps = 49/252 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ-VEHVRAERNLLAEVD 174
+DFEL+ IG G +G+V R TG + A+K +K L G+ V+ E ++ +
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK----LEPGEDFAVVQQEIIMMKDCK 64
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
+ IV + S+ + L++ ME+ GG + + L+E + + ET+ + +H
Sbjct: 65 HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHS 124
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+HRDIK N+LL GH++L+DFG+ + + + + F
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF------------------ 166
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEML 351
+GTP ++APEV K GY CD W++G E+
Sbjct: 167 -----------------------IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELA 203
Query: 352 VGYPPFYSDDPM 363
PP + PM
Sbjct: 204 ELQPPMFDLHPM 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 1e-21
Identities = 59/268 (22%), Positives = 103/268 (38%), Gaps = 63/268 (23%)
Query: 118 FELLTMIGKGAFGEV-----RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE 172
EL +G+GAFGEV + E T V A+K LK+ + E E +++ +
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKV-AVKTLKEGASEE--EREEFLEEASIMKK 57
Query: 173 VDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAI 229
+ IV+L C+ E LY++ EY+PGGD++ L + LT + + +
Sbjct: 58 LSHPNIVRLLGVCT--QGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGM 115
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
E + +++HRD+ N L+ + +++SDFGL + + E D
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLSR-----DIYEDD-------------- 156
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYI-----APEVLLKKGYGMECDWWSLG 344
Y + APE L + + D WS G
Sbjct: 157 -------------------------YYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFG 191
Query: 345 AIMYEML-VGYPPFYSDDPMSTCRKVRK 371
+++E+ +G P+ +
Sbjct: 192 VLLWEIFTLGEQPYPGMSNEEVLELLED 219
|
Length = 258 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 3e-21
Identities = 67/254 (26%), Positives = 106/254 (41%), Gaps = 50/254 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER--NLLAEV 173
D+E+L +G+G FGEV R+ TG V A+KK+ M + A R +L ++
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKIL---MHNEKDGFPITALREIKILKKL 64
Query: 174 DSNCIVKLY---------CSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVA 223
+V L + Y++ Y+ D+ LL LTE + + Y+
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSV-YMVTPYM-DHDLSGLLENPSVKLTESQIKCYML 122
Query: 224 ETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283
+ + I +H++H +HRDIK N+L+D G L+++DFGL +P D
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD---------------- 166
Query: 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAY-STVGTPDYIAPEVLL-KKGYGMECDWW 341
G N + Y + V T Y PE+LL ++ Y D W
Sbjct: 167 GPPPNPKGGGGGGTR---------------KYTNLVVTRWYRPPELLLGERRYTTAVDIW 211
Query: 342 SLGAIMYEMLVGYP 355
+G + EM P
Sbjct: 212 GIGCVFAEMFTRRP 225
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 3e-21
Identities = 73/263 (27%), Positives = 125/263 (47%), Gaps = 52/263 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKL-KKSEMLRRGQVEHVRAERNLLAEVD 174
+ +E++ +G GAFG+V + K TG + A K + KSE ++E E ++LA D
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE----EELEDYMVEIDILASCD 60
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIH 233
IVKL +F + L++++E+ GG + +++ + LTE + R +T+ A+ +H
Sbjct: 61 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH 120
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
++ IHRD+K N+L G ++L+DFG+ + T+Q +D
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGVSAK-NTRTIQRRD------------------ 161
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMY 348
S +GTP ++APEV++ + Y + D WSLG +
Sbjct: 162 ----------------------SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLI 199
Query: 349 EMLVGYPPFYSDDPMSTCRKVRK 371
EM PP + +PM K+ K
Sbjct: 200 EMAQIEPPHHELNPMRVLLKIAK 222
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 5e-21
Identities = 86/305 (28%), Positives = 124/305 (40%), Gaps = 55/305 (18%)
Query: 58 NHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADD 117
N Y + ++ E EK AD D E + E +E R M
Sbjct: 17 NQYAKYFPHVLFTSEEA--FEKYCADLD--PEAYKKCVDLPEGEEVPESNNPREHM---- 68
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR-RGQVEHVRAERNLLAEVDSN 176
+ L T++G+ V T G K + K ML Q + R+E + LA D
Sbjct: 69 YVLTTLVGRNPTTAAFVA---TRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHF 125
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR--KDTL--TEDEARFYVAETVLAIESI 232
IVK + F+ D+ L LIMEY GGD+ + + K+ L E E + VLA++ +
Sbjct: 126 GIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEV 185
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H +HRD+K N+ L G ++L DFG K
Sbjct: 186 HSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK---------------------------- 217
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
Q+ +A S GTP Y+APE+ +K Y + D WSLG I+YE+L
Sbjct: 218 -----------QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
Query: 353 GYPPF 357
+ PF
Sbjct: 267 LHRPF 271
|
Length = 478 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 5e-21
Identities = 70/261 (26%), Positives = 109/261 (41%), Gaps = 61/261 (23%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN- 176
FEL+ ++G G +G+V R TG + A+K + +E + E ++ E N+L + +
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHR 73
Query: 177 CIVKLYCSF-------QDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVL 227
I Y +F DD+ L+L+ME+ G + L+ + + L ED + E +
Sbjct: 74 NIATYYGAFIKKSPPGHDDQ-LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILR 132
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+ +H H IHRDIK N+LL + ++L DFG+ LD + + F
Sbjct: 133 GLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF----------- 181
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWS 342
+GTP ++APEV+ Y D WS
Sbjct: 182 ------------------------------IGTPYWMAPEVIACDENPDATYDYRSDIWS 211
Query: 343 LGAIMYEMLVGYPPFYSDDPM 363
LG EM G PP PM
Sbjct: 212 LGITAIEMAEGAPPLCDMHPM 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 7e-21
Identities = 68/248 (27%), Positives = 108/248 (43%), Gaps = 51/248 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D++E L I +G +G V R+K TG + A+KKLK + + +R E N+L ++
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQH 63
Query: 176 NCIVKL----YCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIE 230
IV + S D +Y++MEY+ D+ +L+ K + E + + + + +
Sbjct: 64 PNIVTVKEVVVGSNLDK--IYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVA 120
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+H + +HRD+K NLLL+ G L++ DFGL
Sbjct: 121 HLHDNWILHRDLKTSNLLLNNRGILKICDFGLA--------------------------- 153
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYE 349
R L+ + + V T Y APE+LL K Y D WS+G I E
Sbjct: 154 ------REYGSPLKPYTQL--------VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAE 199
Query: 350 MLVGYPPF 357
+L P F
Sbjct: 200 LLTKKPLF 207
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 1e-20
Identities = 45/156 (28%), Positives = 82/156 (52%), Gaps = 11/156 (7%)
Query: 119 ELLTMIGKGAFGEVRVCR-EKTTGHVY---AMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
L +G+GAFGEV + + G A+K LK+ Q+E E ++ ++D
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDAS--EQQIEEFLREARIMRKLD 59
Query: 175 SNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVLAIES 231
+VKL C+ ++E LY++MEY+ GGD+++ L + L+ + + + +E
Sbjct: 60 HPNVVKLLGVCT--EEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEY 117
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ ++IHRD+ N L+ + +++SDFGL + L
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 153
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 2e-20
Identities = 68/256 (26%), Positives = 112/256 (43%), Gaps = 73/256 (28%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK---SEMLRRGQVEHVRAERNLLAEVD 174
+++L IG+G F EV + + TG YA+K +KK S QV ++R E L +
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE----QVNNLR-EIQALRRLS 55
Query: 175 SNC-IVKLYCSFQDDEFLY--------LIMEYLPGGDM-MTLLM--RKDTLTEDEARFYV 222
+ I++L E L+ L+ E + DM + L+ RK L E + Y+
Sbjct: 56 PHPNILRL------IEVLFDRKTGRLALVFELM---DMNLYELIKGRKRPLPEKRVKSYM 106
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+ + +++ +H++ HRDIKP+N+L+ L+L+DFG C + +T
Sbjct: 107 YQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSC----RGIYSKPPYTE---- 157
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWW 341
Y + T Y APE LL G YG + D W
Sbjct: 158 --------------------------------Y--ISTRWYRAPECLLTDGYYGPKMDIW 183
Query: 342 SLGAIMYEMLVGYPPF 357
++G + +E+L +P F
Sbjct: 184 AVGCVFFEILSLFPLF 199
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-20
Identities = 72/270 (26%), Positives = 116/270 (42%), Gaps = 60/270 (22%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL-AEV 173
+D +E++ IGKG +G+V K G A+K L + E + AE N+L A
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID----EEIEAEYNILKALS 72
Query: 174 DSNCIVKLYCSF-----QDDEFLYLIMEYLPGGDMMTL----LMRKDTLTEDEARFYVAE 224
D +VK Y + ++ + L+L++E GG + L L R + + E + + E
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132
Query: 225 TVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
++ ++ +H + IHRD+K +N+LL G ++L DFG+ L
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL------------------ 174
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL-----LKKGYGMECD 339
+ R+ ++VGTP ++APEV+ L Y CD
Sbjct: 175 -----------------------TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCD 211
Query: 340 WWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369
WSLG E+ G PP PM K+
Sbjct: 212 VWSLGITAIELGDGDPPLADLHPMRALFKI 241
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 6e-20
Identities = 48/157 (30%), Positives = 81/157 (51%), Gaps = 12/157 (7%)
Query: 119 ELLTMIGKGAFGEVRVCREKTTGHVY----AMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
L +G+GAFGEV K G A+K LK+ + Q+E E ++ ++D
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQ--QIEEFLREARIMRKLD 59
Query: 175 SNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIE 230
IVKL C+ ++E L ++MEY+PGGD++ L R L+ + + + +E
Sbjct: 60 HPNIVKLLGVCT--EEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGME 117
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ ++IHRD+ N L+ + +++SDFGL + L
Sbjct: 118 YLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 6e-20
Identities = 76/253 (30%), Positives = 105/253 (41%), Gaps = 57/253 (22%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEMLRRGQVEHVRAERNLLAEVDS 175
D+ + IG+G +G V R K TG + AMKK++ +SE G E +LL E+
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQH 58
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDE------ARFYVAETVLAI 229
IV L + LYLI E+L M L D+L + + + Y+ + + I
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFLS----MDLKKYLDSLPKGQYMDAELVKSYLYQILQGI 114
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
H +HRD+KP NLL+D G ++L+DFGL + F I
Sbjct: 115 LFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARA----------FGI----------- 153
Query: 290 ERPAAPKRT-QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIM 347
P R E + W Y APEVLL Y D WS+G I
Sbjct: 154 -----PVRVYTHEVVTLW----------------YRAPEVLLGSPRYSTPVDIWSIGTIF 192
Query: 348 YEMLVGYPPFYSD 360
EM P F+ D
Sbjct: 193 AEMATKKPLFHGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 62/248 (25%), Positives = 106/248 (42%), Gaps = 50/248 (20%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN--LLAEVDS 175
+ELL IG GA+G V +K TG A+KK+ + ++ R R LL +
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI---SNVFDDLIDAKRILREIKLLRHLRH 58
Query: 176 NCIVKLYCSFQD---DEF--LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
I+ L + ++F +Y++ E + D+ ++ LT+D ++++ + + ++
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLK 117
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+H + IHRD+KP N+L++ L++ DFGL + +D ++ T
Sbjct: 118 YLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT------------- 164
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYE 349
V T Y APE+LL Y D WS+G I E
Sbjct: 165 -------------------------EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAE 199
Query: 350 MLVGYPPF 357
+L P F
Sbjct: 200 LLTRKPLF 207
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 75/250 (30%), Positives = 115/250 (46%), Gaps = 55/250 (22%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN--LLAEVDS 175
+E+L +GKGA+G V ++ T V A+KK+ + R + R R L E+
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA---FRNATDAQRTFREIMFLQEL-G 64
Query: 176 NC--IVKLYCSF--QDDEFLYLIMEYLPGGDMMTLL---MRKDTLTEDEARFYVAETVLA 228
+ IVKL ++D+ +YL+ EY M T L +R + L + R+ + + + A
Sbjct: 65 DHPNIVKLLNVIKAENDKDIYLVFEY-----METDLHAVIRANILEDVHKRYIMYQLLKA 119
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
++ IH + IHRD+KP N+LL+ ++L+DFGL + L +N
Sbjct: 120 LKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE----------------LEEN 163
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347
E P + Y V T Y APE+LL Y D WS+G I+
Sbjct: 164 PENPV------------------LTDY--VATRWYRAPEILLGSTRYTKGVDMWSVGCIL 203
Query: 348 YEMLVGYPPF 357
EML+G P F
Sbjct: 204 GEMLLGKPLF 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-19
Identities = 64/251 (25%), Positives = 106/251 (42%), Gaps = 49/251 (19%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ-VEHVRAERNLLAEVDS 175
D+EL+ +G G +G+V R TG + A+K +K L G ++ E ++ E
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK----LEPGDDFSLIQQEIFMVKECKH 65
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV + S+ E L++ MEY GG + + L+E + + ET+ + +H
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+HRDIK N+LL G ++L+DFG+ + + + + F
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF------------------- 166
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK---GYGMECDWWSLGAIMYEMLV 352
+GTP ++APEV + GY CD W++G E+
Sbjct: 167 ----------------------IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAE 204
Query: 353 GYPPFYSDDPM 363
PP + PM
Sbjct: 205 LQPPMFDLHPM 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-19
Identities = 60/234 (25%), Positives = 110/234 (47%), Gaps = 45/234 (19%)
Query: 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIV 179
+ ++GKG++GEV + R +T G Y +KKL RR + + E LL+++ IV
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRR-ERKAAEQEAQLLSQLKHPNIV 62
Query: 180 KLYCSFQ-DDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIESIHKHH 236
S++ +D LY++M + GGD+ L + L E++ + + +A++ +H+ H
Sbjct: 63 AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
+HRD+K N+ L + +++ D G+ + L+
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLE----------------------------- 153
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
N+ +A + +GTP Y++PE+ K Y + D W+LG +YEM
Sbjct: 154 ------------NQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-19
Identities = 69/248 (27%), Positives = 101/248 (40%), Gaps = 68/248 (27%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEMLRRGQVEHVRAERNLLAEVDSN 176
F+ + IG+G +G V R K TG V A+KK++ +E G E +LL E++
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET--EGVPSTAIREISLLKELNHP 59
Query: 177 CIVKLYCSFQDDEFLYLIMEYL-----------PGGDMMTLLMRKDTLTEDEARFYVAET 225
IVKL + LYL+ E+L P + L++ Y+ +
Sbjct: 60 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKS----------YLFQL 109
Query: 226 VLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285
+ + H H +HRD+KP NLL++ G ++L+DFGL +
Sbjct: 110 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF------------------- 150
Query: 286 SQNNERPAAPKRT-QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSL 343
P RT E + W Y APE+LL K Y D WSL
Sbjct: 151 -------GVPVRTYTHEVVTLW----------------YRAPEILLGCKYYSTAVDIWSL 187
Query: 344 GAIMYEML 351
G I EM+
Sbjct: 188 GCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 3e-19
Identities = 70/255 (27%), Positives = 110/255 (43%), Gaps = 55/255 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSE--MLRRGQVEHVRAERNLLAEV 173
+ L+ +G+GA G V CR K TG ++A+K + L++ Q+ +R E +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQK-QI--LR-ELEINKSC 56
Query: 174 DSNCIVKLYCSFQDDE--FLYLIMEYLPGGDMMTLL--MRKDT-LTEDEARFYVAETVL- 227
S IVK Y +F D+ + + MEY GG + ++ ++K ++ +AE+VL
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLK 116
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+ +H IHRDIKP N+LL + G ++L DFG+ L S
Sbjct: 117 GLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS------------------ 158
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347
LA + GT Y+APE + K Y + D WSLG +
Sbjct: 159 -------------------------LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTL 193
Query: 348 YEMLVGYPPFYSDDP 362
E+ PF +
Sbjct: 194 LEVAQNRFPFPPEGE 208
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 4e-19
Identities = 64/250 (25%), Positives = 116/250 (46%), Gaps = 40/250 (16%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEM------LRR--GQVE-HVRAERNL--LAE 172
+G+G +G+V + TG + A+KK+K E+ R+ G H R L + E
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
+ I+ L + + +F+ L+M+ + D+ ++ RK LTE + + + + + + +
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQILNGLNVL 135
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
HK +++HRD+ P N+ ++ G +++DFGL + P
Sbjct: 136 HKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYP----------------------P 173
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEML 351
+ ++ E +Q RR S V T Y APE+L+ + Y D WS+G I E+L
Sbjct: 174 YSDTLSKDETMQ-----RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL 228
Query: 352 VGYPPFYSDD 361
G P F ++
Sbjct: 229 TGKPLFPGEN 238
|
Length = 335 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 4e-19
Identities = 71/270 (26%), Positives = 115/270 (42%), Gaps = 60/270 (22%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
D +E++ IGKG +G+V K G + A+K L E + AE N+L +
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI----SDVDEEIEAEYNILQSLP 76
Query: 175 SN-CIVKLYCSF-QDDEF----LYLIMEYLPGGDMMTL----LMRKDTLTEDEARFYVAE 224
++ +VK Y F + D+ L+L++E GG + L L+ L E + +
Sbjct: 77 NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYG 136
Query: 225 TVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
+L ++ +H + IHRD+K +N+LL G ++L DFG+ L + L+
Sbjct: 137 ALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN---------- 186
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL-----LKKGYGMECD 339
++VGTP ++APEV+ Y CD
Sbjct: 187 -------------------------------TSVGTPFWMAPEVIACEQQYDYSYDARCD 215
Query: 340 WWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369
WSLG E+ G PP + P+ T K+
Sbjct: 216 VWSLGITAIELGDGDPPLFDMHPVKTLFKI 245
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 9e-19
Identities = 68/254 (26%), Positives = 110/254 (43%), Gaps = 58/254 (22%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D+ E+L +GKG +G V + TG AMK+++ L + + E ++L + S
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVS 58
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL---MRKDTLTEDEARFYVAETVLAIESI 232
IV Y +F + +Y+ MEY+ G + L + + + ED R V ++ +
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 233 -HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+H+ IHRD+KP N+L++ G ++L DFG + NL S
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFG----------------VSGNLVAS------ 156
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG------YGMECDWWSLGA 345
LA + +G Y+APE + G Y ++ D WSLG
Sbjct: 157 ---------------------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGL 195
Query: 346 IMYEMLVG---YPP 356
+ EM +G YPP
Sbjct: 196 SILEMALGRYPYPP 209
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 1e-18
Identities = 69/251 (27%), Positives = 114/251 (45%), Gaps = 51/251 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSE---MLRRGQVEHVRAERNLLAE 172
+ +E L+ IG+G++G V CR + TG + A+KK +SE ++++ + +R +L +
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIR----MLKQ 56
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
+ +V L F+ L+L+ EY + L + E + + +T+ A+
Sbjct: 57 LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC 116
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
HKH+ IHRD+KP+N+L+ K G ++L DFG + L T D+T
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARIL---TGPGDDYT--------------- 158
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEML 351
V T Y APE+L+ YG D W++G + E+L
Sbjct: 159 -----------------------DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELL 195
Query: 352 VGYP--PFYSD 360
G P P SD
Sbjct: 196 TGQPLWPGKSD 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 1e-18
Identities = 69/261 (26%), Positives = 111/261 (42%), Gaps = 61/261 (23%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN- 176
FEL+ ++G G +G+V R TG + A+K + + + E ++ E N+L + +
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63
Query: 177 CIVKLYCSF-------QDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVL 227
I Y +F DD+ L+L+ME+ G + L+ + +TL E+ + E +
Sbjct: 64 NIATYYGAFIKKNPPGMDDQ-LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 122
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+ +H+H IHRDIK N+LL + ++L DFG+ LD + + F
Sbjct: 123 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF----------- 171
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWS 342
+GTP ++APEV+ Y + D WS
Sbjct: 172 ------------------------------IGTPYWMAPEVIACDENPDATYDFKSDLWS 201
Query: 343 LGAIMYEMLVGYPPFYSDDPM 363
LG EM G PP PM
Sbjct: 202 LGITAIEMAEGAPPLCDMHPM 222
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-18
Identities = 65/233 (27%), Positives = 103/233 (44%), Gaps = 48/233 (20%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEM--LRRGQVEHVRAERNLLAEVDSNCIVKL 181
+GKG+FG V + ++K +K LK+ + L + E LL+++D IVK
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 182 YCSFQDDEFLYLIMEYLPGGDM----MTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
+ SF + + +I EY G D+ L TL+E++ + + +L + +H+
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
+HRD+K N+ L K L++ DFG + L GS
Sbjct: 128 LHRDLKAKNIFL-KNNLLKIGDFG----------------VSRLLMGSCD---------- 160
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
LA + GTP Y++PE L +GY + D WSLG I+YEM
Sbjct: 161 ---------------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 67/257 (26%), Positives = 112/257 (43%), Gaps = 64/257 (24%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKK-------------LKKSEMLRRGQVE 161
++ L+ IG+GA+G V K TG A+KK L++ ++LRR + E
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHE 63
Query: 162 HVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFY 221
++ +++ + SF D +Y++ E + D+ L+ + L+ D +++
Sbjct: 64 NIIGILDIIRPPS-------FESFND---VYIVQELMET-DLYKLI-KTQHLSNDHIQYF 111
Query: 222 VAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ + + ++ IH + +HRD+KP NLLL+ L++ DFGL + E D T
Sbjct: 112 LYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLAR----IADPEHDHTGF-- 165
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDW 340
+ Y V T Y APE++L KGY D
Sbjct: 166 ------------------------------LTEY--VATRWYRAPEIMLNSKGYTKAIDI 193
Query: 341 WSLGAIMYEMLVGYPPF 357
WS+G I+ EML P F
Sbjct: 194 WSVGCILAEMLSNRPLF 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 65/253 (25%), Positives = 106/253 (41%), Gaps = 69/253 (27%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-------KSEMLRRGQVEHVRAERN 168
DDFE L +G G G V + +G + A K + +++++R +V H
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLH------ 54
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
E +S IV Y +F D + + ME++ GG + +L + + E+ + + +A
Sbjct: 55 ---ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEN----ILGKISIA 107
Query: 229 IES-----IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283
+ KH +HRD+KP N+L++ G ++L DFG+ L S
Sbjct: 108 VLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-------------- 153
Query: 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343
+A S VGT Y++PE L Y ++ D WSL
Sbjct: 154 -----------------------------MANSFVGTRSYMSPERLQGTHYTVQSDIWSL 184
Query: 344 GAIMYEMLVG-YP 355
G + EM +G YP
Sbjct: 185 GLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 4e-18
Identities = 78/258 (30%), Positives = 109/258 (42%), Gaps = 56/258 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-D 174
D +E L IG+G +G+V R+K TG + A+KK + EM G E +LL + +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQMLSE 59
Query: 175 SNCIVKLYCSFQDDE-----FLYLIMEYLPGGDM---MTLLMRKDT--LTEDEARFYVAE 224
S IV+L +E LYL+ EYL D+ M R L + ++ +
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 225 TVLAIESIHKHHYIHRDIKPDNLLLDKY-GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283
+ + HKH +HRD+KP NLL+DK G L+++D GL + F+I
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR----------AFSI----- 163
Query: 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWS 342
P K E + W Y APEVLL Y D WS
Sbjct: 164 --------PV--KSYTHEIVTLW----------------YRAPEVLLGSTHYSTPVDIWS 197
Query: 343 LGAIMYEMLVGYPPFYSD 360
+G I EM P F D
Sbjct: 198 VGCIFAEMSRKQPLFPGD 215
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 7e-18
Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 42/255 (16%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK----SEMLRRGQVEHVRAERNLLAEV 173
++++ +IGKG GEV + + A+KK+++ + +L++ +R E + A++
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKK---RFLR-EAKIAADL 59
Query: 174 DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM---RKDTLTEDEARFYVAETVLAI- 229
IV +Y D + +Y M Y+ G + +LL +K++L+++ A L+I
Sbjct: 60 IHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 230 -------ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
E +H +HRD+KPDN+LL +G + + D+G E++ + ++
Sbjct: 120 HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI----FKKLEEEDLLDIDV 175
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342
+ + P + VGTPDY+APE LL D ++
Sbjct: 176 DERNICYSSMTIPGK-------------------IVGTPDYMAPERLLGVPASESTDIYA 216
Query: 343 LGAIMYEMLVGYPPF 357
LG I+Y+ML P+
Sbjct: 217 LGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 8e-18
Identities = 67/253 (26%), Positives = 100/253 (39%), Gaps = 54/253 (21%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F L IG G+FG V R+ T V A+KK+ S + + + E L ++
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
++ + + +L+MEY G L + K L E E + + +H H
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER 136
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFG---LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
IHRDIK N+LL + G ++L+DFG L P
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSASLVSP----------------------------- 167
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEML 351
A S VGTP ++APEV+L + Y + D WSLG E+
Sbjct: 168 -------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 208
Query: 352 VGYPPFYSDDPMS 364
PP ++ + MS
Sbjct: 209 ERKPPLFNMNAMS 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 2e-17
Identities = 50/240 (20%), Positives = 96/240 (40%), Gaps = 55/240 (22%)
Query: 124 IGKGAFGEVRVCR---EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
+G+GAFGEV + + A+K LK+ + + E ++ ++ +V+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLGHPNVVR 60
Query: 181 LY-CSFQDDEFLYLIMEYLPGGDMMTLL---------MRKDTLTEDEARFYVAETVLAIE 230
L +++ LYL++EY+ GGD++ L K TL+ + + + +E
Sbjct: 61 LLGVCTEEEP-LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+ ++HRD+ N L+ + +++SDFGL + + + +
Sbjct: 120 YLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY--------------DDDYYRKKT 165
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
P R W M APE L + + D WS G +++E+
Sbjct: 166 GGKLPIR--------W-----M------------APESLKDGIFTSKSDVWSFGVLLWEI 200
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 3e-17
Identities = 62/263 (23%), Positives = 106/263 (40%), Gaps = 62/263 (23%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKL---KKSEMLRRGQVEHVRAERNLLA 171
+D E ++ +G G G V + TG V A K + KS + ++ + E ++
Sbjct: 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQ-----ILRELQIMH 58
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA--I 229
E S IV Y +F ++ + + ME++ G + + + + + +A V+
Sbjct: 59 ECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-KIAVAVVEGLT 117
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+ H +HRDIKP N+L++ G ++L DFG+ L S
Sbjct: 118 YLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-------------------- 157
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349
+A + VGT Y++PE + Y ++ D WSLG + E
Sbjct: 158 -----------------------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIE 194
Query: 350 MLVGYPPF--------YSDDPMS 364
+ +G PF DDPM
Sbjct: 195 LALGKFPFAFSNIDDDGQDDPMG 217
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 62/246 (25%), Positives = 104/246 (42%), Gaps = 54/246 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL-----L 170
++ + IG GA+G V + +G A+KK+ + A+R L L
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHA------FDVPTLAKRTLRELKIL 58
Query: 171 AEVDSNCIVKLYCSFQ--DDEF--LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV 226
+ I+ + + +F +Y++M+ L D+ ++ LTE+ R+++ + +
Sbjct: 59 RHFKHDNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLL 117
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
++ IH + IHRD+KP NLL+++ LR+ DFG+ + L S + + F
Sbjct: 118 RGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYF---------- 167
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 345
M Y V T Y APE+LL Y D WS+G
Sbjct: 168 -------------------------MTEY--VATRWYRAPELLLSLPEYTTAIDMWSVGC 200
Query: 346 IMYEML 351
I EML
Sbjct: 201 IFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 5e-17
Identities = 68/247 (27%), Positives = 109/247 (44%), Gaps = 51/247 (20%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRG-QVEHVRAERNLLAEVDS 175
+FE L IG+G +G V R+ T+G + A+KK++ + R G + +R E LL +
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVR-MDNERDGIPISSLR-EITLLLNLRH 65
Query: 176 NCIVKLYCSFQDD--EFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIES 231
IV+L + ++L+MEY D+ +LL M +E + + + + + ++
Sbjct: 66 PNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNM-PTPFSESQVKCLMLQLLRGLQY 123
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+H++ IHRD+K NLLL G L+++DFGL +
Sbjct: 124 LHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY-----------------------GL 160
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEM 350
PA P T V T Y APE+LL Y D W++G I+ E+
Sbjct: 161 PAKP-MT-----------------PKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAEL 202
Query: 351 LVGYPPF 357
L P
Sbjct: 203 LAHKPLL 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 7e-17
Identities = 67/260 (25%), Positives = 105/260 (40%), Gaps = 62/260 (23%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ-VEHVRA---ERNLLA 171
D ++ L+ +G GA+G+V + TG A+KKL R Q H + E LL
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKL-----SRPFQSAIHAKRTYRELRLLK 69
Query: 172 EVDSNCIVKLYCSFQDDEFL------YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAET 225
+D ++ L F L YL+ L G D+ + ++ L++D +F V +
Sbjct: 70 HMDHENVIGLLDVFTPASSLEDFQDVYLVTH-LMGADLNNI-VKCQKLSDDHIQFLVYQI 127
Query: 226 VLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285
+ ++ IH IHRD+KP N+ +++ L++ DFGL +
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR--------------------- 166
Query: 286 SQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLG 344
+ M Y V T Y APE++L Y D WS+G
Sbjct: 167 ---------------------HTDDEMTGY--VATRWYRAPEIMLNWMHYNQTVDIWSVG 203
Query: 345 AIMYEMLVGYPPFYSDDPMS 364
IM E+L G F D +
Sbjct: 204 CIMAELLTGKTLFPGSDHID 223
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 1e-16
Identities = 69/270 (25%), Positives = 112/270 (41%), Gaps = 80/270 (29%)
Query: 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV 173
A+D + L IG+GAFG V K +G + A+K++ +S + + Q + LL ++
Sbjct: 2 TAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQ-------KRLLMDL 53
Query: 174 D-----SNC--IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK----------DTLTED 216
D S+C IVK Y + + ++ ME +M + + K + E+
Sbjct: 54 DVVMRSSDCPYIVKFYGALFREGDCWICME------LMDISLDKFYKYVYEVLKSVIPEE 107
Query: 217 EARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275
TV A+ + + IHRD+KP N+LLD+ G+++L DFG+ L S + +D
Sbjct: 108 ILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD 167
Query: 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KK 332
G Y+APE + +
Sbjct: 168 ------------------------------------------AGCRPYMAPERIDPSARD 185
Query: 333 GYGMECDWWSLGAIMYEMLVG---YPPFYS 359
GY + D WSLG +YE+ G YP + S
Sbjct: 186 GYDVRSDVWSLGITLYEVATGKFPYPKWNS 215
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 3e-16
Identities = 66/264 (25%), Positives = 113/264 (42%), Gaps = 54/264 (20%)
Query: 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
K D F+++ IG+G +G+V R+K TG + A+KK++ + +R E +L
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILR 61
Query: 172 EVDSNCIVKLYCSFQDD----EFL------YLIMEYLPGGDMMTLLMRK-DTLTEDEARF 220
+++ IV L D +F YL+ EY+ D+M LL +ED +
Sbjct: 62 QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESGLVHFSEDHIKS 120
Query: 221 YVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280
++ + + + HK +++HRDIK N+LL+ G ++L+DFGL +
Sbjct: 121 FMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR---------------- 164
Query: 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECD 339
+ + V T Y PE+LL ++ YG D
Sbjct: 165 ------------------------LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAID 200
Query: 340 WWSLGAIMYEMLVGYPPFYSDDPM 363
WS G I+ E+ P F ++ +
Sbjct: 201 VWSCGCILGELFTKKPIFQANQEL 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 4e-16
Identities = 74/254 (29%), Positives = 109/254 (42%), Gaps = 57/254 (22%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D +E + IG+G +G V R++ T A+KK++ E G E +LL E+
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRL-EQEDEGVPSTAIREISLLKEMQH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEAR------FYVAETVLAI 229
IV+L ++ LYL+ EYL + L D+ + D A+ Y+ + + I
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLD----LDLKKHMDS-SPDFAKNPRLIKTYLYQILRGI 115
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGH-LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
H H +HRD+KP NLL+D+ + L+L+DFGL + F I
Sbjct: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARA----------FGI---------- 155
Query: 289 NERPAAPKRT-QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAI 346
P RT E + W Y APE+LL + Y D WS+G I
Sbjct: 156 ------PVRTFTHEVVTLW----------------YRAPEILLGSRHYSTPVDIWSVGCI 193
Query: 347 MYEMLVGYPPFYSD 360
EM+ P F D
Sbjct: 194 FAEMVNQKPLFPGD 207
|
Length = 294 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 6e-16
Identities = 74/266 (27%), Positives = 112/266 (42%), Gaps = 60/266 (22%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK---SEMLRRGQVEHVRAERNLLAE 172
D + L +G GA+G V ++ TG A+KKL + SE+ + +R LL
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELR----LLKH 70
Query: 173 VDSNCIVKLYCSFQDDEFL------YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV 226
+ ++ L F D L YL+M ++ G + LM+ + L+ED +F V + +
Sbjct: 71 MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQML 128
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
++ IH IHRD+KP NL +++ L++ DFGL +
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---------------------- 166
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 345
Q + M Y V T Y APEV+L Y D WS+G
Sbjct: 167 --------------------QTDSEMTGY--VVTRWYRAPEVILNWMHYTQTVDIWSVGC 204
Query: 346 IMYEMLVGYPPFYSDDPMSTCRKVRK 371
IM EML G P F D + ++ K
Sbjct: 205 IMAEMLTGKPLFKGHDHLDQLMEIMK 230
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 7e-16
Identities = 67/245 (27%), Positives = 107/245 (43%), Gaps = 50/245 (20%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEMLRRGQVEHVRAERNLLAEVDSN 176
F+ L +G+G + V R +TTG + A+K++ +E G E +L+ E+
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHE 58
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDM---MTLLMRKDTLTEDEARFYVAETVLAIESIH 233
IV+L+ + L L+ EY+ D+ M + L + + + + + I H
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
++ +HRD+KP NLL++K G L+L+DFGL + G +N S
Sbjct: 118 ENRVLHRDLKPQNLLINKRGELKLADFGLAR------------AFGIPVNTFS------- 158
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLV 352
+ V T Y AP+VLL + Y D WS+G IM EM+
Sbjct: 159 ----------------------NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT 196
Query: 353 GYPPF 357
G P F
Sbjct: 197 GRPLF 201
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 9e-16
Identities = 68/252 (26%), Positives = 105/252 (41%), Gaps = 53/252 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN--LLAEV 173
+E L IG+G FGEV R K T + A+KK+ M + + A R +L +
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVL---MENEKEGFPITALREIKILQLL 68
Query: 174 DSNCIVKLY--CSFQDDEF------LYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAE 224
+V L C + + YL+ E+ D+ LL K+ T E + +
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKM 127
Query: 225 TVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
+ + IH++ +HRD+K N+L+ K G L+L+DFGL + F++
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA----------FSL------ 171
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSL 343
++ + T NR V T Y PE+LL ++ YG D W
Sbjct: 172 ----SKNSKPNRYT----------NR-------VVTLWYRPPELLLGERDYGPPIDMWGA 210
Query: 344 GAIMYEMLVGYP 355
G IM EM P
Sbjct: 211 GCIMAEMWTRSP 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 68/258 (26%), Positives = 108/258 (41%), Gaps = 79/258 (30%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-------KSEMLRRGQVEHVRAERN 168
DDFE ++ +G G G V + K +G + A K + +++++R QV H
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH------ 58
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
E +S IV Y +F D + + ME++ GG + +L EA+ + E +L
Sbjct: 59 ---ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--------KEAK-RIPEEILG 106
Query: 229 IESI----------HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278
SI KH +HRD+KP N+L++ G ++L DFG+ L S
Sbjct: 107 KVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--------- 157
Query: 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC 338
+A S VGT Y++PE L Y ++
Sbjct: 158 ----------------------------------MANSFVGTRSYMSPERLQGTHYSVQS 183
Query: 339 DWWSLGAIMYEMLVG-YP 355
D WS+G + E+ +G YP
Sbjct: 184 DIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 65/250 (26%), Positives = 109/250 (43%), Gaps = 65/250 (26%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKK--------SEMLRRGQV-EHVRAERNLLAEVD 174
+G GAFG V R++ TG A+KK+ K R ++ +H+R E N++
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE-NII---- 72
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
+ ++ S +D +Y + E L G D+ LL + L + ++++ + + ++ +H
Sbjct: 73 --SLSDIFISPLED--IYFVTELL-GTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHS 126
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+HRD+KP N+L+++ L++ DFGL + D
Sbjct: 127 AGVVHRDLKPSNILINENCDLKICDFGLARIQD--------------------------- 159
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 353
+M Y V T Y APE++L + Y +E D WS G I EML G
Sbjct: 160 ---------------PQMTGY--VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202
Query: 354 YPPFYSDDPM 363
P F D +
Sbjct: 203 KPLFPGKDHV 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 65/257 (25%), Positives = 107/257 (41%), Gaps = 66/257 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-------KSEMLRRGQVEHVRAERN 168
DDFE ++ +G G G V K +G + A K + +++++R QV H
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH------ 58
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
E +S IV Y +F D + + ME++ GG + +L + + E + ++
Sbjct: 59 ---ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAV 112
Query: 229 IESI----HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
I+ + KH +HRD+KP N+L++ G ++L DFG+ L S
Sbjct: 113 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--------------- 157
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344
+A S VGT Y++PE L Y ++ D WS+G
Sbjct: 158 ----------------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMG 189
Query: 345 AIMYEMLVGYPPFYSDD 361
+ EM +G P D
Sbjct: 190 LSLVEMAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-15
Identities = 67/250 (26%), Positives = 102/250 (40%), Gaps = 48/250 (19%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F L IG G+FG V R+ T V A+KK+ S + + + E L +
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
++ + + +L+MEY G L + K L E E + + +H H+
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRDIK N+LL + G ++L+DFG + A+P
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFG---------------------------SASIASP-- 177
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEMLVGY 354
A S VGTP ++APEV+L + Y + D WSLG E+
Sbjct: 178 ----------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 221
Query: 355 PPFYSDDPMS 364
PP ++ + MS
Sbjct: 222 PPLFNMNAMS 231
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 9e-15
Identities = 65/247 (26%), Positives = 99/247 (40%), Gaps = 48/247 (19%)
Query: 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
L IG G+FG V T V A+KK+ S + + + E L ++ ++
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
+ + +L+MEY G L + K L E E + + +H H+ IHR
Sbjct: 86 YKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 145
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
DIK N+LL + G ++L+DFG S + PA
Sbjct: 146 DIKAGNILLTEPGQVKLADFG------------------------SASKSSPAN------ 175
Query: 301 EQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEMLVGYPPF 357
S VGTP ++APEV+L + Y + D WSLG E+ PP
Sbjct: 176 ---------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
Query: 358 YSDDPMS 364
++ + MS
Sbjct: 221 FNMNAMS 227
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-14
Identities = 75/263 (28%), Positives = 109/263 (41%), Gaps = 65/263 (24%)
Query: 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKK---SEML-RRGQVE-----HVRAERNLLA 171
L +G GA+G V +K TG A+KKL + SE+ +R E H++ E N++
Sbjct: 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE-NVIG 78
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAI 229
+D FQD YL+M Y M T L + L+ED+ ++ V + + +
Sbjct: 79 LLDVFTSAVSGDEFQD---FYLVMPY-----MQTDLQKIMGHPLSEDKVQYLVYQMLCGL 130
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+ IH IHRD+KP NL +++ L++ DFGL + D
Sbjct: 131 KYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA--------------------- 169
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348
M Y V T Y APEV+L Y D WS+G IM
Sbjct: 170 ---------------------EMTGY--VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMA 206
Query: 349 EMLVGYPPFYSDDPMSTCRKVRK 371
EML G F D + ++ K
Sbjct: 207 EMLTGKTLFKGKDYLDQLTQILK 229
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 6e-14
Identities = 66/255 (25%), Positives = 107/255 (41%), Gaps = 52/255 (20%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
A + + ++G GA G V + + G +A+K + E + +AE L D
Sbjct: 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVD-MEGMSEADKNRAQAEVCCLLNCD 89
Query: 175 SNCIVKLYCSF-----QDDE---FLYLIMEYLPGGDMMTLLMRKD----TLTEDEARFYV 222
IVK + F ++ E + L+++Y GD+ + + T E EA
Sbjct: 90 FFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLF 149
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+ +LA+ +H H IHRDIK N+LL G ++L DFG K + +T+ + +G
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK-MYAATVSDD---VGRTF 205
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342
G TP Y+APE+ +K Y + D +S
Sbjct: 206 CG-----------------------------------TPYYVAPEIWRRKPYSKKADMFS 230
Query: 343 LGAIMYEMLVGYPPF 357
LG ++YE+L PF
Sbjct: 231 LGVLLYELLTLKRPF 245
|
Length = 496 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 8e-14
Identities = 75/265 (28%), Positives = 110/265 (41%), Gaps = 70/265 (26%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN 168
Q++ +D E L IG G G+V R K TGHV A+K+++++ + E+ R +
Sbjct: 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG----NKEENKRILMD 63
Query: 169 L---LAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMT----LLMR-KDTLTEDEARF 220
L L D IVK Y F D +++ ME M T LL R + + ED
Sbjct: 64 LDVVLKSHDCPYIVKCYGYFITDSDVFICMEL-----MSTCLDKLLKRIQGPIPEDILG- 117
Query: 221 YVAETVLAIESIH----KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276
TV ++++H KH IHRD+KP N+LLD G+++L DFG+ L
Sbjct: 118 --KMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV--------- 166
Query: 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL----LKK 332
S+ R A G Y+APE +
Sbjct: 167 --------DSKAKTRSA-------------------------GCAAYMAPERIDPPDPNP 193
Query: 333 GYGMECDWWSLGAIMYEMLVGYPPF 357
Y + D WSLG + E+ G P+
Sbjct: 194 KYDIRADVWSLGISLVELATGQFPY 218
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 63/251 (25%), Positives = 96/251 (38%), Gaps = 55/251 (21%)
Query: 120 LLTMIGKGAFGEVRVCR----EKTTGHVYAMKKLKKSEMLRRGQVEHVRA----ERNLLA 171
+ +G+G FG+V +CR TG A+K L S E R+ E +L
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS------GEEQHRSDFEREIEILR 61
Query: 172 EVDSNCIVKL-YCSFQDDEF-LYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLA 228
+D IVK + L LIMEYLP G + L R +D + + ++
Sbjct: 62 TLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKG 121
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
++ + YIHRD+ N+L++ +++SDFGL K L +++D+
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP----EDKDYYYVKEP------ 171
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
E P W APE L + D WS G +Y
Sbjct: 172 GESPI-----------FW-----------------YAPECLRTSKFSSASDVWSFGVTLY 203
Query: 349 EMLVGYPPFYS 359
E+ P S
Sbjct: 204 ELFTYGDPSQS 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 64/250 (25%), Positives = 99/250 (39%), Gaps = 48/250 (19%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F L IG G+FG V R+ V A+KK+ S + + + E L ++
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
++ + + +L+MEY G L + K L E E + + +H H+
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRD+K N+LL + G ++L DFG + AP
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFG---------------------------SASIMAP-- 167
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEMLVGY 354
A VGTP ++APEV+L + Y + D WSLG E+
Sbjct: 168 ----------------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211
Query: 355 PPFYSDDPMS 364
PP ++ + MS
Sbjct: 212 PPLFNMNAMS 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 3e-13
Identities = 64/243 (26%), Positives = 96/243 (39%), Gaps = 61/243 (25%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK--------KSEMLRRGQVEHVRAERNL 169
+E L IG+G +G V + + T + A+K+++ S LR E L
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---------EICL 52
Query: 170 LAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
L E+ IV+LY D+ L L+ EY + + + ++ + + +
Sbjct: 53 LKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGL 112
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
H H+ +HRD+KP NLL++K G L+L+DFGL + F I
Sbjct: 113 AFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARA----------FGI----------- 151
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECDWWSLGAIM 347
P R YS V T Y P+VL K Y D WS G I
Sbjct: 152 -----PVR----------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIF 190
Query: 348 YEM 350
E+
Sbjct: 191 AEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 4e-13
Identities = 62/244 (25%), Positives = 97/244 (39%), Gaps = 51/244 (20%)
Query: 124 IGKGAFGEVRV-CREKT---TGHVYAMKKLKK--SEMLRRGQVEHVRAERNLLAEVDSNC 177
+G+G FG+V + C + TG + A+K LK+ + G + E N+L +
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKK----EINILKTLYHEN 67
Query: 178 IVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IVK CS Q + L LIMEY+P G + L K L + + + + +H
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
HYIHRD+ N+LLD +++ DFGL K + G+ ++ + P
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV----------PEGHEYYRVREDGDSPVF- 175
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
+ A E L + + D WS G +YE+L
Sbjct: 176 ---------------------------WYAVECLKENKFSYASDVWSFGVTLYELLTHCD 208
Query: 356 PFYS 359
S
Sbjct: 209 SKQS 212
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 67/251 (26%), Positives = 108/251 (43%), Gaps = 71/251 (28%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKK--------------LKKSEMLRRGQVEHVRAERNL 169
IG+GA+G V + T A+KK L++ ++LR H+ E N+
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLR-----HLDHE-NV 66
Query: 170 LAEVDSNCIVKLYC--SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
+A D I+ +F D +Y++ E L D+ ++ TL++D ++++ + +
Sbjct: 67 IAIKD---IMPPPHREAFND---VYIVYE-LMDTDLHQIIRSSQTLSDDHCQYFLYQLLR 119
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
++ IH + +HRD+KP NLLL+ L++ DFGL + T ++ DF
Sbjct: 120 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART----TSEKGDF----------- 164
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAI 346
M Y V T Y APE+LL Y D WS+G I
Sbjct: 165 ------------------------MTEY--VVTRWYRAPELLLNCSEYTTAIDVWSVGCI 198
Query: 347 MYEMLVGYPPF 357
E+L P F
Sbjct: 199 FAELLGRKPLF 209
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 6e-13
Identities = 64/248 (25%), Positives = 108/248 (43%), Gaps = 56/248 (22%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKL--KKSEMLRRGQVEHVRAERNLLAEVD 174
+ E + IG GA G V + TG +YA+K + + +RR + E +L +V+
Sbjct: 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR----QICREIEILRDVN 130
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
+VK + F + + +++E++ GG + + + D AR + + I +H+
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHR 186
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
H +HRDIKP NLL++ +++++DFG+ + L Q D P
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSRILA----QTMD----------------PCN 226
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL---LKKGY--GMECDWWSLGAIMYE 349
S+VGT Y++PE + L G G D WSLG + E
Sbjct: 227 ---------------------SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265
Query: 350 MLVGYPPF 357
+G PF
Sbjct: 266 FYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 7e-13
Identities = 64/245 (26%), Positives = 100/245 (40%), Gaps = 64/245 (26%)
Query: 121 LTMIGKGAFGEVRVCR----EKTTGHVYAMKKLKKSEMLRRGQVEHVR---AERNLLAEV 173
+ +GKG FG V +CR + TG V A+KKL+ S EH+R E +L +
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS------TAEHLRDFEREIEILKSL 62
Query: 174 DSNCIVKL--YCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIE 230
+ IVK C L L+MEYLP G + L + ++ L + Y ++ +E
Sbjct: 63 QHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGME 122
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+ Y+HRD+ N+L++ +++ DFGL K L Q+ E
Sbjct: 123 YLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL-------------------PQDKE 163
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPD-----YIAPEVLLKKGYGMECDWWSLGA 345
Y V P + APE L + + + D WS G
Sbjct: 164 ------------------------YYKVREPGESPIFWYAPESLTESKFSVASDVWSFGV 199
Query: 346 IMYEM 350
++YE+
Sbjct: 200 VLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 7e-13
Identities = 60/245 (24%), Positives = 96/245 (39%), Gaps = 46/245 (18%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
AD +E L +G+G++ V + K G + A+K ++ E G E +LL +
Sbjct: 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLK 61
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
IV L+ E L L+ EY+ + L + + ++ + + + IH+
Sbjct: 62 HANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+ +HRD+KP NLL+ G L+L+DFGL + +
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLARA--------------------------KSV 155
Query: 295 PKRT-QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC-DWWSLGAIMYEMLV 352
P T E + W Y P+VLL C D W +G I EM+
Sbjct: 156 PSHTYSNEVVTLW----------------YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQ 199
Query: 353 GYPPF 357
G F
Sbjct: 200 GVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-12
Identities = 32/135 (23%), Positives = 70/135 (51%), Gaps = 8/135 (5%)
Query: 127 GAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186
G +V + + T + +K L+KS R ER + +V L+
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSR--------ERLTIIPHCVPNMVCLHKYIV 55
Query: 187 DDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDN 246
++ ++L++++ GG + + + + + E+ + + AE V+A++++H+ + RD+ P+N
Sbjct: 56 SEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115
Query: 247 LLLDKYGHLRLSDFG 261
+LLD GH++L+ F
Sbjct: 116 ILLDDRGHIQLTYFS 130
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 56/235 (23%), Positives = 101/235 (42%), Gaps = 47/235 (20%)
Query: 124 IGKGAFGEVRVCREK----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIV 179
+G+G FG+V +CR TG A+K LK + ++ E +L + IV
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIV 69
Query: 180 KL--YCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHH 236
K C+ + LIME+LP G + L R K+ + + Y + ++ +
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
Y+HRD+ N+L++ +++ DFGL K ++ ++ +T+ ++L+
Sbjct: 130 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETD---KEYYTVKDDLD------------- 173
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
S V + APE L++ + + D WS G +YE+L
Sbjct: 174 -------------------SPVF---WYAPECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 66/258 (25%), Positives = 108/258 (41%), Gaps = 55/258 (21%)
Query: 118 FELLTMIGKGAFGEVRVCREKTT--GHVYAMKKL----KKSEMLRRGQVE-----HVRAE 166
+EL+ +G+GA+G V R T A+KK+ K + +R E H R
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 167 RNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV 226
+N+ D + IV +F + LYL E L D+ ++ LT+ + ++ + +
Sbjct: 62 KNITCLYDMD-IV-FPGNFNE---LYLYEE-LMEADLHQIIRSGQPLTDAHFQSFIYQIL 115
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
++ IH + +HRD+KP NLL++ L++ DFGL + + + F
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF---------- 165
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 345
M Y V T Y APE++L + Y D WS+G
Sbjct: 166 -------------------------MTEY--VATRWYRAPEIMLSFQSYTKAIDVWSVGC 198
Query: 346 IMYEMLVGYPPFYSDDPM 363
I+ E+L P F D +
Sbjct: 199 ILAELLGRKPVFKGKDYV 216
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 62/249 (24%), Positives = 99/249 (39%), Gaps = 48/249 (19%)
Query: 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
L +G+G + V R K T ++ A+K+++ G E +LL + IV
Sbjct: 10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLKHANIVT 67
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
L+ + L L+ EYL L + ++ + ++ + + + HK +HR
Sbjct: 68 LHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHR 127
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
D+KP NLL+++ G L+L+DFGL + T K
Sbjct: 128 DLKPQNLLINEKGELKLADFGLARAKSVPT-------------------------KTYSN 162
Query: 301 EQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPFYS 359
E + W Y P+VLL Y D W +G I+YEM G P F
Sbjct: 163 EVVTLW----------------YRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF-- 204
Query: 360 DDPMSTCRK 368
P ST ++
Sbjct: 205 --PGSTVKE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 24/45 (53%), Positives = 32/45 (71%)
Query: 318 VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDP 362
+GTPDY+APE+LL K +G DWW+LG ++E L G PPF + P
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETP 585
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 65/256 (25%), Positives = 106/256 (41%), Gaps = 60/256 (23%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK---------KSEMLRRGQVEHVRAE 166
+ ++ L+ +G GA+G V + TG A+KKL K ++H++ E
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 167 RNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV 226
N++ +D + F D +YL+ +L G D+ ++ + LT+D +F + + +
Sbjct: 77 -NVIGLLDVFTPARSLEEFND---VYLVT-HLMGADLNNIV-KCQKLTDDHVQFLIYQIL 130
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
++ IH IHRD+KP NL +++ L++ DFGL + D
Sbjct: 131 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD------------------- 171
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 345
M Y V T Y APE++L Y D WS+G
Sbjct: 172 -----------------------DEMTGY--VATRWYRAPEIMLNWMHYNQTVDIWSVGC 206
Query: 346 IMYEMLVGYPPFYSDD 361
IM E+L G F D
Sbjct: 207 IMAELLTGRTLFPGTD 222
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 57/238 (23%), Positives = 96/238 (40%), Gaps = 44/238 (18%)
Query: 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
L +G+G + V R K T ++ A+K+++ G E +LL ++ IV
Sbjct: 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVT 68
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
L+ D+ L L+ EYL + + ++ + ++ + + + H+ +HR
Sbjct: 69 LHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHR 128
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
D+KP NLL+++ G L+L+DFGL + T K
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSVPT-------------------------KTYSN 163
Query: 301 EQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVGYPPF 357
E + W Y P+VLL Y + D W +G I +EM G P F
Sbjct: 164 EVVTLW----------------YRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 9e-12
Identities = 65/251 (25%), Positives = 108/251 (43%), Gaps = 55/251 (21%)
Query: 118 FELLTMIGKGAFGEVRVCRE-KTTGHVYAMKKLK---KSEMLRRGQVEHVRAERNLLAEV 173
+E + IG+GA+G+V R+ K G A+K+++ E + + V R+L
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 174 DSNCIVKLY----CSFQDDEF-LYLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETV 226
N +V+L+ S D E L L+ E++ D+ T L + + + + + + + +
Sbjct: 63 HPN-VVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
++ +H H +HRD+KP N+L+ G ++L+DFGL +
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR---------------------- 158
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346
+ +Q M S V T Y APEVLL+ Y D WS+G I
Sbjct: 159 ----------------IYSFQ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCI 198
Query: 347 MYEMLVGYPPF 357
EM P F
Sbjct: 199 FAEMFRRKPLF 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 59/242 (24%), Positives = 90/242 (37%), Gaps = 52/242 (21%)
Query: 121 LTMIGKGAFGEVRVCREKTTGHVYAMK--KLKKSEMLRRGQVEHVRAERNLLAEVDSNCI 178
L +G+G++ V + G + A+K +K E + + E +LL + I
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR----EASLLKGLKHANI 65
Query: 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYI 238
V L+ E L + EY+ ++ L R ++ + + + IH H +
Sbjct: 66 VLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHIL 125
Query: 239 HRDIKPDNLLLDKYGHLRLSDFGLC--KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
HRD+KP NLL+ G L+L+DFGL K + T + T+
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTL------------------ 167
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYP 355
W Y P+VLL Y D W G I EML G P
Sbjct: 168 ---------W----------------YRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQP 202
Query: 356 PF 357
F
Sbjct: 203 AF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-11
Identities = 64/253 (25%), Positives = 103/253 (40%), Gaps = 54/253 (21%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK---KSEMLRRGQVEHVRAERNLLAEVD 174
+E + IG GA+G V R+ +GH A+K ++ + L V V + L D
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRL-EAFD 60
Query: 175 SNCIVKLY----CSFQDDEF-LYLIMEYLPGGDMMTLLMRKDT--LTEDEARFYVAETVL 227
IV+L S D E + L+ E++ D+ T L + L + + + + +
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
++ +H + +HRD+KP+N+L+ G ++L+DFGL + C
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC------------------- 160
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347
+M V T Y APEVLL+ Y D WS+G I
Sbjct: 161 -----------------------QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIF 197
Query: 348 YEMLVGYPPFYSD 360
EM P F +
Sbjct: 198 AEMFRRKPLFCGN 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 64/253 (25%), Positives = 101/253 (39%), Gaps = 72/253 (28%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
D E IG GAFG V + G A+KK+ + + V R R L
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPN---VFQNLVSCKRVFREL------- 50
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDM--------MTLLMRKD---------TLTEDEAR 219
K+ C F+ D L + + L + +T LM+ D L+ D +
Sbjct: 51 ---KMLCFFKHDNVLSAL-DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVK 106
Query: 220 FYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279
++ + + ++ +H +HRDIKP NLL++ L++ DFGL + ++E D
Sbjct: 107 VFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLAR------VEEPD---- 156
Query: 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMEC 338
S++ TQ+ V T Y APE+L+ + Y
Sbjct: 157 -----ESKH--------MTQE-----------------VVTQYYRAPEILMGSRHYTSAV 186
Query: 339 DWWSLGAIMYEML 351
D WS+G I E+L
Sbjct: 187 DIWSVGCIFAELL 199
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 72/268 (26%), Positives = 124/268 (46%), Gaps = 49/268 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+++E++ IG G FGEV + + K T + K + + R + + V E N++ E+
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV-IEVNVMRELKH 71
Query: 176 NCIVKLYCSF--QDDEFLYLIMEYLPGGDMMTLLMRKDTL---TEDEARFYVAETVL-AI 229
IV+ F + ++ LY++ME+ GD+ + + + E+ A + +L A+
Sbjct: 72 KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131
Query: 230 ESIHK-------HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
H +HRD+KP N+ L G+ + + T Q NNL
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLST---------GI-RHIGKITAQ------ANNL 175
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRM----LAYSTVGTPDYIAPEVLL--KKGYGM 336
NG RP A ++ + ++ + +A+S VGTP Y +PE+LL K Y
Sbjct: 176 NG------RPIA-------KIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDD 222
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDPMS 364
+ D W+LG I+YE+ G PF+ + S
Sbjct: 223 KSDMWALGCIIYELCSGKTPFHKANNFS 250
|
Length = 1021 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 68/262 (25%), Positives = 107/262 (40%), Gaps = 75/262 (28%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD- 174
DD E++ +G+GA+G V R TG + A+K++ R V + ++ LL ++D
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRI-------RATVN-SQEQKRLLMDLDI 52
Query: 175 ----SNC--IVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--------MRKDTLTEDEARF 220
+C V Y + + +++ ME M T L + T+ ED
Sbjct: 53 SMRSVDCPYTVTFYGALFREGDVWICMEV-----MDTSLDKFYKKVYDKGLTIPEDILGK 107
Query: 221 YVAETVLAIESIH-KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279
V A+E +H K IHRD+KP N+L+++ G ++L DFG+ L S + D
Sbjct: 108 IAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID---- 163
Query: 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPE----VLLKKGYG 335
G Y+APE L +KGY
Sbjct: 164 --------------------------------------AGCKPYMAPERINPELNQKGYD 185
Query: 336 MECDWWSLGAIMYEMLVGYPPF 357
++ D WSLG M E+ G P+
Sbjct: 186 VKSDVWSLGITMIELATGRFPY 207
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-11
Identities = 58/227 (25%), Positives = 92/227 (40%), Gaps = 43/227 (18%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IGKG FG+V K V A+K + L E +L + D IVKL
Sbjct: 3 IGKGNFGDVYKGVLKGNTEV-AVKTCR--STLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDI 242
+ +Y++ME +PGG ++T L + K+ LT + + +E + + IHRD+
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDL 119
Query: 243 KPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQ 302
N L+ + L++SDFG+ + E++ I +G Q P +
Sbjct: 120 AARNCLVGENNVLKISDFGMSR--------EEEGGIYTVSDGLKQ------IPIK----- 160
Query: 303 LQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349
+ APE L Y E D WS G +++E
Sbjct: 161 --------------------WTAPEALNYGRYTSESDVWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 57/259 (22%), Positives = 112/259 (43%), Gaps = 51/259 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +L+ +G G FGEV + + V A+K LK M V+ E NL+ +
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTM----SVQAFLEEANLMKTLQH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIH 233
+ +V+LY +E +Y+I EY+ G ++ L + + + + A+ + I
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 120
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
+ +YIHRD++ N+L+ + +++DFGL + +++ ++T E
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLAR-----VIEDNEYTA----------REGAK 165
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-- 351
P + + APE + + ++ D WS G ++YE++
Sbjct: 166 FPIK-------------------------WTAPEAINFGSFTIKSDVWSFGILLYEIVTY 200
Query: 352 --VGYPPFYSDDPMSTCRK 368
+ YP + D MS ++
Sbjct: 201 GKIPYPGMSNSDVMSALQR 219
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 4e-11
Identities = 57/243 (23%), Positives = 98/243 (40%), Gaps = 53/243 (21%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMK--KLKKSEMLRRGQVEHVRAERNLLAEVD 174
D + ++G G G V T + A+K L + L++ + +E +L + D
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQK----QIMSELEILYKCD 57
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
S I+ Y +F + + + E++ GG +L + + R VA V + +
Sbjct: 58 SPYIIGFYGAFFVENRISICTEFMDGG---SLDVYRKIPEHVLGRIAVA-VVKGLTYLWS 113
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+HRD+KP N+L++ G ++L DFG+ L S
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS------------------------- 148
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354
+A + VGT Y+APE + + YG+ D WSLG E+ +G
Sbjct: 149 ------------------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGR 190
Query: 355 PPF 357
P+
Sbjct: 191 FPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 57/238 (23%), Positives = 96/238 (40%), Gaps = 44/238 (18%)
Query: 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
L +G+G + V R K T ++ A+K+++ G E +LL ++ IV
Sbjct: 11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVT 68
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
L+ ++ L L+ EYL L +++ + ++ + + + H+ +HR
Sbjct: 69 LHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHR 128
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
D+KP NLL+++ G L+L+DFGL + T K
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSIPT-------------------------KTYSN 163
Query: 301 EQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPF 357
E + W Y P++LL Y + D W +G I YEM G P F
Sbjct: 164 EVVTLW----------------YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 8e-11
Identities = 40/146 (27%), Positives = 76/146 (52%), Gaps = 6/146 (4%)
Query: 124 IGKGAFGEVR--VCREKTTGHV-YAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
+G G FG V V K+ V A+K LK+ + G+ E +R E +++A++D CIV+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAA-GKKEFLR-EASVMAQLDHPCIVR 60
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
L + + + L+ME P G ++ L ++ + + + + + + + H++HR
Sbjct: 61 LIGVCKGEPLM-LVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPL 266
D+ N+LL ++SDFG+ + L
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRAL 145
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 63/262 (24%), Positives = 110/262 (41%), Gaps = 60/262 (22%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM----LRRGQVE-----HVRAERN 168
++ LT +G GA+G V + A+KKL + RR E H++ E N
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE-N 75
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
++ +D + S ++ +YL+ L G D+ ++ + L+++ +F + + +
Sbjct: 76 VIGLLD---VFTPATSIENFNEVYLVTN-LMGADLNNIV-KCQKLSDEHVQFLIYQLLRG 130
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
++ IH IHRD+KP N+ +++ LR+ DFGL +
Sbjct: 131 LKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR------------------------ 166
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347
Q + M Y V T Y APE++L Y D WS+G IM
Sbjct: 167 ------------------QADDEMTGY--VATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 206
Query: 348 YEMLVGYPPFYSDDPMSTCRKV 369
E+L G F +D + +++
Sbjct: 207 AELLKGKALFPGNDYIDQLKRI 228
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 66/264 (25%), Positives = 104/264 (39%), Gaps = 84/264 (31%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEH--------VRAE 166
+ ++ L +G+G++ V R K TG + A+K+++ +EH +R E
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIR---------LEHEEGAPFTAIR-E 53
Query: 167 RNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYL-----------PGGDMMTLLMRKDTLTE 215
+LL ++ IV L+ + L L+ EYL GG L+
Sbjct: 54 ASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGG-----------LSM 102
Query: 216 DEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275
R ++ + + + H+ +HRD+KP NLL+ + G L+L+DFGL +
Sbjct: 103 HNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARA---------- 152
Query: 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL-KKG 333
+ P +T YS V T Y P+VLL
Sbjct: 153 ----------------KSVPSKT----------------YSNEVVTLWYRPPDVLLGSTE 180
Query: 334 YGMECDWWSLGAIMYEMLVGYPPF 357
Y D W +G I YEM G P F
Sbjct: 181 YSTSLDMWGVGCIFYEMATGRPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 71/260 (27%), Positives = 102/260 (39%), Gaps = 56/260 (21%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL--LAEVDS 175
++ L IG GA G V + G A+KKL + + Q RA R L L V+
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP---FQNQTHAKRAYRELVLLKCVNH 79
Query: 176 NCIVKLYCSFQD----DEF--LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
I+ L F +EF +YL+ME + + M D + + + + + I
Sbjct: 80 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELD---HERMSYLLYQMLCGI 136
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+ +H IHRD+KP N+++ L++ DFGL
Sbjct: 137 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-------------------------- 170
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349
R A N M Y V T Y APEV+L GY D WS+G IM E
Sbjct: 171 -RTAC-------------TNFMMTPY--VVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214
Query: 350 MLVGYPPFYSDDPMSTCRKV 369
++ G F D + KV
Sbjct: 215 LVKGSVIFQGTDHIDQWNKV 234
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-10
Identities = 64/254 (25%), Positives = 102/254 (40%), Gaps = 61/254 (24%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV---- 173
+++ +IGKG++G V + TG A+KK+ EHV +L E+
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-------NDVFEHVSDATRILREIKLLR 54
Query: 174 -----DSNCIVKLYCSFQDDEF--LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV 226
D I + EF +Y++ E L D+ ++ D LT + +F++ + +
Sbjct: 55 LLRHPDIVEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFLYQLL 113
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
A++ IH + HRD+KP N+L + L++ DFGL +
Sbjct: 114 RALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV--------------------- 152
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEV---LLKKGYGMECDWWSL 343
N+ P A + V T Y APE+ K Y D WS+
Sbjct: 153 AFNDTPTA-----------------IFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSI 194
Query: 344 GAIMYEMLVGYPPF 357
G I E+L G P F
Sbjct: 195 GCIFAEVLTGKPLF 208
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 59/258 (22%), Positives = 99/258 (38%), Gaps = 55/258 (21%)
Query: 119 ELLTMIGKGAFGE--VRVCREKTTGHVYAMKKL----KKSEMLRRGQVEHVRAERNLLAE 172
ELLT+IGK V + + K T + A+KK+ E L+ Q E +
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQ-----QEIITSRQ 55
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIE 230
+ I+ SF D LY++ + G LL + L E F + + + A++
Sbjct: 56 LQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALD 115
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
IH +IHR +K ++LL G + LS
Sbjct: 116 YIHSKGFIHRSVKASHILLSGDGKVVLSGL------------------------------ 145
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAY---STVGTPDYIAPEVLLK--KGYGMECDWWSLGA 345
R ++H ++ R + + S P +++PEVL + +GY + D +S+G
Sbjct: 146 ------RYSVSMIKHGKRQRVVHDFPKSSVKNLP-WLSPEVLQQNLQGYNEKSDIYSVGI 198
Query: 346 IMYEMLVGYPPFYSDDPM 363
E+ G+ PF
Sbjct: 199 TACELANGHVPFKDMPAT 216
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 60/239 (25%), Positives = 99/239 (41%), Gaps = 49/239 (20%)
Query: 123 MIGKGAFGEVR--VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
++GKG FGEV ++KT V K+ E+ + +E +L + D IVK
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-----FLSEARILKQYDHPNIVK 56
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIH 239
L + +Y++ME +PGGD ++ L + KD L + + + + + + IH
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIH 116
Query: 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQ 299
RD+ N L+ + L++SDFG+ + QE D + SS + P
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR-------QEDD-----GIYSSSGLKQIPI------ 158
Query: 300 QEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGYPPF 357
+ APE L Y E D WS G +++E +G P+
Sbjct: 159 ----------------------KWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPY 195
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 72/251 (28%), Positives = 100/251 (39%), Gaps = 60/251 (23%)
Query: 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ-VEHV-RAERN--LLAEVDSN 176
L IG GA G V + TG A+KKL R Q V H RA R L+ V+
Sbjct: 21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLS-----RPFQNVTHAKRAYRELVLMKLVNHK 75
Query: 177 CIVKLYCSFQD----DEF--LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
I+ L F +EF +YL+ME + + M D + + + + + I+
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLD---HERMSYLLYQMLCGIK 132
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+H IHRD+KP N+++ L++ DFGL + T G +
Sbjct: 133 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------TAGTSF-------- 172
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
M Y V T Y APEV+L GY D WS+G IM EM
Sbjct: 173 --------------------MMTPY--VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 210
Query: 351 LVGYPPFYSDD 361
+ G F D
Sbjct: 211 IRGTVLFPGTD 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-09
Identities = 45/156 (28%), Positives = 80/156 (51%), Gaps = 18/156 (11%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +L+ +G G FGEV + V A+K LK+ M E AE NL+ ++
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKV-AIKSLKQGSM----SPEAFLAEANLMKQLQH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL-------MRKDTLTEDEARFYVAETVLA 228
+V+LY + E +Y+I EY+ G ++ L + + L + A+ +AE +
Sbjct: 61 PRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQ--IAEGMAF 117
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
IE + +YIHRD++ N+L+ + +++DFGL +
Sbjct: 118 IE---RKNYIHRDLRAANILVSETLCCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-09
Identities = 58/254 (22%), Positives = 102/254 (40%), Gaps = 60/254 (23%)
Query: 123 MIGKGAFGEVRVCREKT-----TGHV-YAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
+G GAFGEV +G + A+K L+K + + E + E +L++ +
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFL-KEAHLMSNFNHP 59
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV-LAIE----- 230
IVKL +E Y+IME + GGD+++ L + E + + ++
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 231 -SIHKHHYIHRDIKPDNLLLDKYGH-----LRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
+ + H+IHRD+ N L+ + G+ +++ DFGL + + S
Sbjct: 120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR----------- 168
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344
K + W +APE LL + + D WS G
Sbjct: 169 -----------KEGEGLLPVRW-----------------MAPESLLDGKFTTQSDVWSFG 200
Query: 345 AIMYEML-VGYPPF 357
+M+E+L +G P+
Sbjct: 201 VLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 6e-09
Identities = 70/254 (27%), Positives = 105/254 (41%), Gaps = 64/254 (25%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKL------KKSEMLRRGQVEHVRAERNLLA 171
++L +IG G+FG V T A+KK+ K E+L + H+ N++
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHI----NIIF 123
Query: 172 EVD---SNCIVKLYCSFQDDEFLYLIMEYLPGG--DMMTLLMRKD-TLTEDEARFYVAET 225
D + C K + + FL ++ME++P M R + L + Y +
Sbjct: 124 LKDYYYTECFKK----NEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL 179
Query: 226 VLAIESIHKHHYIHRDIKPDNLLLDKYGH-LRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
A+ IH HRD+KP NLL+D H L+L DFG K N L G
Sbjct: 180 CRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK---------------NLLAG 224
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSL 343
+R ++Y + + Y APE++L Y D WSL
Sbjct: 225 -------------------------QRSVSY--ICSRFYRAPELMLGATNYTTHIDLWSL 257
Query: 344 GAIMYEMLVGYPPF 357
G I+ EM++GYP F
Sbjct: 258 GCIIAEMILGYPIF 271
|
Length = 440 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 70/292 (23%), Positives = 112/292 (38%), Gaps = 63/292 (21%)
Query: 86 VSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYA 145
+S ++N +E ++ + L+R ++ L IG GA G V + A
Sbjct: 1 MSRSKRDNNFYSVEIGDSTFTVLKR-------YQNLKPIGSGAQGIVCAAYDAILERNVA 53
Query: 146 MKKLKKSEMLRRGQVEHVRAERNL--LAEVDSNCIVKLYCSFQD----DEF--LYLIMEY 197
+KKL + + Q RA R L + V+ I+ L F +EF +Y++ME
Sbjct: 54 IKKLSRP---FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 198 LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRL 257
+ + M D + + + + + I+ +H IHRD+KP N+++ L++
Sbjct: 111 MDANLCQVIQMELD---HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYST 317
DFGL + S +
Sbjct: 168 LDFGLARTAGTSFMMTPY------------------------------------------ 185
Query: 318 VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369
V T Y APEV+L GY D WS+G IM EM+ G F D + KV
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 62/249 (24%), Positives = 100/249 (40%), Gaps = 60/249 (24%)
Query: 118 FELLTMIGKGAFGEVRVCRE-KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
F +L GA G C + KT HV +++ GQ E ++L ++
Sbjct: 94 FSILETFTPGAEGFAFACIDNKTCEHV----------VIKAGQRGGTATEAHILRAINHP 143
Query: 177 CIVKLYCSFQDDEFLYLIMEYLP--GGDMMTLLMRKDTLTEDEARFYVAETVL-AIESIH 233
I++L +F ++F LI LP D+ L K + + + +VL AI+ +H
Sbjct: 144 SIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDI-LAIERSVLRAIQYLH 199
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFG-LCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
++ IHRDIK +N+ ++ G + L DFG C P+D +
Sbjct: 200 ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN----------------------- 236
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
N+ Y GT APE+L + YG D WS G +++EM
Sbjct: 237 ---------------ANKY---YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
Query: 353 GYPPFYSDD 361
+ + D
Sbjct: 279 CHDSLFEKD 287
|
Length = 391 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 54/220 (24%), Positives = 80/220 (36%), Gaps = 38/220 (17%)
Query: 140 TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ-DDEFLYLIMEYL 198
TGH A+K L+ Q R E L A + IV L S + L+ + EY+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 199 PGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---HL 255
PG + +L L E + + + A+ H +HRD+KP N+++ + G H
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 256 RLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAY 315
++ DFG IG L G +
Sbjct: 122 KVLDFG----------------IGTLLPGVRDADVA------------------TLTRTT 147
Query: 316 STVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
+GTP Y APE L + D ++ G I E L G
Sbjct: 148 EVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 37/143 (25%), Positives = 69/143 (48%), Gaps = 6/143 (4%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
+G G +GEV K A+K LK+ M +VE E ++ E+ +V+L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETV-LAIESIHKHHYIHRD 241
+ Y+I E++ G+++ L + Y+A + A+E + K ++IHRD
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 129
Query: 242 IKPDNLLLDKYGHLRLSDFGLCK 264
+ N L+ + ++++DFGL +
Sbjct: 130 LAARNCLVGENHLVKVADFGLSR 152
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 58/236 (24%), Positives = 93/236 (39%), Gaps = 43/236 (18%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IG+G FGEV R + A+K + E L E +L + IV+L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA-IESIHKHHYIHRDI 242
+ +Y++ME + GGD +T L + + + + E A +E + H IHRD+
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 243 KPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQ 302
N L+ + L++SDFG+ + +E+D +S + K T
Sbjct: 121 AARNCLVTEKNVLKISDFGMSR-------EEEDGVY------ASTGGMKQIPVKWT---- 163
Query: 303 LQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGYPPF 357
APE L Y E D WS G +++E +G P+
Sbjct: 164 ----------------------APEALNYGRYSSESDVWSFGILLWEAFSLGAVPY 197
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 55/284 (19%), Positives = 106/284 (37%), Gaps = 61/284 (21%)
Query: 83 DADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGH 142
A S++D ++ L ++K E + +G + ++ + G+ G V V +
Sbjct: 40 SASESDDDDDDGLIPTKQKAREVV----ASLG---YTVIKTLTPGSEGRVFVATKPGQ-- 90
Query: 143 VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGD 202
+L+ GQ E LL V+ ++++ + +++ + D
Sbjct: 91 -------PDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSD 142
Query: 203 MMTLLMRKDTLTEDEARFYVAETVL-AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFG 261
+ T L ++ + + + +L + +H IHRD+K +N+ ++ + + D G
Sbjct: 143 LYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLG 202
Query: 262 LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTP 321
+ F + AP GT
Sbjct: 203 AAQ-----------FPV--------------VAPA-----------------FLGLAGTV 220
Query: 322 DYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMST 365
+ APEVL + Y + D WS G +++EML YP +DP ST
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEML-AYPSTIFEDPPST 263
|
Length = 357 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 39/157 (24%), Positives = 71/157 (45%), Gaps = 22/157 (14%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-- 174
+ +L IGKG FG+V + + G A+K LK + A + LAE
Sbjct: 7 ELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLK----------DDSTAAQAFLAEASVM 54
Query: 175 -----SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVL 227
N + L Q + LY++ EY+ G ++ L + +T + + +
Sbjct: 55 TTLRHPNLVQLLGVVLQGNP-LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCE 113
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
+E + + +++HRD+ N+L+ + ++SDFGL K
Sbjct: 114 GMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 63/242 (26%), Positives = 95/242 (39%), Gaps = 56/242 (23%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL--LAEVDS 175
++ L IG GA G V + A+KKL + + Q RA R L + V+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---FQNQTHAKRAYRELVLMKCVNH 75
Query: 176 NCIVKLYCSFQD----DEF--LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
I+ L F +EF +YL+ME + + M D + + + + + I
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELD---HERMSYLLYQMLCGI 132
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+ +H IHRD+KP N+++ L++ DFGL + S +
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM------------------ 174
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349
M Y V T Y APEV+L GY D WS+G IM E
Sbjct: 175 ----------------------MTPY--VVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210
Query: 350 ML 351
M+
Sbjct: 211 MV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 57/260 (21%), Positives = 99/260 (38%), Gaps = 60/260 (23%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD--- 174
+ +L+ + G+ GEV VC T H +K + V+ V + E+D
Sbjct: 94 YNILSSLTPGSEGEVFVC----TKHGDEQRK--------KVIVKAVTGGKTPGREIDILK 141
Query: 175 --SNC-IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL-AIE 230
S+ I+ L +++ + ++M D+ T + R L ++A + +L A+
Sbjct: 142 TISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQA-ITIQRRLLEALA 199
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+H IHRD+K +N+ LD+ + L DFG LD Q
Sbjct: 200 YLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC--------------- 244
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
Y GT + +PE+L Y + D WS G +++EM
Sbjct: 245 ------------------------YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
Query: 351 LVGYPPFYSDDPMSTCRKVR 370
V + S+ ++R
Sbjct: 281 SVKNVTLFGKQVKSSSSQLR 300
|
Length = 392 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 41/153 (26%), Positives = 74/153 (48%), Gaps = 20/153 (13%)
Query: 124 IGKGAFGEVR--VCREKTTGHVYAMKKLK-------KSEMLRRGQVEHVRAERNLLAEVD 174
+G G FG V+ V + + A+K LK + EM+R ++ H ++D
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMH---------QLD 53
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIH 233
+ IV++ + E L L+ME GG + L +KD +T + + + ++ +
Sbjct: 54 NPYIVRM-IGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE 112
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266
+++HRD+ N+LL + ++SDFGL K L
Sbjct: 113 GKNFVHRDLAARNVLLVNQHYAKISDFGLSKAL 145
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 36/167 (21%), Positives = 61/167 (36%), Gaps = 21/167 (12%)
Query: 115 ADDFELLTMIGKGAFGEV-----RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
D L +G+GAFG+V + + A+K LK E + E L
Sbjct: 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLK--ETASNDARKDFEREAEL 61
Query: 170 LAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--------------TLTE 215
L IVK Y + + ++ EY+ GD+ L LT
Sbjct: 62 LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121
Query: 216 DEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ + + + H++HRD+ N L+ +++ DFG+
Sbjct: 122 SQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGM 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 4e-07
Identities = 57/238 (23%), Positives = 95/238 (39%), Gaps = 52/238 (21%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
D L +G G FG V+ + + V A+K +K+ M +E + L E
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIEEAKVMMKLSHEK--- 60
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTED--EARFYVAETVLAIESI 232
+V+LY +Y++ EY+ G ++ L K E V E + +ES
Sbjct: 61 -LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES- 118
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+IHRD+ N L+D G +++SDFGL + + + ++T SS ++ P
Sbjct: 119 --KQFIHRDLAARNCLVDDQGCVKVSDFGLSR-----YVLDDEYT-------SSVGSKFP 164
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
W PEVLL + + D W+ G +M+E+
Sbjct: 165 V-----------RWS-----------------PPEVLLYSKFSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 5e-07
Identities = 41/153 (26%), Positives = 74/153 (48%), Gaps = 20/153 (13%)
Query: 124 IGKGAFGEVR--VCREKTTGHVYAMKKLK--------KSEMLRRGQVEHVRAERNLLAEV 173
+G G FG V+ + + K + A+K LK K E+LR E N++ ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLR---------EANVMQQL 53
Query: 174 DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH 233
D+ IV++ + E L+ME G + L + +TE V + + ++ +
Sbjct: 54 DNPYIVRM-IGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE 112
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266
+ +++HRD+ N+LL + ++SDFGL K L
Sbjct: 113 ETNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 145
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 5e-07
Identities = 51/238 (21%), Positives = 98/238 (41%), Gaps = 47/238 (19%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
+G G FG V + + + V A+K + + M +E E ++ ++ +V+LY
Sbjct: 12 LGSGQFGVVHLGKWRAQIKV-AIKAINEGAMSEEDFIE----EAKVMMKLSHPKLVQLYG 66
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDI 242
+ LY++ E++ G ++ L R+ L++D + +E + ++ +IHRD+
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDL 126
Query: 243 KPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQ 302
N L+ G +++SDFG+ + + + ++T SS + P
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTR-----YVLDDEYT-------SSSGAKFPV--------- 165
Query: 303 LQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYS 359
+ PEV Y + D WS G +M+E+ G PF
Sbjct: 166 -------------------KWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 6e-07
Identities = 60/250 (24%), Positives = 96/250 (38%), Gaps = 63/250 (25%)
Query: 123 MIGKGAFGEVRVCREKTTGH---VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIV 179
+IG G FGEV R K G A+K LK + Q +E +++ + D I+
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK--QRRDFLSEASIMGQFDHPNII 68
Query: 180 KLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI------- 232
L + + ++ EY+ G + L + D +F V + V + I
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD------GQFTVIQLVGMLRGIASGMKYL 122
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
Y+HRD+ N+L++ ++SDFGL + L E D P
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL------EDD----------------P 160
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTP---DYIAPEVLLKKGYGMECDWWSLGAIMYE 349
A AY+T G + APE + + + D WS G +M+E
Sbjct: 161 EA-------------------AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE 201
Query: 350 -MLVGYPPFY 358
M G P++
Sbjct: 202 VMSYGERPYW 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 7e-07
Identities = 38/146 (26%), Positives = 73/146 (50%), Gaps = 8/146 (5%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
+G G FGEV + V A+K +K M VE AE N++ + + +VKL+
Sbjct: 14 LGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLH- 67
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARF--YVAETVLAIESIHKHHYIHRD 241
+ E +Y+I E++ G ++ L + + + + A+ + I + +YIHRD
Sbjct: 68 AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 127
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLD 267
++ N+L+ +++DFGL + ++
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIE 153
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 8e-07
Identities = 55/251 (21%), Positives = 106/251 (42%), Gaps = 60/251 (23%)
Query: 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE 172
+ + +LL IGKG FG+V + + G+ A+K +K + AE +++ +
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQ 55
Query: 173 VDSNCIVKLY-CSFQDDEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAI 229
+ + +V+L ++ LY++ EY+ G ++ L + L D + + A+
Sbjct: 56 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
E + ++++HRD+ N+L+ + ++SDFGL K + S+ Q+
Sbjct: 116 EYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQD---------------- 157
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTP-DYIAPEVLLKKGYGMECDWWSLGAIMY 348
T P + APE L +K + + D WS G +++
Sbjct: 158 ---------------------------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLW 190
Query: 349 EML----VGYP 355
E+ V YP
Sbjct: 191 EIYSFGRVPYP 201
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 8e-07
Identities = 37/148 (25%), Positives = 68/148 (45%), Gaps = 7/148 (4%)
Query: 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCI 178
+LL +G G FGEV T V A+K LK M + AE ++ ++ +
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTTPV-AVKTLKPGTM----DPKDFLAEAQIMKKLRHPKL 63
Query: 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHH 236
++LY +E +Y++ E + G ++ L L + A+ + + +
Sbjct: 64 IQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN 123
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
YIHRD+ N+L+ + +++DFGL +
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 42/156 (26%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+L +G G FGEV + T V A+K LK M E E ++ ++ +
Sbjct: 8 LKLERKLGAGQFGEVWMGTWNGTTKV-AVKTLKPGTM----SPEAFLQEAQIMKKLRHDK 62
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFY-----------VAETV 226
+V+LY ++E +Y++ EY+ G ++ D L E + +AE +
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLL------DFLKSGEGKKLRLPQLVDMAAQIAEGM 116
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ES +YIHRD+ N+L+ + +++DFGL
Sbjct: 117 AYLES---RNYIHRDLAARNILVGENLVCKIADFGL 149
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 59/268 (22%), Positives = 97/268 (36%), Gaps = 67/268 (25%)
Query: 107 RLQRHKMGADDFELLTMIGKGAFGEVRVC--------REKTTGHVYAMKKLKKSEML--- 155
+L+ F ++ + GAFG++ +C E G + K E L
Sbjct: 139 KLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAK 198
Query: 156 --RRGQVEHVRAERNLLA--EVDSNCIVKLYCSFQDDEFLYLIME--------YLPGGDM 203
+ G ++ E +LA ++ I+K+ + + Y+I + ++
Sbjct: 199 RVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEA- 257
Query: 204 MTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263
KD + R + + + A+E IH IHRDIK +N+ L+ G + L DFG
Sbjct: 258 ---FDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA 314
Query: 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDY 323
P ++K R Y VGT
Sbjct: 315 MP----------------------------------------FEKEREAFDYGWVGTVAT 334
Query: 324 IAPEVLLKKGYGMECDWWSLGAIMYEML 351
+PE+L GY D WS G I+ +ML
Sbjct: 335 NSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 51/235 (21%), Positives = 92/235 (39%), Gaps = 46/235 (19%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
+ L +G G FG V + + + V A+K +++ M +E + L
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKIDV-AIKMIREGAMSEDDFIEEAKVMMKLSHPN--- 60
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL-AIESIHKH 235
+V+LY ++++ EY+ G ++ L + E + V A+E + +
Sbjct: 61 -LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN 119
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+IHRD+ N L+ + +++SDFGL + L +Q +T SSQ + P
Sbjct: 120 GFIHRDLAARNCLVGEDNVVKVSDFGLAR----YVLDDQ-YT-------SSQGTKFPV-- 165
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
W PEV + + D WS G +M+E+
Sbjct: 166 ---------KWA-----------------PPEVFDYSRFSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 38/151 (25%), Positives = 73/151 (48%), Gaps = 8/151 (5%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +L+ +G G FGEV + V A+K LK M +E E ++ ++
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTMSPESFLE----EAQIMKKLRH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIH 233
+ +V+LY + +E +Y++ EY+ G ++ L + L A+ + I
Sbjct: 61 DKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE 119
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
+ +YIHRD++ N+L+ +++DFGL +
Sbjct: 120 RMNYIHRDLRSANILVGDGLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 52/231 (22%), Positives = 95/231 (41%), Gaps = 56/231 (24%)
Query: 149 LKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLY-------CSFQDD-----EF--LYLI 194
+KK + V+H E ++ +D + IVK+Y +D E +Y++
Sbjct: 35 VKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIV 94
Query: 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH 254
EY+ + ++ + L+E+ AR ++ + + ++ IH + +HRD+KP N+ ++
Sbjct: 95 QEYMETD--LANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL 152
Query: 255 -LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRML 313
L++ DFGL + +D H+ ++ L
Sbjct: 153 VLKIGDFGLARIVD------------------------------------PHYS-HKGYL 175
Query: 314 AYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
+ V T Y +P +LL Y D W+ G I EML G P F +
Sbjct: 176 SEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL 225
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 55/270 (20%), Positives = 103/270 (38%), Gaps = 75/270 (27%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVY-----------AMKKLKKSEMLRRGQVEHVRA 165
L +G+GAFG+V G + A+K LK++ + + R
Sbjct: 6 AVRFLEELGEGAFGKV------YKGELTGPNERLSATSVAIKTLKENAEPK--VQQEFRQ 57
Query: 166 ERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR---------------- 209
E L++++ IV L ++ ++ EYL GD+ L+R
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117
Query: 210 KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269
K +L + + +E + HH++HRD+ N L+ + +++SDFGL +
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSR----- 172
Query: 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL 329
+ S + R +++ +L ++ PE +
Sbjct: 173 -------------DIYSADYYR---------------VQSKSLLPVR------WMPPEAI 198
Query: 330 LKKGYGMECDWWSLGAIMYEML-VGYPPFY 358
L + E D WS G +++E+ G P+Y
Sbjct: 199 LYGKFTTESDIWSFGVVLWEIFSYGLQPYY 228
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 44/253 (17%), Positives = 95/253 (37%), Gaps = 60/253 (23%)
Query: 116 DDFELLTMIGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
+ L+ +G+G+FG V V + + V A+K + ++ +R + E ++
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRV-AIKTVNENASMR--ERIEFLNEASV 62
Query: 170 LAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFY-------- 221
+ E + + +V+L + ++ME + GD+ + L R +
Sbjct: 63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL-RSRRPEAENNPGLGPPTLQKF 121
Query: 222 ---VAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278
AE + + ++HRD+ N ++ + +++ DFG+ + + E D+
Sbjct: 122 IQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR-----DIYETDYY- 175
Query: 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC 338
R + +L ++APE L + +
Sbjct: 176 ------------RKGG---------------KGLLPVR------WMAPESLKDGVFTTKS 202
Query: 339 DWWSLGAIMYEML 351
D WS G +++EM
Sbjct: 203 DVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 57/277 (20%), Positives = 109/277 (39%), Gaps = 75/277 (27%)
Query: 124 IGKGAFGEVRVCREKTTGHVY----------AMKKLKKSEMLRRGQVEHVRAERNLLAEV 173
+G+ AFG++ GH+Y A+K LK ++ Q + E +L+AE+
Sbjct: 13 LGECAFGKI------YKGHLYLPGMDHAQLVAIKTLK--DINNPQQWGEFQQEASLMAEL 64
Query: 174 DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMT-LLMR----------------KDTLTED 216
IV L ++ + ++ EYL GD+ L+MR K +L
Sbjct: 65 HHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 217 EARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276
+ + +E + H ++H+D+ N+L+ + H+++SD GL + + + D+
Sbjct: 125 DFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSA-----DY 179
Query: 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM 336
R Q + L + ++ PE ++ +
Sbjct: 180 Y-------------------RVQPKSLLPIR---------------WMPPEAIMYGKFSS 205
Query: 337 ECDWWSLGAIMYEML-VGYPPFYSDDPMSTCRKVRKK 372
+ D WS G +++E+ G P+Y VRK+
Sbjct: 206 DSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR 242
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 4e-06
Identities = 38/154 (24%), Positives = 76/154 (49%), Gaps = 8/154 (5%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ L +G+G FGEV + T V A+K LK M+ ++ E ++ ++
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKV-AIKTLKPGTMMPEAFLQ----EAQIMKKLRH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT--LTEDEARFYVAETVLAIESIH 233
+ +V LY + +E +Y++ E++ G ++ L D L + A+ + I
Sbjct: 61 DKLVPLY-AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE 119
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ +YIHRD++ N+L+ +++DFGL + ++
Sbjct: 120 RMNYIHRDLRAANILVGDNLVCKIADFGLARLIE 153
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 41/163 (25%), Positives = 69/163 (42%), Gaps = 21/163 (12%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVY----------AMKKLKKSEMLRRGQVEHVRA 165
+D L IG+G FG+V VY A+K K E
Sbjct: 6 EDITLGRCIGEGQFGDVYQ-------GVYMSPENEKIAVAVKTCKNCTSPSVR--EKFLQ 56
Query: 166 ERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM-MTLLMRKDTLTEDEARFYVAE 224
E ++ + D IVKL ++ ++++ME P G++ L + K +L Y +
Sbjct: 57 EAYIMRQFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQ 115
Query: 225 TVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
A+ + ++HRDI N+L+ ++L DFGL + L+
Sbjct: 116 LSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 6e-06
Identities = 25/128 (19%), Positives = 48/128 (37%), Gaps = 11/128 (8%)
Query: 138 KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIV--KLYCSFQDDEFLYLIM 195
T Y +K E + E +L + + K+ S + D + YL+M
Sbjct: 18 GTKDEDYVLKINPSRE-----KGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLM 72
Query: 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHL 255
E++ G L +++ +AE + + + H D+ P N+L+D L
Sbjct: 73 EWIEG----ETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKIL 128
Query: 256 RLSDFGLC 263
+ D+
Sbjct: 129 GIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 7e-06
Identities = 34/162 (20%), Positives = 72/162 (44%), Gaps = 24/162 (14%)
Query: 121 LTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHV----RAERNLLA 171
+T +G+G FGEV + + E+ + +K L+K++ E++ R E ++
Sbjct: 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK------DENLQSEFRRELDMFR 63
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM--------RKDTLTEDEARFYVA 223
++ +V+L ++ E Y+I+EY GD+ L K + + +
Sbjct: 64 KLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123
Query: 224 ETV-LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
+ L ++ + ++HRD+ N L+ +++S L K
Sbjct: 124 TQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 7e-06
Identities = 58/274 (21%), Positives = 102/274 (37%), Gaps = 73/274 (26%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHV-------YAMKKLKKSEMLRRGQVEHVRAERN 168
++ E + IG+GAFG RV + + G + A+K LK+ Q + R E
Sbjct: 5 NNIEYVRDIGQGAFG--RVFQARAPGLLPYEPFTMVAVKMLKEEASADM-QADFQR-EAA 60
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--------------------- 207
L+AE D IVKL + + L+ EY+ GD+ L
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 208 -MRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266
+ L+ E + + + + ++HRD+ N L+ + ++++DFGL +
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR-- 178
Query: 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAP 326
+ D+ +E A P R ++ P
Sbjct: 179 ---NIYSADYYKA---------SENDAIPIR-------------------------WMPP 201
Query: 327 EVLLKKGYGMECDWWSLGAIMYEML-VGYPPFYS 359
E + Y E D W+ G +++E+ G P+Y
Sbjct: 202 ESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 8e-06
Identities = 40/174 (22%), Positives = 80/174 (45%), Gaps = 33/174 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVY--AMKKLKKSEMLRRGQVEHVRAERNLLAEV 173
+D + +IG+G FG+V R K G A+K++K+ + +H R+ E+
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDH----RDFAGEL 58
Query: 174 DSNC-------IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK---------------- 210
+ C I+ L + + +LYL +EY P G+++ L +
Sbjct: 59 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 118
Query: 211 DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
TL+ + + A+ ++ + + +IHRD+ N+L+ + +++DFGL +
Sbjct: 119 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 8e-06
Identities = 53/240 (22%), Positives = 95/240 (39%), Gaps = 55/240 (22%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ-VEHVRAERNLLAEVDS 175
+F L +G G FGEV K V A+K LK ++L++ + V+A + L +
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRVRV-AIKILKSDDLLKQQDFQKEVQALKRLRHKH-- 63
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFY-----VAETVLAIE 230
++ L+ E +Y+I E + G ++ L + A VAE + +E
Sbjct: 64 --LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+ IHRD+ N+L+ + +++DFGL + L ++D + ++
Sbjct: 122 E---QNSIHRDLAARNILVGEDLVCKVADFGLAR------LIKEDVYLSSDKK------- 165
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
P + + APE + + D WS G ++YEM
Sbjct: 166 ---IPYK-------------------------WTAPEAASHGTFSTKSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 56/239 (23%), Positives = 104/239 (43%), Gaps = 31/239 (12%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK-SEMLRRGQVEHVRAERNLLAEV-DS 175
F++L+++G+G FG+V ++ A+K ++ + R ++E E+ A+ D
Sbjct: 131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADR 190
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
++K+ FQ++ I+ G ++ +M+ + + +T +A++ H
Sbjct: 191 FPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTE 250
Query: 236 -HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
H +H D+KP+N+L++ SD +D T N P
Sbjct: 251 LHLMHTDLKPENILMET------SD----TVVDPVT-----------------NRALPPD 283
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
P R + L R + V T Y +PEV+L G+ D WS+G I+YE+ G
Sbjct: 284 PCRVRICDLGGCCDERHSRT-AIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341
|
Length = 467 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 61/251 (24%), Positives = 100/251 (39%), Gaps = 63/251 (25%)
Query: 123 MIGKGAFGEVRVCREKTTG---HVYAMKKLKKSEMLRRGQVEHVR----AERNLLAEVDS 175
+IG G FGEV R K G A+K LK G E R +E +++ + D
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKS------GYTEKQRRDFLSEASIMGQFDH 64
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI--- 232
I+ L + +I E++ G + + L + D +F V + V + I
Sbjct: 65 PNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQND------GQFTVIQLVGMLRGIAAG 118
Query: 233 ----HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
+ +Y+HRD+ N+L++ ++SDFGL + L+ T D T ++L G
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT---SDPTYTSSLGGK--- 172
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
P R + APE + + + D WS G +M+
Sbjct: 173 -----IPIR-------------------------WTAPEAIAYRKFTSASDVWSYGIVMW 202
Query: 349 E-MLVGYPPFY 358
E M G P++
Sbjct: 203 EVMSYGERPYW 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 44/165 (26%), Positives = 72/165 (43%), Gaps = 19/165 (11%)
Query: 116 DDFELLTMIGKGAFGEV-----RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
D LL +G GAFGEV R A+K L E E ++
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL--PESCSEQDESDFLMEALIM 63
Query: 171 AEVDSNCIVKLY-CSFQDDEFLYLIMEYLPGGDMMTLL-------MRKDTLTEDEARFYV 222
++ + IV+L SF+ ++++E + GGD+ + L R +LT + F
Sbjct: 64 SKFNHQNIVRLIGVSFERLPR-FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLR---LSDFGLCK 264
+ + + ++H+IHRDI N LL G R ++DFG+ +
Sbjct: 123 RDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 3e-05
Identities = 38/159 (23%), Positives = 76/159 (47%), Gaps = 18/159 (11%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ L +G+G FGEV + T V A+K LK M E E ++ ++
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL-------MRKDTLTEDEARFYVAETVLA 228
+V+LY + +E +Y++ EY+ G ++ L +R L + A+
Sbjct: 61 EKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASG 114
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ + + +Y+HRD++ N+L+ + +++DFGL + ++
Sbjct: 115 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 153
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 3e-05
Identities = 55/255 (21%), Positives = 100/255 (39%), Gaps = 63/255 (24%)
Query: 124 IGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+G+GAFG+V +C E+ V A+K LK + R H AE LL +
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILV-AVKTLKDASDNARKDF-HREAE--LLTNLQHEH 68
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK-------------DTLTEDEARFYVAE 224
IVK Y + + L ++ EY+ GD+ L LT+ + +
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 225 TVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
+ + H++HRD+ N L+ + +++ DFG+ + + + + +G +
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY----YRVGGH--- 181
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344
P R ++ PE ++ + + E D WSLG
Sbjct: 182 -------TMLPIR-------------------------WMPPESIMYRKFTTESDVWSLG 209
Query: 345 AIMYEMLV-GYPPFY 358
+++E+ G P+Y
Sbjct: 210 VVLWEIFTYGKQPWY 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 38/171 (22%), Positives = 74/171 (43%), Gaps = 32/171 (18%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKS--------EMLRRGQVEHVR----AERNLLA 171
+G+G FGEV +C + + +MLR + R E +++
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV----- 226
+ + I++L D+ L +I EY+ GD+ L ++ E E+ F A +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQR----EIESTFTHANNIPSVSI 128
Query: 227 -------LAIESIHKH----HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266
+ I S K+ +++HRD+ N L+ + ++++DFG+ + L
Sbjct: 129 ANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 9e-05
Identities = 38/172 (22%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+D + +IG+G FG+V K G +K +ML+ E+ R+ E++
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDG----LKMNAAIKMLKEFASEN--DHRDFAGELEV 55
Query: 176 NC-------IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK----------------DT 212
C I+ L + ++ +LY+ +EY P G+++ L + T
Sbjct: 56 LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST 115
Query: 213 LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
LT + + ++ ++ + + +IHRD+ N+L+ + +++DFGL +
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 37/166 (22%), Positives = 72/166 (43%), Gaps = 31/166 (18%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC----- 177
+IG+G FG+V R K G ++ + ++ + R+ E++ C
Sbjct: 2 VIGEGNFGQVLKARIKKDG----LRMDAAIKRMKEYASKD--DHRDFAGELEVLCKLGHH 55
Query: 178 --IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEA----------------- 218
I+ L + + +LYL +EY P G+++ L + L D A
Sbjct: 56 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 219 RFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
F A+ ++ + + +IHRD+ N+L+ + +++DFGL +
Sbjct: 116 HF-AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 39/166 (23%), Positives = 71/166 (42%), Gaps = 24/166 (14%)
Query: 124 IGKGAFGEVRVCREKT-TGHVY--AMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
+G G+FG VR T G V A+K LK ++ ++ E ++ +D +++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIR 60
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL--------AIESI 232
LY L ++ E P G ++ D L +D ++ T+ + +
Sbjct: 61 LYGVVLTHP-LMMVTELAPLGSLL------DRLRKDALGHFLISTLCDYAVQIANGMRYL 113
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL----DCSTLQEQ 274
+IHRD+ N+LL +++ DFGL + L D ++E
Sbjct: 114 ESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 57/274 (20%), Positives = 109/274 (39%), Gaps = 77/274 (28%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHV--------YAMKKLKKSEMLRRGQVEHVRAERN 168
+ L +G+G FG+V + T + A+K LK++ ++ + +E N
Sbjct: 1 NLVLGKTLGEGEFGKVV---KATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFN 55
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM--RK--------------DT 212
LL +V+ ++KLY + D L LI+EY G + + L RK
Sbjct: 56 LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 213 LTEDEARFYVAETVLA--------IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
L + R +++ ++ + + +HRD+ N+L+ + +++SDFGL +
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
Query: 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYI 324
+ E+D + KR++ W +
Sbjct: 176 -----DVYEED-----------------SYVKRSKGRIPVKW-----------------M 196
Query: 325 APEVLLKKGYGMECDWWSLGAIMYEML-VGYPPF 357
A E L Y + D WS G +++E++ +G P+
Sbjct: 197 AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 22/167 (13%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTG---HVYAMKKLKK--SEMLRRGQVEHVRAERNL 169
+ +IG G FGEV R K G A+K LK S+ R + E ++
Sbjct: 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL----TEASI 58
Query: 170 LAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
+ + D I++L + +I EY+ G + L D +F V + V +
Sbjct: 59 MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREND------GKFTVGQLVGML 112
Query: 230 ESI-------HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269
I + +Y+HRD+ N+L++ ++SDFGL + L+ S
Sbjct: 113 RGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 52/268 (19%), Positives = 96/268 (35%), Gaps = 64/268 (23%)
Query: 117 DFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
D L +G+GAFG+V + + A+K LK + R + E LL
Sbjct: 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLT 62
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL----------------MRKDTLTE 215
+ IVK Y D + L ++ EY+ GD+ L K L
Sbjct: 63 NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122
Query: 216 DEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275
+ ++ + + H++HRD+ N L+ +++ DFG+ + + +
Sbjct: 123 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY---- 178
Query: 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYG 335
+ +G + P R ++ PE ++ + +
Sbjct: 179 YRVGGH----------TMLPIR-------------------------WMPPESIMYRKFT 203
Query: 336 MECDWWSLGAIMYEMLV-GYPPFYSDDP 362
E D WS G I++E+ G P++
Sbjct: 204 TESDVWSFGVILWEIFTYGKQPWFQLSN 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 57/248 (22%), Positives = 103/248 (41%), Gaps = 47/248 (18%)
Query: 119 ELLTMIGKG--AFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
ELLT+IG+G V + R K TG ++++ E V ++ E ++ +
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRIN-LEACTNEMVTFLQGELHVSKLFNHP 59
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHK 234
IV +F D L+++ ++ G L+ D ++E + + + A++ IH
Sbjct: 60 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH 119
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
Y+HR +K ++L+ G + LS GL
Sbjct: 120 MGYVHRSVKASHILISVDGKVYLS--GL-------------------------------- 145
Query: 295 PKRTQQEQLQHWQKNRRML---AYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYE 349
R+ + H Q+ R + YS P +++PEVL + +GY + D +S+G E
Sbjct: 146 --RSNLSMINHGQRLRVVHDFPKYSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGITACE 202
Query: 350 MLVGYPPF 357
+ G+ PF
Sbjct: 203 LANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 3e-04
Identities = 17/31 (54%), Positives = 20/31 (64%)
Query: 323 YIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
Y APEV CDWWSLGAI++E+L G
Sbjct: 148 YCAPEVGGISEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 40/139 (28%), Positives = 53/139 (38%), Gaps = 40/139 (28%)
Query: 222 VAETVL-AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280
VA +L AI+ IH IHRDIK +N+L++ + L DFG C F G+
Sbjct: 265 VARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAA----C-------FARGS 313
Query: 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340
+ P Y GT D APEVL Y D
Sbjct: 314 W-----------STP-----------------FHYGIAGTVDTNAPEVLAGDPYTPSVDI 345
Query: 341 WSLGAIMYEMLVGYPPFYS 359
WS G +++E V +S
Sbjct: 346 WSAGLVIFEAAVHTASLFS 364
|
Length = 461 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 39/156 (25%), Positives = 71/156 (45%), Gaps = 10/156 (6%)
Query: 118 FELLTMIGKGAFGEV-----RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE 172
E + ++G GAFG V EK V A+K L++ + E + E ++A
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPV-AIKVLREETS-PKANKEILD-EAYVMAS 65
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIES 231
VD +V+L + LI + +P G ++ + KD + + + +
Sbjct: 66 VDHPHVVRLLG-ICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ + +HRD+ N+L+ H++++DFGL K LD
Sbjct: 125 LEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 4e-04
Identities = 58/259 (22%), Positives = 106/259 (40%), Gaps = 55/259 (21%)
Query: 116 DDFELLTMIGKGAFGEVR------VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
++ +G GAFG+V + + V A+K LK + + E + +E +
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKV-AVKMLKPTA--HSSEREALMSELKI 91
Query: 170 LAEVDSNC-IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT--LTEDEARFYVAETV 226
++ + ++ IV L + + +I EY GD++ L RK LT ++ + +
Sbjct: 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHL-RLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285
+ + + IHRD+ N+LL +G + ++ DFGL + I N+ N
Sbjct: 152 KGMAFLASKNCIHRDLAARNVLL-THGKIVKICDFGLAR------------DIMNDSNYV 198
Query: 286 SQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345
+ N R P + ++APE + Y E D WS G
Sbjct: 199 VKGNAR--LPVK-------------------------WMAPESIFNCVYTFESDVWSYGI 231
Query: 346 IMYEML-VGYPPFYSDDPM 363
+++E+ +G P Y P+
Sbjct: 232 LLWEIFSLGSNP-YPGMPV 249
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 4e-04
Identities = 38/175 (21%), Positives = 70/175 (40%), Gaps = 39/175 (22%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ--------VEHVRAERN------L 169
+G+G FGEV +C M+K + V+ +R + N
Sbjct: 13 LGEGQFGEVHLCE------AEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDF 66
Query: 170 LAEV-------DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-----------KD 211
L E+ D N I++L + L +I EY+ GD+ L R
Sbjct: 67 LKEIKIMSRLKDPN-IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125
Query: 212 TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266
T++ F + ++ + +++HRD+ N L+ K ++++DFG+ + L
Sbjct: 126 TISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 5e-04
Identities = 42/162 (25%), Positives = 73/162 (45%), Gaps = 16/162 (9%)
Query: 118 FELLTMIGKGAFGEVR---VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
F L M+GKG FG VR + E + A+K LK +++ +E E + E D
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLK-ADIFSSSDIEEFLREAACMKEFD 59
Query: 175 SNCIVKLY-CSFQDDEFLYL-----IMEYLPGGDMMTLLMRKD------TLTEDEARFYV 222
++KL S + L I+ ++ GD+ T L+ TL ++
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
+ +E + ++IHRD+ N +L++ + ++DFGL K
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 6e-04
Identities = 34/163 (20%), Positives = 71/163 (43%), Gaps = 18/163 (11%)
Query: 118 FELLTMIGKGAFGEVRVCR----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV 173
+L ++G+G FG V + + + V A+K +K ++E +E + +
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKV-AVKTMKLDIHTYS-EIEEFLSEAACMKDF 58
Query: 174 DSNCIVKLY-CSFQDDEFLYL-----IMEYLPGGDMMTLLMRKDT------LTEDEARFY 221
D ++KL F+ + I+ ++ GD+ + L+ L +
Sbjct: 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF 118
Query: 222 VAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
+ + L +E + ++IHRD+ N +L + + ++DFGL K
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 7e-04
Identities = 55/248 (22%), Positives = 97/248 (39%), Gaps = 59/248 (23%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVR----AERNLLAEVDSNCI 178
+IG G FGEV K G +K L+ G E R +E +++ + + I
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKT---LKPGYTEKQRQDFLSEASIMGQFSHHNI 68
Query: 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH--- 235
++L + +I EY+ G + L D + + + + + I + K+
Sbjct: 69 IRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGMKYLSD 125
Query: 236 -HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+Y+HRD+ N+L++ ++SDFGL + L +D
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVL-------EDD------------------ 160
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTP---DYIAPEVLLKKGYGMECDWWSLGAIMYE-M 350
P+ T Y+T G + APE + + + D WS G +M+E M
Sbjct: 161 PEGT----------------YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM 204
Query: 351 LVGYPPFY 358
G P++
Sbjct: 205 SFGERPYW 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 50/236 (21%), Positives = 94/236 (39%), Gaps = 62/236 (26%)
Query: 145 AMKKLK-KSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM 203
A+K LK K+E R E + E + + + IV L ++ L +I Y D+
Sbjct: 39 AIKTLKDKAEGPLR---EEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL 95
Query: 204 MT-LLMR---------------KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNL 247
L+MR K TL + V + +E + HH +H+D+ N+
Sbjct: 96 HEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNV 155
Query: 248 LLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQ 307
L+ ++++SD GL + + + + +GN+L P R
Sbjct: 156 LVFDKLNVKISDLGLFREVYAADYYK---LMGNSL-----------LPIR---------- 191
Query: 308 KNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGYPPF--YSD 360
+++PE ++ + ++ D WS G +++E+ G P+ YS+
Sbjct: 192 ---------------WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 232
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 50/259 (19%), Positives = 96/259 (37%), Gaps = 69/259 (26%)
Query: 124 IGKGAFGEVRVC--------REKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+G+GAFG+V + ++K V A+K+ +S + E LL +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ------DFQREAELLTVLQH 66
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEAR------------FY 221
IV+ Y + L ++ EY+ GD+ L D
Sbjct: 67 QHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126
Query: 222 VAETVLA-IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280
+A + + + + H++HRD+ N L+ + +++ DFG+ + + + + +G
Sbjct: 127 IASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY----YRVGG 182
Query: 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340
R P R ++ PE +L + + E D
Sbjct: 183 ----------RTMLPIR-------------------------WMPPESILYRKFTTESDI 207
Query: 341 WSLGAIMYEMLV-GYPPFY 358
WS G +++E+ G P+Y
Sbjct: 208 WSFGVVLWEIFTYGKQPWY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 373 | |||
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.93 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.93 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.88 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.88 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.83 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.82 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.78 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.76 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.71 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.63 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.62 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.59 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.55 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.54 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.5 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.41 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.4 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.4 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.4 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.31 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.2 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.14 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.13 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.1 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.08 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.99 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.89 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.87 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.76 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.7 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.63 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.61 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.55 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.53 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.49 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.45 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.42 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.31 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.26 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.23 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.22 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.17 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.04 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.99 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.9 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.9 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.88 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.87 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.76 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.75 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.74 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.67 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.65 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.64 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.52 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.45 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.31 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.25 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.14 | |
| PLN02236 | 344 | choline kinase | 97.14 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.13 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.05 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.98 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.77 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.74 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.11 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.07 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.05 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.97 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.78 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 95.71 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.49 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.4 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 95.36 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.28 |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-82 Score=600.00 Aligned_cols=334 Identities=69% Similarity=1.051 Sum_probs=305.1
Q ss_pred cccCCHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHHHhhhhhHHHhhhccCCCCC
Q 017362 38 EEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADD 117 (373)
Q Consensus 38 ~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 117 (373)
+...++.|++|+++|+.+|+++|..+++.+.+|.+|+..+++.++..+++++++.+.++....++++++++++.++..+|
T Consensus 63 ~~~~s~~T~~k~~~~k~~ien~Y~~~~~~~~~R~er~~~le~~l~~~~~s~~~~~~~~~~~~~kEte~lR~~R~r~~~~D 142 (550)
T KOG0605|consen 63 EFLVSNKTKRKVAAAKQYIENHYSSQIKYLNERKERRKELEEKLASEDVSEEEQNELLKSLLSKETEYLRLRRTRLSLDD 142 (550)
T ss_pred ccccCchhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccccHHHHHHHHHHHhhHHHHHHHhccccCCccc
Confidence 45689999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEec
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~ 197 (373)
|++++.||+|+||.||+|+.+.||..||+|+++++.+...++++|++.|+++|...++||||+||++|++.+++||||||
T Consensus 143 Fe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEy 222 (550)
T KOG0605|consen 143 FELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEY 222 (550)
T ss_pred chhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEe
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc---
Q 017362 198 LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ--- 274 (373)
Q Consensus 198 ~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~--- 274 (373)
+||||++++|++.+.|+++.+++|+++++.||+.||++|||||||||+|+|||..||+||+|||||+.+......+.
T Consensus 223 lPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~ 302 (550)
T KOG0605|consen 223 LPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRL 302 (550)
T ss_pred cCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999987766533221
Q ss_pred cccccCCCCCCCCCCCCC----CCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHH
Q 017362 275 DFTIGNNLNGSSQNNERP----AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 350 (373)
+.......... .....+ .....+.....++|+++++.++++++|||+||||||+.+.+|+..|||||||||||||
T Consensus 303 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEm 381 (550)
T KOG0605|consen 303 DEQMQINLSEA-KPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEM 381 (550)
T ss_pred hhhhhhhhccC-CCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHH
Confidence 00011111111 111112 1233446788999999999999999999999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcC
Q 017362 351 LVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 351 l~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|+|+|||++++|.+||+||++|
T Consensus 382 LvGyPPF~s~tp~~T~rkI~nw 403 (550)
T KOG0605|consen 382 LVGYPPFCSETPQETYRKIVNW 403 (550)
T ss_pred HhCCCCCCCCCHHHHHHHHHHH
Confidence 9999999999999999999987
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-63 Score=470.81 Aligned_cols=319 Identities=46% Similarity=0.800 Sum_probs=280.8
Q ss_pred HHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHHHhhhhhHHHhhhccCCCCCcceeceeeeeCcE
Q 017362 51 AAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFG 130 (373)
Q Consensus 51 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g 130 (373)
+-|.|+++|..+.++..++|..|+..||+++...++.+..+++....+..+|.+|+++.+.++..+-|..++.||-|+||
T Consensus 564 afkFfMEQHVEnvlksyqqr~~Rk~QLEkEM~kagLpd~~q~qMrkmL~QKESnYiRLkRaKMdKSmFvkik~iGvGAFG 643 (1034)
T KOG0608|consen 564 AFKFFMEQHVENVLKSYQQREKRKKQLEKEMVKAGLPDIMQNQMRKMLQQKESNYIRLKRAKMDKSMFVKIKTIGVGAFG 643 (1034)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHHHHHHHHHHHhhhhhHHHHHHhhccccceEEEeeecccccc
Confidence 45678899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEeccCCCCHHHHHhhC
Q 017362 131 EVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK 210 (373)
Q Consensus 131 ~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~ 210 (373)
+|.++....|...||+|.+.+.+...++++.|++.|.+||++.+++|||+||.+|+|.+++|+||+|+||||++.+|.+.
T Consensus 644 eV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrm 723 (1034)
T KOG0608|consen 644 EVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM 723 (1034)
T ss_pred eeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHh
Confidence 99999988999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCC
Q 017362 211 DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290 (373)
Q Consensus 211 ~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (373)
+.|.|+.++||++++..||+++|..|||||||||+|||||.+|||||+|||||+.+.+..... |. ++..+.+. .+.
T Consensus 724 gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk--YY-q~gdH~Rq-DSm 799 (1034)
T KOG0608|consen 724 GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK--YY-QEGDHHRQ-DSM 799 (1034)
T ss_pred ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccc--cc-cCCCcccc-ccC
Confidence 999999999999999999999999999999999999999999999999999999876542211 11 11111111 111
Q ss_pred CCCCC---ccchHHHHHHH--hhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCCCChHHH
Q 017362 291 RPAAP---KRTQQEQLQHW--QKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMST 365 (373)
Q Consensus 291 ~~~~~---~~~~~~~~~~~--~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~ 365 (373)
.+... ...--+++... +..+|.++-+.+||+.|+|||++...+|+..|||||.|||||||+.|++||-+.+|.+|
T Consensus 800 ep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 800 EPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGET 879 (1034)
T ss_pred CCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcc
Confidence 10000 00001223322 56678889999999999999999999999999999999999999999999999999999
Q ss_pred HHHhhcCC
Q 017362 366 CRKVRKKS 373 (373)
Q Consensus 366 ~~kI~~~~ 373 (373)
..||++|.
T Consensus 880 q~kv~nw~ 887 (1034)
T KOG0608|consen 880 QYKVINWR 887 (1034)
T ss_pred eeeeeehh
Confidence 99999983
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-60 Score=432.67 Aligned_cols=220 Identities=49% Similarity=0.889 Sum_probs=207.2
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 191 (373)
....++|++++.||+|+||+|++++.+.+++.||+|++++..+......++..+|+.||..++||+||.++.+|++.+.+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 45678999999999999999999999999999999999999999888899999999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
|||+||++||.|...|.+.+.|+|..+++|+++|+.||.|||++|||||||||+|||||..|||+|+|||||+..-....
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999985432211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
. ..++|||+.|||||++.+.+|+..+|||||||++|||+
T Consensus 181 ~-----------------------------------------t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML 219 (357)
T KOG0598|consen 181 A-----------------------------------------TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEML 219 (357)
T ss_pred c-----------------------------------------cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHh
Confidence 1 11579999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcC
Q 017362 352 VGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+|.+||.+.+...++++|+++
T Consensus 220 ~G~pPF~~~~~~~~~~~I~~~ 240 (357)
T KOG0598|consen 220 TGKPPFYAEDVKKMYDKILKG 240 (357)
T ss_pred hCCCCCcCccHHHHHHHHhcC
Confidence 999999999999999999976
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-59 Score=410.15 Aligned_cols=217 Identities=45% Similarity=0.902 Sum_probs=208.4
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 192 (373)
...++|++++.||.|+||.|.+++.+.+|..||+|++.+..+..-.+++|..+|..+|+.+.||+++++++.|.+..++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 56789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcc
Q 017362 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 272 (373)
|||||++||.|..+|.+.+.|++..+++|++||+.||+|||+++|++|||||+|||||.+|++||+|||+|+.....
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--- 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--- 197 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999876432
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 352 (373)
..+.||||.|+|||++...+|+.++|||||||++|||+.
T Consensus 198 -----------------------------------------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMla 236 (355)
T KOG0616|consen 198 -----------------------------------------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLA 236 (355)
T ss_pred -----------------------------------------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHc
Confidence 236899999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcCC
Q 017362 353 GYPPFYSDDPMSTCRKVRKKS 373 (373)
Q Consensus 353 G~~Pf~~~~~~~~~~kI~~~~ 373 (373)
|++||++.++..+|+||+++.
T Consensus 237 G~pPF~~~~~~~iY~KI~~~~ 257 (355)
T KOG0616|consen 237 GYPPFYDDNPIQIYEKILEGK 257 (355)
T ss_pred CCCCCcCCChHHHHHHHHhCc
Confidence 999999999999999999873
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-55 Score=400.29 Aligned_cols=215 Identities=35% Similarity=0.661 Sum_probs=199.4
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
..+|.+.+.||.|+||+||+|+++.++..||||.+.+..+ .....+.+..|+.+|++++|||||.+++++.+++++|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 5789999999999999999999999999999999988754 455667788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCC------CcEEEeeccccccCCC
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY------GHLRLSDFGLCKPLDC 268 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~------~~vkL~DFGla~~~~~ 268 (373)
||||.||||.+++.+.+.+++..++.++.||+.||.+||+++||||||||.||||+.+ -.+||+|||+|+.+..
T Consensus 88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 9999999999999999999999999999999999999999999999999999999765 4689999999998764
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 348 (373)
.. ++.+.||+|-|||||++..+.|+.|+|+||+|+|+|
T Consensus 168 ~~------------------------------------------~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ily 205 (429)
T KOG0595|consen 168 GS------------------------------------------MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILY 205 (429)
T ss_pred hh------------------------------------------HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHH
Confidence 32 344789999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhcC
Q 017362 349 EMLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 349 ell~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+|++|++||...++.+....|.++
T Consensus 206 q~l~g~~Pf~a~t~~eL~~~~~k~ 229 (429)
T KOG0595|consen 206 QCLTGKPPFDAETPKELLLYIKKG 229 (429)
T ss_pred HHHhCCCCccccCHHHHHHHHhcc
Confidence 999999999999999999888765
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-55 Score=444.22 Aligned_cols=236 Identities=51% Similarity=0.913 Sum_probs=214.2
Q ss_pred HHHHhhhhhHHHhhhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCC
Q 017362 96 KFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175 (373)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h 175 (373)
.++.....-...+...++..+||.++++||+|+||.|.+++++.+++.||+|++.+-.+..+.....|..|.++|...+.
T Consensus 55 ~fl~~~kp~v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns 134 (1317)
T KOG0612|consen 55 EFLNRYKPIVKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNS 134 (1317)
T ss_pred HHHHHhHHHHHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCc
Confidence 33333333444566778889999999999999999999999999999999999999888888888999999999999999
Q ss_pred CceeEEeeEEEeCCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcE
Q 017362 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHL 255 (373)
Q Consensus 176 ~~iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~v 255 (373)
+||+.+..+|+|++++|+||||||||||..+|.+.+.++++.++||+++|+.||+.||+.|+|||||||+|||||..|||
T Consensus 135 ~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHi 214 (1317)
T KOG0612|consen 135 EWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHI 214 (1317)
T ss_pred HHHHHHHHHhcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcE
Confidence 99999999999999999999999999999999998899999999999999999999999999999999999999999999
Q ss_pred EEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC----
Q 017362 256 RLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---- 331 (373)
Q Consensus 256 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---- 331 (373)
||+|||-|-.++.... ..+...||||+|++||++..
T Consensus 215 kLADFGsClkm~~dG~----------------------------------------V~s~~aVGTPDYISPEvLqs~~~~ 254 (1317)
T KOG0612|consen 215 KLADFGSCLKMDADGT----------------------------------------VRSSVAVGTPDYISPEVLQSQGDG 254 (1317)
T ss_pred eeccchhHHhcCCCCc----------------------------------------EEeccccCCCCccCHHHHHhhcCC
Confidence 9999999987763321 11236799999999999973
Q ss_pred -CCCChhhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 017362 332 -KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 332 -~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
+.|+..|||||+||++||||+|..||++++-.+||.||++
T Consensus 255 ~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~ 295 (1317)
T KOG0612|consen 255 KGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMN 295 (1317)
T ss_pred ccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhc
Confidence 5599999999999999999999999999999999999987
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-54 Score=409.52 Aligned_cols=215 Identities=35% Similarity=0.609 Sum_probs=204.3
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
.+|...+.||+|||+.||.+.+..+|+.||+|++.+..+....+.+.+.+|++|.+.++|||||+++++|+|.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 56999999999999999999999999999999999998888999999999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
|+|+.++|+.++.+..+++|.+++.|+.||+.||.|||+++|||||||..|+||+.+.+|||+|||||..+......
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er--- 174 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER--- 174 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccc---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999987643211
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 355 (373)
..+.||||.|+|||++...+++..+||||+|||||-||+|+|
T Consensus 175 --------------------------------------k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~P 216 (592)
T KOG0575|consen 175 --------------------------------------KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRP 216 (592)
T ss_pred --------------------------------------cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCC
Confidence 227899999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHhhc
Q 017362 356 PFYSDDPMSTCRKVRK 371 (373)
Q Consensus 356 Pf~~~~~~~~~~kI~~ 371 (373)
||...+-.+||.+|..
T Consensus 217 PFetk~vkety~~Ik~ 232 (592)
T KOG0575|consen 217 PFETKTVKETYNKIKL 232 (592)
T ss_pred CcccchHHHHHHHHHh
Confidence 9999999999999975
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-53 Score=401.95 Aligned_cols=232 Identities=39% Similarity=0.691 Sum_probs=209.9
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCe
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~ 190 (373)
....+||.+.+.||.|+|++|++|+++.++..||||++.+..+.....+..+..|.++|..| .||.|++||..|+|+..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 44578999999999999999999999999999999999999998888889999999999999 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
+|+|+||+++|+|.+++.+.+.|++..+++|++||+.||+|||++|||||||||+|||||.+||++|+|||-|+.+....
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999987664
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 350 (373)
.......... .+.. ...++|||-.|++||++.....+..||+|+||||||+|
T Consensus 229 ~~~~~~~~~~-----------~a~s-----------------~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQm 280 (604)
T KOG0592|consen 229 KSQENPVDPN-----------QASS-----------------RRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQM 280 (604)
T ss_pred ccccCccCcc-----------cccC-----------------cccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHH
Confidence 3321100000 0000 02379999999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhc
Q 017362 351 LVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 351 l~G~~Pf~~~~~~~~~~kI~~ 371 (373)
+.|.|||.+.+.--+++||+.
T Consensus 281 laG~PPFra~NeyliFqkI~~ 301 (604)
T KOG0592|consen 281 LAGQPPFRAANEYLIFQKIQA 301 (604)
T ss_pred hcCCCCCccccHHHHHHHHHH
Confidence 999999999999999999985
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-54 Score=394.23 Aligned_cols=217 Identities=32% Similarity=0.566 Sum_probs=193.4
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhh----hhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR----GQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 189 (373)
..+.|.+.+.||+|+||.|-+|..+.||+.||||++++...... .....+.+|+++|+++.|||||+++++|..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 45678999999999999999999999999999999988765442 23345789999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCC---CcEEEeeccccccC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY---GHLRLSDFGLCKPL 266 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~---~~vkL~DFGla~~~ 266 (373)
+.||||||+.||+|++++..+..+.+...+.++.|++.||.|||++||+||||||+|||+..+ -.+||+|||+|+..
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 999999999999999999999999999999999999999999999999999999999999776 78999999999976
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCC---ChhhcHHHH
Q 017362 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY---GMECDWWSL 343 (373)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~---~~~~DvwSl 343 (373)
.... ++.+.||||.|.|||++.+.++ ..++|+|||
T Consensus 330 g~~s------------------------------------------fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSl 367 (475)
T KOG0615|consen 330 GEGS------------------------------------------FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSL 367 (475)
T ss_pred ccce------------------------------------------ehhhhcCCccccChhheecCCeecccchheeeec
Confidence 5332 1237899999999999998774 458899999
Q ss_pred HHHHHHHHhCCCCCCCCCh-HHHHHHhhcC
Q 017362 344 GAIMYEMLVGYPPFYSDDP-MSTCRKVRKK 372 (373)
Q Consensus 344 Gvil~ell~G~~Pf~~~~~-~~~~~kI~~~ 372 (373)
|||||-||+|+|||.+... ....+.|++|
T Consensus 368 GcvLfvcLsG~pPFS~~~~~~sl~eQI~~G 397 (475)
T KOG0615|consen 368 GCVLFVCLSGYPPFSEEYTDPSLKEQILKG 397 (475)
T ss_pred cceEEEEeccCCCcccccCCccHHHHHhcC
Confidence 9999999999999998864 4488888876
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-52 Score=384.27 Aligned_cols=265 Identities=32% Similarity=0.571 Sum_probs=211.4
Q ss_pred hhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC
Q 017362 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (373)
Q Consensus 109 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 188 (373)
+...+..++|++++.||.|.-|+||+|..+.++..+|+|++.+..+..+....++..|.+||..++||.++.||..|+.+
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 44567788999999999999999999999999999999999999998888899999999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~ 266 (373)
++.|+|||||+||+|..+++++ ..|++..+++|+++++.||+|||.+|||+|||||+||||.++|||.|+||.|+...
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 9999999999999999999775 47999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCc-c---c-h-----HHHH----H-HHhhhhhccccccccCCCCcccccccC
Q 017362 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPK-R---T-Q-----QEQL----Q-HWQKNRRMLAYSTVGTPDYIAPEVLLK 331 (373)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~---~-~-----~~~~----~-~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 331 (373)
...................++....+++-. + . . .... . -........+.++|||-.|+|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 332111100000000000000000000000 0 0 0 0000 0 000011123458899999999999999
Q ss_pred CCCChhhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCC
Q 017362 332 KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRKKS 373 (373)
Q Consensus 332 ~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~kI~~~~ 373 (373)
.+.+.++|||+|||++||||+|..||.+.+..+|..+|+..+
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~ 351 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQP 351 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCC
Confidence 999999999999999999999999999999999999998753
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-52 Score=404.97 Aligned_cols=220 Identities=40% Similarity=0.743 Sum_probs=202.6
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCC
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~ 189 (373)
..+..++|.++++||+|+||+|+++..+.+++.||||++++..+.....++..+.|..|+... +||+++.+++.|++.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 467889999999999999999999999999999999999999999999999999999998777 5999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
++|+||||+.|||+ -.....+.|++..+++|+++++.||.|||++||||||||.+|||+|..||+||+|||+|+..-..
T Consensus 443 ~l~fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred eEEEEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 99999999999994 44446688999999999999999999999999999999999999999999999999999854311
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 349 (373)
.. .+.++||||.|||||++.++.|+.++|||||||+|||
T Consensus 522 g~-----------------------------------------~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlye 560 (694)
T KOG0694|consen 522 GD-----------------------------------------RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYE 560 (694)
T ss_pred CC-----------------------------------------ccccccCChhhcChhhhccCcccchhhHHHHHHHHHH
Confidence 10 1237899999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhcC
Q 017362 350 MLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 350 ll~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
||+|.+||.++|..+.+..|++.
T Consensus 561 ML~Gq~PF~gddEee~FdsI~~d 583 (694)
T KOG0694|consen 561 MLVGESPFPGDDEEEVFDSIVND 583 (694)
T ss_pred HHcCCCCCCCCCHHHHHHHHhcC
Confidence 99999999999999999999874
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-52 Score=367.93 Aligned_cols=219 Identities=34% Similarity=0.610 Sum_probs=196.9
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEee-EEEeCCe
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC-SFQDDEF 190 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~-~~~~~~~ 190 (373)
.....+|++.++||.|+||+||++.+..+|..+|.|.+.-. ..+....+.+..|+.+|+.++|||||++++ .|..++.
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~-~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG-MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh-hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 34456799999999999999999999999999999999844 455666677889999999999999999998 6665555
Q ss_pred -EEEEEeccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHh--CC--CeeecCCCCCEEEcCCCcEEEeecc
Q 017362 191 -LYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHK--HH--YIHRDIKPDNLLLDKYGHLRLSDFG 261 (373)
Q Consensus 191 -~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~--~g--iiHrDikp~NILl~~~~~vkL~DFG 261 (373)
++||||||.+|||...+.. +..++|..++.++.|+|.||..+|. .. |+||||||.||+|+.+|.|||+|||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence 9999999999999998864 4579999999999999999999998 45 9999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHH
Q 017362 262 LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWW 341 (373)
Q Consensus 262 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Dvw 341 (373)
|++.+...+ +.+.+.||||.||+||++...+|+++||||
T Consensus 174 L~r~l~s~~-----------------------------------------tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiW 212 (375)
T KOG0591|consen 174 LGRFLSSKT-----------------------------------------TFAHSLVGTPYYMSPERIHESGYNFKSDIW 212 (375)
T ss_pred hHhHhcchh-----------------------------------------HHHHhhcCCCcccCHHHHhcCCCCcchhHH
Confidence 999875432 234578999999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHhhcC
Q 017362 342 SLGAIMYEMLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 342 SlGvil~ell~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|+||++|||+.=.+||++.+-.+.|+||-+|
T Consensus 213 slGCllyEMcaL~~PF~g~n~~~L~~KI~qg 243 (375)
T KOG0591|consen 213 SLGCLLYEMCALQSPFYGDNLLSLCKKIEQG 243 (375)
T ss_pred HHHHHHHHHHhcCCCcccccHHHHHHHHHcC
Confidence 9999999999999999999999999999886
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-50 Score=366.90 Aligned_cols=215 Identities=29% Similarity=0.509 Sum_probs=195.0
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCe-E
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF-L 191 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~-~ 191 (373)
+..++.+.++.||+|..|+||+|.++.|++.+|+|++... .++.....+.+|++++..++||+||.+|++|.++.. +
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 4456788899999999999999999999999999999432 334455678999999999999999999999999994 9
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
+|+||||.||+|.+++...+.++|.....++.++++||.|||. ++||||||||+|||++..|.|||||||.++.+..+
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 9999999999999999988999999999999999999999995 99999999999999999999999999999876433
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 350 (373)
++.+.+||..|||||.+.+..|+.++||||||+.++||
T Consensus 233 ------------------------------------------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~ 270 (364)
T KOG0581|consen 233 ------------------------------------------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLEL 270 (364)
T ss_pred ------------------------------------------hcccccccccccChhhhcCCcCCcccceecccHHHHHH
Confidence 35589999999999999999999999999999999999
Q ss_pred HhCCCCCCCC-----ChHHHHHHhhcC
Q 017362 351 LVGYPPFYSD-----DPMSTCRKVRKK 372 (373)
Q Consensus 351 l~G~~Pf~~~-----~~~~~~~kI~~~ 372 (373)
.+|+.||... ++.+.+.-|..+
T Consensus 271 a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ 297 (364)
T KOG0581|consen 271 AIGRFPYPPPNPPYLDIFELLCAIVDE 297 (364)
T ss_pred hhCCCCCCCcCCCCCCHHHHHHHHhcC
Confidence 9999999985 777777777764
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=369.17 Aligned_cols=251 Identities=60% Similarity=1.019 Sum_probs=205.2
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++++.||+|+||+||+|.+..+++.||||++.+...........+..|+.++..++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998766555566678889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
||++||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.++++||+|||+|+.+........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~- 159 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF- 159 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc-
Confidence 9999999999999888999999999999999999999999999999999999999999999999999986543211100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 355 (373)
+.. .......... ............|..++.....+.+||+.|+|||++.+..++.++|||||||++|||++|++
T Consensus 160 ~~~---~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 160 YRN---LNHSLPSDFT--FQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccc---cccccccccc--ccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 000 0000000000 00000011122344444455567899999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcC
Q 017362 356 PFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 356 Pf~~~~~~~~~~kI~~~ 372 (373)
||.+.++.+.+.+|+++
T Consensus 235 Pf~~~~~~~~~~~i~~~ 251 (363)
T cd05628 235 PFCSETPQETYKKVMNW 251 (363)
T ss_pred CCCCCCHHHHHHHHHcC
Confidence 99999999999998864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-48 Score=369.12 Aligned_cols=219 Identities=36% Similarity=0.635 Sum_probs=196.9
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhh--hhHHHHHHHHHHHHhcC-CCceeEEeeEEEeCC
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR--GQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDE 189 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~ 189 (373)
...+.|.+.+.||+|+||+|++|.+..++..||+|++.+...... ...+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 456789999999999999999999999999999998776532211 23456778999999999 999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCC-CcEEEeeccccccCC-
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY-GHLRLSDFGLCKPLD- 267 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~-~~vkL~DFGla~~~~- 267 (373)
.+|+||||+.||+|.+++...+.+.|..++.++.|++.||+|+|++||+||||||+|||++.+ +++||+|||++....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG 173 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence 999999999999999999998999999999999999999999999999999999999999999 999999999998763
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC-CC-hhhcHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YG-MECDWWSLGA 345 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~-~~~DvwSlGv 345 (373)
... +..+.+|||.|+|||++.+.. |+ .++||||+||
T Consensus 174 ~~~------------------------------------------~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GV 211 (370)
T KOG0583|consen 174 EDG------------------------------------------LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGV 211 (370)
T ss_pred CCC------------------------------------------cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHH
Confidence 111 122689999999999999988 85 8899999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHhhcCC
Q 017362 346 IMYEMLVGYPPFYSDDPMSTCRKVRKKS 373 (373)
Q Consensus 346 il~ell~G~~Pf~~~~~~~~~~kI~~~~ 373 (373)
+||-|++|+.||.+.+...++.+|.+++
T Consensus 212 iLy~ml~G~~PF~d~~~~~l~~ki~~~~ 239 (370)
T KOG0583|consen 212 ILYVLLCGRLPFDDSNVPNLYRKIRKGE 239 (370)
T ss_pred HHHHHHhCCCCCCCccHHHHHHHHhcCC
Confidence 9999999999999999999999998763
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-49 Score=371.74 Aligned_cols=214 Identities=36% Similarity=0.641 Sum_probs=197.4
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|-+.+.||+|+||+||+|+.+.+.+.||||.+.+..- .......+.+|++|++.++|||||.++++|+....+++|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 578899999999999999999999999999999987653 3345677999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
||+.| +|..+|...+.++|+.++.++.+++.||.|||+.+|+|||+||.|||++.+|++|+||||+|+.+...+
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t----- 154 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT----- 154 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc-----
Confidence 99966 999999999999999999999999999999999999999999999999999999999999999765332
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 355 (373)
.+.++..|||.|||||+..+++|+..+|+||||||+|||++|+|
T Consensus 155 ------------------------------------~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~P 198 (808)
T KOG0597|consen 155 ------------------------------------SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQP 198 (808)
T ss_pred ------------------------------------eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCC
Confidence 12336789999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcC
Q 017362 356 PFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 356 Pf~~~~~~~~~~kI~~~ 372 (373)
||+..+..+..++|++.
T Consensus 199 PF~a~si~~Lv~~I~~d 215 (808)
T KOG0597|consen 199 PFYARSITQLVKSILKD 215 (808)
T ss_pred CchHHHHHHHHHHHhcC
Confidence 99999999999999875
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-49 Score=347.27 Aligned_cols=214 Identities=30% Similarity=0.493 Sum_probs=187.0
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
+.|+.+.++|+|+||+||+|+++.||+.||||.+..++ .++.-.+-..+|+.+|++++|+|+|.|+++|.....++||+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 46888999999999999999999999999999997654 22333455688999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
|||+..-|..+-.....++.+.++.|+.|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+.+..+.....
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YT- 159 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYT- 159 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhh-
Confidence 9997644444433456799999999999999999999999999999999999999999999999999998864322211
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHHHHHhCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~ 354 (373)
..|.|.+|+|||.+.+ ..|+..+||||+||++.||++|.
T Consensus 160 ----------------------------------------DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~ 199 (396)
T KOG0593|consen 160 ----------------------------------------DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGE 199 (396)
T ss_pred ----------------------------------------hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCC
Confidence 3578999999999998 77999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhc
Q 017362 355 PPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 355 ~Pf~~~~~~~~~~kI~~ 371 (373)
|.|.+.++.+....|+.
T Consensus 200 pL~PG~SDiDQLy~I~k 216 (396)
T KOG0593|consen 200 PLWPGRSDIDQLYLIRK 216 (396)
T ss_pred cCCCCcchHHHHHHHHH
Confidence 99999999888888764
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=368.23 Aligned_cols=254 Identities=64% Similarity=1.066 Sum_probs=208.5
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++++.||+|+||+||+|.+..+++.||||++.............+.+|+.++..++||||+++++.|.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998766555566677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.++|+|||+++.+.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999999865432211100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 355 (373)
......... ..................|...++....+.+||+.|+|||++.+..++.++|||||||++|||++|.+
T Consensus 161 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 161 RILSHALPS---NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred ccccccccc---cccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 000000000 00000001111122234566666666778899999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcC
Q 017362 356 PFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 356 Pf~~~~~~~~~~kI~~~ 372 (373)
||.+.++.+.+.+|+++
T Consensus 238 Pf~~~~~~~~~~~i~~~ 254 (364)
T cd05599 238 PFCSDNPQETYRKIINW 254 (364)
T ss_pred CCCCCCHHHHHHHHHcC
Confidence 99999999999888764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=367.64 Aligned_cols=257 Identities=53% Similarity=0.964 Sum_probs=206.3
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|.+++.||+|+||+||+|.+..+++.||||++.+...........+.+|+.++..++||||++++++|.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999998765555556678889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc-
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ- 274 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~- 274 (373)
||++||+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++++||+|||+|+.+........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999999975432111000
Q ss_pred -cccccCCC----CCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHH
Q 017362 275 -DFTIGNNL----NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 275 -~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 349 (373)
....+... .......................|...+..+..+.+||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence 00000000 0000000000001111222334555555556667899999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhcC
Q 017362 350 MLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 350 ll~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|++|.+||.+.++.+.+.+|+++
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~ 263 (377)
T cd05629 241 CLIGWPPFCSENSHETYRKIINW 263 (377)
T ss_pred hhcCCCCCCCCCHHHHHHHHHcc
Confidence 99999999999998888888764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=348.94 Aligned_cols=221 Identities=40% Similarity=0.750 Sum_probs=205.0
Q ss_pred hhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC
Q 017362 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (373)
Q Consensus 109 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 188 (373)
.+.++..++|..+++||+|.||+|.+|+.+.+++.||||++++..+.....+.|-..|-.+|..++||++..|-.+|+..
T Consensus 161 ~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~ 240 (516)
T KOG0690|consen 161 RKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ 240 (516)
T ss_pred ccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC
Confidence 34567789999999999999999999999999999999999999998899999999999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
+.+|+||||..||.|...|.+...|++..+++|.++|++||.|||+++||+||||.+|.|+|.+|||||+|||||+.--.
T Consensus 241 drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred ceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999974321
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 348 (373)
... ...++||||.|.|||++....|+.++|||.+||+||
T Consensus 321 ~g~-----------------------------------------t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMY 359 (516)
T KOG0690|consen 321 YGD-----------------------------------------TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMY 359 (516)
T ss_pred ccc-----------------------------------------eeccccCChhhcCchhhccccccceeehhhhhHHHH
Confidence 100 022689999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhh
Q 017362 349 EMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 349 ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
||+.|+.||++.+....+.-|+
T Consensus 360 EMmCGRLPFyn~dh~kLFeLIl 381 (516)
T KOG0690|consen 360 EMMCGRLPFYNKDHEKLFELIL 381 (516)
T ss_pred HHHhccCcccccchhHHHHHHH
Confidence 9999999999999988887775
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=358.98 Aligned_cols=217 Identities=32% Similarity=0.504 Sum_probs=192.5
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC--Ce
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--EF 190 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~ 190 (373)
...+.|+.+.+||+|+||.||+|++..+|+.||+|.+..... ......-..+|+.||++++||||++|.+...+. ..
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 346779999999999999999999999999999999986542 344455678899999999999999999998876 78
Q ss_pred EEEEEeccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 191 LYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
+|||+|||+ .||..++...+ .|++.+++.|+.||+.||+|+|.+||+|||||++|||||.+|.+||+|||||+.+...
T Consensus 193 iYlVFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 193 IYLVFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEEEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 999999995 49999987654 6999999999999999999999999999999999999999999999999999977654
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ 348 (373)
... ..++.|-|++|+|||.+++ ..|+.++|+||.||||.
T Consensus 272 ~~~----------------------------------------~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~ 311 (560)
T KOG0600|consen 272 GSA----------------------------------------PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILA 311 (560)
T ss_pred CCc----------------------------------------ccccceEEeeccChHHhcCCcccccceeehhhhHHHH
Confidence 311 1236789999999999998 56999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhc
Q 017362 349 EMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 349 ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
||++|+|.|.+.+..+...+|-+
T Consensus 312 El~~gkPI~~G~tEveQl~kIfk 334 (560)
T KOG0600|consen 312 ELFLGKPILQGRTEVEQLHKIFK 334 (560)
T ss_pred HHHcCCCCcCCccHHHHHHHHHH
Confidence 99999999999999999988853
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=364.88 Aligned_cols=255 Identities=49% Similarity=0.864 Sum_probs=200.2
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++++.||+|+||+||+|.+..+++.||+|++.+..........++.+|+.+++.++||||+++++.|.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999999999998776555666788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|..+........
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~- 159 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY- 159 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc-
Confidence 9999999999998888899999999999999999999999999999999999999999999999999875432211000
Q ss_pred ccccCCCCCCCC-CC---CCCCC----CccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHH
Q 017362 276 FTIGNNLNGSSQ-NN---ERPAA----PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (373)
Q Consensus 276 ~~~~~~~~~~~~-~~---~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 347 (373)
+..+........ .. ..+.. ........... ....+....+.+||+.|+|||++.+..|+.++|||||||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAA-RQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhc-cccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 000000000000 00 00000 00000000000 01112233467899999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhhcC
Q 017362 348 YEMLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 348 ~ell~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|||++|++||.+.++.++..+|+++
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~ 263 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINW 263 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHcc
Confidence 9999999999999999998888764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-48 Score=331.11 Aligned_cols=218 Identities=37% Similarity=0.622 Sum_probs=201.6
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCe
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 190 (373)
..+..++|++.+.||+|-||.||+|+.+.++..||+|++-++.+........+.+|++|-+.++||||+++|++|-|...
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 34678999999999999999999999999999999999999988777777788999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 191 LYLIMEYLPGGDMMTLLM--RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
.||++||.++|.|...|. ....+++..+..|+.|++.||.|+|.+++|||||||+|+|++..|.+||+|||.+-..+.
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 999999999999999998 556799999999999999999999999999999999999999999999999998754321
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 348 (373)
. + ..+.|||..|.|||...+.+++..+|+|++|++.|
T Consensus 177 ~--------------------------k-----------------R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~y 213 (281)
T KOG0580|consen 177 N--------------------------K-----------------RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCY 213 (281)
T ss_pred C--------------------------C-----------------ceeeecccccCCHhhcCCCCccchhhHHHHHHHHH
Confidence 1 1 11689999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhc
Q 017362 349 EMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 349 ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
|+++|.+||.+.+..++|++|.+
T Consensus 214 eflvg~ppFes~~~~etYkrI~k 236 (281)
T KOG0580|consen 214 EFLVGLPPFESQSHSETYKRIRK 236 (281)
T ss_pred HHHhcCCchhhhhhHHHHHHHHH
Confidence 99999999999999999999974
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=361.79 Aligned_cols=251 Identities=59% Similarity=1.018 Sum_probs=205.3
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++++.||+|+||.||+|.+..+++.||||++.............+..|+.++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998766555666778889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
||++||+|.+++.+...+++..++.++.|++.||.|||++||+||||||+|||++.+|+++|+|||+|+.+.........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999999865432111000
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 355 (373)
..... ......... ..........|..++.....+.+||+.|+|||++.+..++.++|||||||++|||++|++
T Consensus 161 ~~~~~--~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 161 RNLTH--NPPSDFSFQ----NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred ccccc--CCccccccc----ccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 00000 000000000 000001122344445555667899999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcC
Q 017362 356 PFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 356 Pf~~~~~~~~~~kI~~~ 372 (373)
||.+.++.+++.+|+++
T Consensus 235 Pf~~~~~~~~~~~i~~~ 251 (360)
T cd05627 235 PFCSETPQETYRKVMNW 251 (360)
T ss_pred CCCCCCHHHHHHHHHcC
Confidence 99999999999988764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=362.93 Aligned_cols=256 Identities=48% Similarity=0.838 Sum_probs=199.5
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
+.|++++.||+|+||+||+|.+..++..||||++.+..........++..|+.++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36899999999999999999999999999999998776656666778999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
||++||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.+....... .
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~-~ 159 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK-Y 159 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc-c
Confidence 999999999999888889999999999999999999999999999999999999999999999999987553221100 0
Q ss_pred ccccCCCCCCCCC-----CCCCCCCccchHHHHH--HHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHH
Q 017362 276 FTIGNNLNGSSQN-----NERPAAPKRTQQEQLQ--HWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 276 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 348 (373)
+..+......... .....+........+. .........+.+.+||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~ 239 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHH
Confidence 0000000000000 0000000000000000 00011122334678999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhcC
Q 017362 349 EMLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 349 ell~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
||++|.+||...++.+...+|+.+
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~ 263 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKVINW 263 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHcc
Confidence 999999999999988888887653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=348.87 Aligned_cols=216 Identities=29% Similarity=0.620 Sum_probs=203.9
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
..+|++.+.||+|.||+|-+|.....|+.||||.+++..+.+...+-++++|++||+.++||||+.+|.+|...+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 46799999999999999999999999999999999999998888889999999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
|||..+|.|++++.+.+.+++..++.+++||+.|+.|+|+++++|||||.+|||+|.|+++||+||||+..+....+
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf--- 208 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF--- 208 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccH---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999977654322
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCC-ChhhcHHHHHHHHHHHHhC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G 353 (373)
..++||+|-|.+||++.+.+| ++.+|.|||||+||-|+.|
T Consensus 209 ---------------------------------------LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyG 249 (668)
T KOG0611|consen 209 ---------------------------------------LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYG 249 (668)
T ss_pred ---------------------------------------HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhc
Confidence 226899999999999999998 7899999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcC
Q 017362 354 YPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 354 ~~Pf~~~~~~~~~~kI~~~ 372 (373)
..||.+.|...+.+.|-+|
T Consensus 250 tMPFDG~Dhk~lvrQIs~G 268 (668)
T KOG0611|consen 250 TMPFDGRDHKRLVRQISRG 268 (668)
T ss_pred ccccCCchHHHHHHHhhcc
Confidence 9999999999999999876
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=354.29 Aligned_cols=217 Identities=43% Similarity=0.852 Sum_probs=198.5
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 191 (373)
.+..++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.++..++||||+++++++.+++.+
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV 93 (329)
T ss_pred CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence 34568899999999999999999999999999999999877655555667889999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
|+||||++||+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 172 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT- 172 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence 9999999999999999888899999999999999999999999999999999999999999999999999987653211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
...+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 173 -------------------------------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 209 (329)
T PTZ00263 173 -------------------------------------------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFI 209 (329)
T ss_pred -------------------------------------------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHH
Confidence 1357999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcC
Q 017362 352 VGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+|.+||.+.++.+++.+|..+
T Consensus 210 tg~~pf~~~~~~~~~~~i~~~ 230 (329)
T PTZ00263 210 AGYPPFFDDTPFRIYEKILAG 230 (329)
T ss_pred cCCCCCCCCCHHHHHHHHhcC
Confidence 999999999999999888764
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=359.61 Aligned_cols=255 Identities=49% Similarity=0.843 Sum_probs=198.8
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++++.||+|+||.||+|.+..+++.||||++.+...........+.+|+.++..++||||+++++.|.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998766555556678889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc-
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ- 274 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~- 274 (373)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|..+........
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999999875432111000
Q ss_pred ---cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 275 ---DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 275 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
........................ .. ........+....+.+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKP-LE-RRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccc-hh-hhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 000000000000000000000000 00 0000001112233568999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcC
Q 017362 352 VGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+|++||.+.++.+...+|..+
T Consensus 239 ~G~~Pf~~~~~~~~~~~i~~~ 259 (376)
T cd05598 239 VGQPPFLADTPAETQLKVINW 259 (376)
T ss_pred hCCCCCCCCCHHHHHHHHhcc
Confidence 999999999998888887654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=351.92 Aligned_cols=214 Identities=30% Similarity=0.496 Sum_probs=186.0
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCce-EeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC-e
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHV-YAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE-F 190 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~-~ 190 (373)
+...++.+...||.|+||+||.+.++ |.. ||+|++......... ...|.+|+.+|..++|||||++++++.+.. .
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~ 114 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGS 114 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 44455666677999999999998875 556 999999876543333 678999999999999999999999999887 7
Q ss_pred EEEEEeccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHhCC-CeeecCCCCCEEEcCCC-cEEEeeccccccC
Q 017362 191 LYLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHH-YIHRDIKPDNLLLDKYG-HLRLSDFGLCKPL 266 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g-iiHrDikp~NILl~~~~-~vkL~DFGla~~~ 266 (373)
+++|||||++|+|..++.. +..++...+..++.||+.||.|||+++ ||||||||+|||++.++ ++||+|||+++..
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence 9999999999999999988 678999999999999999999999999 99999999999999998 9999999999865
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc--CCCCChhhcHHHHH
Q 017362 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL--KKGYGMECDWWSLG 344 (373)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~~~~~DvwSlG 344 (373)
..... ..++..||+.|||||++. ...|+.++||||||
T Consensus 195 ~~~~~-----------------------------------------~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFg 233 (362)
T KOG0192|consen 195 VISKT-----------------------------------------SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFG 233 (362)
T ss_pred ccccc-----------------------------------------cccCCCCCccccChhhhcCCCCcCCccchhhhHH
Confidence 43210 012468999999999999 66899999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHhh
Q 017362 345 AIMYEMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 345 vil~ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
|+||||+||..||.+..+.+....+.
T Consensus 234 IvlWEl~t~~~Pf~~~~~~~~~~~v~ 259 (362)
T KOG0192|consen 234 IVLWELLTGEIPFEDLAPVQVASAVV 259 (362)
T ss_pred HHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 99999999999999998866665554
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-46 Score=353.52 Aligned_cols=218 Identities=41% Similarity=0.827 Sum_probs=196.8
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCC-ceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTG-HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 189 (373)
..+..++|++.+.||+|+||.||+|.+..++ ..||+|++...........+.+.+|+.++..++||||+++++++.+.+
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 4456788999999999999999999876554 689999998766555556677889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
.+|+||||++||+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999999754321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 349 (373)
. ...+||+.|+|||++.+..++.++|||||||++||
T Consensus 185 ~--------------------------------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 220 (340)
T PTZ00426 185 T--------------------------------------------YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYE 220 (340)
T ss_pred c--------------------------------------------ceecCChhhcCHHHHhCCCCCccccccchhhHHHH
Confidence 1 13579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhcC
Q 017362 350 MLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 350 ll~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|++|.+||.+.++..++++|+++
T Consensus 221 ll~G~~Pf~~~~~~~~~~~i~~~ 243 (340)
T PTZ00426 221 ILVGCPPFYANEPLLIYQKILEG 243 (340)
T ss_pred HhcCCCCCCCCCHHHHHHHHhcC
Confidence 99999999999999999988765
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=355.90 Aligned_cols=224 Identities=48% Similarity=0.946 Sum_probs=196.1
Q ss_pred HhhhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEE
Q 017362 107 RLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (373)
Q Consensus 107 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 186 (373)
.+....+..++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++..++||||+++++.+.
T Consensus 34 ~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (370)
T cd05621 34 KIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ 113 (370)
T ss_pred HHHhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 34555667789999999999999999999999999999999998755544445566888999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccC
Q 017362 187 DDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (373)
Q Consensus 187 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~ 266 (373)
+++.+|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|..+
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 114 DDKYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 99999999999999999998854 46899999999999999999999999999999999999999999999999999765
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC----CChhhcHHH
Q 017362 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG----YGMECDWWS 342 (373)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~~~~~DvwS 342 (373)
...... .....+||+.|+|||++.+.. ++.++||||
T Consensus 193 ~~~~~~----------------------------------------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwS 232 (370)
T cd05621 193 DETGMV----------------------------------------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWS 232 (370)
T ss_pred ccCCce----------------------------------------ecccCCCCcccCCHHHHhccCCCCCCCcccCEEe
Confidence 322100 011457999999999997643 789999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 017362 343 LGAIMYEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 343 lGvil~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
|||++|||++|++||.+.+....+.+|+.
T Consensus 233 lG~ilyell~G~~Pf~~~~~~~~~~~i~~ 261 (370)
T cd05621 233 VGVFLFEMLVGDTPFYADSLVGTYSKIMD 261 (370)
T ss_pred ehHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 99999999999999999999999888875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=350.72 Aligned_cols=220 Identities=37% Similarity=0.703 Sum_probs=201.6
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCe
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~ 190 (373)
.+...+|..+.+||+|+||+|.+|..+.+.+.||||++++..+.....++.-..|..+|+.. +-|.++++...|+..+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 46678899999999999999999999999999999999998887777788778888898877 46799999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
+|+||||+.||||+-.+++-+.|.|..+.+|+++|+.||-|||++|||+||||.+||++|.+|||||+|||+|+..-...
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~ 504 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG 504 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998543221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 350 (373)
.. ..+.||||.|+|||++..++|+.++||||+||+||||
T Consensus 505 ~T-----------------------------------------TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEm 543 (683)
T KOG0696|consen 505 VT-----------------------------------------TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 543 (683)
T ss_pred cc-----------------------------------------eeeecCCCcccccceEEecccccchhHHHHHHHHHHH
Confidence 11 1268999999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcC
Q 017362 351 LVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 351 l~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|.|++||.++|..+.++.|+..
T Consensus 544 laGQpPFdGeDE~elF~aI~eh 565 (683)
T KOG0696|consen 544 LAGQPPFDGEDEDELFQAIMEH 565 (683)
T ss_pred HcCCCCCCCCCHHHHHHHHHHc
Confidence 9999999999999999998754
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=362.16 Aligned_cols=217 Identities=31% Similarity=0.581 Sum_probs=200.7
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.+-|++.+.||.|+.|.|.+|++..||+.+|||++.+...........+.+|+.||+.+.||||+.+|+++.....+|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 46699999999999999999999999999999999887555555667788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
.||++||-|.++|.+++++++..++.++.||+.|+.|+|..+|+||||||+|+|||..++|||+|||+|..-....
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk---- 166 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK---- 166 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999997644332
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCC-ChhhcHHHHHHHHHHHHhC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G 353 (373)
+..+-||+|.|.|||++.+.+| +.++||||.|||||.||||
T Consensus 167 --------------------------------------lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG 208 (786)
T KOG0588|consen 167 --------------------------------------LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTG 208 (786)
T ss_pred --------------------------------------cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhC
Confidence 2236799999999999999999 6899999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcCC
Q 017362 354 YPPFYSDDPMSTCRKVRKKS 373 (373)
Q Consensus 354 ~~Pf~~~~~~~~~~kI~~~~ 373 (373)
++||.+.+....+.||.+|.
T Consensus 209 ~LPFdDdNir~LLlKV~~G~ 228 (786)
T KOG0588|consen 209 KLPFDDDNIRVLLLKVQRGV 228 (786)
T ss_pred CCCCCCccHHHHHHHHHcCc
Confidence 99999999999999999873
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=347.81 Aligned_cols=226 Identities=35% Similarity=0.616 Sum_probs=190.5
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhh-----------hhhHHHHHHHHHHHHhcCCCceeE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR-----------RGQVEHVRAERNLLAEVDSNCIVK 180 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~iv~ 180 (373)
....+.|++++.||+|.||.|.+|++..+++.||||++.+..... ...++.+++|+.+|+++.|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 345688999999999999999999999999999999998755322 123468999999999999999999
Q ss_pred EeeEEEeC--CeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEe
Q 017362 181 LYCSFQDD--EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLS 258 (373)
Q Consensus 181 l~~~~~~~--~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~ 258 (373)
|+++..+. +.+|||+|||..|.+...-..+..+++.+++.|+.+++.||+|||.+|||||||||+|+||+.+|+|||+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence 99999875 5799999999998875443223339999999999999999999999999999999999999999999999
Q ss_pred eccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC----C
Q 017362 259 DFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG----Y 334 (373)
Q Consensus 259 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~ 334 (373)
|||.+-.+........ ...+ ..++|||.|+|||...++. -
T Consensus 253 DFGVs~~~~~~~~~~~-------------------------d~~L-----------~~tvGTPAF~APE~c~~~~~~~~~ 296 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGS-------------------------DDQL-----------SRTVGTPAFFAPELCSGGNSFSYS 296 (576)
T ss_pred ccceeeecccCCcccc-------------------------HHHH-----------hhcCCCccccchHhhcCCCCcccc
Confidence 9999876543311100 0111 1379999999999998733 3
Q ss_pred ChhhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCC
Q 017362 335 GMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRKKS 373 (373)
Q Consensus 335 ~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~kI~~~~ 373 (373)
+.+.||||+||+||.|+.|..||.++...+++.||++.+
T Consensus 297 g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~p 335 (576)
T KOG0585|consen 297 GFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDP 335 (576)
T ss_pred chhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCc
Confidence 678999999999999999999999999999999999864
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-46 Score=345.27 Aligned_cols=213 Identities=41% Similarity=0.855 Sum_probs=193.6
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999997665444445677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
||+++|+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~----- 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT----- 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-----
Confidence 999999999999888899999999999999999999999999999999999999999999999999987543210
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 355 (373)
...+||+.|+|||++.+..++.++|||||||++|+|++|.+
T Consensus 156 ---------------------------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~ 196 (291)
T cd05612 156 ---------------------------------------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYP 196 (291)
T ss_pred ---------------------------------------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 13579999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcC
Q 017362 356 PFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 356 Pf~~~~~~~~~~kI~~~ 372 (373)
||.+.++.+.+.+|..+
T Consensus 197 pf~~~~~~~~~~~i~~~ 213 (291)
T cd05612 197 PFFDDNPFGIYEKILAG 213 (291)
T ss_pred CCCCCCHHHHHHHHHhC
Confidence 99999999888888754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=353.74 Aligned_cols=226 Identities=49% Similarity=0.927 Sum_probs=197.8
Q ss_pred HHhhhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEE
Q 017362 106 MRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSF 185 (373)
Q Consensus 106 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~ 185 (373)
..+....+..++|++.+.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.++..++||||+++++.+
T Consensus 33 ~~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~ 112 (371)
T cd05622 33 NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF 112 (371)
T ss_pred hHHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 33556677889999999999999999999999999999999999876554455556678899999999999999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 186 QDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 186 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
.++..+|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|..
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 113 QDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 999999999999999999998854 4689999999999999999999999999999999999999999999999999976
Q ss_pred CCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC----CChhhcHH
Q 017362 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG----YGMECDWW 341 (373)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~~~~~Dvw 341 (373)
+...... .....+||+.|+|||++.... ++.++|||
T Consensus 192 ~~~~~~~----------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~Diw 231 (371)
T cd05622 192 MNKEGMV----------------------------------------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 231 (371)
T ss_pred cCcCCcc----------------------------------------cccCcccCccccCHHHHhccCCCccCCCcccee
Confidence 5322100 011457999999999997543 78999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHhhcC
Q 017362 342 SLGAIMYEMLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 342 SlGvil~ell~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
||||++|||++|.+||.+.+....+.+|++.
T Consensus 232 SlGvilyell~G~~Pf~~~~~~~~~~~i~~~ 262 (371)
T cd05622 232 SVGVFLYEMLVGDTPFYADSLVGTYSKIMNH 262 (371)
T ss_pred ehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 9999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=357.54 Aligned_cols=211 Identities=32% Similarity=0.576 Sum_probs=190.5
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
...|....+||+|+.|.||.|....+++.||||.+.... ....+-+.+|+.+|+..+|+|||.+++.|...+.+++|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~---Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK---QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc---CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 356888899999999999999999999999999998664 33345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
||||+||+|.+.+. ...++|.++..++.+++.||+|||.+||||||||.+|||++.+|.+||+|||+|..+.....
T Consensus 349 MEym~ggsLTDvVt-~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--- 424 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVT-KTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--- 424 (550)
T ss_pred EeecCCCchhhhhh-cccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC---
Confidence 99999999988884 45699999999999999999999999999999999999999999999999999987754421
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 354 (373)
+| .+.+|||+|||||++....|++++||||||++++||+.|.
T Consensus 425 ---------------------KR-----------------~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGE 466 (550)
T KOG0578|consen 425 ---------------------KR-----------------STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGE 466 (550)
T ss_pred ---------------------cc-----------------ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCC
Confidence 11 1689999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHhh
Q 017362 355 PPFYSDDPMSTCRKVR 370 (373)
Q Consensus 355 ~Pf~~~~~~~~~~kI~ 370 (373)
|||..++|..-.+.|-
T Consensus 467 PPYlnE~PlrAlyLIa 482 (550)
T KOG0578|consen 467 PPYLNENPLRALYLIA 482 (550)
T ss_pred CCccCCChHHHHHHHh
Confidence 9999999988777664
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=348.45 Aligned_cols=213 Identities=48% Similarity=0.897 Sum_probs=194.3
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++++.||+|+||.||+|.+..+++.||||++.+...........+..|+.++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765544555677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
||++||+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~------ 154 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY------ 154 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccccc------
Confidence 99999999999988889999999999999999999999999999999999999999999999999998754321
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 355 (373)
....+||+.|+|||++.+..++.++|||||||++|||++|.+
T Consensus 155 --------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~ 196 (333)
T cd05600 155 --------------------------------------ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFP 196 (333)
T ss_pred --------------------------------------cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCC
Confidence 114679999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcC
Q 017362 356 PFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 356 Pf~~~~~~~~~~kI~~~ 372 (373)
||...++.+.+..|..+
T Consensus 197 pf~~~~~~~~~~~i~~~ 213 (333)
T cd05600 197 PFSGSTPNETWENLKYW 213 (333)
T ss_pred CCCCCCHHHHHHHHHhc
Confidence 99999998888777653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=346.42 Aligned_cols=210 Identities=41% Similarity=0.729 Sum_probs=187.7
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEeccCCC
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGG 201 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~gg 201 (373)
+.||+|+||.||+|.+..+|+.||||++.+...........+..|+.++..++||||+++++.+...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765555556677888999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccCC
Q 017362 202 DMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281 (373)
Q Consensus 202 ~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~ 281 (373)
+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~--------- 151 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--------- 151 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc---------
Confidence 99999988889999999999999999999999999999999999999999999999999998743211000
Q ss_pred CCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCCCC
Q 017362 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361 (373)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~ 361 (373)
....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+
T Consensus 152 --------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 199 (323)
T cd05571 152 --------------------------------MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred --------------------------------ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC
Confidence 114579999999999999999999999999999999999999999998
Q ss_pred hHHHHHHhhcC
Q 017362 362 PMSTCRKVRKK 372 (373)
Q Consensus 362 ~~~~~~kI~~~ 372 (373)
.......|..+
T Consensus 200 ~~~~~~~~~~~ 210 (323)
T cd05571 200 HEKLFELILME 210 (323)
T ss_pred HHHHHHHHHcC
Confidence 88888777643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=350.36 Aligned_cols=223 Identities=49% Similarity=0.935 Sum_probs=195.1
Q ss_pred hhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC
Q 017362 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (373)
Q Consensus 109 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 188 (373)
....+..++|++.+.||+|+||.||+|.+..++..||+|++.+...........+..|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~ 115 (370)
T cd05596 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD 115 (370)
T ss_pred ccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 34556778999999999999999999999999999999999876554455556678899999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
+.+|+||||++||+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999999998854 4689999999999999999999999999999999999999999999999999976532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC----CCChhhcHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK----GYGMECDWWSLG 344 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~~DvwSlG 344 (373)
.... .....+||+.|+|||++.+. .++.++||||||
T Consensus 195 ~~~~----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlG 234 (370)
T cd05596 195 NGMV----------------------------------------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234 (370)
T ss_pred CCcc----------------------------------------cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehh
Confidence 2100 01145799999999998754 378999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHhhcC
Q 017362 345 AIMYEMLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 345 vil~ell~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|++|||++|++||.+.+....+.+|++.
T Consensus 235 vilyelltG~~Pf~~~~~~~~~~~i~~~ 262 (370)
T cd05596 235 VFLYEMLVGDTPFYADSLVGTYSKIMDH 262 (370)
T ss_pred HHHHHHHhCCCCcCCCCHHHHHHHHHcC
Confidence 9999999999999999999999988753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=346.51 Aligned_cols=211 Identities=28% Similarity=0.519 Sum_probs=186.7
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-CCceeEEeeEEEeCC-eEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDE-FLY 192 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~-~~~ 192 (373)
.++|.++++||.|+||.||+|..+.+|..||||.+++.-. ...+.- -.+|+..|+++. ||||+++.+++.+.+ .+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee~~-nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEECM-NLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHHHH-HHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 4689999999999999999999999999999999987532 222222 357899999998 999999999999988 999
Q ss_pred EEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 193 LIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
+||||| ..+|+.++..+ ..|++..++.|+.||++||+|+|++||.||||||+|||+..+..|||+|||||+.......
T Consensus 87 fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP 165 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP 165 (538)
T ss_pred eeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCC
Confidence 999999 56999998654 5799999999999999999999999999999999999999999999999999997654321
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~el 350 (373)
. +..|.|.+|+|||+++.. -|+.++|+||+|||++|+
T Consensus 166 Y------------------------------------------TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl 203 (538)
T KOG0661|consen 166 Y------------------------------------------TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAEL 203 (538)
T ss_pred c------------------------------------------chhhhcccccchHHhhhccccCCchHHHHHHHHHHHH
Confidence 1 145889999999999874 589999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhh
Q 017362 351 LVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 351 l~G~~Pf~~~~~~~~~~kI~ 370 (373)
++=+|.|.+.+..+...||.
T Consensus 204 ~sLrPLFPG~sE~Dqi~KIc 223 (538)
T KOG0661|consen 204 YSLRPLFPGASEIDQIYKIC 223 (538)
T ss_pred HHhcccCCCCcHHHHHHHHH
Confidence 99999999999999999985
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=340.78 Aligned_cols=215 Identities=37% Similarity=0.702 Sum_probs=190.0
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCC-ceeEEeeEEEeCCeEEEEE
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~l~~~~~~~~~~~lV~ 195 (373)
+|++++.||+|+||.||+|.+..+++.||||++.+.........+.+..|..++..+.|+ +|+.+++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999876554455567788899999988765 6888999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
||++||+|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~--- 157 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--- 157 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc---
Confidence 99999999999988888999999999999999999999999999999999999999999999999998643211100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 355 (373)
....+||+.|+|||++.+..++.++|||||||++|||++|++
T Consensus 158 --------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~ 199 (324)
T cd05587 158 --------------------------------------TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQP 199 (324)
T ss_pred --------------------------------------eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCC
Confidence 113579999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcC
Q 017362 356 PFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 356 Pf~~~~~~~~~~kI~~~ 372 (373)
||.+.+..+.+..|.+.
T Consensus 200 pf~~~~~~~~~~~i~~~ 216 (324)
T cd05587 200 PFDGEDEDELFQSIMEH 216 (324)
T ss_pred CCCCCCHHHHHHHHHcC
Confidence 99999988888887653
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=341.54 Aligned_cols=215 Identities=37% Similarity=0.699 Sum_probs=189.5
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCeEEEEE
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
+|.+++.||+|+||.||+|.+..++..||||++.+...........+..|..++..+ .|++|+.+++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 589999999999999999999999999999999876544444555667788888776 5799999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
||++||+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++++||+|||+++........
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~--- 157 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--- 157 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc---
Confidence 99999999999988888999999999999999999999999999999999999999999999999998743211100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 355 (373)
....+||+.|+|||++.+..++.++|||||||++|||++|++
T Consensus 158 --------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~ 199 (323)
T cd05616 158 --------------------------------------TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 199 (323)
T ss_pred --------------------------------------cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCC
Confidence 114579999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcC
Q 017362 356 PFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 356 Pf~~~~~~~~~~kI~~~ 372 (373)
||.+.+..+....|..+
T Consensus 200 Pf~~~~~~~~~~~i~~~ 216 (323)
T cd05616 200 PFEGEDEDELFQSIMEH 216 (323)
T ss_pred CCCCCCHHHHHHHHHhC
Confidence 99999998888887653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=340.94 Aligned_cols=208 Identities=44% Similarity=0.821 Sum_probs=187.6
Q ss_pred eeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEeccCCCCH
Q 017362 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM 203 (373)
Q Consensus 124 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~gg~L 203 (373)
||+|+||.||+|.+..++..||+|++.............+..|+.++..++||||+++++.+.+.+.+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999876555555667788999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccCCCC
Q 017362 204 MTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283 (373)
Q Consensus 204 ~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~ 283 (373)
.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~----------- 149 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK----------- 149 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCc-----------
Confidence 999988889999999999999999999999999999999999999999999999999998753211100
Q ss_pred CCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCCCChH
Q 017362 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363 (373)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~ 363 (373)
....+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..
T Consensus 150 ------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~ 199 (312)
T cd05585 150 ------------------------------TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN 199 (312)
T ss_pred ------------------------------cccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH
Confidence 11357999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhcC
Q 017362 364 STCRKVRKK 372 (373)
Q Consensus 364 ~~~~kI~~~ 372 (373)
+.+.+++++
T Consensus 200 ~~~~~~~~~ 208 (312)
T cd05585 200 EMYRKILQE 208 (312)
T ss_pred HHHHHHHcC
Confidence 888888764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=318.05 Aligned_cols=213 Identities=30% Similarity=0.517 Sum_probs=187.9
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
.+|...+.||+|.||+||+|.+..+|+.||||.++.....+. ......+|+..|++++|+||+.++++|.+.+++.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG-i~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG-INRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC-ccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 468889999999999999999999999999999987653322 2344678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 196 EYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
|||+ .||...+..+. .++..+++.|+.+++.||+|||++.|+||||||.|+||+.+|.+||+|||+|+.+......
T Consensus 81 Efm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~-- 157 (318)
T KOG0659|consen 81 EFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI-- 157 (318)
T ss_pred Eecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc--
Confidence 9995 59998886654 7999999999999999999999999999999999999999999999999999987644311
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHHHHHhC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G 353 (373)
....|-|.+|+|||.+.+ ..|+..+|+||.|||+.||+-|
T Consensus 158 ---------------------------------------~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr 198 (318)
T KOG0659|consen 158 ---------------------------------------QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLR 198 (318)
T ss_pred ---------------------------------------cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHcc
Confidence 112378999999999987 5599999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhc
Q 017362 354 YPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 354 ~~Pf~~~~~~~~~~kI~~ 371 (373)
.|-|.++++-+...+|.+
T Consensus 199 ~P~fpG~sDidQL~~If~ 216 (318)
T KOG0659|consen 199 VPFFPGDSDIDQLSKIFR 216 (318)
T ss_pred CCCCCCCchHHHHHHHHH
Confidence 999999999888887753
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=340.35 Aligned_cols=209 Identities=41% Similarity=0.738 Sum_probs=186.3
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEeccCCC
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGG 201 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~gg 201 (373)
+.||+|+||.||+|.+..+|..||+|++.............+..|+.++..++||||+++++.|.+.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765544555667888999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccCC
Q 017362 202 DMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281 (373)
Q Consensus 202 ~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~ 281 (373)
+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--------- 151 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--------- 151 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc---------
Confidence 99999988888999999999999999999999999999999999999999999999999998743211100
Q ss_pred CCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCCCC
Q 017362 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361 (373)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~ 361 (373)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus 152 --------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 199 (323)
T cd05595 152 --------------------------------MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred --------------------------------cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence 013579999999999999999999999999999999999999999998
Q ss_pred hHHHHHHhhc
Q 017362 362 PMSTCRKVRK 371 (373)
Q Consensus 362 ~~~~~~kI~~ 371 (373)
.......+..
T Consensus 200 ~~~~~~~~~~ 209 (323)
T cd05595 200 HERLFELILM 209 (323)
T ss_pred HHHHHHHHhc
Confidence 8888777654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=347.24 Aligned_cols=244 Identities=58% Similarity=0.997 Sum_probs=200.3
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|.+.+.||+|+||+||+|.+..+++.||||++.............+..|+.++..+.||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998776555566778899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
||++|++|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..+.........
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999999866533211000
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 355 (373)
...... ... .............+.......+||+.|+|||++.+..++.++|||||||++|||++|++
T Consensus 161 ~~~~~~---~~~---------~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~ 228 (350)
T cd05573 161 LNDSHN---LLF---------RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228 (350)
T ss_pred cccccc---ccc---------cccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCC
Confidence 000000 000 00000000001111122335689999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHhhc
Q 017362 356 PFYSDDPMSTCRKVRK 371 (373)
Q Consensus 356 Pf~~~~~~~~~~kI~~ 371 (373)
||...++.+.+.+|++
T Consensus 229 Pf~~~~~~~~~~~i~~ 244 (350)
T cd05573 229 PFYSDTLQETYNKIIN 244 (350)
T ss_pred CCCCCCHHHHHHHHhc
Confidence 9999999999988876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=340.79 Aligned_cols=209 Identities=40% Similarity=0.737 Sum_probs=186.7
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEeccCCC
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGG 201 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~gg 201 (373)
+.||+|+||.||+|.+..++..||+|++.+...........+.+|+.+++.++||||+++++.+.+.+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765555556677888999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccCC
Q 017362 202 DMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281 (373)
Q Consensus 202 ~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~ 281 (373)
+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~---------- 150 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA---------- 150 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc----------
Confidence 9999998888899999999999999999999999999999999999999999999999999874321100
Q ss_pred CCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCCCC
Q 017362 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361 (373)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~ 361 (373)
.....+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+
T Consensus 151 -------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~ 199 (328)
T cd05593 151 -------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (328)
T ss_pred -------------------------------ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC
Confidence 0113579999999999999999999999999999999999999999988
Q ss_pred hHHHHHHhhc
Q 017362 362 PMSTCRKVRK 371 (373)
Q Consensus 362 ~~~~~~kI~~ 371 (373)
..+....|..
T Consensus 200 ~~~~~~~~~~ 209 (328)
T cd05593 200 HEKLFELILM 209 (328)
T ss_pred HHHHHHHhcc
Confidence 8888777654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=348.87 Aligned_cols=219 Identities=39% Similarity=0.738 Sum_probs=205.4
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 191 (373)
.+...+++.+..||-||||.|=++........+|+|++++..+.+..+.+|+..|..||..+++|+||++|..|.+.+++
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 45567889999999999999999987666557999999999999999999999999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
|+.||-|-||.|+..|..++.|++..+++|++.++.|++|||++|||+|||||+|.+++.+|-+||.|||+|+.+....-
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998754321
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
..++||||.|.|||+++..+.+.++|+||||+++||||
T Consensus 576 ------------------------------------------TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL 613 (732)
T KOG0614|consen 576 ------------------------------------------TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELL 613 (732)
T ss_pred ------------------------------------------eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHH
Confidence 22789999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcC
Q 017362 352 VGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+|.|||.+.||..||+-|++|
T Consensus 614 ~G~pPFs~~dpmktYn~ILkG 634 (732)
T KOG0614|consen 614 TGSPPFSGVDPMKTYNLILKG 634 (732)
T ss_pred cCCCCCCCCchHHHHHHHHhh
Confidence 999999999999999999987
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=341.85 Aligned_cols=216 Identities=54% Similarity=0.952 Sum_probs=191.1
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|.+.+.||+|+||.||+|.+..+++.||+|++.+...........+..|..++..++|+||+.+++.+.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999998765545555667888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 196 EYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 196 E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
||++||+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|..........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~- 159 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ- 159 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee-
Confidence 99999999999976 4679999999999999999999999999999999999999999999999999997653221100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-----CCCChhhcHHHHHHHHHH
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----KGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~~DvwSlGvil~e 349 (373)
....+||+.|+|||++.+ ..++.++|||||||++||
T Consensus 160 ---------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~e 200 (331)
T cd05624 160 ---------------------------------------SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYE 200 (331)
T ss_pred ---------------------------------------eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhh
Confidence 012469999999999876 568899999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhc
Q 017362 350 MLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 350 ll~G~~Pf~~~~~~~~~~kI~~ 371 (373)
|++|++||.+.+..+.+.+|+.
T Consensus 201 ll~g~~Pf~~~~~~~~~~~i~~ 222 (331)
T cd05624 201 MLYGETPFYAESLVETYGKIMN 222 (331)
T ss_pred hhhCCCCccCCCHHHHHHHHHc
Confidence 9999999999999888888865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=338.39 Aligned_cols=215 Identities=38% Similarity=0.719 Sum_probs=189.4
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-CCceeEEeeEEEeCCeEEEEE
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~lV~ 195 (373)
+|++.+.||+|+||+||+|.++.++..||||++.+.........+.+..|..++..+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999998765444555667778888888875 577888999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
||++||+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++++||+|||+++........
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~--- 157 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT--- 157 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcc---
Confidence 99999999999988889999999999999999999999999999999999999999999999999998753211100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 355 (373)
....+||+.|+|||++.+..++.++|||||||++|||++|.+
T Consensus 158 --------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~ 199 (323)
T cd05615 158 --------------------------------------TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQP 199 (323)
T ss_pred --------------------------------------ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCC
Confidence 013569999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcC
Q 017362 356 PFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 356 Pf~~~~~~~~~~kI~~~ 372 (373)
||.+.++...+..|+..
T Consensus 200 pf~~~~~~~~~~~i~~~ 216 (323)
T cd05615 200 PFDGEDEDELFQSIMEH 216 (323)
T ss_pred CCCCCCHHHHHHHHHhC
Confidence 99999988888887653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=340.07 Aligned_cols=216 Identities=55% Similarity=0.946 Sum_probs=190.9
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++++.||+|+||+||+|.+..+++.||+|++.+...........+..|+.++..++|+||++++++|.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765555556677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 196 EYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 196 E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
||++||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++..+.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~- 159 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ- 159 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc-
Confidence 99999999999976 4579999999999999999999999999999999999999999999999999987543221100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-----CCCChhhcHHHHHHHHHH
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----KGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~~DvwSlGvil~e 349 (373)
....+||+.|+|||++.. ..++.++|||||||++||
T Consensus 160 ---------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~e 200 (331)
T cd05597 160 ---------------------------------------SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYE 200 (331)
T ss_pred ---------------------------------------ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHH
Confidence 012469999999999973 457889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhc
Q 017362 350 MLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 350 ll~G~~Pf~~~~~~~~~~kI~~ 371 (373)
|++|+.||.+.+..+.+.+|++
T Consensus 201 l~~g~~Pf~~~~~~~~~~~i~~ 222 (331)
T cd05597 201 MLYGETPFYAESLVETYGKIMN 222 (331)
T ss_pred HhhCCCCCCCCCHHHHHHHHHc
Confidence 9999999999998888888865
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=331.29 Aligned_cols=222 Identities=31% Similarity=0.526 Sum_probs=194.5
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCe
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 190 (373)
..+..++|++...||.|..++||+|+...+++.||||++...... ..++.+.+|+..|+.++||||++++.+|..+..
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~--~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~ 98 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN--NDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE 98 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh--hhHHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence 446678999999999999999999999999999999999877653 337889999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 191 LYLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
+|+||.||.+|++.+++.. ...|.|..+..++++++.||.|||++|.||||||+.||||+.+|.|||+|||.+..+..
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 9999999999999999976 35699999999999999999999999999999999999999999999999999866543
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC--CCCChhhcHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAI 346 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DvwSlGvi 346 (373)
+.. +.+-++ ...+|||.|||||+++. .+|+.|+|||||||.
T Consensus 179 ~G~------------------------------------R~~~rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGIT 221 (516)
T KOG0582|consen 179 SGD------------------------------------RQVTRF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGIT 221 (516)
T ss_pred cCc------------------------------------eeeEee-ccccCcccccChHHhhhcccCccchhhhhhhhHH
Confidence 320 011111 46899999999999664 679999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHhhc
Q 017362 347 MYEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 347 l~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
..||.+|..||..-.|..+...=++
T Consensus 222 A~ELA~G~aPf~k~pPmkvLl~tLq 246 (516)
T KOG0582|consen 222 ACELAHGHAPFSKYPPMKVLLLTLQ 246 (516)
T ss_pred HHHHhcCCCCcccCChHHHHHHHhc
Confidence 9999999999999888876654443
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=339.10 Aligned_cols=217 Identities=52% Similarity=0.920 Sum_probs=190.9
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++.+.||+|+||.||++.++.++..||+|++.+...........+..|+.++..++|++|+++++.+.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997755545555566888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 196 EYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 196 E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
||++||+|.+++.+ ...+++..++.++.|++.||.|||++||+||||||+|||++.++++||+|||++..+......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~-- 158 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-- 158 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc--
Confidence 99999999999976 467999999999999999999999999999999999999999999999999998754321100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc-----CCCCChhhcHHHHHHHHHH
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DvwSlGvil~e 349 (373)
.....+||+.|+|||++. ...++.++|||||||++||
T Consensus 159 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~e 200 (332)
T cd05623 159 --------------------------------------QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYE 200 (332)
T ss_pred --------------------------------------eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHH
Confidence 011357999999999986 3468999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhcC
Q 017362 350 MLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 350 ll~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|++|++||.+.+..+.+.+|++.
T Consensus 201 ll~g~~Pf~~~~~~~~~~~i~~~ 223 (332)
T cd05623 201 MLYGETPFYAESLVETYGKIMNH 223 (332)
T ss_pred HhcCCCCCCCCCHHHHHHHHhCC
Confidence 99999999999999999988753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=336.81 Aligned_cols=210 Identities=39% Similarity=0.726 Sum_probs=186.1
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCeEEEEEeccCC
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lV~E~~~g 200 (373)
+.||+|+||+||+|.++.++..||||++.+...........+..|..++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999876554455566777888888776 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccC
Q 017362 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (373)
Q Consensus 201 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (373)
|+|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~-------- 152 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT-------- 152 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc--------
Confidence 999999988889999999999999999999999999999999999999999999999999998743211100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCCC
Q 017362 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (373)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 360 (373)
....+||+.|+|||++.+..++.++|||||||++|||++|++||.+.
T Consensus 153 ---------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 199 (320)
T cd05590 153 ---------------------------------TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE 199 (320)
T ss_pred ---------------------------------ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 11357999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHhhcC
Q 017362 361 DPMSTCRKVRKK 372 (373)
Q Consensus 361 ~~~~~~~kI~~~ 372 (373)
+..+.+..|.++
T Consensus 200 ~~~~~~~~i~~~ 211 (320)
T cd05590 200 NEDDLFEAILND 211 (320)
T ss_pred CHHHHHHHHhcC
Confidence 999988888764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=320.40 Aligned_cols=215 Identities=32% Similarity=0.625 Sum_probs=195.7
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.+.|++-..||+|.|+.||+|.+..+|+.+|+|++........ ..+.+.+|+.|-..++|||||+|.+.+....+.|+|
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 5679999999999999999999999999999999987765444 567799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC---CCcEEEeeccccccCCCCCc
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---YGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~---~~~vkL~DFGla~~~~~~~~ 271 (373)
+|+|.|++|..-+..+..++|..+..++.||+.||.|+|.+||||||+||.|+|+-. ..-+||+|||+|..+....
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~- 167 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE- 167 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcc-
Confidence 999999999988877788999999999999999999999999999999999999954 3459999999998765221
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
.+...+|||+|||||++...+|+..+|||+-|||||-||
T Consensus 168 -----------------------------------------~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL 206 (355)
T KOG0033|consen 168 -----------------------------------------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 206 (355)
T ss_pred -----------------------------------------ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHH
Confidence 123578999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcC
Q 017362 352 VGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
.|++||++++....|+.|+.|
T Consensus 207 ~G~~PF~~~~~~rlye~I~~g 227 (355)
T KOG0033|consen 207 VGYPPFWDEDQHRLYEQIKAG 227 (355)
T ss_pred hCCCCCCCccHHHHHHHHhcc
Confidence 999999999999999999976
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=340.24 Aligned_cols=215 Identities=36% Similarity=0.649 Sum_probs=197.2
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-CCceeEEeeEEEeCCeEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYL 193 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~l 193 (373)
...|++.+.||+|.||.||+|..+.+|..+|+|++.+..+......+.+.+|+.+|..+. |||||.++++|.+...+|+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 467999999999999999999999999999999999887765556678999999999998 9999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCC----CcEEEeeccccccCCCC
Q 017362 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY----GHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 194 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~----~~vkL~DFGla~~~~~~ 269 (373)
|||++.||.|.+.+... .+++..+..++.|++.|+.|||+.|++||||||+|+|+... +.+|++|||+|......
T Consensus 114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~ 192 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG 192 (382)
T ss_pred EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC
Confidence 99999999999999877 59999999999999999999999999999999999999543 57999999999876542
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 349 (373)
. .....+|||.|+|||++...+|+..+||||+||++|.
T Consensus 193 ~------------------------------------------~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yi 230 (382)
T KOG0032|consen 193 E------------------------------------------RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYI 230 (382)
T ss_pred c------------------------------------------eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHH
Confidence 1 1225799999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhcC
Q 017362 350 MLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 350 ll~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|+.|.+||.+.+..++..+|+.+
T Consensus 231 LL~G~~PF~~~~~~~~~~~i~~~ 253 (382)
T KOG0032|consen 231 LLSGVPPFWGETEFEIFLAILRG 253 (382)
T ss_pred HhhCCCCCcCCChhHHHHHHHcC
Confidence 99999999999999999999876
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=324.50 Aligned_cols=214 Identities=29% Similarity=0.460 Sum_probs=186.5
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEE--eCCeEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ--DDEFLY 192 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~--~~~~~~ 192 (373)
.++|+.+..|++|+||.||+|+++.|++.||+|.++-... ....--...+|+.+|.+++|||||.+-.+.. .-+.+|
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke-k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE-KEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccc-cCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 5679999999999999999999999999999999986642 2222233578999999999999999987776 345799
Q ss_pred EEEeccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 193 LIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
+|||||+ .||..++..-. +|...+++.++.|++.||.|||.+.|+||||||+|+|++..|.+||+|||||+.+..+--
T Consensus 154 ~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 154 IVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK 232 (419)
T ss_pred eeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcc
Confidence 9999995 59999987644 899999999999999999999999999999999999999999999999999997753310
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~el 350 (373)
..+..+-|.+|+|||.+.+. .|+.++|+||+|||+.||
T Consensus 233 -----------------------------------------~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~ 271 (419)
T KOG0663|consen 233 -----------------------------------------PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAEL 271 (419)
T ss_pred -----------------------------------------cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHH
Confidence 12357899999999999985 599999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhc
Q 017362 351 LVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 351 l~G~~Pf~~~~~~~~~~kI~~ 371 (373)
++++|.|.+.+..+...+|.+
T Consensus 272 l~~kPlf~G~sE~dQl~~If~ 292 (419)
T KOG0663|consen 272 LTQKPLFPGKSEIDQLDKIFK 292 (419)
T ss_pred HhcCCCCCCCchHHHHHHHHH
Confidence 999999999999999888853
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=337.22 Aligned_cols=210 Identities=41% Similarity=0.748 Sum_probs=186.3
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCeEEEEEeccCC
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lV~E~~~g 200 (373)
+.||+|+||.||+|.+..+++.||||++.+...........+..|..++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3699999999999999999999999999876554455566677888888765 799999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccC
Q 017362 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (373)
Q Consensus 201 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (373)
|+|...+.....+++..+..++.|++.||.|||++||+||||||+|||++.++++||+|||+|........
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--------- 151 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--------- 151 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc---------
Confidence 99999998888899999999999999999999999999999999999999999999999999875321110
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCCC
Q 017362 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (373)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 360 (373)
.....+||+.|+|||++.+..++.++|||||||++|||++|++||.+.
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~ 199 (321)
T cd05591 152 --------------------------------TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD 199 (321)
T ss_pred --------------------------------cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC
Confidence 011357999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHhhcC
Q 017362 361 DPMSTCRKVRKK 372 (373)
Q Consensus 361 ~~~~~~~kI~~~ 372 (373)
++.+.+.+|.++
T Consensus 200 ~~~~~~~~i~~~ 211 (321)
T cd05591 200 NEDDLFESILHD 211 (321)
T ss_pred CHHHHHHHHHcC
Confidence 999999888764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=333.23 Aligned_cols=215 Identities=32% Similarity=0.543 Sum_probs=181.1
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC--eEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE--FLY 192 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~--~~~ 192 (373)
..+|...+.||+|+||.||++.+..+|...|||.+.... ....+.+.+|+.+|+.++|||||++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 456888999999999999999999889999999886542 222566889999999999999999999755444 699
Q ss_pred EEEeccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC-CCcEEEeeccccccCCCCC
Q 017362 193 LIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-YGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~-~~~vkL~DFGla~~~~~~~ 270 (373)
+.|||++||+|.+++.+.+ .+++..++.|..|++.||.|||++||||+||||+|||++. +|.+||+|||+++......
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999998876 7999999999999999999999999999999999999999 7999999999998765310
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYE 349 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~e 349 (373)
... ....+..|||.|||||++..+ ..+.++|||||||++.|
T Consensus 173 ~~~--------------------------------------~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvE 214 (313)
T KOG0198|consen 173 TKS--------------------------------------DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVE 214 (313)
T ss_pred ccc--------------------------------------cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEe
Confidence 000 001257899999999999863 23459999999999999
Q ss_pred HHhCCCCCCC-CChHHHHHHhh
Q 017362 350 MLVGYPPFYS-DDPMSTCRKVR 370 (373)
Q Consensus 350 ll~G~~Pf~~-~~~~~~~~kI~ 370 (373)
|+||++||.. ....+.+-+|.
T Consensus 215 M~Tg~~PW~~~~~~~~~~~~ig 236 (313)
T KOG0198|consen 215 MLTGKPPWSEFFEEAEALLLIG 236 (313)
T ss_pred ccCCCCcchhhcchHHHHHHHh
Confidence 9999999987 55565555554
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=329.14 Aligned_cols=204 Identities=35% Similarity=0.677 Sum_probs=179.9
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEe
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E 196 (373)
.|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.++..++|++|+.+++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 37889999999999999999999999999999887654444444567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 197 YLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 197 ~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
|+++|+|..++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~--- 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--- 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe---
Confidence 99999998887543 3689999999999999999999999999999999999999999999999999876432110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 354 (373)
....+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 158 ---------------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~ 198 (285)
T cd05631 158 ---------------------------------------VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQ 198 (285)
T ss_pred ---------------------------------------ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCC
Confidence 01357999999999999999999999999999999999999
Q ss_pred CCCCCCCh
Q 017362 355 PPFYSDDP 362 (373)
Q Consensus 355 ~Pf~~~~~ 362 (373)
+||.+.+.
T Consensus 199 ~pf~~~~~ 206 (285)
T cd05631 199 SPFRKRKE 206 (285)
T ss_pred CCCCCCCc
Confidence 99987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=336.32 Aligned_cols=210 Identities=43% Similarity=0.790 Sum_probs=183.5
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHH-HHHhcCCCceeEEeeEEEeCCeEEEEEeccCC
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN-LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~g 200 (373)
+.||+|+||+||+|.+..+++.||||++.+...........+..|.. +++.++||||+++++.+.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999999999999999998765444444445555555 46788999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccC
Q 017362 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (373)
Q Consensus 201 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (373)
|+|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--------- 151 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--------- 151 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC---------
Confidence 99999998888999999999999999999999999999999999999999999999999999864321110
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCCC
Q 017362 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (373)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 360 (373)
.....+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 199 (323)
T cd05575 152 --------------------------------TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (323)
T ss_pred --------------------------------ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC
Confidence 011357999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHhhcC
Q 017362 361 DPMSTCRKVRKK 372 (373)
Q Consensus 361 ~~~~~~~kI~~~ 372 (373)
+..+.+.+|+++
T Consensus 200 ~~~~~~~~i~~~ 211 (323)
T cd05575 200 DTAEMYDNILNK 211 (323)
T ss_pred CHHHHHHHHHcC
Confidence 999998888765
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=333.94 Aligned_cols=209 Identities=41% Similarity=0.740 Sum_probs=182.2
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHh-cCCCceeEEeeEEEeCCeEEEEEeccCC
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE-VDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~l~~~~~~~~~~~lV~E~~~g 200 (373)
+.||+|+||+||+|.+..+++.||||+++..........+....|..++.. .+||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999987654444444555667777665 4899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccC
Q 017362 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (373)
Q Consensus 201 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (373)
|+|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--------- 151 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--------- 151 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC---------
Confidence 99999998888899999999999999999999999999999999999999999999999999875422110
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCCC
Q 017362 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (373)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 360 (373)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~ 199 (316)
T cd05592 152 --------------------------------KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199 (316)
T ss_pred --------------------------------ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Confidence 011457999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHhhc
Q 017362 361 DPMSTCRKVRK 371 (373)
Q Consensus 361 ~~~~~~~kI~~ 371 (373)
+..+....|.+
T Consensus 200 ~~~~~~~~i~~ 210 (316)
T cd05592 200 DEDELFDSILN 210 (316)
T ss_pred CHHHHHHHHHc
Confidence 98888877654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=334.43 Aligned_cols=213 Identities=38% Similarity=0.716 Sum_probs=185.5
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHH---HhcCCCceeEEeeEEEeCCeEEEE
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL---AEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l---~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
|++++.||+|+||.||+|.+..+++.||||++.+.........+.+..|..++ ..++||||+++++++.+.+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67899999999999999999999999999999876544455556677776655 566899999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
|||++||+|...+. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--- 156 (324)
T cd05589 81 MEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD--- 156 (324)
T ss_pred EcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC---
Confidence 99999999988874 45799999999999999999999999999999999999999999999999999864321110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 354 (373)
.....+||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 157 --------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~ 198 (324)
T cd05589 157 --------------------------------------RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGE 198 (324)
T ss_pred --------------------------------------cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCC
Confidence 011457999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcC
Q 017362 355 PPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 355 ~Pf~~~~~~~~~~kI~~~ 372 (373)
+||.+.+..+...+|.++
T Consensus 199 ~pf~~~~~~~~~~~i~~~ 216 (324)
T cd05589 199 SPFPGDDEEEVFDSIVND 216 (324)
T ss_pred CCCCCCCHHHHHHHHHhC
Confidence 999999988888877653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=337.09 Aligned_cols=210 Identities=42% Similarity=0.773 Sum_probs=183.6
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHH-HHHhcCCCceeEEeeEEEeCCeEEEEEeccCC
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN-LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~g 200 (373)
+.||+|+||+||+|.+..+|+.||+|++.+...........+..|.. +++.++||||+++++.+...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999998764444444455555655 46778999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccC
Q 017362 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (373)
Q Consensus 201 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (373)
|+|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++........
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~-------- 152 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT-------- 152 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCC--------
Confidence 999999988889999999999999999999999999999999999999999999999999998643211000
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCCC
Q 017362 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (373)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 360 (373)
....+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.
T Consensus 153 ---------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (325)
T cd05604 153 ---------------------------------TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR 199 (325)
T ss_pred ---------------------------------cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC
Confidence 11457999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHhhcC
Q 017362 361 DPMSTCRKVRKK 372 (373)
Q Consensus 361 ~~~~~~~kI~~~ 372 (373)
+..+.+.+++++
T Consensus 200 ~~~~~~~~~~~~ 211 (325)
T cd05604 200 DVAEMYDNILHK 211 (325)
T ss_pred CHHHHHHHHHcC
Confidence 999998888764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=335.06 Aligned_cols=210 Identities=44% Similarity=0.780 Sum_probs=182.8
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHH-HHHhcCCCceeEEeeEEEeCCeEEEEEeccCC
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN-LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~g 200 (373)
+.||+|+||.||+|.+..++..||+|++.+...........+..|.. ++..++||||+++++.+.+.+..|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999998765444444445555554 57889999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccC
Q 017362 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (373)
Q Consensus 201 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (373)
|+|...+.....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--------- 151 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--------- 151 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC---------
Confidence 99999998888899999999999999999999999999999999999999999999999999874321110
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCCC
Q 017362 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (373)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 360 (373)
.....+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (321)
T cd05603 152 --------------------------------TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (321)
T ss_pred --------------------------------ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC
Confidence 011357999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHhhcC
Q 017362 361 DPMSTCRKVRKK 372 (373)
Q Consensus 361 ~~~~~~~kI~~~ 372 (373)
+....+..|+++
T Consensus 200 ~~~~~~~~i~~~ 211 (321)
T cd05603 200 DVSQMYDNILHK 211 (321)
T ss_pred CHHHHHHHHhcC
Confidence 988888887764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=335.78 Aligned_cols=210 Identities=42% Similarity=0.771 Sum_probs=182.2
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHH-HHHhcCCCceeEEeeEEEeCCeEEEEEeccCC
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN-LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~g 200 (373)
+.||+|+||+||+|.+..++..||+|++.+...........+..|.. ++..++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999998765433333344444444 56788999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccC
Q 017362 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (373)
Q Consensus 201 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (373)
|+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~-------- 152 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT-------- 152 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCC--------
Confidence 999999988888999999999999999999999999999999999999999999999999998743211100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCCC
Q 017362 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (373)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 360 (373)
....+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.
T Consensus 153 ---------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (325)
T cd05602 153 ---------------------------------TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (325)
T ss_pred ---------------------------------cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC
Confidence 11457999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHhhcC
Q 017362 361 DPMSTCRKVRKK 372 (373)
Q Consensus 361 ~~~~~~~kI~~~ 372 (373)
+..+.+.+|.++
T Consensus 200 ~~~~~~~~i~~~ 211 (325)
T cd05602 200 NTAEMYDNILNK 211 (325)
T ss_pred CHHHHHHHHHhC
Confidence 999988888754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=338.88 Aligned_cols=217 Identities=49% Similarity=0.882 Sum_probs=192.3
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|.+.+.||+|+||+||+|.+..+++.||+|++.............+..|+.++..+.||||+++++.+.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765544555677888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 196 EYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 196 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++++||+|||++..+......
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-- 158 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-- 158 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce--
Confidence 999999999999775 68999999999999999999999999999999999999999999999999999765422110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc------CCCCChhhcHHHHHHHHH
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL------KKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~~~~~DvwSlGvil~ 348 (373)
.....+||+.|+|||++. ...++.++|||||||++|
T Consensus 159 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~ 200 (330)
T cd05601 159 --------------------------------------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAY 200 (330)
T ss_pred --------------------------------------eeecccCCccccCHHHhccccccccCCCCCcceeecccceee
Confidence 011347999999999987 456889999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhcC
Q 017362 349 EMLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 349 ell~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
||++|.+||...+....+.+|++.
T Consensus 201 el~~g~~Pf~~~~~~~~~~~i~~~ 224 (330)
T cd05601 201 EMIYGRSPFHEGTSAKTYNNIMNF 224 (330)
T ss_pred eeccCCCCCCCCCHHHHHHHHHcC
Confidence 999999999999988888888753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=337.50 Aligned_cols=209 Identities=41% Similarity=0.730 Sum_probs=185.3
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEeccCCC
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGG 201 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~gg 201 (373)
+.||+|+||.||+|.+..++..||+|++.+...........+..|+.++..++||||+++++.+.+.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765544555667788999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccC
Q 017362 202 DMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (373)
Q Consensus 202 ~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (373)
+|..++.....+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-------- 152 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-------- 152 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc--------
Confidence 999999888889999999999999999999997 89999999999999999999999999998743211100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCCC
Q 017362 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (373)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 360 (373)
....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 153 ---------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~ 199 (325)
T cd05594 153 ---------------------------------MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199 (325)
T ss_pred ---------------------------------cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC
Confidence 01357999999999999999999999999999999999999999998
Q ss_pred ChHHHHHHhhc
Q 017362 361 DPMSTCRKVRK 371 (373)
Q Consensus 361 ~~~~~~~kI~~ 371 (373)
+..+....|..
T Consensus 200 ~~~~~~~~i~~ 210 (325)
T cd05594 200 DHEKLFELILM 210 (325)
T ss_pred CHHHHHHHHhc
Confidence 88887777654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=331.91 Aligned_cols=209 Identities=40% Similarity=0.729 Sum_probs=182.5
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCeEEEEEeccCC
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lV~E~~~g 200 (373)
+.||+|+||.||+|.++.++..||+|++.+..............|..++... +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999999999999999999876543334455667777777654 899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccC
Q 017362 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (373)
Q Consensus 201 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (373)
|+|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.......
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--------- 151 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--------- 151 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC---------
Confidence 99999998888899999999999999999999999999999999999999999999999999864321110
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCCC
Q 017362 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (373)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 360 (373)
.....+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~ 199 (316)
T cd05620 152 --------------------------------RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199 (316)
T ss_pred --------------------------------ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 011457999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHhhc
Q 017362 361 DPMSTCRKVRK 371 (373)
Q Consensus 361 ~~~~~~~kI~~ 371 (373)
+..+....|..
T Consensus 200 ~~~~~~~~~~~ 210 (316)
T cd05620 200 DEDELFESIRV 210 (316)
T ss_pred CHHHHHHHHHh
Confidence 88888777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=321.88 Aligned_cols=213 Identities=31% Similarity=0.471 Sum_probs=184.6
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCc-eeEEeeEEEeCC----
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC-IVKLYCSFQDDE---- 189 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~l~~~~~~~~---- 189 (373)
...|..+++||+|+||+||+|+.+.+|+.||+|.+...... +.......+|+.+++.++|+| ||.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 34578888899999999999999999999999999765321 223344678999999999999 999999999877
Q ss_pred --eEEEEEeccCCCCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeecccc
Q 017362 190 --FLYLIMEYLPGGDMMTLLMRKD----TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (373)
Q Consensus 190 --~~~lV~E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla 263 (373)
.+|+|+||+ .-||..++.... .++...++.++.||+.||+|||++||+||||||.||||+.+|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 899999999 569999997654 5888999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHH
Q 017362 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWS 342 (373)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwS 342 (373)
+.+.-+.. ..++.++|.+|+|||++.+. .|+..+||||
T Consensus 168 ra~~ip~~-----------------------------------------~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs 206 (323)
T KOG0594|consen 168 RAFSIPMR-----------------------------------------TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWS 206 (323)
T ss_pred HHhcCCcc-----------------------------------------cccccEEEeeccCHHHhcCCCcCCCCcchHh
Confidence 85532210 01256899999999999986 7999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 017362 343 LGAIMYEMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 343 lGvil~ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
+|||++||+++++.|.+.+..+...+|-
T Consensus 207 ~GcIfaEm~~~~~LFpG~se~~ql~~If 234 (323)
T KOG0594|consen 207 LGCIFAEMFTRRPLFPGDSEIDQLFRIF 234 (323)
T ss_pred HHHHHHHHHhCCCCCCCCcHHHHHHHHH
Confidence 9999999999999999999888877764
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=331.81 Aligned_cols=211 Identities=45% Similarity=0.810 Sum_probs=184.3
Q ss_pred eceeeeeCcEEEEEEEEc---CCCceEeeeecchhHhhh-hhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEe
Q 017362 121 LTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKSEMLR-RGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (373)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E 196 (373)
++.||+|+||.||+|.+. .+++.||+|++....... ......+..|+.++..++||||+++++.|.+++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 367999999999999863 468899999998754322 2334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccc
Q 017362 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (373)
Q Consensus 197 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 276 (373)
|++||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----- 155 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT----- 155 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-----
Confidence 999999999998888899999999999999999999999999999999999999999999999999864321110
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCC
Q 017362 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356 (373)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 356 (373)
.....+||+.|+|||++.+..++.++|||||||++|||++|++|
T Consensus 156 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~p 199 (323)
T cd05584 156 ------------------------------------VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199 (323)
T ss_pred ------------------------------------cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCC
Confidence 01135799999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHhhcC
Q 017362 357 FYSDDPMSTCRKVRKK 372 (373)
Q Consensus 357 f~~~~~~~~~~kI~~~ 372 (373)
|.+.+....+.+|+++
T Consensus 200 f~~~~~~~~~~~~~~~ 215 (323)
T cd05584 200 FTAENRKKTIDKILKG 215 (323)
T ss_pred CCCCCHHHHHHHHHcC
Confidence 9999988888887654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=329.60 Aligned_cols=209 Identities=39% Similarity=0.733 Sum_probs=181.9
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHh-cCCCceeEEeeEEEeCCeEEEEEeccCC
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE-VDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~l~~~~~~~~~~~lV~E~~~g 200 (373)
+.||+|+||+||+|.+..++..||||++................|..++.. ++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999987654333444556677777775 4899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccC
Q 017362 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (373)
Q Consensus 201 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (373)
|+|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-------- 152 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-------- 152 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc--------
Confidence 999999988788999999999999999999999999999999999999999999999999998643211100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCCC
Q 017362 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (373)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 360 (373)
....+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.
T Consensus 153 ---------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (316)
T cd05619 153 ---------------------------------TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH 199 (316)
T ss_pred ---------------------------------eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC
Confidence 11357999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHhhc
Q 017362 361 DPMSTCRKVRK 371 (373)
Q Consensus 361 ~~~~~~~kI~~ 371 (373)
+..+..+.|..
T Consensus 200 ~~~~~~~~i~~ 210 (316)
T cd05619 200 DEEELFQSIRM 210 (316)
T ss_pred CHHHHHHHHHh
Confidence 88887776653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=328.46 Aligned_cols=210 Identities=36% Similarity=0.682 Sum_probs=191.7
Q ss_pred hhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC
Q 017362 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (373)
Q Consensus 109 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 188 (373)
....+..+.|..-++||+||||.||-|..+.||+.||+|.+.+..+..+.......+|..+|..+..++||.+-++|.+.
T Consensus 178 E~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk 257 (591)
T KOG0986|consen 178 ELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK 257 (591)
T ss_pred HhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC
Confidence 44567888999999999999999999999999999999999887776666667788999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~ 266 (373)
+.+|+||..|.||||.-.+.+-+ .|++..+++|+++|+.||.+||..+||+|||||+|||+|+.|||+|+|+|||..+
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEec
Confidence 99999999999999998886655 8999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHH
Q 017362 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (373)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvi 346 (373)
..... ..+.+||.+|||||++....|+...|||||||+
T Consensus 338 ~~g~~------------------------------------------~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCl 375 (591)
T KOG0986|consen 338 PEGKP------------------------------------------IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCL 375 (591)
T ss_pred CCCCc------------------------------------------cccccCcccccCHHHHcCCcccCCccHHHHHhH
Confidence 54431 114589999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCC
Q 017362 347 MYEMLVGYPPFYSD 360 (373)
Q Consensus 347 l~ell~G~~Pf~~~ 360 (373)
+|||+.|..||...
T Consensus 376 lYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 376 LYEMIAGHSPFRQR 389 (591)
T ss_pred HHHHHcccCchhhh
Confidence 99999999999754
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=321.71 Aligned_cols=216 Identities=31% Similarity=0.512 Sum_probs=188.8
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe-----CC
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD-----DE 189 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-----~~ 189 (373)
...|..++.||.|+||.|+.|.++.+|+.||||.+... .......++..+|+.+|+.++|+||+.+++.+.. -+
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 45566789999999999999999999999999998743 3344556778899999999999999999999875 34
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
.+|+|+|+| +.||...+.....++++.+.+++.|++.||.|+|+.+++||||||.|+|++.+..+||+|||||+.....
T Consensus 100 DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc
Confidence 589999999 7799999988878999999999999999999999999999999999999999999999999999987533
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ 348 (373)
... ...+..+-|.+|+|||++.. ..|+.++||||+||||.
T Consensus 179 -~~~--------------------------------------~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~A 219 (359)
T KOG0660|consen 179 -FED--------------------------------------GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILA 219 (359)
T ss_pred -Ccc--------------------------------------cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHH
Confidence 000 11235688999999999875 67999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhc
Q 017362 349 EMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 349 ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
|||+|++.|.+.+..+..+.|+.
T Consensus 220 EmL~gkplFpG~d~v~Ql~lI~~ 242 (359)
T KOG0660|consen 220 EMLTGKPLFPGKDYVHQLQLILE 242 (359)
T ss_pred HHHcCCCCCCCCchHHHHHHHHH
Confidence 99999999999999888887764
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=328.24 Aligned_cols=210 Identities=40% Similarity=0.724 Sum_probs=185.6
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCeEEEEEeccCC
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lV~E~~~g 200 (373)
+.||+|+||+||+|.+..++..||||++.+...........+..|..++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999877655555566677888888877 799999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccC
Q 017362 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (373)
Q Consensus 201 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (373)
|+|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-------- 152 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT-------- 152 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc--------
Confidence 999999988889999999999999999999999999999999999999999999999999998642211100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCCC
Q 017362 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (373)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 360 (373)
....+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.
T Consensus 153 ---------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~ 199 (318)
T cd05570 153 ---------------------------------TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199 (318)
T ss_pred ---------------------------------ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC
Confidence 11357999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHhhcC
Q 017362 361 DPMSTCRKVRKK 372 (373)
Q Consensus 361 ~~~~~~~kI~~~ 372 (373)
+..+....|.++
T Consensus 200 ~~~~~~~~i~~~ 211 (318)
T cd05570 200 DEDELFQSILED 211 (318)
T ss_pred CHHHHHHHHHcC
Confidence 888888777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=330.40 Aligned_cols=196 Identities=38% Similarity=0.731 Sum_probs=175.2
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCeEEEEEeccCC
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lV~E~~~g 200 (373)
+.||+|+||.||+|.+..++..||+|++.+...........+..|..++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876554455567788899999888 799999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccC
Q 017362 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (373)
Q Consensus 201 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (373)
|+|..++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--------- 151 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--------- 151 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC---------
Confidence 99999998888999999999999999999999999999999999999999999999999999864211100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCC
Q 017362 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358 (373)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 358 (373)
.....+||+.|+|||++.+..++.++|||||||++|||++|++||.
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 197 (329)
T cd05588 152 --------------------------------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred --------------------------------ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcc
Confidence 0113579999999999999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=337.43 Aligned_cols=216 Identities=32% Similarity=0.572 Sum_probs=197.0
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCe-EEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF-LYL 193 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~-~~l 193 (373)
.++|..++.+|+|+||.+++++++..+..|++|.+.......+.. .....|+.+++++.|||||.+.++|..++. +||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r-~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER-RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh-HHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 468999999999999999999999999999999998765444433 367889999999999999999999998887 999
Q ss_pred EEeccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 194 IMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 194 V~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
||+||+||+|.+.+.+.. .|+++.+..|+.|++.||.|||+.+|+|||||+.|||++.++.|+|+|||+|+.+....
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 999999999999997644 69999999999999999999999999999999999999999999999999999876442
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
.++.+.+|||.||+||++.+.+|+.++|||||||++|||+
T Consensus 161 ----------------------------------------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~ 200 (426)
T KOG0589|consen 161 ----------------------------------------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMC 200 (426)
T ss_pred ----------------------------------------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHH
Confidence 1244789999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcC
Q 017362 352 VGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+=+++|.+.+....+.||.++
T Consensus 201 ~lk~aF~a~~m~~Li~ki~~~ 221 (426)
T KOG0589|consen 201 TLKPAFKASNMSELILKINRG 221 (426)
T ss_pred hcccccCccchHHHHHHHhhc
Confidence 999999999999999999875
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=322.56 Aligned_cols=212 Identities=28% Similarity=0.457 Sum_probs=182.2
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|++.+.||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 4689999999999999999999999999999999865421 22234577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 195 MEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
|||+++ +|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~- 159 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT- 159 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc-
Confidence 999975 8998886544 5899999999999999999999999999999999999999999999999998754321100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHHHHHh
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~ 352 (373)
.....||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 160 ----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~ 199 (288)
T cd07871 160 ----------------------------------------YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMAT 199 (288)
T ss_pred ----------------------------------------ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHh
Confidence 013468999999999876 568999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhh
Q 017362 353 GYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 353 G~~Pf~~~~~~~~~~kI~ 370 (373)
|++||.+.+..+....|.
T Consensus 200 g~~pf~~~~~~~~~~~~~ 217 (288)
T cd07871 200 GRPMFPGSTVKEELHLIF 217 (288)
T ss_pred CCCCCCCCCHHHHHHHHH
Confidence 999999988877766654
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=327.74 Aligned_cols=197 Identities=38% Similarity=0.736 Sum_probs=175.8
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCeEEEEEeccCC
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lV~E~~~g 200 (373)
+.||+|+||+||+|.+..++..||+|++.+...........+..|..++..+ .||+|+.+++.+.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876555555667788899998887 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccC
Q 017362 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (373)
Q Consensus 201 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (373)
|+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-------- 152 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT-------- 152 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc--------
Confidence 999999988888999999999999999999999999999999999999999999999999998743211100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCC
Q 017362 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 359 (373)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 359 (373)
....+||+.|+|||++.+..++.++|||||||++|||++|.+||..
T Consensus 153 ---------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 153 ---------------------------------TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred ---------------------------------eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 1145799999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=322.00 Aligned_cols=213 Identities=33% Similarity=0.527 Sum_probs=183.2
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++.+.||+|+||+||+|.++.++..||+|++..... .....+.+.+|+.++..++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999999876432 2334466788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
||++++++..+......+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++..........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-- 157 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN-- 157 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc--
Confidence 999988776665555679999999999999999999999999999999999999999999999999997653221000
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 355 (373)
.....||+.|+|||++.+..++.++|||||||++|||++|++
T Consensus 158 --------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~ 199 (287)
T cd07848 158 --------------------------------------YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQP 199 (287)
T ss_pred --------------------------------------ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCC
Confidence 013468999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHh
Q 017362 356 PFYSDDPMSTCRKV 369 (373)
Q Consensus 356 Pf~~~~~~~~~~kI 369 (373)
||.+.+..+....|
T Consensus 200 pf~~~~~~~~~~~~ 213 (287)
T cd07848 200 LFPGESEIDQLFTI 213 (287)
T ss_pred CCCCCCHHHHHHHH
Confidence 99987766554433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=311.17 Aligned_cols=216 Identities=32% Similarity=0.595 Sum_probs=191.6
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhh-----hhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCC
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML-----RRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~ 189 (373)
..|...+.||.|..++|..|.++.+|..+|+|++...... ...-.+.-..|+.||+++ .||+|+.+.++|+.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 4577888999999999999999999999999998532111 122235567799999887 7999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
++++|+|.|+.|.|.++|...-.++++.++.|+.|++.|+.|||.++||||||||+|||++++-+|||+|||+|..+...
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999887644
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC------CCCChhhcHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK------KGYGMECDWWSL 343 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~~~~~DvwSl 343 (373)
.- ....||||+|.|||.+.. .+|+..+|+||+
T Consensus 177 ek------------------------------------------LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~ 214 (411)
T KOG0599|consen 177 EK------------------------------------------LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWAC 214 (411)
T ss_pred hh------------------------------------------HHHhcCCCcccChhheeeecccCCCCccchhhHHHH
Confidence 21 115799999999999863 568999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHhhcCC
Q 017362 344 GAIMYEMLVGYPPFYSDDPMSTCRKVRKKS 373 (373)
Q Consensus 344 Gvil~ell~G~~Pf~~~~~~~~~~kI~~~~ 373 (373)
|||||-||.|.|||......-+.+.|+.|+
T Consensus 215 GVImyTLLaGcpPFwHRkQmlMLR~ImeGk 244 (411)
T KOG0599|consen 215 GVIMYTLLAGCPPFWHRKQMLMLRMIMEGK 244 (411)
T ss_pred HHHHHHHHcCCCchhHHHHHHHHHHHHhcc
Confidence 999999999999999999999999999874
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=328.04 Aligned_cols=196 Identities=39% Similarity=0.746 Sum_probs=174.0
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCeEEEEEeccCC
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lV~E~~~g 200 (373)
+.||+|+||+||+|.+..+++.||+|++.+...........+..|..++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876544445556678888888776 899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccC
Q 017362 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (373)
Q Consensus 201 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (373)
|+|..++.....+++..++.++.|++.||.|||++||+||||||+|||++.++++||+|||+++........
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~-------- 152 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-------- 152 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc--------
Confidence 999999988889999999999999999999999999999999999999999999999999998743211100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCC
Q 017362 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358 (373)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 358 (373)
....+||+.|+|||++.+..++.++|||||||++|||++|.+||.
T Consensus 153 ---------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 153 ---------------------------------TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred ---------------------------------cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 013579999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=331.23 Aligned_cols=208 Identities=44% Similarity=0.781 Sum_probs=180.4
Q ss_pred eeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc---CCCceeEEeeEEEeCCeEEEEEeccCC
Q 017362 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV---DSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (373)
Q Consensus 124 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~l~~~~~~~~~~~lV~E~~~g 200 (373)
||+|+||+||+|.+..++..||+|++.+..............|..++... .||||+.+++.+.+.+.+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999776554444455566677776655 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccC
Q 017362 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (373)
Q Consensus 201 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (373)
|+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--------- 151 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--------- 151 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC---------
Confidence 99999998888999999999999999999999999999999999999999999999999999865321110
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHHHHHHHHHHHhCCCCCCC
Q 017362 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGYPPFYS 359 (373)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~Pf~~ 359 (373)
.....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~ 199 (330)
T cd05586 152 --------------------------------TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199 (330)
T ss_pred --------------------------------CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC
Confidence 01145799999999999764 589999999999999999999999999
Q ss_pred CChHHHHHHhhcC
Q 017362 360 DDPMSTCRKVRKK 372 (373)
Q Consensus 360 ~~~~~~~~kI~~~ 372 (373)
.+..+.+++|..+
T Consensus 200 ~~~~~~~~~i~~~ 212 (330)
T cd05586 200 EDTQQMYRNIAFG 212 (330)
T ss_pred CCHHHHHHHHHcC
Confidence 9998888887643
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=316.14 Aligned_cols=207 Identities=39% Similarity=0.758 Sum_probs=188.7
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCC
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~ 189 (373)
..+...+|.++++||+|+|++|.+++.+.|.+.||+|++++.-......+..+..|..+.... +||++|-+...|+.+.
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes 324 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES 324 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence 346788999999999999999999999999999999999987666666778888888888665 6899999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
.+++|.||++||+|+-.+.++..++++.+++|.++|+.||.|||++|||+||||.+|+|+|..||+||+|+|+|+..-.+
T Consensus 325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999853221
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 349 (373)
.. +..++||||.|+|||++++..|++.+|||+|||+|||
T Consensus 405 gd-----------------------------------------~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfe 443 (593)
T KOG0695|consen 405 GD-----------------------------------------TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFE 443 (593)
T ss_pred Cc-----------------------------------------ccccccCCCcccchhhhcccccCceehHHHHHHHHHH
Confidence 10 0126899999999999999999999999999999999
Q ss_pred HHhCCCCCC
Q 017362 350 MLVGYPPFY 358 (373)
Q Consensus 350 ll~G~~Pf~ 358 (373)
|+.|+.||.
T Consensus 444 mmagrspfd 452 (593)
T KOG0695|consen 444 MMAGRSPFD 452 (593)
T ss_pred HHcCCCCcc
Confidence 999999996
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=332.69 Aligned_cols=217 Identities=23% Similarity=0.437 Sum_probs=188.4
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCe
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 190 (373)
.++....+.+++.||+|-||.||+|.+.. ...||+|.++...+ ..+.|.+|+.+|++++|++||++++++..++.
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p 275 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEP 275 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecccc----ChhHHHHHHHHHHhCcccCeEEEEEEEecCCc
Confidence 44455567788999999999999998753 34799999876533 23567899999999999999999999999889
Q ss_pred EEEEEeccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 191 LYLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
+|||||||+.|+|.++|.. ...+.......++.|||.|++||+++++|||||...|||++++..+||+|||||+....
T Consensus 276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCC
Confidence 9999999999999999986 45799999999999999999999999999999999999999999999999999995554
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 348 (373)
..+.... ..--...|.|||.+..+.++.+||||||||+||
T Consensus 356 ~~Y~~~~----------------------------------------~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~ 395 (468)
T KOG0197|consen 356 DEYTASE----------------------------------------GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLW 395 (468)
T ss_pred CceeecC----------------------------------------CCCCCceecCHHHHhhCCcccccceeehhhhHH
Confidence 4332110 122345799999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 349 EMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 349 ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
||+| |+.||...+..++...|-+|
T Consensus 396 E~fT~G~~py~~msn~ev~~~le~G 420 (468)
T KOG0197|consen 396 ELFTYGRVPYPGMSNEEVLELLERG 420 (468)
T ss_pred HHhccCCCCCCCCCHHHHHHHHhcc
Confidence 9999 99999999999999988776
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=325.44 Aligned_cols=204 Identities=45% Similarity=0.812 Sum_probs=176.5
Q ss_pred CcceeceeeeeCcEEEEEEEEc---CCCceEeeeecchhHhhh-hhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCeE
Q 017362 117 DFELLTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKSEMLR-RGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~ 191 (373)
+|++++.||+|+||.||+|.+. .++..||+|++.+..... ....+.+..|+.++..+ .||+|+.+++.+...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999998763 478899999997654332 23346678899999999 589999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
|+||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999875432110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~el 350 (373)
. .....+||+.|+|||++.+. .++.++|||||||++|||
T Consensus 161 ~----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el 200 (332)
T cd05614 161 E----------------------------------------RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFEL 200 (332)
T ss_pred C----------------------------------------ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhh
Confidence 0 01145799999999999865 488999999999999999
Q ss_pred HhCCCCCCCC
Q 017362 351 LVGYPPFYSD 360 (373)
Q Consensus 351 l~G~~Pf~~~ 360 (373)
++|..||...
T Consensus 201 ltg~~pf~~~ 210 (332)
T cd05614 201 LTGASPFTLE 210 (332)
T ss_pred hcCCCCCCCC
Confidence 9999999743
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=316.23 Aligned_cols=207 Identities=35% Similarity=0.690 Sum_probs=181.0
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEe
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E 196 (373)
.|++.+.||+|+||+||++.+..++..||+|++.............+.+|+.+++.++||||+++++.+.+++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48899999999999999999988999999999976554433444557789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 197 YLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 197 ~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
|++||+|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.+++++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--- 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--- 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc---
Confidence 99999999888653 4699999999999999999999999999999999999999999999999999875431110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 354 (373)
....+||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 158 ---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~ 198 (285)
T cd05605 158 ---------------------------------------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198 (285)
T ss_pred ---------------------------------------cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCC
Confidence 01347999999999999999999999999999999999999
Q ss_pred CCCCCCChHHH
Q 017362 355 PPFYSDDPMST 365 (373)
Q Consensus 355 ~Pf~~~~~~~~ 365 (373)
+||.+.+....
T Consensus 199 ~pf~~~~~~~~ 209 (285)
T cd05605 199 SPFRQRKEKVK 209 (285)
T ss_pred CCCCCCchhhH
Confidence 99998765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=322.10 Aligned_cols=209 Identities=28% Similarity=0.460 Sum_probs=185.6
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 192 (373)
+..++|++++.||+|+||.||+|.+..++..||+|++.... .......+.+|+.++..++||||+++++++.+++.+|
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 44689999999999999999999999999999999987542 2334467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH-HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~-giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
+||||++||+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++..+....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 9999999999999998888899999999999999999999986 69999999999999999999999999987543211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 159 ------------------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 196 (331)
T cd06649 159 ------------------------------------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELA 196 (331)
T ss_pred ------------------------------------------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHH
Confidence 01357999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHH
Q 017362 352 VGYPPFYSDDPMSTC 366 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~ 366 (373)
+|+.||...+..+..
T Consensus 197 tg~~p~~~~~~~~~~ 211 (331)
T cd06649 197 IGRYPIPPPDAKELE 211 (331)
T ss_pred hCCCCCCCCCHHHHH
Confidence 999999877765543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=329.06 Aligned_cols=206 Identities=34% Similarity=0.586 Sum_probs=187.9
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
...|.....||+|+||.||+|.+..+++.||+|++..... ...++.+.+|+.+++.++++||.++|++|..+..++++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 3458888999999999999999999999999999987643 55677889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
||||.||++.++|.....+.+..+..++.+++.||.|||..+.+|||||+.|||+..+|.+||+|||++-.+......
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r-- 167 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR-- 167 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhc--
Confidence 999999999999988888899999999999999999999999999999999999999999999999999765432211
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 354 (373)
..+++|||.||||||+...+|+.++||||||++.+||++|.
T Consensus 168 ---------------------------------------r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~Ge 208 (467)
T KOG0201|consen 168 ---------------------------------------RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGE 208 (467)
T ss_pred ---------------------------------------cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCC
Confidence 13789999999999999999999999999999999999999
Q ss_pred CCCCCCChH
Q 017362 355 PPFYSDDPM 363 (373)
Q Consensus 355 ~Pf~~~~~~ 363 (373)
|||....|+
T Consensus 209 PP~s~~hPm 217 (467)
T KOG0201|consen 209 PPHSKLHPM 217 (467)
T ss_pred CCCcccCcc
Confidence 999988774
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=319.45 Aligned_cols=203 Identities=29% Similarity=0.485 Sum_probs=174.3
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|++.+.||+|+||+||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 5789999999999999999999999999999999875432 22234567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 195 MEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
|||++ ++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 158 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH-- 158 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--
Confidence 99995 6787777553 5789999999999999999999999999999999999999999999999999865321110
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHHHHHh
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~ 352 (373)
......||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 159 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~ 199 (303)
T cd07869 159 ---------------------------------------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQ 199 (303)
T ss_pred ---------------------------------------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 0113568999999999875 458999999999999999999
Q ss_pred CCCCCCCCC
Q 017362 353 GYPPFYSDD 361 (373)
Q Consensus 353 G~~Pf~~~~ 361 (373)
|.+||.+..
T Consensus 200 g~~pf~~~~ 208 (303)
T cd07869 200 GVAAFPGMK 208 (303)
T ss_pred CCCCCCCCc
Confidence 999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=330.61 Aligned_cols=207 Identities=27% Similarity=0.375 Sum_probs=178.2
Q ss_pred hhhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe
Q 017362 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (373)
Q Consensus 108 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 187 (373)
+......+++|.....||+|+||.||+|... ++..||||.+....... ...|.+|+.++..++|||+|+|+|+|.+
T Consensus 67 ~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e 142 (361)
T KOG1187|consen 67 YDELRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLE 142 (361)
T ss_pred HHHHHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEec
Confidence 4444556789999999999999999999864 44899999876543211 3449999999999999999999999999
Q ss_pred CC-eEEEEEeccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhC---CCeeecCCCCCEEEcCCCcEEEeecc
Q 017362 188 DE-FLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKH---HYIHRDIKPDNLLLDKYGHLRLSDFG 261 (373)
Q Consensus 188 ~~-~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---giiHrDikp~NILl~~~~~vkL~DFG 261 (373)
.+ ..+||+|||++|+|.+.|.... +++|.....|+.+++.||+|||.. .||||||||.|||+|.++.+||+|||
T Consensus 143 ~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFG 222 (361)
T KOG1187|consen 143 GGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFG 222 (361)
T ss_pred CCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCcc
Confidence 88 4999999999999999998765 899999999999999999999974 49999999999999999999999999
Q ss_pred ccccCCC-CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhcccccc-ccCCCCcccccccCCCCChhhc
Q 017362 262 LCKPLDC-STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLLKKGYGMECD 339 (373)
Q Consensus 262 la~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~gt~~Y~aPE~~~~~~~~~~~D 339 (373)
+|+..+. .... .+. .||.+|+|||++..+..+.++|
T Consensus 223 La~~~~~~~~~~------------------------------------------~~~~~gt~gY~~PEy~~~g~lt~KsD 260 (361)
T KOG1187|consen 223 LAKLGPEGDTSV------------------------------------------STTVMGTFGYLAPEYASTGKLTEKSD 260 (361)
T ss_pred CcccCCccccce------------------------------------------eeecCCCCccCChhhhccCCcCcccc
Confidence 9965542 1100 012 7999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCC
Q 017362 340 WWSLGAIMYEMLVGYPPFYSD 360 (373)
Q Consensus 340 vwSlGvil~ell~G~~Pf~~~ 360 (373)
||||||+|+||++|+.|....
T Consensus 261 VySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 261 VYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred cccchHHHHHHHhCCcccCCC
Confidence 999999999999999988754
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=315.28 Aligned_cols=197 Identities=37% Similarity=0.666 Sum_probs=173.4
Q ss_pred eeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEeccCCCCH
Q 017362 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM 203 (373)
Q Consensus 124 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~gg~L 203 (373)
||+|+||+||+|.+..+++.||+|.+...........+.+..|+.++..++||||+++.+++.....+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999999999999999999876554444556778899999999999999999999999999999999999999
Q ss_pred HHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccccccc
Q 017362 204 MTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279 (373)
Q Consensus 204 ~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 279 (373)
...+.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++..+......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~------- 153 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK------- 153 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-------
Confidence 887743 346999999999999999999999999999999999999999999999999998755322110
Q ss_pred CCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCC
Q 017362 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 359 (373)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 359 (373)
.....||+.|+|||++.+..++.++|+|||||++|||++|+.||..
T Consensus 154 ----------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 199 (280)
T cd05608 154 ----------------------------------TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA 199 (280)
T ss_pred ----------------------------------ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 0134699999999999999999999999999999999999999986
Q ss_pred CC
Q 017362 360 DD 361 (373)
Q Consensus 360 ~~ 361 (373)
.+
T Consensus 200 ~~ 201 (280)
T cd05608 200 RG 201 (280)
T ss_pred CC
Confidence 54
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=323.17 Aligned_cols=208 Identities=27% Similarity=0.436 Sum_probs=175.7
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC-----CeE
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD-----EFL 191 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-----~~~ 191 (373)
+|++.+.||+|+||.||+|.+..++..||||.+.... ........+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 5899999999999999999999999999999986432 1222334678899999999999999999988643 248
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
|+||||+ +++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 9999999 579999998888899999999999999999999999999999999999999999999999999975432110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC--CCCChhhcHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DvwSlGvil~e 349 (373)
.. ......+||+.|+|||++.+ ..++.++|||||||++||
T Consensus 159 ~~--------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~e 200 (338)
T cd07859 159 TA--------------------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 200 (338)
T ss_pred cc--------------------------------------ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHH
Confidence 00 00114579999999999876 678999999999999999
Q ss_pred HHhCCCCCCCCChHH
Q 017362 350 MLVGYPPFYSDDPMS 364 (373)
Q Consensus 350 ll~G~~Pf~~~~~~~ 364 (373)
|++|++||.+.+...
T Consensus 201 l~tg~~pf~~~~~~~ 215 (338)
T cd07859 201 VLTGKPLFPGKNVVH 215 (338)
T ss_pred HHcCCCCCCCCChHH
Confidence 999999998776543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=336.46 Aligned_cols=215 Identities=31% Similarity=0.465 Sum_probs=186.2
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCC-CceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTT-GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
..|.+.+.||+|+||.||+|....+ +..||+|.+.... ......+..|+.+++.++|||||++++.|...+.+|+|
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 4499999999999999999998777 7889999765432 33345678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 195 MEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
|||++||+|.+++.. ..++++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+....
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999999987743 3468999999999999999999999999999999999999999999999999998654221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 350 (373)
.. ....+.+||+.|+|||++.+..++.++|||||||++|||
T Consensus 224 ~~---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el 264 (478)
T PTZ00267 224 SL---------------------------------------DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYEL 264 (478)
T ss_pred cc---------------------------------------ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHH
Confidence 00 001146799999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcC
Q 017362 351 LVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 351 l~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
++|++||.+.+..+...+++.+
T Consensus 265 ~tg~~Pf~~~~~~~~~~~~~~~ 286 (478)
T PTZ00267 265 LTLHRPFKGPSQREIMQQVLYG 286 (478)
T ss_pred HhCCCCCCCCCHHHHHHHHHhC
Confidence 9999999999888888877654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=324.88 Aligned_cols=211 Identities=24% Similarity=0.392 Sum_probs=174.5
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEc-----CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSF 185 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~ 185 (373)
.+..++|++.+.||+|+||.||+|.+. .++..||||++.... .......+..|+.++..+ +||||+++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 456678999999999999999999752 345689999987532 123345688899999999 899999999988
Q ss_pred EeC-CeEEEEEeccCCCCHHHHHhhC------------------------------------------------------
Q 017362 186 QDD-EFLYLIMEYLPGGDMMTLLMRK------------------------------------------------------ 210 (373)
Q Consensus 186 ~~~-~~~~lV~E~~~gg~L~~~l~~~------------------------------------------------------ 210 (373)
... ..+|+||||+++|+|.+++...
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 764 4589999999999999998642
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccCCC
Q 017362 211 --------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282 (373)
Q Consensus 211 --------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~ 282 (373)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~--------- 231 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV--------- 231 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchh---------
Confidence 247788999999999999999999999999999999999999999999999997543211000
Q ss_pred CCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh-CCCCCCCCC
Q 017362 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDD 361 (373)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf~~~~ 361 (373)
...+..+++.|+|||++.+..++.++|||||||++|||++ |.+||.+.+
T Consensus 232 ------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~ 281 (338)
T cd05102 232 ------------------------------RKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281 (338)
T ss_pred ------------------------------cccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence 0013456789999999999999999999999999999997 999998765
Q ss_pred hH
Q 017362 362 PM 363 (373)
Q Consensus 362 ~~ 363 (373)
..
T Consensus 282 ~~ 283 (338)
T cd05102 282 IN 283 (338)
T ss_pred cc
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=324.75 Aligned_cols=208 Identities=42% Similarity=0.745 Sum_probs=182.6
Q ss_pred ceeeeeCcEEEEEEEE---cCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEecc
Q 017362 122 TMIGKGAFGEVRVCRE---KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYL 198 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~ 198 (373)
+.||+|+||.||++.+ ..+|..||+|++...... ......+..|+.++..++||||+++++.+.+++.+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5799999999999876 357899999999875432 223345678999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccc
Q 017362 199 PGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278 (373)
Q Consensus 199 ~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 278 (373)
++|+|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~------- 153 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK------- 153 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-------
Confidence 9999999998888899999999999999999999999999999999999999999999999999875432110
Q ss_pred cCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCC
Q 017362 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358 (373)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 358 (373)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 154 ----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 199 (318)
T cd05582 154 ----------------------------------KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQ 199 (318)
T ss_pred ----------------------------------ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCC
Confidence 0114579999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHhhc
Q 017362 359 SDDPMSTCRKVRK 371 (373)
Q Consensus 359 ~~~~~~~~~kI~~ 371 (373)
..+..+....|.+
T Consensus 200 ~~~~~~~~~~i~~ 212 (318)
T cd05582 200 GKDRKETMTMILK 212 (318)
T ss_pred CCCHHHHHHHHHc
Confidence 9998888887765
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=317.73 Aligned_cols=206 Identities=30% Similarity=0.504 Sum_probs=177.0
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC--C---e
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--E---F 190 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~---~ 190 (373)
-.|...+++|.|+||.||.|....+++.||||......- . --+|+.+|..++|||||+|..+|... . +
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~---knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----Y---KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----c---CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 358888999999999999999999999999998765431 1 22489999999999999999888642 2 4
Q ss_pred EEEEEeccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCC-CcEEEeecccccc
Q 017362 191 LYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY-GHLRLSDFGLCKP 265 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~-~~vkL~DFGla~~ 265 (373)
+.+||||||. +|...+.. +..++.-.++-|..||+.||.|||+.||+||||||.|+|+|.+ |.+||||||-|+.
T Consensus 97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 5689999975 88888864 5679999999999999999999999999999999999999976 8999999999998
Q ss_pred CCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHH
Q 017362 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 344 (373)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG 344 (373)
+.....+. +-.-|..|+|||.+.+ ..|+.+.||||.|
T Consensus 176 L~~~epni------------------------------------------SYicSRyYRaPELifga~~Yt~~IDiWSaG 213 (364)
T KOG0658|consen 176 LVKGEPNI------------------------------------------SYICSRYYRAPELIFGATEYTTSIDIWSAG 213 (364)
T ss_pred eccCCCce------------------------------------------eEEEeccccCHHHHcCccccCceeEEhhhh
Confidence 76553221 4567889999999987 5699999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHhhc
Q 017362 345 AIMYEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 345 vil~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
|+|.||+-|+|.|.+.+..+....|++
T Consensus 214 CV~aELl~g~plFpG~s~~dQL~eIik 240 (364)
T KOG0658|consen 214 CVMAELLKGQPLFPGDSSVDQLVEIIK 240 (364)
T ss_pred HHHHHHhcCCcccCCCCHHHHHHHHHH
Confidence 999999999999999998888777653
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=332.06 Aligned_cols=210 Identities=28% Similarity=0.454 Sum_probs=184.3
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-C-----CceeEEeeEEE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-S-----NCIVKLYCSFQ 186 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~iv~l~~~~~ 186 (373)
....+|.+.+.||+|+||.|-+|.+..|++.||||+++... ........|+.+|..++ | -|+|+++++|.
T Consensus 183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~ 258 (586)
T KOG0667|consen 183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY 258 (586)
T ss_pred eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc
Confidence 33447999999999999999999999999999999998754 23344566888998886 4 38999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC--cEEEeeccc
Q 017362 187 DDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG--HLRLSDFGL 262 (373)
Q Consensus 187 ~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~--~vkL~DFGl 262 (373)
..+++|||+|.+ .-+|.+++..+. .|+...++.++.||+.||.+||+.||||.||||+||||..-+ .|||+|||.
T Consensus 259 fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 259 FRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred cccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccc
Confidence 999999999999 679999997754 689999999999999999999999999999999999996543 799999999
Q ss_pred cccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHH
Q 017362 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342 (373)
Q Consensus 263 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwS 342 (373)
|...... .++-+.+..|+|||++++.+|+.+.||||
T Consensus 338 Sc~~~q~--------------------------------------------vytYiQSRfYRAPEVILGlpY~~~IDmWS 373 (586)
T KOG0667|consen 338 SCFESQR--------------------------------------------VYTYIQSRFYRAPEVILGLPYDTAIDMWS 373 (586)
T ss_pred ccccCCc--------------------------------------------ceeeeeccccccchhhccCCCCCccceee
Confidence 8754322 12456788999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 017362 343 LGAIMYEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 343 lGvil~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
||||++||++|.|.|.+++..+....|+.
T Consensus 374 LGCIlAEL~tG~PLfpG~ne~DQl~~I~e 402 (586)
T KOG0667|consen 374 LGCILAELFTGEPLFPGDNEYDQLARIIE 402 (586)
T ss_pred hhhhHHhHhcCccccCCCCHHHHHHHHHH
Confidence 99999999999999999999999988864
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=327.66 Aligned_cols=199 Identities=25% Similarity=0.382 Sum_probs=175.5
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 191 (373)
.+...+|++++.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+++.++||||++++++|......
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 158 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFT 158 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence 3556789999999999999999999999999999997532 2367899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
|+|||++ +++|..++.....+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+|........
T Consensus 159 ~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 159 CLILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred EEEEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 9999999 578999998888899999999999999999999999999999999999999999999999999864321100
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
. .....+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 238 ~----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell 277 (391)
T PHA03212 238 N----------------------------------------KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMA 277 (391)
T ss_pred c----------------------------------------ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHH
Confidence 0 011457999999999999999999999999999999999
Q ss_pred hCCCCCCCC
Q 017362 352 VGYPPFYSD 360 (373)
Q Consensus 352 ~G~~Pf~~~ 360 (373)
+|..||...
T Consensus 278 tg~~p~~~~ 286 (391)
T PHA03212 278 TCHDSLFEK 286 (391)
T ss_pred HCCCCcCCc
Confidence 999888754
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=335.25 Aligned_cols=221 Identities=29% Similarity=0.492 Sum_probs=188.9
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC--
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE-- 189 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~-- 189 (373)
+...++|.+.+.||+|+||+||+|.+..+++.||||++..... .......+.+|+.++..++|+||++++..+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3456899999999999999999999999999999999876532 2334556788999999999999999988775432
Q ss_pred ------eEEEEEeccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEee
Q 017362 190 ------FLYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSD 259 (373)
Q Consensus 190 ------~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~D 259 (373)
.+++||||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++++||+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEe
Confidence 37899999999999998864 24689999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhc
Q 017362 260 FGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECD 339 (373)
Q Consensus 260 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D 339 (373)
||+++.+....... .....+||+.|+|||++.+..|+.++|
T Consensus 187 FGls~~~~~~~~~~---------------------------------------~~~~~~Gt~~Y~aPE~~~~~~~s~k~D 227 (496)
T PTZ00283 187 FGFSKMYAATVSDD---------------------------------------VGRTFCGTPYYVAPEIWRRKPYSKKAD 227 (496)
T ss_pred cccCeecccccccc---------------------------------------ccccccCCcceeCHHHhCCCCCCcHHH
Confidence 99997653221000 011457999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcC
Q 017362 340 WWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 340 vwSlGvil~ell~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
||||||++|||++|++||.+.+..+.+.+++.+
T Consensus 228 VwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~ 260 (496)
T PTZ00283 228 MFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG 260 (496)
T ss_pred HHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence 999999999999999999999988888887754
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=331.11 Aligned_cols=209 Identities=28% Similarity=0.455 Sum_probs=174.8
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC----
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD---- 188 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~---- 188 (373)
....+|.+++.||+|+||.||+|.+..++..||||.+.... ....+|+.+++.++||||++++++|...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK 135 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence 34578999999999999999999999999999999885432 1234699999999999999998877432
Q ss_pred ----CeEEEEEeccCCCCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC-cEEEee
Q 017362 189 ----EFLYLIMEYLPGGDMMTLLM----RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSD 259 (373)
Q Consensus 189 ----~~~~lV~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~-~vkL~D 259 (373)
.++++||||+++ +|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeec
Confidence 257899999975 6766654 345799999999999999999999999999999999999999665 699999
Q ss_pred ccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhh
Q 017362 260 FGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMEC 338 (373)
Q Consensus 260 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~ 338 (373)
||+|+.+..... ..+.+||+.|+|||++.+. .|+.++
T Consensus 215 FGla~~~~~~~~------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~ 252 (440)
T PTZ00036 215 FGSAKNLLAGQR------------------------------------------SVSYICSRFYRAPELMLGATNYTTHI 252 (440)
T ss_pred cccchhccCCCC------------------------------------------cccCCCCcCccCHHHhcCCCCCCcHH
Confidence 999986532210 1145789999999998764 699999
Q ss_pred cHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 017362 339 DWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 339 DvwSlGvil~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
|||||||++|||++|++||.+.++.+...+|++
T Consensus 253 DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 285 (440)
T PTZ00036 253 DLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ 285 (440)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 999999999999999999999988887777653
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=309.78 Aligned_cols=213 Identities=46% Similarity=0.918 Sum_probs=193.3
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++.+.+.+.+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999899999999998766555556678889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
||+++++|.+++.....+++..+..++.|++.||.|||++|++|+||+|+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~----- 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT----- 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCC-----
Confidence 999999999999888899999999999999999999999999999999999999999999999999987653220
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 355 (373)
....|++.|+|||.+.+..++.++|+||||+++|+|++|.+
T Consensus 156 ---------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 196 (290)
T cd05580 156 ---------------------------------------YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYP 196 (290)
T ss_pred ---------------------------------------CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 13468999999999988889999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcC
Q 017362 356 PFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 356 Pf~~~~~~~~~~kI~~~ 372 (373)
||...++....+++.++
T Consensus 197 p~~~~~~~~~~~~~~~~ 213 (290)
T cd05580 197 PFFDDNPIQIYEKILEG 213 (290)
T ss_pred CCCCCCHHHHHHHHhcC
Confidence 99998888888777653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=305.07 Aligned_cols=209 Identities=34% Similarity=0.592 Sum_probs=180.5
Q ss_pred CCCccee-ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEE----eC
Q 017362 115 ADDFELL-TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQ----DD 188 (373)
Q Consensus 115 ~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~----~~ 188 (373)
+++|.+. ++||-|-.|.|..|.++.|++.+|+|++..+. ..++|+++.-.. .|||||.++++|. ..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~--------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP--------KARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH--------HHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 5677775 57899999999999999999999999986543 356788775444 7999999998876 34
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC---CCcEEEeecccc
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRKDT--LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---YGHLRLSDFGLC 263 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~---~~~vkL~DFGla 263 (373)
..+.+|||+|+||.|...+..++. |+|..+..|+.||+.||.|||+.+|.||||||+|+|... |-.+||+|||+|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 678899999999999999988764 999999999999999999999999999999999999965 457999999999
Q ss_pred ccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHH
Q 017362 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (373)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSl 343 (373)
+...... ...+.+-||.|.|||++....|+..||+||+
T Consensus 212 K~t~~~~------------------------------------------~L~TPc~TPyYvaPevlg~eKydkscdmwSl 249 (400)
T KOG0604|consen 212 KETQEPG------------------------------------------DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSL 249 (400)
T ss_pred cccCCCc------------------------------------------cccCCcccccccCHHHhCchhcCCCCCccch
Confidence 8654221 1226789999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCC----hHHHHHHhhcCC
Q 017362 344 GAIMYEMLVGYPPFYSDD----PMSTCRKVRKKS 373 (373)
Q Consensus 344 Gvil~ell~G~~Pf~~~~----~~~~~~kI~~~~ 373 (373)
|||||-||.|+|||++.- +..+..+|..|+
T Consensus 250 gVimYIlLCGyPPFYS~hg~aispgMk~rI~~gq 283 (400)
T KOG0604|consen 250 GVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQ 283 (400)
T ss_pred hHHHHHhhcCCCcccccCCccCChhHHhHhhccC
Confidence 999999999999999863 678888888875
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=324.09 Aligned_cols=212 Identities=25% Similarity=0.404 Sum_probs=182.2
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC-----eE
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE-----FL 191 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~-----~~ 191 (373)
+|++++.||+|+||.||+|.+..+++.||||.+.... ........+.+|+.++..++||||+++++++.+.. .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 5889999999999999999999999999999986431 12233456788999999999999999999998776 78
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
|+||||++ ++|..++.....+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 99999995 68988888888899999999999999999999999999999999999999999999999999975432210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~el 350 (373)
. .....++|+.|+|||++.+. .++.++|||||||++|||
T Consensus 159 ~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el 198 (372)
T cd07853 159 K----------------------------------------HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAEL 198 (372)
T ss_pred c----------------------------------------cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHH
Confidence 0 01134689999999999874 489999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhh
Q 017362 351 LVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 351 l~G~~Pf~~~~~~~~~~kI~ 370 (373)
++|++||.+.++.+....|.
T Consensus 199 ~~g~~pf~~~~~~~~~~~i~ 218 (372)
T cd07853 199 LGRRILFQAQSPIQQLDLIT 218 (372)
T ss_pred HcCCCCCCCCCHHHHHHHHH
Confidence 99999999998887776664
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=311.83 Aligned_cols=219 Identities=31% Similarity=0.492 Sum_probs=187.1
Q ss_pred hhhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhh----hhHHHHHHHHHHHHhcCCCceeEEee
Q 017362 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR----GQVEHVRAERNLLAEVDSNCIVKLYC 183 (373)
Q Consensus 108 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~l~~ 183 (373)
+.+.....++|-++.+||+|||+.||+|.+....+.||+|+-.....+.. +...+..+|..|.+.++||.||++|+
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD 534 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD 534 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence 55566777889999999999999999999999999999998765544433 34567889999999999999999999
Q ss_pred EEE-eCCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhC--CCeeecCCCCCEEEc---CCCcEEE
Q 017362 184 SFQ-DDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH--HYIHRDIKPDNLLLD---KYGHLRL 257 (373)
Q Consensus 184 ~~~-~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~--giiHrDikp~NILl~---~~~~vkL 257 (373)
+|. |.+.+|-|+|||+|.||..+|.....+++..++.|+.||+.||.||... .|||.||||.|||+- ..|.|||
T Consensus 535 yfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 535 YFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred eeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEe
Confidence 997 6678999999999999999999999999999999999999999999964 699999999999994 5688999
Q ss_pred eeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC----C
Q 017362 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK----G 333 (373)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~ 333 (373)
+||||++.++...+...+ |. .+..-..||.+|.+||.+.-+ .
T Consensus 615 TDFGLSKIMdddSy~~vd---Gm-------------------------------eLTSQgAGTYWYLPPEcFvVgkePPK 660 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVD---GM-------------------------------ELTSQGAGTYWYLPPECFVVGKEPPK 660 (775)
T ss_pred eecchhhhccCCccCccc---ce-------------------------------eeecccCceeeecCcceeecCCCCCc
Confidence 999999998765443211 11 112246899999999999754 3
Q ss_pred CChhhcHHHHHHHHHHHHhCCCCCCCC
Q 017362 334 YGMECDWWSLGAIMYEMLVGYPPFYSD 360 (373)
Q Consensus 334 ~~~~~DvwSlGvil~ell~G~~Pf~~~ 360 (373)
.+.++||||+|||+|+|+.|+-||..+
T Consensus 661 IsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 661 ISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred cccceeeEeeehhhhhhhccCCCCCCc
Confidence 688999999999999999999999765
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=316.57 Aligned_cols=208 Identities=29% Similarity=0.464 Sum_probs=183.5
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 192 (373)
+..++|++.+.||.|+||.||+|.+..++..+|+|++.... .......+.+|+.++..++||||++++++|.+.+.+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 45688999999999999999999999999999999886532 2233456889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH-HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~-giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
+||||++||+|.+++.....+++..+..++.+++.||.|||+. +++||||||+|||++.++.+||+|||++..+....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 158 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence 9999999999999998888899999999999999999999974 79999999999999999999999999986542110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
.....||+.|+|||++.+..++.++|||||||++|||+
T Consensus 159 ------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~ 196 (333)
T cd06650 159 ------------------------------------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 196 (333)
T ss_pred ------------------------------------------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHH
Confidence 11346899999999999989999999999999999999
Q ss_pred hCCCCCCCCChHHH
Q 017362 352 VGYPPFYSDDPMST 365 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~ 365 (373)
+|+.||...+..+.
T Consensus 197 ~g~~p~~~~~~~~~ 210 (333)
T cd06650 197 IGRYPIPPPDAKEL 210 (333)
T ss_pred HCCCCCCCcchhHH
Confidence 99999987665444
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=319.04 Aligned_cols=214 Identities=33% Similarity=0.579 Sum_probs=193.1
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
..=|.+.+.||+|.|++|-+|++.-+|..||||++.+.++. .....++..|+..|+.++|||||+||++......+|||
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD-~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc-hhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 35588999999999999999999999999999999987653 34457788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEE-cCCCcEEEeeccccccCCCCCcc
Q 017362 195 MEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL-DKYGHLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl-~~~~~vkL~DFGla~~~~~~~~~ 272 (373)
+|+=.+|||.+++++. ..+.|+.++.|++||+.||.|+|+..+|||||||+||.+ ..-|-|||+|||++..+.+...
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k- 174 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK- 174 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch-
Confidence 9999999999999875 479999999999999999999999999999999999876 5668999999999977654421
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCC-hhhcHHHHHHHHHHHH
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYG-MECDWWSLGAIMYEML 351 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell 351 (373)
.++.||++.|-|||++++..|+ +++||||||||||-|+
T Consensus 175 -----------------------------------------L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLV 213 (864)
T KOG4717|consen 175 -----------------------------------------LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLV 213 (864)
T ss_pred -----------------------------------------hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHH
Confidence 1267999999999999999996 6799999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhc
Q 017362 352 VGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~~ 371 (373)
.|++||...+..+|.-+|+.
T Consensus 214 CGq~PFqeANDSETLTmImD 233 (864)
T KOG4717|consen 214 CGQPPFQEANDSETLTMIMD 233 (864)
T ss_pred hCCCccccccchhhhhhhhc
Confidence 99999999999999999874
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=307.82 Aligned_cols=210 Identities=34% Similarity=0.669 Sum_probs=181.9
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEe
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E 196 (373)
.|+..+.||+|+||+||+|.+..+++.||+|.+.............+.+|+.++..++|++|+.+++.+.+++..|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 37788999999999999999999999999999876554434444557789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 197 YLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 197 ~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
|+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~--- 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--- 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc---
Confidence 99999999888653 3699999999999999999999999999999999999999999999999999865432110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 354 (373)
.....|++.|+|||++.+..++.++|+|||||++|||++|.
T Consensus 158 ---------------------------------------~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 198 (285)
T cd05632 158 ---------------------------------------IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198 (285)
T ss_pred ---------------------------------------ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCC
Confidence 01357999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHH
Q 017362 355 PPFYSDDPMSTCRK 368 (373)
Q Consensus 355 ~Pf~~~~~~~~~~k 368 (373)
+||.+..+......
T Consensus 199 ~P~~~~~~~~~~~~ 212 (285)
T cd05632 199 SPFRGRKEKVKREE 212 (285)
T ss_pred CCCCCCCHHHHHHH
Confidence 99988766544333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=309.58 Aligned_cols=204 Identities=19% Similarity=0.243 Sum_probs=179.2
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe----CCeEEEEEec
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD----DEFLYLIMEY 197 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~----~~~~~lV~E~ 197 (373)
..||+|++|.||+|.. +|+.||||.+...........+.+.+|+.+|..++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6799999999999986 688999999976543333335778899999999999999999999977 4578999999
Q ss_pred cCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccc
Q 017362 198 LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (373)
Q Consensus 198 ~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 276 (373)
++||+|.+++.....+++.....++.+++.||.|||+ .+++||||||+|||++.++.+||+|||+++.+....
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~------ 177 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP------ 177 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc------
Confidence 9999999999888889999999999999999999998 599999999999999999999999999987543211
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC--CCCChhhcHHHHHHHHHHHHhCC
Q 017362 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~ 354 (373)
...+||+.|+|||++.+ ..|+.++|||||||++|||++|.
T Consensus 178 --------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~ 219 (283)
T PHA02988 178 --------------------------------------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219 (283)
T ss_pred --------------------------------------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCC
Confidence 13468999999999976 68999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhc
Q 017362 355 PPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 355 ~Pf~~~~~~~~~~kI~~ 371 (373)
.||.+.++.+.+..|++
T Consensus 220 ~Pf~~~~~~~~~~~i~~ 236 (283)
T PHA02988 220 IPFENLTTKEIYDLIIN 236 (283)
T ss_pred CCCCCCCHHHHHHHHHh
Confidence 99999998888888754
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=319.62 Aligned_cols=209 Identities=29% Similarity=0.444 Sum_probs=177.5
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC-----
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~----- 189 (373)
.++|++.+.||+|+||.||+|.+..++..||+|++.... ........+.+|+.++..++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 578999999999999999999999999999999986542 22333456778999999999999999999987543
Q ss_pred -eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 190 -FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 190 -~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
.+|+||||+++ +|...+. ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 47999999965 6666653 3588999999999999999999999999999999999999999999999999875321
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 348 (373)
.. ......||+.|+|||++.+..++.++|||||||++|
T Consensus 176 ~~------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ 213 (359)
T cd07876 176 NF------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 213 (359)
T ss_pred Cc------------------------------------------cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHH
Confidence 11 011357899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHh
Q 017362 349 EMLVGYPPFYSDDPMSTCRKV 369 (373)
Q Consensus 349 ell~G~~Pf~~~~~~~~~~kI 369 (373)
+|++|.+||.+.+..+.+.++
T Consensus 214 el~tg~~pf~~~~~~~~~~~~ 234 (359)
T cd07876 214 ELVKGSVIFQGTDHIDQWNKV 234 (359)
T ss_pred HHHhCCCCCCCCCHHHHHHHH
Confidence 999999999988876655544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=307.28 Aligned_cols=196 Identities=35% Similarity=0.615 Sum_probs=171.1
Q ss_pred eeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEeccCCCCH
Q 017362 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM 203 (373)
Q Consensus 124 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~gg~L 203 (373)
||+|+||.||++.++.+|+.||+|.+.............+..|+.++..++||||+++++.+.++..+|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999765543333344566799999999999999999999999999999999999999
Q ss_pred HHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccCC
Q 017362 204 MTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281 (373)
Q Consensus 204 ~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~ 281 (373)
.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---------- 150 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---------- 150 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce----------
Confidence 98885533 589999999999999999999999999999999999999999999999999876532110
Q ss_pred CCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCCCC
Q 017362 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361 (373)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~ 361 (373)
.....||+.|+|||++.+..++.++|||||||++|||++|.+||.+..
T Consensus 151 --------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~ 198 (277)
T cd05607 151 --------------------------------ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198 (277)
T ss_pred --------------------------------eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence 013468999999999999899999999999999999999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=309.93 Aligned_cols=212 Identities=27% Similarity=0.456 Sum_probs=175.9
Q ss_pred CCcceeceeeeeCcEEEEEEEEcC-CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc---CCCceeEEeeEEE-----
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKT-TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV---DSNCIVKLYCSFQ----- 186 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~l~~~~~----- 186 (373)
.+|++.+.||+|+||+||+|.+.. ++..||+|++...... ......+.+|+.++..+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC-CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 369999999999999999999854 5688999988754321 22223455676666655 6999999999885
Q ss_pred eCCeEEEEEeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccc
Q 017362 187 DDEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (373)
Q Consensus 187 ~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~ 264 (373)
....+|+||||++ ++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3456899999996 6899988653 458999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHH
Q 017362 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344 (373)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG 344 (373)
...... ......||+.|+|||++.+..++.++||||||
T Consensus 159 ~~~~~~------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG 196 (290)
T cd07862 159 IYSFQM------------------------------------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVG 196 (290)
T ss_pred eccCCc------------------------------------------ccccccccccccChHHHhCCCCCCccchHHHH
Confidence 543211 01145799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHhhc
Q 017362 345 AIMYEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 345 vil~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
|++|||++|.+||.+.+..+...+|++
T Consensus 197 ~il~el~~g~~~f~~~~~~~~~~~i~~ 223 (290)
T cd07862 197 CIFAEMFRRKPLFRGSSDVDQLGKILD 223 (290)
T ss_pred HHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence 999999999999999998888877764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=307.63 Aligned_cols=210 Identities=29% Similarity=0.464 Sum_probs=175.4
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc---CCCceeEEeeEEEe-----C
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV---DSNCIVKLYCSFQD-----D 188 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~l~~~~~~-----~ 188 (373)
+|++.+.||+|+||+||+|.++.+++.||+|.+...... ......+.+|+.++..+ +||||+++++++.+ .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 588999999999999999999999999999998754211 11222345566666554 79999999998864 3
Q ss_pred CeEEEEEeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~ 266 (373)
..+++||||++ ++|.+++... ..+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 45899999997 4888888653 35899999999999999999999999999999999999999999999999998765
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHH
Q 017362 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (373)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvi 346 (373)
..... .....||+.|+|||++.+..++.++|||||||+
T Consensus 159 ~~~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~ 196 (288)
T cd07863 159 SCQMA------------------------------------------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCI 196 (288)
T ss_pred cCccc------------------------------------------CCCccccccccCchHhhCCCCCCcchhhhHHHH
Confidence 32210 013568999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHhh
Q 017362 347 MYEMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 347 l~ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
+|||++|.+||.+.+..+...+|.
T Consensus 197 l~~l~~g~~~f~~~~~~~~~~~~~ 220 (288)
T cd07863 197 FAEMFRRKPLFCGNSEADQLGKIF 220 (288)
T ss_pred HHHHHhCCcCcCCCCHHHHHHHHH
Confidence 999999999999988887777664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=306.96 Aligned_cols=203 Identities=35% Similarity=0.690 Sum_probs=177.8
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEe
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E 196 (373)
.|++.+.||+|+||.||+|.+..+++.||+|.+.............+..|+.++..++|++|+.+++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 37888999999999999999999999999999876544333334557789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 197 YLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 197 ~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
|++|++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--- 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--- 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc---
Confidence 99999999988543 3589999999999999999999999999999999999999999999999999865431110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 354 (373)
.....||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 158 ---------------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~ 198 (285)
T cd05630 158 ---------------------------------------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198 (285)
T ss_pred ---------------------------------------ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCC
Confidence 01347999999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 017362 355 PPFYSDD 361 (373)
Q Consensus 355 ~Pf~~~~ 361 (373)
+||....
T Consensus 199 ~Pf~~~~ 205 (285)
T cd05630 199 SPFQQRK 205 (285)
T ss_pred CCCCCCC
Confidence 9998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=339.33 Aligned_cols=225 Identities=26% Similarity=0.399 Sum_probs=181.2
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++.++||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999999999999999987543323334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccc
Q 017362 196 EYLPGGDMMTLLMRK-----------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (373)
Q Consensus 196 E~~~gg~L~~~l~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~ 264 (373)
||++||+|.+++... ..++...+..++.|++.||.|||++||+||||||+|||++.+|.++|+|||+++
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999999998641 235567788999999999999999999999999999999999999999999998
Q ss_pred cCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHH
Q 017362 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344 (373)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG 344 (373)
................ ..... .........+||+.|+|||++.+..++.++||||||
T Consensus 162 ~i~~~~~~~~~l~~~~------~~s~~-----------------s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLG 218 (932)
T PRK13184 162 FKKLEEEDLLDIDVDE------RNICY-----------------SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALG 218 (932)
T ss_pred eccccccccccccccc------ccccc-----------------cccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHH
Confidence 6632211100000000 00000 000011245799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChH
Q 017362 345 AIMYEMLVGYPPFYSDDPM 363 (373)
Q Consensus 345 vil~ell~G~~Pf~~~~~~ 363 (373)
|++|||++|.+||...+..
T Consensus 219 VILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 219 VILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred HHHHHHHHCCCCCCCcchh
Confidence 9999999999999876543
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=327.95 Aligned_cols=209 Identities=23% Similarity=0.476 Sum_probs=174.0
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCC------CceeEEeeEE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS------NCIVKLYCSF 185 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~l~~~~ 185 (373)
....++|++++.||+|+||+||+|.+..+++.||||++..... .......|+.++..+.| ++++.++++|
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 3456889999999999999999999999999999999864321 12234456666666544 5688999888
Q ss_pred EeC-CeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCCEEEcCCC----------
Q 017362 186 QDD-EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYG---------- 253 (373)
Q Consensus 186 ~~~-~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~giiHrDikp~NILl~~~~---------- 253 (373)
... ..+|+|||++ |++|.+++.+.+.+++..+..++.||+.||.|||+ .|||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 764 5789999998 78999999888899999999999999999999997 6999999999999998765
Q ss_pred ------cEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccc
Q 017362 254 ------HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPE 327 (373)
Q Consensus 254 ------~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE 327 (373)
.+||+|||++...... ....+||+.|+|||
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~~~--------------------------------------------~~~~~gt~~Y~APE 315 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDERHS--------------------------------------------RTAIVSTRHYRSPE 315 (467)
T ss_pred cCCCCceEEECCCCccccCccc--------------------------------------------cccccCCccccCcH
Confidence 4999999987532111 11468999999999
Q ss_pred cccCCCCChhhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 017362 328 VLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369 (373)
Q Consensus 328 ~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~kI 369 (373)
++.+..|+.++|||||||++|||++|++||.+.+..+....|
T Consensus 316 ~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 316 VVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred HhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 999999999999999999999999999999988876655444
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=299.96 Aligned_cols=218 Identities=33% Similarity=0.563 Sum_probs=187.7
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhh--hhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML--RRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 193 (373)
++|.+.+.||+|++|.||.|.+..++..||+|.+...... .......+.+|+.++..++||||+++++++.+.+.+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999999899999999998654321 12234568889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 194 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
||||++|++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++.........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999987543211000
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhC
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 353 (373)
. ......|++.|+|||++.+..++.++|||||||++|||++|
T Consensus 162 ~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 203 (263)
T cd06625 162 T--------------------------------------GMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTE 203 (263)
T ss_pred c--------------------------------------cccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhC
Confidence 0 00134688999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhc
Q 017362 354 YPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 354 ~~Pf~~~~~~~~~~kI~~ 371 (373)
++||.+.++.+...++..
T Consensus 204 ~~p~~~~~~~~~~~~~~~ 221 (263)
T cd06625 204 KPPWAEFEAMAAIFKIAT 221 (263)
T ss_pred CCCccccchHHHHHHHhc
Confidence 999998877776665543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=304.09 Aligned_cols=217 Identities=18% Similarity=0.311 Sum_probs=183.0
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEc---CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 189 (373)
+...+|++.+.||+|+||.||+|... ..+..||+|.++... .......+.+|+.++..++||||+++++++...+
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 34577999999999999999999765 346689999987542 2233456888999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
..|+||||+++|+|.+++... ..+++..+..++.|++.||+|||++|++||||||+|||++.++.++|+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999999998764 5789999999999999999999999999999999999999999999999998754321
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 348 (373)
.... ......+++.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 199 (266)
T cd05064 160 EAIY----------------------------------------TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMW 199 (266)
T ss_pred cchh----------------------------------------cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHH
Confidence 1000 000234567899999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHhhc
Q 017362 349 EMLV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 349 ell~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
|+++ |.+||.+.++.+..+.|.+
T Consensus 200 ell~~g~~p~~~~~~~~~~~~~~~ 223 (266)
T cd05064 200 EVMSYGERPYWDMSGQDVIKAVED 223 (266)
T ss_pred HHhcCCCCCcCcCCHHHHHHHHHC
Confidence 9875 9999999888877776654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=318.38 Aligned_cols=211 Identities=28% Similarity=0.434 Sum_probs=181.4
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC------
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD------ 188 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~------ 188 (373)
.++|++.+.||+|+||.||+|.+..++..||||++.... ........+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 578999999999999999999999999999999987532 2233345677899999999999999999988643
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
..+|+||||+++ +|...+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 357999999965 77777643 588999999999999999999999999999999999999999999999999975432
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 348 (373)
... ....+||+.|+|||++.+..++.++|||||||++|
T Consensus 179 ~~~------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ 216 (364)
T cd07875 179 SFM------------------------------------------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216 (364)
T ss_pred CCc------------------------------------------ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHH
Confidence 210 11357899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhc
Q 017362 349 EMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 349 ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
||++|.+||.+.+..+.+.+|+.
T Consensus 217 ell~g~~pf~~~~~~~~~~~~~~ 239 (364)
T cd07875 217 EMIKGGVLFPGTDHIDQWNKVIE 239 (364)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999999999998888887764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=309.79 Aligned_cols=212 Identities=27% Similarity=0.454 Sum_probs=180.2
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|.+.+.||+|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.++||||+++++++..++..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 4779999999999999999999999999999999875432 22234567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 195 MEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
|||+++ +|..++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 160 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT- 160 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccc-
Confidence 999965 888887654 45899999999999999999999999999999999999999999999999998754321100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHHHHHh
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~ 352 (373)
.....+|+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 161 ----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~t 200 (309)
T cd07872 161 ----------------------------------------YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMAS 200 (309)
T ss_pred ----------------------------------------cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 013468999999999875 458999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhh
Q 017362 353 GYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 353 G~~Pf~~~~~~~~~~kI~ 370 (373)
|++||.+.+..+....+.
T Consensus 201 g~~pf~~~~~~~~~~~~~ 218 (309)
T cd07872 201 GRPLFPGSTVEDELHLIF 218 (309)
T ss_pred CCCCCCCCChHHHHHHHH
Confidence 999999888776665553
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=307.75 Aligned_cols=214 Identities=19% Similarity=0.366 Sum_probs=177.4
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcC----------------CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCc
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKT----------------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 177 (373)
..++|.+.++||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.++..++|||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence 45789999999999999999997532 34479999987542 2333456888999999999999
Q ss_pred eeEEeeEEEeCCeEEEEEeccCCCCHHHHHhhC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 017362 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK-------------------DTLTEDEARFYVAETVLAIESIHKHHYI 238 (373)
Q Consensus 178 iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-------------------~~l~~~~~~~i~~qi~~aL~~LH~~gii 238 (373)
|+++++++.+.+..|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 999999999999999999999999999998543 2367788999999999999999999999
Q ss_pred eecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccc
Q 017362 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTV 318 (373)
Q Consensus 239 HrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (373)
||||||+|||++.++.+||+|||+++.+....... ......
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~---------------------------------------~~~~~~ 201 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYR---------------------------------------IQGRAV 201 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeE---------------------------------------ecCcCC
Confidence 99999999999999999999999997653221100 011345
Q ss_pred cCCCCcccccccCCCCChhhcHHHHHHHHHHHHh--CCCCCCCCChHHHHHH
Q 017362 319 GTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV--GYPPFYSDDPMSTCRK 368 (373)
Q Consensus 319 gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~--G~~Pf~~~~~~~~~~k 368 (373)
+++.|+|||++....++.++|||||||++|||++ |..||...++.+....
T Consensus 202 ~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~ 253 (304)
T cd05096 202 LPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIEN 253 (304)
T ss_pred CCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHH
Confidence 6889999999998999999999999999999986 6789987776655443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=316.46 Aligned_cols=210 Identities=28% Similarity=0.423 Sum_probs=178.6
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC-----
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~----- 189 (373)
.++|++.+.||+|+||.||+|.+..+++.||||.+.... ........+.+|+.+++.++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 578999999999999999999999999999999987542 12233456778999999999999999999886543
Q ss_pred -eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 190 -FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 190 -~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
.+|+||||+++ +|...+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 47999999965 67666643 588999999999999999999999999999999999999999999999999975432
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 348 (373)
... .....||+.|+|||++.+..++.++|||||||++|
T Consensus 172 ~~~------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ 209 (355)
T cd07874 172 SFM------------------------------------------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 209 (355)
T ss_pred ccc------------------------------------------cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHH
Confidence 210 11357899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhh
Q 017362 349 EMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 349 ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
+|++|++||.+.+..+.+.+++
T Consensus 210 el~~g~~pf~~~~~~~~~~~~~ 231 (355)
T cd07874 210 EMVRHKILFPGRDYIDQWNKVI 231 (355)
T ss_pred HHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999988776665554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=304.37 Aligned_cols=218 Identities=23% Similarity=0.450 Sum_probs=186.0
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCC-----ceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTG-----HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 188 (373)
..++|++.+.||+|+||.||+|.....+ ..||+|.+.... .......+.+|+.++..++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 4568999999999999999999876544 679999986442 223345688899999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRK----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY 252 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~ 252 (373)
...|++|||+++|+|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+|||++.+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 9999999999999999999754 457889999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC
Q 017362 253 GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332 (373)
Q Consensus 253 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 332 (373)
+.++|+|||+++......... ......+++.|+|||++...
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~ 201 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYR---------------------------------------VQSKSLLPVRWMPPEAILYG 201 (283)
T ss_pred CcEEECCCcceeecccccccc---------------------------------------ccCCCcccccccCHHHhccC
Confidence 999999999987543221100 01134578899999999989
Q ss_pred CCChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 333 GYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 333 ~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
.++.++|||||||++|||++ |..||.+.++.+...+|.++
T Consensus 202 ~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~ 242 (283)
T cd05048 202 KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR 242 (283)
T ss_pred cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999999999999998 99999999998888887654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=319.61 Aligned_cols=217 Identities=24% Similarity=0.353 Sum_probs=178.9
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCC-----CceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTT-----GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSF 185 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~ 185 (373)
.+..++|++.+.||+|+||.||+|.+... +..||+|++..... ......+.+|+.+++.+ +|+||++++++|
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 45567899999999999999999986433 35799999975422 23346688899999999 899999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHhhC-------------------------------------------------------
Q 017362 186 QDDEFLYLIMEYLPGGDMMTLLMRK------------------------------------------------------- 210 (373)
Q Consensus 186 ~~~~~~~lV~E~~~gg~L~~~l~~~------------------------------------------------------- 210 (373)
.+.+.+|+||||+++|+|.+++...
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 9999999999999999999998542
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 211 ---------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 211 ---------------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
..+++..+..++.|++.||.|||++||+||||||+|||++.++++||+|||+++.........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~-- 269 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV-- 269 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee--
Confidence 247888999999999999999999999999999999999999999999999997543221000
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh-CC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GY 354 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~ 354 (373)
......+++.|+|||++.+..++.++|||||||++|||++ |.
T Consensus 270 -------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~ 312 (374)
T cd05106 270 -------------------------------------VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGK 312 (374)
T ss_pred -------------------------------------eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 0012345678999999999999999999999999999997 99
Q ss_pred CCCCCCChHHHHHHh
Q 017362 355 PPFYSDDPMSTCRKV 369 (373)
Q Consensus 355 ~Pf~~~~~~~~~~kI 369 (373)
+||.+........++
T Consensus 313 ~Pf~~~~~~~~~~~~ 327 (374)
T cd05106 313 SPYPGILVNSKFYKM 327 (374)
T ss_pred CCCccccccHHHHHH
Confidence 999877654444333
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=320.75 Aligned_cols=218 Identities=30% Similarity=0.583 Sum_probs=196.9
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 191 (373)
......|.+++.||+|.|++|.+|.+..++..||||++.+... +....+++.+|+.+|+.+.|||||+++.+......+
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l-n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL-NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc-ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 3456789999999999999999999999999999999988754 333445688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
|+||||+.+|.+.+++.+.+.+.+..++.++.|++.|++|||+++|||||||++||||+.+-++||+|||++..+.....
T Consensus 131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~ 210 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM 210 (596)
T ss_pred EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999988764321
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCC-ChhhcHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEM 350 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DvwSlGvil~el 350 (373)
..+.||+|.|.|||++.+..| ++.+|+||+|+++|-|
T Consensus 211 ------------------------------------------lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~L 248 (596)
T KOG0586|consen 211 ------------------------------------------LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYAL 248 (596)
T ss_pred ------------------------------------------ccccCCCCCccChHhhcCcccCCcceehhhhhhhheee
Confidence 126799999999999999887 6889999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcC
Q 017362 351 LVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 351 l~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+.|.+||.+.+-.+...+++.|
T Consensus 249 V~GsLPFDG~~lk~Lr~rvl~g 270 (596)
T KOG0586|consen 249 VEGSLPFDGQNLKELRPRVLRG 270 (596)
T ss_pred eecccccCCcccccccchheee
Confidence 9999999998877776666543
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=296.28 Aligned_cols=214 Identities=37% Similarity=0.611 Sum_probs=187.9
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEe
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E 196 (373)
+|.+.+.||+|++|.||+|.+..++..|++|.+...... ......+..|+.+++.++||||+++++.+.+.+..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 588999999999999999999999999999998754332 3345668889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 197 YLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 197 ~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
|++|++|.+++... ..+++..+..++.+++.||.|||+.|++|+||||+||+++.++.++|+|||+++.+......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~-- 157 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-- 157 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch--
Confidence 99999999998764 57899999999999999999999999999999999999999999999999998765432110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 354 (373)
.....|++.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 158 ---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 198 (256)
T cd08529 158 ---------------------------------------ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGK 198 (256)
T ss_pred ---------------------------------------hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCC
Confidence 01346889999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcC
Q 017362 355 PPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 355 ~Pf~~~~~~~~~~kI~~~ 372 (373)
.||...++.+...+++.+
T Consensus 199 ~p~~~~~~~~~~~~~~~~ 216 (256)
T cd08529 199 HPFDANNQGALILKIIRG 216 (256)
T ss_pred CCCCCCCHHHHHHHHHcC
Confidence 999998888877776653
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=302.22 Aligned_cols=230 Identities=43% Similarity=0.777 Sum_probs=191.0
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++++.||+|+||.||++.+..+++.||+|.+.............+.+|+.++..++||||+++++.+..++.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999988765444445567888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
||++|++|.+++...+.+++..+..++.+++.||.|||+.|++||||||+||+++.++.++|+|||+++......... .
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~-~ 159 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN-L 159 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc-c
Confidence 999999999999888889999999999999999999999999999999999999999999999999987432111000 0
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 355 (373)
+.. ..... ..........|++.|+|||.+....++.++|+|||||++|||++|..
T Consensus 160 ~~~--------------~~~~~-----------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~ 214 (305)
T cd05609 160 YEG--------------HIEKD-----------TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCV 214 (305)
T ss_pred ccc--------------ccccc-----------hhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 000 00000 00000113468899999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHhhc
Q 017362 356 PFYSDDPMSTCRKVRK 371 (373)
Q Consensus 356 Pf~~~~~~~~~~kI~~ 371 (373)
||.+.++.+...++..
T Consensus 215 pf~~~~~~~~~~~~~~ 230 (305)
T cd05609 215 PFFGDTPEELFGQVIS 230 (305)
T ss_pred CCCCCCHHHHHHHHHh
Confidence 9999888887777654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=299.15 Aligned_cols=202 Identities=31% Similarity=0.586 Sum_probs=172.6
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCeEEEEEeccCC
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lV~E~~~g 200 (373)
..||+|+|+.|-.|....++..||||++.+.. .-...++.+|++++..+ .|+||++|+++|.++..+|||||-|.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 46999999999999999999999999998763 33456788999999988 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCc---EEEeeccccccCCCCCccccccc
Q 017362 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH---LRLSDFGLCKPLDCSTLQEQDFT 277 (373)
Q Consensus 201 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~---vkL~DFGla~~~~~~~~~~~~~~ 277 (373)
|+|...+.+...|+|..+..++.+|+.||.|||.+||.||||||+|||.....+ ||||||.|...+.....-
T Consensus 161 GplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~----- 235 (463)
T KOG0607|consen 161 GPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC----- 235 (463)
T ss_pred chHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC-----
Confidence 999999999999999999999999999999999999999999999999977665 799999998654322110
Q ss_pred ccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc-----CCCCChhhcHHHHHHHHHHHHh
Q 017362 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DvwSlGvil~ell~ 352 (373)
+++. . .-..+.+|+-.|||||+.. ..-|+.+||.||||||||-||.
T Consensus 236 -------------spas-t---------------P~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLs 286 (463)
T KOG0607|consen 236 -------------SPAS-T---------------PELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLS 286 (463)
T ss_pred -------------CCCC-C---------------ccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHh
Confidence 0000 0 0012678999999999875 2458999999999999999999
Q ss_pred CCCCCCCC
Q 017362 353 GYPPFYSD 360 (373)
Q Consensus 353 G~~Pf~~~ 360 (373)
|++||.+.
T Consensus 287 GYpPFvG~ 294 (463)
T KOG0607|consen 287 GYPPFVGH 294 (463)
T ss_pred CCCCccCc
Confidence 99999853
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=313.27 Aligned_cols=209 Identities=27% Similarity=0.470 Sum_probs=178.7
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC------
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD------ 188 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~------ 188 (373)
.++|++++.||.|+||+||+|.+..++..||||++..... .......+.+|+.+++.++||||++++++|...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4679999999999999999999999999999999875422 223345577899999999999999999888643
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
...|++|+++ +++|..++. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 3478999998 889988774 45799999999999999999999999999999999999999999999999999875432
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil 347 (373)
. ....+||+.|+|||++.+ ..++.++|||||||++
T Consensus 171 ~--------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 206 (343)
T cd07878 171 E--------------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 206 (343)
T ss_pred C--------------------------------------------cCCccccccccCchHhcCCccCCchhhhHhHHHHH
Confidence 1 013578999999999977 5689999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhh
Q 017362 348 YEMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 348 ~ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
|+|++|++||.+.+..+...++.
T Consensus 207 ~el~~g~~pf~~~~~~~~~~~~~ 229 (343)
T cd07878 207 AELLKGKALFPGNDYIDQLKRIM 229 (343)
T ss_pred HHHHHCCCCCCCCCHHHHHHHHH
Confidence 99999999999887776666554
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=300.67 Aligned_cols=208 Identities=31% Similarity=0.567 Sum_probs=180.8
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEE
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 193 (373)
..++|.+.+.||+|+||.||+|.+..++..||+|+++... ......+.+|+.++..++||||+++++.+.+.+.+|+
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence 3467999999999999999999999999999999986542 2233557789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 194 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
||||+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.........
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~- 162 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK- 162 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc-
Confidence 9999999999999988889999999999999999999999999999999999999999999999999998754321100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc---CCCCChhhcHHHHHHHHHHH
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DvwSlGvil~el 350 (373)
.....|++.|+|||++. ...++.++|+|||||++|+|
T Consensus 163 ----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l 202 (267)
T cd06645 163 ----------------------------------------RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202 (267)
T ss_pred ----------------------------------------cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHH
Confidence 01346899999999985 45689999999999999999
Q ss_pred HhCCCCCCCCChHHH
Q 017362 351 LVGYPPFYSDDPMST 365 (373)
Q Consensus 351 l~G~~Pf~~~~~~~~ 365 (373)
++|.+||....+...
T Consensus 203 ~~~~~p~~~~~~~~~ 217 (267)
T cd06645 203 AELQPPMFDLHPMRA 217 (267)
T ss_pred hcCCCCcccccchhh
Confidence 999999987665443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=325.02 Aligned_cols=202 Identities=33% Similarity=0.509 Sum_probs=174.9
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC------
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE------ 189 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~------ 189 (373)
..|..-..||+|+||.||+++++.+|..||||.+++.. .....+...+|+++|++++|||||+++++-.+..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 34566778999999999999999999999999998643 3444677888999999999999999998766543
Q ss_pred eEEEEEeccCCCCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC--CC--cEEEeeccc
Q 017362 190 FLYLIMEYLPGGDMMTLLMRK---DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK--YG--HLRLSDFGL 262 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~--~~--~vkL~DFGl 262 (373)
...+|||||+||||...|.+. ..+++.+...++.+++.||.|||++|||||||||+||++-. +| .-||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 467999999999999999763 36999999999999999999999999999999999999843 34 359999999
Q ss_pred cccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHH
Q 017362 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWW 341 (373)
Q Consensus 263 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~Dvw 341 (373)
|+.++... +..|.+||+.|.+||.... +.|+..+|.|
T Consensus 171 Arel~d~s------------------------------------------~~~S~vGT~~YLhPel~E~q~~y~~tVDLW 208 (732)
T KOG4250|consen 171 ARELDDNS------------------------------------------LFTSLVGTEEYLHPELYERQKKYTATVDLW 208 (732)
T ss_pred cccCCCCC------------------------------------------eeeeecCchhhcChHHHhhccCcCceeehh
Confidence 99876443 2348899999999999984 8899999999
Q ss_pred HHHHHHHHHHhCCCCCCCCC
Q 017362 342 SLGAIMYEMLVGYPPFYSDD 361 (373)
Q Consensus 342 SlGvil~ell~G~~Pf~~~~ 361 (373)
||||++|++.||..||-..-
T Consensus 209 S~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 209 SFGVTLYECATGELPFIPFG 228 (732)
T ss_pred hhhhHHHHHhccCCCCCcCC
Confidence 99999999999999998654
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=299.56 Aligned_cols=208 Identities=30% Similarity=0.544 Sum_probs=180.7
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|++.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.++..++||||+++++++...+.+|+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 568999999999999999999999999999999986432 22345677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
|||+++++|.+++.....+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..+......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~-- 162 (267)
T cd06646 85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK-- 162 (267)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccc--
Confidence 999999999999988888999999999999999999999999999999999999999999999999999765321100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc---CCCCChhhcHHHHHHHHHHHH
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DvwSlGvil~ell 351 (373)
.....|++.|+|||.+. ...++.++|||||||++|||+
T Consensus 163 ---------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~ 203 (267)
T cd06646 163 ---------------------------------------RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELA 203 (267)
T ss_pred ---------------------------------------cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHH
Confidence 01346889999999985 455788999999999999999
Q ss_pred hCCCCCCCCChHHHH
Q 017362 352 VGYPPFYSDDPMSTC 366 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~ 366 (373)
+|.+||...++.+..
T Consensus 204 ~g~~p~~~~~~~~~~ 218 (267)
T cd06646 204 ELQPPMFDLHPMRAL 218 (267)
T ss_pred hCCCCccccchhhhh
Confidence 999999876655543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=316.46 Aligned_cols=212 Identities=24% Similarity=0.359 Sum_probs=176.2
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEE-----cCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCRE-----KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSF 185 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~ 185 (373)
.+..++|++.+.||+|+||.||+|.+ ..++..||||+++.... ....+.+.+|+.++..+ +||||++++++|
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 34456899999999999999999964 34567899999875432 22345678899999999 899999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHhhCC------------------------------------------------------
Q 017362 186 QDDEFLYLIMEYLPGGDMMTLLMRKD------------------------------------------------------ 211 (373)
Q Consensus 186 ~~~~~~~lV~E~~~gg~L~~~l~~~~------------------------------------------------------ 211 (373)
.+.+..|+||||++||+|.+++....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 99999999999999999999986421
Q ss_pred ---------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 212 ---------------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 212 ---------------------~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 47788899999999999999999999999999999999999999999999997653221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 350 (373)
... ......+++.|+|||++.+..++.++|||||||++|||
T Consensus 269 ~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~el 309 (375)
T cd05104 269 NYV---------------------------------------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309 (375)
T ss_pred ccc---------------------------------------ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHH
Confidence 000 00123456789999999999999999999999999999
Q ss_pred Hh-CCCCCCCCChHH
Q 017362 351 LV-GYPPFYSDDPMS 364 (373)
Q Consensus 351 l~-G~~Pf~~~~~~~ 364 (373)
++ |.+||.......
T Consensus 310 lt~g~~p~~~~~~~~ 324 (375)
T cd05104 310 FSLGSSPYPGMPVDS 324 (375)
T ss_pred HhcCCCCCCCCCchH
Confidence 98 999998765443
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=337.57 Aligned_cols=217 Identities=29% Similarity=0.529 Sum_probs=180.6
Q ss_pred hhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe-
Q 017362 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD- 187 (373)
Q Consensus 109 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~- 187 (373)
.......++|.+++.||+|+||+||+|.+..++..||+|++..... .......+..|+.++..++|||||+++++|.+
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 3455667899999999999999999999999999999999875432 23345668889999999999999999999865
Q ss_pred -CCeEEEEEeccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHhC-------CCeeecCCCCCEEEcC----
Q 017362 188 -DEFLYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKH-------HYIHRDIKPDNLLLDK---- 251 (373)
Q Consensus 188 -~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-------giiHrDikp~NILl~~---- 251 (373)
...+||||||+++|+|.++|.. ...+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 4568999999999999999865 35799999999999999999999985 4999999999999964
Q ss_pred -------------CCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccc
Q 017362 252 -------------YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTV 318 (373)
Q Consensus 252 -------------~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (373)
.+.+||+|||++..+..... ....+
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~------------------------------------------~~s~v 202 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESM------------------------------------------AHSCV 202 (1021)
T ss_pred cccccccccccCCCCceEEccCCcccccccccc------------------------------------------ccccC
Confidence 23589999999976532210 11457
Q ss_pred cCCCCcccccccC--CCCChhhcHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 017362 319 GTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRK 368 (373)
Q Consensus 319 gt~~Y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~k 368 (373)
||+.|+|||++.+ ..++.++||||||||||||++|.+||...+.......
T Consensus 203 GTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~ 254 (1021)
T PTZ00266 203 GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLIS 254 (1021)
T ss_pred CCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHH
Confidence 9999999999865 4589999999999999999999999987665444433
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=319.59 Aligned_cols=221 Identities=27% Similarity=0.436 Sum_probs=191.8
Q ss_pred hhccCCCCCcceeceeeeeCcEEEEEEEEcCCCc---e-EeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeE
Q 017362 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGH---V-YAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCS 184 (373)
Q Consensus 109 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~-vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~ 184 (373)
+.+++.-++..+.++||+|+||.||+|..+..+. . ||+|..+.+......++..+.+|.++|..++|||||++||+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 4456667777888999999999999998765422 3 89999886544567778889999999999999999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeecccc
Q 017362 185 FQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (373)
Q Consensus 185 ~~~~~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla 263 (373)
..+...+|+|||+|+||+|.++|.+.+ .++..+...++.+.+.||+|||++++|||||-.+|+|++.++.+||+||||+
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence 999999999999999999999998876 4999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHH
Q 017362 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (373)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSl 343 (373)
+....-... . ....-...|+|||.+....|+.++|||||
T Consensus 310 ~~~~~~~~~-------~----------------------------------~~~klPirWLAPEtl~~~~~s~kTDV~sf 348 (474)
T KOG0194|consen 310 RAGSQYVMK-------K----------------------------------FLKKLPIRWLAPETLNTGIFSFKTDVWSF 348 (474)
T ss_pred cCCcceeec-------c----------------------------------ccccCcceecChhhhccCccccccchhhe
Confidence 754310000 0 01124468999999999999999999999
Q ss_pred HHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 017362 344 GAIMYEMLV-GYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 344 Gvil~ell~-G~~Pf~~~~~~~~~~kI~ 370 (373)
||++||+++ |..||.+....++..+|+
T Consensus 349 GV~~~Eif~~g~~Py~g~~~~~v~~kI~ 376 (474)
T KOG0194|consen 349 GVLLWEIFENGAEPYPGMKNYEVKAKIV 376 (474)
T ss_pred eeeEEeeeccCCCCCCCCCHHHHHHHHH
Confidence 999999999 999999999999999994
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=295.86 Aligned_cols=213 Identities=32% Similarity=0.573 Sum_probs=186.2
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEe
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E 196 (373)
+|++.+.||.|+||.||++.+..++..||+|.+..... ....+.+..|..+++.++||||+++++.+.+.+.+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 58899999999999999999999999999999864321 2345667889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 197 YLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 197 ~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
|+++|+|.+++.. ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-- 156 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY-- 156 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccc--
Confidence 9999999998864 245899999999999999999999999999999999999999999999999998755322110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 354 (373)
.....|++.|+|||++.+..++.++|+||||+++|+|++|.
T Consensus 157 ---------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~ 197 (255)
T cd08219 157 ---------------------------------------ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLK 197 (255)
T ss_pred ---------------------------------------cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhcc
Confidence 11356899999999999889999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcC
Q 017362 355 PPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 355 ~Pf~~~~~~~~~~kI~~~ 372 (373)
+||.+.+......++.++
T Consensus 198 ~p~~~~~~~~~~~~~~~~ 215 (255)
T cd08219 198 HPFQANSWKNLILKVCQG 215 (255)
T ss_pred CCCCCCCHHHHHHHHhcC
Confidence 999998888887777554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=296.36 Aligned_cols=217 Identities=32% Similarity=0.553 Sum_probs=183.5
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHh--hhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC--CeE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM--LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--EFL 191 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~ 191 (373)
.+|++.+.||+|+||.||.|.+..++..||||.+..... ........+.+|+.++..++||||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 579999999999999999999999999999998753221 1123456788899999999999999999998763 568
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
|+||||++|++|.+++.+...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..+.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 89999999999999998877899999999999999999999999999999999999999999999999999876532110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
... ......|+..|+|||++.+..++.++|||||||++|||+
T Consensus 162 ~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~ 203 (265)
T cd06652 162 SGT--------------------------------------GMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEML 203 (265)
T ss_pred ccc--------------------------------------ccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHh
Confidence 000 001346899999999999888999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhh
Q 017362 352 VGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~ 370 (373)
+|++||...+......++.
T Consensus 204 ~g~~p~~~~~~~~~~~~~~ 222 (265)
T cd06652 204 TEKPPWAEFEAMAAIFKIA 222 (265)
T ss_pred hCCCCCCccchHHHHHHHh
Confidence 9999998776666655543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=313.97 Aligned_cols=199 Identities=28% Similarity=0.454 Sum_probs=169.2
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|+.++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++|+||+++++++.+.+.+|+|
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 467888899999999999999999999999999986432 123345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
|||+++|+|... ....+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+......
T Consensus 151 ~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~-- 224 (353)
T PLN00034 151 LEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP-- 224 (353)
T ss_pred EecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc--
Confidence 999999998643 34678888999999999999999999999999999999999999999999998765322100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-----CCCChhhcHHHHHHHHHH
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----KGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~~DvwSlGvil~e 349 (373)
....+||+.|+|||++.. ..++.++|||||||++||
T Consensus 225 ---------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~e 265 (353)
T PLN00034 225 ---------------------------------------CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265 (353)
T ss_pred ---------------------------------------ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHH
Confidence 013579999999998853 234578999999999999
Q ss_pred HHhCCCCCCCC
Q 017362 350 MLVGYPPFYSD 360 (373)
Q Consensus 350 ll~G~~Pf~~~ 360 (373)
|++|+.||...
T Consensus 266 l~~g~~pf~~~ 276 (353)
T PLN00034 266 FYLGRFPFGVG 276 (353)
T ss_pred HHhCCCCCCCC
Confidence 99999999743
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=300.72 Aligned_cols=217 Identities=22% Similarity=0.428 Sum_probs=184.6
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEc-----CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 188 (373)
..++|.+.+.||+|+||+||++.+. .++..+|+|.+.... ......+.+|+.++..++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 4568999999999999999999752 345679999886532 23345688899999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcE
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRKD-------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHL 255 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~~-------------~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~v 255 (373)
+.+|+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++.++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 99999999999999999986433 48999999999999999999999999999999999999999999
Q ss_pred EEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCC
Q 017362 256 RLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYG 335 (373)
Q Consensus 256 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 335 (373)
+|+|||++.......... ......+++.|+|||++.+..++
T Consensus 160 kl~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~ 200 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYR---------------------------------------VGGHTMLPIRWMPPESIMYRKFT 200 (288)
T ss_pred EeccCCccccccCCceee---------------------------------------cCCCCCccccccCHHHhccCCCC
Confidence 999999987543221000 01124567899999999999999
Q ss_pred hhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 336 MECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 336 ~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
.++|||||||++|+|++ |.+||...++.+...+|.++
T Consensus 201 ~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~ 238 (288)
T cd05093 201 TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 238 (288)
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999999999998 99999998888888887765
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=296.06 Aligned_cols=201 Identities=38% Similarity=0.645 Sum_probs=178.1
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEec
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~ 197 (373)
|++++.||+|+||+||+|.+..+++.||+|++......... ......|+.++..++||||+++++++.+....|+||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 78899999999999999999999999999999876543332 22345599999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccccc
Q 017362 198 LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT 277 (373)
Q Consensus 198 ~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 277 (373)
+++++|.+++.....+++..+..++.|++.||.+||++|++|+||||+||+++.++.++|+|||++........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~------ 153 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE------ 153 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc------
Confidence 99999999998778899999999999999999999999999999999999999999999999999875411100
Q ss_pred ccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc-CCCCChhhcHHHHHHHHHHHHhCCCC
Q 017362 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPP 356 (373)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~~DvwSlGvil~ell~G~~P 356 (373)
......+|+.|+|||++. +..++.++||||||+++|+|++|..|
T Consensus 154 -----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p 198 (260)
T PF00069_consen 154 -----------------------------------NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLP 198 (260)
T ss_dssp -----------------------------------EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSS
T ss_pred -----------------------------------ccccccccccccccccccccccccccccccccccccccccccccc
Confidence 011457899999999998 78899999999999999999999999
Q ss_pred CCCC
Q 017362 357 FYSD 360 (373)
Q Consensus 357 f~~~ 360 (373)
|...
T Consensus 199 ~~~~ 202 (260)
T PF00069_consen 199 FEES 202 (260)
T ss_dssp STTS
T ss_pred cccc
Confidence 9987
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=294.20 Aligned_cols=213 Identities=21% Similarity=0.424 Sum_probs=182.5
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|++.+.||+|+||.||++..+ ++..+|+|.+..... ....+..|+.++..++||||+++++++.+....|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 467999999999999999999875 456799998764432 234577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 195 MEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
|||+++|+|.+++.. ...+++..+..++.+++.||.|||++|++||||||+||+++.++.++|+|||+++.........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 999999999999865 3568999999999999999999999999999999999999999999999999987543221100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh-
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV- 352 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~- 352 (373)
.....++..|+|||++.+..++.++|+|||||++|||++
T Consensus 158 ----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~ 197 (256)
T cd05114 158 ----------------------------------------SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTE 197 (256)
T ss_pred ----------------------------------------cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcC
Confidence 002345678999999998899999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcC
Q 017362 353 GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 353 G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|++||...+..+...+|.++
T Consensus 198 g~~p~~~~~~~~~~~~i~~~ 217 (256)
T cd05114 198 GKMPFEKKSNYEVVEMISRG 217 (256)
T ss_pred CCCCCCCCCHHHHHHHHHCC
Confidence 99999999988888887654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=295.93 Aligned_cols=213 Identities=32% Similarity=0.560 Sum_probs=182.9
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++.+.||+|+||.||+|.+..++..||||.+.............+.+|+.+++.++||||+++++.+.+.+..|+||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 67999999999999999999999999999999886544444445567888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 196 EYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 196 E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
||+++|+|.+++.. ...+++..+..++.|++.||.|||++|++|+||||+|||++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 99999999988853 34589999999999999999999999999999999999999999999999999876532210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
. .....|++.|+|||++.+..++.++|+|||||++|||+
T Consensus 162 ~-----------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~ 200 (267)
T cd08228 162 A-----------------------------------------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200 (267)
T ss_pred H-----------------------------------------HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHh
Confidence 0 01346889999999999989999999999999999999
Q ss_pred hCCCCCCCCC--hHHHHHHh
Q 017362 352 VGYPPFYSDD--PMSTCRKV 369 (373)
Q Consensus 352 ~G~~Pf~~~~--~~~~~~kI 369 (373)
+|..||.... ..+....+
T Consensus 201 ~g~~p~~~~~~~~~~~~~~~ 220 (267)
T cd08228 201 ALQSPFYGDKMNLFSLCQKI 220 (267)
T ss_pred cCCCCCccccccHHHHHHHH
Confidence 9999997653 33444443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=302.70 Aligned_cols=206 Identities=30% Similarity=0.469 Sum_probs=181.3
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++.+.||+|+||.||++.+..++..+|+|.+.... .......+.+|+.++..++||||+++++.|.+++.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 47999999999999999999999999999999886432 2233456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
||++|++|.+++.....+++..+..++.|++.||.|||+ ++++|+||||+|||++.++.++|+|||++.......
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---- 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---- 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc----
Confidence 999999999999888889999999999999999999997 699999999999999999999999999986442110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 354 (373)
....+|++.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 155 ---------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~ 195 (308)
T cd06615 155 ---------------------------------------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195 (308)
T ss_pred ---------------------------------------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCC
Confidence 01357899999999998888999999999999999999999
Q ss_pred CCCCCCChHHHH
Q 017362 355 PPFYSDDPMSTC 366 (373)
Q Consensus 355 ~Pf~~~~~~~~~ 366 (373)
+||...+.....
T Consensus 196 ~p~~~~~~~~~~ 207 (308)
T cd06615 196 YPIPPPDAKELE 207 (308)
T ss_pred CCCCCcchhhHH
Confidence 999877654443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=299.25 Aligned_cols=217 Identities=22% Similarity=0.438 Sum_probs=182.3
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEc----CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREK----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 189 (373)
..++|++.+.||+|+||+||+|... .++..||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 3478999999999999999999853 356789999987432 2334456888999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRK-----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY 252 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~-----------------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~ 252 (373)
..|+||||+++++|.+++... ..+++..+..++.+++.||.|||++|++||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 999999999999999998532 247889999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC
Q 017362 253 GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332 (373)
Q Consensus 253 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 332 (373)
+.+||+|||+++......... ......++..|+|||++.+.
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~ 201 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYR---------------------------------------VQPKSLLPIRWMPPEAIMYG 201 (283)
T ss_pred CcEEeccccccccccCCccee---------------------------------------cccCCCccceecChHHhccC
Confidence 999999999998654221100 00134567789999999988
Q ss_pred CCChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhc
Q 017362 333 GYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 333 ~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
.++.++|||||||++|||++ |.+||.+.++.+....+.+
T Consensus 202 ~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 241 (283)
T cd05090 202 KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241 (283)
T ss_pred CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 89999999999999999998 9999998887776666554
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=316.34 Aligned_cols=201 Identities=24% Similarity=0.382 Sum_probs=174.4
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEc--CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeE
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREK--TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 191 (373)
...+|.+++.||.|+||.||+|... .++..||+|.+.... ...+|+.+++.++||||+++++.+.....+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 3467999999999999999999754 356789999876432 245799999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
|+|||++ +++|..++.....+++..+..++.||+.||.|||++|||||||||+|||++.++.++|+|||++..+.....
T Consensus 162 ~lv~e~~-~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 162 CMVMPKY-KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred EEEehhc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 9999999 468999997778899999999999999999999999999999999999999999999999999976543211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
.. .....+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 241 ~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~ 281 (392)
T PHA03207 241 TP---------------------------------------QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281 (392)
T ss_pred cc---------------------------------------cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHH
Confidence 10 011457999999999999999999999999999999999
Q ss_pred hCCCCCCCCCh
Q 017362 352 VGYPPFYSDDP 362 (373)
Q Consensus 352 ~G~~Pf~~~~~ 362 (373)
+|..||.+...
T Consensus 282 ~g~~pf~~~~~ 292 (392)
T PHA03207 282 VKNVTLFGKQV 292 (392)
T ss_pred HCCCCCCCCCC
Confidence 99999987643
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=319.42 Aligned_cols=208 Identities=31% Similarity=0.480 Sum_probs=185.5
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEec
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~ 197 (373)
|.-++.||.|+||.||.|++..+.+.||||.+.-+.-.....-+.+..|+.+|..+.|||++.+-++|..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 55567799999999999999999999999999877655556667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccc
Q 017362 198 LPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (373)
Q Consensus 198 ~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 276 (373)
| -|+-.+++.- +.++.+..+..|+.+.+.||.|||+++.||||||..|||+++.|.|||+|||-|....+.
T Consensus 108 C-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA------- 179 (948)
T KOG0577|consen 108 C-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA------- 179 (948)
T ss_pred H-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch-------
Confidence 9 5566666643 568999999999999999999999999999999999999999999999999988765433
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC---CCCChhhcHHHHHHHHHHHHhC
Q 017362 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~~DvwSlGvil~ell~G 353 (373)
.+++|||.||||||+.. +.|+-++|||||||.+.||...
T Consensus 180 --------------------------------------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAER 221 (948)
T KOG0577|consen 180 --------------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 221 (948)
T ss_pred --------------------------------------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhc
Confidence 37899999999999984 6699999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhc
Q 017362 354 YPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 354 ~~Pf~~~~~~~~~~kI~~ 371 (373)
+||+++.+...-..-|-+
T Consensus 222 kPPlFnMNAMSALYHIAQ 239 (948)
T KOG0577|consen 222 KPPLFNMNAMSALYHIAQ 239 (948)
T ss_pred CCCccCchHHHHHHHHHh
Confidence 999999998887777643
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=297.79 Aligned_cols=218 Identities=17% Similarity=0.297 Sum_probs=181.4
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEc-----CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 187 (373)
+..++|++.+.||+|+||.||+|.+. .++..||+|++..... ......+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 45678999999999999999999764 2356799998864321 2233457889999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEE
Q 017362 188 DEFLYLIMEYLPGGDMMTLLMRK----------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRL 257 (373)
Q Consensus 188 ~~~~~lV~E~~~gg~L~~~l~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL 257 (373)
....++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+|||++.++.++|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 99999999999999999998652 23577889999999999999999999999999999999999999999
Q ss_pred eeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChh
Q 017362 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME 337 (373)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 337 (373)
+|||+++.......... .....+++.|+|||++.+..++.+
T Consensus 161 ~dfg~~~~~~~~~~~~~---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~ 201 (277)
T cd05062 161 GDFGMTRDIYETDYYRK---------------------------------------GGKGLLPVRWMSPESLKDGVFTTY 201 (277)
T ss_pred CCCCCccccCCcceeec---------------------------------------CCCCccCHhhcChhHhhcCCcCch
Confidence 99999876543211100 002346788999999999999999
Q ss_pred hcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhc
Q 017362 338 CDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 338 ~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
+|||||||++|||++ |.+||.+.+..+....+.+
T Consensus 202 ~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05062 202 SDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236 (277)
T ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999999999 7999998888777766554
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=304.18 Aligned_cols=215 Identities=23% Similarity=0.441 Sum_probs=180.1
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCce--EeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCC
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHV--YAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~ 189 (373)
+..++|++.+.||+|+||.||+|.+..++.. +|+|.+... ........+.+|+.++..+ +||||+++++++.+.+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 4467899999999999999999998777754 577766532 2233446688899999999 8999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKD----------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG 253 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~ 253 (373)
.+|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 9999999999999999996542 478999999999999999999999999999999999999999
Q ss_pred cEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC
Q 017362 254 HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG 333 (373)
Q Consensus 254 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~ 333 (373)
.+||+|||++........ .....+++.|+|||++.+..
T Consensus 162 ~~kl~dfg~~~~~~~~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~ 199 (303)
T cd05088 162 VAKIADFGLSRGQEVYVK------------------------------------------KTMGRLPVRWMAIESLNYSV 199 (303)
T ss_pred cEEeCccccCcccchhhh------------------------------------------cccCCCcccccCHHHHhccC
Confidence 999999999853211000 00123467899999998888
Q ss_pred CChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhc
Q 017362 334 YGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 334 ~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
++.++|||||||++|||++ |.+||.+.+..+...++..
T Consensus 200 ~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 238 (303)
T cd05088 200 YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 238 (303)
T ss_pred CcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence 9999999999999999998 9999998888777776643
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=299.09 Aligned_cols=218 Identities=22% Similarity=0.398 Sum_probs=184.6
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcC-----CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKT-----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 188 (373)
...+|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .....+.+.+|+.++..++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 35679999999999999999998743 35789999987542 122346788999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCc
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRK--------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH 254 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~ 254 (373)
...|+||||++|++|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 9999999999999999999654 24789999999999999999999999999999999999999999
Q ss_pred EEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCC
Q 017362 255 LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY 334 (373)
Q Consensus 255 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~ 334 (373)
++|+|||++.......... ......+++.|+|||++.+..+
T Consensus 161 ~kl~d~g~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~ 201 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYR---------------------------------------VGGHTMLPIRWMPPESIMYRKF 201 (280)
T ss_pred EEECCcccceecccCccee---------------------------------------cCCCCcccceecChhhhccCCc
Confidence 9999999987543221100 0013456789999999999999
Q ss_pred ChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 335 GMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 335 ~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+.++|||||||++|||++ |..||...+..+....|.++
T Consensus 202 ~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 202 TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred chhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 999999999999999998 99999988888877776653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=301.73 Aligned_cols=244 Identities=38% Similarity=0.667 Sum_probs=193.0
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++.+.||+|+||.||+|.+..++..||+|.+.............+..|+.++..++||||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999998899999999998765444445667888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 196 EYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 196 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
||++|++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998754 569999999999999999999999999999999999999999999999999997654321110
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhC
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 353 (373)
......... ..... ..................+||..|+|||++.+..++.++|||||||++|+|++|
T Consensus 161 ~~~~~~~~~------~~~~~------~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g 228 (316)
T cd05574 161 SKALRKGSR------RSSVN------SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228 (316)
T ss_pred ccccccccc------ccccc------ccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence 000000000 00000 000000000011112245799999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhc
Q 017362 354 YPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 354 ~~Pf~~~~~~~~~~kI~~ 371 (373)
..||.+.+....+.+++.
T Consensus 229 ~~pf~~~~~~~~~~~~~~ 246 (316)
T cd05574 229 TTPFKGSNRDETFSNILK 246 (316)
T ss_pred CCCCCCCchHHHHHHHhc
Confidence 999999988888777664
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=295.09 Aligned_cols=215 Identities=23% Similarity=0.395 Sum_probs=185.6
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 192 (373)
+...+|.+.+.||+|+||.||+|.+..++..||+|.+.... .....+.+|+.++..++||||+++++.+...+.++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 44567999999999999999999999899999999986542 22456788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 193 LIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
+||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999999999999998653 368999999999999999999999999999999999999999999999999997654221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 350 (373)
... .....+++.|+|||++.+..++.++|||||||++|||
T Consensus 159 ~~~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el 198 (263)
T cd05052 159 YTA----------------------------------------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 198 (263)
T ss_pred eec----------------------------------------cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHH
Confidence 110 0012356789999999999999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHhhc
Q 017362 351 LV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 351 l~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
++ |.+||.+.+..+...++.+
T Consensus 199 ~t~g~~p~~~~~~~~~~~~~~~ 220 (263)
T cd05052 199 ATYGMSPYPGIDLSQVYELLEK 220 (263)
T ss_pred HcCCCCCCCCCCHHHHHHHHHC
Confidence 98 9999999888887777654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=316.07 Aligned_cols=197 Identities=25% Similarity=0.410 Sum_probs=171.8
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.+....+.-||.|+.|.||+|+.. ++.||||.++..+ . .++.-|++++||||+.|.++|.....+|||
T Consensus 123 Fe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~elk---E-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIi 190 (904)
T KOG4721|consen 123 FEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVRELK---E-------TDIKHLRKLKHPNIITFKGVCTQSPCYCII 190 (904)
T ss_pred HHHhhhhhhhccCcccceeeeecc--CceehhHHHhhhh---h-------hhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence 333444566999999999999765 7799999875432 1 245568899999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
||||+.|-|...|....+++......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||-++.....
T Consensus 191 MEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~----- 265 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK----- 265 (904)
T ss_pred eeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999988654311
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 354 (373)
....+++||..|||||++...+.+.|+|||||||+|||||||.
T Consensus 266 -------------------------------------STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~E 308 (904)
T KOG4721|consen 266 -------------------------------------STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGE 308 (904)
T ss_pred -------------------------------------hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcC
Confidence 1123789999999999999999999999999999999999999
Q ss_pred CCCCCCChHHH
Q 017362 355 PPFYSDDPMST 365 (373)
Q Consensus 355 ~Pf~~~~~~~~ 365 (373)
.||.+.+...+
T Consensus 309 iPYkdVdssAI 319 (904)
T KOG4721|consen 309 IPYKDVDSSAI 319 (904)
T ss_pred CCccccchhee
Confidence 99987765543
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=296.85 Aligned_cols=210 Identities=32% Similarity=0.554 Sum_probs=180.9
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEec
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~ 197 (373)
|++.+.||.|+||.||+|.+..++..+++|.+.... ......+.+|+.+++.++||||+++++.+...+..|+||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 678899999999999999999999999999986432 23456688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccc
Q 017362 198 LPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (373)
Q Consensus 198 ~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 276 (373)
+++++|..++.. ...+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++.........
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~---- 159 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR---- 159 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccc----
Confidence 999999988765 457999999999999999999999999999999999999999999999999998754321100
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc-----CCCCChhhcHHHHHHHHHHHH
Q 017362 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DvwSlGvil~ell 351 (373)
.....||+.|+|||++. +..++.++|||||||++|||+
T Consensus 160 -------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~ 202 (282)
T cd06643 160 -------------------------------------RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 202 (282)
T ss_pred -------------------------------------cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHc
Confidence 11356899999999984 455788999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhc
Q 017362 352 VGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~~ 371 (373)
+|.+||.+.++.+...++.+
T Consensus 203 ~g~~p~~~~~~~~~~~~~~~ 222 (282)
T cd06643 203 QIEPPHHELNPMRVLLKIAK 222 (282)
T ss_pred cCCCCccccCHHHHHHHHhh
Confidence 99999998887777666543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=318.33 Aligned_cols=214 Identities=21% Similarity=0.334 Sum_probs=181.8
Q ss_pred hhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC
Q 017362 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (373)
Q Consensus 109 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 188 (373)
..+++..+.+.+...||+|.||+||+|.+.. .||||++...... ..+.+.|++|+..+++.+|.||+-+.|++..+
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt-~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPT-PEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCC-HHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 5566778888999999999999999998743 5999999876543 45889999999999999999999999999887
Q ss_pred CeEEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
.. .||..+|.|.+|+.+|+.. ..|....++.|+.|+++|+.|||.++|||||||..|||+.+++.|||+||||+..-.
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 77 8999999999999999754 468999999999999999999999999999999999999999999999999996432
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC---CCCChhhcHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLG 344 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~~DvwSlG 344 (373)
.-. .. .-.....|...|||||+++. .+|++.+||||||
T Consensus 540 ~w~-g~--------------------------------------~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFG 580 (678)
T KOG0193|consen 540 RWS-GE--------------------------------------QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFG 580 (678)
T ss_pred eec-cc--------------------------------------cccCCCccchhhhcHHHHhhcccCCCCcccchhhhh
Confidence 110 00 00113457889999999985 4589999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHH
Q 017362 345 AIMYEMLVGYPPFYSDDPMSTC 366 (373)
Q Consensus 345 vil~ell~G~~Pf~~~~~~~~~ 366 (373)
|++|||++|..||.......+.
T Consensus 581 iV~YELltg~lPysi~~~dqIi 602 (678)
T KOG0193|consen 581 IVWYELLTGELPYSIQNRDQII 602 (678)
T ss_pred HHHHHHHhCcCCcCCCChhheE
Confidence 9999999999999966655443
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=301.03 Aligned_cols=211 Identities=27% Similarity=0.472 Sum_probs=179.7
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|++.+.||.|+||.||+|.+..++..||+|.+..... ......+.+|+.++..++||||+++++++.+.+.+|+|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 5789999999999999999999999999999999865421 22234567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 195 MEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
|||++ ++|..++.. ...+++..+..++.|++.||.|||+.|++|+||||+|||++.++.++|+|||++.........
T Consensus 83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~- 160 (301)
T cd07873 83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT- 160 (301)
T ss_pred Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc-
Confidence 99996 588888865 356899999999999999999999999999999999999999999999999998754321100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHHHHHh
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~ 352 (373)
.....+++.|+|||++.+ ..++.++|||||||++|||++
T Consensus 161 ----------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t 200 (301)
T cd07873 161 ----------------------------------------YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMST 200 (301)
T ss_pred ----------------------------------------ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHh
Confidence 012457899999999876 458899999999999999999
Q ss_pred CCCCCCCCChHHHHHHh
Q 017362 353 GYPPFYSDDPMSTCRKV 369 (373)
Q Consensus 353 G~~Pf~~~~~~~~~~kI 369 (373)
|++||.+.+..+....+
T Consensus 201 g~~~f~~~~~~~~~~~~ 217 (301)
T cd07873 201 GRPLFPGSTVEEQLHFI 217 (301)
T ss_pred CCCCCCCCCHHHHHHHH
Confidence 99999988876665544
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=290.65 Aligned_cols=214 Identities=30% Similarity=0.534 Sum_probs=188.8
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEe
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E 196 (373)
+|++++.||.|+||.||.+.+..++..+++|.+...... ......+.+|+.+++.++|+||+++++++.+.+.+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 589999999999999999999999999999988654322 3344567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 197 YLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 197 ~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
|+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~-- 157 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM-- 157 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccc--
Confidence 99999999999764 46899999999999999999999999999999999999999999999999998765322100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 354 (373)
.....|++.|+|||++.+..++.++|||||||++|||++|.
T Consensus 158 ---------------------------------------~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~ 198 (256)
T cd08221 158 ---------------------------------------AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLK 198 (256)
T ss_pred ---------------------------------------ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCC
Confidence 11356899999999999888999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcC
Q 017362 355 PPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 355 ~Pf~~~~~~~~~~kI~~~ 372 (373)
.||...++.+.+..|..+
T Consensus 199 ~~~~~~~~~~~~~~~~~~ 216 (256)
T cd08221 199 RTFDATNPLNLVVKIVQG 216 (256)
T ss_pred CCCCCCCHHHHHHHHHcC
Confidence 999999998888887754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=290.32 Aligned_cols=213 Identities=29% Similarity=0.565 Sum_probs=182.8
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe-CCeEEEEE
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD-DEFLYLIM 195 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-~~~~~lV~ 195 (373)
+|++.+.||.|++|.||++.+..+++.||+|.+..... .....+.+..|+.+++.++|+|++++++.+.. ...+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 48999999999999999999998999999999865432 23345567889999999999999999998874 44689999
Q ss_pred eccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 196 EYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 196 E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
||+++++|.+++.. ...+++..+..++.+++.||.+||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-- 157 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-- 157 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC--
Confidence 99999999999865 34589999999999999999999999999999999999999999999999999876532110
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhC
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 353 (373)
......|++.|+|||++.+..++.++|||||||++|+|++|
T Consensus 158 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g 198 (257)
T cd08223 158 ---------------------------------------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATL 198 (257)
T ss_pred ---------------------------------------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcC
Confidence 01134689999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhc
Q 017362 354 YPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 354 ~~Pf~~~~~~~~~~kI~~ 371 (373)
..||...+.......+.+
T Consensus 199 ~~~~~~~~~~~~~~~~~~ 216 (257)
T cd08223 199 KHAFNAKDMNSLVYRIIE 216 (257)
T ss_pred CCCCCCCCHHHHHHHHHh
Confidence 999998887777666644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=293.54 Aligned_cols=214 Identities=23% Similarity=0.453 Sum_probs=183.3
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 192 (373)
+..++|+++++||+|+||.||+|... ++..||+|.+..... ..+.+..|+.+++.++|+||+++++.+.+.+..|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 45678999999999999999999864 556799998765322 2456888999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 193 LIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
+||||+++++|.+++... ..+++..+..++.+++.||.|||+.+++||||||+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 999999999999998653 468899999999999999999999999999999999999999999999999997654221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 350 (373)
... .....++..|+|||++....++.++|||||||++|+|
T Consensus 158 ~~~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l 197 (261)
T cd05072 158 YTA----------------------------------------REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEI 197 (261)
T ss_pred eec----------------------------------------cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHH
Confidence 100 0023467789999999988899999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHhhc
Q 017362 351 LV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 351 l~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
++ |.+||...++.+....+.+
T Consensus 198 ~t~g~~p~~~~~~~~~~~~~~~ 219 (261)
T cd05072 198 VTYGKIPYPGMSNSDVMSALQR 219 (261)
T ss_pred HccCCCCCCCCCHHHHHHHHHc
Confidence 98 9999998888777776654
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=302.76 Aligned_cols=213 Identities=21% Similarity=0.372 Sum_probs=177.3
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCce----EeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHV----YAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 188 (373)
+...+|++.+.||+|+||.||+|.+..++.. ||+|++.... .......+..|+.+++.++||||+++++++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 3457899999999999999999987666554 8999986432 223345688899999999999999999998765
Q ss_pred CeEEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
..++|+||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 567999999999999999764 468899999999999999999999999999999999999999999999999998654
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 347 (373)
...... ......+++.|+|||++.+..++.++|||||||++
T Consensus 161 ~~~~~~---------------------------------------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l 201 (316)
T cd05108 161 ADEKEY---------------------------------------HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 201 (316)
T ss_pred CCCcce---------------------------------------eccCCccceeecChHHhccCCCCchhhhHHHHHHH
Confidence 321100 00123356789999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHH
Q 017362 348 YEMLV-GYPPFYSDDPMSTCR 367 (373)
Q Consensus 348 ~ell~-G~~Pf~~~~~~~~~~ 367 (373)
|||++ |.+||.+.+..+...
T Consensus 202 ~el~t~g~~p~~~~~~~~~~~ 222 (316)
T cd05108 202 WELMTFGSKPYDGIPASEISS 222 (316)
T ss_pred HHHHcCCCCCCCCCCHHHHHH
Confidence 99997 999998877665443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=320.18 Aligned_cols=213 Identities=32% Similarity=0.542 Sum_probs=189.1
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.+.|.|+..||.|+||.||+|..+.++-..|-|++... .....+.+.-|++||+.++||+||+|++.|..++.++++
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 35588999999999999999999999888899988543 356678899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 195 MEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
.|||+||-....+.. ..++++.++..++.+++.||.|||+++|||||||..|||++-+|.|+|+|||.+......
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t---- 183 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST---- 183 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH----
Confidence 999999999888765 458999999999999999999999999999999999999999999999999997543211
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc-----CCCCChhhcHHHHHHHHH
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DvwSlGvil~ 348 (373)
+....+++|||+|||||+.. ..+|+.++||||||+.|.
T Consensus 184 -------------------------------------~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLI 226 (1187)
T KOG0579|consen 184 -------------------------------------RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLI 226 (1187)
T ss_pred -------------------------------------HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHH
Confidence 01122789999999999986 467999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhc
Q 017362 349 EMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 349 ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
||..+.||....+|+-..-||.+
T Consensus 227 EMAqiEPPHhelnpMRVllKiaK 249 (1187)
T KOG0579|consen 227 EMAQIEPPHHELNPMRVLLKIAK 249 (1187)
T ss_pred HHhccCCCccccchHHHHHHHhh
Confidence 99999999999999999988864
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=296.72 Aligned_cols=212 Identities=31% Similarity=0.530 Sum_probs=182.2
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.+.|++++.||.|+||.||+|.+..++..|++|++.... ......+..|+.+++.++||||+++++.+..+...|+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 467999999999999999999999999999999986542 33456688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 195 MEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
|||++|++|..++.. ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.........
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~- 166 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR- 166 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccc-
Confidence 999999999888754 457899999999999999999999999999999999999999999999999998653211100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc-----CCCCChhhcHHHHHHHHH
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DvwSlGvil~ 348 (373)
.....+++.|+|||++. ...++.++|||||||++|
T Consensus 167 ----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~ 206 (292)
T cd06644 167 ----------------------------------------RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLI 206 (292)
T ss_pred ----------------------------------------cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHH
Confidence 01346889999999985 345788999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhh
Q 017362 349 EMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 349 ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
||++|.+||...++.....++.
T Consensus 207 el~~g~~p~~~~~~~~~~~~~~ 228 (292)
T cd06644 207 EMAQIEPPHHELNPMRVLLKIA 228 (292)
T ss_pred HHhcCCCCCccccHHHHHHHHh
Confidence 9999999998887776666554
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=296.89 Aligned_cols=195 Identities=27% Similarity=0.457 Sum_probs=172.5
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++++.||+|+||.||+|.+..++..||+|++.... .......+.+|+.++..++||||+++++.+...+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 36889999999999999999999999999999986532 1233456888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
||+++++|..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++..+....
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----- 149 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----- 149 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-----
Confidence 99999998654 357899999999999999999999999999999999999999999999999987543221
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 355 (373)
....+||+.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus 150 --------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 191 (279)
T cd06619 150 --------------------------------------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRF 191 (279)
T ss_pred --------------------------------------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCC
Confidence 013579999999999999999999999999999999999999
Q ss_pred CCCC
Q 017362 356 PFYS 359 (373)
Q Consensus 356 Pf~~ 359 (373)
||..
T Consensus 192 pf~~ 195 (279)
T cd06619 192 PYPQ 195 (279)
T ss_pred Cchh
Confidence 9975
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=291.24 Aligned_cols=211 Identities=32% Similarity=0.573 Sum_probs=184.5
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|++.+.||.|+||.||+|.+..++..+++|++.... ......+..|+.+++.++||||+++++.+.+...+|+|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 368999999999999999999998889999999987543 22456788899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 195 MEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
|||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 157 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK- 157 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhc-
Confidence 9999999999998776 78999999999999999999999999999999999999999999999999998754321100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC---CCChhhcHHHHHHHHHHH
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK---GYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~~~~~DvwSlGvil~el 350 (373)
.....|+..|+|||.+... .++.++|+|||||++|||
T Consensus 158 ----------------------------------------~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~ 197 (262)
T cd06613 158 ----------------------------------------RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIEL 197 (262)
T ss_pred ----------------------------------------cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHH
Confidence 0134688999999999877 889999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHh
Q 017362 351 LVGYPPFYSDDPMSTCRKV 369 (373)
Q Consensus 351 l~G~~Pf~~~~~~~~~~kI 369 (373)
++|.+||...++......+
T Consensus 198 ~tg~~p~~~~~~~~~~~~~ 216 (262)
T cd06613 198 AELQPPMFDLHPMRALFLI 216 (262)
T ss_pred HhCCCCCCCCCHHHHHHHH
Confidence 9999999987766655443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=315.86 Aligned_cols=209 Identities=24% Similarity=0.449 Sum_probs=187.5
Q ss_pred eeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhh-hhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCe--EEEEEe
Q 017362 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR-RGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF--LYLIME 196 (373)
Q Consensus 120 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~--~~lV~E 196 (373)
...+||+|+|-+||+|.+..+|..||.-.++..+... +...+++..|+.+|+.|+||||+++|++|.+..+ +-+|.|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 4467999999999999999999999987776555433 4456899999999999999999999999998765 889999
Q ss_pred ccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhC--CCeeecCCCCCEEEcC-CCcEEEeeccccccCCCCCccc
Q 017362 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH--HYIHRDIKPDNLLLDK-YGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 197 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~--giiHrDikp~NILl~~-~~~vkL~DFGla~~~~~~~~~~ 273 (373)
++..|+|..++.+.+.+....++.|++||+.||.|||++ .|||||||.+||+|+. .|.|||+|+|||+....+.
T Consensus 124 L~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~--- 200 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH--- 200 (632)
T ss_pred cccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc---
Confidence 999999999999999999999999999999999999987 5999999999999974 5899999999998765442
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhC
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 353 (373)
+.+++|||.|||||+.. ..|+..+||||||++|+||+|+
T Consensus 201 ----------------------------------------aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~ 239 (632)
T KOG0584|consen 201 ----------------------------------------AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTS 239 (632)
T ss_pred ----------------------------------------cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhc
Confidence 44789999999999985 8899999999999999999999
Q ss_pred CCCCCCC-ChHHHHHHhhcC
Q 017362 354 YPPFYSD-DPMSTCRKVRKK 372 (373)
Q Consensus 354 ~~Pf~~~-~~~~~~~kI~~~ 372 (373)
..||.-. ++.++|+||.+|
T Consensus 240 eYPYsEC~n~AQIYKKV~SG 259 (632)
T KOG0584|consen 240 EYPYSECTNPAQIYKKVTSG 259 (632)
T ss_pred cCChhhhCCHHHHHHHHHcC
Confidence 9999854 799999999987
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=292.09 Aligned_cols=217 Identities=31% Similarity=0.560 Sum_probs=184.5
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhH--hhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC--CeE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSE--MLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--EFL 191 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~ 191 (373)
.+|.+.+.||+|+||.||+|.+..++..||+|.+.... .........+.+|+.+++.++|+||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999875321 11233456788999999999999999999998764 468
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
++||||+++++|.+++.....+++..+..++.+++.||.|||++|++|+||||+||+++.++.++|+|||+++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 89999999999999998877899999999999999999999999999999999999999999999999999976532110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
... ......|++.|+|||++.+..++.++|+|||||++|+|+
T Consensus 162 ~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 203 (264)
T cd06653 162 SGT--------------------------------------GIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEML 203 (264)
T ss_pred cCc--------------------------------------cccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHH
Confidence 000 001346899999999999988999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhh
Q 017362 352 VGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~ 370 (373)
+|.+||...+......++.
T Consensus 204 ~g~~p~~~~~~~~~~~~~~ 222 (264)
T cd06653 204 TEKPPWAEYEAMAAIFKIA 222 (264)
T ss_pred hCCCCCCccCHHHHHHHHH
Confidence 9999999877776666654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=292.18 Aligned_cols=217 Identities=32% Similarity=0.556 Sum_probs=183.9
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHh--hhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe--CCeE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM--LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD--DEFL 191 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~ 191 (373)
.+|++.+.||+|+||.||+|.+..++..||+|.+..... ........+.+|+.++..++||||+++++.+.+ ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 479999999999999999999999999999998864321 122345668889999999999999999998875 3678
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
++||||+++++|.+++.....+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||++..+.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 99999999999999998878899999999999999999999999999999999999999999999999999876532110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
... ......|+..|+|||++.+..++.++|||||||++|||+
T Consensus 162 ~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~ 203 (266)
T cd06651 162 SGT--------------------------------------GIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEML 203 (266)
T ss_pred cCC--------------------------------------ccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHH
Confidence 000 001245889999999999988999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhh
Q 017362 352 VGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~ 370 (373)
+|++||.+.++.....++.
T Consensus 204 ~g~~pf~~~~~~~~~~~~~ 222 (266)
T cd06651 204 TEKPPWAEYEAMAAIFKIA 222 (266)
T ss_pred HCCCCccccchHHHHHHHh
Confidence 9999999877666665543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=296.86 Aligned_cols=213 Identities=31% Similarity=0.537 Sum_probs=184.4
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|++.+.||.|+||.||+|.+..++..||+|++.... ....+.+..|+.++..++||||+++++.+.++...|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 467999999999999999999998889999999986432 33446688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 195 MEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
|||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~- 159 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK- 159 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccc-
Confidence 9999999999998664 57999999999999999999999999999999999999999999999999987654221100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc-----CCCCChhhcHHHHHHHHH
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DvwSlGvil~ 348 (373)
.....||+.|+|||++. ...++.++|+|||||++|
T Consensus 160 ----------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~ 199 (280)
T cd06611 160 ----------------------------------------RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLI 199 (280)
T ss_pred ----------------------------------------cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHH
Confidence 01356899999999985 345788999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhc
Q 017362 349 EMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 349 ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
||++|++||...++.....++.+
T Consensus 200 ~l~~g~~p~~~~~~~~~~~~~~~ 222 (280)
T cd06611 200 ELAQMEPPHHELNPMRVLLKILK 222 (280)
T ss_pred HHHhCCCCcccCCHHHHHHHHhc
Confidence 99999999998888777766654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=311.56 Aligned_cols=213 Identities=24% Similarity=0.359 Sum_probs=177.8
Q ss_pred hccCCCCCcceeceeeeeCcEEEEEEEEcCC-----CceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-CCceeEEee
Q 017362 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTT-----GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYC 183 (373)
Q Consensus 110 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~ 183 (373)
+..+..++|++.+.||+|+||.||+|.+... +..||||++.... .....+.+.+|+.++..+. ||||+++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 4556678899999999999999999986432 3469999986532 2233467889999999996 999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHHhhC-----------------------------------------------------
Q 017362 184 SFQDDEFLYLIMEYLPGGDMMTLLMRK----------------------------------------------------- 210 (373)
Q Consensus 184 ~~~~~~~~~lV~E~~~gg~L~~~l~~~----------------------------------------------------- 210 (373)
++.+...+|+|||||++|+|.+++...
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 999999999999999999999988542
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCE
Q 017362 211 -------------------------------------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNL 247 (373)
Q Consensus 211 -------------------------------------------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NI 247 (373)
..+++..+..++.|++.||.|||+.+|+||||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 2377888899999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccc
Q 017362 248 LLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPE 327 (373)
Q Consensus 248 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE 327 (373)
|++.++.+||+|||+++......... ......+++.|+|||
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE 309 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYV---------------------------------------SKGSTFLPVKWMAPE 309 (400)
T ss_pred EEeCCCEEEEEeCCcceecccccccc---------------------------------------ccCCcCCCcceEChh
Confidence 99999999999999987643211000 011346788999999
Q ss_pred cccCCCCChhhcHHHHHHHHHHHHh-CCCCCCCCChH
Q 017362 328 VLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPM 363 (373)
Q Consensus 328 ~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~ 363 (373)
++.+..++.++|||||||++|||++ |..||......
T Consensus 310 ~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 310 SIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred hhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 9999999999999999999999997 99999876543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=294.83 Aligned_cols=212 Identities=37% Similarity=0.606 Sum_probs=185.9
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++.+.||.|+||.||+|.+..++..||+|++.... .......+.+|+.+++.++|+||+++++.+.++..+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 46889999999999999999999999999999986542 2334456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
||+++++|.+++... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||+++.+......
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~--- 154 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK--- 154 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccc---
Confidence 999999999998654 8999999999999999999999999999999999999999999999999999766432100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 355 (373)
.....|++.|+|||++.+..++.++|||||||++|+|++|.+
T Consensus 155 --------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~ 196 (274)
T cd06609 155 --------------------------------------RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEP 196 (274)
T ss_pred --------------------------------------cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 013468899999999999889999999999999999999999
Q ss_pred CCCCCChHHHHHHhhc
Q 017362 356 PFYSDDPMSTCRKVRK 371 (373)
Q Consensus 356 Pf~~~~~~~~~~kI~~ 371 (373)
||...++......|..
T Consensus 197 p~~~~~~~~~~~~~~~ 212 (274)
T cd06609 197 PLSDLHPMRVLFLIPK 212 (274)
T ss_pred CcccCchHHHHHHhhh
Confidence 9988877776655543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=295.08 Aligned_cols=212 Identities=30% Similarity=0.480 Sum_probs=181.6
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++.+.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.+++.++||||+++++.+......|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 469999999999999999999998999999999865431 1223345778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
||+++++|..++.....+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~--- 156 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD--- 156 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCccc---
Confidence 99999988888777778999999999999999999999999999999999999999999999999999765432110
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHHHHHhCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~ 354 (373)
.....++..|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 157 --------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~ 198 (286)
T cd07847 157 --------------------------------------YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQ 198 (286)
T ss_pred --------------------------------------ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCC
Confidence 002357889999999876 45889999999999999999999
Q ss_pred CCCCCCChHHHHHHh
Q 017362 355 PPFYSDDPMSTCRKV 369 (373)
Q Consensus 355 ~Pf~~~~~~~~~~kI 369 (373)
+||.+.++.+....+
T Consensus 199 ~p~~~~~~~~~~~~~ 213 (286)
T cd07847 199 PLWPGKSDVDQLYLI 213 (286)
T ss_pred CCCCCCChHHHHHHH
Confidence 999988766554443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=297.90 Aligned_cols=207 Identities=31% Similarity=0.580 Sum_probs=181.1
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
..+|++++.||+|+||.||+|.+..++..||+|.+..... ...+.+.+|+.++..++||||+++++.|.++...|+|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 4689999999999999999999989999999998875432 2345678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
|||++|++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.........
T Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-- 172 (296)
T cd06654 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 172 (296)
T ss_pred ecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc--
Confidence 999999999998854 56899999999999999999999999999999999999999999999999998754322100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 354 (373)
.....|++.|+|||.+.+..++.++|||||||++|+|++|+
T Consensus 173 ---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~ 213 (296)
T cd06654 173 ---------------------------------------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213 (296)
T ss_pred ---------------------------------------cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCC
Confidence 01346899999999999988999999999999999999999
Q ss_pred CCCCCCChHHHH
Q 017362 355 PPFYSDDPMSTC 366 (373)
Q Consensus 355 ~Pf~~~~~~~~~ 366 (373)
+||...++....
T Consensus 214 ~pf~~~~~~~~~ 225 (296)
T cd06654 214 PPYLNENPLRAL 225 (296)
T ss_pred CCCCCCCHHHhH
Confidence 999988765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=294.08 Aligned_cols=205 Identities=32% Similarity=0.572 Sum_probs=180.3
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++.+.||+|+||.||+|.+..++..+|||.+.............+.+|+.+++.+.||||+++++.+.+++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57899999999999999999998899999999887655444455567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 196 EYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 196 E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
||++|++|.+++.. ...+++..+..++.+++.||.|||++|++|+||||+||+++.++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 99999999998863 34689999999999999999999999999999999999999999999999999875532210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
. .....|++.|+|||++.+..++.++|+||||+++|+|+
T Consensus 162 ~-----------------------------------------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~ 200 (267)
T cd08229 162 A-----------------------------------------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200 (267)
T ss_pred c-----------------------------------------cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHH
Confidence 0 01346889999999999999999999999999999999
Q ss_pred hCCCCCCCCC
Q 017362 352 VGYPPFYSDD 361 (373)
Q Consensus 352 ~G~~Pf~~~~ 361 (373)
+|..||.+..
T Consensus 201 ~g~~p~~~~~ 210 (267)
T cd08229 201 ALQSPFYGDK 210 (267)
T ss_pred hCCCCccccc
Confidence 9999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=290.81 Aligned_cols=204 Identities=33% Similarity=0.569 Sum_probs=180.2
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++.+.||+|+||.||+|.+..+++.||+|.++............+.+|+.+++.++|++|+++++.+.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999998899999999987654444455677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 196 EYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 196 E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
||+++|+|..++.. ...+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 99999999998854 34589999999999999999999999999999999999999999999999999875532211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
. .....|++.|+|||++.+..++.++|+|||||++|+|+
T Consensus 162 ~-----------------------------------------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~ 200 (267)
T cd08224 162 A-----------------------------------------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200 (267)
T ss_pred c-----------------------------------------cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHH
Confidence 0 01346889999999999999999999999999999999
Q ss_pred hCCCCCCCC
Q 017362 352 VGYPPFYSD 360 (373)
Q Consensus 352 ~G~~Pf~~~ 360 (373)
+|+.||...
T Consensus 201 ~g~~p~~~~ 209 (267)
T cd08224 201 ALQSPFYGD 209 (267)
T ss_pred HCCCCcccC
Confidence 999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=291.55 Aligned_cols=212 Identities=21% Similarity=0.386 Sum_probs=179.9
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
..+|++.+.||+|+||.||+|.++ ++..+|+|++..... ....+..|+.++..++||||+++++++.+.+..|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 456889999999999999999875 456899999865422 224577799999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 195 MEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
|||++|++|.+++.. ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||+++.........
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 999999999999865 3468999999999999999999999999999999999999999999999999987543211000
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh-
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV- 352 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~- 352 (373)
.....++..|+|||++.+..++.++|||||||++|||++
T Consensus 158 ----------------------------------------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~ 197 (256)
T cd05059 158 ----------------------------------------SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197 (256)
T ss_pred ----------------------------------------cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhcc
Confidence 001234568999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhc
Q 017362 353 GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 353 G~~Pf~~~~~~~~~~kI~~ 371 (373)
|.+||...++.+...++..
T Consensus 198 g~~p~~~~~~~~~~~~~~~ 216 (256)
T cd05059 198 GKMPYERFSNSEVVESVSA 216 (256)
T ss_pred CCCCCCCCCHHHHHHHHHc
Confidence 8999998888888777654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=290.53 Aligned_cols=214 Identities=22% Similarity=0.386 Sum_probs=182.7
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 192 (373)
+..++|++.+.||+|++|.||+|.+. ++..||+|.+..... ....+.+|+.++..++||||+++++++...+.+|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 45678999999999999999999864 456899999875432 2345778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 193 LIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
+||||+++++|.+++.... .+++..+..++.+++.||.+||+.|++|+||||+||+++.++.++|+|||+++......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 9999999999999997644 68999999999999999999999999999999999999999999999999998664221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 350 (373)
... .....++..|+|||++.+..++.++|+|||||++|||
T Consensus 158 ~~~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el 197 (261)
T cd05068 158 YEA----------------------------------------REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEI 197 (261)
T ss_pred ccc----------------------------------------cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHH
Confidence 100 0012234689999999999999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHhhc
Q 017362 351 LV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 351 l~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
++ |.+||.+.++......|.+
T Consensus 198 ~t~g~~p~~~~~~~~~~~~~~~ 219 (261)
T cd05068 198 VTYGRMPYPGMTNAEVLQQVDQ 219 (261)
T ss_pred HhcCCCCCCCCCHHHHHHHHHc
Confidence 99 9999999888887777654
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=294.26 Aligned_cols=216 Identities=20% Similarity=0.362 Sum_probs=179.3
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCc----eEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGH----VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 188 (373)
+..++|++++.||+|+||+||+|.+..++. .||+|++.... .......+.+|..++..+.||||+++++.+...
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence 456789999999999999999998876666 48999886432 223345678899999999999999999998754
Q ss_pred CeEEEEEeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
..+++|||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 82 -~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 82 -TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred -CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 57799999999999999976 3569999999999999999999999999999999999999999999999999998664
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 347 (373)
....... .....+++.|+|||++.+..++.++|||||||++
T Consensus 161 ~~~~~~~---------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l 201 (279)
T cd05109 161 IDETEYH---------------------------------------ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTV 201 (279)
T ss_pred cccceee---------------------------------------cCCCccchhhCCHHHhccCCCCchhHHHHHHHHH
Confidence 3211000 0022456789999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHhh
Q 017362 348 YEMLV-GYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 348 ~ell~-G~~Pf~~~~~~~~~~kI~ 370 (373)
|||++ |.+||......+....+.
T Consensus 202 ~el~t~g~~p~~~~~~~~~~~~~~ 225 (279)
T cd05109 202 WELMTFGAKPYDGIPAREIPDLLE 225 (279)
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHH
Confidence 99998 999998877666555443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=290.71 Aligned_cols=220 Identities=30% Similarity=0.524 Sum_probs=185.5
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhh------hhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCe
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML------RRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 190 (373)
+|.+...||.|+||.||+|.+..++..||+|.+...... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477888999999999999999888999999988643221 12234678889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
.++||||+++++|.+++.....+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||+++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999998664221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 350 (373)
..... ........|++.|+|||.+.+..++.++|+|||||++|+|
T Consensus 161 ~~~~~-----------------------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l 205 (267)
T cd06628 161 LSTKT-----------------------------------NGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEM 205 (267)
T ss_pred ccCCc-----------------------------------cccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHH
Confidence 10000 0000134688999999999998999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhc
Q 017362 351 LVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 351 l~G~~Pf~~~~~~~~~~kI~~ 371 (373)
++|+.||...+......++..
T Consensus 206 ~~g~~p~~~~~~~~~~~~~~~ 226 (267)
T cd06628 206 LTGKHPFPDCTQLQAIFKIGE 226 (267)
T ss_pred hhCCCCCCCccHHHHHHHHhc
Confidence 999999988776666655543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=297.09 Aligned_cols=218 Identities=20% Similarity=0.374 Sum_probs=184.0
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcC-----CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKT-----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 188 (373)
...+|.+.+.||+|+||.||+|.+.. .+..||||++.... .....+.+..|..++..++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 45678899999999999999998754 35789999987432 122345688899999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhh----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMR----------------KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY 252 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~----------------~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~ 252 (373)
...++++||+++++|.+++.. +..+++..+..++.|++.||.|||++|++||||||+|||++.+
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 999999999999999999853 2347888999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC
Q 017362 253 GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332 (373)
Q Consensus 253 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 332 (373)
+.+||+|||+++......... ......+++.|+|||++...
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~ 201 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYK---------------------------------------LMGNSLLPIRWMSPEAIMYG 201 (283)
T ss_pred CceEecccccccccccchhee---------------------------------------eccCccCCccccCHHHHhcC
Confidence 999999999987653221100 01134567899999999988
Q ss_pred CCChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 333 GYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 333 ~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
.++.++|||||||++|||++ |.+||.+.++.+....|.++
T Consensus 202 ~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~ 242 (283)
T cd05091 202 KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNR 242 (283)
T ss_pred CCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999999999999998 99999999998888888764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=290.54 Aligned_cols=206 Identities=43% Similarity=0.833 Sum_probs=184.0
Q ss_pred eeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEeccCCCCH
Q 017362 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM 203 (373)
Q Consensus 124 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~gg~L 203 (373)
||.|+||.||+|.+..++..||+|++.+.........+.+.+|+.++..++||||+++++.+.++..+|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999888999999999876544445567789999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccCCCC
Q 017362 204 MTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283 (373)
Q Consensus 204 ~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~ 283 (373)
.+++.+...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~------------ 148 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK------------ 148 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc------------
Confidence 99998888899999999999999999999999999999999999999999999999999876542210
Q ss_pred CCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCCCC--
Q 017362 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD-- 361 (373)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~-- 361 (373)
.....|++.|+|||.+....++.++|+||||+++|+|++|.+||...+
T Consensus 149 ------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 198 (262)
T cd05572 149 ------------------------------TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED 198 (262)
T ss_pred ------------------------------cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC
Confidence 113568999999999988889999999999999999999999999877
Q ss_pred hHHHHHHhhc
Q 017362 362 PMSTCRKVRK 371 (373)
Q Consensus 362 ~~~~~~kI~~ 371 (373)
+.+.+.++++
T Consensus 199 ~~~~~~~~~~ 208 (262)
T cd05572 199 PMEIYNDILK 208 (262)
T ss_pred HHHHHHHHhc
Confidence 7777777763
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=310.25 Aligned_cols=204 Identities=34% Similarity=0.636 Sum_probs=179.4
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEeccCCC
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGG 201 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~gg 201 (373)
+.||+|-||+||-|.++.+|+.||||++.+...... +...+++|+.||..+.||.||.|-..|+..+.+++|||-+ .|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 689999999999999999999999999988655433 3467899999999999999999999999999999999999 66
Q ss_pred CHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCC---CcEEEeeccccccCCCCCcccccc
Q 017362 202 DMMTLLM--RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY---GHLRLSDFGLCKPLDCSTLQEQDF 276 (373)
Q Consensus 202 ~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~---~~vkL~DFGla~~~~~~~~~~~~~ 276 (373)
|+...+. .++.+++...++++.||+.||.|||-++|+|.||||+|||+... -.+||||||+|+.+....+
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF----- 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF----- 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh-----
Confidence 7777764 46789999999999999999999999999999999999999654 4799999999998765432
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCC
Q 017362 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356 (373)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 356 (373)
|| +++|||.|.|||+++.++|+..-|+||+|||+|--|.|..|
T Consensus 723 ---------------------------------Rr----sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFP 765 (888)
T KOG4236|consen 723 ---------------------------------RR----SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFP 765 (888)
T ss_pred ---------------------------------hh----hhcCCccccCHHHHhhccccccccceeeeEEEEEEeccccc
Confidence 12 78999999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHhhc
Q 017362 357 FYSDDPMSTCRKVRK 371 (373)
Q Consensus 357 f~~~~~~~~~~kI~~ 371 (373)
|. ..+++-..|.|
T Consensus 766 FN--EdEdIndQIQN 778 (888)
T KOG4236|consen 766 FN--EDEDINDQIQN 778 (888)
T ss_pred CC--CccchhHHhhc
Confidence 95 44455555544
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=293.67 Aligned_cols=218 Identities=18% Similarity=0.309 Sum_probs=183.7
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCC-----CceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTT-----GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 187 (373)
+..++|.+.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.++..++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 4567899999999999999999987643 3789999986542 12334567889999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEE
Q 017362 188 DEFLYLIMEYLPGGDMMTLLMRK----------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRL 257 (373)
Q Consensus 188 ~~~~~lV~E~~~gg~L~~~l~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL 257 (373)
....|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 99999999999999999998643 23678899999999999999999999999999999999999999999
Q ss_pred eeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChh
Q 017362 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME 337 (373)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 337 (373)
+|||+++......... ......+|+.|+|||.+....++.+
T Consensus 161 ~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~ 201 (277)
T cd05032 161 GDFGMTRDIYETDYYR---------------------------------------KGGKGLLPVRWMAPESLKDGVFTTK 201 (277)
T ss_pred CCcccchhhccCcccc---------------------------------------cCCCCCccccccCHHHHhcCCCCcc
Confidence 9999987654221100 0012457889999999998899999
Q ss_pred hcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhc
Q 017362 338 CDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 338 ~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
+|||||||++|||++ |.+||.+.++.+..+.+..
T Consensus 202 ~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05032 202 SDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID 236 (277)
T ss_pred cchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence 999999999999998 9999998888877766653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=293.67 Aligned_cols=208 Identities=33% Similarity=0.490 Sum_probs=176.3
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEe
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E 196 (373)
+|++++.||+|++|.||+|.+..++..||||.+.... ........+.+|+.++..++||||+++++++.+++.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccc-ccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 5889999999999999999999899999999986542 122234567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 197 YLPGGDMMTLLMRK---DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 197 ~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
|++ ++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+|||++.++.++|+|||++.........
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~- 157 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV- 157 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccc-
Confidence 997 5888887542 46899999999999999999999999999999999999999999999999998754321100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHHHHHHHHHHHh
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell~ 352 (373)
.....+++.|+|||++.+. .++.++|||||||++|+|++
T Consensus 158 ----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~t 197 (285)
T cd07861 158 ----------------------------------------YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197 (285)
T ss_pred ----------------------------------------ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHH
Confidence 0134678999999998754 57899999999999999999
Q ss_pred CCCCCCCCChHHHHH
Q 017362 353 GYPPFYSDDPMSTCR 367 (373)
Q Consensus 353 G~~Pf~~~~~~~~~~ 367 (373)
|++||.+.+..+...
T Consensus 198 g~~~~~~~~~~~~~~ 212 (285)
T cd07861 198 KKPLFHGDSEIDQLF 212 (285)
T ss_pred CCCCCCCCCHHHHHH
Confidence 999999876654443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=295.02 Aligned_cols=210 Identities=32% Similarity=0.577 Sum_probs=183.4
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
..+|++.+.||.|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++.+.+.+.+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 457999999999999999999999999999999886542 23346678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
|||+++++|..++.. ..+++..+..++.+++.||.|||++|++|+||||+||+++.++.++|+|||++.........
T Consensus 95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-- 171 (296)
T cd06655 95 MEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-- 171 (296)
T ss_pred EEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc--
Confidence 999999999998854 46899999999999999999999999999999999999999999999999998754322100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 354 (373)
.....|++.|+|||.+.+..++.++|||||||++|+|++|+
T Consensus 172 ---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~ 212 (296)
T cd06655 172 ---------------------------------------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212 (296)
T ss_pred ---------------------------------------CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 01346899999999999988999999999999999999999
Q ss_pred CCCCCCChHHHHHHh
Q 017362 355 PPFYSDDPMSTCRKV 369 (373)
Q Consensus 355 ~Pf~~~~~~~~~~kI 369 (373)
+||...++......+
T Consensus 213 ~pf~~~~~~~~~~~~ 227 (296)
T cd06655 213 PPYLNENPLRALYLI 227 (296)
T ss_pred CCCCCCCHHHHHHHH
Confidence 999988776655444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=299.56 Aligned_cols=215 Identities=22% Similarity=0.353 Sum_probs=174.9
Q ss_pred eeceeeee--CcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEec
Q 017362 120 LLTMIGKG--AFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (373)
Q Consensus 120 ~~~~lG~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~ 197 (373)
++.+||+| +||+||++.++.+|+.||+|.+..... .......+.+|+.+++.++||||++++++|.+++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 789999999999999999999876432 223445677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 198 LPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 198 ~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.++++|||.+............
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 999999999865 346899999999999999999999999999999999999999999999999876443211000000
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC--CCCChhhcHHHHHHHHHHHHhC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G 353 (373)
. .......+++..|+|||++.+ ..|+.++|||||||++|||++|
T Consensus 161 ~----------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g 206 (327)
T cd08227 161 V----------------------------------HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 206 (327)
T ss_pred c----------------------------------ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHC
Confidence 0 000012357788999999976 4689999999999999999999
Q ss_pred CCCCCCCChHHHHHHh
Q 017362 354 YPPFYSDDPMSTCRKV 369 (373)
Q Consensus 354 ~~Pf~~~~~~~~~~kI 369 (373)
++||............
T Consensus 207 ~~pf~~~~~~~~~~~~ 222 (327)
T cd08227 207 HVPFKDMPATQMLLEK 222 (327)
T ss_pred CCCCCCcchhHHHHHH
Confidence 9999876655544443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=294.01 Aligned_cols=218 Identities=22% Similarity=0.417 Sum_probs=183.3
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEc-----CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 187 (373)
+...+|++.++||+|+||.||+|... .++..+|+|.+.... ......+.+|+.++..++|+||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTE 78 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence 34568899999999999999999643 346689999876432 2334568889999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhhCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCC
Q 017362 188 DEFLYLIMEYLPGGDMMTLLMRKD---------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY 252 (373)
Q Consensus 188 ~~~~~lV~E~~~gg~L~~~l~~~~---------------~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~ 252 (373)
....|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++.+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG 158 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence 999999999999999999986542 48899999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC
Q 017362 253 GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332 (373)
Q Consensus 253 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 332 (373)
+.++|+|||++.......... ......+++.|+|||++.+.
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~ 199 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYR---------------------------------------VGGRTMLPIRWMPPESILYR 199 (280)
T ss_pred CCEEECCCCceeEcCCCceee---------------------------------------cCCCccccccccCHHHhccC
Confidence 999999999987543221000 00123467889999999999
Q ss_pred CCChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 333 GYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 333 ~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
.++.++|||||||++|||++ |.+||...+..+....+.++
T Consensus 200 ~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05092 200 KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG 240 (280)
T ss_pred CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcC
Confidence 99999999999999999998 99999988887777766553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=298.23 Aligned_cols=200 Identities=32% Similarity=0.612 Sum_probs=179.8
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEec
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~ 197 (373)
|.++.+||+|+||.||+|.++.+|+.+|||.+.... ..+.+..|+.||.+++.|++|++|+++.....+++||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 788899999999999999999999999999886542 356688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccc
Q 017362 198 LPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (373)
Q Consensus 198 ~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 276 (373)
|..|+..+.+.- +.++++..+..++...+.||.|||...-||||||..|||++.+|+.||+|||.|..+...-.
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA----- 184 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA----- 184 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH-----
Confidence 999999999864 56899999999999999999999999999999999999999999999999999976542210
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCC
Q 017362 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356 (373)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 356 (373)
+ ..+++|||-|||||++..-+|+.++||||||+...||..|+||
T Consensus 185 -------------------K-----------------RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PP 228 (502)
T KOG0574|consen 185 -------------------K-----------------RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPP 228 (502)
T ss_pred -------------------h-----------------hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCC
Confidence 0 1267899999999999999999999999999999999999999
Q ss_pred CCCCChH
Q 017362 357 FYSDDPM 363 (373)
Q Consensus 357 f~~~~~~ 363 (373)
|.+--|.
T Consensus 229 YsDIHPM 235 (502)
T KOG0574|consen 229 YSDIHPM 235 (502)
T ss_pred ccccccc
Confidence 9865543
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=304.05 Aligned_cols=213 Identities=23% Similarity=0.379 Sum_probs=174.8
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEc-----CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSF 185 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~ 185 (373)
.+..++|++.+.||.|+||.||+|... .+++.||+|++.... .......+..|+.++..+ +|+||+++++++
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 455678999999999999999999743 345789999986432 122345677899999999 899999999988
Q ss_pred Ee-CCeEEEEEeccCCCCHHHHHhhC------------------------------------------------------
Q 017362 186 QD-DEFLYLIMEYLPGGDMMTLLMRK------------------------------------------------------ 210 (373)
Q Consensus 186 ~~-~~~~~lV~E~~~gg~L~~~l~~~------------------------------------------------------ 210 (373)
.. +..+|+||||+++++|.+++...
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 64 45789999999999999998542
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccCCCC
Q 017362 211 -------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283 (373)
Q Consensus 211 -------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~ 283 (373)
..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++..+.......
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~---------- 230 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV---------- 230 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh----------
Confidence 257899999999999999999999999999999999999999999999999997653221000
Q ss_pred CCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh-CCCCCCCCCh
Q 017362 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDP 362 (373)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~ 362 (373)
......+++.|+|||++.+..++.++|||||||++|||++ |.+||.+..+
T Consensus 231 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~ 281 (337)
T cd05054 231 -----------------------------RKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI 281 (337)
T ss_pred -----------------------------hccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 0013456788999999999999999999999999999998 9999987554
Q ss_pred HHH
Q 017362 363 MST 365 (373)
Q Consensus 363 ~~~ 365 (373)
.+.
T Consensus 282 ~~~ 284 (337)
T cd05054 282 DEE 284 (337)
T ss_pred cHH
Confidence 433
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=296.47 Aligned_cols=212 Identities=23% Similarity=0.421 Sum_probs=178.2
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCc--eEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCeEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGH--VYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~ 192 (373)
++|++.+.||+|+||.||+|....++. .+++|.++.. ......+.+.+|+.++..+ +||||+++++++.+...+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 679999999999999999998877664 4688877632 1223345688899999888 7999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEE
Q 017362 193 LIMEYLPGGDMMTLLMRKD----------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLR 256 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vk 256 (373)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999996532 488999999999999999999999999999999999999999999
Q ss_pred EeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCCh
Q 017362 257 LSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM 336 (373)
Q Consensus 257 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 336 (373)
|+|||++........ ......+..|+|||++.+..++.
T Consensus 160 l~dfg~~~~~~~~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~ 197 (297)
T cd05089 160 IADFGLSRGEEVYVK------------------------------------------KTMGRLPVRWMAIESLNYSVYTT 197 (297)
T ss_pred ECCcCCCccccceec------------------------------------------cCCCCcCccccCchhhccCCCCc
Confidence 999999863221100 00122355799999999999999
Q ss_pred hhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhc
Q 017362 337 ECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 337 ~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
++|||||||++|||++ |.+||.+.++.+...++.+
T Consensus 198 ~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~ 233 (297)
T cd05089 198 KSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 233 (297)
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence 9999999999999997 9999999888887777754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=289.30 Aligned_cols=210 Identities=23% Similarity=0.367 Sum_probs=176.5
Q ss_pred eeeeeCcEEEEEEEE--cCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEeccCC
Q 017362 123 MIGKGAFGEVRVCRE--KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (373)
Q Consensus 123 ~lG~G~~g~Vy~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~g 200 (373)
+||+|+||.||+|.+ ..++..+|+|++.... ......+.+..|+.+++.++||||+++++++. .+..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 589999999999964 4567899999986442 22334567888999999999999999999876 4567899999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccC
Q 017362 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (373)
Q Consensus 201 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (373)
|+|.+++.....+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++...........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~------ 153 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK------ 153 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee------
Confidence 99999998878899999999999999999999999999999999999999999999999999976542211000
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh-CCCCCCC
Q 017362 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYS 359 (373)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf~~ 359 (373)
......+++.|+|||.+....++.++|+|||||++|||++ |.+||.+
T Consensus 154 --------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 201 (257)
T cd05116 154 --------------------------------AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG 201 (257)
T ss_pred --------------------------------ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 0002345689999999988889999999999999999998 9999998
Q ss_pred CChHHHHHHhhcC
Q 017362 360 DDPMSTCRKVRKK 372 (373)
Q Consensus 360 ~~~~~~~~kI~~~ 372 (373)
.+..++..+|.++
T Consensus 202 ~~~~~~~~~i~~~ 214 (257)
T cd05116 202 MKGNEVTQMIESG 214 (257)
T ss_pred CCHHHHHHHHHCC
Confidence 8888887777653
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=288.42 Aligned_cols=205 Identities=46% Similarity=0.841 Sum_probs=177.3
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHH-HhcCCCceeEEeeEEEeCCeEEEEEeccCC
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL-AEVDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~l~~~~~~~~~~~lV~E~~~g 200 (373)
+.||.|+||.||+|.+..+++.||+|++.+...........+..|..++ ...+|||++++++.+..++.+|+||||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5689999999999999889999999999765443333334445555544 455899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccC
Q 017362 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (373)
Q Consensus 201 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (373)
++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----------- 150 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN----------- 150 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceecccc-----------
Confidence 999999988888999999999999999999999999999999999999999999999999998653211
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCCC
Q 017362 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (373)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 360 (373)
....|++.|+|||.+.+..++.++||||||+++|+|++|.+||...
T Consensus 151 ----------------------------------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 196 (260)
T cd05611 151 ----------------------------------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE 196 (260)
T ss_pred ----------------------------------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence 0346889999999999888999999999999999999999999988
Q ss_pred ChHHHHHHhhc
Q 017362 361 DPMSTCRKVRK 371 (373)
Q Consensus 361 ~~~~~~~kI~~ 371 (373)
++......+..
T Consensus 197 ~~~~~~~~~~~ 207 (260)
T cd05611 197 TPDAVFDNILS 207 (260)
T ss_pred CHHHHHHHHHh
Confidence 88887776643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=301.23 Aligned_cols=197 Identities=24% Similarity=0.421 Sum_probs=160.9
Q ss_pred eceeeeeCcEEEEEEEEc--CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe--CCeEEEEEe
Q 017362 121 LTMIGKGAFGEVRVCREK--TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD--DEFLYLIME 196 (373)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~~lV~E 196 (373)
.++||+|+||+||+|.++ .++..||+|.+..... ...+.+|+.+++.++||||+++++.+.. ...+|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 467999999999999865 4678999999865421 2346779999999999999999999864 456899999
Q ss_pred ccCCCCHHHHHhhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEE----cCCCcEEEeecccc
Q 017362 197 YLPGGDMMTLLMRK---------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLC 263 (373)
Q Consensus 197 ~~~gg~L~~~l~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl----~~~~~vkL~DFGla 263 (373)
|++ ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 994 5888877431 258999999999999999999999999999999999999 46689999999999
Q ss_pred ccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHH
Q 017362 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWS 342 (373)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwS 342 (373)
+.......... .....+||+.|+|||++.+. .++.++||||
T Consensus 160 ~~~~~~~~~~~--------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 201 (317)
T cd07868 160 RLFNSPLKPLA--------------------------------------DLDPVVVTFWYRAPELLLGARHYTKAIDIWA 201 (317)
T ss_pred eccCCCCcccc--------------------------------------ccCCccccccccCCHHHcCCCCcCchhhHHH
Confidence 76542211000 01145789999999999874 5899999999
Q ss_pred HHHHHHHHHhCCCCCCCCC
Q 017362 343 LGAIMYEMLVGYPPFYSDD 361 (373)
Q Consensus 343 lGvil~ell~G~~Pf~~~~ 361 (373)
|||++|||++|.+||....
T Consensus 202 lG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 202 IGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred HHHHHHHHHhCCCCccCCc
Confidence 9999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=297.18 Aligned_cols=205 Identities=32% Similarity=0.587 Sum_probs=179.7
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
..+|++++.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++.+..++..|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc---cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 367999999999999999999998999999999986543 22345678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
|||++|++|.+++.. ..+++..+..++.+++.||.|||+.|++||||||+|||++.++.++|+|||++.........
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-- 171 (297)
T cd06656 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 171 (297)
T ss_pred ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC--
Confidence 999999999998854 56899999999999999999999999999999999999999999999999998754322100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 354 (373)
.....|++.|+|||.+.+..++.++|+|||||++|+|++|.
T Consensus 172 ---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~ 212 (297)
T cd06656 172 ---------------------------------------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212 (297)
T ss_pred ---------------------------------------cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 01346889999999999999999999999999999999999
Q ss_pred CCCCCCChHH
Q 017362 355 PPFYSDDPMS 364 (373)
Q Consensus 355 ~Pf~~~~~~~ 364 (373)
+||.+.++..
T Consensus 213 ~pf~~~~~~~ 222 (297)
T cd06656 213 PPYLNENPLR 222 (297)
T ss_pred CCCCCCCcch
Confidence 9998766543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=293.14 Aligned_cols=218 Identities=23% Similarity=0.408 Sum_probs=182.0
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcC-----CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKT-----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 187 (373)
+..++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+..|+.+++.++|+||+++++++.+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 345779999999999999999999876 67889999886432 12233568889999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC---cEEE
Q 017362 188 DEFLYLIMEYLPGGDMMTLLMRKD-------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---HLRL 257 (373)
Q Consensus 188 ~~~~~lV~E~~~gg~L~~~l~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~---~vkL 257 (373)
....|+||||++|++|.+++.... .+++..+..++.||+.||.|||+++++||||||+|||++.++ .+||
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 999999999999999999987643 489999999999999999999999999999999999998765 6999
Q ss_pred eeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChh
Q 017362 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME 337 (373)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 337 (373)
+|||+++.+........ .....+++.|+|||++.+..++.+
T Consensus 161 ~dfg~~~~~~~~~~~~~---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~ 201 (277)
T cd05036 161 ADFGMARDIYRASYYRK---------------------------------------GGRAMLPIKWMPPEAFLDGIFTSK 201 (277)
T ss_pred ccCccccccCCccceec---------------------------------------CCCCCccHhhCCHHHHhcCCcCch
Confidence 99999986532211000 002234568999999999999999
Q ss_pred hcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhc
Q 017362 338 CDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 338 ~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
+|||||||++|||++ |.+||.+.+..+....+..
T Consensus 202 ~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~ 236 (277)
T cd05036 202 TDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG 236 (277)
T ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999999997 9999998888777766543
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=289.57 Aligned_cols=213 Identities=23% Similarity=0.424 Sum_probs=181.4
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
..+|.+.+.||+|+||+||+|.+.. +..+|+|.+..... ..+.+.+|+.++..++||||+++++++.+...+|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 4679999999999999999997653 44699998875432 234578899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 195 MEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+|||++.++.+||+|||+++.........
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999999999998663 468999999999999999999999999999999999999999999999999987543221100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh-
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV- 352 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~- 352 (373)
.....++..|+|||++.+..++.++|||||||++|||++
T Consensus 158 ----------------------------------------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~ 197 (256)
T cd05113 158 ----------------------------------------SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSL 197 (256)
T ss_pred ----------------------------------------cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcC
Confidence 002345678999999998889999999999999999998
Q ss_pred CCCCCCCCChHHHHHHhhcC
Q 017362 353 GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 353 G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|..||...++.+...++.++
T Consensus 198 g~~p~~~~~~~~~~~~~~~~ 217 (256)
T cd05113 198 GKMPYERFNNSETVEKVSQG 217 (256)
T ss_pred CCCCcCcCCHHHHHHHHhcC
Confidence 99999988888877777654
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=291.81 Aligned_cols=204 Identities=44% Similarity=0.818 Sum_probs=183.7
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEe
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E 196 (373)
+|++.+.||.|+||.||+|.+..++..||+|++.+...........+.+|+.+++.++||||+++++.+.++..+|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999988999999999987655444556788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccc
Q 017362 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (373)
Q Consensus 197 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 276 (373)
|++|++|..++.....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~----- 155 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL----- 155 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc-----
Confidence 999999999998777899999999999999999999999999999999999999999999999999876532210
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCC
Q 017362 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356 (373)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 356 (373)
.....|+..|+|||++....++.++|+||||+++|+|++|..|
T Consensus 156 -------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p 198 (258)
T cd05578 156 -------------------------------------TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198 (258)
T ss_pred -------------------------------------ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCC
Confidence 0134588899999999988899999999999999999999999
Q ss_pred CCCCCh
Q 017362 357 FYSDDP 362 (373)
Q Consensus 357 f~~~~~ 362 (373)
|...+.
T Consensus 199 ~~~~~~ 204 (258)
T cd05578 199 YRGHSR 204 (258)
T ss_pred CCCCCc
Confidence 998773
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=294.34 Aligned_cols=217 Identities=22% Similarity=0.423 Sum_probs=182.6
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEc-----CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 188 (373)
...+|.+.+.||+|+||.||+|.+. .++..+++|.+..... .....+.+|+.++..++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH---HHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 3567999999999999999999753 2455689998865432 2235578899999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRKD----------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY 252 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~ 252 (373)
+..++||||+++++|.+++.... .+++..+..++.||+.||.|||++|++||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999986532 38899999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC
Q 017362 253 GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332 (373)
Q Consensus 253 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 332 (373)
+.++|+|||++.......... ......|++.|+|||++.+.
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~ 200 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYR---------------------------------------VGGHTMLPIRWMPPESIMYR 200 (291)
T ss_pred CcEEECCCCcccccCCCceee---------------------------------------cCCCCCcceeecChHHhccC
Confidence 999999999997543221100 01134578899999999999
Q ss_pred CCChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 333 GYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 333 ~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
.++.++|||||||++|||++ |.+||...++.+....+.++
T Consensus 201 ~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 241 (291)
T cd05094 201 KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG 241 (291)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCC
Confidence 99999999999999999999 99999988887777666543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=287.63 Aligned_cols=208 Identities=25% Similarity=0.404 Sum_probs=175.3
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEeccCCC
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGG 201 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~gg 201 (373)
+.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++||||+++++++.+....|+||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 36899999999999999899999999876432 2334466888999999999999999999999999999999999999
Q ss_pred CHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccC
Q 017362 202 DMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (373)
Q Consensus 202 ~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (373)
+|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++...........
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~------ 152 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST------ 152 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccccccccc------
Confidence 9999996644 689999999999999999999999999999999999999999999999999875432110000
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh-CCCCCCC
Q 017362 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYS 359 (373)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf~~ 359 (373)
.....++..|+|||.+.+..++.++|||||||++|||++ |.+||..
T Consensus 153 ---------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~ 199 (252)
T cd05084 153 ---------------------------------GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN 199 (252)
T ss_pred ---------------------------------CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 001123467999999999999999999999999999998 9999988
Q ss_pred CChHHHHHHhh
Q 017362 360 DDPMSTCRKVR 370 (373)
Q Consensus 360 ~~~~~~~~kI~ 370 (373)
.++......+.
T Consensus 200 ~~~~~~~~~~~ 210 (252)
T cd05084 200 LSNQQTREAIE 210 (252)
T ss_pred cCHHHHHHHHH
Confidence 77776665554
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=293.32 Aligned_cols=219 Identities=18% Similarity=0.308 Sum_probs=181.5
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcC-----CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKT-----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 186 (373)
++..++|++.+.||+|+||.||+|.++. .+..||+|.+..... ......+.+|+.++..++||||+++++++.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 3556889999999999999999997642 345799998864431 222345778999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHhhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEE
Q 017362 187 DDEFLYLIMEYLPGGDMMTLLMRK----------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLR 256 (373)
Q Consensus 187 ~~~~~~lV~E~~~gg~L~~~l~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vk 256 (373)
+....|+||||+++|+|.+++... ..++...+..++.|++.||.|||++|++||||||+|||++.++.++
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 999999999999999999999652 2346778899999999999999999999999999999999999999
Q ss_pred EeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCCh
Q 017362 257 LSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM 336 (373)
Q Consensus 257 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 336 (373)
|+|||+++.......... .....+++.|+|||.+.+..++.
T Consensus 160 L~Dfg~~~~~~~~~~~~~---------------------------------------~~~~~~~~~y~~pE~~~~~~~~~ 200 (288)
T cd05061 160 IGDFGMTRDIYETDYYRK---------------------------------------GGKGLLPVRWMAPESLKDGVFTT 200 (288)
T ss_pred ECcCCccccccccccccc---------------------------------------cCCCcccccccCHHHhccCCCCh
Confidence 999999876532211000 00234677899999999999999
Q ss_pred hhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhc
Q 017362 337 ECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 337 ~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
++|+|||||++|||++ |.+||.+.+..+....+..
T Consensus 201 ~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (288)
T cd05061 201 SSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD 236 (288)
T ss_pred HhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 9999999999999998 8999998888887776654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=288.50 Aligned_cols=217 Identities=29% Similarity=0.521 Sum_probs=182.4
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhH---hhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEE
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSE---MLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 193 (373)
+|.+.+.||.|+||.||+|.. .++..+|+|.+.... .........+.+|+.+++.++|+||+++++++.+.+..|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 478899999999999999976 578899999886432 1223345678889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 194 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
||||++|++|.+++.+...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++..........
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 99999999999999887889999999999999999999999999999999999999999999999999987543211000
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhC
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 353 (373)
. .........|++.|+|||++.+..++.++|+|||||++|+|++|
T Consensus 160 ~-----------------------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g 204 (265)
T cd06631 160 T-----------------------------------HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATG 204 (265)
T ss_pred c-----------------------------------ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhC
Confidence 0 00001135689999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHh
Q 017362 354 YPPFYSDDPMSTCRKV 369 (373)
Q Consensus 354 ~~Pf~~~~~~~~~~kI 369 (373)
.+||...+.......+
T Consensus 205 ~~p~~~~~~~~~~~~~ 220 (265)
T cd06631 205 KPPLASMDRLAAMFYI 220 (265)
T ss_pred CCccccCChHHHHHHh
Confidence 9999887766554444
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=297.08 Aligned_cols=221 Identities=21% Similarity=0.396 Sum_probs=182.1
Q ss_pred hccCCCCCcceeceeeeeCcEEEEEEEEcC-------CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEE
Q 017362 110 RHKMGADDFELLTMIGKGAFGEVRVCREKT-------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKL 181 (373)
Q Consensus 110 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l 181 (373)
+.++..++|.+.+.||+|+||.||+|.+.. +...+|+|.+.... .......+..|+.++..+ +||||+++
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINL 89 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 345556889999999999999999997642 23569999987542 123345677899999998 79999999
Q ss_pred eeEEEeCCeEEEEEeccCCCCHHHHHhhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCC
Q 017362 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRK----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPD 245 (373)
Q Consensus 182 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~ 245 (373)
++++...+..|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||||+
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 169 (307)
T cd05098 90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169 (307)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence 99999999999999999999999999753 24788999999999999999999999999999999
Q ss_pred CEEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcc
Q 017362 246 NLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIA 325 (373)
Q Consensus 246 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~a 325 (373)
|||++.++.++|+|||+++.......... .....+++.|+|
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~---------------------------------------~~~~~~~~~y~a 210 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKK---------------------------------------TTNGRLPVKWMA 210 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhc---------------------------------------cccCCCccceeC
Confidence 99999999999999999875532110000 001234578999
Q ss_pred cccccCCCCChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhc
Q 017362 326 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 326 PE~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
||++.+..++.++|||||||++|||++ |.+||.+.+..+....+..
T Consensus 211 PE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 257 (307)
T cd05098 211 PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 257 (307)
T ss_pred hHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHc
Confidence 999999999999999999999999998 9999988887777766543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=289.14 Aligned_cols=216 Identities=23% Similarity=0.361 Sum_probs=183.9
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCC---CceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTT---GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 191 (373)
.++|++.+.||+|+||+||+|.+..+ ...||+|.+.... .......+..|+.++..++||||+++++.+.+.+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 56799999999999999999988643 4579999886542 233445688899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 192 YLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
|+||||+++++|.+++... ..+++..+..++.+++.||.|||++||+|+||||+|||++.++.++|+|||++..+....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999999998664 478999999999999999999999999999999999999999999999999998764211
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 350 (373)
... ......+++.|+|||.+.+..++.++|||||||++|||
T Consensus 161 ~~~---------------------------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l 201 (266)
T cd05033 161 ATY---------------------------------------TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEV 201 (266)
T ss_pred cce---------------------------------------eccCCCCCccccChhhhccCCCccccchHHHHHHHHHH
Confidence 000 00023456789999999989999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHhhc
Q 017362 351 LV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 351 l~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
++ |..||...+..+...+|.+
T Consensus 202 ~~~g~~p~~~~~~~~~~~~~~~ 223 (266)
T cd05033 202 MSYGERPYWDMSNQDVIKAVED 223 (266)
T ss_pred HccCCCCCCCCCHHHHHHHHHc
Confidence 98 9999998888887777754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=295.37 Aligned_cols=213 Identities=31% Similarity=0.526 Sum_probs=182.6
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+.+|+.++..++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 4689999999999999999999888999999998764322 223456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
||+++++|..+......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~--- 156 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--- 156 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc---
Confidence 99999999888776667999999999999999999999999999999999999999999999999998765322100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHHHHHhCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~ 354 (373)
.....+++.|+|||++.+ ..++.++|||||||++|||++|.
T Consensus 157 --------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~ 198 (286)
T cd07846 157 --------------------------------------YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGE 198 (286)
T ss_pred --------------------------------------cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCC
Confidence 012468899999999875 44788999999999999999999
Q ss_pred CCCCCCChHHHHHHhh
Q 017362 355 PPFYSDDPMSTCRKVR 370 (373)
Q Consensus 355 ~Pf~~~~~~~~~~kI~ 370 (373)
+||.+.+..+...++.
T Consensus 199 ~~~~~~~~~~~~~~~~ 214 (286)
T cd07846 199 PLFPGDSDIDQLYHII 214 (286)
T ss_pred CCCCCCchHHHHHHHH
Confidence 9999887766555543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=290.73 Aligned_cols=218 Identities=22% Similarity=0.362 Sum_probs=182.7
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCC---ceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTG---HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 191 (373)
..+|++.+.||+|+||.||+|.+..++ ..+|+|.+.... .......+..|+.++..++||||+++++++.+++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 467999999999999999999876444 379999886532 122345688899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 192 YLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
|+||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999999764 468999999999999999999999999999999999999999999999999997654221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 350 (373)
.... ......+++.|+|||++.+..++.++|+|||||++||+
T Consensus 161 ~~~~--------------------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el 202 (267)
T cd05066 161 EAAY--------------------------------------TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 202 (267)
T ss_pred ceee--------------------------------------ecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHH
Confidence 1000 00012346789999999988999999999999999998
Q ss_pred Hh-CCCCCCCCChHHHHHHhhcC
Q 017362 351 LV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 351 l~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
++ |..||...++.+....|.++
T Consensus 203 l~~g~~p~~~~~~~~~~~~~~~~ 225 (267)
T cd05066 203 MSYGERPYWEMSNQDVIKAIEEG 225 (267)
T ss_pred hcCCCCCcccCCHHHHHHHHhCC
Confidence 86 99999988887777776643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=291.39 Aligned_cols=213 Identities=21% Similarity=0.358 Sum_probs=184.7
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEE
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 193 (373)
...+|++.+.||.|+||.||+|.+.. +..+|+|++..... .....+..|+.++..++||||+++++++.+.+..|+
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 34679999999999999999999877 88999999876532 234457889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 194 IMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 194 V~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
||||+++++|.+++... ..+++..+..++.+++.||.|||+.|++|+||||+||+++.++.+||+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999999999753 4689999999999999999999999999999999999999999999999999976532211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
. .....+++.|+|||++....++.++|||||||++|+|+
T Consensus 160 ~-----------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~ 198 (261)
T cd05148 160 L-----------------------------------------SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMF 198 (261)
T ss_pred c-----------------------------------------ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence 0 00234677899999999899999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHhhc
Q 017362 352 V-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 352 ~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
+ |.+||...+..++...+..
T Consensus 199 ~~g~~p~~~~~~~~~~~~~~~ 219 (261)
T cd05148 199 TYGQVPYPGMNNHEVYDQITA 219 (261)
T ss_pred cCCCCCCCcCCHHHHHHHHHh
Confidence 8 8999999888888877764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=292.14 Aligned_cols=215 Identities=20% Similarity=0.349 Sum_probs=176.7
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCc----eEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGH----VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 189 (373)
..++|++++.||+|+||+||+|.+..++. .+++|.+.... .......+..|+.+++.++||||+++++++.. .
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~ 81 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A 81 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C
Confidence 45689999999999999999999877766 46777764321 12234567778888899999999999998754 5
Q ss_pred eEEEEEeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 57899999999999999975 45789999999999999999999999999999999999999999999999999976532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 348 (373)
..... ......+++.|+|||++.+..++.++|||||||++|
T Consensus 162 ~~~~~---------------------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~ 202 (279)
T cd05111 162 DDKKY---------------------------------------FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVW 202 (279)
T ss_pred CCccc---------------------------------------ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHH
Confidence 21000 001235778899999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHhh
Q 017362 349 EMLV-GYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 349 ell~-G~~Pf~~~~~~~~~~kI~ 370 (373)
||++ |.+||.+..+....+.+.
T Consensus 203 el~t~g~~p~~~~~~~~~~~~~~ 225 (279)
T cd05111 203 EMMSYGAEPYAGMRPHEVPDLLE 225 (279)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHH
Confidence 9998 999999887776554443
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=289.89 Aligned_cols=213 Identities=23% Similarity=0.410 Sum_probs=179.6
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 192 (373)
+..++|++.++||+|+||.||+|.+..+ ..||+|.+..... ..+.+.+|+.++..++||||+++++.+. ....|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY 76 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence 3457799999999999999999987655 4699999875332 2245788999999999999999998875 45678
Q ss_pred EEEeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 193 LIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..+....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 999999999999999753 358999999999999999999999999999999999999999999999999997654221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 350 (373)
... .....++..|+|||++.+..++.++|||||||++|||
T Consensus 157 ~~~----------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~el 196 (262)
T cd05071 157 YTA----------------------------------------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196 (262)
T ss_pred ccc----------------------------------------ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHH
Confidence 100 0123467889999999989999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHhhc
Q 017362 351 LV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 351 l~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
++ |.+||.+.++.+...++..
T Consensus 197 lt~g~~p~~~~~~~~~~~~~~~ 218 (262)
T cd05071 197 TTKGRVPYPGMVNREVLDQVER 218 (262)
T ss_pred HcCCCCCCCCCChHHHHHHHhc
Confidence 99 9999998888887777654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=288.95 Aligned_cols=217 Identities=29% Similarity=0.510 Sum_probs=186.4
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++.+.||.|+||+||+|....++..+|+|++....... ....+.+|+.+++.++|+||+++++.+.+.+..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999988899999999986543222 4567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcc
Q 017362 196 EYLPGGDMMTLLMRK---DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 196 E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 272 (373)
|+++|++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..+......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999999764 45899999999999999999999999999999999999999999999999998765433211
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHHHHHHHHHHH
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell 351 (373)
.. ......+|++.|+|||++... .++.++|+|||||++|+|+
T Consensus 159 ~~-------------------------------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~ 201 (267)
T cd06610 159 TR-------------------------------------KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELA 201 (267)
T ss_pred cc-------------------------------------cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHH
Confidence 00 001135789999999999877 7899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhc
Q 017362 352 VGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~~ 371 (373)
+|+.||...++...+.+++.
T Consensus 202 ~g~~p~~~~~~~~~~~~~~~ 221 (267)
T cd06610 202 TGAAPYSKYPPMKVLMLTLQ 221 (267)
T ss_pred hCCCCccccChhhhHHHHhc
Confidence 99999998877766665543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=289.28 Aligned_cols=219 Identities=21% Similarity=0.347 Sum_probs=183.7
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCc---eEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGH---VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 189 (373)
+..++|+..+.||+|+||.||+|....++. .+|+|.+.... .....+.+..|+.++..++||||+++++++.+.+
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK 79 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence 446789999999999999999999876554 79999886542 1223456888999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
..|+||||+++++|.+++... ..+++..+..++.+++.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999999998754 5789999999999999999999999999999999999999999999999999876532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 348 (373)
...... .......++.|+|||++....++.++|||||||++|
T Consensus 160 ~~~~~~--------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ 201 (268)
T cd05063 160 DPEGTY--------------------------------------TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMW 201 (268)
T ss_pred ccccce--------------------------------------eccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHH
Confidence 211000 000123456799999999889999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHhhc
Q 017362 349 EMLV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 349 ell~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
||++ |..||...+..+....|.+
T Consensus 202 ell~~g~~p~~~~~~~~~~~~i~~ 225 (268)
T cd05063 202 EVMSFGERPYWDMSNHEVMKAIND 225 (268)
T ss_pred HHHhCCCCCCCcCCHHHHHHHHhc
Confidence 9997 9999998888887777654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=294.56 Aligned_cols=204 Identities=27% Similarity=0.463 Sum_probs=180.4
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEE
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 193 (373)
..++|++++.||+|+||+||++.+..++..||+|++.... .......+.+|+.++..++||||+++++.+.+.+.+|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 4578999999999999999999999899999999876432 12334668889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcc
Q 017362 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 194 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 272 (373)
||||+++++|..++...+.+++..+..++.+++.||.|||+ .+++||||+|+||+++.++.++|+|||++.......
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 99999999999999887889999999999999999999997 699999999999999999999999999986432110
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 352 (373)
....+|+..|+|||++.+..++.++|+|||||++|+|++
T Consensus 159 -----------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~t 197 (284)
T cd06620 159 -----------------------------------------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELAL 197 (284)
T ss_pred -----------------------------------------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHh
Confidence 013468999999999998899999999999999999999
Q ss_pred CCCCCCCCCh
Q 017362 353 GYPPFYSDDP 362 (373)
Q Consensus 353 G~~Pf~~~~~ 362 (373)
|.+||...++
T Consensus 198 g~~p~~~~~~ 207 (284)
T cd06620 198 GKFPFAFSNI 207 (284)
T ss_pred CCCCCcccch
Confidence 9999987654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=296.16 Aligned_cols=221 Identities=22% Similarity=0.412 Sum_probs=185.0
Q ss_pred hccCCCCCcceeceeeeeCcEEEEEEEEc-------CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEE
Q 017362 110 RHKMGADDFELLTMIGKGAFGEVRVCREK-------TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKL 181 (373)
Q Consensus 110 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l 181 (373)
+..+..++|.+.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.++..+ +||||+++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~ 86 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINL 86 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchhe
Confidence 34566788999999999999999999752 234579999886432 233446688899999999 89999999
Q ss_pred eeEEEeCCeEEEEEeccCCCCHHHHHhhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCC
Q 017362 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRK----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPD 245 (373)
Q Consensus 182 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~ 245 (373)
++.+......|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||||+
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 166 (304)
T cd05101 87 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166 (304)
T ss_pred eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence 99999999999999999999999999753 24778889999999999999999999999999999
Q ss_pred CEEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcc
Q 017362 246 NLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIA 325 (373)
Q Consensus 246 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~a 325 (373)
|||++.++.+||+|||+++......... ......+++.|+|
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~a 207 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYK---------------------------------------KTTNGRLPVKWMA 207 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccc---------------------------------------cccCCCCCceeeC
Confidence 9999999999999999997654221100 0012346788999
Q ss_pred cccccCCCCChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhc
Q 017362 326 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 326 PE~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
||++.+..++.++|||||||++|||++ |.+||.+.+..+...++..
T Consensus 208 PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 254 (304)
T cd05101 208 PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 254 (304)
T ss_pred chhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc
Confidence 999999999999999999999999998 8999999888888877754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=294.19 Aligned_cols=206 Identities=30% Similarity=0.531 Sum_probs=176.7
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++++.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.++..++||||+++++.+...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 46899999999999999999999899999999886431 2233466888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 196 EYLPGGDMMTLLMRK---DTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 196 E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~-~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
||++|++|..++... ..+++..+..++.+++.||.|||+ +|++|+||||+||+++.++.++|+|||++..+....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 999999998888653 379999999999999999999996 699999999999999999999999999987543211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC------CCChhhcHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK------GYGMECDWWSLGA 345 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~------~~~~~~DvwSlGv 345 (373)
....+|++.|+|||++.+. .++.++|+|||||
T Consensus 158 ------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~ 195 (286)
T cd06622 158 ------------------------------------------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGL 195 (286)
T ss_pred ------------------------------------------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHH
Confidence 0134688899999998654 3588999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHH
Q 017362 346 IMYEMLVGYPPFYSDDPMSTC 366 (373)
Q Consensus 346 il~ell~G~~Pf~~~~~~~~~ 366 (373)
++|+|++|..||...+.....
T Consensus 196 il~~l~~g~~pf~~~~~~~~~ 216 (286)
T cd06622 196 SILEMALGRYPYPPETYANIF 216 (286)
T ss_pred HHHHHHhCCCCCCCcchhhHH
Confidence 999999999999876655543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=289.92 Aligned_cols=210 Identities=32% Similarity=0.576 Sum_probs=177.1
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeC-----
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDD----- 188 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~----- 188 (373)
.+.|++.+.||+|+||.||+|.+..+++.||+|++.... .....+..|+.++..+ +||||+++++.|...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 467899999999999999999999999999999986532 2234577889999888 799999999998753
Q ss_pred -CeEEEEEeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 189 -EFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 189 -~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
..+|+||||+++++|.+++... ..+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 4689999999999999998763 4689999999999999999999999999999999999999999999999999875
Q ss_pred CCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc-----CCCCChhhcH
Q 017362 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDW 340 (373)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~Dv 340 (373)
....... .....|++.|+|||++. ...++.++||
T Consensus 161 ~~~~~~~-----------------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv 199 (272)
T cd06637 161 LDRTVGR-----------------------------------------RNTFIGTPYWMAPEVIACDENPDATYDFKSDL 199 (272)
T ss_pred ccccccc-----------------------------------------CCcccccccccCHhHhccccCcCCCCCchhhH
Confidence 4321100 01356899999999986 3468899999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 017362 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369 (373)
Q Consensus 341 wSlGvil~ell~G~~Pf~~~~~~~~~~kI 369 (373)
|||||++|||++|.+||...++......+
T Consensus 200 ~slGv~l~el~~g~~p~~~~~~~~~~~~~ 228 (272)
T cd06637 200 WSLGITAIEMAEGAPPLCDMHPMRALFLI 228 (272)
T ss_pred HHHHHHHHHHHhCCCCccccCHHHHHHHH
Confidence 99999999999999999877665555443
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=321.45 Aligned_cols=224 Identities=25% Similarity=0.448 Sum_probs=194.1
Q ss_pred hhccCCCCCcceeceeeeeCcEEEEEEEEc-----CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEee
Q 017362 109 QRHKMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183 (373)
Q Consensus 109 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~ 183 (373)
...++...+.+..+.||+|+||+||+|+.. .....||||.++... .......|++|+++++.++|||||+|+|
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlG 556 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLG 556 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 345567788899999999999999999753 234679999998653 2335677999999999999999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHHhhC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEE
Q 017362 184 SFQDDEFLYLIMEYLPGGDMMTLLMRK--------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL 249 (373)
Q Consensus 184 ~~~~~~~~~lV~E~~~gg~L~~~l~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl 249 (373)
+|..++.+|+|+|||..|||..+|... .+++..+...|+.||+.|+.||-++.||||||...|+||
T Consensus 557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV 636 (774)
T KOG1026|consen 557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV 636 (774)
T ss_pred EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee
Confidence 999999999999999999999999632 238889999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccc
Q 017362 250 DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL 329 (373)
Q Consensus 250 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~ 329 (373)
.++..|||+||||++....+++.... ....-...|||||.+
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk~~---------------------------------------~~t~lPIRWMppEsI 677 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYKVR---------------------------------------GNTLLPIRWMPPESI 677 (774)
T ss_pred ccceEEEecccccchhhhhhhhhccc---------------------------------------CCceeeeecCCHHHh
Confidence 99999999999999976655433210 012345689999999
Q ss_pred cCCCCChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCC
Q 017362 330 LKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRKKS 373 (373)
Q Consensus 330 ~~~~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~~~ 373 (373)
..+.|+.+||||||||+|||+++ |.-||++-+..+..+-|.+|+
T Consensus 678 ly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~ 722 (774)
T KOG1026|consen 678 LYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQ 722 (774)
T ss_pred hcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCC
Confidence 99999999999999999999998 999999999999999998875
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=290.90 Aligned_cols=195 Identities=38% Similarity=0.696 Sum_probs=164.7
Q ss_pred eeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHH---HHHHhcCCCceeEEeeEEEeCCeEEEEEeccC
Q 017362 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER---NLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLP 199 (373)
Q Consensus 123 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~ 199 (373)
.||+|+||.||+|.+..+++.||+|.+.+...........+..|. .++....||+|+.+++.+.+.+.+|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999889999999998764332222222233333 34455689999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccccccc
Q 017362 200 GGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279 (373)
Q Consensus 200 gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 279 (373)
||+|..++.....+++..++.++.|++.||.|||+.+++||||||+||+++.++.++|+|||++..+....
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--------- 151 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--------- 151 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---------
Confidence 99999999888889999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHHHHHHHHHHHhCCCCCC
Q 017362 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGYPPFY 358 (373)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~Pf~ 358 (373)
....+|++.|+|||++.++ .++.++|+||+||++|||++|++||.
T Consensus 152 ----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~ 197 (278)
T cd05606 152 ----------------------------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 197 (278)
T ss_pred ----------------------------------CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence 0134689999999999754 68999999999999999999999998
Q ss_pred CC
Q 017362 359 SD 360 (373)
Q Consensus 359 ~~ 360 (373)
..
T Consensus 198 ~~ 199 (278)
T cd05606 198 QH 199 (278)
T ss_pred CC
Confidence 76
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=291.89 Aligned_cols=195 Identities=38% Similarity=0.688 Sum_probs=163.9
Q ss_pred eeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHH---HHHhcCCCceeEEeeEEEeCCeEEEEEeccC
Q 017362 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN---LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLP 199 (373)
Q Consensus 123 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~---~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~ 199 (373)
.||+|+||.||++.+..++..||+|.+.+.............+|.. ++....||+|+.+++.+...+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999987654322222222333433 3344579999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccccccc
Q 017362 200 GGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279 (373)
Q Consensus 200 gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 279 (373)
||+|..++.....+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++........
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-------- 152 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-------- 152 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--------
Confidence 999999998888899999999999999999999999999999999999999999999999999865432110
Q ss_pred CCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHHHHHhCCCCCC
Q 017362 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPPFY 358 (373)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~Pf~ 358 (373)
....||+.|+|||.+.. ..++.++|+|||||++|||++|..||.
T Consensus 153 -----------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 197 (279)
T cd05633 153 -----------------------------------HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFR 197 (279)
T ss_pred -----------------------------------cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcC
Confidence 02468999999999864 568999999999999999999999997
Q ss_pred CC
Q 017362 359 SD 360 (373)
Q Consensus 359 ~~ 360 (373)
..
T Consensus 198 ~~ 199 (279)
T cd05633 198 QH 199 (279)
T ss_pred CC
Confidence 54
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=288.88 Aligned_cols=215 Identities=22% Similarity=0.356 Sum_probs=177.0
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCc--eEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC------C
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGH--VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD------E 189 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~------~ 189 (373)
|.+.+.||+|+||.||+|....++. .||+|.+.... ......+.+..|..+++.++||||+++++.+... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 4567889999999999999877665 58999886542 2334456788899999999999999999876432 2
Q ss_pred eEEEEEeccCCCCHHHHHhh------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeecccc
Q 017362 190 FLYLIMEYLPGGDMMTLLMR------KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~------~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla 263 (373)
..++||||+++|+|..++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 46899999999999988742 234899999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHH
Q 017362 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (373)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSl 343 (373)
+.......... .....+++.|+|||++.+..++.++|||||
T Consensus 160 ~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~pe~~~~~~~~~~~Di~sl 200 (272)
T cd05075 160 KKIYNGDYYRQ---------------------------------------GRIAKMPVKWIAIESLADRVYTTKSDVWSF 200 (272)
T ss_pred cccCcccceec---------------------------------------CCcccCCcccCCHHHccCCCcChHHHHHHH
Confidence 86542211000 002346778999999999999999999999
Q ss_pred HHHHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 344 GAIMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 344 Gvil~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
||++|||++ |.+||.+.++.+....+.++
T Consensus 201 G~il~el~~~g~~p~~~~~~~~~~~~~~~~ 230 (272)
T cd05075 201 GVTMWEIATRGQTPYPGVENSEIYDYLRQG 230 (272)
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 999999999 89999988888877777654
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=294.50 Aligned_cols=212 Identities=31% Similarity=0.507 Sum_probs=182.1
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhh--hhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML--RRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
+|++.+.||.|+||.||+|.+..++..||||.+...... .......+..|+.+++.++|+||+++++++.+.+.+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488899999999999999999889999999999765432 122234567799999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 195 MEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
|||+ +|+|.+++.... .+++..+..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++.........
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK- 158 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc-
Confidence 9999 899999997766 7999999999999999999999999999999999999999999999999999765432100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHHHHHh
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~ 352 (373)
.....+++.|+|||.+.+ ..++.++|+|||||++|||++
T Consensus 159 ----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~ 198 (298)
T cd07841 159 ----------------------------------------MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLL 198 (298)
T ss_pred ----------------------------------------ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHc
Confidence 012357889999999865 457899999999999999999
Q ss_pred CCCCCCCCChHHHHHHhh
Q 017362 353 GYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 353 G~~Pf~~~~~~~~~~kI~ 370 (373)
|.+||.+.++.+...++.
T Consensus 199 g~~~~~~~~~~~~~~~~~ 216 (298)
T cd07841 199 RVPFLPGDSDIDQLGKIF 216 (298)
T ss_pred CCccccCCccHHHHHHHH
Confidence 999999888877766664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=290.92 Aligned_cols=197 Identities=38% Similarity=0.689 Sum_probs=173.0
Q ss_pred eeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEeccCCCCH
Q 017362 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM 203 (373)
Q Consensus 124 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~gg~L 203 (373)
||+|+||+||+|.+..+|+.||+|.+.............+..|+.++..++||||+++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999765444344455667899999999999999999999999999999999999999
Q ss_pred HHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccCC
Q 017362 204 MTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281 (373)
Q Consensus 204 ~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~ 281 (373)
.+++.... .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---------- 150 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---------- 150 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc----------
Confidence 99997655 799999999999999999999999999999999999999999999999999875432110
Q ss_pred CCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCCCC
Q 017362 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361 (373)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~ 361 (373)
.....+++.|+|||++.+..++.++|+|||||++|+|++|++||...+
T Consensus 151 --------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 198 (277)
T cd05577 151 --------------------------------IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198 (277)
T ss_pred --------------------------------cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence 013468889999999998889999999999999999999999998765
Q ss_pred h
Q 017362 362 P 362 (373)
Q Consensus 362 ~ 362 (373)
.
T Consensus 199 ~ 199 (277)
T cd05577 199 E 199 (277)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=296.13 Aligned_cols=220 Identities=22% Similarity=0.386 Sum_probs=182.7
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcC-------CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEee
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKT-------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYC 183 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~ 183 (373)
.+..++|.+.+.||+|+||.||+|.+.. ....+|+|.+.... .......+..|+.++..+ +||||+++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 3456789999999999999999997632 34579999887432 233456688899999999 6999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHHhhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCE
Q 017362 184 SFQDDEFLYLIMEYLPGGDMMTLLMRK----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNL 247 (373)
Q Consensus 184 ~~~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NI 247 (373)
++.+...+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 999999999999999999999999653 3488899999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccc
Q 017362 248 LLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPE 327 (373)
Q Consensus 248 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE 327 (373)
|++.++.+||+|||+++.......... .....+++.|+|||
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~---------------------------------------~~~~~~~~~y~aPE 206 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKK---------------------------------------TSNGRLPVKWMAPE 206 (314)
T ss_pred EEcCCCcEEEccccccccccccccccc---------------------------------------cccCCCCccccCHH
Confidence 999999999999999986542211000 00123456899999
Q ss_pred cccCCCCChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 328 VLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 328 ~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
++.+..++.++|||||||++|||++ |..||.+.++.+....+..+
T Consensus 207 ~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 252 (314)
T cd05099 207 ALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREG 252 (314)
T ss_pred HHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999999999999999999999 99999998888877776543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=293.66 Aligned_cols=220 Identities=21% Similarity=0.409 Sum_probs=184.4
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCC-----CceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeE
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTT-----GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCS 184 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~ 184 (373)
..+..++|++.+.||+|+||.||++..... ...+|+|.+.... .......+.+|+.++..+ +|+||++++++
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 345667899999999999999999987643 3689999987532 123345688899999999 89999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHhh----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEE
Q 017362 185 FQDDEFLYLIMEYLPGGDMMTLLMR----------------KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLL 248 (373)
Q Consensus 185 ~~~~~~~~lV~E~~~gg~L~~~l~~----------------~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NIL 248 (373)
+...+.+|+||||+++|+|..++.. ...+++..+..++.|++.||.|||+.||+||||||+|||
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 9999999999999999999999854 245889999999999999999999999999999999999
Q ss_pred EcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccc
Q 017362 249 LDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEV 328 (373)
Q Consensus 249 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~ 328 (373)
++.++.+||+|||+++.+........ .....+++.|+|||+
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~---------------------------------------~~~~~~~~~y~aPE~ 205 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRK---------------------------------------TTNGRLPVKWMAPEA 205 (293)
T ss_pred EcCCCeEEeCccccccccccccceec---------------------------------------cCCCCCCccccCHHH
Confidence 99999999999999986543221100 001235678999999
Q ss_pred ccCCCCChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhc
Q 017362 329 LLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 329 ~~~~~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
+.+..++.++|||||||++|||++ |..||.+.+..+.+..+..
T Consensus 206 ~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 249 (293)
T cd05053 206 LFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 249 (293)
T ss_pred hccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHc
Confidence 989999999999999999999997 9999998888887776654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=288.77 Aligned_cols=215 Identities=21% Similarity=0.363 Sum_probs=178.2
Q ss_pred cceeceeeeeCcEEEEEEEEcC---CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCe----
Q 017362 118 FELLTMIGKGAFGEVRVCREKT---TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF---- 190 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~---- 190 (373)
|.+.+.||+|+||.||+|.... ++..||+|.+.... ........+..|+.+++.++||||+++++.+.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI-HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 5678899999999999998754 34789999987542 223345678899999999999999999998865544
Q ss_pred --EEEEEeccCCCCHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccc
Q 017362 191 --LYLIMEYLPGGDMMTLLMRK------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (373)
Q Consensus 191 --~~lV~E~~~gg~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGl 262 (373)
.++||||+++|+|..++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999999999888442 3689999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHH
Q 017362 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342 (373)
Q Consensus 263 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwS 342 (373)
++.......... .....+++.|+|||++.+..++.++||||
T Consensus 160 ~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~S 200 (273)
T cd05035 160 SKKIYSGDYYRQ---------------------------------------GRIAKMPVKWIAIESLADRVYTSKSDVWA 200 (273)
T ss_pred eeeccccccccc---------------------------------------cccccCCccccCHhhcccCCCCcccchHH
Confidence 976542211000 00123567899999998889999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 343 LGAIMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 343 lGvil~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|||++|||++ |.+||.+.++.+....+.++
T Consensus 201 lG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 231 (273)
T cd05035 201 FGVTMWEIATRGQTPYPGVENHEIYDYLRHG 231 (273)
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999999 99999998888887776643
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=286.55 Aligned_cols=215 Identities=22% Similarity=0.401 Sum_probs=184.2
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 191 (373)
++..++|.+.+.||.|+||.||+|.+. ++..||||.+..... ....+.+|+.++..++||||+++++++.+....
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI 76 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence 355788999999999999999999875 457799999875432 235578899999999999999999999998999
Q ss_pred EEEEeccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 192 YLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
|+||||+++++|.+++.... .+++..+..++.+++.||.|||++|++|+||||+||+++.++.++|+|||++..+...
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 99999999999999997643 6899999999999999999999999999999999999999999999999998765421
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 349 (373)
.... .....++..|+|||.+.+..++.++|+|||||++|+
T Consensus 157 ~~~~----------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~ 196 (261)
T cd05034 157 EYTA----------------------------------------REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTE 196 (261)
T ss_pred hhhh----------------------------------------hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHH
Confidence 1000 002235678999999999999999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHhhc
Q 017362 350 MLV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 350 ll~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
|++ |++||.+.++.....++..
T Consensus 197 l~t~g~~p~~~~~~~~~~~~~~~ 219 (261)
T cd05034 197 IVTYGRVPYPGMTNREVLEQVER 219 (261)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHc
Confidence 998 9999998888887777754
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=289.73 Aligned_cols=218 Identities=22% Similarity=0.369 Sum_probs=184.5
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCc----eEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGH----VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 188 (373)
+...+|++.+.||+|+||+||+|.++.++. .+|+|.+..... ......+.+|+.++..++||||+++++++..
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 345789999999999999999999876654 589998865432 3345668889999999999999999999887
Q ss_pred CeEEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
...++||||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 7889999999999999999764 469999999999999999999999999999999999999999999999999998654
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 347 (373)
....... .....+++.|+|||.+....++.++|+|||||++
T Consensus 161 ~~~~~~~---------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l 201 (279)
T cd05057 161 VDEKEYH---------------------------------------AEGGKVPIKWMALESILHRIYTHKSDVWSYGVTV 201 (279)
T ss_pred Cccccee---------------------------------------cCCCcccccccCHHHhhcCCcCchhhHHHHHHHH
Confidence 2211000 0012246789999999888999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 348 YEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 348 ~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
||+++ |.+||.+.++.+...++.++
T Consensus 202 ~el~~~g~~p~~~~~~~~~~~~~~~~ 227 (279)
T cd05057 202 WELMTFGAKPYEGIPAVEIPDLLEKG 227 (279)
T ss_pred HHHhcCCCCCCCCCCHHHHHHHHhCC
Confidence 99998 99999999888888777654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=285.54 Aligned_cols=209 Identities=24% Similarity=0.422 Sum_probs=183.0
Q ss_pred ceeeeeCcEEEEEEEEcCC---CceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEecc
Q 017362 122 TMIGKGAFGEVRVCREKTT---GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYL 198 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~ 198 (373)
+.||+|+||.||+|.+... +..||+|++....... ....+..|+.++..++|+||+++++++.+...+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999998765 8899999997654322 4567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 199 PGGDMMTLLMRK---------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 199 ~gg~L~~~l~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 78999999999999999999999999999999999999999999999999999866433
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 349 (373)
.... ......+++.|+|||.+....++.++|||||||++||
T Consensus 159 ~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 199 (262)
T cd00192 159 DYYR---------------------------------------KKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWE 199 (262)
T ss_pred cccc---------------------------------------cccCCCcCccccCHHHhccCCcchhhccHHHHHHHHH
Confidence 2100 0113467899999999998899999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHhhc
Q 017362 350 MLV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 350 ll~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
|++ |.+||...++.+...++.+
T Consensus 200 l~~~g~~p~~~~~~~~~~~~~~~ 222 (262)
T cd00192 200 IFTLGATPYPGLSNEEVLEYLRK 222 (262)
T ss_pred HHhcCCCCCCCCCHHHHHHHHHc
Confidence 999 6999999988888887764
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=294.08 Aligned_cols=218 Identities=23% Similarity=0.358 Sum_probs=181.9
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEc-----CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeE
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCS 184 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~ 184 (373)
..+..++|.+.+.||+|+||.||+|.+. .++..||+|.+.... .....+.+.+|+.+++.+ +||||+++++.
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 3456678999999999999999999752 345689999887542 123346788999999999 79999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccc
Q 017362 185 FQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (373)
Q Consensus 185 ~~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGl 262 (373)
+...+..|+||||+++|+|.+++.... .+++..+..++.+++.||.|||+++++|+||||+|||++.++.++|+|||+
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999999999997543 389999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHH
Q 017362 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342 (373)
Q Consensus 263 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwS 342 (373)
++.+....... ......+++.|+|||++.+..++.++||||
T Consensus 188 ~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws 228 (302)
T cd05055 188 ARDIMNDSNYV---------------------------------------VKGNARLPVKWMAPESIFNCVYTFESDVWS 228 (302)
T ss_pred cccccCCCcee---------------------------------------ecCCCCcccccCCHhhhccCCCCcHhHHHH
Confidence 87553221000 001234678999999999999999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 017362 343 LGAIMYEMLV-GYPPFYSDDPMSTCRKV 369 (373)
Q Consensus 343 lGvil~ell~-G~~Pf~~~~~~~~~~kI 369 (373)
|||++|||++ |.+||.+.+..+...++
T Consensus 229 lGvil~el~t~g~~p~~~~~~~~~~~~~ 256 (302)
T cd05055 229 YGILLWEIFSLGSNPYPGMPVDSKFYKL 256 (302)
T ss_pred HHHHHHHHHhCCCCCcCCCCchHHHHHH
Confidence 9999999998 99999887766555443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=289.46 Aligned_cols=209 Identities=29% Similarity=0.526 Sum_probs=178.9
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhh---hhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEE
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML---RRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 193 (373)
+|+..+.||+|+||.||++.+..++..||+|++...... .......+..|+.+++.++|+||+++++.+.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999999999999999998643211 12235678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC-cEEEeeccccccCCCCCcc
Q 017362 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 194 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~-~vkL~DFGla~~~~~~~~~ 272 (373)
||||++|++|.+++.....+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++..+......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999998888899999999999999999999999999999999999998876 5999999998766432110
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 352 (373)
... ......||..|+|||++.+..++.++|+|||||++|+|++
T Consensus 161 ~~~-------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 203 (268)
T cd06630 161 AGE-------------------------------------FQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMAT 203 (268)
T ss_pred CCc-------------------------------------cccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHh
Confidence 000 0013468999999999998899999999999999999999
Q ss_pred CCCCCCCCCh
Q 017362 353 GYPPFYSDDP 362 (373)
Q Consensus 353 G~~Pf~~~~~ 362 (373)
|.+||...+.
T Consensus 204 g~~p~~~~~~ 213 (268)
T cd06630 204 AKPPWNAEKH 213 (268)
T ss_pred CCCCCCCCCC
Confidence 9999976554
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=291.44 Aligned_cols=203 Identities=29% Similarity=0.500 Sum_probs=173.6
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|++.+.||.|++|.||+|.++.+++.||||.+..... ......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 4789999999999999999999988999999999865421 12223466799999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 195 MEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
|||+++ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||+++........
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~- 159 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT- 159 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc-
Confidence 999975 999988654 46899999999999999999999999999999999999999999999999998654221100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHHHHHh
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~ 352 (373)
.....+++.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 160 ----------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~ 199 (291)
T cd07844 160 ----------------------------------------YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT 199 (291)
T ss_pred ----------------------------------------ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHh
Confidence 002357889999999876 458999999999999999999
Q ss_pred CCCCCCCCC
Q 017362 353 GYPPFYSDD 361 (373)
Q Consensus 353 G~~Pf~~~~ 361 (373)
|++||.+.+
T Consensus 200 g~~~~~~~~ 208 (291)
T cd07844 200 GRPLFPGST 208 (291)
T ss_pred CCCCCCCCc
Confidence 999998765
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=292.58 Aligned_cols=216 Identities=21% Similarity=0.373 Sum_probs=182.9
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCC----------------ceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCc
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTG----------------HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~----------------~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 177 (373)
...+|++++.||+|+||.||+|.+...+ ..||+|.+..... ....+.+.+|+.++..++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence 3568999999999999999999876533 4589999875432 234567888999999999999
Q ss_pred eeEEeeEEEeCCeEEEEEeccCCCCHHHHHhhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCC
Q 017362 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-----------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDN 246 (373)
Q Consensus 178 iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-----------~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~N 246 (373)
|+++++++.++...++||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999997655 68999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccc
Q 017362 247 LLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAP 326 (373)
Q Consensus 247 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP 326 (373)
|+++.++.++|+|||++.......... ......+++.|+||
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aP 201 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYR---------------------------------------VQGRAPLPIRWMAW 201 (296)
T ss_pred eeecCCCceEEccccceeecccCccee---------------------------------------ecCcCCCCceecCH
Confidence 999999999999999987653221110 01134578899999
Q ss_pred ccccCCCCChhhcHHHHHHHHHHHHh--CCCCCCCCChHHHHHHhh
Q 017362 327 EVLLKKGYGMECDWWSLGAIMYEMLV--GYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 327 E~~~~~~~~~~~DvwSlGvil~ell~--G~~Pf~~~~~~~~~~kI~ 370 (373)
|++.+..++.++|||||||++|||++ |..||...+..+....+.
T Consensus 202 E~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~ 247 (296)
T cd05051 202 ESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAG 247 (296)
T ss_pred HHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHH
Confidence 99998899999999999999999998 889998877777665553
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=289.25 Aligned_cols=210 Identities=34% Similarity=0.561 Sum_probs=182.2
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
..|+.++.||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++.+.||||+++++.+.++...|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 357888999999999999999988999999999875421 234567888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
||++||+|.+++. .+.+++..+..++.+++.||.|||+.+++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 e~~~~~~L~~~i~-~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~--- 157 (277)
T cd06640 82 EYLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--- 157 (277)
T ss_pred ecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc---
Confidence 9999999999885 467999999999999999999999999999999999999999999999999998765322100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 355 (373)
.....++..|+|||++.+..++.++|+|||||++|||++|.+
T Consensus 158 --------------------------------------~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~ 199 (277)
T cd06640 158 --------------------------------------RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEP 199 (277)
T ss_pred --------------------------------------cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCC
Confidence 013468889999999998899999999999999999999999
Q ss_pred CCCCCChHHHHHHh
Q 017362 356 PFYSDDPMSTCRKV 369 (373)
Q Consensus 356 Pf~~~~~~~~~~kI 369 (373)
||...++......+
T Consensus 200 p~~~~~~~~~~~~~ 213 (277)
T cd06640 200 PNSDMHPMRVLFLI 213 (277)
T ss_pred CCCCcChHhHhhhh
Confidence 99887766655443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=286.77 Aligned_cols=213 Identities=23% Similarity=0.434 Sum_probs=179.7
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 192 (373)
+..++|++.+.||+|+||.||+|.+. ++..+|+|.+..... ..+.+.+|+.+++.++|+|++++++.+. ....|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 44578999999999999999999765 556799999875432 2345888999999999999999998875 45688
Q ss_pred EEEeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 193 LIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
+||||+++++|.+++... ..+++..+..++.+++.||.|||+.|++||||||+||+++.++.++|+|||++..+....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999999999998653 358999999999999999999999999999999999999999999999999997653221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 350 (373)
... .....++..|+|||++.+..++.++|+|||||++|||
T Consensus 157 ~~~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l 196 (260)
T cd05070 157 YTA----------------------------------------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196 (260)
T ss_pred ccc----------------------------------------ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHH
Confidence 000 0023456789999999888899999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHhhc
Q 017362 351 LV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 351 l~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
++ |.+||.+.+..+....+.+
T Consensus 197 ~~~g~~p~~~~~~~~~~~~~~~ 218 (260)
T cd05070 197 VTKGRVPYPGMNNREVLEQVER 218 (260)
T ss_pred HhcCCCCCCCCCHHHHHHHHHc
Confidence 99 9999999888887777754
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=290.35 Aligned_cols=214 Identities=32% Similarity=0.567 Sum_probs=178.3
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEE---
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQ--- 186 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~--- 186 (373)
.....++|++.+.||+|+||.||+|.+..++..+|+|++.... .....+.+|+.++..+ +||||+++++.+.
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3446789999999999999999999999999999999876432 1224567788999888 7999999999874
Q ss_pred --eCCeEEEEEeccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeec
Q 017362 187 --DDEFLYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDF 260 (373)
Q Consensus 187 --~~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DF 260 (373)
+++.+|+||||++|++|.+++.. ...+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccC
Confidence 45678999999999999988742 356899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc-----CCCCC
Q 017362 261 GLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYG 335 (373)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~ 335 (373)
|++......... .....|++.|+|||++. ...++
T Consensus 169 g~~~~~~~~~~~-----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~ 207 (286)
T cd06638 169 GVSAQLTSTRLR-----------------------------------------RNTSVGTPFWMAPEVIACEQQLDSTYD 207 (286)
T ss_pred CceeecccCCCc-----------------------------------------cccccCCCcccChhhhchhhhcccccc
Confidence 998765322110 01346999999999985 34588
Q ss_pred hhhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 017362 336 MECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369 (373)
Q Consensus 336 ~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~kI 369 (373)
.++|||||||++|||++|.+||...++.....++
T Consensus 208 ~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~ 241 (286)
T cd06638 208 ARCDVWSLGITAIELGDGDPPLADLHPMRALFKI 241 (286)
T ss_pred chhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc
Confidence 9999999999999999999999887765554443
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=284.48 Aligned_cols=214 Identities=29% Similarity=0.559 Sum_probs=186.9
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEe
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E 196 (373)
+|++.+.||+|+||.||++.+..++..||+|.+...... ......+.+|+.+++.++||||+++++.+.+.+..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 589999999999999999999999999999998754322 2334568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 197 YLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 197 ~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
|+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++.........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-- 157 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL-- 157 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh--
Confidence 999999999986543 5799999999999999999999999999999999999999999999999998754321100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 354 (373)
.....|++.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 158 ---------------------------------------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~ 198 (256)
T cd08218 158 ---------------------------------------ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198 (256)
T ss_pred ---------------------------------------hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCC
Confidence 01346889999999999888999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcC
Q 017362 355 PPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 355 ~Pf~~~~~~~~~~kI~~~ 372 (373)
.||...+..+...+++.+
T Consensus 199 ~~~~~~~~~~~~~~~~~~ 216 (256)
T cd08218 199 HAFEAGNMKNLVLKIIRG 216 (256)
T ss_pred CCccCCCHHHHHHHHhcC
Confidence 999998888888877654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=291.85 Aligned_cols=210 Identities=30% Similarity=0.478 Sum_probs=179.7
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
...|++.+.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 45699999999999999999999889999999998654333334456688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 195 MEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
|||++ |+|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~--- 169 (307)
T cd06607 94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN--- 169 (307)
T ss_pred HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCCC---
Confidence 99996 567666653 4579999999999999999999999999999999999999999999999999986543211
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc---CCCCChhhcHHHHHHHHHHH
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DvwSlGvil~el 350 (373)
...|++.|+|||++. ...++.++|||||||++|||
T Consensus 170 ------------------------------------------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el 207 (307)
T cd06607 170 ------------------------------------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207 (307)
T ss_pred ------------------------------------------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHH
Confidence 245888999999985 35688999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhh
Q 017362 351 LVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 351 l~G~~Pf~~~~~~~~~~kI~ 370 (373)
++|.+||.+.++......+.
T Consensus 208 ~tg~~p~~~~~~~~~~~~~~ 227 (307)
T cd06607 208 AERKPPLFNMNAMSALYHIA 227 (307)
T ss_pred HcCCCCCCCccHHHHHHHHh
Confidence 99999999887766655443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=302.99 Aligned_cols=194 Identities=21% Similarity=0.360 Sum_probs=167.2
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEE
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 193 (373)
...+|.+++.||+|+||.||+|.+..++..||+|+..... ...|+.++..++||||+++++++.+....|+
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 3467999999999999999999999899999999854332 3458889999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcc
Q 017362 194 IMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 194 V~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 272 (373)
|||++. ++|.+++.. ...+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||++.......
T Consensus 135 v~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 211 (357)
T PHA03209 135 VLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-- 211 (357)
T ss_pred EEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence 999994 688888765 4579999999999999999999999999999999999999999999999999986432110
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 352 (373)
......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 212 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~ 251 (357)
T PHA03209 212 ----------------------------------------AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251 (357)
T ss_pred ----------------------------------------ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHH
Confidence 0113569999999999999999999999999999999998
Q ss_pred C-CCCCCC
Q 017362 353 G-YPPFYS 359 (373)
Q Consensus 353 G-~~Pf~~ 359 (373)
+ .++|..
T Consensus 252 ~~~~~f~~ 259 (357)
T PHA03209 252 YPSTIFED 259 (357)
T ss_pred cCCccccC
Confidence 5 444443
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=293.29 Aligned_cols=210 Identities=28% Similarity=0.479 Sum_probs=175.1
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEe
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E 196 (373)
+|++.+.||+|+||.||+|.+..+|..||+|.+..... .......+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 48899999999999999999999999999999865421 22233457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 197 YLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 197 ~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
|++ ++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++..+......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--- 155 (284)
T cd07839 80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC--- 155 (284)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC---
Confidence 996 578887754 567999999999999999999999999999999999999999999999999998754322100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC-CChhhcHHHHHHHHHHHHhCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~ell~G~ 354 (373)
.....+++.|+|||++.+.. ++.++|||||||++|||++|.
T Consensus 156 --------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~ 197 (284)
T cd07839 156 --------------------------------------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 197 (284)
T ss_pred --------------------------------------cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcC
Confidence 01346789999999987644 799999999999999999988
Q ss_pred CCC-CCCChHHHHHHh
Q 017362 355 PPF-YSDDPMSTCRKV 369 (373)
Q Consensus 355 ~Pf-~~~~~~~~~~kI 369 (373)
.|| .+.+..+...+|
T Consensus 198 ~p~~~~~~~~~~~~~~ 213 (284)
T cd07839 198 RPLFPGNDVDDQLKRI 213 (284)
T ss_pred CCCcCCCCHHHHHHHH
Confidence 775 455555554444
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=288.58 Aligned_cols=218 Identities=32% Similarity=0.569 Sum_probs=181.8
Q ss_pred hhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEe
Q 017362 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQD 187 (373)
Q Consensus 109 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~ 187 (373)
.......++|.+...||+|+||.||+|.+..+++.+|+|++.... .....+..|+.++..+ +|||++++++++..
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 334445788999999999999999999999999999999986532 1234466788888888 89999999999875
Q ss_pred C-----CeEEEEEeccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEe
Q 017362 188 D-----EFLYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLS 258 (373)
Q Consensus 188 ~-----~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~ 258 (373)
. ...|+||||++|++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEe
Confidence 3 358999999999999998753 4578999999999999999999999999999999999999999999999
Q ss_pred eccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-----C
Q 017362 259 DFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-----G 333 (373)
Q Consensus 259 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~ 333 (373)
|||++......... .....|++.|+|||++... .
T Consensus 171 dfg~~~~~~~~~~~-----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~ 209 (291)
T cd06639 171 DFGVSAQLTSTRLR-----------------------------------------RNTSVGTPFWMAPEVIACEQQYDYS 209 (291)
T ss_pred ecccchhccccccc-----------------------------------------ccCccCCccccChhhhcCCCCcccc
Confidence 99998765322110 0134688999999998643 3
Q ss_pred CChhhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 017362 334 YGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 334 ~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
++.++|||||||++|||++|++||...++.....++.+
T Consensus 210 ~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~ 247 (291)
T cd06639 210 YDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR 247 (291)
T ss_pred cCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc
Confidence 68999999999999999999999998887777666644
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=300.37 Aligned_cols=210 Identities=29% Similarity=0.455 Sum_probs=180.0
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC------
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD------ 188 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~------ 188 (373)
.++|++.+.||+|+||.||+|.+..++..||||.+.... ........+.+|+.+++.++||||++++++|...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 478999999999999999999999999999999986432 1223345577899999999999999999988644
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
...|+||||++ ++|...+... +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 35799999995 5888887544 89999999999999999999999999999999999999999999999999976532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 348 (373)
... .....||+.|+|||++.+..++.++|||||||++|
T Consensus 171 ~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 208 (353)
T cd07850 171 SFM------------------------------------------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 208 (353)
T ss_pred CCC------------------------------------------CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHH
Confidence 210 01346889999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhh
Q 017362 349 EMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 349 ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
+|++|+.||.+.+....+.+|+
T Consensus 209 ~l~~g~~pf~~~~~~~~~~~~~ 230 (353)
T cd07850 209 EMIRGTVLFPGTDHIDQWNKII 230 (353)
T ss_pred HHHHCCCCCCCCCHHHHHHHHH
Confidence 9999999999988877777664
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=289.83 Aligned_cols=212 Identities=35% Similarity=0.561 Sum_probs=183.0
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++|+||+++++.+.+++..|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE-DDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc-ccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 46999999999999999999999999999999987543 22334467888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
||++++.+..+......+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~--- 156 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS--- 156 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc---
Confidence 99998777776666677999999999999999999999999999999999999999999999999998765433210
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHHHHHHHHHHHhCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~ 354 (373)
.....++++.|+|||++.+. .++.++|+||||+++|+|++|.
T Consensus 157 -------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~ 199 (288)
T cd07833 157 -------------------------------------PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199 (288)
T ss_pred -------------------------------------cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCC
Confidence 01134688999999999888 8899999999999999999999
Q ss_pred CCCCCCChHHHHHH
Q 017362 355 PPFYSDDPMSTCRK 368 (373)
Q Consensus 355 ~Pf~~~~~~~~~~k 368 (373)
+||.+.+..+...+
T Consensus 200 ~~~~~~~~~~~~~~ 213 (288)
T cd07833 200 PLFPGDSDIDQLYL 213 (288)
T ss_pred CCCCCCCHHHHHHH
Confidence 99988766554443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=286.11 Aligned_cols=213 Identities=24% Similarity=0.431 Sum_probs=179.9
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 192 (373)
+..++|+++++||+|+||.||+|... ++..||+|.+..... ....+.+|+.+++.++||||+++++++. .+..|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 45678999999999999999999864 567899999875432 2346788999999999999999998874 45689
Q ss_pred EEEeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 193 LIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 999999999999998653 368999999999999999999999999999999999999999999999999987654221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 350 (373)
... .....++..|+|||++....++.++|||||||++|||
T Consensus 157 ~~~----------------------------------------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el 196 (260)
T cd05067 157 YTA----------------------------------------REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 196 (260)
T ss_pred ccc----------------------------------------ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHH
Confidence 100 0123467889999999989999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHhhc
Q 017362 351 LV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 351 l~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
++ |++||.+.++.+....+.+
T Consensus 197 ~~~g~~p~~~~~~~~~~~~~~~ 218 (260)
T cd05067 197 VTYGRIPYPGMTNPEVIQNLER 218 (260)
T ss_pred HhCCCCCCCCCChHHHHHHHHc
Confidence 98 9999998888777766543
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=283.62 Aligned_cols=207 Identities=34% Similarity=0.587 Sum_probs=182.2
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|++.+.||.|+||.||+|.+..++..|++|.+..... .+.+.+|+.+++.++||||+++++.+.+...+|++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 3679999999999999999999988899999999875432 56688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 195 MEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~- 155 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK- 155 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc-
Confidence 999999999999865 457899999999999999999999999999999999999999999999999998765422100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhC
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 353 (373)
.....|++.|+|||++.+..++.++|||||||++|+|++|
T Consensus 156 ----------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g 195 (256)
T cd06612 156 ----------------------------------------RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEG 195 (256)
T ss_pred ----------------------------------------cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhC
Confidence 0134588999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHH
Q 017362 354 YPPFYSDDPMSTCR 367 (373)
Q Consensus 354 ~~Pf~~~~~~~~~~ 367 (373)
++||...++.....
T Consensus 196 ~~p~~~~~~~~~~~ 209 (256)
T cd06612 196 KPPYSDIHPMRAIF 209 (256)
T ss_pred CCCCCCcchhhhhh
Confidence 99998776655443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=285.05 Aligned_cols=208 Identities=24% Similarity=0.378 Sum_probs=172.1
Q ss_pred eeeeeCcEEEEEEEEc--CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEeccCC
Q 017362 123 MIGKGAFGEVRVCREK--TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (373)
Q Consensus 123 ~lG~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~g 200 (373)
.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.++||||+++++.+.. ...++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 3899999999999765 445679999986542 23344668899999999999999999998864 578999999999
Q ss_pred CCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccccccc
Q 017362 201 GDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279 (373)
Q Consensus 201 g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 279 (373)
++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++..+.........
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~---- 154 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA---- 154 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec----
Confidence 999999874 457999999999999999999999999999999999999999999999999999755322110000
Q ss_pred CCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh-CCCCCC
Q 017362 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFY 358 (373)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf~ 358 (373)
.....+++.|+|||++....++.++|||||||++|||++ |.+||.
T Consensus 155 ----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 200 (257)
T cd05115 155 ----------------------------------RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYK 200 (257)
T ss_pred ----------------------------------cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcC
Confidence 001234678999999988889999999999999999996 999999
Q ss_pred CCChHHHHHHhhc
Q 017362 359 SDDPMSTCRKVRK 371 (373)
Q Consensus 359 ~~~~~~~~~kI~~ 371 (373)
+.++.+....+.+
T Consensus 201 ~~~~~~~~~~~~~ 213 (257)
T cd05115 201 KMKGPEVMSFIEQ 213 (257)
T ss_pred cCCHHHHHHHHHC
Confidence 8888777666654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=319.20 Aligned_cols=152 Identities=43% Similarity=0.736 Sum_probs=141.1
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|.++++||+|+||+||+|.+..++..||||++.............+..|+.++..++||||+++++.+.....+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 47899999999999999999999999999999999876554455556788899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccC
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~ 266 (373)
|||++|++|.+++.....+++..++.|+.||+.||.|||.+|||||||||+||||+.++++||+|||+++..
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~ 154 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccc
Confidence 999999999999988888999999999999999999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=309.29 Aligned_cols=196 Identities=24% Similarity=0.285 Sum_probs=170.0
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
...|.+.+.||+|+||.||+|.+..++..||||.... ..+.+|+.+++.++|+|||++++++...+..|+|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 4579999999999999999999999999999996432 2256799999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 195 MEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
||++ .++|..++... ..+++..+..++.|++.||.|||++|||||||||+||||+.++.++|+|||+++.+.......
T Consensus 239 ~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 239 LPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred EEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 9999 56888888654 469999999999999999999999999999999999999999999999999997653211000
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhC
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 353 (373)
.....+||+.|+|||++.+..++.++|||||||+||||++|
T Consensus 318 ---------------------------------------~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g 358 (461)
T PHA03211 318 ---------------------------------------FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVH 358 (461)
T ss_pred ---------------------------------------cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHc
Confidence 01135799999999999999999999999999999999998
Q ss_pred CCCCCC
Q 017362 354 YPPFYS 359 (373)
Q Consensus 354 ~~Pf~~ 359 (373)
..|+.+
T Consensus 359 ~~~lf~ 364 (461)
T PHA03211 359 TASLFS 364 (461)
T ss_pred CCCccc
Confidence 876654
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=281.41 Aligned_cols=215 Identities=28% Similarity=0.473 Sum_probs=182.7
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCe
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~ 190 (373)
....++.+.+..||.|+.|+||++..+.+|...|||.+..... .....++...++++... ++|+||+.+++|..+..
T Consensus 88 ~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N--kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d 165 (391)
T KOG0983|consen 88 QADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD 165 (391)
T ss_pred ccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC--HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence 3445667788889999999999999999999999999987642 44556677777776554 58999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 191 LYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~-~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
+++.||.| +..+..+|.+ +++++|..+-.+..-++.||.||.. +||||||+||+|||+|..|+|||||||++-.+..
T Consensus 166 V~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 166 VFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec
Confidence 99999999 4456666654 5789999999999999999999984 7999999999999999999999999999987654
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC---CCCChhhcHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGA 345 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~~DvwSlGv 345 (373)
+..+. ...|.+.|||||.+.- ..|+..+|||||||
T Consensus 245 SkAht------------------------------------------rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGI 282 (391)
T KOG0983|consen 245 SKAHT------------------------------------------RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGI 282 (391)
T ss_pred ccccc------------------------------------------cccCCccccCccccCCCCCCccchhhhhhhhcc
Confidence 43221 3479999999999974 45999999999999
Q ss_pred HHHHHHhCCCCCCCC-ChHHHHHHhhc
Q 017362 346 IMYEMLVGYPPFYSD-DPMSTCRKVRK 371 (373)
Q Consensus 346 il~ell~G~~Pf~~~-~~~~~~~kI~~ 371 (373)
.++||.||..||.+. ...++..||++
T Consensus 283 TlveLaTg~yPy~~c~tdFe~ltkvln 309 (391)
T KOG0983|consen 283 TLVELATGQYPYKGCKTDFEVLTKVLN 309 (391)
T ss_pred chhhhhcccCCCCCCCccHHHHHHHHh
Confidence 999999999999986 58899999986
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=289.93 Aligned_cols=204 Identities=29% Similarity=0.463 Sum_probs=172.3
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|.+.+.||+|+||.||+|.+..++..||+|++..... ......+.+|+.++..++|+||+++++++.+++..|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999865421 22223467899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 195 MEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
|||++ ++|.+++.. ...+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||+++........
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~- 159 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT- 159 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC-
Confidence 99995 677776654 356889999999999999999999999999999999999999999999999998753221100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHHHHHh
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~ 352 (373)
.....+++.|+|||++.+ ..++.++|||||||++|||++
T Consensus 160 ----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~ 199 (291)
T cd07870 160 ----------------------------------------YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQ 199 (291)
T ss_pred ----------------------------------------CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHh
Confidence 013457899999999876 458899999999999999999
Q ss_pred CCCCCCCCCh
Q 017362 353 GYPPFYSDDP 362 (373)
Q Consensus 353 G~~Pf~~~~~ 362 (373)
|.+||.+.++
T Consensus 200 g~~~f~~~~~ 209 (291)
T cd07870 200 GQPAFPGVSD 209 (291)
T ss_pred CCCCCCCchh
Confidence 9999986553
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=283.78 Aligned_cols=209 Identities=22% Similarity=0.387 Sum_probs=174.8
Q ss_pred ceeeeeCcEEEEEEEEcCCC---ceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEecc
Q 017362 122 TMIGKGAFGEVRVCREKTTG---HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYL 198 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~ 198 (373)
++||+|+||.||+|....++ ..+|+|.+...... .....+.+|+.+++.++||||+++++++. .+..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 46999999999999875544 78999998765432 33456888999999999999999999876 45679999999
Q ss_pred CCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccc
Q 017362 199 PGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278 (373)
Q Consensus 199 ~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 278 (373)
++|+|.+++.....+++..+..++.|++.||.|||..|++|+||||+|||++.++.+||+|||+++.+........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~---- 153 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR---- 153 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc----
Confidence 9999999998877899999999999999999999999999999999999999999999999999876532210000
Q ss_pred cCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh-CCCCC
Q 017362 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPF 357 (373)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf 357 (373)
......++..|+|||.+.+..++.++|||||||++|||++ |.+||
T Consensus 154 ----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~ 199 (257)
T cd05060 154 ----------------------------------ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPY 199 (257)
T ss_pred ----------------------------------cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCc
Confidence 0001224568999999999999999999999999999998 99999
Q ss_pred CCCChHHHHHHhhc
Q 017362 358 YSDDPMSTCRKVRK 371 (373)
Q Consensus 358 ~~~~~~~~~~kI~~ 371 (373)
...++.+....|.+
T Consensus 200 ~~~~~~~~~~~~~~ 213 (257)
T cd05060 200 GEMKGAEVIAMLES 213 (257)
T ss_pred ccCCHHHHHHHHHc
Confidence 98888777666643
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=313.41 Aligned_cols=194 Identities=34% Similarity=0.602 Sum_probs=171.8
Q ss_pred eeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEeccCCCC
Q 017362 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGD 202 (373)
Q Consensus 123 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~gg~ 202 (373)
+||+|.||+||-|+++.+....|||-+.... ....+-+..|+.+.+.++|.|||+++|++..++++-+.||-+|||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 6999999999999999999999999986543 3345568889999999999999999999999999999999999999
Q ss_pred HHHHHhhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEc-CCCcEEEeeccccccCCCCCcccccccc
Q 017362 203 MMTLLMRK-DTL--TEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD-KYGHLRLSDFGLCKPLDCSTLQEQDFTI 278 (373)
Q Consensus 203 L~~~l~~~-~~l--~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~ 278 (373)
|.++|..+ +++ .|..+.+|..||+.||.|||.+.|||||||.+|||++ -.|.+||+|||-++.+..-+.
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP------- 731 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP------- 731 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCc-------
Confidence 99999764 677 8999999999999999999999999999999999996 579999999999987642211
Q ss_pred cCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC--CCChhhcHHHHHHHHHHHHhCCCC
Q 017362 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK--GYGMECDWWSLGAIMYEMLVGYPP 356 (373)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DvwSlGvil~ell~G~~P 356 (373)
...++.||..|||||++-.+ +|+.++|||||||.+.||.||+||
T Consensus 732 ----------------------------------~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPP 777 (1226)
T KOG4279|consen 732 ----------------------------------CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPP 777 (1226)
T ss_pred ----------------------------------cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCC
Confidence 12367899999999999864 599999999999999999999999
Q ss_pred CCCC
Q 017362 357 FYSD 360 (373)
Q Consensus 357 f~~~ 360 (373)
|...
T Consensus 778 F~El 781 (1226)
T KOG4279|consen 778 FVEL 781 (1226)
T ss_pred eeec
Confidence 9854
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=288.76 Aligned_cols=211 Identities=30% Similarity=0.510 Sum_probs=180.8
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEe
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E 196 (373)
+|++.+.||.|++|.||+|.+..++..||||++..... ......+.+|+.+++.++||||+++++.+.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58999999999999999999999999999999875432 2234556789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 197 YLPGGDMMTLLMRK---DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 197 ~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
|+++ +|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.........
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 156 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT- 156 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc-
Confidence 9975 888887653 36899999999999999999999999999999999999999999999999998754322100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHHHHHh
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~ 352 (373)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 157 ----------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~ 196 (284)
T cd07836 157 ----------------------------------------FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT 196 (284)
T ss_pred ----------------------------------------cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 013467899999999866 457899999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhc
Q 017362 353 GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 353 G~~Pf~~~~~~~~~~kI~~ 371 (373)
|.+||.+.+..+.+.++++
T Consensus 197 g~~~~~~~~~~~~~~~~~~ 215 (284)
T cd07836 197 GRPLFPGTNNEDQLLKIFR 215 (284)
T ss_pred CCCCCCCCCcHHHHHHHHH
Confidence 9999999988887777653
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=294.26 Aligned_cols=208 Identities=34% Similarity=0.616 Sum_probs=179.1
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEec
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~ 197 (373)
|.....||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.++..++||||+++++.+..++..|+||||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 455567999999999999998899999999986543 22345578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccccc
Q 017362 198 LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT 277 (373)
Q Consensus 198 ~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 277 (373)
+++++|..++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..+......
T Consensus 100 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~----- 173 (297)
T cd06659 100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK----- 173 (297)
T ss_pred CCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc-----
Confidence 999999887744 56899999999999999999999999999999999999999999999999998754322100
Q ss_pred ccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCC
Q 017362 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357 (373)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 357 (373)
.....|++.|+|||++.+..++.++|||||||++|||++|++||
T Consensus 174 ------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~ 217 (297)
T cd06659 174 ------------------------------------RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPY 217 (297)
T ss_pred ------------------------------------ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 01356899999999999889999999999999999999999999
Q ss_pred CCCChHHHHHHhh
Q 017362 358 YSDDPMSTCRKVR 370 (373)
Q Consensus 358 ~~~~~~~~~~kI~ 370 (373)
...++.+....+.
T Consensus 218 ~~~~~~~~~~~~~ 230 (297)
T cd06659 218 FSDSPVQAMKRLR 230 (297)
T ss_pred CCCCHHHHHHHHh
Confidence 9887776665543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=282.75 Aligned_cols=212 Identities=31% Similarity=0.599 Sum_probs=184.9
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEe
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E 196 (373)
+|++.+.||+|+||.||+|.+..++..+|+|.+..... .......+..|+.+++.++||||+++++.+...+.+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 58899999999999999999999999999999876533 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC-cEEEeeccccccCCCCCccc
Q 017362 197 YLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 197 ~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~-~vkL~DFGla~~~~~~~~~~ 273 (373)
|++|++|.+++... ..+++..+..++.+++.||.|||++|++|+||+|+||+++.++ .++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-- 157 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-- 157 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc--
Confidence 99999999999763 3589999999999999999999999999999999999998654 579999999976532210
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhC
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 353 (373)
.....|++.|+|||.+.+..++.++|||||||++|+|++|
T Consensus 158 ----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~ 197 (256)
T cd08220 158 ----------------------------------------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASL 197 (256)
T ss_pred ----------------------------------------ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhC
Confidence 0124688999999999988899999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhc
Q 017362 354 YPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 354 ~~Pf~~~~~~~~~~kI~~ 371 (373)
..||...+......++..
T Consensus 198 ~~~~~~~~~~~~~~~~~~ 215 (256)
T cd08220 198 KRAFEAANLPALVLKIMS 215 (256)
T ss_pred CCCcccCchHHHHHHHHh
Confidence 999999888877777654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=296.57 Aligned_cols=221 Identities=20% Similarity=0.379 Sum_probs=183.0
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCC-------CceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEe
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTT-------GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLY 182 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~ 182 (373)
.++...+|++.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.++..+ +||||++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 445567899999999999999999976422 2368999887432 223456788899999999 899999999
Q ss_pred eEEEeCCeEEEEEeccCCCCHHHHHhhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCC
Q 017362 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRKD----------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDN 246 (373)
Q Consensus 183 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~N 246 (373)
+.+...+.+|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++|++||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 164 (334)
T cd05100 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN 164 (334)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence 99999999999999999999999986532 47788899999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccc
Q 017362 247 LLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAP 326 (373)
Q Consensus 247 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP 326 (373)
||++.++.+||+|||+++......... ......+++.|+||
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aP 205 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYK---------------------------------------KTTNGRLPVKWMAP 205 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccc---------------------------------------cccCCCcCceEcCH
Confidence 999999999999999997653221100 00022345789999
Q ss_pred ccccCCCCChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 327 EVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 327 E~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|++.+..++.++|||||||++|||++ |.+||.+.+..+....+.++
T Consensus 206 E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 252 (334)
T cd05100 206 EALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG 252 (334)
T ss_pred HHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 99999999999999999999999998 99999998888887776543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=285.43 Aligned_cols=214 Identities=29% Similarity=0.530 Sum_probs=180.7
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhh-------hhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML-------RRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 189 (373)
+|.+.+.||.|+||.||+|.+..++..||+|.+...... .....+.+..|+.++..++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999999999889999999987542211 1122456788999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
..++||||++|++|.+++...+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999998754321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC--CChhhcHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG--YGMECDWWSLGAIM 347 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~~DvwSlGvil 347 (373)
.... ......|+..|+|||++.... ++.++|+||||+++
T Consensus 162 ~~~~---------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l 202 (272)
T cd06629 162 YDND---------------------------------------QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVV 202 (272)
T ss_pred cccc---------------------------------------ccccccCCccccCHHHhccccCCCCccchhHHHHHHH
Confidence 1000 011346889999999988755 89999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHh
Q 017362 348 YEMLVGYPPFYSDDPMSTCRKV 369 (373)
Q Consensus 348 ~ell~G~~Pf~~~~~~~~~~kI 369 (373)
|||++|..||...+..+...++
T Consensus 203 ~~l~~g~~p~~~~~~~~~~~~~ 224 (272)
T cd06629 203 LEMFAGRRPWSDEEAIAAMFKL 224 (272)
T ss_pred HHHHhCCCCCcCcchHHHHHHh
Confidence 9999999999877665554443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=282.35 Aligned_cols=208 Identities=24% Similarity=0.422 Sum_probs=181.7
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 192 (373)
+..++|++.+.||.|+||.||+|... ++.||+|.+..... ....+.+|+.++..++|+||+++++.+.+....|
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 34678999999999999999999864 78999999876532 4567888999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 193 LIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
+||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 9999999999999997765 79999999999999999999999999999999999999999999999999997652111
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 350 (373)
. ...++..|+|||++....++.++|||||||++|||
T Consensus 157 ~--------------------------------------------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l 192 (256)
T cd05039 157 D--------------------------------------------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192 (256)
T ss_pred c--------------------------------------------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHH
Confidence 0 12345679999999888899999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHhh
Q 017362 351 LV-GYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 351 l~-G~~Pf~~~~~~~~~~kI~ 370 (373)
++ |.+||...+..+....+.
T Consensus 193 ~~~g~~p~~~~~~~~~~~~~~ 213 (256)
T cd05039 193 YSFGRVPYPRIPLKDVVPHVE 213 (256)
T ss_pred HhcCCCCCCCCCHHHHHHHHh
Confidence 97 999999887777665544
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=288.10 Aligned_cols=212 Identities=29% Similarity=0.480 Sum_probs=182.9
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEe
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E 196 (373)
+|++.+.||.|+||.||+|.+..+|..||+|++..... .......+.+|+.+++.++||||+++++++.++..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 58899999999999999999988999999999876432 12334668889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 197 YLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 197 ~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
|+ +++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~--- 155 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR--- 155 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC---
Confidence 99 9999999865 457999999999999999999999999999999999999999999999999998765432100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHHHHHHHHHHHhCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~ 354 (373)
......|++.|+|||++.+. .++.++|||||||++|||++|.
T Consensus 156 -------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~ 198 (286)
T cd07832 156 -------------------------------------LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198 (286)
T ss_pred -------------------------------------ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCC
Confidence 01134689999999998754 4689999999999999999999
Q ss_pred CCCCCCChHHHHHHhh
Q 017362 355 PPFYSDDPMSTCRKVR 370 (373)
Q Consensus 355 ~Pf~~~~~~~~~~kI~ 370 (373)
+||.+.++.+...+++
T Consensus 199 ~~~~~~~~~~~~~~~~ 214 (286)
T cd07832 199 PLFPGENDIEQLAIVF 214 (286)
T ss_pred cCcCCCCHHHHHHHHH
Confidence 9999888777766654
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=294.79 Aligned_cols=197 Identities=24% Similarity=0.417 Sum_probs=160.2
Q ss_pred eceeeeeCcEEEEEEEEcC--CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe--CCeEEEEEe
Q 017362 121 LTMIGKGAFGEVRVCREKT--TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD--DEFLYLIME 196 (373)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~~lV~E 196 (373)
..+||+|+||+||+|..+. ++..||+|.+.... ....+.+|+.+++.++||||+++++++.. +..+|+|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 3579999999999998654 56789999886542 12346789999999999999999998853 567899999
Q ss_pred ccCCCCHHHHHhh---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEE----cCCCcEEEeecccc
Q 017362 197 YLPGGDMMTLLMR---------KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLC 263 (373)
Q Consensus 197 ~~~gg~L~~~l~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl----~~~~~vkL~DFGla 263 (373)
|++ ++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 995 577777642 1258899999999999999999999999999999999999 56789999999999
Q ss_pred ccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHH
Q 017362 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWS 342 (373)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwS 342 (373)
+.......... .....+||+.|+|||++.+ ..++.++||||
T Consensus 160 ~~~~~~~~~~~--------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwS 201 (317)
T cd07867 160 RLFNSPLKPLA--------------------------------------DLDPVVVTFWYRAPELLLGARHYTKAIDIWA 201 (317)
T ss_pred eccCCCccccc--------------------------------------ccCcceecccccCcHHhcCCCccCcHHHHHh
Confidence 86543211000 0114578999999999976 45899999999
Q ss_pred HHHHHHHHHhCCCCCCCCC
Q 017362 343 LGAIMYEMLVGYPPFYSDD 361 (373)
Q Consensus 343 lGvil~ell~G~~Pf~~~~ 361 (373)
|||++|||++|.+||...+
T Consensus 202 lG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 202 IGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred HHHHHHHHHhCCCCccccc
Confidence 9999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=286.44 Aligned_cols=208 Identities=19% Similarity=0.270 Sum_probs=167.5
Q ss_pred ceeeeeCcEEEEEEEEcC--CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEeccC
Q 017362 122 TMIGKGAFGEVRVCREKT--TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLP 199 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~ 199 (373)
+.||+|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+.+...+|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 358999999999996432 34578888775432 12234557789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 200 GGDMMTLLMRKD-----TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 200 gg~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
+|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~- 157 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI- 157 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhee-
Confidence 999999986643 24678889999999999999999999999999999999999999999999986532211000
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-------CCCChhhcHHHHHHHH
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-------KGYGMECDWWSLGAIM 347 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~~~~~DvwSlGvil 347 (373)
......+++.|+|||++.. ..++.++|||||||++
T Consensus 158 --------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l 199 (269)
T cd05042 158 --------------------------------------TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTM 199 (269)
T ss_pred --------------------------------------ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHH
Confidence 0012456788999999753 4578899999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHhh
Q 017362 348 YEMLV-GYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 348 ~ell~-G~~Pf~~~~~~~~~~kI~ 370 (373)
|||++ |.+||....+.+...+++
T Consensus 200 ~el~~~~~~p~~~~~~~~~~~~~~ 223 (269)
T cd05042 200 WELFTAADQPYPDLSDEQVLKQVV 223 (269)
T ss_pred HHHHhCCCCCCCcCCHHHHHHHHh
Confidence 99999 899998887776665554
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=300.63 Aligned_cols=206 Identities=33% Similarity=0.539 Sum_probs=172.6
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCC
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~ 189 (373)
+.+....|+++++||+||.+.||++... +...||+|.+... ..+...+.-+.+|+.+|.++ .|.+|++||++-..++
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 4566778999999999999999999764 3456677765433 23455668899999999999 5899999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKDT-LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~~-l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
++||||||= ..||..+|.++.. ++...+++|..||+.|+.++|+.||||-||||.|+|+-. |.+||+|||+|..+..
T Consensus 434 ~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 434 YLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred eEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 999999964 6799999987654 333689999999999999999999999999999999876 9999999999998776
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC-----------CChh
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-----------YGME 337 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-----------~~~~ 337 (373)
.+..-. ..+-+||+.||+||.+.... .+++
T Consensus 512 DTTsI~---------------------------------------kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~ 552 (677)
T KOG0596|consen 512 DTTSIV---------------------------------------KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRK 552 (677)
T ss_pred ccccee---------------------------------------eccccCcccccCHHHHhhccccccCCCcceeecCc
Confidence 543321 22679999999999997543 4578
Q ss_pred hcHHHHHHHHHHHHhCCCCCCC
Q 017362 338 CDWWSLGAIMYEMLVGYPPFYS 359 (373)
Q Consensus 338 ~DvwSlGvil~ell~G~~Pf~~ 359 (373)
+||||||||||+|+.|++||..
T Consensus 553 SDvWSLGCILYqMvYgktPf~~ 574 (677)
T KOG0596|consen 553 SDVWSLGCILYQMVYGKTPFGQ 574 (677)
T ss_pred cchhhhhhHHHHHHhcCCchHH
Confidence 9999999999999999999964
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=291.03 Aligned_cols=215 Identities=19% Similarity=0.382 Sum_probs=177.7
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCC--------------CceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCcee
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTT--------------GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIV 179 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~--------------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv 179 (373)
..++|++.+.||+|+||.||+|.+..+ ...||+|.+.... .......+.+|+.++..++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcC
Confidence 356899999999999999999987543 2358999987532 233445688899999999999999
Q ss_pred EEeeEEEeCCeEEEEEeccCCCCHHHHHhhCC------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCE
Q 017362 180 KLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNL 247 (373)
Q Consensus 180 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~------------~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NI 247 (373)
++++++...+..|+||||+++++|.+++.... .+++..+..++.+++.||.|||++|++|+||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 99999999999999999999999999986532 368889999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccc
Q 017362 248 LLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPE 327 (373)
Q Consensus 248 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE 327 (373)
|++.++.+||+|||++.......... ......+++.|+|||
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE 201 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYR---------------------------------------IQGRAVLPIRWMAWE 201 (295)
T ss_pred EEcCCCcEEecccccccccccCccee---------------------------------------ccCcCcCceeecChh
Confidence 99999999999999987543221000 001235678999999
Q ss_pred cccCCCCChhhcHHHHHHHHHHHHh--CCCCCCCCChHHHHHHh
Q 017362 328 VLLKKGYGMECDWWSLGAIMYEMLV--GYPPFYSDDPMSTCRKV 369 (373)
Q Consensus 328 ~~~~~~~~~~~DvwSlGvil~ell~--G~~Pf~~~~~~~~~~kI 369 (373)
++..+.++.++|||||||++|+|++ |..||...+..+....+
T Consensus 202 ~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~ 245 (295)
T cd05097 202 SILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENT 245 (295)
T ss_pred hhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHH
Confidence 9999999999999999999999988 77899887766655443
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=282.80 Aligned_cols=211 Identities=30% Similarity=0.585 Sum_probs=182.5
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHh--hhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM--LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
+|+..+.||+|+||.||+|....++..|++|.+..... ........+.+|+.+++.++|+||+++++.+.+...+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47778899999999999999988899999999865331 1123456788899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
|||+++++|.+++.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~--- 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--- 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccc---
Confidence 99999999999998877899999999999999999999999999999999999999999999999999876532210
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC-CChhhcHHHHHHHHHHHHhC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~ell~G 353 (373)
.....|++.|+|||.+.... ++.++|+|||||++|+|++|
T Consensus 158 ---------------------------------------~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g 198 (258)
T cd06632 158 ---------------------------------------AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATG 198 (258)
T ss_pred ---------------------------------------ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhC
Confidence 01346889999999998776 89999999999999999999
Q ss_pred CCCCCCCChHHHHHHh
Q 017362 354 YPPFYSDDPMSTCRKV 369 (373)
Q Consensus 354 ~~Pf~~~~~~~~~~kI 369 (373)
.+||...++.+...++
T Consensus 199 ~~pf~~~~~~~~~~~~ 214 (258)
T cd06632 199 KPPWSQLEGVAAVFKI 214 (258)
T ss_pred CCCcccCcHHHHHHHH
Confidence 9999877765555444
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=282.75 Aligned_cols=214 Identities=34% Similarity=0.633 Sum_probs=184.1
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe--CCeEEEE
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD--DEFLYLI 194 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~~lV 194 (373)
+|++.+.||.|+||.||+|.+..++..||+|.+..... .....+.+..|+.+++.++||||+++++.+.. ...+|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 58899999999999999999999999999999875432 23345668889999999999999999998764 4568999
Q ss_pred EeccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCCeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 195 MEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIH-----KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH-----~~giiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
|||+++++|.+++.. ...+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999865 357999999999999999999999 89999999999999999999999999999986
Q ss_pred CCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHH
Q 017362 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (373)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGv 345 (373)
....... .....|++.|+|||++.+..++.++|+||||+
T Consensus 160 ~~~~~~~-----------------------------------------~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~ 198 (265)
T cd08217 160 LGHDSSF-----------------------------------------AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGC 198 (265)
T ss_pred ccCCccc-----------------------------------------ccccccCCCccChhhhcCCCCCchhHHHHHHH
Confidence 5432110 01346899999999999988999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHhhcC
Q 017362 346 IMYEMLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 346 il~ell~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
++|+|++|..||...+.......+.++
T Consensus 199 il~~l~~g~~p~~~~~~~~~~~~~~~~ 225 (265)
T cd08217 199 LIYELCALSPPFTARNQLQLASKIKEG 225 (265)
T ss_pred HHHHHHHCCCcccCcCHHHHHHHHhcC
Confidence 999999999999988877776666543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=289.37 Aligned_cols=218 Identities=24% Similarity=0.408 Sum_probs=182.3
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcC-----CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKT-----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 188 (373)
..++|++...||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.++||||+++++++.++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 45789999999999999999998743 57789999987542 122345688899999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRK----------------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDN 246 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~----------------------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~N 246 (373)
...|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 9999999999999999999642 247888899999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccc
Q 017362 247 LLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAP 326 (373)
Q Consensus 247 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP 326 (373)
||++.++.++|+|||++........... .....+++.|+||
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~---------------------------------------~~~~~~~~~y~aP 201 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKA---------------------------------------SENDAIPIRWMPP 201 (288)
T ss_pred eEecCCCceEECccccceecccCccccc---------------------------------------cCCCccChhhcCH
Confidence 9999999999999999875432211000 0012356779999
Q ss_pred ccccCCCCChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 327 EVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 327 E~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|++.+..++.++|||||||++|||++ |..||.+.++.+....+.++
T Consensus 202 E~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~ 248 (288)
T cd05050 202 ESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDG 248 (288)
T ss_pred HHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Confidence 99998999999999999999999997 99999988888877776543
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=283.61 Aligned_cols=213 Identities=23% Similarity=0.411 Sum_probs=178.2
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 192 (373)
+..++|.+...||+|++|.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.++|||++++++.+. .+..|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY 76 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence 3456799999999999999999987654 4689998765321 2345788999999999999999998875 45688
Q ss_pred EEEeccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 193 LIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
+||||+++++|.+++.... .+++..+..++.+++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 9999999999999996543 48899999999999999999999999999999999999999999999999997653221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 350 (373)
... .....++..|+|||++.+..++.++|+|||||++|||
T Consensus 157 ~~~----------------------------------------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el 196 (260)
T cd05069 157 YTA----------------------------------------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196 (260)
T ss_pred ccc----------------------------------------cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHH
Confidence 100 0123467789999999888999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHhhc
Q 017362 351 LV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 351 l~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
++ |.+||.+.++.+...++.+
T Consensus 197 ~t~g~~p~~~~~~~~~~~~~~~ 218 (260)
T cd05069 197 VTKGRVPYPGMVNREVLEQVER 218 (260)
T ss_pred HhCCCCCCCCCCHHHHHHHHHc
Confidence 99 9999999888877777654
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=289.92 Aligned_cols=213 Identities=30% Similarity=0.478 Sum_probs=181.7
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC--CeEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--EFLY 192 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~~ 192 (373)
.++|++.+.||.|+||.||+|.+..++..+|+|.+...... ......+.+|+.++..++||||+++++++... ..+|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 35799999999999999999999989999999998755322 22234567799999999999999999999877 8899
Q ss_pred EEEeccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 193 LIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
+||||++ ++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+|||++.++.++|+|||++........
T Consensus 83 lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred EEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 9999996 59999887644 599999999999999999999999999999999999999999999999999876543210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~el 350 (373)
. .....+++.|+|||++.+. .++.++|+|||||++|+|
T Consensus 162 ~-----------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l 200 (293)
T cd07843 162 P-----------------------------------------YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAEL 200 (293)
T ss_pred c-----------------------------------------cccccccccccCchhhcCCccccchhhHHHHHHHHHHH
Confidence 0 0134578999999998764 468999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhh
Q 017362 351 LVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 351 l~G~~Pf~~~~~~~~~~kI~ 370 (373)
++|.+||...++.+.+.++.
T Consensus 201 ~~g~~~f~~~~~~~~~~~~~ 220 (293)
T cd07843 201 LTKKPLFPGKSEIDQLNKIF 220 (293)
T ss_pred HhCCCCCCCCChHHHHHHHH
Confidence 99999999998888877764
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=283.19 Aligned_cols=207 Identities=25% Similarity=0.457 Sum_probs=176.4
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEE-eCCeE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ-DDEFL 191 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-~~~~~ 191 (373)
+...+|.+.+.||+|+||.||++... +..||+|.+.... ....+.+|+.+++.++|+|++++++++. .+...
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 34568999999999999999999754 7789999886432 2346788999999999999999998764 55678
Q ss_pred EEEEeccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 192 YLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
|+||||+++++|.+++.... .+++..+..++.+++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999999999987643 4889999999999999999999999999999999999999999999999998754321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 349 (373)
. ....++..|+|||++.+..++.++|||||||++||
T Consensus 156 ~--------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~ 191 (256)
T cd05082 156 Q--------------------------------------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWE 191 (256)
T ss_pred C--------------------------------------------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHH
Confidence 1 02335678999999999999999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHhh
Q 017362 350 MLV-GYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 350 ll~-G~~Pf~~~~~~~~~~kI~ 370 (373)
|++ |.+||...+..+....|.
T Consensus 192 l~~~g~~p~~~~~~~~~~~~~~ 213 (256)
T cd05082 192 IYSFGRVPYPRIPLKDVVPRVE 213 (256)
T ss_pred HHhCCCCCCCCCCHHHHHHHHh
Confidence 997 999999888777766554
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=293.08 Aligned_cols=209 Identities=32% Similarity=0.610 Sum_probs=179.6
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
+.|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+.++..++||||+++++.+...+..|+||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 34555677999999999999998899999999886432 233456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
||+++++|.+++. ...+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.........
T Consensus 99 e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~--- 174 (292)
T cd06658 99 EFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--- 174 (292)
T ss_pred eCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc---
Confidence 9999999999874 456899999999999999999999999999999999999999999999999998654321100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 355 (373)
.....|++.|+|||++.+..++.++|+|||||++|||++|+.
T Consensus 175 --------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~ 216 (292)
T cd06658 175 --------------------------------------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 216 (292)
T ss_pred --------------------------------------CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 013468999999999998899999999999999999999999
Q ss_pred CCCCCChHHHHHHh
Q 017362 356 PFYSDDPMSTCRKV 369 (373)
Q Consensus 356 Pf~~~~~~~~~~kI 369 (373)
||...++......+
T Consensus 217 p~~~~~~~~~~~~~ 230 (292)
T cd06658 217 PYFNEPPLQAMRRI 230 (292)
T ss_pred CCCCCCHHHHHHHH
Confidence 99988876665544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=285.22 Aligned_cols=218 Identities=22% Similarity=0.380 Sum_probs=181.5
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCc---eEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGH---VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 191 (373)
..+|++.+.||+|+||.||+|.+..++. .||||++.... .......+..|+.+++.++||||+++++++.++...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4568999999999999999999876654 69999987532 233456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 192 YLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
++||||+++++|.+++... +.+++..+..++.|++.||.|||++|++|+||||+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999998753 568999999999999999999999999999999999999999999999999987553221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 350 (373)
.... +. ......++..|+|||++.+..++.++|||||||++|||
T Consensus 161 ~~~~-~~-----------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~ 204 (269)
T cd05065 161 SDPT-YT-----------------------------------SSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 204 (269)
T ss_pred cccc-cc-----------------------------------cccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHH
Confidence 1000 00 00011234679999999999999999999999999998
Q ss_pred Hh-CCCCCCCCChHHHHHHhh
Q 017362 351 LV-GYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 351 l~-G~~Pf~~~~~~~~~~kI~ 370 (373)
++ |.+||...+..+...+|.
T Consensus 205 l~~g~~p~~~~~~~~~~~~i~ 225 (269)
T cd05065 205 MSYGERPYWDMSNQDVINAIE 225 (269)
T ss_pred hcCCCCCCCCCCHHHHHHHHH
Confidence 86 999999888877777664
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=285.96 Aligned_cols=205 Identities=24% Similarity=0.451 Sum_probs=171.6
Q ss_pred eeeeeCcEEEEEEEEcCCCc--eEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCeEEEEEeccC
Q 017362 123 MIGKGAFGEVRVCREKTTGH--VYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIMEYLP 199 (373)
Q Consensus 123 ~lG~G~~g~Vy~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lV~E~~~ 199 (373)
.||+|+||.||+|.+..++. .+|+|.+.... .....+.+..|+.++..+ +||||+++++.+...+.+|+||||++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 58999999999999887765 46888876421 223445688899999999 89999999999999999999999999
Q ss_pred CCCHHHHHhhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeecccc
Q 017362 200 GGDMMTLLMRKD----------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (373)
Q Consensus 200 gg~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla 263 (373)
+|+|.+++.... .+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 999999986543 4789999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHH
Q 017362 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (373)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSl 343 (373)
........ ......++.|+|||++....++.++|||||
T Consensus 160 ~~~~~~~~------------------------------------------~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 197 (270)
T cd05047 160 RGQEVYVK------------------------------------------KTMGRLPVRWMAIESLNYSVYTTNSDVWSY 197 (270)
T ss_pred cccchhhh------------------------------------------ccCCCCccccCChHHHccCCCCchhhHHHH
Confidence 53211000 001234667999999988899999999999
Q ss_pred HHHHHHHHh-CCCCCCCCChHHHHHHhhc
Q 017362 344 GAIMYEMLV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 344 Gvil~ell~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
||++|||++ |.+||.+.+..+...++..
T Consensus 198 G~il~el~~~g~~pf~~~~~~~~~~~~~~ 226 (270)
T cd05047 198 GVLLWEIVSLGGTPYCGMTCAELYEKLPQ 226 (270)
T ss_pred HHHHHHHHcCCCCCccccCHHHHHHHHhC
Confidence 999999997 9999998887777776644
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=285.25 Aligned_cols=209 Identities=35% Similarity=0.581 Sum_probs=180.7
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEec
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~ 197 (373)
|++.+.||.|+||.||+|.+..++..||||++..... ......+.+|+.++..++||||+++++.+.++...|+||||
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 7788899999999999999988999999998764432 23446688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccccc
Q 017362 198 LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT 277 (373)
Q Consensus 198 ~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 277 (373)
+++++|..++. ...+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||++..+......
T Consensus 84 ~~~~~l~~~i~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~----- 157 (277)
T cd06641 84 LGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK----- 157 (277)
T ss_pred CCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhh-----
Confidence 99999998885 457899999999999999999999999999999999999999999999999998754321100
Q ss_pred ccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCC
Q 017362 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357 (373)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 357 (373)
.....|+..|+|||.+.+..++.++|+|||||++|+|++|.+||
T Consensus 158 ------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 201 (277)
T cd06641 158 ------------------------------------RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPH 201 (277)
T ss_pred ------------------------------------hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 01346889999999998888999999999999999999999999
Q ss_pred CCCChHHHHHHhh
Q 017362 358 YSDDPMSTCRKVR 370 (373)
Q Consensus 358 ~~~~~~~~~~kI~ 370 (373)
...++......|.
T Consensus 202 ~~~~~~~~~~~~~ 214 (277)
T cd06641 202 SELHPMKVLFLIP 214 (277)
T ss_pred CccchHHHHHHHh
Confidence 8877666555543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=290.12 Aligned_cols=207 Identities=35% Similarity=0.569 Sum_probs=178.9
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEe
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E 196 (373)
.|+..+.||+|+||.||+|.+..++..||+|.+..... ....+.+.+|+.+++.++||||+++++.+..++..|+|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 47778889999999999999988899999999864422 2344678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccc
Q 017362 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (373)
Q Consensus 197 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 276 (373)
|+++++|.+++. ...+++..+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||++..+......
T Consensus 83 ~~~~~~L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~---- 157 (277)
T cd06642 83 YLGGGSALDLLK-PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK---- 157 (277)
T ss_pred ccCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchh----
Confidence 999999998885 467899999999999999999999999999999999999999999999999998765322100
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCC
Q 017362 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356 (373)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 356 (373)
.....|+..|+|||++.+..++.++|+|||||++|||++|.+|
T Consensus 158 -------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p 200 (277)
T cd06642 158 -------------------------------------RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200 (277)
T ss_pred -------------------------------------hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCC
Confidence 0124688999999999999999999999999999999999999
Q ss_pred CCCCChHHHHH
Q 017362 357 FYSDDPMSTCR 367 (373)
Q Consensus 357 f~~~~~~~~~~ 367 (373)
|...++.....
T Consensus 201 ~~~~~~~~~~~ 211 (277)
T cd06642 201 NSDLHPMRVLF 211 (277)
T ss_pred CcccchhhHHh
Confidence 98766554443
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=281.89 Aligned_cols=212 Identities=30% Similarity=0.545 Sum_probs=185.2
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++.+.||.|++|.||+|.+..++..|++|++..... ......+..|+..+..++|+||+++++.+...+.+|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 478999999999999999999999999999999876532 134566888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
||+++++|.+++.....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++.........
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-- 156 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-- 156 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--
Confidence 999999999999887889999999999999999999999 99999999999999999999999999998765432211
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 354 (373)
.....++..|+|||.+....++.++|+||||+++|+|++|.
T Consensus 157 ---------------------------------------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~ 197 (264)
T cd06623 157 ---------------------------------------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGK 197 (264)
T ss_pred ---------------------------------------ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 01346889999999999999999999999999999999999
Q ss_pred CCCCCC---ChHHHHHHhh
Q 017362 355 PPFYSD---DPMSTCRKVR 370 (373)
Q Consensus 355 ~Pf~~~---~~~~~~~kI~ 370 (373)
+||... +..+....+.
T Consensus 198 ~p~~~~~~~~~~~~~~~~~ 216 (264)
T cd06623 198 FPFLPPGQPSFFELMQAIC 216 (264)
T ss_pred CCCccccccCHHHHHHHHh
Confidence 999877 3444444443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=291.50 Aligned_cols=215 Identities=29% Similarity=0.473 Sum_probs=181.5
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC--CeE
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--EFL 191 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~ 191 (373)
..++|++.+.||.|+||.||+|.+..+|..||+|.+..... .......+.+|+.++..++|+||+++++++.+. +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 35789999999999999999999999999999999865432 122223456799999999999999999998765 568
Q ss_pred EEEEeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 192 YLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
|+||||++ ++|.+++.. ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 84 ~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 99999995 588888865 3679999999999999999999999999999999999999999999999999997654221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~e 349 (373)
.. .....+++.|+|||++.+ ..++.++|||||||++||
T Consensus 163 ~~-----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~e 201 (309)
T cd07845 163 KP-----------------------------------------MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAE 201 (309)
T ss_pred CC-----------------------------------------CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHH
Confidence 00 012356889999999875 558999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhc
Q 017362 350 MLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 350 ll~G~~Pf~~~~~~~~~~kI~~ 371 (373)
|++|++||.+.++.+.+..|.+
T Consensus 202 l~~g~~~f~~~~~~~~~~~~~~ 223 (309)
T cd07845 202 LLAHKPLLPGKSEIEQLDLIIQ 223 (309)
T ss_pred HHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999999888877654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=284.29 Aligned_cols=213 Identities=33% Similarity=0.562 Sum_probs=180.4
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCC---
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE--- 189 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~--- 189 (373)
..++|++.+.||.|++|.||+|.+..++..+++|++..... ..+.+..|+.++..+ .|+||+++++.+.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 46889999999999999999999988899999999875432 235688899999998 7999999999997644
Q ss_pred ---eEEEEEeccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccc
Q 017362 190 ---FLYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (373)
Q Consensus 190 ---~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGl 262 (373)
.+|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 48999999999999998864 35799999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-----CCCChh
Q 017362 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----KGYGME 337 (373)
Q Consensus 263 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~ 337 (373)
+......... .....|++.|+|||++.. ..++.+
T Consensus 160 ~~~~~~~~~~-----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 198 (275)
T cd06608 160 SAQLDSTLGR-----------------------------------------RNTFIGTPYWMAPEVIACDEQPDASYDAR 198 (275)
T ss_pred ceecccchhh-----------------------------------------hcCccccccccCHhHhcccccccCCcccc
Confidence 8754322100 013468999999998864 347889
Q ss_pred hcHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 017362 338 CDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 338 ~DvwSlGvil~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
+|||||||+||+|++|++||...++.....++.+
T Consensus 199 ~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 232 (275)
T cd06608 199 SDVWSLGITAIELADGKPPLCDMHPMRALFKIPR 232 (275)
T ss_pred ccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc
Confidence 9999999999999999999988777666666554
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=290.21 Aligned_cols=210 Identities=31% Similarity=0.483 Sum_probs=180.3
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
..|...+.||+|+||.||++.+..++..||+|.+.............+..|+.+++.++|||++++++++.++...|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34888999999999999999998899999999987543333344567888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 196 EYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 196 E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
||++| +|.+.+.. ...+++..+..++.+++.||.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~---- 179 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN---- 179 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCcc----
Confidence 99975 77777644 5679999999999999999999999999999999999999999999999999986432110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc---CCCCChhhcHHHHHHHHHHHH
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DvwSlGvil~ell 351 (373)
...|++.|+|||++. .+.++.++|||||||++|||+
T Consensus 180 -----------------------------------------~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~ 218 (317)
T cd06635 180 -----------------------------------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 218 (317)
T ss_pred -----------------------------------------cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHH
Confidence 246889999999984 456899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhc
Q 017362 352 VGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~~ 371 (373)
+|++||...+.......+..
T Consensus 219 ~g~~p~~~~~~~~~~~~~~~ 238 (317)
T cd06635 219 ERKPPLFNMNAMSALYHIAQ 238 (317)
T ss_pred hCCCCCCCccHHHHHHHHHh
Confidence 99999998887776666654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=285.74 Aligned_cols=215 Identities=22% Similarity=0.433 Sum_probs=181.8
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcC-----CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKT-----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 189 (373)
.++|+++..||.|+||.||+|..+. +...|++|.+.... .......+.+|+.++..++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 4679999999999999999998753 34679999886532 1224566888999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCC---------CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeec
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKD---------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDF 260 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DF 260 (373)
..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999999997655 6899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcH
Q 017362 261 GLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340 (373)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Dv 340 (373)
|++.......... .....+++.|+|||.+.+..++.++||
T Consensus 162 ~~~~~~~~~~~~~----------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di 201 (275)
T cd05046 162 SLSKDVYNSEYYK----------------------------------------LRNALIPLRWLAPEAVQEDDFSTKSDV 201 (275)
T ss_pred ccccccCcccccc----------------------------------------cCCceeEEeecChhhhccCCCCchhhH
Confidence 9986442211000 013456788999999988889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHHHHHHhhc
Q 017362 341 WSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 341 wSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
|||||++|+|++ |.+||...+......++..
T Consensus 202 ~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~ 233 (275)
T cd05046 202 WSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA 233 (275)
T ss_pred HHHHHHHHHHHhCCCCCccccchHHHHHHHHc
Confidence 999999999998 8999988777776666653
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=287.59 Aligned_cols=212 Identities=33% Similarity=0.494 Sum_probs=177.0
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-CCceeEEeeEEEeCCe----
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEF---- 190 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~---- 190 (373)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.+. ||||+++++.+...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 46999999999999999999999999999999886542 22223356778999999995 6999999999987665
Q ss_pred -EEEEEeccCCCCHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC-CCcEEEeecccc
Q 017362 191 -LYLIMEYLPGGDMMTLLMRK-----DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-YGHLRLSDFGLC 263 (373)
Q Consensus 191 -~~lV~E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~-~~~vkL~DFGla 263 (373)
.|+||||+++ +|.+++... ..+++..+..++.||+.||.|||++||+||||+|+||+++. ++.++|+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999975 888887542 35899999999999999999999999999999999999998 899999999998
Q ss_pred ccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHH
Q 017362 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWS 342 (373)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwS 342 (373)
..+...... .....+++.|+|||++.+ ..++.++||||
T Consensus 159 ~~~~~~~~~-----------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s 197 (295)
T cd07837 159 RAFSIPVKS-----------------------------------------YTHEIVTLWYRAPEVLLGSTHYSTPVDIWS 197 (295)
T ss_pred eecCCCccc-----------------------------------------cCCcccccCCCChHHhhCCCCCCchHHHHH
Confidence 755321100 012357889999998865 45799999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 017362 343 LGAIMYEMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 343 lGvil~ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
|||++|+|++|.+||.+.++.+...+|.
T Consensus 198 lG~~l~~l~~g~~~~~~~~~~~~~~~~~ 225 (295)
T cd07837 198 VGCIFAEMSRKQPLFPGDSELQQLLHIF 225 (295)
T ss_pred HHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 9999999999999999988877766654
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=281.16 Aligned_cols=213 Identities=26% Similarity=0.435 Sum_probs=183.3
Q ss_pred cceeceeeeeCcEEEEEEEEcCCC----ceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEE
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTG----HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 193 (373)
|++.+.||.|+||.||+|.+..++ ..||+|++..... ......+..|+.++..++|+||+++++.+.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 467789999999999999988766 8999999865432 2245678889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 194 IMEYLPGGDMMTLLMRKDT--LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 194 V~E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
||||+++++|.+++..... +++..+..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999999976554 99999999999999999999999999999999999999999999999999876543211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
... ....+++.|+|||.+....++.++|+|||||++|+|+
T Consensus 159 ~~~----------------------------------------~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~ 198 (258)
T smart00219 159 YKK----------------------------------------KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIF 198 (258)
T ss_pred ccc----------------------------------------ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHH
Confidence 000 0123778999999998888999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHhhcC
Q 017362 352 V-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 352 ~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+ |.+||.+.+.......+.++
T Consensus 199 ~~g~~p~~~~~~~~~~~~~~~~ 220 (258)
T smart00219 199 TLGESPYPGMSNEEVLEYLKKG 220 (258)
T ss_pred hCCCCCCCCCCHHHHHHHHhcC
Confidence 8 89999988888887777654
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=282.04 Aligned_cols=214 Identities=22% Similarity=0.402 Sum_probs=180.4
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 191 (373)
++..++|.+.+.||+|+||.||++... .+..+|+|.+.... .....+.+|+.+++.++|+||+++++.+.+ ...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI 75 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence 345688999999999999999999754 45679999887542 234567889999999999999999999887 778
Q ss_pred EEEEeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 192 YLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
|+||||+++++|.+++... ..+++..+..++.+++.||.|||+.|++|+||||+||+++.++.++|+|||++..+...
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 9999999999999999763 35788899999999999999999999999999999999999999999999998765322
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 349 (373)
.... .....++..|+|||++....++.++|+|||||++|+
T Consensus 156 ~~~~----------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~ 195 (260)
T cd05073 156 EYTA----------------------------------------REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLME 195 (260)
T ss_pred Cccc----------------------------------------ccCCcccccccCHhHhccCCcCccccchHHHHHHHH
Confidence 1100 002245678999999998889999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHhhc
Q 017362 350 MLV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 350 ll~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
+++ |.+||.+.+..+....+.+
T Consensus 196 l~t~g~~p~~~~~~~~~~~~~~~ 218 (260)
T cd05073 196 IVTYGRIPYPGMSNPEVIRALER 218 (260)
T ss_pred HHhcCCCCCCCCCHHHHHHHHhC
Confidence 998 9999998888777776654
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=287.74 Aligned_cols=213 Identities=23% Similarity=0.380 Sum_probs=177.2
Q ss_pred CcceeceeeeeCcEEEEEEEEcC-----CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeE
Q 017362 117 DFELLTMIGKGAFGEVRVCREKT-----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 191 (373)
+|++.+.||+|+||.||+|.+.. ....+|+|.+..... ......+.+|+.+++.+.||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 57889999999999999998643 235689998864321 22346688899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCE
Q 017362 192 YLIMEYLPGGDMMTLLMRK------------------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNL 247 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~------------------------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NI 247 (373)
|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999988542 2478899999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccc
Q 017362 248 LLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPE 327 (373)
Q Consensus 248 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE 327 (373)
|++.++.++|+|||+++.......... .....++..|+|||
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~---------------------------------------~~~~~~~~~y~apE 199 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVK---------------------------------------RSKGRIPVKWMAIE 199 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhc---------------------------------------ccCCCCCccccCHH
Confidence 999999999999999875432210000 00234567899999
Q ss_pred cccCCCCChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 017362 328 VLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 328 ~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~ 370 (373)
++.+..++.++|||||||++|||++ |.+||.+..+.+....+.
T Consensus 200 ~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~ 243 (290)
T cd05045 200 SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLK 243 (290)
T ss_pred HHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Confidence 9988899999999999999999998 999999888877766554
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=286.26 Aligned_cols=212 Identities=33% Similarity=0.563 Sum_probs=177.4
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEe----
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQD---- 187 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~---- 187 (373)
...+.|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.++..+ +|+||+++++++..
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 34578999999999999999999999999999999986542 2234577788888888 79999999999853
Q ss_pred --CCeEEEEEeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeecccc
Q 017362 188 --DEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (373)
Q Consensus 188 --~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla 263 (373)
...+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence 46789999999999999998653 45889999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc-----CCCCChhh
Q 017362 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMEC 338 (373)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~ 338 (373)
......... ....+|++.|+|||++. ...++.++
T Consensus 169 ~~~~~~~~~-----------------------------------------~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~ 207 (282)
T cd06636 169 AQLDRTVGR-----------------------------------------RNTFIGTPYWMAPEVIACDENPDATYDYRS 207 (282)
T ss_pred hhhhccccC-----------------------------------------CCcccccccccCHhhcCcccCcCcCCCccc
Confidence 754321100 01356899999999986 35688899
Q ss_pred cHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 017362 339 DWWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369 (373)
Q Consensus 339 DvwSlGvil~ell~G~~Pf~~~~~~~~~~kI 369 (373)
|||||||++|||++|.+||...++......+
T Consensus 208 DvwslG~~l~el~~g~~p~~~~~~~~~~~~~ 238 (282)
T cd06636 208 DIWSLGITAIEMAEGAPPLCDMHPMRALFLI 238 (282)
T ss_pred chhHHHHHHHHHHhCCCCccccCHHhhhhhH
Confidence 9999999999999999999877765555433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=284.60 Aligned_cols=194 Identities=33% Similarity=0.614 Sum_probs=166.2
Q ss_pred CCcceecee--eeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHh-cCCCceeEEeeEEEeCCeEE
Q 017362 116 DDFELLTMI--GKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE-VDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 116 ~~y~~~~~l--G~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~l~~~~~~~~~~~ 192 (373)
++|++.+.+ |.|+||.||+|.++.++..+|+|.+....... . |...... .+||||+++++.|...+.+|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I-----EPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h-----hHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 456666665 99999999999999999999999987543211 1 2222221 27999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC-cEEEeeccccccCCCCCc
Q 017362 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~-~vkL~DFGla~~~~~~~~ 271 (373)
+||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++.......
T Consensus 86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~- 164 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS- 164 (267)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-
Confidence 9999999999999998877999999999999999999999999999999999999999998 99999999987543211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
...|++.|+|||++.+..++.++|||||||++|||+
T Consensus 165 --------------------------------------------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~ 200 (267)
T PHA03390 165 --------------------------------------------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELL 200 (267)
T ss_pred --------------------------------------------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHH
Confidence 235889999999999999999999999999999999
Q ss_pred hCCCCCCCCCh
Q 017362 352 VGYPPFYSDDP 362 (373)
Q Consensus 352 ~G~~Pf~~~~~ 362 (373)
+|.+||.....
T Consensus 201 ~g~~p~~~~~~ 211 (267)
T PHA03390 201 TGKHPFKEDED 211 (267)
T ss_pred HCCCCCCCCCc
Confidence 99999986543
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=285.82 Aligned_cols=218 Identities=20% Similarity=0.328 Sum_probs=183.9
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcC----CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe-
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKT----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD- 187 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~- 187 (373)
+..++|.+.+.||+|+||.||+|.+.. ++..|++|.+... ........+.+|..++..++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 456789999999999999999999865 3578999988643 234445778889999999999999999998765
Q ss_pred CCeEEEEEeccCCCCHHHHHhhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEee
Q 017362 188 DEFLYLIMEYLPGGDMMTLLMRK--------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSD 259 (373)
Q Consensus 188 ~~~~~lV~E~~~gg~L~~~l~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~D 259 (373)
+...++++||+++++|.+++... ..+++..+..++.+++.||.|||+++++||||||+|||++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 56789999999999999998653 4589999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhc
Q 017362 260 FGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECD 339 (373)
Q Consensus 260 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D 339 (373)
||+++.+........ .....++..|+|||++.+..++.++|
T Consensus 161 ~g~~~~~~~~~~~~~---------------------------------------~~~~~~~~~y~apE~~~~~~~~~~~D 201 (280)
T cd05043 161 NALSRDLFPMDYHCL---------------------------------------GDNENRPVKWMALESLVNKEYSSASD 201 (280)
T ss_pred CCCcccccCCceEEe---------------------------------------CCCCCcchhccCHHHHhcCCCCchhh
Confidence 999986543321100 00234567899999999999999999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhc
Q 017362 340 WWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 340 vwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
||||||++||+++ |.+||...++.+....+..
T Consensus 202 i~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 234 (280)
T cd05043 202 VWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD 234 (280)
T ss_pred HHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc
Confidence 9999999999999 9999999888887776654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=279.52 Aligned_cols=207 Identities=27% Similarity=0.425 Sum_probs=174.4
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEeccCCC
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGG 201 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~gg 201 (373)
+.||+|+||.||+|... ++..+|+|.+.... .......+.+|+.+++.++||||+++++.+......++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 36899999999999854 67899999986542 1223346888999999999999999999999999999999999999
Q ss_pred CHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccC
Q 017362 202 DMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (373)
Q Consensus 202 ~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (373)
+|.+++... ..+++..+..++.+++.||.|||++|++|+||||+||+++.++.++|+|||++...........
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~------ 151 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSS------ 151 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccC------
Confidence 999998653 4689999999999999999999999999999999999999999999999999865432211000
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh-CCCCCCC
Q 017362 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYS 359 (373)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf~~ 359 (373)
....+++.|+|||++.+..++.++|||||||++|++++ |.+||..
T Consensus 152 ----------------------------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~ 197 (250)
T cd05085 152 ----------------------------------GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPG 197 (250)
T ss_pred ----------------------------------CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCC
Confidence 01234678999999998889999999999999999998 9999998
Q ss_pred CChHHHHHHhhc
Q 017362 360 DDPMSTCRKVRK 371 (373)
Q Consensus 360 ~~~~~~~~kI~~ 371 (373)
.+...+..++..
T Consensus 198 ~~~~~~~~~~~~ 209 (250)
T cd05085 198 MTNQQAREQVEK 209 (250)
T ss_pred CCHHHHHHHHHc
Confidence 887777766654
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=286.01 Aligned_cols=210 Identities=31% Similarity=0.606 Sum_probs=182.4
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEe
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E 196 (373)
.|...+.||.|++|.||++.+..++..+++|++.... ....+.+.+|+.++..++||||+++++++...+..|+|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 4555678999999999999998899999999885432 2234557889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccc
Q 017362 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (373)
Q Consensus 197 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 276 (373)
|++|++|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.........
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~---- 171 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR---- 171 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc----
Confidence 9999999999866 67999999999999999999999999999999999999999999999999988654221100
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCC
Q 017362 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356 (373)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 356 (373)
.....|++.|+|||++.+..++.++|+|||||++|||++|.+|
T Consensus 172 -------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p 214 (285)
T cd06648 172 -------------------------------------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214 (285)
T ss_pred -------------------------------------cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCC
Confidence 0134689999999999988899999999999999999999999
Q ss_pred CCCCChHHHHHHhhc
Q 017362 357 FYSDDPMSTCRKVRK 371 (373)
Q Consensus 357 f~~~~~~~~~~kI~~ 371 (373)
|.+.++...+.++..
T Consensus 215 ~~~~~~~~~~~~~~~ 229 (285)
T cd06648 215 YFNEPPLQAMKRIRD 229 (285)
T ss_pred CcCCCHHHHHHHHHh
Confidence 999888887776654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=301.12 Aligned_cols=214 Identities=23% Similarity=0.365 Sum_probs=177.3
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEc-----CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-CCceeEEeeE
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCS 184 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~ 184 (373)
..+..++|.+.+.||+|+||.||+|.+. .++..||+|++.... .....+.+..|+.++..+. ||||++++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 4556678899999999999999999854 345689999997542 2233456888999999997 9999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHhhCC-----------------------------------------------------
Q 017362 185 FQDDEFLYLIMEYLPGGDMMTLLMRKD----------------------------------------------------- 211 (373)
Q Consensus 185 ~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------------------------------------------- 211 (373)
+...+.+|+||||+++|+|.+++....
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 999999999999999999999986431
Q ss_pred ---------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCC
Q 017362 212 ---------------------------------------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDN 246 (373)
Q Consensus 212 ---------------------------------------------~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~N 246 (373)
.+++..+..++.|++.||.|||+.|++||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 35677788999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccc
Q 017362 247 LLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAP 326 (373)
Q Consensus 247 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP 326 (373)
||++.++.+||+|||+++.+....... ......+++.|+||
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aP 310 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYI---------------------------------------SKGSTFLPLKWMAP 310 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccc---------------------------------------cCCCcCCCCceeCh
Confidence 999999999999999997543211000 00134678899999
Q ss_pred ccccCCCCChhhcHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 017362 327 EVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMST 365 (373)
Q Consensus 327 E~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~ 365 (373)
|++....++.++|||||||++|||++ |.+||......+.
T Consensus 311 E~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 311 ESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred HHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 99999899999999999999999998 9999987654443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=286.19 Aligned_cols=234 Identities=38% Similarity=0.693 Sum_probs=192.4
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-CCceeEEeeEEEeCCeEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~lV 194 (373)
++|.+.+.||+|+||.||+|.+..++..||+|++.+...........+..|..++..+. ||||+++++.+.+.+.+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999899999999998765544455567888999999998 99999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
|||+++++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.+++++|+|||++...........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999999986643321110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 354 (373)
..... ...... .. ..........|++.|+|||++....++.++|+||||+++|++++|.
T Consensus 161 ~~~~~-------~~~~~~--~~------------~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~ 219 (280)
T cd05581 161 NKGDA-------TNIDSQ--IE------------KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219 (280)
T ss_pred CCCCC-------cccccc--cc------------ccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCC
Confidence 00000 000000 00 0000112457899999999999888999999999999999999999
Q ss_pred CCCCCCChHHHHHHhh
Q 017362 355 PPFYSDDPMSTCRKVR 370 (373)
Q Consensus 355 ~Pf~~~~~~~~~~kI~ 370 (373)
+||...+...+..++.
T Consensus 220 ~p~~~~~~~~~~~~~~ 235 (280)
T cd05581 220 PPFRGSNEYLTFQKIL 235 (280)
T ss_pred CCCCCccHHHHHHHHH
Confidence 9999888777666654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=287.13 Aligned_cols=204 Identities=43% Similarity=0.779 Sum_probs=175.0
Q ss_pred CcceeceeeeeCcEEEEEEEEc---CCCceEeeeecchhHhhh-hhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCeE
Q 017362 117 DFELLTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKSEMLR-RGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~ 191 (373)
+|++.+.||.|+||.||+|.+. .+|..||+|++....... ....+++..|+.++..+ +|++|+.+++.+..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999874 478999999987654322 23346678899999999 589999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
|+||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+|||++.+++++|+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999876532210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC--CCCChhhcHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DvwSlGvil~e 349 (373)
. ......|++.|+|||++.. ..++.++|||||||++|+
T Consensus 161 ~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ 200 (290)
T cd05613 161 E----------------------------------------RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYE 200 (290)
T ss_pred c----------------------------------------ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHH
Confidence 0 0113568999999999875 357889999999999999
Q ss_pred HHhCCCCCCCC
Q 017362 350 MLVGYPPFYSD 360 (373)
Q Consensus 350 ll~G~~Pf~~~ 360 (373)
|++|.+||...
T Consensus 201 ll~g~~p~~~~ 211 (290)
T cd05613 201 LLTGASPFTVD 211 (290)
T ss_pred HhcCCCCCCcC
Confidence 99999999754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=283.44 Aligned_cols=217 Identities=24% Similarity=0.386 Sum_probs=180.0
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCC---CceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTT---GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 189 (373)
+...+|.+.+.||+|+||.||+|.+... ...||||...... .....+.+.+|+.+++.++||||+++++++.+ .
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 3456799999999999999999987543 3468999886542 12344678889999999999999999998876 4
Q ss_pred eEEEEEeccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
..|+||||+++|+|.+++.... .+++..+..++.+++.||.|||+.|++|+||||+|||++.++.++|+|||+++....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 5789999999999999997643 689999999999999999999999999999999999999999999999999876532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 348 (373)
..... .....+++.|+|||++....++.++|||||||++|
T Consensus 160 ~~~~~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 199 (270)
T cd05056 160 ESYYK----------------------------------------ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 199 (270)
T ss_pred cccee----------------------------------------cCCCCccccccChhhhccCCCCchhhhHHHHHHHH
Confidence 21100 00223557899999998889999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 349 EMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 349 ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
||++ |.+||.+.+..+...++.++
T Consensus 200 el~~~g~~pf~~~~~~~~~~~~~~~ 224 (270)
T cd05056 200 EILMLGVKPFQGVKNNDVIGRIENG 224 (270)
T ss_pred HHHHcCCCCCCCCCHHHHHHHHHcC
Confidence 9996 99999988877777666543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=286.17 Aligned_cols=212 Identities=31% Similarity=0.494 Sum_probs=178.0
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++.+.||.|++|+||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++.+....|+||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 579999999999999999999998999999999865432 2233456778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC-CCcEEEeeccccccCCCCCcc
Q 017362 196 EYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-YGHLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~-~~~vkL~DFGla~~~~~~~~~ 272 (373)
||++ ++|.+++.... .+++..+..++.||+.||.|||++|++|+||+|+||+++. ++.+||+|||++.........
T Consensus 81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (294)
T ss_pred eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence 9995 57888776544 3588899999999999999999999999999999999985 567999999999754321100
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHHHHH
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell 351 (373)
.....|++.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 160 -----------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~ 198 (294)
T PLN00009 160 -----------------------------------------FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMV 198 (294)
T ss_pred -----------------------------------------cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 013467899999999876 45799999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhh
Q 017362 352 VGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~ 370 (373)
+|.+||.+.++.+...++.
T Consensus 199 tg~~pf~~~~~~~~~~~~~ 217 (294)
T PLN00009 199 NQKPLFPGDSEIDELFKIF 217 (294)
T ss_pred hCCCCCCCCCHHHHHHHHH
Confidence 9999999888877776653
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=282.89 Aligned_cols=215 Identities=48% Similarity=0.857 Sum_probs=184.6
Q ss_pred eeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEeccCCCCH
Q 017362 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM 203 (373)
Q Consensus 124 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~gg~L 203 (373)
||.|+||.||+|.+..+++.+++|++.............+.+|+.++..++||||+++++.+..+...|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999888999999999776554455667788999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccCCCC
Q 017362 204 MTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283 (373)
Q Consensus 204 ~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~ 283 (373)
.+++.+.+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++............
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-------- 152 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN-------- 152 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc--------
Confidence 999988778999999999999999999999999999999999999999999999999998754322110000
Q ss_pred CCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCCCChH
Q 017362 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363 (373)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~ 363 (373)
..........+++.|+|||++....++.++||||||+++|+|++|.+||...++.
T Consensus 153 -------------------------~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~ 207 (265)
T cd05579 153 -------------------------DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE 207 (265)
T ss_pred -------------------------cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 0000011356889999999999888999999999999999999999999998888
Q ss_pred HHHHHhhc
Q 017362 364 STCRKVRK 371 (373)
Q Consensus 364 ~~~~kI~~ 371 (373)
+...++..
T Consensus 208 ~~~~~~~~ 215 (265)
T cd05579 208 EIFQNILN 215 (265)
T ss_pred HHHHHHhc
Confidence 87777654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=286.83 Aligned_cols=210 Identities=31% Similarity=0.498 Sum_probs=178.1
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEe
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E 196 (373)
+|++++.||.|++|.||+|.+..++..||||.+.... ........+..|+.+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccc-cccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 5889999999999999999999999999999886542 122233568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 197 YLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 197 ~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
|++ ++|..++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+......
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~-- 156 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-- 156 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc--
Confidence 995 688888865 356899999999999999999999999999999999999999999999999998754322100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC-CChhhcHHHHHHHHHHHHhC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~ell~G 353 (373)
.....+++.|+|||++.+.. ++.++|||||||++|||++|
T Consensus 157 ---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg 197 (284)
T cd07860 157 ---------------------------------------YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 197 (284)
T ss_pred ---------------------------------------cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHC
Confidence 01235788999999987654 68899999999999999999
Q ss_pred CCCCCCCChHHHHHHh
Q 017362 354 YPPFYSDDPMSTCRKV 369 (373)
Q Consensus 354 ~~Pf~~~~~~~~~~kI 369 (373)
++||.+.+..+...++
T Consensus 198 ~~p~~~~~~~~~~~~~ 213 (284)
T cd07860 198 RALFPGDSEIDQLFRI 213 (284)
T ss_pred CCCCCCCCHHHHHHHH
Confidence 9999988766655444
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=284.08 Aligned_cols=213 Identities=33% Similarity=0.518 Sum_probs=178.0
Q ss_pred ceeceeeeeCcEEEEEEEEc----CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 119 ELLTMIGKGAFGEVRVCREK----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 119 ~~~~~lG~G~~g~Vy~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.+.+.||.|+||.||+|... ..+..|+||.+... ......+.+.+|+..++.++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 46788999999999999887 34678999999542 2233467788999999999999999999999988889999
Q ss_pred EeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcc
Q 017362 195 MEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 272 (373)
|||+++|+|.++|... ..+++.....++.|++.||.|||+++++|+||+|+|||++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999886 68999999999999999999999999999999999999999999999999999866222111
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 352 (373)
. ......+...|+|||++....++.++||||||+++|||++
T Consensus 160 ~---------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~ 200 (259)
T PF07714_consen 160 K---------------------------------------NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILT 200 (259)
T ss_dssp E---------------------------------------ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHT
T ss_pred c---------------------------------------cccccccccccccccccccccccccccccccccccccccc
Confidence 0 0113456778999999999999999999999999999999
Q ss_pred -CCCCCCCCChHHHHHHhhcC
Q 017362 353 -GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 353 -G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|..||...+..+...++.++
T Consensus 201 ~~~~p~~~~~~~~~~~~~~~~ 221 (259)
T PF07714_consen 201 LGKFPFSDYDNEEIIEKLKQG 221 (259)
T ss_dssp TSSGTTTTSCHHHHHHHHHTT
T ss_pred ccccccccccccccccccccc
Confidence 78999999988888887543
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=288.36 Aligned_cols=214 Identities=20% Similarity=0.399 Sum_probs=176.9
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcC----------------CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCc
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKT----------------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 177 (373)
..++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.++..++|+|
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~ 80 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPN 80 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCC
Confidence 34679999999999999999986432 34469999987542 2233456888999999999999
Q ss_pred eeEEeeEEEeCCeEEEEEeccCCCCHHHHHhhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCC
Q 017362 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-----------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDN 246 (373)
Q Consensus 178 iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-----------~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~N 246 (373)
|+++++++.+.+..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++|++|+||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 9999999999999999999999999999986532 36778999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccc
Q 017362 247 LLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAP 326 (373)
Q Consensus 247 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP 326 (373)
||++.++.++|+|||+++.+....... ......+++.|+||
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~p 201 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYR---------------------------------------IQGRAVLPIRWMSW 201 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCccee---------------------------------------ccCcCcCccccCCH
Confidence 999999999999999987653221100 00123456789999
Q ss_pred ccccCCCCChhhcHHHHHHHHHHHHh--CCCCCCCCChHHHHHH
Q 017362 327 EVLLKKGYGMECDWWSLGAIMYEMLV--GYPPFYSDDPMSTCRK 368 (373)
Q Consensus 327 E~~~~~~~~~~~DvwSlGvil~ell~--G~~Pf~~~~~~~~~~k 368 (373)
|+...+.++.++|||||||++|||++ |..||...++.+...+
T Consensus 202 e~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~ 245 (296)
T cd05095 202 ESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIEN 245 (296)
T ss_pred HHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 99988899999999999999999998 7899988776665543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=311.60 Aligned_cols=204 Identities=25% Similarity=0.378 Sum_probs=160.7
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCC-CceEeee--------------ecchhHhhhhhhHHHHHHHHHHHHhcCCCce
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTT-GHVYAMK--------------KLKKSEMLRRGQVEHVRAERNLLAEVDSNCI 178 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~vaiK--------------~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 178 (373)
..++|++++.||+|+||+||+|..+.. +..+++| .+.+...........+.+|+.++..++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 357899999999999999999876432 2222222 1111111112234557889999999999999
Q ss_pred eEEeeEEEeCCeEEEEEeccCCCCHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC
Q 017362 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK-----DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG 253 (373)
Q Consensus 179 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~ 253 (373)
+++++++.+.+..|+||+++ +++|..++... .......++.++.||+.||.|||++|||||||||+|||++.++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 99999999999999999999 56777776442 2244677889999999999999999999999999999999999
Q ss_pred cEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC
Q 017362 254 HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG 333 (373)
Q Consensus 254 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~ 333 (373)
.+||+|||+++.+...... .....+||+.|+|||++.+..
T Consensus 305 ~vkL~DFGla~~~~~~~~~----------------------------------------~~~~~~gt~~y~aPE~~~~~~ 344 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREA----------------------------------------FDYGWVGTVATNSPEILAGDG 344 (501)
T ss_pred CEEEEeCCCceecCccccc----------------------------------------ccccccCCcCCCCchhhcCCC
Confidence 9999999999765422100 011457999999999999999
Q ss_pred CChhhcHHHHHHHHHHHHhCCCCCC
Q 017362 334 YGMECDWWSLGAIMYEMLVGYPPFY 358 (373)
Q Consensus 334 ~~~~~DvwSlGvil~ell~G~~Pf~ 358 (373)
|+.++|||||||++|||++|..|+.
T Consensus 345 ~~~~~DiwSlGvil~ell~~~~~p~ 369 (501)
T PHA03210 345 YCEITDIWSCGLILLDMLSHDFCPI 369 (501)
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCCc
Confidence 9999999999999999999875443
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=280.01 Aligned_cols=207 Identities=32% Similarity=0.523 Sum_probs=180.7
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEe
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E 196 (373)
+|.+.+.||+|+||.||+|.+..++..||+|.+...... ......+..|+.+++.++|+||+++++.+.+.+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 588999999999999999999889999999998765432 3456788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccc
Q 017362 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (373)
Q Consensus 197 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 276 (373)
|+++++|.+++.....+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.+||+|||++............
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~- 158 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE- 158 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc-
Confidence 9999999999988778999999999999999999999999999999999999999999999999999876433211000
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC---CChhhcHHHHHHHHHHHHhC
Q 017362 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG---YGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~~~~~DvwSlGvil~ell~G 353 (373)
......+++.|+|||++.+.. ++.++||||||+++|+|++|
T Consensus 159 ------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g 202 (264)
T cd06626 159 ------------------------------------EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATG 202 (264)
T ss_pred ------------------------------------cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhC
Confidence 001246889999999998766 89999999999999999999
Q ss_pred CCCCCCCC
Q 017362 354 YPPFYSDD 361 (373)
Q Consensus 354 ~~Pf~~~~ 361 (373)
++||...+
T Consensus 203 ~~pf~~~~ 210 (264)
T cd06626 203 KRPWSELD 210 (264)
T ss_pred CCCccCCc
Confidence 99997653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=288.43 Aligned_cols=206 Identities=32% Similarity=0.585 Sum_probs=179.7
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|.+.+.||+|+||.||++.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++.+...+..|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 468999999999999999999988889999999986432 22346678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
|||+++++|.+++.+ ..+++..+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~-- 171 (293)
T cd06647 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 171 (293)
T ss_pred EecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc--
Confidence 999999999999854 46889999999999999999999999999999999999999999999999998754322110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 354 (373)
.....|++.|+|||.+....++.++|+|||||++|+|++|+
T Consensus 172 ---------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~ 212 (293)
T cd06647 172 ---------------------------------------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212 (293)
T ss_pred ---------------------------------------cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 01346889999999998888999999999999999999999
Q ss_pred CCCCCCChHHH
Q 017362 355 PPFYSDDPMST 365 (373)
Q Consensus 355 ~Pf~~~~~~~~ 365 (373)
+||.+.++...
T Consensus 213 ~pf~~~~~~~~ 223 (293)
T cd06647 213 PPYLNENPLRA 223 (293)
T ss_pred CCCCCCChhhh
Confidence 99987766443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=284.21 Aligned_cols=209 Identities=34% Similarity=0.590 Sum_probs=178.9
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC---CCceeEEeeEEEeCCeEEE
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD---SNCIVKLYCSFQDDEFLYL 193 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~l~~~~~~~~~~~l 193 (373)
.|++.+.||.|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.+. |||++++++.+.++...|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 5788899999999999999999999999999986432 2334456778999988886 9999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 194 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
||||++|++|.+++.. ..+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+......
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK- 157 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc-
Confidence 9999999999998855 57999999999999999999999999999999999999999999999999998765432210
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHHHHHh
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~ 352 (373)
.....|++.|+|||.+.+ ..++.++|+|||||++|+|++
T Consensus 158 ----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~ 197 (277)
T cd06917 158 ----------------------------------------RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMAT 197 (277)
T ss_pred ----------------------------------------cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHh
Confidence 013468999999999875 447899999999999999999
Q ss_pred CCCCCCCCChHHHHHHh
Q 017362 353 GYPPFYSDDPMSTCRKV 369 (373)
Q Consensus 353 G~~Pf~~~~~~~~~~kI 369 (373)
|.+||.+.+.......+
T Consensus 198 g~~p~~~~~~~~~~~~~ 214 (277)
T cd06917 198 GNPPYSDVDAFRAMMLI 214 (277)
T ss_pred CCCCCCCCChhhhhhcc
Confidence 99999887766555433
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=279.34 Aligned_cols=211 Identities=20% Similarity=0.360 Sum_probs=179.7
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
..+|++.+.||+|+||.||+|.+. .+..+|+|.+..... ....+..|+.++..++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 467999999999999999999875 466899998865432 224577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 195 MEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
|||+++++|.+++... ..+++..+..++.+++.||.+||+.|++|+||||+||+++.++.++|+|||++..........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999999999998754 568999999999999999999999999999999999999999999999999987543211000
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh-
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV- 352 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~- 352 (373)
.....++..|+|||++.+..++.++|||||||++|||++
T Consensus 158 ----------------------------------------~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~ 197 (256)
T cd05112 158 ----------------------------------------STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSE 197 (256)
T ss_pred ----------------------------------------cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcC
Confidence 002345678999999998999999999999999999998
Q ss_pred CCCCCCCCChHHHHHHhh
Q 017362 353 GYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 353 G~~Pf~~~~~~~~~~kI~ 370 (373)
|++||...+..+....+.
T Consensus 198 g~~p~~~~~~~~~~~~~~ 215 (256)
T cd05112 198 GKTPYENRSNSEVVETIN 215 (256)
T ss_pred CCCCCCcCCHHHHHHHHh
Confidence 999999888777776654
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=286.51 Aligned_cols=215 Identities=17% Similarity=0.169 Sum_probs=163.5
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCC---CceEeeeecchhHhhhhhh--------HHHHHHHHHHHHhcCCCceeE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTT---GHVYAMKKLKKSEMLRRGQ--------VEHVRAERNLLAEVDSNCIVK 180 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~--------~~~~~~e~~~l~~l~h~~iv~ 180 (373)
.+...+|.+.+.||+|+||+||+|.+..+ +..+|+|+........... ......+...+..+.|++|++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 34567899999999999999999998777 6677887643221100000 011122333455678999999
Q ss_pred EeeEEEeCC----eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEE
Q 017362 181 LYCSFQDDE----FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLR 256 (373)
Q Consensus 181 l~~~~~~~~----~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vk 256 (373)
+++.+.... ..|++|+++ ..++.+.+.....+++..+..++.|++.||.|||+++|+||||||+|||++.++.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred EEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEE
Confidence 998766543 457889988 457777776656678999999999999999999999999999999999999999999
Q ss_pred EeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCCh
Q 017362 257 LSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM 336 (373)
Q Consensus 257 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 336 (373)
|+|||+|+.+........ . .........||+.|+|||++.+..++.
T Consensus 167 l~DFGla~~~~~~~~~~~-~---------------------------------~~~~~~~~~gt~~y~ape~~~~~~~~~ 212 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIE-Y---------------------------------SKEQKDLHRGTLYYAGLDAHNGACVTR 212 (294)
T ss_pred EEEcCCceeeccCCcccc-c---------------------------------ccccccccCCCccccCHHHhCCCCCCc
Confidence 999999986643211100 0 000011357999999999999999999
Q ss_pred hhcHHHHHHHHHHHHhCCCCCCCCC
Q 017362 337 ECDWWSLGAIMYEMLVGYPPFYSDD 361 (373)
Q Consensus 337 ~~DvwSlGvil~ell~G~~Pf~~~~ 361 (373)
++|||||||++|||++|.+||.+.+
T Consensus 213 ~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 213 RGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCccc
Confidence 9999999999999999999998774
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=294.99 Aligned_cols=210 Identities=23% Similarity=0.396 Sum_probs=172.1
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEE-----cCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCRE-----KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSF 185 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~ 185 (373)
.+..++|++.+.||+|+||+||+|.+ ..+++.||||++.... .......+.+|+.++..+ +||||+++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 34567899999999999999999974 3467889999987532 123345688899999999 689999999987
Q ss_pred Ee-CCeEEEEEeccCCCCHHHHHhhC------------------------------------------------------
Q 017362 186 QD-DEFLYLIMEYLPGGDMMTLLMRK------------------------------------------------------ 210 (373)
Q Consensus 186 ~~-~~~~~lV~E~~~gg~L~~~l~~~------------------------------------------------------ 210 (373)
.. +..+|+||||+++|+|.+++...
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 65 45689999999999999998642
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccccc
Q 017362 211 -------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT 277 (373)
Q Consensus 211 -------------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 277 (373)
..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~---- 236 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV---- 236 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchh----
Confidence 236788889999999999999999999999999999999999999999999987643211000
Q ss_pred ccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh-CCCC
Q 017362 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPP 356 (373)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~P 356 (373)
......+++.|+|||++.+..++.++|||||||++|+|++ |.+|
T Consensus 237 -----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p 281 (343)
T cd05103 237 -----------------------------------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281 (343)
T ss_pred -----------------------------------hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 0012346678999999999999999999999999999997 9999
Q ss_pred CCCCCh
Q 017362 357 FYSDDP 362 (373)
Q Consensus 357 f~~~~~ 362 (373)
|.....
T Consensus 282 ~~~~~~ 287 (343)
T cd05103 282 YPGVKI 287 (343)
T ss_pred CCCccc
Confidence 987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=313.30 Aligned_cols=217 Identities=25% Similarity=0.429 Sum_probs=177.2
Q ss_pred hhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-CCceeEEeeEEE-
Q 017362 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQ- 186 (373)
Q Consensus 109 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~- 186 (373)
+...+...++++.+.|.+|||+.||+|.+...+..||+|.+-.. +....+.+++|+++|+.|+ |+|||.++++..
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~ 106 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI 106 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence 44567788899999999999999999999888899999988654 3556778999999999996 999999999432
Q ss_pred e------CCeEEEEEeccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHhCC--CeeecCCCCCEEEcCCCcEE
Q 017362 187 D------DEFLYLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHH--YIHRDIKPDNLLLDKYGHLR 256 (373)
Q Consensus 187 ~------~~~~~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiHrDikp~NILl~~~~~vk 256 (373)
. .-.++|.||||+||.|.++|.. ...|++.++..|+.++|.||.+||.+. |||||||-+||||+.+|+.|
T Consensus 107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~K 186 (738)
T KOG1989|consen 107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYK 186 (738)
T ss_pred cccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEE
Confidence 1 1347899999999999999974 346999999999999999999999887 99999999999999999999
Q ss_pred EeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc---CCC
Q 017362 257 LSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKG 333 (373)
Q Consensus 257 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~ 333 (373)
|||||-|...-..-... ..+...+.+ -...-||.|+|||++- +.+
T Consensus 187 LCDFGSatt~~~~~~~~---------------------------~e~~~ve~e-----I~k~TTp~YRsPEMIDlysg~p 234 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSA---------------------------QEVNYVEEE-----IEKYTTPQYRSPEMIDLYSGLP 234 (738)
T ss_pred eCcccccccccCCCccH---------------------------HHHHHHHHH-----HHhhCCccccChHHHhhhcCCC
Confidence 99999886432111000 000001100 0235799999999884 677
Q ss_pred CChhhcHHHHHHHHHHHHhCCCCCCCC
Q 017362 334 YGMECDWWSLGAIMYEMLVGYPPFYSD 360 (373)
Q Consensus 334 ~~~~~DvwSlGvil~ell~G~~Pf~~~ 360 (373)
.+.|+|||+|||+||-|++...||...
T Consensus 235 I~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 235 IGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred CcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 899999999999999999999999765
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=280.31 Aligned_cols=208 Identities=22% Similarity=0.382 Sum_probs=176.8
Q ss_pred ceeeeeCcEEEEEEEEcC-CC--ceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEecc
Q 017362 122 TMIGKGAFGEVRVCREKT-TG--HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYL 198 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~-~~--~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~ 198 (373)
+.||+|++|.||+|.+.. .+ ..||||.+...... ...+.+..|+.+++.++||||+++++.+.+ ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 368999999999998755 33 36999999775432 456778899999999999999999999988 8899999999
Q ss_pred CCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccc
Q 017362 199 PGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (373)
Q Consensus 199 ~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 276 (373)
++++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++..+.......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~--- 154 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY--- 154 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccce---
Confidence 9999999997654 68999999999999999999999999999999999999999999999999998764321100
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh-CCC
Q 017362 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYP 355 (373)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~ 355 (373)
. ......++..|+|||++.+..++.++|||||||++|||++ |.+
T Consensus 155 ~-----------------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~ 199 (257)
T cd05040 155 V-----------------------------------MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEE 199 (257)
T ss_pred e-----------------------------------cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCC
Confidence 0 0002357789999999999999999999999999999998 999
Q ss_pred CCCCCChHHHHHHhh
Q 017362 356 PFYSDDPMSTCRKVR 370 (373)
Q Consensus 356 Pf~~~~~~~~~~kI~ 370 (373)
||...+..+..+++.
T Consensus 200 p~~~~~~~~~~~~~~ 214 (257)
T cd05040 200 PWAGLSGSQILKKID 214 (257)
T ss_pred CCCCCCHHHHHHHHH
Confidence 998888877766654
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=319.90 Aligned_cols=219 Identities=25% Similarity=0.439 Sum_probs=187.6
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCC-C----ceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTT-G----HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 187 (373)
+.....+....||+|+||.||.|..... + ..||||.+.+. .+......|..|..+|+.++|||||+++|++.+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 4466788889999999999999986532 2 24899988754 346667889999999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeec
Q 017362 188 DEFLYLIMEYLPGGDMMTLLMRK-------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDF 260 (373)
Q Consensus 188 ~~~~~lV~E~~~gg~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DF 260 (373)
....+|++|||.||||..+|.+. ..++......++.+|+.|+.||+++++|||||...|+||+....|||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999999765 35889999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcH
Q 017362 261 GLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340 (373)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Dv 340 (373)
|+|+.+....+.... . ...-...|||||.+..+.++.++||
T Consensus 847 GlArDiy~~~yyr~~----------------------------------~-----~a~lPvkWm~PEsl~d~iFtskSDv 887 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKH----------------------------------G-----EAMLPVKWMPPESLKDGIFTSKSDV 887 (1025)
T ss_pred chhHhhhhchheecc----------------------------------C-----ccccceecCCHHHHhhcccccccch
Confidence 999954433222100 0 1123458999999999999999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 341 WSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 341 wSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|||||+|||+++ |..||.+.+..++..-++.|
T Consensus 888 WsFGVllWEifslG~~PY~~~~n~~v~~~~~~g 920 (1025)
T KOG1095|consen 888 WSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEG 920 (1025)
T ss_pred hhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhC
Confidence 999999999999 99999999999988866654
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=284.87 Aligned_cols=202 Identities=27% Similarity=0.418 Sum_probs=167.8
Q ss_pred cceeceeeeeCcEEEEEEEE----cCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC--CeE
Q 017362 118 FELLTMIGKGAFGEVRVCRE----KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--EFL 191 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~ 191 (373)
|++++.||+|+||+||++.. ..++..||+|++.... .......+.+|+.++..++||||+++++++... ..+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 38999999999999988653 3567899999987542 122345678899999999999999999987653 468
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
|+||||+++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.......
T Consensus 84 ~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred EEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 999999999999999865 4699999999999999999999999999999999999999999999999999876542210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
.. .......++..|+|||++....++.++|||||||++|||+
T Consensus 163 ~~--------------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~ 204 (283)
T cd05080 163 YY--------------------------------------RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204 (283)
T ss_pred hh--------------------------------------ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHH
Confidence 00 0001234567799999998888999999999999999999
Q ss_pred hCCCCCCCC
Q 017362 352 VGYPPFYSD 360 (373)
Q Consensus 352 ~G~~Pf~~~ 360 (373)
+|..||...
T Consensus 205 tg~~p~~~~ 213 (283)
T cd05080 205 THCDSKQSP 213 (283)
T ss_pred hCCCCCCCC
Confidence 999998653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=284.36 Aligned_cols=200 Identities=30% Similarity=0.531 Sum_probs=177.5
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++.+.||.|+||.||+|.++.+++.+|+|.+..... ......+.+|+.+++.++||||+++++.+...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 468889999999999999999999999999999876432 234456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 196 EYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 196 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~-~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
||+++++|.+++... ..+++..+..++.+++.||.|||+ .|++|+||||+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~--- 155 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--- 155 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH---
Confidence 999999999999765 789999999999999999999999 999999999999999999999999999986542110
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhC
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 353 (373)
.....|++.|+|||++.+..++.++|||||||++|+|++|
T Consensus 156 ----------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 195 (265)
T cd06605 156 ----------------------------------------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATG 195 (265)
T ss_pred ----------------------------------------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence 0024688999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 017362 354 YPPFYSD 360 (373)
Q Consensus 354 ~~Pf~~~ 360 (373)
..||...
T Consensus 196 ~~p~~~~ 202 (265)
T cd06605 196 RFPYPPE 202 (265)
T ss_pred CCCCCcc
Confidence 9999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=292.82 Aligned_cols=210 Identities=29% Similarity=0.493 Sum_probs=174.2
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC-----
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~----- 189 (373)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... .......+..|+.++..++||||+++++++....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 478999999999999999999999999999999986421 2233456778999999999999999998876543
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
.+|+||||++ ++|...+ ....+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~-~~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 82 DVYIVQELME-TDLYKLI-KTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred eEEEEehhcc-cCHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 5899999995 5888777 4457999999999999999999999999999999999999999999999999998765322
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ 348 (373)
.... .......||+.|+|||++.+ ..++.++|||||||++|
T Consensus 160 ~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~ 201 (336)
T cd07849 160 HDHT--------------------------------------GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILA 201 (336)
T ss_pred cccc--------------------------------------CCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHH
Confidence 1100 00113578999999998765 56899999999999999
Q ss_pred HHHhCCCCCCCCChHHHH
Q 017362 349 EMLVGYPPFYSDDPMSTC 366 (373)
Q Consensus 349 ell~G~~Pf~~~~~~~~~ 366 (373)
+|++|++||.+.+.....
T Consensus 202 el~~G~~~f~~~~~~~~~ 219 (336)
T cd07849 202 EMLSNRPLFPGKDYLHQL 219 (336)
T ss_pred HHHhCCCCCCCCCHHHHH
Confidence 999999999877654433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=282.02 Aligned_cols=206 Identities=21% Similarity=0.278 Sum_probs=166.3
Q ss_pred ceeeeeCcEEEEEEEEc--CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEeccC
Q 017362 122 TMIGKGAFGEVRVCREK--TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLP 199 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~ 199 (373)
+.||+|+||.||+|... .++..+|+|.+..... ......+.+|+.+++.++||||+++++.+.+....|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 36899999999999754 3456799998865421 2223467889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 200 GGDMMTLLMRKD-----TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 200 gg~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
+|+|.+++.... ..++..+..++.|++.||.|||+.|++||||||+||+++.+++++|+|||++..........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~- 157 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV- 157 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceee-
Confidence 999999986422 45677888999999999999999999999999999999999999999999986432211000
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-------CCChhhcHHHHHHHH
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-------GYGMECDWWSLGAIM 347 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-------~~~~~~DvwSlGvil 347 (373)
......|++.|+|||++... .++.++|||||||++
T Consensus 158 --------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l 199 (269)
T cd05087 158 --------------------------------------TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTI 199 (269)
T ss_pred --------------------------------------cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHH
Confidence 00124578899999998642 368899999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHH
Q 017362 348 YEMLV-GYPPFYSDDPMSTCRK 368 (373)
Q Consensus 348 ~ell~-G~~Pf~~~~~~~~~~k 368 (373)
|||++ |.+||...++.+....
T Consensus 200 ~el~~~g~~p~~~~~~~~~~~~ 221 (269)
T cd05087 200 WELFELGSQPYRHLSDEQVLTY 221 (269)
T ss_pred HHHHhCCCCCCCCCChHHHHHH
Confidence 99996 9999987776655443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=283.42 Aligned_cols=199 Identities=30% Similarity=0.524 Sum_probs=165.7
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHH-HHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL-LAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
++|++.+.||+|+||.||+|.+..+|..||||.+..... .... ..+..|..+ ++..+||||+++++++..++.+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC-cHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 479999999999999999999999999999999875421 1122 234445554 6677999999999999999999999
Q ss_pred EeccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 195 MEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKH-HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
|||++ |+|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++..+...
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99996 678777653 34689999999999999999999997 9999999999999999999999999998754321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC----CCCChhhcHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK----KGYGMECDWWSLGA 345 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~~~~~~DvwSlGv 345 (373)
.. .....|++.|+|||++.+ ..++.++|+|||||
T Consensus 158 ~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~ 195 (283)
T cd06617 158 VA------------------------------------------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGI 195 (283)
T ss_pred cc------------------------------------------cccccCCccccChhhcCCcccccccCccccchhhHH
Confidence 10 012468899999999865 45789999999999
Q ss_pred HHHHHHhCCCCCCC
Q 017362 346 IMYEMLVGYPPFYS 359 (373)
Q Consensus 346 il~ell~G~~Pf~~ 359 (373)
++|+|++|..||..
T Consensus 196 ~l~~l~~g~~p~~~ 209 (283)
T cd06617 196 TMIELATGRFPYDS 209 (283)
T ss_pred HHHHHHhCCCCCCc
Confidence 99999999999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=282.25 Aligned_cols=200 Identities=31% Similarity=0.500 Sum_probs=173.5
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC--CeEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--EFLYL 193 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~~l 193 (373)
++|+..+.||.|++|.||+|.+..+++.+|+|.+..... ......+.+|+++++.++||||+++++.|.+. +.+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 468999999999999999999988999999999875422 23346688899999999999999999988654 46899
Q ss_pred EEeccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 194 IMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 194 V~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
||||++|++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999887643 356899999999999999999999999999999999999999999999999998654321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 349 (373)
.. ....++..|+|||.+.+..++.++|||||||++|+
T Consensus 159 ~~-------------------------------------------~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~ 195 (287)
T cd06621 159 LA-------------------------------------------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLE 195 (287)
T ss_pred cc-------------------------------------------ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHH
Confidence 10 02357889999999999999999999999999999
Q ss_pred HHhCCCCCCCC
Q 017362 350 MLVGYPPFYSD 360 (373)
Q Consensus 350 ll~G~~Pf~~~ 360 (373)
|++|..||...
T Consensus 196 l~~g~~p~~~~ 206 (287)
T cd06621 196 VAQNRFPFPPE 206 (287)
T ss_pred HHhCCCCCCcc
Confidence 99999999866
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=279.67 Aligned_cols=206 Identities=32% Similarity=0.523 Sum_probs=174.1
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 191 (373)
+...+.+.....||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.++..++|+||+++++++.+++..
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFF 80 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEE
Confidence 344566666778999999999999998899999999886543 22345688899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC-CCcEEEeeccccccCC
Q 017362 192 YLIMEYLPGGDMMTLLMRK-DTL--TEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-YGHLRLSDFGLCKPLD 267 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~-~~l--~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~-~~~vkL~DFGla~~~~ 267 (373)
|+||||+++++|.+++... ..+ ++..+..++.|++.||.|||+.||+||||||+||+++. ++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 81 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 9999999999999999764 455 88999999999999999999999999999999999976 6799999999987543
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC--CChhhcHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG--YGMECDWWSLGA 345 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~~DvwSlGv 345 (373)
..... .....|++.|+|||++.... ++.++|+|||||
T Consensus 161 ~~~~~-----------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGv 199 (268)
T cd06624 161 GINPC-----------------------------------------TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGC 199 (268)
T ss_pred cCCCc-----------------------------------------cccCCCCccccChhhhccccccCCchhhhHHHHH
Confidence 21100 01245889999999987644 789999999999
Q ss_pred HHHHHHhCCCCCCCCC
Q 017362 346 IMYEMLVGYPPFYSDD 361 (373)
Q Consensus 346 il~ell~G~~Pf~~~~ 361 (373)
++|+|++|.+||...+
T Consensus 200 vl~~l~~g~~p~~~~~ 215 (268)
T cd06624 200 TIVEMATGKPPFIELG 215 (268)
T ss_pred HHHHHHhCCCCCcccc
Confidence 9999999999997543
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=294.15 Aligned_cols=215 Identities=27% Similarity=0.450 Sum_probs=179.8
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEE----eCCe
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ----DDEF 190 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~----~~~~ 190 (373)
.++|++.+.||.|+||.||+|.+..++..||+|++.... ........+..|+.++..++||||++++++|. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF-DVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc-ccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 378999999999999999999999999999999987542 12234456778999999999999999998876 3457
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
+|+||||+. |+|.+++.....+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred EEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 899999995 6899999877889999999999999999999999999999999999999999999999999987653221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~e 349 (373)
.... ......+|++.|+|||++.+ ..++.++|||||||++||
T Consensus 162 ~~~~-------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~e 204 (334)
T cd07855 162 TEHK-------------------------------------YFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAE 204 (334)
T ss_pred cCCC-------------------------------------cccccccccccccChHHhcCCcccccccchHHHHHHHHH
Confidence 1100 00113478999999999866 458999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHH
Q 017362 350 MLVGYPPFYSDDPMSTCRK 368 (373)
Q Consensus 350 ll~G~~Pf~~~~~~~~~~k 368 (373)
|++|++||.+.+.......
T Consensus 205 l~~g~~pf~~~~~~~~~~~ 223 (334)
T cd07855 205 MLGRRQLFPGKNYVHQLKL 223 (334)
T ss_pred HHcCCCccCCCChHHHHHH
Confidence 9999999998876655443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=286.77 Aligned_cols=214 Identities=18% Similarity=0.313 Sum_probs=176.1
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCc----eEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGH----VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 188 (373)
+..++|+..+.||+|+||.||+|.+..++. .||+|.+..... ......+.+|+.+++.++||||+++++.+...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 345789999999999999999999877775 468888764321 22234578899999999999999999998754
Q ss_pred CeEEEEEeccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
..++|+||+++|+|.+++.... .+++..+..++.|++.||.|||++||+|+||||+|||++.++.+||+|||+++.+.
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence 4679999999999999987643 68999999999999999999999999999999999999999999999999998654
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 347 (373)
...... ......+++.|+|||++.+..++.++|||||||++
T Consensus 161 ~~~~~~---------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l 201 (303)
T cd05110 161 GDEKEY---------------------------------------NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTI 201 (303)
T ss_pred Cccccc---------------------------------------ccCCCccccccCCHHHhccCCCChHHHHHHHHHHH
Confidence 221100 00123467789999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHH
Q 017362 348 YEMLV-GYPPFYSDDPMSTCRK 368 (373)
Q Consensus 348 ~ell~-G~~Pf~~~~~~~~~~k 368 (373)
|||++ |..||.+....+....
T Consensus 202 ~el~t~g~~p~~~~~~~~~~~~ 223 (303)
T cd05110 202 WELMTFGGKPYDGIPTREIPDL 223 (303)
T ss_pred HHHHhCCCCCCCCCCHHHHHHH
Confidence 99997 9999988766554433
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=281.88 Aligned_cols=207 Identities=29% Similarity=0.505 Sum_probs=172.7
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-CCceeEEeeEEEeC--CeEEEE
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDD--EFLYLI 194 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~--~~~~lV 194 (373)
|++++.||+|+||.||+|.+..++..||+|.+..... .... .....|+.++..+. |+||+++++++.+. +.+|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6788999999999999999999999999999875421 1222 23446888888885 99999999999987 889999
Q ss_pred EeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 195 MEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
|||++ |+|.+.+.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++. +.+||+|||++..+......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~- 155 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY- 155 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc-
Confidence 99996 578777765 457899999999999999999999999999999999999999 99999999999765322110
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHHHHHh
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~ 352 (373)
....+++.|+|||++.. ..++.++|||||||++|||++
T Consensus 156 -----------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~ 194 (282)
T cd07831 156 -----------------------------------------TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194 (282)
T ss_pred -----------------------------------------CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHc
Confidence 12457899999998754 457899999999999999999
Q ss_pred CCCCCCCCChHHHHHHhh
Q 017362 353 GYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 353 G~~Pf~~~~~~~~~~kI~ 370 (373)
|.+||.+.++.+....+.
T Consensus 195 ~~~p~~~~~~~~~~~~~~ 212 (282)
T cd07831 195 LFPLFPGTNELDQIAKIH 212 (282)
T ss_pred CCcCCCCCCHHHHHHHHH
Confidence 999999988877666553
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=283.36 Aligned_cols=204 Identities=27% Similarity=0.489 Sum_probs=169.8
Q ss_pred CCCcceeceeeeeCcEEEEEEEE----cCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe--C
Q 017362 115 ADDFELLTMIGKGAFGEVRVCRE----KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD--D 188 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~ 188 (373)
..+|++++.||+|+||.||+|.. ..++..||+|.+.... ......+.+|+.++..++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 35799999999999999999973 4578899999986543 3345668889999999999999999987653 4
Q ss_pred CeEEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
..+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.+++++|+|||++....
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 5689999999999999999764 468999999999999999999999999999999999999999999999999998654
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 347 (373)
....... ......++..|+|||++.+..++.++|||||||++
T Consensus 160 ~~~~~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 201 (284)
T cd05081 160 QDKEYYK--------------------------------------VREPGESPIFWYAPESLTESKFSVASDVWSFGVVL 201 (284)
T ss_pred CCCccee--------------------------------------ecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHH
Confidence 3211000 00012345569999999988999999999999999
Q ss_pred HHHHhCCCCCCC
Q 017362 348 YEMLVGYPPFYS 359 (373)
Q Consensus 348 ~ell~G~~Pf~~ 359 (373)
|||++|..|+.+
T Consensus 202 ~el~~~~~~~~~ 213 (284)
T cd05081 202 YELFTYSDKSCS 213 (284)
T ss_pred HHHhhcCCcCCC
Confidence 999999877653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=278.82 Aligned_cols=212 Identities=19% Similarity=0.328 Sum_probs=171.1
Q ss_pred ceeeeeCcEEEEEEEEcC---CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEE-eCCeEEEEEec
Q 017362 122 TMIGKGAFGEVRVCREKT---TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ-DDEFLYLIMEY 197 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-~~~~~~lV~E~ 197 (373)
+.||+|+||.||+|.+.. .+..||+|.+.... .......+..|..+++.++||||+++++.+. .+...|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 368999999999998643 34579999875421 2334566788999999999999999999765 45668999999
Q ss_pred cCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccc
Q 017362 198 LPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (373)
Q Consensus 198 ~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 276 (373)
+++|+|.+++... ..+++..+..++.|++.||.|||+.+++||||||+|||++.++.+||+|||+++...........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~- 157 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH- 157 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec-
Confidence 9999999998764 35678888999999999999999999999999999999999999999999999754322110000
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh-CCC
Q 017362 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYP 355 (373)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~ 355 (373)
......+++.|+|||++.+..++.++|||||||++|||++ |.+
T Consensus 158 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~ 201 (262)
T cd05058 158 ------------------------------------NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201 (262)
T ss_pred ------------------------------------ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCC
Confidence 0012346778999999998999999999999999999999 678
Q ss_pred CCCCCChHHHHHHhhcC
Q 017362 356 PFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 356 Pf~~~~~~~~~~kI~~~ 372 (373)
||...++.+....+.++
T Consensus 202 ~~~~~~~~~~~~~~~~~ 218 (262)
T cd05058 202 PYPDVDSFDITVYLLQG 218 (262)
T ss_pred CCCCCCHHHHHHHHhcC
Confidence 88888877777666543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=281.32 Aligned_cols=212 Identities=33% Similarity=0.580 Sum_probs=185.7
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEE
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 193 (373)
..+.|++.+.||+|++|.||+|.+..++..|++|++..... ....+..|+.++..++|+||+++++.+......|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 45679999999999999999999988899999999875432 34567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcc
Q 017362 194 IMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 194 V~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 272 (373)
||||++|++|.+++.... .+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 172 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK 172 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh
Confidence 999999999999998776 8999999999999999999999999999999999999999999999999998654321100
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 352 (373)
.....+++.|+|||++.+..++.++|+|||||++|+|++
T Consensus 173 -----------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~ 211 (286)
T cd06614 173 -----------------------------------------RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAE 211 (286)
T ss_pred -----------------------------------------hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHh
Confidence 013458889999999998889999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhh
Q 017362 353 GYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 353 G~~Pf~~~~~~~~~~kI~ 370 (373)
|.+||...++......+.
T Consensus 212 g~~p~~~~~~~~~~~~~~ 229 (286)
T cd06614 212 GEPPYLREPPLRALFLIT 229 (286)
T ss_pred CCCCCCCCCHHHHHHHHH
Confidence 999999888776665554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=282.29 Aligned_cols=211 Identities=31% Similarity=0.523 Sum_probs=181.1
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC--CeEEEEE
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--EFLYLIM 195 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~~lV~ 195 (373)
|++.+.||.|+||.||+|.+..++..+|+|.+.... ........+.+|+.++..+.|||++++++++.+. +..|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 678899999999999999999899999999998653 2233445677899999999999999999999988 8999999
Q ss_pred eccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 196 EYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 196 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
||+++ +|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~-- 156 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA-- 156 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc--
Confidence 99974 898888665 57999999999999999999999999999999999999999999999999999765432110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHHHHHhC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G 353 (373)
......+++.|+|||.+.+ ..++.++|||||||++|||++|
T Consensus 157 --------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~ 198 (287)
T cd07840 157 --------------------------------------DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG 198 (287)
T ss_pred --------------------------------------cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhC
Confidence 0012457889999998765 4589999999999999999999
Q ss_pred CCCCCCCChHHHHHHhh
Q 017362 354 YPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 354 ~~Pf~~~~~~~~~~kI~ 370 (373)
++||...++.....++.
T Consensus 199 ~~p~~~~~~~~~~~~~~ 215 (287)
T cd07840 199 KPIFQGSTELEQLEKIF 215 (287)
T ss_pred CCCCCCCChHHHHHHHH
Confidence 99999988887777664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=275.67 Aligned_cols=208 Identities=26% Similarity=0.395 Sum_probs=176.2
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEeccCCC
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGG 201 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~gg 201 (373)
++||.|+||.||+|.+.. ++.||+|.+...... .....+..|+.+++.++||||+++++++.+....|+||||++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 468999999999999877 899999988754321 34467888999999999999999999999999999999999999
Q ss_pred CHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccC
Q 017362 202 DMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (373)
Q Consensus 202 ~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (373)
+|.+++... ..+++..+..++.+++.||.|||+++++||||||+|||++.++.++|+|||++...........
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~------ 151 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS------ 151 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceec------
Confidence 999998653 4689999999999999999999999999999999999999999999999999875432111000
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh-CCCCCCC
Q 017362 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYS 359 (373)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf~~ 359 (373)
.....++..|+|||.+.+..++.++|+|||||++|||++ |.+||.+
T Consensus 152 ---------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~ 198 (251)
T cd05041 152 ---------------------------------DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPG 198 (251)
T ss_pred ---------------------------------cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCcc
Confidence 001234667999999998899999999999999999999 8999998
Q ss_pred CChHHHHHHhhc
Q 017362 360 DDPMSTCRKVRK 371 (373)
Q Consensus 360 ~~~~~~~~kI~~ 371 (373)
.++......+..
T Consensus 199 ~~~~~~~~~~~~ 210 (251)
T cd05041 199 MSNQQTRERIES 210 (251)
T ss_pred CCHHHHHHHHhc
Confidence 887777666643
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=281.07 Aligned_cols=197 Identities=18% Similarity=0.291 Sum_probs=164.3
Q ss_pred ceeeeeCcEEEEEEEEcCCCc-------eEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 122 TMIGKGAFGEVRVCREKTTGH-------VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~-------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
+.||.|+||.||+|.+...+. .+|+|.+.... ....+.+..|..++..++||||+++++++..+...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 358999999999998765443 48888875432 23345678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCc--------EEEeecccccc
Q 017362 195 MEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH--------LRLSDFGLCKP 265 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~--------vkL~DFGla~~ 265 (373)
|||+++|+|..++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999997644 5899999999999999999999999999999999999987765 68999998764
Q ss_pred CCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHH
Q 017362 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 344 (373)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG 344 (373)
..... ...+++.|+|||++.+ ..++.++||||||
T Consensus 158 ~~~~~---------------------------------------------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 192 (258)
T cd05078 158 VLPKE---------------------------------------------ILLERIPWVPPECIENPQNLSLAADKWSFG 192 (258)
T ss_pred cCCch---------------------------------------------hccccCCccCchhccCCCCCCchhhHHHHH
Confidence 32110 2468889999999987 4589999999999
Q ss_pred HHHHHHHhC-CCCCCCCChHHHH
Q 017362 345 AIMYEMLVG-YPPFYSDDPMSTC 366 (373)
Q Consensus 345 vil~ell~G-~~Pf~~~~~~~~~ 366 (373)
|++|||++| .+||...++....
T Consensus 193 ~~l~~l~~g~~~~~~~~~~~~~~ 215 (258)
T cd05078 193 TTLWEIFSGGDKPLSALDSQKKL 215 (258)
T ss_pred HHHHHHHcCCCCChhhccHHHHH
Confidence 999999998 5777766665443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=262.55 Aligned_cols=217 Identities=27% Similarity=0.474 Sum_probs=182.3
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHh-cCCCceeEEeeEEEeCC
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE-VDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~l~~~~~~~~ 189 (373)
.++..++...+..||+|++|.|-+.++..+|...|+|.+...- ......+...|+++... ..+|++|.+|+.+.+..
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 4556677778889999999999999999999999999987653 23445667778887654 58999999999999999
Q ss_pred eEEEEEeccCCCCHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCCEEEcCCCcEEEeeccccc
Q 017362 190 FLYLIMEYLPGGDMMTLL----MRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l----~~~~~l~~~~~~~i~~qi~~aL~~LH~-~giiHrDikp~NILl~~~~~vkL~DFGla~ 264 (373)
.+++.||.| ..||..+. .+...++|..+-.|+..++.||.|||+ ..+||||+||+||||+.+|+||+||||++-
T Consensus 119 dvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 119 DVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred cEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 999999999 45776654 345689999999999999999999997 589999999999999999999999999997
Q ss_pred cCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC----CCCChhhcH
Q 017362 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK----KGYGMECDW 340 (373)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~~~~~~Dv 340 (373)
.+..+-... --.|...|||||.+.. .+|+.++||
T Consensus 198 ~L~dSiAkt------------------------------------------~daGCkpYmaPEri~~e~n~~gY~vksDv 235 (282)
T KOG0984|consen 198 YLVDSIAKT------------------------------------------MDAGCKPYMAPERINPELNQKGYSVKSDV 235 (282)
T ss_pred eehhhhHHH------------------------------------------HhcCCCccCChhhcCcccCcccceeehhh
Confidence 665432110 1368889999999864 479999999
Q ss_pred HHHHHHHHHHHhCCCCCCCC-ChHHHHHHhhcC
Q 017362 341 WSLGAIMYEMLVGYPPFYSD-DPMSTCRKVRKK 372 (373)
Q Consensus 341 wSlGvil~ell~G~~Pf~~~-~~~~~~~kI~~~ 372 (373)
||||+.++||.+++.||.+. +|.+..+.|+..
T Consensus 236 WSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 236 WSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred hhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 99999999999999999987 688888887654
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=288.31 Aligned_cols=208 Identities=26% Similarity=0.436 Sum_probs=173.2
Q ss_pred CcceeceeeeeCcEEEEEEEEcC--CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC--CeEE
Q 017362 117 DFELLTMIGKGAFGEVRVCREKT--TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--EFLY 192 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~~ 192 (373)
.|++.+.||+|+||.||+|.+.. ++..||+|.+.............+.+|+.++..++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48899999999999999999988 8899999999864322233345677899999999999999999999988 8899
Q ss_pred EEEeccCCCCHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC----CCcEEEeecccc
Q 017362 193 LIMEYLPGGDMMTLLMRK-----DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK----YGHLRLSDFGLC 263 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~----~~~vkL~DFGla 263 (373)
+||||+++ +|.+++... ..+++..+..++.|++.||.|||+.+++||||||+|||++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999964 677766421 36899999999999999999999999999999999999999 999999999999
Q ss_pred ccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHH
Q 017362 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWS 342 (373)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwS 342 (373)
.......... ......++|+.|+|||++.+. .++.++||||
T Consensus 160 ~~~~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s 201 (316)
T cd07842 160 RLFNAPLKPL--------------------------------------ADLDPVVVTIWYRAPELLLGARHYTKAIDIWA 201 (316)
T ss_pred cccCCCcccc--------------------------------------cccCCccccccccCHHHHhCCCCCCcHHHHHH
Confidence 8654321100 001135689999999988764 5899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChH
Q 017362 343 LGAIMYEMLVGYPPFYSDDPM 363 (373)
Q Consensus 343 lGvil~ell~G~~Pf~~~~~~ 363 (373)
|||++|+|++|++||.+.+..
T Consensus 202 lG~~l~~l~~~~~~~~~~~~~ 222 (316)
T cd07842 202 IGCIFAELLTLEPIFKGREAK 222 (316)
T ss_pred HHHHHHHHHhcCCCCcCCccc
Confidence 999999999999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=282.67 Aligned_cols=210 Identities=31% Similarity=0.511 Sum_probs=178.7
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEec
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~ 197 (373)
|++.+.||.|++|.||+|.+..+|..||+|++..... .......+.+|+.+++.++|||++++++++.+.+..|+||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 6788999999999999999998999999999875431 223335677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 198 LPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 198 ~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
++ ++|.+++.... .+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++..+......
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--- 155 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--- 155 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc---
Confidence 95 68999987665 7899999999999999999999999999999999999999999999999998754322100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHHHHHHHHHHHhCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~ 354 (373)
.....+++.|+|||++.+. .++.++|||||||++|+|++|+
T Consensus 156 --------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~ 197 (283)
T cd07835 156 --------------------------------------YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197 (283)
T ss_pred --------------------------------------cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCC
Confidence 0123578899999988764 5789999999999999999999
Q ss_pred CCCCCCChHHHHHHhh
Q 017362 355 PPFYSDDPMSTCRKVR 370 (373)
Q Consensus 355 ~Pf~~~~~~~~~~kI~ 370 (373)
+||...++.....++.
T Consensus 198 ~pf~~~~~~~~~~~~~ 213 (283)
T cd07835 198 PLFPGDSEIDQLFRIF 213 (283)
T ss_pred CCCCCCCHHHHHHHHH
Confidence 9999888766655543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=278.08 Aligned_cols=195 Identities=19% Similarity=0.301 Sum_probs=166.5
Q ss_pred ceeeeeCcEEEEEEEEcCCC----------ceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeE
Q 017362 122 TMIGKGAFGEVRVCREKTTG----------HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 191 (373)
+.||+|+||.||+|.+..++ ..+++|++..... ....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 36899999999999987766 3578887765431 14667889999999999999999999988 778
Q ss_pred EEEEeccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC-------cEEEeecccc
Q 017362 192 YLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-------HLRLSDFGLC 263 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~-------~vkL~DFGla 263 (373)
|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++ .++|+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999997765 799999999999999999999999999999999999999888 8999999998
Q ss_pred ccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC--CCChhhcHH
Q 017362 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK--GYGMECDWW 341 (373)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~Dvw 341 (373)
....... ...+++.|+|||++.+. .++.++|||
T Consensus 156 ~~~~~~~---------------------------------------------~~~~~~~y~aPE~~~~~~~~~~~~~Di~ 190 (259)
T cd05037 156 ITVLSRE---------------------------------------------ERVERIPWIAPECIRNGQASLTIAADKW 190 (259)
T ss_pred ccccccc---------------------------------------------ccccCCCccChhhhcCCCCCcchhhHHH
Confidence 7543210 24577889999999876 789999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCChHHHH
Q 017362 342 SLGAIMYEMLV-GYPPFYSDDPMSTC 366 (373)
Q Consensus 342 SlGvil~ell~-G~~Pf~~~~~~~~~ 366 (373)
||||++|||++ |.+||...++.+..
T Consensus 191 slG~~~~~l~~~~~~p~~~~~~~~~~ 216 (259)
T cd05037 191 SFGTTLLEICSNGEEPLSTLSSSEKE 216 (259)
T ss_pred HHHHHHHHHHhCCCCCcccCCchhHH
Confidence 99999999999 68899877654443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=291.64 Aligned_cols=215 Identities=28% Similarity=0.453 Sum_probs=185.8
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC-----eE
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE-----FL 191 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~-----~~ 191 (373)
+|++.+.||.|++|.||+|.+..++..||||.+.... ........+..|+.+++.++||||+++++++.+.. .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5889999999999999999998889999999987542 12334467888999999999999999999998775 78
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
|+||||++ ++|.+++.+...+++..+..++.+++.||.|||+.||+|+||||+|||++.++.++|+|||++........
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 99999996 58999998877999999999999999999999999999999999999999999999999999986543211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~el 350 (373)
.. .......+|+.|+|||++.+. .++.++|+|||||++|+|
T Consensus 159 ~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l 200 (330)
T cd07834 159 EK--------------------------------------GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAEL 200 (330)
T ss_pred cc--------------------------------------ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHH
Confidence 00 001134689999999999887 899999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhc
Q 017362 351 LVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 351 l~G~~Pf~~~~~~~~~~kI~~ 371 (373)
++|.+||.+.+..+.+.+|+.
T Consensus 201 ~~g~~pf~~~~~~~~~~~i~~ 221 (330)
T cd07834 201 LTRKPLFPGRDYIDQLNLIVE 221 (330)
T ss_pred HcCCCCcCCCCHHHHHHHHHH
Confidence 999999999998888777664
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=281.02 Aligned_cols=210 Identities=30% Similarity=0.463 Sum_probs=178.0
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc---CCCceeEEeeEEEeCCe----
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV---DSNCIVKLYCSFQDDEF---- 190 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~l~~~~~~~~~---- 190 (373)
|++.+.||+|+||.||+|.+..++..||+|.+..... .......+.+|+.++..+ .||||+++++.+.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 6788999999999999999988899999999875432 122234456677776655 69999999999998776
Q ss_pred -EEEEEeccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 191 -LYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 191 -~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
+|++|||++ ++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+.
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 999999996 48988886643 58999999999999999999999999999999999999999999999999987653
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 347 (373)
.... .....+++.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~------------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l 196 (287)
T cd07838 159 FEMA------------------------------------------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIF 196 (287)
T ss_pred CCcc------------------------------------------cccccccccccChHHhccCCCCCcchhhhHHHHH
Confidence 2210 0124578899999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhhc
Q 017362 348 YEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 348 ~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
|||++|.+||.+.+..+...+|..
T Consensus 197 ~~l~~~~~~~~~~~~~~~~~~~~~ 220 (287)
T cd07838 197 AELFRRRPLFRGTSEADQLDKIFD 220 (287)
T ss_pred HHHHhCCCcccCCChHHHHHHHHH
Confidence 999999999999998888877753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=284.24 Aligned_cols=207 Identities=31% Similarity=0.482 Sum_probs=177.2
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEec
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~ 197 (373)
|...+.||+|+||+||+|.+..++..|++|++.............+..|+.++..++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999999899999999998754433334456688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccc
Q 017362 198 LPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (373)
Q Consensus 198 ~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 276 (373)
++ |+|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~------- 174 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA------- 174 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCCC-------
Confidence 96 577777754 457999999999999999999999999999999999999999999999999987532110
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc---CCCCChhhcHHHHHHHHHHHHhC
Q 017362 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DvwSlGvil~ell~G 353 (373)
....|++.|+|||++. ...++.++|||||||++|+|++|
T Consensus 175 --------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g 216 (313)
T cd06633 175 --------------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 216 (313)
T ss_pred --------------------------------------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhC
Confidence 0346889999999985 35688999999999999999999
Q ss_pred CCCCCCCChHHHHHHhh
Q 017362 354 YPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 354 ~~Pf~~~~~~~~~~kI~ 370 (373)
.+||.+.++.....++.
T Consensus 217 ~~p~~~~~~~~~~~~~~ 233 (313)
T cd06633 217 KPPLFNMNAMSALYHIA 233 (313)
T ss_pred CCCCCCCChHHHHHHHH
Confidence 99999888766665554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=258.09 Aligned_cols=211 Identities=27% Similarity=0.476 Sum_probs=183.3
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEe
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E 196 (373)
.|...++||+|.||+||+|+++.+++.||+|.++..+. +........+|+-++++++|.|||++++..-.++.+-+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 46677889999999999999999999999999876542 23333557789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 197 YLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 197 ~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
|| .-+|..+... ++.++.+.++.++.|++.||.|+|++++.||||||.|.||+.+|.+||+|||+|+.+.-+.--
T Consensus 82 ~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrc--- 157 (292)
T KOG0662|consen 82 FC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC--- 157 (292)
T ss_pred Hh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe---
Confidence 99 4578777754 567999999999999999999999999999999999999999999999999999876533100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC-CChhhcHHHHHHHHHHHHh-C
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLV-G 353 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~ell~-G 353 (373)
....+-|.+|++|.++.+.. |+...|+||-|||+.|+.. |
T Consensus 158 --------------------------------------ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanag 199 (292)
T KOG0662|consen 158 --------------------------------------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 199 (292)
T ss_pred --------------------------------------eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcC
Confidence 00246799999999998854 8999999999999999996 9
Q ss_pred CCCCCCCChHHHHHHhh
Q 017362 354 YPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 354 ~~Pf~~~~~~~~~~kI~ 370 (373)
+|.|.+.+..+..++|-
T Consensus 200 rplfpg~dvddqlkrif 216 (292)
T KOG0662|consen 200 RPLFPGNDVDDQLKRIF 216 (292)
T ss_pred CCCCCCCcHHHHHHHHH
Confidence 99999999999988875
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=276.48 Aligned_cols=211 Identities=30% Similarity=0.550 Sum_probs=185.2
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEe
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E 196 (373)
+|++.+.||.|+||.||++.+..++..+|+|.+...... ......+..|+.+++.++|+||+++++.+.+....|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 588999999999999999999999999999998765432 2344567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcc
Q 017362 197 YLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 197 ~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 272 (373)
|+++++|..++.. ...+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~-- 157 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM-- 157 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC--
Confidence 9999999999866 3568999999999999999999999999999999999999999999999999987654221
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 352 (373)
.....|++.|+|||.+.+..++.++|+||||+++|+|++
T Consensus 158 -----------------------------------------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~ 196 (256)
T cd08530 158 -----------------------------------------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMAT 196 (256)
T ss_pred -----------------------------------------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHh
Confidence 002458899999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhc
Q 017362 353 GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 353 G~~Pf~~~~~~~~~~kI~~ 371 (373)
|++||...+..+...++..
T Consensus 197 g~~p~~~~~~~~~~~~~~~ 215 (256)
T cd08530 197 FAPPFEARSMQDLRYKVQR 215 (256)
T ss_pred CCCCCCCCCHHHHHHHHhc
Confidence 9999999888776666554
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=277.13 Aligned_cols=213 Identities=32% Similarity=0.612 Sum_probs=183.4
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEe
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E 196 (373)
+|.+.+.||.|+||.||+|.+..++..||+|.+..... .....+.+.+|+.+++.++|+||+++++.+.+....|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 58899999999999999999999999999999876532 22334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCc-EEEeeccccccCCCCCccc
Q 017362 197 YLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH-LRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 197 ~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~-vkL~DFGla~~~~~~~~~~ 273 (373)
|+++++|.+++.... .+++..+..++.+++.||.|||+.+++|+||||+||+++.++. ++|+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~- 158 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL- 158 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccc-
Confidence 999999999987643 5799999999999999999999999999999999999998864 699999998765322100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhC
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 353 (373)
.....|++.|+|||++....++.++|+|||||++|||++|
T Consensus 159 ----------------------------------------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g 198 (257)
T cd08225 159 ----------------------------------------AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTL 198 (257)
T ss_pred ----------------------------------------ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence 1134689999999999888899999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhc
Q 017362 354 YPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 354 ~~Pf~~~~~~~~~~kI~~ 371 (373)
.+||...+..+....+.+
T Consensus 199 ~~p~~~~~~~~~~~~~~~ 216 (257)
T cd08225 199 KHPFEGNNLHQLVLKICQ 216 (257)
T ss_pred CCCCCCccHHHHHHHHhc
Confidence 999998887777666554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=287.44 Aligned_cols=215 Identities=24% Similarity=0.431 Sum_probs=184.0
Q ss_pred hhhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCC--C----ceeEE
Q 017362 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS--N----CIVKL 181 (373)
Q Consensus 108 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~----~iv~l 181 (373)
++...+..++|.++..+|+|.||.|-.|.+..++..||||+++... ...+..+-|++++.++.+ | .+|.+
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m 156 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQM 156 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence 4455566899999999999999999999999999999999998653 233455668888888832 2 47888
Q ss_pred eeEEEeCCeEEEEEeccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC--------
Q 017362 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-------- 251 (373)
Q Consensus 182 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~-------- 251 (373)
.++|...+..|+|+|.+ |-|+.++|..+. +++...++.++.|++.+++|||+.+++|.||||+|||+..
T Consensus 157 ~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 157 RDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred ehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEec
Confidence 89999999999999998 779999997754 6999999999999999999999999999999999999942
Q ss_pred ------------CCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhcccccccc
Q 017362 252 ------------YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVG 319 (373)
Q Consensus 252 ------------~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 319 (373)
+.+|+|+|||-|+.-... ..+.+.
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~--------------------------------------------hs~iVs 271 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEH--------------------------------------------HSTIVS 271 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceeccC--------------------------------------------cceeee
Confidence 336899999988754322 126789
Q ss_pred CCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCCCChHH---HHHHhhc
Q 017362 320 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMS---TCRKVRK 371 (373)
Q Consensus 320 t~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~---~~~kI~~ 371 (373)
|..|+|||++++.+++.+|||||+||||+|+++|...|+..+..| ++++|+.
T Consensus 272 TRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlG 326 (415)
T KOG0671|consen 272 TRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILG 326 (415)
T ss_pred ccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhC
Confidence 999999999999999999999999999999999999999887665 8888764
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=273.58 Aligned_cols=212 Identities=32% Similarity=0.571 Sum_probs=186.3
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEe
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E 196 (373)
+|++.+.||+|++|.||++.+..++..||+|.+..... .......+.+|+.++..++|||++++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 58899999999999999999988999999999976543 22455778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccc
Q 017362 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (373)
Q Consensus 197 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 276 (373)
|+++++|.+++.....+++..+..++.+++.||.+||+.|++||||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~---- 155 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD---- 155 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc----
Confidence 9999999999988888999999999999999999999999999999999999999999999999999866432210
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCC
Q 017362 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356 (373)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 356 (373)
.....|++.|+|||.+.+..++.++||||||+++|+|++|.+|
T Consensus 156 -------------------------------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p 198 (254)
T cd06627 156 -------------------------------------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198 (254)
T ss_pred -------------------------------------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCC
Confidence 0134688999999999888899999999999999999999999
Q ss_pred CCCCChHHHHHHhh
Q 017362 357 FYSDDPMSTCRKVR 370 (373)
Q Consensus 357 f~~~~~~~~~~kI~ 370 (373)
|...++.....++.
T Consensus 199 ~~~~~~~~~~~~~~ 212 (254)
T cd06627 199 YYDLNPMAALFRIV 212 (254)
T ss_pred CCCccHHHHHHHHh
Confidence 98877655554443
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=277.70 Aligned_cols=205 Identities=23% Similarity=0.409 Sum_probs=175.0
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
..+|++.+.||+|+||.||++. .++..||+|.+.... ....+.+|+.++..++||||+++++.+..+ ..|+|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v 76 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIV 76 (254)
T ss_pred HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEE
Confidence 4679999999999999999885 467889999986532 235678899999999999999999998765 47899
Q ss_pred EeccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcc
Q 017362 195 MEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 272 (373)
|||+++++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++.......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-- 154 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-- 154 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence 99999999999997643 58999999999999999999999999999999999999999999999999986532110
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 352 (373)
.....+..|+|||++.+..++.++|+|||||++|||++
T Consensus 155 ------------------------------------------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~ 192 (254)
T cd05083 155 ------------------------------------------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFS 192 (254)
T ss_pred ------------------------------------------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHh
Confidence 01234567999999998999999999999999999997
Q ss_pred -CCCCCCCCChHHHHHHhhc
Q 017362 353 -GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 353 -G~~Pf~~~~~~~~~~kI~~ 371 (373)
|++||...+..+....+.+
T Consensus 193 ~g~~p~~~~~~~~~~~~~~~ 212 (254)
T cd05083 193 YGRAPYPKMSLKEVKECVEK 212 (254)
T ss_pred CCCCCCccCCHHHHHHHHhC
Confidence 9999998888777666543
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=289.32 Aligned_cols=210 Identities=29% Similarity=0.474 Sum_probs=177.6
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC-----
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD----- 188 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~----- 188 (373)
..++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.++..++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 4588999999999999999999998899999999987532 1222345677899999999999999999988643
Q ss_pred -CeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 189 -EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 189 -~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
...|++++++ |++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 3478999987 8899888754 469999999999999999999999999999999999999999999999999987532
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAI 346 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvi 346 (373)
... ....||+.|+|||++.+ ..++.++|||||||+
T Consensus 172 ~~~--------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~i 207 (345)
T cd07877 172 DEM--------------------------------------------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 207 (345)
T ss_pred ccc--------------------------------------------cccccCCCccCHHHHhCccCCCchhhHHHHHHH
Confidence 110 12468899999999876 568999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHhh
Q 017362 347 MYEMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 347 l~ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
+|||++|++||.+.+......+++
T Consensus 208 l~el~~g~~pf~~~~~~~~~~~~~ 231 (345)
T cd07877 208 MAELLTGRTLFPGTDHIDQLKLIL 231 (345)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999999887766655554
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=283.33 Aligned_cols=203 Identities=25% Similarity=0.457 Sum_probs=170.5
Q ss_pred CCcceeceeeeeCcEEEEEEEE----cCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC--C
Q 017362 116 DDFELLTMIGKGAFGEVRVCRE----KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--E 189 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~ 189 (373)
..|++++.||+|+||.||+|.. ..++..||+|.+.... .......+.+|+.+++.+.||||+++++++.+. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 3478999999999999999974 4568899999986432 233346688999999999999999999998875 5
Q ss_pred eEEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
..|+||||++|++|.+++.+. ..+++..+..++.+++.||.|||+.|++||||||+||+++.++.++|+|||+++.+..
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 789999999999999998664 3689999999999999999999999999999999999999999999999999986542
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 348 (373)
...... ......|+..|+|||++.+..++.++|||||||++|
T Consensus 162 ~~~~~~--------------------------------------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ 203 (284)
T cd05079 162 DKEYYT--------------------------------------VKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLY 203 (284)
T ss_pred Ccccee--------------------------------------ecCCCCCCccccCHHHhccCCCCccccchhhhhhhh
Confidence 211000 001345777899999999889999999999999999
Q ss_pred HHHhCCCCCC
Q 017362 349 EMLVGYPPFY 358 (373)
Q Consensus 349 ell~G~~Pf~ 358 (373)
||++|+.|+.
T Consensus 204 ellt~~~~~~ 213 (284)
T cd05079 204 ELLTYCDSES 213 (284)
T ss_pred hhhcCCCCCc
Confidence 9999887764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=284.08 Aligned_cols=213 Identities=30% Similarity=0.437 Sum_probs=174.7
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC-----
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~----- 189 (373)
.++|++.+.||+|+||.||+|.+..++..||||.+..... .......+.+|+.+++.++||||+++++++.+..
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 4679999999999999999999999999999998864321 1222334567999999999999999999887654
Q ss_pred ---eEEEEEeccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 190 ---FLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 190 ---~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
..|+||||++ ++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++..
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 4599999995 58888876543 689999999999999999999999999999999999999999999999999986
Q ss_pred CCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHHHH
Q 017362 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLG 344 (373)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG 344 (373)
+........ .......+++.|+|||++.+. .++.++||||||
T Consensus 169 ~~~~~~~~~-------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG 211 (310)
T cd07865 169 FSLSKNSKP-------------------------------------NRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAG 211 (310)
T ss_pred ccCCcccCC-------------------------------------CCccCcccCccccCcHHhcCCcccCchhhhHHHH
Confidence 543221100 001134678999999988764 478999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHH
Q 017362 345 AIMYEMLVGYPPFYSDDPMSTC 366 (373)
Q Consensus 345 vil~ell~G~~Pf~~~~~~~~~ 366 (373)
|++|||++|++||.+.++....
T Consensus 212 ~~l~el~t~~~~~~~~~~~~~~ 233 (310)
T cd07865 212 CIMAEMWTRSPIMQGNTEQHQL 233 (310)
T ss_pred HHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999999988765443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=277.49 Aligned_cols=195 Identities=22% Similarity=0.287 Sum_probs=162.7
Q ss_pred ceeeeeCcEEEEEEEEcC------------CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC
Q 017362 122 TMIGKGAFGEVRVCREKT------------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~------------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 189 (373)
+.||+|+||.||+|.... ....|++|++.... ......+..|+.++..++||||+++++++.+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 358999999999997532 22358899876543 233456778889999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCc-------EEEeecc
Q 017362 190 FLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH-------LRLSDFG 261 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~-------vkL~DFG 261 (373)
..++||||+++|+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999999888653 56999999999999999999999999999999999999987664 8999999
Q ss_pred ccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc-CCCCChhhcH
Q 017362 262 LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDW 340 (373)
Q Consensus 262 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~~Dv 340 (373)
++....... ...|++.|+|||++. +..++.++||
T Consensus 158 ~~~~~~~~~---------------------------------------------~~~~~~~y~aPE~~~~~~~~~~~~Di 192 (262)
T cd05077 158 IPITVLSRQ---------------------------------------------ECVERIPWIAPECVEDSKNLSIAADK 192 (262)
T ss_pred CCccccCcc---------------------------------------------cccccccccChhhhcCCCCCCchhHH
Confidence 986542110 346888999999987 4678999999
Q ss_pred HHHHHHHHHHH-hCCCCCCCCChHH
Q 017362 341 WSLGAIMYEML-VGYPPFYSDDPMS 364 (373)
Q Consensus 341 wSlGvil~ell-~G~~Pf~~~~~~~ 364 (373)
|||||++|||+ .|.+||......+
T Consensus 193 wslG~~l~el~~~~~~p~~~~~~~~ 217 (262)
T cd05077 193 WSFGTTLWEICYNGEIPLKDKTLAE 217 (262)
T ss_pred HHHHHHHHHHHhCCCCCCCCcchhH
Confidence 99999999998 5999998765544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=289.38 Aligned_cols=209 Identities=33% Similarity=0.515 Sum_probs=178.5
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC-----
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~----- 189 (373)
.++|++++.||+|+||.||+|.+..++..||||++.... ........+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 578999999999999999999999999999999986432 22223456778999999999999999999987654
Q ss_pred -eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 190 -FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 190 -~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
..|+||||+ |++|..++. ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 358999999 779988875 45799999999999999999999999999999999999999999999999999875432
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil 347 (373)
.. ....+++.|+|||++.+ ..++.++|+|||||++
T Consensus 171 ~~--------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll 206 (343)
T cd07880 171 EM--------------------------------------------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIM 206 (343)
T ss_pred Cc--------------------------------------------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHH
Confidence 11 02457899999999876 4589999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhh
Q 017362 348 YEMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 348 ~ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
|+|++|.+||.+.+......+++
T Consensus 207 ~~l~~g~~pf~~~~~~~~~~~~~ 229 (343)
T cd07880 207 AEMLTGKPLFKGHDHLDQLMEIM 229 (343)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999888777666654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=267.89 Aligned_cols=212 Identities=27% Similarity=0.471 Sum_probs=181.1
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC---
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--- 188 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--- 188 (373)
.+..++|.+.+.||+|||+-||++.+..++..||+|.+.... ....+...+|++..+.++|||++++++....+
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 456789999999999999999999999999999999987654 34567788999999999999999998776543
Q ss_pred --CeEEEEEeccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHhCC--CeeecCCCCCEEEcCCCcEEEeec
Q 017362 189 --EFLYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHH--YIHRDIKPDNLLLDKYGHLRLSDF 260 (373)
Q Consensus 189 --~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiHrDikp~NILl~~~~~vkL~DF 260 (373)
...|+++.|...|+|.+.+.. ...++|.++..|+.+++.||.+||+.. ++||||||.|||+...+.++|.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 348999999999999998864 347999999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC---CCCChh
Q 017362 261 GLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGME 337 (373)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~ 337 (373)
|-++..... ...+.+.-.++.|...+ -|..|+|||.+.- ...+.+
T Consensus 174 GS~~~a~i~------------------------i~~~~~a~~lQe~a~e~--------Ct~pyRAPELf~vk~~~ti~er 221 (302)
T KOG2345|consen 174 GSATQAPIQ------------------------IEGSRQALRLQEWAEER--------CTIPYRAPELFNVKSHCTITER 221 (302)
T ss_pred cCccccceE------------------------eechHHHHHHHHHHHHh--------CCCcccCchheecccCcccccc
Confidence 988754321 12234445677787655 4678999999974 446899
Q ss_pred hcHHHHHHHHHHHHhCCCCCC
Q 017362 338 CDWWSLGAIMYEMLVGYPPFY 358 (373)
Q Consensus 338 ~DvwSlGvil~ell~G~~Pf~ 358 (373)
+|||||||+||+|+.|..||.
T Consensus 222 tDIWSLGCtLYa~mf~~sPfe 242 (302)
T KOG2345|consen 222 TDIWSLGCTLYAMMFGESPFE 242 (302)
T ss_pred cchhhhhHHHHHHHHcCCcch
Confidence 999999999999999999995
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=279.52 Aligned_cols=195 Identities=18% Similarity=0.250 Sum_probs=162.0
Q ss_pred eeeeeCcEEEEEEEEcCC------------------------CceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCce
Q 017362 123 MIGKGAFGEVRVCREKTT------------------------GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCI 178 (373)
Q Consensus 123 ~lG~G~~g~Vy~~~~~~~------------------------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 178 (373)
.||+|+||.||+|....+ ...||+|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 599999999999874321 2358899886543 2234567788999999999999
Q ss_pred eEEeeEEEeCCeEEEEEeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC----
Q 017362 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---- 253 (373)
Q Consensus 179 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~---- 253 (373)
+++++++.+....|+||||+++|+|..++.. .+.+++..+..++.|++.||.|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999999865 45789999999999999999999999999999999999997654
Q ss_pred ---cEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc
Q 017362 254 ---HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL 330 (373)
Q Consensus 254 ---~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 330 (373)
.++|+|||++...... ....+++.|+|||++.
T Consensus 159 ~~~~~kl~d~g~~~~~~~~---------------------------------------------~~~~~~~~~~aPe~~~ 193 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR---------------------------------------------EERVERIPWIAPECVP 193 (274)
T ss_pred ccceeeecCCccccccccc---------------------------------------------cccccCCcccCchhhc
Confidence 4899999987543211 0235788899999987
Q ss_pred C-CCCChhhcHHHHHHHHHHHH-hCCCCCCCCChHHH
Q 017362 331 K-KGYGMECDWWSLGAIMYEML-VGYPPFYSDDPMST 365 (373)
Q Consensus 331 ~-~~~~~~~DvwSlGvil~ell-~G~~Pf~~~~~~~~ 365 (373)
+ ..++.++|||||||++|||+ +|.+||...++.+.
T Consensus 194 ~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 194 GGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 6 56899999999999999995 69999988766543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=328.29 Aligned_cols=208 Identities=32% Similarity=0.534 Sum_probs=181.7
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
-++.-...||.|.||.||.|.+..+|...|+|-++-.... ......+.+|+.++..+.|||+|++|++-.+.+.+||.|
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 4566677899999999999999999999999988765433 344566888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
|||.||+|.+++...+..++...+.|..|++.||.|||++|||||||||.|||++.+|-+|++|||.|..+.......
T Consensus 1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~-- 1391 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM-- 1391 (1509)
T ss_pred HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcC--
Confidence 999999999999998899999999999999999999999999999999999999999999999999998765442110
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC---CCCChhhcHHHHHHHHHHHHh
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~~DvwSlGvil~ell~ 352 (373)
+ ..+ ...+|||.|||||++.+ .+.+.+.|||||||++.||.|
T Consensus 1392 -------------------~-----~el-----------~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~t 1436 (1509)
T KOG4645|consen 1392 -------------------P-----GEL-----------QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMAT 1436 (1509)
T ss_pred -------------------C-----HHH-----------HhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeec
Confidence 0 001 15789999999999986 457889999999999999999
Q ss_pred CCCCCCCCC
Q 017362 353 GYPPFYSDD 361 (373)
Q Consensus 353 G~~Pf~~~~ 361 (373)
|+.||..-|
T Consensus 1437 GkrPW~~~d 1445 (1509)
T KOG4645|consen 1437 GKRPWAELD 1445 (1509)
T ss_pred CCCchhhcc
Confidence 999998644
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=278.93 Aligned_cols=209 Identities=27% Similarity=0.428 Sum_probs=173.8
Q ss_pred ceeeeeCcEEEEEEEEcCCC------ceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 122 TMIGKGAFGEVRVCREKTTG------HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
+.||+|+||.||+|...... ..+|+|.+.... .......+.+|+.+++.++||||+++++++.+....|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 35899999999999876433 679999876432 1233456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC-----cEEEeecccc
Q 017362 196 EYLPGGDMMTLLMRK-------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-----HLRLSDFGLC 263 (373)
Q Consensus 196 E~~~gg~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~-----~vkL~DFGla 263 (373)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999998642 3478899999999999999999999999999999999999887 8999999999
Q ss_pred ccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHH
Q 017362 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (373)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSl 343 (373)
........... .....+++.|+|||++.+..++.++|||||
T Consensus 159 ~~~~~~~~~~~---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 199 (269)
T cd05044 159 RDIYKSDYYRK---------------------------------------EGEGLLPVRWMAPESLLDGKFTTQSDVWSF 199 (269)
T ss_pred ccccccccccc---------------------------------------CcccCCCccccCHHHHccCCcccchhHHHH
Confidence 76532211000 002346788999999999999999999999
Q ss_pred HHHHHHHHh-CCCCCCCCChHHHHHHhhc
Q 017362 344 GAIMYEMLV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 344 Gvil~ell~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
||++|||++ |.+||...+..+....|..
T Consensus 200 G~il~ellt~g~~p~~~~~~~~~~~~~~~ 228 (269)
T cd05044 200 GVLMWEILTLGQQPYPALNNQEVLQHVTA 228 (269)
T ss_pred HHHHHHHHHcCCCCCcccCHHHHHHHHhc
Confidence 999999998 9999998887777766543
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=289.85 Aligned_cols=210 Identities=27% Similarity=0.445 Sum_probs=177.5
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC-----C
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD-----E 189 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-----~ 189 (373)
..+|.+.+.||+|+||+||+|.+..++..||||.+.... ........+..|+.++..++|+||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF-DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 467999999999999999999999999999999987532 1222345567899999999999999999988654 3
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
.+|+||||++ ++|.+++...+.+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 5899999995 789999988888999999999999999999999999999999999999999999999999999765322
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ 348 (373)
.. ......|+..|+|||++.. ..++.++|||||||++|
T Consensus 162 ~~-----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ 200 (337)
T cd07858 162 GD-----------------------------------------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFA 200 (337)
T ss_pred cc-----------------------------------------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHH
Confidence 10 0113468899999999875 46899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHH
Q 017362 349 EMLVGYPPFYSDDPMSTCR 367 (373)
Q Consensus 349 ell~G~~Pf~~~~~~~~~~ 367 (373)
+|++|++||.+.+......
T Consensus 201 ~l~~g~~pf~~~~~~~~~~ 219 (337)
T cd07858 201 ELLGRKPLFPGKDYVHQLK 219 (337)
T ss_pred HHHcCCCCCCCCChHHHHH
Confidence 9999999998876554443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=278.16 Aligned_cols=208 Identities=18% Similarity=0.256 Sum_probs=166.9
Q ss_pred eeeeeCcEEEEEEEEcCC--CceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEeccCC
Q 017362 123 MIGKGAFGEVRVCREKTT--GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (373)
Q Consensus 123 ~lG~G~~g~Vy~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~g 200 (373)
.||+|+||.||+|..... ...+++|.+.... .....+.+.+|+.+++.++||||+++++.+.+....|+||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 599999999999975332 3356677665432 122346788899999999999999999999999999999999999
Q ss_pred CCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccc
Q 017362 201 GDMMTLLMRK----DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (373)
Q Consensus 201 g~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 276 (373)
|+|.+++... ..+++..+..++.|++.||.|||+.+++||||||+|||++.++.++|+|||++..........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~--- 156 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE--- 156 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhh---
Confidence 9999999753 346777888999999999999999999999999999999999999999999975432111000
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-------CCCChhhcHHHHHHHHHH
Q 017362 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-------KGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~~~~~DvwSlGvil~e 349 (373)
.....+|++.|+|||++.. ..++.++|||||||++||
T Consensus 157 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~e 200 (268)
T cd05086 157 ------------------------------------TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWE 200 (268)
T ss_pred ------------------------------------cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHH
Confidence 0013568899999999853 245789999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHhhc
Q 017362 350 MLV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 350 ll~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
|++ |.+||...++.+.+.++++
T Consensus 201 l~~~~~~p~~~~~~~~~~~~~~~ 223 (268)
T cd05086 201 LFENAAQPYSHLSDREVLNHVIK 223 (268)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHh
Confidence 997 6889988888887777654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=273.51 Aligned_cols=207 Identities=50% Similarity=0.922 Sum_probs=184.3
Q ss_pred eeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEeccCCCCH
Q 017362 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM 203 (373)
Q Consensus 124 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~gg~L 203 (373)
||.|+||.||+|.+..+++.+|+|++.............+..|+.+++.++||||+++++.+.++...|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999888999999999877655555667788999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccCCCC
Q 017362 204 MTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283 (373)
Q Consensus 204 ~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~ 283 (373)
.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~----------- 149 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR----------- 149 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCc-----------
Confidence 999988878999999999999999999999999999999999999999999999999998765322100
Q ss_pred CCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCCCChH
Q 017362 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363 (373)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~ 363 (373)
.....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+..
T Consensus 150 ------------------------------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~ 199 (250)
T cd05123 150 ------------------------------TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK 199 (250)
T ss_pred ------------------------------ccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 01346888999999999888999999999999999999999999988887
Q ss_pred HHHHHhhc
Q 017362 364 STCRKVRK 371 (373)
Q Consensus 364 ~~~~kI~~ 371 (373)
....++..
T Consensus 200 ~~~~~~~~ 207 (250)
T cd05123 200 EIYEKILK 207 (250)
T ss_pred HHHHHHhc
Confidence 77777654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=287.23 Aligned_cols=228 Identities=25% Similarity=0.453 Sum_probs=182.1
Q ss_pred CCCcce-eceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhh-----------hHHHHHHHHHHHHhcCCCceeEEe
Q 017362 115 ADDFEL-LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRG-----------QVEHVRAERNLLAEVDSNCIVKLY 182 (373)
Q Consensus 115 ~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~iv~l~ 182 (373)
.++|.. .+.||.|+||+||+|.+..+++.||||++......... ....+.+|+.++..++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 355654 46799999999999999999999999998654322100 012467899999999999999999
Q ss_pred eEEEeCCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccc
Q 017362 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (373)
Q Consensus 183 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGl 262 (373)
+++...+..|+||||++ |+|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+|||++.++.++|+|||+
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence 99999999999999996 69999998888899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHH
Q 017362 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWW 341 (373)
Q Consensus 263 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~Dvw 341 (373)
+.....+........ ..... .+.......+++.|+|||++.+. .++.++|||
T Consensus 166 ~~~~~~~~~~~~~~~-----------~~~~~----------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~ 218 (335)
T PTZ00024 166 ARRYGYPPYSDTLSK-----------DETMQ----------------RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMW 218 (335)
T ss_pred eeecccccccccccc-----------ccccc----------------ccccccccccccCCCCChhcccCCCCCcHHHHH
Confidence 986643221110000 00000 00011134678999999998764 479999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 017362 342 SLGAIMYEMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 342 SlGvil~ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
||||++|||++|.+||.+.++.+...+|.
T Consensus 219 slG~~l~el~tg~~p~~~~~~~~~~~~i~ 247 (335)
T PTZ00024 219 SVGCIFAELLTGKPLFPGENEIDQLGRIF 247 (335)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999999999998887776654
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=286.04 Aligned_cols=215 Identities=27% Similarity=0.416 Sum_probs=176.0
Q ss_pred CcceeceeeeeCcEEEEEEEEcCC--CceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEe----CC
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTT--GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQD----DE 189 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~----~~ 189 (373)
+|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ........+..|+.++..+ .||||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 488999999999999999999877 8899999986431 1222345677899999988 59999999987542 24
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
.+|++|||++ ++|..++.....+++..++.++.||+.||.|||++|++||||||+|||++.+++++|+|||+++.+...
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 5789999984 699999988888999999999999999999999999999999999999999999999999999865422
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ 348 (373)
..... ......+||+.|+|||++.+ ..++.++|||||||++|
T Consensus 159 ~~~~~-------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~ 201 (332)
T cd07857 159 PGENA-------------------------------------GFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILA 201 (332)
T ss_pred ccccc-------------------------------------ccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHH
Confidence 11000 00113578999999998766 56899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhh
Q 017362 349 EMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 349 ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
+|++|.+||.+.+......+++
T Consensus 202 ~l~~g~~pf~~~~~~~~~~~~~ 223 (332)
T cd07857 202 ELLGRKPVFKGKDYVDQLNQIL 223 (332)
T ss_pred HHHhCCcCCCCCCHHHHHHHHH
Confidence 9999999999877665555443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=283.03 Aligned_cols=216 Identities=30% Similarity=0.524 Sum_probs=179.4
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC---
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE--- 189 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~--- 189 (373)
...++|++.+.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.++..++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 346789999999999999999999999999999999875421 2223345678999999999999999999987655
Q ss_pred -------eEEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeecc
Q 017362 190 -------FLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFG 261 (373)
Q Consensus 190 -------~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFG 261 (373)
.+|+||||+++ ++..++... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 79999999976 777777553 479999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcH
Q 017362 262 LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDW 340 (373)
Q Consensus 262 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~Dv 340 (373)
++.......... .....+++.|+|||++.+ ..++.++||
T Consensus 162 ~~~~~~~~~~~~----------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~~Di 201 (302)
T cd07864 162 LARLYNSEESRP----------------------------------------YTNKVITLWYRPPELLLGEERYGPAIDV 201 (302)
T ss_pred ccccccCCcccc----------------------------------------cccceeccCccChHHhcCCCCCCchhHH
Confidence 997654321100 002356788999998865 457899999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 017362 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 341 wSlGvil~ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
|||||++|||++|++||...+..+...+|.
T Consensus 202 ~slG~~~~el~~g~~~~~~~~~~~~~~~~~ 231 (302)
T cd07864 202 WSCGCILGELFTKKPIFQANQELAQLELIS 231 (302)
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 999999999999999999888777666554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=272.69 Aligned_cols=213 Identities=33% Similarity=0.639 Sum_probs=186.5
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEe
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E 196 (373)
+|.+.+.||.|+||.||++.+..++..||+|++..... .......+..|+.+++.++|||++++++.+.+....++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 58899999999999999999988999999999876432 22344567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcc
Q 017362 197 YLPGGDMMTLLMRK----DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 197 ~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 272 (373)
|+++++|.+++... ..+++..+..++.+++.||.+||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 158 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD- 158 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcc-
Confidence 99999999999763 6799999999999999999999999999999999999999999999999999876532210
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 352 (373)
......|++.|+|||.+....++.++|+||||+++|+|++
T Consensus 159 ----------------------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~ 198 (258)
T cd08215 159 ----------------------------------------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCT 198 (258)
T ss_pred ----------------------------------------eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHc
Confidence 0113568999999999998889999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhc
Q 017362 353 GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 353 G~~Pf~~~~~~~~~~kI~~ 371 (373)
|..||...+..+...++.+
T Consensus 199 g~~p~~~~~~~~~~~~~~~ 217 (258)
T cd08215 199 LKHPFEGENLLELALKILK 217 (258)
T ss_pred CCCCCCCCcHHHHHHHHhc
Confidence 9999998887777766554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=269.97 Aligned_cols=207 Identities=38% Similarity=0.600 Sum_probs=182.3
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEe
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E 196 (373)
+|++.+.||+|++|.||++.+..++..+++|++..... .....+.+|+.++..++|++|+++++.+......+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 58889999999999999999988899999999876532 345668889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 197 YLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 197 ~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
|++|++|.+++... ..+++..+..++.+++.||.+||..|++|+||+|+||+++.++.++|+|||++........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---- 153 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---- 153 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc----
Confidence 99999999998775 5899999999999999999999999999999999999999999999999999876543210
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 355 (373)
.....|+..|+|||.+....++.++|+||||+++|+|++|.+
T Consensus 154 --------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~ 195 (253)
T cd05122 154 --------------------------------------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKP 195 (253)
T ss_pred --------------------------------------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 013468899999999998889999999999999999999999
Q ss_pred CCCCCChHHHHHH
Q 017362 356 PFYSDDPMSTCRK 368 (373)
Q Consensus 356 Pf~~~~~~~~~~k 368 (373)
||...++......
T Consensus 196 p~~~~~~~~~~~~ 208 (253)
T cd05122 196 PYSELPPMKALFK 208 (253)
T ss_pred CCCCCchHHHHHH
Confidence 9988765554433
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=281.39 Aligned_cols=206 Identities=30% Similarity=0.594 Sum_probs=176.1
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEec
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~ 197 (373)
|....+||+|+||.||++....++..||||.+.... ......+.+|+.+++.++|+||+++++.+...+..|+||||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 334467999999999999999999999999875432 22345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccccc
Q 017362 198 LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT 277 (373)
Q Consensus 198 ~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 277 (373)
+++++|.+++. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.+++++|+|||++.........
T Consensus 99 ~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~----- 172 (292)
T cd06657 99 LEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR----- 172 (292)
T ss_pred CCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccc-----
Confidence 99999998774 456899999999999999999999999999999999999999999999999988654321100
Q ss_pred ccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCC
Q 017362 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357 (373)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 357 (373)
.....|++.|+|||.+.+..++.++|+|||||++|+|++|.+||
T Consensus 173 ------------------------------------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~ 216 (292)
T cd06657 173 ------------------------------------RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 216 (292)
T ss_pred ------------------------------------ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 01346899999999998888999999999999999999999999
Q ss_pred CCCChHHHHHH
Q 017362 358 YSDDPMSTCRK 368 (373)
Q Consensus 358 ~~~~~~~~~~k 368 (373)
.+.+..+....
T Consensus 217 ~~~~~~~~~~~ 227 (292)
T cd06657 217 FNEPPLKAMKM 227 (292)
T ss_pred CCCCHHHHHHH
Confidence 98776655443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=284.03 Aligned_cols=205 Identities=31% Similarity=0.496 Sum_probs=175.3
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe-CCeEE
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD-DEFLY 192 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-~~~~~ 192 (373)
..++|++.+.||.|+||.||+|.+..++..||+|.+.+.. ........+..|+.++..++||||++++++|.. ....|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 4678999999999999999999999999999999886532 222334567789999999999999999999875 56789
Q ss_pred EEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcc
Q 017362 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 272 (373)
+||||+ +++|..++. ...+++..+..++.|++.||.|||++|++||||+|+|||++.++.++|+|||++.......
T Consensus 87 lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~-- 162 (328)
T cd07856 87 FVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM-- 162 (328)
T ss_pred EEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCCc--
Confidence 999999 668988874 4568999999999999999999999999999999999999999999999999987532110
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHHHHH
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell 351 (373)
....+++.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 163 ------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~ 200 (328)
T cd07856 163 ------------------------------------------TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200 (328)
T ss_pred ------------------------------------------CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHH
Confidence 02467889999999876 56899999999999999999
Q ss_pred hCCCCCCCCChHHH
Q 017362 352 VGYPPFYSDDPMST 365 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~ 365 (373)
+|++||...++...
T Consensus 201 tg~~~f~~~~~~~~ 214 (328)
T cd07856 201 EGKPLFPGKDHVNQ 214 (328)
T ss_pred hCCCCCCCCCHHHH
Confidence 99999988776443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=280.49 Aligned_cols=202 Identities=29% Similarity=0.485 Sum_probs=169.3
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-CCceeEEeeEEEeCCeEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYL 193 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~l 193 (373)
.++|.....||+|+||.||++.+..++..||+|.+..... ......+..|+.++..+. ||||+++++++..+...++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 3567788899999999999999999999999999875432 133456788999998885 9999999999999999999
Q ss_pred EEeccCCCCHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 194 IMEYLPGGDMMTLLM-----RKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 194 V~E~~~gg~L~~~l~-----~~~~l~~~~~~~i~~qi~~aL~~LH~-~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
||||++ +++.++.. ....+++..+..++.+++.||+|||+ .+++||||||+|||++.++.++|+|||++..+.
T Consensus 81 ~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 999985 45554432 23579999999999999999999997 599999999999999999999999999987543
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC---CCChhhcHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK---GYGMECDWWSLG 344 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~~~~~DvwSlG 344 (373)
.... .....|++.|+|||++.+. .++.++||||||
T Consensus 160 ~~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG 197 (288)
T cd06616 160 DSIA------------------------------------------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLG 197 (288)
T ss_pred cCCc------------------------------------------cccccCccCccCHHHhccccccCCcchhhhhHHH
Confidence 2210 0134688999999999876 689999999999
Q ss_pred HHHHHHHhCCCCCCCCC
Q 017362 345 AIMYEMLVGYPPFYSDD 361 (373)
Q Consensus 345 vil~ell~G~~Pf~~~~ 361 (373)
|++|||++|++||...+
T Consensus 198 ~il~el~~g~~p~~~~~ 214 (288)
T cd06616 198 ITLYEVATGKFPYPKWN 214 (288)
T ss_pred HHHHHHHhCCCCchhcc
Confidence 99999999999997654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=275.78 Aligned_cols=213 Identities=30% Similarity=0.562 Sum_probs=179.1
Q ss_pred CcceeceeeeeCcEEEEEEEEcC-CCceEeeeecchhHh-------hhhhhHHHHHHHHHHHHh-cCCCceeEEeeEEEe
Q 017362 117 DFELLTMIGKGAFGEVRVCREKT-TGHVYAMKKLKKSEM-------LRRGQVEHVRAERNLLAE-VDSNCIVKLYCSFQD 187 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~-------~~~~~~~~~~~e~~~l~~-l~h~~iv~l~~~~~~ 187 (373)
+|++.+.||+|+||.||+|.+.. ++..+|+|.+..... ........+..|+.++.. ++||||+++++.+.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999877 678999998754321 122334556778887764 799999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCCEEEcCCCcEEEeeccc
Q 017362 188 DEFLYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (373)
Q Consensus 188 ~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~giiHrDikp~NILl~~~~~vkL~DFGl 262 (373)
.+..|+||||++|++|.+++.. ...+++..+..++.|++.||.|||+ .|++|+||+|+|||++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988743 3468999999999999999999996 7899999999999999999999999999
Q ss_pred cccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHH
Q 017362 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342 (373)
Q Consensus 263 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwS 342 (373)
+........ .....|+..|+|||++.+..++.++|+||
T Consensus 161 ~~~~~~~~~------------------------------------------~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~s 198 (269)
T cd08528 161 AKQKQPESK------------------------------------------LTSVVGTILYSCPEIVKNEPYGEKADVWA 198 (269)
T ss_pred eeecccccc------------------------------------------cccccCcccCcChhhhcCCCCchHHHHHH
Confidence 876432210 11356899999999999888999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 017362 343 LGAIMYEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 343 lGvil~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
||+++|||++|++||...+.......+.+
T Consensus 199 lG~ll~~l~~g~~p~~~~~~~~~~~~~~~ 227 (269)
T cd08528 199 FGCILYQMCTLQPPFYSTNMLSLATKIVE 227 (269)
T ss_pred HHHHHHHHHhCCCcccccCHHHHHHHHhh
Confidence 99999999999999998877776666543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=277.20 Aligned_cols=214 Identities=25% Similarity=0.397 Sum_probs=175.8
Q ss_pred cceeceeeeeCcEEEEEEEEc---CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC-----
Q 017362 118 FELLTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~----- 189 (373)
|.+.+.||+|+||.||+|... .++..||||++.... ......+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 567889999999999999864 357889999986542 22334566888999999999999999999886542
Q ss_pred -eEEEEEeccCCCCHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccc
Q 017362 190 -FLYLIMEYLPGGDMMTLLMRK------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (373)
Q Consensus 190 -~~~lV~E~~~gg~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGl 262 (373)
..+++++|+++|+|..++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 247899999999998887432 2478999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHH
Q 017362 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342 (373)
Q Consensus 263 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwS 342 (373)
++.......... .....+++.|++||.+....++.++||||
T Consensus 160 ~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~pe~~~~~~~~~~sDi~s 200 (273)
T cd05074 160 SKKIYSGDYYRQ---------------------------------------GCASKLPVKWLALESLADNVYTTHSDVWA 200 (273)
T ss_pred cccccCCcceec---------------------------------------CCCccCchhhcCHhHHhcCccchhhhhHH
Confidence 886532211000 00234567899999999999999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHhhc
Q 017362 343 LGAIMYEMLV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 343 lGvil~ell~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
|||++|||++ |.+||.+.+..+.+..+.+
T Consensus 201 lG~il~el~~~g~~p~~~~~~~~~~~~~~~ 230 (273)
T cd05074 201 FGVTMWEIMTRGQTPYAGVENSEIYNYLIK 230 (273)
T ss_pred HHHHHHHHhhCCCCCCCCCCHHHHHHHHHc
Confidence 9999999999 9999998888887776654
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=282.63 Aligned_cols=209 Identities=30% Similarity=0.480 Sum_probs=176.6
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
..|+..+.||+|+||.||+|.+..++..+|+|.+.............+..|+.+++.++|+|++++++++......|+||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 44778889999999999999999899999999886533223334456778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 196 EYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 196 E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
||++ |+|.+++. ....+++..+..++.+++.||.|||+.|++||||+|+|||++.++.++|+|||++.......
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~---- 169 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---- 169 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCcc----
Confidence 9996 57777664 35568999999999999999999999999999999999999999999999999986543211
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc---CCCCChhhcHHHHHHHHHHHH
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DvwSlGvil~ell 351 (373)
...|++.|+|||++. ...++.++|||||||++|+|+
T Consensus 170 -----------------------------------------~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~ 208 (308)
T cd06634 170 -----------------------------------------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 208 (308)
T ss_pred -----------------------------------------cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHH
Confidence 246889999999985 345788999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhh
Q 017362 352 VGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~ 370 (373)
+|.+||...+..+....+.
T Consensus 209 ~g~~p~~~~~~~~~~~~~~ 227 (308)
T cd06634 209 ERKPPLFNMNAMSALYHIA 227 (308)
T ss_pred cCCCCCccccHHHHHHHHh
Confidence 9999998877665554443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=287.41 Aligned_cols=217 Identities=31% Similarity=0.497 Sum_probs=179.1
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeC--CeE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDD--EFL 191 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~--~~~ 191 (373)
.++|++.+.||+|+||.||+|.+..++..+|+|.+.... ........+..|+.++..+ +||||++++++|... ..+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 567999999999999999999998889999999885431 1222345577899999999 999999999988643 468
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
|+||||++ ++|..++... .+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++..+.....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred EEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 99999996 5998888665 889999999999999999999999999999999999999999999999999986543211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~el 350 (373)
... .......+||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 163 ~~~------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el 206 (337)
T cd07852 163 NPE------------------------------------NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEM 206 (337)
T ss_pred ccc------------------------------------CcchhcccccccccCceeeeccccccccchHHHHHHHHHHH
Confidence 000 000113468999999998865 4578999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhh
Q 017362 351 LVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 351 l~G~~Pf~~~~~~~~~~kI~ 370 (373)
++|++||.+.++.+...++.
T Consensus 207 ~tg~~pf~~~~~~~~~~~~~ 226 (337)
T cd07852 207 LLGKPLFPGTSTLNQLEKII 226 (337)
T ss_pred HhCCCCCCCCChHHHHHHHH
Confidence 99999999888777766654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=284.06 Aligned_cols=224 Identities=28% Similarity=0.462 Sum_probs=178.9
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC------
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD------ 188 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~------ 188 (373)
.++|++.+.||+|+||.||+|.+..++..||+|.+..... .......+.+|+.+++.++||||+++++.+.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE-KDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC-CCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 5789999999999999999999999999999998865432 122223467899999999999999999887543
Q ss_pred --CeEEEEEeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 189 --EFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 189 --~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
..+|+||||++ ++|...+.. ...+++..+..++.|++.||.|||++|++|+||||+|||++.++.++|+|||++..
T Consensus 86 ~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 86 KRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred cCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 35799999995 477777755 34799999999999999999999999999999999999999999999999999976
Q ss_pred CCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHHHH
Q 017362 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLG 344 (373)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG 344 (373)
.......... .... .........|++.|+|||++.+. .++.++||||||
T Consensus 165 ~~~~~~~~~~--------------~~~~----------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 214 (311)
T cd07866 165 YDGPPPNPKG--------------GGGG----------------GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIG 214 (311)
T ss_pred ccCCCccccc--------------CCcc----------------cccccccceeccCcCChHHhhCCCccCchhHhHHHH
Confidence 5432211000 0000 00011245789999999988654 589999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHhh
Q 017362 345 AIMYEMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 345 vil~ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
|++|||++|++||.+.++.....+|.
T Consensus 215 ~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 215 CVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999999888877666554
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=284.93 Aligned_cols=214 Identities=19% Similarity=0.299 Sum_probs=172.1
Q ss_pred ceeeee--CcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEeccC
Q 017362 122 TMIGKG--AFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLP 199 (373)
Q Consensus 122 ~~lG~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~ 199 (373)
..||.| +||+||+|.+..+++.||+|++...... ....+.+.+|+.+++.++||||++++++|..++..|+||||++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 346666 9999999999999999999998754322 2345678889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccccc
Q 017362 200 GGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT 277 (373)
Q Consensus 200 gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 277 (373)
+++|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.++++|||.+............ .
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 161 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV-V 161 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc-c
Confidence 99999998764 35899999999999999999999999999999999999999999999999876432211000000 0
Q ss_pred ccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC--CCCChhhcHHHHHHHHHHHHhCCC
Q 017362 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYP 355 (373)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~~ 355 (373)
. .......++..|+|||++.+ ..++.++|||||||++|||++|.+
T Consensus 162 ----------------~-----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~ 208 (328)
T cd08226 162 ----------------Y-----------------DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRV 208 (328)
T ss_pred ----------------c-----------------cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 0 00001235677999999976 357899999999999999999999
Q ss_pred CCCCCChHHHHHHhh
Q 017362 356 PFYSDDPMSTCRKVR 370 (373)
Q Consensus 356 Pf~~~~~~~~~~kI~ 370 (373)
||.+.+..+....++
T Consensus 209 p~~~~~~~~~~~~~~ 223 (328)
T cd08226 209 PFQDMLRTQMLLQKL 223 (328)
T ss_pred CCCCcChHHHHHHHh
Confidence 998877666554444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=279.06 Aligned_cols=205 Identities=43% Similarity=0.752 Sum_probs=174.6
Q ss_pred CcceeceeeeeCcEEEEEEEEc---CCCceEeeeecchhHhhh-hhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCeE
Q 017362 117 DFELLTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKSEMLR-RGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~ 191 (373)
+|++.+.||+|+||.||+|.+. .++..||||++.+..... ......+..|+.++..+ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999863 467889999987654322 23345678899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
|+||||+++|+|.+++.....+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++..+.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 99999999999999998778899999999999999999999999999999999999999999999999999875432210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC--CChhhcHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG--YGMECDWWSLGAIMYE 349 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~~DvwSlGvil~e 349 (373)
. ......|++.|+|||.+.+.. ++.++|+||||+++||
T Consensus 161 ~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~e 200 (288)
T cd05583 161 E----------------------------------------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFE 200 (288)
T ss_pred c----------------------------------------ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHH
Confidence 0 001346899999999987655 7889999999999999
Q ss_pred HHhCCCCCCCCC
Q 017362 350 MLVGYPPFYSDD 361 (373)
Q Consensus 350 ll~G~~Pf~~~~ 361 (373)
|++|..||...+
T Consensus 201 l~tg~~p~~~~~ 212 (288)
T cd05583 201 LLTGASPFTVDG 212 (288)
T ss_pred HHhCCCCcccCc
Confidence 999999997543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=296.85 Aligned_cols=207 Identities=33% Similarity=0.573 Sum_probs=178.3
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHH-hcCCCceeEEeeEEEeCCeEE
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA-EVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~l~~~~~~~~~~~ 192 (373)
....|.+...+|.|+|+.|..|.+..+++.+++|++.+... ...+|..++. .-+||||+++.+.+.++.+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceee
Confidence 36678999999999999999999999999999999977621 1233554444 447999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEE-cCCCcEEEeeccccccCCCCCc
Q 017362 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL-DKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl-~~~~~vkL~DFGla~~~~~~~~ 271 (373)
+|||++.|+-+.+.+.....+. ..+..|+++|+.|+.|||++|+|||||||+|||+ +..|+++|+|||.++.....
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999999998888887766665 7888999999999999999999999999999999 69999999999999865422
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
..+.+-|..|.|||++...+|+.+|||||||++||+||
T Consensus 470 ------------------------------------------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML 507 (612)
T KOG0603|consen 470 ------------------------------------------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEML 507 (612)
T ss_pred ------------------------------------------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHH
Confidence 11457889999999999999999999999999999999
Q ss_pred hCCCCCCCCChH-HHHHHhhcC
Q 017362 352 VGYPPFYSDDPM-STCRKVRKK 372 (373)
Q Consensus 352 ~G~~Pf~~~~~~-~~~~kI~~~ 372 (373)
+|++||.+.... ++..+|..+
T Consensus 508 ~G~tp~~~~P~~~ei~~~i~~~ 529 (612)
T KOG0603|consen 508 TGRTLFAAHPAGIEIHTRIQMP 529 (612)
T ss_pred hCCCccccCCchHHHHHhhcCC
Confidence 999999987655 777777654
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=276.36 Aligned_cols=206 Identities=26% Similarity=0.411 Sum_probs=171.8
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCC----ceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe-CCe
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTG----HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD-DEF 190 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-~~~ 190 (373)
..|+.++.||+|.||.||+|..+.++ ..+|||.++..... ........+|+.++++++||||+.|..+|.. +..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~-tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG-TGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC-CCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 45899999999999999999655443 27899999765321 1223456789999999999999999999987 788
Q ss_pred EEEEEeccCCCCHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCC----CcEEEeecc
Q 017362 191 LYLIMEYLPGGDMMTLLMR-----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY----GHLRLSDFG 261 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~----~~vkL~DFG 261 (373)
+++++||.+ .||+..+.- ...++...++.|+.||+.|++|||++-|+||||||.|||+..+ |.|||+|||
T Consensus 103 v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 103 VWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 999999995 589888853 2468999999999999999999999999999999999999887 899999999
Q ss_pred ccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcH
Q 017362 262 LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDW 340 (373)
Q Consensus 262 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~Dv 340 (373)
|++.+...-..-. ....+|-|.+|+|||.+.+. .|+.+.||
T Consensus 182 laR~~~~plkpl~--------------------------------------s~d~VVVTiWYRAPELLLGa~hYT~AiDv 223 (438)
T KOG0666|consen 182 LARLFNNPLKPLA--------------------------------------SLDPVVVTIWYRAPELLLGARHYTKAIDV 223 (438)
T ss_pred HHHHhhccccccc--------------------------------------cCCceEEEEEecChHHhcccccccchhhh
Confidence 9998764421100 01157889999999999984 59999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCC
Q 017362 341 WSLGAIMYEMLVGYPPFYSDD 361 (373)
Q Consensus 341 wSlGvil~ell~G~~Pf~~~~ 361 (373)
||+|||+.|||+-.|.|.+..
T Consensus 224 WAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 224 WAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred HHHHHHHHHHHccCccccchh
Confidence 999999999999999998653
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=277.03 Aligned_cols=208 Identities=31% Similarity=0.540 Sum_probs=177.3
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-CCceeEEeeEEEeCCeEEEEEe
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYLIME 196 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~lV~E 196 (373)
|.+.+.||+|++|+||+|....++..||||.+..... . .......+|+..+..++ ||||+++++.+.+++..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY-S-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc-c-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 6788999999999999999988899999999865421 1 11223456888899998 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 197 YLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 197 ~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
|+ +|+|.+.+.... .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--- 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC---
Confidence 99 889999887754 789999999999999999999999999999999999999999999999999875532210
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHHHHHhC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G 353 (373)
.....|+..|+|||++.. ..++.++|+||||+++|||++|
T Consensus 155 ---------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g 195 (283)
T cd07830 155 ---------------------------------------YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTL 195 (283)
T ss_pred ---------------------------------------cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhC
Confidence 013468899999998854 4579999999999999999999
Q ss_pred CCCCCCCChHHHHHHhh
Q 017362 354 YPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 354 ~~Pf~~~~~~~~~~kI~ 370 (373)
++||...+..+...++.
T Consensus 196 ~~~~~~~~~~~~~~~~~ 212 (283)
T cd07830 196 RPLFPGSSEIDQLYKIC 212 (283)
T ss_pred CCccCCCChHHHHHHHH
Confidence 99999888877776654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=285.65 Aligned_cols=209 Identities=31% Similarity=0.503 Sum_probs=176.3
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC-----
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~----- 189 (373)
.++|.+.+.||+|+||.||+|.+..++..||+|++.... ........+.+|+.++..++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF-QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc-ccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 468999999999999999999998899999999987532 12223355778999999999999999999987543
Q ss_pred -eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 190 -FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 190 -~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
..|+||||++ .+|..++ ...+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||+++....
T Consensus 93 ~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 93 QDFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred ceEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 4699999995 4777665 34689999999999999999999999999999999999999999999999999875421
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil 347 (373)
.. ....||+.|+|||++.+ ..++.++|||||||++
T Consensus 170 ~~--------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil 205 (342)
T cd07879 170 EM--------------------------------------------TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIM 205 (342)
T ss_pred CC--------------------------------------------CCceeeecccChhhhcCccccCchHHHHHHHHHH
Confidence 10 02467899999999876 4589999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhhc
Q 017362 348 YEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 348 ~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
|||++|+.||.+.+......+|+.
T Consensus 206 ~el~~g~~pf~~~~~~~~~~~~~~ 229 (342)
T cd07879 206 AEMLTGKTLFKGKDYLDQLTQILK 229 (342)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999999999887777766553
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=268.39 Aligned_cols=205 Identities=33% Similarity=0.547 Sum_probs=181.3
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC--CeEEEE
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--EFLYLI 194 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~~lV 194 (373)
+|.+.+.||+|++|.||+|.+..++..|++|++...... ....+.+.+|+.+++.++||||+++++.+.+. ...++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 478889999999999999999889999999998765321 34567788999999999999999999999988 899999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
|||+++++|.+++.....+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~- 158 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE- 158 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccc-
Confidence 9999999999999887799999999999999999999999999999999999999999999999999988665432100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 354 (373)
......++..|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 159 --------------------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~ 200 (260)
T cd06606 159 --------------------------------------GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200 (260)
T ss_pred --------------------------------------cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 001346889999999999888999999999999999999999
Q ss_pred CCCCCCC
Q 017362 355 PPFYSDD 361 (373)
Q Consensus 355 ~Pf~~~~ 361 (373)
.||...+
T Consensus 201 ~p~~~~~ 207 (260)
T cd06606 201 PPWSELG 207 (260)
T ss_pred CCCCCCC
Confidence 9998765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=286.41 Aligned_cols=213 Identities=26% Similarity=0.450 Sum_probs=176.4
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC------
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD------ 188 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~------ 188 (373)
..+|.+.+.||.|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---CchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 478999999999999999999999999999999986543 23456688899999999999999999766543
Q ss_pred --------CeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC-CCcEEEee
Q 017362 189 --------EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-YGHLRLSD 259 (373)
Q Consensus 189 --------~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~-~~~vkL~D 259 (373)
...|+||||++ ++|.+++. ...+++..++.++.|++.||.|||+.||+||||||+|||++. ++.++|+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 35899999996 58988874 457999999999999999999999999999999999999974 56789999
Q ss_pred ccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhh
Q 017362 260 FGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMEC 338 (373)
Q Consensus 260 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~ 338 (373)
||++..+........ ......|++.|+|||++.. ..++.++
T Consensus 159 fg~~~~~~~~~~~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~ 200 (342)
T cd07854 159 FGLARIVDPHYSHKG--------------------------------------YLSEGLVTKWYRSPRLLLSPNNYTKAI 200 (342)
T ss_pred cccceecCCcccccc--------------------------------------ccccccccccccCHHHHhCccccCchh
Confidence 999876532210000 0002357889999998754 5688999
Q ss_pred cHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 017362 339 DWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 339 DvwSlGvil~ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
|||||||++|+|++|.+||.+.++.+...+++
T Consensus 201 DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 201 DMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999999999999888877776654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=311.08 Aligned_cols=216 Identities=34% Similarity=0.544 Sum_probs=168.8
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe-------
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD------- 187 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~------- 187 (373)
.++|+.+..||+||||.||+|+++-+|..||||.|.... .......+.+|+.++++++|||||++|.++..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 367999999999999999999999999999999997653 34555678899999999999999999855510
Q ss_pred -----------------------------------------------------------------------C--------
Q 017362 188 -----------------------------------------------------------------------D-------- 188 (373)
Q Consensus 188 -----------------------------------------------------------------------~-------- 188 (373)
+
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred ---------------------------------CeEEEEEeccCCCCHHHHHhhCCCC-CHHHHHHHHHHHHHHHHHHHh
Q 017362 189 ---------------------------------EFLYLIMEYLPGGDMMTLLMRKDTL-TEDEARFYVAETVLAIESIHK 234 (373)
Q Consensus 189 ---------------------------------~~~~lV~E~~~gg~L~~~l~~~~~l-~~~~~~~i~~qi~~aL~~LH~ 234 (373)
-.+||-||||+...|.+++.++... ....++.+++||+.||.|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 1258999999887777776555444 578899999999999999999
Q ss_pred CCCeeecCCCCCEEEcCCCcEEEeeccccccCCC-CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhcc
Q 017362 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC-STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRML 313 (373)
Q Consensus 235 ~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (373)
+|+|||||||.||+++.++.|||+|||+|+.... ...............+... ..
T Consensus 716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~------------------------~~ 771 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSND------------------------GD 771 (1351)
T ss_pred CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCC------------------------cc
Confidence 9999999999999999999999999999986331 1111111111111111111 01
Q ss_pred ccccccCCCCcccccccCCC---CChhhcHHHHHHHHHHHHhCCCCCCC
Q 017362 314 AYSTVGTPDYIAPEVLLKKG---YGMECDWWSLGAIMYEMLVGYPPFYS 359 (373)
Q Consensus 314 ~~~~~gt~~Y~aPE~~~~~~---~~~~~DvwSlGvil~ell~G~~Pf~~ 359 (373)
.++.+||--|+|||++.+.. |+.|+|+||||||+|||+ .||..
T Consensus 772 ~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~T 817 (1351)
T KOG1035|consen 772 LTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGT 817 (1351)
T ss_pred cccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHh---ccCCc
Confidence 23679999999999998755 999999999999999998 45753
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=276.54 Aligned_cols=210 Identities=32% Similarity=0.523 Sum_probs=181.4
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEec
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~ 197 (373)
|++.+.||+|++|.||+|....+++.||+|++.... ........+..|+.+++.++|+||+++++++.+....|+||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 667889999999999999999999999999987653 2233345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccc
Q 017362 198 LPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (373)
Q Consensus 198 ~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 276 (373)
++ ++|.+++... ..+++..+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~---- 154 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT---- 154 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc----
Confidence 97 5899999776 58999999999999999999999999999999999999999999999999998765422100
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHHHHHHHHHHHhCCC
Q 017362 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGYP 355 (373)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~ 355 (373)
.....+++.|+|||.+.+. .++.++|||||||++|||++|.+
T Consensus 155 -------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~ 197 (282)
T cd07829 155 -------------------------------------YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKP 197 (282)
T ss_pred -------------------------------------cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCC
Confidence 0123467889999999876 78999999999999999999999
Q ss_pred CCCCCChHHHHHHhh
Q 017362 356 PFYSDDPMSTCRKVR 370 (373)
Q Consensus 356 Pf~~~~~~~~~~kI~ 370 (373)
||.+.+..+...+|.
T Consensus 198 ~~~~~~~~~~~~~~~ 212 (282)
T cd07829 198 LFPGDSEIDQLFKIF 212 (282)
T ss_pred CCCCccHHHHHHHHH
Confidence 999988877776654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=276.33 Aligned_cols=206 Identities=27% Similarity=0.445 Sum_probs=173.6
Q ss_pred CCCcceeceeeeeCcEEEEEEEEc----CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe--C
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREK----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD--D 188 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~ 188 (373)
..+|++.+.||+|+||.||+|... .++..||+|++...... .....+..|+.+++.+.||||+++++++.. .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 357888999999999999999864 34789999998765321 345678899999999999999999999887 5
Q ss_pred CeEEEEEeccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
...|+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 68999999999999999997644 69999999999999999999999999999999999999999999999999998664
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 347 (373)
....... ......++..|+|||.+....++.++|||||||++
T Consensus 161 ~~~~~~~--------------------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l 202 (284)
T cd05038 161 EDKDYYY--------------------------------------VKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTL 202 (284)
T ss_pred cCCccee--------------------------------------ccCCCCCcccccCcHHHccCCCCcccchHHHhhhh
Confidence 2211000 00012355679999999988999999999999999
Q ss_pred HHHHhCCCCCCCC
Q 017362 348 YEMLVGYPPFYSD 360 (373)
Q Consensus 348 ~ell~G~~Pf~~~ 360 (373)
|||++|..||...
T Consensus 203 ~el~tg~~p~~~~ 215 (284)
T cd05038 203 YELFTYGDPSQSP 215 (284)
T ss_pred heeeccCCCcccc
Confidence 9999999999754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=276.81 Aligned_cols=214 Identities=30% Similarity=0.491 Sum_probs=174.1
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCe
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~ 190 (373)
.+..++|++.+.||+|+||.||+|.+..++..||||.+..... ......+..|+.++... .||||+++++++.+...
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 4567889999999999999999999988899999999875432 12233455566666555 59999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 191 LYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~-~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
+|+||||++ ++|.+++.. ...+++..+..++.+++.||.|||+ .||+||||+|+||+++.++.++|+|||++..+..
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred EEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 999999984 577777755 4578999999999999999999997 6999999999999999999999999999875432
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC----CChhhcHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG----YGMECDWWSLG 344 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~~~~~DvwSlG 344 (373)
.... ....+++.|+|||++.+.. ++.++||||||
T Consensus 168 ~~~~------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG 205 (296)
T cd06618 168 SKAK------------------------------------------TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLG 205 (296)
T ss_pred CCcc------------------------------------------cCCCCCccccCHhhcCCCCCccccccchhHHHHH
Confidence 2100 0235788999999987654 88999999999
Q ss_pred HHHHHHHhCCCCCCCCC-hHHHHHHhh
Q 017362 345 AIMYEMLVGYPPFYSDD-PMSTCRKVR 370 (373)
Q Consensus 345 vil~ell~G~~Pf~~~~-~~~~~~kI~ 370 (373)
|++|+|++|++||.... ..+...+++
T Consensus 206 ~il~el~~g~~p~~~~~~~~~~~~~~~ 232 (296)
T cd06618 206 ISLVELATGQFPYKNCKTEFEVLTKIL 232 (296)
T ss_pred HHHHHHHhCCCCCCcchhHHHHHHHHh
Confidence 99999999999997643 344555544
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=285.57 Aligned_cols=211 Identities=29% Similarity=0.495 Sum_probs=180.6
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCe---
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF--- 190 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~--- 190 (373)
..++|++...||+|++|.||+|.+..++..||+|++.... ........+.+|+.+++.+.||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 3678999999999999999999999999999999986532 122334557789999999999999999988876654
Q ss_pred ---EEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 191 ---LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 191 ---~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
.|+|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 89999999 6799888854 579999999999999999999999999999999999999999999999999987543
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAI 346 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvi 346 (373)
... ....+|+.|+|||++.+ ..++.++|||||||+
T Consensus 170 ~~~--------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~ 205 (343)
T cd07851 170 DEM--------------------------------------------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 205 (343)
T ss_pred ccc--------------------------------------------cCCcccccccCHHHHhCCCCCCchHhHHHHHHH
Confidence 110 13468889999999865 467899999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHhhc
Q 017362 347 MYEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 347 l~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
+|||++|++||.+.+..+...+|++
T Consensus 206 l~elltg~~pf~~~~~~~~~~~i~~ 230 (343)
T cd07851 206 MAELLTGKTLFPGSDHIDQLKRIMN 230 (343)
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHH
Confidence 9999999999999888877777654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=274.95 Aligned_cols=210 Identities=33% Similarity=0.531 Sum_probs=180.8
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEec
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~ 197 (373)
|++.+.||.|++|.||+|.+..+++.+++|.+..... .......+..|+.+++.++|+||+++++.+.++...|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 6778899999999999999988999999999875432 223345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccc
Q 017362 198 LPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (373)
Q Consensus 198 ~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 276 (373)
+++ +|..++... ..+++..+..++.+++.||.|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~---- 154 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP---- 154 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc----
Confidence 965 888888663 58999999999999999999999999999999999999999999999999998765433200
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHHHHHHHHHHHhCCC
Q 017362 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGYP 355 (373)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~ 355 (373)
.....++..|+|||.+.+. .++.++|+|||||++|+|++|++
T Consensus 155 -------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~ 197 (283)
T cd05118 155 -------------------------------------YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRP 197 (283)
T ss_pred -------------------------------------ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCC
Confidence 0124578899999999876 78999999999999999999999
Q ss_pred CCCCCChHHHHHHhh
Q 017362 356 PFYSDDPMSTCRKVR 370 (373)
Q Consensus 356 Pf~~~~~~~~~~kI~ 370 (373)
||.+.+..+...++.
T Consensus 198 ~~~~~~~~~~~~~~~ 212 (283)
T cd05118 198 LFPGKSEIDQLFKIF 212 (283)
T ss_pred CCCCCCHHHHHHHHH
Confidence 999888877766654
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=290.68 Aligned_cols=203 Identities=32% Similarity=0.535 Sum_probs=179.4
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhH-----HHHHHHHHHHHhcC---CCceeEEeeEE
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQV-----EHVRAERNLLAEVD---SNCIVKLYCSF 185 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~-----~~~~~e~~~l~~l~---h~~iv~l~~~~ 185 (373)
...+|..++.+|.|+||.|++|.++.....|+||.+.++.+.-..-+ -.+-.|+.||+.+. |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 45679999999999999999999999999999999988765433222 23456899999886 99999999999
Q ss_pred EeCCeEEEEEeccC-CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccc
Q 017362 186 QDDEFLYLIMEYLP-GGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (373)
Q Consensus 186 ~~~~~~~lV~E~~~-gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~ 264 (373)
++++++||+||-.. |-||.+++..+..++|..++.|+.|++.|+++||++||||||||-+|++++.+|-+||+|||-|.
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchh
Confidence 99999999999874 55999999999999999999999999999999999999999999999999999999999999886
Q ss_pred cCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCC-ChhhcHHHH
Q 017362 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSL 343 (373)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DvwSl 343 (373)
...... ...++||.+|.|||++.+..| +..-|||+|
T Consensus 719 ~~ksgp-------------------------------------------fd~f~gtv~~aapevl~g~~y~gk~qdiwal 755 (772)
T KOG1152|consen 719 YTKSGP-------------------------------------------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWAL 755 (772)
T ss_pred hhcCCC-------------------------------------------cceeeeeccccchhhhCCCccCCCcchhhhh
Confidence 543221 115789999999999999888 778999999
Q ss_pred HHHHHHHHhCCCCCCC
Q 017362 344 GAIMYEMLVGYPPFYS 359 (373)
Q Consensus 344 Gvil~ell~G~~Pf~~ 359 (373)
|++||-++....||+.
T Consensus 756 gillytivykenpyyn 771 (772)
T KOG1152|consen 756 GILLYTIVYKENPYYN 771 (772)
T ss_pred hheeeEEEeccCCCcC
Confidence 9999999999999985
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=277.24 Aligned_cols=203 Identities=23% Similarity=0.337 Sum_probs=166.2
Q ss_pred CcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEeccCCCCHHHHH
Q 017362 128 AFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL 207 (373)
Q Consensus 128 ~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l 207 (373)
++|.||++.+..++..||||++.... ........+..|+.+++.++||||+++++++.+.+..|++|||+++|+|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 44556666777789999999987642 23345677899999999999999999999999999999999999999999998
Q ss_pred hhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCC
Q 017362 208 MRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285 (373)
Q Consensus 208 ~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~ 285 (373)
... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||.+..+..........
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~--------- 161 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV--------- 161 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc---------
Confidence 753 468999999999999999999999999999999999999999999999999987553221100000
Q ss_pred CCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC--CCCChhhcHHHHHHHHHHHHhCCCCCCCCChH
Q 017362 286 SQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363 (373)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~ 363 (373)
........++..|+|||++.. ..|+.++|+|||||++|||++|.+||.+.+..
T Consensus 162 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~ 216 (314)
T cd08216 162 -------------------------HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT 216 (314)
T ss_pred -------------------------ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 000113467889999999876 46899999999999999999999999876654
Q ss_pred HH
Q 017362 364 ST 365 (373)
Q Consensus 364 ~~ 365 (373)
..
T Consensus 217 ~~ 218 (314)
T cd08216 217 QM 218 (314)
T ss_pred HH
Confidence 43
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=273.33 Aligned_cols=214 Identities=29% Similarity=0.517 Sum_probs=175.7
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHH-HHhcCCCceeEEeeEEEeCCe
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL-LAEVDSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~l~~~~~~~~~ 190 (373)
.+..++.+-+..||.|+||+|++..++.+|+..|||.++.... .....+++.|.+. ++.-..||||++||+...++.
T Consensus 60 ~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd 137 (361)
T KOG1006|consen 60 TFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD 137 (361)
T ss_pred ccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence 3455667777889999999999999999999999999986543 2334556667664 566689999999999999999
Q ss_pred EEEEEeccCCCCHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCCEEEcCCCcEEEeeccccc
Q 017362 191 LYLIMEYLPGGDMMTLLM-----RKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~-----~~~~l~~~~~~~i~~qi~~aL~~LH~-~giiHrDikp~NILl~~~~~vkL~DFGla~ 264 (373)
.++.||+| ..||..+.. .+..++|..+..|..-.+.||.||-. ..|||||+||+|||++..|.|||||||+|-
T Consensus 138 cWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcG 216 (361)
T KOG1006|consen 138 CWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICG 216 (361)
T ss_pred eeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchH
Confidence 99999999 557765543 35679999999999999999999985 689999999999999999999999999997
Q ss_pred cCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC--CCCChhhcHHH
Q 017362 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWS 342 (373)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DvwS 342 (373)
.+..+.... --+|...|||||.+.. .+|+.+|||||
T Consensus 217 qLv~SiAkT------------------------------------------~daGCrpYmAPERi~p~~~gyDiRSDvWS 254 (361)
T KOG1006|consen 217 QLVDSIAKT------------------------------------------VDAGCRPYMAPERIDPSDKGYDIRSDVWS 254 (361)
T ss_pred hHHHHHHhh------------------------------------------hccCCccccChhccCCccCCcchhhhhhh
Confidence 765442211 2368899999999974 56999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCh-HHHHHHhh
Q 017362 343 LGAIMYEMLVGYPPFYSDDP-MSTCRKVR 370 (373)
Q Consensus 343 lGvil~ell~G~~Pf~~~~~-~~~~~kI~ 370 (373)
||+.|||+.||..||..++. .+....|.
T Consensus 255 LGITL~EvAtG~fPyr~w~svfeql~~Vv 283 (361)
T KOG1006|consen 255 LGITLYEVATGNFPYRKWDSVFEQLCQVV 283 (361)
T ss_pred hcceEeeeecCCCCcchHHHHHHHHHHHH
Confidence 99999999999999998864 33333343
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=269.90 Aligned_cols=214 Identities=30% Similarity=0.500 Sum_probs=178.7
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhh--hhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML--RRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
+|.+.+.||+|+||.||++.+..++..+++|+++..... .......+..|..+++.++||||+++++.+.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 588999999999999999998877777777776543221 122334466788899999999999999999999999999
Q ss_pred EeccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 195 MEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999988853 357999999999999999999999999999999999999975 679999999987653221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 350 (373)
.. .....|++.|+|||.+.+..++.++|+||||+++|+|
T Consensus 160 ~~-----------------------------------------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l 198 (260)
T cd08222 160 DL-----------------------------------------ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198 (260)
T ss_pred cc-----------------------------------------ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHH
Confidence 10 0134588999999999888899999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcC
Q 017362 351 LVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 351 l~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
++|..||.+.+......++..+
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~ 220 (260)
T cd08222 199 CCLAHAFEGQNFLSVVLRIVEG 220 (260)
T ss_pred HhCCCCCCCccHHHHHHHHHcC
Confidence 9999999888877777776543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=266.69 Aligned_cols=181 Identities=27% Similarity=0.455 Sum_probs=158.3
Q ss_pred eCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEeccCCCCHHHH
Q 017362 127 GAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL 206 (373)
Q Consensus 127 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~gg~L~~~ 206 (373)
|.+|.||+|.+..+++.||+|.+..... ...|...+....||||+++++.+.+.+..|+||||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8999999999999999999999876431 22344445556799999999999999999999999999999999
Q ss_pred HhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCC
Q 017362 207 LMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286 (373)
Q Consensus 207 l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~ 286 (373)
+.....+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---------------- 139 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---------------- 139 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----------------
Confidence 9887789999999999999999999999999999999999999999999999999876543210
Q ss_pred CCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCC
Q 017362 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 359 (373)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 359 (373)
....+++.|+|||.+.+..++.++|+||+||++|||++|++||..
T Consensus 140 ----------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 140 ----------------------------DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred ----------------------------ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 023467789999999888899999999999999999999988764
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=281.53 Aligned_cols=215 Identities=20% Similarity=0.353 Sum_probs=182.2
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 191 (373)
++..+...+.++||+|-||.|.+|.-. .+..||+|.++.... ......|..|+.+|.+++||||+.++++|..++.+
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDAT--KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccc--hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 345566788999999999999999753 368999999987543 33356799999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 192 YLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
++|+|||++|||..++... ..+.-.....++.||+.|++||.+.+||||||.+.|+|++.++++||+|||+++.+...
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence 9999999999999999876 33345566779999999999999999999999999999999999999999999977544
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 349 (373)
.+.... ...+-...|||||.+.-+.++.++|+|+|||.|||
T Consensus 691 ~yy~vq---------------------------------------gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE 731 (807)
T KOG1094|consen 691 DYYRVQ---------------------------------------GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 731 (807)
T ss_pred Cceeee---------------------------------------cceeeeeeehhHHHHHhccccchhhhhhhHHHHHH
Confidence 332210 13466789999999999999999999999999999
Q ss_pred HHh--CCCCCCCCChHHHHHH
Q 017362 350 MLV--GYPPFYSDDPMSTCRK 368 (373)
Q Consensus 350 ll~--G~~Pf~~~~~~~~~~k 368 (373)
+++ ..-||...+..+....
T Consensus 732 ~~~~C~e~Py~~lt~e~vven 752 (807)
T KOG1094|consen 732 VFMLCREQPYSQLTDEQVVEN 752 (807)
T ss_pred HHHHHhhCchhhhhHHHHHHh
Confidence 886 7899987776665543
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=281.23 Aligned_cols=219 Identities=23% Similarity=0.406 Sum_probs=193.0
Q ss_pred hhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC
Q 017362 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (373)
Q Consensus 109 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 188 (373)
..+++...+..+..+||-|-||.||.|.++.....||||.++...+ .++.|..|..+|+.++|||+|+|+++|..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 4566777788888999999999999999999889999999986543 567899999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~ 266 (373)
..+|||.|||..|+|.++|.+.+ .++.-....++.||..|+.||..++||||||...|+|+..+..||++||||++.+
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 99999999999999999997643 4677778888899999999999999999999999999999999999999999998
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHH
Q 017362 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (373)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvi 346 (373)
...++.... ...-...|.|||.+....++.++|||+|||+
T Consensus 416 tgDTYTAHA----------------------------------------GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVL 455 (1157)
T KOG4278|consen 416 TGDTYTAHA----------------------------------------GAKFPIKWTAPESLAYNTFSIKSDVWAFGVL 455 (1157)
T ss_pred cCCceeccc----------------------------------------CccCcccccCcccccccccccchhhHHHHHH
Confidence 766544311 1234568999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHhhc
Q 017362 347 MYEMLV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 347 l~ell~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
|||+.| |-.||.+.+-...|.-+-+
T Consensus 456 LWEIATYGMsPYPGidlSqVY~LLEk 481 (1157)
T KOG4278|consen 456 LWEIATYGMSPYPGIDLSQVYGLLEK 481 (1157)
T ss_pred HHHHHhcCCCCCCCccHHHHHHHHhc
Confidence 999998 9999999998888865543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=291.43 Aligned_cols=219 Identities=24% Similarity=0.436 Sum_probs=191.8
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCC---ceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTG---HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 187 (373)
.++..+...+.++||.|.||.|+.|+.+..| ..||||.++... ...+...|+.|..||-+++||||++|-++...
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk 701 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK 701 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence 3567788889999999999999999987665 469999998653 24455679999999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccC
Q 017362 188 DEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (373)
Q Consensus 188 ~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~ 266 (373)
...+.||.|||++|+|..+|..+ +.|+.-++..+++.|+.|+.||-++|+|||||...|||++.+-.+|++||||++.+
T Consensus 702 s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 702 SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeec
Confidence 99999999999999999999765 57999999999999999999999999999999999999999999999999999977
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhcccccccc---CCCCcccccccCCCCChhhcHHHH
Q 017362 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVG---TPDYIAPEVLLKKGYGMECDWWSL 343 (373)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g---t~~Y~aPE~~~~~~~~~~~DvwSl 343 (373)
.... +. ++++.| ...|.|||.+....++.++|||||
T Consensus 782 edd~--~~---------------------------------------~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSy 820 (996)
T KOG0196|consen 782 EDDP--EA---------------------------------------AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSY 820 (996)
T ss_pred ccCC--Cc---------------------------------------cccccCCccceeecChhHhhhcccCchhhcccc
Confidence 4332 10 112222 358999999999999999999999
Q ss_pred HHHHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 344 GAIMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 344 Gvil~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
||+|||.+. |..||.+.+.++..+-|..|
T Consensus 821 GIVmWEVmSyGERPYWdmSNQdVIkaIe~g 850 (996)
T KOG0196|consen 821 GIVMWEVMSYGERPYWDMSNQDVIKAIEQG 850 (996)
T ss_pred ceEEEEecccCCCcccccchHHHHHHHHhc
Confidence 999999876 99999999999999988765
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=286.19 Aligned_cols=214 Identities=31% Similarity=0.543 Sum_probs=181.6
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEe--
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQD-- 187 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~-- 187 (373)
.....+-|+++..||.|.+|.||+++++.+++.+|+|++..... .-+.+..|.++++.. .|||++.+|++|.-
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 34456789999999999999999999999999999999875431 223456678887665 79999999999863
Q ss_pred ---CCeEEEEEeccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccc
Q 017362 188 ---DEFLYLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (373)
Q Consensus 188 ---~~~~~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGl 262 (373)
++.++||||||.||+.-+++.. ...+.|..+..|+.+++.||.+||...+||||||-.|||++.+|.|||+|||+
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeee
Confidence 4679999999999999999865 35789999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-----CCCChh
Q 017362 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----KGYGME 337 (373)
Q Consensus 263 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~ 337 (373)
+..++..-. ...+.+|||.|||||++.. ..|+..
T Consensus 170 SaQldsT~g-----------------------------------------rRnT~iGtP~WMAPEViac~e~~d~tyd~R 208 (953)
T KOG0587|consen 170 SAQLDSTVG-----------------------------------------RRNTFIGTPYWMAPEVIACDESPDATYDYR 208 (953)
T ss_pred eeeeecccc-----------------------------------------cccCcCCCcccccceeeecccCCCCCcccc
Confidence 987653210 1226799999999999974 347889
Q ss_pred hcHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 017362 338 CDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369 (373)
Q Consensus 338 ~DvwSlGvil~ell~G~~Pf~~~~~~~~~~kI 369 (373)
||+||||++..||..|.||+.+.-|.-..=+|
T Consensus 209 ~D~WsLGITaIEladG~PPl~DmHPmraLF~I 240 (953)
T KOG0587|consen 209 SDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 240 (953)
T ss_pred cchhhccceeehhcCCCCCccCcchhhhhccC
Confidence 99999999999999999999987776665554
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=264.60 Aligned_cols=213 Identities=27% Similarity=0.446 Sum_probs=182.6
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC-----e
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE-----F 190 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~-----~ 190 (373)
-|.+.-+.||.|+||+||.+.+..+|+.||+|.+... ..+-....++.+|..+|...+|.|++..++..+... .
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 4566678899999999999999999999999988653 233344577889999999999999999998887543 4
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
+|+|.|+| ..||...+.....++.+.++-++.||+.||.|||+.||.||||||.|.|++.|-.+||||||||+.-....
T Consensus 132 iYV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 132 LYVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 78999999 66999999888899999999999999999999999999999999999999999999999999998654322
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYE 349 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~e 349 (373)
. ..++..+-|..|+|||++++. .|+.++||||+|||+.|
T Consensus 211 ~----------------------------------------~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaE 250 (449)
T KOG0664|consen 211 R----------------------------------------LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAE 250 (449)
T ss_pred h----------------------------------------hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHH
Confidence 1 112234678899999999985 59999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhh
Q 017362 350 MLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 350 ll~G~~Pf~~~~~~~~~~kI~ 370 (373)
||..+..|...+|.+..+-|.
T Consensus 251 LLgRrILFQAq~PiqQL~lIt 271 (449)
T KOG0664|consen 251 LLQRKILFQAAGPIEQLQMII 271 (449)
T ss_pred HHhhhhhhhccChHHHHHHHH
Confidence 999999999999988776664
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=282.65 Aligned_cols=216 Identities=21% Similarity=0.387 Sum_probs=185.2
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcC-CCc--eEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKT-TGH--VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~--~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 191 (373)
.++..+.++||+|.||.|+.|.+.. +|. .||||.+...... .....|.+|+.+|.+++|+|+++||++..+ ..+
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 3456677899999999999998864 333 5899999866432 267889999999999999999999999988 667
Q ss_pred EEEEeccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 192 YLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
.||||+++.|+|.+.|.. +..|.......|+.||+.|+.||.++++|||||...|+|+-....|||+||||.+.+...
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 799999999999999976 457889999999999999999999999999999999999999999999999999987644
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 349 (373)
.... .|.....-...|+|||.+....++.++|||+|||.+||
T Consensus 266 ed~Y--------------------------------------vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWE 307 (1039)
T KOG0199|consen 266 EDMY--------------------------------------VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWE 307 (1039)
T ss_pred Ccce--------------------------------------EecCCCcCcccccCHhHhccccccccchhhhhhhhHHh
Confidence 3211 11112234568999999999999999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHhhc
Q 017362 350 MLV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 350 ll~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
|++ |..||.+....++.++|=.
T Consensus 308 MFtyGEePW~G~~g~qIL~~iD~ 330 (1039)
T KOG0199|consen 308 MFTYGEEPWVGCRGIQILKNIDA 330 (1039)
T ss_pred hhccCCCCCCCCCHHHHHHhccc
Confidence 998 9999999999999988853
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=250.43 Aligned_cols=214 Identities=42% Similarity=0.663 Sum_probs=184.7
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEec
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~ 197 (373)
|.+.+.||.|++|.||+|....++..+|+|.+...... .....+..|+..+..++|+|++++++.+......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 56788999999999999999888899999999765322 2456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccc
Q 017362 198 LPGGDMMTLLMRKDT-LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (373)
Q Consensus 198 ~~gg~L~~~l~~~~~-l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 276 (373)
+++++|.+++..... +++..+..++.+++.+|.+||+++++|+||+|.||+++.++.++|+|||++.........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~---- 154 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA---- 154 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc----
Confidence 999999999987666 899999999999999999999999999999999999999999999999998765432100
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccc-cCCCCChhhcHHHHHHHHHHHHhCCC
Q 017362 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL-LKKGYGMECDWWSLGAIMYEMLVGYP 355 (373)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~~~DvwSlGvil~ell~G~~ 355 (373)
......++..|++||.+ ....++.++|+||||+++++|++|++
T Consensus 155 ------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~ 198 (225)
T smart00221 155 ------------------------------------LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPE 198 (225)
T ss_pred ------------------------------------cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 00134678899999998 66778889999999999999999999
Q ss_pred CCCC--CChHHHHHHhhcCC
Q 017362 356 PFYS--DDPMSTCRKVRKKS 373 (373)
Q Consensus 356 Pf~~--~~~~~~~~kI~~~~ 373 (373)
||.+ ++..+..++|.+++
T Consensus 199 pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 199 PFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred CccccchhHHHHHHHHhcCC
Confidence 9988 45558888887763
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=277.64 Aligned_cols=217 Identities=23% Similarity=0.388 Sum_probs=182.7
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcC----CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKT----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 188 (373)
+......+.++||.|-||.||.|.... ..--||||..+.... ....+.|..|..+|+.++||||++|+|++.+.
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIikLIGv~~e~ 463 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ 463 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchhheeeeeecc
Confidence 344455567799999999999997532 234589999887542 44467899999999999999999999999865
Q ss_pred CeEEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
..++|||+++-|.|..+|..+ ..++......|+.||+.||.|||+..+|||||...|||+.....|||+||||++.+.
T Consensus 464 -P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 464 -PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred -ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 578999999999999999764 579999999999999999999999999999999999999999999999999999876
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 347 (373)
...+... ....-...|||||.+.-..++.++|||.|||+|
T Consensus 543 d~~yYka----------------------------------------S~~kLPIKWmaPESINfRrFTtASDVWMFgVCm 582 (974)
T KOG4257|consen 543 DDAYYKA----------------------------------------SRGKLPIKWMAPESINFRRFTTASDVWMFGVCM 582 (974)
T ss_pred ccchhhc----------------------------------------cccccceeecCccccchhcccchhhHHHHHHHH
Confidence 5543321 123345689999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 348 YEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 348 ~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
||+|. |.-||.+....+..-+|-+|
T Consensus 583 WEIl~lGvkPfqgvkNsDVI~~iEnG 608 (974)
T KOG4257|consen 583 WEILSLGVKPFQGVKNSDVIGHIENG 608 (974)
T ss_pred HHHHHhcCCccccccccceEEEecCC
Confidence 99997 99999988777766666554
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=259.58 Aligned_cols=216 Identities=29% Similarity=0.443 Sum_probs=178.8
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe-------
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD------- 187 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~------- 187 (373)
.+.|+-..+||+|.||.||+|+.+.+|+.||+|++--.. .....-....+|+.+|..++|+|++.+++.|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 456888889999999999999999999999998653321 122233446789999999999999999877642
Q ss_pred -CCeEEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 188 -DEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 188 -~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
...+|+||.+|+ .||..+|... ..|+...+..++.++..||.|+|+..|+|||+||.|+||+.+|.+||+|||+++.
T Consensus 95 ~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 95 DRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 335899999994 5999999765 5799999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHH
Q 017362 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 344 (373)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG 344 (373)
+..+..... ++ -+..+-|.+|++||.+.+ ..|+++.|+|..|
T Consensus 174 fs~~~n~~k--------------------pr-----------------ytnrvvTLwYrppEllLG~r~yg~~iDiWgAg 216 (376)
T KOG0669|consen 174 FSTSKNVVK--------------------PR-----------------YTNRVVTLWYRPPELLLGDREYGPPIDIWGAG 216 (376)
T ss_pred eecccccCC--------------------CC-----------------cccceeeeecCCHHHhhcccccCCcchhHhHH
Confidence 754421110 00 114578999999999997 5599999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHh
Q 017362 345 AIMYEMLVGYPPFYSDDPMSTCRKV 369 (373)
Q Consensus 345 vil~ell~G~~Pf~~~~~~~~~~kI 369 (373)
|||.||++|.|.|.+++...+..-|
T Consensus 217 CimaeMwtrspimqgnteqqql~~I 241 (376)
T KOG0669|consen 217 CIMAEMWTRSPIMQGNTEQQQLHLI 241 (376)
T ss_pred HHHHHHHccCccccCChHHHHHHHH
Confidence 9999999999999999988777655
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=301.56 Aligned_cols=187 Identities=20% Similarity=0.307 Sum_probs=161.1
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEe
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E 196 (373)
.|.....||+|+||.||+|.+..++..||+|.+..... ....|+.++..++|||||++++++.+.+..|+|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 46677889999999999999988999999998864321 11235788999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHH---hCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH---KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 197 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
|+++|+|.+++. .+++..+..++.+++.||.||| +.+|+||||||+||+++.++..++. ||.+......
T Consensus 764 y~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---- 835 (968)
T PLN00113 764 YIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---- 835 (968)
T ss_pred CCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----
Confidence 999999999995 3899999999999999999999 6799999999999999999888875 6654322110
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhC
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 353 (373)
....||+.|+|||++.+..|+.++|||||||++|||++|
T Consensus 836 -----------------------------------------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg 874 (968)
T PLN00113 836 -----------------------------------------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTG 874 (968)
T ss_pred -----------------------------------------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhC
Confidence 024689999999999999999999999999999999999
Q ss_pred CCCCCC
Q 017362 354 YPPFYS 359 (373)
Q Consensus 354 ~~Pf~~ 359 (373)
+.||..
T Consensus 875 ~~p~~~ 880 (968)
T PLN00113 875 KSPADA 880 (968)
T ss_pred CCCCCc
Confidence 999954
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=261.06 Aligned_cols=196 Identities=23% Similarity=0.373 Sum_probs=162.0
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHh--cCCCceeEEeeEEEeCC---
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE--VDSNCIVKLYCSFQDDE--- 189 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~l~~~~~~~~--- 189 (373)
....++..+||+|.||+||+|... ++.||||++... ..+.+.+|.+|.+. +.|+||++++++-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc--CceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 455677888999999999999754 689999999754 34568889888876 48999999998776544
Q ss_pred -eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHh---------CCCeeecCCCCCEEEcCCCcEEEee
Q 017362 190 -FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK---------HHYIHRDIKPDNLLLDKYGHLRLSD 259 (373)
Q Consensus 190 -~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---------~giiHrDikp~NILl~~~~~vkL~D 259 (373)
.++||++|.+.|+|.++|. ...++|.....++..++.||+|||+ .+|+|||||..|||+..+++..|+|
T Consensus 281 ~eywLVt~fh~kGsL~dyL~-~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLK-ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred cceeEEeeeccCCcHHHHHH-hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 7899999999999999995 4679999999999999999999995 3699999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC-CC---
Q 017362 260 FGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YG--- 335 (373)
Q Consensus 260 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~--- 335 (373)
||||..+........ +-.-|||..|||||++.+.- ..
T Consensus 360 FGLAl~~~p~~~~~d---------------------------------------~~~qVGT~RYMAPEvLEgainl~d~~ 400 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGD---------------------------------------THGQVGTRRYMAPEVLEGAINLQDRD 400 (534)
T ss_pred cceeEEecCCCCCcc---------------------------------------hhhhhhhhhhcCHHHHhhhcccccHH
Confidence 999988764321110 11358999999999997632 22
Q ss_pred --hhhcHHHHHHHHHHHHhCCCCCC
Q 017362 336 --MECDWWSLGAIMYEMLVGYPPFY 358 (373)
Q Consensus 336 --~~~DvwSlGvil~ell~G~~Pf~ 358 (373)
.+.||||+|.+||||++...-++
T Consensus 401 Afkr~DvYamgLVLWEi~SRC~~~~ 425 (534)
T KOG3653|consen 401 AFKRIDVYAMGLVLWEIASRCTDAD 425 (534)
T ss_pred HHHHHHHHHHHHHHHHHHhhccccc
Confidence 36899999999999999776553
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=277.17 Aligned_cols=202 Identities=22% Similarity=0.340 Sum_probs=145.8
Q ss_pred hccCCCCCcceeceeeeeCcEEEEEEEEcCC----CceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeE-
Q 017362 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTT----GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCS- 184 (373)
Q Consensus 110 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~- 184 (373)
+..+..++|++.+.||+|+||.||+|.+..+ +..||+|.+..... .+....+. +....+.+++.++..
T Consensus 126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e~--l~~~~~~~~~~~~~~~ 198 (566)
T PLN03225 126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNER--VRRACPNSCADFVYGF 198 (566)
T ss_pred CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHHH--HHhhchhhHHHHHHhh
Confidence 3455778999999999999999999999888 89999998764321 11111111 111122222222211
Q ss_pred -----EEeCCeEEEEEeccCCCCHHHHHhhCCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCee
Q 017362 185 -----FQDDEFLYLIMEYLPGGDMMTLLMRKDT--------------------LTEDEARFYVAETVLAIESIHKHHYIH 239 (373)
Q Consensus 185 -----~~~~~~~~lV~E~~~gg~L~~~l~~~~~--------------------l~~~~~~~i~~qi~~aL~~LH~~giiH 239 (373)
......+++||||+++++|.+++..... ..+..+..++.|++.||.|||++||+|
T Consensus 199 ~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiH 278 (566)
T PLN03225 199 LEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVH 278 (566)
T ss_pred hcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence 2456678999999999999999865421 123456789999999999999999999
Q ss_pred ecCCCCCEEEcC-CCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccc
Q 017362 240 RDIKPDNLLLDK-YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTV 318 (373)
Q Consensus 240 rDikp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (373)
|||||+|||++. ++.+||+|||+|+.+...... .....+
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~----------------------------------------~~~~~~ 318 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY----------------------------------------IPKEFL 318 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCcccccccccc----------------------------------------CCcccc
Confidence 999999999985 689999999999755322100 011457
Q ss_pred cCCCCcccccccCC----------------------CCChhhcHHHHHHHHHHHHhCCCCCC
Q 017362 319 GTPDYIAPEVLLKK----------------------GYGMECDWWSLGAIMYEMLVGYPPFY 358 (373)
Q Consensus 319 gt~~Y~aPE~~~~~----------------------~~~~~~DvwSlGvil~ell~G~~Pf~ 358 (373)
||+.|+|||.+... .++.++|||||||+||||+++..|+.
T Consensus 319 ~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 319 LDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred cCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCc
Confidence 89999999976432 23456799999999999999766653
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=269.79 Aligned_cols=216 Identities=26% Similarity=0.435 Sum_probs=183.2
Q ss_pred HHHhhhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCC------Cce
Q 017362 105 YMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS------NCI 178 (373)
Q Consensus 105 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i 178 (373)
|++++..++..++|.+....|+|-||+|..|.+...|..||||+|....... ..=+.|++||+.|.. -+.
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~----KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH----KTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh----hhhhHHHHHHHHhhccCchhhhHH
Confidence 3445566788889999999999999999999999999999999998765432 224568999998852 478
Q ss_pred eEEeeEEEeCCeEEEEEeccCCCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCC-Cc
Q 017362 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD---TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY-GH 254 (373)
Q Consensus 179 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~-~~ 254 (373)
++|+..|...+++|||+|.+ .-+|.++|.+.+ .|....++.|+.|++.||..|-.+||+|.||||+|||++.. ..
T Consensus 497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcce
Confidence 99999999999999999998 669999998754 58999999999999999999999999999999999999876 46
Q ss_pred EEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCC
Q 017362 255 LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY 334 (373)
Q Consensus 255 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~ 334 (373)
+||||||-|......... +..-+.-|.|||++++.+|
T Consensus 576 LKLCDfGSA~~~~eneit-------------------------------------------PYLVSRFYRaPEIiLG~~y 612 (752)
T KOG0670|consen 576 LKLCDFGSASFASENEIT-------------------------------------------PYLVSRFYRAPEIILGLPY 612 (752)
T ss_pred eeeccCcccccccccccc-------------------------------------------HHHHHHhccCcceeecCcc
Confidence 799999988654332211 2234456999999999999
Q ss_pred ChhhcHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 017362 335 GMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRK 368 (373)
Q Consensus 335 ~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~k 368 (373)
+...|+||+||+||||+||+..|.+.+...+.+-
T Consensus 613 d~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl 646 (752)
T KOG0670|consen 613 DYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRL 646 (752)
T ss_pred cCCccceeeceeeEEeeccceecCCCCcHHHHHH
Confidence 9999999999999999999999999988887654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=251.70 Aligned_cols=210 Identities=28% Similarity=0.469 Sum_probs=182.4
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC-----
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~----- 189 (373)
..+|.-++.+|.|+- .|-.|.+...+++||+|.+... ........+..+|..++..+.|+||++++.+|....
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 457888889999999 7778888889999999988655 344444567788999999999999999999997543
Q ss_pred -eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 190 -FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 190 -~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
.+|+|||+| .++|...+. -.++-+.+++++.|++.|+.+||+.||+||||||+||++..+..+||.|||+|+.-+.
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT 170 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc
Confidence 479999999 568888876 3578889999999999999999999999999999999999999999999999986442
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 348 (373)
.. +.+..+.|..|.|||++.+.+|...+||||+|||+.
T Consensus 171 ~~------------------------------------------~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~g 208 (369)
T KOG0665|consen 171 DF------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 208 (369)
T ss_pred cc------------------------------------------ccCchhheeeccCchheeccCCcccchhhhhhhHHH
Confidence 20 123568999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhc
Q 017362 349 EMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 349 ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
||++|...|.+.+.-+.+.||..
T Consensus 209 Eli~~~Vlf~g~d~idQ~~ki~~ 231 (369)
T KOG0665|consen 209 ELILGTVLFPGKDHIDQWNKIIE 231 (369)
T ss_pred HHhhceEEecCchHHHHHHHHHH
Confidence 99999999999999999999864
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=238.85 Aligned_cols=205 Identities=29% Similarity=0.503 Sum_probs=173.8
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-CCceeEEeeEEEeCC--e
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDE--F 190 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~--~ 190 (373)
..++|++++++|+|.|++||.|....+++.++||++++.. ...+.+|+.||..+. ||||+.|++...|+. .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 3688999999999999999999998999999999998654 355889999999996 999999999998764 4
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCC-CcEEEeeccccccCCCC
Q 017362 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY-GHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~-~~vkL~DFGla~~~~~~ 269 (373)
..||+||+.+.|...+. ..++...++.|+.|++.||.|+|++||+|||+||.|++||.. ..++|+|+|||....+.
T Consensus 110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 67999999888877665 568899999999999999999999999999999999999864 57999999999887655
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ 348 (373)
.... -.+.+..|--||.+.. ..|+..-|+|||||++.
T Consensus 187 ~eYn------------------------------------------VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA 224 (338)
T KOG0668|consen 187 KEYN------------------------------------------VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 224 (338)
T ss_pred ceee------------------------------------------eeeehhhcCCchheeechhccccHHHHHHHHHHH
Confidence 3211 2356778899999986 56899999999999999
Q ss_pred HHHhCCCCCC-CCChHHHHHHh
Q 017362 349 EMLVGYPPFY-SDDPMSTCRKV 369 (373)
Q Consensus 349 ell~G~~Pf~-~~~~~~~~~kI 369 (373)
.|+..+.||. +.+..+..-||
T Consensus 225 ~miFrkepFFhG~dN~DQLVkI 246 (338)
T KOG0668|consen 225 SMIFRKEPFFHGHDNYDQLVKI 246 (338)
T ss_pred HHHhccCcccCCCCCHHHHHHH
Confidence 9999888876 45555554454
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=253.80 Aligned_cols=133 Identities=23% Similarity=0.427 Sum_probs=115.5
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-----C---CceeEEeeEE
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-----S---NCIVKLYCSF 185 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~iv~l~~~~ 185 (373)
...+|-+.++||+|-|++||+|.+..+.+.||+|+.+.... ..+....|+.+|..++ | .+||+|++.|
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh----YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH----YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH----HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 34899999999999999999999999999999999986643 3355677888888773 3 4799999999
Q ss_pred Ee----CCeEEEEEeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCCEEEcC
Q 017362 186 QD----DEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDK 251 (373)
Q Consensus 186 ~~----~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~-~giiHrDikp~NILl~~ 251 (373)
.. +.++|||+|++ |.+|..++... ..++...++.|+.||+.||.|||. +||||.||||+|||+..
T Consensus 152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~ 223 (590)
T KOG1290|consen 152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCS 223 (590)
T ss_pred eecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeec
Confidence 74 46799999999 88999999764 479999999999999999999995 79999999999999953
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=271.63 Aligned_cols=211 Identities=20% Similarity=0.314 Sum_probs=178.7
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCc----eEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEE
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGH----VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 193 (373)
....++||+|+||+||+|.+...|+ +||||++.... .......+..|+.+|.+++|||+++|++++.... +.|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 4456789999999999998865544 68999887543 2344567899999999999999999999998766 779
Q ss_pred EEeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcc
Q 017362 194 IMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 194 V~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 272 (373)
|++|||+|.|.+++.. ++.+..+....|..||++|+.|||.+++|||||-..|||+..-.++||+|||+|+.+......
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 9999999999999975 568999999999999999999999999999999999999999999999999999987644321
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 352 (373)
.. +....-.+.|||-|.++...|+.++|||||||.+||++|
T Consensus 855 y~---------------------------------------~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmT 895 (1177)
T KOG1025|consen 855 YS---------------------------------------APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMT 895 (1177)
T ss_pred cc---------------------------------------ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHh
Confidence 10 112334578999999999999999999999999999998
Q ss_pred -CCCCCCCCChHHHHHHhh
Q 017362 353 -GYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 353 -G~~Pf~~~~~~~~~~kI~ 370 (373)
|.-||.+....++-+-+.
T Consensus 896 FGa~Py~gi~~~eI~dlle 914 (1177)
T KOG1025|consen 896 FGAKPYDGIPAEEIPDLLE 914 (1177)
T ss_pred cCCCccCCCCHHHhhHHHh
Confidence 999999888777665443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=240.38 Aligned_cols=198 Identities=46% Similarity=0.853 Sum_probs=172.4
Q ss_pred CcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEeccCCCCHHHHH
Q 017362 128 AFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL 207 (373)
Q Consensus 128 ~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l 207 (373)
+||.||+|.+..+++.+|+|++........ ...+.+|+..++.++|+||+++++.+......++||||+++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 689999999988899999999876543211 567889999999999999999999999999999999999999999999
Q ss_pred hhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCC
Q 017362 208 MRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287 (373)
Q Consensus 208 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~ 287 (373)
.....+++..+..++.+++.+|.+||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---------------- 142 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL---------------- 142 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccc----------------
Confidence 7766699999999999999999999999999999999999999999999999999986543210
Q ss_pred CCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCC-CChHHHH
Q 017362 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS-DDPMSTC 366 (373)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~-~~~~~~~ 366 (373)
.....+++.|+|||.+....++.++|+||||+++|+|++|.+||.. .+.....
T Consensus 143 --------------------------~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~ 196 (244)
T smart00220 143 --------------------------LTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELF 196 (244)
T ss_pred --------------------------cccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 1135688999999999988899999999999999999999999988 5555554
Q ss_pred HHh
Q 017362 367 RKV 369 (373)
Q Consensus 367 ~kI 369 (373)
..+
T Consensus 197 ~~~ 199 (244)
T smart00220 197 KKI 199 (244)
T ss_pred HHH
Confidence 444
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=254.11 Aligned_cols=206 Identities=26% Similarity=0.406 Sum_probs=165.4
Q ss_pred hhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHh--cCCCceeEEeeEEE
Q 017362 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE--VDSNCIVKLYCSFQ 186 (373)
Q Consensus 109 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~l~~~~~ 186 (373)
-..+....+..+.+.||+|-||+||+|.++ |+.||||+|...+ .....+|.+|... ++|+||+.++++-.
T Consensus 204 LVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~ 275 (513)
T KOG2052|consen 204 LVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADN 275 (513)
T ss_pred HhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccc
Confidence 334445678899999999999999998765 8899999997653 2446778888755 59999999997755
Q ss_pred eCC----eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHh--------CCCeeecCCCCCEEEcCCCc
Q 017362 187 DDE----FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK--------HHYIHRDIKPDNLLLDKYGH 254 (373)
Q Consensus 187 ~~~----~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~--------~giiHrDikp~NILl~~~~~ 254 (373)
.++ .++||.+|.+.|||.++|.+ ..++.+....++..++.||++||. -.|.|||||..|||+..+|.
T Consensus 276 ~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~ 354 (513)
T KOG2052|consen 276 KDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 354 (513)
T ss_pred cCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc
Confidence 332 48999999999999999976 789999999999999999999994 35999999999999999999
Q ss_pred EEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC-
Q 017362 255 LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG- 333 (373)
Q Consensus 255 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~- 333 (373)
+.|+|+|||-.....+.. ...+ .+..|||..|||||++...-
T Consensus 355 C~IADLGLAv~h~~~t~~---idi~----------------------------------~N~rVGTKRYMAPEvLdetin 397 (513)
T KOG2052|consen 355 CCIADLGLAVRHDSDTDT---IDIP----------------------------------PNPRVGTKRYMAPEVLDETIN 397 (513)
T ss_pred EEEeeceeeEEecccCCc---ccCC----------------------------------CCCccceeeccChHHhhhhcC
Confidence 999999999876544311 1111 11469999999999996432
Q ss_pred ---C-C-hhhcHHHHHHHHHHHHhC----------CCCCCCC
Q 017362 334 ---Y-G-MECDWWSLGAIMYEMLVG----------YPPFYSD 360 (373)
Q Consensus 334 ---~-~-~~~DvwSlGvil~ell~G----------~~Pf~~~ 360 (373)
+ + ..+||||||.||||+.-. .+||++.
T Consensus 398 ~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 398 MKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred hhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 1 2 358999999999998753 4899853
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=273.06 Aligned_cols=221 Identities=24% Similarity=0.425 Sum_probs=184.9
Q ss_pred hccCCCCCcceeceeeeeCcEEEEEEEEc---C----CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEE
Q 017362 110 RHKMGADDFELLTMIGKGAFGEVRVCREK---T----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKL 181 (373)
Q Consensus 110 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~---~----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l 181 (373)
..++..++..+.+.||+|.||.|++|... . ....||||.++.... ..+...+..|+.+|..+ .|+||+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhh
Confidence 34555666677789999999999999743 1 145799999876532 35567789999999998 59999999
Q ss_pred eeEEEeCCeEEEEEeccCCCCHHHHHhhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCC
Q 017362 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKD----------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPD 245 (373)
Q Consensus 182 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~ 245 (373)
++++...+.+++|+||+..|+|..+|...+ .++......++.||+.|++||++.++|||||...
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR 447 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR 447 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence 999999999999999999999999997655 4889999999999999999999999999999999
Q ss_pred CEEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhcccccccc--CCCC
Q 017362 246 NLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVG--TPDY 323 (373)
Q Consensus 246 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g--t~~Y 323 (373)
|||+..+..+||+|||+|+......+.... ...| ...|
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~----------------------------------------~~~~~LP~kW 487 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTK----------------------------------------SSAGTLPVKW 487 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEec----------------------------------------CCCCccceee
Confidence 999999999999999999865443322100 1122 3459
Q ss_pred cccccccCCCCChhhcHHHHHHHHHHHHh-CCCCCCCCC-hHHHHHHhhcC
Q 017362 324 IAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDD-PMSTCRKVRKK 372 (373)
Q Consensus 324 ~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf~~~~-~~~~~~kI~~~ 372 (373)
||||.+....|+.++|||||||+||||++ |.+||.+.. +.+.++.|..|
T Consensus 488 mApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G 538 (609)
T KOG0200|consen 488 MAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEG 538 (609)
T ss_pred cCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcC
Confidence 99999999999999999999999999999 999999865 67777777665
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=263.43 Aligned_cols=209 Identities=22% Similarity=0.330 Sum_probs=153.9
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEc----------------CCCceEeeeecchhHhhh-----------hhhHHHH
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREK----------------TTGHVYAMKKLKKSEMLR-----------RGQVEHV 163 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~vaiK~~~~~~~~~-----------~~~~~~~ 163 (373)
.++..++|++.++||+|+||+||+|... ..+..||||.+....... ....+..
T Consensus 140 ~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~ 219 (507)
T PLN03224 140 SRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETG 219 (507)
T ss_pred CCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchh
Confidence 4567889999999999999999999642 235679999986432110 0011223
Q ss_pred HHHHHHHHhcCCCce-----eEEeeEEEe--------CCeEEEEEeccCCCCHHHHHhhC--------------------
Q 017362 164 RAERNLLAEVDSNCI-----VKLYCSFQD--------DEFLYLIMEYLPGGDMMTLLMRK-------------------- 210 (373)
Q Consensus 164 ~~e~~~l~~l~h~~i-----v~l~~~~~~--------~~~~~lV~E~~~gg~L~~~l~~~-------------------- 210 (373)
..|+.++..++|+++ +.++++|.. ....|+||||+++++|.+++...
T Consensus 220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~ 299 (507)
T PLN03224 220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD 299 (507)
T ss_pred HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence 346666777766654 556666542 35689999999999999988642
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCC
Q 017362 211 ----DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286 (373)
Q Consensus 211 ----~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~ 286 (373)
..+++..++.++.|++.+|.|||+.+|+||||||+|||++.++.+||+|||++..........
T Consensus 300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~------------- 366 (507)
T PLN03224 300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN------------- 366 (507)
T ss_pred hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-------------
Confidence 123567889999999999999999999999999999999999999999999986543211000
Q ss_pred CCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC--------------------CC--hhhcHHHHH
Q 017362 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG--------------------YG--MECDWWSLG 344 (373)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--------------------~~--~~~DvwSlG 344 (373)
.....+||.|+|||++.... |+ .++||||+|
T Consensus 367 ---------------------------~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlG 419 (507)
T PLN03224 367 ---------------------------PLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAG 419 (507)
T ss_pred ---------------------------ccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHH
Confidence 00234589999999986432 22 247999999
Q ss_pred HHHHHHHhCCC-CCCC
Q 017362 345 AIMYEMLVGYP-PFYS 359 (373)
Q Consensus 345 vil~ell~G~~-Pf~~ 359 (373)
||+|+|++|.+ ||.+
T Consensus 420 vil~em~~~~l~p~~~ 435 (507)
T PLN03224 420 VLLMQMCVPELRPVAN 435 (507)
T ss_pred HHHHHHHhCCCCCccc
Confidence 99999999875 7754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-33 Score=268.23 Aligned_cols=208 Identities=32% Similarity=0.574 Sum_probs=184.5
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEE
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 193 (373)
..++|+.+..+|.|+||.||+++++.+++..|+|+++... ...+.-+..|+-+++.++|||||.+++.+...+.+++
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 4689999999999999999999999999999999997543 3445567789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 194 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
+||||.||+|.+..+-.+++++.++.+.+++.+.||+|||++|=+|||||..|||+++.|.+||+|||.+..+...-..
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K- 168 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK- 168 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhh-
Confidence 9999999999999988999999999999999999999999999999999999999999999999999998655422110
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc---CCCCChhhcHHHHHHHHHHH
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DvwSlGvil~el 350 (373)
..++.|||.|||||+-. .++|+..||+|++|+...|+
T Consensus 169 ----------------------------------------rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel 208 (829)
T KOG0576|consen 169 ----------------------------------------RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIEL 208 (829)
T ss_pred ----------------------------------------hhcccCCccccchhHHHHHhcccccccccccccccchhhh
Confidence 11789999999999875 57899999999999999999
Q ss_pred HhCCCCCCCCChHHH
Q 017362 351 LVGYPPFYSDDPMST 365 (373)
Q Consensus 351 l~G~~Pf~~~~~~~~ 365 (373)
-.=.+|-...-|+..
T Consensus 209 ~eLqpplfdlhpmr~ 223 (829)
T KOG0576|consen 209 GELQPPLFDLHPMRA 223 (829)
T ss_pred hhcCCcccccchHHH
Confidence 988888876655543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=238.62 Aligned_cols=197 Identities=22% Similarity=0.402 Sum_probs=161.7
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEee-EEEeCCeEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYC-SFQDDEFLY 192 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~-~~~~~~~~~ 192 (373)
.+.|.+.+.||+|-||.+-+|.++.++..+++|.+..... ....|.+|...--.+ .|.||+..|+ .|+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 4669999999999999999999999999999999886542 345577777665555 5889998885 578888999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEc--CCCcEEEeeccccccCCCCC
Q 017362 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD--KYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~--~~~~vkL~DFGla~~~~~~~ 270 (373)
++|||+|.|||..-+.. ..+.|...+.++.|+++||.|+|+.++||||||.+||||- +...|||||||+.+..+..-
T Consensus 99 F~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV 177 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV 177 (378)
T ss_pred EeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence 99999999999988744 5688999999999999999999999999999999999993 33589999999987543110
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC-----CChhhcHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-----YGMECDWWSLGA 345 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-----~~~~~DvwSlGv 345 (373)
. ..-.+..|.+||+..... ..+.+|+|.||+
T Consensus 178 ------------------------------~--------------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGI 213 (378)
T KOG1345|consen 178 ------------------------------K--------------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGI 213 (378)
T ss_pred ------------------------------h--------------hhhhhcccCCcHHHhhccccceEecccccchheee
Confidence 0 112456799999876432 467899999999
Q ss_pred HHHHHHhCCCCCCCC
Q 017362 346 IMYEMLVGYPPFYSD 360 (373)
Q Consensus 346 il~ell~G~~Pf~~~ 360 (373)
|+|.||||++||...
T Consensus 214 i~f~cltG~~PWQka 228 (378)
T KOG1345|consen 214 IFFYCLTGKFPWQKA 228 (378)
T ss_pred eeeeeecCCCcchhh
Confidence 999999999999844
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=247.60 Aligned_cols=231 Identities=26% Similarity=0.469 Sum_probs=175.5
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcC---CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCe
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKT---TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~ 190 (373)
.+.|.++.+||.|+|++||++.+.. ....||+|.+.... ...++.+|+++|..+ .+.||+++.+.+..++.
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 4678999999999999999998876 77899999886432 234588899999998 58999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC-CCcEEEeeccccccCCCC
Q 017362 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-YGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~-~~~vkL~DFGla~~~~~~ 269 (373)
..+||||++..+..+++.. ++-..++.|+..++.||.++|..|||||||||.|+|.+. .++-.|.|||||...+..
T Consensus 110 v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred eEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 9999999999999888843 678999999999999999999999999999999999975 577899999999843322
Q ss_pred Cccccccc---------ccCCCCCCCCCC-CCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhh
Q 017362 270 TLQEQDFT---------IGNNLNGSSQNN-ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMEC 338 (373)
Q Consensus 270 ~~~~~~~~---------~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~ 338 (373)
......-. .|.......... ..+....+ .....++....+.+|||+|+|||++... ..+.++
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~-------~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYR-------RCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCcee-------ccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 11110000 000000000000 00111000 0023344555678999999999999874 468999
Q ss_pred cHHHHHHHHHHHHhCCCCCCCC
Q 017362 339 DWWSLGAIMYEMLVGYPPFYSD 360 (373)
Q Consensus 339 DvwSlGvil~ell~G~~Pf~~~ 360 (373)
||||.|||++-++++..||.-.
T Consensus 260 Diws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred ceeeccceeehhhccccccccC
Confidence 9999999999999999999754
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=258.36 Aligned_cols=206 Identities=27% Similarity=0.435 Sum_probs=164.8
Q ss_pred cceeceeeeeCcEE-EEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCeEEEEE
Q 017362 118 FELLTMIGKGAFGE-VRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 118 y~~~~~lG~G~~g~-Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
|.-.+.+|.|+.|+ ||+|.. .|+.||||.+... ......+|+..|... .|||||++|+.-++..++||+.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 44456789999986 788764 4789999987643 234577899999888 6999999999999999999999
Q ss_pred eccCCCCHHHHHhhC--CC-C-CHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC---C--CcEEEeeccccccC
Q 017362 196 EYLPGGDMMTLLMRK--DT-L-TEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---Y--GHLRLSDFGLCKPL 266 (373)
Q Consensus 196 E~~~gg~L~~~l~~~--~~-l-~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~---~--~~vkL~DFGla~~~ 266 (373)
|.| ..+|.+++... .. + ..-..+..+.|++.||++||+.+||||||||.||||+. + ..++|+|||+|+.+
T Consensus 583 ELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 999 67999999763 11 1 11456788999999999999999999999999999976 3 46899999999987
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHH
Q 017362 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (373)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvi 346 (373)
......- ++ .....||-+|+|||++....-+.++|||||||+
T Consensus 662 ~~~~sS~------------------------------------~r--~s~~sGt~GW~APE~L~~~~~~~avDiFslGCv 703 (903)
T KOG1027|consen 662 AGGKSSF------------------------------------SR--LSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCV 703 (903)
T ss_pred CCCcchh------------------------------------hc--ccCCCCcccccCHHHHhccccCcccchhhcCce
Confidence 6442111 00 225679999999999999988999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 347 MYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 347 l~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+|+.++ |..||.+. .+---+|+++
T Consensus 704 fyYvltgG~HpFGd~--~~R~~NIl~~ 728 (903)
T KOG1027|consen 704 FYYVLTGGSHPFGDS--LERQANILTG 728 (903)
T ss_pred EEEEecCCccCCCch--HHhhhhhhcC
Confidence 999999 59999754 3333455554
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-28 Score=211.60 Aligned_cols=184 Identities=42% Similarity=0.727 Sum_probs=160.9
Q ss_pred eeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEeccCCCCH
Q 017362 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM 203 (373)
Q Consensus 124 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~gg~L 203 (373)
||+|++|.||+|....+++.+++|++....... ....+.+|+..+..+.|++|+++++++......++||||++|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999987653211 346688899999999999999999999999999999999999999
Q ss_pred HHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC-CCcEEEeeccccccCCCCCcccccccccCC
Q 017362 204 MTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-YGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281 (373)
Q Consensus 204 ~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~~~~~ 281 (373)
.+++... ..+++..+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+.........
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~--------- 149 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--------- 149 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcch---------
Confidence 9999765 57999999999999999999999999999999999999999 899999999999765433210
Q ss_pred CCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHHHHHHHHHH
Q 017362 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~el 350 (373)
.....+...|++||.+... .++.+.|+|+||+++++|
T Consensus 150 --------------------------------~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 150 --------------------------------LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred --------------------------------hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 0134578899999999887 889999999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-28 Score=229.32 Aligned_cols=146 Identities=16% Similarity=0.150 Sum_probs=116.8
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcC-CCceEeeeecchhHh--hhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKT-TGHVYAMKKLKKSEM--LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 188 (373)
....++|.+.+.||+|+||+||+|.+.. ++..||||++..... ........+.+|+.+|..+.|+|++..+..+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 3456889999999999999999998875 678889998653211 1122345688999999999999998533322
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecC-CCCCEEEcCCCcEEEeeccccccCC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDI-KPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDi-kp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
+..|+||||++|++|.. + . ... ...++.+++.||.|||++||+|||| ||+|||++.++.+||+|||+|+.+.
T Consensus 91 ~~~~LVmE~~~G~~L~~-~-~--~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-A-R--PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred CCcEEEEEccCCCCHHH-h-C--ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 45799999999999963 2 1 111 1467889999999999999999999 9999999999999999999998764
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-28 Score=220.36 Aligned_cols=225 Identities=21% Similarity=0.318 Sum_probs=187.1
Q ss_pred HhhhccCCCCCcceeceeeeeCcEEEEEEEEcCC-----CceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEE
Q 017362 107 RLQRHKMGADDFELLTMIGKGAFGEVRVCREKTT-----GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKL 181 (373)
Q Consensus 107 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l 181 (373)
+++...+...+++....+-+|.||.||.|.++.. .+.|-+|.++.. .++.++..+..|-.++..+.|||+...
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V 352 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSV 352 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccce
Confidence 3455556677888999999999999999976532 334666766543 345677889999999999999999999
Q ss_pred eeEEE-eCCeEEEEEeccCCCCHHHHHhh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCC
Q 017362 182 YCSFQ-DDEFLYLIMEYLPGGDMMTLLMR--------KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY 252 (373)
Q Consensus 182 ~~~~~-~~~~~~lV~E~~~gg~L~~~l~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~ 252 (373)
.+++. +....++++.++.-|+|..+|.. ...++-.+...++.|++.|++|||+.|+||.||...|.+||+.
T Consensus 353 ~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 353 LGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ 432 (563)
T ss_pred eEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh
Confidence 98876 45567899999988999999972 1247778889999999999999999999999999999999999
Q ss_pred CcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC
Q 017362 253 GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332 (373)
Q Consensus 253 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 332 (373)
-.|||+|-.|++.+-+.+++-. |++ --....||+||.+...
T Consensus 433 LqVkltDsaLSRDLFP~DYhcL----GDn-----------------------------------EnRPvkWMslEal~n~ 473 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCL----GDN-----------------------------------ENRPVKWMSLEALQNS 473 (563)
T ss_pred eeEEeccchhccccCccccccc----CCC-----------------------------------CCCcccccCHHHHhhh
Confidence 9999999999998776655421 111 1134579999999999
Q ss_pred CCChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 333 GYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 333 ~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
.|+.++|+|||||+||||+| |+.||..-||.|+..-|+.|
T Consensus 474 ~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG 514 (563)
T KOG1024|consen 474 HYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG 514 (563)
T ss_pred hhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc
Confidence 99999999999999999999 99999999999999888776
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=210.00 Aligned_cols=218 Identities=22% Similarity=0.307 Sum_probs=177.7
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCC-CceeEEeeEEEeCCeE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS-NCIVKLYCSFQDDEFL 191 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~l~~~~~~~~~~ 191 (373)
+..+.|.++++||+|+||.+|+|....+|+.||||+-.... ...++..|..+...+++ ..|+.+..++....+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 45788999999999999999999999999999999865431 22346678888888865 6888888888888888
Q ss_pred EEEEeccCCCCHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC---cEEEeeccccccCC
Q 017362 192 YLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---HLRLSDFGLCKPLD 267 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~---~vkL~DFGla~~~~ 267 (373)
.+||+++ |-+|.+++. +...|+...+.-++-|++.-|+|+|.+++|||||||+|+|..-+. .+.|+|||||+.+.
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999999 889999885 466899999999999999999999999999999999999997554 58899999998775
Q ss_pred CCCcc-cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHH
Q 017362 268 CSTLQ-EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (373)
Q Consensus 268 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvi 346 (373)
..... ...++. -....||..|.+--...+...+...|+=|+|.+
T Consensus 166 d~~t~~HIpyre-----------------------------------~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYv 210 (341)
T KOG1163|consen 166 DIRTRQHIPYRE-----------------------------------DRNLTGTARYASINAHLGIEQSRRDDMESVGYV 210 (341)
T ss_pred cccccccCcccc-----------------------------------CCccceeeeehhhhhhhhhhhhhhhhhhhhcce
Confidence 33211 111111 114679999999888888888999999999999
Q ss_pred HHHHHhCCCCCCCCC---hHHHHHHhhc
Q 017362 347 MYEMLVGYPPFYSDD---PMSTCRKVRK 371 (373)
Q Consensus 347 l~ell~G~~Pf~~~~---~~~~~~kI~~ 371 (373)
|.+..-|..||.+-. -.+-+.||..
T Consensus 211 LmYfnrG~LPWQglka~tk~QKyEkI~E 238 (341)
T KOG1163|consen 211 LMYFNRGSLPWQGLKAATKKQKYEKISE 238 (341)
T ss_pred eeeeecCCCcccccchhhHHHHHHHHHH
Confidence 999999999999764 4445555543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=223.25 Aligned_cols=212 Identities=27% Similarity=0.375 Sum_probs=168.6
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCC-ceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC----CCceeEEeeEE-EeCCe
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTG-HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD----SNCIVKLYCSF-QDDEF 190 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~----h~~iv~l~~~~-~~~~~ 190 (373)
+|.+.++||+|+||.||+|.+..++ ..+|+|+......... ..+..|..++..+. .+++..+++.+ ..+.+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999987664 5789998765422111 14666888888776 26899999999 57888
Q ss_pred EEEEEeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCC-----CcEEEeecccc
Q 017362 191 LYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY-----GHLRLSDFGLC 263 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~-----~~vkL~DFGla 263 (373)
-|+||+.+ |-+|.++.... +.|+...+..++.|++.+|.+||+.|+|||||||+|+++... ..+.|.|||+|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999998 88999988543 579999999999999999999999999999999999999865 36999999999
Q ss_pred ccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHH
Q 017362 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (373)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSl 343 (373)
+.......... . ..+..+ ......||..|+++.+..+...+.+.|+||+
T Consensus 175 r~~~~~~~~~~-------------~-~~~~r~-----------------~~~~~rGT~ry~S~~~H~~~e~~r~DDles~ 223 (322)
T KOG1164|consen 175 RRFKYVGDSGG-------------N-LRPPRP-----------------QKGLFRGTLRYASINVHLGIEQGRRDDLESL 223 (322)
T ss_pred ccccccCCCCc-------------c-cccCCC-----------------CccCCCCccccccHHHhCCCccCCchhhhhH
Confidence 84321110000 0 000000 0114569999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCChH
Q 017362 344 GAIMYEMLVGYPPFYSDDPM 363 (373)
Q Consensus 344 Gvil~ell~G~~Pf~~~~~~ 363 (373)
+.++.|++.|..||.+....
T Consensus 224 ~Y~l~el~~g~LPW~~~~~~ 243 (322)
T KOG1164|consen 224 FYMLLELLKGSLPWEALEMT 243 (322)
T ss_pred HHHHHHHhcCCCCCcccccc
Confidence 99999999999999776543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-27 Score=209.96 Aligned_cols=217 Identities=21% Similarity=0.329 Sum_probs=181.4
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCeE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~ 191 (373)
+..-+|.+.++||+|+||+.+.|.+..++++||||.-... .....++.|....+.+ ..++|+..|.+.+.+.+-
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 4566899999999999999999999999999999975432 1233467788877777 569999999999999888
Q ss_pred EEEEeccCCCCHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC-----cEEEeecccccc
Q 017362 192 YLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-----HLRLSDFGLCKP 265 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~-----~vkL~DFGla~~ 265 (373)
.||||++ |-||.+++. +.+.|+.+.+..++.|++.-|+|+|++.+|.|||||+|+||...+ .|.|+|||+|+.
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9999999 889999885 456899999999999999999999999999999999999997654 488999999997
Q ss_pred CCCCCcc-cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHH
Q 017362 266 LDCSTLQ-EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344 (373)
Q Consensus 266 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG 344 (373)
+..+... ...+. -..+..||-.||+--..++...+...|+=|||
T Consensus 179 YrDp~TkqHIPYr-----------------------------------E~KSLsGTARYMSINTHlGrEQSRRDDLEaLG 223 (449)
T KOG1165|consen 179 YRDPKTKQHIPYR-----------------------------------EHKSLSGTARYMSINTHLGREQSRRDDLEALG 223 (449)
T ss_pred hcCccccccCccc-----------------------------------cccccccceeeeEeeccccchhhhhhhHHHhh
Confidence 7544221 11111 12267899999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCC---ChHHHHHHhh
Q 017362 345 AIMYEMLVGYPPFYSD---DPMSTCRKVR 370 (373)
Q Consensus 345 vil~ell~G~~Pf~~~---~~~~~~~kI~ 370 (373)
-++++.|-|.+||.+. +..+-|+||-
T Consensus 224 HvFmYFLRGsLPWQGLKA~tnK~kYeKIG 252 (449)
T KOG1165|consen 224 HVFMYFLRGSLPWQGLKADTNKEKYEKIG 252 (449)
T ss_pred hhhhhhccCCCccccccCcchHHHHHHhc
Confidence 9999999999999864 5666777764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-29 Score=240.23 Aligned_cols=197 Identities=40% Similarity=0.691 Sum_probs=173.6
Q ss_pred eeeeeCcEEEEEEEE---cCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-CCceeEEeeEEEeCCeEEEEEecc
Q 017362 123 MIGKGAFGEVRVCRE---KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYLIMEYL 198 (373)
Q Consensus 123 ~lG~G~~g~Vy~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~lV~E~~ 198 (373)
.+|.|+||.|+++.. ...+..+|+|++.+......... +...|..++..++ ||.+|.+...|+.+..+|++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 379999999998753 35678899999987655444443 7778999999987 999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccc
Q 017362 199 PGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278 (373)
Q Consensus 199 ~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 278 (373)
.||+|...+.....+++...+++.++++.+++++|+.|++|||+|++||+++.+||+++.|||+++......
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-------- 151 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-------- 151 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh--------
Confidence 999999999999999999999999999999999999999999999999999999999999999987643221
Q ss_pred cCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCC
Q 017362 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358 (373)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 358 (373)
..|||..|||||++. +....+||||||+++|||++|..||.
T Consensus 152 -------------------------------------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~ 192 (612)
T KOG0603|consen 152 -------------------------------------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFG 192 (612)
T ss_pred -------------------------------------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCc
Confidence 238999999999997 78889999999999999999999998
Q ss_pred CCChHHHHHHhhc
Q 017362 359 SDDPMSTCRKVRK 371 (373)
Q Consensus 359 ~~~~~~~~~kI~~ 371 (373)
. ++...|+.
T Consensus 193 ~----~~~~~Il~ 201 (612)
T KOG0603|consen 193 G----DTMKRILK 201 (612)
T ss_pred h----HHHHHHhh
Confidence 8 67777764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.9e-26 Score=209.60 Aligned_cols=207 Identities=42% Similarity=0.687 Sum_probs=175.0
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCC-ceeEEeeEEEeCCeEEEEEe
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKLYCSFQDDEFLYLIME 196 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~l~~~~~~~~~~~lV~E 196 (373)
|.+...||.|+||.||++.+. ..+++|.+.............+.+|..++..+.|+ +|+.+++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 778899999999999999876 78899999876543333567788899999999988 79999999988888899999
Q ss_pred ccCCCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC-cEEEeeccccccCCCCCcc
Q 017362 197 YLPGGDMMTLLMRKD---TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 197 ~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~-~vkL~DFGla~~~~~~~~~ 272 (373)
++.++++.+++.... .++...+..++.|++.++.|+|+.+++||||||+||+++..+ .++++|||++..+......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999997776654 799999999999999999999999999999999999999998 7999999999854432211
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC---CCCChhhcHHHHHHHHHH
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~~DvwSlGvil~e 349 (373)
.... ......+||+.|+|||.+.+ ..++...|+||+|+++++
T Consensus 159 ~~~~-----------------------------------~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~ 203 (384)
T COG0515 159 SSIP-----------------------------------ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYE 203 (384)
T ss_pred cccc-----------------------------------ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHH
Confidence 0000 01225689999999999988 578999999999999999
Q ss_pred HHhCCCCCCCCCh
Q 017362 350 MLVGYPPFYSDDP 362 (373)
Q Consensus 350 ll~G~~Pf~~~~~ 362 (373)
+++|..||.....
T Consensus 204 ~~~~~~p~~~~~~ 216 (384)
T COG0515 204 LLTGLPPFEGEKN 216 (384)
T ss_pred HHhCCCCCCCCCc
Confidence 9999999887763
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-27 Score=248.42 Aligned_cols=177 Identities=12% Similarity=0.161 Sum_probs=120.7
Q ss_pred CceeEEeeEE-------EeCCeEEEEEeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCE
Q 017362 176 NCIVKLYCSF-------QDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNL 247 (373)
Q Consensus 176 ~~iv~l~~~~-------~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NI 247 (373)
+||+.++++| .....++++|||+ +++|.++|.. ...+++..+..++.||+.||.|||++|||||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 5777777776 2334678899988 6699999965 34699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccc
Q 017362 248 LLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPE 327 (373)
Q Consensus 248 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE 327 (373)
||+..|.+|++|||++.......... ....+...... .. ..+.+....................+||+.|||||
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~--~ki~DfG~a~~--~~--~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDAT--TKSREIGSSRR--EE--ILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCc--ccccccccccc--cc--cccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 99988899999998886543211000 00000000000 00 00000000000000000000011357999999999
Q ss_pred cccCCCCChhhcHHHHHHHHHHHHhCCCCCCC
Q 017362 328 VLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 359 (373)
Q Consensus 328 ~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 359 (373)
++.+..|+.++|||||||+||||++|.+||..
T Consensus 186 ~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 186 EDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred hhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 99999999999999999999999999999864
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-26 Score=198.18 Aligned_cols=143 Identities=19% Similarity=0.192 Sum_probs=112.0
Q ss_pred eceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhh-----------------------HHHHHHHHHHHHhcCCCc
Q 017362 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ-----------------------VEHVRAERNLLAEVDSNC 177 (373)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~-----------------------~~~~~~e~~~l~~l~h~~ 177 (373)
...||+|+||.||+|.+. +|+.||||+++......... ......|..++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999986 89999999997653211110 122345888999998777
Q ss_pred eeEEeeEEEeCCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCeeecCCCCCEEEcCCCcEE
Q 017362 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI-HKHHYIHRDIKPDNLLLDKYGHLR 256 (373)
Q Consensus 178 iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~L-H~~giiHrDikp~NILl~~~~~vk 256 (373)
+......... ..+|||||++|+++...+.....+++..+..++.|++.+|.++ |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 6433332222 2379999999888766554567899999999999999999999 799999999999999998 58899
Q ss_pred EeeccccccCC
Q 017362 257 LSDFGLCKPLD 267 (373)
Q Consensus 257 L~DFGla~~~~ 267 (373)
|+|||+|....
T Consensus 158 LiDFG~a~~~~ 168 (190)
T cd05147 158 IIDVSQSVEHD 168 (190)
T ss_pred EEEccccccCC
Confidence 99999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=233.98 Aligned_cols=192 Identities=40% Similarity=0.707 Sum_probs=147.3
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 192 (373)
-.-++|..++.|..|+||.||+++++.+.+.+|+|+ .+..+.- ++ ++....+|.+|
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~lil-------Rn---ilt~a~npfvv------------- 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLIL-------RN---ILTFAGNPFVV------------- 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhcc-cccchhh-------hc---cccccCCccee-------------
Confidence 346789999999999999999999999999999954 3332211 11 34444455544
Q ss_pred EEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcc
Q 017362 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 272 (373)
||=.+++..-+.++... +.+++|||+-||+|||+||+|.||+.-||+|++|||+++..-.....
T Consensus 136 --------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 --------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred --------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 66667776666666554 78999999999999999999999999999999999999765433211
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhcc-ccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRML-AYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
. . .-.+-.+..+.+ ...++|||.|+||||+..++|+..+|||++|+|+||.+
T Consensus 200 n-l--------------------------~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFL 252 (1205)
T KOG0606|consen 200 N-L--------------------------KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 252 (1205)
T ss_pred h-h--------------------------hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHh
Confidence 0 0 000111111111 22469999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhc
Q 017362 352 VGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~~ 371 (373)
.|+.||.+++|++.+..+++
T Consensus 253 VgcvpffGdtpeelfg~vis 272 (1205)
T KOG0606|consen 253 VGCVPFFGDTPEELFGQVIS 272 (1205)
T ss_pred eeeeeccCCCHHHHHhhhhh
Confidence 99999999999999988775
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=199.49 Aligned_cols=143 Identities=17% Similarity=0.194 Sum_probs=116.5
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHH------HHHHHHHHHhcCCCceeEEeeEEE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEH------VRAERNLLAEVDSNCIVKLYCSFQ 186 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~------~~~e~~~l~~l~h~~iv~l~~~~~ 186 (373)
+..++|.+++.||.|+||.||++.. ++..+|||++.......+..... +.+|+..+.++.||+|+.+..++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 3468999999999999999999754 46689999997654333333333 578888999999999999988876
Q ss_pred eC--------CeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEe
Q 017362 187 DD--------EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLS 258 (373)
Q Consensus 187 ~~--------~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~ 258 (373)
+. ...++||||++|.+|.++. .+++. ...+++.+|..+|+.|++||||||+||+++.+| ++|+
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~li 176 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRII 176 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEE
Confidence 44 3578999999999998774 23332 456999999999999999999999999999988 9999
Q ss_pred eccccccC
Q 017362 259 DFGLCKPL 266 (373)
Q Consensus 259 DFGla~~~ 266 (373)
|||.+...
T Consensus 177 Dfg~~~~~ 184 (232)
T PRK10359 177 DLSGKRCT 184 (232)
T ss_pred ECCCcccc
Confidence 99987654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=186.95 Aligned_cols=203 Identities=19% Similarity=0.223 Sum_probs=146.1
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhh-HHHHHHHHHHHHhcC-CCceeEEeeEEEeCCeEEEEE
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ-VEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~-~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~lV~ 195 (373)
+.+...|++|+||+||++.. .+..++.+.+.....+.... -..+.+|+.+|..+. |++|+.++++ +..|++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34567899999999997764 56788877776554332211 225788999999995 4789999885 3468999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecC-CCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDI-KPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDi-kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
||+.|.+|...+.. . ...++.|++.+|.++|++||+|||| ||+|||++.+|+++|+|||+|..........
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~- 149 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM- 149 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH-
Confidence 99999998654321 1 2357889999999999999999999 7999999999999999999997543221000
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCC-hhhcHHHHHHHHHHHHh
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYG-MECDWWSLGAIMYEMLV 352 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~-~~~DvwSlGvil~ell~ 352 (373)
.....+.+.+..+.. ..+++.|++|+...-. ..+ ...+|++.|+.+|.++|
T Consensus 150 ---------------------r~L~~rDl~~llk~~------~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~ 202 (218)
T PRK12274 150 ---------------------RLLAREDLRHLLKHK------RMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVT 202 (218)
T ss_pred ---------------------HHHHHHHHHHHHHHH------HhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHh
Confidence 000001111111111 1278899999866543 344 67899999999999999
Q ss_pred CCCCCCCCC
Q 017362 353 GYPPFYSDD 361 (373)
Q Consensus 353 G~~Pf~~~~ 361 (373)
|..|+.++.
T Consensus 203 ~~~~~~~~~ 211 (218)
T PRK12274 203 RRVLHWEDN 211 (218)
T ss_pred ccCCccccC
Confidence 999998764
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=189.77 Aligned_cols=145 Identities=19% Similarity=0.162 Sum_probs=114.1
Q ss_pred eceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhh-----------------------hhHHHHHHHHHHHHhcCCCc
Q 017362 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR-----------------------GQVEHVRAERNLLAEVDSNC 177 (373)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----------------------~~~~~~~~e~~~l~~l~h~~ 177 (373)
...||+|+||.||+|.+. +|+.||||+++....... ........|...+..+.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 567999999999999986 899999999876521100 00123457888899999988
Q ss_pred eeEEeeEEEeCCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCCEEEcCCCcEE
Q 017362 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLR 256 (373)
Q Consensus 178 iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~giiHrDikp~NILl~~~~~vk 256 (373)
+.......... .||||||++|+++.........++...+..++.+++.+|.++|. .||+||||||+|||++ ++.++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 75443333322 47999999988655443345678899999999999999999999 9999999999999999 89999
Q ss_pred EeeccccccCCCC
Q 017362 257 LSDFGLCKPLDCS 269 (373)
Q Consensus 257 L~DFGla~~~~~~ 269 (373)
|+|||+|..+...
T Consensus 158 liDFG~a~~~~~~ 170 (190)
T cd05145 158 IIDVSQAVELDHP 170 (190)
T ss_pred EEEcccceecCCC
Confidence 9999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=184.46 Aligned_cols=108 Identities=26% Similarity=0.361 Sum_probs=96.2
Q ss_pred CCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccccccc
Q 017362 201 GDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279 (373)
Q Consensus 201 g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 279 (373)
|+|.+++.. ...+++..+..++.|++.||.|||+++ ||+|||++.++.+++ ||++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~---------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE---------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----------
Confidence 689999976 456999999999999999999999999 999999999999999 9998754321
Q ss_pred CCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCC
Q 017362 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 359 (373)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 359 (373)
...||+.|||||++.+..|+.++|||||||++|||++|.+||..
T Consensus 63 ------------------------------------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~ 106 (176)
T smart00750 63 ------------------------------------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNE 106 (176)
T ss_pred ------------------------------------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence 23589999999999999999999999999999999999999976
Q ss_pred CCh
Q 017362 360 DDP 362 (373)
Q Consensus 360 ~~~ 362 (373)
...
T Consensus 107 ~~~ 109 (176)
T smart00750 107 ERE 109 (176)
T ss_pred cch
Confidence 543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-24 Score=219.72 Aligned_cols=206 Identities=26% Similarity=0.404 Sum_probs=165.9
Q ss_pred ceeceeeeeCcEEEEEEEEcCCCceEeeeecch---hHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK---SEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 119 ~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~---~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
.....+|.|++|.|+.+........++.|.+.. ...........+..|+-+-..+.|||++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 456789999999888888776666666665542 11111222233666777778889999988887777766666669
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
|||++ ||..++.....++...+..++.|++.||.|+|++|+.||||||+|++++.+|.+||+|||.+..+.......
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~-- 477 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN-- 477 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh--
Confidence 99999 999999888899999999999999999999999999999999999999999999999999998765432210
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCCh-hhcHHHHHHHHHHHHhCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM-ECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~-~~DvwSlGvil~ell~G~ 354 (373)
-......+|+..|+|||++.+..|++ .+||||.||+++.|.+|+
T Consensus 478 -----------------------------------~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~ 522 (601)
T KOG0590|consen 478 -----------------------------------IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGR 522 (601)
T ss_pred -----------------------------------hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCC
Confidence 01123578999999999999999975 599999999999999999
Q ss_pred CCCCCCCh
Q 017362 355 PPFYSDDP 362 (373)
Q Consensus 355 ~Pf~~~~~ 362 (373)
.||.....
T Consensus 523 ~~Wk~a~~ 530 (601)
T KOG0590|consen 523 FPWKVAKK 530 (601)
T ss_pred Cccccccc
Confidence 99975443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=176.72 Aligned_cols=137 Identities=15% Similarity=0.227 Sum_probs=108.1
Q ss_pred ceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-----CCCceeEEeeEEEeCC---e
Q 017362 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-----DSNCIVKLYCSFQDDE---F 190 (373)
Q Consensus 119 ~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~l~~~~~~~~---~ 190 (373)
.-...||+|+||.||. +..++.. +||++.... ....+.+.+|+.+++.+ +||||+++++++.++. .
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 3456799999999995 6666665 689886542 22345688999999999 6799999999999874 4
Q ss_pred EE-EEEec--cCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHH-HHHHhCCCeeecCCCCCEEEcCC----CcEEEeeccc
Q 017362 191 LY-LIMEY--LPGGDMMTLLMRKDTLTEDEARFYVAETVLAI-ESIHKHHYIHRDIKPDNLLLDKY----GHLRLSDFGL 262 (373)
Q Consensus 191 ~~-lV~E~--~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL-~~LH~~giiHrDikp~NILl~~~----~~vkL~DFGl 262 (373)
+| +|||| +++|+|.+++.+ ..+++. ..++.+++.++ .|||+++||||||||+|||++.. +.++|+||+-
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 34 78999 557999999965 356666 35688888888 99999999999999999999743 4899999544
Q ss_pred cc
Q 017362 263 CK 264 (373)
Q Consensus 263 a~ 264 (373)
+.
T Consensus 156 ~~ 157 (210)
T PRK10345 156 ES 157 (210)
T ss_pred Cc
Confidence 43
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=209.06 Aligned_cols=201 Identities=23% Similarity=0.338 Sum_probs=158.9
Q ss_pred hhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC---CCceeEEeeEE
Q 017362 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD---SNCIVKLYCSF 185 (373)
Q Consensus 109 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~l~~~~ 185 (373)
...++....|.|.+.||+|+||.||+|.... |+.||||+-+....+.--. -..++.+|+ -+.|..+...+
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI------~~q~~~RLk~~~~~~~~~~~~a~ 763 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYI------CLQVMERLKPQMLPSIMHISSAH 763 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeee------hHHHHHhhchhhhcchHHHHHHH
Confidence 4456778889999999999999999999866 9999999987655432111 112233333 34556666665
Q ss_pred EeCCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC-------CCcEEEe
Q 017362 186 QDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-------YGHLRLS 258 (373)
Q Consensus 186 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~-------~~~vkL~ 258 (373)
.-.+.-+||+||.+-|+|.+++.....+++..+.+++.|++..|+.||.++|||+||||+|+||.. +--++|+
T Consensus 764 ~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 764 VFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred ccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEE
Confidence 666667799999999999999998889999999999999999999999999999999999999953 3358999
Q ss_pred eccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhh
Q 017362 259 DFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC 338 (373)
Q Consensus 259 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~ 338 (373)
|||-+-.+..-. . + ......++|-.+-.+|+..+..++...
T Consensus 844 DfG~siDm~lfp--~-----~--------------------------------~~F~~~~~td~f~C~EM~~grpWtYq~ 884 (974)
T KOG1166|consen 844 DFGRSIDMKLFP--D-----G--------------------------------TKFKAVWHTDLFDCIEMREGRPWTYQI 884 (974)
T ss_pred ecccceeeeEcC--C-----C--------------------------------cEEeeeeccccchhHHHhcCCCCchhh
Confidence 999885332100 0 0 001145788899999999999999999
Q ss_pred cHHHHHHHHHHHHhCCC
Q 017362 339 DWWSLGAIMYEMLVGYP 355 (373)
Q Consensus 339 DvwSlGvil~ell~G~~ 355 (373)
|.|.|..+++-||+|+.
T Consensus 885 DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 885 DYFGLAATVHVMLFGKY 901 (974)
T ss_pred hhHHHHHHHHHHHHHHH
Confidence 99999999999999964
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.4e-22 Score=174.57 Aligned_cols=138 Identities=23% Similarity=0.290 Sum_probs=114.1
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHh-----hhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEe
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM-----LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E 196 (373)
+.||+|++|.||+|.+ .+..+++|+...... ........+.+|..++..+.|++|+....++.+....++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999986 577899997653221 111223457789999999999988777777777778899999
Q ss_pred ccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccC
Q 017362 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (373)
Q Consensus 197 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~ 266 (373)
|++|++|.+++..... ....++.+++.+|.++|+.|++|+|++|+|||++ ++.++|+|||++...
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999999865332 7888999999999999999999999999999999 789999999998753
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.8e-22 Score=178.40 Aligned_cols=147 Identities=16% Similarity=0.117 Sum_probs=116.0
Q ss_pred CcceeceeeeeCcEEEEEEE-EcCCCceEeeeecchhHhhh-------------------h--hhHHHHHHHHHHHHhcC
Q 017362 117 DFELLTMIGKGAFGEVRVCR-EKTTGHVYAMKKLKKSEMLR-------------------R--GQVEHVRAERNLLAEVD 174 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~-~~~~~~~vaiK~~~~~~~~~-------------------~--~~~~~~~~e~~~l~~l~ 174 (373)
.|.+.+.||+|+||.||+|. +..+|+.||||++....... . .....+..|...+..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999998 66789999999987542100 0 01123567899998887
Q ss_pred CC--ceeEEeeEEEeCCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCC-CeeecCCCCCEEEcC
Q 017362 175 SN--CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH-YIHRDIKPDNLLLDK 251 (373)
Q Consensus 175 h~--~iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g-iiHrDikp~NILl~~ 251 (373)
+. .++.++.. . ..|+||||++|++|...+.....+....+..++.|++.+|.+||+.| ++||||||+||+++
T Consensus 109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 53 34444442 2 34799999999888776545556777778899999999999999999 99999999999999
Q ss_pred CCcEEEeeccccccCCC
Q 017362 252 YGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 252 ~~~vkL~DFGla~~~~~ 268 (373)
++.++|+|||+|.....
T Consensus 184 ~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 184 DGKVVIIDVSQSVELDH 200 (237)
T ss_pred CCCEEEEEChhhhccCC
Confidence 88999999999886543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=176.33 Aligned_cols=200 Identities=22% Similarity=0.305 Sum_probs=132.2
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCC----------CceeEEeeEEE-
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS----------NCIVKLYCSFQ- 186 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h----------~~iv~l~~~~~- 186 (373)
+.....||.|+++.||.+.+..|++.+|+|++...........+.+++|......+.+ -.++..++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 4567889999999999999999999999999865554445556777776654444322 11222222111
Q ss_pred --------eC---C-----eEEEEEeccCCCCHHHHHhh---CCCC---CHHHH-HHHHHHHHHHHHHHHhCCCeeecCC
Q 017362 187 --------DD---E-----FLYLIMEYLPGGDMMTLLMR---KDTL---TEDEA-RFYVAETVLAIESIHKHHYIHRDIK 243 (373)
Q Consensus 187 --------~~---~-----~~~lV~E~~~gg~L~~~l~~---~~~l---~~~~~-~~i~~qi~~aL~~LH~~giiHrDik 243 (373)
.. . +.+++|+-+ -+||.+++.- .... ....+ ..+..|++..+++||..|++|+||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 11 1 246788877 5688887642 2211 12233 3444899999999999999999999
Q ss_pred CCCEEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCC
Q 017362 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDY 323 (373)
Q Consensus 244 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 323 (373)
|+|+|++.+|.++|+||+.......... ....+..|
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~--------------------------------------------~~~~~~~~ 208 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRYR--------------------------------------------CSEFPVAF 208 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEEE--------------------------------------------GGGS-TTT
T ss_pred eeeEEEcCCCCEEEcChHHHeecCceee--------------------------------------------ccCCCccc
Confidence 9999999999999999998765432110 02345779
Q ss_pred cccccccCC--------CCChhhcHHHHHHHHHHHHhCCCCCCCCCh
Q 017362 324 IAPEVLLKK--------GYGMECDWWSLGAIMYEMLVGYPPFYSDDP 362 (373)
Q Consensus 324 ~aPE~~~~~--------~~~~~~DvwSlGvil~ell~G~~Pf~~~~~ 362 (373)
.+||..... .++.+.|.|+||+++|.|++|..||...++
T Consensus 209 ~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~ 255 (288)
T PF14531_consen 209 TPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSP 255 (288)
T ss_dssp S-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGG
T ss_pred CChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCc
Confidence 999977542 478999999999999999999999986543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-21 Score=169.75 Aligned_cols=134 Identities=22% Similarity=0.272 Sum_probs=107.5
Q ss_pred eeeeeCcEEEEEEEEcCCCceEeeeecchhH-----hhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEec
Q 017362 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSE-----MLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (373)
Q Consensus 123 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~ 197 (373)
.||+|+||.||++. .++..+++|+..... ........++.+|+.++..+.|+++.....++.+....++||||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 38999999999998 457789999864321 11122345678899999999888765555455566677899999
Q ss_pred cCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccC
Q 017362 198 LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (373)
Q Consensus 198 ~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~ 266 (373)
++|++|.+++..... .++.+++.+|.+||+.|++|+|++|+||+++ ++.++|+|||++...
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999988754321 7899999999999999999999999999999 899999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-22 Score=205.46 Aligned_cols=204 Identities=22% Similarity=0.329 Sum_probs=158.4
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHh-hhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM-LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
+|...+.||++-|=+|.+|++.. | .|+||++-+... ..-.....-..|+. ...+++||.+++.-+-..+...|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 68888999999999999998753 3 489999866541 11122222222333 66678999999988888888899999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
+|. ..+|++.|..+..+..-+.++|+.|++.||.-+|..||+|+|||.+||||+.-..+.|+||.-.+....+..+..+
T Consensus 101 qyv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 101 QYV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HHH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 999 6699999988888999999999999999999999999999999999999999999999999987655444333322
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC-----------CChhhcHHHHH
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-----------YGMECDWWSLG 344 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-----------~~~~~DvwSlG 344 (373)
|..=-+ +...-..|+|||.+.... .+++.||||+|
T Consensus 180 f~fFFD----------------------------------TSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~G 225 (1431)
T KOG1240|consen 180 FTFFFD----------------------------------TSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAG 225 (1431)
T ss_pred ceEEEe----------------------------------cCCceeeecChHhhhccccccccCCcccccChhhhhhhhh
Confidence 221000 011224799999997532 56889999999
Q ss_pred HHHHHHHh-CCCCCC
Q 017362 345 AIMYEMLV-GYPPFY 358 (373)
Q Consensus 345 vil~ell~-G~~Pf~ 358 (373)
|+++||++ |.|||.
T Consensus 226 CViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 226 CVIAELFLEGRPLFT 240 (1431)
T ss_pred HHHHHHHhcCCCccc
Confidence 99999998 899995
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-21 Score=172.21 Aligned_cols=207 Identities=19% Similarity=0.282 Sum_probs=166.4
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 192 (373)
+...+..++.+|.+...|+.|+|++. |..++.|++...+...+. ...|..|.-.|+-..||||+.+++.|..+.++.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~ri-srdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARI-SRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred cchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcchhh-cchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 34455667789999999999998765 567788988776544332 345778888899999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCC--CeeecCCCCCEEEcCCCcEEEe--eccccccC
Q 017362 193 LIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHH--YIHRDIKPDNLLLDKYGHLRLS--DFGLCKPL 266 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g--iiHrDikp~NILl~~~~~vkL~--DFGla~~~ 266 (373)
++..|||.|+|+..|+... ..+..++..++.+++.|+.|||+.. |.---|....++||++-+.+|+ |--++..-
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe 343 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE 343 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec
Confidence 9999999999999998764 4677899999999999999999874 4444688889999998877664 32211100
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCC---hhhcHHHH
Q 017362 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYG---MECDWWSL 343 (373)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~---~~~DvwSl 343 (373)
......|.||+||.+...+-+ .++|+|||
T Consensus 344 ------------------------------------------------~gr~y~pawmspealqrkped~n~raadmwsf 375 (448)
T KOG0195|consen 344 ------------------------------------------------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSF 375 (448)
T ss_pred ------------------------------------------------cccccCcccCCHHHHhcCchhcchhhhhHHHH
Confidence 023467899999999877654 57999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHhh
Q 017362 344 GAIMYEMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 344 Gvil~ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
.+++|||.|...||...+|.+.-.||-
T Consensus 376 aillwel~trevpfadlspmecgmkia 402 (448)
T KOG0195|consen 376 AILLWELNTREVPFADLSPMECGMKIA 402 (448)
T ss_pred HHHHHHhhccccccccCCchhhhhhhh
Confidence 999999999999999999999888873
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=3e-20 Score=163.47 Aligned_cols=141 Identities=19% Similarity=0.154 Sum_probs=109.1
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhh-------------------hhhHHHHHHHHHHHHhcCCC-
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR-------------------RGQVEHVRAERNLLAEVDSN- 176 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------------------~~~~~~~~~e~~~l~~l~h~- 176 (373)
.|.+.+.||+|+||.||+|... +|+.||||++....... .........|..++..+.|+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3788899999999999999864 79999999876432000 00112356688888888776
Q ss_pred -ceeEEeeEEEeCCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcE
Q 017362 177 -CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHL 255 (373)
Q Consensus 177 -~iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~v 255 (373)
.++..++ ....++||||++|++|..+... .....++.+++.++.++|+.||+||||||+||+++.++.+
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence 3444443 2345899999999998765421 3456788999999999999999999999999999999999
Q ss_pred EEeeccccccCCC
Q 017362 256 RLSDFGLCKPLDC 268 (373)
Q Consensus 256 kL~DFGla~~~~~ 268 (373)
+|+|||+|.....
T Consensus 165 ~liDfg~~~~~~~ 177 (198)
T cd05144 165 YIIDWPQMVSTDH 177 (198)
T ss_pred EEEECCccccCCC
Confidence 9999999976654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=183.05 Aligned_cols=139 Identities=27% Similarity=0.291 Sum_probs=111.9
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCceEeeeecchh-----HhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEE
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKS-----EMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 192 (373)
|...+.||+|+||+||++..... .+++|+.... ........+.+.+|+.++..++|++++....++.+....+
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 45678999999999999876433 3444432211 1112223456888999999999999988877777777789
Q ss_pred EEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
+||||++|++|.+++. ....++.+++.+|.+||+.|++||||||+|||+ .++.++|+|||+|+...
T Consensus 413 lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~~ 478 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD 478 (535)
T ss_pred EEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence 9999999999999885 457789999999999999999999999999999 67899999999998653
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-19 Score=157.62 Aligned_cols=141 Identities=16% Similarity=0.200 Sum_probs=99.6
Q ss_pred eceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHH---------------------HHHHHHHHHHhcCCCc--
Q 017362 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVE---------------------HVRAERNLLAEVDSNC-- 177 (373)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~---------------------~~~~e~~~l~~l~h~~-- 177 (373)
.+.||+|+||+||+|.+. +++.||||++............ ....|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 567999999999999876 7899999998753211111111 1134555555554432
Q ss_pred eeEEeeEEEeCCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCCEEEcCCCcEE
Q 017362 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLR 256 (373)
Q Consensus 178 iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~giiHrDikp~NILl~~~~~vk 256 (373)
++..++. ...++||||++|+++........... ..+..++.+++.++.++|. +||+|+||||+||+++ ++.++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~ 154 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVY 154 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEE
Confidence 4444433 23589999999954432211111111 6788999999999999999 9999999999999999 89999
Q ss_pred EeeccccccCCC
Q 017362 257 LSDFGLCKPLDC 268 (373)
Q Consensus 257 L~DFGla~~~~~ 268 (373)
|+|||.+.....
T Consensus 155 liDfg~a~~~~~ 166 (187)
T cd05119 155 IIDVPQAVEIDH 166 (187)
T ss_pred EEECcccccccC
Confidence 999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.5e-19 Score=166.55 Aligned_cols=214 Identities=28% Similarity=0.407 Sum_probs=145.6
Q ss_pred hccCCCCCcceeceeeeeCcEEEEEEEEcCCC-----------------------------------ceEeeeecchhHh
Q 017362 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTG-----------------------------------HVYAMKKLKKSEM 154 (373)
Q Consensus 110 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-----------------------------------~~vaiK~~~~~~~ 154 (373)
...+..++|++...||+|....||.|....+| -+.|||.+-.-+.
T Consensus 151 dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~ 230 (598)
T KOG4158|consen 151 DSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEH 230 (598)
T ss_pred hcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccccc
Confidence 44677899999999999999999987644311 1245555432111
Q ss_pred hhhh--hHHHHHHHH------HH-----------HH-----hcCCCceeEEeeEEEe-----------------------
Q 017362 155 LRRG--QVEHVRAER------NL-----------LA-----EVDSNCIVKLYCSFQD----------------------- 187 (373)
Q Consensus 155 ~~~~--~~~~~~~e~------~~-----------l~-----~l~h~~iv~l~~~~~~----------------------- 187 (373)
.+.. ....+-+|. .. +. ..+|||||++..+|.+
T Consensus 231 ~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~ 310 (598)
T KOG4158|consen 231 DSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPS 310 (598)
T ss_pred CCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccc
Confidence 1100 011111221 00 00 1369999999988854
Q ss_pred ----CCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEc--CCC--cEEEee
Q 017362 188 ----DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD--KYG--HLRLSD 259 (373)
Q Consensus 188 ----~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~--~~~--~vkL~D 259 (373)
+..+|+||.-. ..+|..++..+ ..+....+-+++|++.|+.|||++||.|||+|.+|||+. +++ .+.|+|
T Consensus 311 g~g~~~tlylvMkrY-~~tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaD 388 (598)
T KOG4158|consen 311 GAGEPKTLYLVMKRY-RQTLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVAD 388 (598)
T ss_pred ccCCCceEEEehhcc-hhhHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcc
Confidence 23479999988 45899999654 466777888999999999999999999999999999993 333 578999
Q ss_pred ccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC-----C
Q 017362 260 FGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-----Y 334 (373)
Q Consensus 260 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-----~ 334 (373)
||+|-.-+..... ..|.. .-....|.-.-||||+....+ .
T Consensus 389 FGCcLAd~~hGlq-lpy~S----------------------------------~~Vd~GGNa~lmAPEi~ta~PGp~avv 433 (598)
T KOG4158|consen 389 FGCCLADDNHGLQ-LPYES----------------------------------DEVDLGGNAKLMAPEIATAVPGPNAVV 433 (598)
T ss_pred cceeeeccccccc-ccccc----------------------------------ccccCCCcceecchhhhhcCCCCceee
Confidence 9998532221100 00000 001345777889999986432 1
Q ss_pred -ChhhcHHHHHHHHHHHHhCCCCCCCC
Q 017362 335 -GMECDWWSLGAIMYEMLVGYPPFYSD 360 (373)
Q Consensus 335 -~~~~DvwSlGvil~ell~G~~Pf~~~ 360 (373)
-.++|.|+.|.+.||++....||++.
T Consensus 434 ny~kAD~WA~GalaYEIfg~~NPFY~r 460 (598)
T KOG4158|consen 434 NYEKADTWAAGALAYEIFGRSNPFYKR 460 (598)
T ss_pred ccchhhhhhhhhhHHHHhccCCccccc
Confidence 24799999999999999999999983
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.7e-20 Score=188.05 Aligned_cols=251 Identities=30% Similarity=0.500 Sum_probs=195.8
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 191 (373)
+...+.|.+++-+-+|+++.++.+.-..+|...++|+............+....+..++....+|.++.....|.....+
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 45778899999999999999999988788888888888777766666666677777777777789999888888888889
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
+|||+|+.|++|...|+..++.+++.++.++..++.++++||...++|||++|+|+|+..+|+.+++|||+......-..
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999996554322111
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
.... . |....+.. .......+. .++ ....-......+||+.|.+||...+...+..+|||++|++++|.+
T Consensus 960 ~~~~-s-g~~~~~~~---~~~~~~~~~--~~l---~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen 960 TTDL-S-GPSSSGTP---RRLSRSERR--PQL---SADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred cCCc-c-cccccCcc---ccccccccc--ccc---ccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhh
Confidence 0000 0 00000000 000000000 000 000001123678999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcC
Q 017362 352 VGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+|.+||.+..+..++..|+++
T Consensus 1030 ~g~pp~na~tpq~~f~ni~~~ 1050 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIFENILNR 1050 (1205)
T ss_pred cCCCCCCCcchhhhhhccccC
Confidence 999999999999999999876
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.1e-18 Score=151.79 Aligned_cols=138 Identities=20% Similarity=0.283 Sum_probs=104.7
Q ss_pred ceee-eeCcEEEEEEEEcCCCceEeeeecchhHh----h------hhhhHHHHHHHHHHHHhcCCCce--eEEeeEEEeC
Q 017362 122 TMIG-KGAFGEVRVCREKTTGHVYAMKKLKKSEM----L------RRGQVEHVRAERNLLAEVDSNCI--VKLYCSFQDD 188 (373)
Q Consensus 122 ~~lG-~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~------~~~~~~~~~~e~~~l~~l~h~~i--v~l~~~~~~~ 188 (373)
..|| .||.|+||.+... +..++||.+..... . .......+.+|+.++..+.|++| +..++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 7888888887653 67899998754221 0 11233567889999999988774 6666654432
Q ss_pred -Ce---EEEEEeccCC-CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeecccc
Q 017362 189 -EF---LYLIMEYLPG-GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (373)
Q Consensus 189 -~~---~~lV~E~~~g-g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla 263 (373)
.. .++|||+++| .+|.+++.. ..+++.. +.+++.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 22 2599999997 689888754 4566543 568999999999999999999999999999999999999998
Q ss_pred ccC
Q 017362 264 KPL 266 (373)
Q Consensus 264 ~~~ 266 (373)
...
T Consensus 190 ~~~ 192 (239)
T PRK01723 190 ELR 192 (239)
T ss_pred ccC
Confidence 764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-17 Score=138.16 Aligned_cols=134 Identities=20% Similarity=0.269 Sum_probs=112.7
Q ss_pred eeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCC--CceeEEeeEEEeCCeEEEEEec
Q 017362 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS--NCIVKLYCSFQDDEFLYLIMEY 197 (373)
Q Consensus 120 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~l~~~~~~~~~~~lV~E~ 197 (373)
+++.||.|.++.||++.... ..+++|.+..... ...+..|..++..+.+ .++++++..+...+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 45779999999999998643 6899999865421 3457789999998876 5899999888887889999999
Q ss_pred cCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhC---CCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 198 LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH---HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 198 ~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
++|+++..+ +......++.+++.+|.+||.. +++|+||+|+||+++..+.++++|||++...+
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 998877644 5667778899999999999985 79999999999999999999999999987644
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.7e-18 Score=165.19 Aligned_cols=126 Identities=29% Similarity=0.459 Sum_probs=105.5
Q ss_pred CeEEEEEeccCCCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRKD---TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
.++|+.|++|.-.+|.+||.++. ..+......++.|++.|++| +|.+|+|+||.||++..+..+||.||||.+.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 36899999999999999997654 35667888899999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHH
Q 017362 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (373)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGv 345 (373)
..... ...++... ++.-+||+.||+||.+.+..|+.++||||||+
T Consensus 406 ~~~~~------------------~~~~~~a~-----------------~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGl 450 (516)
T KOG1033|consen 406 QDKDE------------------TVAPAAAS-----------------HTQQVGTLLYMSPEQIRGQQYSEKVDIYALGL 450 (516)
T ss_pred cccCC------------------cccchhhh-----------------hhhcccccccCCHHHHhhhhhhhhcchhhHHH
Confidence 54321 01111111 12458999999999999999999999999999
Q ss_pred HHHHHHh
Q 017362 346 IMYEMLV 352 (373)
Q Consensus 346 il~ell~ 352 (373)
||+|+++
T Consensus 451 il~EL~~ 457 (516)
T KOG1033|consen 451 ILAELLI 457 (516)
T ss_pred HHHHHHH
Confidence 9999998
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.1e-19 Score=178.61 Aligned_cols=209 Identities=25% Similarity=0.409 Sum_probs=170.1
Q ss_pred CCCcceeceeeeeCcEEEEEEEEc-CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-CCceeEEeeEEEeCCeEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREK-TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~ 192 (373)
...|.+.+.||+|+|+.|-++... .....+|+|.+.... .......+...|..+-..+. |+|++.+++...+.+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 466888999999999999988763 344567777665443 22334455666777777776 999999999999999999
Q ss_pred EEEeccCCCCHHHHH-hhCC-CCCHHHHHHHHHHHHHHHHHHH-hCCCeeecCCCCCEEEcCCC-cEEEeeccccccCCC
Q 017362 193 LIMEYLPGGDMMTLL-MRKD-TLTEDEARFYVAETVLAIESIH-KHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPLDC 268 (373)
Q Consensus 193 lV~E~~~gg~L~~~l-~~~~-~l~~~~~~~i~~qi~~aL~~LH-~~giiHrDikp~NILl~~~~-~vkL~DFGla~~~~~ 268 (373)
++++|..|+++...+ .... ..+...+.+++.|+..++.|+| ..++.||||||+|.+++..+ .++++|||+|+.+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999888 4444 6888999999999999999999 99999999999999999999 999999999987654
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhcccccccc-CCCCcccccccCCC-CChhhcHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVG-TPDYIAPEVLLKKG-YGMECDWWSLGAI 346 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g-t~~Y~aPE~~~~~~-~~~~~DvwSlGvi 346 (373)
.... .......+| ++.|+|||...+.. .+...|+||.|++
T Consensus 178 ~~g~--------------------------------------~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~ 219 (601)
T KOG0590|consen 178 KNGA--------------------------------------ERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIV 219 (601)
T ss_pred cCCc--------------------------------------ceeeecccCCCCCCCCcccccchhhcCCCccccccccc
Confidence 1100 011224578 99999999998854 4788999999999
Q ss_pred HHHHHhCCCCCCCCCh
Q 017362 347 MYEMLVGYPPFYSDDP 362 (373)
Q Consensus 347 l~ell~G~~Pf~~~~~ 362 (373)
+.-+++|..|+.....
T Consensus 220 l~~~~~g~~p~~~~~~ 235 (601)
T KOG0590|consen 220 LSAMLTGELPWDFPSR 235 (601)
T ss_pred ccccccCCCCcccccc
Confidence 9999999999975443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1e-15 Score=148.68 Aligned_cols=163 Identities=26% Similarity=0.344 Sum_probs=130.4
Q ss_pred HHhcCCCceeEEeeEEEeCCeEEEEEeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCC-eeecCCCCCE
Q 017362 170 LAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHY-IHRDIKPDNL 247 (373)
Q Consensus 170 l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~gi-iHrDikp~NI 247 (373)
|+.+.|.|+.++++.+.++...++|.+||+-|+|.+.+.. .-.+++.-...++++++.||.|||...| .|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 3567899999999999999999999999999999999977 3468888899999999999999998765 9999999999
Q ss_pred EEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccc
Q 017362 248 LLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPE 327 (373)
Q Consensus 248 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE 327 (373)
+++..+.+||+|||+............ .....-..-|.|||
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~---------------------------------------~~~~~~~~lw~aPe 121 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEA---------------------------------------HHPIRKALLWTAPE 121 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccc---------------------------------------cchhHHHHhccCHH
Confidence 999999999999999876532000000 00111234689999
Q ss_pred cccCCC-------CChhhcHHHHHHHHHHHHhCCCCCCC----CChHHHHHHhhc
Q 017362 328 VLLKKG-------YGMECDWWSLGAIMYEMLVGYPPFYS----DDPMSTCRKVRK 371 (373)
Q Consensus 328 ~~~~~~-------~~~~~DvwSlGvil~ell~G~~Pf~~----~~~~~~~~kI~~ 371 (373)
.+.... .+.+.|+||||+|++|+++..-||.. .++.+...+|.+
T Consensus 122 llr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~ 176 (484)
T KOG1023|consen 122 LLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKK 176 (484)
T ss_pred HhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHh
Confidence 998642 36679999999999999999999986 344456656554
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.7e-16 Score=154.40 Aligned_cols=146 Identities=18% Similarity=0.313 Sum_probs=96.1
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhh-------------------------------hhhHHHHH
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR-------------------------------RGQVEHVR 164 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------------------------------~~~~~~~~ 164 (373)
.+|+. +.||+|++|.||.|..+.+|+.||||+.++..... ......+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 78999999999999998889999999997531000 01122344
Q ss_pred HHHHHHHhc----------CCCceeEEeeEEEe-CCeEEEEEeccCCCCHHHH--HhhCC----CCCHHHHHHHHHHHHH
Q 017362 165 AERNLLAEV----------DSNCIVKLYCSFQD-DEFLYLIMEYLPGGDMMTL--LMRKD----TLTEDEARFYVAETVL 227 (373)
Q Consensus 165 ~e~~~l~~l----------~h~~iv~l~~~~~~-~~~~~lV~E~~~gg~L~~~--l~~~~----~l~~~~~~~i~~qi~~ 227 (373)
+|+++..+. .+...+.+-.++.+ ....+|||||++|+.+.++ +...+ .+.+..+..++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 455444433 12222222122211 2335699999999999764 33332 23444444444444
Q ss_pred HHHHHHhCCCeeecCCCCCEEEcCCC----cEEEeeccccccCCCC
Q 017362 228 AIESIHKHHYIHRDIKPDNLLLDKYG----HLRLSDFGLCKPLDCS 269 (373)
Q Consensus 228 aL~~LH~~giiHrDikp~NILl~~~~----~vkL~DFGla~~~~~~ 269 (373)
+..|++|+|+||.||+++.+| .++++|||++..++..
T Consensus 277 -----f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 277 -----FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred -----HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 469999999999999999988 9999999999877543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.59 E-value=9.2e-15 Score=143.29 Aligned_cols=141 Identities=18% Similarity=0.260 Sum_probs=94.2
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhh-------------------------------hhHH------HHH
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR-------------------------------GQVE------HVR 164 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-------------------------------~~~~------~~~ 164 (373)
+.||.|++|.||+|.. .+|+.||||+.++.....- .... .+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5799999999999986 4789999999865310000 0001 122
Q ss_pred HHHHHHHhc----C-CCce--eEEeeEEEeCCeEEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHH-HHHHHHhC
Q 017362 165 AERNLLAEV----D-SNCI--VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVL-AIESIHKH 235 (373)
Q Consensus 165 ~e~~~l~~l----~-h~~i--v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~-aL~~LH~~ 235 (373)
+|..-+..+ . ++++ ++.+.. .....+|||||++|++|.++.... ...+ ...++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~--~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWD--RTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehh--hcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC
Confidence 333333332 2 3332 223322 233467999999999998876432 1222 2345555555 47789999
Q ss_pred CCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 236 giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
|++|+|+||.||+++.+|.++|+|||++..++.
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999987753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=9.2e-14 Score=120.82 Aligned_cols=142 Identities=13% Similarity=0.149 Sum_probs=102.6
Q ss_pred eceeeeeCcEEEEEEEEcC------CCceEeeeecchhHh--------h-----------hhhhHHHH----HHHHHHHH
Q 017362 121 LTMIGKGAFGEVRVCREKT------TGHVYAMKKLKKSEM--------L-----------RRGQVEHV----RAERNLLA 171 (373)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~--------~-----------~~~~~~~~----~~e~~~l~ 171 (373)
...||.|--+.||.|.... .+..+|||+.+.+.. . .......+ .+|...|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999997543 357899998753210 0 01112223 37888888
Q ss_pred hcCC--CceeEEeeEEEeCCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCeeecCCCCCEE
Q 017362 172 EVDS--NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI-HKHHYIHRDIKPDNLL 248 (373)
Q Consensus 172 ~l~h--~~iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~L-H~~giiHrDikp~NIL 248 (373)
++.. -+++.+++. ..-+|||||+.++.+..-..+...+++..+..+..+++.+|..| |+.|+||+||+|.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 8743 456666654 34569999997654433322334566677788889999999998 8999999999999999
Q ss_pred EcCCCcEEEeeccccccCC
Q 017362 249 LDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 249 l~~~~~vkL~DFGla~~~~ 267 (373)
++ ++.+.|+|||.|-...
T Consensus 158 ~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EE-CCcEEEEECCCceeCC
Confidence 97 4789999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.1e-14 Score=121.60 Aligned_cols=129 Identities=19% Similarity=0.217 Sum_probs=95.5
Q ss_pred eceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCce-eEEeeEEEeCCeEEEEEeccC
Q 017362 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCI-VKLYCSFQDDEFLYLIMEYLP 199 (373)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~l~~~~~~~~~~~lV~E~~~ 199 (373)
++.|+.|.++.||++... +..|++|+...... ....+..|..++..+.+.++ ++++... ....++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecC
Confidence 467899999999998754 77899998764421 11235668888887755443 4444443 233579999999
Q ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCC-----eeecCCCCCEEEcCCCcEEEeeccccccC
Q 017362 200 GGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY-----IHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (373)
Q Consensus 200 gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi-----iHrDikp~NILl~~~~~vkL~DFGla~~~ 266 (373)
|.++... ......++.+++.+|..||..++ +|+|++|.||+++ ++.++|+|||.+...
T Consensus 75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 9887643 11123456899999999999885 9999999999999 678999999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.2e-13 Score=113.94 Aligned_cols=135 Identities=21% Similarity=0.237 Sum_probs=103.0
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeec-----chhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEe
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKL-----KKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~-----~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E 196 (373)
..+++|+-+.+|.+.+. |.++++|.= ....+...-...+..+|..+++.+.--.|...+-++.+.+...|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35789999999988653 445666642 22333334445677889999999876666555556667777789999
Q ss_pred ccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccC
Q 017362 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (373)
Q Consensus 197 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~ 266 (373)
|++|-.|.+.+... ...++..+-.-+.-||..||||+||.++||++...+ +.++||||+..-
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 99998888888665 245677888888999999999999999999998755 999999999753
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.6e-12 Score=128.12 Aligned_cols=169 Identities=17% Similarity=0.252 Sum_probs=127.8
Q ss_pred EEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEeccCCCCHHHHHhhCCCC
Q 017362 134 VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTL 213 (373)
Q Consensus 134 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l 213 (373)
.|..+.++.+|.|.+.+.+.- ...+...+-+..|+.++||||++++..+...+.+|||+|-+. -|...+.+.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l--- 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL--- 101 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---
Confidence 355667788888888765532 334456667788999999999999999999999999999883 566666543
Q ss_pred CHHHHHHHHHHHHHHHHHHH-hCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCC
Q 017362 214 TEDEARFYVAETVLAIESIH-KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292 (373)
Q Consensus 214 ~~~~~~~i~~qi~~aL~~LH-~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (373)
........+.||+.||.||| +++++|++|.-+-|+++..|+.||++|.++...........
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~------------------ 163 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAK------------------ 163 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccc------------------
Confidence 37777888999999999997 68999999999999999999999999998864332110000
Q ss_pred CCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhC
Q 017362 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 353 (373)
...---.|..|+.+.... -..|.|-|||+++|++.|
T Consensus 164 -----------------------~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 164 -----------------------SLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -----------------------cchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 111122356666553332 446999999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.5e-13 Score=133.77 Aligned_cols=206 Identities=19% Similarity=0.235 Sum_probs=158.3
Q ss_pred CCCcceeceeee--eCcEEEEEEEE--cCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCC
Q 017362 115 ADDFELLTMIGK--GAFGEVRVCRE--KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (373)
Q Consensus 115 ~~~y~~~~~lG~--G~~g~Vy~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~ 189 (373)
...|.+...+|. |.+|.||.+.. ..++..+|+|.-+... ..+....+-.+|+.-...+ .|++.++.+..+...+
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCC-CCccccccccchhhcccccCccccccccCcccccCC
Confidence 345778888999 99999999988 7888999998733211 1111112223455444455 4899999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCCC-CCHHHHHHHHHHHHH----HHHHHHhCCCeeecCCCCCEEEcCC-CcEEEeecccc
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKDT-LTEDEARFYVAETVL----AIESIHKHHYIHRDIKPDNLLLDKY-GHLRLSDFGLC 263 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~~-l~~~~~~~i~~qi~~----aL~~LH~~giiHrDikp~NILl~~~-~~vkL~DFGla 263 (373)
.+|+-.|++ +.+|..+...... ++...+..+..+... ||.++|..+++|-|+||+||++..+ ...+++|||+.
T Consensus 192 ~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 192 ILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred cceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 999999988 6788888766554 788888888888888 9999999999999999999999999 88999999999
Q ss_pred ccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHH
Q 017362 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (373)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSl 343 (373)
..+........... .....|..-|++||.. .+-++...|++||
T Consensus 271 ~~i~~~~~~~~~~~------------------------------------~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl 313 (524)
T KOG0601|consen 271 SKISDGNFSSVFKV------------------------------------SKRPEGDCIYAAKELL-NGLATFASDIFSL 313 (524)
T ss_pred EEccCCccccceee------------------------------------eecCCCCceEeChhhh-ccccchHhhhcch
Confidence 87765542211000 0123577789999986 6678999999999
Q ss_pred HHHHHHHHhCCCCCCC
Q 017362 344 GAIMYEMLVGYPPFYS 359 (373)
Q Consensus 344 Gvil~ell~G~~Pf~~ 359 (373)
|.+..+..+|..++..
T Consensus 314 ~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 314 GEVILEAILGSHLPSV 329 (524)
T ss_pred hhhhHhhHhhcccccC
Confidence 9999999888666543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.3e-13 Score=134.18 Aligned_cols=199 Identities=24% Similarity=0.259 Sum_probs=153.5
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEc-CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCe
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREK-TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~ 190 (373)
....+|..+..||.|.|+.|+.+... .++..|++|.+.+.-......+. -..|+.+...+ .|.+++..+..|.....
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~-sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIF-SLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhc-chhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34678999999999999999998755 67788999987654332222222 23355455444 58899999988888888
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCC-CcEEEeeccccccCCCC
Q 017362 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY-GHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~-~~vkL~DFGla~~~~~~ 269 (373)
.|+--|||.++++.........+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||+++.+...
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence 89999999999988777666678899999999999999999999999999999999999886 78899999998754322
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCc--ccccccCCCCChhhcHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYI--APEVLLKKGYGMECDWWSLGAIM 347 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~--aPE~~~~~~~~~~~DvwSlGvil 347 (373)
.. ...++-.+. +|.......+..+.|++|||.-+
T Consensus 421 ~~--------------------------------------------~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~ 456 (524)
T KOG0601|consen 421 SG--------------------------------------------VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSV 456 (524)
T ss_pred cc--------------------------------------------cccccccccccchhhccccccccccccccccccc
Confidence 10 111222333 55555567788999999999999
Q ss_pred HHHHhCCCC
Q 017362 348 YEMLVGYPP 356 (373)
Q Consensus 348 ~ell~G~~P 356 (373)
.+.++|.+.
T Consensus 457 ~e~~~~~~l 465 (524)
T KOG0601|consen 457 DEAITGSPL 465 (524)
T ss_pred cccccCccc
Confidence 999888654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.40 E-value=6.6e-12 Score=105.64 Aligned_cols=145 Identities=22% Similarity=0.271 Sum_probs=108.6
Q ss_pred eeceeeeeCcEEEEEEEEcCCCceEeeee-----cchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKK-----LKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 120 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~-----~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.+..|-+|+-+.|+.+.+ .|+.+.||. .+...+...-...+..+|..++.++.--.|.-..-+|.|...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 567789999999998875 477777773 2333333344456788899999988655555555566677777899
Q ss_pred EeccCC-CCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC---cEEEeeccccccC
Q 017362 195 MEYLPG-GDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---HLRLSDFGLCKPL 266 (373)
Q Consensus 195 ~E~~~g-g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~---~vkL~DFGla~~~ 266 (373)
|||++| .++.+++... .....+....++..+-..|.-||..+|||+||..+||++..+| .+.|+|||++..-
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 999987 3677777543 2333444478899999999999999999999999999997655 3589999998654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.31 E-value=1e-11 Score=110.52 Aligned_cols=142 Identities=17% Similarity=0.237 Sum_probs=105.6
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCC--CceeEEeeEEEeC---CeEEEEEe
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS--NCIVKLYCSFQDD---EFLYLIME 196 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~l~~~~~~~---~~~~lV~E 196 (373)
+.||.|.++.||++... +|..+++|+....... .....+..|..++..+.+ ..+++++.+.... +..|+|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 56899999999998764 3578999987654321 123457788999988865 3456666666543 25689999
Q ss_pred ccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 017362 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK------------------------------------------ 234 (373)
Q Consensus 197 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~------------------------------------------ 234 (373)
|++|.++...+.. ..+++.....++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999888765532 456777777777888888887773
Q ss_pred --------------CCCeeecCCCCCEEEcC--CCcEEEeeccccccCC
Q 017362 235 --------------HHYIHRDIKPDNLLLDK--YGHLRLSDFGLCKPLD 267 (373)
Q Consensus 235 --------------~giiHrDikp~NILl~~--~~~vkL~DFGla~~~~ 267 (373)
..++|+|++|+|||++. ++.+.|+||+.+...+
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g~ 208 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLGD 208 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccCC
Confidence 23699999999999998 6778999999887543
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.2e-11 Score=112.39 Aligned_cols=189 Identities=19% Similarity=0.273 Sum_probs=128.0
Q ss_pred EEEEEEEcCCCceEeeeecchhHhhhh-hhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCe-----EEEEEeccCCCCHH
Q 017362 131 EVRVCREKTTGHVYAMKKLKKSEMLRR-GQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF-----LYLIMEYLPGGDMM 204 (373)
Q Consensus 131 ~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~-----~~lV~E~~~gg~L~ 204 (373)
.||++-+...|.+|..-.+......+. .+.+....-++-|-.+.|.|||++..++.+.++ ..++.|||..|+|.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 356655555555554433322211111 111222223334555679999999988876544 78999999999999
Q ss_pred HHHhh----CCCCCHHHHHHHHHHHHHHHHHHHhC--CCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccc
Q 017362 205 TLLMR----KDTLTEDEARFYVAETVLAIESIHKH--HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278 (373)
Q Consensus 205 ~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~--giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 278 (373)
.+|.+ ...+.....++|+-||+.||.|||+. .|+|+++..+-|++..+|-||+.--..... ..+-
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~-h~s~-------- 231 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDST-HPSV-------- 231 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCcccc-chhh--------
Confidence 99975 23588999999999999999999986 599999999999999999998853211110 0000
Q ss_pred cCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCC
Q 017362 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356 (373)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 356 (373)
...+. .++ .--.|-++|.|||.=.....+.++|||+||.+..||..|..-
T Consensus 232 ---------------~~~~~-------~Ek------~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq 281 (458)
T KOG1266|consen 232 ---------------NSTRE-------AEK------SVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQ 281 (458)
T ss_pred ---------------hhhhH-------hhh------hccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheec
Confidence 00000 000 012467899999987777778899999999999999987654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.1e-09 Score=100.33 Aligned_cols=126 Identities=13% Similarity=0.106 Sum_probs=88.6
Q ss_pred CCceEeeeecchhHh---hhh-----hhHHHHHHHHHHHHhcCCCc--eeEEeeEEEe-----CCeEEEEEeccCCC-CH
Q 017362 140 TGHVYAMKKLKKSEM---LRR-----GQVEHVRAERNLLAEVDSNC--IVKLYCSFQD-----DEFLYLIMEYLPGG-DM 203 (373)
Q Consensus 140 ~~~~vaiK~~~~~~~---~~~-----~~~~~~~~e~~~l~~l~h~~--iv~l~~~~~~-----~~~~~lV~E~~~gg-~L 203 (373)
.|+.|.||....... ... .....+.+|...+..+...+ ++.++.++.. ....++|||++++. +|
T Consensus 44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL 123 (268)
T PRK15123 44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISL 123 (268)
T ss_pred CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccH
Confidence 466788886533221 000 11123667888777764322 2333444432 23468999999886 78
Q ss_pred HHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC-------CCcEEEeecccccc
Q 017362 204 MTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-------YGHLRLSDFGLCKP 265 (373)
Q Consensus 204 ~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~-------~~~vkL~DFGla~~ 265 (373)
.+++.. ....+......++.+++..+.-||..||+|+|++|.|||++. ++.+.|+||+.+..
T Consensus 124 ~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 124 EDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 888753 345667788899999999999999999999999999999975 46899999998853
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.13 E-value=5.1e-10 Score=97.00 Aligned_cols=129 Identities=22% Similarity=0.259 Sum_probs=82.6
Q ss_pred EEEEEEEcCCCceEeeeecchhH-----------------------hhhhhhHHHHHHHHHHHHhcCCC--ceeEEeeEE
Q 017362 131 EVRVCREKTTGHVYAMKKLKKSE-----------------------MLRRGQVEHVRAERNLLAEVDSN--CIVKLYCSF 185 (373)
Q Consensus 131 ~Vy~~~~~~~~~~vaiK~~~~~~-----------------------~~~~~~~~~~~~e~~~l~~l~h~--~iv~l~~~~ 185 (373)
.||.|.. ..|..+|||+.+... ...........+|...|..+..- ++++++.+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888876 457789999874311 01111234567899999999765 466666442
Q ss_pred EeCCeEEEEEeccC--CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHH-HHhCCCeeecCCCCCEEEcCCCcEEEeeccc
Q 017362 186 QDDEFLYLIMEYLP--GGDMMTLLMRKDTLTEDEARFYVAETVLAIES-IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (373)
Q Consensus 186 ~~~~~~~lV~E~~~--gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~-LH~~giiHrDikp~NILl~~~~~vkL~DFGl 262 (373)
. -+|||||++ |..+..+. .. .++......++.+++..+.. +|..||||+||.+.|||++.+ .+.|+|||.
T Consensus 80 --~--~~ivME~I~~~G~~~~~l~-~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 --R--NVIVMEYIGEDGVPLPRLK-DV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp --T--TEEEEE--EETTEEGGCHH-HC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred --C--CEEEEEecCCCccchhhHH-hc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 2 359999998 55554433 22 12245567777888885555 589999999999999999987 999999999
Q ss_pred cccCC
Q 017362 263 CKPLD 267 (373)
Q Consensus 263 a~~~~ 267 (373)
|....
T Consensus 153 av~~~ 157 (188)
T PF01163_consen 153 AVDSS 157 (188)
T ss_dssp EEETT
T ss_pred ceecC
Confidence 87544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=9e-10 Score=103.53 Aligned_cols=191 Identities=15% Similarity=0.168 Sum_probs=126.8
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEE-------EeCC
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSF-------QDDE 189 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~-------~~~~ 189 (373)
......||+|+.+.+|-.-.. +-. +-|+++...... -...+..|... .||-+-.-+.+- ....
T Consensus 13 i~~gr~LgqGgea~ly~l~e~--~d~-VAKIYh~Pppa~------~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~ 83 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEV--RDQ-VAKIYHAPPPAA------QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGK 83 (637)
T ss_pred cCCCccccCCccceeeecchh--hch-hheeecCCCchH------HHHHHHHhccCCCCcchhhhhcccHHHhhCCCccc
Confidence 345678999999999954321 223 347776654211 11223334433 555332211111 1122
Q ss_pred eEEEEEeccCCCC-HHHHHh------hCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccc
Q 017362 190 FLYLIMEYLPGGD-MMTLLM------RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (373)
Q Consensus 190 ~~~lV~E~~~gg~-L~~~l~------~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGl 262 (373)
..-+.|..++|-. ...++. ....+.|+-+...++.++.+.+.||..|.+-+|+.++|+|+++++.|.|.|-.-
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence 2557888887642 222221 123578899999999999999999999999999999999999999999987442
Q ss_pred cccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc-----CCCCChh
Q 017362 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGME 337 (373)
Q Consensus 263 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~ 337 (373)
........ +..-.+|.+.|.+||... +.+-+..
T Consensus 164 fqi~~ng~------------------------------------------~~~cpVg~~eftPPElQ~~~sf~g~~r~~~ 201 (637)
T COG4248 164 FQINANGT------------------------------------------LHLCPVGVSEFTPPELQTLPSFVGFERTAN 201 (637)
T ss_pred eeeccCCc------------------------------------------eEecccCccccCCHHHhccccccccCCCcc
Confidence 22111110 112458999999999876 3345678
Q ss_pred hcHHHHHHHHHHHHhC-CCCCCC
Q 017362 338 CDWWSLGAIMYEMLVG-YPPFYS 359 (373)
Q Consensus 338 ~DvwSlGvil~ell~G-~~Pf~~ 359 (373)
.|-|.|||++|++|.| +.||.+
T Consensus 202 hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 202 HDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred ccchhHHHHHHHHHhcCCCCCCc
Confidence 9999999999999986 999986
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.7e-09 Score=103.97 Aligned_cols=135 Identities=17% Similarity=0.240 Sum_probs=109.2
Q ss_pred cEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEE----eCCeEEEEEeccCCC-CH
Q 017362 129 FGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ----DDEFLYLIMEYLPGG-DM 203 (373)
Q Consensus 129 ~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~----~~~~~~lV~E~~~gg-~L 203 (373)
-.+.|+|....+|..|++|.++-........ ...-+++++++.|+|||++.++|. .+..+++|++|.|+. +|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk---~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNK---DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCccc---chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 4678999999999999999995443322222 333567899999999999998887 345689999999974 77
Q ss_pred HHHHhh---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccC
Q 017362 204 MTLLMR---------------KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (373)
Q Consensus 204 ~~~l~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~ 266 (373)
.++... ....+|..++.|+.|+..||.++|+.|+.-+-|.|.+||++.+.+|+|+..|+...+
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeee
Confidence 776532 224678999999999999999999999999999999999998889999887776544
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.99 E-value=7.7e-09 Score=91.45 Aligned_cols=106 Identities=23% Similarity=0.273 Sum_probs=83.3
Q ss_pred HHHHHHHHHHHhcCCC--ceeEEeeEEEeC----CeEEEEEeccCCC-CHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHH
Q 017362 161 EHVRAERNLLAEVDSN--CIVKLYCSFQDD----EFLYLIMEYLPGG-DMMTLLMRKDTLTEDEARFYVAETVLAIESIH 233 (373)
Q Consensus 161 ~~~~~e~~~l~~l~h~--~iv~l~~~~~~~----~~~~lV~E~~~gg-~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH 233 (373)
....+|...+..+..- .++..+++.... ...++|+|+++|. +|.+++......+......++.+++..+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 4466677766666432 244445554432 2358999999985 89999877555778888999999999999999
Q ss_pred hCCCeeecCCCCCEEEcCCC---cEEEeeccccccC
Q 017362 234 KHHYIHRDIKPDNLLLDKYG---HLRLSDFGLCKPL 266 (373)
Q Consensus 234 ~~giiHrDikp~NILl~~~~---~vkL~DFGla~~~ 266 (373)
..||+|+|++|.|||++.++ .+.|+||+-++..
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999999999999887 8999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.2e-08 Score=91.50 Aligned_cols=140 Identities=18% Similarity=0.199 Sum_probs=100.3
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCceEeeeecchhH-----------h------hh--hhhHHHHHHHHHHHHhcCCC--
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSE-----------M------LR--RGQVEHVRAERNLLAEVDSN-- 176 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----------~------~~--~~~~~~~~~e~~~l~~l~h~-- 176 (373)
..+...||-|--|.||.|.+. .|.++|||.-+... . .+ ........+|..+|..+...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 446789999999999999874 67899999643110 0 00 11223456788888888544
Q ss_pred ceeEEeeEEEeCCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEE
Q 017362 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLR 256 (373)
Q Consensus 177 ~iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vk 256 (373)
.++..++. +...+||||+.|-.|...- ++.+.+..++..|+.-+.-+-..||||+|+.+=|||++.+|.+.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 56666654 4456999999886665432 24455555666666666666689999999999999999999999
Q ss_pred EeeccccccCC
Q 017362 257 LSDFGLCKPLD 267 (373)
Q Consensus 257 L~DFGla~~~~ 267 (373)
++||--+....
T Consensus 243 vIDwPQ~v~~~ 253 (304)
T COG0478 243 VIDWPQAVPIS 253 (304)
T ss_pred EEeCcccccCC
Confidence 99999876543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.87 E-value=3.6e-08 Score=86.53 Aligned_cols=142 Identities=18% Similarity=0.259 Sum_probs=91.8
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHH------HHHHHHHHhc---CCCceeEEee
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHV------RAERNLLAEV---DSNCIVKLYC 183 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~------~~e~~~l~~l---~h~~iv~l~~ 183 (373)
+...+|.+++.+-.....-|.+.. .+|..+++|..+............+ .+.+..+..+ .-...+.++.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 346789999999888877777654 5578999998865432211111111 1222222222 2223333222
Q ss_pred EEE-----eCCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEe
Q 017362 184 SFQ-----DDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLS 258 (373)
Q Consensus 184 ~~~-----~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~ 258 (373)
+.. -....++||||++|..|.+... +++ .+...+..+|.-||+.|+.|+|..|.|++++.+ .++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iI 176 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRII 176 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEE
Confidence 222 2234568999999988866542 333 244567788999999999999999999999964 49999
Q ss_pred ecccccc
Q 017362 259 DFGLCKP 265 (373)
Q Consensus 259 DFGla~~ 265 (373)
||+..+.
T Consensus 177 D~~~k~~ 183 (229)
T PF06176_consen 177 DTQGKRM 183 (229)
T ss_pred ECccccc
Confidence 9987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.4e-07 Score=82.57 Aligned_cols=140 Identities=11% Similarity=0.148 Sum_probs=98.4
Q ss_pred eeeeCcEEEEEEEEcCCCceEeeeecchh---HhhhhhhHHHHHHHHHHHHhcCCC--ceeEEeeEEEe--C--CeEEEE
Q 017362 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKS---EMLRRGQVEHVRAERNLLAEVDSN--CIVKLYCSFQD--D--EFLYLI 194 (373)
Q Consensus 124 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~~e~~~l~~l~h~--~iv~l~~~~~~--~--~~~~lV 194 (373)
-|+||-+-|+.... .|..+-+|.-... ...-+.....|.+|+..+..+..- .+++....... + -..+||
T Consensus 26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 36788888987543 3446777765311 011022345688899888877432 24444422211 1 236799
Q ss_pred EeccCC-CCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCc--EEEeecccccc
Q 017362 195 MEYLPG-GDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH--LRLSDFGLCKP 265 (373)
Q Consensus 195 ~E~~~g-g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~--vkL~DFGla~~ 265 (373)
+|-++| -||.+++... .+.+......++.+++..|.-||+.|+.|+|+.+.|||++..|. |.++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998865 3888888553 34577777899999999999999999999999999999987777 99999987654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.3e-07 Score=94.00 Aligned_cols=145 Identities=19% Similarity=0.251 Sum_probs=90.4
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhh--------------------h-----------hhhHHHHHHHHHHH
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML--------------------R-----------RGQVEHVRAERNLL 170 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--------------------~-----------~~~~~~~~~e~~~l 170 (373)
..|+.++-|.||.|..+ +|+.||||+.++.-.. . ....+.+..|++..
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 56899999999999875 4999999997642100 0 00011222333322
Q ss_pred ------Hhc-----CCCceeEEeeEEEeCCeEEEEEeccCCCCHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 017362 171 ------AEV-----DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHKHHYI 238 (373)
Q Consensus 171 ------~~l-----~h~~iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~gii 238 (373)
.++ +.+++.-.--++.-...-.|+|||++|-.+.+... +...++...+.....++.. .-+=..|+.
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~--~q~~~dgff 287 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFL--RQLLRDGFF 287 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHH--HHHHhcCcc
Confidence 222 12333222222222233469999999988888742 2345664443333333322 223348999
Q ss_pred eecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 239 HrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
|.|.+|.||+++.+|++.+.|||+...++..
T Consensus 288 HaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 288 HADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred ccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 9999999999999999999999999877644
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.63 E-value=4.8e-07 Score=80.43 Aligned_cols=142 Identities=18% Similarity=0.172 Sum_probs=93.7
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhh---------------------hHHHHHHHHHHHHhcC--CCce
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRG---------------------QVEHVRAERNLLAEVD--SNCI 178 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~---------------------~~~~~~~e~~~l~~l~--h~~i 178 (373)
..|+.|--+.||+|.. .++..+|+|+++........ .......|..-|.++. +-.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3677888889999875 56789999998654322111 0112233444444442 3344
Q ss_pred eEEeeEEEeCCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCCEEEcCCCcEEE
Q 017362 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRL 257 (373)
Q Consensus 179 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~giiHrDikp~NILl~~~~~vkL 257 (373)
++.+.+.. -.|||||++...+..=..+.-.+..+.+..+..+++..+.-|-. .|+||+||..=|||+. ++.+.|
T Consensus 133 P~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~i 207 (268)
T COG1718 133 PEPIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYI 207 (268)
T ss_pred CCceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEE
Confidence 45554432 24999999543111111122234444788888899999888876 9999999999999999 899999
Q ss_pred eeccccccCCCC
Q 017362 258 SDFGLCKPLDCS 269 (373)
Q Consensus 258 ~DFGla~~~~~~ 269 (373)
+|||-|.....+
T Consensus 208 ID~~QaV~~~hp 219 (268)
T COG1718 208 IDVSQAVTIDHP 219 (268)
T ss_pred EECccccccCCC
Confidence 999998766533
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.61 E-value=5.9e-07 Score=80.57 Aligned_cols=136 Identities=21% Similarity=0.153 Sum_probs=83.8
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCC--ceeEEeeEEEeCCeEEEEEeccC
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN--CIVKLYCSFQDDEFLYLIMEYLP 199 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~l~~~~~~~~~~~lV~E~~~ 199 (373)
..||+|..+.||++. +..+++|...... ....+.+|..++..+..- .+++.+.+..+.+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----TGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEec----CCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 568999999999742 4467789876422 223467788888887543 24667777777777889999998
Q ss_pred CCC-HHHHH---------------------hhC--CCCCHHH-HHHHHH----------HHHH-HHHHHH----hCCCee
Q 017362 200 GGD-MMTLL---------------------MRK--DTLTEDE-ARFYVA----------ETVL-AIESIH----KHHYIH 239 (373)
Q Consensus 200 gg~-L~~~l---------------------~~~--~~l~~~~-~~~i~~----------qi~~-aL~~LH----~~giiH 239 (373)
|.+ +...+ +.- ....... ...+.. .+.. ...+|. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 864 11111 110 0111000 001100 0111 122222 124789
Q ss_pred ecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 240 rDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
+|+.|.||+++.++ +.|+||+.+..-+
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~Gd 184 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGYGN 184 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCcCC
Confidence 99999999999888 9999999886543
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=7.2e-09 Score=102.04 Aligned_cols=188 Identities=21% Similarity=0.279 Sum_probs=138.9
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCc-eeEEeeEEEeCCeEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC-IVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~l~~~~~~~~~~~lV 194 (373)
.-+.....+++|+++++++.+...+...+ .+++... ....-++++|.+++||| .+..++.++.+.+.+++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence 34566677899999999988765554444 5554332 22455888999999999 77778888888899999
Q ss_pred EeccCCC-CHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcc
Q 017362 195 MEYLPGG-DMMTLLM-RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 195 ~E~~~gg-~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 272 (373)
|+++.++ +-..... ..-.+.+-+...+...-..+++++|+.-=+|+| |||... +..+++||+....+....
T Consensus 313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-- 385 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-- 385 (829)
T ss_pred hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc--
Confidence 9999887 2221111 111244445556667777899999998888998 777655 788999999887654321
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 352 (373)
...+..+|+.++|||+.....+....|.||+|+-..+|--
T Consensus 386 ----------------------------------------~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap 425 (829)
T KOG0576|consen 386 ----------------------------------------KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAP 425 (829)
T ss_pred ----------------------------------------ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCC
Confidence 0115689999999999999999999999999998788888
Q ss_pred CCCCCCC
Q 017362 353 GYPPFYS 359 (373)
Q Consensus 353 G~~Pf~~ 359 (373)
|-+|-.+
T Consensus 426 ~~pPr~~ 432 (829)
T KOG0576|consen 426 GLPPRSS 432 (829)
T ss_pred CCCCCCC
Confidence 8887654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.6e-08 Score=100.60 Aligned_cols=111 Identities=20% Similarity=0.415 Sum_probs=82.7
Q ss_pred HHHHHHHHHHh-CCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC-cccccccccCCCCCCCCCCCCCCCCccchHH
Q 017362 224 ETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST-LQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301 (373)
Q Consensus 224 qi~~aL~~LH~-~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (373)
+++.|+.|+|. .++||++|.|++|.++.+|.+||+.|+++-...... +.-..++ +
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd--------------~--------- 163 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYD--------------P--------- 163 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCC--------------C---------
Confidence 34489999996 589999999999999999999999999986544321 1111110 0
Q ss_pred HHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH-hCCCCCCCCChHHHHH
Q 017362 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGYPPFYSDDPMSTCR 367 (373)
Q Consensus 302 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell-~G~~Pf~~~~~~~~~~ 367 (373)
.+.....-...|.|||++....-+.++|+|||||++|-+. .|+..|.+......+.
T Consensus 164 ----------~lp~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~ 220 (700)
T KOG2137|consen 164 ----------PLPLLLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS 220 (700)
T ss_pred ----------CCChhhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhh
Confidence 0111234567899999999988899999999999999999 6888777766555554
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=9.7e-07 Score=87.56 Aligned_cols=143 Identities=22% Similarity=0.271 Sum_probs=89.2
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhh----------------------------hhhhHHHHHHHHHHHHh-
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML----------------------------RRGQVEHVRAERNLLAE- 172 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----------------------------~~~~~~~~~~e~~~l~~- 172 (373)
+.||.-+.|.||+|+.+. |+.||||+-++.--. -.+....+..|++...+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 468999999999998765 999999986542100 00011122333333322
Q ss_pred ---------cCCCc------eeEEeeEEEeCCeEEEEEeccCCCCHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 017362 173 ---------VDSNC------IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHKHH 236 (373)
Q Consensus 173 ---------l~h~~------iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~g 236 (373)
+.|-+ |+++|-.+. ..-.|+||||+|..+.++.. .+..++...+...+.++.. .-|-..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcC
Confidence 23333 444443332 23569999999986665532 2344665544333333222 1233578
Q ss_pred CeeecCCCCCEEEcC----CCcEEEeeccccccCCCC
Q 017362 237 YIHRDIKPDNLLLDK----YGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 237 iiHrDikp~NILl~~----~~~vkL~DFGla~~~~~~ 269 (373)
++|.|-+|.||+++. ++.+.+-|||+...+...
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 999999999999984 678999999999877644
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.45 E-value=4.3e-06 Score=74.54 Aligned_cols=138 Identities=21% Similarity=0.327 Sum_probs=80.6
Q ss_pred eceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCC--ceeEEeeEEE---eCCeEEEEE
Q 017362 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN--CIVKLYCSFQ---DDEFLYLIM 195 (373)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~l~~~~~---~~~~~~lV~ 195 (373)
++.|+.|..+.||.+.... ..+++|+.... .....+..|..++..+... .++.++.... .....+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4678999999999987654 48899997654 1234466777777766432 3556665433 334578999
Q ss_pred eccCCCCHHH----------------HH---hhC----CCCCHHH------HHHH---------------HHHHHH-HHH
Q 017362 196 EYLPGGDMMT----------------LL---MRK----DTLTEDE------ARFY---------------VAETVL-AIE 230 (373)
Q Consensus 196 E~~~gg~L~~----------------~l---~~~----~~l~~~~------~~~i---------------~~qi~~-aL~ 230 (373)
++++|..+.. .+ +.. ..+.... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999988777 11 111 1111000 0000 111222 233
Q ss_pred HHH-------hCCCeeecCCCCCEEEc-CCCcEEEeecccccc
Q 017362 231 SIH-------KHHYIHRDIKPDNLLLD-KYGHLRLSDFGLCKP 265 (373)
Q Consensus 231 ~LH-------~~giiHrDikp~NILl~-~~~~vkL~DFGla~~ 265 (373)
.++ ...++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 333 24599999999999999 667778999998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.42 E-value=2.7e-06 Score=77.13 Aligned_cols=136 Identities=18% Similarity=0.116 Sum_probs=81.7
Q ss_pred eeeeCc-EEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-CCceeEEeeEEEeCCeEEEEEeccCCC
Q 017362 124 IGKGAF-GEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYLIMEYLPGG 201 (373)
Q Consensus 124 lG~G~~-g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~lV~E~~~gg 201 (373)
|-.|.. ..||++... +..+.+|+..... ...+..|..++..+. +--++++++.....+..++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 334444 789987543 4678888875432 223556777777663 344667777777666788999999998
Q ss_pred CHHHHH-------------------hhCC----CCCHH------HHHHH-------------------HHHHHHHHHHH-
Q 017362 202 DMMTLL-------------------MRKD----TLTED------EARFY-------------------VAETVLAIESI- 232 (373)
Q Consensus 202 ~L~~~l-------------------~~~~----~l~~~------~~~~i-------------------~~qi~~aL~~L- 232 (373)
+|.... +.-. ++... ..... ..++...|...
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 776432 0000 11100 00000 01111111110
Q ss_pred ---HhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 233 ---HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 233 ---H~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
....++|+|+.|.|||++.++.+.|+||+.|...+
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~gd 195 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVAD 195 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEcccccccc
Confidence 12348999999999999998778899999886443
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.31 E-value=7.5e-06 Score=87.06 Aligned_cols=147 Identities=20% Similarity=0.338 Sum_probs=90.0
Q ss_pred eeceeeeeCcEEEEEEEEcCCC--ceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-CCce--eEEeeEEEeC---CeE
Q 017362 120 LLTMIGKGAFGEVRVCREKTTG--HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCI--VKLYCSFQDD---EFL 191 (373)
Q Consensus 120 ~~~~lG~G~~g~Vy~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i--v~l~~~~~~~---~~~ 191 (373)
.+..|+.|.+..+|+......+ ..+++|+....... .....+.+|..++..+. |+++ ++++.++.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3577899999999988654332 36777776443211 11235778999998885 5554 7777777664 457
Q ss_pred EEEEeccCCCCHHH--------------------HH---hhCC----C---------CCHHHHHHHHH------------
Q 017362 192 YLIMEYLPGGDMMT--------------------LL---MRKD----T---------LTEDEARFYVA------------ 223 (373)
Q Consensus 192 ~lV~E~~~gg~L~~--------------------~l---~~~~----~---------l~~~~~~~i~~------------ 223 (373)
|+||||++|..+.+ .| +.-. . +...++..+..
T Consensus 120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~ 199 (822)
T PLN02876 120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP 199 (822)
T ss_pred eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence 89999998864321 11 1100 0 01122222211
Q ss_pred ---HHHHHHHHHHh-----------CCCeeecCCCCCEEEcCC-Cc-EEEeeccccccCCC
Q 017362 224 ---ETVLAIESIHK-----------HHYIHRDIKPDNLLLDKY-GH-LRLSDFGLCKPLDC 268 (373)
Q Consensus 224 ---qi~~aL~~LH~-----------~giiHrDikp~NILl~~~-~~-vkL~DFGla~~~~~ 268 (373)
.+...+.+|.. ..+||+|++|+|||++.+ +. +-|.||+++..-++
T Consensus 200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~GdP 260 (822)
T PLN02876 200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGNQ 260 (822)
T ss_pred CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCCh
Confidence 12233556632 249999999999999853 33 57999999876543
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.1e-05 Score=70.29 Aligned_cols=129 Identities=21% Similarity=0.335 Sum_probs=89.7
Q ss_pred CCCcceeceeeeeCc-EEEEEEEEcCCCceEeeeecchhH----------hhh--------hhhHHHHHHHHHHHHhc--
Q 017362 115 ADDFELLTMIGKGAF-GEVRVCREKTTGHVYAMKKLKKSE----------MLR--------RGQVEHVRAERNLLAEV-- 173 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~-g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~--------~~~~~~~~~e~~~l~~l-- 173 (373)
..+++.++.||.|.. |.||++.. .|..||||++..-. ... .....-|..|.....++
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 478999999999999 99999875 47799999932100 000 01223466677665555
Q ss_pred -CCCce--eEEeeEEEeC------------------CeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHH
Q 017362 174 -DSNCI--VKLYCSFQDD------------------EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232 (373)
Q Consensus 174 -~h~~i--v~l~~~~~~~------------------~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~L 232 (373)
.+..+ |+++++..-. ...-||.||++... .++ ..-+.+|..-|..+
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----IRDIPQMLRDLKIL 180 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----hhHHHHHHHHHHHH
Confidence 45555 8998887422 11357888876643 222 23356788888999
Q ss_pred HhCCCeeecCCCCCEEEcCCCcEEEeecccc
Q 017362 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (373)
Q Consensus 233 H~~giiHrDikp~NILl~~~~~vkL~DFGla 263 (373)
|+.||+-+|+++.|.. .-+|+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc-----CCEEEecccC
Confidence 9999999999999986 4589999864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.23 E-value=4.7e-05 Score=66.60 Aligned_cols=137 Identities=19% Similarity=0.253 Sum_probs=93.2
Q ss_pred eceeeeeCcEEEEEEEEcCCCceEeeeecchhHhh-------------hhhhHHHHHHHHHHHHhcC------CCceeEE
Q 017362 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML-------------RRGQVEHVRAERNLLAEVD------SNCIVKL 181 (373)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~~~e~~~l~~l~------h~~iv~l 181 (373)
...||+|+.=.|| .+..+ ...+||++...... .........+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy--~HP~d-p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCY--QHPDD-PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEE--ECCCC-CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 4569999999999 44433 45678988765400 0112234555665554444 7889999
Q ss_pred eeEEEeCCeEEEEEeccCC------CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC--
Q 017362 182 YCSFQDDEFLYLIMEYLPG------GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-- 253 (373)
Q Consensus 182 ~~~~~~~~~~~lV~E~~~g------g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~-- 253 (373)
+|+.+++.-+-+|+|.+-. -+|.+++ ..+.+++ ..... +-.-..+|-+.+|+.+||+|.||++....
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l-~~~~~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYL-KEGGLTE-ELRQA---LDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHH-HcCCccH-HHHHH---HHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 9999998888899997732 3687877 4445665 33333 33445677889999999999999996432
Q ss_pred --cEEEee-cccccc
Q 017362 254 --HLRLSD-FGLCKP 265 (373)
Q Consensus 254 --~vkL~D-FGla~~ 265 (373)
.+.|+| ||-...
T Consensus 158 ~~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 158 EFRLVLIDGLGEKEL 172 (199)
T ss_pred ceEEEEEeCCCCccc
Confidence 578888 675544
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.22 E-value=8.9e-06 Score=68.74 Aligned_cols=130 Identities=15% Similarity=0.204 Sum_probs=90.0
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeE-EeeEEEeCCeEEEEEe
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK-LYCSFQDDEFLYLIME 196 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~-l~~~~~~~~~~~lV~E 196 (373)
..+.+.||+|.+|.||+|.+. |..+|+|+-.... ....+..|..+|..+..-++.+ +|.+.. -++.||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me 92 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRME 92 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhh
Confidence 345678999999999999854 6689999865432 3455778999998887665543 343322 236699
Q ss_pred ccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCC-CCCEEEcCCCcEEEeecccccc
Q 017362 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK-PDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 197 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDik-p~NILl~~~~~vkL~DFGla~~ 265 (373)
|+.|-.|.++-... +.++ +..++.+---|-..||-|..|. |..++|..++.+.|+||.-|+.
T Consensus 93 ~i~G~~L~~~~~~~---~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 93 YIDGRPLGKLEIGG---DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhcCcchhhhhhcc---cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 99988888775322 2223 3344444444667899999997 5555555556999999998874
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.1e-05 Score=72.88 Aligned_cols=33 Identities=30% Similarity=0.404 Sum_probs=27.3
Q ss_pred CCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 235 ~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
.+++|+|+.|.|||++.++..-|+||+.|..-+
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~gD 196 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGVGD 196 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCcCC
Confidence 358999999999999876656799999886543
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.04 E-value=4.3e-05 Score=68.70 Aligned_cols=139 Identities=13% Similarity=0.161 Sum_probs=80.5
Q ss_pred eceeeeeCcEEEEEEEEcC-CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCC-CceeEEeeEEEeCCeEEEEEecc
Q 017362 121 LTMIGKGAFGEVRVCREKT-TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS-NCIVKLYCSFQDDEFLYLIMEYL 198 (373)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~l~~~~~~~~~~~lV~E~~ 198 (373)
++.|..|-...+|++.... .+..|++|+...... .. -...+|..++..+.. .-.+++++.+. + .+||||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~-~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LI-IDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ce-ecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4567788889999986433 356788997754311 11 123457778877743 33445554433 2 3899999
Q ss_pred CCCCHHHH----------H-------hhCC-CC----------C-HHHHHHHHHH----------------------HH-
Q 017362 199 PGGDMMTL----------L-------MRKD-TL----------T-EDEARFYVAE----------------------TV- 226 (373)
Q Consensus 199 ~gg~L~~~----------l-------~~~~-~l----------~-~~~~~~i~~q----------------------i~- 226 (373)
+|.++... + +... .. . ...+..+... +.
T Consensus 75 ~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 154 (235)
T cd05157 75 PGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRD 154 (235)
T ss_pred CCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHH
Confidence 98665321 1 0100 01 1 1222222111 11
Q ss_pred --HHHHH-HH----hCCCeeecCCCCCEEEcC-CCcEEEeeccccccCC
Q 017362 227 --LAIES-IH----KHHYIHRDIKPDNLLLDK-YGHLRLSDFGLCKPLD 267 (373)
Q Consensus 227 --~aL~~-LH----~~giiHrDikp~NILl~~-~~~vkL~DFGla~~~~ 267 (373)
..|.. +- ..+++|+|+.|.|||++. ++.+.|+||..|...+
T Consensus 155 ~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~~ 203 (235)
T cd05157 155 EISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYNY 203 (235)
T ss_pred HHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcCc
Confidence 11111 11 236999999999999998 5789999999887544
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.99 E-value=0.00025 Score=68.68 Aligned_cols=81 Identities=20% Similarity=0.224 Sum_probs=53.3
Q ss_pred eeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhh--h--hhhHHHHHHHHHHHHhcC---CCceeEEeeEEEeCCeEE
Q 017362 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML--R--RGQVEHVRAERNLLAEVD---SNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 120 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~--~~~~~~~~~e~~~l~~l~---h~~iv~l~~~~~~~~~~~ 192 (373)
..+.||.|.+..||++.....++.++||.-....-. . +...++...|.+.|..+. ...+++++.+ +.+..+
T Consensus 30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~ 107 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAV 107 (401)
T ss_pred eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCE
Confidence 356799999999999987544358999985321100 0 123455666777776652 3456777766 445567
Q ss_pred EEEeccCCCC
Q 017362 193 LIMEYLPGGD 202 (373)
Q Consensus 193 lV~E~~~gg~ 202 (373)
+||||+++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999998753
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.90 E-value=4.1e-05 Score=66.52 Aligned_cols=98 Identities=19% Similarity=0.251 Sum_probs=78.5
Q ss_pred HHHHHHHhcCC-CceeEEeeEEEeCCeEEEEEeccCCCCHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHHHh---CCC
Q 017362 165 AERNLLAEVDS-NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL---LMRKDTLTEDEARFYVAETVLAIESIHK---HHY 237 (373)
Q Consensus 165 ~e~~~l~~l~h-~~iv~l~~~~~~~~~~~lV~E~~~gg~L~~~---l~~~~~l~~~~~~~i~~qi~~aL~~LH~---~gi 237 (373)
.|..++..+.+ +++++++|+|-+ ++|.||.+.+++... +..-...+|.....++.+++..+.+++. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 46777777866 699999999832 479999987766421 2222356899999999999999999986 357
Q ss_pred eeecCCCCCEEEcCCCcEEEeeccccccC
Q 017362 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (373)
Q Consensus 238 iHrDikp~NILl~~~~~vkL~DFGla~~~ 266 (373)
.-.|++|+|+-++++|++|++|...+...
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchh
Confidence 78999999999999999999999877544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.90 E-value=1.1e-06 Score=94.17 Aligned_cols=202 Identities=13% Similarity=0.052 Sum_probs=137.3
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCc-eEeeeecchhHhh--hhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe--CC
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGH-VYAMKKLKKSEML--RRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD--DE 189 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~ 189 (373)
..++++.--+|-|.++. |.+..... -+.+++.+..... .+...+....|++.++...|+++...+.-..+ ..
T Consensus 1228 ~e~~EV~l~i~~~~~~R---~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ 1304 (2724)
T KOG1826|consen 1228 MEHSEVNLGISNHFHFR---NKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSEST 1304 (2724)
T ss_pred hhhhheeeecccceeec---cchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCCh
Confidence 34555554555555443 32221111 2344554433221 22233445566677777899998877655443 23
Q ss_pred eEEEEEeccCCCCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHhC-----CCeeecCCCCCEEEcCCCcEEEeec
Q 017362 190 FLYLIMEYLPGGDMMTLLMRK----DTLTEDEARFYVAETVLAIESIHKH-----HYIHRDIKPDNLLLDKYGHLRLSDF 260 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~-----giiHrDikp~NILl~~~~~vkL~DF 260 (373)
..|.+++|+.+|++.+.+.+. ..+.+..+.....+.+.+..-+|++ --+|++||+-|.+|..+..++++++
T Consensus 1305 ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~ 1384 (2724)
T KOG1826|consen 1305 EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKG 1384 (2724)
T ss_pred HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccc
Confidence 468999999999999999763 2344444444444557777777753 2789999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcH
Q 017362 261 GLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340 (373)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Dv 340 (373)
|+.+...+.. ..+...+++|.|++|+....-.++.++|+
T Consensus 1385 gLdKIknp~~-----------------------------------------sf~Gl~l~sp~~v~qli~N~ik~t~rsdi 1423 (2724)
T KOG1826|consen 1385 GLDKIKNPVL-----------------------------------------SFFGLELCSPIYVLQLIKNEIKFTKRSDI 1423 (2724)
T ss_pred ccccccCchH-----------------------------------------hhhhhhhCCHHHHHHHHHHHHhhhhHHHH
Confidence 9998322111 11225688999999999988889999999
Q ss_pred HHHHHHHHHHHhCCCCCCCC
Q 017362 341 WSLGAIMYEMLVGYPPFYSD 360 (373)
Q Consensus 341 wSlGvil~ell~G~~Pf~~~ 360 (373)
|..|+-+|+...|.+||...
T Consensus 1424 lr~s~~ly~rs~~n~~fi~f 1443 (2724)
T KOG1826|consen 1424 LRRSLSLYLRSDGNAYFIFF 1443 (2724)
T ss_pred HHHHHHHHHHhcccHHHHHH
Confidence 99999999999999988543
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.0002 Score=66.95 Aligned_cols=78 Identities=12% Similarity=0.085 Sum_probs=53.3
Q ss_pred ceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCC---CceeEEeeEEEeC---CeEE
Q 017362 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS---NCIVKLYCSFQDD---EFLY 192 (373)
Q Consensus 119 ~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~l~~~~~~~---~~~~ 192 (373)
.-...||.|..+.||..... ++ .+.+|..+.. .....+..|...|+.+.. ..++++++.+.++ +..+
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~-----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 17 SRVECISEQPYAALWALYDS-QG-NPMPLMARSF-----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred heeeecCCccceeEEEEEcC-CC-CEEEEEeccc-----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 34567999999999987532 23 4667774321 012357778888877743 4678888777543 5689
Q ss_pred EEEeccCCCCH
Q 017362 193 LIMEYLPGGDM 203 (373)
Q Consensus 193 lV~E~~~gg~L 203 (373)
+|||+++|+++
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999998754
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.87 E-value=7e-05 Score=68.40 Aligned_cols=134 Identities=16% Similarity=0.184 Sum_probs=76.4
Q ss_pred eeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCc-eeEEeeEEEeCCeEEEEEeccCCCC
Q 017362 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC-IVKLYCSFQDDEFLYLIMEYLPGGD 202 (373)
Q Consensus 124 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~l~~~~~~~~~~~lV~E~~~gg~ 202 (373)
+..|-...+|+.. .++..+++|+...... .-.. ...+|..+++.+.... .++++... . -++||||++|..
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~--~~~~-~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~ 74 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCK--ALGV-DRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEV 74 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccc--cccC-cHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcc
Confidence 4568888999876 4466788887653311 1001 2456778887775432 24444433 2 258999999865
Q ss_pred HHHH--------------H---hhCC----CCCH-HHHHHHHHHH---------HHHHHHHHh--------CCCeeecCC
Q 017362 203 MMTL--------------L---MRKD----TLTE-DEARFYVAET---------VLAIESIHK--------HHYIHRDIK 243 (373)
Q Consensus 203 L~~~--------------l---~~~~----~l~~-~~~~~i~~qi---------~~aL~~LH~--------~giiHrDik 243 (373)
+... + +... +++. ..+..+..++ ...+..+-. ..++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 4321 1 1111 1111 1222222111 111222211 258999999
Q ss_pred CCCEEEcCCCcEEEeeccccccCC
Q 017362 244 PDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 244 p~NILl~~~~~vkL~DFGla~~~~ 267 (373)
|.||+++.++ +.|+||..|..-+
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a~~gd 177 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYASDGD 177 (256)
T ss_pred cCcEEEeCCC-CEEEeccccCcCC
Confidence 9999999877 7899999987544
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00037 Score=64.98 Aligned_cols=139 Identities=16% Similarity=0.087 Sum_probs=81.4
Q ss_pred ceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCC--ceeEEeeE------EEeCCe
Q 017362 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN--CIVKLYCS------FQDDEF 190 (373)
Q Consensus 119 ~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~l~~~------~~~~~~ 190 (373)
.-++.|..|....+|++.. .+..+++|+.... ....+..|..++..+.+. .+++++.. ....+.
T Consensus 17 ~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~ 88 (296)
T cd05153 17 LSFEGISAGIENTNYFVTT--DSGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGK 88 (296)
T ss_pred hheecccCccccceEEEEe--CCCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCc
Confidence 3356778888889998754 3447889987641 123355566666666322 24444431 233456
Q ss_pred EEEEEeccCCCCHHH----H-------H---hh--CC---C------CCHHHH----------HHHHHHHHHHHHHHHh-
Q 017362 191 LYLIMEYLPGGDMMT----L-------L---MR--KD---T------LTEDEA----------RFYVAETVLAIESIHK- 234 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~----~-------l---~~--~~---~------l~~~~~----------~~i~~qi~~aL~~LH~- 234 (373)
.++||+|++|..+.. . | +. .. . ..+... ......+..++.++..
T Consensus 89 ~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~ 168 (296)
T cd05153 89 PAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAF 168 (296)
T ss_pred eEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhh
Confidence 789999999876422 1 1 10 00 0 010000 0011112233444442
Q ss_pred ------CCCeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 235 ------HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 235 ------~giiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
.+++|+|+.|.|||++.++.+.|+||+.|..
T Consensus 169 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 169 DPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999977778999998864
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.75 E-value=6.3e-05 Score=69.56 Aligned_cols=139 Identities=14% Similarity=0.109 Sum_probs=93.8
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhh-----------------hhh--hHHHHHHHHHHHHhcC-C
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML-----------------RRG--QVEHVRAERNLLAEVD-S 175 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----------------~~~--~~~~~~~e~~~l~~l~-h 175 (373)
.-+.+...||-|.-+-||.+-+ ..|.+.++|.-+..... +.. ..-....|+..|+.+. |
T Consensus 92 ~v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~ 170 (465)
T KOG2268|consen 92 SVESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYER 170 (465)
T ss_pred hhhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHc
Confidence 3477888999999999999875 56788899964321100 000 1112345777777763 2
Q ss_pred C-ceeEEeeEEEeCCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCc
Q 017362 176 N-CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH 254 (373)
Q Consensus 176 ~-~iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~ 254 (373)
. -+++.++ -+..++|||++.|-.|...-.-. + +..+...+..-|.-|-.+|+||+|..-=||+++.+++
T Consensus 171 gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~---d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~ 240 (465)
T KOG2268|consen 171 GFPVPKPID----HNRHCVVMELVDGYPLRQVRHVE---D---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK 240 (465)
T ss_pred CCCCCCccc----ccceeeHHHhhcccceeeeeecC---C---hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC
Confidence 2 2333333 34567999999888876554222 2 2334445555566788899999999999999999999
Q ss_pred EEEeecccccc
Q 017362 255 LRLSDFGLCKP 265 (373)
Q Consensus 255 vkL~DFGla~~ 265 (373)
++++||--+-.
T Consensus 241 i~vIDFPQmvS 251 (465)
T KOG2268|consen 241 IVVIDFPQMVS 251 (465)
T ss_pred EEEeechHhhc
Confidence 99999986643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.0002 Score=66.96 Aligned_cols=140 Identities=17% Similarity=0.142 Sum_probs=81.5
Q ss_pred eceeeeeCcEEEEEEEEcC------CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCC-ceeEEeeEEEeCCeEEE
Q 017362 121 LTMIGKGAFGEVRVCREKT------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKLYCSFQDDEFLYL 193 (373)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~l~~~~~~~~~~~l 193 (373)
++.|..|-...||++.... .+..+++|+..... .......+|..++..+... -.+++++.+.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 3456667777899886533 25788999875432 1112345677777776432 23455555542 26
Q ss_pred EEeccCCCCHHHHH-----------------hhCC-CC--------C--HHHHHH-------------------------
Q 017362 194 IMEYLPGGDMMTLL-----------------MRKD-TL--------T--EDEARF------------------------- 220 (373)
Q Consensus 194 V~E~~~gg~L~~~l-----------------~~~~-~l--------~--~~~~~~------------------------- 220 (373)
||||++|..+.... ++.. .. + +.....
T Consensus 75 v~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (302)
T cd05156 75 IEEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELS 154 (302)
T ss_pred hhheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHH
Confidence 89999887654310 1100 00 0 001111
Q ss_pred -HHHHHHHHHHHHHh---------CCCeeecCCCCCEEEcCC----CcEEEeeccccccCCC
Q 017362 221 -YVAETVLAIESIHK---------HHYIHRDIKPDNLLLDKY----GHLRLSDFGLCKPLDC 268 (373)
Q Consensus 221 -i~~qi~~aL~~LH~---------~giiHrDikp~NILl~~~----~~vkL~DFGla~~~~~ 268 (373)
+..++...+.++-. ..++|+|+.|.|||++.+ +.+.|+||..|...+.
T Consensus 155 ~~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~~p 216 (302)
T cd05156 155 LFLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYNYR 216 (302)
T ss_pred HHHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCCCc
Confidence 11122222333431 358999999999999985 8899999999976543
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.0012 Score=62.32 Aligned_cols=31 Identities=26% Similarity=0.288 Sum_probs=26.7
Q ss_pred CCCeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 235 ~giiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
.++||+|+.|+|||++.+..+-|+||+.|..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 4899999999999999665568999999864
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00048 Score=64.69 Aligned_cols=142 Identities=17% Similarity=0.134 Sum_probs=80.8
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCC--ceeEEeeE------EEeC
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN--CIVKLYCS------FQDD 188 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~l~~~------~~~~ 188 (373)
....++.++.|....+|++.. . +..+++|+..... ....+..|..++..+... .+++++.. ....
T Consensus 23 ~~~~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~ 95 (307)
T TIGR00938 23 ELLSLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLA 95 (307)
T ss_pred CceeccccCCccccceEEEEe-C-CCcEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcC
Confidence 344567788888889998764 2 3367889875421 112234455666555321 23344321 1224
Q ss_pred CeEEEEEeccCCCCHH-----------HH---Hhh-CCCC--------CHHH-----HH----------HHHHHHHHHHH
Q 017362 189 EFLYLIMEYLPGGDMM-----------TL---LMR-KDTL--------TEDE-----AR----------FYVAETVLAIE 230 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~-----------~~---l~~-~~~l--------~~~~-----~~----------~i~~qi~~aL~ 230 (373)
+..++||+|++|..+. .. ++. ...+ .... .. .....+...++
T Consensus 96 g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~ 175 (307)
T TIGR00938 96 GKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELD 175 (307)
T ss_pred CeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHH
Confidence 5678999999885431 01 111 0001 0000 00 00112233455
Q ss_pred HHH-------hCCCeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 231 SIH-------KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 231 ~LH-------~~giiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
++. ..+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 176 ~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 176 YLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 553 26899999999999999988778999999854
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00066 Score=64.52 Aligned_cols=84 Identities=17% Similarity=0.176 Sum_probs=51.2
Q ss_pred eeeeeCcEEEEEEEEcCCCceEeeeecchhHhh----hhhhHHHHHHHHHHHHhcC--CC-ceeEEeeEEEeCCeEEEEE
Q 017362 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML----RRGQVEHVRAERNLLAEVD--SN-CIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 123 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~~e~~~l~~l~--h~-~iv~l~~~~~~~~~~~lV~ 195 (373)
.||.|....||++.....+..|+||.-..---. -+-..++..-|...|.... .| .++++|. | +++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~-~-D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH-F-DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE-E-ccccceehH
Confidence 579999999999987544468999975432111 1223455666777776653 34 3444443 3 445556999
Q ss_pred eccCCC-CHHHHHh
Q 017362 196 EYLPGG-DMMTLLM 208 (373)
Q Consensus 196 E~~~gg-~L~~~l~ 208 (373)
|+++.. .|...|.
T Consensus 80 EdL~~~~ilR~~Li 93 (370)
T TIGR01767 80 EDLSHHKIARKGLI 93 (370)
T ss_pred hhCccchHHHHHHH
Confidence 999654 3445543
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00082 Score=63.36 Aligned_cols=146 Identities=21% Similarity=0.251 Sum_probs=94.2
Q ss_pred ceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhh---------------------hH--HHHHHHHHHHHhcCC
Q 017362 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRG---------------------QV--EHVRAERNLLAEVDS 175 (373)
Q Consensus 119 ~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~---------------------~~--~~~~~e~~~l~~l~h 175 (373)
.+-.+|..|--+.||.|.. .+|..+|||+++.+-+.-.. .+ -....|+.=|+++..
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 3556888999999999864 67788999998653221100 11 112223443444433
Q ss_pred CceeEEeeEEEeCCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCeeecCCCCCEEEcCCCc
Q 017362 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI-HKHHYIHRDIKPDNLLLDKYGH 254 (373)
Q Consensus 176 ~~iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~L-H~~giiHrDikp~NILl~~~~~ 254 (373)
..|+-.--... ..-.|||+|+.......=..+.-.++...+..+-.+++.-+.-| |.+++||.||.-=|+|+.. |+
T Consensus 226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G~ 302 (520)
T KOG2270|consen 226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-GK 302 (520)
T ss_pred cCCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-CE
Confidence 22221111111 22359999995433322233445688888888888888888877 5789999999999999875 89
Q ss_pred EEEeeccccccCCC
Q 017362 255 LRLSDFGLCKPLDC 268 (373)
Q Consensus 255 vkL~DFGla~~~~~ 268 (373)
+.|+|.+-+-..+.
T Consensus 303 lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 303 LYIIDVSQSVEHDH 316 (520)
T ss_pred EEEEEccccccCCC
Confidence 99999988765543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00082 Score=71.43 Aligned_cols=152 Identities=18% Similarity=0.203 Sum_probs=111.4
Q ss_pred HHHHHHHHHhcCCCceeEEeeEEEeCCe----EEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 017362 163 VRAERNLLAEVDSNCIVKLYCSFQDDEF----LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYI 238 (373)
Q Consensus 163 ~~~e~~~l~~l~h~~iv~l~~~~~~~~~----~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~gii 238 (373)
..-|...+....|+|++.++.+...... ..+..++++.-++...+......+....+.+..+++.||.++|+....
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~ 308 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLE 308 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccc
Confidence 3346666778899999999877654332 345667888999999999999999999999999999999999999666
Q ss_pred eecCCCC---CEEEcCCCcEEEe--eccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhcc
Q 017362 239 HRDIKPD---NLLLDKYGHLRLS--DFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRML 313 (373)
Q Consensus 239 HrDikp~---NILl~~~~~vkL~--DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (373)
|.-+..+ +...+..+.+.++ ||+....+.......
T Consensus 309 ~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---------------------------------------- 348 (1351)
T KOG1035|consen 309 HVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---------------------------------------- 348 (1351)
T ss_pred eeEEecccccccccCccceeecchhhhcccccCCCcccch----------------------------------------
Confidence 6555544 4444555666666 888776554332111
Q ss_pred ccccccCCCCcccccccCCCCChh--hcHHHHHHHHHHHHhCCCC
Q 017362 314 AYSTVGTPDYIAPEVLLKKGYGME--CDWWSLGAIMYEMLVGYPP 356 (373)
Q Consensus 314 ~~~~~gt~~Y~aPE~~~~~~~~~~--~DvwSlGvil~ell~G~~P 356 (373)
+-.-+..+.+||......+..+ .|+|.+|..+..+..|..+
T Consensus 349 --~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i 391 (1351)
T KOG1035|consen 349 --SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDI 391 (1351)
T ss_pred --hhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcc
Confidence 2344566788888877666554 7999999999999887543
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0018 Score=62.42 Aligned_cols=86 Identities=19% Similarity=0.213 Sum_probs=53.9
Q ss_pred eceeeeeCcEEEEEEEEcCCCceEeeeecchhHhh---hhhhHHHHHHHHHHHHhcC--CC-ceeEEeeEEEeCCeEEEE
Q 017362 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML---RRGQVEHVRAERNLLAEVD--SN-CIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~e~~~l~~l~--h~-~iv~l~~~~~~~~~~~lV 194 (373)
.+.||.|.-.-||++.+...+..|+||.-..---. -+-..++..-|.+.|.... .| .++++|.+ |+....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 67899999999999987444567899864321111 1233466677777777653 34 45555433 44555699
Q ss_pred EeccCCC-CHHHHHh
Q 017362 195 MEYLPGG-DMMTLLM 208 (373)
Q Consensus 195 ~E~~~gg-~L~~~l~ 208 (373)
||+++.. .|.+.|.
T Consensus 112 MEdL~~~~ilR~~Li 126 (409)
T PRK12396 112 MEDLSDHTILRTALI 126 (409)
T ss_pred HHhCcccHHHHHHHH
Confidence 9999653 3444443
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0021 Score=59.37 Aligned_cols=32 Identities=28% Similarity=0.453 Sum_probs=26.8
Q ss_pred CCeeecCCCCCEEEcCCCc-EEEeeccccccCC
Q 017362 236 HYIHRDIKPDNLLLDKYGH-LRLSDFGLCKPLD 267 (373)
Q Consensus 236 giiHrDikp~NILl~~~~~-vkL~DFGla~~~~ 267 (373)
.++|+|+.|+|||++.++. .-|+||+.+..-+
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGD 218 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGD 218 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCC
Confidence 4899999999999997565 4699999987654
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0056 Score=59.31 Aligned_cols=84 Identities=15% Similarity=0.107 Sum_probs=52.9
Q ss_pred eeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhh----hhHHHHHHHHHHHHhcC---CCceeEEeeEEEeCCeEE
Q 017362 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR----GQVEHVRAERNLLAEVD---SNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 120 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~~e~~~l~~l~---h~~iv~l~~~~~~~~~~~ 192 (373)
..+.||.|....||+..+. +..++||.-........ -...+...|...|..+. ...+++++.++.+ ..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCE
Confidence 4678899999999998763 45688997652211001 12344455666666553 2477888877764 356
Q ss_pred EEEeccCC--CCHHHHH
Q 017362 193 LIMEYLPG--GDMMTLL 207 (373)
Q Consensus 193 lV~E~~~g--g~L~~~l 207 (373)
+|||++++ ..+.+-+
T Consensus 112 lvME~L~~~~~ilr~~L 128 (418)
T PLN02756 112 IGMRYLEPPHIILRKGL 128 (418)
T ss_pred EEEeecCCcceehhhhh
Confidence 89999977 2444444
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0034 Score=59.99 Aligned_cols=140 Identities=14% Similarity=0.159 Sum_probs=81.1
Q ss_pred eceeeeeCcEEEEEEEEcC----CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCce-eEEeeEEEeCCeEEEEE
Q 017362 121 LTMIGKGAFGEVRVCREKT----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCI-VKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~l~~~~~~~~~~~lV~ 195 (373)
+..|-.|-.-.+|++.... .+..|++|+..... ...+. -.+|..++..+...++ +++++.+..+ .|+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ 112 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVE 112 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence 3455558888999986432 24678999876532 22222 2557777777754333 4455655433 689
Q ss_pred eccCCCCHHHH-----------------HhhCC------CCCHHHHHHHHHHH-----------------HHHHHHH---
Q 017362 196 EYLPGGDMMTL-----------------LMRKD------TLTEDEARFYVAET-----------------VLAIESI--- 232 (373)
Q Consensus 196 E~~~gg~L~~~-----------------l~~~~------~l~~~~~~~i~~qi-----------------~~aL~~L--- 232 (373)
+|++|.+|... ++... ......+..+..++ ...+..|
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 99987665321 11111 11123333332111 1112222
Q ss_pred -H----hCCCeeecCCCCCEEEcC-CCcEEEeeccccccCCC
Q 017362 233 -H----KHHYIHRDIKPDNLLLDK-YGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 233 -H----~~giiHrDikp~NILl~~-~~~vkL~DFGla~~~~~ 268 (373)
. ...++|+|+++.|||++. ++.+.|+||..|...+.
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~~ 234 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYNPV 234 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccccch
Confidence 1 236899999999999986 47899999999875543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.014 Score=54.63 Aligned_cols=30 Identities=27% Similarity=0.543 Sum_probs=26.4
Q ss_pred CCCeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 235 ~giiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
.+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 57899999999999987 6789999997753
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0019 Score=60.89 Aligned_cols=73 Identities=23% Similarity=0.444 Sum_probs=58.2
Q ss_pred eCCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 187 DDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH-HYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 187 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~-giiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
...+.|++|++- |+.+.-. ..-...++..++.+++..++-+... .+-|||+.-+||||+ +|+|.|+||-+|+.
T Consensus 297 e~~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred CceEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 345788999986 6655321 2345778888888888888777754 799999999999999 89999999999984
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.012 Score=55.36 Aligned_cols=30 Identities=13% Similarity=0.153 Sum_probs=28.0
Q ss_pred CCeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 236 giiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
+++|+|+.++|||++.++.+.++||..|..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.0099 Score=56.45 Aligned_cols=144 Identities=14% Similarity=0.172 Sum_probs=80.1
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCC---CceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCce-eEEeeEEEeCCeE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTT---GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCI-VKLYCSFQDDEFL 191 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~l~~~~~~~~~~ 191 (373)
+++++.. |..|-.-.+|++..... +..|++|+..... ...+. -.+|..++..+..-++ +++++.+.. +
T Consensus 15 ~~i~i~~-l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~~Id-R~~E~~il~~l~~~gl~P~~l~~~~~-G-- 86 (330)
T PLN02421 15 SDFSVER-ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---DYVID-RERELQAIKYLSAAGFGAKLLGVFGN-G-- 86 (330)
T ss_pred CceEEEE-eCCcccceEEEEEecCCCCCCceEEEEEecCCc---CeEec-hHHHHHHHHHHHhcCCCCceeEEeCC-c--
Confidence 3444444 44477788998864322 2378899875432 11112 2457777777754444 455555532 2
Q ss_pred EEEEeccCCCCHHH----------HH-------hhCC-C----C-CHHHHHHHHHHH----------------------H
Q 017362 192 YLIMEYLPGGDMMT----------LL-------MRKD-T----L-TEDEARFYVAET----------------------V 226 (373)
Q Consensus 192 ~lV~E~~~gg~L~~----------~l-------~~~~-~----l-~~~~~~~i~~qi----------------------~ 226 (373)
+|.+|++|..|.. .+ +... + . .+..+..+..++ .
T Consensus 87 -~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~ 165 (330)
T PLN02421 87 -MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELR 165 (330)
T ss_pred -EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHH
Confidence 5899998765421 11 1111 0 1 122333332222 1
Q ss_pred HHHHHHH----hC----CCeeecCCCCCEEEcC-CCcEEEeeccccccCCC
Q 017362 227 LAIESIH----KH----HYIHRDIKPDNLLLDK-YGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 227 ~aL~~LH----~~----giiHrDikp~NILl~~-~~~vkL~DFGla~~~~~ 268 (373)
.-+..+. .. -++|.|+.|.|||++. ++.++|+||..|...++
T Consensus 166 ~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~nd~ 216 (330)
T PLN02421 166 DEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYSYR 216 (330)
T ss_pred HHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCCcc
Confidence 1122221 11 2799999999999975 57899999999876543
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.014 Score=54.83 Aligned_cols=149 Identities=15% Similarity=0.175 Sum_probs=84.5
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCC--CceeEEeeEEEeCC--eEE
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS--NCIVKLYCSFQDDE--FLY 192 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~l~~~~~~~~--~~~ 192 (373)
...++..+..|-.-.+|.... +++.+++. ... ............+|..+++.+.- .-+...++.|.++. ..|
T Consensus 26 ~~~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf 101 (321)
T COG3173 26 GLLIVEEISGGWSNDTFRLGD--TGQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPF 101 (321)
T ss_pred CCceeeeccCCcccceEEEec--CCceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCce
Confidence 344555554444444554433 37788888 321 11222334556678888877643 23344556666555 668
Q ss_pred EEEeccCCCCH------------------HHHHhh--------------CCCCCHHHHHHHHHHH--------------H
Q 017362 193 LIMEYLPGGDM------------------MTLLMR--------------KDTLTEDEARFYVAET--------------V 226 (373)
Q Consensus 193 lV~E~~~gg~L------------------~~~l~~--------------~~~l~~~~~~~i~~qi--------------~ 226 (373)
.||+|+.|..+ .++|.. .+.+...+...+..+. .
T Consensus 102 ~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~ 181 (321)
T COG3173 102 YVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD 181 (321)
T ss_pred EEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence 99999988321 112210 0001111222222222 2
Q ss_pred HHHHHHHhC--------CCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 227 LAIESIHKH--------HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 227 ~aL~~LH~~--------giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
.-..+|+.+ .++|+|+.+.||+++..+-+=|.||+++..-++.
T Consensus 182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~ 232 (321)
T COG3173 182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPL 232 (321)
T ss_pred HHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcH
Confidence 234455532 4899999999999999988999999999876654
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.072 Score=49.49 Aligned_cols=76 Identities=20% Similarity=0.236 Sum_probs=46.0
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc---CCCceeEEeeEEEeCCeEEEE
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV---DSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~l~~~~~~~~~~~lV 194 (373)
.+-...++.|....+|... .++..+.||+-.... ...+..|..-|+.+ ..-.+++.+.+....+..|||
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 3445678889999999875 667789999865321 23466677767666 345688888888877777999
Q ss_pred EeccCCC
Q 017362 195 MEYLPGG 201 (373)
Q Consensus 195 ~E~~~gg 201 (373)
|||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.034 Score=53.87 Aligned_cols=32 Identities=19% Similarity=0.128 Sum_probs=26.5
Q ss_pred CCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 235 ~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
..++|.|+-+.|||.+. +.+.++||..|..-.
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~~n~ 258 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAGFNY 258 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEeccccCCc
Confidence 46899999999999764 569999999886543
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.14 Score=48.43 Aligned_cols=29 Identities=21% Similarity=0.259 Sum_probs=24.8
Q ss_pred CCCeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 235 ~giiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
.++||+|+.|+|||++ + .+.|+||+.|..
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 4689999999999995 3 578999998864
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.023 Score=56.05 Aligned_cols=48 Identities=10% Similarity=0.131 Sum_probs=37.5
Q ss_pred HHHHHHHHHhcCCCceeEEeeEEEe-CCeEEEEEeccCCCCHHHHHhhCC
Q 017362 163 VRAERNLLAEVDSNCIVKLYCSFQD-DEFLYLIMEYLPGGDMMTLLMRKD 211 (373)
Q Consensus 163 ~~~e~~~l~~l~h~~iv~l~~~~~~-~~~~~lV~E~~~gg~L~~~l~~~~ 211 (373)
+..-..+++.+.|++....+..-.. .....+|||++ +.+|.+.+....
T Consensus 29 ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~ 77 (725)
T KOG1093|consen 29 ILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN 77 (725)
T ss_pred HhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence 5556778999999999988877653 23478999999 779999986654
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.2 Score=54.80 Aligned_cols=31 Identities=32% Similarity=0.455 Sum_probs=26.6
Q ss_pred CCCeeecCCCCCEEEcCCC--cEE-Eeecccccc
Q 017362 235 HHYIHRDIKPDNLLLDKYG--HLR-LSDFGLCKP 265 (373)
Q Consensus 235 ~giiHrDikp~NILl~~~~--~vk-L~DFGla~~ 265 (373)
.++||+|+.+.|||++.++ ++. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 5799999999999999875 565 999998853
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.011 Score=55.07 Aligned_cols=51 Identities=25% Similarity=0.450 Sum_probs=36.4
Q ss_pred HHHHHHHHHHHHHHHHHHHh----CCCeeecCCCCCEEEcCCC------------------cEEEeecccccc
Q 017362 215 EDEARFYVAETVLAIESIHK----HHYIHRDIKPDNLLLDKYG------------------HLRLSDFGLCKP 265 (373)
Q Consensus 215 ~~~~~~i~~qi~~aL~~LH~----~giiHrDikp~NILl~~~~------------------~vkL~DFGla~~ 265 (373)
.+-+++++.|++.-.-.+-. ..++|-||||+|||+-+.. .++|.||.++..
T Consensus 278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv 350 (444)
T PHA03111 278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQV 350 (444)
T ss_pred HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHH
Confidence 35677888888776544432 3699999999999994332 356778888764
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.49 E-value=0.14 Score=45.58 Aligned_cols=75 Identities=21% Similarity=0.310 Sum_probs=49.0
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc---CCCceeEEeeEEEeCCeEEEEEecc
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV---DSNCIVKLYCSFQDDEFLYLIMEYL 198 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~l~~~~~~~~~~~lV~E~~ 198 (373)
+.+.-|.--..|... ....++-+|+-... ....+..|+.-|..+ +.-.+++.+.+..+..+.|+||||+
T Consensus 22 ~~v~gG~inea~~v~--dg~~~~FvK~n~~~------~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L 93 (286)
T COG3001 22 EEVSGGDINEAWRLR--DGTDPFFVKCNQRE------QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYL 93 (286)
T ss_pred cccCCccccceeEee--cCCcceEEEecchh------hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeec
Confidence 344445545555443 23457788864332 334566676655444 4567888999999999999999999
Q ss_pred CCCCHH
Q 017362 199 PGGDMM 204 (373)
Q Consensus 199 ~gg~L~ 204 (373)
+-|.+.
T Consensus 94 ~~~~~d 99 (286)
T COG3001 94 PTGPLD 99 (286)
T ss_pred cCCCCC
Confidence 986554
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.048 Score=52.45 Aligned_cols=59 Identities=22% Similarity=0.353 Sum_probs=43.9
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCeeecCCCCCEEEc
Q 017362 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI-HKHHYIHRDIKPDNLLLD 250 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~L-H~~giiHrDikp~NILl~ 250 (373)
..+|-+|++|-++..++... ..++...+.++.-.+.||.-+ --.+++|.|+.|.||++-
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 45778899898998888544 345666666666666666554 356899999999999994
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.012 Score=55.07 Aligned_cols=52 Identities=25% Similarity=0.400 Sum_probs=35.2
Q ss_pred HHHHHHHHHHHHHHHHHHH----hCCCeeecCCCCCEEEcCCC------------------cEEEeeccccccC
Q 017362 215 EDEARFYVAETVLAIESIH----KHHYIHRDIKPDNLLLDKYG------------------HLRLSDFGLCKPL 266 (373)
Q Consensus 215 ~~~~~~i~~qi~~aL~~LH----~~giiHrDikp~NILl~~~~------------------~vkL~DFGla~~~ 266 (373)
.+-+++++.|++.-.--+- -..++|-||||+|||+-+.. .++|.||.++..-
T Consensus 274 ~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 274 VEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 3456777777765432221 24699999999999994322 3678899988653
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.28 E-value=0.18 Score=49.79 Aligned_cols=142 Identities=16% Similarity=0.103 Sum_probs=78.8
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCC--------CceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCce-eEEeeEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTT--------GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCI-VKLYCSFQ 186 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~l~~~~~ 186 (373)
++. -++.|..|-.-.+|++..... +..|.+++..... ...+ .-..|..++..+...+| +++++.+.
T Consensus 106 ~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~ 180 (442)
T PTZ00296 106 DDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELY-NPISEFEVYKTMSKYRIAPQLLNTFS 180 (442)
T ss_pred ccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---ccee-CHHHHHHHHHHHHHCCCCCceEEEeC
Confidence 445 556676777788998875421 4578888875431 1111 22446666666644333 34555553
Q ss_pred eCCeEEEEEeccCCCCHHHH-----------------HhhCC-------CCC-----HHHHHHHHHHH------------
Q 017362 187 DDEFLYLIMEYLPGGDMMTL-----------------LMRKD-------TLT-----EDEARFYVAET------------ 225 (373)
Q Consensus 187 ~~~~~~lV~E~~~gg~L~~~-----------------l~~~~-------~l~-----~~~~~~i~~qi------------ 225 (373)
-+.|.||++|..|... ++... .++ +..+..+...+
T Consensus 181 ----gg~I~efi~g~~l~~~dl~~~~~~~~iA~~L~~lH~~~~~~~~~~~f~~~p~~f~~i~~~~~~~~~~~~~~~~~~~ 256 (442)
T PTZ00296 181 ----GGRIEEWLYGDPLRIDDLKNPSILIGIANVLGKFHTLSRKRHLPEHWDRTPCIFKMMEKWKNQLSKYKNIEKYQRD 256 (442)
T ss_pred ----CCEEEEeeCCccCCHHHcCCHHHHHHHHHHHHHHhcccccccCchhccCCCcHHHHHHHHHHHHHhhccchHhHhh
Confidence 2368999988643211 11110 011 22222222211
Q ss_pred --------HHHHHHHH----------hCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 226 --------VLAIESIH----------KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 226 --------~~aL~~LH----------~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
-....++. ...++|.|+-+.|||.+.+ .++|+||..|..-.
T Consensus 257 ~~~l~~e~~~l~~~l~~~~~l~~~~~~~VfCHNDl~~~NiL~~~~-~l~LIDfEYAg~nd 315 (442)
T PTZ00296 257 IHKYIKESEKFIKFMKVYSKSDNLANDIVFCHNDLQENNIINTNK-CLRLIDFEYSGYNF 315 (442)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccCCeeEEeCCCCccceeecCC-CEEEEeeccccccc
Confidence 11122332 2358999999999988654 49999999987544
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 373 | ||||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-60 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-60 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-60 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-59 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-57 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-57 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-57 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-54 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-50 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-49 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-49 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-49 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-49 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-49 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-49 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-49 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-49 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-49 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-49 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-49 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-49 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-48 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-48 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-48 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-48 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-48 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-48 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-48 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-48 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-48 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-48 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-48 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-48 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-48 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-48 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-48 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-48 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-48 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-48 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-47 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-47 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-47 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-47 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-47 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-47 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-47 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-47 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-47 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-47 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-47 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-47 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-47 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-47 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-47 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-47 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-47 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-47 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-47 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-47 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-47 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-47 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-44 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-44 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-44 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-43 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-42 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-42 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-42 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-42 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-42 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-41 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-41 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-41 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-41 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-41 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-41 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-41 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-41 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-41 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-40 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-39 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-39 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-39 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-39 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-39 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-38 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-38 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-38 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-37 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-35 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-35 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-35 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-35 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-35 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-35 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-35 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-35 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-35 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-34 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-34 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-34 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-34 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-34 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-34 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-34 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-34 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-34 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-34 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-34 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-34 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-34 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-34 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-33 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-30 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-30 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-30 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-30 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-30 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-29 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-29 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-29 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-29 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-29 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-29 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-29 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-29 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-29 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-28 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-28 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-28 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-28 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-28 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-28 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-28 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-28 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-28 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-28 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-28 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-28 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-28 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-28 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-28 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-28 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-28 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-28 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-28 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-28 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-28 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-28 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-28 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-28 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-28 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-28 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-28 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-28 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-28 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-28 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-28 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-28 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-28 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-28 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-28 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-28 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-28 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-28 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-27 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-27 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-27 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-27 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-27 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-27 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-27 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-27 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-27 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-27 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-27 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-27 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-27 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-27 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-27 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-27 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-26 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-26 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-26 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-26 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-26 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-26 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-26 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-26 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-26 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-26 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-26 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-26 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-26 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-26 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-26 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-25 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-25 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-25 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-25 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-25 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-25 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-25 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-25 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-25 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-25 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-25 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-25 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-25 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-25 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-25 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-25 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-25 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-25 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-25 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-25 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-25 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-24 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-24 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-24 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-24 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-24 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-24 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-24 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-24 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-24 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-24 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-24 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-24 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-24 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-24 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-24 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-24 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-24 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-24 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-24 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-24 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-24 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-24 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-24 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-24 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-24 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-23 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-23 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-23 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-23 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-23 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-23 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-23 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-23 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-23 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-23 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-23 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 9e-23 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-22 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-22 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-22 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-22 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-22 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-22 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-22 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-22 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-22 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-22 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-22 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-22 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-22 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-22 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-22 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-22 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-22 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-22 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-22 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-22 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-22 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-22 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-22 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-21 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-21 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-21 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-21 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-21 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-21 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-21 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-21 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-21 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-21 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-21 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-21 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-21 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-21 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-21 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-20 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-20 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-20 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-20 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-20 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-20 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-20 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-20 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-19 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-19 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-19 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-19 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-19 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-19 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-19 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-19 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 9e-19 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-18 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-18 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-18 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-18 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-18 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-18 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-18 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-18 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-18 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-18 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-18 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-18 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-18 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-18 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-18 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-18 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-18 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-18 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-18 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-18 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-18 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-18 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-18 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-18 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-18 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-18 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-18 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-18 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-18 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-18 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-18 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-18 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-17 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-17 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-17 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-17 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-17 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-17 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-17 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-17 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-16 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-16 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-16 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-16 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-16 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-16 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-16 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-16 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-16 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-16 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-15 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-14 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-14 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-14 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-14 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 9e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-13 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-13 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-13 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-13 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-13 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-12 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-12 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-12 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-12 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-12 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-12 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 8e-12 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-11 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-11 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-11 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-11 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-10 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 7e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-09 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-09 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-08 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-08 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-07 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-07 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-07 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-07 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-07 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-07 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-07 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-07 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 9e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 4e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 5e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 5e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-07 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-07 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-07 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 7e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-07 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 8e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-07 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 9e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-06 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-06 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-06 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 2e-06 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 2e-06 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-06 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-06 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-06 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-06 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-06 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-06 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-06 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-06 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-06 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 3e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-06 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-06 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-06 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-06 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-06 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-06 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-06 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-06 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-06 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 4e-06 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-06 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-06 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-06 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-06 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-06 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-06 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-06 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-06 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-06 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-06 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-06 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-06 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-06 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 5e-06 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-06 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-06 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-06 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-06 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-06 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 6e-06 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-06 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 6e-06 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-06 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 6e-06 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-06 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 6e-06 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 7e-06 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 7e-06 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-06 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-06 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 7e-06 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 7e-06 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 7e-06 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 7e-06 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-06 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 8e-06 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 8e-06 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 8e-06 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 8e-06 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-06 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 9e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-05 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-05 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-05 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-05 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-05 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-05 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-05 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-05 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-05 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-05 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-05 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-05 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-05 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-05 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-05 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-05 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-05 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-05 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-05 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-05 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-05 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-05 | ||
| 4ax8_A | 569 | Medium Resolution Structure Of The Bifunctional Kin | 5e-05 | ||
| 4azs_A | 569 | High Resolution (2.2 A) Crystal Structure Of Wbdd. | 5e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-05 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-05 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-05 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-05 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-05 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-04 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-04 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-04 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-04 | ||
| 4azw_A | 471 | Crystal Structure Of Monomeric Wbdd Length = 471 | 1e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-04 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-04 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-04 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-04 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-04 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-04 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-04 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-04 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-04 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-04 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-04 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-04 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-04 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 7e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-04 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-04 |
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AX8|A Chain A, Medium Resolution Structure Of The Bifunctional Kinase- Methyltransferase Wbdd Length = 569 | Back alignment and structure |
|
| >pdb|4AZS|A Chain A, High Resolution (2.2 A) Crystal Structure Of Wbdd. Length = 569 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4AZW|A Chain A, Crystal Structure Of Monomeric Wbdd Length = 471 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 359 bits (924), Expect = e-123
Identities = 116/285 (40%), Positives = 164/285 (57%), Gaps = 48/285 (16%)
Query: 93 NLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKS 152
+ FL+ E +RL+ ++ DDFE+L +IG+GAF EV V + K TG VYAMK + K
Sbjct: 38 YVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKW 97
Query: 153 EMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK-D 211
+ML+RG+V R ER++L D I +L+ +FQD+ +LYL+MEY GGD++TLL + +
Sbjct: 98 DMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGE 157
Query: 212 TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271
+ + ARFY+AE V+AI+S+H+ Y+HRDIKPDN+LLD+ GH+RL+DFG C L
Sbjct: 158 RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKL----- 212
Query: 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK 331
+G+ + + VGTPDY++PE+L
Sbjct: 213 ---------RADGTVR--------------------------SLVAVGTPDYLSPEILQA 237
Query: 332 KG-------YGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369
G YG ECDWW+LG YEM G PFY+D T K+
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI 282
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 351 bits (902), Expect = e-119
Identities = 119/299 (39%), Positives = 175/299 (58%), Gaps = 46/299 (15%)
Query: 76 ILEKKLADADVSEEDQN-NLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRV 134
L+ + D D +N N+ FL + + +++ +M A+D+E++ +IG+GAFGEV++
Sbjct: 28 GLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQL 87
Query: 135 CREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194
R K+T VYAMK L K EM++R ER+++A +S +V+L+ +FQDD +LY++
Sbjct: 88 VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 147
Query: 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH 254
MEY+PGGD++ L+ D + E ARFY AE VLA+++IH +IHRD+KPDN+LLDK GH
Sbjct: 148 MEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH 206
Query: 255 LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLA 314
L+L+DFG C ++ K +
Sbjct: 207 LKLADFGTCMKMN----------------------------------------KEGMVRC 226
Query: 315 YSTVGTPDYIAPEVLLKKG----YGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369
+ VGTPDYI+PEVL +G YG ECDWWS+G +YEMLVG PFY+D + T K+
Sbjct: 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 285
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 351 bits (902), Expect = e-119
Identities = 118/289 (40%), Positives = 168/289 (58%), Gaps = 46/289 (15%)
Query: 87 SEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAM 146
+ N+L++LE + ++++ ++ +DFE+L +IG+GAFGEV V + K V+AM
Sbjct: 45 PLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAM 104
Query: 147 KKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL 206
K L K EML+R + R ER++L DS I L+ +FQDD LYL+M+Y GGD++TL
Sbjct: 105 KILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTL 164
Query: 207 LMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265
L + +D L E+ ARFY+AE V+AI+S+H+ HY+HRDIKPDN+L+D GH+RL+DFG C
Sbjct: 165 LSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224
Query: 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIA 325
L ++ + + VGTPDYI+
Sbjct: 225 LM----------------------------------------EDGTVQSSVAVGTPDYIS 244
Query: 326 PEVLL-----KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369
PE+L K YG ECDWWSLG MYEML G PFY++ + T K+
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 312 bits (801), Expect = e-105
Identities = 81/271 (29%), Positives = 134/271 (49%), Gaps = 39/271 (14%)
Query: 102 ETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVE 161
+ Q K +DF+ ++G+G+F V + RE T YA+K L+K +++ +V
Sbjct: 16 QHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVP 75
Query: 162 HVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFY 221
+V ER++++ +D VKLY +FQDDE LY + Y G+++ + + + E RFY
Sbjct: 76 YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY 135
Query: 222 VAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
AE V A+E +H IHRD+KP+N+LL++ H++++DFG K L
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS-------------- 181
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWW 341
+ R S VGT Y++PE+L +K D W
Sbjct: 182 ---------PESKQARA----------------NSFVGTAQYVSPELLTEKSACKSSDLW 216
Query: 342 SLGAIMYEMLVGYPPFYSDDPMSTCRKVRKK 372
+LG I+Y+++ G PPF + + +K+ K
Sbjct: 217 ALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 247
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 310 bits (797), Expect = e-105
Identities = 94/261 (36%), Positives = 137/261 (52%), Gaps = 44/261 (16%)
Query: 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
K DF++L +G G+FG V + R + G YAMK LKK ++R QVEH ER +L+
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIES 231
V I++++ +FQD + +++IM+Y+ GG++ +LL + A+FY AE LA+E
Sbjct: 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+H I+RD+KP+N+LLDK GH++++DFG K + T
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--------------------- 160
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
Y+ GTPDYIAPEV+ K Y DWWS G ++YEML
Sbjct: 161 -----------------------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEML 197
Query: 352 VGYPPFYSDDPMSTCRKVRKK 372
GY PFY + M T K+
Sbjct: 198 AGYTPFYDSNTMKTYEKILNA 218
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 304 bits (780), Expect = e-102
Identities = 92/286 (32%), Positives = 148/286 (51%), Gaps = 44/286 (15%)
Query: 87 SEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAM 146
E + L K E ++ ++ D F+ + +G G+FG V + + K +G+ YAM
Sbjct: 12 QESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAM 71
Query: 147 KKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL 206
K L K ++++ Q+EH E+ +L V+ +VKL SF+D+ LY++MEY+ GG+M +
Sbjct: 72 KILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSH 131
Query: 207 LMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266
L R +E ARFY A+ VL E +H I+RD+KP+NLL+D+ G+++++DFG K +
Sbjct: 132 LRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAP 326
T ++ GTP+ +AP
Sbjct: 192 KGRT--------------------------------------------WTLCGTPEALAP 207
Query: 327 EVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRKK 372
E++L KGY DWW+LG ++YEM GYPPF++D P+ K+
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 291 bits (746), Expect = 3e-96
Identities = 72/270 (26%), Positives = 126/270 (46%), Gaps = 48/270 (17%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN 168
+ + D FE+L IGKG+FG+V + ++ T +YAMK + K + + R +V +V E
Sbjct: 8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQ 67
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
++ ++ +V L+ SFQD+E ++++++ L GGD+ L + E+ + ++ E V+A
Sbjct: 68 IMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA 127
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
++ + IHRD+KPDN+LLD++GH+ ++DF +
Sbjct: 128 LDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA------------------------ 163
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK---GYGMECDWWSLGA 345
+ + + GT Y+APE+ + GY DWWSLG
Sbjct: 164 ----------------MLPRETQ--ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGV 205
Query: 346 IMYEMLVGYPPFY---SDDPMSTCRKVRKK 372
YE+L G P++ S
Sbjct: 206 TAYELLRGRRPYHIRSSTSSKEIVHTFETT 235
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 6e-95
Identities = 96/276 (34%), Positives = 144/276 (52%), Gaps = 45/276 (16%)
Query: 101 KETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCRE---KTTGHVYAMKKLKKSEMLRR 157
+ K+ + FELL ++GKG +G+V R+ TG ++AMK LKK+ ++R
Sbjct: 2 SSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN 61
Query: 158 G-QVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTED 216
H +AERN+L EV IV L +FQ LYLI+EYL GG++ L R+ ED
Sbjct: 62 AKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED 121
Query: 217 EARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276
A FY+AE +A+ +H+ I+RD+KP+N++L+ GH++L+DFGLCK
Sbjct: 122 TACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK------------ 169
Query: 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM 336
E + ++ GT +Y+APE+L++ G+
Sbjct: 170 ------------------------ESIHDGTV-----THTFCGTIEYMAPEILMRSGHNR 200
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRKK 372
DWWSLGA+MY+ML G PPF ++ T K+ K
Sbjct: 201 AVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC 236
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 284 bits (730), Expect = 4e-94
Identities = 92/287 (32%), Positives = 141/287 (49%), Gaps = 42/287 (14%)
Query: 87 SEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAM 146
+ N ++ DF L +IGKG+FG+V + R K YA+
Sbjct: 9 ELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAV 68
Query: 147 KKLKKSEMLRRGQVEHVRAERNLLAEVDSNC-IVKLYCSFQDDEFLYLIMEYLPGGDMMT 205
K L+K +L++ + +H+ +ERN+L + + +V L+ SFQ + LY +++Y+ GG++
Sbjct: 69 KVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFY 128
Query: 206 LLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265
L R+ E ARFY AE A+ +H + ++RD+KP+N+LLD GH+ L+DFGLCK
Sbjct: 129 HLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK- 187
Query: 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIA 325
E ++H + GTP+Y+A
Sbjct: 188 -----------------------------------ENIEHNST-----TSTFCGTPEYLA 207
Query: 326 PEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRKK 372
PEVL K+ Y DWW LGA++YEML G PPFYS + + K
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 254
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 282 bits (725), Expect = 8e-94
Identities = 90/250 (36%), Positives = 129/250 (51%), Gaps = 41/250 (16%)
Query: 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
K+ +DF+ L ++GKG FG+V + REK TG YAMK L+K ++ + +V H E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIES 231
+ L +FQ + L +MEY GG++ L R+ TE+ ARFY AE V A+E
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+H ++RDIK +NL+LDK GH++++DFGLCK + +
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE----GISDGATM-------------- 162
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
+ GTP+Y+APEVL YG DWW LG +MYEM+
Sbjct: 163 -----------------------KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199
Query: 352 VGYPPFYSDD 361
G PFY+ D
Sbjct: 200 CGRLPFYNQD 209
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 1e-93
Identities = 96/273 (35%), Positives = 150/273 (54%), Gaps = 45/273 (16%)
Query: 103 TEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCRE---KTTGHVYAMKKLKKSEMLRRGQ 159
T +++ K FELL ++G+G+FG+V + ++ +YAMK LKK+ + R +
Sbjct: 11 THHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR 70
Query: 160 VEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEAR 219
V + ER++L EV+ IVKL+ +FQ + LYLI+++L GGD+ T L ++ TE++ +
Sbjct: 71 V-RTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK 129
Query: 220 FYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279
FY+AE LA++ +H I+RD+KP+N+LLD+ GH++L+DFGL K
Sbjct: 130 FYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--------------- 174
Query: 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECD 339
E + H +K AYS GT +Y+APEV+ ++G+ D
Sbjct: 175 ---------------------ESIDHEKK-----AYSFCGTVEYMAPEVVNRRGHTQSAD 208
Query: 340 WWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRKK 372
WWS G +M+EML G PF D T + K
Sbjct: 209 WWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA 241
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 2e-93
Identities = 86/254 (33%), Positives = 129/254 (50%), Gaps = 42/254 (16%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN 168
+ K+ +DF L M+GKG+FG+V + K T +A+K LKK +L VE E+
Sbjct: 10 LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR 69
Query: 169 LLAEVDSN-CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
+L+ + + ++C+FQ E L+ +MEYL GGD+M + A FY AE +L
Sbjct: 70 VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL 129
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
++ +H ++RD+K DN+LLDK GH++++DFG+CK
Sbjct: 130 GLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK----------------------- 166
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347
E + K + GTPDYIAPE+LL + Y DWWS G ++
Sbjct: 167 -------------ENMLGDAK-----TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLL 208
Query: 348 YEMLVGYPPFYSDD 361
YEML+G PF+ D
Sbjct: 209 YEMLIGQSPFHGQD 222
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 281 bits (720), Expect = 9e-93
Identities = 95/293 (32%), Positives = 152/293 (51%), Gaps = 47/293 (16%)
Query: 87 SEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCRE---KTTGHV 143
+ LL + T + K+G ++FELL ++G GA+G+V + R+ TG +
Sbjct: 25 GGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKL 84
Query: 144 YAMKKLKKSEMLRRG-QVEHVRAERNLLAEVDSNC-IVKLYCSFQDDEFLYLIMEYLPGG 201
YAMK LKK+ ++++ EH R ER +L + + +V L+ +FQ + L+LI++Y+ GG
Sbjct: 85 YAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGG 144
Query: 202 DMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFG 261
++ T L +++ TE E + YV E VLA+E +HK I+RDIK +N+LLD GH+ L+DFG
Sbjct: 145 ELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG 204
Query: 262 LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTP 321
L K + ER AY GT
Sbjct: 205 LSKE------------------FVADETER----------------------AYDFCGTI 224
Query: 322 DYIAPEVLL--KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRKK 372
+Y+AP+++ G+ DWWSLG +MYE+L G PF D ++ ++ ++
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR 277
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 2e-92
Identities = 86/254 (33%), Positives = 137/254 (53%), Gaps = 42/254 (16%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN 168
+++G D+FE + ++GKG+FG+V + R K TG +YA+K LKK +L+ VE E+
Sbjct: 16 SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKR 75
Query: 169 LLAEVDSNC-IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
+L+ ++ + +L+C FQ + L+ +ME++ GGD+M + + E ARFY AE +
Sbjct: 76 ILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIIS 135
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
A+ +H I+RD+K DN+LLD GH +L+DFG+CK + T
Sbjct: 136 ALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE----GICNGVTT---------- 181
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347
+ GTPDYIAPE+L + YG DWW++G ++
Sbjct: 182 ---------------------------ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLL 214
Query: 348 YEMLVGYPPFYSDD 361
YEML G+ PF +++
Sbjct: 215 YEMLCGHAPFEAEN 228
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 279 bits (715), Expect = 4e-92
Identities = 81/254 (31%), Positives = 124/254 (48%), Gaps = 42/254 (16%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN 168
R +M DF L ++GKG+FG+V + K T +YA+K LKK +++ VE E+
Sbjct: 13 NRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR 72
Query: 169 LLAEVDSNC-IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
+LA + +L+ FQ + LY +MEY+ GGD+M + + E A FY AE +
Sbjct: 73 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI 132
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+ + I+RD+K DN++LD GH++++DFG+CK
Sbjct: 133 GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK----------------------- 169
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347
E + + GTPDYIAPE++ + YG DWW+ G ++
Sbjct: 170 -------------ENIWDGVT-----TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 211
Query: 348 YEMLVGYPPFYSDD 361
YEML G PF +D
Sbjct: 212 YEMLAGQAPFEGED 225
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 276 bits (707), Expect = 1e-89
Identities = 95/302 (31%), Positives = 144/302 (47%), Gaps = 46/302 (15%)
Query: 61 KEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFEL 120
+E +Q + D N+ + +E + +H++ ++FE
Sbjct: 97 EEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAK----PKHRVTMNEFEY 152
Query: 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
L ++GKG FG+V + +EK TG YAMK LKK ++ + +V H E +L +
Sbjct: 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH-YIH 239
L SFQ + L +MEY GG++ L R+ +ED ARFY AE V A++ +H ++
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 272
Query: 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQ 299
RD+K +NL+LDK GH++++DFGLCK
Sbjct: 273 RDLKLENLMLDKDGHIKITDFGLCK----------------------------------- 297
Query: 300 QEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 359
E ++ + GTP+Y+APEVL YG DWW LG +MYEM+ G PFY+
Sbjct: 298 -EGIKDGAT-----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351
Query: 360 DD 361
D
Sbjct: 352 QD 353
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 2e-89
Identities = 86/253 (33%), Positives = 135/253 (53%), Gaps = 44/253 (17%)
Query: 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
+G DF+LL +IG+G++ +V + R K T +YAMK +KK + ++ V+ E+++
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE 64
Query: 172 EVDSNC--IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
+ SN +V L+ FQ + L+ ++EY+ GGD+M + R+ L E+ ARFY AE LA+
Sbjct: 65 QA-SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLAL 123
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+H+ I+RD+K DN+LLD GH++L+D+G+CK L+ D T
Sbjct: 124 NYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE----GLRPGDTT------------ 167
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349
+ GTP+YIAPE+L + YG DWW+LG +M+E
Sbjct: 168 -------------------------STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 202
Query: 350 MLVGYPPFYSDDP 362
M+ G PF
Sbjct: 203 MMAGRSPFDIVGS 215
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 276 bits (707), Expect = 1e-88
Identities = 80/278 (28%), Positives = 131/278 (47%), Gaps = 45/278 (16%)
Query: 99 EKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRG 158
+ ++ L+ MG D F ++G+G FGEV C+ K TG +YA KKL K + +R
Sbjct: 168 FLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRK 227
Query: 159 QVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMM----TLLMRKDTLT 214
+ E+ +LA+V S IV L +F+ L L+M + GGD+ +
Sbjct: 228 GYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ 287
Query: 215 EDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274
E A FY A+ V +E +H+ + I+RD+KP+N+LLD G++R+SD GL
Sbjct: 288 EPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV---------- 337
Query: 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY 334
E A +T+ GTP ++APE+LL + Y
Sbjct: 338 ---------------ELKAGQTKTK----------------GYAGTPGFMAPELLLGEEY 366
Query: 335 GMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRKK 372
D+++LG +YEM+ PF + ++++++
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR 404
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 276 bits (707), Expect = 3e-88
Identities = 88/341 (25%), Positives = 145/341 (42%), Gaps = 53/341 (15%)
Query: 34 ESTDEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNN 93
T + + V +Q V Q +E + + R + AD S
Sbjct: 111 SHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIY---- 166
Query: 94 LLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSE 153
+ ++ L+R + + F ++GKG FGEV C+ + TG +YA KKL+K
Sbjct: 167 -----FNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR 221
Query: 154 MLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--MRKD 211
+ +R E+ +L +V+S +V L +++ + L L++ + GGD+ + M +
Sbjct: 222 IKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQA 281
Query: 212 TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271
E A FY AE +E +H+ ++RD+KP+N+LLD +GH+R+SD GL
Sbjct: 282 GFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAV------- 334
Query: 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK 331
G + G VGT Y+APEV+
Sbjct: 335 ---HVPEGQTIKGR--------------------------------VGTVGYMAPEVVKN 359
Query: 332 KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRKK 372
+ Y DWW+LG ++YEM+ G PF +V +
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL 400
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 269 bits (691), Expect = 5e-88
Identities = 84/265 (31%), Positives = 136/265 (51%), Gaps = 42/265 (15%)
Query: 99 EKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRG 158
E T +G DF+LL +IG+G++ +V + R K T +YAM+ +KK +
Sbjct: 35 EAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDE 94
Query: 159 QVEHVRAERNLLAEVDSN-CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDE 217
++ V+ E+++ + ++ +V L+ FQ + L+ ++EY+ GGD+M + R+ L E+
Sbjct: 95 DIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH 154
Query: 218 ARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT 277
ARFY AE LA+ +H+ I+RD+K DN+LLD GH++L+D+G+CK
Sbjct: 155 ARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK------------- 201
Query: 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME 337
E L+ + GTP+YIAPE+L + YG
Sbjct: 202 -----------------------EGLRPGDT-----TSTFCGTPNYIAPEILRGEDYGFS 233
Query: 338 CDWWSLGAIMYEMLVGYPPFYSDDP 362
DWW+LG +M+EM+ G PF
Sbjct: 234 VDWWALGVLMFEMMAGRSPFDIVGS 258
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 261 bits (670), Expect = 3e-86
Identities = 75/269 (27%), Positives = 120/269 (44%), Gaps = 43/269 (15%)
Query: 103 TEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEH 162
T + + K DDF++ +GKG FG V + REK + A+K L KS++ + G
Sbjct: 1 TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60
Query: 163 VRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYV 222
+R E + + + I+++Y F D + +YL++E+ P G++ L + E + ++
Sbjct: 61 LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 120
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
E A+ H+ IHRDIKP+NLL+ G L+++DFG
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV------------------ 162
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342
H RR + GT DY+ PE++ K + + D W
Sbjct: 163 ----------------------HAPSLRR---RTMCGTLDYLPPEMIEGKTHDEKVDLWC 197
Query: 343 LGAIMYEMLVGYPPFYSDDPMSTCRKVRK 371
G + YE LVG PPF S T R++
Sbjct: 198 AGVLCYEFLVGMPPFDSPSHTETHRRIVN 226
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 259 bits (665), Expect = 1e-85
Identities = 76/263 (28%), Positives = 120/263 (45%), Gaps = 43/263 (16%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN 168
++ + +DFE+ +GKG FG V + REK + + A+K L K+++ + G +R E
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
+ + + I++LY F D +YLI+EY P G + L + E Y+ E A
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
+ H IHRDIKP+NLLL G L+++DFG
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV------------------------ 157
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
H +RR GT DY+ PE++ + + + D WSLG + Y
Sbjct: 158 ----------------HAPSSRR---TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 198
Query: 349 EMLVGYPPFYSDDPMSTCRKVRK 371
E LVG PPF ++ T +++ +
Sbjct: 199 EFLVGKPPFEANTYQETYKRISR 221
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 270 bits (691), Expect = 5e-85
Identities = 84/280 (30%), Positives = 129/280 (46%), Gaps = 42/280 (15%)
Query: 83 DADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGH 142
A + + + K R +M DF L ++GKG+FG+V + K T
Sbjct: 308 RAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDE 367
Query: 143 VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKLYCSFQDDEFLYLIMEYLPGG 201
+YA+K LKK +++ VE E+ +LA + +L+ FQ + LY +MEY+ GG
Sbjct: 368 LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG 427
Query: 202 DMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFG 261
D+M + + E A FY AE + + + I+RD+K DN++LD GH++++DFG
Sbjct: 428 DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG 487
Query: 262 LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTP 321
+CK E T + GTP
Sbjct: 488 MCK-------------------------ENIWDGVTT----------------KTFCGTP 506
Query: 322 DYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361
DYIAPE++ + YG DWW+ G ++YEML G PF +D
Sbjct: 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 8e-84
Identities = 80/282 (28%), Positives = 130/282 (46%), Gaps = 51/282 (18%)
Query: 88 EEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMK 147
+ + +F + K E + +DF + +IG+G FGEV CR+ TG +YAMK
Sbjct: 165 FIESDKFTRFCQWKNVE----LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK 220
Query: 148 KLKKSEMLRRGQVEHVRAERNLLAEVDSNC---IVKLYCSFQDDEFLYLIMEYLPGGDMM 204
L K + + ER +L+ V + IV + +F + L I++ + GGD+
Sbjct: 221 CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH 280
Query: 205 TLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
L + +E + RFY AE +L +E +H ++RD+KP N+LLD++GH+R+SD GL
Sbjct: 281 YHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC 340
Query: 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYI 324
+ K + +++VGT Y+
Sbjct: 341 ----------------------------------------DFSKKK---PHASVGTHGYM 357
Query: 325 APEVLLKK-GYGMECDWWSLGAIMYEMLVGYPPFYSDDPMST 365
APEVL K Y DW+SLG +++++L G+ PF
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 1e-73
Identities = 78/256 (30%), Positives = 126/256 (49%), Gaps = 41/256 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +GKG F + + T V+A K + KS +L+ Q E + E ++ +
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+V + F+D++F+++++E ++ L R+ LTE EAR+Y+ + VL + +H++
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
IHRD+K NL L++ +++ DFGL +T E D ER
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGL------ATKVEYD-------------GER---- 171
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
K+ GTP+YIAPEVL KKG+ E D WS+G IMY +LVG P
Sbjct: 172 KKV------------------LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 213
Query: 356 PFYSDDPMSTCRKVRK 371
PF + T +++K
Sbjct: 214 PFETSCLKETYLRIKK 229
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 5e-73
Identities = 71/274 (25%), Positives = 122/274 (44%), Gaps = 48/274 (17%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
A DFE + ++G+GAFG+V R YA+KK++ +E ++ + +E LLA ++
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLN 60
Query: 175 SNCIVKLYCSFQDDE-------------FLYLIMEYLPGGDMMTLLM-RKDTLTEDEARF 220
+V+ Y ++ + L++ MEY G + L+ DE
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 221 YVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280
+ + A+ IH IHRD+KP N+ +D+ ++++ DFGL K
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAK---------------- 164
Query: 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECD 339
N++ S + + + L S +GT Y+A EVL G Y + D
Sbjct: 165 NVHRSLDILKLDSQNLPGSSDNLT-----------SAIGTAMYVATEVLDGTGHYNEKID 213
Query: 340 WWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRKKS 373
+SLG I +EM+ YP + ++ +K+R S
Sbjct: 214 MYSLGIIFFEMI--YPFSTGMERVNILKKLRSVS 245
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 5e-73
Identities = 72/257 (28%), Positives = 126/257 (49%), Gaps = 42/257 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+DF++ ++GKG+F V TG A+K + K M + G V+ V+ E + ++
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHK 234
I++LY F+D ++YL++E G+M L + +E+EAR ++ + + + +H
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
H +HRD+ NLLL + +++++DFGL +T + +E+
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGL------ATQLKMP-------------HEK--- 168
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354
T GTP+YI+PE+ + +G+E D WSLG + Y +L+G
Sbjct: 169 -HYT------------------LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
Query: 355 PPFYSDDPMSTCRKVRK 371
PPF +D +T KV
Sbjct: 210 PPFDTDTVKNTLNKVVL 226
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 5e-73
Identities = 78/256 (30%), Positives = 126/256 (49%), Gaps = 41/256 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +GKG F + + T V+A K + KS +L+ Q E + E ++ +
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+V + F+D++F+++++E ++ L R+ LTE EAR+Y+ + VL + +H++
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
IHRD+K NL L++ +++ DFGL +T E D ER
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGL------ATKVEYD-------------GER---- 197
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
K+ GTP+YIAPEVL KKG+ E D WS+G IMY +LVG P
Sbjct: 198 KKV------------------LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 239
Query: 356 PFYSDDPMSTCRKVRK 371
PF + T +++K
Sbjct: 240 PFETSCLKETYLRIKK 255
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 4e-70
Identities = 59/265 (22%), Positives = 96/265 (36%), Gaps = 47/265 (17%)
Query: 101 KETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQV 160
+ Y + F+ L+ +G G++GEV R K G +YA+K+ +
Sbjct: 42 QSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK-DR 100
Query: 161 EHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEA 218
AE +V C V+L ++++ LYL E G + +L E +
Sbjct: 101 ARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQV 159
Query: 219 RFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278
Y+ +T+LA+ +H +H D+KP N+ L G +L DFGL L
Sbjct: 160 WGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL------------ 207
Query: 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC 338
G P Y+APE+ L+ YG
Sbjct: 208 ------------------------------GTAGAGEVQEGDPRYMAPEL-LQGSYGTAA 236
Query: 339 DWWSLGAIMYEMLVGYPPFYSDDPM 363
D +SLG + E+ + +
Sbjct: 237 DVFSLGLTILEVACNMELPHGGEGW 261
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 7e-68
Identities = 64/258 (24%), Positives = 114/258 (44%), Gaps = 44/258 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ + L IG+G+FG+ + + G Y +K++ S M + + E R E +LA +
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK-EREESRREVAVLANMKH 82
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIH 233
IV+ SF+++ LY++M+Y GGD+ + ED+ + + LA++ +H
Sbjct: 83 PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
+HRDIK N+ L K G ++L DFG+ + L+ +
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV----------------------- 179
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
LA + +GTP Y++PE+ K Y + D W+LG ++YE+
Sbjct: 180 ------------------ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTL 221
Query: 354 YPPFYSDDPMSTCRKVRK 371
F + + K+
Sbjct: 222 KHAFEAGSMKNLVLKIIS 239
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 3e-63
Identities = 48/282 (17%), Positives = 101/282 (35%), Gaps = 71/282 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR--------------RGQVE 161
+D+ ++ + +G F ++ +C + YA+KK +KS + + + + +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 162 HVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--------MRKDTL 213
+ E ++ ++ + + + + +Y+I EY+ ++ +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 214 TEDEARFYVAETVLAIESIHKHHYI-HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272
+ + + + IH I HRD+KP N+L+DK G ++LSDFG +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESE-------- 200
Query: 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332
+ + + GT +++ PE +
Sbjct: 201 --------------------------------YMVDKKI---KGSRGTYEFMPPEFFSNE 225
Query: 333 G--YGMECDWWSLGAIMYEMLVGYPPFYSD-DPMSTCRKVRK 371
G + D WSLG +Y M PF + +R
Sbjct: 226 SSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT 267
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 9e-63
Identities = 68/259 (26%), Positives = 121/259 (46%), Gaps = 46/259 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D++++ +GKGAF VR C KTTG +A K + ++ R + + E + ++
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQH 64
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV+L+ S Q++ F YL+ + + GG++ ++ ++ +E +A + + + +I H +
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+HR++KP+NLLL K ++L+DFGL
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAI---------------------------- 156
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
+ + GTP Y++PEVL K Y D W+ G I+Y +LV
Sbjct: 157 ------------EVNDSEAW--HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 202
Query: 353 GYPPFYSDDPMSTCRKVRK 371
GYPPF+ +D +++
Sbjct: 203 GYPPFWDEDQHRLYAQIKA 221
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 4e-62
Identities = 71/267 (26%), Positives = 121/267 (45%), Gaps = 53/267 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+D+E+L IG G++G + R K+ G + K+L M + + + +E NLL E+
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRELKH 64
Query: 176 NCIVKLYCSFQD--DEFLYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAI 229
IV+ Y D + LY++MEY GGD+ +++ + + L E+ + + LA+
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 230 ESIHKHHY-----IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
+ H+ +HRD+KP N+ LD +++L DFGL + L+ T
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-------------- 170
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344
A + VGTP Y++PE + + Y + D WSLG
Sbjct: 171 ---------------------------SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLG 203
Query: 345 AIMYEMLVGYPPFYSDDPMSTCRKVRK 371
++YE+ PPF + K+R+
Sbjct: 204 CLLYELCALMPPFTAFSQKELAGKIRE 230
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 4e-61
Identities = 72/259 (27%), Positives = 124/259 (47%), Gaps = 47/259 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ + ++ M+GKG+FGEV C+++ T YA+K + K+ + + E LL ++D
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDH 80
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I+KL+ +D Y++ E GG++ ++++ +E +A + + I +HKH
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+ +HRD+KP+N+LL +K +++ DFGL
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLST---------------------------- 172
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
+Q+N +M +GT YIAPEV L+ Y +CD WS G I+Y +L
Sbjct: 173 ------------CFQQNTKM--KDRIGTAYYIAPEV-LRGTYDEKCDVWSAGVILYILLS 217
Query: 353 GYPPFYSDDPMSTCRKVRK 371
G PPFY + ++V
Sbjct: 218 GTPPFYGKNEYDILKRVET 236
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 6e-61
Identities = 67/259 (25%), Positives = 119/259 (45%), Gaps = 49/259 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
F + ++G GAF EV + +++ TG ++A+K +KKS + + E +L ++
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKS---PAFRDSSLENEIAVLKKIKH 65
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV L ++ YL+M+ + GG++ ++ + TE +A + + + A++ +H++
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+HRD+KP+NLL ++ + ++DFGL K +
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST------------------- 166
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
GTP Y+APEVL +K Y D WS+G I Y +L
Sbjct: 167 ------------------------ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLC 202
Query: 353 GYPPFYSDDPMSTCRKVRK 371
GYPPFY + K+++
Sbjct: 203 GYPPFYEETESKLFEKIKE 221
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 7e-61
Identities = 62/278 (22%), Positives = 103/278 (37%), Gaps = 61/278 (21%)
Query: 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
+ L ++G+GA V R K TG ++A+K LR V+ E +L
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLK 62
Query: 172 EVDSNCIVKLYCSFQDD--EFLYLIMEYLPGGDMMTLLMRKDT---LTEDEARFYVAETV 226
+++ IVKL+ ++ LIME+ P G + T+L L E E + + V
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 227 LAIESIHKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+ + ++ +HR+IKP N++ D +L+DFG + L+
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE------------ 170
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL--------LKKGY 334
S GT +Y+ P++ +K Y
Sbjct: 171 ------------------------------QFVSLYGTEEYLHPDMYERAVLRKDHQKKY 200
Query: 335 GMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRKK 372
G D WS+G Y G PF + ++V K
Sbjct: 201 GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-60
Identities = 65/286 (22%), Positives = 113/286 (39%), Gaps = 57/286 (19%)
Query: 102 ETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVE 161
TE + Q + + +L IG G +V + +YA+K + E ++
Sbjct: 14 GTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLD 71
Query: 162 HVRAERNLLAEVD--SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEAR 219
R E L ++ S+ I++LY D+++Y++ME D+ + L +K ++ E +
Sbjct: 72 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERK 130
Query: 220 FYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279
Y + A+ +IH+H +H D+KP N L+ G L+L DFG+ + T
Sbjct: 131 SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT--------- 180
Query: 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL--------- 330
++ S VGT +Y+ PE +
Sbjct: 181 ------------------------------TSVVKDSQVGTVNYMPPEAIKDMSSSRENG 210
Query: 331 --KKGYGMECDWWSLGAIMYEMLVGYPPFYS-DDPMSTCRKVRKKS 373
K + D WSLG I+Y M G PF + +S + +
Sbjct: 211 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 256
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 2e-60
Identities = 71/269 (26%), Positives = 113/269 (42%), Gaps = 55/269 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD- 174
+++E ++G+G VR C K T YA+K + + E L EVD
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 175 ------SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
I++L +++ + F +L+ + + G++ L K TL+E E R + +
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
I ++HK + +HRD+KP+N+LLD +++L+DFG LD +
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD----PGEKLR----------- 181
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL------LKKGYGMECDWWS 342
GTP Y+APE++ GYG E D WS
Sbjct: 182 ---------------------------EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWS 214
Query: 343 LGAIMYEMLVGYPPFYSDDPMSTCRKVRK 371
G IMY +L G PPF+ M R +
Sbjct: 215 TGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 2e-60
Identities = 68/264 (25%), Positives = 112/264 (42%), Gaps = 47/264 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+F + IG+G F EV G A+KK++ +++ E +LL +++
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL----MRKDTLTEDEARFYVAETVLAIES 231
++K Y SF +D L +++E GD+ ++ +K + E Y + A+E
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+H +HRDIKP N+ + G ++L D GL + T
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--------------------- 190
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
A+S VGTP Y++PE + + GY + D WSLG ++YEM
Sbjct: 191 --------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 230
Query: 352 VGYPPFYSDD--PMSTCRKVRKKS 373
PFY D S C+K+ +
Sbjct: 231 ALQSPFYGDKMNLYSLCKKIEQCD 254
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-60
Identities = 64/274 (23%), Positives = 105/274 (38%), Gaps = 61/274 (22%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ L ++G+GA V R K TG ++A+K LR V+ E +L +++
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNH 66
Query: 176 NCIVKLYCSFQDD--EFLYLIMEYLPGGDMMTLLMRKDT---LTEDEARFYVAETVLAIE 230
IVKL+ ++ LIME+ P G + T+L L E E + + V +
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 231 SIHKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
+ ++ +HR+IKP N++ D +L+DFG + L+
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE------------------- 167
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL--------LKKGYGMEC 338
EQ S GT +Y+ P++ +K YG
Sbjct: 168 ------------DDEQFV-----------SLYGTEEYLHPDMYERAVLRKDHQKKYGATV 204
Query: 339 DWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRKK 372
D WS+G Y G PF + ++V K
Sbjct: 205 DLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 3e-60
Identities = 57/273 (20%), Positives = 98/273 (35%), Gaps = 68/273 (24%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
DF+ + +IG G FG+V + + G Y +K++K + E E LA++D
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLD 62
Query: 175 SNCIVKLYCSFQDDE----------------FLYLIMEYLPGGDMMTLL--MRKDTLTED 216
IV + + L++ ME+ G + + R + L +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 217 EARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276
A + ++ IH I+RD+KP N+ L +++ DFGL L
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---------- 172
Query: 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM 336
+ GT Y++PE + + YG
Sbjct: 173 --------------------------------KNDGKRTRSKGTLRYMSPEQISSQDYGK 200
Query: 337 ECDWWSLGAIMYEML-VGYPPFYSDDPMSTCRK 368
E D ++LG I+ E+L V F + + R
Sbjct: 201 EVDLYALGLILAELLHVCDTAFETSKFFTDLRD 233
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 4e-60
Identities = 68/259 (26%), Positives = 121/259 (46%), Gaps = 46/259 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D++++ +GKGAF VR C KTTG +A K + ++ R + + E + ++
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQH 87
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV+L+ S Q++ F YL+ + + GG++ ++ ++ +E +A + + + +I H +
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+HR++KP+NLLL K ++L+DFGL
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAI---------------------------- 179
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
+ + GTP Y++PEVL K Y D W+ G I+Y +LV
Sbjct: 180 ------------EVNDSEAW--HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 225
Query: 353 GYPPFYSDDPMSTCRKVRK 371
GYPPF+ +D +++
Sbjct: 226 GYPPFWDEDQHRLYAQIKA 244
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 193 bits (494), Expect = 7e-60
Identities = 70/263 (26%), Positives = 118/263 (44%), Gaps = 49/263 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML---RRGQVEHVRAERNLLAE 172
D +E+ +G G F VR CR+K TG YA K +KK + R E + E N+L E
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
+ I+ L+ F++ + LI+E + GG++ L K++LTEDEA ++ + + + +
Sbjct: 65 IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124
Query: 233 HKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
H H D+KP+N++L ++L DFG+ ++ +F
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE----AGNEFK----------- 169
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
+ GTP+++APE++ + G+E D WS+G I Y
Sbjct: 170 ---------------------------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 202
Query: 349 EMLVGYPPFYSDDPMSTCRKVRK 371
+L G PF + T +
Sbjct: 203 ILLSGASPFLGETKQETLTNISA 225
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 3e-59
Identities = 66/263 (25%), Positives = 122/263 (46%), Gaps = 49/263 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ---VEHVRAERNLLAE 172
D +++ +G G F V+ CREK+TG YA K +KK + + E + E ++L +
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
V + ++ L+ +++ + LI+E + GG++ L +K++L+E+EA ++ + + + +
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 233 HKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
H H D+KP+N++L H++L DFGL ++ +F
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE----DGVEFK----------- 176
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
+ GTP+++APE++ + G+E D WS+G I Y
Sbjct: 177 ---------------------------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 349 EMLVGYPPFYSDDPMSTCRKVRK 371
+L G PF D T +
Sbjct: 210 ILLSGASPFLGDTKQETLANITS 232
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 3e-59
Identities = 78/259 (30%), Positives = 128/259 (49%), Gaps = 46/259 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D ++ ++GKG+FGEV +C++K TG A+K + K ++ ++ E + E LL ++D
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I+KLY F+D + YL+ E GG++ ++ + +E +A + + + I +HK+
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+HRD+KP+NLLL K ++R+ DFGL
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLST---------------------------- 177
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
H++ +++M +GT YIAPEV L Y +CD WS G I+Y +L
Sbjct: 178 ------------HFEASKKM--KDKIGTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLS 222
Query: 353 GYPPFYSDDPMSTCRKVRK 371
G PPF + +KV K
Sbjct: 223 GCPPFNGANEYDILKKVEK 241
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 6e-59
Identities = 62/263 (23%), Positives = 111/263 (42%), Gaps = 52/263 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D F +G GAFG+V + E+++G +K + K + +E + AE +L +D
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDH 79
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGD----MMTLLMRKDTLTEDEARFYVAETVLAIES 231
I+K++ F+D +Y++ME GG+ +++ R L+E + + + A+
Sbjct: 80 PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 232 IHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
H H +H+D+KP+N+L + +++ DFGL +
Sbjct: 140 FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE------------------------ 175
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
++ + + GT Y+APEV K+ +CD WS G +MY
Sbjct: 176 ----------------LFKSDEHS--TNAAGTALYMAPEV-FKRDVTFKCDIWSAGVVMY 216
Query: 349 EMLVGYPPFYSDDPMSTCRKVRK 371
+L G PF +K
Sbjct: 217 FLLTGCLPFTGTSLEEVQQKATY 239
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 9e-59
Identities = 73/259 (28%), Positives = 120/259 (46%), Gaps = 49/259 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ L IG+G++GEV++ +K T A KK+ K + V+ + E ++ +D
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDH 65
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I++LY +F+D+ +YL+ME GG++ ++ K E +A + + + A+ HK
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+ HRD+KP+N L L+L DFGL
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA---------------------------- 157
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
++ + M + VGTP Y++P+V L+ YG ECD WS G +MY +L
Sbjct: 158 ------------RFKPGKMM--RTKVGTPYYVSPQV-LEGLYGPECDEWSAGVMMYVLLC 202
Query: 353 GYPPFYSDDPMSTCRKVRK 371
GYPPF + K+R+
Sbjct: 203 GYPPFSAPTDSEVMLKIRE 221
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 1e-58
Identities = 62/271 (22%), Positives = 108/271 (39%), Gaps = 57/271 (21%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-- 174
+ +L IG G +V + +YA+K + E ++ R E L ++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQH 67
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
S+ I++LY D+++Y++ME D+ + L +K ++ E + Y + A+ +IH+
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
H +H D+KP N L+ G L+L DFG+ + T
Sbjct: 127 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT------------------------ 161
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----------KKGYGMECDWWSL 343
++ S VGT +Y+ PE + K + D WSL
Sbjct: 162 ---------------TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 206
Query: 344 GAIMYEMLVGYPPFYS-DDPMSTCRKVRKKS 373
G I+Y M G PF + +S + +
Sbjct: 207 GCILYYMTYGKTPFQQIINQISKLHAIIDPN 237
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 2e-58
Identities = 69/268 (25%), Positives = 115/268 (42%), Gaps = 54/268 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMK-----KLKKSEMLRRGQVEHVRAERNLL 170
++ +IG+G VR C + TGH +A+K + S E R E ++L
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 171 AEV-DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
+V I+ L S++ F++L+ + + G++ L K L+E E R + + A+
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAV 213
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+H ++ +HRD+KP+N+LLD +RLSDFG
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC------------------------- 248
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL------LKKGYGMECDWWSL 343
H + ++ GTP Y+APE+L GYG E D W+
Sbjct: 249 ---------------HLEPGEKL--RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWAC 291
Query: 344 GAIMYEMLVGYPPFYSDDPMSTCRKVRK 371
G I++ +L G PPF+ + R + +
Sbjct: 292 GVILFTLLAGSPPFWHRRQILMLRMIME 319
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-58
Identities = 69/257 (26%), Positives = 113/257 (43%), Gaps = 54/257 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMK-----KLKKSEMLRRGQVEHVRAERNLL 170
D++ + +G GA GEV++ E+ T A+K K +V E +L
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 171 AEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
+++ CI+K+ F D E Y+++E + GG++ ++ L E + Y + +LA++
Sbjct: 70 KKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 231 SIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+H++ IHRD+KP+N+LL ++ ++++DFG K L E
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-----ILGETSLM---------- 173
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL---LKKGYGMECDWWSLG 344
+ GTP Y+APEVL GY D WSLG
Sbjct: 174 ---------------------------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 206
Query: 345 AIMYEMLVGYPPFYSDD 361
I++ L GYPPF
Sbjct: 207 VILFICLSGYPPFSEHR 223
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 3e-58
Identities = 68/273 (24%), Positives = 124/273 (45%), Gaps = 49/273 (17%)
Query: 106 MRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML---RRGQVEH 162
M + + D +++ +G G F V+ CREK+TG YA K +KK + R E
Sbjct: 2 METFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE 61
Query: 163 VRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYV 222
+ E ++L +V I+ L+ +++ + LI+E + GG++ L +K++L+E+EA ++
Sbjct: 62 IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278
+ + + +H H D+KP+N++L H++L DFGL ++
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE----------- 170
Query: 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC 338
+ + + GTP+++APE++ + G+E
Sbjct: 171 --------------------DGVEFK-----------NIFGTPEFVAPEIVNYEPLGLEA 199
Query: 339 DWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRK 371
D WS+G I Y +L G PF D T +
Sbjct: 200 DMWSIGVITYILLSGASPFLGDTKQETLANITA 232
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 3e-58
Identities = 68/257 (26%), Positives = 113/257 (43%), Gaps = 54/257 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMK-----KLKKSEMLRRGQVEHVRAERNLL 170
D++ + +G GA GEV++ E+ T A++ K +V E +L
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 171 AEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
+++ CI+K+ F D E Y+++E + GG++ ++ L E + Y + +LA++
Sbjct: 195 KKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 231 SIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+H++ IHRD+KP+N+LL ++ ++++DFG K L E
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-----ILGETSLM---------- 298
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL---LKKGYGMECDWWSLG 344
+ GTP Y+APEVL GY D WSLG
Sbjct: 299 ---------------------------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 331
Query: 345 AIMYEMLVGYPPFYSDD 361
I++ L GYPPF
Sbjct: 332 VILFICLSGYPPFSEHR 348
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 4e-58
Identities = 60/271 (22%), Positives = 107/271 (39%), Gaps = 48/271 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DFE + +G+G FG V + K YA+K+++ E V E LA+++
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL--AREKVMREVKALAKLEH 62
Query: 176 NCIVKLYCSFQDDE------------FLYLIMEYLPGGDMMTLLMRKDTLTEDEARF--- 220
IV+ + ++ + +LY+ M+ ++ + + T+ E E
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 221 YVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280
+ A+E +H +HRD+KP N+ +++ DFGL +D
Sbjct: 123 IFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD------------- 169
Query: 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340
+ ++EQ VGT Y++PE + Y + D
Sbjct: 170 ----------------QDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDI 213
Query: 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKVRK 371
+SLG I++E+L YP + + T VR
Sbjct: 214 FSLGLILFELL--YPFSTQMERVRTLTDVRN 242
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 6e-58
Identities = 67/263 (25%), Positives = 117/263 (44%), Gaps = 49/263 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ---VEHVRAERNLLAE 172
D ++ +G G F V+ CREK+TG YA K +KK + E + E ++L E
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
+ ++ L+ +++ + LI+E + GG++ L K++LTE+EA ++ + + + +
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 233 HKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
H H D+KP+N++L +++ DFGL +D +F
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID----FGNEFK----------- 175
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
+ GTP+++APE++ + G+E D WS+G I Y
Sbjct: 176 ---------------------------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 349 EMLVGYPPFYSDDPMSTCRKVRK 371
+L G PF D T V
Sbjct: 209 ILLSGASPFLGDTKQETLANVSA 231
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 7e-58
Identities = 65/255 (25%), Positives = 111/255 (43%), Gaps = 50/255 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ--VEHVRAERNLLAEV 173
D +EL +IGKG F VR C + TG +A+K + ++ E ++ E ++ +
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 174 DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK----DTLTEDEARFYVAETVLAI 229
IV+L ++ D LY++ E++ G D+ ++++ +E A Y+ + + A+
Sbjct: 84 KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 230 ESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
H ++ IHRD+KP +LL + ++L FG+ L S G G
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES---------GLVAGG-- 192
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346
VGTP ++APEV+ ++ YG D W G I
Sbjct: 193 ------------------------------RVGTPHFMAPEVVKREPYGKPVDVWGCGVI 222
Query: 347 MYEMLVGYPPFYSDD 361
++ +L G PFY
Sbjct: 223 LFILLSGCLPFYGTK 237
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 9e-58
Identities = 72/259 (27%), Positives = 124/259 (47%), Gaps = 47/259 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ + ++ M+GKG+FGEV C+++ T YA+K + K+ + + E LL ++D
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDH 80
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I+KL+ +D Y++ E GG++ ++++ +E +A + + I +HKH
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+ +HRD+KP+N+LL +K +++ DFGL
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLST---------------------------- 172
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
+Q+N +M +GT YIAPEV L+ Y +CD WS G I+Y +L
Sbjct: 173 ------------CFQQNTKM--KDRIGTAYYIAPEV-LRGTYDEKCDVWSAGVILYILLS 217
Query: 353 GYPPFYSDDPMSTCRKVRK 371
G PPFY + ++V
Sbjct: 218 GTPPFYGKNEYDILKRVET 236
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 1e-57
Identities = 65/259 (25%), Positives = 118/259 (45%), Gaps = 45/259 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
++++L +GKGAF VR C + G YA + L + + E + +
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTK-KLSARDHQKLEREARICRLLKH 69
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV+L+ S ++ YLI + + GG++ ++ ++ +E +A + + + A+ H+
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+HR++KP+NLLL K ++L+DFGL ++
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE------------------------- 164
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
+ + + GTP Y++PEVL K YG D W+ G I+Y +LV
Sbjct: 165 --------------GEQQAW--FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLV 208
Query: 353 GYPPFYSDDPMSTCRKVRK 371
GYPPF+ +D ++++
Sbjct: 209 GYPPFWDEDQHRLYQQIKA 227
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 2e-57
Identities = 58/254 (22%), Positives = 110/254 (43%), Gaps = 49/254 (19%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKLY 182
+G+G F VR C K+TG YA K LKK + + E +L S ++ L+
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRR-RGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRKDT--LTEDEARFYVAETVLAIESIHKHHYIHR 240
+++ + LI+EY GG++ +L + + ++E++ + + + + +H+++ +H
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHL 155
Query: 241 DIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
D+KP N+LL G +++ DFG+ + +
Sbjct: 156 DLKPQNILLSSIYPLGDIKIVDFGMSRKIG------------------------------ 185
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
+L+ +GTP+Y+APE+L D W++G I Y +L PF
Sbjct: 186 -HACELR-----------EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPF 233
Query: 358 YSDDPMSTCRKVRK 371
+D T + +
Sbjct: 234 VGEDNQETYLNISQ 247
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 2e-57
Identities = 70/253 (27%), Positives = 107/253 (42%), Gaps = 53/253 (20%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS--NCIVKL 181
+G+G+F R C K + +A+K + K + + E L + N IVKL
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPN-IVKL 71
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
+ F D +L+ME L GG++ + +K +E EA + + + V A+ +H +HRD
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRD 131
Query: 242 IKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRT 298
+KP+NLL + +++ DFG A K
Sbjct: 132 LKPENLLFTDENDNLEIKIIDFGF------------------------------ARLKPP 161
Query: 299 QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358
+ L+ + T Y APE+L + GY CD WSLG I+Y ML G PF
Sbjct: 162 DNQPLK-----------TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQ 210
Query: 359 SDDPMSTCRKVRK 371
S D TC +
Sbjct: 211 SHDRSLTCTSAVE 223
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 5e-57
Identities = 73/309 (23%), Positives = 130/309 (42%), Gaps = 50/309 (16%)
Query: 68 QERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMG--ADDFELLTMIG 125
++RR ++ E+ N + + Y + K D +++ +G
Sbjct: 107 RKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELG 166
Query: 126 KGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSF 185
GAFG V E+ TG+ +A K + E VR E ++ + +V L+ +F
Sbjct: 167 TGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 186 QDDEFLYLIMEYLPGGDMM-TLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKP 244
+DD + +I E++ GG++ + + ++EDEA Y+ + + +H+++Y+H D+KP
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKP 283
Query: 245 DNLLL--DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQ 302
+N++ + L+L DFGL LD +Q +
Sbjct: 284 ENIMFTTKRSNELKLIDFGLTAHLD----PKQSVKV------------------------ 315
Query: 303 LQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDP 362
T GT ++ APEV K G D WS+G + Y +L G PF ++
Sbjct: 316 --------------TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND 361
Query: 363 MSTCRKVRK 371
T R V+
Sbjct: 362 DETLRNVKS 370
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 7e-57
Identities = 66/302 (21%), Positives = 110/302 (36%), Gaps = 83/302 (27%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR--GQVEHVRAERNLLAEV 173
+ L IG+G++G VRV E T + A+K + K+++ + VE ++ E L+ ++
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 174 DSNCIVKLYCSFQDDEFLYLIMEYLPGGD------------------------------- 202
I +LY ++D++++ L+ME GG
Sbjct: 86 HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 203 ---------MMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL--DK 251
E + + A+ +H HRDIKP+N L +K
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205
Query: 252 YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRR 311
++L DFGL K E
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGM---------------------------------- 231
Query: 312 MLAYSTVGTPDYIAPEVL--LKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369
+ GTP ++APEVL + YG +CD WS G +++ +L+G PF + T +V
Sbjct: 232 ---TTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQV 288
Query: 370 RK 371
Sbjct: 289 LN 290
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-56
Identities = 66/311 (21%), Positives = 134/311 (43%), Gaps = 50/311 (16%)
Query: 64 MKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTM 123
M+ + + K +++ D+ + + KK + D +++L
Sbjct: 1 MRGSHHHHHHGSKVRGKYDGPKINDYDK--FYEDIWKKYVPQPVEVKQGSVYDYYDILEE 58
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
+G GAFG V C EK TG V+ K + V+ E +++ ++ ++ L+
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTP---YPLDKYTVKNEISIMNQLHHPKLINLHD 115
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDI 242
+F+D + LI+E+L GG++ + +D ++E E Y+ + ++ +H+H +H DI
Sbjct: 116 AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDI 175
Query: 243 KPDNLLL--DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
KP+N++ K +++ DFGL L+ ++ +
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLN----PDEIVKV---------------------- 209
Query: 301 EQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360
T T ++ APE++ ++ G D W++G + Y +L G PF +
Sbjct: 210 ----------------TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 253
Query: 361 DPMSTCRKVRK 371
D + T + V++
Sbjct: 254 DDLETLQNVKR 264
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-56
Identities = 61/271 (22%), Positives = 107/271 (39%), Gaps = 57/271 (21%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-- 174
+ +L IG G +V + +YA+K + E ++ R E L ++
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQH 114
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
S+ I++LY D+++Y++ME D+ + L +K ++ E + Y + A+ +IH+
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
H +H D+KP N L+ G L+L DFG+ + T
Sbjct: 174 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT------------------------ 208
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----------KKGYGMECDWWSL 343
++ S VG +Y+ PE + K + D WSL
Sbjct: 209 ---------------TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 253
Query: 344 GAIMYEMLVGYPPFYS-DDPMSTCRKVRKKS 373
G I+Y M G PF + +S + +
Sbjct: 254 GCILYYMTYGKTPFQQIINQISKLHAIIDPN 284
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 3e-56
Identities = 71/249 (28%), Positives = 113/249 (45%), Gaps = 50/249 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D FE+ + +G+GA V C++K T YA+K LKK+ + VR E +L +
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSH 107
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I+KL F+ + L++E + GG++ ++ K +E +A V + + A+ +H++
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN 167
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+HRD+KP+NLL L+++DFGL K
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSK---------------------------- 199
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
+ M + GTP Y APE+L YG E D WS+G I Y +L
Sbjct: 200 ------------IVEHQVLM--KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLC 245
Query: 353 GYPPFYSDD 361
G+ PFY +
Sbjct: 246 GFEPFYDER 254
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 4e-56
Identities = 56/259 (21%), Positives = 100/259 (38%), Gaps = 49/259 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ + + +G+G FG V C E ++ Y K +K + V+ E ++L
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMM-TLLMRKDTLTEDEARFYVAETVLAIESIHK 234
I+ L+ SF+ E L +I E++ G D+ + L E E YV + A++ +H
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 235 HHYIHRDIKPDNLLL--DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H+ H DI+P+N++ + +++ +FG + L +F +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK----PGDNFRL-------------- 162
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
P+Y APEV D WSLG ++Y +L
Sbjct: 163 ------------------------LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS 198
Query: 353 GYPPFYSDDPMSTCRKVRK 371
G PF ++ +
Sbjct: 199 GINPFLAETNQQIIENIMN 217
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 7e-56
Identities = 78/269 (28%), Positives = 126/269 (46%), Gaps = 56/269 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM----------LRRGQVEHVRA 165
+ + + +G GA+GEV +C+EK A+K +KKS+ E +
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 166 ERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAET 225
E +LL +D I+KL+ F+D ++ YL+ E+ GG++ ++ + E +A + +
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 226 VLAIESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+ I +HKH+ +HRDIKP+N+LL + ++++ DFGL
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS------------------ 197
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342
+ K+ ++ +GT YIAPEV LKK Y +CD WS
Sbjct: 198 ----------------------FFSKDYKL--RDRLGTAYYIAPEV-LKKKYNEKCDVWS 232
Query: 343 LGAIMYEMLVGYPPFYSDDPMSTCRKVRK 371
G IMY +L GYPPF + +KV K
Sbjct: 233 CGVIMYILLCGYPPFGGQNDQDIIKKVEK 261
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 7e-56
Identities = 75/259 (28%), Positives = 124/259 (47%), Gaps = 47/259 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ ++ + +G GA+GEV +CR+K T A+K ++K+ + + E +L +D
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS-VSTSSNSKLLEEVAVLKLLDH 95
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I+KLY F+D YL+ME GG++ ++ + E +A + + + + +HKH
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+ +HRD+KP+NLLL +K +++ DFGL
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSA---------------------------- 187
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
++ ++M +GT YIAPEV L+K Y +CD WS+G I++ +L
Sbjct: 188 ------------VFENQKKM--KERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLA 232
Query: 353 GYPPFYSDDPMSTCRKVRK 371
GYPPF RKV K
Sbjct: 233 GYPPFGGQTDQEILRKVEK 251
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 1e-55
Identities = 64/253 (25%), Positives = 109/253 (43%), Gaps = 51/253 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D +E+ IG G++ + C K T +A+K + KS+ ++E LL
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI------LLRYGQH 75
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I+ L + D +++Y++ E + GG+++ ++R+ +E EA + +E +H
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 236 HYIHRDIKPDNLLL----DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+HRD+KP N+L +R+ DFG K L
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL------------------------- 170
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
R + L + T +++APEVL ++GY CD WSLG ++Y ML
Sbjct: 171 -----RAENGLL-----------MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTML 214
Query: 352 VGYPPFYSDDPMS 364
GY PF + +
Sbjct: 215 TGYTPFANGPDDT 227
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 3e-55
Identities = 59/285 (20%), Positives = 101/285 (35%), Gaps = 48/285 (16%)
Query: 101 KETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQV 160
+E Y + + + + +G+G F V + GH YA+K++ E
Sbjct: 14 RENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ---QDR 70
Query: 161 EHVRAERNLLAEVDSNCIVKLYCSFQDDEF----LYLIMEYLPGGD----MMTLLMRKDT 212
E + E ++ + I++L + +L++ + G + L + +
Sbjct: 71 EEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF 130
Query: 213 LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272
LTED+ + + +E+IH Y HRD+KP N+LL G L D G
Sbjct: 131 LTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA------ 184
Query: 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332
Q LQ W + T Y APE+ +
Sbjct: 185 ------------------CIHVEGSRQALTLQDW--------AAQRCTISYRAPELFSVQ 218
Query: 333 GY---GMECDWWSLGAIMYEMLVGYPPFYSDDP--MSTCRKVRKK 372
+ D WSLG ++Y M+ G P+ S V+ +
Sbjct: 219 SHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ 263
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 1e-54
Identities = 42/282 (14%), Positives = 84/282 (29%), Gaps = 63/282 (22%)
Query: 112 KMGADDFELLTMIGKGAFGEVRVCREKT-----TGHVYAMKKLKKSEMLRRGQVEHVRAE 166
++G+ + ++G+GAF +V + + +K K + +
Sbjct: 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQL 117
Query: 167 RNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK-----DTLTEDEARFY 221
L + +K Y + L+ E G ++ + + + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 222 VAETVLAIESIHKHHYIHRDIKPDNLLL-----------DKYGHLRLSDFGLCKPLDCST 270
+ IE +H IH DIKPDN +L D L L D G
Sbjct: 178 AMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI------ 231
Query: 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL 330
++ + K + T + E+L
Sbjct: 232 -------------------------------DMKLFPKGTIF--TAKCETSGFQCVEMLS 258
Query: 331 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRKK 372
K + + D++ + A +Y ML G ++ + +
Sbjct: 259 NKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFR 300
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 2e-54
Identities = 60/258 (23%), Positives = 111/258 (43%), Gaps = 48/258 (18%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
++G G FG+V C E TG A K +K M + E V+ E +++ ++D
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLDHA 146
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKH 235
+++LY +F+ + L+MEY+ GG++ ++ + LTE + ++ + I +H+
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206
Query: 236 HYIHRDIKPDNLLL-DKYGH-LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
+ +H D+KP+N+L ++ +++ DFGL +
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYK-------------------------- 240
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
++ GTP+++APEV+ D WS+G I Y +L G
Sbjct: 241 --------------PREKL--KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
Query: 354 YPPFYSDDPMSTCRKVRK 371
PF D+ T +
Sbjct: 285 LSPFLGDNDAETLNNILA 302
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 3e-54
Identities = 75/267 (28%), Positives = 118/267 (44%), Gaps = 60/267 (22%)
Query: 116 DDFELL-TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
DD++L ++G G G+V C + TG A+K L S R+ +V+H
Sbjct: 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ-EVDH------HWQASG 80
Query: 175 SNCIVKLYCSFQD----DEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLA 228
IV + +++ L +IME + GG++ + + + TE EA + + A
Sbjct: 81 GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 229 IESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285
I+ +H H+ HRD+KP+NLL +K L+L+DFG K + LQ
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ------------- 187
Query: 286 SQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345
+ TP Y+APEVL + Y CD WSLG
Sbjct: 188 ------------------------------TPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 217
Query: 346 IMYEMLVGYPPFYSDDPMSTCRKVRKK 372
IMY +L G+PPFYS+ + ++++
Sbjct: 218 IMYILLCGFPPFYSNTGQAISPGMKRR 244
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 5e-54
Identities = 58/247 (23%), Positives = 103/247 (41%), Gaps = 46/247 (18%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKL 181
++G+GA V+ C T YA+K ++K R V E +L + +++L
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR---SRVFREVEMLYQCQGHRNVLEL 76
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
F++++ YL+ E + GG +++ + ++ E EA V + A++ +H HRD
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRD 136
Query: 242 IKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRT 298
+KP+N+L ++ +++ DF L +
Sbjct: 137 LKPENILCEHPNQVSPVKICDFDLGSGIK------------------------------- 165
Query: 299 QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----KGYGMECDWWSLGAIMYEMLVG 353
+ + G+ +Y+APEV+ Y CD WSLG I+Y +L G
Sbjct: 166 -LNGDCSPISTPEL--LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222
Query: 354 YPPFYSD 360
YPPF
Sbjct: 223 YPPFVGR 229
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-53
Identities = 62/258 (24%), Positives = 116/258 (44%), Gaps = 44/258 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+D++L+ +G+GA+GEV++ + T A+K + + E+++ E + ++
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNH 64
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+VK Y ++ YL +EY GG++ + + E +A+ + + + + +H
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
HRDIKP+NLLLD+ +L++SDFGL
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLA-----------------------------TVF 155
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVGY 354
+ +E+L + GT Y+APE+L ++ + D WS G ++ ML G
Sbjct: 156 RYNNRERLLN----------KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
Query: 355 PPFYSDDPMSTCRKVRKK 372
P+ D P +C++
Sbjct: 206 LPW--DQPSDSCQEYSDW 221
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 8e-53
Identities = 58/252 (23%), Positives = 99/252 (39%), Gaps = 49/252 (19%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMK-----KLKKSEMLRRGQVEHVRAERNLLA 171
+ ++ +G GAFG V +K +K K+ + + ++ V E +L+
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIME-YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
V+ I+K+ F++ F L+ME + G D+ + R L E A + + V A+
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+ IHRDIK +N+++ + ++L DFG G
Sbjct: 145 YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY----------LERGKLFY------- 187
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYE 349
+ GT +Y APEVL+ Y G E + WSLG +Y
Sbjct: 188 -------------------------TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYT 222
Query: 350 MLVGYPPFYSDD 361
++ PF +
Sbjct: 223 LVFEENPFCELE 234
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 9e-53
Identities = 76/272 (27%), Positives = 114/272 (41%), Gaps = 69/272 (25%)
Query: 116 DDFELLT-MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
DD+++ + ++G G G+V K T +A+K L+ RR E L
Sbjct: 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRA- 111
Query: 175 SNC--IVKLYCSFQD----DEFLYLIMEYLPGGDMMTLLMR-----KDTLTEDEARFYVA 223
S C IV++ +++ + L ++ME L GG+ L R TE EA +
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE---LFSRIQDRGDQAFTEREASEIMK 168
Query: 224 ETVLAIESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280
AI+ +H + HRD+KP+NLL L+L+DFG
Sbjct: 169 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF------------------ 210
Query: 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340
A + T L + TP Y+APEVL + Y CD
Sbjct: 211 -------------AKETTSHNSLT-----------TPCYTPYYVAPEVLGPEKYDKSCDM 246
Query: 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKVRKK 372
WSLG IMY +L GYPPFYS+ ++ ++ +
Sbjct: 247 WSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 278
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-52
Identities = 72/264 (27%), Positives = 120/264 (45%), Gaps = 45/264 (17%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN 168
R K+G + L +G G FG+V++ + TGH A+K L + ++ V ++ E
Sbjct: 6 GRVKIG--HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQ 63
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
L I+KLY +++MEY+ GG++ + + + E EAR + + A
Sbjct: 64 NLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA 123
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
++ H+H +HRD+KP+N+LLD + + +++DFGL N
Sbjct: 124 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS------------------------N 159
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIM 347
RT + G+P+Y APEV+ + Y G E D WS G I+
Sbjct: 160 MMSDGEFLRT------------------SCGSPNYAAPEVISGRLYAGPEVDIWSCGVIL 201
Query: 348 YEMLVGYPPFYSDDPMSTCRKVRK 371
Y +L G PF + + +K+R
Sbjct: 202 YALLCGTLPFDDEHVPTLFKKIRG 225
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 3e-52
Identities = 62/258 (24%), Positives = 116/258 (44%), Gaps = 44/258 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+D++L+ +G+GA+GEV++ + T A+K + + E+++ E + ++
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNH 64
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+VK Y ++ YL +EY GG++ + + E +A+ + + + + +H
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
HRDIKP+NLLLD+ +L++SDFGL
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLA-----------------------------TVF 155
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVGY 354
+ +E+L + GT Y+APE+L ++ + D WS G ++ ML G
Sbjct: 156 RYNNRERLLN----------KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
Query: 355 PPFYSDDPMSTCRKVRKK 372
P+ D P +C++
Sbjct: 206 LPW--DQPSDSCQEYSDW 221
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 4e-52
Identities = 62/256 (24%), Positives = 103/256 (40%), Gaps = 53/256 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVE---HVRAERNLLAE 172
++ L ++GKG FG V T A+K + ++ +L + E LL +
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 173 VDSNC----IVKLYCSFQDDEFLYLIMEY-LPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
V + +++L F+ E L++E LP D+ + K L E +R + + V
Sbjct: 91 VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA 150
Query: 228 AIESIHKHHYIHRDIKPDNLLLD-KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
AI+ H +HRDIK +N+L+D + G +L DFG + L ++ +T
Sbjct: 151 AIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS-----GALLHDEPYT--------- 196
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGA 345
GT Y PE + + Y + WSLG
Sbjct: 197 -----------------------------DFDGTRVYSPPEWISRHQYHALPATVWSLGI 227
Query: 346 IMYEMLVGYPPFYSDD 361
++Y+M+ G PF D
Sbjct: 228 LLYDMVCGDIPFERDQ 243
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 5e-52
Identities = 61/269 (22%), Positives = 104/269 (38%), Gaps = 56/269 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+E+ +G G FG V + TG A+K+ ++ L E E ++ +++
Sbjct: 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNH 71
Query: 176 NCIVKLYCSFQDDEFL------YLIMEYLPGGDMMTLLMRKDT---LTEDEARFYVAETV 226
+V + L L MEY GGD+ L + + L E R +++
Sbjct: 72 PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGH---LRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283
A+ +H++ IHRD+KP+N++L ++ D G K LD
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD---------------- 175
Query: 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343
Q E VGT Y+APE+L +K Y + D+WS
Sbjct: 176 ---------------QGELCT-----------EFVGTLQYLAPELLEQKKYTVTVDYWSF 209
Query: 344 GAIMYEMLVGYPPFYSDDPMSTCRKVRKK 372
G + +E + G+ PF + ++
Sbjct: 210 GTLAFECITGFRPFLPNWQPVQWHGKVRE 238
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-51
Identities = 43/257 (16%), Positives = 83/257 (32%), Gaps = 37/257 (14%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
+F L IG G FG V C ++ G +YA+K+ KK + +R
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL----MRKDTLTEDEARFYVAETVLAIE 230
+ +V+ + ++ +D+ + + EY GG + + E E + + + +
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ---DFTIGNNLNGSSQ 287
IH +H DIKP N+ + + + + S D ++
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS--- 186
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAI 346
G ++A EVL + + D ++L
Sbjct: 187 --------------------------PQVEEGDSRFLANEVLQENYTHLPKADIFALALT 220
Query: 347 MYEMLVGYPPFYSDDPM 363
+ P + D
Sbjct: 221 VVCAAGAEPLPRNGDQW 237
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 5e-51
Identities = 71/282 (25%), Positives = 114/282 (40%), Gaps = 70/282 (24%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+ L IGKG++G V++ + YAMK L K +++R+ R
Sbjct: 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 178 -----------------------IVKLYCSFQD--DEFLYLIMEYLPGGDMMTLLMRKDT 212
+VKL D ++ LY++ E + G +M +
Sbjct: 75 QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKP 133
Query: 213 LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272
L+ED+ARFY + + IE +H IHRDIKP NLL+ + GH++++DFG+
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS--------- 184
Query: 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL--L 330
+ K L +TVGTP ++APE L
Sbjct: 185 --------------------------------NEFKGSDALLSNTVGTPAFMAPESLSET 212
Query: 331 KKGY-GMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRK 371
+K + G D W++G +Y + G PF + M K++
Sbjct: 213 RKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKS 254
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-50
Identities = 74/265 (27%), Positives = 109/265 (41%), Gaps = 51/265 (19%)
Query: 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
H ++ + IG G FG R+ R+K T + A+K +++ + E+V+ E
Sbjct: 17 HDSD--RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINH 70
Query: 171 AEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
+ IV+ L +IMEY GG++ + +EDEARF+ + + +
Sbjct: 71 RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVS 130
Query: 231 SIHKHHYIHRDIKPDNLLLD--KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
H HRD+K +N LLD L++ DFG S
Sbjct: 131 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY------SKSSVLH------------- 171
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIM 347
Q + STVGTP YIAPEVLL++ Y G D WS G +
Sbjct: 172 ------------SQPK-----------STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTL 208
Query: 348 YEMLVGYPPFYSDDPMSTCRKVRKK 372
Y MLVG PF + RK ++
Sbjct: 209 YVMLVGAYPFEDPEEPRDYRKTIQR 233
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-50
Identities = 28/293 (9%), Positives = 80/293 (27%), Gaps = 89/293 (30%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER--------------- 167
++G+ ++ TG + + +E ++ ++ E
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 168 ----------NLLAEVDSNCIVKLYCSFQDDEFL--YLIME------YLPGGDMMTLLMR 209
+L+ + ++++ +D L + + G +++
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 210 KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269
+L + + + S+H + +H ++P +++LD+ G + L+ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR 259
Query: 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL 329
+ + + PE+
Sbjct: 260 V---------------------------------------------VSSVSRGFEPPELE 274
Query: 330 L-----------KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRK 371
+ D W+LG ++Y + P D + + +
Sbjct: 275 ARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFR 327
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 4e-50
Identities = 74/256 (28%), Positives = 120/256 (46%), Gaps = 44/256 (17%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
++ LL IGKG F +V++ R TG A+K + K++ L ++ + E ++ ++
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFREVRIMKILNHP 74
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH 236
IVKL+ + ++ LYLIMEY GG++ L+ + E EAR + V A++ H+
Sbjct: 75 NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
+HRD+K +NLLLD +++++DFG +FT+G L+
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFS----------NEFTVGGKLDAF----------- 173
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVGYP 355
G P Y APE+ K Y G E D WSLG I+Y ++ G
Sbjct: 174 ---------------------CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 212
Query: 356 PFYSDDPMSTCRKVRK 371
PF + +V +
Sbjct: 213 PFDGQNLKELRERVLR 228
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 6e-50
Identities = 63/264 (23%), Positives = 102/264 (38%), Gaps = 45/264 (17%)
Query: 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
++ +G+G+FGEV ++K TG A+KK++ E
Sbjct: 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE--------ELVA 103
Query: 170 LAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
A + S IV LY + ++ ++ + ME L GG + L+ + L ED A +Y+ + + +
Sbjct: 104 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGL 163
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
E +H +H D+K DN+LL G L DFG L L
Sbjct: 164 EYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL----------------- 206
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
+ GT ++APEV++ K + D WS +M
Sbjct: 207 -------------------GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMML 247
Query: 349 EMLVGYPPFYSDDPMSTCRKVRKK 372
ML G P+ C K+ +
Sbjct: 248 HMLNGCHPWTQYFRGPLCLKIASE 271
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 6e-50
Identities = 72/267 (26%), Positives = 122/267 (45%), Gaps = 46/267 (17%)
Query: 106 MRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRA 165
M + + +G + + +G+G+FG+V++ T A+K + + + + V
Sbjct: 1 MAISKRHIG--PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER 58
Query: 166 ERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAET 225
E + L + I+KLY + +++EY GG++ ++ K +TEDE R + +
Sbjct: 59 EISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQI 117
Query: 226 VLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285
+ AIE H+H +HRD+KP+NLLLD +++++DFGL
Sbjct: 118 ICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS---------------------- 155
Query: 286 SQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLG 344
N +T + G+P+Y APEV+ K Y G E D WS G
Sbjct: 156 --NIMTDGNFLKT------------------SCGSPNYAAPEVINGKLYAGPEVDVWSCG 195
Query: 345 AIMYEMLVGYPPFYSDDPMSTCRKVRK 371
++Y MLVG PF + + +KV
Sbjct: 196 IVLYVMLVGRLPFDDEFIPNLFKKVNS 222
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 7e-50
Identities = 60/254 (23%), Positives = 101/254 (39%), Gaps = 51/254 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEH---VRAERNLLAE 172
+++ ++G G FG V + A+K ++K + G++ + V E LL +
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 173 VDSNC--IVKLYCSFQDDEFLYLIMEY-LPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
V S +++L F+ + LI+E P D+ + + L E+ AR + + + A+
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 162
Query: 230 ESIHKHHYIHRDIKPDNLLLD-KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
H +HRDIK +N+L+D G L+L DFG L
Sbjct: 163 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-----------------AL------ 199
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIM 347
+ + GT Y PE + Y G WSLG ++
Sbjct: 200 ---------LKDTVYTDF-----------DGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 239
Query: 348 YEMLVGYPPFYSDD 361
Y+M+ G PF D+
Sbjct: 240 YDMVCGDIPFEHDE 253
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-49
Identities = 73/264 (27%), Positives = 120/264 (45%), Gaps = 45/264 (17%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN 168
R K+G + L +G G FG+V+V + + TGH A+K L + ++ V +R E
Sbjct: 11 GRVKIG--HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQ 68
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
L I+KLY ++++MEY+ GG++ + + L E E+R + +
Sbjct: 69 NLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSG 128
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
++ H+H +HRD+KP+N+LLD + + +++DFGL N
Sbjct: 129 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS------------------------N 164
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIM 347
RT + G+P+Y APEV+ + Y G E D WS G I+
Sbjct: 165 MMSDGEFLRT------------------SCGSPNYAAPEVISGRLYAGPEVDIWSSGVIL 206
Query: 348 YEMLVGYPPFYSDDPMSTCRKVRK 371
Y +L G PF D + +K+
Sbjct: 207 YALLCGTLPFDDDHVPTLFKKICD 230
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 6e-49
Identities = 76/251 (30%), Positives = 116/251 (46%), Gaps = 48/251 (19%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMK--KLKKSEMLRRGQVEHVRAERNLLAE 172
+ F L IGKG+FGEV + T V A+K L+++E ++E ++ E +L++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE----DEIEDIQQEITVLSQ 76
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
DS + K Y S+ D L++IMEYL GG + L + L E + + E + ++ +
Sbjct: 77 CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDL-LEPGPLDETQIATILREILKGLDYL 135
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H IHRDIK N+LL ++G ++L+DFG+ L T
Sbjct: 136 HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQI-------------------- 174
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
KR + VGTP ++APEV+ + Y + D WSLG E+
Sbjct: 175 ---KRN-----------------TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAR 214
Query: 353 GYPPFYSDDPM 363
G PP PM
Sbjct: 215 GEPPHSELHPM 225
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-48
Identities = 58/264 (21%), Positives = 95/264 (35%), Gaps = 59/264 (22%)
Query: 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
+G F ++G GA G + V R A+K++ E LL
Sbjct: 20 IVGKISFCPKDVLGHGAEGTI-VYRGMFDNRDVAVKRILPE------CFSFADREVQLLR 72
Query: 172 EVDS--NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLA 228
E D N +++ +C+ +D +F Y+ +E + + +KD E + +T
Sbjct: 73 ESDEHPN-VIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSG 130
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGH-----LRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283
+ +H + +HRD+KP N+L+ +SDFGLCK L
Sbjct: 131 LAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA---------------V 175
Query: 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL---LKKGYGMECDW 340
G + R GT +IAPE+L K+ D
Sbjct: 176 GRHSFSRR-----------------------SGVPGTEGWIAPEMLSEDCKENPTYTVDI 212
Query: 341 WSLGAIMYEMLV-GYPPFYSDDPM 363
+S G + Y ++ G PF
Sbjct: 213 FSAGCVFYYVISEGSHPFGKSLQR 236
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 4e-48
Identities = 66/260 (25%), Positives = 111/260 (42%), Gaps = 51/260 (19%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMK--KLKKSEMLRRGQVEHVRAERNLLAE 172
DD+EL +IG GA V+ A+K L+K + ++ + E +++
Sbjct: 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ----TSMDELLKEIQAMSQ 69
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGG---DMMTLLMRKD-----TLTEDEARFYVAE 224
IV Y SF + L+L+M+ L GG D++ ++ K L E + E
Sbjct: 70 CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 225 TVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
+ +E +HK+ IHRD+K N+LL + G ++++DFG+ L
Sbjct: 130 VLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFL------------------ 171
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSL 343
+ + R + VGTP ++APEV+ + +GY + D WS
Sbjct: 172 -ATGGDITRNKVRK-----------------TFVGTPCWMAPEVMEQVRGYDFKADIWSF 213
Query: 344 GAIMYEMLVGYPPFYSDDPM 363
G E+ G P++ PM
Sbjct: 214 GITAIELATGAAPYHKYPPM 233
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 6e-48
Identities = 31/287 (10%), Positives = 78/287 (27%), Gaps = 78/287 (27%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE---------- 172
++G+ ++ TG + + +E ++ ++ E L
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 173 ------------VDSNCIVKLYCSFQDDEFLYLIMEYLP-----------GGDMMTLLMR 209
V K+ D+ ++++ + G +++
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 210 KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269
+L + + + S+H + +H ++P +++LD+ G + L+ F S
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS 264
Query: 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL 329
+ + P+ A +L
Sbjct: 265 AV-----SPIG-----------------------------------RGFAPPETTAERML 284
Query: 330 L-----KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRK 371
D W+LG +Y + P D + + +
Sbjct: 285 PFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFR 331
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-47
Identities = 69/248 (27%), Positives = 117/248 (47%), Gaps = 45/248 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ IG+GA G V + TG A++++ + ++ E + E ++ E +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKN 76
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV S+ + L+++MEYL GG + T ++ + + E + E + A+E +H +
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
IHRDIK DN+LL G ++L+DFG C + P
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT------------------------PEQS 171
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
KR+ + VGTP ++APEV+ +K YG + D WSLG + EM+ G P
Sbjct: 172 KRS-----------------TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
Query: 356 PFYSDDPM 363
P+ +++P+
Sbjct: 215 PYLNENPL 222
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-47
Identities = 73/248 (29%), Positives = 117/248 (47%), Gaps = 45/248 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ IG+G+ G V + REK +G A+K + + RR E + E ++ +
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQH 101
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+V++Y S+ E L+++ME+L GG + T ++ + L E++ + A+ +H
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGAL-TDIVSQVRLNEEQIATVCEAVLQALAYLHAQ 160
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
IHRDIK D++LL G ++LSDFG C + P
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS------------------------KDVP 196
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
KR S VGTP ++APEV+ + Y E D WSLG ++ EM+ G P
Sbjct: 197 KRK-----------------SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEP 239
Query: 356 PFYSDDPM 363
P++SD P+
Sbjct: 240 PYFSDSPV 247
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 8e-47
Identities = 57/261 (21%), Positives = 107/261 (40%), Gaps = 47/261 (18%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVE-HVRAERNLLAEVDSN 176
+ + ++G+G++G+V+ + T A+K LKK ++ R E +V+ E LL +
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 177 CIVKLY--CSFQDDEFLYLIMEYLPGG--DMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
+++L ++ + +Y++MEY G +M+ + K +A Y + + +E +
Sbjct: 67 NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQAHGYFCQLIDGLEYL 125
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H +H+DIKP NLLL G L++S G+
Sbjct: 126 HSQGIVHKDIKPGNLLLTTGGTLKISALGVA----------------------------- 156
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGY-GMECDWWSLGAIMYEM 350
A + ++ G+P + PE+ + G + D WS G +Y +
Sbjct: 157 EALHPFAADDTCR----------TSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNI 206
Query: 351 LVGYPPFYSDDPMSTCRKVRK 371
G PF D+ + K
Sbjct: 207 TTGLYPFEGDNIYKLFENIGK 227
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 6e-46
Identities = 51/255 (20%), Positives = 93/255 (36%), Gaps = 41/255 (16%)
Query: 115 ADDFELLTMIGKGA--FGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE 172
+ELLT+IGKG V + R K TG ++++ E V ++ E ++
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN-LEACSNEMVTFLQGELHVSKL 82
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIE 230
+ IV +F D L+++ ++ G L+ D + E + + + A++
Sbjct: 83 FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 142
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
IH Y+HR +K ++L+ G + LS
Sbjct: 143 YIHHMGYVHRSVKASHILISVDGKVYLSGLRSN--------------------------- 175
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL--LKKGYGMECDWWSLGAIMY 348
Q+ +V +++PEVL +GY + D +S+G
Sbjct: 176 -------LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITAC 228
Query: 349 EMLVGYPPFYSDDPM 363
E+ G+ PF
Sbjct: 229 ELANGHVPFKDMPAT 243
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-45
Identities = 74/251 (29%), Positives = 116/251 (46%), Gaps = 51/251 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ F++L +G+G++G V K TG + A+K++ ++ + E +++ + DS
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDS 83
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGG---DMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
+VK Y S+ + L+++MEY G D++ L R TLTEDE + T+ +E +
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYL 141
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H IHRDIK N+LL+ GH +L+DFG+ L
Sbjct: 142 HFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT------------------------D 177
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
KR + +GTP ++APEV+ + GY D WSLG EM
Sbjct: 178 TMAKRN-----------------TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAE 220
Query: 353 GYPPFYSDDPM 363
G PP+ PM
Sbjct: 221 GKPPYADIHPM 231
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-45
Identities = 59/275 (21%), Positives = 95/275 (34%), Gaps = 74/275 (26%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ ++G G+ G V V + G A+K++ + E LL E D
Sbjct: 15 NLVVSEKILGYGSSGTV-VFQGSFQGRPVAVKRMLIDFC------DIALMEIKLLTESDD 67
Query: 176 -NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-------TLTEDEARFYVAETVL 227
+++ YCS D FLY+ +E ++ L+ K+ E + +
Sbjct: 68 HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 228 AIESIHKHHYIHRDIKPDNLLLD-------------KYGHLRLSDFGLCKPLDCSTLQEQ 274
+ +H IHRD+KP N+L+ + + +SDFGLCK L
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK-----KLDSG 181
Query: 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---- 330
+ NLN GT + APE+L
Sbjct: 182 QSSFRTNLNNP--------------------------------SGTSGWRAPELLEESNN 209
Query: 331 ---KKGYGMECDWWSLGAIMYEMLV-GYPPFYSDD 361
K+ D +S+G + Y +L G PF
Sbjct: 210 LQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-44
Identities = 68/309 (22%), Positives = 113/309 (36%), Gaps = 54/309 (17%)
Query: 58 NHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADD 117
++Y + + N+ + D + +L K+ + L
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSL------KDPDVAELFFKDDPEKL 55
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F L IG G+FG V R+ V A+KK+ S + + + E L ++
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
++ + + +L+MEY G L + K L E E + + +H H+
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 175
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRD+K N+LL + G ++L DFG S +
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGS-----ASIMA-----------------------PA 207
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEMLVGY 354
S VGTP ++APEV+L + Y + D WSLG E+
Sbjct: 208 N-----------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
Query: 355 PPFYSDDPM 363
PP ++ + M
Sbjct: 251 PPLFNMNAM 259
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-44
Identities = 76/273 (27%), Positives = 121/273 (44%), Gaps = 54/273 (19%)
Query: 99 EKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRG 158
+K EY ++R + +E++ +G GAFG+V + K TG + A K ++
Sbjct: 2 MRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EE 58
Query: 159 QVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGG---DMMTLLMRKDTLTE 215
++E E +LA D IVKL ++ D L++++E+ PGG +M L LTE
Sbjct: 59 ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL--DRGLTE 116
Query: 216 DEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275
+ + + + A+ +H IHRD+K N+L+ G +RL+DFG+ TLQ
Sbjct: 117 PQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL-KTLQ--- 172
Query: 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL----- 330
KR S +GTP ++APEV++
Sbjct: 173 --------------------KRD-----------------SFIGTPYWMAPEVVMCETMK 195
Query: 331 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
Y + D WSLG + EM PP + +PM
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPM 228
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-43
Identities = 33/283 (11%), Positives = 64/283 (22%), Gaps = 80/283 (28%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
+L+ + G V + R+ +A+K R ++E + A +
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 177 CIVKLYCSFQ--------------------------DDEFLYLIMEYLPGGDMMTLL--- 207
+ + L+M D+ L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP-AASVDLELLFSTL 181
Query: 208 ----MRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263
+ + A+ + ++ +H PDNL + G L L D
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSAL 241
Query: 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDY 323
+ ++ Y
Sbjct: 242 WKVGTRG--------------------------------------------PASSVPVTY 257
Query: 324 IAPEVLLKKG--YGMECDWWSLGAIMYEMLVGYPPFYSDDPMS 364
E L + + W LG +Y + + PF P
Sbjct: 258 APREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 6e-43
Identities = 74/287 (25%), Positives = 120/287 (41%), Gaps = 56/287 (19%)
Query: 79 KKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREK 138
KKL + ++ E+ + L FL +K+ + ++ DDFE ++ +G G G V K
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQ------KVGELKDDDFEKISELGAGNGGVVFKVSHK 55
Query: 139 TTGHVYAMKK--LKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196
+G V A K L+ +R + E +L E +S IV Y +F D + + ME
Sbjct: 56 PSGLVMARKLIHLEIKPAIRN----QIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111
Query: 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH-KHHYIHRDIKPDNLLLDKYGHL 255
++ GG + +L + + E + + + KH +HRD+KP N+L++ G +
Sbjct: 112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 171
Query: 256 RLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAY 315
+L DFG+ L S +A
Sbjct: 172 KLCDFGVSGQLIDS-------------------------------------------MAN 188
Query: 316 STVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDP 362
S VGT Y++PE L Y ++ D WS+G + EM VG P D
Sbjct: 189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 7e-43
Identities = 68/251 (27%), Positives = 106/251 (42%), Gaps = 55/251 (21%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMK--KLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
++GKG +G V R+ + A+K + S + + E L + IV+
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY-----SQPLHEEIALHKHLKHKNIVQ 83
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD---TLTEDEARFYVAETVLAIESIHKHHY 237
SF ++ F+ + ME +PGG + LL K E FY + + ++ +H +
Sbjct: 84 YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143
Query: 238 IHRDIKPDNLLLDKY-GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
+HRDIK DN+L++ Y G L++SDFG K
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSK-------------------------------- 171
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGY 354
+L + GT Y+APE++ K +GYG D WSLG + EM G
Sbjct: 172 -----RLAGINPCTE----TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
Query: 355 PPFYS-DDPMS 364
PPFY +P +
Sbjct: 223 PPFYELGEPQA 233
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 4e-42
Identities = 55/271 (20%), Positives = 104/271 (38%), Gaps = 48/271 (17%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN 168
Q ++G + ++ +G F V ++ +G YA+K+L +E + + E
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN---RAIIQEVC 77
Query: 169 LLAEVDSN-CIVKLYCSF-------QDDEFLYLIMEYLPGGDMMTLLMR---KDTLTEDE 217
+ ++ + IV+ + + +L++ L G ++ L + + L+ D
Sbjct: 78 FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137
Query: 218 ARFYVAETVLAIESIHKHH--YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275
+T A++ +H+ IHRD+K +NLLL G ++L DFG +
Sbjct: 138 VLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI--------- 188
Query: 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL---LKK 332
+ P Q+ L + R TP Y PE++
Sbjct: 189 -------------SHYPDYSWSAQRRALVEEEITR-------NTTPMYRTPEIIDLYSNF 228
Query: 333 GYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
G + D W+LG I+Y + PF +
Sbjct: 229 PIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-40
Identities = 70/263 (26%), Positives = 112/263 (42%), Gaps = 59/263 (22%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV- 173
A FEL+ ++G G +G+V R TG + A+K + + + E ++ E N+L +
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYS 78
Query: 174 DSNCIVKLYCSF------QDDEFLYLIMEYLPGGDMMTLLM--RKDTLTEDEARFYVAET 225
I Y +F D+ L+L+ME+ G + L+ + +TL E+ + E
Sbjct: 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 138
Query: 226 VLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285
+ + +H+H IHRDIK N+LL + ++L DFG+ LD T+
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-RTVG------------- 184
Query: 286 SQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-----GYGMECDW 340
+R + +GTP ++APEV+ Y + D
Sbjct: 185 ----------RRN-----------------TFIGTPYWMAPEVIACDENPDATYDFKSDL 217
Query: 341 WSLGAIMYEMLVGYPPFYSDDPM 363
WSLG EM G PP PM
Sbjct: 218 WSLGITAIEMAEGAPPLCDMHPM 240
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-40
Identities = 61/264 (23%), Positives = 106/264 (40%), Gaps = 55/264 (20%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK---KSEMLRRGQVEHVRA 165
QR++ +D E L +G G G+V R + TGHV A+K+++ E +R ++
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDL--- 74
Query: 166 ERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAET 225
+L D IV+ + +F + +++ ME + + + E
Sbjct: 75 -DVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAI 133
Query: 226 VLAIESIH-KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
V A+ + KH IHRD+KP N+LLD+ G ++L DFG+ G ++
Sbjct: 134 VKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGIS---------------GRLVDD 178
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL-----LKKGYGMECD 339
+++ + G Y+APE + K Y + D
Sbjct: 179 KAKDR---------------------------SAGCAAYMAPERIDPPDPTKPDYDIRAD 211
Query: 340 WWSLGAIMYEMLVGYPPFYSDDPM 363
WSLG + E+ G P+ +
Sbjct: 212 VWSLGISLVELATGQFPYKNCKTD 235
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-40
Identities = 58/267 (21%), Positives = 106/267 (39%), Gaps = 58/267 (21%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK---KSEMLRRGQVEHVRA 165
Q A+D + L IG+GA+G V K +G + A+K+++ + ++ ++
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL--- 71
Query: 166 ERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGG--DMMTLLM--RKDTLTEDEARFY 221
++ D IV+ Y + + ++ ME + + D + E+
Sbjct: 72 -DVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKI 130
Query: 222 VAETVLAIESIH-KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280
TV A+ + IHRDIKP N+LLD+ G+++L DFG+ G
Sbjct: 131 TLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS---------------GQ 175
Query: 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL----LKKGYGM 336
++ ++ G Y+APE + ++GY +
Sbjct: 176 LVDSIAKTR---------------------------DAGCRPYMAPERIDPSASRQGYDV 208
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDPM 363
D WSLG +YE+ G P+ + +
Sbjct: 209 RSDVWSLGITLYELATGRFPYPKWNSV 235
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-39
Identities = 62/268 (23%), Positives = 108/268 (40%), Gaps = 60/268 (22%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK---KSEMLRRGQVEHVRAERNLLA 171
ADD E + +G+GA+G V R +G + A+K+++ S+ +R ++ +
Sbjct: 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDL----DISMR 61
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGG---DMMTLLMRKDTLTEDEARFYVAETVLA 228
VD V Y + + +++ ME + ++ + T+ ED V A
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 229 IESIH-KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+E +H K IHRD+KP N+L++ G +++ DFG+ L
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD------------------ 163
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL----KKGYGMECDWWS 342
+A G Y+APE + +KGY ++ D WS
Sbjct: 164 -------------------------VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWS 198
Query: 343 LGAIMYEMLVGYPPFYSDD-PMSTCRKV 369
LG M E+ + P+ S P ++V
Sbjct: 199 LGITMIELAILRFPYDSWGTPFQQLKQV 226
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-39
Identities = 52/315 (16%), Positives = 97/315 (30%), Gaps = 89/315 (28%)
Query: 116 DDFELLTMIGKGAFGEV---------------------------RVCRE----------- 137
DFE + +G+G FG V +V RE
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 138 -----------------KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
+ ++ + + ++ + + + V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDE---ARFYVAETVLAIESIHKHHY 237
+LY+ M+ ++ + R+ +L + E + A+E +H
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
+HRD+KP N+ +++ DFGL +D + + PA
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMD------------QDEEEQTVLTPMPAYATH 233
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
T VGT Y++PE + Y + D +SLG I++E+L Y
Sbjct: 234 T-----------------GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL--YSFS 274
Query: 358 YSDDPMSTCRKVRKK 372
+ + VR
Sbjct: 275 TQMERVRIITDVRNL 289
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 8e-37
Identities = 48/248 (19%), Positives = 94/248 (37%), Gaps = 52/248 (20%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IG+G+F V + T A +L+ ++ + + + + E +L + IV+ Y
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 184 SFQD----DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY-- 237
S++ + + L+ E + G + T L R + R + + + ++ +H
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 238 IHRDIKPDNLLLD-KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
IHRD+K DN+ + G +++ D GL S
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF-------------------------- 186
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
A + +GTP+++APE+ ++ Y D ++ G M EM P
Sbjct: 187 -----------------AKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP 228
Query: 357 FYSDDPMS 364
+ +
Sbjct: 229 YSECQNAA 236
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-34
Identities = 62/249 (24%), Positives = 106/249 (42%), Gaps = 55/249 (22%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRA----ERNLLA 171
+ +E + IG+G++G V CR + TG + A+KK +SE ++ E +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-----DDPVIKKIALREIRMLK 57
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIE 230
++ +V L F+ L+L+ EY ++ L + + E + +T+ A+
Sbjct: 58 QLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVN 116
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
HKH+ IHRD+KP+N+L+ K+ ++L DFG + L
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLL------------------------ 152
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348
P Y V T Y +PE+L+ YG D W++G +
Sbjct: 153 --TGPSDY----------------YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFA 194
Query: 349 EMLVGYPPF 357
E+L G P +
Sbjct: 195 ELLSGVPLW 203
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-33
Identities = 66/249 (26%), Positives = 110/249 (44%), Gaps = 55/249 (22%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRA----ERNLLA 171
+ +E L ++G+G++G V CR K TG + A+KK +S+ + V+ E LL
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-----DDKMVKKIAMREIKLLK 79
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIE 230
++ +V L + + YL+ E++ ++ L + + L + Y+ + + I
Sbjct: 80 QLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIG 138
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
H H+ IHRDIKP+N+L+ + G ++L DFG + L
Sbjct: 139 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL------------------------ 174
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECDWWSLGAIMY 348
AAP Y V T Y APE+L+ YG D W++G ++
Sbjct: 175 --AAPGEV----------------YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVT 216
Query: 349 EMLVGYPPF 357
EM +G P F
Sbjct: 217 EMFMGEPLF 225
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 70/252 (27%), Positives = 113/252 (44%), Gaps = 56/252 (22%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEH------VRAERN 168
A +E L +G+G F V R+K T + A+KK+K + R + + +R E
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK---LGHRSEAKDGINRTALR-EIK 64
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT-LTEDEARFYVAETVL 227
LL E+ I+ L +F + L+ +++ D+ ++ LT + Y+ T+
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+E +H+H +HRD+KP+NLLLD+ G L+L+DFGL K F
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS----------FGS--------- 164
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECDWWSLGA 345
P R Y+ V T Y APE+L + YG+ D W++G
Sbjct: 165 -------PNRA----------------YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGC 201
Query: 346 IMYEMLVGYPPF 357
I+ E+L+ P
Sbjct: 202 ILAELLLRVPFL 213
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 61/253 (24%), Positives = 106/253 (41%), Gaps = 64/253 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEH--------VRAER 167
+ + L +G+G + V + K T ++ A+K+++ +EH +R E
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR---------LEHEEGAPCTAIR-EV 51
Query: 168 NLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETV 226
+LL ++ IV L+ ++ L L+ EYL D+ L + + + ++ + +
Sbjct: 52 SLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL 110
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
+ H+ +HRD+KP NLL+++ G L+L+DFGL + +I
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARA----------KSI-------- 152
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECDWWSLG 344
P +T Y V T Y P++LL Y + D W +G
Sbjct: 153 --------PTKT----------------YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVG 188
Query: 345 AIMYEMLVGYPPF 357
I YEM G P F
Sbjct: 189 CIFYEMATGRPLF 201
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 4e-32
Identities = 65/259 (25%), Positives = 107/259 (41%), Gaps = 69/259 (26%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEH--------VRAE 166
+ F+ L +G G + V KTTG A+K++K ++ +R E
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK---------LDSEEGTPSTAIR-E 53
Query: 167 RNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL------MRKDTLTEDEARF 220
+L+ E+ IV+LY + L L+ E++ D+ + L + ++
Sbjct: 54 ISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 221 YVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280
+ + + + H++ +HRD+KP NLL++K G L+L DFGL + F I
Sbjct: 113 FQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA----------FGI-- 160
Query: 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL-KKGYGMEC 338
P T +S+ V T Y AP+VL+ + Y
Sbjct: 161 --------------PVNT----------------FSSEVVTLWYRAPDVLMGSRTYSTSI 190
Query: 339 DWWSLGAIMYEMLVGYPPF 357
D WS G I+ EM+ G P F
Sbjct: 191 DIWSCGCILAEMITGKPLF 209
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-32
Identities = 59/257 (22%), Positives = 101/257 (39%), Gaps = 67/257 (26%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSE-------MLRRGQVEHVRAER 167
D + +T +G+G +GEV + T A+K+++ + E +R E
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR---------EV 84
Query: 168 NLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
+LL E+ I++L + L+LI EY D+ + + ++ + ++ + +
Sbjct: 85 SLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLIN 143
Query: 228 AIESIHKHHYIHRDIKPDNLLLD-----KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+ H +HRD+KP NLLL + L++ DFGL + F I
Sbjct: 144 GVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA----------FGI---- 189
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECDW 340
P R ++ + T Y PE+LL + Y D
Sbjct: 190 ------------PIRQ----------------FTHEIITLWYRPPEILLGSRHYSTSVDI 221
Query: 341 WSLGAIMYEMLVGYPPF 357
WS+ I EML+ P F
Sbjct: 222 WSIACIWAEMLMKTPLF 238
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 2e-31
Identities = 58/256 (22%), Positives = 99/256 (38%), Gaps = 59/256 (23%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEH----VRAERNLLA 171
+E + IG GA+G V R+ +GH A+K ++ G VR E LL
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV-PNGGGGGGGLPISTVR-EVALLR 66
Query: 172 EVDSNC---IVKLYCSFQDDEF-----LYLIMEYLPGGDMMTLL--MRKDTLTEDEARFY 221
+++ +V+L + L+ E++ D+ T L L + +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL 125
Query: 222 VAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ + + ++ +H + +HRD+KP+N+L+ G ++L+DFGL + ++
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI----------YSY--- 172
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWW 341
+ W Y APEVLL+ Y D W
Sbjct: 173 -------------QMALTPVVVTLW----------------YRAPEVLLQSTYATPVDMW 203
Query: 342 SLGAIMYEMLVGYPPF 357
S+G I EM P F
Sbjct: 204 SVGCIFAEMFRRKPLF 219
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 61/253 (24%), Positives = 98/253 (38%), Gaps = 63/253 (24%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEM-------LRRGQVEHVRAER 167
+E L IG+G +G V + + T + A+K+++ + LR E
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---------EI 52
Query: 168 NLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETV 226
LL E+ IV+L+ D+ L L+ E+ D+ L + + ++ + +
Sbjct: 53 CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL 111
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
+ H + +HRD+KP NLL+++ G L+L++FGL + F I
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARA----------FGI-------- 153
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECDWWSLG 344
P R YS V T Y P+VL K Y D WS G
Sbjct: 154 --------PVRC----------------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAG 189
Query: 345 AIMYEMLVGYPPF 357
I E+ P
Sbjct: 190 CIFAELANAGRPL 202
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 56/247 (22%), Positives = 102/247 (41%), Gaps = 40/247 (16%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
++++ +G G V + + A+K + + ++ E + +++
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
IV + ++D+ YL+MEY+ G + + L+ D A + + + I+ H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRI 132
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
+HRDIKP N+L+D L++ DFG+ K L ++L
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-------------------------- 166
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
TQ +GT Y +PE + D +S+G ++YEMLVG PPF
Sbjct: 167 TQTN--------------HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPF 212
Query: 358 YSDDPMS 364
+ +S
Sbjct: 213 NGETAVS 219
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-31
Identities = 68/253 (26%), Positives = 109/253 (43%), Gaps = 64/253 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEM-------LRRGQVEHVRAER 167
+ + L IG+G +G V + G +A+KK++ + E +R E
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIR---------EI 51
Query: 168 NLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETV 226
++L E+ + IVKLY + L L+ E+L D+ LL + + L A+ ++ + +
Sbjct: 52 SILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL 110
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
I H +HRD+KP NLL+++ G L+++DFGL + F I
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARA----------FGI-------- 152
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECDWWSLG 344
P R Y+ + T Y AP+VL+ K Y D WS+G
Sbjct: 153 --------PVRK----------------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVG 188
Query: 345 AIMYEMLVGYPPF 357
I EM+ G P F
Sbjct: 189 CIFAEMVNGTPLF 201
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-31
Identities = 66/246 (26%), Positives = 110/246 (44%), Gaps = 50/246 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ-VEHVRAERNLLAEVD 174
+ ++ L +G+G +G V ++ G + A+K+++ + G +R E +LL E+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIR-LDAEDEGIPSTAIR-EISLLKELH 77
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIESIH 233
IV L + L L+ E++ D+ +L K L + + + Y+ + + + H
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
+H +HRD+KP NLL++ G L+L+DFGL + F I
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARA----------FGI--------------- 171
Query: 294 APKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEML 351
P R+ Y+ V T Y AP+VL+ K Y D WS+G I EM+
Sbjct: 172 -PVRS----------------YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMI 214
Query: 352 VGYPPF 357
G P F
Sbjct: 215 TGKPLF 220
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 8e-31
Identities = 58/250 (23%), Positives = 95/250 (38%), Gaps = 62/250 (24%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ E+ ++G+GAFG V C+ K A+K+++ + E L+ V+
Sbjct: 8 KEIEVEEVVGRGAFGVV--CKAKWRAKDVAIKQIESESER-----KAFIVELRQLSRVNH 60
Query: 176 NCIVKLY-CSFQDDEFLYLIMEYLPGGDMMTLLMRKD---TLTEDEARFYVAETVLAIES 231
IVKLY + L+MEY GG + +L + T A + + +
Sbjct: 61 PNIVKLYGACLNP---VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 232 IHKHHY---IHRDIKPDNLLLDK-YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+H IHRD+KP NLLL L++ DFG + + T
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT------ACDIQTHMT---------- 161
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347
+ G+ ++APEV Y +CD +S G I+
Sbjct: 162 ----------------------------NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIIL 193
Query: 348 YEMLVGYPPF 357
+E++ PF
Sbjct: 194 WEVITRRKPF 203
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 55/250 (22%), Positives = 101/250 (40%), Gaps = 33/250 (13%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK-SEMLRRGQVEHVRAERNLLAEVD 174
D ++GKG FG+ + TG V MK+L + E +R E ++ ++
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQR----TFLKEVKVMRCLE 65
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV-LAIESIH 233
++K D+ L I EY+ GG + ++ D+ R A+ + + +H
Sbjct: 66 HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
+ IHRD+ N L+ + ++ ++DFGL + L + T L
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGL------ARLMVDEKTQPEGLRSL-------- 171
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
+K R Y+ VG P ++APE++ + Y + D +S G ++ E++
Sbjct: 172 -------------KKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGR 218
Query: 354 YPPFYSDDPM 363
P
Sbjct: 219 VNADPDYLPR 228
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 53/244 (21%), Positives = 92/244 (37%), Gaps = 42/244 (17%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR-RGQVEHVRAERNLLAEVDSN 176
+ L ++G+G G+V + + A+K + + ++ E +
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMS-ETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH 236
+V ++ + D LY+ M + G D+ +L R+ L A V + A+++ H
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG 154
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
HRD+KP+N+L+ L DFG+ L
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL------------------------- 189
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
TQ +TVGT Y+APE + D ++L ++YE L G PP
Sbjct: 190 -TQ--------------LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
Query: 357 FYSD 360
+ D
Sbjct: 235 YQGD 238
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 63/287 (21%), Positives = 100/287 (34%), Gaps = 81/287 (28%)
Query: 94 LLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK--- 150
+ K + E + +E L IG+G FGEV R + TG A+KK+
Sbjct: 1 MAKQYDSVECPFCD------EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN 54
Query: 151 -----KSEMLRRGQVEHVRAERNLLAEVDSNCIVKLY--------CSFQDDEFLYLIMEY 197
LR E +L + +V L + +YL+ ++
Sbjct: 55 EKEGFPITALR---------EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDF 105
Query: 198 LPGGDMMTLLMRKDT-LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLR 256
D+ LL T E + + + + IH++ +HRD+K N+L+ + G L+
Sbjct: 106 CEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLK 164
Query: 257 LSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQH-----WQKNRR 311
L+DFGL + K +Q + + W
Sbjct: 165 LADFGLARAFS--------------------------LAKNSQPNRYTNRVVTLW----- 193
Query: 312 MLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPF 357
Y PE+LL ++ YG D W G IM EM P
Sbjct: 194 -----------YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 229
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-29
Identities = 45/162 (27%), Positives = 72/162 (44%), Gaps = 27/162 (16%)
Query: 116 DDFELL-TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
DD+++ ++G G G+V K T +A+K L+ RR E L
Sbjct: 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRAS 68
Query: 175 S--NCIVKLYCSFQD----DEFLYLIMEYLPGGDMMTLLMR-----KDTLTEDEARFYVA 223
+ IV++ +++ + L ++ME L GG+ L R TE EA +
Sbjct: 69 QCPH-IVRIVDVYENLYAGRKCLLIVMECLDGGE---LFSRIQDRGDQAFTEREASEIMK 124
Query: 224 ETVLAIESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGL 262
AI+ +H + HRD+KP+NLL L+L+DFG
Sbjct: 125 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 5e-14
Identities = 20/49 (40%), Positives = 28/49 (57%), Gaps = 1/49 (2%)
Query: 324 IAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRKK 372
A E + Y CD WSLG IMY +L GYPPFYS+ ++ ++ +
Sbjct: 166 FAKETT-GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 213
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-29
Identities = 56/249 (22%), Positives = 94/249 (37%), Gaps = 53/249 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D + IG G+FG V R + G A+K L + + +V E ++ +
Sbjct: 37 CDLNIKEKIGAGSFGTV--HRAEWHGSDVAVKILMEQDFHAE-RVNEFLREVAIMKRLRH 93
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDT---LTEDEARFYVAETVLAIE 230
IV + + L ++ EYL G + LL + L E + +
Sbjct: 94 PNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 231 SIHKHHY--IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
+H + +HR++K NLL+DK +++ DFGL S L+ F
Sbjct: 152 YLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL------SRLKASTFLSSK-------- 197
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
S GTP+++APEVL + + D +S G I++
Sbjct: 198 ---------------------------SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILW 230
Query: 349 EMLVGYPPF 357
E+ P+
Sbjct: 231 ELATLQQPW 239
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-29
Identities = 56/261 (21%), Positives = 105/261 (40%), Gaps = 71/261 (27%)
Query: 116 DDFELLTMIGKGAFGEVRVCRE-KTTGHVYAMKKLK-KSEM-------LRRGQVEHVRAE 166
+E + IG+GA+G+V R+ K G A+K+++ ++ +R E
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR---------E 61
Query: 167 RNLLAEVDSNC---IVKLY-----CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTED 216
+L +++ +V+L+ + L L+ E++ D+ T L + + + +
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE 120
Query: 217 EARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276
+ + + + ++ +H H +HRD+KP N+L+ G ++L+DFGL + +
Sbjct: 121 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI----------Y 170
Query: 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM 336
+ + W Y APEVLL+ Y
Sbjct: 171 SF----------------QMALTSVVVTLW----------------YRAPEVLLQSSYAT 198
Query: 337 ECDWWSLGAIMYEMLVGYPPF 357
D WS+G I EM P F
Sbjct: 199 PVDLWSVGCIFAEMFRRKPLF 219
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-29
Identities = 56/275 (20%), Positives = 100/275 (36%), Gaps = 66/275 (24%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK----SEMLRRGQVEHVRAERNLLA 171
++ E IGKG FG V R V A+K L E + + + E +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 172 EVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVA-ETVLA 228
++ IVKLY ++ME++P GD+ L+ K + + + + L
Sbjct: 79 NLNHPNIVKLYGLMH----NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 229 IESIHKHHY--IHRDIKPDNLLLDKYG-----HLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
IE + + +HRD++ N+ L +++DFGL S +
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL------SQQSVHSVS---- 184
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG--YGMECD 339
+G ++APE + + Y + D
Sbjct: 185 ----------------------------------GLLGNFQWMAPETIGAEEESYTEKAD 210
Query: 340 WWSLGAIMYEMLVGYPPF--YSDDPMSTCRKVRKK 372
+S I+Y +L G PF YS + +R++
Sbjct: 211 TYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE 245
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 65/263 (24%), Positives = 105/263 (39%), Gaps = 72/263 (27%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK--KSEMLRRGQVEHVRAERNLLAEVDS 175
+ +IG G+FG V + +G + A+KK+ K R E ++ ++D
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---------ELQIMRKLDH 106
Query: 176 NCIVKLYCSF------QDDEFLYLIMEYLPGGDMMTL--LMR-----KDTLTEDEARFYV 222
IV+L F +D+ +L L+++Y+P T+ + R K TL + Y+
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYM 162
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKY-GHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ ++ IH HRDIKP NLLLD L+L DFG K L
Sbjct: 163 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-------------- 208
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDW 340
+ ++Y + + Y APE++ Y D
Sbjct: 209 --------------------------RGEPNVSY--ICSRYYRAPELIFGATDYTSSIDV 240
Query: 341 WSLGAIMYEMLVGYPPFYSDDPM 363
WS G ++ E+L+G P F D +
Sbjct: 241 WSAGCVLAELLLGQPIFPGDSGV 263
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-28
Identities = 59/255 (23%), Positives = 108/255 (42%), Gaps = 44/255 (17%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ-VEHVRAERNLLAEV 173
+D +EL ++G G EV + R+ A+K L+ +++ R R E A +
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAAL 69
Query: 174 DSNCIVKLYCSFQDDEFL----YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
+ IV +Y + + + Y++MEY+ G + ++ + +T A +A+ A+
Sbjct: 70 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
H++ IHRD+KP N+++ +++ DFG+ + + S T +
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG---NSVTQTAAV------- 179
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349
+GT Y++PE D +SLG ++YE
Sbjct: 180 ----------------------------IGTAQYLSPEQARGDSVDARSDVYSLGCVLYE 211
Query: 350 MLVGYPPFYSDDPMS 364
+L G PPF D P+S
Sbjct: 212 VLTGEPPFTGDSPVS 226
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 57/249 (22%), Positives = 97/249 (38%), Gaps = 60/249 (24%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER--NLLAEV 173
DD++L+ +G+G + EV T +K LK V+ + +R +L +
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--------VKKKKIKREIKILENL 87
Query: 174 -DSNCIVKLYCSFQDDE--FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
I+ L +D L+ E++ D L TLT+ + RFY+ E + A++
Sbjct: 88 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALD 144
Query: 231 SIHKHHYIHRDIKPDNLLLD-KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
H +HRD+KP N+++D ++ LRL D+GL
Sbjct: 145 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-------------------------- 178
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348
P + V + + PE+L+ + Y D WSLG ++
Sbjct: 179 -EFYHP-------------GQEYNVR--VASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 222
Query: 349 EMLVGYPPF 357
M+ PF
Sbjct: 223 SMIFRKEPF 231
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-28
Identities = 41/263 (15%), Positives = 79/263 (30%), Gaps = 58/263 (22%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
LT + + GE+ + + G+ +K LK + R + E L
Sbjct: 10 KQLNFLTKLNENHSGEL--WKGRWQGNDIVVKVLKVRDWSTR-KSRDFNEECPRLRIFSH 66
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEA-RFYVA-ETVLAIES 231
++ + C LI ++P G + +L D++ A + +
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126
Query: 232 IHKHHY--IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+H + ++++D+ R+S +
Sbjct: 127 LHTLEPLIPRHALNSRSVMIDEDMTARISMADV--------------------------- 159
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME---CDWWSLGAI 346
K + Q + P ++APE L KK D WS +
Sbjct: 160 ------KFSFQSP-------------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVL 200
Query: 347 MYEMLVGYPPFYSDDPMSTCRKV 369
++E++ PF M KV
Sbjct: 201 LWELVTREVPFADLSNMEIGMKV 223
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-28
Identities = 65/257 (25%), Positives = 98/257 (38%), Gaps = 73/257 (28%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK--KSEMLRRGQVEHVRAERNLLAEVDS 175
+ +IG G+FG V + + V A+KK+ K R E ++ V
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEV-AIKKVLQDKRFKNR---------ELQIMRIVKH 91
Query: 176 NCIVKLYCSF------QDDEFLYLIMEYLPGGDMMTL--LMR-----KDTLTEDEARFYV 222
+V L F +D+ FL L++EY+P T+ R K T+ + Y+
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYM 147
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKY-GHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ + ++ IH HRDIKP NLLLD G L+L DFG K L
Sbjct: 148 YQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI-------------- 193
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDW 340
++Y + + Y APE++ Y D
Sbjct: 194 --------------------------AGEPNVSY--ICSRYYRAPELIFGATNYTTNIDI 225
Query: 341 WSLGAIMYEMLVGYPPF 357
WS G +M E++ G P F
Sbjct: 226 WSTGCVMAELMQGQPLF 242
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-28
Identities = 49/266 (18%), Positives = 95/266 (35%), Gaps = 51/266 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ E+ +IGKG FG+V + G V A++ + Q++ + E +
Sbjct: 33 EQLEIGELIGKGRFGQV--YHGRWHGEV-AIRLIDIERDNED-QLKAFKREVMAYRQTRH 88
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIESIHK 234
+V + L +I G + +++ K L ++ R E V + +H
Sbjct: 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA 148
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+H+D+K N+ D G + ++DFGL F+I L + ++
Sbjct: 149 KGILHKDLKSKNVFYDN-GKVVITDFGL-------------FSISGVLQAGRREDKLRIQ 194
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL---------LKKGYGMECDWWSLGA 345
G ++APE++ K + D ++LG
Sbjct: 195 N-----------------------GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGT 231
Query: 346 IMYEMLVGYPPFYSDDPMSTCRKVRK 371
I YE+ PF + + ++
Sbjct: 232 IWYELHAREWPFKTQPAEAIIWQMGT 257
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 60/250 (24%), Positives = 108/250 (43%), Gaps = 38/250 (15%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK--------SEMLRRGQVEHVRAER 167
D +E+ +IG G++G V +K V A+KK+ + +LR E
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR---------EI 103
Query: 168 NLLAEVDSNCIVKLY-----CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYV 222
+L ++ + +VK+ + + LY+++E D L LTE + +
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLL 162
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
++ ++ +H +HRD+KP N L+++ +++ DFGL + T+
Sbjct: 163 YNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLAR------------TVDYPE 210
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWW 341
NG+SQ P R++ + V T Y APE++L ++ Y D W
Sbjct: 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGH--VVTRWYRAPELILLQENYTEAIDVW 268
Query: 342 SLGAIMYEML 351
S+G I E+L
Sbjct: 269 SIGCIFAELL 278
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 57/254 (22%), Positives = 94/254 (37%), Gaps = 58/254 (22%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM-LRRGQVEHVRAERNLLAEVD 174
+ L +IG G FG+V R G A+K + +E+VR E L A +
Sbjct: 7 AELTLEEIIGIGGFGKV--YRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
I+ L + L L+ME+ GG + +L + D + + + +H
Sbjct: 65 HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL-SGKRIPPDILVNWAVQIARGMNYLHD 123
Query: 235 HHY---IHRDIKPDNLLLDKYGH--------LRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283
IHRD+K N+L+ + L+++DFGL +
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR------------------- 164
Query: 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343
W + +M S G ++APEV+ + D WS
Sbjct: 165 ---------------------EWHRTTKM---SAAGAYAWMAPEVIRASMFSKGSDVWSY 200
Query: 344 GAIMYEMLVGYPPF 357
G +++E+L G PF
Sbjct: 201 GVLLWELLTGEVPF 214
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 49/255 (19%), Positives = 101/255 (39%), Gaps = 52/255 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ IG G+FG V + K G V A+K L + + Q++ + E +L +
Sbjct: 24 GQITVGQRIGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQ-QLQAFKNEVGVLRKTRH 79
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVA-ETVLAIESI 232
I+ + L ++ ++ G + L +T E + +A +T ++ +
Sbjct: 80 VNILLFMGYST---APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H IHRD+K +N+ L + +++ DFGL +T + +
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGL------ATEKSR------------------ 172
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG---YGMECDWWSLGAIMYE 349
W + + G+ ++APEV+ + Y + D ++ G ++YE
Sbjct: 173 -------------WSGSHQFEQ--LSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYE 217
Query: 350 MLVGYPPFYSDDPMS 364
++ G P+ + +
Sbjct: 218 LMTGQLPYSNINNRD 232
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 54/266 (20%), Positives = 95/266 (35%), Gaps = 65/266 (24%)
Query: 107 RLQRHKMGADDFELLTMIGKGAFGEVRVCR-EKTTGHVYAMKKLKKS---EMLRRGQVEH 162
+L + A +E+ I G G + + G +K L S E
Sbjct: 71 QLNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM----- 125
Query: 163 VRAERNLLAEVDSNCIVKLY-----CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDE 217
AER LAEV IV+++ D Y++MEY+ G + L E
Sbjct: 126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAE 183
Query: 218 ARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT 277
A Y+ E + A+ +H ++ D+KP+N++L + L+L D G
Sbjct: 184 AIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE-EQLKLIDLG---------------- 226
Query: 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTV-GTPDYIAPEVLLKKGYGM 336
A R+ ++ + GTP + APE+ ++ G +
Sbjct: 227 ---------------AV---------------SRINSFGYLYGTPGFQAPEI-VRTGPTV 255
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDP 362
D +++G + + + P
Sbjct: 256 ATDIYTVGRTLAALTLDLPTRNGRYV 281
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 60/255 (23%), Positives = 114/255 (44%), Gaps = 31/255 (12%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER--NLLAEV 173
D++ + +IG+G++G V + +K T A+KK+ + M ++ R R +L +
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFED-LIDCKRILREITILNRL 82
Query: 174 DSNCIVKLY-----CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
S+ I++LY + LY+++E D+ L LTE+ + + +L
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLG 141
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
IH+ IHRD+KP N LL++ +++ DFGL + ++ S ++
Sbjct: 142 ENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN-----------------SEKD 184
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347
+ ++ + +++ ++ V T Y APE++L + Y D WS G I
Sbjct: 185 TNIVNDLEENEEPGPHNKNLKKQLTSH--VVTRWYRAPELILLQENYTKSIDIWSTGCIF 242
Query: 348 YEMLVGYPPFYSDDP 362
E+L +D
Sbjct: 243 AELLNMLQSHINDPT 257
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 68/262 (25%), Positives = 111/262 (42%), Gaps = 59/262 (22%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKS--------------EMLRRGQVE 161
+EL+ +GKGA+G V ++ TG V A+KK+ + +L
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILT----- 63
Query: 162 HVRAERNLLAEVDSNCIVKLYCSFQDDEF--LYLIMEYLPGGDMMTLL---MRKDTLTED 216
+ N IV L + D +YL+ +Y M T L +R + L
Sbjct: 64 ELSGHEN---------IVNLLNVLRADNDRDVYLVFDY-----METDLHAVIRANILEPV 109
Query: 217 EARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276
++ V + + I+ +H +HRD+KP N+LL+ H++++DFGL + +
Sbjct: 110 HKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYG 335
+ N N + ++++P + Y V T Y APE+LL Y
Sbjct: 170 PLSINENTENFDDDQPI------------------LTDY--VATRWYRAPEILLGSTKYT 209
Query: 336 MECDWWSLGAIMYEMLVGYPPF 357
D WSLG I+ E+L G P F
Sbjct: 210 KGIDMWSLGCILGEILCGKPIF 231
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 66/266 (24%), Positives = 105/266 (39%), Gaps = 66/266 (24%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKK--LKKSEMLRRGQVEHVRAERNLLAE 172
D F++ M G+G FG V++ +EK+TG A+KK R Q LA
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ------IMQDLAV 75
Query: 173 VDSNCIVKLYCSF-------QDDEFLYLIMEYLPGGD----MMTLLMRKDTLTEDEARFY 221
+ IV+L F + D +L ++MEY+P R+ + +
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVF 134
Query: 222 VAETVLAIESIHKHHY--IHRDIKPDNLLLDKY-GHLRLSDFGLCKPLDCSTLQEQDFTI 278
+ + + +I +H HRDIKP N+L+++ G L+L DFG K L
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS----------- 183
Query: 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGME 337
+ +AY + + Y APE++ + Y
Sbjct: 184 -----------------------------PSEPNVAY--ICSRYYRAPELIFGNQHYTTA 212
Query: 338 CDWWSLGAIMYEMLVGYPPFYSDDPM 363
D WS+G I EM++G P F D+
Sbjct: 213 VDIWSVGCIFAEMMLGEPIFRGDNSA 238
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 5e-23
Identities = 56/286 (19%), Positives = 100/286 (34%), Gaps = 80/286 (27%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKL------------------------- 149
+ + L +G G+FG V + +G +A+KK+
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKL 65
Query: 150 ------KKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGD- 202
E + Q + +N + + +++L +IMEY+P
Sbjct: 66 VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TL 124
Query: 203 ---MMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD-KYGHLRLS 258
+ + + ++ + Y+ + A+ IH HRDIKP NLL++ K L+L
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLC 184
Query: 259 DFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTV 318
DFG K L + +AY +
Sbjct: 185 DFGSAKKLI----------------------------------------PSEPSVAY--I 202
Query: 319 GTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
+ Y APE++L Y D WS+G + E+++G P F + +
Sbjct: 203 CSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSI 248
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 5e-23
Identities = 66/254 (25%), Positives = 114/254 (44%), Gaps = 51/254 (20%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER--NLLAE 172
+ DF+L +++G+GA+G V K TG + A+KK++ + R R +L
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFAL----RTLREIKILKH 65
Query: 173 VDSNCIVKLY-----CSFQDDEFLYLIMEYLPGGDMMTLL---MRKDTLTEDEARFYVAE 224
I+ ++ SF++ +Y+I E M T L + L++D ++++ +
Sbjct: 66 FKHENIITIFNIQRPDSFENFNEVYIIQEL-----MQTDLHRVISTQMLSDDHIQYFIYQ 120
Query: 225 TVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
T+ A++ +H + IHRD+KP NLL++ L++ DFGL + +D S + T
Sbjct: 121 TLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT------- 173
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSL 343
+ M+ + V T Y APEV+L Y D WS
Sbjct: 174 ----------------------GQQSGMVEF--VATRWYRAPEVMLTSAKYSRAMDVWSC 209
Query: 344 GAIMYEMLVGYPPF 357
G I+ E+ + P F
Sbjct: 210 GCILAELFLRRPIF 223
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-22
Identities = 61/254 (24%), Positives = 110/254 (43%), Gaps = 59/254 (23%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEMLRRGQVEHVRAERNLLAE--VD 174
+E+L +IGKG+FG+V + A+K ++ + R+ E +R +L + +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE-IRILEHLRKQDKDN 157
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL--LMRKDT---LTEDEARFYVAETVLAI 229
+ ++ + +F + + E L M L L++K+ + R + + +
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLS----MNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGH--LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+++HK+ IH D+KP+N+LL + G +++ DFG S
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS----------------------SCY 251
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347
++R Y+ + + Y APEV+L YGM D WSLG I+
Sbjct: 252 EHQRV----------------------YTYIQSRFYRAPEVILGARYGMPIDMWSLGCIL 289
Query: 348 YEMLVGYPPFYSDD 361
E+L GYP +D
Sbjct: 290 AELLTGYPLLPGED 303
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 3e-22
Identities = 60/255 (23%), Positives = 97/255 (38%), Gaps = 66/255 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK---SEMLRRGQVEHVRAER--NLL 170
++ L IG GA G V + A+KKL + ++ + RA R L+
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK------RAYRELVLM 115
Query: 171 AEVDSNCIVKLY------CSFQDDEFLYLIMEYLPGGDMMTLLMR--KDTLTEDEARFYV 222
V+ I+ L + ++ + +YL+ME M L + + L + + +
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-----MDANLCQVIQMELDHERMSYLL 170
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+ + I+ +H IHRD+KP N+++ L++ DFGL +
Sbjct: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--------------- 215
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342
+ M Y V T Y APEV+L GY D WS
Sbjct: 216 -------------------------TSFMMTPY--VVTRYYRAPEVILGMGYKENVDIWS 248
Query: 343 LGAIMYEMLVGYPPF 357
+G IM EM+ F
Sbjct: 249 VGCIMGEMVRHKILF 263
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 8e-22
Identities = 65/263 (24%), Positives = 104/263 (39%), Gaps = 70/263 (26%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK---SEMLRRGQVEHVRAER--NLL 170
+ ++ L+ +G GA+G V + TG A+KKL + S + + R R LL
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK------RTYRELRLL 82
Query: 171 AEVDSNCIVKLY------CSFQDDEFLYLIMEYLPGGDMMTLL---MRKDTLTEDEARFY 221
+ ++ L S ++ +YL+ M L ++ LT+D +F
Sbjct: 83 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-----MGADLNNIVKCQKLTDDHVQFL 137
Query: 222 VAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ + + ++ IH IHRD+KP NL +++ L++ DFGL
Sbjct: 138 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA------------------ 179
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDW 340
R A + T Y V T Y APE++L Y D
Sbjct: 180 ---------RHTADEMTG---------------Y--VATRWYRAPEIMLNWMHYNQTVDI 213
Query: 341 WSLGAIMYEMLVGYPPFYSDDPM 363
WS+G IM E+L G F D +
Sbjct: 214 WSVGCIMAELLTGRTLFPGTDHI 236
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-21
Identities = 61/253 (24%), Positives = 99/253 (39%), Gaps = 58/253 (22%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER--NLLAEV 173
+ L+ IG+GA+G V + A+KK+ E Q R R +L
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ----RTLREIKILLRF 82
Query: 174 DSNCIVKLY-----CSFQDDEFLYLIMEYLPGGDMMTLL---MRKDTLTEDEARFYVAET 225
I+ + + + + +Y++ + M T L ++ L+ D +++ +
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDL-----METDLYKLLKTQHLSNDHICYFLYQI 137
Query: 226 VLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285
+ ++ IH + +HRD+KP NLLL+ L++ DFGL
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA---------------------- 175
Query: 286 SQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 344
R H + Y V T Y APE++L KGY D WS+G
Sbjct: 176 -----------RVADPDHDHTGF---LTEY--VATRWYRAPEIMLNSKGYTKSIDIWSVG 219
Query: 345 AIMYEMLVGYPPF 357
I+ EML P F
Sbjct: 220 CILAEMLSNRPIF 232
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 49/257 (19%), Positives = 90/257 (35%), Gaps = 59/257 (22%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQV--EHV----RAER-- 167
+ + I G++G V + V A+K++ + R R R
Sbjct: 22 SPYTVQRFISSGSYGAVCAGVDSEGIPV-AIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 168 NLLAEVDSNCIVKLY---CSFQDDEF--LYLIMEYLPGGDMMTLL-MRKDTLTEDEARFY 221
LL I+ L F++ LYL+ E + D+ ++ ++ ++ +++
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYF 139
Query: 222 VAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ +L + +H+ +HRD+ P N+LL + + DF L
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA------------------ 181
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDW 340
R + Y V Y APE++++ KG+ D
Sbjct: 182 ---------REDTA-------------DANKTHY--VTHRWYRAPELVMQFKGFTKLVDM 217
Query: 341 WSLGAIMYEMLVGYPPF 357
WS G +M EM F
Sbjct: 218 WSAGCVMAEMFNRKALF 234
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-21
Identities = 66/260 (25%), Positives = 106/260 (40%), Gaps = 65/260 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK---SEMLRRGQVEHVRAER--NLL 170
+ T +G GA+G V +K +G A+KKL + SE+ + RA R LL
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK------RAYRELLLL 77
Query: 171 AEVDSNCIVKLY------CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAE 224
+ ++ L S ++ YL+M ++ D+ ++ +E++ ++ V +
Sbjct: 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLVYQ 134
Query: 225 TVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
+ ++ IH +HRD+KP NL +++ L++ DFGL
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA--------------------- 173
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSL 343
R A + T Y V T Y APEV+L Y D WS+
Sbjct: 174 ------RHADAEMTG---------------Y--VVTRWYRAPEVILSWMHYNQTVDIWSV 210
Query: 344 GAIMYEMLVGYPPFYSDDPM 363
G IM EML G F D +
Sbjct: 211 GCIMAEMLTGKTLFKGKDYL 230
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-21
Identities = 62/262 (23%), Positives = 101/262 (38%), Gaps = 68/262 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK---SEMLRRGQVEHVRAER--NLL 170
++ L IG GA G V + A+KKL + ++ + RA R L+
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK------RAYRELVLM 78
Query: 171 AEVDSNCIVKLY---------CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFY 221
V+ I+ L FQD +Y++ME + ++ ++ + L + +
Sbjct: 79 KCVNHKNIIGLLNVFTPQKSLEEFQD---VYIVMELM-DANLCQVI--QMELDHERMSYL 132
Query: 222 VAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ + + I+ +H IHRD+KP N+++ L++ DFGL +
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-------------- 178
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWW 341
+ M Y V T Y APEV+L GY D W
Sbjct: 179 --------------------------TSFMMTPY--VVTRYYRAPEVILGMGYKENVDIW 210
Query: 342 SLGAIMYEMLVGYPPFYSDDPM 363
S+G IM EM+ G F D +
Sbjct: 211 SVGCIMGEMIKGGVLFPGTDHI 232
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 8e-21
Identities = 56/264 (21%), Positives = 95/264 (35%), Gaps = 75/264 (28%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKL---KKSEMLR--RGQVEHVRAERNLLAE 172
+ L +G G G V + A+KK+ + R E ++
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR--------EIKIIRR 64
Query: 173 VDSNCIVKLY------------CSFQDDEF--LYLIMEYLPGGDMMTLL---MRKDTLTE 215
+D + IVK++ E +Y++ EY M T L + + L E
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-----METDLANVLEQGPLLE 119
Query: 216 DEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPLDCSTLQEQ 274
+ AR ++ + + ++ IH + +HRD+KP NL ++ L++ DFGL + +D
Sbjct: 120 EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD------- 172
Query: 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KG 333
H+ + + T Y +P +LL
Sbjct: 173 -----------------------------PHYSHKGHLSEG--LVTKWYRSPRLLLSPNN 201
Query: 334 YGMECDWWSLGAIMYEMLVGYPPF 357
Y D W+ G I EML G F
Sbjct: 202 YTKAIDMWAAGCIFAEMLTGKTLF 225
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 72/263 (27%), Positives = 103/263 (39%), Gaps = 70/263 (26%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK---SEMLRRGQVEHVRAER--NLL 170
+ L +G GA+G V + TG A+KKL + SE+ + RA R LL
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK------RAYRELRLL 78
Query: 171 AEVDSNCIVKLY------CSFQDDEFLYLIMEYLPGGDMMTLL---MRKDTLTEDEARFY 221
+ ++ L + D YL+M + M T L M+ + L ED +F
Sbjct: 79 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF-----MGTDLGKLMKHEKLGEDRIQFL 133
Query: 222 VAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
V + + + IH IHRD+KP NL +++ L++ DFGL
Sbjct: 134 VYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA------------------ 175
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDW 340
R A + T Y V T Y APEV+L Y D
Sbjct: 176 ---------RQADSEMTG---------------Y--VVTRWYRAPEVILNWMRYTQTVDI 209
Query: 341 WSLGAIMYEMLVGYPPFYSDDPM 363
WS+G IM EM+ G F D +
Sbjct: 210 WSVGCIMAEMITGKTLFKGSDHL 232
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 1e-20
Identities = 51/272 (18%), Positives = 96/272 (35%), Gaps = 67/272 (24%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN--LLAEV 173
D+ +LL +IG+G +G V + A+K + ++ E+N + +
Sbjct: 13 DNLKLLELIGRGRYGAV--YKGSLDERPVAVKVFSFANR------QNFINEKNIYRVPLM 64
Query: 174 DSNCIVKLY-----CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV-- 226
+ + I + + L+MEY P G + L ++ + +A +V
Sbjct: 65 EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTR 122
Query: 227 --------LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278
L +K HRD+ N+L+ G +SDFGL S + +
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL------SMRLTGNRLV 176
Query: 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL-------LK 331
++ +E VGT Y+APEVL
Sbjct: 177 RPGEEDNAAISE---------------------------VGTIRYMAPEVLEGAVNLRDX 209
Query: 332 KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
+ + D ++LG I +E+ + + + +
Sbjct: 210 ESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 1e-20
Identities = 16/157 (10%), Positives = 49/157 (31%), Gaps = 2/157 (1%)
Query: 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
++ + LL G + + A+ + +L ++ + L
Sbjct: 26 ARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRL 85
Query: 171 AEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
+ +D + ++ ++ E++ GG + + + + A + A +
Sbjct: 86 SRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAAD 143
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ H+ P + + G + L+ +
Sbjct: 144 AAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPDAN 180
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 52/262 (19%), Positives = 96/262 (36%), Gaps = 63/262 (24%)
Query: 115 ADDFELLTM-IGKGAFGEV--RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
D FE +G+G +G V ++ YA+K+++ + + E LL
Sbjct: 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREI-----ALLR 73
Query: 172 EVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL---------MRKDTLTEDEARF 220
E+ ++ L D ++L+ +Y D+ ++ + L +
Sbjct: 74 ELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKS 132
Query: 221 YVAETVLAIESIHKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLCKPLDCSTLQEQDF 276
+ + + I +H + +HRD+KP N+L+ + G ++++D G + F
Sbjct: 133 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL----------F 182
Query: 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYG 335
P + L V T Y APE+LL + Y
Sbjct: 183 NS----------------PLKP----LADLDPV--------VVTFWYRAPELLLGARHYT 214
Query: 336 MECDWWSLGAIMYEMLVGYPPF 357
D W++G I E+L P F
Sbjct: 215 KAIDIWAIGCIFAELLTSEPIF 236
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 57/266 (21%), Positives = 85/266 (31%), Gaps = 62/266 (23%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
A L IGKG FGEV R K G A+K E + AE +
Sbjct: 41 ARTIVLQESIGKGRFGEV--WRGKWRGEEVAVKIFSSREE----RSWFREAEIYQTVMLR 94
Query: 175 SNCIVKLYCSFQDDEF----LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
I+ + D L+L+ +Y G + L + T+T + T +
Sbjct: 95 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLA 153
Query: 231 SIH--------KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+H K HRD+K N+L+ K G ++D GL D +T I N
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT---DTIDIAPN- 209
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG------YGM 336
VGT Y+APEVL
Sbjct: 210 ---------------------------------HRVGTKRYMAPEVLDDSINMKHFESFK 236
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDP 362
D +++G + +E+ +
Sbjct: 237 RADIYAMGLVFWEIARRCSIGGIHED 262
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-20
Identities = 52/266 (19%), Positives = 80/266 (30%), Gaps = 62/266 (23%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
A +++ IGKG +GEV K G A+K +E E +
Sbjct: 36 AKQIQMVKQIGKGRYGEV--WMGKWRGEKVAVKVFFTTEE----ASWFRETEIYQTVLMR 89
Query: 175 SNCIVKLYCSFQDDEF----LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
I+ + LYLI +Y G + L + TL +V +
Sbjct: 90 HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-KSTTLDAKSMLKLAYSSVSGLC 148
Query: 231 SIH--------KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+H K HRD+K N+L+ K G ++D GL T +
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR-- 206
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL------LKKGYGM 336
VGT Y+ PEVL +
Sbjct: 207 -----------------------------------VGTKRYMPPEVLDESLNRNHFQSYI 231
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDP 362
D +S G I++E+ +
Sbjct: 232 MADMYSFGLILWEVARRCVSGGIVEE 257
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 4e-20
Identities = 52/268 (19%), Positives = 81/268 (30%), Gaps = 64/268 (23%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
A D LL +GKG +GEV R G A+K + + E +
Sbjct: 7 ARDITLLECVGKGRYGEV--WRGSWQGENVAVKIFSSRDE----KSWFRETELYNTVMLR 60
Query: 175 SNCIVKLY----CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV---- 226
I+ S L+LI Y G + L + TL + ++
Sbjct: 61 HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVS-CLRIVLSIASGL 118
Query: 227 -----LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ K HRD+K N+L+ K G ++D GL + + Q +
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL------AVMHSQSTNQLDV 172
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL------LKKGYG 335
N VGT Y+APEVL
Sbjct: 173 GN-------------------------------NPRVGTKRYMAPEVLDETIQVDCFDSY 201
Query: 336 MECDWWSLGAIMYEMLVGYPPFYSDDPM 363
D W+ G +++E+ +
Sbjct: 202 KRVDIWAFGLVLWEVARRMVSNGIVEDY 229
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 64/265 (24%), Positives = 102/265 (38%), Gaps = 61/265 (23%)
Query: 105 YMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEMLRRGQVEHV 163
++ + D +E+ ++IGKG+FG+V ++ A+K +K K L + Q+E V
Sbjct: 43 DYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE-V 101
Query: 164 RAERNLLAE--VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL--LMRKDT---LTED 216
R + IV L F L L+ E L L L+R ++ +
Sbjct: 102 RLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS----YNLYDLLRNTNFRGVSLN 157
Query: 217 EARFYVAETVLAIESIH--KHHYIHRDIKPDNLLLDKYGH--LRLSDFGLCKPLDCSTLQ 272
R + + A+ + + IH D+KP+N+LL +++ DFG
Sbjct: 158 LTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG----------- 206
Query: 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332
S Q +R Y + + Y +PEVLL
Sbjct: 207 -----------SSCQLGQRI----------------------YQYIQSRFYRSPEVLLGM 233
Query: 333 GYGMECDWWSLGAIMYEMLVGYPPF 357
Y + D WSLG I+ EM G P F
Sbjct: 234 PYDLAIDMWSLGCILVEMHTGEPLF 258
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 49/270 (18%), Positives = 103/270 (38%), Gaps = 65/270 (24%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEMLRRGQVE-----HVR-AERNLL 170
+ L+ +G G F V + ++ AMK ++ + E V A+
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 171 AEVDSNCIVKLYCSFQ----DDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAE 224
+ +N I+KL F + + ++ E L G +++ L+ + + + + +
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQ 139
Query: 225 TVLAIESIHKH-HYIHRDIKPDNLLLD------KYGHLRLSDFGLCKPLDCSTLQEQDFT 277
+L ++ +H+ IH DIKP+N+L++ ++++D G
Sbjct: 140 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG---------------- 183
Query: 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME 337
+ +E +++ T +Y +PEVLL +G
Sbjct: 184 ------NACWYDEH----------------------YTNSIQTREYRSPEVLLGAPWGCG 215
Query: 338 CDWWSLGAIMYEMLVGYPPFYSDDPMSTCR 367
D WS +++E++ G F D+ S +
Sbjct: 216 ADIWSTACLIFELITGDFLFEPDEGHSYTK 245
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-19
Identities = 53/257 (20%), Positives = 99/257 (38%), Gaps = 51/257 (19%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEMLRRGQVEHVRAERNL-LAEVDS 175
F ++ +G G FG V +C+ YA+K ++ + R ++E + + ++++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE-ADILKKIQNDDINN 95
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL--LMRKDT---LTEDEARFYVAETVLAIE 230
N IVK + F + + LI E L +L ++ ++ ++ + Y E + A+
Sbjct: 96 NNIVKYHGKFMYYDHMCLIFEPLG----PSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ---------DFTIGNN 281
+ K H D+KP+N+LLD + + DF
Sbjct: 152 YLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF----- 206
Query: 282 LNGSS-QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340
G + ++ S + T Y APEV+L G+ + D
Sbjct: 207 --GCATFKSDYH----------------------GSIINTRQYRAPEVILNLGWDVSSDM 242
Query: 341 WSLGAIMYEMLVGYPPF 357
WS G ++ E+ G F
Sbjct: 243 WSFGCVLAELYTGSLLF 259
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 4e-19
Identities = 51/266 (19%), Positives = 89/266 (33%), Gaps = 65/266 (24%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+LL + +G FG V + A+K + Q E L +
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKH 77
Query: 176 NCIVKL--YC--SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDE--------AR--FY 221
I++ D L+LI + G + L + + ++ +E AR Y
Sbjct: 78 ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIAETMARGLAY 136
Query: 222 VAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ E + ++ HK HRDIK N+LL ++DFGL + E + G+
Sbjct: 137 LHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL------ALKFEAGKSAGDT 190
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL-----LKKGYGM 336
VGT Y+APEVL ++ +
Sbjct: 191 H---------------------------------GQVGTRRYMAPEVLEGAINFQRDAFL 217
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDP 362
D +++G +++E+
Sbjct: 218 RIDMYAMGLVLWELASRCTAADGPVD 243
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-18
Identities = 40/157 (25%), Positives = 71/157 (45%), Gaps = 9/157 (5%)
Query: 116 DDFELLTMIGKGAFGEVRVCR----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
+ + +G+G FG+V + TG + A+K LK + + E ++L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQ--HRSGWKQEIDILR 88
Query: 172 EVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
+ I+K C L L+MEY+P G + L + ++ + + + +
Sbjct: 89 TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGM 147
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266
+H HYIHRD+ N+LLD +++ DFGL K +
Sbjct: 148 AYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 48/253 (18%), Positives = 98/253 (38%), Gaps = 47/253 (18%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVY-AMKKLK-KSEMLRRGQVEHVRAERNLLAE--V 173
+E++ +G+G FG+V C + G A+K ++ + ++E + + + +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE-INVLKKIKEKDKE 79
Query: 174 DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL--LMRKDT---LTEDEARFYVAETVLA 228
+ V + F + + E L ++++ R + A
Sbjct: 80 NKFLCVLMSDWFNFHGHMCIAFELLG----KNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFG---LCKPLDCSTLQEQDFTIGNNLNGS 285
+ +H++ H D+KP+N+L L + K + ++++ DF GS
Sbjct: 136 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF-------GS 188
Query: 286 S-QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344
+ ++E + V T Y PEV+L+ G+ CD WS+G
Sbjct: 189 ATFDHEHH----------------------TTIVATRHYRPPEVILELGWAQPCDVWSIG 226
Query: 345 AIMYEMLVGYPPF 357
I++E G+ F
Sbjct: 227 CILFEYYRGFTLF 239
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 52/253 (20%), Positives = 102/253 (40%), Gaps = 47/253 (18%)
Query: 118 FELLTMIGKGAFGEVRVCR-EKTTGHVYAMKKLK-KSEMLRRGQVEHVRAERNLLAE--V 173
+E++ +G+GAFG+V C K G A+K +K + E ++ +L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE-IQVLEHLNTTDPN 74
Query: 174 DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL--LMRKDT---LTEDEARFYVAETVLA 228
+ V++ F+ + ++ E L ++ ++++ D R + +
Sbjct: 75 STFRCVQMLEWFEHHGHICIVFELLG----LSTYDFIKENGFLPFRLDHIRKMAYQICKS 130
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL---CKPLDCSTLQEQDFTIGNNLNGS 285
+ +H + H D+KP+N+L + + + + + L ++ DF GS
Sbjct: 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF-------GS 183
Query: 286 S-QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344
+ ++E + V T Y APEV+L G+ CD WS+G
Sbjct: 184 ATYDDEHH----------------------STLVSTRHYRAPEVILALGWSQPCDVWSIG 221
Query: 345 AIMYEMLVGYPPF 357
I+ E +G+ F
Sbjct: 222 CILIEYYLGFTVF 234
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 48/268 (17%), Positives = 91/268 (33%), Gaps = 31/268 (11%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL---AEVD 174
+ ++ +G G F V + + AMK +K +E E E LL D
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT----ETALDEIRLLKSVRNSD 94
Query: 175 SN-----CIVKLYCSFQ----DDEFLYLIMEYLPGGDMMTLLMRKDT--LTEDEARFYVA 223
N +V+L F+ + + ++ E L G ++ +++ + L + +
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQ 153
Query: 224 ETVLAIESIHKH-HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+ + ++ +H IH DIKP+N+LL S + +
Sbjct: 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 283 NGSSQNNERPAAPKRTQQEQLQH--------WQKNRRMLAYSTVGTPDYIAPEVLLKKGY 334
++ N + ++ W + T Y + EVL+ GY
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF---TEDIQTRQYRSLEVLIGSGY 270
Query: 335 GMECDWWSLGAIMYEMLVGYPPFYSDDP 362
D WS + +E+ G F
Sbjct: 271 NTPADIWSTACMAFELATGDYLFEPHSG 298
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 48/160 (30%), Positives = 74/160 (46%), Gaps = 12/160 (7%)
Query: 116 DDFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
+ L +GKG FG V +CR + T V A+KKL+ S + E +L
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVV-AVKKLQHSTE---EHLRDFEREIEIL 65
Query: 171 AEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVL 227
+ + IVK C L LIMEYLP G + L + K+ + + Y ++
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+E + YIHRD+ N+L++ +++ DFGL K L
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-18
Identities = 48/160 (30%), Positives = 73/160 (45%), Gaps = 12/160 (7%)
Query: 116 DDFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
+ L +GKG FG V +CR + T V A+KKL+ S + E +L
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVV-AVKKLQHSTE---EHLRDFEREIEIL 96
Query: 171 AEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVL 227
+ + IVK C L LIMEYLP G + L K+ + + Y ++
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 156
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+E + YIHRD+ N+L++ +++ DFGL K L
Sbjct: 157 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 196
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-17
Identities = 43/194 (22%), Positives = 77/194 (39%), Gaps = 48/194 (24%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE----- 172
+++ IG+G+FG + A+K E R++ L +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF------------EPRRSDAPQLRDEYRTY 59
Query: 173 ---VDSNCIVKLYCSFQDDEFLYLIMEYLPG---GDMMTLLMRKDTLTEDEARFYVAETV 226
I +Y Q+ L+++ L G D++ L RK ++ +TV
Sbjct: 60 KLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSV----------KTV 108
Query: 227 L--------AIESIHKHHYIHRDIKPDNLLLDKYGH-----LRLSDFGLCKP-LDCSTLQ 272
++SIH+ ++RDIKPDN L+ + + + DFG+ K D T Q
Sbjct: 109 AMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ 168
Query: 273 EQDFTIGNNLNGSS 286
+ NL+G++
Sbjct: 169 HIPYREKKNLSGTA 182
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 40/160 (25%), Positives = 74/160 (46%), Gaps = 11/160 (6%)
Query: 116 DDFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
+ + +G+G FG+V +CR + T V A+K LK + ++ E +L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQV-AVKSLKPESGGN--HIADLKKEIEIL 77
Query: 171 AEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVL 227
+ IVK C+ + LIME+LP G + L K+ + + Y +
Sbjct: 78 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICK 137
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
++ + Y+HRD+ N+L++ +++ DFGL K ++
Sbjct: 138 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-17
Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 12/162 (7%)
Query: 116 DDFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
+ ++ +GKG FG V +CR + T V A+K+L+ S Q + E +L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALV-AVKQLQHSGPD---QQRDFQREIQIL 78
Query: 171 AEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVL 227
+ S+ IVK + L L+MEYLP G + L + L Y ++
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICK 138
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269
+E + +HRD+ N+L++ H++++DFGL K L
Sbjct: 139 GMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-17
Identities = 39/172 (22%), Positives = 69/172 (40%), Gaps = 49/172 (28%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE----- 172
F + IG G FGE+R+ + T A+K +E +++ L
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIK------------LEPMKSRAPQLHLEYRFY 58
Query: 173 ---VDSNCIVKLYCSFQDDEFLYLIMEYLPGG----DMMTLLMRKDTLTEDEARFYVAET 225
+ I ++Y ++ +++E L G D+ L R +L +T
Sbjct: 59 KQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSL----------KT 106
Query: 226 VL--------AIESIHKHHYIHRDIKPDNLLLDKYGHLR-----LSDFGLCK 264
VL +E +H + I+RD+KP+N L+ + G+ + DF L K
Sbjct: 107 VLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 5e-17
Identities = 43/169 (25%), Positives = 67/169 (39%), Gaps = 45/169 (26%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER-NLLAEV--- 173
+ L IG G+FG++ + + G A+K E V+ + L E
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL------------ECVKTKHPQLHIESKIY 58
Query: 174 ----DSNCIVKLYCSFQDDEFLYLIMEYLPG---GDMMTLLMRKDTLTEDEARFYVAETV 226
I + + ++ ++ME L G D+ RK +L +TV
Sbjct: 59 KMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSL----------KTV 107
Query: 227 L--------AIESIHKHHYIHRDIKPDNLLLDKYGH---LRLSDFGLCK 264
L IE IH ++IHRD+KPDN L+ + + DFGL K
Sbjct: 108 LLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-16
Identities = 40/155 (25%), Positives = 68/155 (43%), Gaps = 7/155 (4%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+D L IG+G FGEV R + + A+K +++ E +L +
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPD--LKAKFLQEARILKQYSH 171
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIESI 232
IV+L C+ + +Y++ME + GGD +T L L V + +E +
Sbjct: 172 PNIVRLIGVCT--QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL 229
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
IHRD+ N L+ + L++SDFG+ +
Sbjct: 230 ESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 9e-16
Identities = 43/193 (22%), Positives = 71/193 (36%), Gaps = 35/193 (18%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK---------KSEM--LRRGQVEHVRAE 166
+ L IG G FG + + A +K SE+ +R + +
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98
Query: 167 RNLLAEVDSNCIVKLYCS----FQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYV 222
++D I Y S F+ + +++ME L G D+ + + T +
Sbjct: 99 WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKK------- 150
Query: 223 AETVL--------AIESIHKHHYIHRDIKPDNLLLD--KYGHLRLSDFGLCKP-LDCSTL 271
TVL +E IH++ Y+H DIK NLLL + L+D+GL
Sbjct: 151 -STVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
Query: 272 QEQDFTIGNNLNG 284
++ NG
Sbjct: 210 KQYQENPRKGHNG 222
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 37/158 (23%), Positives = 65/158 (41%), Gaps = 9/158 (5%)
Query: 116 DDFELLTMIGKGAFGEVR--VCREKTTGHVY-AMKKLKKSEMLRRGQVEHVRAERNLLAE 172
D LL +G G+FG VR + V A+K LK + + ++ E N +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 173 VDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVLAI 229
+D +++LY + ++ E P G ++ L + Y + +
Sbjct: 78 LDHRNLIRLYGVVL---TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 134
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ +IHRD+ NLLL +++ DFGL + L
Sbjct: 135 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 44/170 (25%), Positives = 67/170 (39%), Gaps = 45/170 (26%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAE-RNLLAEV--- 173
F L IG G+FGE+ + T A+K E+V+ + LL E
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL------------ENVKTKHPQLLYESKIY 56
Query: 174 ----DSNCIVKLYCSFQDDEFLYLIMEYLPG---GDMMTLLMRKDTLTEDEARFYVAETV 226
I + + ++ L+M+ L G D+ RK +L +TV
Sbjct: 57 RILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSL----------KTV 105
Query: 227 L--------AIESIHKHHYIHRDIKPDNLLLDKYGH---LRLSDFGLCKP 265
L +E +H ++HRDIKPDN L+ + + DFGL K
Sbjct: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 7e-15
Identities = 35/198 (17%), Positives = 69/198 (34%), Gaps = 42/198 (21%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHV-----YAMKKLKK--------SEMLRRGQVEHVR 164
+++ IG+G FG + + ++ V +K + +R
Sbjct: 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI 96
Query: 165 AERNLLAEVDSNCIVKLYCS----FQDDEFLYLIMEYLPGGDMMTLLM---RKDTLTEDE 217
+ ++ + K + S + ++IM+ G D+ + ++ +
Sbjct: 97 QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSR---- 151
Query: 218 ARFYVAETVL--------AIESIHKHHYIHRDIKPDNLLLD--KYGHLRLSDFGLCKP-L 266
+TVL +E IH+H Y+H DIK NLLL+ + L D+GL
Sbjct: 152 ------KTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYC 205
Query: 267 DCSTLQEQDFTIGNNLNG 284
+ +G
Sbjct: 206 PEGVHKAYAADPKRCHDG 223
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 9e-15
Identities = 37/160 (23%), Positives = 73/160 (45%), Gaps = 14/160 (8%)
Query: 116 DDFELLTMIGKGAFGEV-----RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
+F+ + ++G GAFG V EK V A+K+L+++ + + E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATS--PKANKEILDEAYVM 71
Query: 171 AEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVL 227
A VD+ + +L C + LI + +P G ++ + KD + + +
Sbjct: 72 ASVDNPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ + +HRD+ N+L+ H++++DFGL K L
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 27/173 (15%), Positives = 59/173 (34%), Gaps = 33/173 (19%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHV--------YAMKKLKKSEMLRRGQVEHVRAERNL 169
++L + + G + +T +++K K L Q RA + L
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103
Query: 170 -------LAEVDSNCIVKLYCS-FQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFY 221
L I D++ +L++ L G + + L
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK------HVL 156
Query: 222 VAETVL--------AIESIHKHHYIHRDIKPDNLLL--DKYGHLRLSDFGLCK 264
+VL A+E +H++ Y+H ++ +N+ + + + L+ +G
Sbjct: 157 SERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 54/247 (21%), Positives = 103/247 (41%), Gaps = 53/247 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ L +G+G FGEV + T V A+K LK M E E ++ ++
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSP----EAFLQEAQVMKKLRH 321
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIES 231
+V+LY S +E +Y++ EY+ G ++ L + L + A+ +
Sbjct: 322 EKLVQLYAVVS---EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 378
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+ + +Y+HRD++ N+L+ + +++DFGL + +++ ++T + Q +
Sbjct: 379 VERMNYVHRDLRAANILVGENLVCKVADFGLAR-----LIEDNEYT-------ARQGAKF 426
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
P K T APE L + ++ D WS G ++ E+
Sbjct: 427 PI--KWT--------------------------APEAALYGRFTIKSDVWSFGILLTELT 458
Query: 352 -VGYPPF 357
G P+
Sbjct: 459 TKGRVPY 465
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-14
Identities = 37/148 (25%), Positives = 69/148 (46%), Gaps = 8/148 (5%)
Query: 124 IGKGAFGEVR--VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKL 181
+G G FG V+ + K A+K LK + E + E N++ ++D+ IV++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA-EANVMQQLDNPYIVRM 83
Query: 182 Y--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIH 239
C E L+ME G + L + + + V + + ++ + + +++H
Sbjct: 84 IGICE---AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 140
Query: 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
RD+ N+LL + ++SDFGL K L
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGLSKALR 168
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 36/151 (23%), Positives = 72/151 (47%), Gaps = 10/151 (6%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D + +G G +GEV K A+K LK+ M +VE E ++ E+
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH 275
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIES 231
+V+L C+ + Y+I E++ G+++ L + ++ + + A+E
Sbjct: 276 PNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 333
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ K ++IHR++ N L+ + ++++DFGL
Sbjct: 334 LEKKNFIHRNLAARNCLVGENHLVKVADFGL 364
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 54/247 (21%), Positives = 103/247 (41%), Gaps = 53/247 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ L +G+G FGEV + T V A+K LK M E E ++ ++
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSP----EAFLQEAQVMKKLRH 238
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIES 231
+V+LY S +E +Y++ EY+ G ++ L + L + A+ +
Sbjct: 239 EKLVQLYAVVS---EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+ + +Y+HRD++ N+L+ + +++DFGL + +++ ++T + Q +
Sbjct: 296 VERMNYVHRDLRAANILVGENLVCKVADFGLAR-----LIEDNEYT-------ARQGAKF 343
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
P K T APE L + ++ D WS G ++ E+
Sbjct: 344 PI--KWT--------------------------APEAALYGRFTIKSDVWSFGILLTELT 375
Query: 352 -VGYPPF 357
G P+
Sbjct: 376 TKGRVPY 382
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-14
Identities = 30/150 (20%), Positives = 63/150 (42%), Gaps = 10/150 (6%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ + IG G FG V + V A+K +++ M E E ++ ++
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAM----SEEDFIEEAEVMMKLSH 62
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESI 232
+V+LY C + + L+ E++ G + L ++ + + + +
Sbjct: 63 PKLVQLYGVCL--EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ IHRD+ N L+ + +++SDFG+
Sbjct: 121 EEACVIHRDLAARNCLVGENQVIKVSDFGM 150
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 6e-14
Identities = 53/249 (21%), Positives = 93/249 (37%), Gaps = 52/249 (20%)
Query: 116 DDFELLTMIGKGAFGEVR--VCREKTTGHVY-AMKKLKKSEMLRRGQVEHVRAERNLLAE 172
+ EL IG+G FG+V + + A+K K E E + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS--VREKFLQEALTMRQ 447
Query: 173 VDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVLAI 229
D IVKL + + +++IME G++ + L +RK +L Y + A+
Sbjct: 448 FDHPHIVKLIGVIT---ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTAL 504
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+ ++HRDI N+L+ ++L DFGL + +++ +
Sbjct: 505 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-----YMEDSTYYKA---------- 549
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349
+ P + W +APE + + + D W G M+E
Sbjct: 550 SKGKLPIK--------W-----------------MAPESINFRRFTSASDVWMFGVCMWE 584
Query: 350 ML-VGYPPF 357
+L G PF
Sbjct: 585 ILMHGVKPF 593
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 8e-14
Identities = 37/160 (23%), Positives = 73/160 (45%), Gaps = 14/160 (8%)
Query: 116 DDFELLTMIGKGAFGEV-----RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
+F+ + ++G GAFG V EK V A+K+L+++ + + E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATS--PKANKEILDEAYVM 71
Query: 171 AEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVL 227
A VD+ + +L C + LI + +P G ++ + KD + + +
Sbjct: 72 ASVDNPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ + +HRD+ N+L+ H++++DFGL K L
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 1e-13
Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 11/153 (7%)
Query: 116 DDFELLTMIGKGAFGEVR--VCREKTTGHVY-AMKKLKKSEMLRRGQVEHVRAERNLLAE 172
+D L ++G+G FGEV V + A+K KK L E +E ++
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD--NKEKFMSEAVIMKN 69
Query: 173 VDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAI 229
+D IVKL +E ++IME P G++ L R K++L Y + A+
Sbjct: 70 LDHPHIVKLIGIIE---EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 126
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ + +HRDI N+L+ ++L DFGL
Sbjct: 127 AYLESINCVHRDIAVRNILVASPECVKLGDFGL 159
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 55/253 (21%), Positives = 92/253 (36%), Gaps = 55/253 (21%)
Query: 116 DDFELLTMIGKGAFGEVR--VCREKTTGHVY-AMKKLKKSEMLRRGQVEHVRAERNLLAE 172
+ +IG G GEV R V A+K LK R Q +E +++ +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER--QRRDFLSEASIMGQ 106
Query: 173 VDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAI 229
D I++L + ++ EY+ G + T L T + + +
Sbjct: 107 FDHPNIIRLEGVVT--RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGM 164
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+ Y+HRD+ N+L+D ++SDFGL + L+ + D
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE----DDPDA------------- 207
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYI---APEVLLKKGYGMECDWWSLGAI 346
AY+T G I APE + + + D WS G +
Sbjct: 208 ------------------------AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVV 243
Query: 347 MYEML-VGYPPFY 358
M+E+L G P++
Sbjct: 244 MWEVLAYGERPYW 256
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 39/158 (24%), Positives = 69/158 (43%), Gaps = 11/158 (6%)
Query: 116 DDFELLTMIGKGAFGEVR--VCREKTTGHVY-AMKKLKKSEMLRRGQVEHVRAERNLLAE 172
+ EL IG+G FG+V + + A+K K E E + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFLQEALTMRQ 72
Query: 173 VDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVLAI 229
D IVKL + + +++IME G++ + L +RK +L Y + A+
Sbjct: 73 FDHPHIVKLIGVIT---ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 129
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ ++HRDI N+L+ ++L DFGL + ++
Sbjct: 130 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-13
Identities = 37/150 (24%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
++ LL +G G FG V++ + K V A+K +K+ M + E + ++
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSM----SEDEFFQEAQTMMKLSH 62
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIESI 232
+VK Y CS + +Y++ EY+ G ++ L L + + + +
Sbjct: 63 PKLVKFYGVCS--KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
H +IHRD+ N L+D+ +++SDFG+
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGM 150
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 3e-13
Identities = 37/151 (24%), Positives = 72/151 (47%), Gaps = 10/151 (6%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D + +G G +GEV K A+K LK+ M +VE E ++ E+
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH 68
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIES 231
+V+L C+ + Y+I E++ G+++ L + ++ + + A+E
Sbjct: 69 PNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ K ++IHRD+ N L+ + ++++DFGL
Sbjct: 127 LEKKNFIHRDLAARNCLVGENHLVKVADFGL 157
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 4e-13
Identities = 35/150 (23%), Positives = 68/150 (45%), Gaps = 10/150 (6%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D L +G G FG V+ + + V A+K +K+ M + E ++ +
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSM----SEDEFIEEAKVMMNLSH 78
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIESI 232
+V+LY C+ +++I EY+ G ++ L + + + A+E +
Sbjct: 79 EKLVQLYGVCT--KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
++HRD+ N L++ G +++SDFGL
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGL 166
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 4e-13
Identities = 42/151 (27%), Positives = 74/151 (49%), Gaps = 12/151 (7%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +L+ +G G FGEV + V A+K LK+ M + AE NL+ ++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSP----DAFLAEANLMKQLQH 67
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIES 231
+V+LY + E +Y+I EY+ G ++ L LT ++ A+ +
Sbjct: 68 QRLVRLYAVVT---QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
I + +YIHRD++ N+L+ +++DFGL
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSCKIADFGL 155
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 47/254 (18%), Positives = 97/254 (38%), Gaps = 55/254 (21%)
Query: 115 ADDFELLTMIGKGAFGEVR--VCREKTTGHVY-AMKKLKKSEMLRRGQVEHVRAERNLLA 171
A + + ++G G FGEV + + + A+K LK + Q E +++
Sbjct: 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--QRRDFLGEASIMG 101
Query: 172 EVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLA 228
+ D I++L + + + ++ EY+ G + + L T + +
Sbjct: 102 QFDHPNIIRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
++ + Y+HRD+ N+L++ ++SDFGL + L+
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE--------------------- 198
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYI---APEVLLKKGYGMECDWWSLGA 345
+ AY+T G I +PE + + + D WS G
Sbjct: 199 --------------------DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGI 238
Query: 346 IMYEML-VGYPPFY 358
+++E++ G P++
Sbjct: 239 VLWEVMSYGERPYW 252
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 5e-13
Identities = 39/151 (25%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +L +G G FGEV + V A+K +K M VE AE N++ +
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQH 242
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIES 231
+ +VKL+ + E +Y+I E++ G ++ L + + A+ +
Sbjct: 243 DKLVKLHAVVT---KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 299
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
I + +YIHRD++ N+L+ +++DFGL
Sbjct: 300 IEQRNYIHRDLRAANILVSASLVCKIADFGL 330
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 6e-13
Identities = 50/255 (19%), Positives = 93/255 (36%), Gaps = 58/255 (22%)
Query: 116 DDFELLTMIGKGAFGEV-----RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
+IG G FGEV + K V A+K LK + Q E ++
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPV-AIKTLKAGYTEK--QRVDFLGEAGIM 100
Query: 171 AEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVL 227
+ + I++L S + + +I EY+ G + L + + + +
Sbjct: 101 GQFSHHNIIRLEGVIS--KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 158
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
++ + +Y+HRD+ N+L++ ++SDFGL + L
Sbjct: 159 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL--------------------- 197
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYI---APEVLLKKGYGMECDWWSLG 344
++ Y+T G I APE + + + D WS G
Sbjct: 198 --------------------EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFG 237
Query: 345 AIMYEML-VGYPPFY 358
+M+E++ G P++
Sbjct: 238 IVMWEVMTYGERPYW 252
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 6e-13
Identities = 37/151 (24%), Positives = 74/151 (49%), Gaps = 12/151 (7%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +LL IGKG FG+V G+ A+K +K + AE +++ ++
Sbjct: 21 KELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRH 73
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIES 231
+ +V+L ++ LY++ EY+ G ++ L + L D + + A+E
Sbjct: 74 SNLVQLLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ ++++HRD+ N+L+ + ++SDFGL
Sbjct: 133 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 163
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 37/151 (24%), Positives = 74/151 (49%), Gaps = 12/151 (7%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +LL IGKG FG+V G+ A+K +K + AE +++ ++
Sbjct: 193 KELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRH 245
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIES 231
+ +V+L ++ LY++ EY+ G ++ L + L D + + A+E
Sbjct: 246 SNLVQLLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 304
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ ++++HRD+ N+L+ + ++SDFGL
Sbjct: 305 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 335
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 32/160 (20%), Positives = 63/160 (39%), Gaps = 14/160 (8%)
Query: 116 DDFELLTMIGKGAFGEV-----RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
+ L ++G G FG V E V +K ++ + + V +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPV-CIKVIEDKSGRQ--SFQAVTDHMLAI 69
Query: 171 AEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVL 227
+D IV+L C L L+ +YLP G ++ + + L + +
Sbjct: 70 GSLDHAHIVRLLGLCP---GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAK 126
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ + +H +HR++ N+LL ++++DFG+ L
Sbjct: 127 GMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 28/165 (16%), Positives = 62/165 (37%), Gaps = 23/165 (13%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVY-------AMKKLKKSEMLRRGQVEHVRAERN 168
+D +G+G F ++ + G +K L K+ E +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS---ESFFEAAS 64
Query: 169 LLAEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAET 225
+++++ +V Y C + L+ E++ G + T L + K+ + +
Sbjct: 65 MMSKLSHKHLVLNYGVCV--CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQL 122
Query: 226 VLAIESIHKHHYIHRDIKPDNLLLDKYGHLR--------LSDFGL 262
A+ + ++ IH ++ N+LL + + LSD G+
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI 167
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 5e-12
Identities = 39/149 (26%), Positives = 73/149 (48%), Gaps = 10/149 (6%)
Query: 124 IGKGAFGEVR--VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKL 181
+G G FG VR V R + A+K LK+ E + E ++ ++D+ IV+L
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMREAQIMHQLDNPYIVRL 401
Query: 182 Y--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVLAIESIHKHHYI 238
C E L L+ME GG + L+ +++ + + + + ++ + + +++
Sbjct: 402 IGVCQ---AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458
Query: 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
HR++ N+LL + ++SDFGL K L
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALG 487
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 6e-12
Identities = 39/164 (23%), Positives = 65/164 (39%), Gaps = 20/164 (12%)
Query: 116 DDFELLTMIGKGAFGEVR----VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
F L M+GKG FG VR + + V A+K LK + +E E +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKV-AVKMLKADIIASS-DIEEFLREAACMK 80
Query: 172 EVDSNCIVKLY-CSFQDD-----EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAET 225
E D + KL S + +I+ ++ GD+ L + E+ +
Sbjct: 81 EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL-LASRIGENPFNLPLQTL 139
Query: 226 VLAIESIHK-------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
V + I ++IHRD+ N +L + + ++DFGL
Sbjct: 140 VRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGL 183
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 8e-12
Identities = 31/150 (20%), Positives = 69/150 (46%), Gaps = 9/150 (6%)
Query: 119 ELLTMIGKGAFGEVR----VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
+IGKG FG V + + + A+K L + ++ QVE E L+ ++
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQC-AIKSLSRITEMQ--QVEAFLREGLLMRGLN 80
Query: 175 SNCIVKLY-CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVLAIESI 232
++ L + ++++ Y+ GD++ + + T + + + +E +
Sbjct: 81 HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ ++HRD+ N +LD+ ++++DFGL
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGL 170
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 66.0 bits (160), Expect = 8e-12
Identities = 48/341 (14%), Positives = 103/341 (30%), Gaps = 93/341 (27%)
Query: 5 RSWLQKLQPRDK-----MRGSGK--------------KKEAGG----NGSNEESTDE--E 39
R L +L+P + GSGK K N N S + E
Sbjct: 141 RQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLE 200
Query: 40 ALSNVTKQKVAAAKQYIENHY---------KEQMKNLQERRERRN---IL----EKKLAD 83
L + Q ++ + +++ L + + N +L K +
Sbjct: 201 MLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWN 260
Query: 84 A-D------VSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVC- 135
A + ++ + + FL T ++ L H M E+ +++ K + + R
Sbjct: 261 AFNLSCKILLTTRFK-QVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLK--YLDCRPQD 317
Query: 136 --REKTTGHVYAMK---KLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKL--------Y 182
RE T + + + + + +HV ++ L + + + L +
Sbjct: 318 LPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDK--LTTIIESSLNVLEPAEYRKMF 375
Query: 183 --CS-FQDD--------EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIES 231
S F ++ + ++ L + + + + S
Sbjct: 376 DRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI--------S 427
Query: 232 IHKHHYIHRDIKPDNL------LLDKYGHLRLSDFGLCKPL 266
I Y+ +K +N ++D Y + D P
Sbjct: 428 IP-SIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPP 467
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 8e-12
Identities = 39/171 (22%), Positives = 72/171 (42%), Gaps = 27/171 (15%)
Query: 116 DDFELLTMIGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
D +L +G+GAFG+V + + T V A+K LK+ + + +E +
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTV-AVKMLKEGATHS--EHRALMSELKI 83
Query: 170 LAEVDSNC-IVKLY-CSFQDDEFLYLIMEYLPGGDMMTLLM--RKDTLTEDEARFYVAET 225
L + + +V L + L +I+E+ G++ T L R + + A + +
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 226 VLAIESIHK--------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
L +E + IHRD+ N+LL + +++ DFGL
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 194
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 9e-12
Identities = 27/150 (18%), Positives = 63/150 (42%), Gaps = 9/150 (6%)
Query: 119 ELLTMIGKGAFGEVR----VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
+IG+G FG V + + H A+K L + + +V E ++ +
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHC-AVKSLNRITDIG--EVSQFLTEGIIMKDFS 84
Query: 175 SNCIVKLY-CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVLAIESI 232
++ L + + +++ Y+ GD+ + T + + + ++ +
Sbjct: 85 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 144
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
++HRD+ N +LD+ ++++DFGL
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGL 174
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 1e-11
Identities = 55/251 (21%), Positives = 95/251 (37%), Gaps = 60/251 (23%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEH-VRAERNLLAEVDSNCIVKL 181
+G+G FG V + A+KKL + +++ E ++A+ +V+L
Sbjct: 38 KMGEGGFG--VVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 182 Y-CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTED-EARFYVAE-TVLAIESIHKHHY 237
S D+ L+ Y+P G ++ L T R +A+ I +H++H+
Sbjct: 96 LGFSSDGDDLC-LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH 154
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRDIK N+LLD+ ++SDFGL + +
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARASE------------------------------ 184
Query: 298 TQQEQLQHWQKNRRMLAYST--VGTPDYIAPE----VLLKKGYGMECDWWSLGAIMYEML 351
+ ++ VGT Y+APE + K D +S G ++ E++
Sbjct: 185 --KFAQTV---------MTSRIVGTTAYMAPEALRGEITPK-----SDIYSFGVVLLEII 228
Query: 352 VGYPPFYSDDP 362
G P
Sbjct: 229 TGLPAVDEHRE 239
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 41/171 (23%), Positives = 73/171 (42%), Gaps = 30/171 (17%)
Query: 116 DDFELLTMIGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
++ + +G GAFG+V + +E V A+K LK + + E + +E +
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKV-AVKMLKSTAHAD--EKEALMSELKI 102
Query: 170 LAEVDS--NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAET 225
++ + N IV L C+ + +I EY GD++ L RK + E + F +A +
Sbjct: 103 MSHLGQHEN-IVNLLGACT--HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANS 159
Query: 226 VLAIESIHK--------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ + + IHRD+ N+LL ++ DFGL
Sbjct: 160 TASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL 210
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 40/149 (26%), Positives = 73/149 (48%), Gaps = 10/149 (6%)
Query: 124 IGKGAFGEVR--VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKL 181
+G G FG VR V R + A+K LK+ E + E ++ ++D+ IV+L
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMREAQIMHQLDNPYIVRL 75
Query: 182 Y--CSFQDDEFLYLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHKHHYI 238
C E L L+ME GG + L+ +++ + + + + ++ + + +++
Sbjct: 76 IGVCQ---AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132
Query: 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
HRD+ N+LL + ++SDFGL K L
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALG 161
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 29/165 (17%), Positives = 71/165 (43%), Gaps = 23/165 (13%)
Query: 116 DDFELLTMIGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
+ + +G+G+FG V V +++ V A+K + ++ +R + E ++
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMR--ERIEFLNEASV 81
Query: 170 LAEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLM--RKDTLTEDEARFYVAET 225
+ E + + +V+L S + +IME + GD+ + L R
Sbjct: 82 MKEFNCHHVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 226 VLAI--------ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
++ + ++ + ++HRD+ N ++ + +++ DFG+
Sbjct: 140 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 184
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 27/150 (18%), Positives = 63/150 (42%), Gaps = 9/150 (6%)
Query: 119 ELLTMIGKGAFGEVR----VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
+IG+G FG V + + H A+K L + + +V E ++ +
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHC-AVKSLNRITDIG--EVSQFLTEGIIMKDFS 148
Query: 175 SNCIVKLY-CSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIESI 232
++ L + + +++ Y+ GD+ + T + + + ++ +
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 208
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
++HRD+ N +LD+ ++++DFGL
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGL 238
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 5e-11
Identities = 31/163 (19%), Positives = 63/163 (38%), Gaps = 19/163 (11%)
Query: 116 DDFELLTMIGKGAFGEVR----VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
+ L ++G+G FG V + T+ V A+K +K +R E + E +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKV-AVKTMKLDNSSQREIEEFLS-EAACMK 91
Query: 172 EVDSNCIVKLY-CSFQDD----EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV 226
+ +++L + +I+ ++ GD+ T L L + +
Sbjct: 92 DFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL-LYSRLETGPKHIPLQTLL 150
Query: 227 LAIESIHK-------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ I +++HRD+ N +L + ++DFGL
Sbjct: 151 KFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGL 193
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 6e-11
Identities = 39/173 (22%), Positives = 69/173 (39%), Gaps = 30/173 (17%)
Query: 116 DDFELLTMIGKGAFGEV--------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER 167
D L +G+GAFG+V + K V A+K LK + + + +E
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTV-AVKMLKDDATEK--DLSDLVSEM 91
Query: 168 NLLAEVDSNC-IVKLY-CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVA 223
++ + + I+ L QD LY+I+EY G++ L R + V
Sbjct: 92 EMMKMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 224 ETVLAIESIHK--------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
E + + + IHRD+ N+L+ + ++++DFGL
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL 203
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 6e-11
Identities = 36/165 (21%), Positives = 69/165 (41%), Gaps = 23/165 (13%)
Query: 116 DDFELLTMIGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
+ L+ +G GAFGEV + + + V A+K L + + E +
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQV-AVKTLPEVCSEQ--DELDFLMEALI 86
Query: 170 LAEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV- 226
+++ + IV+ +++ME + GGD+ + L + + + +
Sbjct: 87 ISKFNHQNIVRCIGVSL--QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 227 LAI------ESIHKHHYIHRDIKPDNLLLDKYGHLRL---SDFGL 262
+A + + ++H+IHRDI N LL G R+ DFG+
Sbjct: 145 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 189
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 9e-11
Identities = 35/165 (21%), Positives = 65/165 (39%), Gaps = 23/165 (13%)
Query: 116 DDFELLTMIGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
+ L+ +G GAFGEV + + + V A+K L + + E +
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQV-AVKTLPEVCSEQ--DELDFLMEALI 127
Query: 170 LAEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
+++ + IV+ ++++E + GGD+ + L + + + +
Sbjct: 128 ISKFNHQNIVRCIGVSL--QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185
Query: 228 AIESIHK-------HHYIHRDIKPDNLLLDKYGHLRL---SDFGL 262
I +H+IHRDI N LL G R+ DFG+
Sbjct: 186 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 230
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 38/173 (21%), Positives = 68/173 (39%), Gaps = 30/173 (17%)
Query: 116 DDFELLTMIGKGAFGEV--------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER 167
D L +G+G FG+V + K V A+K LK + + + +E
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTV-AVKMLKDDATEK--DLSDLVSEM 137
Query: 168 NLLAEVDSNC-IVKLY-CSFQDDEFLYLIMEYLPGGDMMTLLM--RKDTLTEDEARFYVA 223
++ + + I+ L QD LY+I+EY G++ L R + V
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196
Query: 224 ETVLAIESIHK--------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
E + + + IHRD+ N+L+ + ++++DFGL
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL 249
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 40/168 (23%), Positives = 66/168 (39%), Gaps = 38/168 (22%)
Query: 116 DDFELLTMIGKGAFGEVRVCREK-TTGHVYAMKKLKKS------------EMLRRGQVEH 162
++F+ +IG G FG +V + G A+K+ E L H
Sbjct: 39 NNFDHKFLIGHGVFG--KVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETL--SFCRH 94
Query: 163 VRAERNLLAEVDSNCIVKL--YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTED---E 217
+L V L +C + + LI +Y+ G++ L D T E
Sbjct: 95 ----PHL---------VSLIGFC--DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWE 139
Query: 218 ARFYVA-ETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
R + + +H IHRD+K N+LLD+ +++DFG+ K
Sbjct: 140 QRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 2e-10
Identities = 41/175 (23%), Positives = 70/175 (40%), Gaps = 34/175 (19%)
Query: 116 DDFELLTMIGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
+ +G GAFG+V + + V A+K LK S L + E + +E +
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTV-AVKMLKPSAHLT--EREALMSELKV 79
Query: 170 LAEVDS--NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVA 223
L+ + + N IV L C+ +I EY GD++ L R + + +
Sbjct: 80 LSYLGNHMN-IVNLLGACT--IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 224 ETVLAIES----------------IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ LA++ + + IHRD+ N+LL ++ DFGL
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGL 191
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 2e-10
Identities = 42/171 (24%), Positives = 70/171 (40%), Gaps = 30/171 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCR------EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
D L +G+GAFG+V + K V A+K LK + R + + E L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLV-AVKALKDPTLAAR---KDFQREAEL 70
Query: 170 LAEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLM--RKDTLTEDEARFYVAET 225
L + IVK Y C D + L ++ EY+ GD+ L D + + + A+
Sbjct: 71 LTNLQHEHIVKFYGVCG--DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128
Query: 226 VLAIESIHK--------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
L + + H++HRD+ N L+ +++ DFG+
Sbjct: 129 ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGM 179
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 2e-10
Identities = 35/171 (20%), Positives = 59/171 (34%), Gaps = 29/171 (16%)
Query: 116 DDFELLTMIGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
+ +G+ FG+V + T V A+K LK E R E L
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAV-AIKTLKDKAEGP--LREEFRHEAML 65
Query: 170 LAEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAET 225
A + +V L + D+ L +I Y GD+ L + ++
Sbjct: 66 RARLQHPNVVCLLGVVT--KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 226 VLAIESIHK--------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
L HH +H+D+ N+L+ ++++SD GL
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGL 174
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 38/175 (21%), Positives = 73/175 (41%), Gaps = 29/175 (16%)
Query: 116 DDFELLTMIGKGAFGEV---RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE 172
+D + +IG+G FG+V R+ ++ A+K++K+ E +L +
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDA-AIKRMKEYASKD--DHRDFAGELEVLCK 81
Query: 173 VDS--NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETV 226
+ N I+ L C +LYL +EY P G+++ L R A +
Sbjct: 82 LGHHPN-IINLLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 227 LAIESIHK--------------HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
L+ + + +IHRD+ N+L+ + +++DFGL + +
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE 193
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 37/178 (20%), Positives = 70/178 (39%), Gaps = 35/178 (19%)
Query: 116 DDFELLTMIGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
+ L +G+G FG+V + V A+K LK++ ++ + +E N+
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTV-AVKMLKENASPS--ELRDLLSEFNV 79
Query: 170 LAEVDSNCIVKLY-CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
L +V+ ++KLY QD L LI+EY G + L + + +
Sbjct: 80 LKQVNHPHVIKLYGACSQDGP-LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 229 IESIHK------------------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
++ + +HRD+ N+L+ + +++SDFGL
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGL 196
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 6e-10
Identities = 39/170 (22%), Positives = 69/170 (40%), Gaps = 29/170 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCR------EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
D L +G+GAFG+V + E+ V A+K LK++ R + + E L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLV-AVKALKEASESAR---QDFQREAEL 96
Query: 170 LAEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETV 226
L + IV+ + C+ + L ++ EY+ GD+ L VA
Sbjct: 97 LTMLQHQHIVRFFGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154
Query: 227 LAIESIHK--------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
L + + H++HRD+ N L+ + +++ DFG+
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGM 204
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 39/178 (21%), Positives = 70/178 (39%), Gaps = 35/178 (19%)
Query: 116 DDFELLTMIGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
++ E ++G GAFG+V + + + V A+K LK+ + E + +E +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQV-AVKMLKEKADSS--EREALMSELKM 101
Query: 170 LAEVDSNC-IVKLY-CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
+ ++ S+ IV L +YLI EY GD++ L K ++ Y + L
Sbjct: 102 MTQLGSHENIVNLLGACTLSGP-IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 228 AIESIHK-----------------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
E +HRD+ N+L+ +++ DFGL
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 218
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 40/175 (22%), Positives = 70/175 (40%), Gaps = 34/175 (19%)
Query: 116 DDFELLTMIGKGAFGEV--------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER 167
D L +G+GAFG+V + V A+K LK + + + +E
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKV-AVKMLKSDATEK--DLSDLISEM 125
Query: 168 NLLAEVDS--NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLM--RKDTLTEDEARFY 221
++ + N I+ L C+ D LY+I+EY G++ L R L +
Sbjct: 126 EMMKMIGKHKN-IINLLGACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 182
Query: 222 VAETVLAIESIHK--------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
E L+ + + IHRD+ N+L+ + ++++DFGL
Sbjct: 183 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL 237
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 42/179 (23%), Positives = 68/179 (37%), Gaps = 37/179 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCR------EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
++ E + IG+GAFG V R + V A+K LK+ + E L
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMV-AVKMLKEEASAD--MQADFQREAAL 103
Query: 170 LAEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
+AE D+ IVKL C+ + + L+ EY+ GD+ L T T
Sbjct: 104 MAEFDNPNIVKLLGVCA--VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 161
Query: 228 AIESIHK------------------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ S ++HRD+ N L+ + ++++DFGL
Sbjct: 162 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 220
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 5e-09
Identities = 32/200 (16%), Positives = 61/200 (30%), Gaps = 48/200 (24%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKL-----KKSEMLRRGQVEHVRAERNLL 170
+ + IG+G FGEV + A+K + + E + E +
Sbjct: 20 EKLQRCEKIGEGVFGEV--FQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 171 AEVD-----------------SNCIVKLYC----------------------SFQDDEFL 191
E+ S V+ F D+ L
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLD 250
++++E+ GG + MR + A+ + + ++ + HRD+ N+LL
Sbjct: 138 FIVLEFEFGGIDL-EQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196
Query: 251 KYGHLRLSDFGLCKPLDCST 270
K +L K +
Sbjct: 197 KTSLKKLHYTLNGKSSTIPS 216
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 4e-08
Identities = 45/177 (25%), Positives = 72/177 (40%), Gaps = 46/177 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKS-------------EMLRRGQ 159
D+F ++G+G FG+V K G + A+K+LK+ EM+
Sbjct: 30 DNFSNKNILGRGGFGKVY----KGRLADGTLVAVKRLKEERTQGGELQFQTEVEMI--SM 83
Query: 160 VEHVRAERNLLAEVDSNCIVKL--YCSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTE 215
H RNL ++L +C L+ Y+ G + + L +
Sbjct: 84 AVH----RNL---------LRLRGFCM--TPTERLLVYPYMANGSVASCLRERPESQPPL 128
Query: 216 D-EARFYVAE-TVLAIESIHKH---HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
D R +A + + +H H IHRD+K N+LLD+ + DFGL K +D
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 33/173 (19%), Positives = 59/173 (34%), Gaps = 13/173 (7%)
Query: 116 DDFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
D +L +G+GAFG+V + T A+K LK+ + + +E +L
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 79
Query: 171 AEVDS--NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
+ N + L + L +I+E+ G++ T L K Y +
Sbjct: 80 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP----YKTKGARF 135
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ I D+K + S F K L +E + +
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKD 188
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 38/150 (25%), Positives = 60/150 (40%), Gaps = 23/150 (15%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKK-LKKS-------EMLRRGQVEHVRAERNLLAEVD 174
+IGKGA E + R+ +K+ +KK E +R+ E LA V
Sbjct: 343 LIGKGA--EADIKRDSYLDFDVIIKERVKKGYRDERLDENIRK---SRTAREARYLALVK 397
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
I Y D + ++M Y+ G KD + ++ Y ++ +HK
Sbjct: 398 DFGIPAPYIFDVDLDNKRIMMSYINGKLA------KDVIEDNLDIAYKIGEIVG--KLHK 449
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
+ IH D+ N + D L + DFGL K
Sbjct: 450 NDVIHNDLTTSNFIFD--KDLYIIDFGLGK 477
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 373 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.97 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.95 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.8 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.5 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.36 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.29 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.27 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.0 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.83 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.79 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.63 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.57 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.56 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.39 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.33 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.16 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.92 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.85 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.69 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.65 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.6 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.57 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.57 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.54 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.35 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.24 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.0 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.9 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.51 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.35 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.66 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 88.69 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 86.21 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.01 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-61 Score=448.64 Aligned_cols=221 Identities=36% Similarity=0.648 Sum_probs=204.4
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 192 (373)
...++|++++.||+|+||+||+|.++.+|+.||||++.+.........+.+.+|+.+|+.++|||||+++++|.+++.+|
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 34578999999999999999999999999999999999877766777788999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcc
Q 017362 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 272 (373)
||||||+||+|.+++.+.+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+......
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 99999999999999998899999999999999999999999999999999999999999999999999999876432111
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 352 (373)
....+.+|||.|||||++.+..|+.++|||||||++|||++
T Consensus 189 ---------------------------------------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~ 229 (311)
T 4aw0_A 189 ---------------------------------------ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 229 (311)
T ss_dssp ---------------------------------------CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHH
T ss_pred ---------------------------------------ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHh
Confidence 11236799999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcC
Q 017362 353 GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 353 G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|++||.+.+..+++.+|+++
T Consensus 230 G~~PF~~~~~~~~~~~i~~~ 249 (311)
T 4aw0_A 230 GLPPFRAGNEGLIFAKIIKL 249 (311)
T ss_dssp SSCSSCCSSHHHHHHHHHHT
T ss_pred CCCCCCCCCHHHHHHHHHcC
Confidence 99999999999999999876
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-58 Score=438.15 Aligned_cols=216 Identities=30% Similarity=0.556 Sum_probs=189.8
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|++++.||+|+||+||+|.++.+|+.||||++.+... .....+.+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 4789999999999999999999999999999999986543 234467789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcc
Q 017362 195 MEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 272 (373)
||||+||+|.+++... ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+....
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-- 179 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-- 179 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH--
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc--
Confidence 9999999999999654 357999999999999999999999999999999999999999999999999998653210
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 352 (373)
....+.+|||.|||||++.+..|+.++||||||||||||++
T Consensus 180 ---------------------------------------~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemlt 220 (350)
T 4b9d_A 180 ---------------------------------------ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCT 220 (350)
T ss_dssp ---------------------------------------HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred ---------------------------------------ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHH
Confidence 01125689999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcC
Q 017362 353 GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 353 G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|++||.+.+..+++.+|+++
T Consensus 221 G~~PF~~~~~~~~~~~i~~~ 240 (350)
T 4b9d_A 221 LKHAFEAGSMKNLVLKIISG 240 (350)
T ss_dssp SSCSCCCSSHHHHHHHHHHT
T ss_pred CCCCCCCcCHHHHHHHHHcC
Confidence 99999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-58 Score=421.89 Aligned_cols=215 Identities=30% Similarity=0.596 Sum_probs=181.5
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|++++.||+|+||+||+|.++.+|+.||||++.+...........+.+|+.+|+.++|||||+++++|.+++.+|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 36899999999999999999999999999999999876655555567899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
|||+ +|+|.+++.+.+.+++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+......
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---- 166 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---- 166 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC----
Confidence 9999 78999999999999999999999999999999999999999999999999999999999999997643221
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCC-ChhhcHHHHHHHHHHHHhC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G 353 (373)
...+.+|||.|||||++.+..| +.++|||||||++|||++|
T Consensus 167 --------------------------------------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg 208 (275)
T 3hyh_A 167 --------------------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCR 208 (275)
T ss_dssp ----------------------------------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHS
T ss_pred --------------------------------------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHC
Confidence 0125689999999999998886 5899999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcC
Q 017362 354 YPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 354 ~~Pf~~~~~~~~~~kI~~~ 372 (373)
++||.+.+..+++++|.++
T Consensus 209 ~~PF~~~~~~~~~~~i~~~ 227 (275)
T 3hyh_A 209 RLPFDDESIPVLFKNISNG 227 (275)
T ss_dssp SCSSCCSSHHHHHHHHHHT
T ss_pred CCCCCCCCHHHHHHHHHcC
Confidence 9999999999999998865
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-58 Score=434.44 Aligned_cols=212 Identities=29% Similarity=0.578 Sum_probs=192.6
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
..|+++++||+|+||+||+|.++.+|+.||||++..... ...+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 569999999999999999999999999999999976542 23455788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
|||+||+|.+++.+ ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.....
T Consensus 151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~---- 225 (346)
T 4fih_A 151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP---- 225 (346)
T ss_dssp CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC----
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC----
Confidence 99999999998865 5799999999999999999999999999999999999999999999999999987643211
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 355 (373)
...+.+|||.|||||++.+..|+.++||||||||+|||++|++
T Consensus 226 -------------------------------------~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~ 268 (346)
T 4fih_A 226 -------------------------------------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 268 (346)
T ss_dssp -------------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred -------------------------------------cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 1226799999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcC
Q 017362 356 PFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 356 Pf~~~~~~~~~~kI~~~ 372 (373)
||.+.++.+++.+|.++
T Consensus 269 PF~~~~~~~~~~~i~~~ 285 (346)
T 4fih_A 269 PYFNEPPLKAMKMIRDN 285 (346)
T ss_dssp TTTTSCHHHHHHHHHHS
T ss_pred CCCCcCHHHHHHHHHcC
Confidence 99999999999888753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-58 Score=431.46 Aligned_cols=219 Identities=42% Similarity=0.732 Sum_probs=189.6
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEc---CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 188 (373)
+...++|++++.||+|+||+||+|++. .+++.||||++.+...... ....+.+|+.+|+.++|||||+++++|.++
T Consensus 20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 98 (304)
T 3ubd_A 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTE 98 (304)
T ss_dssp CCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEET
T ss_pred cCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEEC
Confidence 445678999999999999999999874 4678999999976543222 234578899999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
+.+|+|||||+||+|.+++.+.+.+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+....
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 99999999999999999999989999999999999999999999999999999999999999999999999999985432
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 348 (373)
.. ....+.+|||.|||||++.+..|+.++|||||||+||
T Consensus 179 ~~-----------------------------------------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvily 217 (304)
T 3ubd_A 179 HE-----------------------------------------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMF 217 (304)
T ss_dssp -------------------------------------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHH
T ss_pred CC-----------------------------------------ccccccccCcccCCHHHhccCCCCCCCcccchHHHHH
Confidence 21 0122678999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhcC
Q 017362 349 EMLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 349 ell~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
||++|++||.+.+..+++.+|+++
T Consensus 218 emltG~~PF~~~~~~~~~~~i~~~ 241 (304)
T 3ubd_A 218 EMLTGTLPFQGKDRKETMTMILKA 241 (304)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred HHHhCCCCCCCcCHHHHHHHHHcC
Confidence 999999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-58 Score=430.32 Aligned_cols=215 Identities=29% Similarity=0.449 Sum_probs=189.1
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEE
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 193 (373)
..+.|++.++||+|+||+||+|.++.+|+.||||+++.... ..+|+.+++.++|||||+++++|.+++.+||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 35678999999999999999999999999999999976432 2469999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC-cEEEeeccccccCCCCCcc
Q 017362 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 194 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~-~vkL~DFGla~~~~~~~~~ 272 (373)
|||||+||+|.+++.+.+.+++..++.|+.||+.||.|||++|||||||||+||||+.+| ++||+|||+|+.+......
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999999999999888999999999999999999999999999999999999999988 6999999999876533211
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 352 (373)
.. .......+|||.|||||++.+..|+.++|||||||+||||++
T Consensus 208 ~~------------------------------------~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemlt 251 (336)
T 4g3f_A 208 KS------------------------------------LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN 251 (336)
T ss_dssp ------------------------------------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred cc------------------------------------eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHH
Confidence 00 001124689999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcC
Q 017362 353 GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 353 G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|++||.+.+..+++.+|.++
T Consensus 252 G~~Pf~~~~~~~~~~~i~~~ 271 (336)
T 4g3f_A 252 GCHPWTQYFRGPLCLKIASE 271 (336)
T ss_dssp SSCSSTTTCCSCCHHHHHHS
T ss_pred CcCCCCCCCHHHHHHHHHcC
Confidence 99999999988888888764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-57 Score=436.27 Aligned_cols=213 Identities=29% Similarity=0.578 Sum_probs=192.9
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
...|+++++||+|+||+||+|.++.+|+.||||++.... ....+.+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT---CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 357999999999999999999999999999999997653 23345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
||||+||+|.+++.. ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.....
T Consensus 227 mEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--- 302 (423)
T 4fie_A 227 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--- 302 (423)
T ss_dssp EECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC---
T ss_pred EeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc---
Confidence 999999999998854 5699999999999999999999999999999999999999999999999999987643211
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 354 (373)
...+.+||+.|||||++.+..|+.++||||||||+|||++|+
T Consensus 303 --------------------------------------~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~ 344 (423)
T 4fie_A 303 --------------------------------------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 344 (423)
T ss_dssp --------------------------------------CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred --------------------------------------cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 122679999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcC
Q 017362 355 PPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 355 ~Pf~~~~~~~~~~kI~~~ 372 (373)
+||.+.++.+.+..|.+.
T Consensus 345 ~PF~~~~~~~~~~~i~~~ 362 (423)
T 4fie_A 345 PPYFNEPPLKAMKMIRDN 362 (423)
T ss_dssp CTTTTSCHHHHHHHHHHS
T ss_pred CCCCCcCHHHHHHHHHcC
Confidence 999999999999888753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-55 Score=406.98 Aligned_cols=212 Identities=24% Similarity=0.430 Sum_probs=184.2
Q ss_pred CCc-ceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe----CCe
Q 017362 116 DDF-ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD----DEF 190 (373)
Q Consensus 116 ~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~----~~~ 190 (373)
.+| ++.++||+|+||+||+|.++.++..||+|++..... .....+.+.+|+.+|+.++|||||+++++|.+ .+.
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 455 677889999999999999999999999999976543 23445779999999999999999999999975 356
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeeecCCCCCEEEcC-CCcEEEeeccccccCC
Q 017362 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH--YIHRDIKPDNLLLDK-YGHLRLSDFGLCKPLD 267 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiHrDikp~NILl~~-~~~vkL~DFGla~~~~ 267 (373)
+|||||||+||+|.+++.+...+++..++.|+.||+.||.|||++| ||||||||+||||+. +|++||+|||+|+...
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 8999999999999999998889999999999999999999999998 999999999999984 7999999999997543
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 347 (373)
... ..+.+|||.|||||++.+ .|+.++|||||||+|
T Consensus 184 ~~~-------------------------------------------~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvil 219 (290)
T 3fpq_A 184 ASF-------------------------------------------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCM 219 (290)
T ss_dssp TTS-------------------------------------------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHH
T ss_pred CCc-------------------------------------------cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHH
Confidence 211 225789999999998864 699999999999999
Q ss_pred HHHHhCCCCCCCC-ChHHHHHHhhcC
Q 017362 348 YEMLVGYPPFYSD-DPMSTCRKVRKK 372 (373)
Q Consensus 348 ~ell~G~~Pf~~~-~~~~~~~kI~~~ 372 (373)
|||++|++||.+. +....+.+|.++
T Consensus 220 yelltg~~Pf~~~~~~~~~~~~i~~~ 245 (290)
T 3fpq_A 220 LEMATSEYPYSECQNAAQIYRRVTSG 245 (290)
T ss_dssp HHHHHSSCTTTTCSSHHHHHHHHTTT
T ss_pred HHHHHCCCCCCCCCcHHHHHHHHHcC
Confidence 9999999999865 455666666553
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=410.96 Aligned_cols=219 Identities=22% Similarity=0.426 Sum_probs=190.5
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEc-----CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 186 (373)
.+..++|.+.+.||+|+||+||+|.+. .++..||||+++... ....+.+.+|+.+|+.++|||||+++++|.
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 456688999999999999999999865 357889999997542 334567899999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHhhC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC
Q 017362 187 DDEFLYLIMEYLPGGDMMTLLMRK-------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG 253 (373)
Q Consensus 187 ~~~~~~lV~E~~~gg~L~~~l~~~-------------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~ 253 (373)
+++.+|||||||+||+|.++|... ..+++..+..++.|++.||.|||+++||||||||+|||++.++
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 999999999999999999999753 3699999999999999999999999999999999999999999
Q ss_pred cEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC
Q 017362 254 HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG 333 (373)
Q Consensus 254 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~ 333 (373)
++||+|||+|+........ ......+||+.|||||++.+..
T Consensus 166 ~~Ki~DFGla~~~~~~~~~---------------------------------------~~~~~~~gt~~ymAPE~~~~~~ 206 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYY---------------------------------------RVGGHTMLPIRWMPPESIMYRK 206 (299)
T ss_dssp CEEECCCSCHHHHTGGGCE---------------------------------------EETTTEEECGGGCCHHHHHHCC
T ss_pred cEEECCcccceecCCCCce---------------------------------------eecCceecChhhcCHHHHcCCC
Confidence 9999999999865422111 0112457999999999999999
Q ss_pred CChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 334 YGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 334 ~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|+.++|||||||+||||+| |++||.+.++.+...+|.++
T Consensus 207 ~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~ 246 (299)
T 4asz_A 207 FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 246 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT
T ss_pred CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999999999999998 99999999999999998775
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-55 Score=439.33 Aligned_cols=218 Identities=35% Similarity=0.624 Sum_probs=192.2
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHH---HHHHHhcCCCceeEEeeEEEe
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAE---RNLLAEVDSNCIVKLYCSFQD 187 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e---~~~l~~l~h~~iv~l~~~~~~ 187 (373)
..+..++|++++.||+|+||+||+|.++.+|+.||||++.+..+........+.+| +.+++.++|||||+++++|++
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 36778999999999999999999999999999999999988776655555555555 455567789999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 188 DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 188 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
.+.+|||||||+||+|.++|.+.+.|++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 99999999999999999999998999999999999999999999999999999999999999999999999999998654
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAI 346 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvi 346 (373)
... ..+.+|||.|||||++.+ ..|+.++||||||||
T Consensus 344 ~~~-------------------------------------------~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvi 380 (689)
T 3v5w_A 344 KKK-------------------------------------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCM 380 (689)
T ss_dssp SCC-------------------------------------------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHH
T ss_pred CCC-------------------------------------------CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHH
Confidence 221 126799999999999975 579999999999999
Q ss_pred HHHHHhCCCCCCCCC---hHHHHHHhhc
Q 017362 347 MYEMLVGYPPFYSDD---PMSTCRKVRK 371 (373)
Q Consensus 347 l~ell~G~~Pf~~~~---~~~~~~kI~~ 371 (373)
||||++|++||.+.+ ..++...|+.
T Consensus 381 lYEmLtG~~PF~~~~~~~~~~i~~~i~~ 408 (689)
T 3v5w_A 381 LFKLLRGHSPFRQHKTKDKHEIDRMTLT 408 (689)
T ss_dssp HHHHHHSSCTTCGGGCCCHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHhhcC
Confidence 999999999998643 4455666654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-54 Score=407.18 Aligned_cols=219 Identities=21% Similarity=0.401 Sum_probs=185.6
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEc-----CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 186 (373)
.+..++|.+.++||+|+||+||+|.++ .++..||||+++... ....+.|.+|+.+|+.++|||||+++++|.
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 113 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQHQHIVRFFGVCT 113 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 455678999999999999999999864 367899999997542 334567999999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC
Q 017362 187 DDEFLYLIMEYLPGGDMMTLLMRK---------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK 251 (373)
Q Consensus 187 ~~~~~~lV~E~~~gg~L~~~l~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~ 251 (373)
+.+.+|||||||+||+|.+++... .++++..+..|+.|++.||.|||+++||||||||+||||+.
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence 999999999999999999999653 35899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC
Q 017362 252 YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK 331 (373)
Q Consensus 252 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 331 (373)
++++||+|||+|+.+...... ......+||+.|||||++.+
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~---------------------------------------~~~~~~~gt~~ymAPE~~~~ 234 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYY---------------------------------------RVGGRTMLPIRWMPPESILY 234 (329)
T ss_dssp TTEEEECCCC-------------------------------------------------------CCCCGGGCCHHHHTT
T ss_pred CCcEEEcccccceeccCCCcc---------------------------------------eecCcccccccccChhhhcC
Confidence 999999999999865432111 01124689999999999999
Q ss_pred CCCChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 332 KGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 332 ~~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
..|+.++|||||||+||||+| |++||.+.+..+....|.++
T Consensus 235 ~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g 276 (329)
T 4aoj_A 235 RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276 (329)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT
T ss_pred CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 999999999999999999999 99999999999999988765
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-54 Score=403.96 Aligned_cols=220 Identities=22% Similarity=0.398 Sum_probs=191.0
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEc-----CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 186 (373)
++..++++++++||+|+||+||+|... .+++.||||+++... .....+.|.+|+.+++.++|||||++++++.
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 456678999999999999999999853 467899999997542 2334567999999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHhhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEc
Q 017362 187 DDEFLYLIMEYLPGGDMMTLLMRK----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD 250 (373)
Q Consensus 187 ~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~ 250 (373)
+++.+|||||||++|+|.++|... ..+++..+..++.||+.||.|||+++||||||||+||||+
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 999999999999999999999643 3589999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc
Q 017362 251 KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL 330 (373)
Q Consensus 251 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 330 (373)
.++++||+|||+|+........ ......+||+.|||||++.
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~---------------------------------------~~~~~~~gt~~ymAPE~l~ 220 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYY---------------------------------------KLLGNSLLPIRWMAPEAIM 220 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCB---------------------------------------CSSSSSCBCGGGCCHHHHH
T ss_pred CCCCEEECCcccceeccCCCce---------------------------------------eEecccccCCcccCHHHHh
Confidence 9999999999999865422111 0122568999999999999
Q ss_pred CCCCChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 331 KKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 331 ~~~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
++.|+.++|||||||+||||+| |.+||.+.+..+....|.++
T Consensus 221 ~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~ 263 (308)
T 4gt4_A 221 YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR 263 (308)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTT
T ss_pred CCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999999999999999998 99999999999999998876
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-54 Score=401.15 Aligned_cols=217 Identities=21% Similarity=0.304 Sum_probs=180.8
Q ss_pred hccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC
Q 017362 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 110 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 189 (373)
.+++..++|.+.++||+|+||+||+|.+. ..||||+++... ......+.|.+|+.+|+.++|||||++++++.+ +
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~ 104 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D 104 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C
Confidence 35678899999999999999999999754 359999987543 233456789999999999999999999998754 5
Q ss_pred eEEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
.+|||||||+||+|.++|... ..+++..+..|+.||+.||.|||+++||||||||+||||+.++++||+|||+|+....
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 689999999999999999754 5799999999999999999999999999999999999999999999999999986542
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC---CCCChhhcHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGA 345 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~~DvwSlGv 345 (373)
.... ....+.+||+.|||||++.+ ..|+.++|||||||
T Consensus 185 ~~~~---------------------------------------~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gv 225 (307)
T 3omv_A 185 WSGS---------------------------------------QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGI 225 (307)
T ss_dssp ------------------------------------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHH
T ss_pred CCcc---------------------------------------eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHH
Confidence 2110 01125689999999999974 45899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHhh
Q 017362 346 IMYEMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 346 il~ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
+||||+||++||.+.++......++
T Consensus 226 vl~Elltg~~Pf~~~~~~~~~~~~~ 250 (307)
T 3omv_A 226 VLYELMTGELPYSHINNRDQIIFMV 250 (307)
T ss_dssp HHHHHHHSSCTTTTCCCHHHHHHHH
T ss_pred HHHHHHHCCCCCCCCChHHHHHHHH
Confidence 9999999999999877665554443
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=411.64 Aligned_cols=218 Identities=25% Similarity=0.459 Sum_probs=189.1
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe------C
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD------D 188 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~------~ 188 (373)
.++|++++.||+|+||+||+|.++.+|+.||||++.+... .......+.+|+.+|+.++|||||++++++.. .
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 4689999999999999999999999999999999976532 23345678899999999999999999998764 3
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
+.+|||||||+ |+|.+++...+.+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+..
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred CEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 67899999995 68999998889999999999999999999999999999999999999999999999999999987643
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIM 347 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil 347 (373)
..... .....+.+||+.|||||++.+. .|+.++||||+|||+
T Consensus 211 ~~~~~-------------------------------------~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il 253 (398)
T 4b99_A 211 SPAEH-------------------------------------QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIF 253 (398)
T ss_dssp ------------------------------------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHH
T ss_pred Ccccc-------------------------------------ccccccceeChHhcCHHHhcCCCCCCChhheehhHHHH
Confidence 21110 1112367999999999998875 469999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhhc
Q 017362 348 YEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 348 ~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
|||++|++||.+.+..+...+|++
T Consensus 254 ~ell~G~~pF~g~~~~~~l~~I~~ 277 (398)
T 4b99_A 254 GEMLARRQLFPGKNYVHQLQLIMM 277 (398)
T ss_dssp HHHHHTSCSSCCSSHHHHHHHHHH
T ss_pred HHHHHCCCCCCCCCHHHHHHHHHH
Confidence 999999999999999999988864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-53 Score=395.28 Aligned_cols=211 Identities=27% Similarity=0.474 Sum_probs=165.6
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC------
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE------ 189 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~------ 189 (373)
++|++++.||+|+||+||+|.++.+|+.||||++.... .....+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 46999999999999999999999999999999987542 2334467889999999999999999999997644
Q ss_pred ------eEEEEEeccCCCCHHHHHhhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeec
Q 017362 190 ------FLYLIMEYLPGGDMMTLLMRKDT---LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDF 260 (373)
Q Consensus 190 ------~~~lV~E~~~gg~L~~~l~~~~~---l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DF 260 (373)
++|+|||||+||+|.+++..... .++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 47999999999999999987654 455678999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcH
Q 017362 261 GLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340 (373)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Dv 340 (373)
|+|+.+........... + ........+.+|||.|||||++.+..|+.++||
T Consensus 163 Gla~~~~~~~~~~~~~~-----------------~------------~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~Di 213 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLT-----------------P------------MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDI 213 (299)
T ss_dssp CCC-------------------------------------------------------CCCTTSCHHHHTTCCCCTHHHH
T ss_pred ccceecCCCcccccccc-----------------c------------cccccccCCcccCccccCHHHHcCCCCCCHHHH
Confidence 99987654321110000 0 000011235789999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCC
Q 017362 341 WSLGAIMYEMLVGYPPFYSD 360 (373)
Q Consensus 341 wSlGvil~ell~G~~Pf~~~ 360 (373)
|||||++|||++ ||.+.
T Consensus 214 wSlGvilyell~---Pf~~~ 230 (299)
T 4g31_A 214 FSLGLILFELLY---PFSTQ 230 (299)
T ss_dssp HHHHHHHHHHHS---CCSSH
T ss_pred HHHHHHHHHHcc---CCCCc
Confidence 999999999996 88654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=395.74 Aligned_cols=222 Identities=23% Similarity=0.394 Sum_probs=186.8
Q ss_pred hhccCCCCCcceeceeeeeCcEEEEEEEEcCC-----CceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCC-CceeEEe
Q 017362 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTT-----GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS-NCIVKLY 182 (373)
Q Consensus 109 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~l~ 182 (373)
.++++..++|++.+.||+|+||+||+|.+..+ ++.||||++..... ....+.+.+|+.+|..+.| ||||+++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 34577889999999999999999999987643 35799999875432 3345678899999999976 8999999
Q ss_pred eEEEeC-CeEEEEEeccCCCCHHHHHhhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCC
Q 017362 183 CSFQDD-EFLYLIMEYLPGGDMMTLLMRK----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPD 245 (373)
Q Consensus 183 ~~~~~~-~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~ 245 (373)
++|.+. +.+|||||||++|+|.++|... ..+++..+..|+.||+.||.|||+++||||||||+
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~ 214 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 214 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence 999764 5689999999999999999652 35899999999999999999999999999999999
Q ss_pred CEEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcc
Q 017362 246 NLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIA 325 (373)
Q Consensus 246 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~a 325 (373)
|||++.++++||+|||+|+.+....... ...+.+||+.|||
T Consensus 215 NILl~~~~~vKi~DFGlar~~~~~~~~~---------------------------------------~~~~~~gt~~ymA 255 (353)
T 4ase_A 215 NILLSEKNVVKICDFGLARDIYKDPDYV---------------------------------------RKGDARLPLKWMA 255 (353)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSE---------------------------------------EETTEEECGGGCC
T ss_pred ceeeCCCCCEEECcchhhhhcccCCCce---------------------------------------eeccccccccccC
Confidence 9999999999999999998764332110 1125689999999
Q ss_pred cccccCCCCChhhcHHHHHHHHHHHHh-CCCCCCCCChH-HHHHHhhc
Q 017362 326 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPM-STCRKVRK 371 (373)
Q Consensus 326 PE~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~-~~~~kI~~ 371 (373)
||++.+..|+.++|||||||+||||+| |.+||.+.+.. ..+..|.+
T Consensus 256 PE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~ 303 (353)
T 4ase_A 256 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 303 (353)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH
T ss_pred HHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHc
Confidence 999999999999999999999999998 99999987644 44444443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=393.11 Aligned_cols=235 Identities=26% Similarity=0.444 Sum_probs=180.3
Q ss_pred CCCcceeceeeeeCcEEEEEEEEc---CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCe
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~ 190 (373)
.++|++.+.||+|+||+||+|.++ .+++.||||++.+.. ....+.+|+.+|..+ .|||||+++++|.+.++
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 478999999999999999999875 457889999886542 234577899999988 69999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCC-CcEEEeeccccccCCCC
Q 017362 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY-GHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~-~~vkL~DFGla~~~~~~ 269 (373)
+|+|||||+||+|.+++ ..+++..++.|+.||+.||.|||++|||||||||+|||++.+ +++||+|||+|+.....
T Consensus 95 ~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 99999999999999998 359999999999999999999999999999999999999877 89999999999876654
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMY 348 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ 348 (373)
......+............... .....++....+.+|||.|||||++.+. .|+.++||||+|||+|
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ 238 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNKC-------------SICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFL 238 (361)
T ss_dssp SCGGGGGC---------------------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccc-------------cccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHH
Confidence 3322221111000000000000 0000112233467999999999999875 5899999999999999
Q ss_pred HHHhCCCCCCC-CChHHHHHHhh
Q 017362 349 EMLVGYPPFYS-DDPMSTCRKVR 370 (373)
Q Consensus 349 ell~G~~Pf~~-~~~~~~~~kI~ 370 (373)
||++|++||.. .+..+...+|.
T Consensus 239 ell~G~~Pf~~~~~~~~~l~~I~ 261 (361)
T 4f9c_A 239 SLLSGRYPFYKASDDLTALAQIM 261 (361)
T ss_dssp HHHHTCSSSSCCSSHHHHHHHHH
T ss_pred HHHHCCCCCCCCCCHHHHHHHHH
Confidence 99999999965 45556655554
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=416.20 Aligned_cols=213 Identities=31% Similarity=0.555 Sum_probs=193.5
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|++++.||+|+||+||+|.++.+|+.||||++..... ...+.+.+|+.+|+.++|||||+++++|.+.+.+|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 4689999999999999999999999999999999876432 2345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCC--CcEEEeeccccccCCCCCc
Q 017362 195 MEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY--GHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~--~~vkL~DFGla~~~~~~~~ 271 (373)
||||+||+|.+++.. .+.+++..++.|+.||+.||.|||++||+||||||+|||++.+ +++||+|||+|+.+.....
T Consensus 233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence 999999999999865 4579999999999999999999999999999999999999854 8999999999987653321
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
..+.+||+.|||||++.+..|+.++|||||||+||||+
T Consensus 313 ------------------------------------------~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml 350 (573)
T 3uto_A 313 ------------------------------------------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL 350 (573)
T ss_dssp ------------------------------------------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 12568999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcC
Q 017362 352 VGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+|.+||.+.+..+++.+|+++
T Consensus 351 ~G~~Pf~~~~~~~~~~~i~~~ 371 (573)
T 3uto_A 351 SGLSPFGGENDDETLRNVKSC 371 (573)
T ss_dssp HSCCSSCCSSHHHHHHHHHTT
T ss_pred HCCCCCCCcCHHHHHHHHHhC
Confidence 999999999999999999875
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=389.49 Aligned_cols=227 Identities=48% Similarity=0.922 Sum_probs=203.6
Q ss_pred HHHhhhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeE
Q 017362 105 YMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCS 184 (373)
Q Consensus 105 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~ 184 (373)
...+....+..++|++++.||+|+||+||+|.++.+++.||+|++.+...........+.+|+.++..++||||++++++
T Consensus 58 ~~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 137 (410)
T 3v8s_A 58 INKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA 137 (410)
T ss_dssp HHHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEE
T ss_pred HHHHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 34456677889999999999999999999999999999999999988766555566678899999999999999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccc
Q 017362 185 FQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (373)
Q Consensus 185 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~ 264 (373)
|.+...+|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+
T Consensus 138 ~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 138 FQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp EECSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 9999999999999999999999865 469999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC----CChhhcH
Q 017362 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG----YGMECDW 340 (373)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~~~~~Dv 340 (373)
........ ...+.+||+.|+|||++.+.. |+.++||
T Consensus 217 ~~~~~~~~----------------------------------------~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~Di 256 (410)
T 3v8s_A 217 KMNKEGMV----------------------------------------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 256 (410)
T ss_dssp ECCTTSEE----------------------------------------ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHH
T ss_pred eeccCCcc----------------------------------------cccCCcCCccccCHHHhhccCCCcCCCCcceE
Confidence 65433211 122568999999999998766 8899999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHhhcC
Q 017362 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 341 wSlGvil~ell~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|||||++|||++|++||.+.+..+++.+|+++
T Consensus 257 wSlGvilyell~G~~Pf~~~~~~~~~~~i~~~ 288 (410)
T 3v8s_A 257 WSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH 288 (410)
T ss_dssp HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred ecchHHHHHHHhCCCCCCCCChhhHHHHHHhc
Confidence 99999999999999999999999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=375.85 Aligned_cols=219 Identities=41% Similarity=0.735 Sum_probs=199.8
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 192 (373)
+..++|++++.||+|+||+||+|.++.+++.||||++.+..........++.+|+.++..++||||++++++|.+.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 45689999999999999999999999999999999998876656667788999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcc
Q 017362 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 272 (373)
+||||++||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.......
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~- 160 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA- 160 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC-
Confidence 9999999999999998888999999999999999999999999999999999999999999999999999975322110
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 352 (373)
...+.+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 161 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 200 (337)
T 1o6l_A 161 ----------------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200 (337)
T ss_dssp ----------------------------------------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhc
Confidence 0125689999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcC
Q 017362 353 GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 353 G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|.+||.+.+..+++.+|+.+
T Consensus 201 g~~Pf~~~~~~~~~~~i~~~ 220 (337)
T 1o6l_A 201 GRLPFYNQDHERLFELILME 220 (337)
T ss_dssp SSCSSCCSSHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHcC
Confidence 99999999999999888754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-50 Score=381.29 Aligned_cols=220 Identities=39% Similarity=0.769 Sum_probs=195.7
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCe
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~ 190 (373)
.+..++|++++.||+|+||+||+|.++.+++.||||++.+.........+.+..|..++..+ .||||++++++|.+.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 45678999999999999999999999999999999999887666666778889999999988 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
+|+||||++||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999997533211
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 350 (373)
. ...+.+||+.|+|||++.+..|+.++|||||||++|||
T Consensus 179 ~-----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 217 (353)
T 3txo_A 179 V-----------------------------------------TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEM 217 (353)
T ss_dssp ------------------------------------------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHH
T ss_pred c-----------------------------------------cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHH
Confidence 0 01256899999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcC
Q 017362 351 LVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 351 l~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
++|.+||.+.+..+++.+|+++
T Consensus 218 l~G~~Pf~~~~~~~~~~~i~~~ 239 (353)
T 3txo_A 218 LCGHAPFEAENEDDLFEAILND 239 (353)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHC
T ss_pred HhCCCCCCCCCHHHHHHHHHcC
Confidence 9999999999999999999865
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=387.54 Aligned_cols=228 Identities=49% Similarity=0.907 Sum_probs=204.8
Q ss_pred hHHHhhhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEee
Q 017362 104 EYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183 (373)
Q Consensus 104 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~ 183 (373)
....+.+..+..++|++++.||+|+||+||+|.++.+++.||||++.+...........+.+|+.++..++||||+++++
T Consensus 49 ~~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~ 128 (412)
T 2vd5_A 49 IVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128 (412)
T ss_dssp HHHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred hhhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence 34566777888999999999999999999999999999999999998876655666677889999999999999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccc
Q 017362 184 SFQDDEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (373)
Q Consensus 184 ~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGl 262 (373)
+|.+.+.+|+||||++||+|.+++.+. ..+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+
T Consensus 129 ~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 129 AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechh
Confidence 999999999999999999999999775 4799999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc-------CCCCC
Q 017362 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-------KKGYG 335 (373)
Q Consensus 263 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-------~~~~~ 335 (373)
|+........ .....+||+.|+|||++. ...|+
T Consensus 209 a~~~~~~~~~----------------------------------------~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~ 248 (412)
T 2vd5_A 209 CLKLRADGTV----------------------------------------RSLVAVGTPDYLSPEILQAVGGGPGTGSYG 248 (412)
T ss_dssp CEECCTTSCE----------------------------------------ECSSCCSCGGGCCHHHHHHHHTCTTCSEEC
T ss_pred heeccCCCcc----------------------------------------ccceeccccCcCCHHHHhhcccCcCCCCCC
Confidence 9865432110 012468999999999997 45789
Q ss_pred hhhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 017362 336 MECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 336 ~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
.++|||||||++|||++|++||.+.+..+++.+|++
T Consensus 249 ~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~ 284 (412)
T 2vd5_A 249 PECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH 284 (412)
T ss_dssp THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred hHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 999999999999999999999999999999999976
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=389.40 Aligned_cols=225 Identities=51% Similarity=0.903 Sum_probs=202.3
Q ss_pred HhhhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEE
Q 017362 107 RLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (373)
Q Consensus 107 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 186 (373)
.+....+..++|+++++||+|+||+||+|.++.+++.||||++.+...........+.+|+.++..++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 45566788899999999999999999999999999999999998866655555666889999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 187 DDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 187 ~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
+.+.+|+|||||+||+|.+++.. ...+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~ 224 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence 99999999999999999999987 57899999999999999999999999999999999999999999999999999976
Q ss_pred CCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc-----CCCCChhhcH
Q 017362 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDW 340 (373)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~Dv 340 (373)
....... .....+||+.|+|||++. ...|+.++||
T Consensus 225 ~~~~~~~----------------------------------------~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~Dv 264 (437)
T 4aw2_A 225 LMEDGTV----------------------------------------QSSVAVGTPDYISPEILQAMEGGKGRYGPECDW 264 (437)
T ss_dssp CCTTSCE----------------------------------------ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHH
T ss_pred cccCCCc----------------------------------------ccccccCCcCeeChHHHhhcccCCCCCCCcCee
Confidence 5432111 012468999999999997 5679999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 017362 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 341 wSlGvil~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
|||||++|||++|++||.+.+..+++.+|++
T Consensus 265 wSlGvil~elltG~~Pf~~~~~~~~~~~i~~ 295 (437)
T 4aw2_A 265 WSLGVCMYEMLYGETPFYAESLVETYGKIMN 295 (437)
T ss_dssp HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred HHHHHHHHHHHhCCCCCCCCChhHHHHhhhh
Confidence 9999999999999999999999999999975
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=377.03 Aligned_cols=199 Identities=26% Similarity=0.328 Sum_probs=162.1
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC----eE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----FL 191 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~----~~ 191 (373)
.+|.+.++||+|+||+||+|.+ +|+.||||++..... .......|+..+..++|||||++++++.+++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4688999999999999999986 588999999975431 1112334555667889999999999998654 58
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCeeecCCCCCEEEcCCCcEEEeecccc
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH--------HYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------giiHrDikp~NILl~~~~~vkL~DFGla 263 (373)
|||||||+||+|.++|.. ..++++.+..++.|++.||.|||++ +||||||||+||||+.++++||+|||+|
T Consensus 77 ~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999999999965 4699999999999999999999987 9999999999999999999999999999
Q ss_pred ccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC------CCChh
Q 017362 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK------GYGME 337 (373)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~------~~~~~ 337 (373)
+.......... ......+||+.|||||++.+. .|+.+
T Consensus 156 ~~~~~~~~~~~-------------------------------------~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k 198 (303)
T 3hmm_A 156 VRHDSATDTID-------------------------------------IAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 198 (303)
T ss_dssp EEEETTTTEES-------------------------------------CC-----CCGGGCCHHHHTTCSCTTCHHHHHH
T ss_pred ccccCCCCcee-------------------------------------eecccccccccccCHHHhcccccccCCccChh
Confidence 86543321100 001145899999999999764 47889
Q ss_pred hcHHHHHHHHHHHHhCCCCCC
Q 017362 338 CDWWSLGAIMYEMLVGYPPFY 358 (373)
Q Consensus 338 ~DvwSlGvil~ell~G~~Pf~ 358 (373)
+|||||||+||||+||.+||.
T Consensus 199 ~DVwS~Gvvl~El~tg~~~~~ 219 (303)
T 3hmm_A 199 ADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp HHHHHHHHHHHHHHHTBCBTT
T ss_pred HhhhhHHHHHHHHHHCCCCCC
Confidence 999999999999999988764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=370.06 Aligned_cols=216 Identities=43% Similarity=0.832 Sum_probs=199.8
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 192 (373)
+..++|++++.||+|+||+||+|.++.+|+.||+|++.+.........+.+.+|+.++..++||||+++++++.+...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 45688999999999999999999999999999999998876655566788899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcc
Q 017362 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 272 (373)
+||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--- 159 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 159 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence 99999999999999998889999999999999999999999999999999999999999999999999999764321
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 352 (373)
..+.+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 160 -----------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 198 (318)
T 1fot_A 160 -----------------------------------------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198 (318)
T ss_dssp -----------------------------------------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHh
Confidence 114689999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcC
Q 017362 353 GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 353 G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|.+||.+.+..+++.+|+++
T Consensus 199 g~~pf~~~~~~~~~~~i~~~ 218 (318)
T 1fot_A 199 GYTPFYDSNTMKTYEKILNA 218 (318)
T ss_dssp SSCTTCCSSHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHhC
Confidence 99999999999999998764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=373.73 Aligned_cols=221 Identities=38% Similarity=0.723 Sum_probs=198.0
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCC
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~ 189 (373)
..+..++|.+.+.||+|+||+||+|.++.+++.||||++.+...........+..|..++..+ +||||++++++|.+.+
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 345678999999999999999999999999999999999887655556677788899999877 9999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
.+|+||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999999754321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 349 (373)
.. ...+.+||+.|+|||++.+..|+.++|||||||++||
T Consensus 172 ~~-----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 210 (345)
T 1xjd_A 172 DA-----------------------------------------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYE 210 (345)
T ss_dssp TC-----------------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHH
T ss_pred CC-----------------------------------------cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHH
Confidence 10 0125689999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhcC
Q 017362 350 MLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 350 ll~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|++|.+||.+.+..+++.+|..+
T Consensus 211 ll~g~~Pf~~~~~~~~~~~i~~~ 233 (345)
T 1xjd_A 211 MLIGQSPFHGQDEEELFHSIRMD 233 (345)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHC
T ss_pred HhcCCCCCCCCCHHHHHHHHHhC
Confidence 99999999999999999988764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=375.30 Aligned_cols=220 Identities=36% Similarity=0.676 Sum_probs=198.6
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCe
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~ 190 (373)
.+..++|++++.||+|+||+||+|.++.+++.||||++.+.........+.+..|..++..+ .||||++++++|.+.+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 45678999999999999999999999999999999999887665666678888999999887 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999997532211
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 350 (373)
. ...+.+||+.|+|||++.+..|+.++|||||||++|||
T Consensus 176 ~-----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 214 (353)
T 2i0e_A 176 V-----------------------------------------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 214 (353)
T ss_dssp C-----------------------------------------CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHH
T ss_pred c-----------------------------------------ccccccCCccccChhhhcCCCcCCcccccchHHHHHHH
Confidence 0 01256899999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcC
Q 017362 351 LVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 351 l~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
++|++||.+.+..+++.+|+++
T Consensus 215 l~G~~Pf~~~~~~~~~~~i~~~ 236 (353)
T 2i0e_A 215 LAGQAPFEGEDEDELFQSIMEH 236 (353)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHC
T ss_pred HcCCCCCCCCCHHHHHHHHHhC
Confidence 9999999999999999998764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=370.51 Aligned_cols=217 Identities=41% Similarity=0.809 Sum_probs=201.0
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 191 (373)
....++|++++.||+|+||.||+|.++.+|+.||||++.+.........+.+.+|+.++..++||||+++++++.+...+
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 45678999999999999999999999999999999999887666666778899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~- 195 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT- 195 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCCc-
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999998653221
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
.+.+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 196 -------------------------------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 232 (350)
T 1rdq_E 196 -------------------------------------------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA 232 (350)
T ss_dssp -------------------------------------------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred -------------------------------------------ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHh
Confidence 1468999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcC
Q 017362 352 VGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+|.+||.+.++.+++.+|+++
T Consensus 233 ~g~~Pf~~~~~~~~~~~i~~~ 253 (350)
T 1rdq_E 233 AGYPPFFADQPIQIYEKIVSG 253 (350)
T ss_dssp HSSCSSCCSSHHHHHHHHHHC
T ss_pred hCCCCCCCCCHHHHHHHHHcC
Confidence 999999999999999998765
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-49 Score=376.42 Aligned_cols=221 Identities=41% Similarity=0.752 Sum_probs=189.5
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHH-HHhcCCCceeEEeeEEEeCC
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL-LAEVDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~l~~~~~~~~ 189 (373)
..+..++|++++.||+|+||+||+|.++.++..||||++.+..........++..|..+ ++.++||||++++++|.+.+
T Consensus 33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 34567899999999999999999999999999999999987765555555667777776 56789999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
.+|+||||++||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999999753211
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 349 (373)
.. ...+.+||+.|+|||++.+..|+.++|||||||++||
T Consensus 193 ~~-----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 231 (373)
T 2r5t_A 193 NS-----------------------------------------TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYE 231 (373)
T ss_dssp CC-----------------------------------------CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred CC-----------------------------------------ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHH
Confidence 10 0125689999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhcC
Q 017362 350 MLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 350 ll~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|++|.+||.+.+..+++.+|+++
T Consensus 232 ll~G~~Pf~~~~~~~~~~~i~~~ 254 (373)
T 2r5t_A 232 MLYGLPPFYSRNTAEMYDNILNK 254 (373)
T ss_dssp HHHSSCTTCCSBHHHHHHHHHHS
T ss_pred HHcCCCCCCCCCHHHHHHHHHhc
Confidence 99999999999999999999875
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=374.47 Aligned_cols=207 Identities=39% Similarity=0.753 Sum_probs=184.4
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCe
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~ 190 (373)
.+..++|++++.||+|+||+||+|.++.+++.||||++.+...........+..|..++..+ +||||++++++|.+.+.
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 45678999999999999999999999999999999999877655555566788899999877 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
+|+||||++||+|..++.....+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+......
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999997532111
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 350 (373)
. ...+.+||+.|+|||++.+..|+.++|||||||++|||
T Consensus 208 ~-----------------------------------------~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyel 246 (396)
T 4dc2_A 208 D-----------------------------------------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 246 (396)
T ss_dssp C-----------------------------------------CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHH
T ss_pred C-----------------------------------------ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHH
Confidence 0 01257899999999999999999999999999999999
Q ss_pred HhCCCCCCC
Q 017362 351 LVGYPPFYS 359 (373)
Q Consensus 351 l~G~~Pf~~ 359 (373)
++|++||..
T Consensus 247 l~G~~Pf~~ 255 (396)
T 4dc2_A 247 MAGRSPFDI 255 (396)
T ss_dssp HHSSCSSTT
T ss_pred HhCCCCCcc
Confidence 999999964
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=365.25 Aligned_cols=207 Identities=39% Similarity=0.753 Sum_probs=187.4
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCe
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~ 190 (373)
.+..++|++++.||+|+||.||+|.++.+++.||||++.+...........+..|..++..+ +||||++++++|.+.+.
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 35678999999999999999999999999999999999877655555667788999999887 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
+|+||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999997532211
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 350 (373)
. ...+.+||+.|+|||++.+..|+.++|||||||++|||
T Consensus 165 ~-----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 203 (345)
T 3a8x_A 165 D-----------------------------------------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 203 (345)
T ss_dssp C-----------------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHH
T ss_pred C-----------------------------------------cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHH
Confidence 0 01256899999999999999999999999999999999
Q ss_pred HhCCCCCCC
Q 017362 351 LVGYPPFYS 359 (373)
Q Consensus 351 l~G~~Pf~~ 359 (373)
++|.+||..
T Consensus 204 l~g~~pf~~ 212 (345)
T 3a8x_A 204 MAGRSPFDI 212 (345)
T ss_dssp HHSSCTTTT
T ss_pred HhCCCCcCC
Confidence 999999975
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=361.56 Aligned_cols=218 Identities=31% Similarity=0.561 Sum_probs=196.3
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 191 (373)
....++|++++.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 89 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL 89 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence 3456889999999999999999999999999999999976532 334456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
|+||||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++++||+|||++........
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 169 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK 169 (328)
T ss_dssp EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG
T ss_pred EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc
Confidence 99999999999999998888999999999999999999999999999999999999999999999999999976542211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCC-hhhcHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYG-MECDWWSLGAIMYEM 350 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~el 350 (373)
....+||+.|+|||++.+..++ .++|||||||++|+|
T Consensus 170 ------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el 207 (328)
T 3fe3_A 170 ------------------------------------------LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTL 207 (328)
T ss_dssp ------------------------------------------GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHH
Confidence 1146899999999999988875 899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcC
Q 017362 351 LVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 351 l~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
++|.+||.+.+..+...+|+++
T Consensus 208 l~g~~pf~~~~~~~~~~~i~~~ 229 (328)
T 3fe3_A 208 VSGSLPFDGQNLKELRERVLRG 229 (328)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHC
T ss_pred HhCCCCCCCCCHHHHHHHHHhC
Confidence 9999999999999999888765
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=367.15 Aligned_cols=208 Identities=35% Similarity=0.703 Sum_probs=189.9
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCe
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 190 (373)
..+..++|++++.||+|+||.||+|.+..+++.||||++.+...........+.+|+.++..++|||||+++++|.+.+.
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 45677899999999999999999999999999999999988776666677889999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
+|+||||++||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+....
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999998654221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC---CCCChhhcHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGAIM 347 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~~DvwSlGvil 347 (373)
. ..+.+||+.|+|||++.. ..|+.++|||||||++
T Consensus 170 ~------------------------------------------~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il 207 (384)
T 4fr4_A 170 Q------------------------------------------ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTA 207 (384)
T ss_dssp C------------------------------------------BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHH
T ss_pred c------------------------------------------eeccCCCccccCCeeeccCCCCCCCccceeechHHHH
Confidence 1 125689999999999974 4689999999999999
Q ss_pred HHHHhCCCCCCCC
Q 017362 348 YEMLVGYPPFYSD 360 (373)
Q Consensus 348 ~ell~G~~Pf~~~ 360 (373)
|||++|.+||...
T Consensus 208 ~elltG~~Pf~~~ 220 (384)
T 4fr4_A 208 YELLRGRRPYHIR 220 (384)
T ss_dssp HHHHHSSCSSCCC
T ss_pred HHHHhCCCCCCCC
Confidence 9999999999854
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=362.62 Aligned_cols=216 Identities=31% Similarity=0.559 Sum_probs=194.3
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhh---hhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR---GQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 191 (373)
.++|++.+.||+|+||+||+|.++.+|..||+|++.+...... ...+.+.+|+.++..++||||++++++|.+...+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 5679999999999999999999999999999999976543211 1346788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC----cEEEeeccccccCC
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG----HLRLSDFGLCKPLD 267 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~----~vkL~DFGla~~~~ 267 (373)
|+||||++||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++ ++||+|||++....
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~ 170 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence 99999999999999998888999999999999999999999999999999999999998877 89999999998654
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 347 (373)
.... ....+||+.|+|||++.+..|+.++|||||||++
T Consensus 171 ~~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil 208 (361)
T 2yab_A 171 DGVE------------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208 (361)
T ss_dssp TTCC------------------------------------------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred CCCc------------------------------------------cccCCCCccEECchHHcCCCCCccccHHHHHHHH
Confidence 3210 1146799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhhcC
Q 017362 348 YEMLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 348 ~ell~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|+|++|.+||.+.+..+++.+|.++
T Consensus 209 ~~ll~g~~Pf~~~~~~~~~~~i~~~ 233 (361)
T 2yab_A 209 YILLSGASPFLGDTKQETLANITAV 233 (361)
T ss_dssp HHHHHSCCSSCCSSHHHHHHHHHTT
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 9999999999999999999988764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=350.84 Aligned_cols=220 Identities=25% Similarity=0.445 Sum_probs=190.5
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 191 (373)
.+..++|++++.||+|+||.||+|.+..++..||+|++...........+.+.+|+.++..++||||+++++++.+.+.+
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 34568899999999999999999999999999999998654433445567789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
|+||||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++++||+|||++........
T Consensus 87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 99999999999999998888999999999999999999999999999999999999999999999999999976542211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
. .....+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 167 ~----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll 206 (294)
T 4eqm_A 167 T----------------------------------------QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEML 206 (294)
T ss_dssp ------------------------------------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHH
T ss_pred c----------------------------------------ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHH
Confidence 0 011457999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhc
Q 017362 352 VGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~~ 371 (373)
+|.+||.+.+..+...+++.
T Consensus 207 ~g~~pf~~~~~~~~~~~~~~ 226 (294)
T 4eqm_A 207 VGEPPFNGETAVSIAIKHIQ 226 (294)
T ss_dssp HSSCSSCSSCHHHHHHHHHS
T ss_pred hCCCCCCCCChHHHHHHHhh
Confidence 99999999888776655543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=389.68 Aligned_cols=220 Identities=36% Similarity=0.676 Sum_probs=199.3
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCe
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~ 190 (373)
.+..++|++++.||+|+||+||+|.++.+++.||||++.+.........+.+..|..++..+ .||+|+.++++|.+.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 45678999999999999999999999999999999999887666666778888999999887 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
+||||||++||+|..++...+.+++..+++|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 99999999999999999988899999999999999999999999999999999999999999999999999998543221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 350 (373)
. ...+.+||+.|+|||++.+..|+.++|||||||+||||
T Consensus 497 ~-----------------------------------------~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyel 535 (674)
T 3pfq_A 497 V-----------------------------------------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 535 (674)
T ss_dssp C-----------------------------------------CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHH
T ss_pred c-----------------------------------------ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHH
Confidence 0 01257899999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcC
Q 017362 351 LVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 351 l~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
++|.+||.+.+..+++.+|+++
T Consensus 536 ltG~~Pf~~~~~~~~~~~i~~~ 557 (674)
T 3pfq_A 536 LAGQAPFEGEDEDELFQSIMEH 557 (674)
T ss_dssp HHSSCSSCCSSHHHHHHHHHSS
T ss_pred HcCCCCCCCCCHHHHHHHHHhC
Confidence 9999999999999999999875
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=374.25 Aligned_cols=220 Identities=35% Similarity=0.626 Sum_probs=196.4
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCe
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 190 (373)
..+..++|.+.+.||+|+||.||+|.++.+|+.||||++.+...........+..|+.++..++||||++++++|.+...
T Consensus 180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 259 (543)
T 3c4z_A 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD 259 (543)
T ss_dssp SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence 55778999999999999999999999999999999999988766656667788999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccC
Q 017362 191 LYLIMEYLPGGDMMTLLMRK----DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~ 266 (373)
+|+||||++||+|..++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 99999999999999998763 36999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHH
Q 017362 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (373)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvi 346 (373)
...... ....+||+.|+|||++.+..|+.++|||||||+
T Consensus 340 ~~~~~~-----------------------------------------~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvi 378 (543)
T 3c4z_A 340 KAGQTK-----------------------------------------TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVT 378 (543)
T ss_dssp CTTCCC-----------------------------------------BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHH
T ss_pred cCCCcc-----------------------------------------cccccCCccccChhhhcCCCCChHHhcCcchHH
Confidence 432110 114589999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCC----ChHHHHHHhhc
Q 017362 347 MYEMLVGYPPFYSD----DPMSTCRKVRK 371 (373)
Q Consensus 347 l~ell~G~~Pf~~~----~~~~~~~kI~~ 371 (373)
+|||++|++||.+. +..+...+|+.
T Consensus 379 lyelltG~~PF~~~~~~~~~~~~~~~i~~ 407 (543)
T 3c4z_A 379 LYEMIAARGPFRARGEKVENKELKQRVLE 407 (543)
T ss_dssp HHHHHHSSCSSCCTTCCCCHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCCccchhHHHHHHHHhh
Confidence 99999999999876 34666666654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=375.65 Aligned_cols=221 Identities=34% Similarity=0.656 Sum_probs=196.1
Q ss_pred hhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC
Q 017362 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (373)
Q Consensus 109 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 188 (373)
....+..++|++.+.||+|+||.||+|.++.+|+.||||++.+...........+.+|+.++..++||||++++++|.+.
T Consensus 177 ~~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 256 (576)
T 2acx_A 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK 256 (576)
T ss_dssp HTSCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhcCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC
Confidence 34557889999999999999999999999999999999999887666666677889999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~ 266 (373)
+.+|+||||++||+|.+++...+ .+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+..
T Consensus 257 ~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 99999999999999999997654 4999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHH
Q 017362 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (373)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvi 346 (373)
..... ....+||+.|+|||++.+..|+.++|||||||+
T Consensus 337 ~~~~~------------------------------------------~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvi 374 (576)
T 2acx_A 337 PEGQT------------------------------------------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCL 374 (576)
T ss_dssp CTTCC------------------------------------------EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHH
T ss_pred ccCcc------------------------------------------ccccCCCccccCHHHHcCCCCCccchHHHHHHH
Confidence 42211 114589999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCC----hHHHHHHhhc
Q 017362 347 MYEMLVGYPPFYSDD----PMSTCRKVRK 371 (373)
Q Consensus 347 l~ell~G~~Pf~~~~----~~~~~~kI~~ 371 (373)
+|||++|.+||.+.+ ..++...|..
T Consensus 375 lyeLltG~~PF~~~~~~~~~~~i~~~i~~ 403 (576)
T 2acx_A 375 LYEMIAGQSPFQQRKKKIKREEVERLVKE 403 (576)
T ss_dssp HHHHHHSSCSSSCSSSCCCHHHHHHHHHH
T ss_pred HHHHHhCCCCCcccccchhHHHHHHHhhc
Confidence 999999999998764 3455555543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=370.76 Aligned_cols=222 Identities=40% Similarity=0.733 Sum_probs=188.2
Q ss_pred hccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC
Q 017362 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 110 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 189 (373)
...+..++|++++.||+|+||.||+|.+..+++.||||++.............+.+|+.++..++||||++++++|.+.+
T Consensus 142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 221 (446)
T 4ejn_A 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD 221 (446)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT
T ss_pred ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC
Confidence 34566789999999999999999999999999999999998765555556677888999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
.+|+||||++||+|.+++.....+++..++.++.||+.||.|||+ +|||||||||+|||++.++++||+|||+|+....
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 999999999999999999888899999999999999999999998 9999999999999999999999999999975332
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 348 (373)
... .....+||+.|+|||++.+..|+.++|||||||++|
T Consensus 302 ~~~-----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 340 (446)
T 4ejn_A 302 DGA-----------------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 340 (446)
T ss_dssp ----------------------------------------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHH
T ss_pred CCc-----------------------------------------ccccccCCccccCHhhcCCCCCCCccchhhhHHHHH
Confidence 110 012468999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhcC
Q 017362 349 EMLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 349 ell~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
||++|.+||.+.+..+....|+..
T Consensus 341 ell~g~~Pf~~~~~~~~~~~i~~~ 364 (446)
T 4ejn_A 341 EMMCGRLPFYNQDHEKLFELILME 364 (446)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred HHhhCCCCCCCCCHHHHHHHHHhC
Confidence 999999999999999888887653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=356.58 Aligned_cols=215 Identities=31% Similarity=0.619 Sum_probs=192.6
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|++.+.||+|+||.||+|.++.++..||+|++..... .....+.+.+|+.++..++||||+++++++.+.+..|+|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4579999999999999999999999999999999976543 233456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC---cEEEeeccccccCCCCCc
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---HLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~---~vkL~DFGla~~~~~~~~ 271 (373)
|||++||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++........
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~ 186 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence 99999999999998888999999999999999999999999999999999999998654 599999999976542211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
....+||+.|+|||++.+..|+.++|||||||++|+|+
T Consensus 187 ------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 224 (362)
T 2bdw_A 187 ------------------------------------------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 224 (362)
T ss_dssp ------------------------------------------CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence 11467999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcC
Q 017362 352 VGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+|++||.+.+..+.+..|..+
T Consensus 225 ~g~~Pf~~~~~~~~~~~i~~~ 245 (362)
T 2bdw_A 225 VGYPPFWDEDQHRLYAQIKAG 245 (362)
T ss_dssp HSSCSSCCSSHHHHHHHHHHT
T ss_pred HCCCCCCCCCHHHHHHHHHhC
Confidence 999999999999888888764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=352.40 Aligned_cols=221 Identities=43% Similarity=0.779 Sum_probs=185.8
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEc---CCCceEeeeecchhHhhh-hhhHHHHHHHHHHHHhcCCCceeEEeeEEE
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKSEMLR-RGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 186 (373)
..+..++|++++.||+|+||.||+|.+. .+++.||+|++.+..... ......+.+|+.++..++||||+++++++.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 3466789999999999999999999885 688999999997654322 233456788999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccC
Q 017362 187 DDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (373)
Q Consensus 187 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~ 266 (373)
+.+.+|+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+++..
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 99999999999999999999988889999999999999999999999999999999999999999999999999998753
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHH
Q 017362 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (373)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvi 346 (373)
..... .....+||+.|+|||++.+..++.++|||||||+
T Consensus 172 ~~~~~-----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 210 (327)
T 3a62_A 172 IHDGT-----------------------------------------VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGAL 210 (327)
T ss_dssp ------------------------------------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHH
T ss_pred ccCCc-----------------------------------------cccccCCCcCccCHhhCcCCCCCCcccchhHHHH
Confidence 21110 0124679999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHhhcC
Q 017362 347 MYEMLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 347 l~ell~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+|||++|.+||.+.+..++..+|+++
T Consensus 211 l~el~~g~~pf~~~~~~~~~~~i~~~ 236 (327)
T 3a62_A 211 MYDMLTGAPPFTGENRKKTIDKILKC 236 (327)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHT
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHhC
Confidence 99999999999999999988888754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=346.21 Aligned_cols=212 Identities=31% Similarity=0.565 Sum_probs=188.7
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEE
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 193 (373)
..++|++.+.||+|+||+||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||++++++|.+.+.+|+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 3568999999999999999999999999999999987543 2334568889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 194 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
||||++||+|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|.........
T Consensus 95 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 172 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (297)
T ss_dssp EEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-
T ss_pred EEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc-
Confidence 99999999999999664 6999999999999999999999999999999999999999999999999999765432211
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhC
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 353 (373)
....+||+.|+|||++.+..|+.++|||||||++|||++|
T Consensus 173 ----------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 212 (297)
T 3fxz_A 173 ----------------------------------------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212 (297)
T ss_dssp ----------------------------------------BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHS
T ss_pred ----------------------------------------cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhC
Confidence 1146799999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHhh
Q 017362 354 YPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 354 ~~Pf~~~~~~~~~~kI~ 370 (373)
.+||.+.++......+.
T Consensus 213 ~~pf~~~~~~~~~~~~~ 229 (297)
T 3fxz_A 213 EPPYLNENPLRALYLIA 229 (297)
T ss_dssp SCTTTTSCHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHH
Confidence 99999988877665553
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=354.08 Aligned_cols=212 Identities=32% Similarity=0.565 Sum_probs=188.2
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEE
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 193 (373)
..++|.+.+.||+|+||+||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 45789999999999999999999999999999999987655444445678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 194 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
||||+ +|+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 87 v~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~-- 163 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-- 163 (336)
T ss_dssp EECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT--
T ss_pred EEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc--
Confidence 99999 789999998888999999999999999999999999999999999999999999999999999976543211
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCC-ChhhcHHHHHHHHHHHHh
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DvwSlGvil~ell~ 352 (373)
....+||+.|+|||++.+..+ +.++|||||||++|+|++
T Consensus 164 ----------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~ 203 (336)
T 3h4j_B 164 ----------------------------------------LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLV 203 (336)
T ss_dssp ----------------------------------------TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHh
Confidence 114679999999999998876 789999999999999999
Q ss_pred CCCCCCCCChHHHHHH
Q 017362 353 GYPPFYSDDPMSTCRK 368 (373)
Q Consensus 353 G~~Pf~~~~~~~~~~k 368 (373)
|.+||.+.+..+...+
T Consensus 204 g~~Pf~~~~~~~~~~~ 219 (336)
T 3h4j_B 204 GRLPFDDEFIPNLFKK 219 (336)
T ss_dssp SSCSSBCSSSTTCBCC
T ss_pred CCCCCCCccHHHHHHH
Confidence 9999987655444433
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=348.85 Aligned_cols=212 Identities=26% Similarity=0.447 Sum_probs=190.8
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|++.+.||+|+||+||+|.+..++..||+|++.... .....+.+|+.++..++||||+++++++.+.+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 578999999999999999999999999999999987442 2345678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC--CCcEEEeeccccccCCCCCc
Q 017362 195 MEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK--YGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~--~~~vkL~DFGla~~~~~~~~ 271 (373)
|||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||++..+.....
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 99999999999997654 7999999999999999999999999999999999999987 78999999999987643221
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
....+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 160 ------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 197 (321)
T 1tki_A 160 ------------------------------------------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL 197 (321)
T ss_dssp ------------------------------------------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHH
Confidence 11457999999999999988999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcC
Q 017362 352 VGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+|.+||.+.+..+...+|+++
T Consensus 198 ~g~~pf~~~~~~~~~~~i~~~ 218 (321)
T 1tki_A 198 SGINPFLAETNQQIIENIMNA 218 (321)
T ss_dssp HSSCTTCCSSHHHHHHHHHHT
T ss_pred hCCCCCcCCCHHHHHHHHHcC
Confidence 999999999999988888764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=364.01 Aligned_cols=216 Identities=30% Similarity=0.606 Sum_probs=192.0
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|++.+.||+|+||+||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3579999999999999999999999999999999876543 233456688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEc---CCCcEEEeeccccccCCCCCc
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD---KYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~---~~~~vkL~DFGla~~~~~~~~ 271 (373)
|||++||+|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|........
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~ 168 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence 99999999999999989999999999999999999999999999999999999998 468899999999976543211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
. ....+||+.|+|||++.+..|+.++|||||||++|+|+
T Consensus 169 ~-----------------------------------------~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell 207 (444)
T 3soa_A 169 A-----------------------------------------WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILL 207 (444)
T ss_dssp B-----------------------------------------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred e-----------------------------------------eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHH
Confidence 0 11468999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcC
Q 017362 352 VGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+|.+||.+.+..+.+.+|..+
T Consensus 208 ~G~~Pf~~~~~~~~~~~i~~~ 228 (444)
T 3soa_A 208 VGYPPFWDEDQHRLYQQIKAG 228 (444)
T ss_dssp HSSCSCCCSSHHHHHHHHHHT
T ss_pred hCCCCCCCccHHHHHHHHHhC
Confidence 999999999999999888765
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=366.07 Aligned_cols=221 Identities=30% Similarity=0.566 Sum_probs=199.9
Q ss_pred hccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC
Q 017362 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 110 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 189 (373)
...+..++|.+.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++.+.+
T Consensus 10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 89 (476)
T 2y94_A 10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS 89 (476)
T ss_dssp CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 34566789999999999999999999999999999999998776555555678899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++......
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999999865432
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCC-ChhhcHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMY 348 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DvwSlGvil~ 348 (373)
.. ..+.+||+.|+|||++.+..+ +.++|||||||++|
T Consensus 170 ~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ 207 (476)
T 2y94_A 170 EF------------------------------------------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILY 207 (476)
T ss_dssp CC------------------------------------------BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHH
T ss_pred cc------------------------------------------ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHH
Confidence 11 114689999999999998776 78999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhcC
Q 017362 349 EMLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 349 ell~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+|++|.+||.+.+..+.+.+|.++
T Consensus 208 elltG~~Pf~~~~~~~~~~~i~~~ 231 (476)
T 2y94_A 208 ALLCGTLPFDDDHVPTLFKKICDG 231 (476)
T ss_dssp HHHHSSCSSCCSSSHHHHHHHHTT
T ss_pred HHhhCCCCCCCCCHHHHHHHHhcC
Confidence 999999999999999999888765
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=347.36 Aligned_cols=215 Identities=31% Similarity=0.564 Sum_probs=191.3
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhh---hhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR---GQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 191 (373)
.++|.+.+.||+|+||.||+|.+..++..||+|++........ ...+.+.+|+.++..++||||+++++++.+...+
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4569999999999999999999999999999999876432211 1346788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC----cEEEeeccccccCC
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG----HLRLSDFGLCKPLD 267 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~----~vkL~DFGla~~~~ 267 (373)
|+||||++||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 99999999999999998888999999999999999999999999999999999999999887 89999999998654
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 347 (373)
.... ....+||+.|+|||++.+..++.++|||||||++
T Consensus 170 ~~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 207 (326)
T 2y0a_A 170 FGNE------------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207 (326)
T ss_dssp TTSC------------------------------------------CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred CCCc------------------------------------------cccccCCcCcCCceeecCCCCCcHHHHHHHHHHH
Confidence 2211 1145799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhhc
Q 017362 348 YEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 348 ~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
|+|++|.+||.+.+..+....|..
T Consensus 208 ~~ll~g~~pf~~~~~~~~~~~~~~ 231 (326)
T 2y0a_A 208 YILLSGASPFLGDTKQETLANVSA 231 (326)
T ss_dssp HHHHHSCCSSCCSSHHHHHHHHHH
T ss_pred HHHHHCcCCCCCCCHHHHHHHHHh
Confidence 999999999999988888777654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=347.95 Aligned_cols=221 Identities=26% Similarity=0.442 Sum_probs=185.8
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC---
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE--- 189 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~--- 189 (373)
...++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.++..++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 34678999999999999999999999999999999998754444455677889999999999999999999987654
Q ss_pred -eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 190 -FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 190 -~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
..|+||||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred cccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 3499999999999999998888999999999999999999999999999999999999999999999999999976543
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 348 (373)
..... ......+||+.|+|||++.+..++.++|||||||++|
T Consensus 169 ~~~~~--------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~ 210 (311)
T 3ork_A 169 SGNSV--------------------------------------TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLY 210 (311)
T ss_dssp ---------------------------------------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHH
T ss_pred ccccc--------------------------------------ccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHH
Confidence 21100 0011457999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhc
Q 017362 349 EMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 349 ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
||++|.+||.+.++.+....++.
T Consensus 211 ~ll~g~~pf~~~~~~~~~~~~~~ 233 (311)
T 3ork_A 211 EVLTGEPPFTGDSPVSVAYQHVR 233 (311)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHH
T ss_pred HHHhCCCCCCCCChHHHHHHHhc
Confidence 99999999999988777665543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=348.87 Aligned_cols=215 Identities=31% Similarity=0.567 Sum_probs=185.4
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhh--hhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR--GQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 192 (373)
.++|++.+.||+|+||+||+|.++.+++.||||++........ ...+.+.+|+.++..++||||+++++++.+.+.+|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4579999999999999999999999999999999976543322 13567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCc---EEEeecccccc
Q 017362 193 LIMEYLPGGDMMTLLMRK----DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH---LRLSDFGLCKP 265 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~---vkL~DFGla~~ 265 (373)
+||||++||+|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999998887542 35899999999999999999999999999999999999987655 99999999986
Q ss_pred CCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHH
Q 017362 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (373)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGv 345 (373)
....... ....+||+.|+|||++.+..|+.++|||||||
T Consensus 183 ~~~~~~~-----------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 221 (351)
T 3c0i_A 183 LGESGLV-----------------------------------------AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGV 221 (351)
T ss_dssp CCTTSCB-----------------------------------------CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHH
T ss_pred ecCCCee-----------------------------------------ecCCcCCcCccCHHHHcCCCCCchHhhHHHHH
Confidence 6432110 11457999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHhhc
Q 017362 346 IMYEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 346 il~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
++|+|++|.+||.+. ..+....|++
T Consensus 222 il~~ll~g~~pf~~~-~~~~~~~i~~ 246 (351)
T 3c0i_A 222 ILFILLSGCLPFYGT-KERLFEGIIK 246 (351)
T ss_dssp HHHHHHHSSCSSCSS-HHHHHHHHHH
T ss_pred HHHHHHHCCCCCCCc-HHHHHHHHHc
Confidence 999999999999875 4455555554
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=335.06 Aligned_cols=218 Identities=34% Similarity=0.596 Sum_probs=194.7
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCe
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 190 (373)
..+..++|++.+.||+|+||+||+|.+..++..||+|++.............+.+|+.++..++||||+++++++.+...
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 4 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 83 (279)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence 35677899999999999999999999999999999999987665555556778899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
.|+||||+++|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999986443211
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 350 (373)
.....||+.|+|||++.+..++.++|||||||++|+|
T Consensus 164 -------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 200 (279)
T 3fdn_A 164 -------------------------------------------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 200 (279)
T ss_dssp -----------------------------------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred -------------------------------------------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHH
Confidence 0135799999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhc
Q 017362 351 LVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 351 l~G~~Pf~~~~~~~~~~kI~~ 371 (373)
++|.+||...+..+...+|..
T Consensus 201 ~~g~~p~~~~~~~~~~~~~~~ 221 (279)
T 3fdn_A 201 LVGKPPFEANTYQETYKRISR 221 (279)
T ss_dssp HHSSCTTCCSSHHHHHHHHHH
T ss_pred HHCCCCCCCCcHHHHHHHHHh
Confidence 999999999998888877654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=350.43 Aligned_cols=212 Identities=28% Similarity=0.574 Sum_probs=188.8
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|++++.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.++..++||||+++++++.+...+|+|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 4689999999999999999999999999999999875432 2234688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC--CCcEEEeeccccccCCCCCc
Q 017362 195 MEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK--YGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~--~~~vkL~DFGla~~~~~~~~ 271 (373)
|||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+.......
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 99999999999997654 7999999999999999999999999999999999999974 57899999999986643211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 207 ------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 244 (387)
T 1kob_A 207 ------------------------------------------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL 244 (387)
T ss_dssp ------------------------------------------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHH
Confidence 11357999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhc
Q 017362 352 VGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~~ 371 (373)
+|.+||.+.+..++..+|..
T Consensus 245 tg~~Pf~~~~~~~~~~~i~~ 264 (387)
T 1kob_A 245 SGLSPFAGEDDLETLQNVKR 264 (387)
T ss_dssp HSCCSSCCSSHHHHHHHHHH
T ss_pred hCCCCCCCCCHHHHHHHHHh
Confidence 99999999998888887764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=348.85 Aligned_cols=224 Identities=22% Similarity=0.353 Sum_probs=191.5
Q ss_pred CCCCCcceeceeeee--CcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCe
Q 017362 113 MGADDFELLTMIGKG--AFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 190 (373)
...++|++++.||+| +||+||+|.+..+++.||||++..... .......+.+|+.+++.++||||++++++|.+.+.
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 456789999999999 999999999999999999999976532 33455778889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 191 LYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999999775 6799999999999999999999999999999999999999999999999999865432
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC--CCCChhhcHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAI 346 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DvwSlGvi 346 (373)
........ .......+||+.|+|||++.+ ..|+.++|||||||+
T Consensus 181 ~~~~~~~~----------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 226 (389)
T 3gni_B 181 HGQRQRVV----------------------------------HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGIT 226 (389)
T ss_dssp TTEECSCB----------------------------------CCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHH
T ss_pred cccccccc----------------------------------ccccccccccccccCHHHHhccCCCCCcHhHHHHHHHH
Confidence 21110000 000113579999999999987 679999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHhhc
Q 017362 347 MYEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 347 l~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
+|||++|.+||.+.+..+...++++
T Consensus 227 l~el~~g~~pf~~~~~~~~~~~~~~ 251 (389)
T 3gni_B 227 ACELANGHVPFKDMPATQMLLEKLN 251 (389)
T ss_dssp HHHHHHSSCTTTTCCSTTHHHHC--
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 9999999999999887777766654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=332.20 Aligned_cols=220 Identities=32% Similarity=0.589 Sum_probs=196.5
Q ss_pred hccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC
Q 017362 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 110 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 189 (373)
...+..++|++.+.||+|+||.||+|.+..++..||+|++.............+.+|+.++..++||||+++++++.+.+
T Consensus 8 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 87 (284)
T 2vgo_A 8 KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK 87 (284)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred ccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC
Confidence 34566789999999999999999999999999999999998765544445567889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
..|+||||+++|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999998654321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 349 (373)
. .....||+.|+|||++.+..++.++|||||||++|+
T Consensus 168 ~-------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 204 (284)
T 2vgo_A 168 R-------------------------------------------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYE 204 (284)
T ss_dssp C-------------------------------------------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHH
T ss_pred c-------------------------------------------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHH
Confidence 1 014579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhcC
Q 017362 350 MLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 350 ll~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|++|.+||...+..+....|.+.
T Consensus 205 l~~g~~pf~~~~~~~~~~~~~~~ 227 (284)
T 2vgo_A 205 FLVGMPPFDSPSHTETHRRIVNV 227 (284)
T ss_dssp HHHSSCTTCCSSHHHHHHHHHTT
T ss_pred HHHCCCCCCCCCHhHHHHHHhcc
Confidence 99999999998888888777653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=348.42 Aligned_cols=233 Identities=27% Similarity=0.472 Sum_probs=178.4
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-CCceeEEeeEEEeCC--eE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDE--FL 191 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~--~~ 191 (373)
.++|++++.||+|+||+||+|.+..+++.||||++.... ........+.+|+.++..+. ||||+++++++...+ .+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 478999999999999999999999999999999986542 23344566788999999997 999999999998654 78
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
|+|||||+ |+|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+|+.+.....
T Consensus 87 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred EEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 99999996 689888865 5799999999999999999999999999999999999999999999999999987643211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~el 350 (373)
........... ....+ ..........+||+.|+|||++.+ ..|+.++||||||||+|||
T Consensus 165 ~~~~~~~~~~~-------------------~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 224 (388)
T 3oz6_A 165 VTNNIPLSINE-------------------NTENF-DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224 (388)
T ss_dssp CCCCGGGCCC-----------------------------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred ccccccccccc-------------------ccccc-ccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHH
Confidence 11000000000 00000 000112235689999999999987 6799999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhh
Q 017362 351 LVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 351 l~G~~Pf~~~~~~~~~~kI~ 370 (373)
++|++||.+.+..+...+|+
T Consensus 225 l~g~~pf~~~~~~~~~~~i~ 244 (388)
T 3oz6_A 225 LCGKPIFPGSSTMNQLERII 244 (388)
T ss_dssp HHSSCSCCCSSHHHHHHHHH
T ss_pred HhCCCCCCCCCHHHHHHHHH
Confidence 99999999999998888876
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=346.98 Aligned_cols=221 Identities=21% Similarity=0.396 Sum_probs=190.1
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEc-------CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEe
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREK-------TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLY 182 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~ 182 (373)
..+..++|++.+.||+|+||.||+|.+. .++..||||++.... .......+.+|+.++..+ +||||++++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 153 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 153 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 3456789999999999999999999874 345679999997542 234456789999999999 899999999
Q ss_pred eEEEeCCeEEEEEeccCCCCHHHHHhhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCC
Q 017362 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRKD----------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDN 246 (373)
Q Consensus 183 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~N 246 (373)
+++.+.+.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 99999999999999999999999997643 48999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccc
Q 017362 247 LLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAP 326 (373)
Q Consensus 247 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP 326 (373)
||++.++++||+|||+|+......... ......||+.|+||
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~---------------------------------------~~~~~~~t~~y~aP 274 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYK---------------------------------------KTTNGRLPVKWMAP 274 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTC---------------------------------------TTTTTTSCGGGCCH
T ss_pred EEECCCCCEEEccccCCcccCccccee---------------------------------------cccCCCcccceECH
Confidence 999999999999999998654321110 01134688999999
Q ss_pred ccccCCCCChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 327 EVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 327 E~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|++.+..|+.++|||||||++|||++ |.+||.+.+..+....+.++
T Consensus 275 E~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 321 (370)
T 2psq_A 275 EALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 321 (370)
T ss_dssp HHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred hHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence 99999999999999999999999999 99999999888888776554
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=338.08 Aligned_cols=219 Identities=25% Similarity=0.399 Sum_probs=182.4
Q ss_pred hhhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe
Q 017362 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (373)
Q Consensus 108 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 187 (373)
.....+..++|++.+.||+|+||+||+|.+ ++..||||++..... .....+.+.+|+.++..++||||+++++++.+
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 345567788999999999999999999976 578999999876432 23445678899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhhCCC---CCHHHHHHHHHHHHHHHHHHHhCC--CeeecCCCCCEEEcCCCcEEEeeccc
Q 017362 188 DEFLYLIMEYLPGGDMMTLLMRKDT---LTEDEARFYVAETVLAIESIHKHH--YIHRDIKPDNLLLDKYGHLRLSDFGL 262 (373)
Q Consensus 188 ~~~~~lV~E~~~gg~L~~~l~~~~~---l~~~~~~~i~~qi~~aL~~LH~~g--iiHrDikp~NILl~~~~~vkL~DFGl 262 (373)
...+|+||||+++|+|.+++..... +++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 9999999999999999999977653 999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHH
Q 017362 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342 (373)
Q Consensus 263 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwS 342 (373)
++........ .....||+.|+|||++.+..++.++||||
T Consensus 186 a~~~~~~~~~-----------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Diws 224 (309)
T 3p86_A 186 SRLKASTFLS-----------------------------------------SKSAAGTPEWMAPEVLRDEPSNEKSDVYS 224 (309)
T ss_dssp ---------------------------------------------------------CCTTSCHHHHTTCCCCTTHHHHH
T ss_pred Cccccccccc-----------------------------------------cccCCCCccccChhhhcCCCCCchhhHHH
Confidence 9754321100 11457999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 017362 343 LGAIMYEMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 343 lGvil~ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
|||++|||++|..||.+.++.+....+.
T Consensus 225 lG~il~elltg~~Pf~~~~~~~~~~~~~ 252 (309)
T 3p86_A 225 FGVILWELATLQQPWGNLNPAQVVAAVG 252 (309)
T ss_dssp HHHHHHHHHHCCCTTTTSCHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999999999998888776653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=357.67 Aligned_cols=211 Identities=28% Similarity=0.424 Sum_probs=180.4
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC------
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD------ 188 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~------ 188 (373)
.++|++++.||+|+||+||+|.+..+++.||||++.... ........+.+|+.+++.++||||++++++|...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 578999999999999999999999999999999997642 2344456788999999999999999999999765
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
..+|+||||+++ +|...+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|+....
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred CeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 357999999965 56666643 499999999999999999999999999999999999999999999999999976542
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 348 (373)
... ....+||+.|+|||++.+..|+.++|||||||++|
T Consensus 217 ~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 254 (464)
T 3ttj_A 217 SFM------------------------------------------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254 (464)
T ss_dssp CCC------------------------------------------C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred Ccc------------------------------------------cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHH
Confidence 210 12468999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhc
Q 017362 349 EMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 349 ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
||++|++||.+.+..+.+.+|++
T Consensus 255 ell~g~~pF~g~~~~~~~~~i~~ 277 (464)
T 3ttj_A 255 EMVRHKILFPGRDYIDQWNKVIE 277 (464)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999999999999988888764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=336.73 Aligned_cols=217 Identities=35% Similarity=0.645 Sum_probs=182.6
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhh-----------------------hhhHHHHHHHHHH
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR-----------------------RGQVEHVRAERNL 169 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----------------------~~~~~~~~~e~~~ 169 (373)
+..++|++.+.||+|+||.||+|.+..+++.||||++....... ....+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 44688999999999999999999999999999999987653221 1123568889999
Q ss_pred HHhcCCCceeEEeeEEEe--CCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCE
Q 017362 170 LAEVDSNCIVKLYCSFQD--DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNL 247 (373)
Q Consensus 170 l~~l~h~~iv~l~~~~~~--~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NI 247 (373)
++.++||||+++++++.+ ...+|+||||+++++|.+++ ....+++..+..++.|++.||.|||++||+||||||+||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 999999999999999987 56899999999999998865 456799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccc
Q 017362 248 LLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPE 327 (373)
Q Consensus 248 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE 327 (373)
|++.++++||+|||++......... ....+||+.|+|||
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~~-----------------------------------------~~~~~gt~~y~aPE 207 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDAL-----------------------------------------LSNTVGTPAFMAPE 207 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSCE-----------------------------------------ECCCCSCGGGCCGG
T ss_pred EECCCCCEEEecCCCcccccccccc-----------------------------------------ccCCcCCccccChh
Confidence 9999999999999999865432110 11457999999999
Q ss_pred cccCCC---CChhhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 017362 328 VLLKKG---YGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 328 ~~~~~~---~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
++.+.. ++.++|||||||++|+|++|.+||.+.+......+|..
T Consensus 208 ~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 254 (298)
T 2zv2_A 208 SLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKS 254 (298)
T ss_dssp GCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred hhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhc
Confidence 998765 48899999999999999999999999888777776654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=360.98 Aligned_cols=216 Identities=36% Similarity=0.655 Sum_probs=194.1
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEE
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 193 (373)
..++|++.+.||+|+||+||+|.+..+++.||||++.+...........+.+|+.++..++||||+++++++.+.+.+|+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 35679999999999999999999999999999999976654444556778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEE---cCCCcEEEeeccccccCCCCC
Q 017362 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 194 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl---~~~~~vkL~DFGla~~~~~~~ 270 (373)
||||++||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.+....
T Consensus 104 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 183 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183 (484)
T ss_dssp EECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc
Confidence 99999999999999888899999999999999999999999999999999999999 567899999999997654321
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 350 (373)
. ....+||+.|+|||++.+ .|+.++|||||||++|+|
T Consensus 184 ~------------------------------------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l 220 (484)
T 3nyv_A 184 K------------------------------------------MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYIL 220 (484)
T ss_dssp S------------------------------------------HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHH
T ss_pred c------------------------------------------cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHH
Confidence 1 013579999999999866 699999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcC
Q 017362 351 LVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 351 l~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
++|.+||.+.+..+...+|.++
T Consensus 221 l~g~~pf~~~~~~~~~~~i~~~ 242 (484)
T 3nyv_A 221 LSGCPPFNGANEYDILKKVEKG 242 (484)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHC
T ss_pred HHCCCCCCCCCHHHHHHHHHcC
Confidence 9999999999999999888765
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=333.62 Aligned_cols=212 Identities=26% Similarity=0.444 Sum_probs=181.3
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++++.||+|+||+||+|.+..+++.||||++.... ........+.+|+.++..++||||+++++++.+++.+|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccC-CcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 68999999999999999999999999999999997653 22334466888999999999999999999999999999999
Q ss_pred eccCCCCHHHHH-hhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 196 EYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 196 E~~~gg~L~~~l-~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
||+++ +|.+.+ .....+++..++.++.|++.||.|||++||+||||||+|||++.++++||+|||+++........
T Consensus 81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 157 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-- 157 (292)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC--
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc--
Confidence 99976 555555 44678999999999999999999999999999999999999999999999999999865422110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC-CChhhcHHHHHHHHHHHHhC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~ell~G 353 (373)
....+||+.|+|||++.+.. ++.++|||||||++|||++|
T Consensus 158 ---------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~ 198 (292)
T 3o0g_A 158 ---------------------------------------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 198 (292)
T ss_dssp ---------------------------------------CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTT
T ss_pred ---------------------------------------ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHc
Confidence 11457999999999998766 89999999999999999987
Q ss_pred CCC-CCCCChHHHHHHhh
Q 017362 354 YPP-FYSDDPMSTCRKVR 370 (373)
Q Consensus 354 ~~P-f~~~~~~~~~~kI~ 370 (373)
..| |.+.+..+...+|.
T Consensus 199 ~~p~~~~~~~~~~~~~i~ 216 (292)
T 3o0g_A 199 GRPLFPGNDVDDQLKRIF 216 (292)
T ss_dssp SCCSCCCSSHHHHHHHHH
T ss_pred CCCCcCCCCHHHHHHHHH
Confidence 666 66667777766664
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=329.00 Aligned_cols=215 Identities=31% Similarity=0.621 Sum_probs=192.5
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+.+|+.++..++||||+++++++.+.+..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 6889999999999999999999999999999999976543 334456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCc---EEEeeccccccCCCCCc
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH---LRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~---vkL~DFGla~~~~~~~~ 271 (373)
|||++|++|.+.+.....+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||++........
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 999999999999988889999999999999999999999999999999999999987665 99999999976543211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
.....||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 164 ------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~ 201 (284)
T 3kk8_A 164 ------------------------------------------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201 (284)
T ss_dssp ------------------------------------------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHH
Confidence 11357999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcC
Q 017362 352 VGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+|.+||.+.+..+....+..+
T Consensus 202 ~g~~pf~~~~~~~~~~~~~~~ 222 (284)
T 3kk8_A 202 VGYPPFWDEDQHRLYAQIKAG 222 (284)
T ss_dssp HSSCSSCCSSHHHHHHHHHHT
T ss_pred HCCCCCCCCchhHHHHHHHhc
Confidence 999999999988888777653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=346.96 Aligned_cols=210 Identities=30% Similarity=0.603 Sum_probs=181.9
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCeEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYL 193 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~l 193 (373)
.++|++.+.||+|+||+||+|.++.+++.||||++.+... ...+|+.++..+ +||||+++++++.+.+.+|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 4579999999999999999999999999999999976531 134577788777 79999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCC----CcEEEeeccccccCCCC
Q 017362 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY----GHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 194 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~----~~vkL~DFGla~~~~~~ 269 (373)
||||++||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+... +.+||+|||+++.....
T Consensus 94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 99999999999999888899999999999999999999999999999999999998543 35999999999865322
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 349 (373)
.. ...+.+||+.|+|||++.+..|+.++|||||||++||
T Consensus 174 ~~-----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 212 (342)
T 2qr7_A 174 NG-----------------------------------------LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYT 212 (342)
T ss_dssp TC-----------------------------------------CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CC-----------------------------------------ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHH
Confidence 10 0124689999999999998889999999999999999
Q ss_pred HHhCCCCCCC---CChHHHHHHhhcC
Q 017362 350 MLVGYPPFYS---DDPMSTCRKVRKK 372 (373)
Q Consensus 350 ll~G~~Pf~~---~~~~~~~~kI~~~ 372 (373)
|++|.+||.+ .+..+...+|.++
T Consensus 213 ll~g~~Pf~~~~~~~~~~~~~~i~~~ 238 (342)
T 2qr7_A 213 MLTGYTPFANGPDDTPEEILARIGSG 238 (342)
T ss_dssp HHHSSCSSCSSTTSCHHHHHHHHHHC
T ss_pred HhcCCCCCCCCCcCCHHHHHHHHccC
Confidence 9999999986 4566677766543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=339.43 Aligned_cols=212 Identities=29% Similarity=0.492 Sum_probs=171.8
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|++++.||+|+||+||+|.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 468999999999999999999999999999999987543 223345678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 195 MEYLPGGDMMTLLMRK------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
|||++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99997 5999988653 3599999999999999999999999999999999999999999999999999986542
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil 347 (373)
.... ....+||+.|+|||++.+ ..++.++|||||||++
T Consensus 161 ~~~~-----------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 199 (317)
T 2pmi_A 161 PVNT-----------------------------------------FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCIL 199 (317)
T ss_dssp CCCC-----------------------------------------CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHH
T ss_pred Cccc-----------------------------------------CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHH
Confidence 2110 114579999999999986 4689999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhh
Q 017362 348 YEMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 348 ~ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
|||++|.+||.+.+..+....|.
T Consensus 200 ~el~~g~~pf~~~~~~~~~~~i~ 222 (317)
T 2pmi_A 200 AEMITGKPLFPGTNDEEQLKLIF 222 (317)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHH
T ss_pred HHHHhCCCCCCCCChHHHHHHHH
Confidence 99999999999999888887765
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=336.48 Aligned_cols=209 Identities=33% Similarity=0.591 Sum_probs=186.5
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEec
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~ 197 (373)
|...+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.++..++||||+++++++...+..|+||||
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 777889999999999999999899999999987543 33456688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccccc
Q 017362 198 LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT 277 (373)
Q Consensus 198 ~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 277 (373)
++||+|.+++. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 124 ~~~~~L~~~l~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~----- 197 (321)
T 2c30_A 124 LQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK----- 197 (321)
T ss_dssp CCSCBHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-----
T ss_pred CCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc-----
Confidence 99999999885 457999999999999999999999999999999999999999999999999999765432110
Q ss_pred ccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCC
Q 017362 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357 (373)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 357 (373)
....+||+.|+|||++.+..++.++|||||||++|||++|.+||
T Consensus 198 ------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf 241 (321)
T 2c30_A 198 ------------------------------------RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPY 241 (321)
T ss_dssp ------------------------------------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ------------------------------------cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 11457999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHhhc
Q 017362 358 YSDDPMSTCRKVRK 371 (373)
Q Consensus 358 ~~~~~~~~~~kI~~ 371 (373)
.+.++.+....+..
T Consensus 242 ~~~~~~~~~~~~~~ 255 (321)
T 2c30_A 242 FSDSPVQAMKRLRD 255 (321)
T ss_dssp TTSCHHHHHHHHHH
T ss_pred CCCCHHHHHHHHhc
Confidence 99988888777654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=347.64 Aligned_cols=204 Identities=34% Similarity=0.550 Sum_probs=171.8
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 192 (373)
...++|++++.||+|+||+||+|.+..+++.||||++..... ..+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT----SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc----ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 446889999999999999999999999999999999975432 2245778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCc--EEEeeccccccCCCCC
Q 017362 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH--LRLSDFGLCKPLDCST 270 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~--vkL~DFGla~~~~~~~ 270 (373)
+||||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+|+......
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 99999999999999988888999999999999999999999999999999999999987765 9999999987432111
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChh-hcHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME-CDWWSLGAIMYE 349 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DvwSlGvil~e 349 (373)
. ....+||+.|+|||++.+..++.+ +|||||||++|+
T Consensus 173 ~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e 210 (361)
T 3uc3_A 173 Q------------------------------------------PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYV 210 (361)
T ss_dssp --------------------------------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHH
T ss_pred C------------------------------------------CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHH
Confidence 0 114579999999999998888665 999999999999
Q ss_pred HHhCCCCCCCCCh
Q 017362 350 MLVGYPPFYSDDP 362 (373)
Q Consensus 350 ll~G~~Pf~~~~~ 362 (373)
|++|++||.+.+.
T Consensus 211 ll~g~~Pf~~~~~ 223 (361)
T 3uc3_A 211 MLVGAYPFEDPEE 223 (361)
T ss_dssp HHHSSCSCC----
T ss_pred HHhCCCCCCCCcc
Confidence 9999999987554
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=357.16 Aligned_cols=214 Identities=33% Similarity=0.667 Sum_probs=190.3
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|++++.||+|+||+||+|.+..+++.||||++.+... .......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHH-BCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4579999999999999999999999999999999976543 233456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEc---CCCcEEEeeccccccCCCCCc
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD---KYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~---~~~~vkL~DFGla~~~~~~~~ 271 (373)
|||++||+|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+.......
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 179 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc
Confidence 99999999999998888999999999999999999999999999999999999995 456899999999976542211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
....+||+.|+|||++.+ .|+.++|||||||++|+|+
T Consensus 180 ------------------------------------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll 216 (486)
T 3mwu_A 180 ------------------------------------------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILL 216 (486)
T ss_dssp --------------------------------------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHH
Confidence 114579999999999875 5999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcC
Q 017362 352 VGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+|.+||.+.+..+...+|.++
T Consensus 217 ~g~~pf~~~~~~~~~~~i~~~ 237 (486)
T 3mwu_A 217 SGTPPFYGKNEYDILKRVETG 237 (486)
T ss_dssp HSSCSSCCSSHHHHHHHHHHT
T ss_pred hCCCCCCCCCHHHHHHHHHhC
Confidence 999999999999998888764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=342.10 Aligned_cols=219 Identities=26% Similarity=0.471 Sum_probs=192.1
Q ss_pred hhHHHhhhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-----CCc
Q 017362 103 TEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-----SNC 177 (373)
Q Consensus 103 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~ 177 (373)
...+.+....+..++|.++++||+|+||+||+|.+..+++.||||++.... .....+..|+.++..+. |||
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~ 97 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNN 97 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCC
Confidence 334556777788899999999999999999999999999999999987432 22345677899998886 999
Q ss_pred eeEEeeEEEeCCeEEEEEeccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC----
Q 017362 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---- 251 (373)
Q Consensus 178 iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~---- 251 (373)
|+++++++...+..|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 98 iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp BCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCC
T ss_pred eecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccc
Confidence 999999999999999999999 999999997754 5999999999999999999999999999999999999975
Q ss_pred ---------------------CCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhh
Q 017362 252 ---------------------YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNR 310 (373)
Q Consensus 252 ---------------------~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (373)
++.+||+|||+|+.....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----------------------------------------- 215 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----------------------------------------- 215 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----------------------------------------
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCC-----------------------------------------
Confidence 789999999999754321
Q ss_pred hccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 017362 311 RMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 311 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+....|.
T Consensus 216 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~ 272 (360)
T 3llt_A 216 ---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMME 272 (360)
T ss_dssp ---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHH
Confidence 114679999999999999999999999999999999999999999998888776654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=357.54 Aligned_cols=216 Identities=35% Similarity=0.640 Sum_probs=188.9
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhh----------hhHHHHHHHHHHHHhcCCCceeEEee
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR----------GQVEHVRAERNLLAEVDSNCIVKLYC 183 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~iv~l~~ 183 (373)
..++|.+++.||+|+||+||+|.++.++..||||++.+...... ...+.+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 46789999999999999999999999999999999976543211 33467889999999999999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC---cEEEeec
Q 017362 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---HLRLSDF 260 (373)
Q Consensus 184 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~---~vkL~DF 260 (373)
++.+...+|+|||||+||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 9999999999999999999999998888999999999999999999999999999999999999998876 6999999
Q ss_pred cccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcH
Q 017362 261 GLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340 (373)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Dv 340 (373)
|+|........ ....+||+.|+|||++. ..|+.++||
T Consensus 194 g~a~~~~~~~~------------------------------------------~~~~~gt~~y~aPE~~~-~~~~~~~Di 230 (504)
T 3q5i_A 194 GLSSFFSKDYK------------------------------------------LRDRLGTAYYIAPEVLK-KKYNEKCDV 230 (504)
T ss_dssp TTCEECCTTSC------------------------------------------BCCCCSCTTTCCHHHHT-TCBCTHHHH
T ss_pred CCCEEcCCCCc------------------------------------------cccccCCcCCCCHHHhc-cCCCchHHH
Confidence 99986543211 11467999999999986 569999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHhhcC
Q 017362 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 341 wSlGvil~ell~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|||||++|+|++|.+||.+.+..+...+|.++
T Consensus 231 wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 262 (504)
T 3q5i_A 231 WSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG 262 (504)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 99999999999999999999999999888765
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=341.84 Aligned_cols=207 Identities=28% Similarity=0.521 Sum_probs=180.4
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|++++.||+|+||+||+|.+..+++.||||++..... ....+.+.+|+.++..++||||+++++++.+.+..|+|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 5789999999999999999999999999999999865432 12235578899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
|||++||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-- 161 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-- 161 (323)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE--
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc--
Confidence 999999999999988888999999999999999999999999999999999999999999999999999765322110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCC-ChhhcHHHHHHHHHHHHhC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G 353 (373)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|
T Consensus 162 -------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 204 (323)
T 3tki_A 162 -------------------------------------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204 (323)
T ss_dssp -------------------------------------CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred -------------------------------------cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhC
Confidence 01124689999999999988776 7899999999999999999
Q ss_pred CCCCCCCCh
Q 017362 354 YPPFYSDDP 362 (373)
Q Consensus 354 ~~Pf~~~~~ 362 (373)
.+||...+.
T Consensus 205 ~~pf~~~~~ 213 (323)
T 3tki_A 205 ELPWDQPSD 213 (323)
T ss_dssp SCSCSSSCT
T ss_pred CCCCCCCch
Confidence 999987654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=337.84 Aligned_cols=209 Identities=32% Similarity=0.577 Sum_probs=162.6
Q ss_pred Cccee---ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-CCceeEEeeEEEeCCeEE
Q 017362 117 DFELL---TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 117 ~y~~~---~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~ 192 (373)
+|++. +.||+|+||+||+|.+..+++.||||++.... ...+.+|+.++..+. ||||+++++++.+....|
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~ 82 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF 82 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence 35554 78999999999999999999999999986542 345678999999997 999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC---cEEEeeccccccCCCC
Q 017362 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---HLRLSDFGLCKPLDCS 269 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~---~vkL~DFGla~~~~~~ 269 (373)
+||||++||+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 83 LVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp EEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred EEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 9999999999999999988999999999999999999999999999999999999998766 8999999999765422
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 349 (373)
... ....+||+.|+|||++.+..|+.++|||||||++|+
T Consensus 163 ~~~-----------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ 201 (325)
T 3kn6_A 163 NQP-----------------------------------------LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYT 201 (325)
T ss_dssp --------------------------------------------------------------CCCCHHHHHHHHHHHHHH
T ss_pred CCc-----------------------------------------ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHH
Confidence 110 114578999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCh-------HHHHHHhhcC
Q 017362 350 MLVGYPPFYSDDP-------MSTCRKVRKK 372 (373)
Q Consensus 350 ll~G~~Pf~~~~~-------~~~~~kI~~~ 372 (373)
|++|.+||.+.+. .+...+|.++
T Consensus 202 ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~ 231 (325)
T 3kn6_A 202 MLSGQVPFQSHDRSLTCTSAVEIMKKIKKG 231 (325)
T ss_dssp HHHSSCTTC-------CCCHHHHHHHHTTT
T ss_pred HHhCCCCCCCCccccccccHHHHHHHHHcC
Confidence 9999999987543 4556665543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=336.46 Aligned_cols=216 Identities=28% Similarity=0.490 Sum_probs=183.4
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCe
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 190 (373)
.+-..++|++++.||+|+||+||+|.+. +++.||+|++.... ........+.+|+.++..++||||+++++++.+...
T Consensus 16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 93 (311)
T 3niz_A 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC 93 (311)
T ss_dssp EECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred ecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence 4455789999999999999999999985 58899999997543 223344668899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 191 LYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
+|+||||+++ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 94 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp EEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred EEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9999999975 788877654 46999999999999999999999999999999999999999999999999999865422
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ 348 (373)
... ....+||+.|+|||++.+ ..++.++|||||||++|
T Consensus 173 ~~~-----------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 211 (311)
T 3niz_A 173 VRS-----------------------------------------YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFA 211 (311)
T ss_dssp CC--------------------------------------------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHH
T ss_pred ccc-----------------------------------------ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHH
Confidence 110 113579999999999976 56899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhh
Q 017362 349 EMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 349 ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
+|++|.+||.+.+..+...+|.
T Consensus 212 ~ll~g~~pf~~~~~~~~~~~i~ 233 (311)
T 3niz_A 212 EMITGKPLFPGVTDDDQLPKIF 233 (311)
T ss_dssp HHHHSSCSCCCSSTTTHHHHHH
T ss_pred HHHhCCCCCCCCChHHHHHHHH
Confidence 9999999999988877777664
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=327.54 Aligned_cols=212 Identities=34% Similarity=0.616 Sum_probs=189.7
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|++.+.||+|+||+||+|.+..++..||+|++.... ....+.+.+|+.++..++||||+++++++.+....|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF---VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc---cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 356999999999999999999999999999999987653 23356688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEE---cCCCcEEEeeccccccCCCCCc
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl---~~~~~vkL~DFGla~~~~~~~~ 271 (373)
|||++|++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164 (277)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence 9999999999999888889999999999999999999999999999999999999 7889999999999976543211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
.....||+.|+|||++.+ .++.++|||||||++|+|+
T Consensus 165 ------------------------------------------~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~ 201 (277)
T 3f3z_A 165 ------------------------------------------MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLL 201 (277)
T ss_dssp ------------------------------------------BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHH
T ss_pred ------------------------------------------hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHH
Confidence 114579999999999865 4999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcC
Q 017362 352 VGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+|.+||.+.+..+...++.++
T Consensus 202 ~g~~p~~~~~~~~~~~~~~~~ 222 (277)
T 3f3z_A 202 CGYPPFSAPTDSEVMLKIREG 222 (277)
T ss_dssp HSSCSSCCSSHHHHHHHHHHC
T ss_pred HCCCCCCCCCHHHHHHHHHhC
Confidence 999999999988888887654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=329.21 Aligned_cols=218 Identities=33% Similarity=0.568 Sum_probs=195.3
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 192 (373)
...++|.+.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.++..++||||+++++++.+.+..|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 34678999999999999999999999999999999997765444555677889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcc
Q 017362 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 272 (373)
+||||+++++|.+++.....+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.........
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 171 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 171 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence 99999999999999988888999999999999999999999999999999999999999999999999999765422110
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 352 (373)
.....||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 172 -----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 210 (294)
T 2rku_A 172 -----------------------------------------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV 210 (294)
T ss_dssp -----------------------------------------BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHh
Confidence 113579999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhc
Q 017362 353 GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 353 G~~Pf~~~~~~~~~~kI~~ 371 (373)
|.+||...+..+.+..+..
T Consensus 211 g~~p~~~~~~~~~~~~~~~ 229 (294)
T 2rku_A 211 GKPPFETSCLKETYLRIKK 229 (294)
T ss_dssp SSCTTCCSSHHHHHHHHHT
T ss_pred CCCCCCCCCHHHHHHHHhh
Confidence 9999999888887777654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=341.94 Aligned_cols=213 Identities=34% Similarity=0.576 Sum_probs=174.3
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 191 (373)
....++|++.+.||+|+||+||+|.+..+++.||||++.... ..+.+.+|+.++..++||||+++++++.+.+..
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 123 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI 123 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeE
Confidence 344678999999999999999999999999999999997542 234577899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC---CCcEEEeeccccccCCC
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---YGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~---~~~vkL~DFGla~~~~~ 268 (373)
|+||||++||+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp EEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 999999999999999988888999999999999999999999999999999999999975 89999999999875432
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 348 (373)
... ....+||+.|+|||++.+..++.++|||||||++|
T Consensus 204 ~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 241 (349)
T 2w4o_A 204 QVL------------------------------------------MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITY 241 (349)
T ss_dssp ---------------------------------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred ccc------------------------------------------cccccCCCCccCHHHhcCCCCCcccchHHHHHHHH
Confidence 110 11457999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHH-HHHHhhc
Q 017362 349 EMLVGYPPFYSDDPMS-TCRKVRK 371 (373)
Q Consensus 349 ell~G~~Pf~~~~~~~-~~~kI~~ 371 (373)
||++|..||...+..+ ...+|++
T Consensus 242 ell~g~~pf~~~~~~~~~~~~i~~ 265 (349)
T 2w4o_A 242 ILLCGFEPFYDERGDQFMFRRILN 265 (349)
T ss_dssp HHHHSSCTTCCTTCHHHHHHHHHT
T ss_pred HHHhCCCCCCCCcccHHHHHHHHh
Confidence 9999999998776544 5666654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=337.02 Aligned_cols=216 Identities=30% Similarity=0.566 Sum_probs=191.9
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhh---hhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR---GQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 191 (373)
.++|++.+.||+|+||.||+|.+..++..||+|++........ ...+.+.+|+.++..++||||+++++++.+...+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 4579999999999999999999999999999999876432211 1346688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC----cEEEeeccccccCC
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG----HLRLSDFGLCKPLD 267 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~----~vkL~DFGla~~~~ 267 (373)
|+||||++|++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++ ++||+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 99999999999999998888899999999999999999999999999999999999999888 89999999997654
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 347 (373)
.... .....||+.|+|||++.+..++.++|||||||++
T Consensus 171 ~~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 208 (321)
T 2a2a_A 171 DGVE------------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208 (321)
T ss_dssp TTCC------------------------------------------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred cccc------------------------------------------ccccCCCCCccCcccccCCCCCCccccHHHHHHH
Confidence 3210 1145799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhhcC
Q 017362 348 YEMLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 348 ~ell~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|+|++|.+||.+.+..+....|.++
T Consensus 209 ~~l~~g~~pf~~~~~~~~~~~i~~~ 233 (321)
T 2a2a_A 209 YILLSGASPFLGDTKQETLANITSV 233 (321)
T ss_dssp HHHHHSCCSSCCSSHHHHHHHHHTT
T ss_pred HHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 9999999999999988888777653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=333.60 Aligned_cols=218 Identities=22% Similarity=0.382 Sum_probs=182.9
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 192 (373)
+..++|.+.+.||+|+||+||+|.+..++..||+|++.... ....+.+.+|+.++..++||||+++++++.+++..|
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 45689999999999999999999999999999999885432 344567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 193 LIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
+||||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999999999987 56799999999999999999999999999999999999999999999999999987653321
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
...... .............+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 164 ~~~~~~---------------------------~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 216 (310)
T 3s95_A 164 QPEGLR---------------------------SLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216 (310)
T ss_dssp -------------------------------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred cccccc---------------------------cccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHh
Confidence 110000 00000111123568999999999999999999999999999999999
Q ss_pred hCCCCCCCC
Q 017362 352 VGYPPFYSD 360 (373)
Q Consensus 352 ~G~~Pf~~~ 360 (373)
+|.+||...
T Consensus 217 ~g~~~~~~~ 225 (310)
T 3s95_A 217 GRVNADPDY 225 (310)
T ss_dssp HTCCSSTTT
T ss_pred cCCCCCcch
Confidence 999999764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=336.44 Aligned_cols=218 Identities=33% Similarity=0.568 Sum_probs=195.3
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 192 (373)
....+|.+.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.++..++||||+++++++.+.+.+|
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 34578999999999999999999999999999999998765444556677889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcc
Q 017362 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 272 (373)
+||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 197 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence 99999999999999988888999999999999999999999999999999999999999999999999999865422110
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 352 (373)
....+||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 198 -----------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 236 (335)
T 2owb_A 198 -----------------------------------------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV 236 (335)
T ss_dssp -----------------------------------------BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHH
Confidence 113579999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhc
Q 017362 353 GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 353 G~~Pf~~~~~~~~~~kI~~ 371 (373)
|..||...+..+.+..+.+
T Consensus 237 g~~pf~~~~~~~~~~~~~~ 255 (335)
T 2owb_A 237 GKPPFETSCLKETYLRIKK 255 (335)
T ss_dssp SSCTTCCSSHHHHHHHHHH
T ss_pred CcCCCCCCCHHHHHHHHhc
Confidence 9999999888887776654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=339.01 Aligned_cols=222 Identities=23% Similarity=0.359 Sum_probs=189.6
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCCc---eEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGH---VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 187 (373)
.++..++|++.+.||+|+||+||+|.+..++. .||||++.... .....+.+.+|+.++..++||||+++++++.+
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 45677899999999999999999999976555 49999997542 23345678899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccC
Q 017362 188 DEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (373)
Q Consensus 188 ~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~ 266 (373)
.+..|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999999999654 57999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHH
Q 017362 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (373)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvi 346 (373)
........ ......+|+.|+|||++.+..++.++|||||||+
T Consensus 202 ~~~~~~~~--------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i 243 (325)
T 3kul_A 202 EDDPDAAY--------------------------------------TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVV 243 (325)
T ss_dssp C----CCE--------------------------------------ECC---CCGGGSCHHHHHHCEECHHHHHHHHHHH
T ss_pred ccCcccee--------------------------------------eccCCCCcccccCHhHhcCCCCCcHHHHHHHHHH
Confidence 43211100 0113457889999999998999999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 347 MYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 347 l~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+|||++ |.+||.+.+..+....+..+
T Consensus 244 l~ell~~g~~p~~~~~~~~~~~~~~~~ 270 (325)
T 3kul_A 244 MWEVLAYGERPYWNMTNRDVISSVEEG 270 (325)
T ss_dssp HHHHHTTSCCTTTTSCHHHHHHHHHTT
T ss_pred HHHHHcCCCCCcccCCHHHHHHHHHcC
Confidence 999999 99999999998888877653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=344.44 Aligned_cols=207 Identities=19% Similarity=0.310 Sum_probs=175.3
Q ss_pred hhccCCCCCcceeceeeeeCcEEEEEE-----EEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC---CCceeE
Q 017362 109 QRHKMGADDFELLTMIGKGAFGEVRVC-----REKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD---SNCIVK 180 (373)
Q Consensus 109 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~ 180 (373)
....+..++|.+.+.||+|+||+||+| .+..+++.||||++.... ...+..|..++..+. |+||+.
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~ 131 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMK 131 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhh
Confidence 345567788999999999999999999 466789999999987542 234666777777776 899999
Q ss_pred EeeEEEeCCeEEEEEeccCCCCHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC----
Q 017362 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMR-----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---- 251 (373)
Q Consensus 181 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~---- 251 (373)
+++++...+..|+||||++||+|.+++.. ...+++..+..++.||+.||.|||++|||||||||+|||++.
T Consensus 132 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTC
T ss_pred hheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccC
Confidence 99999999999999999999999999974 457999999999999999999999999999999999999998
Q ss_pred -------CCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCc
Q 017362 252 -------YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYI 324 (373)
Q Consensus 252 -------~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 324 (373)
++++||+|||+|+.+...... ......+||+.|+
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~---------------------------------------~~~~~~~gt~~y~ 252 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKG---------------------------------------TIFTAKCETSGFQ 252 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTT---------------------------------------EEECCSSCTTSCC
T ss_pred ccccccccCCEEEeeCchhhhhhccCCC---------------------------------------ceeeeecCCCCCC
Confidence 899999999999754311100 0112568999999
Q ss_pred ccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCCC
Q 017362 325 APEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (373)
Q Consensus 325 aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 360 (373)
|||++.+..|+.++|||||||++|||++|++||...
T Consensus 253 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 253 CVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp CHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred ChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence 999999999999999999999999999999999643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=334.97 Aligned_cols=216 Identities=27% Similarity=0.430 Sum_probs=181.2
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhh--hhhhHHHHHHHHHHHHhc---CCCceeEEeeEEEe
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML--RRGQVEHVRAERNLLAEV---DSNCIVKLYCSFQD 187 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~l---~h~~iv~l~~~~~~ 187 (373)
+..++|++++.||+|+||+||+|.+..+++.||||++...... .......+.+|+.++..+ .||||+++++++.+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4578999999999999999999999999999999998643211 111123455677666655 59999999999987
Q ss_pred CC-----eEEEEEeccCCCCHHHHHhhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeec
Q 017362 188 DE-----FLYLIMEYLPGGDMMTLLMRKDT--LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDF 260 (373)
Q Consensus 188 ~~-----~~~lV~E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DF 260 (373)
.. .+|+||||++ |+|.+++..... +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 65 5899999996 699999977654 999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcH
Q 017362 261 GLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340 (373)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Dv 340 (373)
|+|+....... ....+||+.|+|||++.+..++.++||
T Consensus 165 g~a~~~~~~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di 202 (308)
T 3g33_A 165 GLARIYSYQMA------------------------------------------LTPVVVTLWYRAPEVLLQSTYATPVDM 202 (308)
T ss_dssp SCTTTSTTCCC------------------------------------------SGGGGCCCSSCCHHHHHTSCCCSTHHH
T ss_pred ccccccCCCcc------------------------------------------cCCccccccccCchHHcCCCCCchHHH
Confidence 99976542211 114679999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 017362 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 341 wSlGvil~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
|||||++|||++|.+||.+.+..+...+|.+
T Consensus 203 wslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 233 (308)
T 3g33_A 203 WSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 233 (308)
T ss_dssp HHHHHHHHHTTTSSCSCCCSSHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999999999999999988887753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=331.94 Aligned_cols=211 Identities=29% Similarity=0.473 Sum_probs=180.8
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++++.||+|+||+||+|.+ .+++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 6799999999999999999998 6789999999865432 2233456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 196 EYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 196 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
||+++ +|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 156 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-- 156 (288)
T ss_dssp ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc--
Confidence 99975 899888764 67999999999999999999999999999999999999999999999999999765321100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHHHHHHHHHHHhC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G 353 (373)
....+||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 157 ---------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g 197 (288)
T 1ob3_A 157 ---------------------------------------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197 (288)
T ss_dssp --------------------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred ---------------------------------------cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 1135789999999999764 589999999999999999999
Q ss_pred CCCCCCCChHHHHHHhh
Q 017362 354 YPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 354 ~~Pf~~~~~~~~~~kI~ 370 (373)
.+||.+.+..+...+|.
T Consensus 198 ~~pf~~~~~~~~~~~~~ 214 (288)
T 1ob3_A 198 TPLFPGVSEADQLMRIF 214 (288)
T ss_dssp SCSCCCSSHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHH
Confidence 99999998888777764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=339.15 Aligned_cols=210 Identities=30% Similarity=0.480 Sum_probs=185.3
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
..|++++.||+|+||+||+|.+..++..||||++...........+.+.+|+.++..++||||+++++++.+.+..|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45999999999999999999999999999999987543333445567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 196 EYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 196 E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
||++ |+|.+++. ....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~----- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-----
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-----
Confidence 9996 57877775 4568999999999999999999999999999999999999999999999999999764321
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc---CCCCChhhcHHHHHHHHHHHH
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DvwSlGvil~ell 351 (373)
...+||+.|+|||++. ...++.++|||||||++|||+
T Consensus 208 ----------------------------------------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell 247 (348)
T 1u5q_A 208 ----------------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 247 (348)
T ss_dssp ----------------------------------------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHH
Confidence 1457999999999985 567899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhc
Q 017362 352 VGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~~ 371 (373)
+|.+||.+.+..+...++..
T Consensus 248 ~g~~p~~~~~~~~~~~~~~~ 267 (348)
T 1u5q_A 248 ERKPPLFNMNAMSALYHIAQ 267 (348)
T ss_dssp HSSCTTTTSCHHHHHHHHHH
T ss_pred hCCCCCCCCChHHHHHHHHh
Confidence 99999999888777766654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=325.41 Aligned_cols=219 Identities=30% Similarity=0.568 Sum_probs=188.2
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCe
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 190 (373)
..+..++|.+.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++.+.+.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD 85 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence 45667899999999999999999999998999999999987655455556778999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
.|+||||+++++|.+++.....+++..+..++.|++.||.|||++|++|+||||+|||++.++.+||+|||++.......
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999997654221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCC-ChhhcHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYE 349 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DvwSlGvil~e 349 (373)
. .....||+.|+|||++.+..+ +.++||||||+++|+
T Consensus 166 ~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~ 203 (276)
T 2h6d_A 166 F------------------------------------------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYA 203 (276)
T ss_dssp -----------------------------------------------------CCTGGGTTSCCCHHHHHHHHHHHHHHH
T ss_pred c------------------------------------------eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHH
Confidence 0 013569999999999988776 689999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhc
Q 017362 350 MLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 350 ll~G~~Pf~~~~~~~~~~kI~~ 371 (373)
|++|..||...+..+...+|..
T Consensus 204 l~~g~~p~~~~~~~~~~~~~~~ 225 (276)
T 2h6d_A 204 LLCGTLPFDDEHVPTLFKKIRG 225 (276)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHH
T ss_pred HHhCCCCCCCCcHHHHHHHhhc
Confidence 9999999999888888777654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=336.97 Aligned_cols=205 Identities=28% Similarity=0.482 Sum_probs=179.3
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC--e
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE--F 190 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~--~ 190 (373)
...++|.+.+.||+|+||+||+|.+..+++.||||++..... ....+.+.+|+.++..++||||+++++++.+.. .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 456789999999999999999999999999999999976543 233566788999999999999999999998765 7
Q ss_pred EEEEEeccCCCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEE----cCCCcEEEeecccc
Q 017362 191 LYLIMEYLPGGDMMTLLMRKD---TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLC 263 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl----~~~~~vkL~DFGla 263 (373)
.|+||||++|++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 899999999999999997643 39999999999999999999999999999999999999 78888999999999
Q ss_pred ccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc--------CCCCC
Q 017362 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL--------KKGYG 335 (373)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--------~~~~~ 335 (373)
+....... ..+.+||+.|+|||++. +..++
T Consensus 164 ~~~~~~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 201 (319)
T 4euu_A 164 RELEDDEQ------------------------------------------FVSLYGTEEYLHPDMYERAVLRKDHQKKYG 201 (319)
T ss_dssp EECCTTCC------------------------------------------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBC
T ss_pred eecCCCCc------------------------------------------eeecccCCCccCHHHhhhccccccccCCCC
Confidence 86543211 11457999999999986 57799
Q ss_pred hhhcHHHHHHHHHHHHhCCCCCCCCC
Q 017362 336 MECDWWSLGAIMYEMLVGYPPFYSDD 361 (373)
Q Consensus 336 ~~~DvwSlGvil~ell~G~~Pf~~~~ 361 (373)
.++|||||||++|||++|.+||...+
T Consensus 202 ~~~DiwslG~il~el~~g~~pf~~~~ 227 (319)
T 4euu_A 202 ATVDLWSIGVTFYHAATGSLPFRPFE 227 (319)
T ss_dssp TTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999997543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=328.07 Aligned_cols=215 Identities=33% Similarity=0.650 Sum_probs=167.5
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|++.+.||+|+||.||+|.+..+++.||||++...........+.+.+|+.++..++||||+++++++.+.+..|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 56899999999999999999999999999999999876554455567789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 195 MEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
|||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~- 168 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK- 168 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc-
Confidence 9999999999999765 57999999999999999999999999999999999999999999999999999765422100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhC
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 353 (373)
.....||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 169 ----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 208 (278)
T 3cok_A 169 ----------------------------------------HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIG 208 (278)
T ss_dssp ---------------------------------------------------------------CTHHHHHHHHHHHHHHS
T ss_pred ----------------------------------------ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 1135799999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHhh
Q 017362 354 YPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 354 ~~Pf~~~~~~~~~~kI~ 370 (373)
.+||...+..+...++.
T Consensus 209 ~~p~~~~~~~~~~~~~~ 225 (278)
T 3cok_A 209 RPPFDTDTVKNTLNKVV 225 (278)
T ss_dssp SCSSCCCSCC-----CC
T ss_pred CCCCCChhHHHHHHHHh
Confidence 99998877665555443
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=355.98 Aligned_cols=213 Identities=34% Similarity=0.637 Sum_probs=184.8
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++++.||+|+||+||+|.++.++..||||++.+.... ......+.+|+.+++.++||||++++++|.+...+|+||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4699999999999999999999999999999999865432 223466889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCC---CcEEEeeccccccCCCCCcc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY---GHLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~---~~vkL~DFGla~~~~~~~~~ 272 (373)
||++||+|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++.. +.+||+|||+|........
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~- 194 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK- 194 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC-
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc-
Confidence 999999999999888899999999999999999999999999999999999999764 5599999999976542211
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 352 (373)
....+||+.|+|||++. ..|+.++|||||||++|+|++
T Consensus 195 -----------------------------------------~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~ 232 (494)
T 3lij_A 195 -----------------------------------------MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLA 232 (494)
T ss_dssp -----------------------------------------BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHh
Confidence 11467999999999985 579999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcC
Q 017362 353 GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 353 G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|.+||.+.++.+...+|.++
T Consensus 233 g~~pf~~~~~~~~~~~i~~~ 252 (494)
T 3lij_A 233 GYPPFGGQTDQEILRKVEKG 252 (494)
T ss_dssp SSCSSCCSSHHHHHHHHHHT
T ss_pred CCCCCCCCCHHHHHHHHHhC
Confidence 99999999999998888764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=337.15 Aligned_cols=216 Identities=22% Similarity=0.312 Sum_probs=183.2
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCeEE
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~ 192 (373)
..++|++.+.||+|+||+||+|.+..+++.||||++..... .+.+..|+.++..+ +||||+++++++.+.+..|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 45789999999999999999999999999999999865421 23477899999999 9999999999999999999
Q ss_pred EEEeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCc-----EEEeeccccccC
Q 017362 193 LIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH-----LRLSDFGLCKPL 266 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~-----vkL~DFGla~~~ 266 (373)
+||||+ +++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+|+.+
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999999 9999999976 468999999999999999999999999999999999999999887 999999999865
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHH
Q 017362 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (373)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvi 346 (373)
......... + .......+||+.|+|||++.+..++.++|||||||+
T Consensus 161 ~~~~~~~~~----------------~------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 206 (330)
T 2izr_A 161 IDPETKKHI----------------P------------------YREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHM 206 (330)
T ss_dssp BCTTTCCBC----------------C------------------CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred ecCCCCccc----------------c------------------ccccCCcCCCccccChHHHcCCCCCchhHHHHHHHH
Confidence 432211000 0 000125689999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCC---ChHHHHHHh
Q 017362 347 MYEMLVGYPPFYSD---DPMSTCRKV 369 (373)
Q Consensus 347 l~ell~G~~Pf~~~---~~~~~~~kI 369 (373)
+|||++|.+||.+. +..+.+.+|
T Consensus 207 l~ell~g~~Pf~~~~~~~~~~~~~~i 232 (330)
T 2izr_A 207 FMYFLRGSLPWQGLKADTLKERYQKI 232 (330)
T ss_dssp HHHHHHSSCTTTTCCCSSHHHHHHHH
T ss_pred HHHHhcCCCCccccccccHHHHHHHH
Confidence 99999999999984 344445544
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=345.72 Aligned_cols=198 Identities=35% Similarity=0.599 Sum_probs=167.2
Q ss_pred CCCccee-ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHH-HhcCCCceeEEeeEEEe----C
Q 017362 115 ADDFELL-TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL-AEVDSNCIVKLYCSFQD----D 188 (373)
Q Consensus 115 ~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~l~~~~~~----~ 188 (373)
.++|.+. +.||+|+||+||+|.+..+++.||||++... ..+.+|+.++ ...+||||++++++|.. .
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 4678777 7899999999999999999999999998643 2356677776 44589999999999876 5
Q ss_pred CeEEEEEeccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC---CCcEEEeecccc
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---YGHLRLSDFGLC 263 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~---~~~vkL~DFGla 263 (373)
..+|+|||||+||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 67999999999999999997653 5999999999999999999999999999999999999998 789999999999
Q ss_pred ccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHH
Q 017362 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (373)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSl 343 (373)
+....... ....+||+.|+|||++.+..|+.++|||||
T Consensus 212 ~~~~~~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 249 (400)
T 1nxk_A 212 KETTSHNS------------------------------------------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 249 (400)
T ss_dssp EECC-----------------------------------------------------CTTCCGGGSCCCCSSSHHHHHHH
T ss_pred cccCCCCc------------------------------------------cccCCCCCCccCHhhcCCCCCCCcccHHHH
Confidence 75432110 114679999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCh
Q 017362 344 GAIMYEMLVGYPPFYSDDP 362 (373)
Q Consensus 344 Gvil~ell~G~~Pf~~~~~ 362 (373)
||++|||++|.+||.+.+.
T Consensus 250 G~il~ell~g~~pf~~~~~ 268 (400)
T 1nxk_A 250 GVIMYILLCGYPPFYSNHG 268 (400)
T ss_dssp HHHHHHHHHSSCSCCCCTT
T ss_pred HHHHHHHHhCCCCCCCCcc
Confidence 9999999999999987654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=339.56 Aligned_cols=237 Identities=29% Similarity=0.457 Sum_probs=199.4
Q ss_pred HHhcCCCCHHHHHHHHHHHHhhhhhHHHhhhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhh
Q 017362 80 KLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ 159 (373)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~ 159 (373)
++.+.++.++.......++... .....+..++|++++.||+|+||+||+|.+..++..||+|++.... ....
T Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~ 74 (360)
T 3eqc_A 3 KLEELELDEQQRKRLEAFLTQK------QKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAI 74 (360)
T ss_dssp ---CCCCCHHHHHHHHHHHHHH------HTCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHH
T ss_pred chhhhhhhhhhhhhHHHHhhhh------hcccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHH
Confidence 3455566666655555444322 3445677899999999999999999999999999999999987542 2334
Q ss_pred HHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCe
Q 017362 160 VEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH-HYI 238 (373)
Q Consensus 160 ~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~-gii 238 (373)
...+.+|+.++..++||||+++++++.+++.+|+||||++|++|.+++.....+++..+..++.+++.||.|||+. ||+
T Consensus 75 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~ 154 (360)
T 3eqc_A 75 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 154 (360)
T ss_dssp HHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCC
T ss_pred HHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEE
Confidence 5678899999999999999999999999999999999999999999998888899999999999999999999985 999
Q ss_pred eecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccc
Q 017362 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTV 318 (373)
Q Consensus 239 HrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (373)
||||||+|||++.++++||+|||++...... .....+
T Consensus 155 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-------------------------------------------~~~~~~ 191 (360)
T 3eqc_A 155 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-------------------------------------------MANSFV 191 (360)
T ss_dssp CSCCSGGGEEECTTCCEEECCCCCCHHHHHH-------------------------------------------C----C
T ss_pred cCCccHHHEEECCCCCEEEEECCCCcccccc-------------------------------------------cccCCC
Confidence 9999999999999999999999998643211 112457
Q ss_pred cCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 017362 319 GTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCR 367 (373)
Q Consensus 319 gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~ 367 (373)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+...
T Consensus 192 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 240 (360)
T 3eqc_A 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 240 (360)
T ss_dssp CCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHH
T ss_pred CCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999999999999999999999999999999999999887766543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=332.10 Aligned_cols=214 Identities=29% Similarity=0.455 Sum_probs=183.7
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|++++.||+|+||+||+|.+..+++.||||++.... ........+.+|+.++..++||||+++++++.+.+..|+|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 368999999999999999999999999999999886543 2233346678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
|||+++++|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 158 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY-- 158 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc--
Confidence 999999999999888888999999999999999999999999999999999999999999999999999765422100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHHHHHhC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G 353 (373)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 159 ---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g 199 (311)
T 4agu_A 159 ---------------------------------------YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199 (311)
T ss_dssp ----------------------------------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHS
T ss_pred ---------------------------------------cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhC
Confidence 113579999999999986 6689999999999999999999
Q ss_pred CCCCCCCChHHHHHHhh
Q 017362 354 YPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 354 ~~Pf~~~~~~~~~~kI~ 370 (373)
.+||.+.+..+....+.
T Consensus 200 ~~p~~~~~~~~~~~~~~ 216 (311)
T 4agu_A 200 VPLWPGKSDVDQLYLIR 216 (311)
T ss_dssp SCSCCCSSHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHH
Confidence 99999998887776654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=342.39 Aligned_cols=207 Identities=29% Similarity=0.558 Sum_probs=179.3
Q ss_pred eceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEeccCC
Q 017362 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (373)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~g 200 (373)
.+.||+|+||.||+|.+..+|..||+|++..... ...+.+.+|+.++..++||||+++++++.+.+.+|+||||++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 5689999999999999999999999999976432 2345688999999999999999999999999999999999999
Q ss_pred CCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEE--cCCCcEEEeeccccccCCCCCccccccc
Q 017362 201 GDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL--DKYGHLRLSDFGLCKPLDCSTLQEQDFT 277 (373)
Q Consensus 201 g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl--~~~~~vkL~DFGla~~~~~~~~~~~~~~ 277 (373)
|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+.....
T Consensus 171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~------ 244 (373)
T 2x4f_A 171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK------ 244 (373)
T ss_dssp CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB------
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc------
Confidence 9999988654 469999999999999999999999999999999999999 5678999999999986643211
Q ss_pred ccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCC
Q 017362 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357 (373)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 357 (373)
....+||+.|+|||++.+..++.++|||||||++|||++|.+||
T Consensus 245 ------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 288 (373)
T 2x4f_A 245 ------------------------------------LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPF 288 (373)
T ss_dssp ------------------------------------CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ------------------------------------cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCC
Confidence 11357999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHhhcC
Q 017362 358 YSDDPMSTCRKVRKK 372 (373)
Q Consensus 358 ~~~~~~~~~~kI~~~ 372 (373)
.+.+..+...+|++.
T Consensus 289 ~~~~~~~~~~~i~~~ 303 (373)
T 2x4f_A 289 LGDNDAETLNNILAC 303 (373)
T ss_dssp CCSSHHHHHHHHHHT
T ss_pred CCCCHHHHHHHHHhc
Confidence 999999888888753
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=329.84 Aligned_cols=212 Identities=32% Similarity=0.639 Sum_probs=187.4
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.++..++||||+++++++.+.+..|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 3579999999999999999999999999999999976432 2234578899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEE---cCCCcEEEeeccccccCCCCCc
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl---~~~~~vkL~DFGla~~~~~~~~ 271 (373)
|||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~- 163 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI- 163 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT-
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc-
Confidence 9999999999999888889999999999999999999999999999999999999 788999999999986532110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
....+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 164 ------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 201 (304)
T 2jam_A 164 ------------------------------------------MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILL 201 (304)
T ss_dssp ------------------------------------------THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHH
Confidence 01346999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcC
Q 017362 352 VGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+|.+||.+.+..+...+|.++
T Consensus 202 ~g~~pf~~~~~~~~~~~i~~~ 222 (304)
T 2jam_A 202 CGYPPFYEETESKLFEKIKEG 222 (304)
T ss_dssp HSSCTTTTSCHHHHHHHHHHC
T ss_pred HCCCCCCCCCHHHHHHHHHcC
Confidence 999999999888888877654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=337.01 Aligned_cols=223 Identities=23% Similarity=0.389 Sum_probs=192.6
Q ss_pred hhccCCCCCcceeceeeeeCcEEEEEEEEc-----CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEee
Q 017362 109 QRHKMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183 (373)
Q Consensus 109 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~ 183 (373)
....+..++|++++.||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.++..++||||+++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 117 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLG 117 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 345677899999999999999999999986 345889999997542 2334567889999999999999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHHhhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 017362 184 SFQDDEFLYLIMEYLPGGDMMTLLMRK------------------------DTLTEDEARFYVAETVLAIESIHKHHYIH 239 (373)
Q Consensus 184 ~~~~~~~~~lV~E~~~gg~L~~~l~~~------------------------~~l~~~~~~~i~~qi~~aL~~LH~~giiH 239 (373)
++.+.+.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+|
T Consensus 118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH 197 (343)
T 1luf_A 118 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 197 (343)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 999999999999999999999999763 56999999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhcccccccc
Q 017362 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVG 319 (373)
Q Consensus 240 rDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 319 (373)
|||||+|||++.++.+||+|||++.......... ......|
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~---------------------------------------~~~~~~~ 238 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYK---------------------------------------ADGNDAI 238 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC-------------------------------------------CCB
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCcccc---------------------------------------ccCCCcc
Confidence 9999999999999999999999997653221100 0113568
Q ss_pred CCCCcccccccCCCCChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 320 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 320 t~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....|.++
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 292 (343)
T 1luf_A 239 PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG 292 (343)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT
T ss_pred cceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCC
Confidence 999999999999999999999999999999999 99999999998888877654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=324.98 Aligned_cols=217 Identities=19% Similarity=0.336 Sum_probs=189.5
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCe
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 190 (373)
..+..++|++.+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.++..++||||+++++++.+...
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred EEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence 3466789999999999999999999886 567899999976432 23558889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 191 LYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
.|+||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 99999999999999999654 46999999999999999999999999999999999999999999999999999765322
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 349 (373)
... ......||+.|+|||++.+..++.++|||||||++|+
T Consensus 160 ~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ 199 (269)
T 4hcu_A 160 QYT----------------------------------------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWE 199 (269)
T ss_dssp HHH----------------------------------------STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred ccc----------------------------------------cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHH
Confidence 100 0114567889999999999999999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHhhcC
Q 017362 350 MLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 350 ll~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|++ |.+||.+.+..+....+..+
T Consensus 200 ll~~g~~p~~~~~~~~~~~~~~~~ 223 (269)
T 4hcu_A 200 VFSEGKIPYENRSNSEVVEDISTG 223 (269)
T ss_dssp HHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred HhcCCCCCCCCCCHHHHHHHHhcC
Confidence 999 99999999998888877653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=336.77 Aligned_cols=217 Identities=26% Similarity=0.434 Sum_probs=180.3
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 191 (373)
....++|++++.||+|+||+||+|.+..+++.||||++..... .......+.+|+.++..++||||+++++++.+.+.+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL 108 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence 3456789999999999999999999999999999999975432 223345577899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEc-----CCCcEEEeeccccccC
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD-----KYGHLRLSDFGLCKPL 266 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~-----~~~~vkL~DFGla~~~ 266 (373)
|+||||++ |+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|...
T Consensus 109 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 109 HLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 99999996 59999999888999999999999999999999999999999999999994 4556999999999765
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHHHHH
Q 017362 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGA 345 (373)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlGv 345 (373)
...... ....+||+.|+|||++.+. .++.++|||||||
T Consensus 188 ~~~~~~-----------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 226 (329)
T 3gbz_A 188 GIPIRQ-----------------------------------------FTHEIITLWYRPPEILLGSRHYSTSVDIWSIAC 226 (329)
T ss_dssp C----------------------------------------------------CCTTCCHHHHTTCCCCCTHHHHHHHHH
T ss_pred CCcccc-----------------------------------------cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHH
Confidence 322100 1145789999999999875 4899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHhhc
Q 017362 346 IMYEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 346 il~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
++|||++|.+||.+.+..+...+|.+
T Consensus 227 il~ell~g~~pf~~~~~~~~~~~~~~ 252 (329)
T 3gbz_A 227 IWAEMLMKTPLFPGDSEIDQLFKIFE 252 (329)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred HHHHHHHCCCCcCCCCHHHHHHHHHH
Confidence 99999999999999998888877753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=337.54 Aligned_cols=221 Identities=30% Similarity=0.516 Sum_probs=185.6
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhh--hhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML--RRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 192 (373)
.++|++.+.||+|+||+||+|.+..++..||+|++...... .....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 35699999999999999999999999999999999876432 2345577899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhh----------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 017362 193 LIMEYLPGGDMMTLLMR----------------------------------------KDTLTEDEARFYVAETVLAIESI 232 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~----------------------------------------~~~l~~~~~~~i~~qi~~aL~~L 232 (373)
+||||++||+|.+++.. ...+++..+..++.||+.||.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 99999999999999842 11246788999999999999999
Q ss_pred HhCCCeeecCCCCCEEEcCCC--cEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhh
Q 017362 233 HKHHYIHRDIKPDNLLLDKYG--HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNR 310 (373)
Q Consensus 233 H~~giiHrDikp~NILl~~~~--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (373)
|++||+||||||+|||++.++ .+||+|||++..+........
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~------------------------------------ 228 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY------------------------------------ 228 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------------------------------------
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCcccc------------------------------------
Confidence 999999999999999998776 899999999976532211000
Q ss_pred hccccccccCCCCcccccccC--CCCChhhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcC
Q 017362 311 RMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 311 ~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
.......||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+...+++++
T Consensus 229 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 291 (345)
T 3hko_A 229 -YGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNK 291 (345)
T ss_dssp -------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred -ccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhc
Confidence 00114579999999999975 67899999999999999999999999999988888887654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=329.71 Aligned_cols=215 Identities=24% Similarity=0.357 Sum_probs=180.0
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.++..++||||+++++++.+.+.+|+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 57899999999999999999999999999999999866544444557788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
|||++|++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-- 190 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT-- 190 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc--
Confidence 999999999999988888999999999999999999999999999999999999999999999999998765322110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 354 (373)
......||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 191 --------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 232 (309)
T 2h34_A 191 --------------------------------------QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS 232 (309)
T ss_dssp --------------------------------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSS
T ss_pred --------------------------------------cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCC
Confidence 011357999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHh
Q 017362 355 PPFYSDDPMSTCRKV 369 (373)
Q Consensus 355 ~Pf~~~~~~~~~~kI 369 (373)
+||.+.+.......+
T Consensus 233 ~pf~~~~~~~~~~~~ 247 (309)
T 2h34_A 233 PPYQGDQLSVMGAHI 247 (309)
T ss_dssp CSSCSCHHHHHHHHH
T ss_pred CCCCCchHHHHHHHh
Confidence 999987766444433
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=336.98 Aligned_cols=216 Identities=31% Similarity=0.599 Sum_probs=189.1
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhH-----hhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeC
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSE-----MLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDD 188 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~ 188 (373)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+.+|+.++..+ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 357999999999999999999999899999999986532 11122345678899999999 899999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
...|+||||++|++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++..+..
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 99999999999999999998888899999999999999999999999999999999999999999999999999976543
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC------CCCChhhcHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK------KGYGMECDWWS 342 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~~~~~DvwS 342 (373)
... ....+||+.|+|||++.+ ..++.++||||
T Consensus 253 ~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~s 290 (365)
T 2y7j_A 253 GEK------------------------------------------LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWA 290 (365)
T ss_dssp TCC------------------------------------------BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHH
T ss_pred Ccc------------------------------------------cccCCCCCCccChhhccccccccCcCCCchhhHHh
Confidence 211 114679999999999863 36899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHhhcC
Q 017362 343 LGAIMYEMLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 343 lGvil~ell~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|||++|||++|.+||.+.+.......|..+
T Consensus 291 lG~il~ell~g~~pf~~~~~~~~~~~i~~~ 320 (365)
T 2y7j_A 291 CGVILFTLLAGSPPFWHRRQILMLRMIMEG 320 (365)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHHhC
Confidence 999999999999999998888888777654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=340.56 Aligned_cols=210 Identities=32% Similarity=0.493 Sum_probs=179.7
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC-----
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~----- 189 (373)
.++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 578999999999999999999999999999999986532 22334567889999999999999999999998763
Q ss_pred -eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 190 -FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 190 -~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
.+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 469999999 8899999865 6799999999999999999999999999999999999999999999999999986432
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil 347 (373)
. ....+||+.|+|||++.+ ..|+.++|||||||++
T Consensus 181 ~--------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 216 (367)
T 1cm8_A 181 E--------------------------------------------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIM 216 (367)
T ss_dssp S--------------------------------------------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHH
T ss_pred c--------------------------------------------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHH
Confidence 1 114579999999999987 6799999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhhc
Q 017362 348 YEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 348 ~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
|||++|++||.+.+..+...+|++
T Consensus 217 ~ell~g~~pf~~~~~~~~l~~i~~ 240 (367)
T 1cm8_A 217 AEMITGKTLFKGSDHLDQLKEIMK 240 (367)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999999999998888877753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=333.54 Aligned_cols=225 Identities=22% Similarity=0.363 Sum_probs=175.6
Q ss_pred hhhccCCCCCcceeceeeeeCcEEEEEEEEcCCCc---eEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeE
Q 017362 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGH---VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCS 184 (373)
Q Consensus 108 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~ 184 (373)
+....+..++|++.+.||+|+||+||+|.+..++. .||||++..... .....+.+.+|+.+++.++||||++++++
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence 44566778899999999999999999999876664 899999976532 33446778999999999999999999999
Q ss_pred EEeCCeE------EEEEeccCCCCHHHHHhhCC------CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCC
Q 017362 185 FQDDEFL------YLIMEYLPGGDMMTLLMRKD------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY 252 (373)
Q Consensus 185 ~~~~~~~------~lV~E~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~ 252 (373)
+.+.... |+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED 173 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC
Confidence 9877655 99999999999999996532 59999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC
Q 017362 253 GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332 (373)
Q Consensus 253 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 332 (373)
+.+||+|||+|+......... ......+|+.|+|||++.+.
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~ 214 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYR---------------------------------------QGCASKLPVKWLALESLADN 214 (323)
T ss_dssp SCEEECCCCC--------------------------------------------------------CCGGGCCHHHHHHC
T ss_pred CCEEEeecccccccccccccc---------------------------------------ccccccCcccccCchhhcCC
Confidence 999999999997654321110 00134578899999999999
Q ss_pred CCChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 333 GYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 333 ~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
.++.++|||||||++|||++ |.+||.+.+..+....+..+
T Consensus 215 ~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~ 255 (323)
T 3qup_A 215 LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG 255 (323)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC
Confidence 99999999999999999999 99999999988888877654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=324.69 Aligned_cols=214 Identities=32% Similarity=0.595 Sum_probs=188.0
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhh---hhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR---GQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 192 (373)
++|++.+.||+|+||.||+|.+..+++.||+|++........ ...+.+.+|+.++..++||||+++++++.+....|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 569999999999999999999999999999999876432211 13567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC----cEEEeeccccccCCC
Q 017362 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG----HLRLSDFGLCKPLDC 268 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~----~vkL~DFGla~~~~~ 268 (373)
+||||+++++|.+++.....+++..+..++.|++.||.|||++|++||||||+|||++.++ .+||+|||++.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 9999999999999998888899999999999999999999999999999999999998877 899999999976532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 348 (373)
... .....||+.|+|||++.+..++.++|||||||++|
T Consensus 165 ~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 202 (283)
T 3bhy_A 165 GNE------------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 202 (283)
T ss_dssp -------------------------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred CCc------------------------------------------ccccCCCcCccCcceecCCCCCcchhhhhHHHHHH
Confidence 210 01357999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhc
Q 017362 349 EMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 349 ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
+|++|.+||.+.+..+....+..
T Consensus 203 ~l~~g~~p~~~~~~~~~~~~~~~ 225 (283)
T 3bhy_A 203 ILLSGASPFLGETKQETLTNISA 225 (283)
T ss_dssp HHHHSSCTTCCSSHHHHHHHHHT
T ss_pred HHHHCCCCCCCcchHHHHHHhHh
Confidence 99999999999988888777654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=344.82 Aligned_cols=221 Identities=20% Similarity=0.356 Sum_probs=186.8
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEE-----EcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEE
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSF 185 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~ 185 (373)
.++..++|++++.||+|+||+||+|. +..++..||||++.... .......+.+|+.++..++||||+++++++
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 143 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVS 143 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34667889999999999999999999 44567899999986432 233345688899999999999999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHhhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC---cE
Q 017362 186 QDDEFLYLIMEYLPGGDMMTLLMRK-------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---HL 255 (373)
Q Consensus 186 ~~~~~~~lV~E~~~gg~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~---~v 255 (373)
.+....|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+| .+
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 9999999999999999999999764 3589999999999999999999999999999999999999655 59
Q ss_pred EEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCC
Q 017362 256 RLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYG 335 (373)
Q Consensus 256 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 335 (373)
||+|||+|+.+...... .......||+.|+|||++.+..++
T Consensus 224 kL~DFG~a~~~~~~~~~---------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~ 264 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYY---------------------------------------RKGGCAMLPVKWMPPEAFMEGIFT 264 (367)
T ss_dssp EECCCHHHHHHHHHSSC---------------------------------------TTCCGGGSCGGGCCHHHHHHCCCC
T ss_pred EECCCcccccccccccc---------------------------------------ccCCCcCCcccEECHHHhcCCCCC
Confidence 99999999743211100 001145789999999999999999
Q ss_pred hhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 336 MECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 336 ~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
.++|||||||++|||++ |.+||.+.+..+....|.++
T Consensus 265 ~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~ 302 (367)
T 3l9p_A 265 SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 302 (367)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999999999998 99999999999888887754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=344.12 Aligned_cols=222 Identities=25% Similarity=0.384 Sum_probs=190.8
Q ss_pred hccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC
Q 017362 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 110 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 189 (373)
...+..++|.+.+.||+|+||+||+|.+..++..||||++.... .......+.+|+.+++.++||||+++++++.+.+
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 34566789999999999999999999999899999999987532 2233456788999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
.+|+||||++||+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 9999999999999999997643 699999999999999999999999999999999999999999999999999976432
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 348 (373)
...... .....+|+.|+|||++.+..++.++|||||||++|
T Consensus 266 ~~~~~~---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ 306 (377)
T 3cbl_A 266 GVYAAS---------------------------------------GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLW 306 (377)
T ss_dssp SEEECC---------------------------------------SSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred Cceeec---------------------------------------CCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHH
Confidence 211100 00224678899999999899999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 349 EMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 349 ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
||++ |.+||.+.+..+....+.++
T Consensus 307 el~t~g~~p~~~~~~~~~~~~~~~~ 331 (377)
T 3cbl_A 307 ETFSLGASPYPNLSNQQTREFVEKG 331 (377)
T ss_dssp HHHTTSCCSSTTSCHHHHHHHHHTT
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9998 99999999888877766543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=350.62 Aligned_cols=230 Identities=26% Similarity=0.407 Sum_probs=166.6
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC-----
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD----- 188 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~----- 188 (373)
..++|++++.||+|+||+||+|.+..+++.||||++.... ........+.+|+.+|..++||||+++++++...
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 3578999999999999999999999999999999986532 2334456788999999999999999999999543
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
..+|+||||+ +|+|.+++.....+++..++.++.||+.||.|||++|||||||||+||||+.++++||+|||+|+....
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 130 DELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp CCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred ceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 5699999998 679999998888899999999999999999999999999999999999999999999999999987653
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHH--HHhhhhhccccccccCCCCccccccc-CCCCChhhcHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQ--HWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGA 345 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~~DvwSlGv 345 (373)
.......... .+. .....+. ....+........+||+.|+|||++. ...|+.++|||||||
T Consensus 209 ~~~~~~~~~~---------------~~~-~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~ 272 (458)
T 3rp9_A 209 PENGNSQLPI---------------SPR-EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGC 272 (458)
T ss_dssp CTTCCCCCC-------------------------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHH
T ss_pred cccccccccc---------------Ccc-ccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHH
Confidence 3211100000 000 0000000 00011112234678999999999874 567999999999999
Q ss_pred HHHHHHh-----------CCCCCCCCC
Q 017362 346 IMYEMLV-----------GYPPFYSDD 361 (373)
Q Consensus 346 il~ell~-----------G~~Pf~~~~ 361 (373)
|||||++ |.+||.+.+
T Consensus 273 il~elltg~~~~~~~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 273 IFAELLNMIKENVAYHADRGPLFPGSS 299 (458)
T ss_dssp HHHHHHTTSTTTCSSGGGCCCSCC---
T ss_pred HHHHHHHhccccccccccccccCCCCc
Confidence 9999999 888887765
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=322.50 Aligned_cols=217 Identities=23% Similarity=0.378 Sum_probs=189.1
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCe
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 190 (373)
.++..++|++++.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.++..++||||+++++++.+...
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 77 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP 77 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred eEechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCc
Confidence 3566789999999999999999999775 566899999976432 23558889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 191 LYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
.|+||||+++++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 999999999999999997654 5999999999999999999999999999999999999999999999999999865433
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 349 (373)
.... .....||+.|+|||++.+..++.++|||||||++|+
T Consensus 158 ~~~~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 197 (268)
T 3sxs_A 158 QYVS----------------------------------------SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWE 197 (268)
T ss_dssp CEEE----------------------------------------CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHH
T ss_pred hhhc----------------------------------------ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHH
Confidence 2110 113457888999999999899999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHhhcC
Q 017362 350 MLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 350 ll~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|++ |.+||...+..+...++.++
T Consensus 198 l~~~g~~p~~~~~~~~~~~~~~~~ 221 (268)
T 3sxs_A 198 VFSLGKMPYDLYTNSEVVLKVSQG 221 (268)
T ss_dssp HHTTTCCTTTTSCHHHHHHHHHTT
T ss_pred HHcCCCCCccccChHHHHHHHHcC
Confidence 999 99999999888888777654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=330.71 Aligned_cols=223 Identities=22% Similarity=0.356 Sum_probs=192.2
Q ss_pred hhccCCCCCcceeceeeeeCcEEEEEEEEc-----CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEee
Q 017362 109 QRHKMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183 (373)
Q Consensus 109 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~ 183 (373)
....+..++|.+.+.||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.++..++||||+++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 93 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYG 93 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence 445677889999999999999999999873 455889999997542 2344567889999999999999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHHhhCCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCCee
Q 017362 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDT------------------------LTEDEARFYVAETVLAIESIHKHHYIH 239 (373)
Q Consensus 184 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~------------------------l~~~~~~~i~~qi~~aL~~LH~~giiH 239 (373)
++.+.+..|+||||++||+|.+++..... +++..+..++.||+.||.|||++||+|
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 173 (314)
T 2ivs_A 94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH 173 (314)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 99999999999999999999999976543 899999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhcccccccc
Q 017362 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVG 319 (373)
Q Consensus 240 rDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 319 (373)
|||||+|||++.++.+||+|||++.......... ......|
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~---------------------------------------~~~~~~~ 214 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV---------------------------------------KRSQGRI 214 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEE---------------------------------------CSSCCCS
T ss_pred cccchheEEEcCCCCEEEccccccccccccccce---------------------------------------eccCCCC
Confidence 9999999999999999999999998654322110 0113467
Q ss_pred CCCCcccccccCCCCChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 320 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 320 t~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+.......+..+
T Consensus 215 ~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 268 (314)
T 2ivs_A 215 PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTG 268 (314)
T ss_dssp CGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred cccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcC
Confidence 899999999999999999999999999999999 99999999888887776543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=337.07 Aligned_cols=223 Identities=22% Similarity=0.391 Sum_probs=192.1
Q ss_pred hhccCCCCCcceeceeeeeCcEEEEEEEEcCC-------CceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeE
Q 017362 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTT-------GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVK 180 (373)
Q Consensus 109 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~ 180 (373)
...++..++|.+.+.||+|+||+||+|.+..+ +..||||++.... .......+.+|+.++..+ +||||++
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~ 139 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIIN 139 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhh
Confidence 34567788999999999999999999987533 3579999987642 234456788999999999 9999999
Q ss_pred EeeEEEeCCeEEEEEeccCCCCHHHHHhhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCC
Q 017362 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD----------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKP 244 (373)
Q Consensus 181 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp 244 (373)
+++++.+.+.+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||
T Consensus 140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 219 (382)
T 3tt0_A 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 219 (382)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence 9999999999999999999999999997653 499999999999999999999999999999999
Q ss_pred CCEEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCc
Q 017362 245 DNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYI 324 (373)
Q Consensus 245 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 324 (373)
+|||++.++.+||+|||+|+......... ......||+.|+
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~---------------------------------------~~~~~~~t~~y~ 260 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYYK---------------------------------------KTTNGRLPVKWM 260 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTTC---------------------------------------CCTTCCCGGGGS
T ss_pred ceEEEcCCCcEEEcccCcccccccccccc---------------------------------------cccCCCCCccee
Confidence 99999999999999999998654321110 011346889999
Q ss_pred ccccccCCCCChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 325 APEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 325 aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+..+
T Consensus 261 aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 309 (382)
T 3tt0_A 261 APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 309 (382)
T ss_dssp CHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred CHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999999999999999999999999 99999999988888777654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=339.18 Aligned_cols=217 Identities=23% Similarity=0.379 Sum_probs=183.7
Q ss_pred hhccCCCCCcceeceeeeeCcEEEEEEE-----EcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEe
Q 017362 109 QRHKMGADDFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLY 182 (373)
Q Consensus 109 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~ 182 (373)
...++..++|++.+.||+|+||.||+|. +..+++.||||++.... .....+.+.+|+.++..+ +||||++++
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3456778999999999999999999998 45567899999997542 233456788999999999 789999999
Q ss_pred eEEEeCC-eEEEEEeccCCCCHHHHHhhCCC-------------------------------------------------
Q 017362 183 CSFQDDE-FLYLIMEYLPGGDMMTLLMRKDT------------------------------------------------- 212 (373)
Q Consensus 183 ~~~~~~~-~~~lV~E~~~gg~L~~~l~~~~~------------------------------------------------- 212 (373)
+++.+.+ .+|+||||++||+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9998755 48999999999999999976433
Q ss_pred -----------------CCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 213 -----------------LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 213 -----------------l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++.........
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-- 250 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV-- 250 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE--
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccch--
Confidence 8999999999999999999999999999999999999999999999999998653321100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh-CC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GY 354 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~ 354 (373)
......||+.|+|||++.+..++.++|||||||++|||++ |.
T Consensus 251 -------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 293 (359)
T 3vhe_A 251 -------------------------------------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 293 (359)
T ss_dssp -------------------------------------EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred -------------------------------------hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCC
Confidence 0114578999999999999999999999999999999998 99
Q ss_pred CCCCCCChHHHH
Q 017362 355 PPFYSDDPMSTC 366 (373)
Q Consensus 355 ~Pf~~~~~~~~~ 366 (373)
+||.+.+..+..
T Consensus 294 ~p~~~~~~~~~~ 305 (359)
T 3vhe_A 294 SPYPGVKIDEEF 305 (359)
T ss_dssp CSSTTCCCSHHH
T ss_pred CCCCccchhHHH
Confidence 999987644433
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=324.64 Aligned_cols=211 Identities=28% Similarity=0.559 Sum_probs=182.1
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|.+.+.||+|+||+||+|.+..++..||+|++.... .....+.+.+|+.++..++||||+++++++.+....|+|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 467999999999999999999999999999999987653 233456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEE---cCCCcEEEeeccccccCC
Q 017362 195 MEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl---~~~~~vkL~DFGla~~~~ 267 (373)
|||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999999998854 3679999999999999999999999999999999999999 556889999999997653
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 347 (373)
.... .....||+.|+|||++. ..++.++|||||||++
T Consensus 179 ~~~~------------------------------------------~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il 215 (285)
T 3is5_A 179 SDEH------------------------------------------STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVM 215 (285)
T ss_dssp --------------------------------------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHH
T ss_pred Cccc------------------------------------------CcCcccccCcCChHHhc-cCCCcccCeehHHHHH
Confidence 2210 11457999999999985 6789999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhh
Q 017362 348 YEMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 348 ~ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
|||++|++||.+.+..+...++.
T Consensus 216 ~~ll~g~~pf~~~~~~~~~~~~~ 238 (285)
T 3is5_A 216 YFLLTGCLPFTGTSLEEVQQKAT 238 (285)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCHHHHHhhhc
Confidence 99999999999988877776654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=336.70 Aligned_cols=211 Identities=28% Similarity=0.432 Sum_probs=177.8
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC-----
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~----- 189 (373)
.++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 578999999999999999999999999999999987542 22334566889999999999999999999998765
Q ss_pred -eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 190 -FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 190 -~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
.+|+||||++ |+|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 103 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 103 QDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp CEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred cceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 7899999996 47888875 4589999999999999999999999999999999999999999999999999975432
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 348 (373)
... ....+||+.|+|||++.+..|+.++|||||||++|
T Consensus 180 ~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 217 (371)
T 2xrw_A 180 SFM------------------------------------------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 217 (371)
T ss_dssp ----------------------------------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred ccc------------------------------------------cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHH
Confidence 110 11457999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhc
Q 017362 349 EMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 349 ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
||++|.+||.+.+..+.+.+|++
T Consensus 218 el~~g~~pf~~~~~~~~~~~i~~ 240 (371)
T 2xrw_A 218 EMIKGGVLFPGTDHIDQWNKVIE 240 (371)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHC
T ss_pred HHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999999999999888888765
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=324.85 Aligned_cols=220 Identities=20% Similarity=0.406 Sum_probs=189.2
Q ss_pred hhhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe
Q 017362 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (373)
Q Consensus 108 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 187 (373)
.....+..++|++++.||+|+||+||+|.+. ++..||+|++..... ..+.+.+|+.++..++||||+++++++.+
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 90 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence 4456678889999999999999999999875 567899999976432 23458889999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccC
Q 017362 188 DEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (373)
Q Consensus 188 ~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~ 266 (373)
.+..|+||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccc
Confidence 9999999999999999999976 467999999999999999999999999999999999999999999999999999765
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHH
Q 017362 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (373)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvi 346 (373)
...... ......||+.|+|||++.+..++.++|||||||+
T Consensus 171 ~~~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~ 210 (283)
T 3gen_A 171 LDDEYT----------------------------------------SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL 210 (283)
T ss_dssp CCHHHH----------------------------------------STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHH
T ss_pred cccccc----------------------------------------cccCCccCcccCCHHHhccCCCCchhhHHHHHHH
Confidence 322100 0113467889999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 347 MYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 347 l~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+|+|++ |.+||...+..+....|.++
T Consensus 211 l~~l~t~g~~p~~~~~~~~~~~~~~~~ 237 (283)
T 3gen_A 211 MWEIYSLGKMPYERFTNSETAEHIAQG 237 (283)
T ss_dssp HHHHHTTTCCTTTTSCHHHHHHHHHTT
T ss_pred HHHHHhCCCCCccccChhHHHHHHhcc
Confidence 999998 99999999998888887654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=324.99 Aligned_cols=220 Identities=24% Similarity=0.379 Sum_probs=178.8
Q ss_pred hccCCCCCcceeceeeeeCcEEEEEEEEcCC---CceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEE
Q 017362 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTT---GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (373)
Q Consensus 110 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 186 (373)
..++..++|++.+.||+|+||.||+|.+..+ +..||+|++.... .....+.+.+|+.++..++||||+++++++.
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence 3466778999999999999999999998653 4569999987532 2334567889999999999999999999984
Q ss_pred eCCeEEEEEeccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 187 DDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 187 ~~~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
.+..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence 567889999999999999997654 699999999999999999999999999999999999999999999999999976
Q ss_pred CCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHH
Q 017362 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (373)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGv 345 (373)
........ .....+|+.|+|||++.+..++.++|||||||
T Consensus 166 ~~~~~~~~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 205 (281)
T 1mp8_A 166 MEDSTYYK----------------------------------------ASKGKLPIKWMAPESINFRRFTSASDVWMFGV 205 (281)
T ss_dssp -----------------------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHH
T ss_pred cCcccccc----------------------------------------cccCCCcccccChhhcccCCCCCccCchHHHH
Confidence 54321100 11345788999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 346 IMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 346 il~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
++|||++ |.+||.+.+..+....|.++
T Consensus 206 ~l~ell~~g~~pf~~~~~~~~~~~i~~~ 233 (281)
T 1mp8_A 206 CMWEILMHGVKPFQGVKNNDVIGRIENG 233 (281)
T ss_dssp HHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred HHHHHHhcCCCCCCcCCHHHHHHHHHcC
Confidence 9999997 99999998888888777653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=339.29 Aligned_cols=220 Identities=21% Similarity=0.364 Sum_probs=178.6
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEc---CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 188 (373)
++..++|++.+.||+|+||+||+|.+. .++..||||++.... .....+.+.+|+.++..++||||+++++++.+.
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 566789999999999999999999876 457789999987542 233456788999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
+.+|+||||++||+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999999997654 69999999999999999999999999999999999999999999999999998654
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 347 (373)
....... ......+|+.|+|||++.+..++.++|||||||++
T Consensus 199 ~~~~~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il 240 (373)
T 2qol_A 199 DDPEAAY--------------------------------------TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 240 (373)
T ss_dssp -----------------------------------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred cCCccce--------------------------------------eccCCCcCCCccChhhhccCCcCchhcHHHHHHHH
Confidence 2211000 00123467899999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHhhc
Q 017362 348 YEMLV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 348 ~ell~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
|||++ |.+||...+..+....|..
T Consensus 241 ~ellt~g~~P~~~~~~~~~~~~i~~ 265 (373)
T 2qol_A 241 WEVMSYGERPYWEMSNQDVIKAVDE 265 (373)
T ss_dssp HHHHTTC-CTTTTCCHHHHHHHHHT
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 99998 9999999988888777654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=331.83 Aligned_cols=215 Identities=29% Similarity=0.495 Sum_probs=185.6
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEE
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 193 (373)
..++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.++..++||||+++++++.+.+..|+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 4678999999999999999999999999999999986543 223334567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 194 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
||||+++++|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..+......
T Consensus 102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 180 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV- 180 (331)
T ss_dssp EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc-
Confidence 9999999999988877888999999999999999999999999999999999999999999999999999765322100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHHHHHHHHHHHh
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell~ 352 (373)
....+||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 181 ----------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 220 (331)
T 4aaa_A 181 ----------------------------------------YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM 220 (331)
T ss_dssp -------------------------------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHh
Confidence 1145799999999999875 78999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhh
Q 017362 353 GYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 353 G~~Pf~~~~~~~~~~kI~ 370 (373)
|.+||.+.+..+...+++
T Consensus 221 g~~pf~~~~~~~~~~~~~ 238 (331)
T 4aaa_A 221 GEPLFPGDSDIDQLYHIM 238 (331)
T ss_dssp SSCSCCCSSHHHHHHHHH
T ss_pred CCCCCCCCCcHHHHHHHH
Confidence 999999998887776664
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=331.57 Aligned_cols=217 Identities=22% Similarity=0.376 Sum_probs=178.4
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceE----eeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVY----AMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~v----aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 188 (373)
+..++|++++.||+|+||+||+|.+..++..+ |+|.+.... .......+.+|+.++..++||||+++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 45688999999999999999999988777654 777765432 233456788999999999999999999999876
Q ss_pred CeEEEEEeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
. .++||||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++++||+|||+|+.+.
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 5 7799999999999999977 4579999999999999999999999999999999999999999999999999998654
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 347 (373)
...... ......||+.|+|||++.+..++.++|||||||++
T Consensus 169 ~~~~~~---------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 209 (327)
T 3poz_A 169 AEEKEY---------------------------------------HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 209 (327)
T ss_dssp TTCC----------------------------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCcccc---------------------------------------cccCCCccccccChHHhccCCCCchhhhhhhHHHH
Confidence 322110 01134678899999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHhhc
Q 017362 348 YEMLV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 348 ~ell~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
|||++ |.+||.+.+..+....+..
T Consensus 210 ~ellt~g~~p~~~~~~~~~~~~~~~ 234 (327)
T 3poz_A 210 WELMTFGSKPYDGIPASEISSILEK 234 (327)
T ss_dssp HHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred HHHHhcCCCCccCCCHHHHHHHHHc
Confidence 99999 9999999888777666544
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=330.36 Aligned_cols=200 Identities=29% Similarity=0.452 Sum_probs=167.1
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHh-cCCCceeEEeeEEEeCCeEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE-VDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~l~~~~~~~~~~~lV 194 (373)
++|+++++||+|+||+||+|.+..+++.||||++........ .......|+..+.. ..||||++++++|.+.+.+|+|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK-DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChH-HHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 679999999999999999999999999999998765322222 22334445554444 4999999999999999999999
Q ss_pred EeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 195 MEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
|||+ +++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~-- 212 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA-- 212 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC--
Confidence 9999 77888888664 4699999999999999999999999999999999999999999999999999876542211
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhC
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 353 (373)
.....||+.|+|||++.+ .++.++|||||||++|||++|
T Consensus 213 ----------------------------------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g 251 (311)
T 3p1a_A 213 ----------------------------------------GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACN 251 (311)
T ss_dssp ------------------------------------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHT
T ss_pred ----------------------------------------CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhC
Confidence 113569999999999875 799999999999999999999
Q ss_pred CCCCCCC
Q 017362 354 YPPFYSD 360 (373)
Q Consensus 354 ~~Pf~~~ 360 (373)
..||.+.
T Consensus 252 ~~~~~~~ 258 (311)
T 3p1a_A 252 MELPHGG 258 (311)
T ss_dssp CCCCSSH
T ss_pred CCCCCCc
Confidence 7777543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=334.37 Aligned_cols=212 Identities=26% Similarity=0.461 Sum_probs=177.4
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|.+++.||+|+||+||+|.+..+++.||||++..... ......+.+|+.++..++||||+++++++.+.+.+|+||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 679999999999999999999999999999999875432 111123456899999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 196 EYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 196 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
||++ |+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~-- 156 (324)
T 3mtl_A 80 EYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT-- 156 (324)
T ss_dssp ECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred cccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc--
Confidence 9996 5888888764 46999999999999999999999999999999999999999999999999999754322100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHHHHHhC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G 353 (373)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 157 ---------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g 197 (324)
T 3mtl_A 157 ---------------------------------------YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG 197 (324)
T ss_dssp ---------------------------------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHS
T ss_pred ---------------------------------------cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 113578999999999987 5689999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhc
Q 017362 354 YPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 354 ~~Pf~~~~~~~~~~kI~~ 371 (373)
.+||.+.+..+....|.+
T Consensus 198 ~~pf~~~~~~~~~~~i~~ 215 (324)
T 3mtl_A 198 RPLFPGSTVEEQLHFIFR 215 (324)
T ss_dssp SCSCCCSSHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHH
Confidence 999999998888777653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=344.01 Aligned_cols=205 Identities=33% Similarity=0.649 Sum_probs=170.4
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhh-----hhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR-----RGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 189 (373)
.++|.+.+.||+|+||+||+|.+..+++.||||++.+..... ......+.+|+.++..++||||+++++++.. +
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 468999999999999999999999999999999997654321 1122347789999999999999999999854 5
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC---cEEEeeccccccC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---HLRLSDFGLCKPL 266 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~---~vkL~DFGla~~~ 266 (373)
..|+||||+++|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 5799999999999999998888999999999999999999999999999999999999997554 5999999999865
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC---CCCChhhcHHHH
Q 017362 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSL 343 (373)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~~DvwSl 343 (373)
..... ....+||+.|+|||++.+ ..|+.++|||||
T Consensus 293 ~~~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Diwsl 330 (419)
T 3i6u_A 293 GETSL------------------------------------------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 330 (419)
T ss_dssp C-----------------------------------------------------CTTCCTTTTC----CTTHHHHHHHHH
T ss_pred CCCcc------------------------------------------ccccCCCCCccCceeeecCCCCCCCchhhhHhH
Confidence 42210 114679999999999864 678999999999
Q ss_pred HHHHHHHHhCCCCCCCCCh
Q 017362 344 GAIMYEMLVGYPPFYSDDP 362 (373)
Q Consensus 344 Gvil~ell~G~~Pf~~~~~ 362 (373)
||++|+|++|.+||.....
T Consensus 331 G~il~~lltg~~pf~~~~~ 349 (419)
T 3i6u_A 331 GVILFICLSGYPPFSEHRT 349 (419)
T ss_dssp HHHHHHHHHSSCSSCCCSS
T ss_pred HHHHHHHHHCCCCCCCCcc
Confidence 9999999999999987543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=321.74 Aligned_cols=217 Identities=32% Similarity=0.576 Sum_probs=190.2
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhH------hhhhhhHHHHHHHHHHHHhcC-CCceeEEeeEEE
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSE------MLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQ 186 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~ 186 (373)
..++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+.+|+.++..+. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3688999999999999999999999999999999986532 111233456788999999995 999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccC
Q 017362 187 DDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (373)
Q Consensus 187 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~ 266 (373)
+....|+||||+++++|.+++.....+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++...
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 99999999999999999999988888999999999999999999999999999999999999999999999999999765
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc------CCCCChhhcH
Q 017362 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL------KKGYGMECDW 340 (373)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~~~~~Dv 340 (373)
..... .....||+.|+|||++. ...++.++||
T Consensus 175 ~~~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di 212 (298)
T 1phk_A 175 DPGEK------------------------------------------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDM 212 (298)
T ss_dssp CTTCC------------------------------------------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHH
T ss_pred CCCcc------------------------------------------cccccCCccccCHHHhccccccccccCCccccc
Confidence 43211 11457999999999985 4568999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHhhcC
Q 017362 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 341 wSlGvil~ell~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|||||++|+|++|.+||.+.+..+....|.++
T Consensus 213 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (298)
T 1phk_A 213 WSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244 (298)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred HhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence 99999999999999999999888887777653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=339.31 Aligned_cols=209 Identities=44% Similarity=0.788 Sum_probs=178.2
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEc---CCCceEeeeecchhHhh-hhhhHHHHHHHHHHHHhc-CCCceeEEeeEEE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKSEML-RRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQ 186 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~ 186 (373)
.+..++|++++.||+|+||+||+|.+. .+++.||||++...... .....+.+.+|+.++..+ .||||+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 345689999999999999999999984 58899999998754321 112234566789999999 6999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccC
Q 017362 187 DDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (373)
Q Consensus 187 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~ 266 (373)
+...+|+||||+++|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++.+
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 99999999999999999999988889999999999999999999999999999999999999999999999999999765
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC--CCCChhhcHHHHH
Q 017362 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLG 344 (373)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DvwSlG 344 (373)
...... .....+||+.|+|||++.+ ..++.++||||||
T Consensus 210 ~~~~~~----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG 249 (355)
T 1vzo_A 210 VADETE----------------------------------------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLG 249 (355)
T ss_dssp CGGGGG----------------------------------------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHH
T ss_pred ccCCCC----------------------------------------cccCcccCcCccChhhhcCCCCCCCchhhHHHHH
Confidence 322110 1124679999999999986 4478999999999
Q ss_pred HHHHHHHhCCCCCCCC
Q 017362 345 AIMYEMLVGYPPFYSD 360 (373)
Q Consensus 345 vil~ell~G~~Pf~~~ 360 (373)
|++|||++|.+||...
T Consensus 250 ~il~ell~g~~pf~~~ 265 (355)
T 1vzo_A 250 VLMYELLTGASPFTVD 265 (355)
T ss_dssp HHHHHHHHSSCTTSCT
T ss_pred HHHHHHHHCCCCCccC
Confidence 9999999999999754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=337.46 Aligned_cols=209 Identities=28% Similarity=0.477 Sum_probs=177.5
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe-----
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD----- 187 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~----- 187 (373)
...++|++.+.||+|+||+||+|.+..+|+.||||++..... ...+|+.+++.++||||++++++|..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 456889999999999999999999999999999999865421 12369999999999999999999843
Q ss_pred ---------------------------------CCeEEEEEeccCCCCHHHHHh----hCCCCCHHHHHHHHHHHHHHHH
Q 017362 188 ---------------------------------DEFLYLIMEYLPGGDMMTLLM----RKDTLTEDEARFYVAETVLAIE 230 (373)
Q Consensus 188 ---------------------------------~~~~~lV~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~ 230 (373)
..++|+||||++ |+|.+.+. ....+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 345899999997 47766664 3568999999999999999999
Q ss_pred HHHhCCCeeecCCCCCEEEc-CCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhh
Q 017362 231 SIHKHHYIHRDIKPDNLLLD-KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKN 309 (373)
Q Consensus 231 ~LH~~giiHrDikp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (373)
|||++||+||||||+|||++ .++.+||+|||+|+.+.....
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-------------------------------------- 197 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-------------------------------------- 197 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--------------------------------------
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--------------------------------------
Confidence 99999999999999999998 689999999999986543221
Q ss_pred hhccccccccCCCCcccccccCC-CCChhhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 017362 310 RRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 310 ~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
....+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+...+|++
T Consensus 198 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 256 (383)
T 3eb0_A 198 ----SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQ 256 (383)
T ss_dssp ----CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ----CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 1145789999999998875 499999999999999999999999999999888877753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=332.91 Aligned_cols=215 Identities=31% Similarity=0.522 Sum_probs=179.9
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhh--hhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR--RGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 192 (373)
.++|++++.||+|+||.||+|.+..+|+.||||++....... ......+.+|+.++..++||||+++++++.+.+..|
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 578999999999999999999999999999999997543211 112245778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 193 LIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
+||||+++ +|..++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 167 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence 99999975 888888654 3699999999999999999999999999999999999999999999999999986542211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~el 350 (373)
. ....+||+.|+|||++.+. .++.++|||||||++|||
T Consensus 168 ~-----------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 206 (346)
T 1ua2_A 168 A-----------------------------------------YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAEL 206 (346)
T ss_dssp C-----------------------------------------CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHH
T ss_pred c-----------------------------------------CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHH
Confidence 0 1145799999999999764 589999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhc
Q 017362 351 LVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 351 l~G~~Pf~~~~~~~~~~kI~~ 371 (373)
++|.+||.+.+..+...+|..
T Consensus 207 l~g~~~~~~~~~~~~~~~i~~ 227 (346)
T 1ua2_A 207 LLRVPFLPGDSDLDQLTRIFE 227 (346)
T ss_dssp HHSSCSSCCSSHHHHHHHHHH
T ss_pred HHCCCCCCCCCHHHHHHHHHH
Confidence 999999999999888888764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=337.20 Aligned_cols=203 Identities=31% Similarity=0.529 Sum_probs=179.9
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhh-----hhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR-----GQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 189 (373)
.++|++.+.||+|+||+||+|.+..++..||||++........ .....+.+|+.++..++||||++++++|.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 3579999999999999999999999999999999976542211 12334677999999999999999999999999
Q ss_pred eEEEEEeccCCC-CHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 190 FLYLIMEYLPGG-DMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 190 ~~~lV~E~~~gg-~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
.+|+||||+++| +|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 182 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence 999999999777 9999998888999999999999999999999999999999999999999999999999999986543
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCC-ChhhcHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIM 347 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DvwSlGvil 347 (373)
... ....+||+.|+|||++.+..+ +.++|||||||++
T Consensus 183 ~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il 220 (335)
T 3dls_A 183 GKL------------------------------------------FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTL 220 (335)
T ss_dssp TCC------------------------------------------BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHH
T ss_pred CCc------------------------------------------eeccCCCccccChhhhcCCCCCCCcccchhHHHHH
Confidence 211 114579999999999998887 8999999999999
Q ss_pred HHHHhCCCCCCC
Q 017362 348 YEMLVGYPPFYS 359 (373)
Q Consensus 348 ~ell~G~~Pf~~ 359 (373)
|+|++|.+||..
T Consensus 221 ~el~~g~~pf~~ 232 (335)
T 3dls_A 221 YTLVFEENPFCE 232 (335)
T ss_dssp HHHHHSSCSCSS
T ss_pred HHHHhCCCchhh
Confidence 999999999975
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=325.94 Aligned_cols=220 Identities=22% Similarity=0.393 Sum_probs=193.8
Q ss_pred hhhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe
Q 017362 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (373)
Q Consensus 108 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 187 (373)
+...++..++|++.+.||+|+||+||+|.+..++..||+|++... ....+.+.+|+.++..++||||+++++++.+
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 80 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 345677889999999999999999999999999999999998754 2345678899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 188 DEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 188 ~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
.+..|+||||++|++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 81 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 81 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 99999999999999999999763 4599999999999999999999999999999999999999999999999999986
Q ss_pred CCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHH
Q 017362 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (373)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGv 345 (373)
........ .....||+.|+|||++.+..++.++|||||||
T Consensus 161 ~~~~~~~~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 200 (288)
T 3kfa_A 161 MTGDTYTA----------------------------------------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 200 (288)
T ss_dssp SCSSSSEE----------------------------------------ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred ccCCcccc----------------------------------------ccCCccccCcCChhhhccCCCCchhhHHHHHH
Confidence 64332111 11346789999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHhhc
Q 017362 346 IMYEMLV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 346 il~ell~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
++|+|++ |.+||.+.+.......+..
T Consensus 201 il~~ll~~g~~p~~~~~~~~~~~~~~~ 227 (288)
T 3kfa_A 201 LLWEIATYGMSPYPGIDLSQVYELLEK 227 (288)
T ss_dssp HHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHhc
Confidence 9999999 9999999888777766543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=332.77 Aligned_cols=220 Identities=23% Similarity=0.378 Sum_probs=184.9
Q ss_pred hccCCCCCcceeceeeeeCcEEEEEEEEc-----CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEee
Q 017362 110 RHKMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYC 183 (373)
Q Consensus 110 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~ 183 (373)
..++..++|.+.+.||+|+||+||+|.+. .++..||||++.... .....+.+.+|+.++..+ +||||+++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 35667889999999999999999999973 356689999997542 233456788999999999 8999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHHhhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeee
Q 017362 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKD-----------------------TLTEDEARFYVAETVLAIESIHKHHYIHR 240 (373)
Q Consensus 184 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~-----------------------~l~~~~~~~i~~qi~~aL~~LH~~giiHr 240 (373)
++.+.+.+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 9999999999999999999999997643 37999999999999999999999999999
Q ss_pred cCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccC
Q 017362 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGT 320 (373)
Q Consensus 241 Dikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 320 (373)
||||+|||++.++.+||+|||++.......... ......||
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~---------------------------------------~~~~~~~t 237 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYV---------------------------------------VRGNARLP 237 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSE---------------------------------------EETTEEEC
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccce---------------------------------------eccCccCc
Confidence 999999999999999999999997653221100 01145688
Q ss_pred CCCcccccccCCCCChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 017362 321 PDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 321 ~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~ 370 (373)
+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+......+++
T Consensus 238 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 288 (344)
T 1rjb_A 238 VKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 288 (344)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred cCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHH
Confidence 99999999999999999999999999999998 999999887655554443
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=342.14 Aligned_cols=215 Identities=27% Similarity=0.455 Sum_probs=183.4
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC--e
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE--F 190 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~--~ 190 (373)
...++|.+.+.||+|+||+||+|.+..+++.||||++..... ....+.+.+|+.++..++||||+++++++.+.. .
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 456789999999999999999999999999999999976532 233566788999999999999999999998765 7
Q ss_pred EEEEEeccCCCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEE----cCCCcEEEeecccc
Q 017362 191 LYLIMEYLPGGDMMTLLMRKD---TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLC 263 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl----~~~~~vkL~DFGla 263 (373)
.|+||||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 899999999999999997643 39999999999999999999999999999999999999 77888999999999
Q ss_pred ccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC--------CCCC
Q 017362 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--------KGYG 335 (373)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~~ 335 (373)
+....... ..+.+||+.|+|||++.+ ..++
T Consensus 164 ~~~~~~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 201 (396)
T 4eut_A 164 RELEDDEQ------------------------------------------FVSLYGTEEYLHPDMYERAVLRKDHQKKYG 201 (396)
T ss_dssp EECCCGGG------------------------------------------SSCSSSCCTTCCHHHHHHHCC--CHHHHHH
T ss_pred eEccCCCc------------------------------------------cccccCCccccCHHHhhccccccccccCCC
Confidence 86542210 114679999999999875 5688
Q ss_pred hhhcHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHhhc
Q 017362 336 MECDWWSLGAIMYEMLVGYPPFYSD----DPMSTCRKVRK 371 (373)
Q Consensus 336 ~~~DvwSlGvil~ell~G~~Pf~~~----~~~~~~~kI~~ 371 (373)
.++|||||||++|||++|.+||... +..+...+|+.
T Consensus 202 ~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 202 ATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 9999999999999999999999753 34455555554
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=340.53 Aligned_cols=227 Identities=29% Similarity=0.446 Sum_probs=176.1
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC-----
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD----- 188 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~----- 188 (373)
..++|++.+.||+|+||+||+|.+..+++.||||++.... ........+.+|+.++..++||||+++++++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 3688999999999999999999999999999999997542 2334456788999999999999999999999876
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
..+|+||||++ |+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|+....
T Consensus 103 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 103 DELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp CCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred CeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 56999999995 69999998888899999999999999999999999999999999999999999999999999987653
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccc-cCCCCChhhcHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL-LKKGYGMECDWWSLGAIM 347 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~~~DvwSlGvil 347 (373)
............ ...+ .......+....+.+||+.|+|||++ ....|+.++||||||||+
T Consensus 182 ~~~~~~~~~~~~--------~~~~-----------~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il 242 (432)
T 3n9x_A 182 EKDTNIVNDLEE--------NEEP-----------GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIF 242 (432)
T ss_dssp ------------------------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHH
T ss_pred cccccccccccc--------cccc-----------cccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHH
Confidence 321100000000 0000 00000111223467899999999986 456699999999999999
Q ss_pred HHHHh-----------CCCCCCCCC
Q 017362 348 YEMLV-----------GYPPFYSDD 361 (373)
Q Consensus 348 ~ell~-----------G~~Pf~~~~ 361 (373)
|||++ |+++|.+.+
T Consensus 243 ~ell~g~~p~~~~~~~~~p~f~g~~ 267 (432)
T 3n9x_A 243 AELLNMLQSHINDPTNRFPLFPGSS 267 (432)
T ss_dssp HHHHTTCTTTCSSGGGCCCSCCCSC
T ss_pred HHHHhcccccccccccccccCCCcc
Confidence 99998 566665544
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=318.28 Aligned_cols=213 Identities=27% Similarity=0.436 Sum_probs=174.5
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhh-hhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCe
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR-RGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 190 (373)
++..++|++.+.||+|+||.||+|.+. +..||||++....... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 456789999999999999999999874 7899999987653222 2334678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCC---CeeecCCCCCEEEcC--------CCcEEEee
Q 017362 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH---YIHRDIKPDNLLLDK--------YGHLRLSD 259 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiHrDikp~NILl~~--------~~~vkL~D 259 (373)
.|+||||++|++|.+++. ...+++..+..++.|++.||.|||++| |+||||||+|||++. ++.+||+|
T Consensus 81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999999884 568999999999999999999999999 999999999999986 78899999
Q ss_pred ccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhc
Q 017362 260 FGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECD 339 (373)
Q Consensus 260 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D 339 (373)
||++....... .....||+.|+|||++.+..++.++|
T Consensus 160 fg~~~~~~~~~-------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~D 196 (271)
T 3dtc_A 160 FGLAREWHRTT-------------------------------------------KMSAAGAYAWMAPEVIRASMFSKGSD 196 (271)
T ss_dssp CCC--------------------------------------------------------CCGGGSCHHHHHHCCCSHHHH
T ss_pred CCccccccccc-------------------------------------------ccCCCCccceeCHHHhccCCCCchhh
Confidence 99997543221 01357999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 017362 340 WWSLGAIMYEMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 340 vwSlGvil~ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
||||||++|+|++|.+||.+.+.......+.
T Consensus 197 i~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 227 (271)
T 3dtc_A 197 VWSYGVLLWELLTGEVPFRGIDGLAVAYGVA 227 (271)
T ss_dssp HHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHhhh
Confidence 9999999999999999999988777666554
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=327.38 Aligned_cols=210 Identities=28% Similarity=0.536 Sum_probs=174.5
Q ss_pred CCCccee-ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCeEE
Q 017362 115 ADDFELL-TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 115 ~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~ 192 (373)
.+.|++. +.||+|+||+||+|.+..+++.||||++.... ......+.+|+.++..+ +||||+++++++.+.+.+|
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 4678885 78999999999999999999999999997542 23345688899999885 7999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCc---EEEeeccccccCCCC
Q 017362 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH---LRLSDFGLCKPLDCS 269 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~---vkL~DFGla~~~~~~ 269 (373)
+||||++||+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||++......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999999999999988888999999999999999999999999999999999999998776 999999998765322
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-----CCCChhhcHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----KGYGMECDWWSLG 344 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~~DvwSlG 344 (373)
..... .........+||+.|+|||++.. ..++.++||||||
T Consensus 168 ~~~~~----------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG 213 (316)
T 2ac3_A 168 GDCSP----------------------------------ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG 213 (316)
T ss_dssp ------------------------------------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHH
T ss_pred Ccccc----------------------------------ccccccccccCCcCccChHHhhcccccccCCCcccccHhHH
Confidence 10000 00000114579999999999975 5589999999999
Q ss_pred HHHHHHHhCCCCCCCCC
Q 017362 345 AIMYEMLVGYPPFYSDD 361 (373)
Q Consensus 345 vil~ell~G~~Pf~~~~ 361 (373)
|++|||++|.+||.+.+
T Consensus 214 ~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 214 VILYILLSGYPPFVGRC 230 (316)
T ss_dssp HHHHHHHHSSCSCCCCC
T ss_pred HHHHHHHHCCCCCcccc
Confidence 99999999999998764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=332.05 Aligned_cols=219 Identities=20% Similarity=0.318 Sum_probs=182.9
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCce----EeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHV----YAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 187 (373)
.+..++|++++.||+|+||+||+|.+..++.. ||+|.+.... .......+.+|+.++..++||||+++++++.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 85 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 45678999999999999999999999888876 6666654322 1223345677999999999999999999886
Q ss_pred CCeEEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccC
Q 017362 188 DEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (373)
Q Consensus 188 ~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~ 266 (373)
....|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++++||+|||+|+..
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 45688999999999999999764 57999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHH
Q 017362 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (373)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvi 346 (373)
....... ......||+.|+|||++.+..++.++|||||||+
T Consensus 166 ~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~ 206 (325)
T 3kex_A 166 PPDDKQL---------------------------------------LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVT 206 (325)
T ss_dssp CCCTTCC---------------------------------------C-----CCTTTSCHHHHHHCCCCHHHHHHHHHHH
T ss_pred Ccccccc---------------------------------------cccCCCCcccccChHHhccCCCChhhHhHHhHHH
Confidence 4332110 0113568889999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 347 MYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 347 l~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+|||++ |.+||.+.+..+....+.++
T Consensus 207 l~el~~~g~~p~~~~~~~~~~~~~~~~ 233 (325)
T 3kex_A 207 VWELMTFGAEPYAGLRLAEVPDLLEKG 233 (325)
T ss_dssp HHHHHTTSCCTTTTSCTTHHHHHHHTT
T ss_pred HHHHHhCCCCCccccCHHHHHHHHHcC
Confidence 999999 99999998888777766543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=322.43 Aligned_cols=207 Identities=19% Similarity=0.284 Sum_probs=178.8
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCC-------ceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTG-------HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCS 184 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~ 184 (373)
++..++|.+.+.||+|+||+||+|.+..++ ..||+|++.... ....+.+.+|+.++..++||||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 456789999999999999999999988776 469999987543 3445678899999999999999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHhhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCc--------E
Q 017362 185 FQDDEFLYLIMEYLPGGDMMTLLMRKDT-LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH--------L 255 (373)
Q Consensus 185 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~-l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~--------v 255 (373)
+.+.+..|+||||++||+|.+++..... +++..+..++.|++.||.|||++||+||||||+|||++.++. +
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999999999987654 999999999999999999999999999999999999998887 9
Q ss_pred EEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCC
Q 017362 256 RLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGY 334 (373)
Q Consensus 256 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~ 334 (373)
||+|||++....... ...||+.|+|||++.+ ..+
T Consensus 161 kl~Dfg~~~~~~~~~---------------------------------------------~~~~~~~y~aPE~~~~~~~~ 195 (289)
T 4fvq_A 161 KLSDPGISITVLPKD---------------------------------------------ILQERIPWVPPECIENPKNL 195 (289)
T ss_dssp EECCCCSCTTTSCHH---------------------------------------------HHHHTTTTSCHHHHHCGGGC
T ss_pred eeccCcccccccCcc---------------------------------------------ccCCcCcccCHHHhCCCCCC
Confidence 999999986542110 2458899999999988 779
Q ss_pred ChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 017362 335 GMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTC 366 (373)
Q Consensus 335 ~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~ 366 (373)
+.++|||||||++|||++ |.+||...+.....
T Consensus 196 ~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~ 228 (289)
T 4fvq_A 196 NLATDKWSFGTTLWEICSGGDKPLSALDSQRKL 228 (289)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred CchhHHHHHHHHHHHHHcCCCCCccccchHHHH
Confidence 999999999999999999 55666555554443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=318.23 Aligned_cols=213 Identities=23% Similarity=0.411 Sum_probs=183.2
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe----C
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD----D 188 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~----~ 188 (373)
.....|.+.+.||+|+||+||+|.+..++..||+|++..... .....+.+.+|+.+++.++||||+++++++.. .
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence 345568999999999999999999999999999999876543 33445778899999999999999999999875 4
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeeecCCCCCEEEc-CCCcEEEeecccccc
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH--YIHRDIKPDNLLLD-KYGHLRLSDFGLCKP 265 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiHrDikp~NILl~-~~~~vkL~DFGla~~ 265 (373)
..+|+||||+++|+|.+++.....+++..+..++.|++.||.|||+.| |+||||||+|||++ .++.+||+|||++..
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred ceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 568999999999999999988888999999999999999999999999 99999999999997 789999999999965
Q ss_pred CCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHH
Q 017362 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (373)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGv 345 (373)
..... .....||+.|+|||++. ..++.++|||||||
T Consensus 182 ~~~~~-------------------------------------------~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~ 217 (290)
T 1t4h_A 182 KRASF-------------------------------------------AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGM 217 (290)
T ss_dssp CCTTS-------------------------------------------BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHH
T ss_pred ccccc-------------------------------------------cccccCCcCcCCHHHHh-ccCCCcchHHHHHH
Confidence 43221 11457999999999886 55999999999999
Q ss_pred HHHHHHhCCCCCCCCC-hHHHHHHhh
Q 017362 346 IMYEMLVGYPPFYSDD-PMSTCRKVR 370 (373)
Q Consensus 346 il~ell~G~~Pf~~~~-~~~~~~kI~ 370 (373)
++|+|++|.+||.... .......+.
T Consensus 218 ~l~~l~~g~~pf~~~~~~~~~~~~~~ 243 (290)
T 1t4h_A 218 CMLEMATSEYPYSECQNAAQIYRRVT 243 (290)
T ss_dssp HHHHHHHSSCTTTTCSSHHHHHHHHT
T ss_pred HHHHHHhCCCCCCCcCcHHHHHHHHh
Confidence 9999999999998744 444444443
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=337.00 Aligned_cols=210 Identities=28% Similarity=0.476 Sum_probs=168.9
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC------
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD------ 188 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~------ 188 (373)
.++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 578999999999999999999999999999999986532 2233456788999999999999999999999754
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
..+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 5689999999 7899988855 6799999999999999999999999999999999999999999999999999975431
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil 347 (373)
. ....+||+.|+|||++.+ ..|+.++|||||||++
T Consensus 185 ~--------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 220 (367)
T 2fst_X 185 E--------------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 220 (367)
T ss_dssp --------------------------------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHH
T ss_pred c--------------------------------------------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHH
Confidence 1 114579999999999987 6799999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhhc
Q 017362 348 YEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 348 ~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
|||++|++||.+.+..+...+|++
T Consensus 221 ~ell~g~~pf~~~~~~~~l~~i~~ 244 (367)
T 2fst_X 221 AELLTGRTLFPGTDHIDQLKLILR 244 (367)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999999999998888877753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=335.13 Aligned_cols=213 Identities=20% Similarity=0.247 Sum_probs=172.9
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCC-----CceEeeeecchhHhhh--------hhhHHHHHHHHHHHHhcCCCcee
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTT-----GHVYAMKKLKKSEMLR--------RGQVEHVRAERNLLAEVDSNCIV 179 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv 179 (373)
+..++|++.+.||+|+||+||+|.+..+ ++.||||++....... ......+..|+..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 4456999999999999999999998764 5789999986542111 11112344566677788999999
Q ss_pred EEeeEEEeC----CeEEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEc--CC
Q 017362 180 KLYCSFQDD----EFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD--KY 252 (373)
Q Consensus 180 ~l~~~~~~~----~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~--~~ 252 (373)
++++++.+. ...|+||||+ |++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ .+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 999998865 5589999999 99999999775 6799999999999999999999999999999999999999 88
Q ss_pred CcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC
Q 017362 253 GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332 (373)
Q Consensus 253 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 332 (373)
+++||+|||+|+.+......... ........+||+.|+|||++.+.
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~----------------------------------~~~~~~~~~gt~~y~aPE~~~~~ 236 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAY----------------------------------AADPKRCHDGTIEFTSIDAHNGV 236 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCS----------------------------------SCCSSCCCCCCTTTCCHHHHTTC
T ss_pred CeEEEEECCcceecccCCccccc----------------------------------ccCcccccCCCCCccCHHHhCCC
Confidence 99999999999876432211000 00001245799999999999999
Q ss_pred CCChhhcHHHHHHHHHHHHhCCCCCCCC
Q 017362 333 GYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (373)
Q Consensus 333 ~~~~~~DvwSlGvil~ell~G~~Pf~~~ 360 (373)
.++.++|||||||++|||++|.+||.+.
T Consensus 237 ~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 237 APSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 9999999999999999999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=338.91 Aligned_cols=209 Identities=26% Similarity=0.475 Sum_probs=182.9
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc------CCCceeEEeeEEE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV------DSNCIVKLYCSFQ 186 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~l~~~~~ 186 (373)
....+|++++.||+|+||+||+|.+..+++.||||++.... .....+..|+.++..+ .|+||+.+++.+.
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 34567999999999999999999999999999999997543 2234466677777776 5779999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCc--EEEeeccc
Q 017362 187 DDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH--LRLSDFGL 262 (373)
Q Consensus 187 ~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~--vkL~DFGl 262 (373)
....+|+||||++ ++|.+++.... .+++..++.++.||+.||.|||++|||||||||+|||++.++. +||+|||+
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 9999999999995 69999987654 4999999999999999999999999999999999999999987 99999999
Q ss_pred cccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHH
Q 017362 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342 (373)
Q Consensus 263 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwS 342 (373)
|...... ..+.+||+.|+|||++.+..|+.++||||
T Consensus 249 a~~~~~~--------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 284 (429)
T 3kvw_A 249 SCYEHQR--------------------------------------------VYTYIQSRFYRAPEVILGARYGMPIDMWS 284 (429)
T ss_dssp CEETTCC--------------------------------------------CCSSCSCGGGCCHHHHHTBCCCTHHHHHH
T ss_pred ceecCCc--------------------------------------------ccccCCCCCccChHHHhCCCCCchHHHHh
Confidence 8654321 11467999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 017362 343 LGAIMYEMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 343 lGvil~ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
|||++|||++|++||.+.+..+....|+
T Consensus 285 lG~il~elltG~~pf~~~~~~~~l~~i~ 312 (429)
T 3kvw_A 285 LGCILAELLTGYPLLPGEDEGDQLACMI 312 (429)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999999999999888877765
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=332.64 Aligned_cols=217 Identities=27% Similarity=0.416 Sum_probs=183.4
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe-------
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD------- 187 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~------- 187 (373)
.++|++++.||+|+||+||+|.+..+++.||||++..... .......+.+|+.++..++||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 5789999999999999999999999999999999865432 22233557789999999999999999999987
Q ss_pred -CCeEEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 188 -DEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 188 -~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
.+.+|+||||+++ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 4468999999965 777776553 5799999999999999999999999999999999999999999999999999986
Q ss_pred CCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHH
Q 017362 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 344 (373)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG 344 (373)
+........ ......+||+.|+|||++.+ ..++.++||||||
T Consensus 174 ~~~~~~~~~-------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG 216 (351)
T 3mi9_A 174 FSLAKNSQP-------------------------------------NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG 216 (351)
T ss_dssp CCCCSSSSC-------------------------------------CCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHH
T ss_pred ccccccccc-------------------------------------cccCCcccccCccCchhhcCCCCCCcHhHHHHHH
Confidence 643211100 00124679999999999976 5589999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHhh
Q 017362 345 AIMYEMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 345 vil~ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
|++|||++|.+||.+.+..+....|.
T Consensus 217 ~il~ell~g~~pf~~~~~~~~~~~i~ 242 (351)
T 3mi9_A 217 CIMAEMWTRSPIMQGNTEQHQLALIS 242 (351)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 99999999999999999888777664
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=329.74 Aligned_cols=206 Identities=29% Similarity=0.492 Sum_probs=174.1
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCC--CceeEEeeEEEeCC
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS--NCIVKLYCSFQDDE 189 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~l~~~~~~~~ 189 (373)
.+..++|++++.||+|+||.||+|.+ .+++.||||++.... ......+.+.+|+.++..+.| |||+++++++.+..
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 45678899999999999999999987 468899999987543 223445678899999999987 99999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
.+|+|||+ .+++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+.+...
T Consensus 83 ~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 83 YIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 99999995 5889999999989999999999999999999999999999999999999997 689999999999865432
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-----------CCCChhh
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----------KGYGMEC 338 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~~~~~ 338 (373)
.... .....+||+.|+|||++.+ ..++.++
T Consensus 161 ~~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 201 (343)
T 3dbq_A 161 TTSV---------------------------------------VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 201 (343)
T ss_dssp ------------------------------------------------CCCCSSCCHHHHHHCC-----------CCHHH
T ss_pred cccc---------------------------------------cCCCCcCCcCcCCHHHHhhccccccccccccCCCchh
Confidence 1100 0114679999999999865 6789999
Q ss_pred cHHHHHHHHHHHHhCCCCCCCC
Q 017362 339 DWWSLGAIMYEMLVGYPPFYSD 360 (373)
Q Consensus 339 DvwSlGvil~ell~G~~Pf~~~ 360 (373)
|||||||++|||++|.+||...
T Consensus 202 DiwslG~il~ell~g~~pf~~~ 223 (343)
T 3dbq_A 202 DVWSLGCILYYMTYGKTPFQQI 223 (343)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTC
T ss_pred hHHHHHHHHHHHHhCCCcchhh
Confidence 9999999999999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=346.60 Aligned_cols=210 Identities=15% Similarity=0.213 Sum_probs=171.0
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHH---HHHHhcCCCceeEEe-------eE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER---NLLAEVDSNCIVKLY-------CS 184 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~~iv~l~-------~~ 184 (373)
.++|.+.+.||+|+||+||+|.+..+|+.||||++...........+.+.+|+ .+++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 57899999999999999999999899999999999765444445567788999 455566899999998 66
Q ss_pred EEeCC-----------------eEEEEEeccCCCCHHHHHhhCCCCCH-------HHHHHHHHHHHHHHHHHHhCCCeee
Q 017362 185 FQDDE-----------------FLYLIMEYLPGGDMMTLLMRKDTLTE-------DEARFYVAETVLAIESIHKHHYIHR 240 (373)
Q Consensus 185 ~~~~~-----------------~~~lV~E~~~gg~L~~~l~~~~~l~~-------~~~~~i~~qi~~aL~~LH~~giiHr 240 (373)
+.+.+ ..|+||||+ +|+|.+++.....+++ ..+..++.||+.||.|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 66553 289999999 6899999987555555 7888899999999999999999999
Q ss_pred cCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccC
Q 017362 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGT 320 (373)
Q Consensus 241 Dikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 320 (373)
||||+|||++.++.+||+|||+|+..... ....+|
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~~--------------------------------------------~~~~~g- 265 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGAR--------------------------------------------VVSSVS- 265 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTCE--------------------------------------------EECCCC-
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCCc--------------------------------------------ccCCCC-
Confidence 99999999999999999999999753211 114568
Q ss_pred CCCcccccccCC-----------CCChhhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 017362 321 PDYIAPEVLLKK-----------GYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 321 ~~Y~aPE~~~~~-----------~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+.......+.
T Consensus 266 ~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~ 326 (377)
T 3byv_A 266 RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIF 326 (377)
T ss_dssp TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGG
T ss_pred cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhh
Confidence 999999999987 89999999999999999999999998776655444443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=328.02 Aligned_cols=212 Identities=25% Similarity=0.446 Sum_probs=173.3
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC------
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE------ 189 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~------ 189 (373)
++|++++.||+|+||.||+|.++.+++.||||++.... .....+.+.+|+.+++.++||||++++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 57999999999999999999999999999999987543 2334567899999999999999999999986543
Q ss_pred ---------------------------------------------------eEEEEEeccCCCCHHHHHhhCCC---CCH
Q 017362 190 ---------------------------------------------------FLYLIMEYLPGGDMMTLLMRKDT---LTE 215 (373)
Q Consensus 190 ---------------------------------------------------~~~lV~E~~~gg~L~~~l~~~~~---l~~ 215 (373)
.+|+||||++||+|.+++..... .++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 38999999999999999977543 566
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCC
Q 017362 216 DEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295 (373)
Q Consensus 216 ~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (373)
..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~------------------ 225 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT------------------ 225 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------------------
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccc------------------
Confidence 67899999999999999999999999999999999999999999999987654321110000
Q ss_pred ccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCC
Q 017362 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358 (373)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 358 (373)
...........+||+.|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 226 -----------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 226 -----------PMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp -----------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred -----------cccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 0000011224689999999999999999999999999999999999988873
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=328.03 Aligned_cols=223 Identities=22% Similarity=0.404 Sum_probs=189.8
Q ss_pred hhccCCCCCcceeceeeeeCcEEEEEEEEc-------CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeE
Q 017362 109 QRHKMGADDFELLTMIGKGAFGEVRVCREK-------TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVK 180 (373)
Q Consensus 109 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~ 180 (373)
....+..++|.+.+.||+|+||+||+|.+. .++..||||++.... .......+.+|+.++..+ +||||++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~ 105 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIIN 105 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEee
Confidence 345667789999999999999999999875 356789999997542 233456788999999999 8999999
Q ss_pred EeeEEEeCCeEEEEEeccCCCCHHHHHhhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCC
Q 017362 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD----------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKP 244 (373)
Q Consensus 181 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp 244 (373)
+++++.+.+.+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||
T Consensus 106 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 185 (334)
T 2pvf_A 106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 185 (334)
T ss_dssp EEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCcc
Confidence 9999999999999999999999999997653 389999999999999999999999999999999
Q ss_pred CCEEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCc
Q 017362 245 DNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYI 324 (373)
Q Consensus 245 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 324 (373)
+|||++.++.+||+|||++........... .....+|+.|+
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~---------------------------------------~~~~~~~~~y~ 226 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNIDYYKK---------------------------------------TTNGRLPVKWM 226 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTSSEEC---------------------------------------CSCCCCCGGGC
T ss_pred ceEEEcCCCCEEEccccccccccccccccc---------------------------------------cCCCCccccee
Confidence 999999999999999999986543221100 11346789999
Q ss_pred ccccccCCCCChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 325 APEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 325 aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+.++
T Consensus 227 aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 275 (334)
T 2pvf_A 227 APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275 (334)
T ss_dssp CHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT
T ss_pred ChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcC
Confidence 9999999999999999999999999999 99999999888887776543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=320.93 Aligned_cols=212 Identities=34% Similarity=0.570 Sum_probs=187.8
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.+.|++++.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.++..++||||+++++++.+...+|+|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 4569999999999999999999999999999999976532 33456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
|||++|++|.+++. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 99 ~e~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 175 (303)
T 3a7i_A 99 MEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-- 175 (303)
T ss_dssp EECCTTEEHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC--
T ss_pred EEeCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccc--
Confidence 99999999999985 467999999999999999999999999999999999999999999999999999765422110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 354 (373)
.....||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 176 ---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 216 (303)
T 3a7i_A 176 ---------------------------------------RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216 (303)
T ss_dssp ---------------------------------------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred ---------------------------------------cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCC
Confidence 11457999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHhh
Q 017362 355 PPFYSDDPMSTCRKVR 370 (373)
Q Consensus 355 ~Pf~~~~~~~~~~kI~ 370 (373)
+||...++......+.
T Consensus 217 ~p~~~~~~~~~~~~~~ 232 (303)
T 3a7i_A 217 PPHSELHPMKVLFLIP 232 (303)
T ss_dssp CTTTTSCHHHHHHHHH
T ss_pred CCCCCcCHHHHHHHhh
Confidence 9999888777665554
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=335.40 Aligned_cols=216 Identities=28% Similarity=0.476 Sum_probs=179.0
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC--CCceeEEeeEEEeCC
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD--SNCIVKLYCSFQDDE 189 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~l~~~~~~~~ 189 (373)
.+...+|++++.||+|+||+||+|.+.. ++.||||++..... .....+.+.+|+.++..+. ||||+++++++...+
T Consensus 52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 52 SVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129 (390)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred cccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence 3445679999999999999999998764 88999999876432 2344577899999999996 599999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
.+|+||| +.+++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+.+...
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred EEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9999999 56889999999888999999999999999999999999999999999999995 589999999999865422
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-----------CCCChhh
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----------KGYGMEC 338 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~~~~~ 338 (373)
... ......+||+.|+|||++.+ ..|+.++
T Consensus 208 ~~~---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 248 (390)
T 2zmd_A 208 TTS---------------------------------------VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKS 248 (390)
T ss_dssp ---------------------------------------------CCSCCCGGGCCHHHHHCC------------CCHHH
T ss_pred Ccc---------------------------------------ccCCCCCcCCCccChHHhhhccccccccccccCCCChh
Confidence 110 00124689999999999975 4689999
Q ss_pred cHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHhh
Q 017362 339 DWWSLGAIMYEMLVGYPPFYSDD-PMSTCRKVR 370 (373)
Q Consensus 339 DvwSlGvil~ell~G~~Pf~~~~-~~~~~~kI~ 370 (373)
||||||||+|||++|++||.... .......++
T Consensus 249 DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~ 281 (390)
T 2zmd_A 249 DVWSLGCILYYMTYGKTPFQQIINQISKLHAII 281 (390)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh
Confidence 99999999999999999998753 334444444
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=316.96 Aligned_cols=217 Identities=19% Similarity=0.333 Sum_probs=189.5
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCe
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 190 (373)
..+..++|++.+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.++..++||||+++++++.+.+.
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 77 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 77 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred eEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3456789999999999999999999885 567899999976532 23568889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 191 LYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
.|+||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 99999999999999999765 56899999999999999999999999999999999999999999999999999765321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 349 (373)
... ......||+.|+|||++.+..++.++||||||+++|+
T Consensus 158 ~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 197 (267)
T 3t9t_A 158 QYT----------------------------------------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWE 197 (267)
T ss_dssp HHH----------------------------------------STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred ccc----------------------------------------ccccccccccccChhhhcCCCccchhchhhhHHHHHH
Confidence 100 0113567889999999998999999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHhhcC
Q 017362 350 MLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 350 ll~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|++ |.+||.+.+..+....|.++
T Consensus 198 l~~~g~~p~~~~~~~~~~~~i~~~ 221 (267)
T 3t9t_A 198 VFSEGKIPYENRSNSEVVEDISTG 221 (267)
T ss_dssp HHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred HhccCCCCCCCCCHHHHHHHHhcC
Confidence 999 99999999988888877654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=319.54 Aligned_cols=210 Identities=20% Similarity=0.283 Sum_probs=179.9
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCe
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~ 190 (373)
.+..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.++..+ .|++++.+++++.+...
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 80 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 80 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence 455788999999999999999999999999999999986432 223477799999998 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCc-----EEEeeccccc
Q 017362 191 LYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH-----LRLSDFGLCK 264 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~-----vkL~DFGla~ 264 (373)
.|+||||+ +++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99999999 999999998654 6999999999999999999999999999999999999987776 9999999998
Q ss_pred cCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHH
Q 017362 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344 (373)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG 344 (373)
........... + ........||+.|+|||++.+..++.++||||||
T Consensus 160 ~~~~~~~~~~~----------------~------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 205 (298)
T 1csn_A 160 FYRDPVTKQHI----------------P------------------YREKKNLSGTARYMSINTHLGREQSRRDDLEALG 205 (298)
T ss_dssp ESBCTTTCCBC----------------C------------------CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred ccccccccccc----------------c------------------ccCccCCCCCcccCCchhhcCCCCChHHHHHHHH
Confidence 66433211000 0 0001256799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCC
Q 017362 345 AIMYEMLVGYPPFYSDD 361 (373)
Q Consensus 345 vil~ell~G~~Pf~~~~ 361 (373)
|++|||++|.+||.+.+
T Consensus 206 ~il~el~~g~~pf~~~~ 222 (298)
T 1csn_A 206 HVFMYFLRGSLPWQGLK 222 (298)
T ss_dssp HHHHHHHHSSCTTSSCC
T ss_pred HHHHHHHcCCCCcchhh
Confidence 99999999999998743
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=349.77 Aligned_cols=218 Identities=22% Similarity=0.392 Sum_probs=191.7
Q ss_pred hccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC
Q 017362 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 110 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 189 (373)
..++..++|++.+.||+|+||.||+|.+..++..||||++.... ...+.+.+|+.+|..++||||+++++++.+..
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 289 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 34566788999999999999999999999889999999997542 23466889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 999999999999999999763 468999999999999999999999999999999999999999999999999998664
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 347 (373)
...... .....+|+.|+|||++....++.++|||||||+|
T Consensus 370 ~~~~~~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l 409 (495)
T 1opk_A 370 GDTYTA----------------------------------------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 409 (495)
T ss_dssp TCCEEC----------------------------------------CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred CCceee----------------------------------------cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHH
Confidence 322110 1134578899999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHhhc
Q 017362 348 YEMLV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 348 ~ell~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
|||++ |.+||.+.+..+....+.+
T Consensus 410 ~el~t~g~~p~~~~~~~~~~~~~~~ 434 (495)
T 1opk_A 410 WEIATYGMSPYPGIDLSQVYELLEK 434 (495)
T ss_dssp HHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 99999 9999999888887776654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=328.25 Aligned_cols=214 Identities=27% Similarity=0.524 Sum_probs=184.9
Q ss_pred CCCccee-ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCeEE
Q 017362 115 ADDFELL-TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 115 ~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~ 192 (373)
.++|.+. +.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.++..+ .||||+++++++.+.+.+|
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~ 105 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII 105 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence 4567777 899999999999999999999999999876532 223345688899999988 4699999999999999999
Q ss_pred EEEeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC---CCcEEEeeccccccCC
Q 017362 193 LIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---YGHLRLSDFGLCKPLD 267 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~---~~~vkL~DFGla~~~~ 267 (373)
+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 999999999999998553 67999999999999999999999999999999999999988 7899999999998654
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 347 (373)
.... ....+||+.|+|||++.+..++.++|||||||++
T Consensus 186 ~~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 223 (327)
T 3lm5_A 186 HACE------------------------------------------LREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223 (327)
T ss_dssp --------------------------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred Cccc------------------------------------------cccccCCcCccCCeeecCCCCCchhhHHHHHHHH
Confidence 2210 1135799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhhc
Q 017362 348 YEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 348 ~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
|+|++|.+||.+.+..+....|..
T Consensus 224 ~~ll~g~~pf~~~~~~~~~~~i~~ 247 (327)
T 3lm5_A 224 YMLLTHTSPFVGEDNQETYLNISQ 247 (327)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCchHHHHHHHh
Confidence 999999999999998888777654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=325.06 Aligned_cols=219 Identities=23% Similarity=0.348 Sum_probs=187.1
Q ss_pred hccCCCCCcceeceeeeeCcEEEEEEEE-----cCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEee
Q 017362 110 RHKMGADDFELLTMIGKGAFGEVRVCRE-----KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYC 183 (373)
Q Consensus 110 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~ 183 (373)
..++..++|.+.+.||+|+||.||+|.+ ..++..||||++..... ....+.+.+|+.++..+ +||||+++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence 3456678999999999999999999985 45678999999975432 23446788999999999 9999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHHhhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCC
Q 017362 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKD------------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPD 245 (373)
Q Consensus 184 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~------------------~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~ 245 (373)
++.+.+..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 174 (313)
T 1t46_A 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (313)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccc
Confidence 9999999999999999999999997654 4899999999999999999999999999999999
Q ss_pred CEEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcc
Q 017362 246 NLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIA 325 (373)
Q Consensus 246 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~a 325 (373)
|||++.++.+||+|||++.......... ......||+.|+|
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~a 215 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYV---------------------------------------VKGNARLPVKWMA 215 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSE---------------------------------------ECSSSEECGGGCC
T ss_pred eEEEcCCCCEEEccccccccccccccce---------------------------------------eccCCCCcceeeC
Confidence 9999999999999999998664332110 0113468899999
Q ss_pred cccccCCCCChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 017362 326 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKV 369 (373)
Q Consensus 326 PE~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI 369 (373)
||++.+..++.++|||||||++|||++ |.+||.+.+......++
T Consensus 216 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 260 (313)
T 1t46_A 216 PESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260 (313)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHH
T ss_pred hHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHH
Confidence 999999999999999999999999999 99999887655544443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=340.34 Aligned_cols=213 Identities=24% Similarity=0.450 Sum_probs=186.0
Q ss_pred hhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC
Q 017362 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (373)
Q Consensus 109 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 188 (373)
....+..++|++.+.||+|+||.||+|.+. +..||||+++... ..+.+.+|+.+|+.++||||+++++++.+.
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 258 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence 345677899999999999999999999875 7799999997542 345688999999999999999999998766
Q ss_pred C-eEEEEEeccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 189 E-FLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 189 ~-~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
. .+|+||||+++|+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 259 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 5 7999999999999999997654 379999999999999999999999999999999999999999999999999974
Q ss_pred CCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHH
Q 017362 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (373)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGv 345 (373)
..... ....+|+.|+|||++.+..++.++|||||||
T Consensus 339 ~~~~~--------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~ 374 (450)
T 1k9a_A 339 ASSTQ--------------------------------------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGI 374 (450)
T ss_dssp CC--------------------------------------------------CCCTTTSCHHHHHSSCCCHHHHHHHHHH
T ss_pred ccccc--------------------------------------------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHH
Confidence 32110 0235788999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 346 IMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 346 il~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+||||++ |.+||.+.+..+....|.++
T Consensus 375 ~l~el~t~g~~P~~~~~~~~~~~~i~~~ 402 (450)
T 1k9a_A 375 LLWEIYSFGRVPYPRIPLKDVVPRVEKG 402 (450)
T ss_dssp HHHHHHTTTCCSSTTSCTTTHHHHHHTT
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999998 99999998888888777654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=324.31 Aligned_cols=208 Identities=28% Similarity=0.469 Sum_probs=175.6
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEE----EcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCR----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 187 (373)
.+..++|++++.||+|+||+||+|. +..+++.||||++.... ....+.+.+|+.++..++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 4567899999999999999999998 56688999999987542 3345678899999999999999999999864
Q ss_pred --CCeEEEEEeccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccc
Q 017362 188 --DEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (373)
Q Consensus 188 --~~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~ 264 (373)
...+|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++++||+|||++.
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 456899999999999999997754 59999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHH
Q 017362 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344 (373)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG 344 (373)
......... .......||+.|+|||++.+..++.++||||||
T Consensus 163 ~~~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 204 (295)
T 3ugc_A 163 VLPQDKEFF--------------------------------------KVKEPGESPIFWYAPESLTESKFSVASDVWSFG 204 (295)
T ss_dssp ---------------------------------------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred cccCCccee--------------------------------------eeccCCCCccceeCcHHhcCCCCChHHHHHHHH
Confidence 654321100 001134578889999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCC
Q 017362 345 AIMYEMLVGYPPFYSD 360 (373)
Q Consensus 345 vil~ell~G~~Pf~~~ 360 (373)
|++|||++|..||...
T Consensus 205 ~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 205 VVLYELFTYIEKSKSP 220 (295)
T ss_dssp HHHHHHHHTTCTTCSH
T ss_pred HHHHHHHhcccccCCC
Confidence 9999999999998643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=321.00 Aligned_cols=224 Identities=22% Similarity=0.328 Sum_probs=187.4
Q ss_pred hhccCCCCCcceec-eeeeeCcEEEEEEEE--cCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEE
Q 017362 109 QRHKMGADDFELLT-MIGKGAFGEVRVCRE--KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSF 185 (373)
Q Consensus 109 ~~~~~~~~~y~~~~-~lG~G~~g~Vy~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~ 185 (373)
.+..+..++|.+.. .||+|+||+||+|.+ ..++..||||++.... ......+.+.+|+.++..++||||+++++++
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 87 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC 87 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 34456678899998 999999999999954 5667899999997653 2233456788999999999999999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 186 QDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 186 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
..+..|+||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 88 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 88 -EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp -ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred -CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 5677899999999999999999888899999999999999999999999999999999999999999999999999986
Q ss_pred CCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHH
Q 017362 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (373)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGv 345 (373)
......... ......||+.|+|||++.+..++.++|||||||
T Consensus 167 ~~~~~~~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 208 (291)
T 1xbb_A 167 LRADENYYK--------------------------------------AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGV 208 (291)
T ss_dssp CCTTCSEEE--------------------------------------C----CCCGGGCCHHHHHHCEEEHHHHHHHHHH
T ss_pred eccCCCccc--------------------------------------ccccCCCCceeeChHHhccCCCChhhhHHHHHH
Confidence 643321100 001245789999999999889999999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 346 IMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 346 il~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
++|+|++ |.+||.+.+..+....+..+
T Consensus 209 il~~l~~~g~~p~~~~~~~~~~~~~~~~ 236 (291)
T 1xbb_A 209 LMWEAFSYGQKPYRGMKGSEVTAMLEKG 236 (291)
T ss_dssp HHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 9999999 99999999888877776543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=329.24 Aligned_cols=212 Identities=24% Similarity=0.358 Sum_probs=183.1
Q ss_pred hhhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe
Q 017362 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (373)
Q Consensus 108 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 187 (373)
+.......++|++.+.||+|+||+||+|.+ .++..||||++.... ....+.+.+|+.++..++||||+++++++.+
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 444555678999999999999999999986 468899999886542 3345678899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeecccc
Q 017362 188 DEFLYLIMEYLPGGDMMTLLMRKD----TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (373)
Q Consensus 188 ~~~~~lV~E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla 263 (373)
.+..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccc
Confidence 999999999999999999986543 5899999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHH
Q 017362 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (373)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSl 343 (373)
+......... ......||+.|+|||++.+..++.++|||||
T Consensus 187 ~~~~~~~~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 227 (321)
T 2qkw_B 187 KKGTELDQTH---------------------------------------LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSF 227 (321)
T ss_dssp EECSSSSCCC---------------------------------------CBCCCEEETTTCCHHHHHHCBCCTHHHHHHH
T ss_pred cccccccccc---------------------------------------cccccCCCccccCHHHhcCCCCCcccchHhH
Confidence 7643221100 0113569999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCh
Q 017362 344 GAIMYEMLVGYPPFYSDDP 362 (373)
Q Consensus 344 Gvil~ell~G~~Pf~~~~~ 362 (373)
||++|||++|++||....+
T Consensus 228 G~il~ell~g~~p~~~~~~ 246 (321)
T 2qkw_B 228 GVVLFEVLCARSAIVQSLP 246 (321)
T ss_dssp HHHHHHHHHCCTTCSCSSS
T ss_pred HHHHHHHHhCCCcccccCc
Confidence 9999999999999987654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=340.64 Aligned_cols=207 Identities=29% Similarity=0.470 Sum_probs=174.9
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC------
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD------ 188 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~------ 188 (373)
..+|++.+.||+|+||+||+|.+..+++.||||++..... ...+|+.+++.++||||++++++|...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 3469999999999999999999999999999999865321 134699999999999999999988542
Q ss_pred CeEEEEEeccCCCCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCC-CcEEEeecccc
Q 017362 189 EFLYLIMEYLPGGDMMTLLM----RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY-GHLRLSDFGLC 263 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~-~~vkL~DFGla 263 (373)
.++++||||+++ +|...+. ....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence 247899999975 6665553 35689999999999999999999999999999999999999965 67899999999
Q ss_pred ccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHH
Q 017362 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWS 342 (373)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwS 342 (373)
+.+..... ....+||+.|+|||++.+. .|+.++||||
T Consensus 205 ~~~~~~~~------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwS 242 (420)
T 1j1b_A 205 KQLVRGEP------------------------------------------NVSYICSRYYRAPELIFGATDYTSSIDVWS 242 (420)
T ss_dssp EECCTTCC------------------------------------------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHH
T ss_pred hhcccCCC------------------------------------------ceeeeeCCCcCCHHHHcCCCCCCchhhhHH
Confidence 86542211 1146799999999999765 7999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 017362 343 LGAIMYEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 343 lGvil~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
||||+|||++|++||.+.+..+...+|++
T Consensus 243 lG~il~ell~G~~pf~~~~~~~~l~~i~~ 271 (420)
T 1j1b_A 243 AGCVLAELLLGQPIFPGDSGVDQLVEIIK 271 (420)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999999999999999998888777753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=330.71 Aligned_cols=205 Identities=21% Similarity=0.285 Sum_probs=173.8
Q ss_pred hccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC
Q 017362 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 110 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 189 (373)
...+..++|++.+.||+|+||+||+|.+. ++.||||++.... ........|+.++..++||||+++++++.+..
T Consensus 18 n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (322)
T 3soc_A 18 NLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGT 91 (322)
T ss_dssp CEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred ccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCC
Confidence 34466789999999999999999999865 7899999997543 22234556888899999999999999998754
Q ss_pred ----eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCeeecCCCCCEEEcCCCcE
Q 017362 190 ----FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH----------HYIHRDIKPDNLLLDKYGHL 255 (373)
Q Consensus 190 ----~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~----------giiHrDikp~NILl~~~~~v 255 (373)
.+|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+
T Consensus 92 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~ 170 (322)
T 3soc_A 92 SVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170 (322)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred CCCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeE
Confidence 37999999999999999965 4599999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC----
Q 017362 256 RLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---- 331 (373)
Q Consensus 256 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---- 331 (373)
||+|||+|+.+....... .....+||+.|+|||++.+
T Consensus 171 kL~DFg~a~~~~~~~~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~ 211 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAG---------------------------------------DTHGQVGTRRYMAPEVLEGAINF 211 (322)
T ss_dssp EECCCTTCEEECTTSCCC---------------------------------------CCTTCCCCGGGCCHHHHTTCCCC
T ss_pred EEccCCcccccccccCcc---------------------------------------ccccCccCccccCHhhccccccc
Confidence 999999997654322110 0113579999999999986
Q ss_pred -CCCChhhcHHHHHHHHHHHHhCCCCCCCC
Q 017362 332 -KGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (373)
Q Consensus 332 -~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 360 (373)
..++.++|||||||++|||++|++||.+.
T Consensus 212 ~~~~~~~~DiwslG~il~el~tg~~pf~~~ 241 (322)
T 3soc_A 212 QRDAFLRIDMYAMGLVLWELASRCTAADGP 241 (322)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred CcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 35678899999999999999999999764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=331.14 Aligned_cols=214 Identities=27% Similarity=0.446 Sum_probs=184.1
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC-----C
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD-----E 189 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-----~ 189 (373)
.++|++++.||+|+||.||+|.+..++..||||++.... .......+.+|+.++..++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 468999999999999999999999999999999987532 233446788999999999999999999999765 3
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
..|+||||++ |+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred eEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 6899999996 599998855 56999999999999999999999999999999999999999999999999999865432
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ 348 (373)
.... ......+||+.|+|||++.+ ..++.++|||||||++|
T Consensus 182 ~~~~--------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ 223 (364)
T 3qyz_A 182 HDHT--------------------------------------GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILA 223 (364)
T ss_dssp GCBC--------------------------------------CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHH
T ss_pred CCcc--------------------------------------ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHH
Confidence 1110 00124589999999998765 45899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhh
Q 017362 349 EMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 349 ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
+|++|.+||.+.+..+...+|+
T Consensus 224 ell~g~~pf~~~~~~~~~~~i~ 245 (364)
T 3qyz_A 224 EMLSNRPIFPGKHYLDQLNHIL 245 (364)
T ss_dssp HHHHSSCSSCCSSGGGHHHHHH
T ss_pred HHHHCCCCCCCCChHHHHHHHH
Confidence 9999999999999888887775
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=327.33 Aligned_cols=216 Identities=23% Similarity=0.444 Sum_probs=185.0
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceE--eeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCC
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVY--AMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~v--aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~ 189 (373)
+..++|++.+.||+|+||.||+|.+..++..+ |+|.+.... .......+.+|+.++..+ +||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 45689999999999999999999998888765 999886432 233445688899999999 8999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKD----------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG 253 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~ 253 (373)
.+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999997654 699999999999999999999999999999999999999999
Q ss_pred cEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC
Q 017362 254 HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG 333 (373)
Q Consensus 254 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~ 333 (373)
.+||+|||+++....... .....+|+.|+|||++.+..
T Consensus 180 ~~kL~Dfg~~~~~~~~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~ 217 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYVK------------------------------------------KTMGRLPVRWMAIESLNYSV 217 (327)
T ss_dssp CEEECCTTCEESSCEECC------------------------------------------C----CCTTTCCHHHHHHCE
T ss_pred eEEEcccCcCcccccccc------------------------------------------ccCCCCCccccChhhhcccc
Confidence 999999999874321100 01345789999999999889
Q ss_pred CChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 334 YGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 334 ~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
++.++|||||||++|||++ |.+||.+.+..+...++..+
T Consensus 218 ~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~ 257 (327)
T 1fvr_A 218 YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 257 (327)
T ss_dssp ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred CCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC
Confidence 9999999999999999998 99999999998888887654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=326.06 Aligned_cols=223 Identities=17% Similarity=0.287 Sum_probs=191.0
Q ss_pred hhccCCCCCcceeceeeeeCcEEEEEEEEc-----CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEee
Q 017362 109 QRHKMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183 (373)
Q Consensus 109 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~ 183 (373)
...++..++|++.+.||+|+||.||+|.+. .++..||||++.... .......+.+|+.+++.++||||+++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 345677789999999999999999999876 357789999987542 2233456889999999999999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHHhhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC
Q 017362 184 SFQDDEFLYLIMEYLPGGDMMTLLMRK----------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG 253 (373)
Q Consensus 184 ~~~~~~~~~lV~E~~~gg~L~~~l~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~ 253 (373)
++.+.+..|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence 999999999999999999999998652 4579999999999999999999999999999999999999999
Q ss_pred cEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC
Q 017362 254 HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG 333 (373)
Q Consensus 254 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~ 333 (373)
.+||+|||++.......... ......||+.|+|||++.+..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~ 216 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYR---------------------------------------KGGKGLLPVRWMSPESLKDGV 216 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEE---------------------------------------GGGSSEECGGGCCHHHHHHCC
T ss_pred eEEECcCccccccccccccc---------------------------------------cccCCCCCCCccChhhhccCC
Confidence 99999999997543221100 011346889999999999999
Q ss_pred CChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 334 YGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 334 ~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
++.++|||||||++|||++ |.+||.+.+..+....+.++
T Consensus 217 ~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 256 (322)
T 1p4o_A 217 FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 256 (322)
T ss_dssp CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcC
Confidence 9999999999999999999 99999999988888777653
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=320.44 Aligned_cols=216 Identities=33% Similarity=0.605 Sum_probs=185.8
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe--CCeEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD--DEFLY 192 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~~ 192 (373)
.++|++++.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+ ...+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 5789999999999999999999999999999999976432 23345678899999999999999999998854 57899
Q ss_pred EEEeccCCCCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHhCC-----CeeecCCCCCEEEcCCCcEEEeecccc
Q 017362 193 LIMEYLPGGDMMTLLMRK----DTLTEDEARFYVAETVLAIESIHKHH-----YIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g-----iiHrDikp~NILl~~~~~vkL~DFGla 263 (373)
+||||++|++|.+++... ..+++..+..++.|++.||.|||+.| |+||||||+|||++.++.+||+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999999999653 34999999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHH
Q 017362 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (373)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSl 343 (373)
......... .....||+.|+|||++.+..++.++|||||
T Consensus 164 ~~~~~~~~~-----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 202 (279)
T 2w5a_A 164 RILNHDTSF-----------------------------------------AKTFVGTPYYMSPEQMNRMSYNEKSDIWSL 202 (279)
T ss_dssp HHC---CHH-----------------------------------------HHHHHSCCTTCCHHHHHCC-CCHHHHHHHH
T ss_pred eeecccccc-----------------------------------------ccccCCCccccChHHhccCCCCchhhHHHH
Confidence 765322100 013469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHhhcC
Q 017362 344 GAIMYEMLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 344 Gvil~ell~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
||++|+|++|.+||...+..+...+|.++
T Consensus 203 G~il~~l~~g~~p~~~~~~~~~~~~i~~~ 231 (279)
T 2w5a_A 203 GCLLYELCALMPPFTAFSQKELAGKIREG 231 (279)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred HHHHHHHHHCCCCCcccCHHHHHHHHhhc
Confidence 99999999999999999888888777654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=317.59 Aligned_cols=213 Identities=27% Similarity=0.468 Sum_probs=168.0
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 191 (373)
++..++|++++.||+|+||+||+|.+..+++.||+|++..... .......+..+...++.++||||+++++++.+.+..
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 4667899999999999999999999999999999999976432 222334445555667888999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeecCCCCCEEEcCCCcEEEeeccccccC
Q 017362 192 YLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKH-HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-giiHrDikp~NILl~~~~~vkL~DFGla~~~ 266 (373)
|+||||++ |+|.+++.. ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99999996 488777643 56899999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccc----cCCCCChhhcHHH
Q 017362 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL----LKKGYGMECDWWS 342 (373)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~~~~~DvwS 342 (373)
..... .....||+.|+|||++ .+..++.++||||
T Consensus 161 ~~~~~------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~s 198 (290)
T 3fme_A 161 VDDVA------------------------------------------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWS 198 (290)
T ss_dssp ---------------------------------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHH
T ss_pred ccccc------------------------------------------ccccCCCccccChhhcChhhcCcCCCcHHHHHH
Confidence 32211 0134799999999996 5667899999999
Q ss_pred HHHHHHHHHhCCCCCCCC-ChHHHHHH
Q 017362 343 LGAIMYEMLVGYPPFYSD-DPMSTCRK 368 (373)
Q Consensus 343 lGvil~ell~G~~Pf~~~-~~~~~~~k 368 (373)
|||++|+|++|.+||... .+......
T Consensus 199 lG~il~~l~~g~~p~~~~~~~~~~~~~ 225 (290)
T 3fme_A 199 LGITMIELAILRFPYDSWGTPFQQLKQ 225 (290)
T ss_dssp HHHHHHHHHHTSCSSCCCSCHHHHHHH
T ss_pred HHHHHHHHHHCCCCccccCchHHHHHH
Confidence 999999999999999863 44444433
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=315.94 Aligned_cols=212 Identities=18% Similarity=0.271 Sum_probs=184.1
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC--
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD-- 188 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-- 188 (373)
..+..++|++.+.||+|+||+||+|.+. +..||+|++..... .....+.+.+|+.++..++||||+++++++.+.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 3466789999999999999999999875 78999999976532 233446688999999999999999999999887
Q ss_pred CeEEEEEeccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCC--CeeecCCCCCEEEcCCCcEEEeeccccc
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHH--YIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g--iiHrDikp~NILl~~~~~vkL~DFGla~ 264 (373)
...|+||||++||+|.+++.... .+++..+..++.|++.||.|||++| ++||||||+|||++.++.++|+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence 78899999999999999998765 4899999999999999999999999 9999999999999999999999999875
Q ss_pred cCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCCh---hhcHH
Q 017362 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM---ECDWW 341 (373)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~---~~Dvw 341 (373)
..... ...||+.|+|||++.+..++. ++|||
T Consensus 162 ~~~~~----------------------------------------------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~ 195 (271)
T 3kmu_A 162 SFQSP----------------------------------------------GRMYAPAWVAPEALQKKPEDTNRRSADMW 195 (271)
T ss_dssp TTSCT----------------------------------------------TCBSCGGGSCHHHHHSCGGGSCHHHHHHH
T ss_pred eeccc----------------------------------------------CccCCccccChhhhccCCCCCCCchhhHH
Confidence 42211 357899999999998765544 89999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 017362 342 SLGAIMYEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 342 SlGvil~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
||||++|||++|.+||.+.+..+...++..
T Consensus 196 slG~il~el~~g~~p~~~~~~~~~~~~~~~ 225 (271)
T 3kmu_A 196 SFAVLLWELVTREVPFADLSNMEIGMKVAL 225 (271)
T ss_dssp HHHHHHHHHHHCSCTTTTSCHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCccccChHHHHHHHHh
Confidence 999999999999999999888887666653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=342.48 Aligned_cols=217 Identities=22% Similarity=0.391 Sum_probs=187.6
Q ss_pred hccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC
Q 017362 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 110 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 189 (373)
..++..++|.+.+.||+|+||+||+|.+. ++..||||++.... ...+.+.+|+.+|+.++||||+++++++. .+
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 45677889999999999999999999875 46789999997643 23567899999999999999999999886 56
Q ss_pred eEEEEEeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 789999999999999999754 368999999999999999999999999999999999999999999999999998654
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 347 (373)
..... ......+|+.|+|||++....++.++|||||||+|
T Consensus 336 ~~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l 375 (454)
T 1qcf_A 336 DNEYT----------------------------------------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 375 (454)
T ss_dssp CHHHH----------------------------------------TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCcee----------------------------------------ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHH
Confidence 22110 01134578899999999989999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 348 YEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 348 ~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|||++ |.+||.+.+..+....|.++
T Consensus 376 ~el~t~g~~P~~~~~~~~~~~~i~~~ 401 (454)
T 1qcf_A 376 MEIVTYGRIPYPGMSNPEVIRALERG 401 (454)
T ss_dssp HHHHTTSCCSSTTCCHHHHHHHHHHT
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999 99999999988888777653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=319.18 Aligned_cols=217 Identities=31% Similarity=0.561 Sum_probs=175.7
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 192 (373)
...++|++.+.||+|+||.||+|.+..++..||||++.............+.+|+.++..++||||+++++++.+.+..|
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 45678999999999999999999999999999999997644334455677889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 193 LIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999999864 46799999999999999999999999999999999999999999999999999875432
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 348 (373)
.... .....||+.|+|||++.+..++.++|||||||++|
T Consensus 189 ~~~~-----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ 227 (310)
T 2wqm_A 189 KTTA-----------------------------------------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLY 227 (310)
T ss_dssp ---------------------------------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred CCcc-----------------------------------------ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHH
Confidence 2100 11357999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCC--hHHHHHHhh
Q 017362 349 EMLVGYPPFYSDD--PMSTCRKVR 370 (373)
Q Consensus 349 ell~G~~Pf~~~~--~~~~~~kI~ 370 (373)
+|++|..||.+.. ..+...++.
T Consensus 228 ~l~~g~~p~~~~~~~~~~~~~~~~ 251 (310)
T 2wqm_A 228 EMAALQSPFYGDKMNLYSLCKKIE 251 (310)
T ss_dssp HHHHSSCTTC---CCHHHHHHHHH
T ss_pred HHHhCCCCCcccchhHHHHHHHhh
Confidence 9999999997643 334444443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=316.54 Aligned_cols=206 Identities=28% Similarity=0.524 Sum_probs=181.6
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++++.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 579999999999999999999999999999999875432 234467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
||+++++|.+++.....+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..+......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~--- 161 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE--- 161 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE---
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch---
Confidence 99999999999987778999999999999999999999999999999999999999999999999999765322110
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCC-ChhhcHHHHHHHHHHHHhCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G~ 354 (373)
......+||+.|+|||++.+..+ +.++|||||||++|||++|.
T Consensus 162 ------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~ 205 (276)
T 2yex_A 162 ------------------------------------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205 (276)
T ss_dssp ------------------------------------CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSS
T ss_pred ------------------------------------hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCC
Confidence 01124579999999999988776 78999999999999999999
Q ss_pred CCCCCCCh
Q 017362 355 PPFYSDDP 362 (373)
Q Consensus 355 ~Pf~~~~~ 362 (373)
.||...+.
T Consensus 206 ~p~~~~~~ 213 (276)
T 2yex_A 206 LPWDQPSD 213 (276)
T ss_dssp CCCSCSCT
T ss_pred CCCCCCch
Confidence 99987654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=322.38 Aligned_cols=218 Identities=32% Similarity=0.560 Sum_probs=181.8
Q ss_pred hhhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEE
Q 017362 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQ 186 (373)
Q Consensus 108 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~ 186 (373)
+.......++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+|+.++..+ +||||+++++++.
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 4445556789999999999999999999999999999999986532 2335678899999998 8999999999998
Q ss_pred e------CCeEEEEEeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEe
Q 017362 187 D------DEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLS 258 (373)
Q Consensus 187 ~------~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~ 258 (373)
. ...+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEe
Confidence 7 56899999999999999999764 579999999999999999999999999999999999999999999999
Q ss_pred eccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc-----CCC
Q 017362 259 DFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKG 333 (373)
Q Consensus 259 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~ 333 (373)
|||++......... .....||+.|+|||++. +..
T Consensus 172 Dfg~~~~~~~~~~~-----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~ 210 (326)
T 2x7f_A 172 DFGVSAQLDRTVGR-----------------------------------------RNTFIGTPYWMAPEVIACDENPDAT 210 (326)
T ss_dssp CCTTTC------------------------------------------------------CCGGGCCHHHHC--------
T ss_pred eCcCceecCcCccc-----------------------------------------cccccCCccccChhhhccccccCcC
Confidence 99998765322100 11357999999999997 567
Q ss_pred CChhhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 017362 334 YGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 334 ~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
++.++|||||||++|+|++|.+||.+.++......+.
T Consensus 211 ~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (326)
T 2x7f_A 211 YDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP 247 (326)
T ss_dssp CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred CCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh
Confidence 8999999999999999999999999888777666554
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=323.67 Aligned_cols=219 Identities=31% Similarity=0.518 Sum_probs=184.4
Q ss_pred hhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC
Q 017362 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (373)
Q Consensus 109 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 188 (373)
.......++|++++.||+|+||.||+|.+..++..||+|++.... ....+.+.+|+.++..++||||+++++++.+.
T Consensus 12 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 88 (302)
T 2j7t_A 12 RRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHD 88 (302)
T ss_dssp BSSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC
T ss_pred ccccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC
Confidence 333445678999999999999999999999999999999987543 33456788899999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
+..|+||||+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++....
T Consensus 89 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 89 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 168 (302)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999999999998865 5679999999999999999999999999999999999999999999999999875321
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc-----CCCCChhhcHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWS 342 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DvwS 342 (373)
.. ........||+.|+|||++. ...++.++||||
T Consensus 169 ~~-----------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~s 207 (302)
T 2j7t_A 169 KT-----------------------------------------LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWS 207 (302)
T ss_dssp HH-----------------------------------------HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHH
T ss_pred cc-----------------------------------------ccccccccCChhhcCCeeeccccCCCCCCchhhhHHH
Confidence 00 00011457999999999984 677899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 017362 343 LGAIMYEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 343 lGvil~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
|||++|+|++|.+||...++.....++.+
T Consensus 208 lG~il~~l~~g~~p~~~~~~~~~~~~~~~ 236 (302)
T 2j7t_A 208 LGITLIEMAQIEPPHHELNPMRVLLKIAK 236 (302)
T ss_dssp HHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCccCCHHHHHHHHhc
Confidence 99999999999999999888877766654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=324.69 Aligned_cols=222 Identities=21% Similarity=0.331 Sum_probs=183.9
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCC----ceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEE
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTG----HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 186 (373)
.++..++|.+.+.||+|+||+||+|.+..++ ..||||++.... .......+.+|+.++..++||||+++++++.
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 3567789999999999999999999876543 359999987542 2334456889999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 187 DDEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 187 ~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
+.+..|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999999999764 5799999999999999999999999999999999999999999999999999976
Q ss_pred CCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHH
Q 017362 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (373)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGv 345 (373)
......... ......+|+.|+|||++.+..++.++|||||||
T Consensus 197 ~~~~~~~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 238 (333)
T 1mqb_A 197 LEDDPEATY--------------------------------------TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGI 238 (333)
T ss_dssp ----------------------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHH
T ss_pred hcccccccc--------------------------------------ccCCCCccccccCchhcccCCCCchhhhHHHHH
Confidence 542211000 001235788999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 346 IMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 346 il~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
++|||++ |..||.+.+..+....|.++
T Consensus 239 il~ellt~g~~pf~~~~~~~~~~~~~~~ 266 (333)
T 1mqb_A 239 VMWEVMTYGERPYWELSNHEVMKAINDG 266 (333)
T ss_dssp HHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred HHHHHHcCCCCCcccCCHHHHHHHHHCC
Confidence 9999999 99999999888888777654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=316.52 Aligned_cols=201 Identities=22% Similarity=0.371 Sum_probs=174.3
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCeEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYL 193 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~l 193 (373)
.++|++++.||+|+||+||+|.+..+++.||||++..... .......+.+|+..+..+ +||||+++++++.+.+..|+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3579999999999999999999999999999999875422 223345677888889888 99999999999999999999
Q ss_pred EEeccCCCCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCC-----------------
Q 017362 194 IMEYLPGGDMMTLLMRK----DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY----------------- 252 (373)
Q Consensus 194 V~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~----------------- 252 (373)
||||++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 99999999999999764 679999999999999999999999999999999999999844
Q ss_pred --CcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc
Q 017362 253 --GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL 330 (373)
Q Consensus 253 --~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 330 (373)
..+||+|||++....... ...||+.|+|||++.
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~---------------------------------------------~~~gt~~y~aPE~~~ 203 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISSPQ---------------------------------------------VEEGDSRFLANEVLQ 203 (289)
T ss_dssp -CCCEEECCCTTCEETTCSC---------------------------------------------CCCCCGGGCCHHHHT
T ss_pred CceEEEEcccccccccCCcc---------------------------------------------ccCCCccccChhHhc
Confidence 479999999987654221 346999999999998
Q ss_pred CC-CCChhhcHHHHHHHHHHHHhCCCCCCCCC
Q 017362 331 KK-GYGMECDWWSLGAIMYEMLVGYPPFYSDD 361 (373)
Q Consensus 331 ~~-~~~~~~DvwSlGvil~ell~G~~Pf~~~~ 361 (373)
+. .++.++|||||||++|+|++|.+||...+
T Consensus 204 ~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~ 235 (289)
T 1x8b_A 204 ENYTHLPKADIFALALTVVCAAGAEPLPRNGD 235 (289)
T ss_dssp TCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH
T ss_pred CCCCCCchhhHHHHHHHHHHHhcCCCCCcchh
Confidence 76 56789999999999999999999886543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=325.63 Aligned_cols=217 Identities=22% Similarity=0.375 Sum_probs=178.8
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceE----eeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVY----AMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~v----aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 188 (373)
+..++|++++.||+|+||+||+|.+..++..| |+|.+... ........+.+|+.++..++||||+++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC--SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc--cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 55789999999999999999999998888766 55554322 1233456788999999999999999999999876
Q ss_pred CeEEEEEeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
. .++||||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++++||+|||+++...
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 5 7899999999999999976 4579999999999999999999999999999999999999999999999999998654
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 347 (373)
...... ......||+.|+|||++.+..|+.++|||||||++
T Consensus 169 ~~~~~~---------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 209 (327)
T 3lzb_A 169 AEEKEY---------------------------------------HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 209 (327)
T ss_dssp --------------------------------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred Cccccc---------------------------------------cccCCCccccccCHHHHcCCCCChHHHHHHHHHHH
Confidence 221100 01134578899999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHhhc
Q 017362 348 YEMLV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 348 ~ell~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
|||++ |.+||.+.+..+....+..
T Consensus 210 ~ell~~g~~p~~~~~~~~~~~~~~~ 234 (327)
T 3lzb_A 210 WELMTFGSKPYDGIPASEISSILEK 234 (327)
T ss_dssp HHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHc
Confidence 99999 9999999888877766654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=322.59 Aligned_cols=212 Identities=26% Similarity=0.478 Sum_probs=183.5
Q ss_pred hhccCCCCCcceeceeeeeCcEEEEEEEE-cCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCC------ceeEE
Q 017362 109 QRHKMGADDFELLTMIGKGAFGEVRVCRE-KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN------CIVKL 181 (373)
Q Consensus 109 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~------~iv~l 181 (373)
+...+..++|++++.||+|+||+||+|.+ ..++..||||++.... ...+.+.+|+.++..+.|+ +++++
T Consensus 7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~ 82 (339)
T 1z57_A 7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQM 82 (339)
T ss_dssp STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence 34455678999999999999999999998 5688999999987542 2345577888888888655 59999
Q ss_pred eeEEEeCCeEEEEEeccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC--------
Q 017362 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-------- 251 (373)
Q Consensus 182 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~-------- 251 (373)
++++.+.+.+|+||||+ +++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 83 LEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred ecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccC
Confidence 99999999999999999 889999997765 6899999999999999999999999999999999999987
Q ss_pred -----------CCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccC
Q 017362 252 -----------YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGT 320 (373)
Q Consensus 252 -----------~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 320 (373)
++.+||+|||+++...... ...+||
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--------------------------------------------~~~~gt 197 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDEHH--------------------------------------------STLVST 197 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTSCC--------------------------------------------CSSCSC
T ss_pred CccccccccccCCCceEeeCcccccCcccc--------------------------------------------ccccCC
Confidence 6789999999997543211 145799
Q ss_pred CCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 017362 321 PDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369 (373)
Q Consensus 321 ~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~kI 369 (373)
+.|+|||++.+..++.++|||||||++|||++|.+||...+..+....+
T Consensus 198 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 246 (339)
T 1z57_A 198 RHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMM 246 (339)
T ss_dssp GGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHH
T ss_pred ccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 9999999999999999999999999999999999999998877765544
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=333.25 Aligned_cols=206 Identities=22% Similarity=0.392 Sum_probs=177.2
Q ss_pred HhhhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC--------CCce
Q 017362 107 RLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD--------SNCI 178 (373)
Q Consensus 107 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i 178 (373)
.+....+..++|++++.||+|+||+||+|.+..+++.||||++.... ...+.+.+|+.++..+. |+||
T Consensus 28 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~i 103 (397)
T 1wak_A 28 LVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMV 103 (397)
T ss_dssp SSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGB
T ss_pred EEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCccee
Confidence 34445556789999999999999999999999999999999997542 23456788999998885 7889
Q ss_pred eEEeeEEE----eCCeEEEEEeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CCeeecCCCCCEEEcC
Q 017362 179 VKLYCSFQ----DDEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKH-HYIHRDIKPDNLLLDK 251 (373)
Q Consensus 179 v~l~~~~~----~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~-giiHrDikp~NILl~~ 251 (373)
+++++.|. +...+|+||||+ +++|.+.+... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.
T Consensus 104 v~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~ 182 (397)
T 1wak_A 104 VQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSV 182 (397)
T ss_dssp CCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECC
T ss_pred eeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEec
Confidence 99999998 556899999999 66777776554 4699999999999999999999998 9999999999999997
Q ss_pred CC-------------------------------------------------cEEEeeccccccCCCCCcccccccccCCC
Q 017362 252 YG-------------------------------------------------HLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282 (373)
Q Consensus 252 ~~-------------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~~~~~ 282 (373)
++ .+||+|||+|.......
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~------------ 250 (397)
T 1wak_A 183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF------------ 250 (397)
T ss_dssp CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS------------
T ss_pred cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC------------
Confidence 76 79999999997653221
Q ss_pred CCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCCCC
Q 017362 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361 (373)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~ 361 (373)
...+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+
T Consensus 251 --------------------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 251 --------------------------------TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp --------------------------------CSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred --------------------------------ccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 14579999999999999999999999999999999999999998765
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=326.33 Aligned_cols=219 Identities=22% Similarity=0.380 Sum_probs=186.1
Q ss_pred hccCCCCCcceeceeeeeCcEEEEEEEEcCCCc-----eEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEee
Q 017362 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGH-----VYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYC 183 (373)
Q Consensus 110 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~ 183 (373)
..++..++|.+.+.||+|+||+||+|.+..++. .||+|++.... .....+.+.+|+.++..+ +||||+++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 456778999999999999999999999876654 79999987542 233456788999999999 8999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHHhh--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEE
Q 017362 184 SFQDDEFLYLIMEYLPGGDMMTLLMR--------------KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL 249 (373)
Q Consensus 184 ~~~~~~~~~lV~E~~~gg~L~~~l~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl 249 (373)
++.+.+.+|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 99999999999999999999999864 2458999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccc
Q 017362 250 DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL 329 (373)
Q Consensus 250 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~ 329 (373)
+.++.+||+|||++......... .......||+.|+|||++
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~---------------------------------------~~~~~~~~~~~y~aPE~~ 238 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNY---------------------------------------IVKGNARLPVKWMAPESI 238 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTS---------------------------------------EECSSCEECGGGSCHHHH
T ss_pred CCCCeEEECccccccccccccce---------------------------------------eecCCCCCCccccCHHHh
Confidence 99999999999999765322110 001135678999999999
Q ss_pred cCCCCChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 017362 330 LKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKV 369 (373)
Q Consensus 330 ~~~~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI 369 (373)
.+..++.++|||||||++|||++ |.+||.+........++
T Consensus 239 ~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 279 (333)
T 2i1m_A 239 FDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 279 (333)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred ccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence 99999999999999999999998 99999987655554444
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=315.81 Aligned_cols=207 Identities=25% Similarity=0.428 Sum_probs=177.3
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhh----hHHHHHHHHHHHHhcCCCceeEEeeEEE
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRG----QVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 186 (373)
..+..++|++.+.||+|+||+||+|.+..+++.||+|++......... ..+.+.+|+.++..++||||+++++++.
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (287)
T 4f0f_A 14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93 (287)
T ss_dssp CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence 456788999999999999999999999999999999998654322211 1267889999999999999999999997
Q ss_pred eCCeEEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCC--CeeecCCCCCEEEcCCCc-----EEEe
Q 017362 187 DDEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHH--YIHRDIKPDNLLLDKYGH-----LRLS 258 (373)
Q Consensus 187 ~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--iiHrDikp~NILl~~~~~-----vkL~ 258 (373)
+.. ++||||+++|+|.+++... ..+++..+..++.|++.||.|||++| |+||||||+|||++.++. +||+
T Consensus 94 ~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 94 NPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp TTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred CCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 665 6999999999999888654 47999999999999999999999999 999999999999988876 9999
Q ss_pred eccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc--CCCCCh
Q 017362 259 DFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL--KKGYGM 336 (373)
Q Consensus 259 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~~~ 336 (373)
|||+++..... .....||+.|+|||++. ...++.
T Consensus 172 Dfg~~~~~~~~--------------------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~ 207 (287)
T 4f0f_A 172 DFGLSQQSVHS--------------------------------------------VSGLLGNFQWMAPETIGAEEESYTE 207 (287)
T ss_dssp CCTTCBCCSSC--------------------------------------------EECCCCCCTTSCGGGSSCSSCEECH
T ss_pred CCCcccccccc--------------------------------------------ccccCCCccccCchhhccCCCCcCc
Confidence 99998743321 01357999999999994 456899
Q ss_pred hhcHHHHHHHHHHHHhCCCCCCCCChH
Q 017362 337 ECDWWSLGAIMYEMLVGYPPFYSDDPM 363 (373)
Q Consensus 337 ~~DvwSlGvil~ell~G~~Pf~~~~~~ 363 (373)
++|||||||++|||++|.+||...+..
T Consensus 208 ~~Di~slG~~l~~l~~g~~pf~~~~~~ 234 (287)
T 4f0f_A 208 KADTYSFAMILYTILTGEGPFDEYSYG 234 (287)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTTTCCCC
T ss_pred hhhHHHHHHHHHHHHcCCCCCcccccc
Confidence 999999999999999999999876543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=315.79 Aligned_cols=217 Identities=23% Similarity=0.414 Sum_probs=186.3
Q ss_pred hccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC
Q 017362 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 110 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 189 (373)
+.++..++|++++.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|+.++..++||||+++++++.+ +
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 80 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc----ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-C
Confidence 34566789999999999999999999874 56789999987543 224568889999999999999999998864 4
Q ss_pred eEEEEEeccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
..|+||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 5889999999999999996543 69999999999999999999999999999999999999999999999999998664
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 347 (373)
...... .....+|+.|+|||++.+..++.++|||||||++
T Consensus 161 ~~~~~~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 200 (279)
T 1qpc_A 161 DNEYTA----------------------------------------REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200 (279)
T ss_dssp SSCEEC----------------------------------------CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHH
T ss_pred Cccccc----------------------------------------ccCCCCccCccChhhhccCCCCchhhhHHHHHHH
Confidence 322110 1134578899999999988999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 348 YEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 348 ~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|||++ |.+||.+.+..+....+.++
T Consensus 201 ~el~~~g~~p~~~~~~~~~~~~~~~~ 226 (279)
T 1qpc_A 201 TEIVTHGRIPYPGMTNPEVIQNLERG 226 (279)
T ss_dssp HHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred HHHHhCCCCCCcccCHHHHHHHHhcc
Confidence 99999 99999999888887777543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=321.38 Aligned_cols=225 Identities=20% Similarity=0.322 Sum_probs=181.4
Q ss_pred hhhccCCCCCcceeceeeeeCcEEEEEEEEcC---CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeE
Q 017362 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKT---TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCS 184 (373)
Q Consensus 108 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~ 184 (373)
+....+..++|.+.+.||+|+||+||+|.+.. ++..||+|++..... .....+.+.+|+.++..++||||++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 45556778899999999999999999998764 456899999875432 23345678899999999999999999999
Q ss_pred EEeCC-----eEEEEEeccCCCCHHHHHh------hCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC
Q 017362 185 FQDDE-----FLYLIMEYLPGGDMMTLLM------RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG 253 (373)
Q Consensus 185 ~~~~~-----~~~lV~E~~~gg~L~~~l~------~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~ 253 (373)
+.+.. ..|+||||+++|+|.+++. ....+++..+..++.|++.||.|||++||+||||||+|||++.++
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC
Confidence 98755 3599999999999999984 335699999999999999999999999999999999999999999
Q ss_pred cEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC
Q 017362 254 HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG 333 (373)
Q Consensus 254 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~ 333 (373)
.+||+|||++.......... ......+++.|+|||++.+..
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~ 225 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYR---------------------------------------QGRIAKMPVKWIAIESLADRV 225 (313)
T ss_dssp CEEECSCSCC-------------------------------------------------------CCGGGSCHHHHHSSC
T ss_pred cEEEeecCcceecccccccC---------------------------------------cccccCCCccccCchhhcCCC
Confidence 99999999997654221100 001345788999999999999
Q ss_pred CChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 334 YGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 334 ~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
++.++|||||||++|+|++ |.+||.+.+..+....+.++
T Consensus 226 ~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 265 (313)
T 3brb_A 226 YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG 265 (313)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred ccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC
Confidence 9999999999999999999 99999999888888777654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=319.11 Aligned_cols=210 Identities=33% Similarity=0.587 Sum_probs=180.2
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEE
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 193 (373)
..++|++.+.||+|+||.||+|.+..+|..||||++.... ..+.+.+|+.++..++||||+++++++.+.+.+|+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 3578999999999999999999999999999999987532 23568889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcc
Q 017362 194 IMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 194 V~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 272 (373)
||||+++++|.+++. ....+++..+..++.+++.||.|||+.|++|+||||+|||++.++.+||+|||++.........
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 181 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK 181 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc
Confidence 999999999999986 4568999999999999999999999999999999999999999999999999999765322110
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 352 (373)
.....||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 182 -----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 220 (314)
T 3com_A 182 -----------------------------------------RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAE 220 (314)
T ss_dssp -----------------------------------------BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHh
Confidence 114579999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHh
Q 017362 353 GYPPFYSDDPMSTCRKV 369 (373)
Q Consensus 353 G~~Pf~~~~~~~~~~kI 369 (373)
|.+||...++......+
T Consensus 221 g~~p~~~~~~~~~~~~~ 237 (314)
T 3com_A 221 GKPPYADIHPMRAIFMI 237 (314)
T ss_dssp SSCTTTTSCHHHHHHHH
T ss_pred CCCCCCCCChHHHHHHH
Confidence 99999987776655443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=316.29 Aligned_cols=214 Identities=33% Similarity=0.663 Sum_probs=187.5
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3579999999999999999999998999999999876532 233456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCC---CcEEEeeccccccCCCCCc
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY---GHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~---~~vkL~DFGla~~~~~~~~ 271 (373)
|||+++++|.+++.....+++..+..++.||+.||.|||++|++||||||+|||++.+ +.+||+|||++........
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~ 179 (287)
T 2wei_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (287)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence 9999999999999888889999999999999999999999999999999999999764 4799999999976542210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
.....||+.|+|||++.+ .++.++|||||||++|+|+
T Consensus 180 ------------------------------------------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~ 216 (287)
T 2wei_A 180 ------------------------------------------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILL 216 (287)
T ss_dssp ------------------------------------------CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHH
Confidence 013468999999999865 5999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcC
Q 017362 352 VGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+|.+||.+.+..+....|..+
T Consensus 217 ~g~~p~~~~~~~~~~~~~~~~ 237 (287)
T 2wei_A 217 SGTPPFYGKNEYDILKRVETG 237 (287)
T ss_dssp HSSCSSCCSSHHHHHHHHHHC
T ss_pred hCCCCCCCCCHHHHHHHHHcC
Confidence 999999999888887777654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=316.54 Aligned_cols=218 Identities=26% Similarity=0.464 Sum_probs=183.5
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhh-hhhHHHHHHHHHHHHhcCCCceeEEeeEEE--eCCeE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR-RGQVEHVRAERNLLAEVDSNCIVKLYCSFQ--DDEFL 191 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~--~~~~~ 191 (373)
.++|.+.+.||+|+||.||+|.+..++..||+|++....... ......+.+|+.++..++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999999999999999998765432 234567899999999999999999999984 45678
Q ss_pred EEEEeccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 192 YLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
|+||||++++ |.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999876 7777755 457999999999999999999999999999999999999999999999999999765422
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC--CChhhcHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG--YGMECDWWSLGAIM 347 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~~DvwSlGvil 347 (373)
.... ......||+.|+|||++.+.. ++.++|||||||++
T Consensus 163 ~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il 203 (305)
T 2wtk_C 163 AADD---------------------------------------TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203 (305)
T ss_dssp CSSC---------------------------------------EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHH
T ss_pred cccc---------------------------------------ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHH
Confidence 1110 011456999999999998654 48899999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhhcC
Q 017362 348 YEMLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 348 ~ell~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|||++|..||.+.+..+....|.++
T Consensus 204 ~~l~~g~~p~~~~~~~~~~~~i~~~ 228 (305)
T 2wtk_C 204 YNITTGLYPFEGDNIYKLFENIGKG 228 (305)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHC
T ss_pred HHHHhCCCCCCCchHHHHHHHHhcC
Confidence 9999999999999888888777553
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=316.61 Aligned_cols=221 Identities=23% Similarity=0.373 Sum_probs=187.1
Q ss_pred ccCCCCCcceec-eeeeeCcEEEEEEEEc--CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe
Q 017362 111 HKMGADDFELLT-MIGKGAFGEVRVCREK--TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (373)
Q Consensus 111 ~~~~~~~y~~~~-~lG~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 187 (373)
..+..++|.+.. .||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.++..++||||+++++++ .
T Consensus 4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~ 80 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-Q 80 (287)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-c
Confidence 345667888887 9999999999999864 467889999997642 234456788999999999999999999999 4
Q ss_pred CCeEEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccC
Q 017362 188 DEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (373)
Q Consensus 188 ~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~ 266 (373)
.+..|+||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 56689999999999999999654 46999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHH
Q 017362 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (373)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvi 346 (373)
........ ......||+.|+|||++.+..++.++|||||||+
T Consensus 161 ~~~~~~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 202 (287)
T 1u59_A 161 GADDSYYT--------------------------------------ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVT 202 (287)
T ss_dssp TTCSCEEC--------------------------------------CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHH
T ss_pred ccCcceee--------------------------------------ccccccccccccCHHHhccCCCCchhhHHHHHHH
Confidence 43221100 0113457899999999998899999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 347 MYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 347 l~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+|||++ |.+||.+.+..+....|.++
T Consensus 203 l~ellt~g~~p~~~~~~~~~~~~i~~~ 229 (287)
T 1u59_A 203 MWEALSYGQKPYKKMKGPEVMAFIEQG 229 (287)
T ss_dssp HHHHHTTSCCTTTTCCTHHHHHHHHTT
T ss_pred HHHHHcCCCCCcccCCHHHHHHHHhcC
Confidence 999998 99999998888888777654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=328.21 Aligned_cols=210 Identities=24% Similarity=0.387 Sum_probs=180.9
Q ss_pred HHhhhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEE
Q 017362 106 MRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSF 185 (373)
Q Consensus 106 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~ 185 (373)
+.+....+..++|++.+.||+|+||.||+|.+ .++..||||++...... .....+.+|+.++..++||||+++++++
T Consensus 20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CCTHHHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred ecHHHHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 34566677889999999999999999999975 46889999999765322 1223578899999999999999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CCeeecCCCCCEEEcCCCcEEEe
Q 017362 186 QDDEFLYLIMEYLPGGDMMTLLMRKD----TLTEDEARFYVAETVLAIESIHKH---HYIHRDIKPDNLLLDKYGHLRLS 258 (373)
Q Consensus 186 ~~~~~~~lV~E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---giiHrDikp~NILl~~~~~vkL~ 258 (373)
.+.+..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999997643 499999999999999999999999 99999999999999999999999
Q ss_pred eccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhh
Q 017362 259 DFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC 338 (373)
Q Consensus 259 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~ 338 (373)
|||++.......... .....||+.|+|||++.+..++.++
T Consensus 177 Dfg~~~~~~~~~~~~----------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~ 216 (326)
T 3uim_A 177 DFGLAKLMDYKDTHV----------------------------------------TTAVRGTIGHIAPEYLSTGKSSEKT 216 (326)
T ss_dssp CCSSCEECCSSSSCE----------------------------------------ECCCCSCGGGCCHHHHHHSEECHHH
T ss_pred cCccccccCcccccc----------------------------------------cccccCCcCccCHHHhccCCCCccc
Confidence 999998664322110 1135699999999999999999999
Q ss_pred cHHHHHHHHHHHHhCCCCCC
Q 017362 339 DWWSLGAIMYEMLVGYPPFY 358 (373)
Q Consensus 339 DvwSlGvil~ell~G~~Pf~ 358 (373)
|||||||++|||++|.+||.
T Consensus 217 Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 217 DVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp HHHHHHHHHHHHHHCCCSBC
T ss_pred cchhHHHHHHHHHhCCCccc
Confidence 99999999999999999995
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=325.91 Aligned_cols=204 Identities=33% Similarity=0.673 Sum_probs=173.1
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhh-----hhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCe
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML-----RRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 190 (373)
++|.+.+.||+|+||.||+|.+..+++.||||++...... .......+.+|+.++..++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 5799999999999999999999999999999998764321 1122345788999999999999999999987665
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCc---EEEeeccccccCC
Q 017362 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH---LRLSDFGLCKPLD 267 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~---vkL~DFGla~~~~ 267 (373)
.|+||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 168 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence 8999999999999999988889999999999999999999999999999999999999987665 9999999997654
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc---CCCCChhhcHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLG 344 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DvwSlG 344 (373)
.... .....||+.|+|||++. ...++.++||||||
T Consensus 169 ~~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG 206 (322)
T 2ycf_A 169 ETSL------------------------------------------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 206 (322)
T ss_dssp CCHH------------------------------------------HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHH
T ss_pred cccc------------------------------------------cccccCCcCccCchhhccCCCCCCCchhhHHHHH
Confidence 2210 01346999999999974 56789999999999
Q ss_pred HHHHHHHhCCCCCCCCCh
Q 017362 345 AIMYEMLVGYPPFYSDDP 362 (373)
Q Consensus 345 vil~ell~G~~Pf~~~~~ 362 (373)
|++|+|++|.+||.....
T Consensus 207 ~il~~l~~g~~pf~~~~~ 224 (322)
T 2ycf_A 207 VILFICLSGYPPFSEHRT 224 (322)
T ss_dssp HHHHHHHHSSCSSCSTTC
T ss_pred HHHHHHHhCCCCCcccch
Confidence 999999999999986543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=328.92 Aligned_cols=209 Identities=29% Similarity=0.465 Sum_probs=181.0
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeE---
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL--- 191 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~--- 191 (373)
.++|.+.+.||+|+||+||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 478999999999999999999999999999999997542 2233456788999999999999999999999877655
Q ss_pred ---EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 192 ---YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 192 ---~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
|+||||++ ++|.+++. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred eeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 99999996 68888873 3599999999999999999999999999999999999999999999999999975432
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil 347 (373)
. ....+||+.|+|||++.+ ..++.++|||||||++
T Consensus 197 ~--------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (371)
T 4exu_A 197 E--------------------------------------------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIM 232 (371)
T ss_dssp -----------------------------------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHH
T ss_pred C--------------------------------------------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHH
Confidence 1 114579999999999987 7799999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhhc
Q 017362 348 YEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 348 ~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
|+|++|.+||.+.+..+...+|+.
T Consensus 233 ~el~~g~~pf~~~~~~~~~~~i~~ 256 (371)
T 4exu_A 233 AEMLTGKTLFKGKDYLDQLTQILK 256 (371)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCChHHHHHHHHH
Confidence 999999999999998888877753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=319.41 Aligned_cols=195 Identities=28% Similarity=0.479 Sum_probs=172.9
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-CCceeEEeeEEEe--CCeE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQD--DEFL 191 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~--~~~~ 191 (373)
.++|++++.||+|+||+||+|.+..+++.||||++.... ...+.+|+.++..+. ||||+++++++.+ ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 578999999999999999999999999999999987432 355788999999997 9999999999998 6778
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC-cEEEeeccccccCCCCC
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPLDCST 270 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~-~vkL~DFGla~~~~~~~ 270 (373)
++||||+++++|..++. .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus 109 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred EEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 99999999999999884 489999999999999999999999999999999999999777 89999999997654321
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~e 349 (373)
. ....+||+.|+|||++.+ ..++.++|||||||++||
T Consensus 186 ~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ 223 (330)
T 3nsz_A 186 E------------------------------------------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 223 (330)
T ss_dssp C------------------------------------------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred c------------------------------------------cccccccccccChhhhcCCCcCCchhhHHHHHHHHHH
Confidence 1 114579999999999987 679999999999999999
Q ss_pred HHhCCCCCCCC
Q 017362 350 MLVGYPPFYSD 360 (373)
Q Consensus 350 ll~G~~Pf~~~ 360 (373)
|++|..||...
T Consensus 224 ll~g~~p~~~~ 234 (330)
T 3nsz_A 224 MIFRKEPFFHG 234 (330)
T ss_dssp HHHTCSSSSCC
T ss_pred HHhCCCCcccC
Confidence 99999999643
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=332.17 Aligned_cols=208 Identities=29% Similarity=0.427 Sum_probs=173.1
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC----
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE---- 189 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~---- 189 (373)
...+|.+.+.||+|+||+||+|.+..++. ||+|.+..... ...+|+.+++.++||||++++++|....
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence 34579999999999999999999877766 78887754321 1235899999999999999999996543
Q ss_pred --eEEEEEeccCCCCHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEc-CCCcEEEeecccc
Q 017362 190 --FLYLIMEYLPGGDMMTLL---MRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD-KYGHLRLSDFGLC 263 (373)
Q Consensus 190 --~~~lV~E~~~gg~L~~~l---~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~-~~~~vkL~DFGla 263 (373)
++|+||||++++.+.... .....+++..++.++.||+.||.|||++||+||||||+|||++ .++++||+|||+|
T Consensus 110 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 110 EVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp CEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 388999999775443332 2356899999999999999999999999999999999999999 7999999999999
Q ss_pred ccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHH
Q 017362 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWS 342 (373)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwS 342 (373)
+.+..... ..+.+||+.|+|||++.+. .|+.++||||
T Consensus 190 ~~~~~~~~------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwS 227 (394)
T 4e7w_A 190 KILIAGEP------------------------------------------NVSYICSRYYRAPELIFGATNYTTNIDIWS 227 (394)
T ss_dssp EECCTTCC------------------------------------------CCSSCSCGGGCCHHHHTTCSSCCTHHHHHH
T ss_pred ccccCCCC------------------------------------------CcccccCcCccCHHHHcCCCCCCcHHHHHH
Confidence 86543211 1146799999999999765 5999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 017362 343 LGAIMYEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 343 lGvil~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
|||++|||++|++||.+.+..+....|++
T Consensus 228 lG~il~ell~g~~pf~~~~~~~~l~~i~~ 256 (394)
T 4e7w_A 228 TGCVMAELMQGQPLFPGESGIDQLVEIIK 256 (394)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999999999999999998888777754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=333.41 Aligned_cols=203 Identities=17% Similarity=0.191 Sum_probs=159.0
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc--CCCceeEEe-------eEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV--DSNCIVKLY-------CSF 185 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~l~-------~~~ 185 (373)
..+|.+.+.||+|+||+||+|.+..+++.||||++...........+.+.+|+.++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 44599999999999999999999999999999999876544455566778885544444 699988765 444
Q ss_pred EeC-----------------CeEEEEEeccCCCCHHHHHhhC-CCCCHHHH------HHHHHHHHHHHHHHHhCCCeeec
Q 017362 186 QDD-----------------EFLYLIMEYLPGGDMMTLLMRK-DTLTEDEA------RFYVAETVLAIESIHKHHYIHRD 241 (373)
Q Consensus 186 ~~~-----------------~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~------~~i~~qi~~aL~~LH~~giiHrD 241 (373)
... ..+|+||||++ |+|.+++... ..+++... ..++.||+.||.|||++||||||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 433 33899999998 8999999763 23444444 56679999999999999999999
Q ss_pred CCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCC
Q 017362 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTP 321 (373)
Q Consensus 242 ikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 321 (373)
|||+|||++.+|++||+|||+|+...... ....||+
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~~--------------------------------------------~~~~~t~ 255 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTRG--------------------------------------------PASSVPV 255 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCEE--------------------------------------------EGGGSCG
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCCc--------------------------------------------cCccCCc
Confidence 99999999999999999999998653211 0245779
Q ss_pred CCcccccccC--CCCChhhcHHHHHHHHHHHHhCCCCCCCCCh
Q 017362 322 DYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYPPFYSDDP 362 (373)
Q Consensus 322 ~Y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~ 362 (373)
.|+|||++.+ ..|+.++|||||||++|||++|++||.+.++
T Consensus 256 ~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~ 298 (371)
T 3q60_A 256 TYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298 (371)
T ss_dssp GGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCT
T ss_pred CCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCc
Confidence 9999999987 7799999999999999999999999987743
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=327.51 Aligned_cols=217 Identities=23% Similarity=0.475 Sum_probs=189.0
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhh--------------HHHHHHHHHHHHhcCCC
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ--------------VEHVRAERNLLAEVDSN 176 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~--------------~~~~~~e~~~l~~l~h~ 176 (373)
.....++|.+++.||+|+||.||+|.+ ++..||||++.......... .+.+.+|+.++..++||
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 103 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE 103 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence 345568999999999999999999998 89999999998765432221 16788999999999999
Q ss_pred ceeEEeeEEEeCCeEEEEEeccCCCCHHHH------Hhh--CCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCCE
Q 017362 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTL------LMR--KDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNL 247 (373)
Q Consensus 177 ~iv~l~~~~~~~~~~~lV~E~~~gg~L~~~------l~~--~~~l~~~~~~~i~~qi~~aL~~LH~-~giiHrDikp~NI 247 (373)
||+++++++.+.+..|+||||+++|+|.++ +.. ...+++..+..++.|++.||.|||+ +||+||||||+||
T Consensus 104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183 (348)
T ss_dssp TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence 999999999999999999999999999998 655 5689999999999999999999999 9999999999999
Q ss_pred EEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccc
Q 017362 248 LLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPE 327 (373)
Q Consensus 248 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE 327 (373)
|++.++++||+|||++....... .....||+.|+|||
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~~-------------------------------------------~~~~~~~~~y~aPE 220 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDKK-------------------------------------------IKGSRGTYEFMPPE 220 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTTE-------------------------------------------ECSSCSCGGGCCGG
T ss_pred EEcCCCcEEEecccccccccccc-------------------------------------------ccCCCCCcCccCch
Confidence 99999999999999997653221 11457999999999
Q ss_pred cccCC-CCCh-hhcHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHhhcC
Q 017362 328 VLLKK-GYGM-ECDWWSLGAIMYEMLVGYPPFYSDDP-MSTCRKVRKK 372 (373)
Q Consensus 328 ~~~~~-~~~~-~~DvwSlGvil~ell~G~~Pf~~~~~-~~~~~kI~~~ 372 (373)
++.+. .++. ++|||||||++|||++|.+||...+. .+...+|..+
T Consensus 221 ~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~ 268 (348)
T 2pml_X 221 FFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTK 268 (348)
T ss_dssp GGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSC
T ss_pred hhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc
Confidence 99887 6766 99999999999999999999998876 7777777654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=322.07 Aligned_cols=215 Identities=23% Similarity=0.382 Sum_probs=182.3
Q ss_pred hhccCCCCCcceeceeeeeCcEEEEEEEE-----cCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEe
Q 017362 109 QRHKMGADDFELLTMIGKGAFGEVRVCRE-----KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLY 182 (373)
Q Consensus 109 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~ 182 (373)
....+..++|++.+.||+|+||+||+|.+ ..+++.||||++.... .......+.+|+.++..+ +||||++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 34456788999999999999999999985 3567899999997642 233445688999999999 789999999
Q ss_pred eEEEeCC-eEEEEEeccCCCCHHHHHhhCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCC
Q 017362 183 CSFQDDE-FLYLIMEYLPGGDMMTLLMRKDT----------------LTEDEARFYVAETVLAIESIHKHHYIHRDIKPD 245 (373)
Q Consensus 183 ~~~~~~~-~~~lV~E~~~gg~L~~~l~~~~~----------------l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~ 245 (373)
+++...+ .+|+||||++||+|.+++..... +++..+..++.|++.||.|||++||+||||||+
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~ 177 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 177 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccc
Confidence 9988754 58999999999999999977543 899999999999999999999999999999999
Q ss_pred CEEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcc
Q 017362 246 NLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIA 325 (373)
Q Consensus 246 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~a 325 (373)
|||++.++++||+|||+++......... ......||+.|+|
T Consensus 178 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~---------------------------------------~~~~~~~t~~y~a 218 (316)
T 2xir_A 178 NILLSEKNVVKICDFGLARDIYKDPDYV---------------------------------------RKGDARLPLKWMA 218 (316)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSE---------------------------------------EETTEEECGGGCC
T ss_pred eEEECCCCCEEECCCccccccccCccce---------------------------------------eccCCCcceeecC
Confidence 9999999999999999998654321100 0113568999999
Q ss_pred cccccCCCCChhhcHHHHHHHHHHHHh-CCCCCCCCChHH
Q 017362 326 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMS 364 (373)
Q Consensus 326 PE~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~ 364 (373)
||++.+..++.++|||||||++|||++ |.+||.+.+..+
T Consensus 219 PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 258 (316)
T 2xir_A 219 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258 (316)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred chhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence 999999999999999999999999998 999998876443
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=326.44 Aligned_cols=210 Identities=30% Similarity=0.460 Sum_probs=167.6
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCe----
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF---- 190 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~---- 190 (373)
.++|++.+.||+|+||+||+|.+..++..||||++.... ........++..+..++||||++++++|.....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP----RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCT----TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc----cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 478999999999999999999999999999999886542 122345667888888999999999999976433
Q ss_pred ---EEEEEeccCCCCHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHHH--hCCCeeecCCCCCEEEcC-CCcEEEeec
Q 017362 191 ---LYLIMEYLPGGDMMTLL----MRKDTLTEDEARFYVAETVLAIESIH--KHHYIHRDIKPDNLLLDK-YGHLRLSDF 260 (373)
Q Consensus 191 ---~~lV~E~~~gg~L~~~l----~~~~~l~~~~~~~i~~qi~~aL~~LH--~~giiHrDikp~NILl~~-~~~vkL~DF 260 (373)
+|+||||++++ |...+ .....+++..+..++.|++.||.||| ++||+||||||+|||++. ++.+||+||
T Consensus 98 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Df 176 (360)
T 3e3p_A 98 DIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176 (360)
T ss_dssp CEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCC
T ss_pred ceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeC
Confidence 88999999764 44433 34668999999999999999999999 999999999999999997 899999999
Q ss_pred cccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC-CChhhc
Q 017362 261 GLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECD 339 (373)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~D 339 (373)
|++........ ....+||+.|+|||++.+.. ++.++|
T Consensus 177 g~a~~~~~~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~D 214 (360)
T 3e3p_A 177 GSAKKLSPSEP------------------------------------------NVAYICSRYYRAPELIFGNQHYTTAVD 214 (360)
T ss_dssp TTCBCCCTTSC------------------------------------------CCSTTSCGGGCCHHHHTTCSSCCTHHH
T ss_pred CCceecCCCCC------------------------------------------cccccCCcceeCHHHHcCCCCCCcHHH
Confidence 99986543221 11457899999999997654 899999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 017362 340 WWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 340 vwSlGvil~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
||||||++|||++|.+||.+.+..+....|++
T Consensus 215 i~slG~il~ell~g~~pf~~~~~~~~~~~~~~ 246 (360)
T 3e3p_A 215 IWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR 246 (360)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCcCCCChHHHHHHHHH
Confidence 99999999999999999999998888887753
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=318.33 Aligned_cols=214 Identities=25% Similarity=0.429 Sum_probs=176.5
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEE--------
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ-------- 186 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-------- 186 (373)
.++|.+++.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 578999999999999999999999999999999986542 344567889999999999999999998873
Q ss_pred ------eCCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEc-CCCcEEEee
Q 017362 187 ------DDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD-KYGHLRLSD 259 (373)
Q Consensus 187 ------~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~-~~~~vkL~D 259 (373)
+....|+||||++ |+|.+++. .+.+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ccccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 4467899999997 69999885 46799999999999999999999999999999999999997 567999999
Q ss_pred ccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhh
Q 017362 260 FGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMEC 338 (373)
Q Consensus 260 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~ 338 (373)
||+++......... .......||+.|+|||++.+ ..++.++
T Consensus 165 fg~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 206 (320)
T 2i6l_A 165 FGLARIMDPHYSHK--------------------------------------GHLSEGLVTKWYRSPRLLLSPNNYTKAI 206 (320)
T ss_dssp CTTCBCC----------------------------------------------CCCGGGSCCTTCCHHHHHCTTCCCHHH
T ss_pred CccccccCCCcccc--------------------------------------cccccccccccccCcHHhcCcccCCchh
Confidence 99998654221100 00113568999999999876 6799999
Q ss_pred cHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 017362 339 DWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 339 DvwSlGvil~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
|||||||++|||++|.+||.+.+..+...+|+.
T Consensus 207 Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 239 (320)
T 2i6l_A 207 DMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239 (320)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred hhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999999999999999999998888777653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=314.87 Aligned_cols=218 Identities=24% Similarity=0.362 Sum_probs=182.3
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcC---CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKT---TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 187 (373)
..+..++|.+.+.||+|+||+||+|.+.. ++..||+|++.... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 35667899999999999999999998653 34469999987642 23345678899999999999999999999875
Q ss_pred CCeEEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccC
Q 017362 188 DEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (373)
Q Consensus 188 ~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~ 266 (373)
+ ..|+||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 85 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 85 E-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred C-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 4 568999999999999999764 46999999999999999999999999999999999999999999999999999765
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHH
Q 017362 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (373)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvi 346 (373)
....... .....||+.|+|||++.+..++.++|||||||+
T Consensus 164 ~~~~~~~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 203 (281)
T 3cc6_A 164 EDEDYYK----------------------------------------ASVTRLPIKWMSPESINFRRFTTASDVWMFAVC 203 (281)
T ss_dssp -------------------------------------------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred ccccccc----------------------------------------cccCCCCcceeCchhhccCCCCchhccHHHHHH
Confidence 4321100 113467889999999998999999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHhhc
Q 017362 347 MYEMLV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 347 l~ell~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
+|||++ |.+||...+..+....+..
T Consensus 204 l~~llt~g~~p~~~~~~~~~~~~~~~ 229 (281)
T 3cc6_A 204 MWEILSFGKQPFFWLENKDVIGVLEK 229 (281)
T ss_dssp HHHHHTTTCCTTTTSCGGGHHHHHHH
T ss_pred HHHHHhCCCCCcccCChHHHHHHHhc
Confidence 999998 9999988777776665543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=326.99 Aligned_cols=214 Identities=28% Similarity=0.448 Sum_probs=184.3
Q ss_pred hhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-CC-----ceeEEe
Q 017362 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SN-----CIVKLY 182 (373)
Q Consensus 109 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~l~ 182 (373)
.......++|++.+.||+|+||+||+|.+..+++.||||++.... .....+..|+.++..+. |+ +|+.++
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 344455789999999999999999999999999999999997542 22345667888887774 44 599999
Q ss_pred eEEEeCCeEEEEEeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHH--hCCCeeecCCCCCEEEc--CCCcEE
Q 017362 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIH--KHHYIHRDIKPDNLLLD--KYGHLR 256 (373)
Q Consensus 183 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH--~~giiHrDikp~NILl~--~~~~vk 256 (373)
+.+...+.+|+||||++ |+|.+++... ..+++..++.++.|++.||.||| +.|||||||||+|||++ .++.+|
T Consensus 123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp EEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEE
T ss_pred eeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEE
Confidence 99999999999999995 5999999765 46999999999999999999999 57999999999999994 478899
Q ss_pred EeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCCh
Q 017362 257 LSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM 336 (373)
Q Consensus 257 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 336 (373)
|+|||+|+...... ...+||+.|+|||++.+..|+.
T Consensus 202 L~DFG~a~~~~~~~--------------------------------------------~~~~~t~~y~aPE~~~~~~~~~ 237 (382)
T 2vx3_A 202 IVDFGSSCQLGQRI--------------------------------------------YQYIQSRFYRSPEVLLGMPYDL 237 (382)
T ss_dssp ECCCTTCEETTCCC--------------------------------------------CSSCSCGGGCCHHHHTTCCCCT
T ss_pred EEeccCceeccccc--------------------------------------------ccccCCccccChHHHcCCCCCc
Confidence 99999997653211 1457999999999999999999
Q ss_pred hhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 017362 337 ECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 337 ~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
++|||||||++|||++|.+||.+.+..+...+|++
T Consensus 238 ~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 272 (382)
T 2vx3_A 238 AIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 272 (382)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999999999999999999999999988888764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=318.33 Aligned_cols=207 Identities=24% Similarity=0.437 Sum_probs=176.3
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEE----EcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCR----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 187 (373)
.+....|++++.||+|+||.||+|. +..+++.||+|++.... .....+.+.+|+.++..++||||+++++++.+
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 4556679999999999999999998 56789999999997653 23445678899999999999999999999987
Q ss_pred C--CeEEEEEeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccc
Q 017362 188 D--EFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (373)
Q Consensus 188 ~--~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~ 264 (373)
. ..+|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccc
Confidence 6 678999999999999999944 5679999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHH
Q 017362 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344 (373)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG 344 (373)
......... .......||+.|+|||++.+..++.++||||||
T Consensus 175 ~~~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 216 (302)
T 4e5w_A 175 AIETDKEYY--------------------------------------TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFG 216 (302)
T ss_dssp ECCTTCCEE--------------------------------------ECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHH
T ss_pred cccCCCcce--------------------------------------eccCCCCCCccccCCeeecCCCCCcchhHHHHH
Confidence 765332110 001145688999999999999999999999999
Q ss_pred HHHHHHHhCCCCCC
Q 017362 345 AIMYEMLVGYPPFY 358 (373)
Q Consensus 345 vil~ell~G~~Pf~ 358 (373)
|++|+|++|..||.
T Consensus 217 ~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 217 VTLHELLTYCDSDS 230 (302)
T ss_dssp HHHHHHHTTTCGGG
T ss_pred HHHHHHHHccCCCc
Confidence 99999999999864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=315.97 Aligned_cols=217 Identities=19% Similarity=0.305 Sum_probs=170.9
Q ss_pred hhhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe
Q 017362 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (373)
Q Consensus 108 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 187 (373)
....++..++|++.+.||+|+||+||+|.+. ..||+|++.... ......+.+.+|+.+++.++||||+++++++ .
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~ 90 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 90 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-C
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-c
Confidence 4556788999999999999999999999754 359999987543 2334457788999999999999999999954 5
Q ss_pred CCeEEEEEeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccC
Q 017362 188 DEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (373)
Q Consensus 188 ~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~ 266 (373)
....++||||++|++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 91 APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccc
Confidence 5668999999999999999954 457999999999999999999999999999999999999999999999999999754
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc---CCCCChhhcHHHH
Q 017362 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSL 343 (373)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DvwSl 343 (373)
....... ......||+.|+|||++. +..++.++|||||
T Consensus 171 ~~~~~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~sl 211 (289)
T 3og7_A 171 SRWSGSH---------------------------------------QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAF 211 (289)
T ss_dssp ----------------------------------------------------CCCTTCCHHHHC----CCSCHHHHHHHH
T ss_pred ccccccc---------------------------------------cccccCCCccccCchhhcccCCCCCCcccchHHH
Confidence 3211000 011357999999999997 5678999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHH
Q 017362 344 GAIMYEMLVGYPPFYSDDPMSTCRK 368 (373)
Q Consensus 344 Gvil~ell~G~~Pf~~~~~~~~~~k 368 (373)
||++|+|++|.+||.+.+..+....
T Consensus 212 G~il~el~~g~~p~~~~~~~~~~~~ 236 (289)
T 3og7_A 212 GIVLYELMTGQLPYSNINNRDQIIE 236 (289)
T ss_dssp HHHHHHHHHSSCTTSSCCCHHHHHH
T ss_pred HHHHHHHHHCCCCccccchHHHHHH
Confidence 9999999999999988655444433
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=321.00 Aligned_cols=221 Identities=28% Similarity=0.488 Sum_probs=166.6
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCe
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 190 (373)
..+..++|++.+.||+|+||.||+|.+..++..||||++..... ......+.+|+.++..++||||+++++++.+.+.
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 34667899999999999999999999988999999999875432 2334567889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccc
Q 017362 191 LYLIMEYLPGGDMMTLLMR--------KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGl 262 (373)
.|+||||++|++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999999864 45699999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHH
Q 017362 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWW 341 (373)
Q Consensus 263 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~Dvw 341 (373)
+........... ........||+.|+|||++.+ ..++.++|||
T Consensus 168 ~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~ 211 (303)
T 2vwi_A 168 SAFLATGGDITR------------------------------------NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIW 211 (303)
T ss_dssp HHHCC---------------------------------------------------CCCTTCCHHHHHHHHCCCTHHHHH
T ss_pred hheeccCCCccc------------------------------------hhhhcccCCCccccCHHHhccccCCCchhhHH
Confidence 976543211000 000114579999999999976 5689999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 017362 342 SLGAIMYEMLVGYPPFYSDDPMSTCRKV 369 (373)
Q Consensus 342 SlGvil~ell~G~~Pf~~~~~~~~~~kI 369 (373)
||||++|||++|.+||...++......+
T Consensus 212 slG~il~~l~~g~~pf~~~~~~~~~~~~ 239 (303)
T 2vwi_A 212 SFGITAIELATGAAPYHKYPPMKVLMLT 239 (303)
T ss_dssp HHHHHHHHHHHSSCTTTTSCGGGHHHHH
T ss_pred HHHHHHHHHHhCCCCCccCchhhHHHHH
Confidence 9999999999999999987766655443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=324.52 Aligned_cols=215 Identities=22% Similarity=0.357 Sum_probs=176.0
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHh--------hhhhhHHHHHHHHHHHHhcCCCceeEEee
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM--------LRRGQVEHVRAERNLLAEVDSNCIVKLYC 183 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~~e~~~l~~l~h~~iv~l~~ 183 (373)
....++|.+.+.||+|+||.||+|.+.. +..||||++..... ......+.+.+|+.++..++||||+++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 96 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD 96 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence 3457899999999999999999998754 89999998854321 12223467899999999999999999999
Q ss_pred EEEe-----CCeEEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEE
Q 017362 184 SFQD-----DEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRL 257 (373)
Q Consensus 184 ~~~~-----~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL 257 (373)
++.. ...+|+||||++ |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred eEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEE
Confidence 9854 346899999997 6888887654 37999999999999999999999999999999999999999999999
Q ss_pred eeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCCh
Q 017362 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGM 336 (373)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~ 336 (373)
+|||++........ ....+||+.|+|||++.+ ..++.
T Consensus 176 ~Dfg~~~~~~~~~~------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~ 213 (362)
T 3pg1_A 176 CDFNLAREDTADAN------------------------------------------KTHYVTHRWYRAPELVMQFKGFTK 213 (362)
T ss_dssp CCTTC---------------------------------------------------------CGGGCCHHHHTTCTTCCT
T ss_pred EecCcccccccccc------------------------------------------cceecccceecCcHHhcCCCCCCc
Confidence 99999974332110 114579999999999987 67999
Q ss_pred hhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 017362 337 ECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 337 ~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
++|||||||++|+|++|.+||.+.+..+...+|.
T Consensus 214 ~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 247 (362)
T 3pg1_A 214 LVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247 (362)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred HhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999999999999999999888887775
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=337.24 Aligned_cols=217 Identities=22% Similarity=0.395 Sum_probs=182.9
Q ss_pred hccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC
Q 017362 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 110 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 189 (373)
..++..++|++.+.||+|+||.||+|.+.. +..||||++..... ..+.+.+|+.+|+.++||||+++++++.+ +
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 251 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence 345677889999999999999999999864 45799999976432 23568899999999999999999999876 6
Q ss_pred eEEEEEeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
.+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 789999999999999999643 469999999999999999999999999999999999999999999999999998654
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 347 (373)
...... .....+|+.|+|||++....++.++|||||||++
T Consensus 332 ~~~~~~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l 371 (452)
T 1fmk_A 332 DNEYTA----------------------------------------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 371 (452)
T ss_dssp ---------------------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCceec----------------------------------------ccCCcccccccCHhHHhcCCCCccccHHhHHHHH
Confidence 221100 0134578899999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 348 YEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 348 ~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|||++ |.+||.+.+..+....|.++
T Consensus 372 ~el~t~g~~P~~~~~~~~~~~~i~~~ 397 (452)
T 1fmk_A 372 TELTTKGRVPYPGMVNREVLDQVERG 397 (452)
T ss_dssp HHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999 99999999988888877654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=316.88 Aligned_cols=203 Identities=29% Similarity=0.400 Sum_probs=169.1
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHh--cCCCceeEEeeEEEe--
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE--VDSNCIVKLYCSFQD-- 187 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~l~~~~~~-- 187 (373)
....++|++.+.||+|+||+||+|.+ +++.||||++.... ...+..|.+++.. ++||||+++++++.+
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 34578999999999999999999986 58899999987542 2335556676666 799999999998754
Q ss_pred --CCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCeeecCCCCCEEEcCCCcEEE
Q 017362 188 --DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH--------KHHYIHRDIKPDNLLLDKYGHLRL 257 (373)
Q Consensus 188 --~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~giiHrDikp~NILl~~~~~vkL 257 (373)
...+|+||||+++|+|.+++. ...+++..+..++.|++.||.||| ++||+||||||+|||++.++++||
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred CCCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 346899999999999999994 457999999999999999999999 999999999999999999999999
Q ss_pred eeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-----
Q 017362 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK----- 332 (373)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----- 332 (373)
+|||+|+.......... ......+||+.|+|||++.+.
T Consensus 155 ~Dfg~a~~~~~~~~~~~-------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~ 197 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLD-------------------------------------VGNNPRVGTKRYMAPEVLDETIQVDC 197 (301)
T ss_dssp CCCTTCEEEETTTTEEE-------------------------------------CCCCCCCCCGGGCCHHHHTTCCCTTC
T ss_pred eeCCCeeeccccccccc-------------------------------------ccccccccccceeChhhhcCcCCCCc
Confidence 99999976543221100 001145799999999999876
Q ss_pred -CCChhhcHHHHHHHHHHHHhC----------CCCCCCC
Q 017362 333 -GYGMECDWWSLGAIMYEMLVG----------YPPFYSD 360 (373)
Q Consensus 333 -~~~~~~DvwSlGvil~ell~G----------~~Pf~~~ 360 (373)
.++.++|||||||++|||++| .+||...
T Consensus 198 ~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 198 FDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred ccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 566899999999999999999 9999753
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=326.97 Aligned_cols=212 Identities=21% Similarity=0.231 Sum_probs=172.0
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcC---CCceEeeeecchhHhh--------hhhhHHHHHHHHHHHHhcCCCceeEE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKT---TGHVYAMKKLKKSEML--------RRGQVEHVRAERNLLAEVDSNCIVKL 181 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~l 181 (373)
+..++|.+.+.||+|+||+||+|.+.. ++..||||++...... .......+.+|+.++..++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 456789999999999999999999987 7889999998654211 11122346678888999999999999
Q ss_pred eeEEEe----CCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC--cE
Q 017362 182 YCSFQD----DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG--HL 255 (373)
Q Consensus 182 ~~~~~~----~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~--~v 255 (373)
++++.+ ....|+||||+ |++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 999988 78899999999 999999998777899999999999999999999999999999999999999887 99
Q ss_pred EEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCC
Q 017362 256 RLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYG 335 (373)
Q Consensus 256 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 335 (373)
||+|||+|+.+......... .........||+.|+|||++.+..++
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~----------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~ 238 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQY----------------------------------QENPRKGHNGTIEFTSLDAHKGVALS 238 (345)
T ss_dssp EECCCTTCEESSGGGCCCCC----------------------------------CCCGGGCSCSCTTTCCHHHHHTCCCC
T ss_pred EEEeCCCceecccccccccc----------------------------------hhccccccCCCccccCHHHhcCCCCC
Confidence 99999999876432110000 00001246899999999999999999
Q ss_pred hhhcHHHHHHHHHHHHhCCCCCCC
Q 017362 336 MECDWWSLGAIMYEMLVGYPPFYS 359 (373)
Q Consensus 336 ~~~DvwSlGvil~ell~G~~Pf~~ 359 (373)
.++|||||||++|||++|.+||.+
T Consensus 239 ~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 239 RRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp HHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred chhhHHHHHHHHHHHHhCCCCccc
Confidence 999999999999999999999965
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=313.15 Aligned_cols=217 Identities=22% Similarity=0.330 Sum_probs=181.3
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCc---eEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeE-E
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGH---VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL-Y 192 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~-~ 192 (373)
.|.+.+.||+|+||+||+|.+..++. .||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+.. |
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 46677999999999999998765544 79999987532 234456788999999999999999999999876655 9
Q ss_pred EEEeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCc
Q 017362 193 LIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 271 (373)
+||||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999999976 45789999999999999999999999999999999999999999999999999986543211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
... .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 180 ~~~-------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 222 (298)
T 3pls_A 180 YSV-------------------------------------QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELL 222 (298)
T ss_dssp GCS-------------------------------------CCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccc-------------------------------------ccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHh
Confidence 100 0011456899999999999999999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHhhcC
Q 017362 352 V-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 352 ~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+ |.+||...++.+....+..+
T Consensus 223 ~g~~~~~~~~~~~~~~~~~~~~ 244 (298)
T 3pls_A 223 TRGAPPYRHIDPFDLTHFLAQG 244 (298)
T ss_dssp HTSCCTTTTSCGGGHHHHHHTT
T ss_pred hCCCCCCccCCHHHHHHHhhcC
Confidence 9 67777777777777666543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=318.77 Aligned_cols=213 Identities=27% Similarity=0.454 Sum_probs=180.7
Q ss_pred CCCcceeceeeeeCcEEEEEEEEc-CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc---CCCceeEEeeEEE----
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREK-TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV---DSNCIVKLYCSFQ---- 186 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~l~~~~~---- 186 (373)
.++|++++.||+|+||.||+|.+. .+++.||+|++...... ......+.+|+.++..+ .||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 578999999999999999999985 67889999998754321 11122355677666655 8999999999987
Q ss_pred -eCCeEEEEEeccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeecccc
Q 017362 187 -DDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (373)
Q Consensus 187 -~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla 263 (373)
....+|+||||++ |+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 5567899999997 69999997643 4999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHH
Q 017362 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (373)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSl 343 (373)
....... ......||+.|+|||++.+..++.++|||||
T Consensus 168 ~~~~~~~------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 205 (326)
T 1blx_A 168 RIYSFQM------------------------------------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSV 205 (326)
T ss_dssp CCCCGGG------------------------------------------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHH
T ss_pred ccccCCC------------------------------------------CccccccccceeCHHHHhcCCCCcchhHHHH
Confidence 7653211 0114679999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 017362 344 GAIMYEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 344 Gvil~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
||++|+|++|.+||.+.+..+...+|++
T Consensus 206 G~il~~l~~g~~pf~~~~~~~~~~~i~~ 233 (326)
T 1blx_A 206 GCIFAEMFRRKPLFRGSSDVDQLGKILD 233 (326)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 9999999999999999998888877763
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=323.11 Aligned_cols=220 Identities=20% Similarity=0.352 Sum_probs=182.4
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEE-----EcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 186 (373)
++..++|++++.||+|+||.||+|. +..++..||||++.... .......+.+|+.++..++||||+++++++.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 4667899999999999999999998 45678899999986432 2334456888999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHhhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC---CCcEE
Q 017362 187 DDEFLYLIMEYLPGGDMMTLLMRKD-------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---YGHLR 256 (373)
Q Consensus 187 ~~~~~~lV~E~~~gg~L~~~l~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~---~~~vk 256 (373)
+....|+||||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++. ++.+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999999997653 4899999999999999999999999999999999999984 44699
Q ss_pred EeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCCh
Q 017362 257 LSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM 336 (373)
Q Consensus 257 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 336 (373)
|+|||++.......... ......||+.|+|||++.+..++.
T Consensus 184 l~Dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~ 224 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYR---------------------------------------KGGCAMLPVKWMPPEAFMEGIFTS 224 (327)
T ss_dssp ECCCHHHHHHHC---------------------------------------------CCGGGSCGGGCCHHHHHHCCCCH
T ss_pred ECccccccccccccccc---------------------------------------cCCCcCCCcceeCHhHhcCCCCCc
Confidence 99999987542211000 011356899999999999999999
Q ss_pred hhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 337 ECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 337 ~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
++|||||||++|+|++ |.+||.+.+..+....|..+
T Consensus 225 ~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 261 (327)
T 2yfx_A 225 KTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 261 (327)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC
Confidence 9999999999999998 99999999888887777653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=316.55 Aligned_cols=221 Identities=23% Similarity=0.402 Sum_probs=178.3
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcC-CCc--eEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKT-TGH--VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~--~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 188 (373)
.+..++|++++.||+|+||+||+|.+.. ++. .||||++...........+.+.+|+.++..++||||+++++++.+.
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 4567889999999999999999998643 333 6899999866444455667889999999999999999999999876
Q ss_pred CeEEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
. .++||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++....
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 5 78999999999999999764 579999999999999999999999999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 347 (373)
....... ......||+.|+|||++.+..++.++|||||||++
T Consensus 173 ~~~~~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 214 (291)
T 1u46_A 173 QNDDHYV--------------------------------------MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 214 (291)
T ss_dssp C-CCEEE--------------------------------------C-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHH
T ss_pred ccccchh--------------------------------------hhccCCCCceeeCchhhcCCCCCchhhHHHHHHHH
Confidence 3321100 01134688899999999988999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHhhc
Q 017362 348 YEMLV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 348 ~ell~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
|+|++ |.+||.+.+..+....+..
T Consensus 215 ~~l~~~g~~p~~~~~~~~~~~~~~~ 239 (291)
T 1u46_A 215 WEMFTYGQEPWIGLNGSQILHKIDK 239 (291)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred HHHHhCCCCCcccCCHHHHHHHHHc
Confidence 99999 9999999998888877754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=346.00 Aligned_cols=219 Identities=23% Similarity=0.383 Sum_probs=182.1
Q ss_pred CCCCCcceec-eeeeeCcEEEEEEEEc--CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC
Q 017362 113 MGADDFELLT-MIGKGAFGEVRVCREK--TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 113 ~~~~~y~~~~-~lG~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 189 (373)
+..+++.+.. .||+|+||.||+|.+. .++..||||+++... .....+.+.+|+.+|+.++|||||++++++.+ +
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 408 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence 4455666666 8999999999999875 355679999997642 23345778999999999999999999999976 5
Q ss_pred eEEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.+..
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 689999999999999999654 4699999999999999999999999999999999999999999999999999986542
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 348 (373)
...... ......+|+.|+|||++.+..++.++|||||||+||
T Consensus 489 ~~~~~~--------------------------------------~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ 530 (613)
T 2ozo_A 489 DDSYYT--------------------------------------ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMW 530 (613)
T ss_dssp ---------------------------------------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred CCceee--------------------------------------eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHH
Confidence 211000 001235678999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 349 EMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 349 ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
||++ |.+||.+.+..+....|.++
T Consensus 531 ellt~G~~Pf~~~~~~~~~~~i~~~ 555 (613)
T 2ozo_A 531 EALSYGQKPYKKMKGPEVMAFIEQG 555 (613)
T ss_dssp HHHTTSCCTTTTCCSHHHHHHHHTT
T ss_pred HHHHCCCCCCCCCCHHHHHHHHHcC
Confidence 9998 99999999999988888764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=315.02 Aligned_cols=219 Identities=17% Similarity=0.303 Sum_probs=181.0
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCC---CceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEE-eCCe
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTT---GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ-DDEF 190 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-~~~~ 190 (373)
..+|++.+.||+|+||+||+|.+..+ ...||+|.+.... .....+.+.+|+.+++.++||||+++++++. .++.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 45799999999999999999987543 3358999887532 2344567889999999999999999999864 5567
Q ss_pred EEEEEeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 191 LYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
.|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 8999999999999999976 346899999999999999999999999999999999999999999999999999865432
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 349 (373)
..... .......||+.|+|||++.+..++.++|||||||++|+
T Consensus 182 ~~~~~-------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 224 (298)
T 3f66_A 182 EYYSV-------------------------------------HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 224 (298)
T ss_dssp GGCBC------------------------------------------CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred chhcc-------------------------------------ccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHH
Confidence 21100 00114568899999999999999999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHhhcC
Q 017362 350 MLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 350 ll~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|++ |.+||.+.+..+....+.++
T Consensus 225 l~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
T 3f66_A 225 LMTRGAPPYPDVNTFDITVYLLQG 248 (298)
T ss_dssp HHTTSCCSSTTSCTTTHHHHHHTT
T ss_pred HHhCCCCCCccCCHHHHHHHHhcC
Confidence 999 78888888777776666543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=321.55 Aligned_cols=222 Identities=27% Similarity=0.469 Sum_probs=181.9
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC----
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD---- 188 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~---- 188 (373)
...++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.++..++||||+++++++...
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 34689999999999999999999999999999999986432 233345678899999999999999999987754
Q ss_pred -CeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 189 -EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 189 -~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
...|+||||++ |+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 86 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 86 FNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp CCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 67899999996 689998865 579999999999999999999999999999999999999999999999999998765
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAI 346 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvi 346 (373)
......... ..........+||+.|+|||++.+ ..++.++|||||||+
T Consensus 164 ~~~~~~~~~-------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~i 212 (353)
T 2b9h_A 164 ESAADNSEP-------------------------------TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCI 212 (353)
T ss_dssp -----------------------------------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHH
T ss_pred cccccccCc-------------------------------cccccchhhccccccccCCeeeccCCCccchhhHHHHHHH
Confidence 332110000 000001124689999999998865 679999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHh
Q 017362 347 MYEMLVGYPPFYSDDPMSTCRKV 369 (373)
Q Consensus 347 l~ell~G~~Pf~~~~~~~~~~kI 369 (373)
+|+|++|.+||.+.+..+....|
T Consensus 213 l~~l~~g~~pf~~~~~~~~~~~~ 235 (353)
T 2b9h_A 213 LAELFLRRPIFPGRDYRHQLLLI 235 (353)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHH
T ss_pred HHHHHhCCCCCCCCCcHHHHHHH
Confidence 99999999999998877665554
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=347.16 Aligned_cols=211 Identities=23% Similarity=0.347 Sum_probs=179.0
Q ss_pred ceeeeeCcEEEEEEEE--cCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEeccC
Q 017362 122 TMIGKGAFGEVRVCRE--KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLP 199 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~ 199 (373)
+.||+|+||+||+|.+ ..++..||||+++... ......+.+.+|+.+|..++|||||++++++.+ +..|+||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 4799999999999955 4567889999997653 233445779999999999999999999999865 45889999999
Q ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccccccc
Q 017362 200 GGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279 (373)
Q Consensus 200 gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 279 (373)
+|+|.+++.....+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.+........
T Consensus 453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~----- 527 (635)
T 4fl3_A 453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK----- 527 (635)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----------
T ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc-----
Confidence 999999998888999999999999999999999999999999999999999999999999999986643211000
Q ss_pred CCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh-CCCCCC
Q 017362 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFY 358 (373)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf~ 358 (373)
......||+.|+|||++.+..++.++|||||||++|||++ |.+||.
T Consensus 528 ---------------------------------~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~ 574 (635)
T 4fl3_A 528 ---------------------------------AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 574 (635)
T ss_dssp ----------------------------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ---------------------------------cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 0113457889999999999999999999999999999998 999999
Q ss_pred CCChHHHHHHhhcC
Q 017362 359 SDDPMSTCRKVRKK 372 (373)
Q Consensus 359 ~~~~~~~~~kI~~~ 372 (373)
+.+..+....|.++
T Consensus 575 ~~~~~~~~~~i~~~ 588 (635)
T 4fl3_A 575 GMKGSEVTAMLEKG 588 (635)
T ss_dssp TCCHHHHHHHHHTT
T ss_pred CCCHHHHHHHHHcC
Confidence 99998888877654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=322.96 Aligned_cols=208 Identities=28% Similarity=0.458 Sum_probs=179.4
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCe----
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF---- 190 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~---- 190 (373)
.++|.+.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++.+...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 478999999999999999999999999999999987542 223345678899999999999999999999987654
Q ss_pred --EEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 191 --LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 191 --~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
+|+||||++ ++|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 499999996 68888774 3599999999999999999999999999999999999999999999999999875431
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil 347 (373)
.. ...+||+.|+|||++.+ ..++.++|||||||++
T Consensus 179 ~~--------------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il 214 (353)
T 3coi_A 179 EM--------------------------------------------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIM 214 (353)
T ss_dssp -------------------------------------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHH
T ss_pred Cc--------------------------------------------cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHH
Confidence 10 13578999999999987 6789999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhh
Q 017362 348 YEMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 348 ~ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
|+|++|.+||.+.+..+....|+
T Consensus 215 ~el~~g~~pf~~~~~~~~~~~i~ 237 (353)
T 3coi_A 215 AEMLTGKTLFKGKDYLDQLTQIL 237 (353)
T ss_dssp HHHHHSSCSSBSSCHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999998887777664
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=320.89 Aligned_cols=208 Identities=27% Similarity=0.467 Sum_probs=179.9
Q ss_pred CCCCCcceeceeeeeCcEEEEEEE----EcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEE--
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCR----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ-- 186 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-- 186 (373)
+..++|++++.||+|+||.||+|. +..++..||||++.... ....+.+.+|+.++..++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 456789999999999999999998 46788999999987543 334466889999999999999999999887
Q ss_pred eCCeEEEEEeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 187 DDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 187 ~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
+...+|+||||++|++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence 45679999999999999999976 45699999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHH
Q 017362 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (373)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGv 345 (373)
......... ......||+.|+|||++.+..++.++|||||||
T Consensus 177 ~~~~~~~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 218 (327)
T 3lxl_A 177 LPLDKDYYV--------------------------------------VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGV 218 (327)
T ss_dssp CCTTCSEEE--------------------------------------CSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHH
T ss_pred cccCCccce--------------------------------------eeccCCccccccCHHHhccCCCChHHhHHHHHH
Confidence 643321100 011356899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCC
Q 017362 346 IMYEMLVGYPPFYSDD 361 (373)
Q Consensus 346 il~ell~G~~Pf~~~~ 361 (373)
++|+|++|..||....
T Consensus 219 il~~ll~g~~p~~~~~ 234 (327)
T 3lxl_A 219 VLYELFTYCDKSCSPS 234 (327)
T ss_dssp HHHHHHTTTCGGGSHH
T ss_pred HHHHHHhCCCCCcccc
Confidence 9999999999997544
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=318.07 Aligned_cols=211 Identities=25% Similarity=0.441 Sum_probs=180.5
Q ss_pred hccCCCCCcceeceeeeeCcEEEEEEEEcCCC-ceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCc------eeEEe
Q 017362 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTG-HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC------IVKLY 182 (373)
Q Consensus 110 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~l~ 182 (373)
......++|++++.||+|+||+||+|.+..++ ..||+|++.... ...+.+..|+.++..+.|++ ++.++
T Consensus 13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 88 (355)
T 2eu9_A 13 IGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLMS 88 (355)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred cCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence 34455789999999999999999999998776 689999997542 23355778888888887655 89999
Q ss_pred eEEEeCCeEEEEEeccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEE-----------
Q 017362 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL----------- 249 (373)
Q Consensus 183 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl----------- 249 (373)
+++...+.+|+||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 89 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 89 DWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECC
T ss_pred eeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccc
Confidence 9999999999999999 667777776653 69999999999999999999999999999999999999
Q ss_pred --------cCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCC
Q 017362 250 --------DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTP 321 (373)
Q Consensus 250 --------~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 321 (373)
+.++.+||+|||+++...... ...+||+
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--------------------------------------------~~~~gt~ 203 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHEHH--------------------------------------------TTIVATR 203 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTSCC--------------------------------------------CSSCSCG
T ss_pred cccccccccCCCcEEEeecCccccccccc--------------------------------------------cCCcCCC
Confidence 678899999999997543211 1457999
Q ss_pred CCcccccccCCCCChhhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 017362 322 DYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKV 369 (373)
Q Consensus 322 ~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~kI 369 (373)
.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+....+
T Consensus 204 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 251 (355)
T 2eu9_A 204 HYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMM 251 (355)
T ss_dssp GGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999999999999999999999999999999988877655544
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=312.82 Aligned_cols=211 Identities=25% Similarity=0.452 Sum_probs=177.8
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC-C
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD-E 189 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-~ 189 (373)
..+..++|++.+.||+|+||+||+|.+. +..||||++.... ..+.+.+|+.++..++||||+++++++.+. +
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 88 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred ccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC
Confidence 4566789999999999999999999864 7899999987532 345688899999999999999999987654 4
Q ss_pred eEEEEEeccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
.+|+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 7899999999999999997654 38999999999999999999999999999999999999999999999999987543
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 347 (373)
... ....+|+.|+|||++.+..++.++|||||||++
T Consensus 169 ~~~--------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 204 (278)
T 1byg_A 169 STQ--------------------------------------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILL 204 (278)
T ss_dssp ---------------------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred ccc--------------------------------------------cCCCccccccCHHHhCCCCCCchhcHHHHHHHH
Confidence 210 023578999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 348 YEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 348 ~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|||++ |.+||...+..+....+.++
T Consensus 205 ~~l~t~g~~p~~~~~~~~~~~~~~~~ 230 (278)
T 1byg_A 205 WEIYSFGRVPYPRIPLKDVVPRVEKG 230 (278)
T ss_dssp HHHHTTSCCSCTTSCGGGHHHHHTTT
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHhcC
Confidence 99998 99999998888877776543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=309.67 Aligned_cols=206 Identities=22% Similarity=0.320 Sum_probs=173.4
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeE-EEeCCeEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCS-FQDDEFLYL 193 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~-~~~~~~~~l 193 (373)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.++..+.|++++..+.. +......|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-----SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-----chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 578999999999999999999999999999999986542 12347789999999998776555544 467788999
Q ss_pred EEeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEE---cCCCcEEEeeccccccCCCC
Q 017362 194 IMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 194 V~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl---~~~~~vkL~DFGla~~~~~~ 269 (373)
||||+ +++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99999 9999999974 4579999999999999999999999999999999999999 58899999999999866433
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 349 (373)
...... + ........||+.|+|||++.+..++.++|||||||++||
T Consensus 162 ~~~~~~----------------~------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ 207 (296)
T 3uzp_A 162 RTHQHI----------------P------------------YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMY 207 (296)
T ss_dssp TTCCBC----------------C------------------CCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred cccccc----------------c------------------cccccccccccccCChhhhcCCCCCcchhhHHHHHHHHH
Confidence 211000 0 000124679999999999999999999999999999999
Q ss_pred HHhCCCCCCCC
Q 017362 350 MLVGYPPFYSD 360 (373)
Q Consensus 350 ll~G~~Pf~~~ 360 (373)
|++|++||.+.
T Consensus 208 l~~g~~pf~~~ 218 (296)
T 3uzp_A 208 FNLGSLPWQGL 218 (296)
T ss_dssp HHHSSCTTSSC
T ss_pred HHhCCCCCCCc
Confidence 99999999874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=309.46 Aligned_cols=207 Identities=22% Similarity=0.314 Sum_probs=170.9
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeE-EEeCCeEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCS-FQDDEFLYL 193 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~-~~~~~~~~l 193 (373)
.++|++.+.||+|+||+||+|.+..+++.||||++..... ...+..|+.++..+.|++++..+.. +.+.+..|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 5789999999999999999999999999999998765432 1236779999999988776666554 467888999
Q ss_pred EEeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEE---cCCCcEEEeeccccccCCCC
Q 017362 194 IMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 194 V~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl---~~~~~vkL~DFGla~~~~~~ 269 (373)
||||+ +++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 99999 9999999974 4579999999999999999999999999999999999999 78999999999999876433
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 349 (373)
...... + ........||+.|+|||++.+..++.++|||||||++|+
T Consensus 162 ~~~~~~----------------~------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ 207 (296)
T 4hgt_A 162 RTHQHI----------------P------------------YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMY 207 (296)
T ss_dssp TTCCBC----------------C------------------CCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred ccCccC----------------C------------------CCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHH
Confidence 211000 0 000124679999999999999999999999999999999
Q ss_pred HHhCCCCCCCCC
Q 017362 350 MLVGYPPFYSDD 361 (373)
Q Consensus 350 ll~G~~Pf~~~~ 361 (373)
|++|.+||.+.+
T Consensus 208 l~~g~~pf~~~~ 219 (296)
T 4hgt_A 208 FNLGSLPWQGLK 219 (296)
T ss_dssp HHHSSCTTSSCC
T ss_pred HhcCCCCCcccc
Confidence 999999998754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=322.15 Aligned_cols=204 Identities=17% Similarity=0.238 Sum_probs=172.7
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcC--------CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeE------
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKT--------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK------ 180 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~------ 180 (373)
.++|++.+.||+|+||.||+|.+.. .++.||||++... ..+.+|+.++..++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 5789999999999999999999987 4889999998754 24778999999999999887
Q ss_pred ---------EeeEEEe-CCeEEEEEeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEE
Q 017362 181 ---------LYCSFQD-DEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLL 248 (373)
Q Consensus 181 ---------l~~~~~~-~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NIL 248 (373)
+++++.. ....|+||||+ +++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 5677765 78899999999 99999999876 78999999999999999999999999999999999999
Q ss_pred EcCCC--cEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccc
Q 017362 249 LDKYG--HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAP 326 (373)
Q Consensus 249 l~~~~--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP 326 (373)
++.++ .+||+|||+++.+......... .........||+.|+||
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~----------------------------------~~~~~~~~~gt~~y~aP 237 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAY----------------------------------VEGSRSPHEGDLEFISM 237 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCC----------------------------------CTTSSCTTCSCTTTCCH
T ss_pred EcCCCCceEEEecCcceeeccCCCccccc----------------------------------cccccccccCCccccCH
Confidence 99998 9999999999876532111000 00001145799999999
Q ss_pred ccccCCCCChhhcHHHHHHHHHHHHhCCCCCCCCC
Q 017362 327 EVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361 (373)
Q Consensus 327 E~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~ 361 (373)
|++.+..++.++|||||||++|||++|.+||...+
T Consensus 238 E~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 238 DLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp HHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 99999999999999999999999999999998764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=328.79 Aligned_cols=203 Identities=25% Similarity=0.426 Sum_probs=157.8
Q ss_pred CCcce-eceeeeeCcEEEEEEEEc--CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe--CCe
Q 017362 116 DDFEL-LTMIGKGAFGEVRVCREK--TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD--DEF 190 (373)
Q Consensus 116 ~~y~~-~~~lG~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~ 190 (373)
+.|++ .++||+|+||+||+|.++ .++..||||++..... ...+.+|+.+|..++||||++++++|.+ ...
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 44776 457999999999999976 5688999999875422 2357789999999999999999999964 678
Q ss_pred EEEEEeccCCCCHHHHHhhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEE----cCCCcEEE
Q 017362 191 LYLIMEYLPGGDMMTLLMRK---------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL----DKYGHLRL 257 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl----~~~~~vkL 257 (373)
+|+||||++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999999995 5888887531 249999999999999999999999999999999999999 77899999
Q ss_pred eeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCCh
Q 017362 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGM 336 (373)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~ 336 (373)
+|||+|+.+....... ......+||+.|+|||++.+. .|+.
T Consensus 174 ~Dfg~a~~~~~~~~~~--------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~ 215 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPL--------------------------------------ADLDPVVVTFWYRAPELLLGARHYTK 215 (405)
T ss_dssp CCTTCCC------------------------------------------------------CCCTTCCHHHHTTCCSCCH
T ss_pred EECCCceecCCCCccc--------------------------------------ccCCCceecCcccCchhhcCCCcccc
Confidence 9999998654221000 001246899999999999874 5999
Q ss_pred hhcHHHHHHHHHHHHhCCCCCCCCCh
Q 017362 337 ECDWWSLGAIMYEMLVGYPPFYSDDP 362 (373)
Q Consensus 337 ~~DvwSlGvil~ell~G~~Pf~~~~~ 362 (373)
++|||||||++|||++|.+||.+.+.
T Consensus 216 ~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 216 AIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred hhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 99999999999999999999987654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=316.68 Aligned_cols=224 Identities=23% Similarity=0.384 Sum_probs=162.6
Q ss_pred hhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-CCceeEEeeEEE-
Q 017362 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQ- 186 (373)
Q Consensus 109 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~- 186 (373)
+..++...+|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.++..+. ||||+++++++.
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 97 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI 97 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence 344566778999999999999999999999999999999885542 233456788999999996 999999999994
Q ss_pred -------eCCeEEEEEeccCCCCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHhCC--CeeecCCCCCEEEcCCCc
Q 017362 187 -------DDEFLYLIMEYLPGGDMMTLLMR---KDTLTEDEARFYVAETVLAIESIHKHH--YIHRDIKPDNLLLDKYGH 254 (373)
Q Consensus 187 -------~~~~~~lV~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiHrDikp~NILl~~~~~ 254 (373)
....+|+||||++ |+|.+++.. ...+++..+..++.||+.||.|||++| |+||||||+|||++.+++
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~ 176 (337)
T 3ll6_A 98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT 176 (337)
T ss_dssp CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC
T ss_pred cccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC
Confidence 3345899999995 789888864 567999999999999999999999999 999999999999999999
Q ss_pred EEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccc---cC
Q 017362 255 LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL---LK 331 (373)
Q Consensus 255 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~---~~ 331 (373)
+||+|||++............. . ............||+.|+|||++ .+
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~------------------~-----------~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 227 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSA------------------Q-----------RRALVEEEITRNTTPMYRTPEIIDLYSN 227 (337)
T ss_dssp EEBCCCTTCBCCSSCC------------------------------------------------------------CCTT
T ss_pred EEEecCccceeccccCcccccc------------------c-----------ccccchhhccccCCCCcCChhhhhcccc
Confidence 9999999998765332110000 0 00000001145799999999998 56
Q ss_pred CCCChhhcHHHHHHHHHHHHhCCCCCCCCChHHH
Q 017362 332 KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMST 365 (373)
Q Consensus 332 ~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~ 365 (373)
..++.++|||||||++|+|++|.+||...+....
T Consensus 228 ~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 261 (337)
T 3ll6_A 228 FPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261 (337)
T ss_dssp SCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence 7789999999999999999999999987655443
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=310.83 Aligned_cols=195 Identities=27% Similarity=0.497 Sum_probs=172.7
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe--------
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD-------- 187 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-------- 187 (373)
.+|++++.||+|+||.||+|.+..+++.||+|++.... +.+.+|+.++..++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 56999999999999999999999899999999987542 235679999999999999999998865
Q ss_pred --------CCeEEEEEeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEE
Q 017362 188 --------DEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRL 257 (373)
Q Consensus 188 --------~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL 257 (373)
...+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 44589999999999999999654 57999999999999999999999999999999999999999999999
Q ss_pred eeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChh
Q 017362 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME 337 (373)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 337 (373)
+|||++........ .....||+.|+|||++.+..++.+
T Consensus 164 ~Dfg~~~~~~~~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~ 201 (284)
T 2a19_B 164 GDFGLVTSLKNDGK------------------------------------------RTRSKGTLRYMSPEQISSQDYGKE 201 (284)
T ss_dssp CCCTTCEESSCCSC------------------------------------------CCCCCSCCTTSCHHHHHCSCCCTH
T ss_pred Ccchhheecccccc------------------------------------------ccccCCcccccChhhhccCCCcch
Confidence 99999976543211 113569999999999999999999
Q ss_pred hcHHHHHHHHHHHHhCCCCCCC
Q 017362 338 CDWWSLGAIMYEMLVGYPPFYS 359 (373)
Q Consensus 338 ~DvwSlGvil~ell~G~~Pf~~ 359 (373)
+|||||||++|+|++|..||..
T Consensus 202 ~Di~slG~il~~l~~~~~~~~~ 223 (284)
T 2a19_B 202 VDLYALGLILAELLHVCDTAFE 223 (284)
T ss_dssp HHHHHHHHHHHHHHSCCSSHHH
T ss_pred hhhHHHHHHHHHHHhcCCcchh
Confidence 9999999999999999999853
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=340.20 Aligned_cols=217 Identities=22% Similarity=0.393 Sum_probs=186.9
Q ss_pred hccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC
Q 017362 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 110 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 189 (373)
..++..++|++.+.||+|+||.||+|.+.. +..||||++..... ..+.+.+|+.+|+.++||||+++++++.+ +
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 334 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence 455677889999999999999999998864 45799999976432 23568899999999999999999999876 6
Q ss_pred eEEEEEeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+++...
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 789999999999999999643 469999999999999999999999999999999999999999999999999998654
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 347 (373)
..... ......+|+.|+|||++....++.++|||||||+|
T Consensus 415 ~~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l 454 (535)
T 2h8h_A 415 DNEYT----------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 454 (535)
T ss_dssp CHHHH----------------------------------------TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCcee----------------------------------------cccCCcCcccccCHHHhccCCCCchhhHHHHHHHH
Confidence 21100 01134578899999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 348 YEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 348 ~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|||++ |.+||.+.+..+....|.++
T Consensus 455 ~el~t~g~~P~~~~~~~~~~~~i~~~ 480 (535)
T 2h8h_A 455 TELTTKGRVPYPGMVNREVLDQVERG 480 (535)
T ss_dssp HHHTTTTCCSSTTCCHHHHHHHHHTT
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999 99999999988888877654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=326.47 Aligned_cols=218 Identities=17% Similarity=0.308 Sum_probs=173.0
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCC---CceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEE-eCCeE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTT---GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ-DDEFL 191 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-~~~~~ 191 (373)
..|.+.+.||+|+||+||+|.+..+ +..||+|.+... ......+.+.+|+.+++.++||||+++++++. ..+..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 4578899999999999999987543 246899988643 22345677889999999999999999999875 45678
Q ss_pred EEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 192 YLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999999764 468999999999999999999999999999999999999999999999999998653221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 350 (373)
.... .......||+.|+|||++.+..++.++|||||||++|||
T Consensus 247 ~~~~-------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el 289 (373)
T 3c1x_A 247 FDSV-------------------------------------HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 289 (373)
T ss_dssp ------------------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred cccc-------------------------------------cccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHH
Confidence 1000 001134688999999999999999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHhhcC
Q 017362 351 LV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 351 l~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
++ |.+||.+.+..+....+.++
T Consensus 290 lt~~~~p~~~~~~~~~~~~~~~~ 312 (373)
T 3c1x_A 290 MTRGAPPYPDVNTFDITVYLLQG 312 (373)
T ss_dssp HTTSCCSCTTSCSSCHHHHHHTT
T ss_pred HhCcCCCCCCCCHHHHHHHHHcC
Confidence 99 89999888777776666543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=315.24 Aligned_cols=213 Identities=26% Similarity=0.448 Sum_probs=175.3
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe----
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD---- 187 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~---- 187 (373)
.+..++|++++.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++..++||||+++++++..
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence 356678999999999999999999999999999999886532 3345668899999999999999999999873
Q ss_pred CCeEEEEEeccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeecccc
Q 017362 188 DEFLYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (373)
Q Consensus 188 ~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla 263 (373)
....|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 3478999999999999999875 467999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC---CChhhcH
Q 017362 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG---YGMECDW 340 (373)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~~~~~Dv 340 (373)
.......... ........+ ....||+.|+|||++.+.. ++.++||
T Consensus 182 ~~~~~~~~~~------------------------~~~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~~~Di 229 (317)
T 2buj_A 182 NQACIHVEGS------------------------RQALTLQDW--------AAQRCTISYRAPELFSVQSHCVIDERTDV 229 (317)
T ss_dssp EESCEEEESH------------------------HHHHHHHHH--------HHHHSCGGGCCGGGSSCCSEEEECTHHHH
T ss_pred hhcccccccc------------------------ccccccccc--------ccccCCcccCCHhHhccCCCcCCCchhhH
Confidence 7543211000 000000111 1346899999999997654 7899999
Q ss_pred HHHHHHHHHHHhCCCCCCC
Q 017362 341 WSLGAIMYEMLVGYPPFYS 359 (373)
Q Consensus 341 wSlGvil~ell~G~~Pf~~ 359 (373)
|||||++|||++|..||..
T Consensus 230 ~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 230 WSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp HHHHHHHHHHHHSSCTTHH
T ss_pred HHHHHHHHHHHhCCCChhh
Confidence 9999999999999999953
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=314.08 Aligned_cols=203 Identities=26% Similarity=0.357 Sum_probs=172.6
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHh-hhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEe
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM-LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E 196 (373)
|...+.||+|+||+||+|.+ ++..||+|++..... ......+.+.+|+.++..++||||+++++++.+.+..|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 44558999999999999975 578999999865321 223345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 197 YLPGGDMMTLLMR---KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 197 ~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
|+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 9999999999864 3469999999999999999999999999999999999999999999999999997654321100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhC
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 353 (373)
......||+.|+|||++.+ .++.++|||||||++|+|++|
T Consensus 191 ---------------------------------------~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g 230 (307)
T 2nru_A 191 ---------------------------------------MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITG 230 (307)
T ss_dssp ---------------------------------------ECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHC
T ss_pred ---------------------------------------cccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHC
Confidence 0113579999999998864 589999999999999999999
Q ss_pred CCCCCCCCh
Q 017362 354 YPPFYSDDP 362 (373)
Q Consensus 354 ~~Pf~~~~~ 362 (373)
.+||...+.
T Consensus 231 ~~p~~~~~~ 239 (307)
T 2nru_A 231 LPAVDEHRE 239 (307)
T ss_dssp CCSBCTTBS
T ss_pred CCCcccCcc
Confidence 999987543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=309.77 Aligned_cols=207 Identities=31% Similarity=0.524 Sum_probs=176.1
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCe
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 190 (373)
.....++|.....||+|+||.||+|.+..++..||||++.... ....+.+.+|+.++..++||||+++++++.+.+.
T Consensus 17 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 93 (295)
T 2clq_A 17 YDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93 (295)
T ss_dssp EEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence 3344566667779999999999999999999999999987542 2334668889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC-CCcEEEeeccccccC
Q 017362 191 LYLIMEYLPGGDMMTLLMRK---DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-YGHLRLSDFGLCKPL 266 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~-~~~vkL~DFGla~~~ 266 (373)
.|+||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 99999999999999999765 25679999999999999999999999999999999999987 899999999999765
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC--CChhhcHHHHH
Q 017362 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG--YGMECDWWSLG 344 (373)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~~DvwSlG 344 (373)
...... .....||+.|+|||++.+.. ++.++||||||
T Consensus 174 ~~~~~~-----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG 212 (295)
T 2clq_A 174 AGINPC-----------------------------------------TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLG 212 (295)
T ss_dssp CC----------------------------------------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHH
T ss_pred CCCCCc-----------------------------------------ccccCCCccccChhhhcCCCCCCCcHHHHHHHH
Confidence 422100 11457999999999997654 89999999999
Q ss_pred HHHHHHHhCCCCCCCCC
Q 017362 345 AIMYEMLVGYPPFYSDD 361 (373)
Q Consensus 345 vil~ell~G~~Pf~~~~ 361 (373)
|++|+|++|.+||...+
T Consensus 213 ~il~~l~~g~~pf~~~~ 229 (295)
T 2clq_A 213 CTIIEMATGKPPFYELG 229 (295)
T ss_dssp HHHHHHHHTSCTTGGGS
T ss_pred HHHHHHHHCCCCccCCC
Confidence 99999999999997643
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=317.47 Aligned_cols=203 Identities=34% Similarity=0.584 Sum_probs=150.3
Q ss_pred CCCCCcceec-eeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe----
Q 017362 113 MGADDFELLT-MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD---- 187 (373)
Q Consensus 113 ~~~~~y~~~~-~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~---- 187 (373)
...++|.+++ .||+|+||+||+|.+..+++.||||++..... ........+..+.||||+++++++..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 97 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVCILDVYENMHHG 97 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-------HHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-------HHHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence 3467899965 69999999999999999999999999865421 11222334567799999999999986
Q ss_pred CCeEEEEEeccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC---CCcEEEeeccc
Q 017362 188 DEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---YGHLRLSDFGL 262 (373)
Q Consensus 188 ~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~---~~~vkL~DFGl 262 (373)
...+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 98 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 98 KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 456899999999999999997754 6999999999999999999999999999999999999976 45599999999
Q ss_pred cccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHH
Q 017362 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342 (373)
Q Consensus 263 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwS 342 (373)
+....... ....+||+.|+|||++.+..++.++||||
T Consensus 178 ~~~~~~~~-------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~Di~s 214 (336)
T 3fhr_A 178 AKETTQNA-------------------------------------------LQTPCYTPYYVAPEVLGPEKYDKSCDMWS 214 (336)
T ss_dssp CEEC-----------------------------------------------------------------CHHHHHHHHHH
T ss_pred ceeccccc-------------------------------------------cccCCCCcCccChhhhCCCCCCchhhHHH
Confidence 97543211 11457899999999998899999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHH
Q 017362 343 LGAIMYEMLVGYPPFYSDDPMST 365 (373)
Q Consensus 343 lGvil~ell~G~~Pf~~~~~~~~ 365 (373)
|||++|+|++|.+||.+.+....
T Consensus 215 lG~il~~l~~g~~pf~~~~~~~~ 237 (336)
T 3fhr_A 215 LGVIMYILLCGFPPFYSNTGQAI 237 (336)
T ss_dssp HHHHHHHHHHSSCCC--------
T ss_pred HHHHHHHHHHCCCCCCCccchhh
Confidence 99999999999999987665443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=310.26 Aligned_cols=195 Identities=29% Similarity=0.497 Sum_probs=165.9
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 192 (373)
+..++|++.+.||+|+||+||+|.+. +..||||++... ...+.+.+|+.++..++||||+++++++.+ ..|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 45678999999999999999999864 778999998643 234568889999999999999999998874 478
Q ss_pred EEEeccCCCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHh---CCCeeecCCCCCEEEcCCCc-EEEeecccccc
Q 017362 193 LIMEYLPGGDMMTLLMRKD---TLTEDEARFYVAETVLAIESIHK---HHYIHRDIKPDNLLLDKYGH-LRLSDFGLCKP 265 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~giiHrDikp~NILl~~~~~-vkL~DFGla~~ 265 (373)
+||||++||+|.+++.... .+++..+..++.|++.||.|||+ +||+||||||+|||++.++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 9999999999999997654 47899999999999999999999 89999999999999998887 79999999865
Q ss_pred CCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHH
Q 017362 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (373)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGv 345 (373)
..... ....||+.|+|||++.+..++.++|||||||
T Consensus 156 ~~~~~--------------------------------------------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 191 (307)
T 2eva_A 156 IQTHM--------------------------------------------TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGI 191 (307)
T ss_dssp -----------------------------------------------------CCTTSSCHHHHTCCCCCTHHHHHHHHH
T ss_pred ccccc--------------------------------------------ccCCCCCceEChhhhCCCCCCcHHHHHHHHH
Confidence 43110 1346999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCC
Q 017362 346 IMYEMLVGYPPFYSD 360 (373)
Q Consensus 346 il~ell~G~~Pf~~~ 360 (373)
++|||++|..||...
T Consensus 192 il~el~~g~~p~~~~ 206 (307)
T 2eva_A 192 ILWEVITRRKPFDEI 206 (307)
T ss_dssp HHHHHHHTCCTTTTT
T ss_pred HHHHHHHCCCCchhh
Confidence 999999999999854
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=314.36 Aligned_cols=208 Identities=28% Similarity=0.511 Sum_probs=158.2
Q ss_pred hhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHH-HHHhcCCCceeEEeeEEEe
Q 017362 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN-LLAEVDSNCIVKLYCSFQD 187 (373)
Q Consensus 109 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~l~~~~~~ 187 (373)
....+..++|++++.||+|+||.||+|.+..+++.||||++..... ......+..|.. +++.++||||+++++++.+
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 3456778999999999999999999999999999999999875421 122233444554 6777899999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeecCCCCCEEEcCCCcEEEeecc
Q 017362 188 DEFLYLIMEYLPGGDMMTLLMR-----KDTLTEDEARFYVAETVLAIESIHKH-HYIHRDIKPDNLLLDKYGHLRLSDFG 261 (373)
Q Consensus 188 ~~~~~lV~E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~-giiHrDikp~NILl~~~~~vkL~DFG 261 (373)
.+..|+||||+++ +|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence 9999999999975 88877753 56899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccc----cCCCCChh
Q 017362 262 LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL----LKKGYGME 337 (373)
Q Consensus 262 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~~~~ 337 (373)
+++....... .....||+.|+|||++ .+..++.+
T Consensus 172 ~~~~~~~~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 209 (327)
T 3aln_A 172 ISGQLVDSIA------------------------------------------KTRDAGCRPYMAPERIDPSASRQGYDVR 209 (327)
T ss_dssp SSCC------------------------------------------------------------------------CCSH
T ss_pred Cceecccccc------------------------------------------cccCCCCccccCceeeccccCcCCCCch
Confidence 9976532210 0124699999999999 46678999
Q ss_pred hcHHHHHHHHHHHHhCCCCCCCCC
Q 017362 338 CDWWSLGAIMYEMLVGYPPFYSDD 361 (373)
Q Consensus 338 ~DvwSlGvil~ell~G~~Pf~~~~ 361 (373)
+|||||||++|+|++|..||.+.+
T Consensus 210 ~Di~slG~il~~l~~g~~pf~~~~ 233 (327)
T 3aln_A 210 SDVWSLGITLYELATGRFPYPKWN 233 (327)
T ss_dssp HHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred hhHHHHHHHHHHHHHCCCCCCCcc
Confidence 999999999999999999998643
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=327.30 Aligned_cols=209 Identities=22% Similarity=0.319 Sum_probs=176.2
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCC-CceeEEeeEEEeCCeEE
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS-NCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~l~~~~~~~~~~~ 192 (373)
..++|+++++||+|+||.||+|.+..+++.||||++..... ...+..|+.++..+.| ++|+.+..++.+.+..|
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 35789999999999999999999999999999998765432 1236789999999987 56666677778888999
Q ss_pred EEEeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEE---cCCCcEEEeeccccccCCC
Q 017362 193 LIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl---~~~~~vkL~DFGla~~~~~ 268 (373)
|||||+ +++|.+++.. ...+++..+..++.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+.+..
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999999 9999999975 5679999999999999999999999999999999999999 6889999999999987643
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 348 (373)
....... + .......+||+.|+|||++.+..++.++|||||||+||
T Consensus 159 ~~~~~~~----------------~------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~ 204 (483)
T 3sv0_A 159 TSTHQHI----------------P------------------YRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLM 204 (483)
T ss_dssp TTTCCBC----------------C------------------CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred Ccccccc----------------c------------------cccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHH
Confidence 3211000 0 00011468999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCh
Q 017362 349 EMLVGYPPFYSDDP 362 (373)
Q Consensus 349 ell~G~~Pf~~~~~ 362 (373)
||++|.+||.+...
T Consensus 205 elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 205 YFLRGSLPWQGLKA 218 (483)
T ss_dssp HHHHSSCTTSSCCC
T ss_pred HHHhCCCCCccccc
Confidence 99999999987543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=313.96 Aligned_cols=207 Identities=26% Similarity=0.404 Sum_probs=174.9
Q ss_pred CCCCCc-ceeceeeeeCcEEEEEEEE----cCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe
Q 017362 113 MGADDF-ELLTMIGKGAFGEVRVCRE----KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (373)
Q Consensus 113 ~~~~~y-~~~~~lG~G~~g~Vy~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 187 (373)
+..++| ++++.||+|+||+||+|.. ..+++.||||++.... .......+.+|+.++..++||||+++++++.+
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCED 104 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEec
Confidence 334555 9999999999999988754 3478899999997642 23345678899999999999999999999987
Q ss_pred --CCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 188 --DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 188 --~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
...+|+||||+++|+|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 105 AGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp TTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred CCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 46789999999999999999654 599999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHH
Q 017362 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (373)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGv 345 (373)
......... ......||+.|+|||++.+..++.++|||||||
T Consensus 184 ~~~~~~~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 225 (318)
T 3lxp_A 184 VPEGHEYYR--------------------------------------VREDGDSPVFWYAPECLKEYKFYYASDVWSFGV 225 (318)
T ss_dssp CCTTCSEEE--------------------------------------C---CCCCGGGCCHHHHHHCEEEHHHHHHHHHH
T ss_pred ccccccccc--------------------------------------cccCCCCCceeeChHHhcCCCCCcHHHHHHHHH
Confidence 653321100 011356889999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCC
Q 017362 346 IMYEMLVGYPPFYSD 360 (373)
Q Consensus 346 il~ell~G~~Pf~~~ 360 (373)
++|+|++|..||...
T Consensus 226 il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 226 TLYELLTHCDSSQSP 240 (318)
T ss_dssp HHHHHHTTTCGGGSH
T ss_pred HHHHHHhCCCccccc
Confidence 999999999999754
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=317.14 Aligned_cols=210 Identities=27% Similarity=0.423 Sum_probs=178.7
Q ss_pred hhhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhh---hhHHHHHHHHHHHHhcC--CCceeEEe
Q 017362 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR---GQVEHVRAERNLLAEVD--SNCIVKLY 182 (373)
Q Consensus 108 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~l~--h~~iv~l~ 182 (373)
........++|++.+.||+|+||.||+|.+..+++.||||++........ .....+..|+.++..+. ||||++++
T Consensus 35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 33445667899999999999999999999999999999999976543221 11234567899999986 59999999
Q ss_pred eEEEeCCeEEEEEeccCC-CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEc-CCCcEEEeec
Q 017362 183 CSFQDDEFLYLIMEYLPG-GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD-KYGHLRLSDF 260 (373)
Q Consensus 183 ~~~~~~~~~~lV~E~~~g-g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~-~~~~vkL~DF 260 (373)
+++.+.+..++|||++.+ ++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 115 DWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp EEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred EEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 999999999999999976 89999998888999999999999999999999999999999999999999 7899999999
Q ss_pred cccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCC-Chhhc
Q 017362 261 GLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECD 339 (373)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~D 339 (373)
|++....... .....||+.|+|||++.+..+ +.++|
T Consensus 195 g~~~~~~~~~-------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~D 231 (320)
T 3a99_A 195 GSGALLKDTV-------------------------------------------YTDFDGTRVYSPPEWIRYHRYHGRSAA 231 (320)
T ss_dssp TTCEECCSSC-------------------------------------------BCCCCSCGGGSCHHHHHHSCBCHHHHH
T ss_pred cccccccccc-------------------------------------------ccCCCCCccCCChHHhccCCCCCccch
Confidence 9997654221 113579999999999987776 78899
Q ss_pred HHHHHHHHHHHHhCCCCCCCC
Q 017362 340 WWSLGAIMYEMLVGYPPFYSD 360 (373)
Q Consensus 340 vwSlGvil~ell~G~~Pf~~~ 360 (373)
||||||++|||++|.+||...
T Consensus 232 i~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 232 VWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp HHHHHHHHHHHHHSSCSCCSH
T ss_pred HHhHHHHHHHHHHCCCCCCCh
Confidence 999999999999999999753
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=339.70 Aligned_cols=220 Identities=24% Similarity=0.380 Sum_probs=185.2
Q ss_pred hccCCCCCcceeceeeeeCcEEEEEEEEcCC---CceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEE
Q 017362 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTT---GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (373)
Q Consensus 110 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 186 (373)
...+..++|++.+.||+|+||+||+|.+..+ +..||||.+.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3456678899999999999999999988643 4579999886532 2334467889999999999999999999985
Q ss_pred eCCeEEEEEeccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 187 DDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 187 ~~~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
.+.+|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++++||+|||+++.
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred -cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 456899999999999999997654 699999999999999999999999999999999999999999999999999986
Q ss_pred CCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHH
Q 017362 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (373)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGv 345 (373)
........ .....||+.|+|||++.+..++.++|||||||
T Consensus 541 ~~~~~~~~----------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~ 580 (656)
T 2j0j_A 541 MEDSTYYK----------------------------------------ASKGKLPIKWMAPESINFRRFTSASDVWMFGV 580 (656)
T ss_dssp CCC--------------------------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred cCCCccee----------------------------------------ccCCCCCcceeCHHHhcCCCCCchhhHHHHHH
Confidence 54321100 11345788999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 346 IMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 346 il~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
++|||++ |.+||.+.+..+...+|.++
T Consensus 581 il~ellt~g~~Pf~~~~~~~~~~~i~~~ 608 (656)
T 2j0j_A 581 CMWEILMHGVKPFQGVKNNDVIGRIENG 608 (656)
T ss_dssp HHHHHHTTSCCTTTTCCHHHHHHHHHHT
T ss_pred HHHHHHHcCCCCCCCCCHHHHHHHHHcC
Confidence 9999997 99999999998888877654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=318.11 Aligned_cols=201 Identities=25% Similarity=0.442 Sum_probs=171.6
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-----------CCceeE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-----------SNCIVK 180 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~ 180 (373)
.+..++|++++.||+|+||+||+|.+..+++.||||++.... .....+.+|+.++..+. ||||++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 455689999999999999999999999999999999997543 22345677888888775 899999
Q ss_pred EeeEEEeCC----eEEEEEeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CCeeecCCCCCEEEcC--
Q 017362 181 LYCSFQDDE----FLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKH-HYIHRDIKPDNLLLDK-- 251 (373)
Q Consensus 181 l~~~~~~~~----~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~-giiHrDikp~NILl~~-- 251 (373)
+++++...+ .+++||||+ +++|.+++... ..+++..+..++.||+.||.|||++ ||+||||||+|||++.
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence 999998654 789999999 89999999763 4599999999999999999999998 9999999999999953
Q ss_pred ----CCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccc
Q 017362 252 ----YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPE 327 (373)
Q Consensus 252 ----~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE 327 (373)
.+.+||+|||++....... ...+||+.|+|||
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~~--------------------------------------------~~~~~t~~y~aPE 205 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEHY--------------------------------------------TNSIQTREYRSPE 205 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBCC--------------------------------------------CSCCSCGGGCCHH
T ss_pred CCcCcceEEEcccccccccCCCC--------------------------------------------CCCCCCccccCcH
Confidence 4489999999997653221 1357999999999
Q ss_pred cccCCCCChhhcHHHHHHHHHHHHhCCCCCCCCC
Q 017362 328 VLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361 (373)
Q Consensus 328 ~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~ 361 (373)
++.+..++.++|||||||++|||++|.+||.+.+
T Consensus 206 ~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 206 VLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp HHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred HHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 9999999999999999999999999999998765
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=316.46 Aligned_cols=207 Identities=25% Similarity=0.381 Sum_probs=164.0
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHH--HHhcCCCceeEEeeEEEe-
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL--LAEVDSNCIVKLYCSFQD- 187 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~--l~~l~h~~iv~l~~~~~~- 187 (373)
..+..++|++.+.||+|+||+||+|.. +++.||||++..... ..+..|..+ +..++||||+++++.+..
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR------QNFINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch------hhHHHHHHHHHHHhccCcchhhheeccccc
Confidence 346678999999999999999999975 688999999875431 223334444 455899999999976542
Q ss_pred ----CCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCeeecCCCCCEEEcCCCc
Q 017362 188 ----DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH---------HYIHRDIKPDNLLLDKYGH 254 (373)
Q Consensus 188 ----~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---------giiHrDikp~NILl~~~~~ 254 (373)
...+|+||||+++|+|.+++... .+++..+..++.||+.||.|||+. ||+||||||+|||++.++.
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence 33678999999999999999654 458999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC---
Q 017362 255 LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--- 331 (373)
Q Consensus 255 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--- 331 (373)
+||+|||+|+.+......... .........+||+.|+|||++.+
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~---------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~ 205 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPG---------------------------------EEDNAAISEVGTIRYMAPEVLEGAVN 205 (336)
T ss_dssp EEECCCTTCEECSSSSCC------------------------------------------CCTTSCGGGCCHHHHTTCCC
T ss_pred EEEeeccceeecccccccCcc---------------------------------ccccccccCCCccceeCchhhcCCcc
Confidence 999999999876533211000 00001124679999999999987
Q ss_pred ----CCCChhhcHHHHHHHHHHHHhCCCCCCC
Q 017362 332 ----KGYGMECDWWSLGAIMYEMLVGYPPFYS 359 (373)
Q Consensus 332 ----~~~~~~~DvwSlGvil~ell~G~~Pf~~ 359 (373)
..++.++|||||||++|||++|..||..
T Consensus 206 ~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 206 LRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp GGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred cccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 4567899999999999999999776654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=308.54 Aligned_cols=218 Identities=28% Similarity=0.444 Sum_probs=166.1
Q ss_pred hccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC
Q 017362 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 110 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 189 (373)
+.....++|++++.||+|+||.||+|.+..+++.||||++..... .......+..+..++..++||||+++++++.+.+
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT 97 (318)
T ss_dssp EEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence 345567899999999999999999999999999999999976432 1222334445556788889999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKH-HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~-giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
.+|+||||+ ++.+..++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++++||+|||++....
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999999999 5666665543 56899999999999999999999995 99999999999999999999999999987543
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc-----CCCCChhhcHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWS 342 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DvwS 342 (373)
.... .....||+.|+|||++. ...++.++||||
T Consensus 177 ~~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~s 214 (318)
T 2dyl_A 177 DDKA------------------------------------------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWS 214 (318)
T ss_dssp ----------------------------------------------------CCTTCCHHHHC--------CCTHHHHHH
T ss_pred CCcc------------------------------------------ccccCCCccccChhhcccccccccCCccccchhh
Confidence 2210 01346999999999995 566899999999
Q ss_pred HHHHHHHHHhCCCCCCCC-ChHHHHHHhhc
Q 017362 343 LGAIMYEMLVGYPPFYSD-DPMSTCRKVRK 371 (373)
Q Consensus 343 lGvil~ell~G~~Pf~~~-~~~~~~~kI~~ 371 (373)
|||++|||++|.+||... +..+...+++.
T Consensus 215 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 244 (318)
T 2dyl_A 215 LGISLVELATGQFPYKNCKTDFEVLTKVLQ 244 (318)
T ss_dssp HHHHHHHHHHSSCTTTTCCSHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCccHHHHHHHhc
Confidence 999999999999999873 45555555543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=308.78 Aligned_cols=214 Identities=29% Similarity=0.481 Sum_probs=176.5
Q ss_pred HHHhhhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC--CCceeEEe
Q 017362 105 YMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD--SNCIVKLY 182 (373)
Q Consensus 105 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~l~ 182 (373)
.+.++...+...+|++++.||+|+||.||+|.+. +++.||||++..... .....+.+.+|+.++..+. ||||++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~ 94 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEE
Confidence 3446667778889999999999999999999875 588999999865432 2334567889999999997 59999999
Q ss_pred eEEEeCCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccc
Q 017362 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (373)
Q Consensus 183 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGl 262 (373)
+++.+.+.+|+||| +.+++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++. +.+||+|||+
T Consensus 95 ~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~ 172 (313)
T 3cek_A 95 DYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGI 172 (313)
T ss_dssp EEEECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred EEeecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccc
Confidence 99999999999999 558899999998889999999999999999999999999999999999999964 8999999999
Q ss_pred cccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-----------
Q 017362 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK----------- 331 (373)
Q Consensus 263 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----------- 331 (373)
+.......... .....+||+.|+|||++.+
T Consensus 173 ~~~~~~~~~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 213 (313)
T 3cek_A 173 ANQMQPDTTSV---------------------------------------VKDSQVGTVNYMPPEAIKDMSSSRENGKSK 213 (313)
T ss_dssp SCC-----------------------------------------------------CCGGGCCHHHHTTCC---------
T ss_pred cccccCccccc---------------------------------------cccCCCCCCCcCCHHHHhhccccccccccc
Confidence 97654221100 0113579999999999975
Q ss_pred CCCChhhcHHHHHHHHHHHHhCCCCCCCCC
Q 017362 332 KGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361 (373)
Q Consensus 332 ~~~~~~~DvwSlGvil~ell~G~~Pf~~~~ 361 (373)
..++.++|||||||++|||++|..||....
T Consensus 214 ~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 214 SKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp -CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 478999999999999999999999998653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=309.14 Aligned_cols=202 Identities=25% Similarity=0.370 Sum_probs=165.8
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHh--cCCCceeEEeeEEEeC--
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE--VDSNCIVKLYCSFQDD-- 188 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~l~~~~~~~-- 188 (373)
...++|++.+.||+|+||.||+|.+. +..||||++.... ......|.+++.. ++||||+++++++.+.
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 34578999999999999999999875 8899999986542 1234445555554 4899999999999987
Q ss_pred --CeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCeeecCCCCCEEEcCCCcEEEe
Q 017362 189 --EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH--------HYIHRDIKPDNLLLDKYGHLRLS 258 (373)
Q Consensus 189 --~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------giiHrDikp~NILl~~~~~vkL~ 258 (373)
..+|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 789999999999999999965 4799999999999999999999998 99999999999999999999999
Q ss_pred eccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChh-
Q 017362 259 DFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME- 337 (373)
Q Consensus 259 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~- 337 (373)
|||+|..+........ ......+||+.|+|||++.+..++..
T Consensus 185 Dfg~a~~~~~~~~~~~-------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~ 227 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVD-------------------------------------IPPNTRVGTKRYMPPEVLDESLNRNHF 227 (337)
T ss_dssp CCTTCEECC----------------------------------------------CCSSCSCGGGCCHHHHTTCCCTTCT
T ss_pred eCCCceeecccccccc-------------------------------------CCCCCCccCcceeChhhcccccCCccc
Confidence 9999976543211100 00114579999999999988776654
Q ss_pred -----hcHHHHHHHHHHHHhC----------CCCCCCC
Q 017362 338 -----CDWWSLGAIMYEMLVG----------YPPFYSD 360 (373)
Q Consensus 338 -----~DvwSlGvil~ell~G----------~~Pf~~~ 360 (373)
+|||||||++|||++| ..||...
T Consensus 228 ~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 228 QSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred cCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 9999999999999999 7777653
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=311.92 Aligned_cols=208 Identities=28% Similarity=0.480 Sum_probs=177.3
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEE----EcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEE
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCR----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 186 (373)
..+..++|++++.||+|+||.||+|. +..+++.||||++.... ....+.+.+|+.++..++||||+++++++.
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCY 112 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 34567789999999999999999998 45688999999987542 344567889999999999999999999987
Q ss_pred eCC--eEEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeecccc
Q 017362 187 DDE--FLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (373)
Q Consensus 187 ~~~--~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla 263 (373)
..+ .+|+||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence 644 789999999999999999775 46999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHH
Q 017362 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (373)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSl 343 (373)
........... ......+|+.|+|||++.+..++.++|||||
T Consensus 193 ~~~~~~~~~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 234 (326)
T 2w1i_A 193 KVLPQDKEYYK--------------------------------------VKEPGESPIFWYAPESLTESKFSVASDVWSF 234 (326)
T ss_dssp EECCSSCSEEE--------------------------------------CSSCCSCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred hhccccccccc--------------------------------------cccCCCCceeEECchhhcCCCCCchhhHHHH
Confidence 87643321100 0113457888999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCC
Q 017362 344 GAIMYEMLVGYPPFYS 359 (373)
Q Consensus 344 Gvil~ell~G~~Pf~~ 359 (373)
||++|||++|..||..
T Consensus 235 G~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 235 GVVLYELFTYIEKSKS 250 (326)
T ss_dssp HHHHHHHHHTTCGGGS
T ss_pred HHHHHHHHhcCCCCCC
Confidence 9999999999999864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=314.53 Aligned_cols=225 Identities=20% Similarity=0.291 Sum_probs=183.5
Q ss_pred HhhhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEE
Q 017362 107 RLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (373)
Q Consensus 107 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 186 (373)
.+....+..++|++.+.||+|+||.||+|.+.. .||+|++.... ......+.+.+|+.++..++||||+++++++.
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 99 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIER-DNEDQLKAFKREVMAYRQTRHENVVLFMGACM 99 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCS-CCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCC-CCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence 356677889999999999999999999998753 59999987542 12223345677999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 187 DDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 187 ~~~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
+.+.+|+||||++|++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++ ++.+||+|||++..
T Consensus 100 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 100 SPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp CSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred cCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 9999999999999999999997654 699999999999999999999999999999999999998 68999999999875
Q ss_pred CCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC---------CCCCh
Q 017362 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---------KGYGM 336 (373)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---------~~~~~ 336 (373)
........ .........||+.|+|||++.. ..++.
T Consensus 179 ~~~~~~~~------------------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~ 222 (319)
T 2y4i_B 179 SGVLQAGR------------------------------------REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSK 222 (319)
T ss_dssp ---------------------------------------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCH
T ss_pred cccccccc------------------------------------cccccccCCCcccccChHHhhhccccccccccCCCc
Confidence 43211000 0001113569999999999975 45799
Q ss_pred hhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcC
Q 017362 337 ECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 337 ~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
++|||||||++|||++|..||.+.+.......+..+
T Consensus 223 ~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 258 (319)
T 2y4i_B 223 HSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG 258 (319)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC
Confidence 999999999999999999999999888887776543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=305.07 Aligned_cols=206 Identities=31% Similarity=0.518 Sum_probs=164.1
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe--------
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD-------- 187 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-------- 187 (373)
++|++++.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.++..++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 5799999999999999999999999999999998653 2344668899999999999999999998865
Q ss_pred -----CCeEEEEEeccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeecc
Q 017362 188 -----DEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFG 261 (373)
Q Consensus 188 -----~~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFG 261 (373)
...+|+||||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 356899999999999999997544 68899999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcH
Q 017362 262 LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDW 340 (373)
Q Consensus 262 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~Dv 340 (373)
++............. . ...+ ..........||+.|+|||++.+. .++.++||
T Consensus 162 ~~~~~~~~~~~~~~~---------~--~~~~----------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 214 (303)
T 1zy4_A 162 LAKNVHRSLDILKLD---------S--QNLP----------------GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDM 214 (303)
T ss_dssp CCSCTTC----------------------------------------------------CTTSCHHHHTSCSCCCTHHHH
T ss_pred chhhcccccchhccc---------c--cccc----------------ccccccccCCCcccccCcccccCCCCCcchhhH
Confidence 998654321100000 0 0000 000011246799999999999865 68999999
Q ss_pred HHHHHHHHHHHh
Q 017362 341 WSLGAIMYEMLV 352 (373)
Q Consensus 341 wSlGvil~ell~ 352 (373)
|||||++|||++
T Consensus 215 ~slG~il~~l~~ 226 (303)
T 1zy4_A 215 YSLGIIFFEMIY 226 (303)
T ss_dssp HHHHHHHHHHHS
T ss_pred HHHHHHHHHHHh
Confidence 999999999998
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=311.55 Aligned_cols=205 Identities=29% Similarity=0.477 Sum_probs=168.2
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhh---hhHHHHHHHHHHHHhc----CCCceeEEeeE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR---GQVEHVRAERNLLAEV----DSNCIVKLYCS 184 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~l----~h~~iv~l~~~ 184 (373)
+...++|++.+.||+|+||.||+|.+..+++.||||++........ .....+..|+.++..+ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 3446789999999999999999999999999999999976532211 1223355688888888 89999999999
Q ss_pred EEeCCeEEEEEec-cCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEc-CCCcEEEeeccc
Q 017362 185 FQDDEFLYLIMEY-LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD-KYGHLRLSDFGL 262 (373)
Q Consensus 185 ~~~~~~~~lV~E~-~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~-~~~~vkL~DFGl 262 (373)
+.+.+..|+|||| +++++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 9999999999999 78999999998888899999999999999999999999999999999999999 889999999999
Q ss_pred cccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCC-ChhhcHH
Q 017362 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWW 341 (373)
Q Consensus 263 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~Dvw 341 (373)
+........ ....||+.|+|||++.+..+ +.++|||
T Consensus 187 ~~~~~~~~~-------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~ 223 (312)
T 2iwi_A 187 GALLHDEPY-------------------------------------------TDFDGTRVYSPPEWISRHQYHALPATVW 223 (312)
T ss_dssp CEECCSSCB-------------------------------------------CCCCSCTTTSCHHHHHHSCBCHHHHHHH
T ss_pred hhhcccCcc-------------------------------------------cccCCcccccCceeeecCCCCCccchHH
Confidence 986543211 14569999999999987776 4589999
Q ss_pred HHHHHHHHHHhCCCCCCC
Q 017362 342 SLGAIMYEMLVGYPPFYS 359 (373)
Q Consensus 342 SlGvil~ell~G~~Pf~~ 359 (373)
||||++|||++|+.||..
T Consensus 224 slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 224 SLGILLYDMVCGDIPFER 241 (312)
T ss_dssp HHHHHHHHHHHSSCSCCS
T ss_pred HHHHHHHHHHHCCCCCCC
Confidence 999999999999999964
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=322.33 Aligned_cols=197 Identities=17% Similarity=0.233 Sum_probs=164.3
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhh-----hhhhHHHHHHHHHHHHhcC---------CCce
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML-----RRGQVEHVRAERNLLAEVD---------SNCI 178 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~---------h~~i 178 (373)
+..++|++++.||+|+||+||+|.+ +|+.||||++...... .....+.+.+|+.+++.++ ||||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 3457799999999999999999987 6899999999765321 1223466888999988885 7777
Q ss_pred eEEeeEEE-----------------e-------------CCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHH
Q 017362 179 VKLYCSFQ-----------------D-------------DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228 (373)
Q Consensus 179 v~l~~~~~-----------------~-------------~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~a 228 (373)
+.+.+.+. + ...+|+||||+++|++.+.+.+ ..+++..++.++.||+.|
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence 76666543 2 6789999999999977777644 678999999999999999
Q ss_pred HHHHH-hCCCeeecCCCCCEEEcCCC--------------------cEEEeeccccccCCCCCcccccccccCCCCCCCC
Q 017362 229 IESIH-KHHYIHRDIKPDNLLLDKYG--------------------HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287 (373)
Q Consensus 229 L~~LH-~~giiHrDikp~NILl~~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~ 287 (373)
|.||| ++|||||||||+|||++.++ .+||+|||+|+.....
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------------------ 235 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------------------ 235 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------------------
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------------------
Confidence 99999 99999999999999999987 9999999999865321
Q ss_pred CCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHH-HHHHHhCCCCCCC
Q 017362 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI-MYEMLVGYPPFYS 359 (373)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvi-l~ell~G~~Pf~~ 359 (373)
..+||+.|+|||++.+.. +.++||||||++ .++++.|.+||.+
T Consensus 236 ----------------------------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 236 ----------------------------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp ----------------------------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred ----------------------------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 357999999999998766 999999998777 7888899999954
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=305.85 Aligned_cols=200 Identities=28% Similarity=0.390 Sum_probs=169.6
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHh--cCCCceeEEeeEEEeCC---
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE--VDSNCIVKLYCSFQDDE--- 189 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~l~~~~~~~~--- 189 (373)
.++|.+.+.||+|+||.||+|.+ +++.||||++.... ...+..|..++.. ++||||+++++++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 46799999999999999999987 48899999986542 2446678888877 78999999999998876
Q ss_pred -eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCeeecCCCCCEEEcCCCcEEEeec
Q 017362 190 -FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH--------KHHYIHRDIKPDNLLLDKYGHLRLSDF 260 (373)
Q Consensus 190 -~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~giiHrDikp~NILl~~~~~vkL~DF 260 (373)
.+|+||||+++|+|.+++.. ..+++..+..++.|++.||.||| +.||+||||||+|||++.++++||+||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred ceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 79999999999999999965 46999999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC------CC
Q 017362 261 GLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK------GY 334 (373)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~------~~ 334 (373)
|++........... .......||+.|+|||++.+. .+
T Consensus 192 g~~~~~~~~~~~~~-------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 234 (342)
T 1b6c_B 192 GLAVRHDSATDTID-------------------------------------IAPNHRVGTKRYMAPEVLDDSINMKHFES 234 (342)
T ss_dssp TTCEEEETTTTEEE-------------------------------------ECCCSCCCCGGGCCHHHHTSCCCTTCHHH
T ss_pred CCceeccccccccc-------------------------------------cccccCCcCcccCCHhhhccccccccccc
Confidence 99976543221100 001145799999999999875 34
Q ss_pred ChhhcHHHHHHHHHHHHhC----------CCCCCCC
Q 017362 335 GMECDWWSLGAIMYEMLVG----------YPPFYSD 360 (373)
Q Consensus 335 ~~~~DvwSlGvil~ell~G----------~~Pf~~~ 360 (373)
+.++|||||||++|||++| ..||...
T Consensus 235 ~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 235 FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp HHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 4789999999999999999 7899765
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=337.52 Aligned_cols=198 Identities=24% Similarity=0.390 Sum_probs=169.9
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcC-CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKT-TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 189 (373)
..+..++|++.+.||+|+||+||+|.+.. +++.||||++.... .......+.+|+.++..++||||+++++++.+.+
T Consensus 75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 152 (681)
T 2pzi_A 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD 152 (681)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence 34556899999999999999999999975 78999999986532 2334456888999999999999999999998766
Q ss_pred e-----EEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccc
Q 017362 190 F-----LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (373)
Q Consensus 190 ~-----~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~ 264 (373)
. .|+||||++|++|.+++.. .+++..+..++.||+.||.|||++|||||||||+|||++.+ .+||+|||+++
T Consensus 153 ~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 153 RHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp TTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccch
Confidence 5 7999999999999988754 79999999999999999999999999999999999999985 99999999997
Q ss_pred cCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHH
Q 017362 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344 (373)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG 344 (373)
..... ...+||+.|+|||++.+. ++.++||||||
T Consensus 230 ~~~~~---------------------------------------------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG 263 (681)
T 2pzi_A 230 RINSF---------------------------------------------GYLYGTPGFQAPEIVRTG-PTVATDIYTVG 263 (681)
T ss_dssp ETTCC---------------------------------------------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHH
T ss_pred hcccC---------------------------------------------CccCCCccccCHHHHcCC-CCCceehhhhH
Confidence 65322 145799999999998654 59999999999
Q ss_pred HHHHHHHhCCCCCCC
Q 017362 345 AIMYEMLVGYPPFYS 359 (373)
Q Consensus 345 vil~ell~G~~Pf~~ 359 (373)
|++|+|++|.+||.+
T Consensus 264 ~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 264 RTLAALTLDLPTRNG 278 (681)
T ss_dssp HHHHHHHSCCCEETT
T ss_pred HHHHHHHhCCCCCcc
Confidence 999999999999875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=297.28 Aligned_cols=180 Identities=13% Similarity=0.128 Sum_probs=160.0
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 192 (373)
+..++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|..++..++||||+++++++.+.+..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 55688999999999999999999999999999999998764433445577889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcc
Q 017362 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 272 (373)
+||||++|++|.+++.. + .....+..++.|++.||.|||++||+||||||+|||++.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 99999999999999844 3 4666788899999999999999999999999999999999999997544
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 352 (373)
|++| ++.++|||||||++|||++
T Consensus 175 --------------------------------------------------~~~~-------~~~~~Di~slG~il~ellt 197 (286)
T 3uqc_A 175 --------------------------------------------------TMPD-------ANPQDDIRGIGASLYALLV 197 (286)
T ss_dssp --------------------------------------------------CCTT-------CCHHHHHHHHHHHHHHHHH
T ss_pred --------------------------------------------------ccCC-------CCchhHHHHHHHHHHHHHH
Confidence 3333 7899999999999999999
Q ss_pred CCCCCCCCCh
Q 017362 353 GYPPFYSDDP 362 (373)
Q Consensus 353 G~~Pf~~~~~ 362 (373)
|++||.+.+.
T Consensus 198 g~~Pf~~~~~ 207 (286)
T 3uqc_A 198 NRWPLPEAGV 207 (286)
T ss_dssp SEECSCCCSB
T ss_pred CCCCCCcCCc
Confidence 9999987665
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=315.62 Aligned_cols=204 Identities=27% Similarity=0.423 Sum_probs=158.9
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCeEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYL 193 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~l 193 (373)
.+.|.+.+.||+|+||+||.+ ...+|+.||||++.... .+.+.+|+.++..+ +||||+++++++.+.+.+|+
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~l 86 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 86 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred hheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEE
Confidence 344556788999999999875 45679999999986532 23467899999876 89999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCC-------HHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCC-------------C
Q 017362 194 IMEYLPGGDMMTLLMRKDTLT-------EDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY-------------G 253 (373)
Q Consensus 194 V~E~~~gg~L~~~l~~~~~l~-------~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~-------------~ 253 (373)
||||++ |+|.+++....... +..+..++.||+.||.|||++||+||||||+|||++.+ +
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence 999995 69999997654332 33456799999999999999999999999999999754 4
Q ss_pred cEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC--
Q 017362 254 HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-- 331 (373)
Q Consensus 254 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-- 331 (373)
++||+|||+|+......... .......+||+.|+|||++.+
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~-------------------------------------~~~~~~~~gt~~y~aPE~~~~~~ 208 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSF-------------------------------------RTNLNNPSGTSGWRAPELLEESN 208 (434)
T ss_dssp EEEECCCTTCEECCC---------------------------------------------------CCTTSCHHHHSCCC
T ss_pred EEEEcccccceecCCCCccc-------------------------------------eeeecCCCCCCCccCHHHhcccc
Confidence 89999999998764321100 000114579999999999976
Q ss_pred -----CCCChhhcHHHHHHHHHHHHh-CCCCCCCCChH
Q 017362 332 -----KGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPM 363 (373)
Q Consensus 332 -----~~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~ 363 (373)
..++.++|||||||++|||++ |.+||.+....
T Consensus 209 ~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 209 NLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp TTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred ccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 668999999999999999999 99999765443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=331.22 Aligned_cols=204 Identities=28% Similarity=0.501 Sum_probs=176.2
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe------C
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD------D 188 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~------~ 188 (373)
.++|++.+.||+|+||+||+|.+..+|..||||++.... .....+.+.+|+.++..++||||+++++++.+ .
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 478999999999999999999999999999999987542 23445678899999999999999999998765 6
Q ss_pred CeEEEEEeccCCCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCc---EEEeeccc
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRKD---TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH---LRLSDFGL 262 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~---vkL~DFGl 262 (373)
+..|+||||++||+|.+++.... .+++..+..++.+++.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 77899999999999999997644 6999999999999999999999999999999999999997765 99999999
Q ss_pred cccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHH
Q 017362 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342 (373)
Q Consensus 263 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwS 342 (373)
+........ ....+||+.|+|||++.+..++.++||||
T Consensus 171 a~~~~~~~~------------------------------------------~~~~~gt~~Y~APE~l~~~~~s~ksDIwS 208 (676)
T 3qa8_A 171 AKELDQGEL------------------------------------------CTEFVGTLQYLAPELLEQKKYTVTVDYWS 208 (676)
T ss_dssp CCBTTSCCC------------------------------------------CCCCCSCCTTCSSCSSCCSCCSTTHHHHH
T ss_pred ccccccccc------------------------------------------cccccCCcccCChHHhccCCCCchhHHHH
Confidence 986543211 11457999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCh
Q 017362 343 LGAIMYEMLVGYPPFYSDDP 362 (373)
Q Consensus 343 lGvil~ell~G~~Pf~~~~~ 362 (373)
|||++|+|++|.+||.+...
T Consensus 209 LGviLyeLltG~~Pf~~~~~ 228 (676)
T 3qa8_A 209 FGTLAFECITGFRPFLPNWQ 228 (676)
T ss_dssp HHHHHHHHHSSCSSCCSSCH
T ss_pred HHHHHHHHHHCCCCCCcccc
Confidence 99999999999999987543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=314.88 Aligned_cols=208 Identities=25% Similarity=0.399 Sum_probs=165.1
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCC
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~ 189 (373)
..+...+|.+.+.||+|+||+|+. ....+++.||||++..... ..+.+|+.++..+ +|||||++++++.+..
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 91 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQ 91 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETT
T ss_pred EEEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 445567899999999999999764 4457789999999865421 2255799999998 7999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC-----CCcEEEeecccc
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-----YGHLRLSDFGLC 263 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~-----~~~vkL~DFGla 263 (373)
.+|+||||++ |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. ...+||+|||+|
T Consensus 92 ~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 92 FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9999999995 69999997654 4666677899999999999999999999999999999953 236889999999
Q ss_pred ccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc---CCCCChhhcH
Q 017362 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDW 340 (373)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~Dv 340 (373)
+.+....... ......+||+.|+|||++. ...++.++||
T Consensus 171 ~~~~~~~~~~--------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~t~~~Di 212 (432)
T 3p23_A 171 KKLAVGRHSF--------------------------------------SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDI 212 (432)
T ss_dssp ECC--------------------------------------------------CCSCTTSCCGGGTSCC---CCCTHHHH
T ss_pred eeccCCCcce--------------------------------------eeccccCCCcCccChhhhhcccccCCCcHHHH
Confidence 8664321100 0012467999999999998 4667889999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHH
Q 017362 341 WSLGAIMYEMLV-GYPPFYSDDPMS 364 (373)
Q Consensus 341 wSlGvil~ell~-G~~Pf~~~~~~~ 364 (373)
|||||++|||++ |.+||.......
T Consensus 213 wSlG~il~ellt~g~~pf~~~~~~~ 237 (432)
T 3p23_A 213 FSAGCVFYYVISEGSHPFGKSLQRQ 237 (432)
T ss_dssp HHHHHHHHHHHTTSCBTTBSTTTHH
T ss_pred HHHHHHHHHHHcCCCCCcchhhHHH
Confidence 999999999999 999997654443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=314.06 Aligned_cols=212 Identities=16% Similarity=0.191 Sum_probs=164.7
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCC-Cce--------------
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS-NCI-------------- 178 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i-------------- 178 (373)
....|...+.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.++..+.| ++.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 34568889999999999999999999999999999874433333345678889999988876 211
Q ss_pred -------eEEeeEEEe-----CCeEEEEEeccCCCCHHHHHhh-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 017362 179 -------VKLYCSFQD-----DEFLYLIMEYLPGGDMMTLLMR-------KDTLTEDEARFYVAETVLAIESIHKHHYIH 239 (373)
Q Consensus 179 -------v~l~~~~~~-----~~~~~lV~E~~~gg~L~~~l~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~giiH 239 (373)
..+...+.. ...++++|+++ +++|.+++.. ...+++..+..++.||+.||.|||++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 111111121 22467888876 7899998841 335788899999999999999999999999
Q ss_pred ecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhcccccccc
Q 017362 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVG 319 (373)
Q Consensus 240 rDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 319 (373)
|||||+|||++.++.+||+|||+++..... ....+|
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~--------------------------------------------~~~~~g 270 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--------------------------------------------AVSPIG 270 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEE--------------------------------------------ECCCCC
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCc--------------------------------------------cccCCC
Confidence 999999999999999999999998754321 114578
Q ss_pred CCCCcccccc----------cCCCCChhhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 017362 320 TPDYIAPEVL----------LKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 320 t~~Y~aPE~~----------~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
+.|+|||++ ....|+.++|||||||++|||++|++||.+.+..+....+..
T Consensus 271 -~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~ 331 (413)
T 3dzo_A 271 -RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFR 331 (413)
T ss_dssp -TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGS
T ss_pred -CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHh
Confidence 999999999 566689999999999999999999999998877666555543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=290.52 Aligned_cols=179 Identities=34% Similarity=0.618 Sum_probs=154.1
Q ss_pred CCCccee-ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHH-HhcCCCceeEEeeEEEe----C
Q 017362 115 ADDFELL-TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL-AEVDSNCIVKLYCSFQD----D 188 (373)
Q Consensus 115 ~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~l~~~~~~----~ 188 (373)
.++|.++ +.||+|+||.||+|.+..+++.||||++... ..+.+|+.++ ...+||||+++++++.+ .
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 4678887 7899999999999999999999999998643 2356677777 66699999999999987 6
Q ss_pred CeEEEEEeccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC---CCcEEEeecccc
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---YGHLRLSDFGLC 263 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~---~~~vkL~DFGla 263 (373)
..+|+||||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 78999999999999999998754 6999999999999999999999999999999999999998 789999999988
Q ss_pred ccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHH
Q 017362 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (373)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSl 343 (373)
.... +..|+.++|||||
T Consensus 168 ~~~~---------------------------------------------------------------~~~~~~~~Diwsl 184 (299)
T 3m2w_A 168 KETT---------------------------------------------------------------GEKYDKSCDMWSL 184 (299)
T ss_dssp EECT---------------------------------------------------------------TCGGGGHHHHHHH
T ss_pred cccc---------------------------------------------------------------cccCCchhhHHHH
Confidence 5321 2447889999999
Q ss_pred HHHHHHHHhCCCCCCCCChHH
Q 017362 344 GAIMYEMLVGYPPFYSDDPMS 364 (373)
Q Consensus 344 Gvil~ell~G~~Pf~~~~~~~ 364 (373)
||++|||++|.+||.+.+...
T Consensus 185 G~il~el~tg~~pf~~~~~~~ 205 (299)
T 3m2w_A 185 GVIMYILLCGYPPFYSNHGLA 205 (299)
T ss_dssp HHHHHHHHHSSCSCCC-----
T ss_pred HHHHHHHHHCCCCCCCCcchh
Confidence 999999999999998765443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=312.54 Aligned_cols=189 Identities=16% Similarity=0.178 Sum_probs=135.7
Q ss_pred eeeeCcEEEEEEEEcCCCceEeeeecchhHh-------hhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCCeEEEEE
Q 017362 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEM-------LRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 124 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++.|++|.+..++....|+.||+|++.+... ......+.+.+|+++|+++ .|+||+++++++.++..+||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4567777777766667799999999965421 1233446789999999999 7999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
||++|++|.++|...+++++. .|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.......
T Consensus 322 Eyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~---- 394 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS---- 394 (569)
T ss_dssp ECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C----
T ss_pred ecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc----
Confidence 999999999999988888875 4789999999999999999999999999999999999999999986542211
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 355 (373)
...+.+||+.|||||++.+ .+..++|+||+|+++++|++|..
T Consensus 395 -------------------------------------~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 395 -------------------------------------WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp -------------------------------------CSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred -------------------------------------cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 1125689999999999865 46788999999999887766554
Q ss_pred CC
Q 017362 356 PF 357 (373)
Q Consensus 356 Pf 357 (373)
||
T Consensus 437 ~~ 438 (569)
T 4azs_A 437 NW 438 (569)
T ss_dssp HH
T ss_pred hh
Confidence 43
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=268.14 Aligned_cols=192 Identities=19% Similarity=0.204 Sum_probs=148.8
Q ss_pred eceeeeeCcEEEEEEEEcCCCceEeeeecchhH-----hhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSE-----MLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
.+.||+|+||+||+|. ..+..+++|...... .......+.+.+|+.++..++||||+.+..++.+.+..|+||
T Consensus 341 ~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 341 EHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp -------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 4689999999999994 457788998754321 122233466899999999999999996666666777889999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
||++|++|.+++.. +..++.|++.||.|||++||+||||||+|||++. ++||+|||+|+.........
T Consensus 419 E~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~-- 486 (540)
T 3en9_A 419 SYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA-- 486 (540)
T ss_dssp ECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH--
T ss_pred ECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc--
Confidence 99999999999865 6689999999999999999999999999999998 99999999998764321100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC--CCCChhhcHHHHHHHHHHHHhC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G 353 (373)
.+...+..+.+||+.|||||++.. .+|+..+|+||..+-..+.+.+
T Consensus 487 --------------------------------~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~ 534 (540)
T 3en9_A 487 --------------------------------VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVER 534 (540)
T ss_dssp --------------------------------HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHT
T ss_pred --------------------------------cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHh
Confidence 000011225689999999999987 7789999999999999999988
Q ss_pred CCCCC
Q 017362 354 YPPFY 358 (373)
Q Consensus 354 ~~Pf~ 358 (373)
+.+|.
T Consensus 535 r~rY~ 539 (540)
T 3en9_A 535 RARYV 539 (540)
T ss_dssp CSCCC
T ss_pred ccccC
Confidence 88874
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=226.54 Aligned_cols=135 Identities=13% Similarity=0.115 Sum_probs=108.8
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhh---------------hhHHHHHHHHHHHHhcCCCceeEE
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR---------------GQVEHVRAERNLLAEVDSNCIVKL 181 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---------------~~~~~~~~e~~~l~~l~h~~iv~l 181 (373)
.|.+.+.||+|+||.||+|.+ .+|+.||||++........ .....+.+|+.++..+. | +++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 344559999999999999999 8899999999865321111 23456889999999998 4 556
Q ss_pred eeEEEeCCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeecc
Q 017362 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFG 261 (373)
Q Consensus 182 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFG 261 (373)
.+.+.. +..|+||||++||+|.+ +.. .....++.|++.||.|||++||+||||||+|||++ +|++||+|||
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence 555544 45689999999999988 421 23557999999999999999999999999999999 9999999999
Q ss_pred ccc
Q 017362 262 LCK 264 (373)
Q Consensus 262 la~ 264 (373)
+|+
T Consensus 238 ~a~ 240 (282)
T 1zar_A 238 QSV 240 (282)
T ss_dssp TCE
T ss_pred CCe
Confidence 885
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-23 Score=190.59 Aligned_cols=142 Identities=15% Similarity=0.133 Sum_probs=109.8
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCce--EeeeecchhHhhh---------------------hhhHHHHHHHHHHHHhc
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHV--YAMKKLKKSEMLR---------------------RGQVEHVRAERNLLAEV 173 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~--vaiK~~~~~~~~~---------------------~~~~~~~~~e~~~l~~l 173 (373)
-|++.+.||+|+||.||+|.+..+|.. ||||+++...... ......+.+|+.++..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478899999999999999998778888 9999875432110 01123578899999999
Q ss_pred CCCce--eEEeeEEEeCCeEEEEEeccCC-C----CHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHH-hCCCeeecCCCC
Q 017362 174 DSNCI--VKLYCSFQDDEFLYLIMEYLPG-G----DMMTLLMRKDTLTEDEARFYVAETVLAIESIH-KHHYIHRDIKPD 245 (373)
Q Consensus 174 ~h~~i--v~l~~~~~~~~~~~lV~E~~~g-g----~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH-~~giiHrDikp~ 245 (373)
.|+++ +.++.. ...||||||+++ | +|.++... +++..+..++.|++.||.||| ++|||||||||+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 88754 333432 246799999942 3 67666432 335578899999999999999 999999999999
Q ss_pred CEEEcCCCcEEEeeccccccCC
Q 017362 246 NLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 246 NILl~~~~~vkL~DFGla~~~~ 267 (373)
|||++. .++|+|||+|....
T Consensus 201 NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 201 NIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp SEEESS--SEEECCCTTCEETT
T ss_pred HEEEcC--cEEEEECcccccCC
Confidence 999998 99999999997654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.80 E-value=9.1e-21 Score=180.47 Aligned_cols=142 Identities=15% Similarity=0.133 Sum_probs=100.5
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhh-----------hhhhH--------HHHHHHHHHHHhcCCCc
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML-----------RRGQV--------EHVRAERNLLAEVDSNC 177 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~--------~~~~~e~~~l~~l~h~~ 177 (373)
-|.+...||.|+||.||+|.+ .+|+.||||+++..... ..... -....|...|..+.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 389999999999999999987 46899999987542110 00000 11234566666664444
Q ss_pred eeEEeeEEEeCCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC----
Q 017362 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---- 253 (373)
Q Consensus 178 iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~---- 253 (373)
+....-+... ..+|||||++|++|..+.. .+.+..++.|++.+|.+||++|||||||||.|||++.+|
T Consensus 175 v~vp~p~~~~--~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 175 FPVPEPIAQS--RHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp CSCCCEEEEE--TTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred CCCCeeeecc--CceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence 3221111112 2369999999988865432 234567889999999999999999999999999998877
Q ss_pred ------cEEEeeccccccCC
Q 017362 254 ------HLRLSDFGLCKPLD 267 (373)
Q Consensus 254 ------~vkL~DFGla~~~~ 267 (373)
.+.|+||+-+-...
T Consensus 247 ~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 247 PSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp TTSEEEEEEECCCTTCEETT
T ss_pred ccccccceEEEEeCCcccCC
Confidence 48999999876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=7.5e-14 Score=126.47 Aligned_cols=140 Identities=13% Similarity=0.092 Sum_probs=110.9
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-CCceeEEeeEEEeCCeEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~lV 194 (373)
..|.+...+|.|+.+.||++... +..+++|+...... .....+.+|..++..+. +..++++++++.+.+..|+|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~---~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC---CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 46888899999999999998643 67899999875321 11234778999988884 67788899999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK---------------------------------------- 234 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---------------------------------------- 234 (373)
|||++|.+|.+.+. +......++.+++.+|..||+
T Consensus 89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999999877631 222345678899999999998
Q ss_pred -------------------CCCeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 235 -------------------HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 235 -------------------~giiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
..++|+|++|.|||++.++.+.|+||+.+..
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4589999999999998765667999998864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.36 E-value=1.7e-12 Score=116.79 Aligned_cols=136 Identities=13% Similarity=0.088 Sum_probs=99.2
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCc--eeEEeeEEEeCCeEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC--IVKLYCSFQDDEFLY 192 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~l~~~~~~~~~~~ 192 (373)
..+|.+....+.|..+.||++.. .+|..+++|+.... ....+..|..++..+.+.+ +++++.++.+++..|
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~ 91 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW 91 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence 34566655545666799999854 55678999987543 1133667888888875433 566888888878899
Q ss_pred EEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 017362 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH------------------------------------ 236 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g------------------------------------ 236 (373)
+||||++|.+|. . ...+ ...++.+++..|..||+..
T Consensus 92 ~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 92 LLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp EEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999999998883 2 1122 2356677777788888643
Q ss_pred ----------------------CeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 237 ----------------------YIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 237 ----------------------iiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
++|+|++|+|||++.++.+.|+|||.|..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998766677999999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.29 E-value=8.8e-12 Score=118.19 Aligned_cols=143 Identities=19% Similarity=0.256 Sum_probs=106.5
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCceEeeeecc--hhHhhhhhhHHHHHHHHHHHHhcC--CCceeEEeeEEEeC---Ce
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK--KSEMLRRGQVEHVRAERNLLAEVD--SNCIVKLYCSFQDD---EF 190 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~l~~~~~~~---~~ 190 (373)
...++.|+.|.++.||++... +..+++|+.. ..... .....+.+|..++..+. +..+++++..+.+. +.
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~ 115 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR 115 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence 345678899999999998753 4678889876 33211 12235777999998886 35578888888776 44
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 017362 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK------------------------------------ 234 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~------------------------------------ 234 (373)
.|+||||++|..+.+.. ...++......++.+++..|..||+
T Consensus 116 ~~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 116 AFYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp CEEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred eEEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 78999999998775421 2347788889999999999999997
Q ss_pred ----------------------CCCeeecCCCCCEEEcCCCc--EEEeeccccccC
Q 017362 235 ----------------------HHYIHRDIKPDNLLLDKYGH--LRLSDFGLCKPL 266 (373)
Q Consensus 235 ----------------------~giiHrDikp~NILl~~~~~--vkL~DFGla~~~ 266 (373)
..++|+|++|+|||++.++. +.|+||+.|...
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 35899999999999997753 689999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.27 E-value=3.8e-12 Score=117.93 Aligned_cols=135 Identities=19% Similarity=0.229 Sum_probs=98.7
Q ss_pred eceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCc--eeEEeeEEEeCC---eEEEE
Q 017362 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNC--IVKLYCSFQDDE---FLYLI 194 (373)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~--iv~l~~~~~~~~---~~~lV 194 (373)
++.++.|.+..||++. ..+++|+.... .....+.+|..++..+ .+.. ++..+....+.. ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4568999999999753 46888986533 2235578899998877 3322 444444433333 34799
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK---------------------------------------- 234 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---------------------------------------- 234 (373)
|++++|.+|..... ..++......++.+++..|..||+
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999988875433 347788888888888888888886
Q ss_pred ------------------CCCeeecCCCCCEEEcC--CCcEEEeeccccccCC
Q 017362 235 ------------------HHYIHRDIKPDNLLLDK--YGHLRLSDFGLCKPLD 267 (373)
Q Consensus 235 ------------------~giiHrDikp~NILl~~--~~~vkL~DFGla~~~~ 267 (373)
..++|+|++|+|||++. .+.+.|+||+.+...+
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~ 225 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISD 225 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEEC
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCC
Confidence 13699999999999998 4567899999987543
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.83 E-value=8.1e-08 Score=88.85 Aligned_cols=136 Identities=16% Similarity=0.154 Sum_probs=94.4
Q ss_pred eeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCC---ceeEEeeEEE-eCCeEEEEE
Q 017362 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN---CIVKLYCSFQ-DDEFLYLIM 195 (373)
Q Consensus 120 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~l~~~~~-~~~~~~lV~ 195 (373)
-+..++.|....||+. +..+++|+.... .....+..|..+|..+.+. .++..+.+.. ..+..|+||
T Consensus 23 ~v~~l~~G~~n~v~~v-----g~~~VlR~~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~ 92 (306)
T 3tdw_A 23 SVESLGEGFRNYAILV-----NGDWVFRFPKSQ-----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGY 92 (306)
T ss_dssp CEEEEEECSSEEEEEE-----TTTEEEEEESSH-----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEE
T ss_pred eeeecCCCcceeEEEE-----CCEEEEEecCCc-----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEE
Confidence 3556888999999987 467888885322 2345688899999988642 3566666654 445678999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH---------------------------------------- 235 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---------------------------------------- 235 (373)
|+++|..+..... ..++......++.++...|..||+.
T Consensus 93 e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 93 RKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp ECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred eccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 9999988876321 2244555555555555555555532
Q ss_pred --------------------CCeeecCCCCCEEEcC---CCc-EEEeeccccccCC
Q 017362 236 --------------------HYIHRDIKPDNLLLDK---YGH-LRLSDFGLCKPLD 267 (373)
Q Consensus 236 --------------------giiHrDikp~NILl~~---~~~-vkL~DFGla~~~~ 267 (373)
.++|+|++|.|||++. ++. +.|+||+.+...+
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 3599999999999987 455 4899999887544
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.79 E-value=7.6e-08 Score=86.98 Aligned_cols=133 Identities=18% Similarity=0.150 Sum_probs=93.3
Q ss_pred eeeeCcE-EEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-CCceeEEeeEEEeCCeEEEEEeccCCC
Q 017362 124 IGKGAFG-EVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYLIMEYLPGG 201 (373)
Q Consensus 124 lG~G~~g-~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~lV~E~~~gg 201 (373)
+..|..| .||+......+..+.+|+-... ....+.+|..+|..+. +--+++++.++.+.+..|+|||+++|.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 4445554 6898777667778999986543 2344677888887773 334778888899999999999999998
Q ss_pred CHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------------
Q 017362 202 DMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH---------------------------------------------- 235 (373)
Q Consensus 202 ~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---------------------------------------------- 235 (373)
++.+..... ......+..++...|..||..
T Consensus 106 ~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 106 TAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp EHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 877654321 112233444555555555521
Q ss_pred ------------CCeeecCCCCCEEEcCCCcEEEeeccccccC
Q 017362 236 ------------HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (373)
Q Consensus 236 ------------giiHrDikp~NILl~~~~~vkL~DFGla~~~ 266 (373)
.++|+|+.|.|||++.++.+-|+||+.+...
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 2689999999999998777779999998643
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.57 E-value=1.1e-07 Score=91.25 Aligned_cols=80 Identities=18% Similarity=0.196 Sum_probs=49.6
Q ss_pred eeceeeeeCcEEEEEEEEcCCCceEeeeecchhHh-hh---hhhHHHHHHHHHHHHhcCC--C-ceeEEeeEEEeCCeEE
Q 017362 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM-LR---RGQVEHVRAERNLLAEVDS--N-CIVKLYCSFQDDEFLY 192 (373)
Q Consensus 120 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~---~~~~~~~~~e~~~l~~l~h--~-~iv~l~~~~~~~~~~~ 192 (373)
.++.||.|.++.||++....++..++||....... .. ......+..|..++..+.. | .++.++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 45689999999999997655677899997653211 00 1123446678888877632 3 34455543 445567
Q ss_pred EEEeccCCC
Q 017362 193 LIMEYLPGG 201 (373)
Q Consensus 193 lV~E~~~gg 201 (373)
+|||+++|.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.39 E-value=2.8e-06 Score=79.10 Aligned_cols=32 Identities=19% Similarity=0.204 Sum_probs=28.7
Q ss_pred CCCeeecCCCCCEEEcCCCcEEEeeccccccC
Q 017362 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (373)
Q Consensus 235 ~giiHrDikp~NILl~~~~~vkL~DFGla~~~ 266 (373)
.+++|+|++|.|||++.++.+.|+||+.|...
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g 253 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSFD 253 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEEC
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcccC
Confidence 57999999999999988889999999988643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=9.9e-07 Score=83.03 Aligned_cols=86 Identities=8% Similarity=0.048 Sum_probs=53.6
Q ss_pred ceecee-eeeCcEEEEEEEEc--C----CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCC---CceeEEeeEEEeC
Q 017362 119 ELLTMI-GKGAFGEVRVCREK--T----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS---NCIVKLYCSFQDD 188 (373)
Q Consensus 119 ~~~~~l-G~G~~g~Vy~~~~~--~----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~l~~~~~~~ 188 (373)
...+.| +.|....+|++... . ++..+++|+..............+..|..++..+.. ..+++++.++.+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345677 88889999987643 0 156788998654320000001235667777776632 3567777776655
Q ss_pred ---CeEEEEEeccCCCCHH
Q 017362 189 ---EFLYLIMEYLPGGDMM 204 (373)
Q Consensus 189 ---~~~~lV~E~~~gg~L~ 204 (373)
+..|+||||++|..+.
T Consensus 103 ~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTTSSCEEEEECCCCBCCC
T ss_pred CccCCceEEEEecCCCChh
Confidence 3468999999986653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.16 E-value=6.9e-06 Score=79.24 Aligned_cols=34 Identities=12% Similarity=0.151 Sum_probs=29.1
Q ss_pred HhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 233 H~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
+...++|+|++|+|||++.++ +.|+||+.+..-+
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~ 263 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP 263 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEEC
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCc
Confidence 356799999999999999876 9999999987543
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.92 E-value=0.0001 Score=68.10 Aligned_cols=77 Identities=18% Similarity=0.160 Sum_probs=58.7
Q ss_pred ceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC---CCceeEEeeEEEeCCeEEEEE
Q 017362 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD---SNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 119 ~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~l~~~~~~~~~~~lV~ 195 (373)
.-+..|+.|....+|+... ++..+++|+.... ....+..|...|..+. ...+++.+....+.+..|+||
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvm 110 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLL 110 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEE
Confidence 3457789999999998864 4668889987543 2345777888877763 356888888888788899999
Q ss_pred eccCCCCH
Q 017362 196 EYLPGGDM 203 (373)
Q Consensus 196 E~~~gg~L 203 (373)
||++|..+
T Consensus 111 e~l~G~~~ 118 (312)
T 3jr1_A 111 EALNKSKN 118 (312)
T ss_dssp ECCCCCCC
T ss_pred EeccCCCC
Confidence 99998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.85 E-value=3.3e-05 Score=70.78 Aligned_cols=135 Identities=13% Similarity=0.007 Sum_probs=73.9
Q ss_pred eeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCce-eEEeeEEEeCCeEEEEEecc
Q 017362 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCI-VKLYCSFQDDEFLYLIMEYL 198 (373)
Q Consensus 120 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~l~~~~~~~~~~~lV~E~~ 198 (373)
-++.|+.|....+|++ ..+++|+....... ......|..++..+....+ ++++.. +.+.-++|+||+
T Consensus 22 ~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i 89 (301)
T 3dxq_A 22 GPLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYI 89 (301)
T ss_dssp SCEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECC
T ss_pred ceeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeec
Confidence 3788999999999988 46888887643110 1112346666655532222 455544 333346899999
Q ss_pred -CCCCHHHH------------------HhhCC-CC----C-HHHHHHHHHH--------------HHHHHHHHH------
Q 017362 199 -PGGDMMTL------------------LMRKD-TL----T-EDEARFYVAE--------------TVLAIESIH------ 233 (373)
Q Consensus 199 -~gg~L~~~------------------l~~~~-~l----~-~~~~~~i~~q--------------i~~aL~~LH------ 233 (373)
+|.++... ++... .+ . ...+..+... +...+..+.
T Consensus 90 ~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~ 169 (301)
T 3dxq_A 90 AGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAH 169 (301)
T ss_dssp TTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSS
T ss_pred CCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhc
Confidence 66444210 11111 01 1 1111111111 111111111
Q ss_pred --hCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 234 --KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 234 --~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
...++|+|+.|.||+ ..++.+.|+||..|...+
T Consensus 170 ~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g~ 204 (301)
T 3dxq_A 170 PLPLAACHCDPLCENFL-DTGERMWIVDWEYSGMND 204 (301)
T ss_dssp CCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEEC
T ss_pred CCCceeeccCCCcCCEE-ECCCCEEEEecccccCCC
Confidence 124899999999999 666789999999886543
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00014 Score=67.11 Aligned_cols=141 Identities=13% Similarity=0.054 Sum_probs=77.1
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCc--eeEEeeE------EEeCC
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC--IVKLYCS------FQDDE 189 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~l~~~------~~~~~ 189 (373)
..-++.|+.|....+|++... ++ .+++|+..... .. +.+..|..++..+.... +++++.. ....+
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~--~~---~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g 96 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--EK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSG 96 (322)
T ss_dssp EEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETT
T ss_pred ceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC--CH---HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECC
Confidence 344567788888999998653 33 68899886521 11 22445666665553211 2333321 12345
Q ss_pred eEEEEEeccCCCCHHH--------------HHhh--CC---C----CCHHHHHH---------------HHHHHHHHHHH
Q 017362 190 FLYLIMEYLPGGDMMT--------------LLMR--KD---T----LTEDEARF---------------YVAETVLAIES 231 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~--------------~l~~--~~---~----l~~~~~~~---------------i~~qi~~aL~~ 231 (373)
..++||+|++|..+.. .++. .+ . ........ +...+...+..
T Consensus 97 ~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 176 (322)
T 2ppq_A 97 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY 176 (322)
T ss_dssp EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred EEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHH
Confidence 6789999999864311 1111 00 0 11100000 00113344555
Q ss_pred HHh-------CCCeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 232 IHK-------HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 232 LH~-------~giiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
++. .+++|+|+.|+|||++.++.+.|+||+.+..
T Consensus 177 l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 177 LAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 552 4699999999999999876668999998754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.65 E-value=8.8e-05 Score=70.43 Aligned_cols=142 Identities=15% Similarity=0.195 Sum_probs=83.2
Q ss_pred CCcceeceeeeeCcEEEEEEEEcC-------CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-CCceeEEeeEEEe
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKT-------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQD 187 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~ 187 (373)
+.++ ++.|..|-...+|++.... ++..|++|+.... ......+.+|..+++.+. +.-.+++++.+.+
T Consensus 51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~ 125 (379)
T 3feg_A 51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE 125 (379)
T ss_dssp GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT
T ss_pred CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC
Confidence 4444 3457778888899987632 3468899986431 112344567888887763 3333666666543
Q ss_pred CCeEEEEEeccCCCCHHH--------------HH---hhCC-----CC--CHHHHHHHHHHHHH----------------
Q 017362 188 DEFLYLIMEYLPGGDMMT--------------LL---MRKD-----TL--TEDEARFYVAETVL---------------- 227 (373)
Q Consensus 188 ~~~~~lV~E~~~gg~L~~--------------~l---~~~~-----~l--~~~~~~~i~~qi~~---------------- 227 (373)
+ +||||++|..|.. .| +.-. .. -+..+..+..++-.
T Consensus 126 g----~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
T 3feg_A 126 G----RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYS 201 (379)
T ss_dssp E----EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTT
T ss_pred c----cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHH
Confidence 2 9999999854421 11 1111 11 24556656544422
Q ss_pred ---HHHHHH----h----CCCeeecCCCCCEEEcCC----CcEEEeeccccccC
Q 017362 228 ---AIESIH----K----HHYIHRDIKPDNLLLDKY----GHLRLSDFGLCKPL 266 (373)
Q Consensus 228 ---aL~~LH----~----~giiHrDikp~NILl~~~----~~vkL~DFGla~~~ 266 (373)
.+..|. . ..++|+|+.++|||++.+ +.+.|+||..|...
T Consensus 202 l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~ 255 (379)
T 3feg_A 202 LKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN 255 (379)
T ss_dssp HHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred HHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence 233333 2 259999999999999876 78999999998643
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00023 Score=65.77 Aligned_cols=138 Identities=12% Similarity=0.158 Sum_probs=76.6
Q ss_pred ceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCC--ceeEEeeE-----EEeCCeEEEE
Q 017362 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN--CIVKLYCS-----FQDDEFLYLI 194 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~l~~~-----~~~~~~~~lV 194 (373)
..|+ |....||++.. .+|..+++|+...... ....+..|..++..+... .++.++.. ....+..++|
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 88889998753 3466799999863211 123355576666655321 23444432 2235567899
Q ss_pred EeccCCCCHH-----H------H---Hhh---C------CCCCHHHH----HH------------------HHHHHHHHH
Q 017362 195 MEYLPGGDMM-----T------L---LMR---K------DTLTEDEA----RF------------------YVAETVLAI 229 (373)
Q Consensus 195 ~E~~~gg~L~-----~------~---l~~---~------~~l~~~~~----~~------------------i~~qi~~aL 229 (373)
|++++|..+. . . ++. . ..++.... .. .+.+++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999875321 1 1 111 0 01121110 11 111122222
Q ss_pred HHH----HhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 230 ESI----HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 230 ~~L----H~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
..+ ....++|+|++|.|||++ + .+.|+||+.|..-+
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g~ 225 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNGP 225 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEEC
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcCc
Confidence 221 124589999999999999 4 89999999886543
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00016 Score=67.21 Aligned_cols=33 Identities=27% Similarity=0.334 Sum_probs=28.5
Q ss_pred CCCeeecCCCCCEEEcCC----CcEEEeeccccccCC
Q 017362 235 HHYIHRDIKPDNLLLDKY----GHLRLSDFGLCKPLD 267 (373)
Q Consensus 235 ~giiHrDikp~NILl~~~----~~vkL~DFGla~~~~ 267 (373)
..++|+|+.|.|||++.+ +.+.|+||+.|..-+
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 479999999999999874 789999999987544
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00037 Score=63.25 Aligned_cols=80 Identities=16% Similarity=0.074 Sum_probs=54.2
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCC---CceeEEeeEEEeCCeE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS---NCIVKLYCSFQDDEFL 191 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~l~~~~~~~~~~ 191 (373)
.....-+..+|.|..+.||+... .+|+.|.+|+..... ......+..|...|+.+.. --+++.++. +. -
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~---~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~ 85 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDA---PALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--R 85 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTC---CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--T
T ss_pred CCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCC---cchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--c
Confidence 34566788899999999999864 578899999865432 1122346778888877732 234455543 23 3
Q ss_pred EEEEeccCCCC
Q 017362 192 YLIMEYLPGGD 202 (373)
Q Consensus 192 ~lV~E~~~gg~ 202 (373)
++||||++++.
T Consensus 86 ~lv~e~l~~~~ 96 (288)
T 3f7w_A 86 TLAMEWVDERP 96 (288)
T ss_dssp EEEEECCCCCC
T ss_pred eEEEEeecccC
Confidence 68999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00013 Score=70.58 Aligned_cols=74 Identities=20% Similarity=0.259 Sum_probs=47.5
Q ss_pred eeceeeeeCcEEEEEEEEcC-------CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCC-ceeEEeeEEEeCCeE
Q 017362 120 LLTMIGKGAFGEVRVCREKT-------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKLYCSFQDDEFL 191 (373)
Q Consensus 120 ~~~~lG~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~l~~~~~~~~~~ 191 (373)
.++.|+.|-...||++.... .+..+++|+..... ..+.+..|..++..+... ..+++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-----cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 35678888899999997642 25688999874311 113344687777776432 33566665542
Q ss_pred EEEEeccCCCC
Q 017362 192 YLIMEYLPGGD 202 (373)
Q Consensus 192 ~lV~E~~~gg~ 202 (373)
.+||||++|..
T Consensus 148 g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 GRLEEYIPSRP 158 (429)
T ss_dssp EEEECCCCEEE
T ss_pred CEEEEEeCCcc
Confidence 28999998733
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00034 Score=65.93 Aligned_cols=74 Identities=15% Similarity=0.082 Sum_probs=41.9
Q ss_pred eceeeeeCcEEEEEEEEcC--------CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCc-eeEEeeEEEeCCeE
Q 017362 121 LTMIGKGAFGEVRVCREKT--------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC-IVKLYCSFQDDEFL 191 (373)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~l~~~~~~~~~~ 191 (373)
+..|+.|....+|++.... .+..+++|+...... .......|..++..+...+ ++++++.+ .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 4567888888999987542 125788998754311 1111345777776663222 44666544 22
Q ss_pred EEEEeccCCCC
Q 017362 192 YLIMEYLPGGD 202 (373)
Q Consensus 192 ~lV~E~~~gg~ 202 (373)
++||||++|..
T Consensus 110 ~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 GRIEEWLYGDP 120 (369)
T ss_dssp EEEEECCCSEE
T ss_pred cEEEEEecCCc
Confidence 58999998854
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0013 Score=61.23 Aligned_cols=33 Identities=18% Similarity=0.181 Sum_probs=28.6
Q ss_pred CCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 235 ~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
..++|+|+.|.||+++.++.+.|+||+.+...+
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP 238 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence 469999999999999988899999998876543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0014 Score=63.81 Aligned_cols=76 Identities=14% Similarity=0.217 Sum_probs=46.9
Q ss_pred eeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCce-eEEeeEEEeCCeEEEEEecc
Q 017362 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCI-VKLYCSFQDDEFLYLIMEYL 198 (373)
Q Consensus 120 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~l~~~~~~~~~~~lV~E~~ 198 (373)
-++.|+.|-...+|++.....+..+++|+..... ...+. ...|..++..+...++ +++++.+. +. +||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~id-R~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEIIN-REREKKISCILYNKNIAKKIYVFFT--NG--RIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSCSC-HHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhhcC-HHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEee
Confidence 3567888989999999865434788899874321 11111 2468888887754444 56666662 22 599999
Q ss_pred CCCCH
Q 017362 199 PGGDM 203 (373)
Q Consensus 199 ~gg~L 203 (373)
+|..|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87443
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.51 E-value=0.013 Score=50.58 Aligned_cols=99 Identities=17% Similarity=0.175 Sum_probs=66.0
Q ss_pred CHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccccccc
Q 017362 202 DMMTLLMR-KDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279 (373)
Q Consensus 202 ~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~-~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 279 (373)
+|.+.|.. ..+++|++++.++.|.+.+|.-+-. ..-..+=+-|..|+|..+|.|-+.+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc---------------
Confidence 78898865 5689999999999999999887622 1212333446899999999988764 2110
Q ss_pred CCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh-CCC
Q 017362 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYP 355 (373)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~ 355 (373)
.....+.|||... ...+.+.=|||||+++|..+- |-+
T Consensus 98 --------------------------------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 --------------------------------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -----------------------------------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred --------------------------------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1122456888763 455788899999999999886 443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.35 E-value=0.0048 Score=59.27 Aligned_cols=75 Identities=15% Similarity=0.102 Sum_probs=45.6
Q ss_pred eeceeeeeCcEEEEEEEEcCC-------CceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-CCceeEEeeEEEeCCeE
Q 017362 120 LLTMIGKGAFGEVRVCREKTT-------GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 120 ~~~~lG~G~~g~Vy~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~ 191 (373)
-++.|..|-...+|++..... +..|++++..... ...+ ...+|..++..+. +.-.+++++.+ .+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~i-dR~~E~~~l~~L~~~gi~P~l~~~~--~~-- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFY-DSKVELDVFRYLSNINIAPNIIADF--PE-- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCC-CHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhc-CHHHHHHHHHHHHhcCCCCCEEEEc--CC--
Confidence 345677788889999876421 5778999864321 1111 1245777776663 33345556543 22
Q ss_pred EEEEeccCCCC
Q 017362 192 YLIMEYLPGGD 202 (373)
Q Consensus 192 ~lV~E~~~gg~ 202 (373)
++||||++|..
T Consensus 146 ~~I~efI~G~~ 156 (424)
T 3mes_A 146 GRIEEFIDGEP 156 (424)
T ss_dssp EEEEECCCSEE
T ss_pred CEEEEEeCCcc
Confidence 58999999865
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.66 E-value=0.096 Score=49.69 Aligned_cols=31 Identities=29% Similarity=0.391 Sum_probs=26.2
Q ss_pred CCeeecCCCCCEEE------cCCCcEEEeeccccccC
Q 017362 236 HYIHRDIKPDNLLL------DKYGHLRLSDFGLCKPL 266 (373)
Q Consensus 236 giiHrDikp~NILl------~~~~~vkL~DFGla~~~ 266 (373)
.++|+|+.++|||+ +.++.+.|+||.+|...
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 37899999999999 45678999999998754
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=88.69 E-value=1.7 Score=37.28 Aligned_cols=85 Identities=13% Similarity=0.089 Sum_probs=59.6
Q ss_pred cCCCceeEEeeEEEeCCeEEEEEeccCCC-CHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC
Q 017362 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGG-DMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK 251 (373)
Q Consensus 173 l~h~~iv~l~~~~~~~~~~~lV~E~~~gg-~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~ 251 (373)
..||+++.. .+-.+++.+.+.++.-+.+ ++.. + ..++......++..|+.... |...=+|--|.|+||+++.
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i---k~~~~~eKlr~l~ni~~l~~--~~~~r~tf~L~P~NL~f~~ 114 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I---KSFTKNEKLRYLLNIKNLEE--VNRTRYTFVLAPDELFFTR 114 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G---GGSCHHHHHHHHHHGGGGGG--GGGSSEECCCSGGGEEECT
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H---HhcCHHHHHHHHHHHHHHHH--HhcCceEEEEecceEEEcC
Confidence 358888866 4556667766666654422 3322 2 34677788888888877663 3345678889999999999
Q ss_pred CCcEEEeeccccc
Q 017362 252 YGHLRLSDFGLCK 264 (373)
Q Consensus 252 ~~~vkL~DFGla~ 264 (373)
++.+++.-.|+-.
T Consensus 115 ~~~p~i~~RGik~ 127 (215)
T 4ann_A 115 DGLPIAKTRGLQN 127 (215)
T ss_dssp TSCEEESCCEETT
T ss_pred CCCEEEEEccCcc
Confidence 9999998888643
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=86.21 E-value=2.8 Score=35.98 Aligned_cols=92 Identities=11% Similarity=0.034 Sum_probs=63.1
Q ss_pred cCCCceeEEeeEEEeCCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCC
Q 017362 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY 252 (373)
Q Consensus 173 l~h~~iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~ 252 (373)
..||++ -...-.+++.+.+.++.-+++.-...+ ..++.....+++..|+.... -|...-+|--|.|+||+++.+
T Consensus 47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~-~~~~~r~tf~l~P~NL~f~~~ 120 (219)
T 4ano_A 47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVK-HHSARRLIFIVCPENLMFNRA 120 (219)
T ss_dssp GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHS-SCCSSSEECCCCGGGEEECTT
T ss_pred ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHH-HhhhCceeEEEeCceEEEeCC
Confidence 357887 333446777777777765444322333 34677777777777766444 123567888899999999999
Q ss_pred CcEEEeeccccccCCCCC
Q 017362 253 GHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 253 ~~vkL~DFGla~~~~~~~ 270 (373)
+.++|.-.|+-..+++-.
T Consensus 121 ~~p~i~hRGi~~~lpP~e 138 (219)
T 4ano_A 121 LEPFFLHVGVKESLPPDE 138 (219)
T ss_dssp CCEEESCCEETTTBSSCS
T ss_pred CcEEEEEcCCcccCCCCC
Confidence 999999999876665443
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.01 E-value=0.15 Score=49.34 Aligned_cols=64 Identities=5% Similarity=-0.043 Sum_probs=18.4
Q ss_pred ceeceeeeeCcEEEEEEEEcCCCceEee------eecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEE
Q 017362 119 ELLTMIGKGAFGEVRVCREKTTGHVYAM------KKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (373)
Q Consensus 119 ~~~~~lG~G~~g~Vy~~~~~~~~~~vai------K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 186 (373)
.+.+.|| ||+||++.......+||+ |..+...+ .......+.++..++...+|||+++.+.+-.
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~-~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGV-SEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccc-cccccccccccccccccccccccCCCcceEE
Confidence 4556677 999999987655568999 66544322 2333455777888888899999999876654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 373 | ||||
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-71 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-68 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-64 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-61 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-61 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-60 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-59 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-59 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-59 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-59 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-59 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-59 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-58 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-58 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-56 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-54 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-54 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-52 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-52 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-52 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-50 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-50 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-48 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-48 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-48 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-48 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-47 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-47 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-47 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-46 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-46 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-46 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-45 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-45 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-45 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-45 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-44 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-44 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-43 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-42 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-42 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-42 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-41 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-40 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-40 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-40 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-40 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-39 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-38 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-38 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-36 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-36 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-36 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-14 |
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 4e-71
Identities = 80/263 (30%), Positives = 135/263 (51%), Gaps = 39/263 (14%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN 168
Q K +DF+ ++G+G+F V + RE T YA+K L+K +++ +V +V ER+
Sbjct: 1 QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 60
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
+++ +D VKLY +FQDDE LY + Y G+++ + + + E RFY AE V A
Sbjct: 61 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 120
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
+E +H IHRD+KP+N+LL++ H++++DFG K
Sbjct: 121 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK------------------------ 156
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
++++ A S VGT Y++PE+L +K D W+LG I+Y
Sbjct: 157 ---------------VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIY 201
Query: 349 EMLVGYPPFYSDDPMSTCRKVRK 371
+++ G PPF + + +K+ K
Sbjct: 202 QLVAGLPPFRAGNEYLIFQKIIK 224
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 3e-68
Identities = 74/256 (28%), Positives = 115/256 (44%), Gaps = 43/256 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+DFE+ +GKG FG V + REK + + A+K L K+++ + G +R E + + +
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I++LY F D +YLI+EY P G + L + E Y+ E A+ H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
IHRDIKP+NLLL G L+++DFG S
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR------------------------ 161
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
+ GT DY+ PE++ + + + D WSLG + YE LVG P
Sbjct: 162 -------------------TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 202
Query: 356 PFYSDDPMSTCRKVRK 371
PF ++ T +++ +
Sbjct: 203 PFEANTYQETYKRISR 218
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 6e-64
Identities = 64/249 (25%), Positives = 101/249 (40%), Gaps = 46/249 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DDFE ++ +G G G V K +G V A K + ++ + E +L E +S
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNS 63
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH-K 234
IV Y +F D + + ME++ GG + +L + + E + + + K
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
H +HRD+KP N+L++ G ++L DFG+ L S
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------------------------- 158
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354
+A S VGT Y++PE L Y ++ D WS+G + EM VG
Sbjct: 159 ------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200
Query: 355 PPFYSDDPM 363
P D
Sbjct: 201 YPIPPPDAK 209
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 3e-61
Identities = 66/263 (25%), Positives = 114/263 (43%), Gaps = 50/263 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D +E++ +G GAFG+V + K T + A K + ++E E ++LA D
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDH 68
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHK 234
IVKL +F + L++++E+ GG + +++ + LTE + + +T+ A+ +H
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+ IHRD+K N+L G ++L+DFG+
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT--------------------------- 161
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYE 349
S +GTP ++APEV++ + Y + D WSLG + E
Sbjct: 162 --------------RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIE 207
Query: 350 MLVGYPPFYSDDPMSTCRKVRKK 372
M PP + +PM K+ K
Sbjct: 208 MAEIEPPHHELNPMRVLLKIAKS 230
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 3e-61
Identities = 61/258 (23%), Positives = 109/258 (42%), Gaps = 42/258 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+D++L+ +G+GA+GEV++ + T A+K + + E+++ E + ++
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNH 62
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+VK Y ++ YL +EY GG++ + + E +A+ + + + + +H
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
HRDIKP+NLLLD+ +L++SDFGL
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFR---------------------------- 154
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVGY 354
NR L GT Y+APE+L ++ + D WS G ++ ML G
Sbjct: 155 -----------YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 203
Query: 355 PPFYSDDPMSTCRKVRKK 372
P+ K+
Sbjct: 204 LPWDQPSDSCQEYSDWKE 221
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-60
Identities = 72/268 (26%), Positives = 123/268 (45%), Gaps = 53/268 (19%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
A+D+E+L IG G++G + R K+ G + K+L M + + + +E NLL E+
Sbjct: 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK 61
Query: 175 SNCIVKLYCSFQD--DEFLYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLA 228
IV+ Y D + LY++MEY GGD+ +++ + + L E+ + + LA
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 229 IESIHK-----HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283
++ H+ H +HRD+KP N+ LD +++L DFGL + L+
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN---------------- 165
Query: 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343
+ A + VGTP Y++PE + + Y + D WSL
Sbjct: 166 -------------------------HDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSL 200
Query: 344 GAIMYEMLVGYPPFYSDDPMSTCRKVRK 371
G ++YE+ PPF + K+R+
Sbjct: 201 GCLLYELCALMPPFTAFSQKELAGKIRE 228
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 1e-59
Identities = 85/258 (32%), Positives = 126/258 (48%), Gaps = 42/258 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-D 174
+DF L M+GKG+FG+V + K T +A+K LKK +L VE E+ +L+ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
+ ++C+FQ E L+ +MEYL GGD+M + A FY AE +L ++ +H
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
++RD+K DN+LLDK GH++++DFG+CK + F
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF------------------ 163
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354
GTPDYIAPE+LL + Y DWWS G ++YEML+G
Sbjct: 164 -----------------------CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 200
Query: 355 PPFYSDDPMSTCRKVRKK 372
PF+ D +R
Sbjct: 201 SPFHGQDEEELFHSIRMD 218
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 194 bits (493), Expect = 2e-59
Identities = 67/265 (25%), Positives = 116/265 (43%), Gaps = 48/265 (18%)
Query: 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
+H D +++ +G GAFG V E+ TG+ +A K + E VR E
Sbjct: 20 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQT 76
Query: 170 LAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLA 228
++ + +V L+ +F+DD + +I E++ GG++ + + ++EDEA Y+ +
Sbjct: 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136
Query: 229 IESIHKHHYIHRDIKPDNLLL--DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
+ +H+++Y+H D+KP+N++ + L+L DFGL LD
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD------------------- 177
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346
+ T GT ++ APEV K G D WS+G +
Sbjct: 178 -----------------------PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 214
Query: 347 MYEMLVGYPPFYSDDPMSTCRKVRK 371
Y +L G PF ++ T R V+
Sbjct: 215 SYILLSGLSPFGGENDDETLRNVKS 239
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 192 bits (488), Expect = 4e-59
Identities = 93/256 (36%), Positives = 136/256 (53%), Gaps = 44/256 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DF++L +G G+FG V + R + G YAMK LKK ++R QVEH ER +L+ V
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I++++ +FQD + +++IM+Y+ GG++ +LL + A+FY AE LA+E +H
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
I+RD+KP+N+LLDK GH++++DFG K + T
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT------------------------- 158
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
Y+ GTPDYIAPEV+ K Y DWWS G ++YEML GY
Sbjct: 159 -------------------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199
Query: 356 PFYSDDPMSTCRKVRK 371
PFY + M T K+
Sbjct: 200 PFYDSNTMKTYEKILN 215
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 190 bits (484), Expect = 4e-59
Identities = 70/270 (25%), Positives = 116/270 (42%), Gaps = 55/270 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR------RGQVEHVRAERNL 169
+++E ++G+G VR C K T YA+K + + + E E ++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 170 LAEVDSN-CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
L +V + I++L +++ + F +L+ + + G++ L K TL+E E R + +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
I ++HK + +HRD+KP+N+LLD +++L+DFG LD
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE------------------ 164
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL------KKGYGMECDWWS 342
GTP Y+APE++ GYG E D WS
Sbjct: 165 ------------------------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWS 200
Query: 343 LGAIMYEMLVGYPPFYSDDPMSTCRKVRKK 372
G IMY +L G PPF+ M R +
Sbjct: 201 TGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 230
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 5e-59
Identities = 90/261 (34%), Positives = 129/261 (49%), Gaps = 41/261 (15%)
Query: 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
K+ +DF+ L ++GKG FG+V + REK TG YAMK L+K ++ + +V H E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIES 231
+ L +FQ + L +MEY GG++ L R+ TE+ ARFY AE V A+E
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+H ++RDIK +NL+LDK GH++++DFGLCK
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--------------------- 159
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
+ GTP+Y+APEVL YG DWW LG +MYEM+
Sbjct: 160 --------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199
Query: 352 VGYPPFYSDDPMSTCRKVRKK 372
G PFY+ D + +
Sbjct: 200 CGRLPFYNQDHERLFELILME 220
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 7e-59
Identities = 65/257 (25%), Positives = 112/257 (43%), Gaps = 45/257 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ IG+GA G V + TG A++++ + ++ E + E ++ E +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKN 76
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV S+ + L+++MEYL GG + ++ E + E + A+E +H +
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSN 135
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
IHRDIK DN+LL G ++L+DFG C +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-------------------------- 169
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
+ + VGTP ++APEV+ +K YG + D WSLG + EM+ G P
Sbjct: 170 ---------------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
Query: 356 PFYSDDPMSTCRKVRKK 372
P+ +++P+ +
Sbjct: 215 PYLNENPLRALYLIATN 231
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (483), Expect = 1e-58
Identities = 72/260 (27%), Positives = 119/260 (45%), Gaps = 47/260 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D ++ ++G GAF EV + +K T + A+K + K + G+ + E +L ++
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKH 66
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV L ++ LYLIM+ + GG++ ++ K TE +A + + + A++ +H
Sbjct: 67 PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+HRD+KP+NLL D+ + +SDFGL K D +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---------------------- 164
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
+ + GTP Y+APEVL +K Y D WS+G I Y +L
Sbjct: 165 --------------------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC 204
Query: 353 GYPPFYSDDPMSTCRKVRKK 372
GYPPFY ++ ++ K
Sbjct: 205 GYPPFYDENDAKLFEQILKA 224
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (483), Expect = 2e-58
Identities = 62/260 (23%), Positives = 100/260 (38%), Gaps = 48/260 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
F L IG G+FG V R+ V A+KK+ S + + + E L ++
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
++ + + +L+MEY G L + K L E E + + +H H
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+ IHRD+K N+LL + G ++L DFG + +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------------------------- 169
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEMLV 352
S VGTP ++APEV+L + Y + D WSLG E+
Sbjct: 170 --------------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 209
Query: 353 GYPPFYSDDPMSTCRKVRKK 372
PP ++ + MS + +
Sbjct: 210 RKPPLFNMNAMSALYHIAQN 229
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 191 bits (485), Expect = 3e-58
Identities = 62/259 (23%), Positives = 120/259 (46%), Gaps = 48/259 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D +++L +G GAFG V C EK TG V+ K + L + V+ E +++ ++
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHH 85
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHK 234
++ L+ +F+D + LI+E+L GG++ + +D ++E E Y+ + ++ +H+
Sbjct: 86 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145
Query: 235 HHYIHRDIKPDNLLLD--KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H +H DIKP+N++ + K +++ DFGL L+
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---------------------- 183
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
+ T T ++ APE++ ++ G D W++G + Y +L
Sbjct: 184 --------------------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS 223
Query: 353 GYPPFYSDDPMSTCRKVRK 371
G PF +D + T + V++
Sbjct: 224 GLSPFAGEDDLETLQNVKR 242
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 182 bits (463), Expect = 6e-56
Identities = 57/262 (21%), Positives = 106/262 (40%), Gaps = 42/262 (16%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
+D +EL ++G G EV + R+ A+K L+ R E A ++
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 175 SNCIVKLYCSFQDDE----FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
IV +Y + + + Y++MEY+ G + ++ + +T A +A+ A+
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
H++ IHRD+KP N+++ +++ DFG+ + +
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI------------------------ 161
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
N + +GT Y++PE D +SLG ++YE+
Sbjct: 162 --------------ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 207
Query: 351 LVGYPPFYSDDPMSTCRKVRKK 372
L G PPF D P+S + ++
Sbjct: 208 LTGEPPFTGDSPVSVAYQHVRE 229
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 180 bits (458), Expect = 2e-54
Identities = 94/294 (31%), Positives = 156/294 (53%), Gaps = 48/294 (16%)
Query: 82 ADADVSEEDQNNLLKFLEKKETEYMR----LQRHKMGADDFELLTMIGKGAFGEVRVCRE 137
A A +Q ++ +FL K + ++++ ++ D F+ + +G G+FG V + +
Sbjct: 3 AAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKH 62
Query: 138 KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197
K +G+ YAMK L K ++++ Q+EH E+ +L V+ +VKL SF+D+ LY++MEY
Sbjct: 63 KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 198 LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRL 257
+ GG+M + L R +E ARFY A+ VL E +H I+RD+KP+NLL+D+ G++++
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQV 182
Query: 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYST 317
+DFG K + T ++
Sbjct: 183 TDFGFAKRVKGRT--------------------------------------------WTL 198
Query: 318 VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRK 371
GTP+ +APE++L KGY DWW+LG ++YEM GYPPF++D P+ K+
Sbjct: 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 179 bits (456), Expect = 7e-54
Identities = 77/260 (29%), Positives = 119/260 (45%), Gaps = 47/260 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN---LLAE 172
+DF + +IG+G FGEV CR+ TG +YAMK L K + + ER L++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
D IV + +F + L I++ + GGD+ L + +E + RFY AE +L +E +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H ++RD+KP N+LLD++GH+R+SD GL
Sbjct: 124 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---------------------- 161
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEML 351
+++VGT Y+APEVL K Y DW+SLG +++++L
Sbjct: 162 ---------------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 200
Query: 352 VGYPPFYSDDPMSTCRKVRK 371
G+ PF R
Sbjct: 201 RGHSPFRQHKTKDKHEIDRM 220
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 1e-53
Identities = 55/259 (21%), Positives = 96/259 (37%), Gaps = 49/259 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ + + +G+G FG V C E ++ Y K +K V+ E ++L
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHK 234
I+ L+ SF+ E L +I E++ G D+ + L E E YV + A++ +H
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 235 HHYIHRDIKPDNLLLD--KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H+ H DI+P+N++ + +++ +FG + L
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---------------------- 158
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
P+Y APEV D WSLG ++Y +L
Sbjct: 159 --------------------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS 198
Query: 353 GYPPFYSDDPMSTCRKVRK 371
G PF ++ +
Sbjct: 199 GINPFLAETNQQIIENIMN 217
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 2e-52
Identities = 48/258 (18%), Positives = 96/258 (37%), Gaps = 52/258 (20%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+ IG+G+F V + T A +L+ ++ + + + + E +L +
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPN 69
Query: 178 IVKLYCSFQD----DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH 233
IV+ Y S++ + + L+ E + G + T L R + R + + + ++ +H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 234 KHHY--IHRDIKPDNLLL-DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
IHRD+K DN+ + G +++ D GL S
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--------------------- 168
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
A + +GTP+++APE+ ++ Y D ++ G M EM
Sbjct: 169 ----------------------FAKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEM 205
Query: 351 LVGYPPFYSDDPMSTCRK 368
P+ + +
Sbjct: 206 ATSEYPYSECQNAAQIYR 223
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 3e-52
Identities = 67/263 (25%), Positives = 115/263 (43%), Gaps = 49/263 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML---RRGQVEHVRAERNLLAE 172
D ++ +G G F V+ CREK+TG YA K +KK R E + E ++L E
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
+ ++ L+ +++ + LI+E + GG++ L K++LTE+EA ++ + + + +
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 233 HKHHYIHRDIKPDNLLLDKYG----HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
H H D+KP+N++L +++ DFGL +D
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---------------- 173
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
+ GTP+++APE++ + G+E D WS+G I Y
Sbjct: 174 --------------------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 207
Query: 349 EMLVGYPPFYSDDPMSTCRKVRK 371
+L G PF D T V
Sbjct: 208 ILLSGASPFLGDTKQETLANVSA 230
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 9e-52
Identities = 44/261 (16%), Positives = 93/261 (35%), Gaps = 48/261 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ IG G+FG V + A+K L + + Q++ + E +L +
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQ-QLQAFKNEVGVLRKTRH 63
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT-LTEDEARFYVAETVLAIESIHK 234
I+ + L ++ ++ G + L +T + +T ++ +H
Sbjct: 64 VNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
IHRD+K +N+ L + +++ DFGL + Q +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL---------------- 166
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEML 351
G+ ++APEV+ K Y + D ++ G ++YE++
Sbjct: 167 -----------------------SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203
Query: 352 VGYPPFYSDDPMSTCRKVRKK 372
G P+ + + + +
Sbjct: 204 TGQLPYSNINNRDQIIFMVGR 224
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-50
Identities = 64/256 (25%), Positives = 106/256 (41%), Gaps = 44/256 (17%)
Query: 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM--LRRGQVEHVRAERNLLAEVDSN 176
E L +G+G F V R+K T + A+KK+K + G E LL E+
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH 236
I+ L +F + L+ +++ + + LT + Y+ T+ +E +H+H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
+HRD+KP+NLLLD+ G L+L+DFGL K
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFG----------------------------- 151
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYP 355
+ V T Y APE+L + YG+ D W++G I+ E+L+ P
Sbjct: 152 ------------SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 199
Query: 356 PFYSDDPMSTCRKVRK 371
D + ++ +
Sbjct: 200 FLPGDSDLDQLTRIFE 215
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 6e-50
Identities = 91/281 (32%), Positives = 149/281 (53%), Gaps = 47/281 (16%)
Query: 99 EKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCRE---KTTGHVYAMKKLKKSEML 155
+ T + K+G ++FELL ++G GA+G+V + R+ TG +YAMK LKK+ ++
Sbjct: 7 HELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV 66
Query: 156 RRGQ-VEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTL 213
++ + EH R ER +L + S +V L+ +FQ + L+LI++Y+ GG++ T L +++
Sbjct: 67 QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF 126
Query: 214 TEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273
TE E + YV E VLA+E +HK I+RDIK +N+LLD GH+ L+DFGL
Sbjct: 127 TEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS---------- 176
Query: 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL--K 331
+ + + AY GT +Y+AP+++
Sbjct: 177 ------------------------------KEFVADETERAYDFCGTIEYMAPDIVRGGD 206
Query: 332 KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRKK 372
G+ DWWSLG +MYE+L G PF D ++ ++ ++
Sbjct: 207 SGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR 247
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 1e-48
Identities = 53/262 (20%), Positives = 99/262 (37%), Gaps = 47/262 (17%)
Query: 117 DFELLTM----IGKGAFGEVR--VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
D +LLT+ +G G FG V+ + K A+K LK E + + AE N++
Sbjct: 4 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVM 62
Query: 171 AEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
++D+ IV++ + + + L+ME G + L + + + V + + ++
Sbjct: 63 QQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 121
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+ + +++HRD+ N+LL + ++SDFGL K L
Sbjct: 122 YLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD--------------------- 160
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
+N + APE + + + D WS G +M+E
Sbjct: 161 -----------------ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEA 203
Query: 351 L-VGYPPFYSDDPMSTCRKVRK 371
G P+ + K
Sbjct: 204 FSYGQKPYRGMKGSEVTAMLEK 225
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 1e-48
Identities = 60/261 (22%), Positives = 102/261 (39%), Gaps = 51/261 (19%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEH---VRAERNLLA 171
+++ ++G G FG V + A+K ++K + G++ + V E LL
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 172 EVDSNC--IVKLYCSFQDDEFLYLIMEYL-PGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
+V S +++L F+ + LI+E P D+ + + L E+ AR + + + A
Sbjct: 63 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 122
Query: 229 IESIHKHHYIHRDIKPDNLLLD-KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+ H +HRDIK +N+L+D G L+L DFG L +
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---------------- 166
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAI 346
GT Y PE + Y G WSLG +
Sbjct: 167 ---------------------------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 199
Query: 347 MYEMLVGYPPFYSDDPMSTCR 367
+Y+M+ G PF D+ + +
Sbjct: 200 LYDMVCGDIPFEHDEEIIRGQ 220
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-48
Identities = 71/277 (25%), Positives = 120/277 (43%), Gaps = 60/277 (21%)
Query: 106 MRLQRHKMGADDFELLT-MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVR 164
++++++ + DD+++ + ++G G G+V K T +A+K L+ RR H R
Sbjct: 2 LQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWR 60
Query: 165 AERNLLAEVDSNCIVKLYCSFQD----DEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEA 218
A + IV++ +++ + L ++ME L GG++ + + + TE EA
Sbjct: 61 ASQ-------CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA 113
Query: 219 RFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY---GHLRLSDFGLCKPLDCSTLQEQD 275
+ AI+ +H + HRD+KP+NLL L+L+DFG K
Sbjct: 114 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--- 170
Query: 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYG 335
+ TP Y+APEVL + Y
Sbjct: 171 ---------------------------------------TTPCYTPYYVAPEVLGPEKYD 191
Query: 336 MECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKVRKK 372
CD WSLG IMY +L GYPPFYS+ ++ ++ +
Sbjct: 192 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 228
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 4e-48
Identities = 57/265 (21%), Positives = 96/265 (36%), Gaps = 47/265 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+E L IG+G FGEV R + TG A+KK+ + G E +L +
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKH 68
Query: 176 NCIVKLYCSFQDDEF--------LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
+V L + +YL+ ++ L T E + + +
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+ IH++ +HRD+K N+L+ + G L+L+DFGL + +
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLA------------------ 170
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAI 346
+ ++ + V T Y PE+LL ++ YG D W G I
Sbjct: 171 -------------------KNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCI 211
Query: 347 MYEMLVGYPPFYSDDPMSTCRKVRK 371
M EM P + + +
Sbjct: 212 MAEMWTRSPIMQGNTEQHQLALISQ 236
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 5e-48
Identities = 50/265 (18%), Positives = 91/265 (34%), Gaps = 44/265 (16%)
Query: 113 MGADDFELLTMIGKGAFGEVRVCREKTT---GHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
+G D LL +G G+FG VR A+K LK + + ++ E N
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 170 LAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLA 228
+ +D +++LY + ++ E P G ++ L + Y +
Sbjct: 65 MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
+ + +IHRD+ NLLL +++ DFGL + L +
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN------------------- 164
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
+ ++ + APE L + + D W G ++
Sbjct: 165 -------------------DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLW 205
Query: 349 EMLV-GYPPFYSDDPMSTCRKVRKK 372
EM G P+ + K+ K+
Sbjct: 206 EMFTYGQEPWIGLNGSQILHKIDKE 230
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 1e-47
Identities = 45/258 (17%), Positives = 95/258 (36%), Gaps = 47/258 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D L +G G FG V+ + + + A+K +K+ M + E ++ +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSH 58
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHK 234
+V+LY +++I EY+ G ++ L + + + A+E +
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
++HRD+ N L++ G +++SDFGL +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSR------------------------------ 148
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VG 353
+ + + + + PEVL+ + + D W+ G +M+E+ +G
Sbjct: 149 ----------YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 198
Query: 354 YPPFYSDDPMSTCRKVRK 371
P+ T + +
Sbjct: 199 KMPYERFTNSETAEHIAQ 216
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-47
Identities = 52/260 (20%), Positives = 103/260 (39%), Gaps = 55/260 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +LL IGKG FG+V + + G+ A+K +K + AE +++ ++
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRH 59
Query: 176 NCIVKLY-CSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESI 232
+ +V+L ++ LY++ EY+ G ++ L + L D + + A+E +
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
++++HRD+ N+L+ + ++SDFGL K +
Sbjct: 120 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---------------------- 157
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML- 351
+ + APE L +K + + D WS G +++E+
Sbjct: 158 ----------------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 195
Query: 352 VGYPPFYSDDPMSTCRKVRK 371
G P+ +V K
Sbjct: 196 FGRVPYPRIPLKDVVPRVEK 215
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-47
Identities = 55/270 (20%), Positives = 103/270 (38%), Gaps = 49/270 (18%)
Query: 106 MRLQRHKMGADDFELLTMIGKGAFGEVR--VCREKTTGHVYAMKKLKKSEMLRRGQVEHV 163
+ L+R + D E +G G FG VR V R + A+K LK+ + E +
Sbjct: 3 LFLKRDNLLIADIE----LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEM 56
Query: 164 RAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM-RKDTLTEDEARFYV 222
E ++ ++D+ IV+L Q + L L+ME GG + L+ +++ + +
Sbjct: 57 MREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 115
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+ + ++ + + +++HRD+ N+LL + ++SDFGL K L +
Sbjct: 116 HQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS----- 170
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342
+ + APE + + + D WS
Sbjct: 171 ---------------------------------AGKWPLKWYAPECINFRKFSSRSDVWS 197
Query: 343 LGAIMYEML-VGYPPFYSDDPMSTCRKVRK 371
G M+E L G P+ + +
Sbjct: 198 YGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 227
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 1e-46
Identities = 57/262 (21%), Positives = 97/262 (37%), Gaps = 46/262 (17%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
+ L+ IG+GA+G V + A+KK+ E + + E +L
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFR 64
Query: 175 SNCIVKLYCSFQDDEF----LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
I+ + + ++ +L G D+ LL + L+ D +++ + + ++
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLK 123
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
IH + +HRD+KP NLLL+ L++ DFGL + D
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD--------------------- 162
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYE 349
+ V T Y APE++L GY D WS+G I+ E
Sbjct: 163 -----------------HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAE 205
Query: 350 MLVGYPPFYSDDPMSTCRKVRK 371
ML P F + +
Sbjct: 206 MLSNRPIFPGKHYLDQLNHILG 227
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 157 bits (399), Expect = 2e-46
Identities = 48/259 (18%), Positives = 97/259 (37%), Gaps = 46/259 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D + +G G +GEV K A+K LK+ M +VE E ++ E+
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH 72
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIH 233
+V+L + Y+I E++ G+++ L + ++ + + A+E +
Sbjct: 73 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 132
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
K ++IHRD+ N L+ + ++++DFGL + + T
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA------------------ 174
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
+ APE L + ++ D W+ G +++E+
Sbjct: 175 ----------------------GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 212
Query: 354 YPPFYSDDPMSTCRKVRKK 372
Y +S ++ +K
Sbjct: 213 GMSPYPGIDLSQVYELLEK 231
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 3e-46
Identities = 65/258 (25%), Positives = 102/258 (39%), Gaps = 44/258 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
++F+ + IG+G +G V R K TG V A+KK++ + G E +LL E++
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT-LTEDEARFYVAETVLAIESIHK 234
IVKL + LYL+ E+L + T + + Y+ + + + H
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
H +HRD+KP NLL++ G ++L+DFGL +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--------------------- 159
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVG 353
V T Y APE+LL Y D WSLG I EM+
Sbjct: 160 --------------------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199
Query: 354 YPPFYSDDPMSTCRKVRK 371
F D + ++ +
Sbjct: 200 RALFPGDSEIDQLFRIFR 217
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 156 bits (396), Expect = 1e-45
Identities = 44/263 (16%), Positives = 92/263 (34%), Gaps = 39/263 (14%)
Query: 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK-SEMLRRGQVEHVRAERNLL 170
++ ++ +IG G FGEV K G +K Q +E +++
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 81
Query: 171 AEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAI 229
+ D ++ L + +I E++ G + + L + D T + + +
Sbjct: 82 GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGM 141
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+ + +Y+HRD+ N+L++ ++SDFGL + L+ T +
Sbjct: 142 KYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGG-------- 193
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349
+ APE + + + D WS G +M+E
Sbjct: 194 ----------------------------KIPIRWTAPEAIQYRKFTSASDVWSYGIVMWE 225
Query: 350 ML-VGYPPFYSDDPMSTCRKVRK 371
++ G P++ + +
Sbjct: 226 VMSYGERPYWDMTNQDVINAIEQ 248
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 1e-45
Identities = 52/259 (20%), Positives = 100/259 (38%), Gaps = 49/259 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +L+ +G G FGEV + V A+K LK+ M + AE NL+ ++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 67
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIH 233
+V+LY + +Y+I EY+ G ++ L LT ++ A+ + I
Sbjct: 68 QRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
+ +YIHRD++ N+L+ +++DFGL + ++
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-------------------------- 160
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV- 352
N + APE + + ++ D WS G ++ E++
Sbjct: 161 --------------DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH 206
Query: 353 GYPPFYSDDPMSTCRKVRK 371
G P+ + + +
Sbjct: 207 GRIPYPGMTNPEVIQNLER 225
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 155 bits (392), Expect = 3e-45
Identities = 42/260 (16%), Positives = 83/260 (31%), Gaps = 45/260 (17%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS-N 176
+++ IG+G+FG + A+K + R +R E +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGCT 61
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH 236
I +Y Q+ L+++ L L + + + + ++SIH+
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 237 YIHRDIKPDNLLLDKY-----GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
++RDIKPDN L+ + + + DFG+ K ++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPY-------------- 167
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
+ GT Y++ L + D +LG + L
Sbjct: 168 --------------------REKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL 207
Query: 352 VGYPPFYSDDPMSTCRKVRK 371
G P+ + +K +
Sbjct: 208 RGSLPWQGLKAATNKQKYER 227
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 4e-45
Identities = 44/258 (17%), Positives = 88/258 (34%), Gaps = 47/258 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ + IG G FG V + A+K +++ M E E ++ ++
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSE----EDFIEEAEVMMKLSH 59
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL-AIESIHK 234
+V+LY + + L+ E++ G + L + L E + V + + +
Sbjct: 60 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
IHRD+ N L+ + +++SDFG+ +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTR------------------------------ 149
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-G 353
++ + T + +PEV Y + D WS G +M+E+ G
Sbjct: 150 ----------FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 199
Query: 354 YPPFYSDDPMSTCRKVRK 371
P+ + +
Sbjct: 200 KIPYENRSNSEVVEDIST 217
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 153 bits (387), Expect = 1e-44
Identities = 60/257 (23%), Positives = 101/257 (39%), Gaps = 44/257 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ + L IG+G +G V + G +A+KK++ E G E ++L E+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRL-EKEDEGIPSTTIREISILKELKH 59
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+ IVKLY + L L+ E+L L + + L A+ ++ + + I H
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+HRD+KP NLL+++ G L+++DFGL + +
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK----------------------- 156
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVGY 354
+ T Y AP+VL+ Y D WS+G I EM+ G
Sbjct: 157 ------------------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
Query: 355 PPFYSDDPMSTCRKVRK 371
P F ++ +
Sbjct: 199 PLFPGVSEADQLMRIFR 215
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 1e-44
Identities = 49/259 (18%), Positives = 97/259 (37%), Gaps = 49/259 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ L +G+G FGEV + T V A+K LK M E E ++ ++
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRH 71
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIH 233
+V+LY ++ +Y++ EY+ G ++ L + L + A+ + +
Sbjct: 72 EKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
+ +Y+HRD++ N+L+ + +++DFGL + ++
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-------------------------- 164
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV- 352
N + APE L + ++ D WS G ++ E+
Sbjct: 165 --------------DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 210
Query: 353 GYPPFYSDDPMSTCRKVRK 371
G P+ +V +
Sbjct: 211 GRVPYPGMVNREVLDQVER 229
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 3e-44
Identities = 62/267 (23%), Positives = 102/267 (38%), Gaps = 60/267 (22%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +IG G+FG V + +G + A+KK+ + + + E ++ ++D
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-------NRELQIMRKLDH 72
Query: 176 NCIVKLYCSF------QDDEFLYLIMEYLPGGDMMTLL---MRKDTLTEDEARFYVAETV 226
IV+L F +D+ +L L+++Y+P K TL + Y+ +
Sbjct: 73 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285
++ IH HRDIKP NLLLD L+L DFG K L
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN------------- 179
Query: 286 SQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLG 344
S + + Y APE++ Y D WS G
Sbjct: 180 -----------------------------VSYICSRYYRAPELIFGATDYTSSIDVWSAG 210
Query: 345 AIMYEMLVGYPPFYSDDPMSTCRKVRK 371
++ E+L+G P F D + ++ K
Sbjct: 211 CVLAELLLGQPIFPGDSGVDQLVEIIK 237
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 5e-44
Identities = 56/322 (17%), Positives = 114/322 (35%), Gaps = 79/322 (24%)
Query: 89 EDQNNLLKFLEKKETEYMRLQRHKMGAD--------DFELLTMIGKGAFGEVRVCREKTT 140
E Q +++ + EY + + D + E ++G GAFG+V
Sbjct: 2 ESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGI 61
Query: 141 GH-----VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKLYCSFQDDEFLYLI 194
A+K LK+ + E + +E ++ ++ S+ IV L + +YLI
Sbjct: 62 SKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 119
Query: 195 MEYLPGGDMMTLLMRK-----------------------DTLTEDEARFYVAETVLAIES 231
EY GD++ L K + LT ++ + + +E
Sbjct: 120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 179
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+ +HRD+ N+L+ +++ DFGL + +
Sbjct: 180 LEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM------------------------ 215
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
+ ++ + ++APE L + Y ++ D WS G +++E+
Sbjct: 216 ---------------SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 260
Query: 352 -VGYPPFYSDDPMSTCRKVRKK 372
+G P+ + K+ +
Sbjct: 261 SLGVNPYPGIPVDANFYKLIQN 282
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (380), Expect = 2e-43
Identities = 53/287 (18%), Positives = 95/287 (33%), Gaps = 71/287 (24%)
Query: 116 DDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
++ E + IG+GAFG V R + A+K LK+ + E L+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALM 70
Query: 171 AEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD------------------- 211
AE D+ IVKL + + L+ EY+ GD+ L
Sbjct: 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 212 -----TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266
L+ E + + + + ++HRD+ N L+ + ++++DFGL + +
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAP 326
+ + D ++ P
Sbjct: 191 YSADYYKADGND---------------------------------------AIPIRWMPP 211
Query: 327 EVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRKK 372
E + Y E D W+ G +++E+ G P+Y VR
Sbjct: 212 ESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG 258
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-42
Identities = 43/260 (16%), Positives = 84/260 (32%), Gaps = 42/260 (16%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK--SEMLRRGQVEHVRAERNLLAE 172
+F+ + ++G GAFG V G + K E + + E ++A
Sbjct: 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
VD+ + +L + G + + KD + + + + +
Sbjct: 68 VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+HRD+ N+L+ H++++DFGL K L
Sbjct: 128 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE----------------------- 164
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML- 351
+ A ++A E +L + Y + D WS G ++E++
Sbjct: 165 ----------------EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208
Query: 352 VGYPPFYSDDPMSTCRKVRK 371
G P+ + K
Sbjct: 209 FGSKPYDGIPASEISSILEK 228
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 3e-42
Identities = 50/259 (19%), Positives = 90/259 (34%), Gaps = 44/259 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK-SEMLRRGQVEHVRAERNLLAEVD 174
+ EL IG+G FG+V + + +K E E + + D
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIH 233
IVKL ++ +++IME G++ + L + +L Y + A+ +
Sbjct: 67 HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
++HRDI N+L+ ++L DFGL + ++ ST
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----------------------- 162
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV- 352
A ++APE + + + D W G M+E+L+
Sbjct: 163 -----------------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH 205
Query: 353 GYPPFYSDDPMSTCRKVRK 371
G PF ++
Sbjct: 206 GVKPFQGVKNNDVIGRIEN 224
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 3e-42
Identities = 48/274 (17%), Positives = 96/274 (35%), Gaps = 60/274 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-D 174
+D + +IG+G FG+V R K G + E + E +L ++
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD----------------TLTEDEA 218
I+ L + + +LYL +EY P G+++ L + TL+ +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 219 RFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278
+ A+ ++ + + +IHRD+ N+L+ + +++DFGL + + +
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK------ 183
Query: 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC 338
++A E L Y
Sbjct: 184 ------------------------------------TMGRLPVRWMAIESLNYSVYTTNS 207
Query: 339 DWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRK 371
D WS G +++E++ G P+ K+ +
Sbjct: 208 DVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (370), Expect = 5e-42
Identities = 45/261 (17%), Positives = 82/261 (31%), Gaps = 43/261 (16%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
+ + L IG G+FG++ + + G A+K + + E + +
Sbjct: 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYKMMQ 60
Query: 175 S-NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH 233
I + + ++ ++ME L + + + IE IH
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 234 KHHYIHRDIKPDNLL---LDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
++IHRD+KPDN L K + + DFGL K +
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA--------------------- 159
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
+ Q + GT Y + L D SLG ++
Sbjct: 160 -------------RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYF 206
Query: 351 LVGYPPFYSDDPMSTCRKVRK 371
+G P+ + +K +
Sbjct: 207 NLGSLPWQGLKAATKRQKYER 227
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 8e-42
Identities = 58/265 (21%), Positives = 101/265 (38%), Gaps = 51/265 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCRE-KTTGHVYAMKKLKKSEMLRRGQVEHVR--AERNLLAE 172
+E + IG+GA+G+V R+ K G A+K+++ + +R A L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 173 VDSNCIVKLYCSFQDDEF-----LYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETV 226
+ +V+L+ L L+ E++ L + + + + + + +
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
++ +H H +HRD+KP N+L+ G ++L+DFGL +
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR---------------------- 164
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346
+ +M S V T Y APEVLL+ Y D WS+G I
Sbjct: 165 --------------------IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCI 204
Query: 347 MYEMLVGYPPFYSDDPMSTCRKVRK 371
EM P F + K+
Sbjct: 205 FAEMFRRKPLFRGSSDVDQLGKILD 229
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-41
Identities = 68/263 (25%), Positives = 102/263 (38%), Gaps = 54/263 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ L +G GA+G V + TG A+KKL + + E LL +
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMRH 76
Query: 176 NCIVKLYCSFQDDEFL------YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
++ L F DE L YL+M ++ G + LM+ + L ED +F V + + +
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGL 134
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
IH IHRD+KP NL +++ L++ DFGL + D
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM------------------- 175
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348
V T Y APEV+L Y D WS+G IM
Sbjct: 176 -------------------------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMA 210
Query: 349 EMLVGYPPFYSDDPMSTCRKVRK 371
EM+ G F D + +++ K
Sbjct: 211 EMITGKTLFKGSDHLDQLKEIMK 233
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 143 bits (361), Expect = 2e-40
Identities = 57/271 (21%), Positives = 102/271 (37%), Gaps = 59/271 (21%)
Query: 99 EKKETEYMRLQRHKM---GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML 155
+ EY + H + DD++L+ +G+G + EV T +K LK
Sbjct: 15 THRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--- 71
Query: 156 RRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQD--DEFLYLIMEYLPGGDMMTLLMRKDT 212
+ + ++ E +L + I+ L +D L+ E++ D L
Sbjct: 72 ---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT--- 125
Query: 213 LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD-KYGHLRLSDFGLCKPLDCSTL 271
LT+ + RFY+ E + A++ H +HRD+KP N+++D ++ LRL D+GL +
Sbjct: 126 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185
Query: 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK 331
V + + PE+L+
Sbjct: 186 Y------------------------------------------NVRVASRYFKGPELLVD 203
Query: 332 -KGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361
+ Y D WSLG ++ M+ PF+
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 6e-40
Identities = 47/263 (17%), Positives = 89/263 (33%), Gaps = 46/263 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGH----VYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
+IG G FGEV KT+ A+K LK Q E ++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMG 64
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIE 230
+ + I++L + + +I EY+ G + L KD + + + ++
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+ +Y+HRD+ N+L++ ++SDFGL + L+
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE----------------------- 161
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
+ APE + + + D WS G +M+E+
Sbjct: 162 ---------------DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEV 206
Query: 351 LV-GYPPFYSDDPMSTCRKVRKK 372
+ G P++ + +
Sbjct: 207 MTYGERPYWELSNHEVMKAINDG 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 7e-40
Identities = 60/262 (22%), Positives = 97/262 (37%), Gaps = 52/262 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
++ L IG GA G V + A+KKL + + + E L+ V+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 75
Query: 176 NCIVKLYCSF------QDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
I+ L F ++ + +YL+ME + + M D + + + + + I
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD---HERMSYLLYQMLCGI 132
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+ +H IHRD+KP N+++ L++ DFGL + S
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF------------------- 173
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349
+ V T Y APEV+L GY D WS+G IM E
Sbjct: 174 -----------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210
Query: 350 MLVGYPPFYSDDPMSTCRKVRK 371
M+ F D + KV +
Sbjct: 211 MVRHKILFPGRDYIDQWNKVIE 232
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 9e-40
Identities = 39/255 (15%), Positives = 89/255 (34%), Gaps = 45/255 (17%)
Query: 123 MIGKGAFGEV---RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIV 179
+IG+G FG V + A+K L + G+V E ++ + ++
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 180 KLY-CSFQDDEFLYLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHKHHY 237
L + + +++ Y+ GD+ + T + + + ++ + +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 151
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
+HRD+ N +LD+ ++++DFGL + + G
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG------------------ 193
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPP 356
++A E L + + + D WS G +++E++ G PP
Sbjct: 194 -------------------AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 234
Query: 357 FYSDDPMSTCRKVRK 371
+ + + +
Sbjct: 235 YPDVNTFDITVYLLQ 249
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-39
Identities = 60/262 (22%), Positives = 102/262 (38%), Gaps = 52/262 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ ++ L+ +G GA+G V + TG A+KKL + + E LL +
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 76
Query: 176 NCIVKLYCSFQDDEFL-----YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
++ L F L ++ +L G D+ + ++ LT+D +F + + + ++
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 135
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
IH IHRD+KP NL +++ L++ DFGL + D
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------------------- 175
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYE 349
V T Y APE++L Y D WS+G IM E
Sbjct: 176 ------------------------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 211
Query: 350 MLVGYPPFYSDDPMSTCRKVRK 371
+L G F D + + + +
Sbjct: 212 LLTGRTLFPGTDHIDQLKLILR 233
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 5e-39
Identities = 54/258 (20%), Positives = 96/258 (37%), Gaps = 44/258 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+E L IG+G +G V + + T + A+K+++ + G E LL E+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV+L+ D+ L L+ E+ L + + ++ + + + H
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+ +HRD+KP NLL+++ G L+L++FGL +
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV------------------------- 155
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVG- 353
+ V T Y P+VL Y D WS G I E+
Sbjct: 156 ----------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 199
Query: 354 YPPFYSDDPMSTCRKVRK 371
P F +D +++ +
Sbjct: 200 RPLFPGNDVDDQLKRIFR 217
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 2e-38
Identities = 38/273 (13%), Positives = 93/273 (34%), Gaps = 57/273 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKT-----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
+ + +G+G+FG V K A+K + ++ +R + E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 77
Query: 171 AEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD----------TLTEDEARF 220
E + + +V+L + +IME + GD+ + L + +
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 221 YVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280
E + ++ + ++HRD+ N ++ + +++ DFG+ + + + +
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG-- 195
Query: 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340
+ +++PE L + D
Sbjct: 196 -------------------------------------LLPVRWMSPESLKDGVFTTYSDV 218
Query: 341 WSLGAIMYEML-VGYPPFYSDDPMSTCRKVRKK 372
WS G +++E+ + P+ R V +
Sbjct: 219 WSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 251
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 3e-38
Identities = 53/282 (18%), Positives = 97/282 (34%), Gaps = 66/282 (23%)
Query: 116 DDFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
+ +G GAFG+V + A+K LK S L + E + +E +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--TEREALMSELKVL 80
Query: 171 AEVDSN-CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD------------------ 211
+ + ++ IV L + +I EY GD++ L RK
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 212 TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271
L ++ + + + + + IHRD+ N+LL ++ DFGL + +
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIK---- 196
Query: 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK 331
+ ++ + ++APE +
Sbjct: 197 -----------------------------------NDSNYVVKGNARLPVKWMAPESIFN 221
Query: 332 KGYGMECDWWSLGAIMYEML-VGYPPFYSDDPMSTCRKVRKK 372
Y E D WS G ++E+ +G P+ S K+ K+
Sbjct: 222 CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE 263
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 2e-36
Identities = 55/270 (20%), Positives = 84/270 (31%), Gaps = 62/270 (22%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
A L IGKG FGEV R K G A+K E + AE +
Sbjct: 2 ARTIVLQESIGKGRFGEV--WRGKWRGEEVAVKIFSSREE----RSWFREAEIYQTVMLR 55
Query: 175 SNCIVKLYCSFQDDEF----LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
I+ + D L+L+ +Y G + L + T+T + T +
Sbjct: 56 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLA 114
Query: 231 SIH--------KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+H K HRD+K N+L+ K G ++D GL D +T
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT------------ 162
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL------KKGYGM 336
+ VGT Y+APEVL
Sbjct: 163 -------------------------DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFK 197
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDPMSTC 366
D +++G + +E+ +
Sbjct: 198 RADIYAMGLVFWEIARRCSIGGIHEDYQLP 227
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 5e-36
Identities = 49/270 (18%), Positives = 92/270 (34%), Gaps = 62/270 (22%)
Query: 116 DDFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
D +L +G+GAFG+V + T A+K LK+ + + L+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILI 71
Query: 171 AEVDSNCIVKL-YCSFQDDEFLYLIMEYLPGGDMMTLL----------------MRKDTL 213
+V L + L +I+E+ G++ T L + KD L
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 214 TEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273
T + Y + +E + IHRD+ N+LL + +++ DFGL + +
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY------ 185
Query: 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG 333
+ + ++APE + +
Sbjct: 186 ---------------------------------KDPDYVRKGDARLPLKWMAPETIFDRV 212
Query: 334 YGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
Y ++ D WS G +++E+ Y +
Sbjct: 213 YTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 5e-36
Identities = 47/281 (16%), Positives = 98/281 (34%), Gaps = 66/281 (23%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTT-------GHVYAMKKLKKSEMLRRGQVEHVRAERN 168
D L +G+GAFG+V + A+K LK + + +E
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEME 70
Query: 169 LLAEVDS-NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK----------------D 211
++ + I+ L + D LY+I+EY G++ L + +
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 212 TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271
L+ + + +E + IHRD+ N+L+ + ++++DFGL + +
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK 331
++ + ++APE L
Sbjct: 191 YKK---------------------------------------TTNGRLPVKWMAPEALFD 211
Query: 332 KGYGMECDWWSLGAIMYEML-VGYPPFYSDDPMSTCRKVRK 371
+ Y + D WS G +++E+ +G P+ + +++
Sbjct: 212 RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 252
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 116 bits (290), Expect = 5e-30
Identities = 45/264 (17%), Positives = 99/264 (37%), Gaps = 53/264 (20%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL-------L 170
+ L+ +G G F V + ++ AMK ++ ++ + ++ + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 171 AEVDSNCIVKLYCSFQD--DEFLYLIMEYLPGGDMMTLLMRKD---TLTEDEARFYVAET 225
+ +N I+KL F ++++M + G+ + L++K + + +
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 226 VLAIESIHKHHYI-HRDIKPDNLLLDKYGHLR-LSDFGLCKPLDCSTLQEQDFTIGNNLN 283
+L ++ +H+ I H DIKP+N+L++ L + + E
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-------- 186
Query: 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343
+++ T +Y +PEVLL +G D WS
Sbjct: 187 -------------------------------TNSIQTREYRSPEVLLGAPWGCGADIWST 215
Query: 344 GAIMYEMLVGYPPFYSDDPMSTCR 367
+++E++ G F D+ S +
Sbjct: 216 ACLIFELITGDFLFEPDEGHSYTK 239
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 68.3 bits (166), Expect = 4e-14
Identities = 20/160 (12%), Positives = 50/160 (31%), Gaps = 28/160 (17%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKS---------------EMLRRGQVEHVRAER 167
++G+G V C + +K K + R E
Sbjct: 7 LMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 168 NLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
L ++ + K+Y + ++ME + ++ + + + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYRV-------RVENPDEVLDMILE 114
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ + +H D+ N+L+ + G + + DF +
Sbjct: 115 EVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVG 153
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 373 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.74 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.33 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.1 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.61 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.06 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.0 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-57 Score=414.13 Aligned_cols=217 Identities=34% Similarity=0.594 Sum_probs=200.6
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 192 (373)
+..++|++++.||+|+||+||+|.++.+++.||+|++.+.........+.+.+|+.+++.++|||||++++++.+++.+|
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 82 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence 34688999999999999999999999999999999998876666666778899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcc
Q 017362 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 272 (373)
+|||||+||+|.+++.....+++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+......
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-- 160 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 160 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC--
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc--
Confidence 999999999999999988899999999999999999999999999999999999999999999999999997654221
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 352 (373)
....+||+.|||||++.+..|+.++|||||||+||||++
T Consensus 161 -----------------------------------------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~ 199 (263)
T d2j4za1 161 -----------------------------------------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 199 (263)
T ss_dssp -----------------------------------------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhc
Confidence 114679999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcC
Q 017362 353 GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 353 G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|++||.+.++.+++.+|.++
T Consensus 200 G~~Pf~~~~~~~~~~~i~~~ 219 (263)
T d2j4za1 200 GKPPFEANTYQETYKRISRV 219 (263)
T ss_dssp SSCTTCCSSHHHHHHHHHTT
T ss_pred CCCCCCCCCHHHHHHHHHcC
Confidence 99999999999999998765
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-57 Score=424.40 Aligned_cols=219 Identities=41% Similarity=0.735 Sum_probs=203.2
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 192 (373)
+..++|++++.||+|+||+||+|.++.+|+.||||++.+.........+++.+|+.+|+.++||||++++++|.+.+.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 56789999999999999999999999999999999999877666677788999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcc
Q 017362 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 272 (373)
+|||||+||+|..++.+.+.+++..++.|++||+.||.|||++|||||||||+|||++.+|++||+|||+|+.......
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~- 160 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA- 160 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999986543211
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 352 (373)
...+.+|||.|+|||++.+.+|+.++|||||||++|||++
T Consensus 161 ----------------------------------------~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~ 200 (337)
T d1o6la_ 161 ----------------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200 (337)
T ss_dssp ----------------------------------------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHH
Confidence 1225789999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcC
Q 017362 353 GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 353 G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|++||.+.+..+++++|.++
T Consensus 201 G~~pf~~~~~~~~~~~i~~~ 220 (337)
T d1o6la_ 201 GRLPFYNQDHERLFELILME 220 (337)
T ss_dssp SSCSSCCSSHHHHHHHHHHC
T ss_pred CCCCCCCcCHHHHHHHHhcC
Confidence 99999999999999998765
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-57 Score=416.94 Aligned_cols=221 Identities=36% Similarity=0.656 Sum_probs=200.4
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 192 (373)
...++|++++.||+|+||+||+|.++.+++.||||++.+.........+.+.+|+.+++.++||||++++++|.+++.+|
T Consensus 5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 84 (288)
T d1uu3a_ 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 84 (288)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred CCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence 34578999999999999999999999999999999998876666667788999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcc
Q 017362 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 272 (373)
+|||||+||+|.+++...+.+++..++.++.|++.||.|||++|||||||||+|||++.+|++||+|||+|+.+......
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 99999999999999998899999999999999999999999999999999999999999999999999999876432111
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 352 (373)
....+.+||+.|+|||++.+..|+.++|||||||+||||++
T Consensus 165 ---------------------------------------~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~ 205 (288)
T d1uu3a_ 165 ---------------------------------------ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 205 (288)
T ss_dssp --------------------------------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHH
T ss_pred ---------------------------------------cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhh
Confidence 01225689999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcC
Q 017362 353 GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 353 G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|++||.+.++.+++.+|+++
T Consensus 206 g~~Pf~~~~~~~~~~~i~~~ 225 (288)
T d1uu3a_ 206 GLPPFRAGNEYLIFQKIIKL 225 (288)
T ss_dssp SSCSSCCSSHHHHHHHHHTT
T ss_pred CCCCCCCcCHHHHHHHHHcC
Confidence 99999999999999999876
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.6e-56 Score=413.63 Aligned_cols=215 Identities=43% Similarity=0.836 Sum_probs=201.0
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEE
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 193 (373)
..++|++++.||+|+||+||+|.++.+|+.||||++.+.........+.+.+|+.+++.++|||||++++++.+++.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 35789999999999999999999999999999999988766666677889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccc
Q 017362 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (373)
Q Consensus 194 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 273 (373)
|||||+||+|..++.....+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---- 157 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 157 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999865422
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhC
Q 017362 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 353 (373)
..+.+||+.|||||++.+..|+.++|||||||++|||++|
T Consensus 158 ----------------------------------------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG 197 (316)
T d1fota_ 158 ----------------------------------------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 197 (316)
T ss_dssp ----------------------------------------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHS
T ss_pred ----------------------------------------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhC
Confidence 1256899999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcC
Q 017362 354 YPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 354 ~~Pf~~~~~~~~~~kI~~~ 372 (373)
++||.+.++.+++.+|+++
T Consensus 198 ~~Pf~~~~~~~~~~~i~~~ 216 (316)
T d1fota_ 198 YTPFYDSNTMKTYEKILNA 216 (316)
T ss_dssp SCTTCCSSHHHHHHHHHHC
T ss_pred CCCCCCcCHHHHHHHHHcC
Confidence 9999999999999999875
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-55 Score=404.21 Aligned_cols=211 Identities=31% Similarity=0.571 Sum_probs=190.4
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
.+|++++.||+|+||+||+|.++.+|+.||||++.... ....+.+.+|+.+++.++|||||+++++|.+++.+|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc---ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 57999999999999999999999999999999997653 233467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
|||+||+|.+++.+ ..+++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+......
T Consensus 97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~--- 172 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--- 172 (293)
T ss_dssp ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC---
T ss_pred EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccc---
Confidence 99999999988755 57999999999999999999999999999999999999999999999999999876432211
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 355 (373)
....+||+.|+|||++.+..|+.++|||||||++|||++|++
T Consensus 173 --------------------------------------~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~ 214 (293)
T d1yhwa1 173 --------------------------------------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214 (293)
T ss_dssp --------------------------------------BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred --------------------------------------ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCC
Confidence 124689999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHhhc
Q 017362 356 PFYSDDPMSTCRKVRK 371 (373)
Q Consensus 356 Pf~~~~~~~~~~kI~~ 371 (373)
||.+.++.+...++.+
T Consensus 215 Pf~~~~~~~~~~~~~~ 230 (293)
T d1yhwa1 215 PYLNENPLRALYLIAT 230 (293)
T ss_dssp TTTTSCHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHh
Confidence 9999998888777654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-55 Score=403.57 Aligned_cols=207 Identities=28% Similarity=0.521 Sum_probs=181.8
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|++++.||+|+||+||+|.++.+|+.||||++..... ....+.+.+|+.+++.++|||||++++++.+++.+|+|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 4789999999999999999999999999999999976532 22335688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
||||+||+|.+++.....+++..++.++.||+.||.|||++|||||||||+|||++.++++||+|||+|+.+......
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~-- 159 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-- 159 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE--
T ss_pred EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc--
Confidence 999999999999988889999999999999999999999999999999999999999999999999999865422111
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCC-ChhhcHHHHHHHHHHHHhC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G 353 (373)
....+.+||+.|||||++.+..+ +.++|||||||++|||++|
T Consensus 160 -------------------------------------~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G 202 (271)
T d1nvra_ 160 -------------------------------------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 202 (271)
T ss_dssp -------------------------------------CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred -------------------------------------ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhC
Confidence 11235789999999999998886 6789999999999999999
Q ss_pred CCCCCCCCh
Q 017362 354 YPPFYSDDP 362 (373)
Q Consensus 354 ~~Pf~~~~~ 362 (373)
++||...+.
T Consensus 203 ~~pf~~~~~ 211 (271)
T d1nvra_ 203 ELPWDQPSD 211 (271)
T ss_dssp SCSCSSSST
T ss_pred CCCCCCCCh
Confidence 999987654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-54 Score=410.70 Aligned_cols=216 Identities=41% Similarity=0.813 Sum_probs=201.0
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEE
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 192 (373)
...++|++++.||+|+||+||+|.++.+|+.||||++.+.........+.+.+|+.+|+.++|||||+++++|.+...+|
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 117 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence 34578999999999999999999999999999999998776666667788999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcc
Q 017362 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 272 (373)
+||||++||+|..++.+.+.+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+....
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~-- 195 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-- 195 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB--
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc--
Confidence 999999999999999988899999999999999999999999999999999999999999999999999998654221
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 352 (373)
.+.+||+.|||||++.+..|+.++|||||||++|||++
T Consensus 196 ------------------------------------------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemlt 233 (350)
T d1rdqe_ 196 ------------------------------------------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233 (350)
T ss_dssp ------------------------------------------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHh
Confidence 14689999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcC
Q 017362 353 GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 353 G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|++||.+.++..++.+|.++
T Consensus 234 G~~Pf~~~~~~~~~~~i~~~ 253 (350)
T d1rdqe_ 234 GYPPFFADQPIQIYEKIVSG 253 (350)
T ss_dssp SSCSSCCSSHHHHHHHHHHC
T ss_pred CCCCCCCcCHHHHHHHHhcC
Confidence 99999999999999998875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-55 Score=407.26 Aligned_cols=214 Identities=33% Similarity=0.600 Sum_probs=179.0
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.+.|++++.||+|+||+||+|.++.+++.||||++.+.... .....+.+|+.+|+.++|||||+++++|.+++.+|+|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 46799999999999999999999999999999999865432 2235678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEc---CCCcEEEeeccccccCCCCCc
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD---KYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~---~~~~vkL~DFGla~~~~~~~~ 271 (373)
||||+||+|.+++...+.+++..++.++.||+.||.|||++|||||||||+|||+. .++++||+|||+|+.......
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~ 165 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 165 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence 99999999999999888999999999999999999999999999999999999994 578999999999976532210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
..+.+||+.|||||++.+..|+.++|||||||++|||+
T Consensus 166 ------------------------------------------~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell 203 (307)
T d1a06a_ 166 ------------------------------------------LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILL 203 (307)
T ss_dssp -------------------------------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHH
Confidence 12468999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcC
Q 017362 352 VGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+|.+||.+.+..+++.+|+++
T Consensus 204 ~g~~Pf~~~~~~~~~~~i~~~ 224 (307)
T d1a06a_ 204 CGYPPFYDENDAKLFEQILKA 224 (307)
T ss_dssp HSSCSCCCSSHHHHHHHHHTT
T ss_pred hCCCCCCCCCHHHHHHHHhcc
Confidence 999999999999999998875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-55 Score=398.47 Aligned_cols=216 Identities=33% Similarity=0.617 Sum_probs=182.6
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe--CCeEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD--DEFLY 192 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~~ 192 (373)
.++|++++.||+|+||+||+|.++.+|+.||||++..... .....+.+.+|+.+++.++|||||++++++.+ .+.+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 4789999999999999999999999999999999976643 33445778899999999999999999999965 45689
Q ss_pred EEEeccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----CeeecCCCCCEEEcCCCcEEEeecccc
Q 017362 193 LIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHH-----YIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g-----iiHrDikp~NILl~~~~~vkL~DFGla 263 (373)
+|||||+||+|.+++.. ...+++..++.++.||+.||.|||++| ||||||||+|||++.+|.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999999853 467999999999999999999999876 999999999999999999999999999
Q ss_pred ccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHH
Q 017362 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (373)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSl 343 (373)
+.+..... ...+.+|||.|||||++.+..|+.++|||||
T Consensus 162 ~~~~~~~~-----------------------------------------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSl 200 (269)
T d2java1 162 RILNHDTS-----------------------------------------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSL 200 (269)
T ss_dssp HHC----------------------------------------------------CCCSCCCHHHHTTCCCCHHHHHHHH
T ss_pred eecccCCC-----------------------------------------ccccCCCCcccCCHHHHcCCCCChHHHHHhh
Confidence 87542211 1125689999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHhhcC
Q 017362 344 GAIMYEMLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 344 Gvil~ell~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
||++|||++|.+||.+.+..++..+|.++
T Consensus 201 Gvilyel~tg~~Pf~~~~~~~~~~~i~~~ 229 (269)
T d2java1 201 GCLLYELCALMPPFTAFSQKELAGKIREG 229 (269)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHHT
T ss_pred CHHHHHHhhCCCCCCCCCHHHHHHHHHcC
Confidence 99999999999999999999999998765
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-54 Score=403.79 Aligned_cols=211 Identities=29% Similarity=0.464 Sum_probs=192.2
Q ss_pred CcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEe
Q 017362 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (373)
Q Consensus 117 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E 196 (373)
.|+.++.||+|+||+||+|.+..+++.||||++...........+.+.+|+.+|+.++|||||+++++|.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 49999999999999999999999999999999987655455566778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccc
Q 017362 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (373)
Q Consensus 197 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 276 (373)
||+||+|..++.....+++..++.++.||+.||.|||++|||||||||+|||++.++++||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~------- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------- 168 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-------
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC-------
Confidence 9999999888888889999999999999999999999999999999999999999999999999999754321
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC---CCCChhhcHHHHHHHHHHHHhC
Q 017362 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~~DvwSlGvil~ell~G 353 (373)
.+.+||+.|||||++.+ ..|+.++|||||||++|||++|
T Consensus 169 --------------------------------------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g 210 (309)
T d1u5ra_ 169 --------------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 210 (309)
T ss_dssp --------------------------------------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred --------------------------------------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHC
Confidence 14679999999999964 4589999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcC
Q 017362 354 YPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 354 ~~Pf~~~~~~~~~~kI~~~ 372 (373)
.+||.+.++.+...+|.++
T Consensus 211 ~~Pf~~~~~~~~~~~i~~~ 229 (309)
T d1u5ra_ 211 KPPLFNMNAMSALYHIAQN 229 (309)
T ss_dssp SCTTTTSCHHHHHHHHHHS
T ss_pred CCCCCCCCHHHHHHHHHhC
Confidence 9999999999888888754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-55 Score=401.42 Aligned_cols=213 Identities=31% Similarity=0.526 Sum_probs=189.8
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
+.|++++.||+|+||+||+|.++.++..||||++.... ....+.+.+|+.+|+.++|||||++++++.+++.+|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 46899999999999999999999999999999987542 334566888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 196 EYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 196 E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
|||+||+|.+++.+ ...+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+......
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~---- 164 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---- 164 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH----
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc----
Confidence 99999999999765 5679999999999999999999999999999999999999999999999999987542110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccccccc-----CCCCChhhcHHHHHHHHHH
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DvwSlGvil~e 349 (373)
....+.+||+.|+|||++. ...|+.++|||||||++||
T Consensus 165 -------------------------------------~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilye 207 (288)
T d2jfla1 165 -------------------------------------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIE 207 (288)
T ss_dssp -------------------------------------HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHH
T ss_pred -------------------------------------ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHH
Confidence 0112568999999999984 4568999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhcC
Q 017362 350 MLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 350 ll~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|++|++||.+.++.+...+|+++
T Consensus 208 mltg~~Pf~~~~~~~~~~~i~~~ 230 (288)
T d2jfla1 208 MAEIEPPHHELNPMRVLLKIAKS 230 (288)
T ss_dssp HHHSSCTTTTSCGGGHHHHHHHS
T ss_pred HhhCCCCCCCCCHHHHHHHHHcC
Confidence 99999999999999999988765
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-55 Score=410.21 Aligned_cols=208 Identities=30% Similarity=0.483 Sum_probs=186.0
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeE
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 191 (373)
++..++|++++.||+|+||+||+|.++.+|+.||+|+++... .......+.+|+.+|+.++|||||+++++|.+++.+
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 79 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 79 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 456789999999999999999999999999999999987542 233456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
|+|||||+||+|.+++.+.+.+++..++.++.|++.||.|||+ +|||||||||+|||++.+|++||+|||+|+.+...
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 9999999999999999888899999999999999999999997 59999999999999999999999999999754211
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 350 (373)
...+.+||+.|+|||++.+..|+.++|||||||++|||
T Consensus 159 ------------------------------------------~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~el 196 (322)
T d1s9ja_ 159 ------------------------------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 196 (322)
T ss_dssp ------------------------------------------TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHH
T ss_pred ------------------------------------------ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHH
Confidence 12257899999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHH
Q 017362 351 LVGYPPFYSDDPMS 364 (373)
Q Consensus 351 l~G~~Pf~~~~~~~ 364 (373)
++|++||.+.+..+
T Consensus 197 l~G~~Pf~~~~~~~ 210 (322)
T d1s9ja_ 197 AVGRYPIPPPDAKE 210 (322)
T ss_dssp HHSSCCSSCCCTTH
T ss_pred HHCCCCCCCCCHHH
Confidence 99999998876543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=399.97 Aligned_cols=216 Identities=39% Similarity=0.742 Sum_probs=196.5
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHH-hcCCCceeEEeeEEEeCCeEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA-EVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
++|++++.||+|+||+||+|.++.+++.||||++.+.........+.+..|..++. .++|||||++++++.+++.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 68999999999999999999999999999999998876655666677777877765 68999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
||||+||+|.+++.....+++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+........
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~-- 159 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-- 159 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC--
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccccc--
Confidence 999999999999998889999999999999999999999999999999999999999999999999999865422111
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 354 (373)
....+||+.|+|||++.+..|+.++|||||||++|||++|+
T Consensus 160 ---------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~ 200 (320)
T d1xjda_ 160 ---------------------------------------TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 200 (320)
T ss_dssp ---------------------------------------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred ---------------------------------------ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCC
Confidence 11468999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcC
Q 017362 355 PPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 355 ~Pf~~~~~~~~~~kI~~~ 372 (373)
+||.+.++.+++.+|.++
T Consensus 201 ~PF~~~~~~~~~~~i~~~ 218 (320)
T d1xjda_ 201 SPFHGQDEEELFHSIRMD 218 (320)
T ss_dssp CSSCCSSHHHHHHHHHHC
T ss_pred CCCCCCCHHHHHHHHHcC
Confidence 999999999999998765
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1e-53 Score=404.65 Aligned_cols=213 Identities=31% Similarity=0.555 Sum_probs=192.3
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|++++.||+|+||+||+|.++.+|+.||||++..... ...+.+.+|+.+|+.++|||||+++++|.+++.+|+|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4689999999999999999999999999999999976532 2346688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC--CCcEEEeeccccccCCCCCc
Q 017362 195 MEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK--YGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~--~~~vkL~DFGla~~~~~~~~ 271 (373)
||||+||+|.+++.. .+.+++..++.|+.||+.||.|||++|||||||||+|||++. ++.+||+|||+|+.+.....
T Consensus 102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 999999999999854 457999999999999999999999999999999999999964 68999999999987653321
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
..+.+||+.|||||++.+..|+.++|||||||++|||+
T Consensus 182 ------------------------------------------~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell 219 (350)
T d1koaa2 182 ------------------------------------------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL 219 (350)
T ss_dssp ------------------------------------------EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHH
Confidence 11468999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcC
Q 017362 352 VGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+|++||.+.+..+++.+|.++
T Consensus 220 ~G~~Pf~~~~~~~~~~~i~~~ 240 (350)
T d1koaa2 220 SGLSPFGGENDDETLRNVKSC 240 (350)
T ss_dssp HSSCSSCCSSHHHHHHHHHHT
T ss_pred hCCCCCCCCCHHHHHHHHHhC
Confidence 999999999999999998764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=393.66 Aligned_cols=216 Identities=31% Similarity=0.559 Sum_probs=194.8
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhh---hhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR---GQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 191 (373)
.++|++++.||+|+||+||+|.++.+|+.||||++.+...... ...+.+.+|+.+|+.++|||||+++++|.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 4679999999999999999999999999999999976533221 2356789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC----cEEEeeccccccCC
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG----HLRLSDFGLCKPLD 267 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~----~vkL~DFGla~~~~ 267 (373)
|+|||||+||+|.+++...+.+++..++.++.|++.||.|||++|||||||||+|||++.++ ++||+|||+|+...
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 99999999999999998888999999999999999999999999999999999999998776 59999999998764
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 347 (373)
.... ..+.+||+.|+|||++.+..|+.++|||||||++
T Consensus 169 ~~~~------------------------------------------~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvil 206 (293)
T d1jksa_ 169 FGNE------------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 206 (293)
T ss_dssp TSCB------------------------------------------CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred CCcc------------------------------------------ccccCCCCcccCHHHHcCCCCCCcccchhhhHHH
Confidence 3321 1146799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhhcC
Q 017362 348 YEMLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 348 ~ell~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|||++|.+||.+.+..+++.+|.++
T Consensus 207 yell~g~~Pf~~~~~~~~~~~i~~~ 231 (293)
T d1jksa_ 207 YILLSGASPFLGDTKQETLANVSAV 231 (293)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHTT
T ss_pred HHHHcCCCCCCCCCHHHHHHHHHhc
Confidence 9999999999999999999998775
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.4e-53 Score=402.44 Aligned_cols=213 Identities=29% Similarity=0.584 Sum_probs=192.0
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|++++.||+|+||+||+|.++.+|+.||||++...... ....+.+|+.+|+.++|||||+++++|.+++.+|+|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 36799999999999999999999999999999998765322 235678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEc--CCCcEEEeeccccccCCCCCc
Q 017362 195 MEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD--KYGHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~--~~~~vkL~DFGla~~~~~~~~ 271 (373)
||||+||+|.+++...+ .+++..++.++.||+.||.|||++|||||||||+||||+ .++++||+|||+|+.+.....
T Consensus 105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 99999999998876654 699999999999999999999999999999999999998 578999999999987653321
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
..+.+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 185 ------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 222 (352)
T d1koba_ 185 ------------------------------------------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL 222 (352)
T ss_dssp ------------------------------------------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHH
Confidence 12468999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcC
Q 017362 352 VGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+|.+||.+.+..+.+.+|.++
T Consensus 223 tG~~Pf~~~~~~~~~~~i~~~ 243 (352)
T d1koba_ 223 SGLSPFAGEDDLETLQNVKRC 243 (352)
T ss_dssp HSCCSSCCSSHHHHHHHHHHC
T ss_pred hCCCCCCCCCHHHHHHHHHhC
Confidence 999999999999999998764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=383.22 Aligned_cols=210 Identities=24% Similarity=0.428 Sum_probs=182.9
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe----CCeEEE
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD----DEFLYL 193 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~----~~~~~l 193 (373)
|++.++||+|+||+||+|.+..++..||+|++..... .....+.+.+|+.+|+.++|||||+++++|.+ ...+|+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 3677889999999999999999999999999876543 23445678999999999999999999999875 456899
Q ss_pred EEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeeecCCCCCEEEc-CCCcEEEeeccccccCCCCC
Q 017362 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH--YIHRDIKPDNLLLD-KYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 194 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiHrDikp~NILl~-~~~~vkL~DFGla~~~~~~~ 270 (373)
||||++||+|.+++.+...+++..++.++.||+.||.|||+++ ||||||||+|||++ .++++||+|||+|+......
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~ 169 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 169 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc
Confidence 9999999999999988889999999999999999999999998 99999999999996 57999999999997543221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 350 (373)
..+.+|||.|||||++.+ .|+.++|||||||++|||
T Consensus 170 -------------------------------------------~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel 205 (270)
T d1t4ha_ 170 -------------------------------------------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEM 205 (270)
T ss_dssp -------------------------------------------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHH
T ss_pred -------------------------------------------cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHH
Confidence 125689999999999865 699999999999999999
Q ss_pred HhCCCCCCCC-ChHHHHHHhhcC
Q 017362 351 LVGYPPFYSD-DPMSTCRKVRKK 372 (373)
Q Consensus 351 l~G~~Pf~~~-~~~~~~~kI~~~ 372 (373)
++|++||.+. +..+.+++|.++
T Consensus 206 ~~g~~Pf~~~~~~~~~~~~i~~~ 228 (270)
T d1t4ha_ 206 ATSEYPYSECQNAAQIYRRVTSG 228 (270)
T ss_dssp HHSSCTTTTCSSHHHHHHHHTTT
T ss_pred HHCCCCCCCcccHHHHHHHHHcC
Confidence 9999999865 456666776654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.1e-53 Score=401.11 Aligned_cols=207 Identities=36% Similarity=0.660 Sum_probs=182.5
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHH---HHHHHhcCCCceeEEeeEEEeCCe
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAE---RNLLAEVDSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e---~~~l~~l~h~~iv~l~~~~~~~~~ 190 (373)
..++|++++.||+|+||+||+|.++.+|+.||||++.+...........+.+| +.+++.++|||||+++++|.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 56899999999999999999999999999999999987655444333334444 666777789999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
+|+|||||+||+|.+++.+...+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~ 161 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 161 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc
Confidence 99999999999999999988999999999999999999999999999999999999999999999999999998654321
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~e 349 (373)
....+||+.|+|||++.. ..|+.++|||||||+|||
T Consensus 162 -------------------------------------------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilye 198 (364)
T d1omwa3 162 -------------------------------------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFK 198 (364)
T ss_dssp -------------------------------------------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHH
T ss_pred -------------------------------------------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHH
Confidence 114689999999999975 569999999999999999
Q ss_pred HHhCCCCCCCCChH
Q 017362 350 MLVGYPPFYSDDPM 363 (373)
Q Consensus 350 ll~G~~Pf~~~~~~ 363 (373)
|++|++||.+.+..
T Consensus 199 mltG~~Pf~~~~~~ 212 (364)
T d1omwa3 199 LLRGHSPFRQHKTK 212 (364)
T ss_dssp HHHSSCSSCSSCSS
T ss_pred HHhCCCCCCCCCHH
Confidence 99999999876543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.7e-53 Score=387.20 Aligned_cols=220 Identities=26% Similarity=0.452 Sum_probs=189.1
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC----e
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----F 190 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~----~ 190 (373)
.++|++.+.||+|+||+||+|.+..+|+.||||++.+....+......+.+|+.+++.++|||||++++++.+.+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 578999999999999999999999999999999998765545556678999999999999999999999998654 3
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCC
Q 017362 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 270 (373)
+|+||||++||+|..++...+.+++..++.++.||+.||.|||++|||||||||+|||++.++.++|+|||++.......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 89999999999999999888899999999999999999999999999999999999999999999999999987654321
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 350 (373)
.. .....+.+||+.|+|||++.+..|+.++|||||||++|||
T Consensus 166 ~~--------------------------------------~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyel 207 (277)
T d1o6ya_ 166 NS--------------------------------------VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 207 (277)
T ss_dssp ---------------------------------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cc--------------------------------------ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHH
Confidence 11 0012256899999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcC
Q 017362 351 LVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 351 l~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
++|.+||.+.++.+...+++++
T Consensus 208 ltG~~Pf~~~~~~~~~~~~~~~ 229 (277)
T d1o6ya_ 208 LTGEPPFTGDSPVSVAYQHVRE 229 (277)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHC
T ss_pred HhCCCCCCCcCHHHHHHHHHhc
Confidence 9999999999999988887754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4e-52 Score=381.64 Aligned_cols=216 Identities=32% Similarity=0.580 Sum_probs=193.0
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhh------hhhHHHHHHHHHHHHhcC-CCceeEEeeEEEe
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR------RGQVEHVRAERNLLAEVD-SNCIVKLYCSFQD 187 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~ 187 (373)
.++|++++.||+|+||+||+|+++.+|+.||||++.+..... ....+.+.+|+.+++.++ ||||++++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 478999999999999999999999999999999987643221 223356888999999997 9999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 188 DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 188 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
++.+|||||||+||||.+++...+.+++..++.++.||+.||.|||++|||||||||+|||++.++++||+|||+|+.+.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999888899999999999999999999999999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC------CCCChhhcHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK------KGYGMECDWW 341 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~~~~~Dvw 341 (373)
.... ....+||+.|+|||++.+ ..++.++|||
T Consensus 162 ~~~~------------------------------------------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~Diw 199 (277)
T d1phka_ 162 PGEK------------------------------------------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMW 199 (277)
T ss_dssp TTCC------------------------------------------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHH
T ss_pred CCCc------------------------------------------eeeeeccCCCCCHHHhhccccccCCCCCchheEc
Confidence 3211 114679999999999863 4578999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHhhcC
Q 017362 342 SLGAIMYEMLVGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 342 SlGvil~ell~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|+||++|||++|.+||.+.++.+...+|+++
T Consensus 200 slGvilyeml~g~~Pf~~~~~~~~~~~i~~~ 230 (277)
T d1phka_ 200 STGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 230 (277)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred ccchhhhhhccCCCCCCCCCHHHHHHHHHhC
Confidence 9999999999999999999999999998876
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-52 Score=390.24 Aligned_cols=212 Identities=26% Similarity=0.448 Sum_probs=191.6
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV 194 (373)
.++|++++.||+|+||+||+|.++.+++.||||++..... ....+.+|+.+|+.++|||||+++++|.+++.+|+|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 5789999999999999999999999999999999976532 234578899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCC--CcEEEeeccccccCCCCCc
Q 017362 195 MEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY--GHLRLSDFGLCKPLDCSTL 271 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~--~~vkL~DFGla~~~~~~~~ 271 (373)
||||+||+|.+++...+ .+++..++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.......
T Consensus 80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence 99999999999997665 79999999999999999999999999999999999999854 4899999999986543221
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHH
Q 017362 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (373)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 351 (373)
..+.+||+.|+|||.+.+..|+.++|||||||++|+|+
T Consensus 160 ------------------------------------------~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll 197 (321)
T d1tkia_ 160 ------------------------------------------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL 197 (321)
T ss_dssp ------------------------------------------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------ccccccccccccchhccCCCCCchhhcccHHHHHHHHH
Confidence 12467999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcC
Q 017362 352 VGYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 352 ~G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+|.+||.+.+..+++.+|+++
T Consensus 198 ~G~~Pf~~~~~~~~~~~i~~~ 218 (321)
T d1tkia_ 198 SGINPFLAETNQQIIENIMNA 218 (321)
T ss_dssp HSSCTTCCSSHHHHHHHHHHT
T ss_pred hCCCCCCCCCHHHHHHHHHhC
Confidence 999999999999999999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-52 Score=386.58 Aligned_cols=220 Identities=22% Similarity=0.372 Sum_probs=190.6
Q ss_pred hhhccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe
Q 017362 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (373)
Q Consensus 108 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 187 (373)
+.++++..++|++.+.||+|+||+||+|.++.+++.||||+++... ...+.+.+|+.+|+.++|||||+++++|.+
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhCCCCCEecCCccEee
Confidence 3456778889999999999999999999999999999999987542 234568899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 188 DEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 188 ~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
++.+|+|||||++|+|.+++... ..+++..+..++.|++.||.|||++|||||||||+|||++.++++||+|||+|+.
T Consensus 85 ~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceee
Confidence 99999999999999999999764 5789999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHH
Q 017362 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (373)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGv 345 (373)
........ .....||+.|+|||++.+..|+.++|||||||
T Consensus 165 ~~~~~~~~----------------------------------------~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv 204 (287)
T d1opja_ 165 MTGDTYTA----------------------------------------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 204 (287)
T ss_dssp CCSSSSEE----------------------------------------ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHH
T ss_pred cCCCCcee----------------------------------------eccccccccccChHHHcCCCCCchhhhhhHHH
Confidence 64332111 11356899999999999999999999999999
Q ss_pred HHHHHHhCC-CCCCCCChHHHHHHhhc
Q 017362 346 IMYEMLVGY-PPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 346 il~ell~G~-~Pf~~~~~~~~~~kI~~ 371 (373)
++|||++|. +||.+.+..+..+.|.+
T Consensus 205 ~l~ell~~~~p~~~~~~~~~~~~~i~~ 231 (287)
T d1opja_ 205 LLWEIATYGMSPYPGIDLSQVYELLEK 231 (287)
T ss_dssp HHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred HHHHHHhCCCCCCCcchHHHHHHHHhc
Confidence 999999955 55556666666655543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-52 Score=380.57 Aligned_cols=215 Identities=19% Similarity=0.276 Sum_probs=178.9
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCe
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 190 (373)
+++..++|++.+.||+|+||+||+|..+ ..||||+++.... .....+.+.+|+.+|..++|||||++++++. .+.
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~ 77 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQ 77 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccE
Confidence 4677899999999999999999999753 3699999975532 3445678999999999999999999999765 456
Q ss_pred EEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 191 LYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 191 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
+|+|||||+||+|.+++... ..+++..+..++.||+.||.|||++|||||||||+|||++.++++||+|||+|+.....
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 89999999999999999754 56999999999999999999999999999999999999999999999999999765422
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC---CCCChhhcHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGAI 346 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~~DvwSlGvi 346 (373)
... ....+.+||+.|||||++.+ ..|+.++|||||||+
T Consensus 158 ~~~---------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~ 198 (276)
T d1uwha_ 158 SGS---------------------------------------HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIV 198 (276)
T ss_dssp -----------------------------------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHH
T ss_pred CCc---------------------------------------ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHH
Confidence 110 00125689999999999974 358999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHh
Q 017362 347 MYEMLVGYPPFYSDDPMSTCRKV 369 (373)
Q Consensus 347 l~ell~G~~Pf~~~~~~~~~~kI 369 (373)
||||+||++||.+.++......+
T Consensus 199 l~el~tg~~Pf~~~~~~~~~~~~ 221 (276)
T d1uwha_ 199 LYELMTGQLPYSNINNRDQIIFM 221 (276)
T ss_dssp HHHHHHSSCTTTTCCCHHHHHHH
T ss_pred HHHHHHCCCCCCCCChHHHHHHH
Confidence 99999999999987766554443
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-51 Score=383.16 Aligned_cols=223 Identities=21% Similarity=0.358 Sum_probs=180.7
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCCc---eEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGH---VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 188 (373)
++..++|++.+.||+|+||+||+|.++.++. .||||.+.... .....+.+.+|+.+|+.++|||||++++++.++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 4556889999999999999999999876654 58899886532 233456789999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
+.+|+|||||+||+|.+++... +.+++..+..++.||+.||.|||++|||||||||+||||+.++++||+|||+|+.+.
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999999999988764 579999999999999999999999999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 347 (373)
....... ........||+.|||||++.+..|+.++|||||||+|
T Consensus 180 ~~~~~~~------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl 223 (299)
T d1jpaa_ 180 DDTSDPT------------------------------------YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVM 223 (299)
T ss_dssp ----------------------------------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHH
T ss_pred CCCCcce------------------------------------eeecccccCCccccCHHHHhcCCCCcccccccchHHH
Confidence 3221100 0001134689999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 348 YEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 348 ~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|||+| |.+||.+.++.+...+|.++
T Consensus 224 ~el~t~g~~Pf~~~~~~~~~~~i~~~ 249 (299)
T d1jpaa_ 224 WEVMSYGERPYWDMTNQDVINAIEQD 249 (299)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99998 89999999999999888764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=374.68 Aligned_cols=214 Identities=19% Similarity=0.329 Sum_probs=179.7
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEE
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 193 (373)
..++|++++.||+|+||+||+|.+. ++..||||++.... ...+.+.+|+.+++.++|||||++++++.+++.+|+
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l 77 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 77 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc----CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence 4678999999999999999999875 56789999997543 223568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcc
Q 017362 194 IMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 194 V~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 272 (373)
||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+........
T Consensus 78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 99999999999998654 56899999999999999999999999999999999999999999999999999865432111
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 352 (373)
......||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 158 ----------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t 197 (263)
T d1sm2a_ 158 ----------------------------------------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 197 (263)
T ss_dssp -----------------------------------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHT
T ss_pred ----------------------------------------eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHH
Confidence 0113579999999999999999999999999999999999
Q ss_pred -CCCCCCCCChHHHHHHhhcC
Q 017362 353 -GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 353 -G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|.+||...+..+...+|.++
T Consensus 198 ~~~~~~~~~~~~~~~~~i~~~ 218 (263)
T d1sm2a_ 198 EGKIPYENRSNSEVVEDISTG 218 (263)
T ss_dssp TSCCTTCSCCHHHHHHHHHHT
T ss_pred CCCCCCCCCCHHHHHHHHHhc
Confidence 68888888888888888764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=386.47 Aligned_cols=220 Identities=23% Similarity=0.388 Sum_probs=185.7
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCCc-----eEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeE
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGH-----VYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCS 184 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~ 184 (373)
+++..++|++.+.||+|+||+||+|.+..+++ .||+|.+.... .......+.+|+.++..+ +|||||+++++
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~ 109 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGA 109 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence 35667899999999999999999999876543 69999886543 233446688899999988 89999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHhhC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeec
Q 017362 185 FQDDEFLYLIMEYLPGGDMMTLLMRK-----------------------DTLTEDEARFYVAETVLAIESIHKHHYIHRD 241 (373)
Q Consensus 185 ~~~~~~~~lV~E~~~gg~L~~~l~~~-----------------------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrD 241 (373)
+.+.+.+|+|||||+||+|.+++... ..+++..+..|+.|++.||.|||++||||||
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD 189 (325)
T d1rjba_ 110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189 (325)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 99999999999999999999999654 2489999999999999999999999999999
Q ss_pred CCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCC
Q 017362 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTP 321 (373)
Q Consensus 242 ikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 321 (373)
|||+|||++.++++||+|||+|+........ ....+.+||+
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~---------------------------------------~~~~~~~gt~ 230 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNY---------------------------------------VVRGNARLPV 230 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTS---------------------------------------EEETTEEECG
T ss_pred CchhccccccCCeEEEeeccccccccCCCce---------------------------------------eeeccccCCC
Confidence 9999999999999999999999865432111 0112457899
Q ss_pred CCcccccccCCCCChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhc
Q 017362 322 DYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 322 ~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
.|||||++.+..|+.++|||||||++|||++ |.+||.+.+..+...++++
T Consensus 231 ~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~ 281 (325)
T d1rjba_ 231 KWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ 281 (325)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH
T ss_pred ccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 9999999999999999999999999999998 9999998877777666654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=382.07 Aligned_cols=211 Identities=30% Similarity=0.487 Sum_probs=181.6
Q ss_pred eeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhh--hhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEec
Q 017362 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR--GQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (373)
Q Consensus 120 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~ 197 (373)
.+++||+|+||+||+|.++.+|+.||||++........ .....+.+|+.+++.++|||||+++++|.+++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 46889999999999999999999999999976543221 1234688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccccc
Q 017362 198 LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT 277 (373)
Q Consensus 198 ~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 277 (373)
++|+++..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+........
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~----- 156 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA----- 156 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-----
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccc-----
Confidence 999888877777778999999999999999999999999999999999999999999999999999865432111
Q ss_pred ccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHHHHHHHHHHHhCCCC
Q 017362 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGYPP 356 (373)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~P 356 (373)
..+.+||+.|+|||++... .|+.++|||||||++|||++|.+|
T Consensus 157 ------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~p 200 (299)
T d1ua2a_ 157 ------------------------------------YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF 200 (299)
T ss_dssp ------------------------------------CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred ------------------------------------ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCC
Confidence 1146899999999998754 589999999999999999999999
Q ss_pred CCCCChHHHHHHhhc
Q 017362 357 FYSDDPMSTCRKVRK 371 (373)
Q Consensus 357 f~~~~~~~~~~kI~~ 371 (373)
|.+.+..++..+|.+
T Consensus 201 f~~~~~~~~l~~i~~ 215 (299)
T d1ua2a_ 201 LPGDSDLDQLTRIFE 215 (299)
T ss_dssp SCCSSHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHH
Confidence 999999999888764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-51 Score=375.85 Aligned_cols=219 Identities=23% Similarity=0.392 Sum_probs=187.4
Q ss_pred CCCCCcceece-eeeeCcEEEEEEEEcC--CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC
Q 017362 113 MGADDFELLTM-IGKGAFGEVRVCREKT--TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 113 ~~~~~y~~~~~-lG~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 189 (373)
+..++|.+... ||+|+||+||+|.++. ++..||||++.... .....+.+.+|+.+|+.++|||||++++++.+ +
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 81 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C
Confidence 44567888884 9999999999998754 45579999987542 23445678999999999999999999999875 4
Q ss_pred eEEEEEeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
.+|+|||||+||+|.+++.. +..+++..+..++.|++.||.|||++|||||||||+|||++.++++||+|||+|+.+..
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 68999999999999999765 45799999999999999999999999999999999999999999999999999987653
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 348 (373)
...... ......||+.|+|||++.+..|+.++|||||||++|
T Consensus 162 ~~~~~~--------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~ 203 (285)
T d1u59a_ 162 DDSYYT--------------------------------------ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMW 203 (285)
T ss_dssp CSCEEC--------------------------------------CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred cccccc--------------------------------------cccccccCccccChHHHhCCCCCccchhhcchHHHH
Confidence 321110 011457999999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 349 EMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 349 ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
||++ |.+||.+.+..++...|.++
T Consensus 204 E~lt~G~~Pf~~~~~~~~~~~i~~~ 228 (285)
T d1u59a_ 204 EALSYGQKPYKKMKGPEVMAFIEQG 228 (285)
T ss_dssp HHHTTSCCTTTTCCTHHHHHHHHTT
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9998 99999999999998888765
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=374.47 Aligned_cols=217 Identities=23% Similarity=0.408 Sum_probs=186.8
Q ss_pred hccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC
Q 017362 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 110 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 189 (373)
.+++..++|++.+.||+|+||+||+|.++ ++..||||++.... ...+.+.+|+.++..++|||||++++++.+ +
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~ 80 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc----CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence 34567789999999999999999999975 56789999997542 234568999999999999999999998754 5
Q ss_pred eEEEEEeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++++||+|||+|+.+.
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence 678999999999999987543 369999999999999999999999999999999999999999999999999998765
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 347 (373)
...... .....||+.|+|||++.+..|+.++|||||||++
T Consensus 161 ~~~~~~----------------------------------------~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl 200 (272)
T d1qpca_ 161 DNEYTA----------------------------------------REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200 (272)
T ss_dssp SSCEEC----------------------------------------CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHH
T ss_pred CCcccc----------------------------------------ccccCCcccccChHHHhCCCCCchhhhhhhHHHH
Confidence 332111 1145799999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 348 YEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 348 ~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|||+| |.+||...+..+....|.++
T Consensus 201 ~ellt~~~~~~~~~~~~~~~~~i~~~ 226 (272)
T d1qpca_ 201 TEIVTHGRIPYPGMTNPEVIQNLERG 226 (272)
T ss_dssp HHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHhc
Confidence 99999 67778888888888888764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-51 Score=374.71 Aligned_cols=211 Identities=22% Similarity=0.345 Sum_probs=180.3
Q ss_pred ceeeeeCcEEEEEEEEc--CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEEeccC
Q 017362 122 TMIGKGAFGEVRVCREK--TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLP 199 (373)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~ 199 (373)
++||+|+||+||+|.+. .+++.||||+++... .+....+.+.+|+.+|+.++|||||++++++.+ +..|+||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 57999999999999864 355789999997543 334455779999999999999999999999865 45789999999
Q ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccccccc
Q 017362 200 GGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279 (373)
Q Consensus 200 gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 279 (373)
+|+|.+++.....+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.+........
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~----- 165 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK----- 165 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE-----
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccc-----
Confidence 999999999888999999999999999999999999999999999999999999999999999987643321110
Q ss_pred CCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh-CCCCCC
Q 017362 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFY 358 (373)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf~ 358 (373)
......||+.|+|||++.+..|+.++|||||||++|||++ |.+||.
T Consensus 166 ---------------------------------~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~ 212 (277)
T d1xbba_ 166 ---------------------------------AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 212 (277)
T ss_dssp ---------------------------------C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ---------------------------------cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCC
Confidence 0114579999999999999999999999999999999998 999999
Q ss_pred CCChHHHHHHhhcC
Q 017362 359 SDDPMSTCRKVRKK 372 (373)
Q Consensus 359 ~~~~~~~~~kI~~~ 372 (373)
+.+..+....|.++
T Consensus 213 ~~~~~~~~~~i~~~ 226 (277)
T d1xbba_ 213 GMKGSEVTAMLEKG 226 (277)
T ss_dssp TCCHHHHHHHHHTT
T ss_pred CCCHHHHHHHHHcC
Confidence 99999988888765
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=385.87 Aligned_cols=203 Identities=34% Similarity=0.588 Sum_probs=174.6
Q ss_pred CCCcceec-eeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHh-cCCCceeEEeeEEEe----C
Q 017362 115 ADDFELLT-MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE-VDSNCIVKLYCSFQD----D 188 (373)
Q Consensus 115 ~~~y~~~~-~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~l~~~~~~----~ 188 (373)
.++|.++. .||+|+||+||+|.+..+++.||||++.... .+.+|+.++.+ .+|||||+++++|.+ .
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--------~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSH--------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcH--------HHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 57899885 5999999999999999999999999986542 36678888655 589999999999976 4
Q ss_pred CeEEEEEeccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC---CCcEEEeecccc
Q 017362 189 EFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---YGHLRLSDFGLC 263 (373)
Q Consensus 189 ~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~---~~~vkL~DFGla 263 (373)
..+|+|||||+||+|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++. ++++||+|||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 6789999999999999999764 36999999999999999999999999999999999999985 567999999999
Q ss_pred ccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHH
Q 017362 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (373)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSl 343 (373)
+....... ....+||+.|||||++.+..|+.++|||||
T Consensus 162 ~~~~~~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~y~~~~DiwSl 199 (335)
T d2ozaa1 162 KETTSHNS------------------------------------------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 199 (335)
T ss_dssp EECCCCCC------------------------------------------CCCCSCCCSSCCCCCCCGGGGSHHHHHHHH
T ss_pred eeccCCCc------------------------------------------cccccCCcccCCcHHHcCCCCCHHHHHHhh
Confidence 86543321 114689999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHH
Q 017362 344 GAIMYEMLVGYPPFYSDDPMSTCR 367 (373)
Q Consensus 344 Gvil~ell~G~~Pf~~~~~~~~~~ 367 (373)
||+||+|++|++||.+.+..+...
T Consensus 200 Gvily~lltg~~Pf~~~~~~~~~~ 223 (335)
T d2ozaa1 200 GVIMYILLCGYPPFYSNHGLAISP 223 (335)
T ss_dssp HHHHHHHTTSSCSCEETTCC----
T ss_pred chhHHHHhhCCCCCCCCCHHHHHH
Confidence 999999999999998876555443
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=366.64 Aligned_cols=214 Identities=21% Similarity=0.418 Sum_probs=190.2
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEE
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 193 (373)
..++|+++++||+|+||+||+|.++ ++..||||++++... ..+.+.+|+.++..++||||+++++++.+++.+|+
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC----CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence 4589999999999999999999984 678999999986532 23568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcc
Q 017362 194 IMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (373)
Q Consensus 194 V~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 272 (373)
||||+++|+|..++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++++||+|||+|+.+......
T Consensus 77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 9999999999998654 457999999999999999999999999999999999999999999999999999865433211
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHh
Q 017362 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (373)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 352 (373)
. .....||+.|+|||++.+..|+.++|||||||++|||+|
T Consensus 157 ~----------------------------------------~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t 196 (258)
T d1k2pa_ 157 S----------------------------------------SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 196 (258)
T ss_dssp C----------------------------------------CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred e----------------------------------------ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHh
Confidence 0 113569999999999999999999999999999999998
Q ss_pred -CCCCCCCCChHHHHHHhhcC
Q 017362 353 -GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 353 -G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|++||.+.+..++..+|.++
T Consensus 197 ~g~~Pf~~~~~~~~~~~i~~~ 217 (258)
T d1k2pa_ 197 LGKMPYERFTNSETAEHIAQG 217 (258)
T ss_dssp TSCCTTTTSCHHHHHHHHHTT
T ss_pred cCCCCCCCCCHHHHHHHHHhC
Confidence 89999999999999998875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-50 Score=367.57 Aligned_cols=219 Identities=24% Similarity=0.372 Sum_probs=180.1
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCC---CceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTT---GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 187 (373)
.++..++|++.+.||+|+||+||+|.+..+ +..||||.+.... .....+.+.+|+.+++.++|||||++++++.
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 356678999999999999999999988654 3468899886432 2344567899999999999999999999986
Q ss_pred CCeEEEEEeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccC
Q 017362 188 DEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (373)
Q Consensus 188 ~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~ 266 (373)
.+.+|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.+
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence 4678999999999999998765 457999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHH
Q 017362 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (373)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvi 346 (373)
...... ......||+.|+|||++.+..|+.++|||||||+
T Consensus 159 ~~~~~~----------------------------------------~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvi 198 (273)
T d1mp8a_ 159 EDSTYY----------------------------------------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVC 198 (273)
T ss_dssp ----------------------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHH
T ss_pred cCCcce----------------------------------------eccceecCcccchhhHhccCCCCCccccccchHH
Confidence 432111 0124578999999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 347 MYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 347 l~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+|||++ |.+||.+.++.+.+.+|.++
T Consensus 199 l~e~lt~g~~P~~~~~~~~~~~~i~~~ 225 (273)
T d1mp8a_ 199 MWEILMHGVKPFQGVKNNDVIGRIENG 225 (273)
T ss_dssp HHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 999998 99999999999999998876
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-50 Score=370.57 Aligned_cols=213 Identities=30% Similarity=0.460 Sum_probs=181.5
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++++.||+|+||+||+|.+..+|+.||||++.... ......+.+.+|+.+|+.++|||||+++++|.+++.+|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 68999999999999999999999999999999997653 22334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCcccc
Q 017362 196 EYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (373)
Q Consensus 196 E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 274 (373)
||+.++.+...... ...+++..++.++.|++.||.|||++|||||||||+|||++.++++||+|||+|+........
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~-- 158 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-- 158 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC--
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccc--
Confidence 99966544433333 456999999999999999999999999999999999999999999999999999765432111
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC-CChhhcHHHHHHHHHHHHhC
Q 017362 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVG 353 (373)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~ell~G 353 (373)
....+||+.|+|||++.... ++.++|||||||++|+|++|
T Consensus 159 ---------------------------------------~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G 199 (298)
T d1gz8a_ 159 ---------------------------------------YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199 (298)
T ss_dssp ---------------------------------------TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred ---------------------------------------ceeecccceeeehhhhccccCCCccccccccchhhhHHhhC
Confidence 12468999999999988766 48899999999999999999
Q ss_pred CCCCCCCChHHHHHHhh
Q 017362 354 YPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 354 ~~Pf~~~~~~~~~~kI~ 370 (373)
++||.+.+..+...+|.
T Consensus 200 ~~Pf~~~~~~~~~~~i~ 216 (298)
T d1gz8a_ 200 RALFPGDSEIDQLFRIF 216 (298)
T ss_dssp SCSCCCSSHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHH
Confidence 99999999888877765
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=367.05 Aligned_cols=221 Identities=21% Similarity=0.335 Sum_probs=181.6
Q ss_pred cCCCCCcceeceeeeeCcEEEEEEEEcCCC----ceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe
Q 017362 112 KMGADDFELLTMIGKGAFGEVRVCREKTTG----HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (373)
Q Consensus 112 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 187 (373)
++..+.|++.++||+|+||+||+|.++.++ ..||||++.... .......+.+|+.+++.++|||||++++++.+
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~ 80 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 80 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec
Confidence 566788999999999999999999887654 469999986542 23344568899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccC
Q 017362 188 DEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (373)
Q Consensus 188 ~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~ 266 (373)
.+.+++|||||.+|++.+++... ..+++..+..++.|++.||.|||+++||||||||+||||+.++++||+|||+|+.+
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999999999988654 57999999999999999999999999999999999999999999999999999875
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHH
Q 017362 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (373)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvi 346 (373)
....... .......||+.|+|||++.+..|+.++|||||||+
T Consensus 161 ~~~~~~~--------------------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvi 202 (283)
T d1mqba_ 161 EDDPEAT--------------------------------------YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIV 202 (283)
T ss_dssp ---------------------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHH
T ss_pred cCCCccc--------------------------------------eEeccCCCCccccCHHHHccCCCCCcccccccHHH
Confidence 4321100 00113568999999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 347 MYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 347 l~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
+|||++ |.+||...+..+.+..|.++
T Consensus 203 l~el~t~~~~~~~~~~~~~~~~~i~~~ 229 (283)
T d1mqba_ 203 MWEVMTYGERPYWELSNHEVMKAINDG 229 (283)
T ss_dssp HHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred HHHHHhCCCCccccCCHHHHHHHHhcc
Confidence 999999 56677777888888777654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=369.26 Aligned_cols=217 Identities=21% Similarity=0.363 Sum_probs=180.6
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCc----eEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGH----VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 189 (373)
..++|++++.||+|+||+||+|.+..+|+ .||+|.+.... .....+.+.+|+.+++.++|||||++++++.++
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~- 83 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 83 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 45789999999999999999999987776 47888776432 233456789999999999999999999999875
Q ss_pred eEEEEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
..++||||+++|+|.+++... ..+++..+..++.||+.||.|||++|||||||||+|||++.++++||+|||+|+....
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 467888999999999888664 5799999999999999999999999999999999999999999999999999987643
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 348 (373)
..... ......||+.|+|||++.++.|+.++|||||||++|
T Consensus 164 ~~~~~---------------------------------------~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~ 204 (317)
T d1xkka_ 164 EEKEY---------------------------------------HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVW 204 (317)
T ss_dssp TCC-----------------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred ccccc---------------------------------------cccccccCccccChHHHhcCCCChhhhhhhHHHHHH
Confidence 32110 011357999999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 349 EMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 349 ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
||+| |.+||.+.+..+....|.++
T Consensus 205 el~t~g~~p~~~~~~~~~~~~i~~~ 229 (317)
T d1xkka_ 205 ELMTFGSKPYDGIPASEISSILEKG 229 (317)
T ss_dssp HHHTTSCCTTTTSCGGGHHHHHHHT
T ss_pred HHHHCCCCCCCCCCHHHHHHHHHcC
Confidence 9998 89999999888888777654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-49 Score=368.13 Aligned_cols=224 Identities=23% Similarity=0.375 Sum_probs=193.0
Q ss_pred hhhccCCCCCcceeceeeeeCcEEEEEEEEc-----CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEe
Q 017362 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLY 182 (373)
Q Consensus 108 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~ 182 (373)
+...++..++|++++.||+|+||+||+|+.+ .++..||||++.... .......+.+|+.+++.++||||++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~ 82 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLL 82 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccce
Confidence 3445677889999999999999999999875 356789999987543 233456789999999999999999999
Q ss_pred eEEEeCCeEEEEEeccCCCCHHHHHhhCC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 017362 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRKD------------------------TLTEDEARFYVAETVLAIESIHKHHYI 238 (373)
Q Consensus 183 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~------------------------~l~~~~~~~i~~qi~~aL~~LH~~gii 238 (373)
+++.+.+.+++||||+++|+|.+++.... .+++..+..++.|++.||.|||++++|
T Consensus 83 ~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iv 162 (301)
T d1lufa_ 83 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV 162 (301)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeE
Confidence 99999999999999999999999996432 388999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccc
Q 017362 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTV 318 (373)
Q Consensus 239 HrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (373)
||||||+|||++.++++||+|||+|+.+...... ....+..
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~---------------------------------------~~~~~~~ 203 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYY---------------------------------------KADGNDA 203 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB---------------------------------------C----CC
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccc---------------------------------------cccCCCC
Confidence 9999999999999999999999999765422111 0112467
Q ss_pred cCCCCcccccccCCCCChhhcHHHHHHHHHHHHhC-CCCCCCCChHHHHHHhhcC
Q 017362 319 GTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG-YPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 319 gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G-~~Pf~~~~~~~~~~kI~~~ 372 (373)
||+.|+|||++.+..|+.++|||||||++|||++| .+||.+.++.+...+|.++
T Consensus 204 ~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~ 258 (301)
T d1lufa_ 204 IPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG 258 (301)
T ss_dssp BCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT
T ss_pred cCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcC
Confidence 99999999999999999999999999999999998 5899999999999998876
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-50 Score=366.35 Aligned_cols=203 Identities=29% Similarity=0.461 Sum_probs=176.2
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhh---HHHHHHHHHHHHhcC--CCceeEEeeEEEeCC
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ---VEHVRAERNLLAEVD--SNCIVKLYCSFQDDE 189 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~---~~~~~~e~~~l~~l~--h~~iv~l~~~~~~~~ 189 (373)
.++|++.+.||+|+||+||+|.+..+|+.||||++.+........ ...+.+|+.+++.++ |||||+++++|.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 468999999999999999999999999999999997654322211 223567999999886 899999999999999
Q ss_pred eEEEEEeccCC-CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCC-CcEEEeeccccccCC
Q 017362 190 FLYLIMEYLPG-GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY-GHLRLSDFGLCKPLD 267 (373)
Q Consensus 190 ~~~lV~E~~~g-g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~-~~vkL~DFGla~~~~ 267 (373)
.+|+||||+.+ +++.+++.....+++..++.++.||+.||.|||++|||||||||+|||++.+ +.+||+|||+|+...
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 99999999976 6888888888899999999999999999999999999999999999999854 799999999997643
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCC-ChhhcHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAI 346 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DvwSlGvi 346 (373)
... ..+.+||+.|+|||++.+..+ +.++|||||||+
T Consensus 163 ~~~-------------------------------------------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvi 199 (273)
T d1xwsa_ 163 DTV-------------------------------------------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 199 (273)
T ss_dssp SSC-------------------------------------------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHH
T ss_pred ccc-------------------------------------------ccccccCCCcCCHHHHcCCCCCCcccccccceee
Confidence 221 125689999999999987765 678999999999
Q ss_pred HHHHHhCCCCCCCC
Q 017362 347 MYEMLVGYPPFYSD 360 (373)
Q Consensus 347 l~ell~G~~Pf~~~ 360 (373)
+|||++|++||.+.
T Consensus 200 lyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 200 LYDMVCGDIPFEHD 213 (273)
T ss_dssp HHHHHHSSCSCCSH
T ss_pred ehhHhhCCCCCCCc
Confidence 99999999999753
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-49 Score=363.46 Aligned_cols=217 Identities=22% Similarity=0.383 Sum_probs=181.9
Q ss_pred hccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC
Q 017362 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 110 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 189 (373)
.+++..++|++.+.||+|+||+||+|.++.+ ..||||++.... ...+.+.+|+.+++.++|||||++++++.+ +
T Consensus 11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~----~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~ 84 (285)
T d1fmka3 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 84 (285)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc----CCHHHHHHHHHHHHhcccCCEeEEEEEEec-C
Confidence 4567778999999999999999999998655 579999997543 223568899999999999999999999865 5
Q ss_pred eEEEEEeccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
.+|+||||+++|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.++++||+|||+|+...
T Consensus 85 ~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 164 (285)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhcc
Confidence 57899999999999988864 3579999999999999999999999999999999999999999999999999998654
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 347 (373)
..... ......||+.|+|||++..+.++.++|||||||++
T Consensus 165 ~~~~~----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil 204 (285)
T d1fmka3 165 DNEYT----------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 204 (285)
T ss_dssp ---------------------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCCce----------------------------------------eeccccccccccChHHHhCCCCCcHHhhhcchHHH
Confidence 22111 01145799999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 348 YEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 348 ~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|||++ |.+||.+.+..+...+|.++
T Consensus 205 ~el~t~~~p~~~~~~~~~~~~~i~~~ 230 (285)
T d1fmka3 205 TELTTKGRVPYPGMVNREVLDQVERG 230 (285)
T ss_dssp HHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHhc
Confidence 99999 57777788888888887754
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=366.87 Aligned_cols=214 Identities=26% Similarity=0.419 Sum_probs=178.7
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCC-CceEeeeecchhHhhhhhhHHHHHHHHHHHHhc---CCCceeEEeeEEEe---
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTT-GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV---DSNCIVKLYCSFQD--- 187 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~l~~~~~~--- 187 (373)
.++|++++.||+|+||+||+|.+..+ ++.||||++...... ......+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 47899999999999999999999655 678999998754322 22222355677766555 79999999999863
Q ss_pred --CCeEEEEEeccCCCCHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccc
Q 017362 188 --DEFLYLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (373)
Q Consensus 188 --~~~~~lV~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~ 264 (373)
...+|+||||++++++..... ....+++..++.++.|++.||+|||++|||||||||+|||++.++.+||+|||+++
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 346899999998877654443 34579999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHH
Q 017362 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344 (373)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG 344 (373)
....... ....+||+.|+|||++.+..|+.++||||||
T Consensus 165 ~~~~~~~------------------------------------------~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG 202 (305)
T d1blxa_ 165 IYSFQMA------------------------------------------LTSVVVTLWYRAPEVLLQSSYATPVDLWSVG 202 (305)
T ss_dssp CCCGGGG------------------------------------------GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHH
T ss_pred hhccccc------------------------------------------CCCcccChhhcCcchhcCCCCChhehhhchH
Confidence 5432211 1256899999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHhhc
Q 017362 345 AIMYEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 345 vil~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
|++|||++|++||.+.++.++..+|++
T Consensus 203 ~il~ell~g~~pf~~~~~~~~~~~i~~ 229 (305)
T d1blxa_ 203 CIFAEMFRRKPLFRGSSDVDQLGKILD 229 (305)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred HHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 999999999999999999999888764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.1e-49 Score=362.82 Aligned_cols=212 Identities=28% Similarity=0.450 Sum_probs=184.5
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|+++++||+|+||+||+|.++ +|+.||||++..... .....+.+.+|+.+|+.++|||||+++++|.+.+..|+||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 68999999999999999999985 789999999976532 3344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
||+.++++..+....+.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|.........
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~--- 156 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--- 156 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccc---
Confidence 99988877777777888999999999999999999999999999999999999999999999999999765432111
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHHHHHHHHHHHhCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~ 354 (373)
....+||+.|+|||++.+. .++.++|||||||++|||++|+
T Consensus 157 --------------------------------------~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~ 198 (286)
T d1ob3a_ 157 --------------------------------------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198 (286)
T ss_dssp -------------------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred --------------------------------------cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCC
Confidence 1145799999999999764 4699999999999999999999
Q ss_pred CCCCCCChHHHHHHhh
Q 017362 355 PPFYSDDPMSTCRKVR 370 (373)
Q Consensus 355 ~Pf~~~~~~~~~~kI~ 370 (373)
+||.+.+..+.+.+|.
T Consensus 199 ~pf~~~~~~~~~~~i~ 214 (286)
T d1ob3a_ 199 PLFPGVSEADQLMRIF 214 (286)
T ss_dssp CSCCCSSHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHH
Confidence 9999999888887765
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=361.63 Aligned_cols=221 Identities=23% Similarity=0.404 Sum_probs=179.2
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcC-CC--ceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKT-TG--HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~--~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 189 (373)
+..++|++++.||+|+||+||+|.... ++ ..||||++.+.........+.+.+|+.+|+.++|||||++++++.+ +
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 456789999999999999999998643 33 3689999987665556666789999999999999999999999976 4
Q ss_pred eEEEEEeccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
.+|+||||+++|+|.+.+.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 67899999999999988765 45799999999999999999999999999999999999999999999999999987654
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 348 (373)
..... .......||+.|+|||++.+..++.++|||||||++|
T Consensus 164 ~~~~~--------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~ 205 (273)
T d1u46a_ 164 NDDHY--------------------------------------VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLW 205 (273)
T ss_dssp -CCEE--------------------------------------EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred CCCcc--------------------------------------eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHH
Confidence 32111 0111356888999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 349 EMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 349 ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
||++ |.+||.+.+..++..+|.+.
T Consensus 206 emlt~G~~Pf~~~~~~~~~~~i~~~ 230 (273)
T d1u46a_ 206 EMFTYGQEPWIGLNGSQILHKIDKE 230 (273)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHHHTS
T ss_pred HHHhCCCCCCCCcCHHHHHHHHHhC
Confidence 9998 89999999999999988754
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=361.02 Aligned_cols=219 Identities=23% Similarity=0.350 Sum_probs=172.0
Q ss_pred hccCCCCCcceeceeeeeCcEEEEEEEEcC-----CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEee
Q 017362 110 RHKMGADDFELLTMIGKGAFGEVRVCREKT-----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYC 183 (373)
Q Consensus 110 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~ 183 (373)
++++..++|++++.||+|+||+||+|.+.. +++.||||++..... ......+..|..++.++ +|+||+.+++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 345667899999999999999999998754 346899999875432 23345577777777776 6889999999
Q ss_pred EEEeC-CeEEEEEeccCCCCHHHHHhhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCC
Q 017362 184 SFQDD-EFLYLIMEYLPGGDMMTLLMRK----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDN 246 (373)
Q Consensus 184 ~~~~~-~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~N 246 (373)
++... ..+|+|||||++|+|.+++... ..+++..+..++.||+.||.|||++|||||||||+|
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~N 164 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 164 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccc
Confidence 88754 4689999999999999999653 348999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCccc
Q 017362 247 LLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAP 326 (373)
Q Consensus 247 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP 326 (373)
|||+.++++||+|||+|+......... ...+.+||+.|+||
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~~~---------------------------------------~~~~~~gt~~y~AP 205 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPDYV---------------------------------------RKGDARLPLKWMAP 205 (299)
T ss_dssp EEECGGGCEEECC------CCSCTTSC---------------------------------------CTTSCCCGGGGCCH
T ss_pred eeECCCCcEEEccCcchhhcccccccc---------------------------------------ccCceeeCccccch
Confidence 999999999999999998654322110 11246899999999
Q ss_pred ccccCCCCChhhcHHHHHHHHHHHHhC-CCCCCCCChHHHHHHh
Q 017362 327 EVLLKKGYGMECDWWSLGAIMYEMLVG-YPPFYSDDPMSTCRKV 369 (373)
Q Consensus 327 E~~~~~~~~~~~DvwSlGvil~ell~G-~~Pf~~~~~~~~~~kI 369 (373)
|++.+..|+.++|||||||++|||++| .+||.+.+..+.+.++
T Consensus 206 E~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 206 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred hHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999999999999999999999985 6789877655544443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=363.66 Aligned_cols=216 Identities=23% Similarity=0.425 Sum_probs=185.1
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEEcCCCce--EeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEeeEEEeCC
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHV--YAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~ 189 (373)
+..++|++.++||+|+||+||+|.++.++.. ||||.+.... .....+.+.+|+.+|..+ +|||||++++++.+.+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 4568999999999999999999999888764 6777765332 233455689999999998 7999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRK----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG 253 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~ 253 (373)
.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++|||||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999999654 5699999999999999999999999999999999999999999
Q ss_pred cEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC
Q 017362 254 HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG 333 (373)
Q Consensus 254 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~ 333 (373)
.+||+|||+|+....... .....||+.|+|||.+.+..
T Consensus 165 ~~kl~DfG~a~~~~~~~~------------------------------------------~~~~~gt~~y~aPE~l~~~~ 202 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVK------------------------------------------KTMGRLPVRWMAIESLNYSV 202 (309)
T ss_dssp CEEECCTTCEESSCEECC------------------------------------------C----CCTTTCCHHHHHHCE
T ss_pred ceEEcccccccccccccc------------------------------------------ccceecCCcccchHHhccCC
Confidence 999999999976432211 01356999999999999999
Q ss_pred CChhhcHHHHHHHHHHHHhC-CCCCCCCChHHHHHHhhcC
Q 017362 334 YGMECDWWSLGAIMYEMLVG-YPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 334 ~~~~~DvwSlGvil~ell~G-~~Pf~~~~~~~~~~kI~~~ 372 (373)
|+.++|||||||++|||++| .+||.+.+..+.+.+|.++
T Consensus 203 ~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~ 242 (309)
T d1fvra_ 203 YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242 (309)
T ss_dssp ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence 99999999999999999995 5789999999999998875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=355.65 Aligned_cols=211 Identities=25% Similarity=0.449 Sum_probs=180.2
Q ss_pred ccCCCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe-CC
Q 017362 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD-DE 189 (373)
Q Consensus 111 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-~~ 189 (373)
+++..++|++++.||+|+||.||+|.++ |..||||+++... ..+.+.+|+.+++.++||||+++++++.+ .+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 4567789999999999999999999874 7789999997542 34568899999999999999999999865 45
Q ss_pred eEEEEEeccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
.+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+||||||||+|||++.+|++||+|||+++...
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC
Confidence 6899999999999999996543 58999999999999999999999999999999999999999999999999997543
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 347 (373)
... ....+|+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~--------------------------------------------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il 190 (262)
T d1byga_ 155 STQ--------------------------------------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILL 190 (262)
T ss_dssp ---------------------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCC--------------------------------------------ccccccccCCChHHHhCCCCChHHHHHhHHHHH
Confidence 211 134689999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 348 YEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 348 ~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
|||++ |.+||...+..+...+|.++
T Consensus 191 ~el~t~~~~p~~~~~~~~~~~~i~~~ 216 (262)
T d1byga_ 191 WEIYSFGRVPYPRIPLKDVVPRVEKG 216 (262)
T ss_dssp HHHHTTSCCSCTTSCGGGHHHHHTTT
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHcC
Confidence 99998 89999999999999998765
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=361.97 Aligned_cols=218 Identities=26% Similarity=0.374 Sum_probs=183.0
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe-------
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD------- 187 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~------- 187 (373)
.++|+++++||+|+||+||+|.+..+|+.||||++..... .......+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 4789999999999999999999999999999999876543 23345668899999999999999999999865
Q ss_pred -CCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccC
Q 017362 188 -DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (373)
Q Consensus 188 -~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~ 266 (373)
...+|+||||++++++.........+++..++.++.|++.||.|||++|||||||||+|||++.++.+||+|||+|+.+
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 3468999999988877766666778999999999999999999999999999999999999999999999999999766
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHHHHH
Q 017362 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGA 345 (373)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlGv 345 (373)
........ ....+.+||+.|+|||++.+. .|+.++|||||||
T Consensus 168 ~~~~~~~~-------------------------------------~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGv 210 (318)
T d3blha1 168 SLAKNSQP-------------------------------------NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGC 210 (318)
T ss_dssp CC-----C-------------------------------------CCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred cccccccc-------------------------------------ccccceecCHHHhhHHHHcCCCCCCcHHHcccCCc
Confidence 53321110 011256899999999999865 6899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHhh
Q 017362 346 IMYEMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 346 il~ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
++|||++|++||.+.++.+....|.
T Consensus 211 il~el~~g~~pf~~~~~~~~~~~i~ 235 (318)
T d3blha1 211 IMAEMWTRSPIMQGNTEQHQLALIS 235 (318)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred eeeeHhhCCCCCCCCCHHHHHHHHH
Confidence 9999999999999998888877664
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-48 Score=358.23 Aligned_cols=222 Identities=22% Similarity=0.398 Sum_probs=185.8
Q ss_pred hccCCCCCcceeceeeeeCcEEEEEEEEcCCC-------ceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEE
Q 017362 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTG-------HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKL 181 (373)
Q Consensus 110 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l 181 (373)
++.+..++|++++.||+|+||.||+|+...++ ..||||++++.. .......+.+|...+..+ +|||||++
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~ 84 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINL 84 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEec
Confidence 34567789999999999999999999876543 479999997643 233446678888888887 89999999
Q ss_pred eeEEEeCCeEEEEEeccCCCCHHHHHhhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCC
Q 017362 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKD----------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPD 245 (373)
Q Consensus 182 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~ 245 (373)
+++|.+++.+|+|||||++|+|.+++.... .+++..+..++.||+.||.|||++|||||||||+
T Consensus 85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence 999999999999999999999999996542 4899999999999999999999999999999999
Q ss_pred CEEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcc
Q 017362 246 NLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIA 325 (373)
Q Consensus 246 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~a 325 (373)
|||++.++.+||+|||+++......... .....+||+.|+|
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~a 205 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYK---------------------------------------KTTNGRLPVKWMA 205 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTC---------------------------------------CCTTSCCGGGGSC
T ss_pred ceeecCCCCeEeccchhhcccccccccc---------------------------------------ccccCCCChhhhh
Confidence 9999999999999999998664332111 0124679999999
Q ss_pred cccccCCCCChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcC
Q 017362 326 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 326 PE~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~~ 372 (373)
||++.++.|+.++|||||||++|||++ |.+||.+.+..+.+..|.++
T Consensus 206 PE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~ 253 (299)
T d1fgka_ 206 PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 253 (299)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred hhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcC
Confidence 999999999999999999999999998 89999999999988888765
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-48 Score=365.80 Aligned_cols=207 Identities=29% Similarity=0.454 Sum_probs=176.5
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe------CC
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD------DE 189 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~------~~ 189 (373)
-+|+.+++||+|+||+||+|.++.+|+.||||++..... ...+|+.+|+.++||||++++++|.. ..
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence 369999999999999999999999999999999875431 13469999999999999999999854 34
Q ss_pred eEEEEEeccCCCCHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC-cEEEeecccccc
Q 017362 190 FLYLIMEYLPGGDMMTLL---MRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKP 265 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l---~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~-~vkL~DFGla~~ 265 (373)
++|+|||||+++.+..+. .....+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence 589999999776443332 3456799999999999999999999999999999999999999775 899999999986
Q ss_pred CCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHH
Q 017362 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 344 (373)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG 344 (373)
...... ..+.+||+.|+|||++.+ ..|+.++||||||
T Consensus 173 ~~~~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG 210 (350)
T d1q5ka_ 173 LVRGEP------------------------------------------NVSYICSRYYRAPELIFGATDYTSSIDVWSAG 210 (350)
T ss_dssp CCTTSC------------------------------------------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHH
T ss_pred ccCCcc------------------------------------------cccccccccccChHHhhcccCCCcceeecccc
Confidence 543221 125689999999999875 5689999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHhhc
Q 017362 345 AIMYEMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 345 vil~ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
|++|||++|.+||...+..+.+.+|++
T Consensus 211 ~il~el~~g~~pf~~~~~~~~l~~i~~ 237 (350)
T d1q5ka_ 211 CVLAELLLGQPIFPGDSGVDQLVEIIK 237 (350)
T ss_dssp HHHHHHHHTSCSSCCSSHHHHHHHHHH
T ss_pred eEEEehhhCCCCCCCCCHHHHHHHHHH
Confidence 999999999999999999888887753
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=361.53 Aligned_cols=214 Identities=28% Similarity=0.453 Sum_probs=178.5
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC-----
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~----- 189 (373)
.++|++++.||+|+||+||+|.++.+|+.||||++.+.. .....+.+.+|+.+|+.++||||+++++++....
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 467999999999999999999999999999999997543 2344567889999999999999999999997653
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
.+|+| +|+.||+|.+++.. ..+++..++.++.|++.||.|||++|||||||||+|||++.++++||+|||+|+.....
T Consensus 85 ~~~l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 85 DVYLV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp CEEEE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred eEEEE-EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 34555 55669999999865 47999999999999999999999999999999999999999999999999999865433
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC-CCCChhhcHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ 348 (373)
.... ......+||+.|+|||++.. ..|+.++||||+||++|
T Consensus 163 ~~~~--------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ 204 (345)
T d1pmea_ 163 HDHT--------------------------------------GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILA 204 (345)
T ss_dssp GCBC--------------------------------------CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHH
T ss_pred Cccc--------------------------------------eeeccccccceechHHHhhcCCCCCchhhhhccCceeh
Confidence 2110 01125689999999999854 56799999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhh
Q 017362 349 EMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 349 ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
||++|.+||.+.+..++...++
T Consensus 205 eml~g~~pf~~~~~~~~~~~~~ 226 (345)
T d1pmea_ 205 EMLSNRPIFPGKHYLDQLNHIL 226 (345)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHH
T ss_pred HHhhCCCCCCCCCHHHHHHHHh
Confidence 9999999999998877776654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=362.69 Aligned_cols=218 Identities=41% Similarity=0.749 Sum_probs=185.8
Q ss_pred CCCCCcceeceeeeeCcEEEEEEEE---cCCCceEeeeecchhHhhh-hhhHHHHHHHHHHHHhcCC-CceeEEeeEEEe
Q 017362 113 MGADDFELLTMIGKGAFGEVRVCRE---KTTGHVYAMKKLKKSEMLR-RGQVEHVRAERNLLAEVDS-NCIVKLYCSFQD 187 (373)
Q Consensus 113 ~~~~~y~~~~~lG~G~~g~Vy~~~~---~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h-~~iv~l~~~~~~ 187 (373)
+..++|++++.||+|+||+||+|.+ +.+|+.||||++.+..... ....+.+.+|+.++++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 4568899999999999999999987 3478999999987643221 2234567889999999977 899999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCC
Q 017362 188 DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (373)
Q Consensus 188 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~ 267 (373)
...+|+||||+.||+|.+++.....+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+.
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 99999999999999999999998999999999999999999999999999999999999999999999999999998664
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC--CCChhhcHHHHHH
Q 017362 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK--GYGMECDWWSLGA 345 (373)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DvwSlGv 345 (373)
..... ...+..||+.|+|||.+.+. .++.++|||||||
T Consensus 181 ~~~~~----------------------------------------~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~ 220 (322)
T d1vzoa_ 181 ADETE----------------------------------------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGV 220 (322)
T ss_dssp GGGGG----------------------------------------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHH
T ss_pred ccccc----------------------------------------cccccccccccchhHHhhcCCcCCCchhhhHHHHH
Confidence 32111 11256799999999999765 4688999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHhh
Q 017362 346 IMYEMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 346 il~ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
+||||++|.+||.+.+..+....|.
T Consensus 221 iLyelltG~~PF~~~~~~~~~~~i~ 245 (322)
T d1vzoa_ 221 LMYELLTGASPFTVDGEKNSQAEIS 245 (322)
T ss_dssp HHHHHHHSSCTTSCTTSCCCHHHHH
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999998876665555443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=361.31 Aligned_cols=209 Identities=32% Similarity=0.494 Sum_probs=177.5
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC-----
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~----- 189 (373)
.++|++++.||+|+||+||+|.++.+|+.||||++.+.. ......+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 678999999999999999999999999999999997643 23445567889999999999999999999998665
Q ss_pred -eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCC
Q 017362 190 -FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (373)
Q Consensus 190 -~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~ 268 (373)
.+|+||||+ |++|..+. +...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus 96 ~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp CCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence 479999999 66777766 456799999999999999999999999999999999999999999999999999976542
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHHHHHHH
Q 017362 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIM 347 (373)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil 347 (373)
.. ...+||+.|+|||++.+. .++.++|||||||++
T Consensus 174 ~~--------------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil 209 (346)
T d1cm8a_ 174 EM--------------------------------------------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIM 209 (346)
T ss_dssp SC--------------------------------------------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHH
T ss_pred cc--------------------------------------------ccccccccccCHHHHcCCCCCCccchhhcchHHH
Confidence 21 146799999999999874 568999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhh
Q 017362 348 YEMLVGYPPFYSDDPMSTCRKVR 370 (373)
Q Consensus 348 ~ell~G~~Pf~~~~~~~~~~kI~ 370 (373)
|||++|++||.+.+..+...++.
T Consensus 210 ~ell~g~~pf~~~~~~~~~~~~~ 232 (346)
T d1cm8a_ 210 AEMITGKTLFKGSDHLDQLKEIM 232 (346)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHH
T ss_pred HHHHHCcCCCCCCChHHHHHHHH
Confidence 99999999999998877766554
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=355.55 Aligned_cols=221 Identities=24% Similarity=0.346 Sum_probs=189.6
Q ss_pred hccCCCCCcceeceeeeeCcEEEEEEEEc-----CCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhc-CCCceeEEee
Q 017362 110 RHKMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYC 183 (373)
Q Consensus 110 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~ 183 (373)
.+++..++|++.+.||+|+||.||+|.+. .++..||||+++... .......+.+|+.+++.+ +|||||++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 34567789999999999999999999863 456789999997643 233456788999999999 6999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHHhhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCC
Q 017362 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKD------------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPD 245 (373)
Q Consensus 184 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~------------------~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~ 245 (373)
++.+.+.+|+|||||++|+|.+++.... .+++..+..++.||+.||.|||++|+|||||||+
T Consensus 95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~ 174 (311)
T d1t46a_ 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (311)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence 9999999999999999999999997543 5899999999999999999999999999999999
Q ss_pred CEEEcCCCcEEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcc
Q 017362 246 NLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIA 325 (373)
Q Consensus 246 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~a 325 (373)
|||++.++++||+|||+++......... .....+||+.|+|
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~---------------------------------------~~~~~~gt~~y~a 215 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYV---------------------------------------VKGNARLPVKWMA 215 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSE---------------------------------------ECSSSEECGGGCC
T ss_pred cccccccCcccccccchheeccCCCcce---------------------------------------EeeecccChHHcC
Confidence 9999999999999999998664322110 1124689999999
Q ss_pred cccccCCCCChhhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhc
Q 017362 326 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 326 PE~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~~~kI~~ 371 (373)
||++.+..++.++|||||||++|||+| |.+||.+.+..+...++++
T Consensus 216 PE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~ 262 (311)
T d1t46a_ 216 PESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262 (311)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHH
T ss_pred HHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 999999999999999999999999998 7888888877777666654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=354.25 Aligned_cols=222 Identities=17% Similarity=0.278 Sum_probs=192.2
Q ss_pred hccCCCCCcceeceeeeeCcEEEEEEEEcC-----CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeE
Q 017362 110 RHKMGADDFELLTMIGKGAFGEVRVCREKT-----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCS 184 (373)
Q Consensus 110 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~ 184 (373)
.+++..++|++.+.||+|+||+||+|.+.. ++..||||+++... .......+.+|+.+++.++|||||+++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 356778999999999999999999998752 35689999997543 23345678899999999999999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHhhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCc
Q 017362 185 FQDDEFLYLIMEYLPGGDMMTLLMRK----------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH 254 (373)
Q Consensus 185 ~~~~~~~~lV~E~~~gg~L~~~l~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~ 254 (373)
+..++..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.+++
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence 99999999999999999999998642 34789999999999999999999999999999999999999999
Q ss_pred EEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCC
Q 017362 255 LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY 334 (373)
Q Consensus 255 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~ 334 (373)
+||+|||+|+.+....... .....+||+.|+|||.+.+..+
T Consensus 172 ~Kl~DFGla~~~~~~~~~~---------------------------------------~~~~~~~t~~y~aPe~l~~~~~ 212 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYR---------------------------------------KGGKGLLPVRWMSPESLKDGVF 212 (308)
T ss_dssp EEECCTTCCCGGGGGGCEE---------------------------------------GGGSSEECGGGCCHHHHHHCCC
T ss_pred EEEeecccceeccCCccee---------------------------------------eccceecccccCCHHHHccCCC
Confidence 9999999998654321110 1124579999999999999999
Q ss_pred ChhhcHHHHHHHHHHHHhC-CCCCCCCChHHHHHHhhcC
Q 017362 335 GMECDWWSLGAIMYEMLVG-YPPFYSDDPMSTCRKVRKK 372 (373)
Q Consensus 335 ~~~~DvwSlGvil~ell~G-~~Pf~~~~~~~~~~kI~~~ 372 (373)
+.++|||||||++|||+|| .+||.+.+..++...|.++
T Consensus 213 ~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~ 251 (308)
T d1p4oa_ 213 TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 251 (308)
T ss_dssp CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred CcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Confidence 9999999999999999997 6999999999999988775
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-46 Score=348.28 Aligned_cols=208 Identities=21% Similarity=0.275 Sum_probs=176.4
Q ss_pred CCCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCC-CceeEEeeEEEeCCeEE
Q 017362 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS-NCIVKLYCSFQDDEFLY 192 (373)
Q Consensus 114 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~l~~~~~~~~~~~ 192 (373)
..++|++++.||+|+||+||+|.+..+|+.||||++..... ...+.+|+.++..+.| +|++.+++++.+....|
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 77 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 77 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence 35789999999999999999999999999999999865421 2236678888988866 89999999999999999
Q ss_pred EEEeccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC-----CCcEEEeeccccccC
Q 017362 193 LIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-----YGHLRLSDFGLCKPL 266 (373)
Q Consensus 193 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~-----~~~vkL~DFGla~~~ 266 (373)
+||||+ |++|.+++... ..+++..+..++.|++.||.|||++|||||||||+|||++. ++.+||+|||+|+.+
T Consensus 78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 999999 78999988765 47999999999999999999999999999999999999974 578999999999876
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHH
Q 017362 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (373)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvi 346 (373)
......... + .....+.+||+.|||||++.+..++.++|||||||+
T Consensus 157 ~~~~~~~~~----------------~------------------~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~ 202 (293)
T d1csna_ 157 RDPVTKQHI----------------P------------------YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHV 202 (293)
T ss_dssp BCTTTCCBC----------------C------------------CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred ccCccccce----------------e------------------ecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHH
Confidence 433211000 0 001125689999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCC
Q 017362 347 MYEMLVGYPPFYSDD 361 (373)
Q Consensus 347 l~ell~G~~Pf~~~~ 361 (373)
+|||++|.+||.+.+
T Consensus 203 l~elltg~~Pf~~~~ 217 (293)
T d1csna_ 203 FMYFLRGSLPWQGLK 217 (293)
T ss_dssp HHHHHHSSCTTSSCC
T ss_pred HHHHHhCCCcCCCcc
Confidence 999999999998654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=346.53 Aligned_cols=213 Identities=25% Similarity=0.405 Sum_probs=187.5
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCCeEEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lV~ 195 (373)
++|++++.||+|+||+||+|.+..+++.||||+++... ........+.+|+.+++.++||||++++++|.+....++||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 58999999999999999999999999999999997653 23445677899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 196 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
+++.|++|..++...+.+++..++.++.|++.||+|||++|||||||||+|||++.++++||+|||+|+........
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~--- 157 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--- 157 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC---
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc---
Confidence 99999999999888889999999999999999999999999999999999999999999999999999876533211
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC-CChhhcHHHHHHHHHHHHhCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVGY 354 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~ell~G~ 354 (373)
.....+++.|+|||++.... ++.++|||||||++|||++|+
T Consensus 158 --------------------------------------~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~ 199 (292)
T d1unla_ 158 --------------------------------------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 199 (292)
T ss_dssp --------------------------------------CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTS
T ss_pred --------------------------------------ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCC
Confidence 11346888999999998765 699999999999999999988
Q ss_pred CCC-CCCChHHHHHHhh
Q 017362 355 PPF-YSDDPMSTCRKVR 370 (373)
Q Consensus 355 ~Pf-~~~~~~~~~~kI~ 370 (373)
.|| .+.+..+...+|.
T Consensus 200 ~p~~~~~~~~~~~~~~~ 216 (292)
T d1unla_ 200 RPLFPGNDVDDQLKRIF 216 (292)
T ss_dssp CCSCCCSSHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHH
Confidence 875 5566777776654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=357.11 Aligned_cols=210 Identities=28% Similarity=0.418 Sum_probs=174.6
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe------CC
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD------DE 189 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~------~~ 189 (373)
++|+++++||+|+||+||+|.++.+|+.||||++.+.. ........+.+|+.+++.++|||||+++++|.. ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh-cCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 68999999999999999999999999999999997653 234445678899999999999999999999964 36
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
.+|+|||||.++ +...+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++.....
T Consensus 96 ~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence 889999999665 44554 346999999999999999999999999999999999999999999999999998754322
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 349 (373)
.. ....+||+.|+|||++.+..++.++||||+||++||
T Consensus 173 ~~------------------------------------------~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~e 210 (355)
T d2b1pa1 173 FM------------------------------------------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210 (355)
T ss_dssp --------------------------------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred cc------------------------------------------cccccccccccChhhhcCCCCCCCcccccccchHHH
Confidence 10 114579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhc
Q 017362 350 MLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 350 ll~G~~Pf~~~~~~~~~~kI~~ 371 (373)
|++|++||.+.+......+|+.
T Consensus 211 ll~g~~pF~~~~~~~~~~~i~~ 232 (355)
T d2b1pa1 211 MVRHKILFPGRDYIDQWNKVIE 232 (355)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHH
T ss_pred HhhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999998888887753
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.8e-46 Score=344.95 Aligned_cols=212 Identities=21% Similarity=0.305 Sum_probs=170.0
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCc-eeEEeeEEEeCCeEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC-IVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~l~~~~~~~~~~~lV 194 (373)
++|++++.||+|+||+||+|.+..+|+.||||++..... ...+..|+.+++.++|++ |+.+..++.+.+..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 579999999999999999999999999999999875421 223678999999998765 55556667888899999
Q ss_pred EeccCCCCHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC---CCcEEEeeccccccCCCCC
Q 017362 195 MEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---YGHLRLSDFGLCKPLDCST 270 (373)
Q Consensus 195 ~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~---~~~vkL~DFGla~~~~~~~ 270 (373)
|||+ +++|...+. ....+++..+..++.|++.||.|||++|||||||||+|||++. +..+||+|||+|+.+....
T Consensus 82 me~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 9999 556655554 4568999999999999999999999999999999999999864 5579999999998765332
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 350 (373)
..... ......+.+||+.|||||++.+..|+.++|||||||++|||
T Consensus 161 ~~~~~----------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el 206 (299)
T d1ckia_ 161 THQHI----------------------------------PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYF 206 (299)
T ss_dssp TCCBC----------------------------------CCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHH
T ss_pred cccce----------------------------------eccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHH
Confidence 11100 00012256899999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHH
Q 017362 351 LVGYPPFYSDDPMSTCR 367 (373)
Q Consensus 351 l~G~~Pf~~~~~~~~~~ 367 (373)
++|.+||...+..+...
T Consensus 207 ~tg~~P~~~~~~~~~~~ 223 (299)
T d1ckia_ 207 NLGSLPWQGLKAATKRQ 223 (299)
T ss_dssp HHSSCTTCCCC------
T ss_pred HhCCCcccccchHHHHH
Confidence 99999998766554443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.9e-46 Score=348.81 Aligned_cols=196 Identities=28% Similarity=0.475 Sum_probs=171.5
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-CCceeEEeeEEEe--CCeE
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQD--DEFL 191 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~--~~~~ 191 (373)
.++|+++++||+|+||+||+|+++.+|+.||||+++... .+.+.+|+.+|..+. ||||++++++|.. ...+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 568999999999999999999999999999999987542 345788999999995 9999999999984 4569
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC-cEEEeeccccccCCCCC
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPLDCST 270 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~-~vkL~DFGla~~~~~~~ 270 (373)
|+|||||++++|..+. ..+++..++.++.||+.||.|||++|||||||||+|||++.++ .+||+|||+|+......
T Consensus 108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred eEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 9999999999997664 4699999999999999999999999999999999999998655 69999999998654321
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCC-CCChhhcHHHHHHHHHH
Q 017362 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYE 349 (373)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~e 349 (373)
. ....+||+.|+|||++.+. .|+.++|||||||++||
T Consensus 185 ~------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e 222 (328)
T d3bqca1 185 E------------------------------------------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 222 (328)
T ss_dssp C------------------------------------------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred c------------------------------------------ccccccCccccCcccccCCCCCCcccchhhhhhhhHH
Confidence 1 1146799999999998875 47999999999999999
Q ss_pred HHhCCCCCCCCC
Q 017362 350 MLVGYPPFYSDD 361 (373)
Q Consensus 350 ll~G~~Pf~~~~ 361 (373)
|++|..||....
T Consensus 223 ~~~g~~pf~~~~ 234 (328)
T d3bqca1 223 MIFRKEPFFHGH 234 (328)
T ss_dssp HHHTCSSSSCCS
T ss_pred hccCCCCCCCCc
Confidence 999999998654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=354.61 Aligned_cols=211 Identities=28% Similarity=0.436 Sum_probs=179.6
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeC-----C
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD-----E 189 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-----~ 189 (373)
.++|++++.||+|+||+||+|.+..+|+.||||++.+.. ......+.+.+|+.+|+.++|||||+++++|... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 478999999999999999999999999999999997653 2333456788999999999999999999999643 2
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCC
Q 017362 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (373)
Q Consensus 190 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 269 (373)
..++||+|+.||+|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|++|||+|......
T Consensus 96 ~~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~ 174 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174 (348)
T ss_dssp CCCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG
T ss_pred ceEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcc
Confidence 3456667778999999884 457999999999999999999999999999999999999999999999999998754321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC-CChhhcHHHHHHHHH
Q 017362 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMY 348 (373)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~ 348 (373)
..+..||+.|+|||++.+.. ++.++|||||||++|
T Consensus 175 --------------------------------------------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~ 210 (348)
T d2gfsa1 175 --------------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 210 (348)
T ss_dssp --------------------------------------------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHH
T ss_pred --------------------------------------------cccccccccccCchhhcCCccCCcccchhhhhHHHH
Confidence 11467999999999987765 689999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhc
Q 017362 349 EMLVGYPPFYSDDPMSTCRKVRK 371 (373)
Q Consensus 349 ell~G~~Pf~~~~~~~~~~kI~~ 371 (373)
+|++|.+||.+.+......+|++
T Consensus 211 ~ll~g~~pF~~~~~~~~~~~i~~ 233 (348)
T d2gfsa1 211 ELLTGRTLFPGTDHIDQLKLILR 233 (348)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999999999999988888764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=341.30 Aligned_cols=213 Identities=17% Similarity=0.301 Sum_probs=172.2
Q ss_pred eceeeeeCcEEEEEEEEcCCC---ceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEe-CCeEEEEEe
Q 017362 121 LTMIGKGAFGEVRVCREKTTG---HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD-DEFLYLIME 196 (373)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-~~~~~lV~E 196 (373)
.++||+|+||+||+|.+..++ ..||||++... ......+.+.+|+.+|++++||||+++++++.+ +..+|+|||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 578999999999999986543 36899998642 234456779999999999999999999999875 568999999
Q ss_pred ccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccccccCCCCCccccc
Q 017362 197 YLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (373)
Q Consensus 197 ~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 275 (373)
||++|+|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++..........
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~- 188 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV- 188 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT-
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc-
Confidence 99999999988754 4678889999999999999999999999999999999999999999999999987653321110
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCCCChhhcHHHHHHHHHHHHhCCC
Q 017362 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (373)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 355 (373)
.......||+.|+|||++....++.++|||||||++|||++|..
T Consensus 189 ------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~ 232 (311)
T d1r0pa_ 189 ------------------------------------HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 232 (311)
T ss_dssp ------------------------------------TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred ------------------------------------eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCC
Confidence 00113579999999999999999999999999999999999655
Q ss_pred CCC-CCChHHHHHHhhcC
Q 017362 356 PFY-SDDPMSTCRKVRKK 372 (373)
Q Consensus 356 Pf~-~~~~~~~~~kI~~~ 372 (373)
||. ..+..+....|.++
T Consensus 233 p~~~~~~~~~~~~~i~~g 250 (311)
T d1r0pa_ 233 PPYPDVNTFDITVYLLQG 250 (311)
T ss_dssp CSCC------CHHHHHTT
T ss_pred CCCCCCCHHHHHHHHHcC
Confidence 555 44566666666654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=341.79 Aligned_cols=200 Identities=26% Similarity=0.316 Sum_probs=162.8
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCCCceeEEeeEEEeCC----eE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----FL 191 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~----~~ 191 (373)
.+|.+.+.||+|+||+||+|+. +|+.||||++..... .......|+..+..++|||||++++++.+.+ .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 4688999999999999999985 588999999875431 1112223444556789999999999998654 58
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHh--------CCCeeecCCCCCEEEcCCCcEEEeecccc
Q 017362 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK--------HHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (373)
Q Consensus 192 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~--------~giiHrDikp~NILl~~~~~vkL~DFGla 263 (373)
|+|||||++|+|.+++.+. .+++..+..++.+++.||.|||+ +|||||||||+||||+.++++||+|||+|
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 9999999999999999664 69999999999999999999996 59999999999999999999999999999
Q ss_pred ccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccCCC------CChh
Q 017362 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG------YGME 337 (373)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~------~~~~ 337 (373)
+.......... ......+||+.|+|||++.+.. ++.+
T Consensus 156 ~~~~~~~~~~~-------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k 198 (303)
T d1vjya_ 156 VRHDSATDTID-------------------------------------IAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 198 (303)
T ss_dssp EEEETTTTEEC-------------------------------------C----CCSCGGGCCHHHHTTCSCTTCHHHHHH
T ss_pred ccccCCCccee-------------------------------------ccccceecccCcCChhhccccccccCCCcCcc
Confidence 87643321110 0011468999999999987643 6789
Q ss_pred hcHHHHHHHHHHHHhCCCCCCC
Q 017362 338 CDWWSLGAIMYEMLVGYPPFYS 359 (373)
Q Consensus 338 ~DvwSlGvil~ell~G~~Pf~~ 359 (373)
+|||||||+||||++|.+||..
T Consensus 199 ~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 199 ADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp HHHHHHHHHHHHHHHTBCBTTB
T ss_pred hhhhhhHHHHHHHhhCCCCCCc
Confidence 9999999999999999988853
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-39 Score=307.42 Aligned_cols=199 Identities=24% Similarity=0.415 Sum_probs=161.7
Q ss_pred CCCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-----------CCceeEEee
Q 017362 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-----------SNCIVKLYC 183 (373)
Q Consensus 115 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~l~~ 183 (373)
.++|+++++||+|+||+||+|+++.+|+.||||++++... ..+.+.+|+.+++.+. |+||+++++
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~ 87 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 87 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence 4569999999999999999999999999999999986542 2244667777777664 578999998
Q ss_pred EEEe--CCeEEEEEeccCCCCHHHH-H--hhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCCEEEcCCCc---
Q 017362 184 SFQD--DEFLYLIMEYLPGGDMMTL-L--MRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGH--- 254 (373)
Q Consensus 184 ~~~~--~~~~~lV~E~~~gg~L~~~-l--~~~~~l~~~~~~~i~~qi~~aL~~LH~-~giiHrDikp~NILl~~~~~--- 254 (373)
++.. ....++||+++..+..... . .....+++..++.++.|++.||.|||+ +||+||||||+|||++.++.
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred EeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccc
Confidence 8764 4567777777765543322 2 234579999999999999999999998 89999999999999987654
Q ss_pred ---EEEeeccccccCCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhhhccccccccCCCCcccccccC
Q 017362 255 ---LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK 331 (373)
Q Consensus 255 ---vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 331 (373)
++|+|||.|....... ...+||+.|+|||++..
T Consensus 168 ~~~~kl~dfg~s~~~~~~~--------------------------------------------~~~~gt~~y~aPE~~~~ 203 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEHY--------------------------------------------TNSIQTREYRSPEVLLG 203 (362)
T ss_dssp EEEEEECCCTTCEETTBCC--------------------------------------------CSCCSCGGGCCHHHHHT
T ss_pred cceeeEeeccccccccccc--------------------------------------------ccccccccccChhhccc
Confidence 9999999987543221 14689999999999999
Q ss_pred CCCChhhcHHHHHHHHHHHHhCCCCCCCCC
Q 017362 332 KGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361 (373)
Q Consensus 332 ~~~~~~~DvwSlGvil~ell~G~~Pf~~~~ 361 (373)
..|+.++|+|||||++++|++|++||...+
T Consensus 204 ~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 204 APWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred cCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 999999999999999999999999998654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=9e-28 Score=206.86 Aligned_cols=137 Identities=14% Similarity=0.161 Sum_probs=106.8
Q ss_pred cceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhh---------------hhhhHHHHHHHHHHHHhcCCCceeEEe
Q 017362 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML---------------RRGQVEHVRAERNLLAEVDSNCIVKLY 182 (373)
Q Consensus 118 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---------------~~~~~~~~~~e~~~l~~l~h~~iv~l~ 182 (373)
+.+.++||+|+||+||+|.+. +|+.||||+++..... ..........|...+..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 457899999999999999874 6889999987542110 011123345678889999999999887
Q ss_pred eEEEeCCeEEEEEeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCcEEEeeccc
Q 017362 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (373)
Q Consensus 183 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiHrDikp~NILl~~~~~vkL~DFGl 262 (373)
+... .++||||+++..+.. +++..+..++.|++.+|.|||++||+||||||+|||++.+ .++|+|||+
T Consensus 81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred EecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 6532 369999998865532 4555677899999999999999999999999999999964 589999999
Q ss_pred cccCC
Q 017362 263 CKPLD 267 (373)
Q Consensus 263 a~~~~ 267 (373)
|....
T Consensus 149 a~~~~ 153 (191)
T d1zara2 149 SVEVG 153 (191)
T ss_dssp CEETT
T ss_pred cccCC
Confidence 97654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.74 E-value=2.9e-08 Score=87.17 Aligned_cols=140 Identities=11% Similarity=0.053 Sum_probs=91.1
Q ss_pred CCcceeceeeeeCcEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-CCceeEEeeEEEeCCeEEEE
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYLI 194 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~lV 194 (373)
..|+..+..+.++.+.||+.. .++..+.+|+....... ....+.+|...+..+. +--+++++.++.+++..|+|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~---~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc---chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 356666665556667899875 45667788887654321 2233566777776663 44467788888888999999
Q ss_pred EeccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 017362 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK---------------------------------------- 234 (373)
Q Consensus 195 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---------------------------------------- 234 (373)
|++++|.++....... .. ...++.++...+..||+
T Consensus 89 ~~~l~G~~~~~~~~~~--~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDE--QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHTTTC--SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred EEeccccccccccccc--cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 9999998776543211 11 11122223333333331
Q ss_pred -------------------CCCeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 235 -------------------HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 235 -------------------~giiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
..++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1278999999999999876667999998864
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.33 E-value=6.3e-07 Score=83.56 Aligned_cols=81 Identities=17% Similarity=0.215 Sum_probs=48.8
Q ss_pred eceeeeeCcEEEEEEEEcCCCceEeeeecchhHhh----hhhhHHHHHHHHHHHHhcC-C--CceeEEeeEEEeCCeEEE
Q 017362 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML----RRGQVEHVRAERNLLAEVD-S--NCIVKLYCSFQDDEFLYL 193 (373)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~~e~~~l~~l~-h--~~iv~l~~~~~~~~~~~l 193 (373)
.+.||.|....||++.+..+++.++||.-...... -.....+...|...|..+. + ..+++++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 56789999999999987777888999964321100 0112334556777776552 2 345555543 4455679
Q ss_pred EEeccCCCCH
Q 017362 194 IMEYLPGGDM 203 (373)
Q Consensus 194 V~E~~~gg~L 203 (373)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999977543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.10 E-value=3.5e-06 Score=72.99 Aligned_cols=134 Identities=12% Similarity=0.071 Sum_probs=79.1
Q ss_pred eeeC-cEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCC--CceeEEeeEEEeCCeEEEEEeccCCC
Q 017362 125 GKGA-FGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS--NCIVKLYCSFQDDEFLYLIMEYLPGG 201 (373)
Q Consensus 125 G~G~-~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~l~~~~~~~~~~~lV~E~~~gg 201 (373)
..|. -+.||+... .++..+.+|...... ...+..|...+..+.. -.+++++....+++..|+||++++|.
T Consensus 19 ~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 19 TIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp SCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred CCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 4444 367898764 456678888765432 1225567776665532 33677788888888899999999886
Q ss_pred CHHHH--------------Hhh---C----CCCC--HHHHH-----HH---------------HHHHHHHHHHHHhC---
Q 017362 202 DMMTL--------------LMR---K----DTLT--EDEAR-----FY---------------VAETVLAIESIHKH--- 235 (373)
Q Consensus 202 ~L~~~--------------l~~---~----~~l~--~~~~~-----~i---------------~~qi~~aL~~LH~~--- 235 (373)
++... +.+ . ..+. ..... .+ .......+..+...
T Consensus 92 ~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 171 (255)
T d1nd4a_ 92 DLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD 171 (255)
T ss_dssp ETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCS
T ss_pred ccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCc
Confidence 54321 100 0 0000 00000 00 00011123333321
Q ss_pred ----CCeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 236 ----HYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 236 ----giiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
.++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 172 ~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 172 GEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp SCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 379999999999999876678999998864
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.61 E-value=7e-05 Score=67.34 Aligned_cols=130 Identities=11% Similarity=0.191 Sum_probs=72.2
Q ss_pred cEEEEEEEEcCCCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcCC---CceeE--E--eeEEEeCCeEEEEEeccCCC
Q 017362 129 FGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS---NCIVK--L--YCSFQDDEFLYLIMEYLPGG 201 (373)
Q Consensus 129 ~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~--l--~~~~~~~~~~~lV~E~~~gg 201 (373)
--.||++.. .+|..|++|+.+... ...+.+..|...+..+.. |-... . -..+......+.|+++++|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~----~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCC----CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 357998864 578889999986531 122345667777766532 21111 1 12334566788999999773
Q ss_pred CHH-----HH---------Hhh----C-----CC-------------------CCHHHHHHHHHHHHHHHHHHHh-----
Q 017362 202 DMM-----TL---------LMR----K-----DT-------------------LTEDEARFYVAETVLAIESIHK----- 234 (373)
Q Consensus 202 ~L~-----~~---------l~~----~-----~~-------------------l~~~~~~~i~~qi~~aL~~LH~----- 234 (373)
.+. .+ ++. . .. ++......+...+-..+..+..
T Consensus 110 ~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~ 189 (325)
T d1zyla1 110 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED 189 (325)
T ss_dssp ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhcccc
Confidence 211 11 110 0 01 1111111222222223333321
Q ss_pred --CCCeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 235 --HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 235 --~giiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
.++||+|+.|+|||++. + ..++||+-|..
T Consensus 190 ~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 190 FTVLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp SCCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred CCceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 36899999999999974 3 45899999874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.06 E-value=0.00063 Score=62.55 Aligned_cols=78 Identities=18% Similarity=0.290 Sum_probs=48.6
Q ss_pred CCcceeceeeeeCcEEEEEEEEcC-------CCceEeeeecchhHhhhhhhHHHHHHHHHHHHhcC-CCceeEEeeEEEe
Q 017362 116 DDFELLTMIGKGAFGEVRVCREKT-------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQD 187 (373)
Q Consensus 116 ~~y~~~~~lG~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~ 187 (373)
+++++ +.|+.|-.=.+|++.... ....|.+++.... ... ....+|..+++.+. +.-.+++++++.+
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~----~~~-idr~~E~~i~~~ls~~gl~Pkll~~~~~ 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETE-SHLVAESVIFTLLSERHLGPKLYGIFSG 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCH-HHHHHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc----chh-hHHHHHHHHHHHHHhCCCCCeEEEEcCC
Confidence 34444 567888889999987643 2345777765421 111 23456777777764 4444567776643
Q ss_pred CCeEEEEEeccCCCCH
Q 017362 188 DEFLYLIMEYLPGGDM 203 (373)
Q Consensus 188 ~~~~~lV~E~~~gg~L 203 (373)
.+||||++|..|
T Consensus 117 ----g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ----GRLEEYIPSRPL 128 (395)
T ss_dssp ----EEEECCCCEEEC
T ss_pred ----ceEEEEeccccC
Confidence 489999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.00 E-value=0.0019 Score=57.05 Aligned_cols=31 Identities=26% Similarity=0.210 Sum_probs=27.6
Q ss_pred CCCeeecCCCCCEEEcCCCcEEEeecccccc
Q 017362 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (373)
Q Consensus 235 ~giiHrDikp~NILl~~~~~vkL~DFGla~~ 265 (373)
.|+||+|+.++||+++.+..+-|.||+.|..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4799999999999999887778999999853
|